Citrus Sinensis ID: 037905
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 606 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LP77 | 655 | Probable inactive recepto | yes | no | 0.955 | 0.883 | 0.581 | 0.0 | |
| Q9LVI6 | 647 | Probable inactive recepto | no | no | 0.960 | 0.899 | 0.596 | 0.0 | |
| Q9FMD7 | 625 | Probable inactive recepto | no | no | 0.973 | 0.944 | 0.585 | 0.0 | |
| Q9M8T0 | 627 | Probable inactive recepto | no | no | 0.948 | 0.917 | 0.592 | 0.0 | |
| O48788 | 658 | Probable inactive recepto | no | no | 0.955 | 0.879 | 0.506 | 1e-154 | |
| Q9LVM0 | 654 | Probable inactive recepto | no | no | 0.924 | 0.856 | 0.469 | 1e-139 | |
| Q9C9Y8 | 640 | Probable inactive recepto | no | no | 0.919 | 0.870 | 0.460 | 1e-135 | |
| Q9FHK7 | 640 | Probable leucine-rich rep | no | no | 0.927 | 0.878 | 0.450 | 1e-129 | |
| Q9M9C5 | 670 | Probable leucine-rich rep | no | no | 0.902 | 0.816 | 0.458 | 1e-126 | |
| Q9SUQ3 | 638 | Probable inactive recepto | no | no | 0.932 | 0.885 | 0.439 | 1e-124 |
| >sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 702 bits (1811), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/619 (58%), Positives = 451/619 (72%), Gaps = 40/619 (6%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTD-GPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAI 59
L +DR ALL+LR A+GGRT WN+ PC W GV C RVT LR PG+ LSG +P I
Sbjct: 33 LNADRTALLSLRSAVGGRTFRWNIKQTSPCNWAGVKCESNRVTALRLPGVALSGDIPEGI 92
Query: 60 -GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
GNLT+L T+SLR NAL G++P D + SNLR+LYLQGN FSGEIP +LFSL +L+RLNL
Sbjct: 93 FGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLNL 152
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
A N+F+G IS+ F LT+L TL+L+ NQL+GSIPDL L QFNVS N LNGSIPK
Sbjct: 153 ASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDL--PLVQFNVSNNSLNGSIPKNL 210
Query: 179 ARLPSSAFEGNSLCGKPLVSC-----------NGG--------GDDDDDDGSNLSGGAIA 219
R S +F SLCGKPL C +GG G ++ + LSGGAIA
Sbjct: 211 QRFESDSFLQTSLCGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLSGGAIA 270
Query: 220 GIVIGSVIGLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDG 279
GIVIG V+G +I+++L+ LCR+K +++ + D++ T KQ E EIP +K A D
Sbjct: 271 GIVIGCVVGFALIVLILMVLCRKKSNKRSRAVDIS-------TIKQQEPEIPGDKEAVDN 323
Query: 280 ENTSS-------DLSGVVKG-ESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFG 331
N S ++G K E G K LVFFG + FDLEDLLRASAEVLGKGTFG
Sbjct: 324 GNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFG 383
Query: 332 TAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391
TAYKA L+ VVAVKRLKDV +++KEF+EK+E+VG+MDHENLVPLRAYY+SRDEKLLV+
Sbjct: 384 TAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVY 443
Query: 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNIL 451
D+MPMGSLSALLHGNRGAGR+PLNW+ RS +A+GA+R + YLHS+G + SHGNIKSSNIL
Sbjct: 444 DFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQGTSTSHGNIKSSNIL 503
Query: 452 LSKSYEARISDFGLAHLASPSST-PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT 510
L+KS++A++SDFGLA L S+T PNR GYRAPEVTD ++VSQK DVYSFGV+LLEL+T
Sbjct: 504 LTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELIT 563
Query: 511 GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV-QLLQLAINCTA 569
GKAP+ +++NEEGVDLPRWV+SV ++EW EVFD ELL EEEM+ +++QL + CT+
Sbjct: 564 GKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTS 623
Query: 570 QYPDNRPSMAEVTSQIEEI 588
Q+PD RP M+EV ++E +
Sbjct: 624 QHPDQRPEMSEVVRKMENL 642
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 696 bits (1795), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/620 (59%), Positives = 452/620 (72%), Gaps = 38/620 (6%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTD-GPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAI 59
LA+D++ALL+ R A+GGRTLLW++ PC W GV C G RVT LR PG LSG +P I
Sbjct: 31 LAADKSALLSFRSAVGGRTLLWDVKQTSPCNWTGVLCDGGRVTALRLPGETLSGHIPEGI 90
Query: 60 -GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
GNLT+L T+SLR N L G++P D S+LR LYLQGN FSGEIP +LFSL NL+RLNL
Sbjct: 91 FGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNLVRLNL 150
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
A+N FSG IS+ F LTRL TLYL+ N+L+GS+ L SL QFNVS N LNGSIPK
Sbjct: 151 AENEFSGEISSGFKNLTRLKTLYLENNKLSGSL--LDLDLSLDQFNVSNNLLNGSIPKSL 208
Query: 179 ARLPSSAFEGNSLCGKPLVSC-NGG-----------------GDDDDDDGSNLSGGAIAG 220
+ S +F G SLCGKPLV C N G G ++ LSGGAIAG
Sbjct: 209 QKFDSDSFVGTSLCGKPLVVCSNEGTVPSQPISVGNIPGTVEGSEEKKKRKKLSGGAIAG 268
Query: 221 IVIGSVIGLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGE 280
IVIG V+GL +I+++L+ L R+K + + + D+A T K E+EIP EK A +
Sbjct: 269 IVIGCVVGLSLIVMILMVLFRKKGNERTRAIDLA-------TIKHHEVEIPGEKAAVEAP 321
Query: 281 NTSSDL-----SGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYK 335
S + S V E SG+K LVFFG + FDLEDLLRASAEVLGKGTFGTAYK
Sbjct: 322 ENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYK 381
Query: 336 ATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395
A L+ +VAVKRLKDVT++++EF+EK+EVVG+MDHENLVPLRAYYYS DEKLLV+D+MP
Sbjct: 382 AVLDAVTLVAVKRLKDVTMADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMP 441
Query: 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS 455
MGSLSALLHGN+GAGR PLNWE RSG+ALGA+R + YLHS+ P +SHGN+KSSNILL+ S
Sbjct: 442 MGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLSSHGNVKSSNILLTNS 501
Query: 456 YEARISDFGLAHLASPSS-TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
++AR+SDFGLA L S SS TPNR GYRAPEVTD R+VSQKADVYSFGV+LLELLTGKAP
Sbjct: 502 HDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAP 561
Query: 515 TQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ---NVEEEMVQLLQLAINCTAQY 571
+ +++NEEG+DL RWV SV +EEW EVFD EL+ + +VEEEM ++LQL I+CT Q+
Sbjct: 562 SNSVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQH 621
Query: 572 PDNRPSMAEVTSQIEEICRS 591
PD RP M EV +I+E+ +S
Sbjct: 622 PDKRPVMVEVVRRIQELRQS 641
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FMD7|Y5659_ARATH Probable inactive receptor kinase At5g16590 OS=Arabidopsis thaliana GN=At5g16590 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 685 bits (1767), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 358/611 (58%), Positives = 442/611 (72%), Gaps = 21/611 (3%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIG 60
L +DR AL+ LR + GR LLWNLT PC W GV C RVT LR PG+GLSG LPIAIG
Sbjct: 25 LEADRRALIALRDGVHGRPLLWNLTAPPCTWGGVQCESGRVTALRLPGVGLSGPLPIAIG 84
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
NLT+L T+S RFNAL G +P DFA L+ LR LYLQGN FSGEIP LF+L N+IR+NLA+
Sbjct: 85 NLTKLETLSFRFNALNGPLPPDFANLTLLRYLYLQGNAFSGEIPSFLFTLPNIIRINLAQ 144
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFAR 180
NNF G I + N TRL TLYLQ+NQLTG IP++ L QFNVS N+LNGSIP +
Sbjct: 145 NNFLGRIPDNVNSATRLATLYLQDNQLTGPIPEIKI--KLQQFNVSSNQLNGSIPDPLSG 202
Query: 181 LPSSAFEGNSLCGKPLVSC--NGGGDDDDDDG-----SNLSGGAIAGIVIGSVIGLLIIL 233
+P +AF GN LCGKPL +C NG G+ G LS GAI GIVIG + LL++
Sbjct: 203 MPKTAFLGNLLCGKPLDACPVNGTGNGTVTPGGKGKSDKLSAGAIVGIVIGCFVLLLVLF 262
Query: 234 VLLIGLCRRKRDRQ---RSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLSGVV 290
+++ LCR+K+ Q S + AP T++A + P G EN GV
Sbjct: 263 LIVFCLCRKKKKEQVVQSRSIEAAPVPTSSAAVAKESNGPPAVVANGASEN------GVS 316
Query: 291 KGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLK 350
K + S K+L FF K FDL+ LL+ASAEVLGKGTFG++YKA+ + G+VVAVKRL+
Sbjct: 317 KNPAAVS--KDLTFFVKSFGEFDLDGLLKASAEVLGKGTFGSSYKASFDHGLVVAVKRLR 374
Query: 351 DVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG 410
DV V EKEFREK++V+GS+ H NLV L AYY+SRDEKL+V +YM GSLSALLHGN+G+G
Sbjct: 375 DVVVPEKEFREKLQVLGSISHANLVTLIAYYFSRDEKLVVFEYMSRGSLSALLHGNKGSG 434
Query: 411 RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470
R+PLNWETR+ +ALGA+RAI+YLHS+ SHGNIKSSNILLS+S+EA++SD+ LA + S
Sbjct: 435 RSPLNWETRANIALGAARAISYLHSRDATTSHGNIKSSNILLSESFEAKVSDYCLAPMIS 494
Query: 471 PSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWV 530
P+STPNRIDGYRAPEVTDARK+SQKADVYSFGVL+LELLTGK+PT L+EEGVDLPRWV
Sbjct: 495 PTSTPNRIDGYRAPEVTDARKISQKADVYSFGVLILELLTGKSPTHQQLHEEGVDLPRWV 554
Query: 531 QSVVKEEWTAEVFDLELLRYQ-NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589
S+ +++ ++VFD EL RYQ + E M++LL + I+CT QYPD+RP+M EVT IEE+
Sbjct: 555 SSITEQQSPSDVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVTRLIEEVS 614
Query: 590 RSSLQQGQAHD 600
RS G D
Sbjct: 615 RSPASPGPLSD 625
|
Might be involved in early recognition of growth promoting fungi. Appears to be specific for P.indica. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/611 (59%), Positives = 445/611 (72%), Gaps = 36/611 (5%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLT-DGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIA- 58
L SDR ALL +R ++ GR LLWN++ PC W GV C RVT LR PG GL G LPI
Sbjct: 26 LESDRRALLAVRNSVRGRPLLWNMSASSPCNWHGVHCDAGRVTALRLPGSGLFGSLPIGG 85
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
IGNLT+L T+SLRFN+L G IPSDF+ L LR LYLQGN FSGEIP LLF+L ++IR+NL
Sbjct: 86 IGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQGNAFSGEIPSLLFTLPSIIRINL 145
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
+N FSG I + N TRL TLYL+ NQL+G IP++ L QFNVS N+LNGSIP
Sbjct: 146 GENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEITL--PLQQFNVSSNQLNGSIPSSL 203
Query: 179 ARLPSSAFEGNSLCGKPLVSCNG----GGD-------DDDDDGSNLSGGAIAGIVIGSVI 227
+ P +AFEGN+LCGKPL +C GGD + D LS GAI GIVIG V+
Sbjct: 204 SSWPRTAFEGNTLCGKPLDTCEAESPNGGDAGGPNTPPEKKDSDKLSAGAIVGIVIGCVV 263
Query: 228 GLLIILVLLIGLCR-RKRDRQRSSKDV-APAATATATA---KQTEIEIPREKGAGDGENT 282
GLL++L++L LCR RK++ S++V AP A AT++A K+T + +P K G
Sbjct: 264 GLLLLLLILFCLCRKRKKEENVPSRNVEAPVAAATSSAAIPKETVVVVPPAKATGSE--- 320
Query: 283 SSDLSGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGI 342
SG V K+L FF K FDL+ LL+ASAEVLGKGT G++YKA+ E G+
Sbjct: 321 ----SGAVN--------KDLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGL 368
Query: 343 VVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSAL 402
VVAVKRL+DV V EKEFRE++ V+GSM H NLV L AYY+SRDEKLLV +YM GSLSA+
Sbjct: 369 VVAVKRLRDVVVPEKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAI 428
Query: 403 LHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISD 462
LHGN+G GRTPLNWETR+G+ALGA+RAI+YLHS+ SHGNIKSSNILLS SYEA++SD
Sbjct: 429 LHGNKGNGRTPLNWETRAGIALGAARAISYLHSRDGTTSHGNIKSSNILLSDSYEAKVSD 488
Query: 463 FGLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE 522
+GLA + S +S PNRIDGYRAPE+TDARK+SQKADVYSFGVL+LELLTGK+PT LNEE
Sbjct: 489 YGLAPIISSTSAPNRIDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQLNEE 548
Query: 523 GVDLPRWVQSVVKEEWTAEVFDLELLRYQ-NVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
GVDLPRWVQSV +++ ++V D EL RYQ E +++LL++ ++CTAQ+PD+RPSMAEV
Sbjct: 549 GVDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEV 608
Query: 582 TSQIEEICRSS 592
T IEE+ SS
Sbjct: 609 TRLIEEVSHSS 619
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|O48788|Y2267_ARATH Probable inactive receptor kinase At2g26730 OS=Arabidopsis thaliana GN=At2g26730 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 545 bits (1403), Expect = e-154, Method: Compositional matrix adjust.
Identities = 308/608 (50%), Positives = 394/608 (64%), Gaps = 29/608 (4%)
Query: 2 ASDRAALLTLRKAIGGRT-LLWNLTDGPCKWVGVFCTGERVTM--LRFPGMGLSGQLPI- 57
+++ ALLT + I L WN +D C WVGV C + ++ LR PG GL GQ+P
Sbjct: 26 TAEKQALLTFLQQIPHENRLQWNESDSACNWVGVECNSNQSSIHSLRLPGTGLVGQIPSG 85
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
++G LTEL +SLR N L G IPSDF+ L++LR+LYLQ N FSGE P L NLIRL+
Sbjct: 86 SLGRLTELRVLSLRSNRLSGQIPSDFSNLTHLRSLYLQHNEFSGEFPTSFTQLNNLIRLD 145
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKR 177
++ NNF+G+I N LT L L+L N +G++P + L FNVS N LNGSIP
Sbjct: 146 ISSNNFTGSIPFSVNNLTHLTGLFLGNNGFSGNLPSISL--GLVDFNVSNNNLNGSIPSS 203
Query: 178 FARLPSSAFEGN-SLCGKPLVSCN-------------GGGDDDDDDGSNLSGGAIAGIVI 223
+R + +F GN LCG PL C + S LS AI I++
Sbjct: 204 LSRFSAESFTGNVDLCGGPLKPCKSFFVSPSPSPSLINPSNRLSSKKSKLSKAAIVAIIV 263
Query: 224 GSVIGLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTS 283
S + L++L LL+ LC RKR ++ P AT +++P GA +
Sbjct: 264 ASALVALLLLALLLFLCLRKRRGSNEARTKQPKPAGVATRN---VDLP--PGASSSKEEV 318
Query: 284 SDLSGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIV 343
+ S + GE++ + LVF G +FDLEDLLRASAEVLGKG+ GT+YKA LE G
Sbjct: 319 TGTSSGMGGETERN---KLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTT 375
Query: 344 VAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALL 403
V VKRLKDV S+KEF +MEVVG + H N++PLRAYYYS+DEKLLV D+MP GSLSALL
Sbjct: 376 VVVKRLKDVMASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALL 435
Query: 404 HGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDF 463
HG+RG+GRTPL+W+ R +A+ A+R +A+LH HGNIK+SNILL + + +SD+
Sbjct: 436 HGSRGSGRTPLDWDNRMRIAITAARGLAHLHVSAKL-VHGNIKASNILLHPNQDTCVSDY 494
Query: 464 GLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG 523
GL L S SS PNR+ GY APEV + RKV+ K+DVYSFGVLLLELLTGK+P QA L EEG
Sbjct: 495 GLNQLFSNSSPPNRLAGYHAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEG 554
Query: 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583
+DLPRWV SVV+EEWTAEVFD+EL+RY N+EEEMVQLLQ+A+ C + PD RP M EV
Sbjct: 555 IDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLR 614
Query: 584 QIEEICRS 591
IE++ RS
Sbjct: 615 MIEDVNRS 622
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 495 bits (1274), Expect = e-139, Method: Compositional matrix adjust.
Identities = 288/613 (46%), Positives = 380/613 (61%), Gaps = 53/613 (8%)
Query: 1 LASDRAALLTLRKAIGG-RTLLWNLTDGPCK-WVGVFCT--GERVTMLRFPGMGLSGQLP 56
L SDR ALL ++ R L WN T+ CK WVGV CT G V LR PG+GL G +P
Sbjct: 45 LNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVTCTSDGTSVHALRLPGIGLLGPIP 104
Query: 57 I-AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
+G L L +SLR N L G +P D L +L +YLQ N FSGE+P + N+
Sbjct: 105 PNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYIYLQHNNFSGEVPSFVSRQLNI-- 162
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
L+L+ N+F+G I A F L +L L LQ N+L+G +P+L S L + N+S N LNGSIP
Sbjct: 163 LDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVPNLDTVS-LRRLNLSNNHLNGSIP 221
Query: 176 KRFARLPSSAFEGNSL-CGKPLVSCNGGGDDDD---------------DDGSN--LSGGA 217
PSS+F GN+L CG PL C +GS L
Sbjct: 222 SALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPHKEGSKRKLHVST 281
Query: 218 IAGIVIGSVIGLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAG 277
I I G LL+I V+++ C +K+D++ S + T T AKQ E G+G
Sbjct: 282 IIPIAAGGAALLLLITVIILCCCIKKKDKREDS--IVKVKTLTEKAKQ-------EFGSG 332
Query: 278 DGENTSSDLSGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKAT 337
E + LVFF FDLEDLLRASAEVLGKG++GTAYKA
Sbjct: 333 VQEPEKN----------------KLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAV 376
Query: 338 LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPM 396
LE V VKRLK+V ++EF ++ME++ + +H ++VPLRAYYYS+DEKL+V DY P
Sbjct: 377 LEESTTVVVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPA 436
Query: 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG-PANSHGNIKSSNILLSKS 455
G+LS+LLHGNRG+ +TPL+W++R + L A++ IA+LH+ G P SHGNIKSSN+++ +
Sbjct: 437 GNLSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQE 496
Query: 456 YEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPT 515
+A ISDFGL L + P R GYRAPEV + RK + K+DVYSFGVL+LE+LTGK+P
Sbjct: 497 SDACISDFGLTPLMAVPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPV 556
Query: 516 QALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNR 575
Q+ ++ VDLPRWVQSVV+EEWT+EVFD+EL+R+QN+EEEMVQ+LQ+A+ C AQ P+ R
Sbjct: 557 QSPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVR 616
Query: 576 PSMAEVTSQIEEI 588
P+M +V IEEI
Sbjct: 617 PTMDDVVRMIEEI 629
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 483 bits (1242), Expect = e-135, Method: Compositional matrix adjust.
Identities = 286/621 (46%), Positives = 364/621 (58%), Gaps = 64/621 (10%)
Query: 1 LASDRAALLTLRKAI-GGRTLLWNLTDGPC-KWVGVFCT--GERVTMLRFPGMGLSGQLP 56
+ SD+ ALL + R L WN T C W G+ C+ RVT LR PG GL G LP
Sbjct: 25 IESDKQALLEFASLVPHSRKLNWNSTIPICASWTGITCSKNNARVTALRLPGSGLYGPLP 84
Query: 57 -IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
L L +SLR N L+G IPS L +R+LY N FSG IP +L L+
Sbjct: 85 EKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRSLYFHENNFSGTIPPVLSH--RLVN 142
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
L+L+ N+ SG I LT+L L LQ N L+G IP+L L N+SFN LNGS+P
Sbjct: 143 LDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPIPNLPP--RLKYLNLSFNNLNGSVP 200
Query: 176 KRFARLPSSAFEGNSL-CGKPLVSCNGGGDDDDDDGSN------------------LSGG 216
P+S+F+GNSL CG PL C + LS G
Sbjct: 201 SSVKSFPASSFQGNSLLCGAPLTPCPENTTAPSPSPTTPTEGPGTTNIGRGTAKKVLSTG 260
Query: 217 AIAGIVIGSVIGLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGA 276
AI GI +G + L IIL ++ C +KRD Q +P+ K
Sbjct: 261 AIVGIAVGGSVLLFIILAIITLCCAKKRD-----------------GGQDSTAVPKAK-P 302
Query: 277 GDGENTSSDLSGVVKGESKGSGVK-----NLVFFGKGDRAFDLEDLLRASAEVLGKGTFG 331
G +N K E GSGV+ LVFF FDLEDLLRASAEVLGKG++G
Sbjct: 303 GRSDN---------KAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYG 353
Query: 332 TAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLV 390
T YKA LE G V VKRLK+V ++EF ++ME VG + H N+ PLRAYY+S+DEKLLV
Sbjct: 354 TTYKAILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLV 413
Query: 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS-HGNIKSSN 449
+DY G+ S LLHGN GR L+WETR + L A+R I+++HS A HGNIKS N
Sbjct: 414 YDYYQGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPN 473
Query: 450 ILLSKSYEARISDFGLAHLASPSS-TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLEL 508
+LL++ +SDFG+A L S + P+R GYRAPE + RK +QK+DVYSFGVLLLE+
Sbjct: 474 VLLTQELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEM 533
Query: 509 LTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ-NVEEEMVQLLQLAINC 567
LTGKA + +EE VDLP+WVQSVV+EEWT EVFD+EL++ Q NVEEEMVQ+LQ+A+ C
Sbjct: 534 LTGKAAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMAC 593
Query: 568 TAQYPDNRPSMAEVTSQIEEI 588
+++PD+RPSM EV + +EEI
Sbjct: 594 VSKHPDSRPSMEEVVNMMEEI 614
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 464 bits (1193), Expect = e-129, Method: Compositional matrix adjust.
Identities = 284/630 (45%), Positives = 379/630 (60%), Gaps = 68/630 (10%)
Query: 1 LASDRAALLTLRKAIGGRTLL-WNLTDGPCK-WVGVFC----TGERVTMLRFPGMGLSGQ 54
LASD ALL ++ L WN C W+G+ C RV +R PG+GL G
Sbjct: 29 LASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCDESNPTSRVVAVRLPGVGLYGS 88
Query: 55 LPIA-IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIP-GLLFSLG- 111
+P A +G L L +SLR N+L GT+PSD L +L LYLQ N FSGE+ L S+
Sbjct: 89 IPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQHNNFSGELTTNSLPSISK 148
Query: 112 NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
L+ L+L+ N+ SG I + L+++ LYLQ N G I L S+ N+S+N L+
Sbjct: 149 QLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDSLD-LPSVKVVNLSYNNLS 207
Query: 172 GSIPKRFARLPSSAFEGNSL-CGKPLVSCNGGGDDDDDD-----GSNL-------SGGAI 218
G IP+ + P +F GNSL CG PL +C+GG + NL S I
Sbjct: 208 GPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNLPRPLTENLHPVRRRQSKAYI 267
Query: 219 AGIVIGSVIGLLII-LVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAG 277
IV+G + +L + +V L+ L ++ + +E+G G
Sbjct: 268 IAIVVGCSVAVLFLGIVFLVCLVKKTK---------------------------KEEGGG 300
Query: 278 DGENTSSDLSGVVKGESKGSGVKN-----LVFFGKGDRAFDLEDLLRASAEVLGKGTFGT 332
+G T K + GSGV++ L FF + + FDLEDLL+ASAEVLGKG+FGT
Sbjct: 301 EGVRTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGT 360
Query: 333 AYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVH 391
AYKA LE V VKRL++V S+KEF ++ME+VG ++ H N VPL AYYYS+DEKLLV+
Sbjct: 361 AYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVY 420
Query: 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNIL 451
YM GSL ++HGNRG ++WETR +A G S+AI+YLHS HG+IKSSNIL
Sbjct: 421 KYMTKGSLFGIMHGNRG--DRGVDWETRMKIATGTSKAISYLHSLKFV--HGDIKSSNIL 476
Query: 452 LSKSYEARISDFGLAHLAS-PSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT 510
L++ E +SD L L + P+ TP I GY APEV + R+VSQ++DVYSFGV++LE+LT
Sbjct: 477 LTEDLEPCLSDTSLVTLFNLPTHTPRTI-GYNAPEVIETRRVSQRSDVYSFGVVILEMLT 535
Query: 511 GKAP-TQALLNEEGV--DLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINC 567
GK P TQ L +E V DLPRWV+SVV+EEWTAEVFD+ELL++QN+EEEMVQ+LQLA+ C
Sbjct: 536 GKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALAC 595
Query: 568 TAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597
A+ P++RP M EV IE++ R L Q Q
Sbjct: 596 VARNPESRPKMEEVARMIEDVRR--LDQSQ 623
|
Probable leucine-rich repeat receptor-like protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M9C5|Y1680_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g68400 OS=Arabidopsis thaliana GN=At1g68400 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 451 bits (1159), Expect = e-126, Method: Compositional matrix adjust.
Identities = 278/606 (45%), Positives = 365/606 (60%), Gaps = 59/606 (9%)
Query: 22 WNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPS 81
WN T PC+W GV C RVT L + L+G + ++ +LT L +SL+ N L G IP
Sbjct: 51 WNTTTNPCQWTGVSCNRNRVTRLVLEDINLTGSI-SSLTSLTSLRVLSLKHNNLSGPIP- 108
Query: 82 DFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLY 141
+ + L+ L+ L+L N FSG P + SL L RL+L+ NNFSG I D LT L TL
Sbjct: 109 NLSNLTALKLLFLSNNQFSGNFPTSITSLTRLYRLDLSFNNFSGQIPPDLTDLTHLLTLR 168
Query: 142 LQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGN-SLCGKPLVSCN 200
L+ N+ +G IP++ S L FNVS N NG IP ++ P S F N SLCG PL+ C
Sbjct: 169 LESNRFSGQIPNIN-LSDLQDFNVSGNNFNGQIPNSLSQFPESVFTQNPSLCGAPLLKCT 227
Query: 201 G--------------------------------GGDDDDDDGSNLSGGAIAGIVIGSVIG 228
G D ++ S +S ++ I++G I
Sbjct: 228 KLSSDPTKPGRPDEAKASPLNKPETVPSSPTSIHGGDKSNNTSRISTISLIAIILGDFI- 286
Query: 229 LLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLSG 288
+L + LL+ C ++ A K+ +I + N +
Sbjct: 287 ILSFVSLLLYYCFWRQ---------------YAVNKKKHSKILEGEKIVYSSNPYPTSTQ 331
Query: 289 VVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKR 348
+++ G K + F +G R F+LEDLLRASAE+LGKG FGTAYKA LE G VAVKR
Sbjct: 332 NNNNQNQQVGDKGKMVFFEGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKR 391
Query: 349 LKD-VTVS-EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGN 406
LKD VTV+ +KEF ++MEV+G + H NLV L+AYY++R+EKLLV+DYMP GSL LLHGN
Sbjct: 392 LKDAVTVAGKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGN 451
Query: 407 RGAGRTPLNWETRSGLALGASRAIAYLH--SKGPANSHGNIKSSNILLSKSYEARISDFG 464
RG GRTPL+W TR +A GA+R +A++H K +HG+IKS+N+LL +S AR+SDFG
Sbjct: 452 RGPGRTPLDWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFG 511
Query: 465 LAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG- 523
L+ A PS T + +GYRAPE+ D RK +QK+DVYSFGVLLLE+LTGK P G
Sbjct: 512 LSIFA-PSQTVAKSNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGG 570
Query: 524 -VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVT 582
VDLPRWVQSVV+EEWTAEVFDLEL+RY+++EEEMV LLQ+A+ CTA D+RP M V
Sbjct: 571 AVDLPRWVQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVV 630
Query: 583 SQIEEI 588
IE+I
Sbjct: 631 KLIEDI 636
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1146), Expect = e-124, Method: Compositional matrix adjust.
Identities = 266/605 (43%), Positives = 354/605 (58%), Gaps = 40/605 (6%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTDGPCK-WVGVFCT--GERVTMLRFPGMGLSGQLPI 57
L RA L L R+L WN T C W GV C G R+ +R PG+GL+GQ+P
Sbjct: 27 LEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLNGQIPP 86
Query: 58 -AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL-GNLIR 115
I L+ L +SLR N + G P DF +L +L LYLQ N SG +P L FS+ NL
Sbjct: 87 NTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLP-LDFSVWKNLTS 145
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFN-KLNGSI 174
+NL+ N F+GTI + ++L R+ +L L N L+G IPDL SSL ++S N L G I
Sbjct: 146 VNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDLAGPI 205
Query: 175 PKRFARLPSSAFEG---------NSLCGKPLVSCNGGGDDDDDDGSNLSGGAIAGIVIGS 225
P R P S++ G +L P S LS IVI
Sbjct: 206 PDWLRRFPFSSYTGIDIIPPGGNYTLVTPPPPSEQTHQKPSKARFLGLSETVFLLIVIAV 265
Query: 226 VIGLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSD 285
I ++ L ++ +C +R +R + Q + + EK E+ ++
Sbjct: 266 SIVVITALAFVLTVCYVRRKLRRGD------GVISDNKLQKKGGMSPEKFVSRMEDVNNR 319
Query: 286 LSGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVA 345
LS FF + +FDLEDLLRASAEVLGKGTFGT YKA LE VA
Sbjct: 320 LS----------------FFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVA 363
Query: 346 VKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHG 405
VKRLKDV +++F ++ME++G + HEN+V L+AYYYS+DEKL+V+DY GS+++LLHG
Sbjct: 364 VKRLKDVAAGKRDFEQQMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHG 423
Query: 406 NRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN-SHGNIKSSNILLSKSYEARISDFG 464
NRG R PL+WETR +A+GA++ IA +H + HGNIKSSNI L+ +SD G
Sbjct: 424 NRGENRIPLDWETRMKIAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLG 483
Query: 465 LAHLASPSSTP-NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG 523
L + SP + P +R GYRAPEVTD RK SQ +DVYSFGV+LLELLTGK+P +E
Sbjct: 484 LTAVMSPLAPPISRQAGYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEI 543
Query: 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583
+ L RWV SVV+EEWTAEVFD+ELLRY N+EEEMV++LQ+A++C + D RP M+++
Sbjct: 544 IHLVRWVHSVVREEWTAEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVR 603
Query: 584 QIEEI 588
IE +
Sbjct: 604 LIENV 608
|
Arabidopsis thaliana (taxid: 3702) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 606 | ||||||
| 224079499 | 623 | predicted protein [Populus trichocarpa] | 0.965 | 0.939 | 0.722 | 0.0 | |
| 224065140 | 625 | leucine-rich repeat transmembrane protei | 0.970 | 0.940 | 0.715 | 0.0 | |
| 255580373 | 651 | ATP binding protein, putative [Ricinus c | 0.985 | 0.917 | 0.721 | 0.0 | |
| 225453189 | 639 | PREDICTED: probable inactive receptor ki | 0.958 | 0.909 | 0.709 | 0.0 | |
| 359491530 | 672 | PREDICTED: probable inactive receptor ki | 0.970 | 0.875 | 0.680 | 0.0 | |
| 147845715 | 639 | hypothetical protein VITISV_018964 [Viti | 0.958 | 0.909 | 0.706 | 0.0 | |
| 255585468 | 661 | ATP binding protein, putative [Ricinus c | 0.986 | 0.904 | 0.639 | 0.0 | |
| 224135633 | 652 | predicted protein [Populus trichocarpa] | 0.963 | 0.895 | 0.645 | 0.0 | |
| 356499089 | 669 | PREDICTED: probable inactive receptor ki | 0.976 | 0.884 | 0.657 | 0.0 | |
| 356524700 | 649 | PREDICTED: probable inactive receptor ki | 0.971 | 0.907 | 0.656 | 0.0 |
| >gi|224079499|ref|XP_002305880.1| predicted protein [Populus trichocarpa] gi|222848844|gb|EEE86391.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 866 bits (2238), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 437/605 (72%), Positives = 503/605 (83%), Gaps = 20/605 (3%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTDGPCKWVGVFCTGERVTM--LRFPGMGLSGQLPIA 58
LAS+RAAL+TLR A+GGR+LLWNL++ PC+WVGVFC + T+ LR P MG SGQLP+A
Sbjct: 29 LASERAALVTLRDAVGGRSLLWNLSENPCQWVGVFCDQKNSTVVELRLPAMGFSGQLPVA 88
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+GNLT L T+SLRFNAL G IP+D + +LRNLYLQGN FSGEIP LF L NL+RLNL
Sbjct: 89 LGNLTSLQTLSLRFNALSGRIPADIGDIISLRNLYLQGNFFSGEIPEFLFKLQNLVRLNL 148
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
A NNFSG IS FN LTRL TLYL+ NQLTGSIPDL L QFNVSFN L G IP++
Sbjct: 149 ANNNFSGVISPSFNNLTRLDTLYLEGNQLTGSIPDLNL--PLDQFNVSFNNLTGRIPQKL 206
Query: 179 ARLPSSAFEGNSLCGKPLVSCNGGGDDDDDDGSNLSGGAIAGIVIGSVIGLLIILVLLIG 238
+ P+SAF+G LCG PLVSCNG + G LSGGAIAGIVIG VIG L+IL++LI
Sbjct: 207 SNKPASAFQGTFLCGGPLVSCNG----TSNGGDKLSGGAIAGIVIGCVIGFLLILLILIF 262
Query: 239 LCRRKRDRQR-SSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLSG-VVKGESKG 296
LCRRKRD++ SKDV +++E+EIP EK AG N S+ +G VVK E+K
Sbjct: 263 LCRRKRDKKEVGSKDVE-------QPRESEVEIPGEKAAGGSGNVSAGQTGAVVKSEAKS 315
Query: 297 SGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSE 356
SG KNLVFFG RAFDLEDLL+ASAEVLGKGTFGTAYKATL++G+VVAVKRLK+VTV E
Sbjct: 316 SGTKNLVFFGNAVRAFDLEDLLKASAEVLGKGTFGTAYKATLDVGMVVAVKRLKEVTVPE 375
Query: 357 KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNW 416
KEFREK+EVVG+M+HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGN+G+GRTPLNW
Sbjct: 376 KEFREKIEVVGNMNHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNKGSGRTPLNW 435
Query: 417 ETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN 476
ETRSG+ALGA+R IAY+HS+GPANSHGNIKSSNILL+ S+EAR+SDFGLAHLA P+ TPN
Sbjct: 436 ETRSGIALGAARGIAYIHSQGPANSHGNIKSSNILLTTSFEARVSDFGLAHLAGPTPTPN 495
Query: 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE 536
RIDGYRAPEVTDARKVSQKADVYSFG+LLLELLTGKAPT LN+EGVDLPRWVQSVV+E
Sbjct: 496 RIDGYRAPEVTDARKVSQKADVYSFGILLLELLTGKAPTHTQLNDEGVDLPRWVQSVVRE 555
Query: 537 EWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQG 596
EW+AEVFD ELLRYQ VEE+MVQLLQLA +CTAQYPDNRPSM+EV S++E++CRSS Q+
Sbjct: 556 EWSAEVFDPELLRYQTVEEDMVQLLQLASDCTAQYPDNRPSMSEVRSRMEDLCRSSSQE- 614
Query: 597 QAHDL 601
HD+
Sbjct: 615 --HDI 617
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224065140|ref|XP_002301687.1| leucine-rich repeat transmembrane protein [Populus trichocarpa] gi|222843413|gb|EEE80960.1| leucine-rich repeat transmembrane protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 861 bits (2224), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/604 (71%), Positives = 499/604 (82%), Gaps = 16/604 (2%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTDGPCKWVGVFC--TGERVTMLRFPGMGLSGQLPIA 58
LAS+RAAL+TLR A+GGR+LLWNL+D PC+WVGVFC G V LR PGMGLSG+LP+A
Sbjct: 29 LASERAALVTLRDAVGGRSLLWNLSDNPCQWVGVFCDQKGSTVVELRLPGMGLSGRLPVA 88
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+GNLT L ++S+RFNAL G IP+D + +LRNLYLQGN FSGEIP LF L NL+RLNL
Sbjct: 89 LGNLTSLQSLSVRFNALSGPIPADIGNIVSLRNLYLQGNFFSGEIPEFLFRLQNLVRLNL 148
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
A NNFSG IS FN LTRL TLYL+ENQ TGSIPDL L QFNVSFN L G +P++
Sbjct: 149 ANNNFSGVISPSFNNLTRLDTLYLEENQFTGSIPDLNL--PLDQFNVSFNNLTGPVPQKL 206
Query: 179 ARLPSSAFEGNSLCGKPLVSCNGGGDDDDDDGSNLSGGAIAGIVIGSVIGLLIILVLLIG 238
+ P S+F+G LCGKPLVSCNG + + +D LSGGAIAGI +G VIG L++L++LI
Sbjct: 207 SNKPLSSFQGTLLCGKPLVSCNGASNGNGND-DKLSGGAIAGIAVGCVIGFLLLLMILIF 265
Query: 239 LCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLS-GVVKGESKGS 297
LCRRKRD+ SKDV K+ +EIP K AG+G N S+ + VVK E+K S
Sbjct: 266 LCRRKRDKTVGSKDVE-------LPKEIAVEIPSGKAAGEGGNVSAGHAVAVVKSEAKSS 318
Query: 298 GVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEK 357
G KNLVFFG RAF LEDLL+ASAEVLGKGTFGTAYKATL++G+VVAVKRLK+VTV EK
Sbjct: 319 GTKNLVFFGNTARAFGLEDLLKASAEVLGKGTFGTAYKATLDVGLVVAVKRLKEVTVPEK 378
Query: 358 EFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWE 417
EFREK+E G M+HENLVPLRAYYYS+DEKLLVHDYMPMGSLSALLHGN+G+GRTPLNWE
Sbjct: 379 EFREKIEGAGKMNHENLVPLRAYYYSQDEKLLVHDYMPMGSLSALLHGNKGSGRTPLNWE 438
Query: 418 TRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR 477
TRSG+ALGA+R IAY+HS+GPA+SHGNIKSSNILL+ S EAR+SDFGLAHLA + TPNR
Sbjct: 439 TRSGIALGAARGIAYIHSQGPASSHGNIKSSNILLTTSLEARVSDFGLAHLAGLTPTPNR 498
Query: 478 IDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE 537
IDGYRAPEVTDARKVSQKADVYSFG+LLLELLTGKAPT + LN+EGVDLPRWVQSVVKEE
Sbjct: 499 IDGYRAPEVTDARKVSQKADVYSFGILLLELLTGKAPTHSQLNDEGVDLPRWVQSVVKEE 558
Query: 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597
WTAEVFDLELLRYQ VEE+MVQLLQLAI+CTAQYPDNRPSM++V SQIE++CRSS Q+
Sbjct: 559 WTAEVFDLELLRYQTVEEDMVQLLQLAIDCTAQYPDNRPSMSKVRSQIEDLCRSSSQE-- 616
Query: 598 AHDL 601
HD+
Sbjct: 617 -HDI 619
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255580373|ref|XP_002531014.1| ATP binding protein, putative [Ricinus communis] gi|223529412|gb|EEF31374.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 857 bits (2213), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/614 (72%), Positives = 506/614 (82%), Gaps = 17/614 (2%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTDG-PCKWVGVFCTGERVTMLRFPGMGLSGQLPIAI 59
L SDR AL LRKA+GGR+LLWN+++G PC WVGVFC RV LR P MGLSG+LP+ +
Sbjct: 32 LTSDRIALEALRKAVGGRSLLWNISNGNPCTWVGVFCERNRVVELRLPAMGLSGRLPLGL 91
Query: 60 GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
GNLTEL ++SLRFNAL G IP+D L++LRNLYLQGNLFSGEIP LF+L NLIRLNLA
Sbjct: 92 GNLTELQSLSLRFNALSGPIPADIGNLASLRNLYLQGNLFSGEIPEFLFNLQNLIRLNLA 151
Query: 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFA 179
N FSG IS FNKLTRLGTLYL+ENQL GSIP+L +SL QFNVSFN L+G IP++ +
Sbjct: 152 HNKFSGVISPSFNKLTRLGTLYLEENQLNGSIPELN-LNSLDQFNVSFNNLSGPIPEKLS 210
Query: 180 RLPSSAFEGNSLCGKPLVSCNGGGDDDDDDGSN-LSGGAIAGIVIGSVIGLLIILVLLIG 238
P+++F GN+LCGKPL+ CNG DDD N LSGGAIAGIVIG VIGLL+IL++LI
Sbjct: 211 GKPANSFLGNTLCGKPLIPCNGTSSGGDDDDDNKLSGGAIAGIVIGCVIGLLLILLILIF 270
Query: 239 LCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKG-AGDGENTSSDLSGVV-----KG 292
LCR+KR ++ KD T K E EIPREK A G N S+ +G V KG
Sbjct: 271 LCRKKRTKEGGVKD-------TGEPKHGEAEIPREKAVAQSGGNVSTGFAGTVTSAVAKG 323
Query: 293 ESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDV 352
E+K SG K+LVFFG R FDLEDLLRASAEVLGKGTFGT YKATLEMG+ VAVKRLKDV
Sbjct: 324 EAKSSGAKSLVFFGNTPRVFDLEDLLRASAEVLGKGTFGTTYKATLEMGVAVAVKRLKDV 383
Query: 353 TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRT 412
TVSE+EFREK+E VG ++HENLVPLR YYY++DEKLLV+DYMPMGSLSALLHGNRGAGRT
Sbjct: 384 TVSEREFREKIEAVGKINHENLVPLRGYYYNKDEKLLVYDYMPMGSLSALLHGNRGAGRT 443
Query: 413 PLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472
PLNWETRS +ALGA+RA+A+LHS+G A SHGNIKSSNILL+ S+EAR+SDFGLAHLA P+
Sbjct: 444 PLNWETRSSIALGAARAVAHLHSQGQATSHGNIKSSNILLTTSFEARVSDFGLAHLAGPT 503
Query: 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQS 532
TPNRIDGYRAPEVTDARKVSQKADVYSFG+LLLELLTGKAPT + LNEEGVDLPRWVQS
Sbjct: 504 PTPNRIDGYRAPEVTDARKVSQKADVYSFGILLLELLTGKAPTHSHLNEEGVDLPRWVQS 563
Query: 533 VVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
VVK+EWT+EVFDLELLRYQNVE+EMVQLLQLAINCTAQYPDNRPSMAEV +QIEE+CRSS
Sbjct: 564 VVKDEWTSEVFDLELLRYQNVEDEMVQLLQLAINCTAQYPDNRPSMAEVKNQIEELCRSS 623
Query: 593 LQQGQAHDLENGSS 606
Q + D+E+ S
Sbjct: 624 SQDTRL-DVEDDKS 636
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225453189|ref|XP_002276147.1| PREDICTED: probable inactive receptor kinase At1g48480 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2131), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 435/613 (70%), Positives = 497/613 (81%), Gaps = 32/613 (5%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTDG-PCKWVGVFCTGERVTMLRFPGMGLSGQLPI-A 58
LAS+RAALL LR A+GGR+LLWN++ PC WVGV C RV LR PGMGLSGQLP +
Sbjct: 25 LASERAALLVLRSAVGGRSLLWNVSQSTPCLWVGVKCQQNRVVELRLPGMGLSGQLPAGS 84
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
IGNLTELHT+SLRFNAL G++P D A NLRNLYLQGN FSG+IP LF+L NLIRLNL
Sbjct: 85 IGNLTELHTLSLRFNALSGSVPPDLASCVNLRNLYLQGNFFSGDIPEFLFTLSNLIRLNL 144
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
A NNFSG IS+DFNKLTRLGTLYL +N LTGSIP L +L QFNVS N+L+GSIP +
Sbjct: 145 AGNNFSGEISSDFNKLTRLGTLYLNDNHLTGSIPKLNL--NLQQFNVSNNQLDGSIPSKL 202
Query: 179 ARLPSSAFEGNSLCGKPLVSCNGGGDDDDDDGSNLSGGAIAGIVIGSVIGLLIILVLLIG 238
+ P++AF+GNSLCG PL SC S LSGGAIAGI+IGSV+ ++ILV+LI
Sbjct: 203 SNFPATAFQGNSLCGGPLQSC--------PHKSKLSGGAIAGIIIGSVVAFVLILVVLIL 254
Query: 239 LCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLSGVVKGE----- 293
LCR+K ++ S DVAP K TE E+ EK GDG++TS + ++G
Sbjct: 255 LCRKKSSKKTGSTDVAPV-------KHTETEMLGEKSVGDGDSTS--MGYPIRGAAVLAA 305
Query: 294 ---SKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGI---VVAVK 347
SKGSG K LVFF +R FDLEDLLRASAEVLGKGTFGTAYKA+L+M + VVAVK
Sbjct: 306 AATSKGSGDKRLVFFRNSNRIFDLEDLLRASAEVLGKGTFGTAYKASLDMEVERVVVAVK 365
Query: 348 RLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNR 407
RLKDV+VSEKEFREK+E+ G+MDHENLVPLRAYYYS+DEKL+V+DYMPMGSLSALLHGNR
Sbjct: 366 RLKDVSVSEKEFREKIEIAGAMDHENLVPLRAYYYSKDEKLIVYDYMPMGSLSALLHGNR 425
Query: 408 GAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467
GAGRTPLNWE RSG+ALGA+R IAY+HS+G A+SHGNIKSSNILL+KSYEAR+SDFGLAH
Sbjct: 426 GAGRTPLNWEARSGIALGAARGIAYIHSRGSASSHGNIKSSNILLTKSYEARVSDFGLAH 485
Query: 468 LASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLP 527
L P++TPNR+ GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPT ALLNEEGVDLP
Sbjct: 486 LVGPTATPNRVAGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLP 545
Query: 528 RWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
RWVQSVV+EEWTAEVFDLELLRYQNVEEEMVQLLQLA++C AQYPD RPSM +VTS+IEE
Sbjct: 546 RWVQSVVREEWTAEVFDLELLRYQNVEEEMVQLLQLALDCAAQYPDKRPSMLDVTSRIEE 605
Query: 588 ICRSSLQQGQAHD 600
+CRSS Q Q D
Sbjct: 606 LCRSSSQHEQEPD 618
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491530|ref|XP_002279127.2| PREDICTED: probable inactive receptor kinase At1g48480-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 825 bits (2130), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/613 (68%), Positives = 478/613 (77%), Gaps = 25/613 (4%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLT-DGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAI 59
LA+DR ALL LRK + GRTLLWN++ D PC W GV C RV LR PG L+G++P I
Sbjct: 53 LAADRTALLGLRKVVSGRTLLWNVSQDSPCLWAGVKCEKNRVVGLRLPGCSLTGKIPAGI 112
Query: 60 -GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
GNLTEL +SLR NAL G +PSD ++LRNLYL GN FSGEIP LF L ++RLNL
Sbjct: 113 IGNLTELRVLSLRMNALEGPLPSDLGSCADLRNLYLFGNAFSGEIPASLFGLTKIVRLNL 172
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
A NN SG IS DFNKLTRL TLYLQEN L+GSIPDL L QFNVSFN L G +P
Sbjct: 173 AANNLSGEISTDFNKLTRLKTLYLQENILSGSIPDLTL--KLDQFNVSFNLLKGEVPAAL 230
Query: 179 ARLPSSAFEGNSLCGKPLVSCNGGGD---DDDDDGSNLSGGAIAGIVIGSVIGLLIILVL 235
+P+SAF GNS+CG PL SC+GG D +D LSGGAIAGIVIGSV+G ++IL++
Sbjct: 231 RSMPASAFLGNSMCGTPLKSCSGGNDIIVPKNDKKHKLSGGAIAGIVIGSVVGFVLILII 290
Query: 236 LIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSS----------- 284
L LC +KR ++ S+ DVA K +E+EI EK G+ EN +
Sbjct: 291 LFVLCGKKRGKKTSAVDVA-------AVKHSEVEIQGEKPIGEVENGNGYSVAAAAAAAM 343
Query: 285 DLSGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVV 344
+G KG+ G K LVFFG R FDLEDLLRASAEVLGKGTFGTAYKA LEMG VV
Sbjct: 344 TGNGNAKGDMSNGGAKRLVFFGNAARVFDLEDLLRASAEVLGKGTFGTAYKAILEMGTVV 403
Query: 345 AVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLH 404
AVKRLKDVT+SE EFREK+E VG+MDHE+LVPLRAYYYSRDEKLLV+DYMPMGSLSALLH
Sbjct: 404 AVKRLKDVTISENEFREKIEGVGAMDHEHLVPLRAYYYSRDEKLLVYDYMPMGSLSALLH 463
Query: 405 GNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464
GN+GAGRTPLNWE RSG+ALGA+R I YLHS+GP+ SHGNIKSSNILL+KSY+AR+SDFG
Sbjct: 464 GNKGAGRTPLNWEIRSGIALGAARGIEYLHSQGPSVSHGNIKSSNILLTKSYDARVSDFG 523
Query: 465 LAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGV 524
LAHL PSSTPNR+ GYRAPEVTD RKVSQKADVYSFGVL+LELLTGKAPT A+LNEEGV
Sbjct: 524 LAHLVGPSSTPNRVAGYRAPEVTDPRKVSQKADVYSFGVLILELLTGKAPTHAILNEEGV 583
Query: 525 DLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584
DLPRWVQS+V+EEWT+EVFDLELLRYQNVEEEMVQLLQLAI+CTAQYPD RP ++EVT +
Sbjct: 584 DLPRWVQSIVREEWTSEVFDLELLRYQNVEEEMVQLLQLAIDCTAQYPDKRPPISEVTKR 643
Query: 585 IEEICRSSLQQGQ 597
IEE+CRSSL++ Q
Sbjct: 644 IEELCRSSLREYQ 656
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147845715|emb|CAN82203.1| hypothetical protein VITISV_018964 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2118), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/613 (70%), Positives = 494/613 (80%), Gaps = 32/613 (5%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTDG-PCKWVGVFCTGERVTMLRFPGMGLSGQLPIA- 58
LAS+RAALL LR A+GGR+LLWN++ PC WVGV C RV LR PGMGLSGQLP
Sbjct: 25 LASERAALLVLRSAVGGRSLLWNVSQSTPCLWVGVKCQQNRVVELRLPGMGLSGQLPAGX 84
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
IGNLTELHT+SLRFNAL G++P D A NLRNLYLQGN FSG+IP LF+L NLIRLNL
Sbjct: 85 IGNLTELHTLSLRFNALSGSVPPDLASCVNLRNLYLQGNFFSGDIPEFLFTLSNLIRLNL 144
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
A NNFSG IS+DFNKLTRLGTLYL +N LTGSIP L +L QFNVS N+L+GSIP +
Sbjct: 145 AGNNFSGEISSDFNKLTRLGTLYLNDNHLTGSIPKLNL--NLQQFNVSNNQLDGSIPSKL 202
Query: 179 ARLPSSAFEGNSLCGKPLVSCNGGGDDDDDDGSNLSGGAIAGIVIGSVIGLLIILVLLIG 238
+ P++AF+GNSLCG PL SC S LSGGAIAGI+IGSV+ ++ILV+LI
Sbjct: 203 SNFPATAFQGNSLCGGPLQSC--------PHKSKLSGGAIAGIIIGSVVAFVLILVVLIL 254
Query: 239 LCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLSGVVKGE----- 293
LCR+K ++ S DVAP K TE E+ EK GDG++TS + ++G
Sbjct: 255 LCRKKSSKKTGSTDVAPV-------KHTETEMLGEKSVGDGDSTS--MGYPIRGAAVLAA 305
Query: 294 ---SKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGI---VVAVK 347
SKGSG K LVFF +R FDLEDLLRASAEVLGKGTFGTAYKA+L+M + VVAVK
Sbjct: 306 AATSKGSGDKRLVFFRNSNRIFDLEDLLRASAEVLGKGTFGTAYKASLDMEVERVVVAVK 365
Query: 348 RLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNR 407
RLKDV+VSEKEFREK+E+ G+MDHENLVPLRAYYYS+DEKL+V+DYMPMGSLSALLHGNR
Sbjct: 366 RLKDVSVSEKEFREKIEIAGAMDHENLVPLRAYYYSKDEKLIVYDYMPMGSLSALLHGNR 425
Query: 408 GAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467
GAGRTPLNWE RSG+ALGA+R IAY+HS+G A+SHGNIKSSNILL+KSYEAR+SDFGLAH
Sbjct: 426 GAGRTPLNWEARSGIALGAARGIAYIHSRGSASSHGNIKSSNILLTKSYEARVSDFGLAH 485
Query: 468 LASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLP 527
L P++TPNR+ GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPT ALLNEEGVDLP
Sbjct: 486 LVGPTATPNRVAGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTHALLNEEGVDLP 545
Query: 528 RWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
RWVQSVV+EEWTAEVFDLELLRYQNVEEEM QLLQLA++C AQYPD RPSM +VTS+IEE
Sbjct: 546 RWVQSVVREEWTAEVFDLELLRYQNVEEEMXQLLQLALDCAAQYPDKRPSMLDVTSRIEE 605
Query: 588 ICRSSLQQGQAHD 600
+CRSS Q D
Sbjct: 606 LCRSSSXHEQEPD 618
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255585468|ref|XP_002533427.1| ATP binding protein, putative [Ricinus communis] gi|223526727|gb|EEF28958.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2069), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/646 (63%), Positives = 488/646 (75%), Gaps = 48/646 (7%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTD-GPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAI 59
LA+DRAALL LR ++GGRTL WN+T PC W GV C G RVT+LR PG+ LSGQLP I
Sbjct: 23 LAADRAALLKLRSSVGGRTLFWNITQQSPCSWAGVACEGNRVTVLRLPGVALSGQLPEGI 82
Query: 60 -GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
NLT+L T+SLR NAL G +PSD +NLRNLYLQGN+FSGEIP LF L +L+RLNL
Sbjct: 83 FANLTQLRTLSLRLNALNGHLPSDLGSCTNLRNLYLQGNMFSGEIPEFLFGLHDLVRLNL 142
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
+NNF+G IS F TRL TL+L+ N+L+GS+PDL L QFNVS N LNGSIP+R
Sbjct: 143 GENNFTGEISPSFGNFTRLRTLFLENNRLSGSVPDL-KLDKLEQFNVSNNLLNGSIPERL 201
Query: 179 ARLPSSAFEGNSLCGKPLVSCNGGGD--------DDDDDG---SNLSGGAIAGIVIGSVI 227
S+F GNSLCG+PL SC+G + D+ +G NLS GAIAGIVIGS++
Sbjct: 202 HLFDPSSFLGNSLCGQPLASCSGNSNVVVPSTPTDEAGNGGKKKNLSAGAIAGIVIGSIV 261
Query: 228 GLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLS 287
GL +I+++L+ LCR+K ++ S D+A + KQ E+ +P EK G+ EN S
Sbjct: 262 GLFLIVLILMFLCRKKGSKKSRSIDIA-------SIKQQELAMPGEKPIGEVENGSGGGY 314
Query: 288 GVVKGESKG----------------------SGVKNLVFFGKGDRAFDLEDLLRASAEVL 325
G G +G K LVFFGK R FDLEDLLRASAEVL
Sbjct: 315 GNGNGNGYSVAAAAAAAMVGHGKGGAAGGEVNGGKKLVFFGKAARVFDLEDLLRASAEVL 374
Query: 326 GKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRD 385
GKGTFGTAYKA LEMG VVAVKRLKDVT++E+EF+EK+E VG++DHE+LVPLRAYY+SRD
Sbjct: 375 GKGTFGTAYKAVLEMGTVVAVKRLKDVTITEREFKEKIETVGALDHESLVPLRAYYFSRD 434
Query: 386 EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNI 445
EKLLV+DYMPMGSLSALLHGN+G GRTPLNWE RSG+ALGA+R I Y+HS+GP SHGNI
Sbjct: 435 EKLLVYDYMPMGSLSALLHGNKGGGRTPLNWEIRSGIALGAARGIQYIHSQGPNVSHGNI 494
Query: 446 KSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLL 505
KSSNILL++SYEAR+SDFGLAHL PSSTPNR+ GYRAPEVTD RKVSQKADVYSFGVLL
Sbjct: 495 KSSNILLTQSYEARVSDFGLAHLVGPSSTPNRVAGYRAPEVTDPRKVSQKADVYSFGVLL 554
Query: 506 LELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAI 565
LELLTGK PT ALLNEEGVDLPRWVQS+V+EEWT+EVFDLELLRYQNVEEEMVQLLQL I
Sbjct: 555 LELLTGKPPTHALLNEEGVDLPRWVQSIVREEWTSEVFDLELLRYQNVEEEMVQLLQLGI 614
Query: 566 NCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ-----AHDLENGSS 606
+C AQYPDNRPSM+EVT++IEE+ RSS+++ Q DL++ SS
Sbjct: 615 DCAAQYPDNRPSMSEVTNRIEELRRSSIREDQDPEPDVVDLDDSSS 660
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135633|ref|XP_002322122.1| predicted protein [Populus trichocarpa] gi|222869118|gb|EEF06249.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 786 bits (2031), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/624 (64%), Positives = 471/624 (75%), Gaps = 40/624 (6%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLT-DGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAI 59
L+ D +ALL+LR A+ GRTLLWN++ PC W GV C RVT+LR PG L+G++P+ I
Sbjct: 22 LSPDHSALLSLRSAVHGRTLLWNVSLQSPCSWTGVKCEQNRVTVLRLPGFALTGEIPLGI 81
Query: 60 -GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
NLT+L T+SLR NAL G +P D + +LRNLYLQGNLFSGEIP LFSL +L+RLNL
Sbjct: 82 FSNLTQLRTLSLRLNALTGNLPQDLSNCKSLRNLYLQGNLFSGEIPDFLFSLKDLVRLNL 141
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
A+NNF+G IS F+ TRL TL+L++N LTGS+PDL L QFNVS N LNGSIP F
Sbjct: 142 AENNFTGEISPGFDNFTRLRTLFLEDNLLTGSLPDL-KLEKLKQFNVSNNLLNGSIPDTF 200
Query: 179 ARLPSSAFEGNSLCGKPLVSC-------------NGGGDDDDDDGSNLSGGAIAGIVIGS 225
S+F G SLCGKPL C NGGG LSGGAIAGIVIGS
Sbjct: 201 KGFGPSSFGGTSLCGKPLPDCKDSGGAIVVPSTPNGGGQGKR---KKLSGGAIAGIVIGS 257
Query: 226 VIGLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGE----- 280
++GLL+I+++L+ LCR+ + S D+A + KQ E+EI +K + E
Sbjct: 258 IVGLLLIVMILMFLCRKNSSNKSRSIDIA-------SIKQQEMEIQGDKPIVEAENGGGY 310
Query: 281 ----NTSSDLSGVVKGESKGS-----GVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFG 331
+ ++ + + G KG G K LVFFGK R FDLEDLLRASAEVLGKGTFG
Sbjct: 311 GNGYSVAAAAAAAMVGNGKGGDLNSGGAKKLVFFGKAPRVFDLEDLLRASAEVLGKGTFG 370
Query: 332 TAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391
TAYKA LEMG VVAVKRL+DVT+SE EFREK+E VG+MDHENLVPLRAYYYSRDEKLLV+
Sbjct: 371 TAYKAVLEMGTVVAVKRLRDVTISEIEFREKIETVGAMDHENLVPLRAYYYSRDEKLLVY 430
Query: 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNIL 451
DYM MGSLSALLHGN+GAGR PLNWE RSG+AL A+R I YLHS+GP SHGNIKSSNIL
Sbjct: 431 DYMSMGSLSALLHGNKGAGRAPLNWEIRSGIALAAARGIEYLHSQGPNVSHGNIKSSNIL 490
Query: 452 LSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTG 511
L++SY+AR+SDFGLAHL P STPNR+ GYRAPEVTD RKVSQKADVYSFGVLLLELLTG
Sbjct: 491 LTQSYDARVSDFGLAHLVGPPSTPNRVAGYRAPEVTDPRKVSQKADVYSFGVLLLELLTG 550
Query: 512 KAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQY 571
KAP ALLNEEGVDLPRWVQS+V+EEWT+EVFDLELLRYQNVEEEMVQLLQL I+C AQY
Sbjct: 551 KAPAHALLNEEGVDLPRWVQSIVREEWTSEVFDLELLRYQNVEEEMVQLLQLGIDCAAQY 610
Query: 572 PDNRPSMAEVTSQIEEICRSSLQQ 595
PDNRPSM+ VT +IEE+CRSSL++
Sbjct: 611 PDNRPSMSAVTRRIEELCRSSLRE 634
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356499089|ref|XP_003518376.1| PREDICTED: probable inactive receptor kinase At1g48480-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2006), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/610 (65%), Positives = 463/610 (75%), Gaps = 18/610 (2%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLTD-GPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAI 59
LASDRA LL LR A+GGRTLLWN T PC W GV C RV MLR P MGLSG LP +
Sbjct: 52 LASDRAGLLLLRSAVGGRTLLWNATQTSPCSWTGVVCASGRVIMLRLPAMGLSGSLPSGL 111
Query: 60 GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
GNLTEL T+SLRFNAL G IP DFA L LRNLYLQGN FSG++ +F+L NL+RLNL
Sbjct: 112 GNLTELQTLSLRFNALTGQIPDDFANLKALRNLYLQGNFFSGQVSDSVFALQNLVRLNLG 171
Query: 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFA 179
NNFSG IS FN LTRL TLYL+ N TGSIPDL A L QFNVSFN L GSIP RF+
Sbjct: 172 NNNFSGEISPKFNSLTRLATLYLERNNFTGSIPDLDA-PPLDQFNVSFNSLTGSIPNRFS 230
Query: 180 RLPSSAFEGNSL-CGKPLVSCNGGGDDDDDDGSNLSGGAIAGIVIGSVIGLLIILVLLIG 238
RL +AF GNSL CGKPL C G ++ LSGGAIAGIVIGSV+G+L+IL+LL
Sbjct: 231 RLDRTAFLGNSLLCGKPLQLCPG----TEEKKGKLSGGAIAGIVIGSVVGVLLILLLLFF 286
Query: 239 LCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLSGVVKGESKGSG 298
LCR K +R+ ++ + P + E+ + RE G G + + S G G
Sbjct: 287 LCR-KNNRKNENETLPPEKRVV----EGEV-VSRESGGNSGSAVAGSVEKSEIRSSSGGG 340
Query: 299 V---KNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS 355
K+LVFFG R F L++LLRASAEVLGKGTFGT YKAT+EMG VAVKRLKDVT +
Sbjct: 341 AGDNKSLVFFGNVSRVFSLDELLRASAEVLGKGTFGTTYKATMEMGASVAVKRLKDVTAT 400
Query: 356 EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLN 415
EKEFREK+E VG M H NLV LR YY+SRDEKL+V+DYMPMGSLSALLH N G GRTPLN
Sbjct: 401 EKEFREKIEQVGKMVHHNLVSLRGYYFSRDEKLVVYDYMPMGSLSALLHANGGVGRTPLN 460
Query: 416 WETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP 475
WETRS +ALGA+R IAY+HS GP +SHGNIKSSNILL+K++EAR+SDFGLA+LA P+STP
Sbjct: 461 WETRSAIALGAARGIAYIHSHGPTSSHGNIKSSNILLTKTFEARVSDFGLAYLALPTSTP 520
Query: 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK 535
NR+ GYRAPEVTDARK+SQKADVYSFG++LLELLTGKAPT + L EEGVDLPRWVQSVV+
Sbjct: 521 NRVSGYRAPEVTDARKISQKADVYSFGIMLLELLTGKAPTHSSLTEEGVDLPRWVQSVVQ 580
Query: 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL-- 593
+EW EVFD+ELLRYQNVEEEMV+LLQLA+ CTAQYPD RPSM V S+IEEIC SL
Sbjct: 581 DEWNTEVFDMELLRYQNVEEEMVKLLQLALECTAQYPDKRPSMDVVASKIEEICHPSLEK 640
Query: 594 QQGQAHDLEN 603
++G+ HD ++
Sbjct: 641 EEGKNHDFKD 650
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524700|ref|XP_003530966.1| PREDICTED: probable inactive receptor kinase At1g48480-like isoform 1 [Glycine max] gi|356524702|ref|XP_003530967.1| PREDICTED: probable inactive receptor kinase At1g48480-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 775 bits (2002), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 406/618 (65%), Positives = 472/618 (76%), Gaps = 29/618 (4%)
Query: 1 LASDRAALLTLRKAIGGRTLLWNLT-DGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAI 59
LAS+RAALL LR A+GGRTL WN T + PC W GV C + V L PG+ LSG++P+ I
Sbjct: 24 LASERAALLALRSAVGGRTLFWNATRESPCNWAGVQCEHDHVVELHLPGVALSGEIPVGI 83
Query: 60 -GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
GNLT+L T+SLRFNALRG++PSD A NLRNLY+Q NL SG+IP LF +L+RLNL
Sbjct: 84 FGNLTQLRTLSLRFNALRGSLPSDLASCVNLRNLYIQRNLLSGQIPPFLFDFADLVRLNL 143
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
NNFSG FN LTRL TL+L+ NQL+G IPDL + L QFNVS N LNGS+P +
Sbjct: 144 GFNNFSGPFPTAFNSLTRLKTLFLENNQLSGPIPDLDKLT-LDQFNVSDNLLNGSVPLKL 202
Query: 179 ARLPSSAFEGNSLCGKPLVSC-----------NGGGDDDDDDGSNLSGGAIAGIVIGSVI 227
P +F GNSLCG+PL C N D + ++ S LSGGAIAGIV+GSV+
Sbjct: 203 QAFPPDSFLGNSLCGRPLSLCPGDVADPLSVDNNAKDSNTNNKSKLSGGAIAGIVVGSVV 262
Query: 228 GLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLS 287
LL+++ L I LCR K + S+ D+A T +TE ++ +KG D EN + +
Sbjct: 263 FLLLLVFLFIFLCRNKSAKNTSAVDIA-----TVKHPETESKVLADKGVSDVENGAGHAN 317
Query: 288 G--------VVKGESKGS--GVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKAT 337
G V G SK + K LVFFG RAFDLEDLLRASAEVLGKGTFGTAYKA
Sbjct: 318 GNSAVAAVAVGNGGSKAAEGNAKKLVFFGNAARAFDLEDLLRASAEVLGKGTFGTAYKAV 377
Query: 338 LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397
LE G VVAVKRLKDVT+SEKEFREK+E VG+MDHE+LVPLRAYY+SRDEKLLV+DYM MG
Sbjct: 378 LEAGPVVAVKRLKDVTISEKEFREKIEAVGAMDHESLVPLRAYYFSRDEKLLVYDYMSMG 437
Query: 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE 457
SLSALLHGN+GAGRTPLNWE RSG+ALGA+R I YLHS+GP SHGNIKSSNILL+KSY+
Sbjct: 438 SLSALLHGNKGAGRTPLNWEVRSGIALGAARGIEYLHSRGPNVSHGNIKSSNILLTKSYD 497
Query: 458 ARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517
AR+SDFGLAHL SPSSTPNR+ GYRAPEVTD RKVSQK DVYSFGVLLLELLTGKAPT A
Sbjct: 498 ARVSDFGLAHLVSPSSTPNRVAGYRAPEVTDPRKVSQKVDVYSFGVLLLELLTGKAPTHA 557
Query: 518 LLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS 577
LLNEEGVDLPRWVQSVV+EEWT+EVFDLELLRYQNVEEEMVQLLQLA++C AQYPD RPS
Sbjct: 558 LLNEEGVDLPRWVQSVVREEWTSEVFDLELLRYQNVEEEMVQLLQLAVDCAAQYPDMRPS 617
Query: 578 MAEVTSQIEEICRSSLQQ 595
M+EV +I+E+ RSSL++
Sbjct: 618 MSEVVRRIQELRRSSLKE 635
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 606 | ||||||
| TAIR|locus:2088500 | 647 | RLK902 "receptor-like kinase 9 | 0.541 | 0.506 | 0.649 | 4.7e-172 | |
| TAIR|locus:2198090 | 655 | RKL1 "receptor-like kinase 1" | 0.536 | 0.496 | 0.626 | 1.5e-168 | |
| TAIR|locus:2174190 | 625 | LRR1 [Arabidopsis thaliana (ta | 0.495 | 0.48 | 0.661 | 4.9e-168 | |
| TAIR|locus:2075502 | 627 | AT3G02880 [Arabidopsis thalian | 0.481 | 0.465 | 0.682 | 1.9e-164 | |
| TAIR|locus:2043858 | 658 | AT2G26730 [Arabidopsis thalian | 0.476 | 0.439 | 0.648 | 2.4e-140 | |
| TAIR|locus:2161308 | 654 | AT5G58300 [Arabidopsis thalian | 0.473 | 0.438 | 0.591 | 8.9e-128 | |
| TAIR|locus:2202359 | 670 | AT1G68400 [Arabidopsis thalian | 0.470 | 0.425 | 0.627 | 5.6e-126 | |
| TAIR|locus:2077898 | 640 | AT3G08680 [Arabidopsis thalian | 0.491 | 0.465 | 0.569 | 2.8e-120 | |
| TAIR|locus:2128414 | 638 | AT4G23740 [Arabidopsis thalian | 0.503 | 0.478 | 0.553 | 1.1e-118 | |
| TAIR|locus:2156784 | 640 | RUL1 "REDUCED IN LATERAL GROWT | 0.526 | 0.498 | 0.541 | 5.3e-117 |
| TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1096 (390.9 bits), Expect = 4.7e-172, Sum P(2) = 4.7e-172
Identities = 219/337 (64%), Positives = 263/337 (78%)
Query: 264 KQTEIEIPREKGAGDG-ENTSS----DLXXXXXXXXXXXXXXNLVFFGKGDRAFDLEDLL 318
K E+EIP EK A + EN S LVFFG + FDLEDLL
Sbjct: 305 KHHEVEIPGEKAAVEAPENRSYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLL 364
Query: 319 RASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLR 378
RASAEVLGKGTFGTAYKA L+ +VAVKRLKDVT++++EF+EK+EVVG+MDHENLVPLR
Sbjct: 365 RASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADREFKEKIEVVGAMDHENLVPLR 424
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
AYYYS DEKLLV+D+MPMGSLSALLHGN+GAGR PLNWE RSG+ALGA+R + YLHS+ P
Sbjct: 425 AYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDP 484
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-PNRIDGYRAPEVTDARKVSQKAD 497
+SHGN+KSSNILL+ S++AR+SDFGLA L S SST PNR GYRAPEVTD R+VSQKAD
Sbjct: 485 LSSHGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKAD 544
Query: 498 VYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ---NVE 554
VYSFGV+LLELLTGKAP+ +++NEEG+DL RWV SV +EEW EVFD EL+ + +VE
Sbjct: 545 VYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVE 604
Query: 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
EEM ++LQL I+CT Q+PD RP M EV +I+E+ +S
Sbjct: 605 EEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQS 641
|
|
| TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1069 (381.4 bits), Expect = 1.5e-168, Sum P(2) = 1.5e-168
Identities = 210/335 (62%), Positives = 259/335 (77%)
Query: 264 KQTEIEIPREKGAGDGENTSSDLXXXXXXXXXXXXXXN--------LVFFGKGDRAFDLE 315
KQ E EIP +K A D N S LVFFG + FDLE
Sbjct: 308 KQQEPEIPGDKEAVDNGNVYSVSAAAAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLE 367
Query: 316 DLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLV 375
DLLRASAEVLGKGTFGTAYKA L+ VVAVKRLKDV +++KEF+EK+E+VG+MDHENLV
Sbjct: 368 DLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVMMADKEFKEKIELVGAMDHENLV 427
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
PLRAYY+SRDEKLLV+D+MPMGSLSALLHGNRGAGR+PLNW+ RS +A+GA+R + YLHS
Sbjct: 428 PLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHS 487
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-PNRIDGYRAPEVTDARKVSQ 494
+G + SHGNIKSSNILL+KS++A++SDFGLA L S+T PNR GYRAPEVTD ++VSQ
Sbjct: 488 QGTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQ 547
Query: 495 KADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554
K DVYSFGV+LLEL+TGKAP+ +++NEEGVDLPRWV+SV ++EW EVFD ELL E
Sbjct: 548 KGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDE 607
Query: 555 EEMV-QLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
EEM+ +++QL + CT+Q+PD RP M+EV ++E +
Sbjct: 608 EEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENL 642
|
|
| TAIR|locus:2174190 LRR1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 4.9e-168, Sum P(2) = 4.9e-168
Identities = 199/301 (66%), Positives = 248/301 (82%)
Query: 301 NLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFR 360
+L FF K FDL+ LL+ASAEVLGKGTFG++YKA+ + G+VVAVKRL+DV V EKEFR
Sbjct: 325 DLTFFVKSFGEFDLDGLLKASAEVLGKGTFGSSYKASFDHGLVVAVKRLRDVVVPEKEFR 384
Query: 361 EKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS 420
EK++V+GS+ H NLV L AYY+SRDEKL+V +YM GSLSALLHGN+G+GR+PLNWETR+
Sbjct: 385 EKLQVLGSISHANLVTLIAYYFSRDEKLVVFEYMSRGSLSALLHGNKGSGRSPLNWETRA 444
Query: 421 GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG 480
+ALGA+RAI+YLHS+ SHGNIKSSNILLS+S+EA++SD+ LA + SP+STPNRIDG
Sbjct: 445 NIALGAARAISYLHSRDATTSHGNIKSSNILLSESFEAKVSDYCLAPMISPTSTPNRIDG 504
Query: 481 YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540
YRAPEVTDARK+SQKADVYSFGVL+LELLTGK+PT L+EEGVDLPRWV S+ +++ +
Sbjct: 505 YRAPEVTDARKISQKADVYSFGVLILELLTGKSPTHQQLHEEGVDLPRWVSSITEQQSPS 564
Query: 541 EVFDLELLRYQN-VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQAH 599
+VFD EL RYQ+ E M++LL + I+CT QYPD+RP+M EVT IEE+ RS G
Sbjct: 565 DVFDPELTRYQSDSNENMIRLLNIGISCTTQYPDSRPTMPEVTRLIEEVSRSPASPGPLS 624
Query: 600 D 600
D
Sbjct: 625 D 625
|
|
| TAIR|locus:2075502 AT3G02880 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1035 (369.4 bits), Expect = 1.9e-164, Sum P(2) = 1.9e-164
Identities = 200/293 (68%), Positives = 244/293 (83%)
Query: 301 NLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFR 360
+L FF K FDL+ LL+ASAEVLGKGT G++YKA+ E G+VVAVKRL+DV V EKEFR
Sbjct: 327 DLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKASFEHGLVVAVKRLRDVVVPEKEFR 386
Query: 361 EKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS 420
E++ V+GSM H NLV L AYY+SRDEKLLV +YM GSLSA+LHGN+G GRTPLNWETR+
Sbjct: 387 ERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKGSLSAILHGNKGNGRTPLNWETRA 446
Query: 421 GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG 480
G+ALGA+RAI+YLHS+ SHGNIKSSNILLS SYEA++SD+GLA + S +S PNRIDG
Sbjct: 447 GIALGAARAISYLHSRDGTTSHGNIKSSNILLSDSYEAKVSDYGLAPIISSTSAPNRIDG 506
Query: 481 YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540
YRAPE+TDARK+SQKADVYSFGVL+LELLTGK+PT LNEEGVDLPRWVQSV +++ +
Sbjct: 507 YRAPEITDARKISQKADVYSFGVLILELLTGKSPTHQQLNEEGVDLPRWVQSVTEQQTPS 566
Query: 541 EVFDLELLRYQ-NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
+V D EL RYQ E +++LL++ ++CTAQ+PD+RPSMAEVT IEE+ SS
Sbjct: 567 DVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDSRPSMAEVTRLIEEVSHSS 619
|
|
| TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 957 (341.9 bits), Expect = 2.4e-140, Sum P(2) = 2.4e-140
Identities = 188/290 (64%), Positives = 227/290 (78%)
Query: 302 LVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFRE 361
LVF G +FDLEDLLRASAEVLGKG+ GT+YKA LE G V VKRLKDV S+KEF
Sbjct: 334 LVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLEEGTTVVVKRLKDVMASKKEFET 393
Query: 362 KMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421
+MEVVG + H N++PLRAYYYS+DEKLLV D+MP GSLSALLHG+RG+GRTPL+W+ R
Sbjct: 394 QMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSLSALLHGSRGSGRTPLDWDNRMR 453
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGY 481
+A+ A+R +A+LH HGNIK+SNILL + + +SD+GL L S SS PNR+ GY
Sbjct: 454 IAITAARGLAHLHVSAKL-VHGNIKASNILLHPNQDTCVSDYGLNQLFSNSSPPNRLAGY 512
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541
APEV + RKV+ K+DVYSFGVLLLELLTGK+P QA L EEG+DLPRWV SVV+EEWTAE
Sbjct: 513 HAPEVLETRKVTFKSDVYSFGVLLLELLTGKSPNQASLGEEGIDLPRWVLSVVREEWTAE 572
Query: 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
VFD+EL+RY N+EEEMVQLLQ+A+ C + PD RP M EV IE++ RS
Sbjct: 573 VFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPVMQEVLRMIEDVNRS 622
|
|
| TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 890 (318.4 bits), Expect = 8.9e-128, Sum P(2) = 8.9e-128
Identities = 171/289 (59%), Positives = 225/289 (77%)
Query: 302 LVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFRE 361
LVFF FDLEDLLRASAEVLGKG++GTAYKA LE V VKRLK+V ++EF +
Sbjct: 341 LVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVAAGKREFEQ 400
Query: 362 KMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS 420
+ME++ + +H ++VPLRAYYYS+DEKL+V DY P G+LS+LLHGNRG+ +TPL+W++R
Sbjct: 401 QMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRV 460
Query: 421 GLALGASRAIAYLHSKG-PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID 479
+ L A++ IA+LH+ G P SHGNIKSSN+++ + +A ISDFGL L + P R
Sbjct: 461 KITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRGA 520
Query: 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539
GYRAPEV + RK + K+DVYSFGVL+LE+LTGK+P Q+ ++ VDLPRWVQSVV+EEWT
Sbjct: 521 GYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLPRWVQSVVREEWT 580
Query: 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
+EVFD+EL+R+QN+EEEMVQ+LQ+A+ C AQ P+ RP+M +V IEEI
Sbjct: 581 SEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEI 629
|
|
| TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 891 (318.7 bits), Expect = 5.6e-126, Sum P(2) = 5.6e-126
Identities = 184/293 (62%), Positives = 227/293 (77%)
Query: 302 LVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKD-VTVS-EKEF 359
+VFF +G R F+LEDLLRASAE+LGKG FGTAYKA LE G VAVKRLKD VTV+ +KEF
Sbjct: 346 MVFF-EGTRRFELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVAGKKEF 404
Query: 360 REKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETR 419
++MEV+G + H NLV L+AYY++R+EKLLV+DYMP GSL LLHGNRG GRTPL+W TR
Sbjct: 405 EQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPLDWTTR 464
Query: 420 SGLALGASRAIAYLHS--KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR 477
+A GA+R +A++H K +HG+IKS+N+LL +S AR+SDFGL+ A PS T +
Sbjct: 465 LKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFA-PSQTVAK 523
Query: 478 IDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG--VDLPRWVQSVVK 535
+GYRAPE+ D RK +QK+DVYSFGVLLLE+LTGK P G VDLPRWVQSVV+
Sbjct: 524 SNGYRAPELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRWVQSVVR 583
Query: 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
EEWTAEVFDLEL+RY+++EEEMV LLQ+A+ CTA D+RP M V IE+I
Sbjct: 584 EEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDI 636
|
|
| TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 2.8e-120, Sum P(2) = 2.8e-120
Identities = 172/302 (56%), Positives = 219/302 (72%)
Query: 302 LVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFRE 361
LVFF FDLEDLLRASAEVLGKG++GT YKA LE G V VKRLK+V ++EF +
Sbjct: 324 LVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAGKREFEQ 383
Query: 362 KMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS 420
+ME VG + H N+ PLRAYY+S+DEKLLV+DY G+ S LLHGN GR L+WETR
Sbjct: 384 QMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAALDWETRL 443
Query: 421 GLALGASRAIAYLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSST-PNRI 478
+ L A+R I+++HS A HGNIKS N+LL++ +SDFG+A L S + P+R
Sbjct: 444 RICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHTLIPSRS 503
Query: 479 DGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW 538
GYRAPE + RK +QK+DVYSFGVLLLE+LTGKA + +EE VDLP+WVQSVV+EEW
Sbjct: 504 LGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQSVVREEW 563
Query: 539 TAEVFDLELLRYQ-NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597
T EVFD+EL++ Q NVEEEMVQ+LQ+A+ C +++PD+RPSM EV + +EEI S G
Sbjct: 564 TGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIRPSGSGPGS 623
Query: 598 AH 599
+
Sbjct: 624 GN 625
|
|
| TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 858 (307.1 bits), Expect = 1.1e-118, Sum P(2) = 1.1e-118
Identities = 172/311 (55%), Positives = 224/311 (72%)
Query: 302 LVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFRE 361
L FF + +FDLEDLLRASAEVLGKGTFGT YKA LE VAVKRLKDV +++F +
Sbjct: 320 LSFFEGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRDFEQ 379
Query: 362 KMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421
+ME++G + HEN+V L+AYYYS+DEKL+V+DY GS+++LLHGNRG R PL+WETR
Sbjct: 380 QMEIIGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMK 439
Query: 422 LALGASRAIAYLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTP-NRID 479
+A+GA++ IA +H + HGNIKSSNI L+ +SD GL + SP + P +R
Sbjct: 440 IAIGAAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPPISRQA 499
Query: 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539
GYRAPEVTD RK SQ +DVYSFGV+LLELLTGK+P +E + L RWV SVV+EEWT
Sbjct: 500 GYRAPEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHSVVREEWT 559
Query: 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC--RSSLQQGQ 597
AEVFD+ELLRY N+EEEMV++LQ+A++C + D RP M+++ IE + R+S++
Sbjct: 560 AEVFDIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPEP 619
Query: 598 A--HDLENGSS 606
ENG+S
Sbjct: 620 ELKPKSENGAS 630
|
|
| TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 5.3e-117, Sum P(2) = 5.3e-117
Identities = 182/336 (54%), Positives = 234/336 (69%)
Query: 272 REKGAGDGENT-----SSDLXXXXXXXXXXXXXXNLVFFGKGDRAFDLEDLLRASAEVLG 326
+E+G G+G T +S L FF + + FDLEDLL+ASAEVLG
Sbjct: 295 KEEGGGEGVRTQMGGVNSKKPQDFGSGVQDPEKNKLFFFERCNHNFDLEDLLKASAEVLG 354
Query: 327 KGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HENLVPLRAYYYSRD 385
KG+FGTAYKA LE V VKRL++V S+KEF ++ME+VG ++ H N VPL AYYYS+D
Sbjct: 355 KGSFGTAYKAVLEDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKD 414
Query: 386 EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNI 445
EKLLV+ YM GSL ++HGNRG ++WETR +A G S+AI+YLHS HG+I
Sbjct: 415 EKLLVYKYMTKGSLFGIMHGNRGD--RGVDWETRMKIATGTSKAISYLHSLKFV--HGDI 470
Query: 446 KSSNILLSKSYEARISDFGLAHLAS-PSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVL 504
KSSNILL++ E +SD L L + P+ TP I GY APEV + R+VSQ++DVYSFGV+
Sbjct: 471 KSSNILLTEDLEPCLSDTSLVTLFNLPTHTPRTI-GYNAPEVIETRRVSQRSDVYSFGVV 529
Query: 505 LLELLTGKAP-TQALLNEEGV--DLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLL 561
+LE+LTGK P TQ L +E V DLPRWV+SVV+EEWTAEVFD+ELL++QN+EEEMVQ+L
Sbjct: 530 ILEMLTGKTPLTQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQML 589
Query: 562 QLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597
QLA+ C A+ P++RP M EV IE++ R L Q Q
Sbjct: 590 QLALACVARNPESRPKMEEVARMIEDVRR--LDQSQ 623
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LP77 | Y1848_ARATH | No assigned EC number | 0.5815 | 0.9554 | 0.8839 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_LG_IV000713 | hypothetical protein (623 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 606 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-39 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-36 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-23 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-20 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 8e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-18 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-17 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-16 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-15 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-13 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-11 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-10 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 6e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-09 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-09 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-09 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 9e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 9e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-06 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 5e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-05 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 9e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 7e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.003 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.004 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 4e-52
Identities = 157/562 (27%), Positives = 242/562 (43%), Gaps = 74/562 (13%)
Query: 43 MLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGE 102
ML G LP + G+ L + L N G +P LS L L L N SGE
Sbjct: 456 MLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGE 514
Query: 103 IPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP-DLGAFSSLA 161
IP L S L+ L+L+ N SG I A F+++ L L L +NQL+G IP +LG SL
Sbjct: 515 IPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLV 574
Query: 162 QFNVSFNKLNGSIPKR--FARLPSSAFEGNSLCGKPLVSCNGGGDDDDDDGSNLSGGAIA 219
Q N+S N L+GS+P F + +SA G+ D G SG
Sbjct: 575 QVNISHNHLHGSLPSTGAFLAINASAVA---------------GNIDLCGGDTTSGLPPC 619
Query: 220 GIVIGSVIGLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDG 279
V + I L + A A G
Sbjct: 620 KRVRKTPSWWFYITCTLGAF-------------LVLALVAFGFVFIR------------G 654
Query: 280 ENTSSDLSGVVKGESKGSGVKNLVFF-GKGDRAFDLEDLLRASAE--VLGKGTFGTAYKA 336
N +K G L FF K ++ + D+L + E V+ +G G +YK
Sbjct: 655 RNNLE-----LKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKG 709
Query: 337 -TLEMGIVVAVKRLKDV-TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394
+++ G+ VK + DV ++ E + +G + H N+V L S L+H+Y+
Sbjct: 710 KSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765
Query: 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLS 453
+LS +L L+WE R +A+G ++A+ +LH + PA GN+ I++
Sbjct: 766 EGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817
Query: 454 KSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
E + L L + Y APE + + +++K+D+Y FG++L+ELLTGK+
Sbjct: 818 GKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKS 876
Query: 514 PTQAL--LNEEGVDLPRWVQSVVK-EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQ 570
P A ++ V+ R+ S + W ++ QN E+V+++ LA++CTA
Sbjct: 877 PADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN---EIVEVMNLALHCTAT 933
Query: 571 YPDNRPSMAEVTSQIEEICRSS 592
P RP +V +E RSS
Sbjct: 934 DPTARPCANDVLKTLESASRSS 955
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-40
Identities = 73/201 (36%), Positives = 99/201 (49%), Gaps = 16/201 (7%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREK---MEVVGSMDHENLVPLR 378
LG G+FGT YKA G +VAVK LK + K+ + + ++ + H N+V L
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+ +D LV +Y G L L PL+ + +AL R + YLHS G
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRG-----GPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEVT-DARKVS 493
H ++K NILL ++ +I+DFGLA L SS+ G Y APEV
Sbjct: 120 I--HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 494 QKADVYSFGVLLLELLTGKAP 514
K DV+S GV+L ELLTGK P
Sbjct: 178 PKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 66/193 (34%), Positives = 99/193 (51%), Gaps = 15/193 (7%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLK--DVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
LG+G FGT Y A + G VA+K +K D + +E ++E++ ++H N+V L +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
+ LV +Y GSL LL N G L+ + + L + YLHS G
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG----KLSEDEILRILLQILEGLEYLHSNGII-- 114
Query: 442 HGNIKSSNILLSK-SYEARISDFGLA-HLASPSSTPNRIDG---YRAPEV-TDARKVSQK 495
H ++K NILL + + +++DFGL+ L S S I G Y APEV S+K
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 496 ADVYSFGVLLLEL 508
+D++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 5e-38
Identities = 71/265 (26%), Positives = 110/265 (41%), Gaps = 27/265 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEV--VGSMDHENLVPLRA 379
E LG+G+FG Y A + G +VA+K +K + + R E+ + + H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ D+ LV +Y G L LL L+ + A+ YLHSKG
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDARKVSQKA 496
H ++K NILL + +++DFGLA P G Y APEV + +
Sbjct: 120 --HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 497 DVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
D++S GV+L ELLTGK P + + K + ++ E
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLL-----ELFKKIGKPKPP------FPPPEWDISPE 226
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEV 581
L++ + P+ R + E
Sbjct: 227 AKDLIR---KLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 51/284 (17%)
Query: 323 EVLGKGTFGTAYKATLEM-----GIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLV 375
+ LG+G FG YK TL+ VAVK LK+ E +EF E+ ++ + H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + +V +YMP G L L + L + +AL ++ + YL S
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLES 120
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------YRAPEVTDA 489
K H ++ + N L++++ +ISDFGL+ + G + APE
Sbjct: 121 KNFV--HRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 490 RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD-------LPRWVQSVVKEEWTAE 541
K + K+DV+SFGVLL E+ T G+ P + NEE ++ LPR E E
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPR------PENCPDE 232
Query: 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585
+++L M+Q C A P++RP+ +E+ +
Sbjct: 233 LYEL-----------MLQ-------CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 8e-37
Identities = 79/277 (28%), Positives = 127/277 (45%), Gaps = 38/277 (13%)
Query: 323 EVLGKGTFGTAYKATLEM-----GIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLV 375
+ LG+G FG YK L+ + VAVK LK+ + +EF + ++ +DH N+V
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + +V +YM G L + L NR L+ AL +R + YL S
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLES 120
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG----YR--APEVTDA 489
K H ++ + N L+ ++ +ISDFGL+ R G R APE
Sbjct: 121 KNFI--HRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAPESLKE 177
Query: 490 RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548
K + K+DV+SFGVLL E+ T G+ P + NEE + ++++ L
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---VLEYLKN-----------GYRLP 223
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585
+ N E+ L+ C A+ P++RP+ +E+ +
Sbjct: 224 QPPNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 37/277 (13%)
Query: 323 EVLGKGTFGTAYKATLEMG-----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLV 375
+ LG+G FG YK TL+ + VAVK LK+ + +EF + ++ +DH N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + ++V +YMP G L L NR L+ AL +R + YL S
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES 121
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG----YR--APEVTDA 489
K H ++ + N L+ ++ +ISDFGL+ ++ G R APE
Sbjct: 122 KNFI--HRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESLKE 178
Query: 490 RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548
K + K+DV+SFGVLL E+ T G+ P + N E + +++ L
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---VLEYLKK-----------GYRLP 224
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585
+ N E+ +L+ C A+ P++RP+ +E+ +
Sbjct: 225 KPPNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 48/287 (16%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
+ LG+G FG YK L+ VAVK LK+ E K+F ++ V+ + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGA----GRTPLNWETRSGLALGASRAIAY 432
L + LV +YM G L L +R ++ L+ + A+ ++ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR---------- 482
L SK H ++ + N L+ + +ISDFGL S D YR
Sbjct: 121 LASKKFV--HRDLAARNCLVGEDLVVKISDFGL------SRDVYDDDYYRKKTGGKLPIR 172
Query: 483 --APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWT 539
APE + K+DV+SFGVLL E+ T G P L NEE + +++
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRK------- 222
Query: 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
L + + +E+ +L+ +C P++RP+ +E+ ++E
Sbjct: 223 ----GYRLPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE--FREKMEVVGSMDHENLVPLRA 379
E +GKG FG YKA G VA+K +K + +KE E ++++ H N+V
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINE-IQILKKCKHPNIVKYYG 64
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
Y +DE +V ++ GSL LL L + + + + YLHS G
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQ----TLTESQIAYVCKELLKGLEYLHSNGII 120
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDARKVSQKA 496
H +IK++NILL+ E ++ DFGL+ S + N + G + APEV + + KA
Sbjct: 121 --HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 497 DVYSFGVLLLELLTGKAP 514
D++S G+ +EL GK P
Sbjct: 179 DIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 45/217 (20%)
Query: 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFREKM---EVVGSMDHENLVPLR 378
E+LG+G+FG+ Y A + G ++AVK ++ SE+E ++ S+ H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62
Query: 379 AYYYSRDEKLLVH-----DYMPMGSLSALLHGNRGAGRTPLNWE------TRSGLALGAS 427
YY S ++ +Y+ GSLS+LL L E TR L
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-----KLP-EPVIRKYTRQIL----- 111
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLA---------SPSSTPNR 477
+AYLHS G H +IK +NIL+ +++DFG A L S TP
Sbjct: 112 EGLAYLHSNGIV--HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY- 168
Query: 478 IDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+ APEV + + AD++S G ++E+ TGK P
Sbjct: 169 ---WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 111 bits (277), Expect = 2e-26
Identities = 78/281 (27%), Positives = 115/281 (40%), Gaps = 30/281 (10%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREK----MEVVGSMDHE-NLVPL 377
LG+G+FG Y A +VA+K L S+ + E+ ++++ S++H N+V L
Sbjct: 6 RKLGEGSFGEVYLARDRK--LVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
++ LV +Y+ GSL LL G + + A+ YLHSKG
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE--ALFILAQILSALEYLHSKG 121
Query: 438 PANSHGNIKSSNILLSKSY-EARISDFGLAHLASPSSTPNRID----------GYRAPEV 486
H +IK NILL + ++ DFGLA L + + I GY APEV
Sbjct: 122 --IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179
Query: 487 ---TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543
S +D++S G+ L ELLTG P + N ++ E T +
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ---TLKIILELPTPSL- 235
Query: 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584
L N E L A+ P NR S + S
Sbjct: 236 -ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLR 378
+++G+G FG YK LE G VA+K++ + E K ++++++ ++ H N+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLN------WETRSGLALGASRAIAY 432
+ D ++ +Y GSL ++ G P + ++ GL AY
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGL--------AY 114
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEVTD 488
LH +G H +IK++NIL +K +++DFG+A L S + G + APEV +
Sbjct: 115 LHEQGVI--HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAP 514
S +D++S G ++ELLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 65/194 (33%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+GKG FG G VAVK LKD + + + F + V+ ++ H NLV L
Sbjct: 12 ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
+ +V +YM GSL L R GR + + G AL + YL K H
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFV--H 125
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-GYRAPEVTDARKVSQKADVYSF 501
++ + N+L+S+ A++SDFGLA AS ++ + APE +K S K+DV+SF
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSF 185
Query: 502 GVLLLELLT-GKAP 514
G+LL E+ + G+ P
Sbjct: 186 GILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 67/228 (29%), Positives = 109/228 (47%), Gaps = 32/228 (14%)
Query: 324 VLGKGTFGTAYKATL-----EMGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVP 376
VLG G FGT YK ++ I VA+K L++ T + KE ++ V+ S+DH ++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGA--GRTPLNWETRSGLALGASRAIAYLH 434
L S + L+ MP+G L + ++ + LNW + +A G ++YL
Sbjct: 74 LLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ--IAKG----MSYLE 126
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------APEVTD 488
K H ++ + N+L+ +I+DFGLA L +G + A E
Sbjct: 127 EKRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESIL 184
Query: 489 ARKVSQKADVYSFGVLLLELLT-GKAPTQAL-------LNEEGVDLPR 528
R + K+DV+S+GV + EL+T G P + + L E+G LP+
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 71/279 (25%), Positives = 113/279 (40%), Gaps = 40/279 (14%)
Query: 315 EDLLRASAEVLGKGTFGTAYKATL-EMGIVVAVKRLK--DVTVSEKEFREKMEVVGSMDH 371
DL R VLG+G+ G YK G + A+K++ K+ +++ + S +
Sbjct: 1 SDLERVK--VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES 58
Query: 372 ENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
+V +Y E +V +YM GSL+ LL L + R L + +
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQIL-----KGLD 113
Query: 432 YLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---------Y 481
YLH+K + H +IK SN+L++ E +I+DFG++ N +D Y
Sbjct: 114 YLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGIS-----KVLENTLDQCNTFVGTVTY 166
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541
+PE S AD++S G+ LLE GK P +L +Q++
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL---MQAICDGP---- 219
Query: 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAE 580
L + E + C + P RPS AE
Sbjct: 220 ---PPSLPAEEFSPEFRDFISA---CLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 4e-23
Identities = 73/288 (25%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 325 LGKGTFGTAYKATLE-----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPL 377
LG+G FG + G VAVK L +F ++E++ ++DHEN+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 378 R--AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
+ L+ +Y+P GSL L +R +N + + + + YL S
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS 127
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR-------APEVTD 488
+ H ++ + NIL+ +ISDFGLA + + APE
Sbjct: 128 QRYI--HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLR 185
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL-EL 547
K S +DV+SFGV L EL T P+Q +++ + + V L EL
Sbjct: 186 TSKFSSASDVWSFGVTLYELFTYGDPSQ-------SPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 548 L-------RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
L R + +E+ L++L C P +RPS A++ ++ +
Sbjct: 239 LKEGERLPRPPSCPDEVYDLMKL---CWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 5e-23
Identities = 75/267 (28%), Positives = 124/267 (46%), Gaps = 29/267 (10%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
+G G FG + VA+K +++ +SE++F E+ +V+ + H LV L R
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGN 444
LV ++M G LS L RG + ET G+ L +AYL S H +
Sbjct: 72 SPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLESSNVI--HRD 125
Query: 445 IKSSNILLSKSYEARISDFGLAHLA----SPSSTPNRID-GYRAPEVTDARKVSQKADVY 499
+ + N L+ ++ ++SDFG+ SST + + +PEV K S K+DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 500 SFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV 558
SFGVL+ E+ + GK P + N E V E A L + + + +
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSE-----------VVETINA---GFRLYKPRLASQSVY 231
Query: 559 QLLQLAINCTAQYPDNRPSMAEVTSQI 585
+L+Q +C + P++RPS + + Q+
Sbjct: 232 ELMQ---HCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.3 bits (246), Expect = 6e-23
Identities = 65/283 (22%), Positives = 122/283 (43%), Gaps = 52/283 (18%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKR--LKDVTVSEKEFREK-MEVVGSMDHENLVPLR 378
+ +GKG+FG Y G + +K L +++ E+E ++++ ++H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTP------LNWETRSGLALGASRAIAY 432
+ + + +V +Y G LS + + P L+W + LAL Y
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIK-KQKKEGKPFPEEQILDWFVQLCLAL------KY 118
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--------TPNRIDGYRAP 484
LHS+ H +IK NI L+ + ++ DFG++ + S + TP Y +P
Sbjct: 119 LHSRKIL--HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY----YLSP 172
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA--EV 542
E+ + + K+D++S G +L EL T K P + N + ++K ++
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG-ENLLEL-----ALKILKGQYPPIPSQ 226
Query: 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585
+ EL +V L L + P+ RPS+A++
Sbjct: 227 YSSEL-------RNLVSSL-LQKD-----PEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 75/267 (28%), Positives = 120/267 (44%), Gaps = 29/267 (10%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG G FG + I VA+K +++ +SE +F E+ +V+ + H NLV L +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGN 444
+V +YM G L L +G T E + A+ YL S G H +
Sbjct: 72 RPIFIVTEYMANGCLLNYLRERKGKLGT----EWLLDMCSDVCEAMEYLESNGFI--HRD 125
Query: 445 IKSSNILLSKSYEARISDFGLAHLA----SPSSTPNRID-GYRAPEVTDARKVSQKADVY 499
+ + N L+ + ++SDFGLA SS + + PEV D + S K+DV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 500 SFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV 558
SFGVL+ E+ + GK P R+ S V E +A L R + E+
Sbjct: 186 SFGVLMWEVFSEGKMP-----------YERFSNSEVVESVSA---GYRLYRPKLAPTEVY 231
Query: 559 QLLQLAINCTAQYPDNRPSMAEVTSQI 585
++ C + P++RP+ ++ SQ+
Sbjct: 232 TIMYS---CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 60/165 (36%), Positives = 82/165 (49%), Gaps = 5/165 (3%)
Query: 22 WNLTDGPCKWVGVFCTG-ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP 80
WN + C W G+ C RV + G +SG++ AI L + T++L N L G IP
Sbjct: 51 WNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIP 110
Query: 81 SD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGT 139
D F S+LR L L N F+G IP S+ NL L+L+ N SG I D + L
Sbjct: 111 DDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV 168
Query: 140 LYLQENQLTGSIP-DLGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
L L N L G IP L +SL ++ N+L G IP+ ++ S
Sbjct: 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKS 213
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 63/159 (39%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
LSG++P IG LT L+ + L +N L G IPS L NL+ L+L N SG IP +FSL
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSL 283
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVS---F 167
LI L+L+ N+ SG I +L L L+L N TG IP A +SL + V
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP--VALTSLPRLQVLQLWS 341
Query: 168 NKLNGSIPKRFAR---LPSSAFEGNSLCGK-PLVSCNGG 202
NK +G IPK + L N+L G+ P C+ G
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSG 380
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG G FG + T VAVK LK T+S + F ++ +++ + H+ LV L A
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGN 444
+ +V +YM GSL L G G+ L +A + +AYL S+ H +
Sbjct: 74 EPIYIVTEYMSKGSLLDFLKS--GEGKK-LRLPQLVDMAAQIAEGMAYLESRNYI--HRD 128
Query: 445 IKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------APEVTDARKVSQKADV 498
+ + NIL+ ++ +I+DFGLA L R +G + APE + + + K+DV
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAR-EGAKFPIKWTAPEAANYGRFTIKSDV 187
Query: 499 YSFGVLLLELLT-GKAPTQALLNEE 522
+SFG+LL E++T G+ P + N E
Sbjct: 188 WSFGILLTEIVTYGRVPYPGMTNRE 212
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 69/216 (31%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVK--RLKDVTVSE-KEFREKMEVVGSMDHENLVPLRAY 380
+G GTFG Y A L+ G ++AVK R++D KE ++M+V+ + H NLV
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---- 63
Query: 381 YYS----RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
YY R++ + +Y G+L LL R + T L +AYLHS
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLL-----EGLAYLHSH 118
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG--------YRAPEVTD 488
G H +IK +NI L + ++ DFG A ++T + Y APEV
Sbjct: 119 GI--VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 489 ARKVSQK---ADVYSFGVLLLELLTGKAPTQALLNE 521
K AD++S G ++LE+ TGK P L NE
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-20
Identities = 76/271 (28%), Positives = 126/271 (46%), Gaps = 33/271 (12%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG+G FG + T VA+K LK T+S + F ++ +V+ + HE LV L A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 72
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAG-RTPLNWETRSGLALGASRAIAYLHSKGPANSHG 443
+ +V +YM GSL L G G R P + + +A G +AY+ H
Sbjct: 73 EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG----MAYVERMNYV--HR 126
Query: 444 NIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARKVSQKADV 498
+++++NIL+ ++ +++DFGLA L + R + APE + + K+DV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 499 YSFGVLLLELLT-GKAPTQALLNEEGVD-LPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
+SFG+LL EL T G+ P ++N E +D + R + E + DL
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC--------- 237
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
C + P+ RP+ + + +E+
Sbjct: 238 ---------QCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 15/199 (7%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVV--GSMDHENLVPLRA 379
E +G+G G YKAT G VA+K+++ + + + E++ H N+V
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMR-LR-KQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
Y DE +V +YM GSL+ ++ N +N + + + + YLHS+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVI 138
Query: 440 NSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDARKVSQK 495
H +IKS NILLSK +++DFG A L S N + G + APEV + K
Sbjct: 139 --HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPK 196
Query: 496 ADVYSFGVLLLELLTGKAP 514
D++S G++ +E+ G+ P
Sbjct: 197 VDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 40/279 (14%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLV 375
+V+G G FG + L++ I VA+K LK S+K+ F + ++G DH N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-GSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L +++ +YM GSL L N G G+ G + + YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSE 124
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG-----YRAPEVTDA 489
H ++ + NIL++ + ++SDFGL+ L +T G + APE
Sbjct: 125 MNYV--HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182
Query: 490 RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL- 547
RK + +DV+SFG+++ E+++ G+ P + N Q V+K +E
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----------QDVIKA--------VEDG 224
Query: 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
R + L QL ++C + + RP+ +++ S ++
Sbjct: 225 YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 29/269 (10%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG G FG + T VAVK LK T+S + F E+ +++ + H+ LV L A S
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVSE 72
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGN 444
+ +V +YM GSL L G GR L +A + +AY+ H +
Sbjct: 73 EPIYIVTEYMSKGSLLDFL--KDGEGRA-LKLPNLVDMAAQVAAGMAYIERMNYI--HRD 127
Query: 445 IKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARKVSQKADVY 499
++S+NIL+ +I+DFGLA L + R + APE + + K+DV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 500 SFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV 558
SFG+LL EL+T G+ P + N E V V+ + R ++ +
Sbjct: 188 SFGILLTELVTKGRVPYPGMNNRE-------VLEQVERGY----------RMPCPQDCPI 230
Query: 559 QLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
L +L + C + P+ RP+ + S +E+
Sbjct: 231 SLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 7e-20
Identities = 72/271 (26%), Positives = 131/271 (48%), Gaps = 32/271 (11%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG G FG + VAVK LK T+S + F E+ ++ ++ H+ LV L A
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAG-RTPLNWETRSGLALGASRAIAYLHSKGPANSHG 443
+ ++ +YM GSL L + G P + + +A G +AY+ K H
Sbjct: 74 EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG----MAYIERKNYI--HR 127
Query: 444 NIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------YRAPEVTDARKVSQKAD 497
+++++N+L+S+S +I+DFGLA + + R +G + APE + + K+D
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAR-EGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 498 VYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
V+SFG+LL E++T GK P + N + V S ++ + + R +N +E
Sbjct: 187 VWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGY-------RMPRMENCPDE 232
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
+ +++ C + + RP+ + S +++
Sbjct: 233 LYDIMKT---CWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 8e-20
Identities = 71/275 (25%), Positives = 128/275 (46%), Gaps = 36/275 (13%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVK--RLKDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
E +GKG FG YK L+ VAVK R +++F ++ E++ DH N+V L
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+ +V + +P GSL L + L + ++L A+ + YL SK
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLESKNCI- 115
Query: 441 SHGNIKSSNILLSKSYEARISDFGLAH-----LASPSSTPNRID-GYRAPEVTDARKVSQ 494
H ++ + N L+ ++ +ISDFG++ + + S +I + APE + + +
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 495 KADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD--LELLRYQ 551
++DV+S+G+LL E + G P + N++ T E + + Q
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQ----------------TRERIESGYRMPAPQ 218
Query: 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
EE+ +L+ C A P+NRPS +E+ ++++
Sbjct: 219 LCPEEIYRLMLQ---CWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 70/270 (25%), Positives = 127/270 (47%), Gaps = 31/270 (11%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG G FG + AT VAVK +K ++S + F + V+ ++ H+ LV L A ++
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VVTK 72
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGN 444
+ ++ ++M GSL L + G + PL + + +A++ + H +
Sbjct: 73 EPIYIITEFMAKGSLLDFLKSDEG-SKQPL--PKLIDFSAQIAEGMAFIEQRNYI--HRD 127
Query: 445 IKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARKVSQKADVY 499
++++NIL+S S +I+DFGLA + + R + APE + + K+DV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 500 SFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL-LRYQNVEEEM 557
SFG+LL+E++T G+ P + N E V++ LE R E
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSNPE----------VIRA--------LERGYRMPRPENCP 229
Query: 558 VQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
+L + + C P+ RP+ + S +++
Sbjct: 230 EELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 51/153 (33%), Positives = 83/153 (54%), Gaps = 4/153 (2%)
Query: 32 VGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRN 91
+G F + +L G L G++P ++ NLT L ++L N L G IP + ++ +L+
Sbjct: 160 IGSF---SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKW 216
Query: 92 LYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSI 151
+YL N SGEIP + L +L L+L NN +G I + L L L+L +N+L+G I
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 152 P-DLGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
P + + L ++S N L+G IP+ +L +
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN 309
|
Length = 968 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 35/274 (12%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ LG G FG + VA+K LK ++S + F + ++ + H LV L A
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA-VV 70
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS- 441
+++ ++ +YM GSL L G L +A + +A++ K N
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERK---NYI 124
Query: 442 HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------YRAPEVTDARKVSQK 495
H +++++NIL+S++ +I+DFGLA L + R +G + APE + + K
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIK 183
Query: 496 ADVYSFGVLLLELLT-GKAPTQALLNEEGV-DLPRWVQSVVKEEWTAEVFDLELLRYQNV 553
+DV+SFG+LL E++T G+ P + N E + +L R + + E+++L
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL-------- 235
Query: 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
M C + P+ RP+ + S +E+
Sbjct: 236 ---MRL-------CWKEKPEERPTFEYLRSVLED 259
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 66/240 (27%), Positives = 116/240 (48%), Gaps = 32/240 (13%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLK-DVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS 383
LG G FG ++ + + VA+K LK D + +++F+++++ + + H++L+ L A
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 384 RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS-H 442
+ ++ + M GSL A L G L + +A + +AYL + NS H
Sbjct: 74 GEPVYIITELMEKGSLLAFLRSPEGQV---LPVASLIDMACQVAEGMAYLEEQ---NSIH 127
Query: 443 GNIKSSNILLSKSYEARISDFGLA-------HLASPSSTPNRIDGYRAPEVTDARKVSQK 495
++ + NIL+ + +++DFGLA +L+S P + + APE S K
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK---WTAPEAASHGTFSTK 184
Query: 496 ADVYSFGVLLLELLT-GKAPTQALLNEEGVDL-------------PRWVQSVVKEEWTAE 541
+DV+SFG+LL E+ T G+ P + N E D P+ + ++ E W AE
Sbjct: 185 SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAE 244
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 87/293 (29%), Positives = 127/293 (43%), Gaps = 50/293 (17%)
Query: 325 LGKGTFGTAYKATLE-----MGIVVAVKRLKDVTVSE-KEFREKMEVVGSMDHENLVPLR 378
LGKG FG+ + G VVAVK+L+ T ++F ++E++ S+ H+N+V +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 379 AYYYS--RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS---RAIAYL 433
YS R LV +Y+P GSL L +R + R L L AS + + YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE------RLDHRK-LLLYASQICKGMEYL 124
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL----------ASPSSTPNRIDGYRA 483
SK H ++ + NIL+ +I DFGL + P +P I Y A
Sbjct: 125 GSK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESP--IFWY-A 179
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLT----GKAPTQALLNEEGVDLPRWVQSVVKEEWT 539
PE K S +DV+SFGV+L EL T +P + G D Q +V
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQG--QMIVYHL-- 235
Query: 540 AEVFDLELL----RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
+ELL R ++ + C P RPS +E+ Q+E I
Sbjct: 236 -----IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 61/225 (27%), Positives = 100/225 (44%), Gaps = 28/225 (12%)
Query: 323 EVLGKGTFGTAYKATLEMGI------VVAVKRLKDVTV--SEKEFREKMEVVGSMDHENL 374
LG+G FG + +VAVK LK+ + K+F + E++ + HEN+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALL--HG-------NRGAGRTPLNWETRSGLALG 425
V D ++V +YM G L+ L HG + + L +A+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR--- 482
+ + YL S+ H ++ + N L+ +I DFG++ ++ R+ G+
Sbjct: 131 IASGMVYLASQHFV--HRDLATRNCLVGYDLVVKIGDFGMSRDVY-TTDYYRVGGHTMLP 187
Query: 483 ----APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
PE RK + ++DV+SFGV+L E+ T GK P L NEE
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 75/269 (27%), Positives = 127/269 (47%), Gaps = 29/269 (10%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG+G FG + T VA+K LK T+ + F ++ +++ + H+ LVPL A S
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-SE 72
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGN 444
+ +V ++M GSL L G G+ L +A + +AY+ H +
Sbjct: 73 EPIYIVTEFMGKGSLLDFL--KEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYI--HRD 127
Query: 445 IKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARKVSQKADVY 499
++++NIL+ + +I+DFGLA L + R + APE + + K+DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 500 SFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV 558
SFG+LL EL+T G+ P ++N E V V+ + Q E +
Sbjct: 188 SFGILLTELVTKGRVPYPGMVNRE-------VLEQVERGYRMPC-------PQGCPESLH 233
Query: 559 QLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
+L++L C + PD RP+ + S +E+
Sbjct: 234 ELMKL---CWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 12/195 (6%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLK-DVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
E++G+G FG + G VAVK +K DVT + F E+ V+ + H+NLV L
Sbjct: 12 EIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
+ +V + M G+L L R GR ++ +L + + YL SK
Sbjct: 69 L-HNGLYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESKKLV-- 122
Query: 442 HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-GYRAPEVTDARKVSQKADVYS 500
H ++ + NIL+S+ A++SDFGLA + S +++ + APE +K S K+DV+S
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182
Query: 501 FGVLLLELLT-GKAP 514
+GVLL E+ + G+AP
Sbjct: 183 YGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKME------VVGSMDHENLVP 376
+GKG+FG +K + V +K + +S+ RE+ E V+ +D ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDSSYII- 62
Query: 377 LRAYYYS--RDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
YY S KL +V +Y G L LL RG PL + + +A+L
Sbjct: 63 --RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHL 117
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-PNRIDG---YRAPEVTDA 489
HSK H +IKS N+ L +I D G+A L S ++ N I G Y +PE+ +
Sbjct: 118 HSKKIL--HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED 175
Query: 490 RKVSQKADVYSFGVLLLELLTGKAPTQA 517
+ ++K+DV++ GV+L E TGK P A
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 45/218 (20%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKE-F-----REKMEVVGSMDHENLVPL 377
+G+GT+G YKA + G +VA+K+++ +EKE F RE ++++ + H N+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR--MENEKEGFPITAIRE-IKLLQKLRHPNIVRL 63
Query: 378 RAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS-------- 427
+ S+ + +V +YM L+ LL + S
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLD--------------SPEVKFTESQIKCYMKQ 108
Query: 428 --RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTP--NRIDG-- 480
+ YLHS G H +IK SNIL++ +++DFGLA +S NR+
Sbjct: 109 LLEGLQYLHSNGIL--HRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166
Query: 481 YRAPEV-TDARKVSQKADVYSFGVLLLELLTGKAPTQA 517
YR PE+ A + + D++S G +L EL GK Q
Sbjct: 167 YRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 45/216 (20%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLK-----DVTVSEKEFREKMEVVGSMDHENLVP 376
+ +G GT+G YKA + G +VA+K +K D + ++E + ++ H N+V
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE----ISMLKECRHPNIV- 63
Query: 377 LRAYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLN--------WETRSGLALG 425
AY+ Y R +KL +V +Y GSL + RG PL+ ET GLA
Sbjct: 64 --AYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLA-- 115
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---Y 481
YLH G H +IK +NILL++ + +++DFG+ A L + + G +
Sbjct: 116 ------YLHETGKI--HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYW 167
Query: 482 RAPEVTDARKVS---QKADVYSFGVLLLELLTGKAP 514
APEV + K D+++ G+ +EL + P
Sbjct: 168 MAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 11/204 (5%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG G FG ++ VAVK LK T+ K+F + +++ + H L+ L A
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGN 444
+ +V + M GSL L G GAGR L +A + +AYL ++ H +
Sbjct: 74 EPIYIVTELMKYGSLLEYLQG--GAGRA-LKLPQLIDMAAQVASGMAYLEAQNYI--HRD 128
Query: 445 IKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARKVSQKADVY 499
+ + N+L+ ++ +++DFGLA + R + APE + S K+DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 500 SFGVLLLELLT-GKAPTQALLNEE 522
SFG+LL E++T G+ P + N E
Sbjct: 189 SFGILLTEIVTYGRMPYPGMTNAE 212
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKR--LKDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
EV+G G Y A L VA+KR L+ S E R++++ + +H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---K 63
Query: 380 YYYS---RDEKLLVHDYMPMGSLSALL-HGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
YY S DE LV Y+ GSL ++ G L+ + + + + YLHS
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG---LDEAIIATVLKEVLKGLEYLHS 120
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASP----SSTPNRIDG---YRAPEVT 487
G H +IK+ NILL + +I+DFG+ A LA G + APEV
Sbjct: 121 NG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 488 DARK-VSQKADVYSFGVLLLELLTGKAP 514
+ KAD++SFG+ +EL TG AP
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 16/209 (7%)
Query: 311 AFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD 370
A ++++L + +GKG FG G VAVK +K+ ++ E V+ +
Sbjct: 2 ALNMKEL--KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQAFLAEAS-VMTQLR 57
Query: 371 HENLVPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429
H NLV L L +V +YM GSL L R GR+ L + +L A
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEA 114
Query: 430 IAYLHSKGPANS--HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-GYRAPEV 486
+ YL AN+ H ++ + N+L+S+ A++SDFGL AS + ++ + APE
Sbjct: 115 MEYLE----ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEA 170
Query: 487 TDARKVSQKADVYSFGVLLLELLT-GKAP 514
+K S K+DV+SFG+LL E+ + G+ P
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 76/285 (26%), Positives = 117/285 (41%), Gaps = 48/285 (16%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
+ LG G+FG + I VAVK LK +S+ +F ++ ++ S+DHENL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI- 59
Query: 377 LRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
R Y L +V + P+GSL L G ++ T A+ + + YL S
Sbjct: 60 -RLYGVVLTHPLMMVTELAPLGSLLDRLR-KDALGHFLIS--TLCDYAVQIANGMRYLES 115
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------------A 483
K H ++ + NILL+ + +I DFGL + P D Y A
Sbjct: 116 KRFI--HRDLAARNILLASDDKVKIGDFGLMR-----ALPQNEDHYVMEEHLKVPFAWCA 168
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542
PE R S +DV+ FGV L E+ T G+ P L + +
Sbjct: 169 PESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ----------------ILKK 212
Query: 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
D E R + E + + + C A P +RP+ A + + E
Sbjct: 213 IDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 6e-18
Identities = 59/203 (29%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLV 375
E LG+GT+G YKA + G +VA+K+++ +E+E RE + ++ + H N+V
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALRE-ISLLKELKHPNIV 61
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L ++ + LV +Y M L L G PL+ + R +AY HS
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG----PLSPNLIKSIMYQLLRGLAYCHS 116
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA---HLASPSSTPNRID-GYRAPEVT-DAR 490
H ++K NIL+++ +++DFGLA + + T + YRAPE+ ++
Sbjct: 117 HRIL--HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSK 174
Query: 491 KVSQKADVYSFGVLLLELLTGKA 513
S D++S G + E++TGK
Sbjct: 175 HYSTAVDIWSVGCIFAEMITGKP 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK---DVTVSEKEFREKMEVVGSMDHENLVPLR 378
E LG+G++G+ YKA E G VVA+K + D+ KE + ++ D +V
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVKYY 64
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
Y+ + +V +Y GS+S ++ + +T L E + + + + YLHS
Sbjct: 65 GSYFKNTDLWIVMEYCGAGSVSDIM---KITNKT-LTEEEIAAILYQTLKGLEYLHSNKK 120
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEVTDARKVSQ 494
H +IK+ NILL++ +A+++DFG++ L + N + G + APEV +
Sbjct: 121 I--HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 495 KADVYSFGVLLLELLTGKAP 514
KAD++S G+ +E+ GK P
Sbjct: 179 KADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 9e-18
Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 31/270 (11%)
Query: 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS 383
LG G +G Y+ + + VAVK LK+ T+ +EF ++ V+ + H NLV L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 384 RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHG 443
++ ++M G+L L R R +N +A S A+ YL K H
Sbjct: 74 EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKNFI--HR 128
Query: 444 NIKSSNILLSKSYEARISDFGLAHL------ASPSSTPNRIDGYRAPEVTDARKVSQKAD 497
++ + N L+ +++ +++DFGL+ L + + I + APE K S K+D
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK-WTAPESLAYNKFSIKSD 187
Query: 498 VYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
V++FGVLL E+ T G +P G+DL + V ++++ + E R + +
Sbjct: 188 VWAFGVLLWEIATYGMSPY------PGIDLSQ-VYELLEKGYRME-------RPEGCPPK 233
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
+ +L++ C P +RPS AE+ E
Sbjct: 234 VYELMR---ACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 22/201 (10%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLK----DVTVSEKEFREKMEVVGSMDHENLVPLRA 379
+G+GT+G YKA G +VA+K++K + + RE ++++ ++H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE-IKLLKELNHPNIIKLLD 65
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ + + LV ++M L L+ + L + +A+ HS G
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP------NRIDGYRAPEVT-DARKV 492
H ++K N+L++ +++DFGLA P R YRAPE+ +
Sbjct: 121 --HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW--YRAPELLLGDKGY 176
Query: 493 SQKADVYSFGVLLLELLTGKA 513
S D++S G + ELL+ +
Sbjct: 177 STPVDIWSVGCIFAELLSRRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 75/270 (27%), Positives = 123/270 (45%), Gaps = 38/270 (14%)
Query: 324 VLGKGTFGTA--YKATLEMGIVVAVKRLKDVTVSEKEFREKM---EVVGSMDHENLVPLR 378
VLGKG FG A Y+ T E +V K + +SEKE R+ + ++ + H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII--- 62
Query: 379 AYY--YSRDEKLLVH-DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
AYY + D LL+ +Y G+L + +G E A++Y+H
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSSTPNRIDG---YRAPEVTDARK 491
G H +IK+ NI L+K+ ++ DFG++ L S S + G Y +PE+ K
Sbjct: 120 AGIL--HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 492 VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551
+ K+D+++ G +L ELLT K + + V +V+ +T V Y
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTF------DATNPLNLVVKIVQGNYTPVV-----SVYS 226
Query: 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
E++ L+ + Q P+ RP+ EV
Sbjct: 227 ---SELISLVH---SLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 9/199 (4%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKM---EVVGSMDHENLVPLRAY 380
LGKG++G+ YK L A+K + ++S+KE + + ++ S++H N++ +
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+ ++ +V +Y P G LS + R R + + + + R + LH +
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL- 125
Query: 441 SHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG--YRAPEVTDARKVSQKADV 498
H ++KS+NILL + +I D G++ + + +I Y APEV R S K+D+
Sbjct: 126 -HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDI 184
Query: 499 YSFGVLLLELLTGKAPTQA 517
+S G LL E+ T P +A
Sbjct: 185 WSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 69/271 (25%), Positives = 125/271 (46%), Gaps = 31/271 (11%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE--FREKMEVVGSMDHENLVPLRAY 380
E+LGKG FG +K TL+ VAVK K+ E + F + ++ DH N+V L
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
R +V + +P G + L + +T + AL A+ +AYL SK
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT----KQLVKFALDAAAGMAYLESKNCI- 115
Query: 441 SHGNIKSSNILLSKSYEARISDFGLAH-----LASPSSTPNRIDGYRAPEVTDARKVSQK 495
H ++ + N L+ ++ +ISDFG++ + S S + APE + + S +
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 496 ADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554
+DV+S+G+LL E + G P + N++ + V++ + + Q
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQA-------REQVEKGY-------RMSCPQKCP 220
Query: 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585
+++ +++Q C P+NRP +E+ ++
Sbjct: 221 DDVYKVMQ---RCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 4e-17
Identities = 76/273 (27%), Positives = 121/273 (44%), Gaps = 39/273 (14%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG G FG VA+K +K+ ++SE EF E+ +V+ + HE LV L +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLAL--GASRAIAYLHSKGPANSH 442
+V +YM G L L R G+ + L + +AYL SK H
Sbjct: 72 RPIYIVTEYMSNGCLLNYL---REHGKRF---QPSQLLEMCKDVCEGMAYLESK--QFIH 123
Query: 443 GNIKSSNILLSKSYEARISDFGLA-------HLASPSST-PNRIDGYRAPEVTDARKVSQ 494
++ + N L+ ++SDFGL+ + +S S P R + PEV K S
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVR---WSPPEVLLYSKFSS 180
Query: 495 KADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553
K+DV++FGVL+ E+ + GK P + N E V+ + Q L L R
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYERFNNSETVE--KVSQG------------LRLYRPHLA 226
Query: 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
E++ ++ +C + + RP+ ++ S IE
Sbjct: 227 SEKVYAIM---YSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 6e-17
Identities = 71/206 (34%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 325 LGKGTFGTAYKATLEM-GIVVAVKRL-KDVTVSEKE----FREKMEVVGSMDHENLVPLR 378
LGKG+FG + G + A+K L K + KE E+ ++ ++H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERN-ILSRINHPFIVKL- 58
Query: 379 AYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG-----LALGASRAIAY 432
Y + +EKL LV +Y P G L + L GR E R+ + L A+ Y
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS---EERARFYAAEIVL----ALEY 108
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEVTD 488
LHS G + ++K NILL +++DFGLA L+S S N G Y APEV
Sbjct: 109 LHSLGII--YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAP 514
+ + D +S GVLL E+LTGK P
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 8e-17
Identities = 76/285 (26%), Positives = 120/285 (42%), Gaps = 53/285 (18%)
Query: 325 LGKGTFGTAYKATLEMG----IVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLR 378
LG G FG+ K M + VAVK LK ++ +KEF + V+ +DH +V R
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV--R 60
Query: 379 AYYYSRDEKL-LVHDYMPMGSLSALLHGNRG-AGRTPLNWETRSGLALGASRAIAYLHSK 436
+ E L LV + P+G L L R A + +AYL SK
Sbjct: 61 LIGVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK 114
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------------AP 484
H ++ + N+LL ++A+ISDFG++ S D YR AP
Sbjct: 115 HFV--HRDLAARNVLLVNRHQAKISDFGMSRALGAGS-----DYYRATTAGRWPLKWYAP 167
Query: 485 EVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543
E + K S K+DV+S+GV L E + G P + +G ++ ++S
Sbjct: 168 ECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---KGAEVIAMLES----------- 213
Query: 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
L R + +E+ ++ C P++RP+ +E+ S
Sbjct: 214 GERLPRPEECPQEIYSIMLS---CWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 32/229 (13%)
Query: 323 EVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLV 375
+VLG G FGT YK + I VA+K L + T + EF ++ ++ SMDH +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRG--AGRTPLNWETRSGLALGASRAIAYL 433
L S +L V MP G L +H ++ + LNW + ++ + YL
Sbjct: 73 RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL 125
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAP------EVT 487
+ H ++ + N+L+ +I+DFGLA L DG + P E
Sbjct: 126 EERRLV--HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 488 DARKVSQKADVYSFGVLLLELLT--GKA----PTQAL--LNEEGVDLPR 528
RK + ++DV+S+GV + EL+T GK PT+ + L E+G LP+
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 64/201 (31%), Positives = 99/201 (49%), Gaps = 21/201 (10%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREK-------MEVVGSMDHENLVP 376
+G G+FG Y AT VVAVK++ + S K+ EK ++ + + H N +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKM---SYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
+ Y LV +Y +GS S LL + PL + + GA + +AYLHS
Sbjct: 86 YKGCYLKEHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQ-- 494
H +IK+ NILL++ + +++DFG A +SP+++ + APEV A Q
Sbjct: 141 --NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYD 198
Query: 495 -KADVYSFGVLLLELLTGKAP 514
K DV+S G+ +EL K P
Sbjct: 199 GKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 3e-16
Identities = 70/267 (26%), Positives = 116/267 (43%), Gaps = 29/267 (10%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR 384
LG G FG + I VA+K + + +SE++F E+ +V+ + H LV L +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71
Query: 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGN 444
+V ++M G L L +G L+ + + + YL H +
Sbjct: 72 KPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLERNSFI--HRD 125
Query: 445 IKSSNILLSKSYEARISDFGLAHLA-----SPSSTPNRIDGYRAPEVTDARKVSQKADVY 499
+ + N L+S + ++SDFG+ + SS + PEV + K S K+DV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 500 SFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV 558
SFGVL+ E+ T GK P + N E V E + F L Y+ M
Sbjct: 186 SFGVLMWEVFTEGKMPFEKKSNYEVV------------EMISRGFRL----YRPKLASM- 228
Query: 559 QLLQLAINCTAQYPDNRPSMAEVTSQI 585
+ ++ +C + P+ RP+ AE+ I
Sbjct: 229 TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-16
Identities = 78/296 (26%), Positives = 124/296 (41%), Gaps = 65/296 (21%)
Query: 7 ALLTLRKAIGGRTLL-WNLTDGPC-----KWVGVFCTGERVTMLRF-PGMGLSGQLPIAI 59
AL TL+ ++G WN PC W G C + F G+GL Q
Sbjct: 376 ALQTLKSSLGLPLRFGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQ----- 428
Query: 60 GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
LRG IP+D +KL +L+++ L GN G IP L S+ +L L+L+
Sbjct: 429 --------------GLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLS 474
Query: 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFA 179
N+F+G+I +LT L L L N L+G +P A SFN
Sbjct: 475 YNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP--AALGGRLLHRASFN----------- 521
Query: 180 RLPSSAFEGNS-LCGKP-LVSCNGGGDDDDDDGSNLSGGAIAGIVIGSVIGLLIILVLLI 237
F N+ LCG P L +C G +LS GA GI G + L +++ +
Sbjct: 522 ------FTDNAGLCGIPGLRAC----------GPHLSVGAKIGIAFGVSVAFLFLVICAM 565
Query: 238 GLCRRK----RDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLSGV 289
+R+ R ++ ++++ A T ++ ++++ R G ++ +G
Sbjct: 566 CWWKRRQNILRAQRIAAREAPYAKARTHFSR--DVQMTRHHRQNHGSARTAAENGP 619
|
Length = 623 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-16
Identities = 48/141 (34%), Positives = 72/141 (51%), Gaps = 2/141 (1%)
Query: 36 CTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQ 95
C+ + L L G++P ++G L V L+ N+ G +PS+F KL + L +
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDIS 436
Query: 96 GNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-L 154
N G I + + +L L+LA+N F G + D RL L L NQ +G++P L
Sbjct: 437 NNNLQGRINSRKWDMPSLQMLSLARNKFFGGL-PDSFGSKRLENLDLSRNQFSGAVPRKL 495
Query: 155 GAFSSLAQFNVSFNKLNGSIP 175
G+ S L Q +S NKL+G IP
Sbjct: 496 GSLSELMQLKLSENKLSGEIP 516
|
Length = 968 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 27/205 (13%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE----------FREKMEVVGSMDHEN 373
LG+GT+ YKA E G +VA+K++K + E++ RE ++++ + H N
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIK---LGERKEAKDGINFTALRE-IKLLQELKHPN 63
Query: 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
++ L + + LV ++M L ++ ++ TP + ++ + L R + YL
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIK-DKSIVLTPADIKSYMLMTL---RGLEYL 118
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSS--TPNRID-GYRAPEVT-D 488
HS H ++K +N+L++ +++DFGLA SP+ T + YRAPE+
Sbjct: 119 HSNWIL--HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 489 ARKVSQKADVYSFGVLLLELLTGKA 513
AR D++S G + ELL
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 67/259 (25%), Positives = 107/259 (41%), Gaps = 49/259 (18%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKD---VTVSEKEFREKMEVVGSMDHEN 373
E LG+G FG YK L VA+K LK+ V + EFR++ E++ + H N
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ-EFRQEAELMSDLQHPN 69
Query: 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGN---RGAGRTPLNWETRSGL-------- 422
+V L ++ +Y+ G L L N G + +S L
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 423 ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH---------LASPSS 473
A+ + + YL S H ++ + N L+ + +ISDFGL+ + S S
Sbjct: 130 AIQIAAGMEYLSSHHFV--HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE---------- 522
P R + PE K + ++D++SFGV+L E+ + G P N+E
Sbjct: 188 LPVR---WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL 244
Query: 523 ---GVDLPRWVQSVVKEEW 538
D P V +++ E W
Sbjct: 245 LPCPEDCPARVYALMIECW 263
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE---KMEVVGSMDHENLVPLR 378
E +GKG+FG YKA VVA+K + D+ +E E + +++ + +
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYIT--- 62
Query: 379 AYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
YY + + KL ++ +Y GS LL L+ + + + YLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLK------PGKLDETYIAFILREVLLGLEYLHE 116
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEVTDARK 491
+G H +IK++NILLS+ + +++DFG++ L S S N G + APEV
Sbjct: 117 EGKI--HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 492 VSQKADVYSFGVLLLELLTGKAP 514
+KAD++S G+ +EL G+ P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 8e-16
Identities = 78/283 (27%), Positives = 124/283 (43%), Gaps = 51/283 (18%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAY 380
EV+G+GT+G YKA + G +VA+K + + E+E +E+ ++ +H N+
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 381 YYSR------DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ + D+ LV + GS++ L+ G R G+ L E + + R +AYLH
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK-RLKEEWIAYILRETLRGLAYLH 130
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEV---- 486
H +IK NILL+K+ E ++ DFG+ A L S N G + APEV
Sbjct: 131 ENKVI--HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACD 188
Query: 487 -TDARKVSQKADVYSFGVLLLELLTGKAP------TQALLNEEGVDLPRWVQSVVK--EE 537
++DV+S G+ +EL GK P +AL +PR +K E
Sbjct: 189 EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFK-----IPRNPPPTLKSPEN 243
Query: 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAE 580
W+ + D + E C + + RP M E
Sbjct: 244 WSKKFNDF-------ISE-----------CLIKNYEQRPFMEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 75/273 (27%), Positives = 118/273 (43%), Gaps = 49/273 (17%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREK-----MEV--VGSMDHENLVP 376
+G G+FG Y A + VVA+K++ + S K+ EK EV + + H N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE 79
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
+ Y LV +Y +GS S +L + PL + + GA + +AYLHS
Sbjct: 80 YKGCYLREHTAWLVMEYC-LGSASDILE----VHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQ-- 494
H +IK+ NILL++ +++DFG A L SP+++ + APEV A Q
Sbjct: 135 E--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYD 192
Query: 495 -KADVYSFGVLLLELLTGKAP------TQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547
K DV+S G+ +EL K P AL + D P ++ +W+
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP----TLSSNDWS-------- 240
Query: 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAE 580
+ + C + P +RPS E
Sbjct: 241 -------DYFRNFVDS---CLQKIPQDRPSSEE 263
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 79/300 (26%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 324 VLGKGTFGTAYKATL-----EMGIV-VAVKRLKDVTVSEKEFRE---KMEVVGSMDHENL 374
LG+G FG KAT G VAVK LK+ S E R+ + ++ ++H ++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE-NASSSELRDLLSEFNLLKQVNHPHV 65
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLH-------------GNRGA------GRTPLN 415
+ L LL+ +Y GSL + L GNR + L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 416 WETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSST 474
A SR + YL H ++ + N+L+++ + +ISDFGL+ + S
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLV--HRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 475 PNRIDG-----YRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPR 528
R G + A E + ++DV+SFGVLL E++T G P + P
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-------PE 236
Query: 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
+ +++K + E R +N EEM L+ + C Q PD RP+ A+++ ++E++
Sbjct: 237 RLFNLLKTGYRME-------RPENCSEEMYNLM---LTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 19/202 (9%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPL 377
V+G+G +G K G +VA+K+ K+ V + RE ++V+ + HEN+V L
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALRE-VKVLRQLRHENIVNL 65
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ + + LV +Y+ +L LL + G G P RS +AIAY HS
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPG-GLPPD--AVRS-YIWQLLQAIAYCHSHN 120
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAPEV-TDARK 491
H +IK NIL+S+S ++ DFG A D YRAPE+
Sbjct: 121 II--HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 492 VSQKADVYSFGVLLLELLTGKA 513
+ DV++ G ++ ELL G+
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE---KMEVVGS 368
DLE L LG G G K G ++AVK ++ + ++E ++ +++++
Sbjct: 2 DLEYL-----GELGAGNSGVVSKVLHRPTGKIMAVKTIR-LEINEAIQKQILRELDILHK 55
Query: 369 MDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR 428
+ +V +Y+ + + +YM GSL +L GR P +A+ +
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPE--RILGKIAVAVLK 111
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH--LASPSSTPNRIDGYRAPEV 486
+ YLH K H ++K SNIL++ + ++ DFG++ + S + T Y APE
Sbjct: 112 GLTYLHEKHKI-IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPER 170
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKAP 514
S K+D++S G+ L+EL TG+ P
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 323 EVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLV 375
++LG G FGT +K + I VA+K ++D + + +E + M +GS+DH +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGA--GRTPLNWETRSGLALGASRAIAYL 433
L +L V P+GSL + +R + + LNW + ++ + YL
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYL 125
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAP------EVT 487
H N+ + NILL +I+DFG+A L P ++ P E
Sbjct: 126 EEHRMV--HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESI 183
Query: 488 DARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDL 526
+ + ++DV+S+GV + E+++ G P + E DL
Sbjct: 184 LFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLV 375
+V+G G FG ++ L+M + VA+K LK +EK+ F + ++G H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQDFLSEASIMGQFSHHNII 69
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L +++ +YM G+L L + G + G+ G + + YL
Sbjct: 70 RLEGVVTKFKPAMIITEYMENGALDKYLRDHDGE-FSSYQL---VGMLRGIAAGMKYLSD 125
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS--PSSTPNRIDG-----YRAPEVTD 488
H ++ + NIL++ + E ++SDFGL+ + P T G + APE
Sbjct: 126 MNYV--HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 489 ARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
RK + +DV+SFG+++ E+++ G+ P + N E
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 75/281 (26%), Positives = 124/281 (44%), Gaps = 37/281 (13%)
Query: 323 EVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTVSEK--EFREKMEVVGSMDHENLVP 376
V+GKG FG Y TL I AVK L +T E+ +F ++ ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 377 LRAYYYSRD-EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + L+V YM G L + R P + G L ++ + YL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNP-TVKDLIGFGLQVAKGMEYLAS 116
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAH--LASPSSTPNRIDGYRAP------EVT 487
K H ++ + N +L +S+ +++DFGLA + + G + P E
Sbjct: 117 KKFV--HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547
+K + K+DV+SFGVLL EL+T AP ++ + V+ L+
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD----------------SFDITVYLLQG 218
Query: 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
R E L ++ ++C P+ RP+ +E+ S+IE+I
Sbjct: 219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 324 VLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFREK----------MEVVGSMDHE 372
++G G+FG+ Y G ++AVK+++ +VS K + ++ + HE
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPL--NW--ETRSGLALGASR 428
N+V D + +Y+P GS++ALL+ N GA L N+ + GL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLN----- 120
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------ 482
YLH++G H +IK +NIL+ +ISDFG++ +S + +G R
Sbjct: 121 ---YLHNRGII--HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175
Query: 483 ----APEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
APEV ++KAD++S G L++E+LTGK P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 83/287 (28%), Positives = 126/287 (43%), Gaps = 44/287 (15%)
Query: 325 LGKGTFGTAYKATL--EMG-----IVVAVKRL-KDVTVSEK-EFREKMEVVGSMDHENLV 375
LG G FG Y+ T +G I VAVK L K T EK EF ++ ++ + +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTP--LNWETRSGLALGASRAIAYL 433
L + + ++ + M G L + L R P L + + L ++ YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 434 HSKGPANSHGNIKSSNILLS-KSYEAR----ISDFGLAHLASPSSTPNRIDGYR------ 482
H ++ + N L+S K Y+A I DFGLA S R +G
Sbjct: 123 EQMHFI--HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY-KSDYYRKEGEGLLPVRW 179
Query: 483 -APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540
APE K + ++DV+SFGVL+ E+LT G+ P AL N+E V V
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHVTAGG-- 230
Query: 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
L + +N +++ QL+ NC AQ P RP+ + ++
Sbjct: 231 -----RLQKPENCPDKIYQLMT---NCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (189), Expect = 2e-15
Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
+G G+FG Y A + VVA+K++ K ++ ++++ + + H N + +
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
Y LV +Y +GS S LL + PL + + GA + +AYLHS
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQ---KA 496
H +IK+ NILL++ + +++DFG A +ASP+++ + APEV A Q K
Sbjct: 148 --HRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKV 205
Query: 497 DVYSFGVLLLELLTGKAP 514
DV+S G+ +EL K P
Sbjct: 206 DVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 78/290 (26%), Positives = 130/290 (44%), Gaps = 40/290 (13%)
Query: 323 EVLGKGTFGTA----YKATLE-MGIVVAVKRLK--DVTVSEKEFREKMEVVGSMDHENLV 375
VLG+G FG Y + G +VAVK LK + +++++ ++ ++ HEN+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 376 PLRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR---AI 430
+ + K L+ +Y+P+GSL L P + + L L A + +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---------PKHKLNLAQLLLFAQQICEGM 120
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI--DG-----YRA 483
AYLHS+ H ++ + N+LL +I DFGLA R+ DG + A
Sbjct: 121 AYLHSQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLN--EEGVDLPRWVQSVVKEEWTAE 541
E K S +DV+SFGV L ELLT Q+ EE + + +VV+ E
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR---LIE 235
Query: 542 VFD--LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589
+ + + L +N +E+ L++ NC RP+ + ++E+
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKEMH 282
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 81/302 (26%), Positives = 131/302 (43%), Gaps = 64/302 (21%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSEKEFR------EKMEVVGSMD 370
+ LG+G FG KA VAVK LKD +EK+ E M+++G
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGK-- 74
Query: 371 HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG--------RTPLNWETRSGL 422
H+N++ L +V +Y G+L L R G R P T+ L
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 423 ---ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID 479
A +R + +L SK H ++ + N+L+++ + +I+DFGLA + ID
Sbjct: 135 VSFAYQVARGMEFLASKKCI--HRDLAARNVLVTEDHVMKIADFGLAR------DIHHID 186
Query: 480 GYR------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDL 526
YR APE R + ++DV+SFGVLL E+ T G +P + EE L
Sbjct: 187 YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 246
Query: 527 PRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
+KE + E + QN +E+ L++ +C + P RP+ ++ ++
Sbjct: 247 -------LKEGYRME-------KPQNCTQELYHLMR---DCWHEVPSQRPTFKQLVEDLD 289
Query: 587 EI 588
+
Sbjct: 290 RM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 75/293 (25%), Positives = 131/293 (44%), Gaps = 63/293 (21%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLK-DVTVSEKE----------FREKMEVVGSMD 370
E++GKGT+G Y A + G ++AVK+++ T++ + R ++E + +D
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 371 HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGR------TPLNWETRSGLAL 424
H N+V + + + + +Y+P GS+ + L R GR + GLA
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFFTEQVLEGLA- 122
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS---PSSTPNRIDG- 480
YLHSKG H ++K+ N+L+ +ISDFG++ + + + G
Sbjct: 123 -------YLHSKGIL--HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 481 --YRAPEV--TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE 536
+ APEV + ++ S K D++S G ++LE+ G+ P W E
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------------W----SDE 215
Query: 537 EWTAEVFDLELLRYQ-NVEEEMVQLL-QLAIN----CTAQYPDNRPSMAEVTS 583
E A +F L R + ++ L +A++ C PDNRP+ E+
Sbjct: 216 EAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 54/279 (19%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFREKM---EVVGSMDHENLVPLRAY 380
LG G FG YKA E G + A K ++ T SE+E + M E++ + +H +V L
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 381 YYSRDEKLLVHDYMPMGSLSA-LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+Y + ++ ++ P G++ A +L +RG + R L A+ YLHS
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSMKII 132
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGY------RAPEVTDARKVS 493
H ++K+ N+LL+ + +++DFG++ A T R D + APEV +
Sbjct: 133 --HRDLKAGNVLLTLDGDIKLADFGVS--AKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 494 Q-----KADVYSFGVLLLELLTGKA------PTQALLNEEGVDLPRWVQSVVKEEWTAEV 542
KAD++S G+ L+E+ + P + LL + P Q +W+ E
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP---SKWSMEF 245
Query: 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
D L+ A++ ++P+ RPS A++
Sbjct: 246 RD---------------FLKTALD---KHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 23/200 (11%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEK----EFREKMEVVGSMDHENLVPLRA 379
+G+G G +KA E G VA+K++ + RE ++ + + H +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE-IKALQACQHPYVVKLLD 66
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ +LV +YMP LS +L + PL + +AY+H+ G
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLR-DE---ERPLPEAQVKSYMRMLLKGVAYMHANGIM 121
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP-------NRIDGYRAPEVT-DARK 491
H ++K +N+L+S +I+DFGLA L S R YRAPE+ ARK
Sbjct: 122 --HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR--WYRAPELLYGARK 177
Query: 492 VSQKADVYSFGVLLLELLTG 511
D+++ G + ELL G
Sbjct: 178 YDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLK----DVTVSE--KEFREKMEVVGSMDHENLV 375
E+LG G+FG+ Y+ L+ G AVK + T E K+ +++ ++ + H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 376 PLRAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPL-NWETRSGLALGASRAIAY 432
+ R+E L + +P GSL+ LL G+ P+ TR L + Y
Sbjct: 66 --QYLGTEREEDNLYIFLELVPGGSLAKLL-KKYGSFPEPVIRLYTRQILL-----GLEY 117
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDA 489
LH + H +IK +NIL+ + +++DFG+A S G + APEV
Sbjct: 118 LHDRNTV--HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 490 RKV-SQKADVYSFGVLLLELLTGKAP 514
+ AD++S G +LE+ TGK P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 63/233 (27%), Positives = 102/233 (43%), Gaps = 59/233 (25%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKRL-KDVTVSEKE----FREKMEVVGSMD-HENLV 375
+++G+G+F T A E A+K L K + EK+ EK EV+ ++ H ++
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEK-EVLTRLNGHPGII 65
Query: 376 PLRAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR----- 428
L YY +DE+ L V +Y P G L + L +R
Sbjct: 66 KL--YYTFQDEENLYFVLEYAPNGELLQYIR-------------KYGSLDEKCTRFYAAE 110
Query: 429 ---AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG----- 480
A+ YLHSKG H ++K NILL K +I+DFG A + P+S+P G
Sbjct: 111 ILLALEYLHSKGII--HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNI 168
Query: 481 -------------------YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
Y +PE+ + + + +D+++ G ++ ++LTGK P
Sbjct: 169 DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 61/204 (29%), Positives = 84/204 (41%), Gaps = 25/204 (12%)
Query: 324 VLGKGTFGTA----YKATLEMGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENL 374
V+GKG FG + T +M A+K + EK E+ ++ ++H L
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKM---FAMKYMNKQKCVEKGSVRNVLNER-RILQELNHPFL 62
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLS-ALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
V L + + LV D + G L L + + W LAL YL
Sbjct: 63 VNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLAL------EYL 116
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDAR 490
HSKG H +IK NILL + I+DF +A +P + G Y APEV +
Sbjct: 117 HSKGII--HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ 174
Query: 491 KVSQKADVYSFGVLLLELLTGKAP 514
S D +S GV E L GK P
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 62/218 (28%), Positives = 112/218 (51%), Gaps = 27/218 (12%)
Query: 307 KGDRAFDLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKM-- 363
GD L++ ++ +G+G+ G AT G VAVK++ D+ ++ RE +
Sbjct: 14 PGDPRSYLDNFVK-----IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQR--RELLFN 65
Query: 364 EVVGSMD--HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421
EVV D H N+V + + Y DE +V +++ G+L+ ++ R +N E +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAT 119
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR--ID 479
+ L +A+++LH++G H +IKS +ILL+ ++SDFG S P R +
Sbjct: 120 VCLAVLKALSFLHAQGVI--HRDIKSDSILLTSDGRVKLSDFGFCAQVS-KEVPRRKSLV 176
Query: 480 G---YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
G + APEV + D++S G++++E++ G+ P
Sbjct: 177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-15
Identities = 54/148 (36%), Positives = 69/148 (46%), Gaps = 4/148 (2%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
LSG++P + L L + L N G IP L L+ L L N FSGEIP L
Sbjct: 296 LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKH 355
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP-DLGAFSSLAQFNVSFNK 169
NL L+L+ NN +G I L L L N L G IP LGA SL + + N
Sbjct: 356 NNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS 415
Query: 170 LNGSIPKRFARLPSSAF---EGNSLCGK 194
+G +P F +LP F N+L G+
Sbjct: 416 FSGELPSEFTKLPLVYFLDISNNNLQGR 443
|
Length = 968 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 21/208 (10%)
Query: 318 LRASAEVLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFREK-------MEVVGSM 369
L + +G G+FG Y A + VVA+K++ + S K+ EK + + +
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKL 72
Query: 370 DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429
H N + R Y LV +Y +GS S LL + PL + + GA +
Sbjct: 73 RHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLE----VHKKPLQEVEIAAVTHGALQG 127
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDA 489
+AYLHS H ++K+ NILLS+ ++ DFG A + +P++ + APEV A
Sbjct: 128 LAYLHSHNMI--HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILA 185
Query: 490 RKVSQ---KADVYSFGVLLLELLTGKAP 514
Q K DV+S G+ +EL K P
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 22/222 (9%)
Query: 325 LGKGTFGTAYKATL------EMGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPL 377
LG+G FG + A + I+VAVK LKD + + K+F + E++ ++ HE++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALL--HGNRGA----GRTPLNWETRSGLALGASRAIA 431
D ++V +YM G L+ L HG G P L + A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAP 484
++ H ++ + N L+ ++ +I DFG++ S+ R+ G + P
Sbjct: 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY-STDYYRVGGHTMLPIRWMPP 191
Query: 485 EVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD 525
E RK + ++DV+S GV+L E+ T GK P L N E ++
Sbjct: 192 ESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 60/200 (30%), Positives = 104/200 (52%), Gaps = 22/200 (11%)
Query: 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKM--EVVGSMD--HENLVPLRA 379
+G+G+ G AT + G VAVK++ + +++ RE + EVV D HEN+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
Y DE +V +++ G+L+ ++ R +N E + + L RA++YLH++G
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR-----IDGYRAPEVTDARKVSQ 494
H +IKS +ILL+ ++SDFG S P R + APEV
Sbjct: 141 --HRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKSLVGTPYWMAPEVISRLPYGT 197
Query: 495 KADVYSFGVLLLELLTGKAP 514
+ D++S G++++E++ G+ P
Sbjct: 198 EVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 324 VLGKGTFGTAYKATLEM----GIVVAVKRLKDVTVSEKEFRE---KMEVVGSMDHENLVP 376
V+G G FG L++ I VA+K LK +EK+ R+ + ++G DH N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLK-AGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L ++V +YM GSL A L + G G+ G + + YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ----FTVIQLVGMLRGIASGMKYLSDM 125
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHL------ASPSSTPNRID-GYRAPEVTDA 489
G H ++ + NIL++ + ++SDFGL+ + A+ ++ +I + APE
Sbjct: 126 GYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183
Query: 490 RKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVDLP 527
RK + +DV+S+G+++ E+++ G+ P + N EEG LP
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 69/288 (23%), Positives = 121/288 (42%), Gaps = 48/288 (16%)
Query: 324 VLGKGTFGTAY----KATLEMG--IVVAVKRL--KDVTVSEKEFREKMEVVGSMDHENLV 375
LG+G FG + K E G +V VK L + EFR ++++ + H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRT----PLNWETRSGLALGASRAIA 431
L + ++ +Y +G L L + PL+ + + L + +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 432 YLHSKGPANS---HGNIKSSNILLSKSYEARISDFGLA--------HLASPSSTPNRIDG 480
+L +N+ H ++ + N L+S E ++S L+ + + P R
Sbjct: 132 HL-----SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR--- 183
Query: 481 YRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWT 539
+ APE S K+DV+SFGVL+ E+ T G+ P L +EE ++
Sbjct: 184 WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN-------------R 230
Query: 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
+ LEL + + +L+ C A P +RPS +E+ S + E
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMT---RCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 4e-14
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 36/215 (16%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRL----KDVTVSEKEFREKMEVVG---SMDHENLV 375
EVLGKG +GT Y G ++AVK++ +V +EKE+ + E V S+ H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNR-GAGRTP-LNWETRSGLALGASRAIAYL 433
+ + +++P GS+S++L NR G P T+ L +AYL
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQIL-----DGVAYL 118
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAH--------------LASPSSTPNRID 479
H+ H +IK +N++L + ++ DFG A L S TP
Sbjct: 119 HNNCVV--HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY--- 173
Query: 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+ APEV + +K+D++S G + E+ TGK P
Sbjct: 174 -WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 57/200 (28%), Positives = 105/200 (52%), Gaps = 22/200 (11%)
Query: 325 LGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFREKM--EVVGSMD--HENLVPLRA 379
+G+G+ G AT++ G +VAVK++ + +++ RE + EVV D HEN+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
Y DE +V +++ G+L+ ++ R +N E + + L +A++ LH++G
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR-----IDGYRAPEVTDARKVSQ 494
H +IKS +ILL+ ++SDFG S P R + APE+
Sbjct: 139 --HRDIKSDSILLTHDGRVKLSDFGFCAQVS-KEVPRRKSLVGTPYWMAPELISRLPYGP 195
Query: 495 KADVYSFGVLLLELLTGKAP 514
+ D++S G++++E++ G+ P
Sbjct: 196 EVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 325 LGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSEK-EFREKMEVVGSMDHENLVPL 377
LG+G FG + A + ++VAVK LK+ + S + +F+ + E++ + H+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALL--HG------NRGAGRTPLNWETRSGLALGASRA 429
L+V +YM G L+ L HG G P LA+ + A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YR 482
++ H ++ + N L+ + +I DFG++ S+ R+ G +
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY-STDYYRVGGRTMLPIRWM 191
Query: 483 APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD 525
PE RK + ++D++SFGV+L E+ T GK P L N E ++
Sbjct: 192 PPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 324 VLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE----FREKMEVVGSMDHENLVPLR 378
+G G +G A G VA+K++ +V + RE ++++ + HEN++ L
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-IKLLRHLRHENIIGLL 65
Query: 379 AYYYSRD----EKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
+ +V + M L ++ + PL + R + YL
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYL 119
Query: 434 HSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI--DG-----YRAPE 485
HS AN H ++K SNIL++ + + +I DFGLA P + YRAPE
Sbjct: 120 HS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176
Query: 486 V-TDARKVSQKADVYSFGVLLLELLTGKA 513
+ + + ++ D++S G + ELLT K
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 30/206 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM---DHENLVPLR 378
+ LG GTFG+ Y A E G +VA+K++K S +E EV +H N+V L+
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWET-RS---GLALGASRAIAYLH 434
+ DE V +YM G+L L+ +G P + RS + G +A++H
Sbjct: 65 EVFRENDELYFVFEYME-GNLYQLMKDRKG---KPFSESVIRSIIYQILQG----LAHIH 116
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPS------STPNRIDGYRAPEVT 487
G H ++K N+L+S +I+DFGLA + S ST R YRAPE+
Sbjct: 117 KHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST--R--WYRAPEIL 170
Query: 488 -DARKVSQKADVYSFGVLLLELLTGK 512
+ S D+++ G ++ EL T +
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 16/213 (7%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHE 372
D E+L E +GKG+FG +K V ++ D+ +E E + + + +
Sbjct: 1 DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 373 NLVPLRAYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429
+ + YY Y +D KL ++ +Y+ GS LL PL+ + + +
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKG 113
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPE 485
+ YLHS+ H +IK++N+LLS+ E +++DFG+A L N G + APE
Sbjct: 114 LDYLHSE--KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171
Query: 486 VTDARKVSQKADVYSFGVLLLELLTGKAPTQAL 518
V KAD++S G+ +EL G+ P L
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 29/205 (14%)
Query: 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVPLR 378
LG G FG ++ A+K +K + E F EK E++ +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEK-EILEECNHPFIVKLY 59
Query: 379 AYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
+ +D+K + + +Y G L +L R G + R +A A YLH++
Sbjct: 60 RTF--KDKKYIYMLMEYCLGGELWTIL---RDRGLFD-EYTARFYIA-CVVLAFEYLHNR 112
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-------TPNRIDGYRAPEVTDA 489
G + ++K N+LL + ++ DFG A TP Y APE+
Sbjct: 113 GII--YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTP----EYVAPEIILN 166
Query: 490 RKVSQKADVYSFGVLLLELLTGKAP 514
+ D +S G+LL ELLTG+ P
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 60/203 (29%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 324 VLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKE-FREKMEVVGSMDHENLVPLRAYY 381
VLGKGT+G Y A L + +A+K + + + E++ + + H N+V
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRG---AGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+ + +P GSLSALL G + + T+ L + YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDNQI 129
Query: 439 ANSHGNIKSSNILLSK-SYEARISDFG----LAHLASPSSTPNRIDGYRAPEVTD--ARK 491
H +IK N+L++ S +ISDFG LA + + T Y APEV D R
Sbjct: 130 V--HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 492 VSQKADVYSFGVLLLELLTGKAP 514
AD++S G ++E+ TGK P
Sbjct: 188 YGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 29/227 (12%)
Query: 325 LGKGTFGTAYKAT------LEMGIVVAVKRLKDVTVS-EKEFREKMEVVGSMDHENLVPL 377
LG+G FG + A + ++VAVK LKD T++ K+F+ + E++ ++ HE++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALL--HGNRG---AGRTPLNWETRSGL------ALGA 426
D ++V +YM G L+ L HG P + GL A
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 427 SRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------ 480
+ + YL S+ H ++ + N L+ + +I DFG++ S+ R+ G
Sbjct: 133 ASGMVYLASQHFV--HRDLATRNCLVGANLLVKIGDFGMSRDVY-STDYYRVGGHTMLPI 189
Query: 481 -YRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD 525
+ PE RK + ++DV+SFGV+L E+ T GK P L N E ++
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 57/217 (26%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSEKEFRE---KMEVVGSMDHENLV 375
EV+G G FG + L++ I VA+K LK +EK+ R+ + ++G DH N++
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L +++ ++M G+L + L N G T + G+ G + + YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ-FTVIQL---VGMLRGIAAGMKYLSE 124
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSSTPNRIDG--------YRAPEV 486
H ++ + NIL++ + ++SDFGL+ L +S P + APE
Sbjct: 125 MNYV--HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 487 TDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
RK + +DV+S+G+++ E+++ G+ P + N++
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 47/180 (26%), Positives = 72/180 (40%), Gaps = 48/180 (26%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
+G++P+A+ +L L + L N G IP + K +NL L L N +GEIP L S
Sbjct: 320 FTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSS 379
Query: 111 GNLI------------------------RLNLAKNNFSGTISADFNKL------------ 134
GNL R+ L N+FSG + ++F KL
Sbjct: 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNN 439
Query: 135 ------------TRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLP 182
L L L N+ G +PD L ++S N+ +G++P++ L
Sbjct: 440 LQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499
|
Length = 968 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPL 377
+G G +G A + G VA+K+L + +++ +RE + ++ MDHEN++ L
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRE-LRLLKHMDHENVIGL 79
Query: 378 RAYYYSRDEKLLVHD-YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
+ D Y+ + A L N L+ + L R + Y+HS
Sbjct: 80 LDVFTPASSLEDFQDVYLVTHLMGADL--NNIVKCQKLSDDHIQFLVYQILRGLKYIHSA 137
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------YRAPEVT-DA 489
G H ++K SNI +++ E +I DFGLA T G YRAPE+ +
Sbjct: 138 GII--HRDLKPSNIAVNEDCELKILDFGLARHTDDEMT-----GYVATRWYRAPEIMLNW 190
Query: 490 RKVSQKADVYSFGVLLLELLTGK 512
+Q D++S G ++ ELLTGK
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-13
Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFREKM---EVVGSMDHENLVPL-RA 379
LG G FG YKA E G++ A K + T SE+E + M +++ S DH N+V L A
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 380 YYYSRDEKLLVHDYMPMGSLSA-LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+YY + +L+ ++ G++ A +L R + + L A+ YLH
Sbjct: 71 FYYENNLWILI-EFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLHENKI 124
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGY------RAPEV-----T 487
H ++K+ NIL + + +++DFG++ A + T R D + APEV +
Sbjct: 125 I--HRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAPTQAL 518
R KADV+S G+ L+E+ + P L
Sbjct: 181 KDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 41/219 (18%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLVPL 377
LG+GTFG YKA ++ G VVA+K++ + +EK+ RE ++++ + H N+VPL
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI--LMHNEKDGFPITALRE-IKILKKLKHPNVVPL 72
Query: 378 RAYYYSRDEKL--------LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429
R +K +V YM LS LL L L
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLENPS----VKLTESQIKCYMLQLLEG 127
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG-------- 480
I YLH H +IK++NIL+ +I+DFGLA P P G
Sbjct: 128 INYLHENHIL--HRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTN 185
Query: 481 ------YRAPE-VTDARKVSQKADVYSFGVLLLELLTGK 512
YR PE + R+ + D++ G + E+ T +
Sbjct: 186 LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 324 VLGKGTFGTA----YKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
V+G+G+FG A + + + + ++ K + E +E + ++ M H N+V +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV-LLAKMKHPNIVAFKE 65
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRG---AGRTPLNWETRSGLALGASRAIAYLHSK 436
+ + +V +Y G L + RG T L W + L + ++H K
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLG------VQHIHEK 119
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSSTPNRIDG---YRAPEVTDARKV 492
H +IKS NI L+++ + ++ DFG A L SP + G Y PE+ +
Sbjct: 120 RVL--HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPY 177
Query: 493 SQKADVYSFGVLLLELLTGKAPTQA 517
+ K+D++S G +L EL T K P QA
Sbjct: 178 NNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 9e-13
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 25/208 (12%)
Query: 323 EVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLV 375
+VLG G FGT YK ++ I VA+K L++ T + KE ++ V+ S+D+ ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALL--HGNRGAGRTPLNWETRSGLALGASRAIAYL 433
L + +L+ MP G L + H + + LNW + ++ + YL
Sbjct: 73 RLLGICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAP------EVT 487
+ H ++ + N+L+ +I+DFGLA L +G + P E
Sbjct: 126 EERRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183
Query: 488 DARKVSQKADVYSFGVLLLELLT-GKAP 514
R + ++DV+S+GV + EL+T G P
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 28/205 (13%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLK-----DVTVSEKEFREKMEVVGSMDHENLVPLR 378
+G GT+G YKA L G + AVK +K D ++ ++E + +V H N+V
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQE----IFMVKECKHCNIVAYF 72
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
Y SR++ + +Y GSL + H + + R L + +AYLHSKG
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKG- 126
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGY------RAPEVTDARK- 491
H +IK +NILL+ + + +++DFG+A A ++T + + APEV K
Sbjct: 127 -KMHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 492 --VSQKADVYSFGVLLLELLTGKAP 514
+Q D+++ G+ +EL + P
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 33/211 (15%)
Query: 325 LGKGTFGTAYKATL----EMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVPL 377
+G+G+FG KA L E G +K + +S KE R+++ V+ +M H N+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRG---AGRTPLNWETRSGLALGASRAIAYLH 434
+ + +V DY G L ++ RG L+W + LAL ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVH 118
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--------STPNRIDGYRAPEV 486
+ H +IKS NI L+K ++ DFG+A + + + TP Y +PE+
Sbjct: 119 DRKIL--HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY----YLSPEI 172
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKAPTQA 517
+ R + K+D+++ G +L E+ T K +A
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 20/197 (10%)
Query: 325 LGKGTFGTAYKATLEM-GIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
+G G FG A ++ G VA+K++ ++++ +RE ++++ + HEN++ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRE-LKLLKHLRHENIISLSD 76
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ S E + Y L LH R PL + R + Y+HS G
Sbjct: 77 IFISPLEDI----YFVTELLGTDLH--RLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVV 130
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSST---PNRIDGYRAPEVT-DARKVSQK 495
H ++K SNIL++++ + +I DFGLA + P T R YRAPE+ +K +
Sbjct: 131 --HRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY--YRAPEIMLTWQKYDVE 186
Query: 496 ADVYSFGVLLLELLTGK 512
D++S G + E+L GK
Sbjct: 187 VDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 66/238 (27%), Positives = 108/238 (45%), Gaps = 37/238 (15%)
Query: 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLK-DVTVSEKEFR----EKMEVVGSMDHENLVP 376
++LGKG+FG + A L+ A+K LK DV + + + EK + + +H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWET--RSGLALGASRAIAYLH 434
L + +++ V +Y+ G L + H + + L T + + G + +LH
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFH-IQSCHKFDLPRATFYAAEIICG----LQFLH 113
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGL--------AHLASPSSTPNRIDGYRAPEV 486
SKG + ++K NILL +I+DFG+ A + TP+ Y APE+
Sbjct: 114 SKGIV--YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD----YIAPEI 167
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVD--------LPRWVQSVVKE 536
+K + D +SFGVLL E+L G++P EE PRW+ K+
Sbjct: 168 LLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFR-EKMEVVGSMDHENLVPLRAY 380
E +G+G GT Y A + G VA+K++ +KE ++ V+ H N+V
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
Y DE +V +Y+ GSL+ ++ T ++ + + +A+ +LHS
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSNQVI- 137
Query: 441 SHGNIKSSNILLSKSYEARISDFGLAHLASPS----STPNRIDGYRAPEVTDARKVSQKA 496
H +IKS NILL +++DFG +P ST + APEV + K
Sbjct: 138 -HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 497 DVYSFGVLLLELLTGKAPTQALLNE 521
D++S G++ +E++ G+ P LNE
Sbjct: 197 DIWSLGIMAIEMVEGEPP---YLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 67/286 (23%), Positives = 118/286 (41%), Gaps = 54/286 (18%)
Query: 325 LGKGTFGTAYKATLEMGIVVA---VKRLKDVTVSEKE---FREKMEVVGSMDHENLVPLR 378
+G G FG G+ A VK L+ + + E F ++++ ++H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRA-SATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
LLV ++ P+G L L NRG + +A + + +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 439 AN-SHGNIKSSNILLSKSYEARISDFGLAHLASPSS---------TPNRIDGYRAPEVTD 488
A+ H ++ N L+ +I D+GLA P P R + APE+ +
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR---WLAPELVE 175
Query: 489 AR-------KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541
R ++K++++S GV + EL T L++E V ++ VV+E+
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQ---- 226
Query: 542 VFDLEL------LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
D++L L+Y + E++Q L P+ RP+ EV
Sbjct: 227 --DIKLPKPQLDLKYSDRWYEVMQFCWLD-------PETRPTAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 33/219 (15%)
Query: 323 EVLGKGTFGTAYKATLEM----GIVVAVKRLK---DVTVSEKEFREKMEVVGSMDHENLV 375
+G+G FG Y+ I VAVK K +V EK F ++ ++ DH ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIV 70
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA---SRAIAY 432
L + + +V + P+G L + L N+ + L L + S A+AY
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQVNK-------YSLDLASLILYSYQLSTALAY 122
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL--------ASPSSTPNRIDGYRAP 484
L SK H +I + N+L+S ++ DFGL+ AS P + + AP
Sbjct: 123 LESKRFV--HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK---WMAP 177
Query: 485 EVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
E + R+ + +DV+ FGV + E+L G P Q + N +
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 75/284 (26%), Positives = 132/284 (46%), Gaps = 48/284 (16%)
Query: 323 EVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTVSE--KEFREKMEVVGSM-DHENLVP 376
+V+G+G FG KA ++ + + A+KR+K+ + ++F ++EV+ + H N++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRG---------AGRTPLNWETRSGLALGA- 426
L R L +Y P G+L L +R A T ++ L A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 427 -SRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA--HLASPSSTPNRID-GYR 482
+R + YL K H ++ + NIL+ ++Y A+I+DFGL+ T R+ +
Sbjct: 133 VARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 190
Query: 483 APEVTDARKVSQKADVYSFGVLLLELLT-GKAP----TQALLNEEGVDLPRWVQSVVKEE 537
A E + + +DV+S+GVLL E+++ G P T A L E+ LP+
Sbjct: 191 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---LPQG-------- 239
Query: 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ LE + N ++E+ L++ C + P RPS A++
Sbjct: 240 -----YRLE--KPLNCDDEVYDLMR---QCWREKPYERPSFAQI 273
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 68/283 (24%), Positives = 117/283 (41%), Gaps = 55/283 (19%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKM--EV--VGSMDHENLVPL 377
E +GKG+FGT K G ++ K + ++EKE ++++ EV + + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE-KQQLVSEVNILRELKHPNIVR- 63
Query: 378 RAYYYSRD---EKLLVHDYMPM---GSLSALL-HGNRGAGRTPLN--WETRSGLALGASR 428
YY R ++ M G L+ L+ + W + L L
Sbjct: 64 ---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL---- 116
Query: 429 AIAYLHSKGPANS---HGNIKSSNILLSKSYEARISDFGLAHLASPSS--------TPNR 477
A+ H++ + H ++K +NI L + ++ DFGLA + S TP
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY- 175
Query: 478 IDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE 537
Y +PE + +K+D++S G L+ EL P A + + S +KE
Sbjct: 176 ---YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKIKE- 224
Query: 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAE 580
+ + RY E+ ++++ +N PD RPS E
Sbjct: 225 --GKFRRIP-YRYS---SELNEVIKSMLNVD---PDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 28/202 (13%)
Query: 328 GTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLVPLRAY 380
GT+G Y+A + G +VA+K+LK EKE RE + ++ + H N+V ++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLRE-INILLKLQHPNIVTVKEV 72
Query: 381 YY-SRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
S +K+ +V +Y+ L +L+ + E + L L +A+LH
Sbjct: 73 VVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS---EVKC-LMLQLLSGVAHLHD--- 124
Query: 439 ANS--HGNIKSSNILLSKSYEARISDFGLAHL-ASPSS--TPNRID-GYRAPEVT-DARK 491
N H ++K+SN+LL+ +I DFGLA SP T + YRAPE+ A++
Sbjct: 125 -NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKE 183
Query: 492 VSQKADVYSFGVLLLELLTGKA 513
S D++S G + ELLT K
Sbjct: 184 YSTAIDMWSVGCIFAELLTKKP 205
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFR-EKMEVVGSMDHENLVPLRAY 380
E +G+G GT + A + G VA+K++ +KE ++ V+ + + N+V
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+ DE +V +Y+ GSL+ ++ T ++ + + +A+ +LH AN
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVV------TETCMDEAQIAAVCRECLQALEFLH----AN 134
Query: 441 S--HGNIKSSNILLSKSYEARISDFGLAHLASPS----STPNRIDGYRAPEVTDARKVSQ 494
H +IKS N+LL +++DFG +P ST + APEV +
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 495 KADVYSFGVLLLELLTGKAPTQALLNE 521
K D++S G++ +E++ G+ P LNE
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP---YLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 58/204 (28%), Positives = 93/204 (45%), Gaps = 28/204 (13%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFREKMEVVG--------SMDHENLV 375
+G+GT+G Y+A G +VA+K+++ + E R+ + + ++ H N+V
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVR----MDNE-RDGIPISSLREITLLLNLRHPNIV 69
Query: 376 PLRAYYYSR--DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
L+ + D LV +Y L++LL TP + L L R + YL
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYL 124
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---SSTPNRID-GYRAPEVTDA 489
H H ++K SN+LL+ +I+DFGLA TP + YRAPE+
Sbjct: 125 HENFII--HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 490 RKVSQKA-DVYSFGVLLLELLTGK 512
A D+++ G +L ELL K
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 57/212 (26%), Positives = 100/212 (47%), Gaps = 24/212 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV--TVSEKE-----FREKMEVVGSMDHENL 374
+ LG G F + Y+A ++ G ++AVK++ V T SE+E R+++ ++ ++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ + L ++M GS+S LL + T L R ++YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL-----RGLSYLH 120
Query: 435 SKGPANSHGNIKSSNILL-SKSYEARISDFGLA-HLASPSSTPNRIDG-------YRAPE 485
H ++K +N+L+ S RI+DFG A LA+ + G + APE
Sbjct: 121 ENQII--HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 486 VTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517
V + + DV+S G +++E+ T K P A
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 59/235 (25%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 323 EVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTVSEK--EFREKMEVVGSMDHENLV 375
E LG+ FG YK L + +VA+K LKD+ ++ EF+++ ++ + H N+V
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALL-----HGNRGAG-------RTPLNWETRSGLA 423
L ++ +Y+ G L L H + G ++ L+ +A
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 424 LGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH---------LASPSST 474
+ + + YL S H ++ + NIL+ + +ISD GL+ + S
Sbjct: 131 IQIAAGMEYLSSH--FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPR 528
P R + PE K S +D++SFGV+L E+ + G P N+E +++ R
Sbjct: 189 PIR---WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 31/205 (15%)
Query: 325 LGKGTFGTAYKATLEMG------IVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLR 378
+G GTFG + + V+A+ + + + EK V+ + H ++ R
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEK-RVLKEVSHPFII--R 65
Query: 379 AYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS--RAIAYLH 434
++ D++ L + +Y+P G L + L R +GR + +GL + A+ YLH
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYL---RNSGR----FSNSTGLFYASEIVCALEYLH 118
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPNRIDGYRAPEVTDA 489
SK + ++K NILL K +++DFG A + TP Y APEV +
Sbjct: 119 SKEIV--YRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE----YLAPEVIQS 172
Query: 490 RKVSQKADVYSFGVLLLELLTGKAP 514
+ ++ D ++ G+L+ E+L G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK------DVTVSEKEFREKMEVVGSMDHENLV 375
E++G+G +G Y+ + G VVA+K + DV+ ++E ++ S N+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQS-QPPNIT 65
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
Y ++ +Y GS+ L+ A + ++ R L A+ Y+H
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY-ISVIIREVLV-----ALKYIHK 119
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEV-TDAR 490
G H +IK++NIL++ + ++ DFG+ A L SS + G + APEV T+ +
Sbjct: 120 VGVI--HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 491 KVSQKADVYSFGVLLLELLTGKAP 514
KAD++S G+ + E+ TG P
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 70/278 (25%), Positives = 134/278 (48%), Gaps = 48/278 (17%)
Query: 324 VLGKGTFGTAY----KATLEMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVP 376
V+G+G FG + KA ++ V +K++ +++ E + + +V+ + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKL---VIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII- 62
Query: 377 LRAYYYS--RDEKL-LVHDYMPMGSLSALLHGNRGA---GRTPLNWETRSGLALGASRAI 430
YY + D+ L +V +Y P G+L+ + + T L++ + LAL
Sbjct: 63 --EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL------ 114
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEA-RISDFGLAHLASPSSTPNRIDG---YRAPEV 486
++H+K H ++K+ NILL K +I DFG++ + S S + G Y +PE+
Sbjct: 115 HHVHTKLIL--HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPEL 172
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546
+ + +QK+D+++ G +L EL + K +A E +LP V ++ + A + D
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLK---RAF---EAANLPALVLKIMSGTF-APISD-- 223
Query: 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584
RY L QL ++ P RP ++++ +Q
Sbjct: 224 --RYSP------DLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 22/229 (9%)
Query: 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLK-DVTVSEKEFR----EKMEVVGSMDHENLVP 376
+VLGKG+FG A L+ G AVK LK DV + + + EK + + ++ L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L + +++ V +++ G L + H + GR L T + + +LHSK
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL--MFH-IQDKGRFDLYRATFYAAEIVC--GLQFLHSK 115
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHL----ASPSSTPNRIDGYRAPEVTDARKV 492
G + ++K N++L + +I+DFG+ + +ST Y APE+ K
Sbjct: 116 G--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 493 SQKADVYSFGVLLLELLTGKAPTQA-----LLNEEGVDLPRWVQSVVKE 536
+ D +SFGVLL E+L G++P L VD P + + + KE
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKE 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPL 377
++G+G++G K E G +VA+K+ D V + RE + ++ + HENLV L
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE-IRMLKQLRHENLVNL 65
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ + LV +++ L L G L+ R I + HS
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCHSHN 120
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSST-----PNRIDGYRAPE--VTDA 489
H +IK NIL+S+S ++ DFG A LA+P R YRAPE V D
Sbjct: 121 II--HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR--WYRAPELLVGDT 176
Query: 490 RKVSQKADVYSFGVLLLELLTG 511
K + D+++ G L+ E+LTG
Sbjct: 177 -KYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 56/221 (25%), Positives = 107/221 (48%), Gaps = 17/221 (7%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK-DVTVS-EKEFREKMEVVGSMDHENLVPLRA 379
E+LG G GT YKA L ++AVK + D+TV +K+ ++E++ D ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
++ + + ++M GSL + P + R +A+ + + YL S
Sbjct: 67 AFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGR--IAVAVVKGLTYLWSLKIL 117
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAH--LASPSSTPNRIDGYRAPEVTDARKVSQKAD 497
H ++K SN+L++ + ++ DFG++ + S + T + Y APE + +D
Sbjct: 118 --HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 498 VYSFGVLLLELLTGKAPTQALLNEEGVDLP-RWVQSVVKEE 537
V+S G+ +EL G+ P + +G +P + +Q +V E+
Sbjct: 176 VWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 42/217 (19%)
Query: 323 EVLGKGTFGTAY---KAT-LEMGIVVAVKRLKDVTVSEKE-FREKME--VVGSMDHENLV 375
+VLG+G+FG + K T + G + A+K LK T+ ++ R KME ++ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 376 PLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETR----------SGLAL 424
L Y + + KL L+ D++ G L T L+ E + LAL
Sbjct: 62 KLH-YAFQTEGKLYLILDFLRGGDLF-----------TRLSKEVMFTEEDVKFYLAELAL 109
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-----HLASPSSTPNRID 479
A+ +LHS G + ++K NILL + +++DFGL+ H S ++
Sbjct: 110 ----ALDHLHSLGII--YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQ 516
Y APEV + R +Q AD +SFGVL+ E+LTG P Q
Sbjct: 164 -YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 41/232 (17%)
Query: 324 VLGKGTFG----TAYKATLEMGIVVAVKRLKDVTVSEKEFR----EKMEVVGSMDHENLV 375
VLGKG+FG K T E+ V +K KDV + + + EK + + H L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLK--KDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL-ALGASRAIAYLH 434
L + + ++D V +Y+ G L + H R +GR E R+ A + +LH
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDL--MFHIQR-SGRFD---EPRARFYAAEIVLGLQFLH 113
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGL--------AHLASPSSTPNRIDGYRAPEV 486
+G + ++K N+LL +I+DFG+ ++ TP+ Y APE+
Sbjct: 114 ERGII--YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPD----YIAPEI 167
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKAP---------TQALLNEEGVDLPRW 529
+ D ++ GVLL E+L G++P Q++L +E V PRW
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE-VRYPRW 218
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 25/205 (12%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLV 375
E LG+GT+ T YK G +VA LK++ + +E RE + ++ + HEN+V
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVA---LKEIHLDAEEGTPSTAIRE-ISLMKELKHENIV 61
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALL--HGNRGAGRTPLNWETRSGLALGASRAIAYL 433
L ++ ++ +LV +YM L + HG RGA L+ T + IA+
Sbjct: 62 RLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGA----LDPNTVKSFTYQLLKGIAFC 116
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSST-PNRIDG--YRAPEV-TD 488
H H ++K N+L++K E +++DFGLA P +T N + YRAP+V
Sbjct: 117 HENRVL--HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 489 ARKVSQKADVYSFGVLLLELLTGKA 513
+R S D++S G ++ E++TG+
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGRP 199
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 30/209 (14%)
Query: 323 EVLGKGTFGTAYKATLEMG---IVVAVKRLKDVTVSEKEFREKMEVV--GSMDHENLVPL 377
+ +G+G+FG Y A + V+ L + V EKE +K EV+ M H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK-EVILLAKMKHPNIVTF 64
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTP---LNWETRSGLALGASRAIAYLH 434
A + +V +Y G L ++ RG + L+W + L L ++H
Sbjct: 65 FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL------KHIH 118
Query: 435 SKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLASPSS--------TPNRIDGYRAPE 485
+ H +IKS NI LSK+ A++ DFG+A + S TP Y +PE
Sbjct: 119 DRKIL--HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY----YLSPE 172
Query: 486 VTDARKVSQKADVYSFGVLLLELLTGKAP 514
+ R + K D++S G +L EL T K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 56/290 (19%)
Query: 324 VLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVP 376
VLG G FGT YK + I VA+K L++ T + KE ++ V+ + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRG--AGRTPLNWETRSGLALGASRAIAYLH 434
L + +L V MP G L + N+ + LNW + ++ ++YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE 126
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAP------EVTD 488
H ++ + N+L+ +I+DFGLA L T DG + P E
Sbjct: 127 EVRLV--HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 489 ARKVSQKADVYSFGVLLLELLT-GKAPTQAL-------LNEEGVDLPRWVQSVVKEEWTA 540
R+ + ++DV+S+GV + EL+T G P + L E+G LP+ T
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ------PPICTI 238
Query: 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590
+V+ + + C + RP E+ + + R
Sbjct: 239 DVY------------------MIMVKCWMIDSECRPRFRELVDEFSRMAR 270
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 66/298 (22%), Positives = 123/298 (41%), Gaps = 59/298 (19%)
Query: 325 LGKGTFGTAYKATL------EMGIVVAVKRLKD--VTVSEKEFREKMEVVGSMDHENLVP 376
+G+G FG ++A E +VAVK LK+ + +F+ + ++ DH N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNR-----------------GAGRTPLNWETR 419
L L+ +YM G L+ L G PL+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 420 SGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH---------LAS 470
+A + +AYL + H ++ + N L+ ++ +I+DFGL+ +
Sbjct: 133 LCIAKQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE 190
Query: 471 PSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRW 529
+ P R + PE + + ++DV+++GV+L E+ + G P + +EE +
Sbjct: 191 NDAIPIR---WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI----- 242
Query: 530 VQSVVKEEWTAEVFDLELLRY-QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
V D +L N E+ L++L C ++ P +RPS A + ++
Sbjct: 243 ----------YYVRDGNVLSCPDNCPLELYNLMRL---CWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY- 381
E +GKG+FG YK V ++ D+ +E E + + + + + + YY
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 382 -YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
Y + KL ++ +Y+ GS LL PL + + + + YLHS+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSE--R 121
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEVTDARKVSQK 495
H +IK++N+LLS+ + +++DFG+A L N G + APEV K
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 496 ADVYSFGVLLLELLTGKAPTQAL 518
AD++S G+ +EL G+ P L
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 75/242 (30%), Positives = 117/242 (48%), Gaps = 47/242 (19%)
Query: 308 GDRAFDLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE------FR 360
G R D D++ +G+GT+G YKA + G +VA+K+++ +EKE R
Sbjct: 2 GKRCVDKFDII----GQIGEGTYGQVYKARDKDTGELVALKKVR--LDNEKEGFPITAIR 55
Query: 361 EKMEVVGSMDHENLVPLRAYYYSRDEKL----------LVHDYMP---MGSL-SALLHGN 406
E ++++ ++H N+V L+ + + L LV +YM MG L S L+H +
Sbjct: 56 E-IKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFS 114
Query: 407 RGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466
++ + + GL Y H K H +IK SNILL+ + +++DFGLA
Sbjct: 115 EDHIKSFMK-QLLEGLN--------YCHKKNFL--HRDIKCSNILLNNKGQIKLADFGLA 163
Query: 467 HL-ASPSSTP--NRIDG--YRAPE-VTDARKVSQKADVYSFGVLLLELLTGKAPTQALLN 520
L S S P N++ YR PE + + DV+S G +L EL T K QA N
Sbjct: 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA--N 221
Query: 521 EE 522
+E
Sbjct: 222 QE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 52/203 (25%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 327 KGTFGTAYKATLEM-GIVVAVKRLKDVT-VSEKEFR----EKMEVVGSMDHENLVPLRAY 380
KG FG+ Y A G A+K LK +++ + E+ ++ + + L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETR--SGLALGASRAIAYLHSKGP 438
+ S+D LV +Y+ G ++L+ + G P +W + + + LG + LH +G
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDWAKQYIAEVVLG----VEDLHQRGI 118
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAH--LASP--SSTPNRIDGYRAPEVTDARKVSQ 494
H +IK N+L+ ++ +++DFGL+ L + TP+ Y APE +
Sbjct: 119 I--HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD----YLAPETILGVGDDK 172
Query: 495 KADVYSFGVLLLELLTGKAPTQA 517
+D +S G ++ E L G P A
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPFHA 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 46/217 (21%)
Query: 326 GKGTFGTAYKA---TLEMGIVVAVKRLK-----DVTVSEKEFREKMEVVGSMDHENLVPL 377
G+GT+G YKA + G A+K+ K +S+ RE + ++ + HEN+V L
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE-IALLRELKHENVVSL 67
Query: 378 RAYYYSRDEKL--LVHDYMPMGSLSALLHGNRGAGRTPLN--------WETRSGLALGAS 427
+ +K L+ DY L ++ +R A R + W+ +G
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG------ 120
Query: 428 RAIAYLHSKGPAN--SHGNIKSSNILLSKSYEAR----ISDFGLAHL-ASPSSTPNRIDG 480
+ YLHS N H ++K +NIL+ R I D GLA L +P +D
Sbjct: 121 --VHYLHS----NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 481 ------YRAPEVT-DARKVSQKADVYSFGVLLLELLT 510
YRAPE+ AR ++ D+++ G + ELLT
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLK-----DVTVSEKEFREKMEVVGSMDHENLVPLR 378
+G GT+G YKA + G + A+K +K D V ++E + ++ H N+V
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQE----IIMMKDCKHSNIVAYF 72
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
Y RD+ + ++ GSL + H + + + +R L + + YLHSKG
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKG- 126
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDARK--- 491
H +IK +NILL+ + +++DFG+ A + + + G + APEV +
Sbjct: 127 -KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 492 VSQKADVYSFGVLLLELLTGKAP 514
+Q D+++ G+ +EL + P
Sbjct: 186 YNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 26/214 (12%)
Query: 325 LGKGTFGTAYKATLEM---GIVVAVKRLKDVTVSEKEFREKM----EVVGSMDHENLVPL 377
LG G FG K +M I VA+K LK+ EK R++M E++ +D+ +V
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIV-- 58
Query: 378 RAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
R E L LV + G L+ L + + L S + YL K
Sbjct: 59 RMIGVCEAEALMLVMEMASGGPLNKFL----SGKKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGL--AHLASPSSTPNRIDG-----YRAPEVTDA 489
H ++ + N+LL + A+ISDFGL A A S R G + APE +
Sbjct: 115 NFV--HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 490 RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
RK S ++DV+S+G+ + E + G+ P + + E
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 67/278 (24%), Positives = 106/278 (38%), Gaps = 55/278 (19%)
Query: 325 LGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEK----------EFREKMEVVGSMDHEN 373
LG+GTF YK L + V ++V+V K F E ++ + H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
LV L RDE ++V +Y+ G L LH + L+W+ +A + A+ YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNN--VSLHWKLD--VAKQLASALHYL 117
Query: 434 HSKGPANSHGNIKSSNILLSK-------SYEARISDFGLAHLASPSSTPNRIDGYRAPEV 486
K HGN+ NIL+++ ++SD G+ + APE
Sbjct: 118 EDKKLV--HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPEC 175
Query: 487 --TDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543
++ AD +SFG LLE+ + G+ P L + E
Sbjct: 176 IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--------------------- 214
Query: 544 DLELLRYQNV----EEEMVQLLQLAINCTAQYPDNRPS 577
+ YQ+ + +L L C P RPS
Sbjct: 215 --KERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 43/224 (19%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSE--KEFREKMEVVG-------------S 368
LG+GT+G KA G +VA+K++K + +S + R+ + + G
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 369 MDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR 428
+ HEN++ L Y D LV D M L ++ + L + L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILN 130
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA--HLASPSSTPNRIDG------ 480
+ LH H ++ +NI ++ +I+DFGLA + P S D
Sbjct: 131 GLNVLHKWYFM--HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 481 ----------YRAPE-VTDARKVSQKADVYSFGVLLLELLTGKA 513
YRAPE + A K D++S G + ELLTGK
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232
|
Length = 335 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 41/217 (18%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFREKM---EVVGSMDHENLVPLRAY 380
LG G FG YKA E G+ A K ++ SE+E + M +++ H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA--------Y 432
Y+ ++ ++ ++ G+L +++ E GL R + +
Sbjct: 71 YFYENKLWILIEFCDGGALDSIML------------ELERGLTEPQIRYVCRQMLEALNF 118
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGY------RAPEV 486
LHS H ++K+ NILL+ + +++DFG++ A ST + D + APEV
Sbjct: 119 LHSHKVI--HRDLKAGNILLTLDGDVKLADFGVS--AKNKSTLQKRDTFIGTPYWMAPEV 174
Query: 487 ----TDA-RKVSQKADVYSFGVLLLELLTGKAPTQAL 518
T KAD++S G+ L+EL + P L
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 31/209 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV---TVSEKEFREKMEVVGSMDHENLVPLR 378
+G+G +G AT G+ VA+K++ T ++ RE ++++ HEN++ +
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLRE-IKILRRFKHENIIGIL 69
Query: 379 AYYYSRD-----EKLLVHDYMPMGSLSALLHGNRGAGRT-PLNWETRSGLALGASRAIAY 432
+ +V + M L L+ +T L+ + R + Y
Sbjct: 70 DIIRPPSFESFNDVYIVQELMET-DLYKLI-------KTQHLSNDHIQYFLYQILRGLKY 121
Query: 433 LHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI-------DGYRAP 484
+HS AN H ++K SN+LL+ + + +I DFGLA +A P YRAP
Sbjct: 122 IHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178
Query: 485 EVTDARKVSQKA-DVYSFGVLLLELLTGK 512
E+ K KA D++S G +L E+L+ +
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 320 ASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE----KEFREKMEVVGSMDHENL 374
S + +G G +G+ A G VA+K+L SE + +RE + ++ M HEN+
Sbjct: 18 TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRE-LTLLKHMQHENV 76
Query: 375 VPLRAYYYSRDEKLLVHD-YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
+ L + S D Y+ M + L G PL+ + L + Y+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYI 133
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-YRAPEVT-DARK 491
HS G H ++K N+ +++ E +I DFGLA A T + YRAPEV +
Sbjct: 134 HSAGII--HRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 492 VSQKADVYSFGVLLLELLTGK 512
+Q D++S G ++ E+LTGK
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHE 372
D E+L E +GKG+FG +K V ++ D+ +E E + + + +
Sbjct: 1 DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 373 NLVPLRAYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429
+ + YY Y + KL ++ +Y+ GS LL P + + + +
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG------PFDEFQIATMLKEILKG 113
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPE 485
+ YLHS+ H +IK++N+LLS+ + +++DFG+A L N G + APE
Sbjct: 114 LDYLHSE--KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 171
Query: 486 VTDARKVSQKADVYSFGVLLLELLTGKAP 514
V KAD++S G+ +EL G+ P
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 29/219 (13%)
Query: 312 FDLEDLLRASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKME---VVG 367
DL DL +G GT G YK + G V+AVK+++ E+ R M+ V+
Sbjct: 12 ADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 368 SMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG-LALGA 426
S D +V Y+ + + + + M L LL R G P E G + +
Sbjct: 70 SHDCPYIVKCYGYFITDSDVFICMELMST-CLDKLL--KRIQGPIP---EDILGKMTVAI 123
Query: 427 SRAIAYLHSKGPANSHG----NIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-- 480
+A+ YL K HG ++K SNILL S ++ DFG++ S R G
Sbjct: 124 VKALHYLKEK-----HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCA 178
Query: 481 -YRAPEVTDARKVSQK----ADVYSFGVLLLELLTGKAP 514
Y APE D + K ADV+S G+ L+EL TG+ P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 56/295 (18%)
Query: 323 EVLGKGTFGTAYKATL--EMGIV--VAVKRLKDVTVSEKEFREKMEVVGSM---DHENLV 375
++LG+G FG+ + L + G VAVK +K + E E + M DH N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 376 PLRAYYYSRDEK------LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL--ALGAS 427
L + +++ +M G L + L +R G P ++ L + +
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG-LPEKLPLQTLLKFMVDIA 123
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR----- 482
+ YL ++ H ++ + N +L + ++DFGL S D YR
Sbjct: 124 LGMEYLSNRNFI--HRDLAARNCMLREDMTVCVADFGL------SKKIYSGDYYRQGRIA 175
Query: 483 -------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVV 534
A E R + K+DV++FGV + E+ T G+ P + N E D R +
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235
Query: 535 K-EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
+ E+ E++DL M C P +RP+ ++ +E I
Sbjct: 236 QPEDCLDELYDL-----------MYS-------CWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 43/273 (15%)
Query: 325 LGKGTFGTAYKATLEM---GIVVAVKRLK----DVTVSEKEFREKMEVVGSMDHENLVPL 377
LG G FGT K +M VAVK LK D + ++ RE V+ +D+ +V
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREA-NVMQQLDNPYIV-- 59
Query: 378 RAYYYSRDEK-LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
R E +LV + +G L+ L N+ + + L S + YL
Sbjct: 60 RMIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEET 114
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAPEVTDA 489
H ++ + N+LL + A+ISDFGL+ + + APE +
Sbjct: 115 NFV--HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 490 RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548
K S K+DV+SFGVL+ E + G+ P + + +G ++ + ++S + E
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGM---KGNEVTQMIESGERMECP--------- 220
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
Q EM L++L C D RP A V
Sbjct: 221 --QRCPPEMYDLMKL---CWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 5e-11
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 44/215 (20%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLKD----VTVSEKEFREKMEVVGSMDHENLVPLRA 379
LGKG +G +KA VVA+K++ D T +++ FRE M + DH N+V L
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74
Query: 380 YYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS---------R 428
+ ++K LV +YM T L+ R+ + +
Sbjct: 75 VIKAENDKDIYLVFEYM----------------ETDLHAVIRANILEDVHKRYIMYQLLK 118
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------- 480
A+ Y+HS H ++K SNILL+ +++DFGLA S
Sbjct: 119 ALKYIHSGNVI--HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 481 -YRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKA 513
YRAPE+ + ++ D++S G +L E+L GK
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKP 211
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 53/249 (21%), Positives = 111/249 (44%), Gaps = 49/249 (19%)
Query: 347 KRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKL----LVHDYMPMGSLSAL 402
K L D+T +E ++ + +D N++ + + + L L+ +Y G L +
Sbjct: 59 KVLIDITENE------IKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREV 112
Query: 403 LHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISD 462
L + L+++T+ +A+ + + L+ K + N+ S + L++++Y+ +I
Sbjct: 113 LDKEKD-----LSFKTKLDMAIDCCKGLYNLY-KYTNKPYKNLTSVSFLVTENYKLKIIC 166
Query: 463 FGLAH-LASPSSTPNRID--GYRAPEV-TDA-RKVSQKADVYSFGVLLLELLTGKAPTQA 517
GL L+SP ++ Y + ++ D + + K D+YS GV+L E+ TGK P
Sbjct: 167 HGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-- 222
Query: 518 LLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEM----VQLLQLAIN-CTAQYP 572
E + T E++D L+ +N ++ ++ + CT+
Sbjct: 223 ----ENLT-------------TKEIYD--LIINKNNSLKLPLDCPLEIKCIVEACTSHDS 263
Query: 573 DNRPSMAEV 581
RP++ E+
Sbjct: 264 IKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 33/229 (14%)
Query: 324 VLGKGTFGTAYKATLE-MGIVVAVKRLK-DVTVSEKEFR----EKMEVVGSMDHENLVPL 377
VLGKG+FG A L+ A+K LK DV + + + E+ + + +H L L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ +++ V +Y+ G L + + +GR + + +LH KG
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIIC--GLQFLHKKG 116
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHL--------ASPSSTPNRIDGYRAPEVTDA 489
+ ++K N+LL K +I+DFG+ ++ TP+ Y APE+
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD----YIAPEILKG 170
Query: 490 RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVD--------LPRWV 530
+K ++ D +SFGVLL E+L G++P +E D PRW+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 6e-11
Identities = 66/280 (23%), Positives = 123/280 (43%), Gaps = 40/280 (14%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREK----MEVVGSMDHENLVPLRA 379
+GKG F YKA L G VVA+K+++ + + + R+ ++++ +DH N++ A
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRT---PLNWETRSGLALGASRAIAYLHSK 436
+ +E +V + G LS ++ + R W+ L A+ ++HSK
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHSK 125
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--------TPNRIDGYRAPEVTD 488
H +IK +N+ ++ + ++ D GL S + TP Y +PE
Sbjct: 126 RIM--HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY----YMSPERIH 179
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548
+ K+D++S G LL E+ A Q+ + ++L + + K ++ L
Sbjct: 180 ENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKIEKCDYPP----LPAD 231
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
Y EE+ L+ IN P+ RP ++ V +E+
Sbjct: 232 HYS---EELRDLVSRCINPD---PEKRPDISYVLQVAKEM 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 8e-11
Identities = 71/300 (23%), Positives = 118/300 (39%), Gaps = 73/300 (24%)
Query: 325 LGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSEKE-FREKME------VVGSMDH 371
LG+G+FG Y+ E VA+K TV+E RE++E V+ +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIK-----TVNENASMRERIEFLNEASVMKEFNC 68
Query: 372 ENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAI- 430
++V L + L+V + M G L + L R P + I
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRR-----PEAENNPGLGPPTLQKFIQ 123
Query: 431 ---------AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGY 481
AYL +K H ++ + N ++++ +I DFG+ D Y
Sbjct: 124 MAAEIADGMAYLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRDI------YETDYY 175
Query: 482 R------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPR 528
R APE + K+DV+SFGV+L E+ T + P Q L NEE +
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF-- 233
Query: 529 WVQSVVKEEWTAEVFDLELLRY-QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
V D L +N +++++L+++ C P RP+ E+ S +++
Sbjct: 234 -------------VIDGGHLDLPENCPDKLLELMRM---CWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 66/229 (28%), Positives = 102/229 (44%), Gaps = 29/229 (12%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLK-DVTVSEKEFR----EKMEVVGSMDHENLVP 376
VLGKG+FG A L E G + AVK LK DV + + + EK + + +H L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL-ALGASRAIAYLHS 435
L + + D V +++ G L + +R E R+ A + A+ +LH
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD------EARARFYAAEITSALMFLHD 114
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA----HLASPSSTPNRIDGYRAPEVTDARK 491
KG + ++K N+LL +++DFG+ +ST Y APE+
Sbjct: 115 KGII--YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 492 VSQKADVYSFGVLLLELLTGKAPTQA---------LLNEEGVDLPRWVQ 531
D ++ GVLL E+L G AP +A +LN+E V P W+
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE-VVYPTWLS 220
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 33/228 (14%)
Query: 325 LGKGTFGTAYKATL--------EMGIVVAVKRLKDVTVSEKEFRE---KMEVVGSMD-HE 372
LG+G FG +A + + VAVK LKD ++K+ + +ME++ + H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKD-NATDKDLADLISEMELMKLIGKHK 78
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG-----------RTPLNWETRSG 421
N++ L ++ +Y G+L L R G L+++
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA----HLASPSSTPN- 476
A +R + YL S+ H ++ + N+L+++ +I+DFGLA + T N
Sbjct: 139 CAYQVARGMEYLESRRCI--HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 477 RID-GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
R+ + APE R + ++DV+SFG+L+ E+ T G +P + EE
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFR-EKMEVVGSMDHENLVPLRAY 380
E +G+G GT Y A + G VA+K++ +KE ++ V+ + N+V
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
Y DE +V +Y+ GSL+ ++ T ++ + + +A+ +LHS
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHSNQVI- 137
Query: 441 SHGNIKSSNILLSKSYEARISDFGLAHLASPS----STPNRIDGYRAPEVTDARKVSQKA 496
H +IKS NILL +++DFG +P ST + APEV + K
Sbjct: 138 -HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196
Query: 497 DVYSFGVLLLELLTGKAPTQALLNE 521
D++S G++ +E++ G+ P LNE
Sbjct: 197 DIWSLGIMAIEMVEGEPP---YLNE 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 324 VLGKGTFGT---AYKATLEMGIVVAVKRLKDVTVSEKEFREKMEV--VGSMDHENLVPLR 378
VLG G GT A + + V V ++ ++ ++K R + EV + + D ++V
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN-RAQAEVCCLLNCDFFSIVKCH 97
Query: 379 AYYYSRDEK--------LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLA-LGASRA 429
+ +D + LV DY G L + RT E +GL + A
Sbjct: 98 EDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR--EHEAGLLFIQVLLA 155
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----------STPNRID 479
+ ++HSK H +IKS+NILL + ++ DFG + + + + TP
Sbjct: 156 VHHVHSKHMI--HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY--- 210
Query: 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
Y APE+ + S+KAD++S GVLL ELLT K P
Sbjct: 211 -YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFR-EKMEVVGSMDHENLVPLRAY 380
E +G+G GT Y A + G VA++++ +KE ++ V+ + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
Y DE +V +Y+ GSL+ ++ T ++ + + +A+ +LHS
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSNQVI- 138
Query: 441 SHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDARKVSQKA 496
H +IKS NILL +++DFG A + S + + G + APEV + K
Sbjct: 139 -HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 497 DVYSFGVLLLELLTGKAPTQALLNE 521
D++S G++ +E++ G+ P LNE
Sbjct: 198 DIWSLGIMAIEMIEGEPP---YLNE 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 60/218 (27%), Positives = 108/218 (49%), Gaps = 27/218 (12%)
Query: 307 KGDRAFDLEDLLRASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKM-- 363
+GD LE+ ++ +G+G+ G A + G VAVK + + +++ RE +
Sbjct: 16 QGDPRSLLENYIK-----IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFN 67
Query: 364 EVVGSMD--HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421
EVV D H+N+V + Y +E ++ +++ G+L+ ++ R LN E +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR------LNEEQIAT 121
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR---- 477
+ +A+ YLHS+G H +IKS +ILL+ ++SDFG S P R
Sbjct: 122 VCESVLQALCYLHSQGVI--HRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLV 178
Query: 478 -IDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+ APEV + D++S G++++E++ G+ P
Sbjct: 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 68/297 (22%), Positives = 121/297 (40%), Gaps = 51/297 (17%)
Query: 325 LGKGTFGTAYKATL------EMGIVVAVKRLKD-VTVSEK-EFREKMEVVGSMDHENLVP 376
LG+G+FG Y+ E VAVK + + ++ E+ EF + V+ ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNR-----GAGRTPLNWETRSGLALGASRAIA 431
L L+V + M G L + L R GR P + +A + +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR--------- 482
YL++K H ++ + N +++ + +I DFG+ + D YR
Sbjct: 134 YLNAKKFV--HRDLAARNCMVAHDFTVKIGDFGM------TRDIYETDYYRKGGKGLLPV 185
Query: 483 ---APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEW 538
APE + +D++SFGV+L E+ + + P Q L NE+ V+K
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ----------VLKFVM 235
Query: 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595
D + N E + L+++ C P RP+ E+ + +++ S +
Sbjct: 236 DGGYLD----QPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 61/269 (22%), Positives = 118/269 (43%), Gaps = 28/269 (10%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRL---KDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
LG G G+ K + G V+A K + +V ++ RE ++++ +V
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE-LQIMHECRSPYIVSFYGA 71
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+ + + + ++M GSL + + G P+ E +A+ + YL++
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIY---KKGG--PIPVEILGKIAVAVVEGLTYLYNVHRI- 125
Query: 441 SHGNIKSSNILLSKSYEARISDFGLAH--LASPSSTPNRIDGYRAPEVTDARKVSQKADV 498
H +IK SNIL++ + ++ DFG++ + S + T Y +PE K + K+DV
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDV 185
Query: 499 YSFGVLLLELLTGKAP-TQALLNEEGVDLP----RWVQSVVKEEWTAEVFDLELLRYQNV 553
+S G+ ++EL GK P + ++++G D P +Q +V+E L +
Sbjct: 186 WSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPR----LPSSDFPED 241
Query: 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVT 582
+ V C + P RP+ ++
Sbjct: 242 LRDFVDA------CLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 71/302 (23%), Positives = 125/302 (41%), Gaps = 66/302 (21%)
Query: 325 LGKGTFGTAYKATL--------EMGIVVAVKRLKDVTVSEKEFR------EKMEVVGSMD 370
LG+G FG A + + VAVK LKD +EK+ E M+++G
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD-DATEKDLSDLVSEMEMMKMIGK-- 79
Query: 371 HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG-----------RTPLNWETR 419
H+N++ L ++ +Y G+L L R G + ++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 420 SGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID 479
+R + YL S+ H ++ + N+L++++ +I+DFGLA N ID
Sbjct: 140 VSCTYQVARGMEYLASQKCI--HRDLAARNVLVTENNVMKIADFGLAR------DVNNID 191
Query: 480 GYR------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDL 526
Y+ APE R + ++DV+SFGVL+ E+ T G +P + EE L
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 251
Query: 527 PRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
+KE + + N E+ +++ +C P +RP+ ++ ++
Sbjct: 252 -------LKEGHRMD-------KPANCTNELYMMMR---DCWHAIPSHRPTFKQLVEDLD 294
Query: 587 EI 588
I
Sbjct: 295 RI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 57/205 (27%), Positives = 103/205 (50%), Gaps = 27/205 (13%)
Query: 324 VLGKGTFGTAYKAT-LEMGIVVAVKR-LKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
++G G+FG Y+A ++ VA+K+ L+D +E + ++ +++H N++ L+ YY
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE----LLIMKNLNHINIIFLKDYY 128
Query: 382 YS----RDEKLL----VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
Y+ ++EK + V +++P + H R PL L RA+AY+
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAYI 186
Query: 434 HSKGPANSHGNIKSSNILLS-KSYEARISDFG-----LAHLASPSSTPNRIDGYRAPEVT 487
HSK H ++K N+L+ ++ ++ DFG LA S S +R YRAPE+
Sbjct: 187 HSKFIC--HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF--YRAPELM 242
Query: 488 -DARKVSQKADVYSFGVLLLELLTG 511
A + D++S G ++ E++ G
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 66/243 (27%), Positives = 98/243 (40%), Gaps = 52/243 (21%)
Query: 317 LLRASAEVLGKGTFGTAYKATL--------EMGIVVAVKRLKDVTVSEKEFREKME--VV 366
LLRA LG G FG Y+ E+ VAVK L + + E ME ++
Sbjct: 10 LLRA----LGHGAFGEVYEGLYRGRDGDAVELQ--VAVKTLPESCSEQDESDFLMEALIM 63
Query: 367 GSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRG-AGR-TPLNWETRSGLAL 424
+H+N+V L + R + ++ + M G L + L NR R + L + A
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLS---KSYEARISDFGLAHLASPSSTPNRIDGY 481
++ YL H +I + N LL+ A+I+DFG+A D Y
Sbjct: 124 DVAKGCKYLEENHFI--HRDIAARNCLLTCKGPGRVAKIADFGMAR-----------DIY 170
Query: 482 RA-----------------PEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEG 523
RA PE + K DV+SFGVLL E+ + G P N+E
Sbjct: 171 RASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
Query: 524 VDL 526
++
Sbjct: 231 MEF 233
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 19/208 (9%)
Query: 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAY 380
E +GKGT+G YK T + G + AVK L ++ ++E + ++ S+ +H N+V
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87
Query: 381 YYSRDEKL-----LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
+Y D+ + LV + GS++ L+ G G+ L+ S + GA + +LH+
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHN 146
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDARK 491
H ++K +NILL+ ++ DFG+ A L S N G + APEV +
Sbjct: 147 NRII--HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 204
Query: 492 -----VSQKADVYSFGVLLLELLTGKAP 514
+ DV+S G+ +EL G P
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKE---FREKMEVV-G 367
DL+DL +G+G FGT K G ++AVKR++ TV EKE ++VV
Sbjct: 5 DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMR 58
Query: 368 SMDHENLVPLRAYYYSRDEKLLVHDYM--PMGSLSALLHGNRGAGRTPLNWETRSGLALG 425
S D +V + + + + M + ++ ++ + E +A+
Sbjct: 59 SSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEV---LKSVIPEEILGKIAVA 115
Query: 426 ASRAIAYLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLA-HLAS-----------PS 472
+A+ YL K H ++K SNILL ++ ++ DFG++ L P
Sbjct: 116 TVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPY 173
Query: 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
P RID P D V ++DV+S G+ L E+ TGK P
Sbjct: 174 MAPERID----PSARDGYDV--RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 49/216 (22%)
Query: 323 EVLGKGTFGTA----YKATLEMGIVVAVK--------RLKDV--TVSEKEFREKMEVVGS 368
+ LG G+FG +K + G A+K +LK V ++EK ++ S
Sbjct: 7 KTLGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKR------ILQS 57
Query: 369 MDHENLVPLRAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETR---SGLA 423
+ H LV Y +D+ L V +Y+P G L + L R +GR P R + +
Sbjct: 58 IRHPFLV--NLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPV-ARFYAAQVV 111
Query: 424 LGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPNRI 478
L A+ YLHS + ++K N+LL +I+DFG A + TP
Sbjct: 112 L----ALEYLHSLDIV--YRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPE-- 163
Query: 479 DGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
Y APE+ ++ + D ++ G+L+ E+L G P
Sbjct: 164 --YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 8e-10
Identities = 65/276 (23%), Positives = 109/276 (39%), Gaps = 48/276 (17%)
Query: 323 EVLGKGTFGTAYKATL----------EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHE 372
E LG+GTF +K + +++ V SE F E ++ + H+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSE-SFFEAASMMSQLSHK 59
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
+LV DE ++V +Y+ GSL L N+ E LA A+ +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAW----ALHF 115
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP---------NRIDGYRA 483
L KG +HGN+ + N+LL + + + + L+ P + RI +
Sbjct: 116 LEDKGL--THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-WVP 172
Query: 484 PE-VTDARKVSQKADVYSFGVLLLELLTG-KAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541
PE + + + +S AD +SFG L E+ +G P AL +++ + + +WT
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWT-- 230
Query: 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS 577
E+ L+ C PD RPS
Sbjct: 231 --------------ELANLIN---QCMDYEPDFRPS 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 42/216 (19%)
Query: 325 LGKGTFGTAY----KATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRA- 379
+ KG +G + K+T G + A+K +K + + K V + E + +A
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIK-----KADMIRKN-QVDQVLTERDILSQAQ 51
Query: 380 ------YYYS--RDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAI 430
YYS + L LV +Y+P G L++LL N G+ L+ + A+
Sbjct: 52 SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLE-NVGS----LDEDVARIYIAEIVLAL 106
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---------- 480
YLHS G H ++K NIL+ + +++DFGL+ + N D
Sbjct: 107 EYLHSNGII--HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164
Query: 481 --YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
Y APEV + S+ D +S G +L E L G P
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 9e-10
Identities = 62/256 (24%), Positives = 109/256 (42%), Gaps = 50/256 (19%)
Query: 312 FDLEDLLRASAEVLGKGTFGTAYKATLEM--GIVVAVKRLKD----VTVSEKEFREKMEV 365
FD+ + E +G G +G A ++ G VA+K++ T++++ RE +++
Sbjct: 1 FDVGSRYKPI-ENIGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVPTLAKRTLRE-LKI 57
Query: 366 VGSMDHENLVPLRAYYYSRDEKL----LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421
+ H+N++ +R +V D M L ++H ++ PL E
Sbjct: 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ-----PLTEEHIRY 111
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR---- 477
R + Y+HS H ++K SN+L+++ E RI DFG+A S S T ++
Sbjct: 112 FLYQLLRGLKYIHSANVI--HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 478 ----IDGYRAPEVT-DARKVSQKADVYSFGVLLLE------LLTGK-------------- 512
YRAPE+ + + D++S G + E L GK
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229
Query: 513 APTQALLNEEGVDLPR 528
+P++ +LN G D R
Sbjct: 230 SPSEEVLNRIGSDRVR 245
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 9e-10
Identities = 59/214 (27%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 321 SAEVLGKGTFGTAYKATL--EMGIV---VAVKRLKDVTVSEKE----FREKMEVVGSMDH 371
+++L +GTFG + L E V VK +KD SE + +E + G + H
Sbjct: 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYG-LSH 67
Query: 372 ENLVP-LRAYYYSRDEKLLVHDYMPMGSLSALLHGNR-GAGRTPLNWETRS--GLALGAS 427
+N++P L + +++ YM G+L L R G P T+ +A+ +
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------TPNRIDGY 481
++YLH +G H +I + N ++ + + +I+D L+ P NR +
Sbjct: 128 CGMSYLHKRGVI--HKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLT-GKAP 514
A E ++ S +DV+SFGVLL EL+T G+ P
Sbjct: 186 MALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 60/268 (22%), Positives = 124/268 (46%), Gaps = 26/268 (9%)
Query: 325 LGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFRE----KMEVVGSMDHENLVPLRA 379
+G+G F Y+AT + G+ VA+K+++ + + + R +++++ ++H N++ A
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ +E +V + G LS ++ + R + +T + A+ ++HS+
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHMHSRRVM 128
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP-NRIDG---YRAPEVTDARKVSQK 495
H +IK +N+ ++ + ++ D GL S +T + + G Y +PE + K
Sbjct: 129 --HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 496 ADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555
+D++S G LL E+ A Q+ + ++L + + E D L + E
Sbjct: 187 SDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKKI-------EQCDYPPLPSDHYSE 235
Query: 556 EMVQLLQLAINCTAQYPDNRPSMAEVTS 583
E+ QL+ + IN P+ RP + V
Sbjct: 236 ELRQLVNMCINPD---PEKRPDITYVYD 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRL------KDVTVSEKEFREKMEVVGSMDHENLVPL 377
LG+G FG Y ++ G +AVK++ + +++++ ++ HE +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV-- 67
Query: 378 RAYY--YSRDEKLLVH-DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
YY DE L + +YMP GS+ L T TR L + YLH
Sbjct: 68 -QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL-----EGVEYLH 121
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAH-----------LASPSSTPNRIDGYRA 483
S H +IK +NIL + ++ DFG + + S + TP + +
Sbjct: 122 SNMIV--HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY----WMS 175
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
PEV +KADV+S G ++E+LT K P
Sbjct: 176 PEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 74/292 (25%), Positives = 124/292 (42%), Gaps = 48/292 (16%)
Query: 325 LGKGTFGTAYKATL--------EMGIVVAVKRLKDVTVSEK--EFREKMEVVGSMDHENL 374
LG+G FG K L G VAVK LK + + ++++E++ ++ HEN+
Sbjct: 12 LGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68
Query: 375 VPLRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
V + L+ +++P GSL L N+ +N + + A+ + + Y
Sbjct: 69 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMDY 124
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STPNRIDG---YRAPE 485
L S+ H ++ + N+L+ ++ +I DFGL + + +D + APE
Sbjct: 125 LGSRQYV--HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 486 VTDARKVSQKADVYSFGVLLLELLT----GKAPTQALLNEEG-----VDLPRWVQSVVKE 536
K +DV+SFGV L ELLT +P L G + + R V+ V++E
Sbjct: 183 CLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VLEE 241
Query: 537 EWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
L R N EE+ QL++ C P R + + E I
Sbjct: 242 G-------KRLPRPPNCPEEVYQLMR---KCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 28/206 (13%)
Query: 325 LGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLVPL 377
LG+G G+ K L G++ A LK +T RE +E+ S +V
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFA---LKTITTDPNPDLQKQILRE-LEINKSCKSPYIVKY 64
Query: 378 RAYYYSRDEKLL--VHDYMPMGSLSALL-----HGNRGAGRTPLNWETRSGLALGASRAI 430
+ + +Y GSL ++ G R G L +A + +
Sbjct: 65 YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVL-----GKIAESVLKGL 118
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA--SPSSTPNRIDGYRAPEVTD 488
+YLHS+ H +IK SNILL++ + ++ DFG++ S + T Y APE
Sbjct: 119 SYLHSRKII--HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQ 176
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAP 514
+ S +DV+S G+ LLE+ + P
Sbjct: 177 GKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 23/201 (11%)
Query: 325 LGKGTFGTA-YKATLEMGIVVAVKRLKDVTVSE----KEFREKMEVVGSMDHENLVPLRA 379
+G G +GT G VA+K+L SE + +RE + ++ M HEN++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRE-LRLLKHMKHENVIGLLD 81
Query: 380 YYYSRDEKL-LVHDY---MP-MGS-LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
+ + D L HD+ MP MG+ L L+ + L+ + L + + Y+
Sbjct: 82 VF-TPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK------LSEDRIQFLVYQMLKGLKYI 134
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-YRAPEVT-DARK 491
H+ G H ++K N+ +++ E +I DFGLA T + YRAPEV +
Sbjct: 135 HAAGII--HRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMH 192
Query: 492 VSQKADVYSFGVLLLELLTGK 512
+Q D++S G ++ E+LTGK
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 57/209 (27%), Positives = 85/209 (40%), Gaps = 32/209 (15%)
Query: 324 VLGKGTFG----TAYKATLEMGIVVAVKRLK----------DVTVSEKEFREKMEVVGSM 369
VLG+G FG YK T E+ A+K LK + + EK E S
Sbjct: 6 VLGRGHFGKVLLAEYKKTGEL---YAIKALKKGDIIARDEVESLMCEKRI---FETANSE 59
Query: 370 DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429
H LV L A + + D V +Y G L +H + + + + L L
Sbjct: 60 RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGL----- 114
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH----LASPSSTPNRIDGYRAPE 485
YLH + ++K N+LL +I+DFGL +ST + APE
Sbjct: 115 -QYLHENKIV--YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 486 VTDARKVSQKADVYSFGVLLLELLTGKAP 514
V ++ D + GVL+ E+L G++P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 28/212 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
E++G GT+G YK ++ G + A+K + E+E ++++ ++ H + A Y
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI---ATY 68
Query: 382 YSR----------DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
Y D+ LV ++ GS++ L+ +G L E + + R ++
Sbjct: 69 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLS 125
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVT 487
+LH H +IK N+LL+++ E ++ DFG+ A L N G + APEV
Sbjct: 126 HLHQHKVI--HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 488 DARKVSQ-----KADVYSFGVLLLELLTGKAP 514
+ K+D++S G+ +E+ G P
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 66/241 (27%), Positives = 94/241 (39%), Gaps = 69/241 (28%)
Query: 324 VLGKGTFGTAY----KATLEMGIVVAVKRLK--DVTVSEKE--FREKMEVVGSMDHENLV 375
V+G+G FG + K T G V A+K L+ D+ + R + +++ D +V
Sbjct: 8 VIGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIV 64
Query: 376 PLRAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETR---SGLALGASRAI 430
L YY +DE+ L V +YMP G L LL R P R + L L A+
Sbjct: 65 KL--YYSFQDEEHLYLVMEYMPGGDLMNLL--IR-KDVFPEET-ARFYIAELVL----AL 114
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA------------------------ 466
+H G H +IK NIL+ +++DFGL
Sbjct: 115 DSVHKLGFI--HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 467 ------------HLA-SPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
A S TP+ Y APEV + D +S GV+L E+L G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPD----YIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 514 P 514
P
Sbjct: 229 P 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 64/280 (22%), Positives = 122/280 (43%), Gaps = 37/280 (13%)
Query: 324 VLGKGTFGTAYKATL------EMGIVVAVKRLKDVT-VSEKE-FREKMEVVGSM-DHENL 374
LG G FG +AT + + VAVK LK SE+E +++++ + +HEN+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
V L L++ +Y G L L R + L E + ++ +A+L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLA 158
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSSTPNRIDG-----YRAPEVTD 488
SK H ++ + N+LL+ +I DFGLA + + S+ + + + APE
Sbjct: 159 SKNCI--HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216
Query: 489 ARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547
+ ++DV+S+G+LL E+ + G P + + ++KE + +
Sbjct: 217 NCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLIKEGY-------RM 263
Query: 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
+ ++ E+ +++ C P RP+ ++ I +
Sbjct: 264 AQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 323 EVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKEFREKM---EVVGSMDHENL 374
++LGKGTFG KAT G A+K L K+V +++ E + V+ + H L
Sbjct: 1 KLLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS--RAIAY 432
L+ + + D V +Y G L H +R T E R+ GA A+ Y
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFT----EERARF-YGAEIVSALEY 110
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGL--------AHLASPSSTPNRIDGYRAP 484
LHS+ + +IK N++L K +I+DFGL A + + TP Y AP
Sbjct: 111 LHSRDVV--YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE----YLAP 164
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAP 514
EV + + D + GV++ E++ G+ P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 322 AEVLGKGTFGTAYKA-TLEMGIVVAVKRLK---DVTVSEKEFRE---KMEVVGSMDHENL 374
++LG+G FG Y ++ G +A K+++ + + KE +++++ ++ HE +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 375 VPLRAYYYSRDEKLLV--HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
V R EK L +YMP GS+ L + TR L ++Y
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL-----EGMSY 121
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH-----------LASPSSTPNRIDGY 481
LHS H +IK +NIL + ++ DFG + + S + TP +
Sbjct: 122 LHSNMIV--HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY----W 175
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+PEV +KADV+S G ++E+LT K P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 53/184 (28%), Positives = 90/184 (48%), Gaps = 22/184 (11%)
Query: 340 MGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD-YM 394
+GI VAVK+L ++ T +++ +RE + ++ ++H+N++ L + + D Y+
Sbjct: 45 LGINVAVKKLSRPFQNQTHAKRAYRE-LVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103
Query: 395 PM----GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNI 450
M +L ++H L+ E S L I +LHS G H ++K SNI
Sbjct: 104 VMELMDANLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSAGII--HRDLKPSNI 154
Query: 451 LLSKSYEARISDFGLAHLASPS--STPNRIDGY-RAPEVTDARKVSQKADVYSFGVLLLE 507
++ +I DFGLA A + TP + Y RAPEV + D++S G ++ E
Sbjct: 155 VVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 508 LLTG 511
L+ G
Sbjct: 215 LVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 77/304 (25%), Positives = 131/304 (43%), Gaps = 56/304 (18%)
Query: 325 LGKGTFGTAYKATLEMGI---------VVAVKRLKDVTVSEKEFR------EKMEVVGSM 369
LG+G FG A +G+ VAVK LK +EK+ E M+++G
Sbjct: 26 LGEGCFGQVVMAE-AIGLDKEKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGK- 82
Query: 370 DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG--------RTP---LNWET 418
H+N++ L ++ +Y G+L L R G + P L+++
Sbjct: 83 -HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 419 RSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA----HLASPSST 474
A +R + YL SK H ++ + N+L+++ +I+DFGLA H+ T
Sbjct: 142 LVSCAYQVARGMEYLASKKCI--HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 475 PN-RID-GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQ 531
N R+ + APE R + ++DV+SFGVLL E+ T G +P + EE L
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL----- 254
Query: 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
+KE + + N E+ +++ +C P RP+ ++ ++ I
Sbjct: 255 --LKEGHRMD-------KPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRILAL 302
Query: 592 SLQQ 595
+ Q
Sbjct: 303 TSNQ 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSM---DHENLVPLR 378
E LG+G +G K G ++AVKR++ S+++ R M++ SM D V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 379 AYYYSRDEKLLVHDYMPMGSL-----SALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
+ + + + M SL G P + + +A+ +A+ YL
Sbjct: 67 GALFREGDVWICMEVMDT-SLDKFYKKVYDKGLT----IPEDILGK--IAVSIVKALEYL 119
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HL-----------ASPSSTPNRIDGY 481
HSK H ++K SN+L++++ + ++ DFG++ +L P P RI+
Sbjct: 120 HSKLSV-IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERIN-- 176
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
PE + + K+DV+S G+ ++EL TG+ P
Sbjct: 177 --PE-LNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
EV+G GT+G YK ++ G + A+K + E+E + ++ ++ H + A Y
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNI---ATY 78
Query: 382 YS---------RDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
Y D++L LV ++ GS++ L+ +G L + + + R +A
Sbjct: 79 YGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLA 135
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVT 487
+LH+ H +IK N+LL+++ E ++ DFG+ A L N G + APEV
Sbjct: 136 HLHAHKVI--HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 488 DARK-----VSQKADVYSFGVLLLELLTGKAP 514
+ ++D++S G+ +E+ G P
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 27/203 (13%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLV---- 375
+G G +G+ A + G+ VAVK+L + + +++ +RE + ++ M HEN++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGLLD 83
Query: 376 ---PLRAYYYSRDEKLLVHDYMPMGS-LSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
P R+ D L+ H MG+ L+ ++ + L + L R +
Sbjct: 84 VFTPARSLEEFNDVYLVTH---LMGADLNNIVKCQK------LTDDHVQFLIYQILRGLK 134
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDGYRAPEVT-DA 489
Y+HS H ++K SN+ +++ E +I DFGLA H + YRAPE+ +
Sbjct: 135 YIHSADII--HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 192
Query: 490 RKVSQKADVYSFGVLLLELLTGK 512
+Q D++S G ++ ELLTG+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 67/288 (23%), Positives = 113/288 (39%), Gaps = 51/288 (17%)
Query: 323 EVLGKGTFGTAYKA--TLEMGIVVAVKRLKDVTVSEKEF----REKMEVVGSM------- 369
E LG G FG YK ++A LK++ V F RE+ + +G +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLA---LKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62
Query: 370 ----DHENLVPLRAYYYSRDEKLLVHDYM---PMGSLSALLHGNRGAGRTPLNWETRSGL 422
H N+V + D +V D + P+G L + W +
Sbjct: 63 KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 423 ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-- 480
L A+ YLH K H ++ +NI+L + + I+DFGLA P S + G
Sbjct: 123 VL----ALRYLH-KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTI 177
Query: 481 -YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539
Y PE+ +KADV++FG +L ++ T + P + ++ +V+
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS------TNMLSLATKIVEAV-- 229
Query: 540 AEVFDLELLRYQNVEEEMV-QLLQLAIN-CTAQYPDNRPSMAEVTSQI 585
Y+ + E M + + I C + RP + +V++ I
Sbjct: 230 ----------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 56/202 (27%), Positives = 92/202 (45%), Gaps = 24/202 (11%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
+G+G++G +K E G +VA+K+ D + + RE + ++ + H NLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE-IRMLKQLKHPNLVNLIE 67
Query: 380 YYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+ R KL LV +Y L+ L RG + L +A+ + H
Sbjct: 68 VF-RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTL-----QAVNFCHKHNC 121
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAPE--VTDARK 491
H ++K NIL++K + ++ DFG A + + + D YRAPE V D +
Sbjct: 122 I--HRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDT-Q 177
Query: 492 VSQKADVYSFGVLLLELLTGKA 513
DV++ G + ELLTG+
Sbjct: 178 YGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 38/231 (16%)
Query: 316 DLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLK-DVTVSE--KEFREKMEVVGSMDHE 372
+LL + K +VAVK++ D E K ++++ + H
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALL--HGNRGAGRTPLNWETRSGLAL-GASRA 429
N++P + E +V M GS LL H G L E L A
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-----LP-ELAIAFILKDVLNA 113
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR---IDGY----- 481
+ Y+HSKG H ++K+S+ILLS + +S GL + S R + +
Sbjct: 114 LDYIHSKGFI--HRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSV 169
Query: 482 -----RAPEV--TDARKVSQKADVYSFGVLLLELLTGKAP------TQALL 519
+PEV + + ++K+D+YS G+ EL G P TQ LL
Sbjct: 170 KNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSE----KEFREKMEVVGSMDHENLVPL 377
E +G+GT+G YKA G VVA+K+++ T +E RE + ++ ++H N+V L
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE-ISLLKELNHPNIVKL 64
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG-RTPLNWETRSGLALGASRAIAYLHSK 436
++ ++ LV +++ L + + +G PL L G +A+ HS
Sbjct: 65 LDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQG----LAFCHSH 119
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSSTPNR---IDGYRAPEV-TDARK 491
H ++K N+L++ +++DFGLA P T YRAPE+ +
Sbjct: 120 RVL--HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 177
Query: 492 VSQKADVYSFGVLLLELLTGKA 513
S D++S G + E++T +A
Sbjct: 178 YSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 325 LGKGTFGT---AYKATLEMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPL 377
+G G +G+ AY L VAVK+L + + + + +RE + ++ M HEN++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHARRTYRE-LRLLKHMKHENVIGL 79
Query: 378 RAYYYSR------DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
+ +E LV + M L+ ++ + L+ E L R +
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMG-ADLNNIVKCQK------LSDEHVQFLIYQLLRGLK 132
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN-RIDGYRAPEVT-DA 489
Y+HS G H ++K SN+ +++ E RI DFGLA A T YRAPE+ +
Sbjct: 133 YIHSAGII--HRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNW 190
Query: 490 RKVSQKADVYSFGVLLLELLTGKA 513
+Q D++S G ++ ELL GKA
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKGKA 214
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 66/203 (32%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVP 376
+V+GKG+FG A + G AVK L+ T+ +K+ E+ ++ ++ H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 377 LRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L Y + EKL V DY+ G L H R R L R A AS AI YLHS
Sbjct: 61 LH-YSFQTAEKLYFVLDYVNGGEL--FFHLQRE--RCFLEPRARFYAAEVAS-AIGYLHS 114
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLA-SPSSTPNRIDG---YRAPEVTDARK 491
+ ++K NILL ++DFGL P T + G Y APEV
Sbjct: 115 LNII--YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 492 VSQKADVYSFGVLLLELLTGKAP 514
+ D + G +L E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 61/202 (30%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 324 VLGKGTFGTAYKAT-LEMGIVVAVKRL-KDVTVSEKEFREKME----VVGSMDHENLVPL 377
V+GKG+FG A G AVK L K + +KE + M ++ ++ H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL-ALGASRAIAYLHSK 436
+ + D+ V DY+ G L L R P E R+ A + A+ YLHS
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQRER---SFP---EPRARFYAAEIASALGYLHSL 115
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLA-SPSSTPNRIDG---YRAPEVTDARKV 492
+ ++K NILL ++DFGL S T + G Y APEV +
Sbjct: 116 NII--YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY 173
Query: 493 SQKADVYSFGVLLLELLTGKAP 514
+ D + G +L E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 48/195 (24%), Positives = 92/195 (47%), Gaps = 11/195 (5%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYY 381
LG G G K + ++ ++L + + + +++V+ + +V +
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
YS E + ++M GSL +L + A R P E +++ R +AYL K
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL---KEAKRIP--EEILGKVSIAVLRGLAYLREKHQI-M 126
Query: 442 HGNIKSSNILLSKSYEARISDFGLAH--LASPSSTPNRIDGYRAPEVTDARKVSQKADVY 499
H ++K SNIL++ E ++ DFG++ + S +++ Y +PE S ++D++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 500 SFGVLLLELLTGKAP 514
S G+ L+EL G+ P
Sbjct: 187 SMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 39/231 (16%)
Query: 325 LGKGTFGTAYKATLEMGI---------VVAVKRLKDVTVSEKEFR------EKMEVVGSM 369
LG+G FG A +GI VAVK LKD ++K+ E M+++G
Sbjct: 20 LGEGCFGQVVMAE-AIGIDKDKPNKPVTVAVKMLKD-DATDKDLSDLVSEMEMMKMIGK- 76
Query: 370 DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG--------RTP---LNWET 418
H+N++ L ++ +Y G+L L R G + P L ++
Sbjct: 77 -HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 419 RSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS-----PSS 473
A +R + YL S+ H ++ + N+L+++ +I+DFGLA +
Sbjct: 136 LVSCAYQVARGMEYLASQKCI--HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 474 TPNRID-GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
T R+ + APE R + ++DV+SFGVLL E+ T G +P + EE
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFREKM----EVVGSMDHENLVPLRA 379
+G+G +G + A + G +VA+KR+K + + + +++ + E LV L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-L 67
Query: 380 YYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
Y + DE L L +Y+P G LL+ N G R +A A+ LH G
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLN-NLGVLS---EDHARFYMA-EMFEAVDALHELG- 121
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDARKVSQK 495
H ++K N L+ S +++DFGL+ + N + G Y APEV +
Sbjct: 122 -YIHRDLKPENFLIDASGHIKLTDFGLS--KGIVTYANSVVGSPDYMAPEVLRGKGYDFT 178
Query: 496 ADVYSFGVLLLELLTGKAPTQA-LLNEEGVDLPRW 529
D +S G +L E L G P NE +L W
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 323 EVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKEFREKM---EVVGSMDHENL 374
++LGKGTFG KAT G A+K L K+V +++ E + V+ + H L
Sbjct: 1 KLLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS--RAIAY 432
L+ + + D V +Y G L H +R + E R+ GA A+ Y
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFS----EDRARF-YGAEIVSALGY 110
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGL--------AHLASPSSTPNRIDGYRAP 484
LHS + ++K N++L K +I+DFGL A + + TP Y AP
Sbjct: 111 LHSCDVV--YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE----YLAP 164
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAP 514
EV + + D + GV++ E++ G+ P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 67/292 (22%), Positives = 120/292 (41%), Gaps = 52/292 (17%)
Query: 324 VLGKGTFGTAYKATLEM----GIVVAVKRLK-DVTVSE--KEFREKMEVVGSMDHENLVP 376
+LGKG FG+ +A L+ VAVK LK D+ S +EF + + DH N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 377 LRAYYYSRDEK------LLVHDYMPMGSLSALLHGNRGAGRTPLNW--ETRSGLALGASR 428
L K +++ +M G L L +R G P +T + +
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSR-IGEEPFTLPLQTLVRFMIDIAS 124
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA---------HLASPSSTPNRID 479
+ YL SK H ++ + N +L+++ ++DFGL+ S P +
Sbjct: 125 GMEYLSSKNFI--HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK-- 180
Query: 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEW 538
+ A E + +DV++FGV + E++T G+ P + N
Sbjct: 181 -WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------------------ 221
Query: 539 TAEVFDLELL--RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
+E+++ + R + + + + +L C + P RPS + Q+E I
Sbjct: 222 -SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 8/96 (8%)
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YR 482
R + YLHS G H +IK N+L++ + +I DFGLA + P + + YR
Sbjct: 114 RGLKYLHSAGIL--HRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYR 171
Query: 483 APEV-TDARKVSQKADVYSFGVLLLELLTGKAPTQA 517
APE+ +R + D++S G + ELL + QA
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 59/220 (26%), Positives = 85/220 (38%), Gaps = 51/220 (23%)
Query: 325 LGKGTFGTAY----KATLEMGIVVAV--KRLK-----DVTVSEKEFREKMEVVGSMDHEN 373
LGKG FG KAT +M + KRLK + ++EK+ EK+
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-------SSR 53
Query: 374 LVPLRAY-YYSRDEKLLVHDYMPMGSLSALL--HGNRGAGRTPLNWETRSGLALGASRAI 430
+ AY + ++D+ LV M G L + G G +RAI
Sbjct: 54 FIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG---------------FPEARAI 98
Query: 431 AY----------LHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRI- 478
Y LH + + ++K N+LL RISD GLA L R
Sbjct: 99 FYAAQIICGLEHLHQRRIV--YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAG 156
Query: 479 -DGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517
GY APEV D ++ G L E++ G++P +
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 71/292 (24%), Positives = 133/292 (45%), Gaps = 56/292 (19%)
Query: 323 EVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTVSEKEFRE---KMEVVGSM-DHENLV 375
+V+G+G FG +A ++ + + A+K LK+ SE + R+ ++EV+ + H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNII 66
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTP-----------LNWETRSGLAL 424
L +R + +Y P G+L L +R P L + A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH------LASPSSTPNRI 478
+ + YL K H ++ + N+L+ ++ ++I+DFGL+ + P R
Sbjct: 127 DVATGMQYLSEK--QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVR- 183
Query: 479 DGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAP----TQALLNEEGVDLPRWVQSV 533
+ A E + + K+DV+SFGVLL E+++ G P T A L E+ LP
Sbjct: 184 --WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK---LP------ 232
Query: 534 VKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585
+ + +E + +N ++E+ +L++ C P RP A+++ Q+
Sbjct: 233 -------QGYRME--KPRNCDDEVYELMR---QCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 47/204 (23%), Positives = 92/204 (45%), Gaps = 20/204 (9%)
Query: 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFRE---KMEVVGSMDHENLVPLRAY 380
LGKG +G+ YK G+ +A+K ++ + + E +F + +++++ +V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPA 439
++ + +YM GSL L G P + L + L K
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV-----LRRITYAVVKGLKFLKEEH 122
Query: 440 NS-HGNIKSSNILLSKSYEARISDFGLAH--LASPSSTPNRIDGYRAPE------VTDAR 490
N H ++K +N+L++ + + ++ DFG++ +AS + T Y APE
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 491 KVSQKADVYSFGVLLLELLTGKAP 514
+ ++DV+S G+ +LE+ G+ P
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 61/271 (22%), Positives = 109/271 (40%), Gaps = 37/271 (13%)
Query: 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVPLRA 379
E +G+G FG + L VAVK ++ + +F ++ ++ H N+V L
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ +V + + G L G L + + A+ + YL SK
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR-TEGP---RLKVKELIQMVENAAAGMEYLESK--H 114
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAH------LASPSSTPNRIDGYRAPEVTDARKVS 493
H ++ + N L+++ +ISDFG++ AS + APE + + S
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 494 QKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD--LELLRY 550
++DV+SFG+LL E + G P L N++ T E + + L
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQ----------------TREAIEQGVRLPCP 218
Query: 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ + + +L++ C P RPS + V
Sbjct: 219 ELCPDAVYRLME---RCWEYDPGQRPSFSTV 246
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 18/199 (9%)
Query: 324 VLGKGTFGTAYKAT-LEMGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLR 378
V+G+G +G K E +VA+K+ KD V E RE ++++ ++ EN+V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRE-LKMLRTLKQENIVELK 66
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+ R + LV +Y+ L L G + RS + +AI + H
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGV----PPEKVRSYI-YQLIKAIHWCHKNDI 121
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAPEVTDARKVS 493
H +IK N+L+S + ++ DFG A S S N + YR+PE+
Sbjct: 122 V--HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 494 QKADVYSFGVLLLELLTGK 512
+ D++S G +L EL G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 65/232 (28%), Positives = 102/232 (43%), Gaps = 43/232 (18%)
Query: 324 VLGKGTFGTAY----KATLEMGIVVAVKRLK-DVTVSEKEFR----EKMEVVGSMDHENL 374
VLGKG+FG K T E+ A+K LK DV + + + EK + S L
Sbjct: 7 VLGKGSFGKVMLAERKGTDEL---YAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
L + + + D V +Y+ G L + G + P + +A+G + +LH
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAVFYAAEIAIG----LFFLH 118
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----------YRA 483
SKG + ++K N++L +I+DFG+ N DG Y A
Sbjct: 119 SKGII--YRDLKLDNVMLDSEGHIKIADFGMC-------KENMWDGVTTKTFCGTPDYIA 169
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK 535
PE+ + + D ++FGVLL E+L G+AP EG D QS+++
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF------EGEDEDELFQSIME 215
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAY 380
E +GKGT+G +K + G AVK L + ++E + ++ ++ DH N+V
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 381 YYSRDEK-----LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
YY +D K LV + GS++ L+ G G + + + A + +LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER-MEEPIIAYILHEALMGLQHLHV 142
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDARK 491
H ++K +NILL+ ++ DFG+ A L S N G + APEV +
Sbjct: 143 N--KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ 200
Query: 492 -----VSQKADVYSFGVLLLELLTGKAPTQAL 518
+ DV+S G+ +EL G P L
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 49/184 (26%), Positives = 86/184 (46%), Gaps = 22/184 (11%)
Query: 344 VAVKRLK-DVTVSEK-EFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401
VAVK L+ D + + + +F ++++++ + N+ L ++ +YM G L+
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 402 LLH------GNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN-SHGNIKSSNILLSK 454
L L++ T +A + + YL S N H ++ + N L+ K
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGK 165
Query: 455 SYEARISDFGLAHLASPSSTPNRIDGYRAP--------EVTDARKVSQKADVYSFGVLLL 506
+Y +I+DFG++ SS R+ G RAP E K + K+DV++FGV L
Sbjct: 166 NYTIKIADFGMSRNLY-SSDYYRVQG-RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 507 ELLT 510
E+LT
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 15/202 (7%)
Query: 324 VLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVPL 377
VLGKG FG + G + A K+L+ + +++ EK +++ ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEK-QILEKVNSRFVVSL 65
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
Y ++D LV M G L ++ AG +E + A
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG-----FEEGRAVFYAAEICCGLEDLHQ 120
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRID--GYRAPEVTDARKVSQ 494
+ ++K NILL RISD GLA H+ + R+ GY APEV + +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180
Query: 495 KADVYSFGVLLLELLTGKAPTQ 516
D ++ G LL E++ G++P Q
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 12/138 (8%)
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+YS E + ++M GSL +L + AGR P N + +A+ R + YL K
Sbjct: 68 FYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAV--LRGLTYLREK-HKI 121
Query: 441 SHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEVTDARKVSQKA 496
H ++K SNIL++ E ++ DFG++ L S N G Y +PE + ++
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTHYTVQS 179
Query: 497 DVYSFGVLLLELLTGKAP 514
D++S G+ L+E+ G+ P
Sbjct: 180 DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 24/205 (11%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLK----DVTVSEKEFREKMEVVGSMDHENLVPL 377
E +G+GT+GT +KA E +VA+KR++ D V RE + ++ + H+N+V L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE-ICLLKELKHKNIVRL 64
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+S + LV +Y L G ++ E + +A+ HS
Sbjct: 65 YDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAPEVT-DA 489
H ++K N+L++K+ E +++DFGLA P R YR P+V A
Sbjct: 120 VL--HRDLKPQNLLINKNGELKLADFGLAR---AFGIPVRCYSAEVVTLWYRPPDVLFGA 174
Query: 490 RKVSQKADVYSFGVLLLELLTGKAP 514
+ S D++S G + EL P
Sbjct: 175 KLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 69/292 (23%), Positives = 125/292 (42%), Gaps = 57/292 (19%)
Query: 325 LGKGTFGTAYKATLEMGIV-------VAVKRLKD-VTVSEK-EFREKMEVVGSMDHENLV 375
LG+G+FG Y+ + G+V VA+K + + ++ E+ EF + V+ + ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNR-----GAGRTPLNWETRSGLALGASRAI 430
L L++ + M G L + L R + P + + +A + +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 431 AYLHSKGPANS--HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------ 482
AYL+ AN H ++ + N ++++ + +I DFG+ + D YR
Sbjct: 133 AYLN----ANKFVHRDLAARNCMVAEDFTVKIGDFGM------TRDIYETDYYRKGGKGL 182
Query: 483 ------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVK 535
+PE + +DV+SFGV+L E+ T + P Q + NE+ V V
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-------VLRFVM 235
Query: 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587
E + D N + + +L+++ C P RPS E+ S I+E
Sbjct: 236 EGGLLDKPD-------NCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 46/226 (20%)
Query: 318 LRASAE------VLGKGTFGTA----YKATLEMGIVVAVKRL-KDVTVSEKE---FREKM 363
LR AE V+G+G FG +K++ + V A+K L K + + F E+
Sbjct: 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQ---VYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 364 EVVGSMDHENLVPLRAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421
+++ + E +V L +Y +D+K L V +YMP G L L+ P W R
Sbjct: 95 DIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKW-ARFY 147
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDF---------GLAHLASPS 472
A A+ +HS G H ++K N+LL KS +++DF G+ +
Sbjct: 148 TA-EVVLALDAIHSMGFI--HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV 204
Query: 473 STPNRIDGYRAPEVTDARKVS----QKADVYSFGVLLLELLTGKAP 514
TP+ Y +PEV ++ ++ D +S GV L E+L G P
Sbjct: 205 GTPD----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 62/261 (23%), Positives = 99/261 (37%), Gaps = 51/261 (19%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKD-VTVS-EKEFREKMEVVGSMDHENL 374
E LG+ FG YK L E VA+K LKD +EF+ + + + H N+
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALL-----HGNRGAGRTPLNWETRSGL------- 422
V L ++ Y L L H + G T + +S L
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSD--VGSTDDDKTVKSTLEPADFVH 128
Query: 423 -ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH---------LASPS 472
+ + +L S H ++ + N+L+ +ISD GL L S
Sbjct: 129 IVTQIAAGMEFLSSHHVV--HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGV------- 524
P R + +PE K S +D++S+GV+L E+ + G P N++ +
Sbjct: 187 LLPIR---WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ 243
Query: 525 ------DLPRWVQSVVKEEWT 539
D P WV +++ E W
Sbjct: 244 VLPCPDDCPAWVYTLMLECWN 264
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 37/216 (17%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKR--------------LKDVT----VSEKEFREKM 363
E +G+GT+G YKA G +VA+K+ L++++ +SE + ++
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 364 EVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLA 423
V ++ +N P Y LV +Y+ L + N PL +T
Sbjct: 67 LDVEHVEEKNGKPS--LY-------LVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFM 116
Query: 424 LGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEA-RISDFGLAHLAS---PSSTPNRID 479
+ +A+ H G H ++K N+L+ K +I+D GL S S T +
Sbjct: 117 YQLLKGVAHCHKHGVM--HRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVT 174
Query: 480 -GYRAPEV-TDARKVSQKADVYSFGVLLLELLTGKA 513
YRAPEV + S D++S G + E+ +
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQP 210
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 326 GKGTFGTAYKATLEMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+G AY A LE VA+K+L ++ T +++ +RE + ++ ++H+N++ L +
Sbjct: 36 AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRE-LVLMKCVNHKNIIGLLNVF 92
Query: 382 YSRDEKLLVHD-YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+ D Y+ M + A L + L+ E S L I +LHS G
Sbjct: 93 TPQKSLEEFQDVYIVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGII- 148
Query: 441 SHGNIKSSNILLSKSYEARISDFGLAHLASPS--STPNRIDGY-RAPEVTDARKVSQKAD 497
H ++K SNI++ +I DFGLA A S TP + Y RAPEV + D
Sbjct: 149 -HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 498 VYSFGVLLLELLTGK 512
++S G ++ E++ G
Sbjct: 208 IWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 39/211 (18%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLK----DVTVSEKEFREKMEVVGSMDHENLVPL 377
E +G+GT+G YKA G +VA+K+++ D V RE + ++ ++H N+V L
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE-ISLLKELNHPNIVRL 63
Query: 378 RAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
+S + KL LV +++ + L + T L+ + IAY HS
Sbjct: 64 LDVVHS-ENKLYLVFEFLDLD----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG--------------YR 482
H ++K N+L+ + +++DFGLA R G YR
Sbjct: 119 RVL--HRDLKPQNLLIDREGALKLADFGLA----------RAFGVPVRTYTHEVVTLWYR 166
Query: 483 APEV-TDARKVSQKADVYSFGVLLLELLTGK 512
APE+ +R+ S D++S G + E++ +
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 23/207 (11%)
Query: 324 VLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVPL 377
VLGKG FG + G + A KRL+ + +++ EK +++ ++ + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEK-QILEKVNSQFVVNL 65
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLH--GNRGAGRTPLNWETRSGLALGASR--AIAYL 433
Y ++D LV M G L ++ GN G +E L A + L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-------FEEERALFYAAEILCGLEDL 118
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRID--GYRAPEVTDAR 490
H + + ++K NILL RISD GLA + S R+ GY APEV + +
Sbjct: 119 HRENTV--YRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 491 KVSQKADVYSFGVLLLELLTGKAPTQA 517
+ + D + G L+ E++ G++P +
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 31/213 (14%)
Query: 322 AEVLGKGTFGTAYKA-TLEMGIVVAVKRLK---DVTVSEKEFRE---KMEVVGSMDHENL 374
++LG+G FG Y + G +AVK++ D + KE +++++ ++ H+ +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 375 VPLRAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
V +EK L +YMP GS+ L TR L + ++Y
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL-----QGVSY 121
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH-----------LASPSSTPNRIDGY 481
LHS H +IK +NIL + ++ DFG + + S + TP +
Sbjct: 122 LHSNMIV--HRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY----W 175
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+PEV +KADV+S ++E+LT K P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 31/213 (14%)
Query: 322 AEVLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFRE------KMEVVGSMDHENL 374
++LG+G FG Y + G +AVK+++ S + +E +++++ ++ HE +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 375 VPLRAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
V E+ L ++MP GS+ L TR L ++Y
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQIL-----EGVSY 121
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH-----------LASPSSTPNRIDGY 481
LHS H +IK +NIL ++ DFG + + S + TP +
Sbjct: 122 LHSNMIV--HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY----W 175
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+PEV +KAD++S G ++E+LT K P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 324 VLGKGTFGTA----YKATLEMGIVVAVKRLKD----------VTVSEKEFREKMEVVGSM 369
VLGKG FG +AT +M A K+L+ + ++EK+ EK+
Sbjct: 7 VLGKGGFGEVCACQVRATGKM---YACKKLEKKRIKKRKGEAMALNEKQILEKV------ 57
Query: 370 DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLH--GNRGAGRTPLNWETRSGLALGAS 427
+ +V L Y ++D LV M G L ++ GN G ++ + A
Sbjct: 58 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG-------FDEERAVFYAAE 110
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRID--GYRAP 484
+ ++K NILL RISD GLA + + R+ GY AP
Sbjct: 111 ITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAP 170
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517
EV + + D + G L+ E++ GK+P +
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 71/288 (24%), Positives = 128/288 (44%), Gaps = 48/288 (16%)
Query: 323 EVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHE-NLVP 376
+V+G+G FG KA ++ + + A+KR+K+ ++F ++EV+ + H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTP-----------LNWETRSGLALG 425
L R L +Y P G+L L +R P L+ + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH------LASPSSTPNRID 479
+R + YL K H ++ + NIL+ ++Y A+I+DFGL+ + P R
Sbjct: 121 VARGMDYLSQK--QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR-- 176
Query: 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD-LPRWVQSVVKEE 537
+ A E + + +DV+S+GVLL E+++ G P + E + LP
Sbjct: 177 -WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---------- 225
Query: 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585
+ + LE N ++E+ L++ C + P RPS A++ +
Sbjct: 226 ---QGYRLEKPL--NCDDEVYDLMR---QCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 305 FGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEM-GIVVAVK--RLKDVTVSEKEFRE 361
FGK D LE L G+G++ T YK ++ G +VA+K RL++ +
Sbjct: 1 FGKADSYEKLEKL--------GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR 52
Query: 362 KMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421
+ ++ + H N+V L ++++ LV +Y+ L + + G G P N +
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPG-GLHPENVKL--- 107
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS-PSST-PNRID 479
R ++Y+H + H ++K N+L+S + E +++DFGLA S PS T N +
Sbjct: 108 FLFQLLRGLSYIHQRYIL--HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165
Query: 480 G--YRAPEV-TDARKVSQKADVYSFGVLLLELLTGKA 513
YR P+V + + S D++ G + +E++ G A
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-08
Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 324 VLGKGTFGTAYKATLEM----GIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVP 376
+LG G FG + L++ + VA+ L+ S+K+ F + +G DH N+V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRA-GCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L + ++V +YM G+L + L + G L G+ G + + YL
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSEM 126
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARK 491
G H + + +L++ +IS F + + G + APE
Sbjct: 127 GYV--HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184
Query: 492 VSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVDLP 527
S +DV+SFG+++ E+++ G+ P + E+G LP
Sbjct: 185 FSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 68/296 (22%), Positives = 119/296 (40%), Gaps = 53/296 (17%)
Query: 320 ASAEVLGKGTFGTAYKATL---EMGIVVAVKRLKDVTVSEKEFREKMEVVGSM---DHEN 373
A + LG+G FG+ + L + + VAVK +K + E + + M DH N
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 374 LVPLRAYYYSRDEK------LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA- 426
++ L E +++ +M G L + L +R G P T+ +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSR-LGDCPQYLPTQMLVKFMTD 120
Query: 427 -SRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR--- 482
+ + YL SK + H ++ + N +L+++ ++DFGL S D YR
Sbjct: 121 IASGMEYLSSK--SFIHRDLAARNCMLNENMNVCVADFGL------SKKIYNGDYYRQGR 172
Query: 483 ---------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQS 532
A E R + K+DV+SFGV + E+ T G+ P + N E D +++
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYD---YLRQ 229
Query: 533 VVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
+ + + D L L +C P +RPS + ++E+
Sbjct: 230 GNRLKQPPDCLD--------------GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 38/118 (32%), Positives = 59/118 (50%), Gaps = 3/118 (2%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
LP + NL L + L FN L +P + LSNL NL L GN S ++P + L L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
L+L+ N+ +S+ + L L L L N+L +G S+L ++S N+++
Sbjct: 212 EELDLSNNSIIELLSS-LSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 323 EVLGKGTFGTAY----KATLEMGIVVAVKRLK-DVTVSEKEFREKM---EVVGSMDHENL 374
++LGKGTFG KAT G A+K LK +V V++ E + V+ + H L
Sbjct: 1 KLLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS--RAIAY 432
L+ + + D V +Y G L L R + E R+ GA A+ Y
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRER------VFSEDRARF-YGAEIVSALDY 110
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGL--------AHLASPSSTPNRIDGYRAP 484
LHS+ + ++K N++L K +I+DFGL A + + TP Y AP
Sbjct: 111 LHSEKNV-VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE----YLAP 165
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAP 514
EV + + D + GV++ E++ G+ P
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 32/212 (15%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHEN---------- 373
+GKGTFG Y+ + + A+K L S+KE K EV ++ N
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL-----SKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 374 --LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA-SRAI 430
+V L+ + + + LV DYM G L L GR E R+ + A+
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE---GRFS---EDRAKFYIAELVLAL 109
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL-ASPSSTPNRIDG---YRAPEV 486
+LH + ++K NILL + + DFGL+ + + T N G Y APEV
Sbjct: 110 EHLHKYDIV--YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167
Query: 487 T-DARKVSQKADVYSFGVLLLELLTGKAPTQA 517
D + ++ D +S GVL+ E+ G +P A
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-08
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 35/222 (15%)
Query: 339 EMGIVVAVKRLKDVTVSE----KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLL-VHDY 393
G VA+K L+ E FR + + + H N+V L + L V +Y
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS 453
+P +L +L A L L L A+A H++G H ++K NI++S
Sbjct: 61 VPGRTLREVL-----AADGALPAGETGRLMLQVLDALACAHNQGIV--HRDLKPQNIMVS 113
Query: 454 KS---YEARISDFGLAHLASPSSTPNRID-----------GYRAPEVTDARKVSQKADVY 499
++ A++ DFG+ L + Y APE V+ +D+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 500 SFGVLLLELLTGKAPTQAL---------LNEEGVDLPRWVQS 532
++G++ LE LTG+ Q L+ V LP W+
Sbjct: 174 AWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAG 215
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 33/213 (15%)
Query: 323 EVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKE----FREKMEVVGSMDHEN 373
+VLGKG+FG K T E V A+K L KDV + + + EK + + H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDE---VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL-ALGASRAIAY 432
L L + ++D V +Y+ G L + +R E RS A + A+ +
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD------EPRSRFYAAEVTLALMF 111
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGL--------AHLASPSSTPNRIDGYRAP 484
LH G + ++K NILL +++DFG+ + TP+ Y AP
Sbjct: 112 LHRHGVI--YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD----YIAP 165
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517
E+ + D ++ GVL+ E++ G+ P +A
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 42/239 (17%)
Query: 323 EVLGKGTFGTAY----KATLEMGIVVAVKRLK-DVTVSEKEFREKM---EVVGSMDHENL 374
++LGKGTFG KA+ G A+K LK +V +++ E + V+ + H L
Sbjct: 1 KLLGKGTFGKVILVREKAS---GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS--RAIAY 432
L+ + ++D V +Y+ G L H R + E R+ GA A+ Y
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGEL--FFH----LSRERVFSEDRTRF-YGAEIVSALDY 110
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGL--------AHLASPSSTPNRIDGYRAP 484
LHS + ++K N++L K +I+DFGL A + + TP Y AP
Sbjct: 111 LHSGKIV--YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE----YLAP 164
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAPTQ--------ALLNEEGVDLPRWVQSVVK 535
EV + + D + GV++ E++ G+ P L+ E + PR + + K
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAK 223
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 25/203 (12%)
Query: 325 LGKGTFGTAYKATLE-MGIVVAVKRL---KDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
+G G GT YK G + A+K + + TV + RE +E++ ++H N+V
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE-IEILRDVNHPNVVKCHDM 140
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+ E ++ ++M GSL G A L + +A IAYLH +
Sbjct: 141 FDHNGEIQVLLEFMDGGSLE----GTHIADEQFL-----ADVARQILSGIAYLHRRHIV- 190
Query: 441 SHGNIKSSNILLSKSYEARISDFG----LAHLASPSSTPNRIDGYRAPE-----VTDARK 491
H +IK SN+L++ + +I+DFG LA P ++ Y +PE +
Sbjct: 191 -HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAY 249
Query: 492 VSQKADVYSFGVLLLELLTGKAP 514
D++S GV +LE G+ P
Sbjct: 250 DGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 55/195 (28%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 326 GKGTFGTAYKATLEMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+G AY A L+ VA+K+L ++ T +++ +RE + ++ ++H+N++ L +
Sbjct: 29 AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRE-LVLMKCVNHKNIISLLNVF 85
Query: 382 YSRDEKLLVHD-YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+ D Y+ M + A L + L+ E S L I +LHS G
Sbjct: 86 TPQKSLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGII- 141
Query: 441 SHGNIKSSNILLSKSYEARISDFGLAHLASPS--STPNRIDG-YRAPEVTDARKVSQKAD 497
H ++K SNI++ +I DFGLA A S TP + YRAPEV + D
Sbjct: 142 -HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 200
Query: 498 VYSFGVLLLELLTGK 512
++S G ++ E++ K
Sbjct: 201 IWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 23/172 (13%)
Query: 360 REKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETR 419
R ++ + + DH +V + S D+ LL+ +Y G L+ + R P E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK-QRLKEHLPFQ-EYE 170
Query: 420 SGLAL-GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS------ 472
GL A+ +HS+ H ++KS+NI L + ++ DFG + S S
Sbjct: 171 VGLLFYQIVLALDEVHSR--KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 473 ----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT----GKAPTQ 516
TP Y APE+ + ++ S+KAD++S GV+L ELLT K P+Q
Sbjct: 229 SSFCGTPY----YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276
|
Length = 478 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 55/234 (23%), Positives = 93/234 (39%), Gaps = 33/234 (14%)
Query: 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPL 377
E LG G+FG A + G A+K LK + + ++ ++ + H +V +
Sbjct: 24 ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWET--RSGLALGASRAIAYLHS 435
+ + + +++ G L L R AGR P + + L L A YLHS
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVL----AFEYLHS 136
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPNRIDGYRAPEVTDAR 490
K + ++K N+LL +++DFG A + TP Y APEV ++
Sbjct: 137 KDII--YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPE----YLAPEVIQSK 190
Query: 491 KVSQKADVYSFGVLLLELLTGKAP--------TQALLNEEGVDLPRWVQSVVKE 536
+ D ++ GVLL E + G P + + P W ++
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARD 244
|
Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 45/195 (23%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYY 381
LG G G +K + + ++ ++L + + + +++V+ + +V +
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
YS E + ++M GSL +L + AGR P + +++ + + YL K
Sbjct: 73 YSDGEISICMEHMDGGSLDQVL---KKAGRIP--EQILGKVSIAVIKGLTYLREKHKI-M 126
Query: 442 HGNIKSSNILLSKSYEARISDFGLAH--LASPSSTPNRIDGYRAPEVTDARKVSQKADVY 499
H ++K SNIL++ E ++ DFG++ + S +++ Y +PE S ++D++
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIW 186
Query: 500 SFGVLLLELLTGKAP 514
S G+ L+E+ G+ P
Sbjct: 187 SMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 38/215 (17%)
Query: 324 VLGKGTFGTAY----KATLEMGIVVAVKRLKDVTVSEKE----FREKMEVVGSMDHENLV 375
++G+G FG KAT G + A+K +K + +E F E+ +++ + +
Sbjct: 8 LVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA-SRAIAYLH 434
L+ + +D LV +Y P G L +LL NR + E + L AI +H
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYED--QFD-EDMAQFYLAELVLAIHSVH 119
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLA-------HLAS--PSSTPNRIDGYRAPE 485
G H +IK N+L+ ++ +++DFG A + S P TP+ Y APE
Sbjct: 120 QMGYV--HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD----YIAPE 173
Query: 486 VTDARKVSQKA------DVYSFGVLLLELLTGKAP 514
V K D +S GV+ E++ G++P
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 40/226 (17%)
Query: 318 LRASAE------VLGKGTFGTA----YKATLEMGIVVAVKRLKDVTVSEKEF-REKMEVV 366
LR AE V+G+G FG +K+T ++ + + + + + S+ F E+ +++
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 367 GSMDHENLVPLRAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLAL 424
+ +V L +Y +D++ L V +YMP G L L+ + + LAL
Sbjct: 98 AFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDF---------GLAHLASPSSTP 475
A ++ ++H ++K N+LL KS +++DF G+ + TP
Sbjct: 156 DAIHSMGFIHR--------DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 207
Query: 476 NRIDGYRAPEVTDARK----VSQKADVYSFGVLLLELLTGKAPTQA 517
+ Y +PEV ++ ++ D +S GV L E+L G P A
Sbjct: 208 D----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 323 EVLGKGTFGTAYKA----TLEMGIVVAVKRLK----DVTVSEKEFREKMEVVGSMDHENL 374
E +G+GT+G YKA T E +A+K+++ D V RE + ++ M H N+
Sbjct: 8 EKIGEGTYGVVYKARDRVTNE---TIALKKIRLEQEDEGVPSTAIRE-ISLLKEMQHGNI 63
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
V L+ +S LV +Y+ + L + + + P +T L R IAY H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQIL---RGIAYCH 119
Query: 435 SKGPANSHGNIKSSNILLSKSYEA-RISDFGLAH-LASPSSTPNR---IDGYRAPEV-TD 488
S H ++K N+L+ + A +++DFGLA P T YRAPE+
Sbjct: 120 SHRVL--HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177
Query: 489 ARKVSQKADVYSFGVLLLELLTGK 512
+R S D++S G + E++ K
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 21/217 (9%)
Query: 325 LGKGTFGTAYKATLEMGIV---VAVKRLK-DVTVSEK-EFREKMEVVGSMDHENLVPLRA 379
+G G FG + G V VK L+ +V E+ +F E+ + S+ H NL+
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
LLV ++ P+G L L R A + T +A + + +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN-- 120
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---TPNRI---DGYRAPEVTD----- 488
H ++ N LL+ +I D+GL+H TP+++ + APE+ D
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180
Query: 489 --ARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
+++++V+S GV + EL G P + L +E+
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ 217
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 57/266 (21%), Positives = 121/266 (45%), Gaps = 26/266 (9%)
Query: 325 LGKGTFGTAYKATLEMG-IVVAVKRLKDVTVSEKEFRE----KMEVVGSMDHENLVPLRA 379
+G+G F Y+AT + VA+K+++ + + + R+ +++++ ++H N++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ +E +V + G LS ++ + R + T + A+ ++HS+
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAVEHMHSRRVM 128
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-PNRIDG---YRAPEVTDARKVSQK 495
H +IK +N+ ++ + ++ D GL S +T + + G Y +PE + K
Sbjct: 129 --HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186
Query: 496 ADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555
+D++S G LL E+ A Q+ + ++L Q + E D L ++ E
Sbjct: 187 SDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQKI-------EQCDYPPLPTEHYSE 235
Query: 556 EMVQLLQLAINCTAQYPDNRPSMAEV 581
++ +L+ + I PD RP + V
Sbjct: 236 KLRELVSMCIYPD---PDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 323 EVLGKGTFGTAYKATLEM-GIVVAVKRL-KDVTVSEKEFR----EKMEVVGSMDHENLVP 376
+V+GKG+FG A ++ G AVK L K + ++ KE + E+ ++ ++ H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L + + ++ V D++ G L H R R+ R A AS A+ YLHS
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL--FFHLQRE--RSFPEPRARFYAAEIAS-ALGYLHSI 115
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAH----LASPSSTPNRIDGYRAPEVTDARKV 492
+ ++K NILL ++DFGL + ++T Y APEV +
Sbjct: 116 NIV--YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 493 SQKADVYSFGVLLLELLTGKAP 514
D + G +L E+L G P
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 59/202 (29%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 323 EVLGKGTFGTAYKATLEMG-IVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVP 376
+V+GKG+FG A + AVK L+ + +K+ E+ ++ ++ H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L + + D+ V DY+ G L H R R L R A AS A+ YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGEL--FYHLQRE--RCFLEPRARFYAAEIAS-ALGYLHSL 115
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEVTDARKV 492
+ ++K NILL ++DFGL + T + G Y APEV +
Sbjct: 116 NIV--YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 493 SQKADVYSFGVLLLELLTGKAP 514
+ D + G +L E+L G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 35/234 (14%)
Query: 323 EVLGKGTFGTAY-------KATLEMG--------IVVAVKRLK-DVTVSEK-EFREKMEV 365
E LG+G FG + L G ++VAVK L+ DVT + + +F +++++
Sbjct: 11 EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70
Query: 366 VGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNR------GAGRTP-LNWET 418
+ + + N++ L S D ++ +YM G L+ L A P ++
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130
Query: 419 RSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI 478
+A+ + + YL S H ++ + N L+ Y +I+DFG++ S RI
Sbjct: 131 LLYMAVQIASGMKYLASLNFV--HRDLATRNCLVGNHYTIKIADFGMSRNLY-SGDYYRI 187
Query: 479 DG-------YRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGV 524
G + A E K + +DV++FGV L E+ T K +LL++E V
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 33/209 (15%)
Query: 324 VLGKGTFGTAY----KATLEMGIVVAVKRLK-DVTVSEKEFREKM---EVVGSMDHEN-L 374
VLGKG+FG K T E + A+K LK DV + + + M V+ L
Sbjct: 7 VLGKGSFGKVMLAERKGTDE---LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFL 63
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNR-GAGRTPLNWETRSGLALGASRAIAYL 433
L + + + D V +Y+ G L + H + G + P + +A+G + +L
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHAVFYAAEIAIG----LFFL 117
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLA--HLASPSST------PNRIDGYRAPE 485
HSKG + ++K N++L +I+DFG+ ++ +T P+ Y APE
Sbjct: 118 HSKGII--YRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPD----YIAPE 171
Query: 486 VTDARKVSQKADVYSFGVLLLELLTGKAP 514
+ + + D ++FGVLL E+L G+ P
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 23/208 (11%)
Query: 325 LGKGTFGTAYKATLEMGI---VVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+G+GT+G YKA + G A+K+++ +S RE + ++ + H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE-IALLRELKHPNVIALQKVF 67
Query: 382 YSRDEK--LLVHDYMPMGSLSAL-LHGNRGAGRTPLNWETR--SGLALGASRAIAYLHSK 436
S ++ L+ DY + H A + P+ L I YLH+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 437 GPANSHGNIKSSNILL----SKSYEARISDFGLAHL-ASPSSTPNRIDG------YRAPE 485
H ++K +NIL+ + +I+D G A L SP +D YRAPE
Sbjct: 128 WVL--HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 486 VT-DARKVSQKADVYSFGVLLLELLTGK 512
+ AR ++ D+++ G + ELLT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 56/200 (28%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 324 VLGKGTFGT---AYKATLEMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVP 376
+G G G AY G VA+K+L ++VT +++ +RE + ++ ++H+N++
Sbjct: 23 PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRE-LVLMKLVNHKNIIG 79
Query: 377 -LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + + + Y+ M + A L + L+ E S L I +LHS
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQ---VIQMDLDHERMSYLLYQMLCGIKHLHS 136
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--TPNRIDGY-RAPEVTDARKV 492
G H ++K SNI++ +I DFGLA A S TP + Y RAPEV
Sbjct: 137 AGII--HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY 194
Query: 493 SQKADVYSFGVLLLELLTGK 512
+ D++S G ++ E++ G
Sbjct: 195 KENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 9e-07
Identities = 34/107 (31%), Positives = 46/107 (42%), Gaps = 24/107 (22%)
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-------------------HLAS 470
I Y+HSKG H ++K NILL E I D+G A S
Sbjct: 126 IEYVHSKGVL--HRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 471 PSSTPNRIDG---YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+ P +I G Y APE S+ D+Y+ GV+L ++LT P
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 30/213 (14%)
Query: 323 EVLGKGTFGTA----YKATLEMGIVVAVKRLKDVTVSEKEF-REKMEVVGSMDHENLVPL 377
+V+G+G FG +K++ ++ + + + + + S+ F E+ +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ +V +YMP G L L+ + + LAL A +HS G
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG 162
Query: 438 PANSHGNIKSSNILLSKSYEARISDF---------GLAHLASPSSTPNRIDGYRAPEVTD 488
H ++K N+LL K +++DF G+ + TP+ Y +PEV
Sbjct: 163 LI--HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD----YISPEVLK 216
Query: 489 ARK----VSQKADVYSFGVLLLELLTGKAPTQA 517
++ ++ D +S GV L E+L G P A
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV--TVSE--KEFREKMEVVGSMDHENLVPL 377
EV+GKG++G A G VA+K++ DV VS+ + RE ++++ + H ++V +
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILRE-IKLLRLLRHPDIVEI 64
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ + Y+ + + LH A L E RA+ Y+H+
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHT-- 121
Query: 438 PANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI--------DGYRAPEVTD 488
AN H ++K NIL + + +I DFGLA +A + TP I YRAPE+
Sbjct: 122 -ANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDTPTAIFWTDYVATRWYRAPELCG 179
Query: 489 A--RKVSQKADVYSFGVLLLELLTGK 512
+ K + D++S G + E+LTGK
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 359 FREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWET 418
F E ++ + H +L + E ++V +++ G L L +G R P+ W+
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKI 120
Query: 419 RSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEA-------RISDFGLAHLA-S 470
L + A++YL K HGN+ + NILL++ A ++SD G++ A S
Sbjct: 121 TVAQQLAS--ALSYLEDKNLV--HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS 176
Query: 471 PSSTPNRIDGYRAPE-VTDARKVSQKADVYSFGVLLLEL-LTGKAPTQ 516
RI + APE V +S AD +SFG LLE+ G+ P +
Sbjct: 177 REERVERIP-WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK 223
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 325 LGKGTFGTAYKATLEMGIV---VAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+G+GT+G YKA + G A+K+++ +S RE + ++ + H N++ L+ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE-IALLRELKHPNVISLQKVF 67
Query: 382 YSR-DEKL-LVHDYMPMGSLSAL-LHGNRGAGRTPLNWE--TRSGLALGASRAIAYLHSK 436
S D K+ L+ DY + H A + P+ L I YLH+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 437 GPANSHGNIKSSNILL----SKSYEARISDFGLAHL-ASPSSTPNRIDG------YRAPE 485
H ++K +NIL+ + +I+D G A L SP +D YRAPE
Sbjct: 128 WVL--HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 486 VT-DARKVSQKADVYSFGVLLLELLTGK 512
+ AR ++ D+++ G + ELLT +
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFREKME--VVGSMDHENLVPLRA 379
E LG+G++ T YK + G +VA+K + T F E ++ + H N+V L
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
++++ V +YM L+ + + G G P N R +AY+H +
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPG-GLHPYNVRL---FMFQLLRGLAYIHGQHIL 125
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLAS-PSSTPNR---IDGYRAPEV-TDARKVSQ 494
H ++K N+L+S E +++DFGLA S PS T + YR P+V A S
Sbjct: 126 --HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 495 KADVYSFGVLLLELLTGK 512
D++ G + +E+L G+
Sbjct: 184 ALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 1e-06
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 324 VLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVPL 377
V+G+G++ L+ + A+K +K V++ E EK + +H LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ + + V +Y+ G L + H R + L E + S A+ YLH +G
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLALNYLHERG 116
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLA-SPSSTPNRIDG---YRAPEVTDARKVS 493
+ ++K N+LL +++D+G+ P T + G Y APE+
Sbjct: 117 II--YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 494 QKADVYSFGVLLLELLTGKAP 514
D ++ GVL+ E++ G++P
Sbjct: 175 FSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 69/263 (26%), Positives = 112/263 (42%), Gaps = 34/263 (12%)
Query: 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKM-----EVVGSMDHENLVPLR 378
LGKG FG ++ G + A K+L D +K+ EKM E++ ++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKL-DKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLH--GNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
+ S+ LV M G L ++ G RG L E + + I +LHS
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-----LEMERVIHYSAQITCGILHLHSM 114
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNR--IDGYRAPEVTDARKVS 493
+ ++K N+LL R+SD GLA L + R +GY APE+ S
Sbjct: 115 DIV--YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 494 QKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL-LRYQN 552
D ++ G + E++ G+ P + + V KEE + E+ +QN
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFK-----------DHKEKVAKEELKRRTLEDEVKFEHQN 221
Query: 553 VEEEMVQLLQLAINCTAQYPDNR 575
EE + +L + A+ P++R
Sbjct: 222 FTEESKDICRLFL---AKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 39/220 (17%)
Query: 323 EVLGKGTFGTAYKATL-------------EMGIVVAVKRL----KDVTVSEKEFREKMEV 365
E LG+GT Y L E I V +K L +D++++ F E +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLA---FFETASM 57
Query: 366 VGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALG 425
+ + H+++V L E ++V +++ G L +H TP ++ LA
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLA-- 115
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG-LAHLASPS------STPNRI 478
A++YL K HGN+ + NILL++ E + G L+ P S +
Sbjct: 116 --SALSYLEDKDLV--HGNVCTKNILLAR--EGIDGECGPFIKLSDPGIPITVLSRQECV 169
Query: 479 D--GYRAPE-VTDARKVSQKADVYSFGVLLLEL-LTGKAP 514
+ + APE V D++ +S AD +SFG L E+ G+ P
Sbjct: 170 ERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 19/202 (9%)
Query: 324 VLGKGTFGTAYKATLE-MGIVVAVKRLK-DVTVSEKEFREKM---EVVGSMDHEN-LVPL 377
VLGKG+FG A + + A+K LK DV + + + M V+ D L L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNR-GAGRTPLNWETRSGLALGASRAIAYLHSK 436
+ + + D V +Y+ G L + H + G + P + +++G + +LH +
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVFYAAEISVG----LFFLHRR 120
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI----DGYRAPEVTDARKV 492
G + ++K N++L +I+DFG+ R Y APE+ +
Sbjct: 121 GII--YRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 493 SQKADVYSFGVLLLELLTGKAP 514
+ D +++GVLL E+L G+ P
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 29/202 (14%)
Query: 325 LGKGTFGTAY-----KATLEMGIVVAVKRLKDVTVSEKEFREKM------EVVGSMDHEN 373
LGKG+FGT Y KA E +K LK++ V E E + +++ +DH
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEE----RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRT---PLNWETRSGLALGASRAI 430
+V A + RD ++ +Y L L + G+T E L LG +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG----V 119
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STPNRIDGYRAPEV 486
Y+H + H ++K+ NI L + +I DFG++ L S +T Y +PE
Sbjct: 120 HYMHQRRIL--HRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 487 TDARKVSQKADVYSFGVLLLEL 508
+ K+D++S G +L E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 22/204 (10%)
Query: 325 LGKGTFGTAYKAT--LEMGIVVAVKRLKDVTVSE----KEFREK--MEVVGSMDHENLVP 376
+G+G +G +KA G VA+KR++ T E RE + + + +H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 377 L----RAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
L R+ KL LV +++ L+ L G ET + R +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT---ETIKDMMFQLLRGLD 124
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID---GYRAPEVTD 488
+LHS H ++K NIL++ S + +++DFGLA + S + YRAPEV
Sbjct: 125 FLHSHRVV--HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182
Query: 489 ARKVSQKADVYSFGVLLLELLTGK 512
+ D++S G + E+ K
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 61/212 (28%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 324 VLGKGTFGTAY---KAT-LEMGIVVAVKRLKDVTVSEKEF--------REKMEVVGSMDH 371
VLG G +G + K + G + A+K LK T+ +K R+ +E V
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 372 ENLVPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA-SRA 429
LV L Y + D KL L+ DY+ G L L+ R E+ + + A
Sbjct: 67 --LVTLH-YAFQTDTKLHLILDYVNGGELFTHLY-QREHFT-----ESEVRVYIAEIVLA 117
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAP 484
+ +LH G + +IK NILL ++DFGL+ Y AP
Sbjct: 118 LDHLHQLGII--YRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 485 EV--TDARKVSQKADVYSFGVLLLELLTGKAP 514
EV + + D +S GVL ELLTG +P
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 35/206 (16%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-------FRE--KMEVVGSMDHENL 374
+G+G +GT YKA L G VA+K+++ V E RE ++ + S +H N+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 375 VPLR----AYYYSRDEKL-LVHDYMPMGSLSALL--HGNRGAGRTPLNWETRSGLALGAS 427
V L R+ KL LV +++ L+ L G + R L
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL----- 117
Query: 428 RAIAYLHSKGPANS--HGNIKSSNILLSKSYEARISDFGLAHLASPSS--TPNRID-GYR 482
R + +LHS + H ++K NIL++ + +I+DFGLA + S T + YR
Sbjct: 118 RGVDFLHS----HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR 173
Query: 483 APEVTDARKVSQKADVYSFGVLLLEL 508
APEV + D++S G + EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 324 VLGKGTFGTAYKATL----EMGIVVAVKRLKDVTV--SEKEF---REKMEVVGSMDHENL 374
VLGKG +G ++ + G + A+K LK T+ ++K+ + + ++ ++ H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 375 VPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA-SRAIAY 432
V L Y + KL L+ +Y+ G L L R + E + L S A+ +
Sbjct: 63 VDL-IYAFQTGGKLYLILEYLSGGELFMHLE------REGIFMEDTACFYLSEISLALEH 115
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLA----HLASPSSTPNRIDGYRAPEVTD 488
LH +G + ++K NILL +++DFGL H + + T Y APE+
Sbjct: 116 LHQQGII--YRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILM 173
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAPTQA 517
+ D +S G L+ ++LTG P A
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 57/221 (25%), Positives = 91/221 (41%), Gaps = 54/221 (24%)
Query: 325 LGKGTFGTAYKAT---LEMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPL 377
LG+G +G A VA+K++ +V ++++ RE + H+N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 378 R----AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS------ 427
+ + +E L + M L ++ RSG L +
Sbjct: 68 YDMDIVFPGNFNELYLYEELME-ADLHQII---------------RSGQPLTDAHFQSFI 111
Query: 428 ----RAIAYLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-- 480
+ Y+HS AN H ++K N+L++ E +I DFGLA S + P G
Sbjct: 112 YQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN--PGENAGFM 166
Query: 481 --------YRAPEVTDARKVSQKA-DVYSFGVLLLELLTGK 512
YRAPE+ + + KA DV+S G +L ELL K
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 72/311 (23%), Positives = 128/311 (41%), Gaps = 71/311 (22%)
Query: 323 EVLGKGTFGTAYKATLE-----------------MGIVVAVKRLK-DVTVSEK-EFREKM 363
E LG+G FG + E ++VAVK L+ D + + +F +++
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 364 EVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALL--HGNRGAG----RTPLNWE 417
+++ + N++ L A + D ++ +YM G L+ L H + A +++
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 418 TRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR 477
T +A + + YL S H ++ + N L+ K+Y +I+DFG+ S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFV--HRDLATRNCLVGKNYTIKIADFGM------SRNLYS 182
Query: 478 IDGYR--APEVTDAR----------KVSQKADVYSFGVLLLELLT--GKAPTQALLNEEG 523
D YR V R K + +DV++FGV L E+LT + P L +E+
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242
Query: 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQ-------LLQLAINCTAQYPDNRP 576
+ E T E F R Q + + + L +L ++C + RP
Sbjct: 243 I------------ENTGEFF-----RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERP 285
Query: 577 SMAEVTSQIEE 587
S E+ + + E
Sbjct: 286 SFQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 444 NIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI--DGYRAPEVTDARKVS--QKADVY 499
++K +NILL + RISD GLA S + GY APEV + V+ AD +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVL-QKGVAYDSSADWF 180
Query: 500 SFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE 536
S G +L +LL G +P + ++ ++ R ++ E
Sbjct: 181 SLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 5e-06
Identities = 15/42 (35%), Positives = 19/42 (45%), Gaps = 5/42 (11%)
Query: 1 LASDRAALLTLRKAI----GGRTLLWNLTDG-PCKWVGVFCT 37
L DR ALL + ++ G WN + PC W GV C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 22/203 (10%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLK----DVTVSEKEFREKMEVVGSMDHENLVPL 377
E +G+GT+G YK + G +VA+K+++ + V RE + ++ + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIRE-ISLLKELQHPNIVCL 64
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ L+ +++ M L L E + I + HS+
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDA--ELVKSYLYQILQGILFCHSRR 121
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAPEV-TDA 489
H ++K N+L+ +++DFGLA P R+ YRAPEV +
Sbjct: 122 VL--HRDLKPQNLLIDNKGVIKLADFGLAR---AFGIPVRVYTHEVVTLWYRAPEVLLGS 176
Query: 490 RKVSQKADVYSFGVLLLELLTGK 512
+ S D++S G + E+ T K
Sbjct: 177 PRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 37/124 (29%), Positives = 57/124 (45%), Gaps = 6/124 (4%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
+ + + NL EL L N + ++PS L NL+NL L N S ++P LL +L
Sbjct: 131 IPPLIGLLKSNLKEL---DLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNL 185
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
NL L+L+ N S + + L+ L L L N + + L +L+ +S NKL
Sbjct: 186 SNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKL 244
Query: 171 NGSI 174
Sbjct: 245 EDLP 248
|
Length = 394 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 48/204 (23%), Positives = 93/204 (45%), Gaps = 26/204 (12%)
Query: 324 VLGKGTFGTAYKATL----EMGIVVAVKRLKDVTVSEKEFR---EKMEVVGSMDHENLVP 376
V+GKG++G + +L G +K+L S +E + ++ +++ + H N+V
Sbjct: 7 VVGKGSYG---EVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 377 LRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGA---GRTPLNWETRSGLALGASRAIAY 432
R + D L +V + G L L +G + W + +AL Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------QY 117
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSSTPNRIDG---YRAPEVTD 488
LH K H ++K+ N+ L+++ ++ D G+A L + + + G Y +PE+
Sbjct: 118 LHEKHIL--HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 489 ARKVSQKADVYSFGVLLLELLTGK 512
+ + K+DV++ G + E+ T K
Sbjct: 176 NKPYNYKSDVWALGCCVYEMATLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 27/206 (13%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKR---------LKDVTVSEKEFREKMEVVGSMDHENL 374
+G G +GT YKA G VA+K L TV E +++E + DH N+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLE---AFDHPNI 64
Query: 375 VPLRAYYYS----RDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429
V L + R+ K+ LV +++ L L G L ET L R
Sbjct: 65 VRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPG---LPAETIKDLMRQFLRG 120
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS--PSSTPNRID-GYRAPEV 486
+ +LH+ H ++K NIL++ + +++DFGLA + S + TP + YRAPEV
Sbjct: 121 LDFLHANCIV--HRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 487 TDARKVSQKADVYSFGVLLLELLTGK 512
+ D++S G + E+ K
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 38/215 (17%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKR--LKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
LG G+ G + A + VAVK+ L D + RE ++++ +DH+N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALRE-IKIIRRLDHDNIVKVYEVL 71
Query: 382 YSRDEKL--------------LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
L +V +YM + L G PL+ E
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG-------PLSEEHARLFMYQLL 124
Query: 428 RAIAYLHSKGPANS-HGNIKSSNILLS-KSYEARISDFGLAHLASPS-------STPNRI 478
R + Y+HS AN H ++K +N+ ++ + +I DFGLA + P S
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 479 DGYRAPE-VTDARKVSQKADVYSFGVLLLELLTGK 512
YR+P + ++ D+++ G + E+LTGK
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 24/205 (11%)
Query: 324 VLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKEF-------REKMEVVGSMDHENLV 375
++G+G FG Y + G + A+K L + K+ R + +V + D +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNW---ETRSGLALGASRAIAY 432
+ +++ D+ + D M G L L + + + E GL +R + Y
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI--DGYRAPEV-TDA 489
++K +NILL + RISD GLA S + GY APEV
Sbjct: 121 R----------DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG 170
Query: 490 RKVSQKADVYSFGVLLLELLTGKAP 514
AD +S G +L +LL G +P
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 19/202 (9%)
Query: 324 VLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVPL 377
VLGKG FG + G + A K+L+ + +++ EK ++ ++ +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK-RILEKVNSRFVVSL 65
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLH--GNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
Y ++D LV M G L ++ GN G ++ + + A
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG-------FDEQRAIFYAAELCCGLEDL 118
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRID--GYRAPEVTDARKV 492
+ + ++K NILL RISD GLA + + R+ GY APEV + K
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178
Query: 493 SQKADVYSFGVLLLELLTGKAP 514
+ D + G L+ E++ G++P
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 37/207 (17%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKME------------VVGSMDHE 372
LG+GT+ T YK +L D V+ KE R + E ++ + H
Sbjct: 14 LGEGTYATVYKGR---------SKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLH--GNRGAGRTPLNWETRSGLALGASRAI 430
N+V L ++ LV +Y+ L L GN +N R +
Sbjct: 65 NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNS------INMHNVKLFLFQLLRGL 117
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS-PSST-PNRIDG--YRAPEV 486
Y H + H ++K N+L+++ E +++DFGLA S P+ T N + YR P++
Sbjct: 118 NYCHRRKVL--HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175
Query: 487 -TDARKVSQKADVYSFGVLLLELLTGK 512
+ S + D++ G + E+ TG+
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 54/214 (25%), Positives = 93/214 (43%), Gaps = 29/214 (13%)
Query: 323 EVLGKGTFGTAYKATLEMG-IVVAVKRLKDVTVSEKE----FREKMEVVGSMDHENLVPL 377
+V+G+G FG L+ V A+K L + ++ FRE+ +V+ + D++ + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLN----WETRSGLALGASRAIAYL 433
+ + LV DY G L LL ++ R P + + +A+ + + Y+
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVIAIDSVHQLHYV 124
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFG-----LAHLASPSSTPNRIDGYRAPEVTD 488
H +IK NIL+ + R++DFG + SS Y +PE+
Sbjct: 125 HR--------DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 489 AR-----KVSQKADVYSFGVLLLELLTGKAPTQA 517
A K + D +S GV + E+L G+ P A
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 2e-05
Identities = 20/60 (33%), Positives = 28/60 (46%)
Query: 88 NLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQL 147
NL++L L N + G L NL L+L+ NN + F+ L L +L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 15/94 (15%)
Query: 428 RAIAYLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI-------D 479
R + Y+HS AN H ++K SN+LL+ + + +I DFGLA +S
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR---TTSEKGDFMTEYVVTR 172
Query: 480 GYRAPEVT-DARKVSQKADVYSFGVLLLELLTGK 512
YRAPE+ + + + DV+S G + ELL K
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 21/105 (20%)
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------- 480
A+ YLH+ G H ++K N+L++ +++DFGL+ + S T N +G
Sbjct: 113 ALEYLHNYGIV--HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 481 -----------YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
Y APEV + + D ++ G++L E L G P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 50/224 (22%), Positives = 98/224 (43%), Gaps = 17/224 (7%)
Query: 324 VLGKGTFGTAYKATLEMG-IVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVPL 377
V+G+G++ L+ + A+K +K V + E EK + + LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ + + LV +Y+ G L + H R + L E A A+ +LH +G
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDL--MFHMQR---QRKLPEEHARFYAAEICIALNFLHERG 116
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLA-SPSSTPNRIDG---YRAPEVTDARKVS 493
+ ++K N+LL +++D+G+ P T + G Y APE+ +
Sbjct: 117 II--YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYG 174
Query: 494 QKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE 537
D ++ GVL+ E++ G++P + + ++ ++ V+ E+
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK 218
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 76/252 (30%)
Query: 321 SAEVLGKGTFGTA----YKATLEMGIVVAVKRLKDVTVSEKE----FREKMEVVGSMDHE 372
S +V+G+G FG K T G + A+K+L+ + EKE R + +++ D+
Sbjct: 5 SIKVIGRGAFGEVRLVQKKDT---GHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61
Query: 373 NLVPLRAYYYS-RDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETR-----SGLAL 424
+V L YYS +DE L+ +Y+P G + LL T ETR + LA+
Sbjct: 62 WVVKL---YYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAI 114
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGL------AH----------- 467
+ + Y+H +IK N+LL ++SDFGL +H
Sbjct: 115 DSIHKLGYIHR--------DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166
Query: 468 --------LASPSSTPNRIDG-----------------YRAPEVTDARKVSQKADVYSFG 502
++ P S+ + + Y APEV +++ D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226
Query: 503 VLLLELLTGKAP 514
V++ E+L G P
Sbjct: 227 VIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 42/146 (28%), Positives = 68/146 (46%), Gaps = 22/146 (15%)
Query: 389 LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSS 448
++ +M GS ++LL G ++ + GA R + YLH G H NIK+S
Sbjct: 76 VISPFMAYGSANSLLKTYFPEG---MSEALIGNILFGALRGLNYLHQNGYI--HRNIKAS 130
Query: 449 NILLSKSYEARISDFGLAHLASPSSTPNR-------------IDGYRAPEV--TDARKVS 493
+IL+S + +S GL+HL S + + + +PE+ D +
Sbjct: 131 HILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYN 188
Query: 494 QKADVYSFGVLLLELLTGKAPTQALL 519
K+D+YS G+ EL TG+ P Q +L
Sbjct: 189 VKSDIYSVGITACELATGRVPFQDML 214
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 51/200 (25%), Positives = 85/200 (42%), Gaps = 18/200 (9%)
Query: 325 LGKGTFGTAY----KATLEMGIVVAVKRLKDVTVSEKEFR-EKMEVVGSMDHENLVPLRA 379
+GKG+FG + T + + +++ V+ SE + V+ ++ +VPL+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR-AIAYLHSKGP 438
+ S ++ LV ++ G L H + GR +R+ A+ LH
Sbjct: 61 SFQSPEKLYLVLAFINGGEL---FHHLQREGRFD---LSRARFYTAELLCALENLHKFNV 114
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHL-ASPSSTPNRIDG---YRAPEVTDARKVSQ 494
+ ++K NILL + DFGL L N G Y APE+ ++
Sbjct: 115 I--YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 495 KADVYSFGVLLLELLTGKAP 514
D ++ GVLL E+LTG P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 43/167 (25%), Positives = 67/167 (40%), Gaps = 20/167 (11%)
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSL----SALLHGNRGAGRTPLNWETRSGLALGASR 428
N+V L Y S D LV + G L S L+ + W +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDA-- 100
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-YRAPEVT 487
LH +G ++ +NILL +++ F S ++ Y APEV
Sbjct: 101 ----LHREGIVCR--DLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVG 154
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAPTQ----ALLNEEGVDLPRWV 530
+ ++ D +S G +L ELLTGK + + +++P WV
Sbjct: 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 48/203 (23%), Positives = 88/203 (43%), Gaps = 51/203 (25%)
Query: 410 GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469
+ PL E + +R + +L S+ H ++ + NILLS++ +I DFGLA
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCI--HRDLAARNILLSENNVVKICDFGLAR-- 221
Query: 470 SPSSTPNRIDGYRAPEVT---DAR-------------KV-SQKADVYSFGVLLLELLT-G 511
D Y+ P+ DAR KV + ++DV+SFGVLL E+ + G
Sbjct: 222 ---------DIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 272
Query: 512 KAPTQAL-LNEEGVD-LPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTA 569
+P + ++EE L + E T E++ + ++C
Sbjct: 273 ASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIY------------------SIMLDCWH 314
Query: 570 QYPDNRPSMAEVTSQIEEICRSS 592
P++RP+ +E+ + ++ + +
Sbjct: 315 NNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 10/120 (8%)
Query: 411 RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470
++PL E + +R + +L S+ H ++ + NILLS++ +I DFGLA
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCI--HRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 471 PSSTPNRIDGYR------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQAL-LNEE 522
R R APE + + ++DV+SFGVLL E+ + G +P + +NEE
Sbjct: 226 KDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 5e-05
Identities = 58/221 (26%), Positives = 81/221 (36%), Gaps = 59/221 (26%)
Query: 370 DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429
D+ N + L + +L+ DY+ G L LL G E + + A
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLK-KEGKLSEA---EVKK-IIRQLVEA 121
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARI--SDFGLAHLASPSSTPNRIDG---YRAP 484
+ LH H +IK N+L + + RI D+GL TP+ DG Y +P
Sbjct: 122 LNDLHKH--NIIHNDIKLENVLYDR-AKDRIYLCDYGLCK---IIGTPSCYDGTLDYFSP 175
Query: 485 EVTDARKVSQKADVYSF-----GVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539
E K+ SF GVL ELLTGK P +E D
Sbjct: 176 E-----KIKGHNYDVSFDWWAVGVLTYELLTGKHPF-----KEDED-------------- 211
Query: 540 AEVFDLE-LLRYQ------------NVEEEMVQLLQLAINC 567
E DLE LL+ Q N + + +L+ IN
Sbjct: 212 -EELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINY 251
|
Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 57/225 (25%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 325 LGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLVPL 377
LG+GT+ T +K ++ +VA LK++ + +E RE + ++ ++ H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVA---LKEIRLEHEEGAPCTAIRE-VSLLKNLKHANIVTL 68
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
++ LV +Y+ S L G ++ R ++Y H +
Sbjct: 69 HDIIHTERCLTLVFEYLD----SDLKQYLDNCGNL-MSMHNVKIFMFQLLRGLSYCHKRK 123
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLAS-PSST-PNRIDG--YRAPEV-TDARKV 492
H ++K N+L+++ E +++DFGLA S P+ T N + YR P+V + +
Sbjct: 124 IL--HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 493 SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE 537
S D++ G +L E+ TG+ P + S VKEE
Sbjct: 182 STPIDMWGVGCILYEMATGR--------------PMFPGSTVKEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 60/249 (24%), Positives = 95/249 (38%), Gaps = 65/249 (26%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVK--RLKDVTVSEKEFREKME--VVGSMDHENLVPL 377
+ LG G FG A ++ + A+K R KDV + K E ++ D+E +V L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA-SRAIAYLHSK 436
+ +D V DY+P G + +LL R + E + + + AI +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI------RMEVFPEVLARFYIAELTLAIESVHKM 120
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGL----------------AHLASPSSTPNRI-- 478
G H +IK NIL+ +++DFGL +H+ S P+ +
Sbjct: 121 GFI--HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 479 ---------------------------------DGYRAPEVTDARKVSQKADVYSFGVLL 505
Y APEV + +Q D +S GV+L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 506 LELLTGKAP 514
E+L G+ P
Sbjct: 239 FEMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 323 EVLGKGTFGTAY----KATLEMGIVVAVKRLKDVTVSEK-----EFREKMEVVGSMDHEN 373
+VLG G +G + + + G + A+K LK T+ +K R + +V+ +
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 374 LVPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA-SRAIA 431
+ Y + D KL L+ DY+ G L L + R E + G A+
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHL-----SQRERFK-EQEVQIYSGEIVLALE 119
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH--LASPSSTPNRIDG---YRAPEV 486
+LH G + +IK NILL + ++DFGL+ G Y AP++
Sbjct: 120 HLHKLGII--YRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDI 177
Query: 487 TDARKV--SQKADVYSFGVLLLELLTGKAP 514
+ D +S GVL+ ELLTG +P
Sbjct: 178 VRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 7e-05
Identities = 41/190 (21%), Positives = 76/190 (40%), Gaps = 23/190 (12%)
Query: 347 KRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGN 406
KR+K + + + ++ +G ++HEN++ + S ++ S +
Sbjct: 198 KRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA 257
Query: 407 RGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466
PL +TR+ + A+ Y+H K H +IK NI L+ + + DFG A
Sbjct: 258 FDWKDRPLLKQTRAIMKQLLC-AVEYIHDK--KLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 467 HLASPSSTPNRIDGY--------RAPEVTDARKVSQKADVYSFGVLLLELLT-------- 510
P Y +PE+ + D++S G++LL++L+
Sbjct: 315 ---MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371
Query: 511 -GKAPTQALL 519
G P + LL
Sbjct: 372 GGGKPGKQLL 381
|
Length = 501 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 33/105 (31%), Positives = 46/105 (43%), Gaps = 13/105 (12%)
Query: 411 RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470
PLN E + L A+ LH + KS NILL+ + G +
Sbjct: 11 GRPLNEEEIWAVCLQCLGALRELHRQA--------KSGNILLTWD--GLLKLDGSVAFKT 60
Query: 471 PSSTPNRIDGY-RAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
P +R D Y APEV + ++KAD+YS G+ L E L + P
Sbjct: 61 PEQ--SRPDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 23/158 (14%)
Query: 442 HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------APEVTDARKVSQK 495
H ++ + NILLS++ +I DFGLA R R APE R + +
Sbjct: 202 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 261
Query: 496 ADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554
+DV+SFGVLL E+ + G +P + + EE+ + E R + +
Sbjct: 262 SDVWSFGVLLWEIFSLGASPYPGV--------------KIDEEFCRRL--KEGTRMRAPD 305
Query: 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
++ Q ++C P RP+ +E+ + + +++
Sbjct: 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLV 375
+ LG+G++ T YK + G +VA LK++ + +E RE ++ + H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVA---LKEIRLEHEEGAPFTAIRE-ASLLKDLKHANIV 66
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALL--HGNRGAGRTPLNWETRSGLALGASRAIAYL 433
L +++ LV +Y+ L + G G + N L R +AY
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLL---RGLAYC 119
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS-PSST-PNRIDG--YRAPEV-TD 488
H + H ++K N+L+S+ E +++DFGLA S PS T N + YR P+V
Sbjct: 120 HQRRVL--HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 489 ARKVSQKADVYSFGVLLLELLTGKA 513
+ + S D++ G + E+ TG+
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 63/245 (25%), Positives = 96/245 (39%), Gaps = 65/245 (26%)
Query: 321 SAEVLGKGTFGTA-YKATLEMGIVVAVKRLKDVTVSEKE----FREKMEVVGSMDHENLV 375
S +V+G+G FG + G V A+K L+ + EKE R + +++ D +V
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 376 PLRAYYYSRDEKL---LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
+ +YS +KL L+ +++P G + LL + L E AI
Sbjct: 65 KM---FYSFQDKLNLYLIMEFLPGGDMMTLL-----MKKDTLTEEETQFYIAETVLAIDS 116
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGL------AH------------------- 467
+H G H +IK N+LL ++SDFGL AH
Sbjct: 117 IHQLGFI--HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 468 -----------------LA-SPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELL 509
LA S TP+ Y APEV ++ D +S GV++ E+L
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPD----YIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
Query: 510 TGKAP 514
G P
Sbjct: 231 IGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 47/205 (22%), Positives = 90/205 (43%), Gaps = 25/205 (12%)
Query: 324 VLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVPL 377
V+G+G++ L+ + A+K +K V++ E EK + +H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ + + V +++ G L + H R + L E + S A+ +LH +G
Sbjct: 62 HSCFQTESRLFFVIEFVSGGDL--MFHMQR---QRKLPEEHARFYSAEISLALNFLHERG 116
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAH--------LASPSSTPNRIDGYRAPEVTDA 489
+ ++K N+LL +++D+G+ ++ TPN Y APE+
Sbjct: 117 II--YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPN----YIAPEILRG 170
Query: 490 RKVSQKADVYSFGVLLLELLTGKAP 514
D ++ GVL+ E++ G++P
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 62/241 (25%), Positives = 93/241 (38%), Gaps = 65/241 (26%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKRL--KDVTVSEKEFR---EKMEVVGSMDHENLVP 376
++LGKG G + L G + A+K L K++ K R E+ E++ ++DH L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQ-EILATLDHPFLPT 65
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG--LALGASR------ 428
L A + + LV DY P G L LL + + G L+ +R
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLL-------------QRQPGKCLSEEVARFYAAEV 112
Query: 429 --AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA------------HLASPSST 474
A+ YLH G + ++K NILL +S +SDF L+ L S
Sbjct: 113 LLALEYLHLLGIV--YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 475 PNRI---------------------DGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
+ + Y APEV D ++ G+LL E+L G
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTT 230
Query: 514 P 514
P
Sbjct: 231 P 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 28/171 (16%)
Query: 370 DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429
+H N+VP RA + + +E +V +M GS L+ + G + L + + G +A
Sbjct: 57 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---AIAYILQGVLKA 113
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID---------- 479
+ Y+H G H ++K+S+IL+S + +S GL S + R+
Sbjct: 114 LDYIHHMGYV--HRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSV 169
Query: 480 ---GYRAPEV--TDARKVSQKADVYSFGVLLLELLTGKAP------TQALL 519
+ +PEV + + K+D+YS G+ EL G P TQ LL
Sbjct: 170 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 33/207 (15%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKME------------VVGSMD 370
E LG+GT+ T +K +L + V+ KE R + E ++ +
Sbjct: 12 EKLGEGTYATVFKGR---------SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 371 HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAI 430
H N+V L ++ LV +Y L L ++ R +
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS-PSST-PNRIDG--YRAPEV 486
AY H + H ++K N+L+++ E +++DFGLA S P+ T N + YR P+V
Sbjct: 118 AYCHRRKVL--HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175
Query: 487 -TDARKVSQKADVYSFGVLLLELLTGK 512
+ + S + D++ G + E+ +G+
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 48/217 (22%)
Query: 325 LGKGTFGTAYKA-TLEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLVPL 377
+G+GTFG +KA + +VA+K++ + +EKE RE ++++ + HEN+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALRE-IKILQLLKHENVVNL 76
Query: 378 ------RAYYYSRDEK--LLV-----HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLAL 424
+A Y+R + LV HD L+ LL N+ T + + L
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFCEHD------LAGLLS-NKNVKFTLSEIKKVMKMLL 129
Query: 425 GASRAIAYLHSKGPANS--HGNIKSSNILLSKSYEARISDFGLAHLASPS--STPNRIDG 480
+ Y+H N H ++K++NIL++K +++DFGLA S S S PNR
Sbjct: 130 NG---LYYIHR----NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182
Query: 481 ------YRAPEV-TDARKVSQKADVYSFGVLLLELLT 510
YR PE+ R D++ G ++ E+ T
Sbjct: 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 50/205 (24%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 325 LGKGTFGTAYKATLEMGIV--VAVKRL-KDVTVSEKE----FREKMEVVGSMDHENLVPL 377
LG G+FG AT + VA+KR K + +K+ F E+ +++ ++H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER-KILNYINHPFCVNL 96
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ LV +++ G L N+ R P G A + + + +
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNK---RFP----NDVGCFYAAQIVLIFEYLQS 149
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPNRIDGYRAPEVTDARKV 492
+ ++K N+LL K +++DFG A + + TP Y APE+
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPE----YIAPEILLNVGH 205
Query: 493 SQKADVYSFGVLLLELLTGKAPTQA 517
+ AD ++ G+ + E+L G P A
Sbjct: 206 GKAADWWTLGIFIYEILVGCPPFYA 230
|
Length = 340 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 41/220 (18%)
Query: 323 EVLGKGTFGTAYKATLE-------MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLV 375
+V+G+G FG ++ M I+ + LK + FRE+ V+ + D + +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC--FREERNVLVNGDCQWIT 64
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALG----ASRAIA 431
L + + LV DY G L LL ++ R P E + + A +I
Sbjct: 65 TLHYAFQDENYLYLVMDYYVGGDLLTLL--SKFEDRLP---EDMARFYIAEMVLAIHSIH 119
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDF---------GLAHLASPSSTPNRIDGYR 482
LH H +IK N+LL + R++DF G + TP+ Y
Sbjct: 120 QLHY-----VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD----YI 170
Query: 483 APEVTDAR-----KVSQKADVYSFGVLLLELLTGKAPTQA 517
+PE+ A K + D +S GV + E+L G+ P A
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 26/87 (29%), Positives = 40/87 (45%), Gaps = 9/87 (10%)
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYR 482
+ YLH H ++K+ NI ++ + I D G A P P +
Sbjct: 168 EGLRYLH--AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVETN 223
Query: 483 APEVTDARKVSQKADVYSFGVLLLELL 509
APEV K + KAD++S G++L E+L
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 65/253 (25%), Positives = 94/253 (37%), Gaps = 75/253 (29%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRL--KDVTVSEKEFREKME--VVGSMDHENLVPLRA 379
+G G FG ++ + A+K L DV + + K E ++ D+E +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL-- 66
Query: 380 YYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
YY +D+ L V DY+P G + +LL G L + L AI +H G
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDLARFYIAELTC----AIESVHKMG 121
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGL-------------------------------- 465
H +IK NIL+ + +++DFGL
Sbjct: 122 FI--HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 466 ---------------------AHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVL 504
AH S TPN Y APEV +Q D +S GV+
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAH--SLVGTPN----YIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 505 LLELLTGKAPTQA 517
L E+L G+ P A
Sbjct: 234 LYEMLVGQPPFLA 246
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 39/216 (18%)
Query: 323 EVLGKGTFGTAY---KAT-LEMGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHEN 373
+VLG G +G + K T + G + A+K L+ + +K R + V+ +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 374 LVPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR---- 428
+ Y + + KL L+ DY+ G + L+ R + R
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-------------QRDNFSEDEVRFYSG 112
Query: 429 ----AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH--LASPSSTPNRIDG-- 480
A+ +LH G + +IK NILL ++DFGL+ L+ G
Sbjct: 113 EIILALEHLHKLGIV--YRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 481 -YRAPEVTDARKVSQKA-DVYSFGVLLLELLTGKAP 514
Y APE+ + KA D +S G+L+ ELLTG +P
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 58/242 (23%), Positives = 93/242 (38%), Gaps = 59/242 (24%)
Query: 321 SAEVLGKGTFGTA-YKATLEMGIVVAVKRLKDVTVSEKE----FREKMEVVGSMDHENLV 375
S +V+G+G FG + G + A+K L+ + EKE R + +++ D +V
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVV 64
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
+ + + L+ +++P G + LL + L+ E AI +H
Sbjct: 65 KMFYSFQDKRNLYLIMEFLPGGDMMTLL-----MKKDTLSEEATQFYIAETVLAIDAIHQ 119
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGL------AH---------------------- 467
G H +IK N+LL ++SDFGL AH
Sbjct: 120 LGFI--HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 468 --------------LA-SPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGK 512
LA S TP+ Y APEV ++ D +S GV++ E+L G
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPD----YIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233
Query: 513 AP 514
P
Sbjct: 234 PP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 31/107 (28%), Positives = 49/107 (45%), Gaps = 18/107 (16%)
Query: 428 RAIAYLHSKGPANS--HGNIKSSNILLSKSYEARISDFGLAHLASPSS-TPNRIDGY--- 481
RAI YLH N H +IK+ NI ++ + + DFG A P N+ G+
Sbjct: 193 RAIQYLHE----NRIIHRDIKAENIFINHPGDVCLGDFGAA--CFPVDINANKYYGWAGT 246
Query: 482 ---RAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVD 525
APE+ D++S G++L E+ T +L ++G+D
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKDGLD 290
|
Length = 391 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 64/215 (29%), Positives = 100/215 (46%), Gaps = 37/215 (17%)
Query: 323 EVLGKGTFGTAYKATLEM---GIVVAVKRL-KDVTVSEKE---FREKMEVVGSMDHENLV 375
+V+G+G FG A ++M G V A+K L K + E FRE+ +V+ + D +
Sbjct: 7 KVIGRGAFGEV--AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT 64
Query: 376 PLRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLN----WETRSGLALGASRA 429
L +Y +DE LV DY G L LL ++ R P + + LA+ +
Sbjct: 65 NL--HYAFQDENNLYLVMDYYVGGDLLTLL--SKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG--LAHLASPSSTPNRIDG---YRAP 484
+ Y+H +IK N+LL K+ R++DFG L LA + N G Y +P
Sbjct: 121 LGYVHR--------DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 485 EVTDAR-----KVSQKADVYSFGVLLLELLTGKAP 514
E+ A + + D +S GV + E+L G+ P
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 26/82 (31%), Positives = 38/82 (46%), Gaps = 12/82 (14%)
Query: 444 NIKSSNILLSKSYEARISDFGLA-HLASPSS-------TPNRIDGYRAPEVTDARKVSQK 495
++K N+LL RISD GLA L S TP G+ APE+ +
Sbjct: 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP----GFMAPELLQGEEYDFS 177
Query: 496 ADVYSFGVLLLELLTGKAPTQA 517
D ++ GV L E++ + P +A
Sbjct: 178 VDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 19/59 (32%), Positives = 26/59 (44%)
Query: 65 LHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNF 123
L ++ L N L F L NL+ L L GN + P L +L L+L+ NN
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 14/149 (9%)
Query: 323 EVLGKGTFGTAYKA-TLEMGIVVAVK--RLKDVTVSEKEFREKME--VVGSMDHENLVPL 377
+ LG G FG A ++ + A+K R KDV + + K E ++ D+E +V L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA-SRAIAYLHSK 436
+ +D V DY+P G + +LL R + E + + + A+ +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLI------RMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGL 465
G H +IK NIL+ + +++DFGL
Sbjct: 121 GFI--HRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 10/93 (10%)
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDGY------ 481
A+AYLH +G H ++K+ NI L + A + DFG A L + TP + G+
Sbjct: 197 ALAYLHGRGII--HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP-QCYGWSGTLET 253
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+PE+ K D++S G++L E+
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 38/131 (29%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 52 SGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLG 111
S + NL L ++ L N LR I L+NL +L L N + +IP L+ L
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNISELLE-LTNLTSLDLDNNNIT-DIPPLIGLLK 139
Query: 112 -NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
NL L+L+ N ++ + L L L L N L+ L S+L ++S NK+
Sbjct: 140 SNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKI 198
Query: 171 NGSIPKRFARL 181
+ +P L
Sbjct: 199 S-DLPPEIELL 208
|
Length = 394 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 44/186 (23%), Positives = 82/186 (44%), Gaps = 33/186 (17%)
Query: 413 PLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472
PL+ + + ++ + +L SK H ++ + N+LL+ A+I DFGLA
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNCI--HRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 473 ST---------PNRIDGYRAPE-VTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNE 521
S P + + APE + D Q +DV+S+G+LL E+ + GK+P +L
Sbjct: 266 SNYVVKGNARLPVK---WMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGIL-- 319
Query: 522 EGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
V+ +VK + D E+ ++++ C P RP+ +++
Sbjct: 320 --VN--SKFYKMVKRGYQMSRPDFAPP-------EIYSIMKM---CWNLEPTERPTFSQI 365
Query: 582 TSQIEE 587
+ I+
Sbjct: 366 SQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 606 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.68 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.55 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.52 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.49 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.43 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.43 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.35 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.31 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.31 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.3 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.3 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.3 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.26 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.26 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.24 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.24 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.17 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.17 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.13 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.1 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.06 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.94 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.92 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.81 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.77 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.64 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.63 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.63 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.61 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.59 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.57 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.53 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.41 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.33 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.3 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.23 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.21 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-60 Score=557.21 Aligned_cols=500 Identities=28% Similarity=0.463 Sum_probs=313.0
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|+.|+|++|.+++.+|..+..+++|+.|+|++|++.+.+|..+ .+++|+.|+|++|++++.+|..|.++++|+.|+|
T Consensus 428 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~L 506 (968)
T PLN00113 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKL 506 (968)
T ss_pred CCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEEC
Confidence 566677777777776666666666666666666666665555433 3355666666666665555555555556666666
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSLCGK 194 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l~~~ 194 (606)
++|++.+.+|..+..+++|++|+|++|++++.+|. +..+++|+.|+|++|++++.+|..+..++ .+++.+|++.+.
T Consensus 507 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~ 586 (968)
T PLN00113 507 SENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGS 586 (968)
T ss_pred cCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceee
Confidence 66666555555555555666666666666555553 55555566666666666555555444332 234455554431
Q ss_pred -CCc----------------CCCCCCC---CCCC-CCCCCCCCceeeehhhHHHHHHHHHHHHhhhhhccccccCCcCCc
Q 037905 195 -PLV----------------SCNGGGD---DDDD-DGSNLSGGAIAGIVIGSVIGLLIILVLLIGLCRRKRDRQRSSKDV 253 (606)
Q Consensus 195 -p~~----------------~c~~~~~---~~~~-~~~~~~~~~~~~iv~g~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 253 (606)
|.. .|..... .+.. ..+......+++++++++ ++++++++++++++++++.+.. ..
T Consensus 587 ~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~ 663 (968)
T PLN00113 587 LPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAF--LVLALVAFGFVFIRGRNNLELK-RV 663 (968)
T ss_pred CCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHH--HHHHHHHHHHHHHHhhhccccc-cc
Confidence 110 1211100 0000 001111111222222222 2222222222222222211110 00
Q ss_pred CcccccccccccccccccccCCCCCCCCCCCCCCccccCccCCCCcceEEEecCCCCCcCHHHHHHHH--hcccccCCce
Q 037905 254 APAATATATAKQTEIEIPREKGAGDGENTSSDLSGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRAS--AEVLGKGTFG 331 (606)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ig~G~~g 331 (606)
. . +.+ .. ....+.......++++++.... .++||+|+||
T Consensus 664 ~----~-------------~~~----~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g 704 (968)
T PLN00113 664 E----N-------------EDG----TW------------------ELQFFDSKVSKSITINDILSSLKEENVISRGKKG 704 (968)
T ss_pred c----c-------------ccc----cc------------------cccccccccchhhhHHHHHhhCCcccEEccCCCe
Confidence 0 0 000 00 0000000111234555544332 3579999999
Q ss_pred EEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhhhhhcCCCCC
Q 037905 332 TAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG 410 (606)
Q Consensus 332 ~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 410 (606)
.||+|+. .++..||||+++..... ...|++.+++++||||++++|+|.+....++||||+++|+|.++++
T Consensus 705 ~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------ 775 (968)
T PLN00113 705 ASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------ 775 (968)
T ss_pred eEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------
Confidence 9999986 57899999998654322 2345888999999999999999999999999999999999999996
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCCCcccccCccccCC
Q 037905 411 RTPLNWETRSGLALGASRAIAYLHSKG-PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDA 489 (606)
Q Consensus 411 ~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~ 489 (606)
.++|..+.+++.|+|+||+|||..+ ..++||||||+||+++.++.+++. ||.+..........++.+|+|||++.+
T Consensus 776 --~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~ 852 (968)
T PLN00113 776 --NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRET 852 (968)
T ss_pred --cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccccCcccccC
Confidence 2789999999999999999999541 335599999999999999988876 666554433334456788999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc-cChHHHHHHHHHHHHHcc
Q 037905 490 RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY-QNVEEEMVQLLQLAINCT 568 (606)
Q Consensus 490 ~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~~l~~l~~~Cl 568 (606)
..++.++|||||||++|||+||+.||..... .......|+............+|+..... ....++..++.+++.+||
T Consensus 853 ~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl 931 (968)
T PLN00113 853 KDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCT 931 (968)
T ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhC
Confidence 9999999999999999999999999954322 23456666654443333334444443221 223456778999999999
Q ss_pred CcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 569 AQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 569 ~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
+.+|++||||.||++.|+++.+...+
T Consensus 932 ~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 932 ATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred cCCchhCcCHHHHHHHHHHhhccccc
Confidence 99999999999999999999775543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=424.52 Aligned_cols=281 Identities=41% Similarity=0.690 Sum_probs=247.4
Q ss_pred CCCCcCHHHHHHHHh-----cccccCCceEEEEEEEcCCcEEEEEEeccCccC-HHHHHHHHHHHcCCCCCCcccceEEE
Q 037905 308 GDRAFDLEDLLRASA-----EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS-EKEFREKMEVVGSMDHENLVPLRAYY 381 (606)
Q Consensus 308 ~~~~~~~~~~~~~~~-----~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~ 381 (606)
..+.|++.++..|+. +.||+|+||.||+|...+|..||||++...... .++|.+|++++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 456799999999984 579999999999999998999999998876554 77799999999999999999999999
Q ss_pred EeCC-ceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCCCCCCCCCEEecCCCcEE
Q 037905 382 YSRD-EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG-PANSHGNIKSSNILLSKSYEAR 459 (606)
Q Consensus 382 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~i~HrDlkp~Nill~~~~~~k 459 (606)
.+.+ +.+||||||++|+|.++++..... +++|..|++|+.++|+||+|||+.. ..|+||||||+|||+|+++++|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9988 599999999999999999975432 7899999999999999999999976 4788999999999999999999
Q ss_pred EeecccCccCCC-CCC---C-CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHh
Q 037905 460 ISDFGLAHLASP-SST---P-NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV 534 (606)
Q Consensus 460 l~DfG~a~~~~~-~~~---~-~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (606)
|+|||+|+.... ... . .+|.+|+|||++.....+.|+|||||||++.|++||+.+.+.........+..|+...+
T Consensus 218 lsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred ccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999977654 322 1 68899999999999999999999999999999999999887655444456899998888
Q ss_pred hccccccccchhhhcccChH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 535 KEEWTAEVFDLELLRYQNVE-EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 535 ~~~~~~~~~d~~~~~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.++...+++|+.+....... +++..+..++.+|++.+|++||+|.||++.|+.+...
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 88889999999986444333 6888899999999999999999999999999776544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=395.59 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=220.3
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEE
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 391 (606)
+..+++ ...+.||+|-||.||.|.++....||+|.++....+.+.|.+|+++|++++|+|||+++|+|..++..+|||
T Consensus 203 i~r~~l--~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 203 IPREEL--KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred ecHHHH--HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 444444 557889999999999999997779999999998889999999999999999999999999999988999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
|||+.|+|.++|+... ...+...+.+.++.|||+||+||++++++ ||||.++||||+++..+||+|||+|+....
T Consensus 281 E~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~~I--HRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKNYI--HRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCCcc--chhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999998632 34689999999999999999999999966 999999999999999999999999995443
Q ss_pred CCCCCC-----cccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 472 SSTPNR-----IDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 472 ~~~~~~-----~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
...... ...|.|||.+....|+.|||||||||+||||+| |+.||.... ..+.++.+ ..++
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~ev~~~l-e~Gy------- 421 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEEVLELL-ERGY------- 421 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHHHHHHH-hccC-------
Confidence 322111 234999999999999999999999999999999 999996543 33333333 3332
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
+.+.+..|+..++++|..||+.+|++||||+.+...|+++...+.
T Consensus 422 ---Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 422 ---RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred ---cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 334566788899999999999999999999999999999876554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=389.18 Aligned_cols=262 Identities=35% Similarity=0.491 Sum_probs=214.7
Q ss_pred CcCHHHHHHHHhcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCC-c
Q 037905 311 AFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRD-E 386 (606)
Q Consensus 311 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~ 386 (606)
.++.+++.. .+.||+|+||+||+|.+.....||||++.....+ .++|.+|+.++.+++|||||+++|+|.... .
T Consensus 37 ~i~~~~l~~--~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 37 EIDPDELPI--EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred ecChHHhhh--hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 344555433 4569999999999999984444999999875443 458999999999999999999999999877 7
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeeccc
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGL 465 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~ 465 (606)
.++|||||++|+|.++++.. ....+++..+++++.|||+||.|||++++ ||||||||+|||++.++ .+||+|||+
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCcc
Confidence 89999999999999999864 13469999999999999999999999994 55999999999999998 999999999
Q ss_pred CccCCC---CCC-CCCcccccCccccC--CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 466 AHLASP---SST-PNRIDGYRAPEVTD--ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 466 a~~~~~---~~~-~~~~~~y~aPE~~~--~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
++.... ..+ ..+|+.|||||++. ...|+.|+||||||+++|||+||+.||..... ......+..++..
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLR 264 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCC
Confidence 976653 222 57788999999999 56899999999999999999999999975422 2222223323222
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
+..+.++...+..+|.+||..||+.||++.+|+..|+.+......
T Consensus 265 ----------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 265 ----------PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred ----------CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 222233667899999999999999999999999999999775554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=366.21 Aligned_cols=253 Identities=28% Similarity=0.394 Sum_probs=212.0
Q ss_pred CcCHHHHHHHHhcccccCCceEEEEEEEc-CCcEEEEEEeccC--ccCHHHHHHHHHHHcCCCCCCcccceEEEEeCC-c
Q 037905 311 AFDLEDLLRASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDV--TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRD-E 386 (606)
Q Consensus 311 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~ 386 (606)
.++..|+.+ .+.||+|..|+||++.++ +++.+|+|++... ....+++.+|++++++.+||+||.++|.|+... +
T Consensus 75 ~i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 75 GISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred ccCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 356666644 578999999999999864 7899999999543 334678999999999999999999999999988 5
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCcEEEeeccc
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGL 465 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~~kl~DfG~ 465 (606)
..++||||++|+|..++... +.+++...-+|+.+|++||.|||+ .+|+ ||||||+|||++..|.+||||||.
T Consensus 153 isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~II--HRDIKPsNlLvNskGeVKicDFGV 225 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERKII--HRDIKPSNLLVNSKGEVKICDFGV 225 (364)
T ss_pred EEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccCee--eccCCHHHeeeccCCCEEeccccc
Confidence 99999999999999999854 358999999999999999999996 6655 999999999999999999999999
Q ss_pred CccCCC--CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 466 AHLASP--SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 466 a~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
++.... ..++.||..|||||.+++..|+.++||||||++++|+.+|+.||... .....+....+..++.+..
T Consensus 226 S~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv~~pp----- 299 (364)
T KOG0581|consen 226 SGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIVDEPP----- 299 (364)
T ss_pred cHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHhcCCC-----
Confidence 987654 35678899999999999999999999999999999999999999764 2223344455555544321
Q ss_pred chhhhcccChH-HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLELLRYQNVE-EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~~~~~~~~~-~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+..+. .+..++..++..|+++||.+|||++|+++|
T Consensus 300 ------P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 ------PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ------CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11112 366788999999999999999999999887
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.32 Aligned_cols=252 Identities=29% Similarity=0.438 Sum_probs=213.8
Q ss_pred hcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||+||+|+. ++...||||.+++... ...+|++|++++..++|||||+++|.|..++..++|+||
T Consensus 491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY 570 (774)
T KOG1026|consen 491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY 570 (774)
T ss_pred hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence 57799999999999973 3457899999987654 357899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecc
Q 037905 394 MPMGSLSALLHGNRGAG---------RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG 464 (606)
|..|||.++|....... +.+++..+.+.||.|||.||+||-++.++ ||||.++|+||.++..|||+|||
T Consensus 571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FV--HRDLATRNCLVge~l~VKIsDfG 648 (774)
T KOG1026|consen 571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFV--HRDLATRNCLVGENLVVKISDFG 648 (774)
T ss_pred cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCccc--ccchhhhhceeccceEEEecccc
Confidence 99999999998543211 34489999999999999999999999866 99999999999999999999999
Q ss_pred cCccCCCCCCCC------CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcc
Q 037905 465 LAHLASPSSTPN------RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEE 537 (606)
Q Consensus 465 ~a~~~~~~~~~~------~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (606)
++|.......+. -...|||||.+..++||.+||||||||||||+++ |+.||.+..+++ |-..++++
T Consensus 649 LsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------VIe~i~~g 721 (774)
T KOG1026|consen 649 LSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------VIECIRAG 721 (774)
T ss_pred cchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-------HHHHHHcC
Confidence 998765432221 1235999999999999999999999999999999 999998876655 22233333
Q ss_pred ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 538 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.. .+.++.++.++++||..||+..|++||+|+||-.+|+.....+
T Consensus 722 ~l----------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 722 QL----------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred Cc----------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 21 3456778899999999999999999999999999999987654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=366.14 Aligned_cols=240 Identities=26% Similarity=0.399 Sum_probs=205.0
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
...++||+|+|+.||+++. .+|+.||+|++.+.. -.++.+.+|+++.+.|+|||||+++++|.+.+..|+|.|+|
T Consensus 21 ~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC 100 (592)
T KOG0575|consen 21 KRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELC 100 (592)
T ss_pred eeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEec
Confidence 3467899999999999996 889999999998743 34577999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
..++|.++++.. .++.+.+++.++.||+.||.|||+.+|+ |||||..|+|+++++++||+|||+|......
T Consensus 101 ~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~~Ii--HRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E 173 (592)
T KOG0575|consen 101 HRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSLGII--HRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE 173 (592)
T ss_pred CCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhcCce--ecccchhheeecCcCcEEecccceeeeecCccc
Confidence 999999999843 4799999999999999999999999966 9999999999999999999999999877643
Q ss_pred --CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 --STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
.+..||+.|.|||++.....+..+||||+||++|-||.|++||+.. ++.+.+..+....+.
T Consensus 174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk------~vkety~~Ik~~~Y~----------- 236 (592)
T KOG0575|consen 174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK------TVKETYNKIKLNEYS----------- 236 (592)
T ss_pred ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc------hHHHHHHHHHhcCcc-----------
Confidence 4568899999999999999999999999999999999999999752 233333333333221
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.....+-.+||.++|+.+|.+|||+.+|+.+
T Consensus 237 -~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 -MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 122233445677889999999999999999876
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=354.49 Aligned_cols=244 Identities=27% Similarity=0.413 Sum_probs=200.1
Q ss_pred HhcccccCCceEEEEEE-EcCCcEEEEEEeccCccC--------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEE
Q 037905 321 SAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVS--------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 391 (606)
+.+.||+|+||.|-+|. ..+|+.||||++.+.... ...+++|+++|++++|||||++.++|...+..|+||
T Consensus 176 i~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVl 255 (475)
T KOG0615|consen 176 ISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVL 255 (475)
T ss_pred eeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEE
Confidence 46789999999999997 568999999999765321 234679999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC---CcEEEeecccCcc
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS---YEARISDFGLAHL 468 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~---~~~kl~DfG~a~~ 468 (606)
||++||+|.+.+-.+. .+.+..-..++.|++.|+.|||++||. ||||||+|||+..+ ..+||+|||+|+.
T Consensus 256 E~v~GGeLfd~vv~nk-----~l~ed~~K~~f~Qll~avkYLH~~GI~--HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 256 EYVEGGELFDKVVANK-----YLREDLGKLLFKQLLTAVKYLHSQGII--HRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred EEecCccHHHHHHhcc-----ccccchhHHHHHHHHHHHHHHHHcCcc--cccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999998654 467777788999999999999999977 99999999999765 6799999999998
Q ss_pred CCCC---CCCCCcccccCccccCCCCC---CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccc
Q 037905 469 ASPS---STPNRIDGYRAPEVTDARKV---SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 469 ~~~~---~~~~~~~~y~aPE~~~~~~~---~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
.+.. .+..||+.|.|||++.+..+ ..+.|+||+|||||-+++|.+||..... -+...+++.+..+..
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-----~~sl~eQI~~G~y~f-- 401 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-----DPSLKEQILKGRYAF-- 401 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-----CccHHHHHhcCcccc--
Confidence 8653 46789999999999976543 3478999999999999999999975321 122233333332211
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+..+.+...+..+++.++|..||++|||+.|++++
T Consensus 402 ------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 402 ------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred ------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 123345566778888899999999999999999876
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=335.73 Aligned_cols=250 Identities=23% Similarity=0.356 Sum_probs=205.9
Q ss_pred HHhcccccCCceEEEEEE-EcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEE-EEeCCc-eEEEEee
Q 037905 320 ASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAY-YYSRDE-KLLVHDY 393 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~-~~lv~e~ 393 (606)
.+.++||+|+||.||++. ..+|..+|.|.++-...+ .++...|+.+|++++|||||+++++ +..+.+ .+|||||
T Consensus 22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHh
Confidence 456889999999999997 578999999999755444 3568899999999999999999984 444455 7899999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK--GPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
+..|||...++..+ .....+++..+++++.|++.||.++|.+ .-.+.||||||.||+++.+|.+||+|||++++...
T Consensus 102 c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s 180 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS 180 (375)
T ss_pred hcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcc
Confidence 99999999998654 2345699999999999999999999993 22366999999999999999999999999998876
Q ss_pred CC----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 472 SS----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 472 ~~----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
.. +..||+.||+||.+.+..|+.+|||||+||++|||+.-++||.+ .++....+.+.+..+.
T Consensus 181 ~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g------~n~~~L~~KI~qgd~~-------- 246 (375)
T KOG0591|consen 181 KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG------DNLLSLCKKIEQGDYP-------- 246 (375)
T ss_pred hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc------ccHHHHHHHHHcCCCC--------
Confidence 43 46789999999999999999999999999999999999999965 3555555555444321
Q ss_pred hcccCh-HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 548 LRYQNV-EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 548 ~~~~~~-~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
+.+ .-....+..++..|+..||+.||+...++..++.
T Consensus 247 ---~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 247 ---PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ---CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 122 4456789999999999999999996555555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=346.41 Aligned_cols=189 Identities=30% Similarity=0.438 Sum_probs=169.9
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
+.||+|+||+||+|++ .++..||||.+...... .+.+..|+.+++.++|||||++++++..++..|+|||||.|||
T Consensus 16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD 95 (429)
T KOG0595|consen 16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD 95 (429)
T ss_pred hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence 4599999999999985 46899999999765433 3457899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC------CcEEEeecccCccCCCC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS------YEARISDFGLAHLASPS 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~------~~~kl~DfG~a~~~~~~ 472 (606)
|.++++... .+++..++.++.|+|.||++||+++|+ ||||||.|||++.. -.+||+|||+|+...+.
T Consensus 96 Ls~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~Ii--HRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 96 LSDYIRRRG-----RLPEATARHFMQQLASALQFLHENNII--HRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--eccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999998643 589999999999999999999999966 99999999999865 45899999999988764
Q ss_pred ---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccc
Q 037905 473 ---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQAL 518 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~ 518 (606)
.+..|++-|||||+++.++|+.|+|+||+|+++|+|++|++||...
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 3567788899999999999999999999999999999999999753
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.13 Aligned_cols=238 Identities=25% Similarity=0.374 Sum_probs=198.1
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.++||+|+||+||+++. ++++.+|+|++++.... .+...+|..++.+++||.||.+...|++.+..|+|+||+.|
T Consensus 30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G 109 (357)
T KOG0598|consen 30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG 109 (357)
T ss_pred eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence 57899999999999984 56899999999876543 34578899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
|.|..+|+... .+++..+..++..|+.||.|||++||+ ||||||+|||+|++|.++|+|||+++.... .
T Consensus 110 GeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~gIi--yRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t 182 (357)
T KOG0598|consen 110 GELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKGII--YRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT 182 (357)
T ss_pred ccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCCee--eccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence 99999998643 589999999999999999999999966 999999999999999999999999986543 3
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
.+..||+.|||||++.+..|+.++|+||+|+++|||++|.+||.. .+...+.+.+.++.... .+..
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~------~~~~~~~~~I~~~k~~~--------~p~~ 248 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA------EDVKKMYDKILKGKLPL--------PPGY 248 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC------ccHHHHHHHHhcCcCCC--------CCcc
Confidence 456788999999999999999999999999999999999999964 34455555555543110 0111
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCC----CHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRP----SMAEVTS 583 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RP----s~~~v~~ 583 (606)
.. .+..+++.+.+..+|++|. ++.+|.+
T Consensus 249 ls---~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 249 LS---EEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CC---HHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 22 3455667799999999996 4555443
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.00 Aligned_cols=255 Identities=21% Similarity=0.318 Sum_probs=208.1
Q ss_pred HHhcccccCCceEEEEEEEcCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 320 ASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
...++||+|-||.|.++..+.+..||||+++.... .+++|.+|+++|.+++||||++++|+|..++..++|+|||++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 35789999999999999998889999999987543 3578999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCC--
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP-- 475 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 475 (606)
+|.+++..... ..+.....++|+.|||.||+||.+.+++ ||||.++|+|+|.++++||+|||+++........
T Consensus 621 DLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~nfV--Hrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v 695 (807)
T KOG1094|consen 621 DLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLNFV--HRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV 695 (807)
T ss_pred cHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhchh--hccccccceeecCcccEEecCcccccccccCCceee
Confidence 99999987531 1245566778999999999999999866 9999999999999999999999999865433221
Q ss_pred ----CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 476 ----NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT--GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 476 ----~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
.-...|||||.+.-.+++.++|||+||+++||+++ .+.||....++. .++-....+..+-.. .-
T Consensus 696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~-------~~ 765 (807)
T KOG1094|consen 696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQ-------VV 765 (807)
T ss_pred ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcc-------ee
Confidence 12245999999999999999999999999999876 789998765543 222122222211111 11
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
...+.-|+..++++|.+||..|-++|||++++...|++.+
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 2345667888999999999999999999999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=323.74 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=198.1
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
...++|+|+||.||+++.+ +|+.||||+|.....+ .+-..+|++++++++|+|+|.++++|......++|+||++.
T Consensus 6 ~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh 85 (396)
T KOG0593|consen 6 KLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH 85 (396)
T ss_pred hhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch
Confidence 3467999999999999954 6999999999765443 35578999999999999999999999999999999999988
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++.+-+.... ..++...+..++.|++.|+.|+|+++++ ||||||+|||++.+|.+||||||.|+......
T Consensus 86 -TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n~I--HRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 86 -TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNNCI--HRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred -HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcCee--cccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 5545554332 3488899999999999999999999966 99999999999999999999999999877432
Q ss_pred -CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCC--------ChhHHHHHHhh-ccccccc
Q 037905 474 -TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGV--------DLPRWVQSVVK-EEWTAEV 542 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~-~~~~~~~ 542 (606)
.+..|..|+|||.+.+ -+|+..+||||+||++.||++|.+.|.+..+-+.. +++.--+.++. +++...+
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv 238 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV 238 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence 3456778999999877 68999999999999999999999999765433211 11111122222 2222222
Q ss_pred cchhhhccc----ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLRYQ----NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.-|.....+ ..+....-++++++.|++.||++|++.+|++.+
T Consensus 239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111 112233468999999999999999999999765
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=376.84 Aligned_cols=257 Identities=30% Similarity=0.434 Sum_probs=212.5
Q ss_pred HhcccccCCceEEEEEEEc--CC----cEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLE--MG----IVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~--~~----~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
....||+|+||.||+|+.. .| ..||||.++... ....+|.+|..+|++++|||||+++|.|.+....++++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 3568999999999999853 23 459999998753 345789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 393 YMPMGSLSALLHGNRGAG--RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
||++|||..+|++.+... ...+.....+.++.|||+|+.||++++++ ||||.++|+|+++...|||+|||+|+...
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fv--HRDLAaRNCLL~~~r~VKIaDFGlArDiy 853 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFV--HRDLAARNCLLDERRVVKIADFGLARDIY 853 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCc--CcchhhhheeecccCcEEEcccchhHhhh
Confidence 999999999999763322 34588999999999999999999999966 99999999999999999999999998433
Q ss_pred CCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 471 PSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 471 ~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
... ...-...|||||.+....|+.|+|||||||++||++| |..||....+.+ .+..+...+
T Consensus 854 ~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------v~~~~~~gg------ 921 (1025)
T KOG1095|consen 854 DKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------VLLDVLEGG------ 921 (1025)
T ss_pred hchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------HHHHHHhCC------
Confidence 211 1111235999999999999999999999999999999 999997654432 112223332
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccC
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQG 596 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~ 596 (606)
+.+.+..|+..++++|.+||+.+|++||+|..|++++..+....+...
T Consensus 922 -----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 922 -----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred -----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 234556788899999999999999999999999999999987766543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=362.78 Aligned_cols=250 Identities=25% Similarity=0.491 Sum_probs=214.3
Q ss_pred hcccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.++||.|.||.||+|+++ ....||||.++.... .+.+|..|+.+|.+++||||+++.|+.......+||+|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 578999999999999864 347799999987644 35679999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP 475 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 475 (606)
+|+|..+|+.+.+ .+.+-+.+-++++||.||.||-+.+++ ||||.++|||++.+..+|++|||++|...+....
T Consensus 714 NGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~YV--HRDLAARNILVNsnLvCKVsDFGLSRvledd~~~ 787 (996)
T KOG0196|consen 714 NGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMNYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 787 (996)
T ss_pred CCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcCch--hhhhhhhheeeccceEEEeccccceeecccCCCc
Confidence 9999999997653 488889999999999999999999977 9999999999999999999999999977654422
Q ss_pred -CCc------ccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 476 -NRI------DGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 476 -~~~------~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
..| ..|.|||.+..+++|.+||||||||||||+++ |++||....+++ +...+.+++
T Consensus 788 ~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd-------VIkaIe~gy--------- 851 (996)
T KOG0196|consen 788 AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VIKAIEQGY--------- 851 (996)
T ss_pred cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH-------HHHHHHhcc---------
Confidence 222 23999999999999999999999999999999 999998766554 222233332
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
+.+.+.+|+..|.+||..||++|-.+||.|.||+..|.++.+...+
T Consensus 852 -RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~S 897 (996)
T KOG0196|consen 852 -RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNS 897 (996)
T ss_pred -CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchh
Confidence 2234466888999999999999999999999999999999876443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=346.38 Aligned_cols=237 Identities=25% Similarity=0.385 Sum_probs=198.9
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhhh
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSAL 402 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 402 (606)
+-||+|+.|.||+|+++ ++.||||+++.. -..+++-|++++||||+.+.|+|....-+|||||||..|-|.+.
T Consensus 130 eWlGSGaQGAVF~Grl~-netVAVKKV~el------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH-NETVAVKKVREL------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeecc-CceehhHHHhhh------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 45999999999999998 789999988542 23457789999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---CCCCCcc
Q 037905 403 LHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---STPNRID 479 (606)
Q Consensus 403 l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~ 479 (606)
|+... ++.....+.+..+||.||.|||.+.|+ |||||.-||||..+..|||+|||-++..... ..+.+|.
T Consensus 203 Lka~~-----~itp~llv~Wsk~IA~GM~YLH~hKII--HRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV 275 (904)
T KOG4721|consen 203 LKAGR-----PITPSLLVDWSKGIAGGMNYLHLHKII--HRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV 275 (904)
T ss_pred HhccC-----ccCHHHHHHHHHHhhhhhHHHHHhhHh--hhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence 98643 578888999999999999999999855 9999999999999999999999998876553 2467888
Q ss_pred cccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHH
Q 037905 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQ 559 (606)
Q Consensus 480 ~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 559 (606)
.|||||++....+++|+||||||||||||+||..||....... .+.. +-......+.+..++.-
T Consensus 276 aWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------IIwG----------VGsNsL~LpvPstcP~G 339 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------IIWG----------VGSNSLHLPVPSTCPDG 339 (904)
T ss_pred hhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe------eEEe----------ccCCcccccCcccCchH
Confidence 8999999999999999999999999999999999997532211 0000 00111223445677788
Q ss_pred HHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 560 LLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 560 l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
+.-|+++||+..|..||+|.+|+.||+-..
T Consensus 340 fklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 340 FKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 888999999999999999999999997553
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=339.94 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=203.4
Q ss_pred HHHHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHH--HHHHHHHHcCCC-CCCcccceEEEEeCC-ceEEEE
Q 037905 317 LLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE--FREKMEVVGSMD-HENLVPLRAYYYSRD-EKLLVH 391 (606)
Q Consensus 317 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lv~ 391 (606)
-+|.+.++||.|.||.||+|+ .++|..||||+++....+-++ =.+|++.+++|+ ||||+++.+.+.+.+ ..++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 356778899999999999998 567899999999887655444 357999999998 999999999999887 899999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
|||+. +|++++++.. ..+++..++.|+.||++||+|+|++|+. |||+||+|||+.....+||+|||+||....
T Consensus 90 E~Md~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~GfF--HRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 90 EFMDC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKHGFF--HRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred Hhhhh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhcCcc--cccCChhheEecccceeEeccccccccccc
Confidence 99976 9999998753 4699999999999999999999999976 999999999999888999999999998754
Q ss_pred C---CCCCCcccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh----ccccc---
Q 037905 472 S---STPNRIDGYRAPEVTD-ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK----EEWTA--- 540 (606)
Q Consensus 472 ~---~~~~~~~~y~aPE~~~-~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~--- 540 (606)
. ..+..|..|+|||++. +..|+.+.||||+|||++|+.+-++.|.+..+.+ .+.... .++- +.|..
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D--qi~KIc-~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID--QIYKIC-EVLGTPDKDSWPEGYN 239 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH--HHHHHH-HHhCCCccccchhHHH
Confidence 3 3456788899999875 5678999999999999999999999997643322 111111 1110 00100
Q ss_pred --cccchhhhc--c----cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 --EVFDLELLR--Y----QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 --~~~d~~~~~--~----~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+...+.. . .-.+.+..+.++++.+|+++||++||||.|.+++
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000000000 0 0123466788999999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=341.29 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=202.4
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceE
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKL 388 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 388 (606)
+.++++ ...+.||+|+||+||+|+|. | .||||++...... -+.|.+|+..+++-+|.||+-++|||..... +
T Consensus 389 Ip~~ev--~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEV--LLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHh--hccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 444444 34678999999999999986 3 5899999765443 3569999999999999999999999987766 9
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 389 LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
||+-+|+|.+|+.+++..+ ..++..+.+.|+.|||+||.|||.++|+ |||||..|||+.+++.|||+|||++..
T Consensus 464 IiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~II--HrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKNII--HRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhhhh--hhhccccceEEccCCcEEEecccceee
Confidence 9999999999999999754 4689999999999999999999999966 999999999999999999999999854
Q ss_pred CCC------CCCCCCcccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 469 ASP------SSTPNRIDGYRAPEVTDA---RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 469 ~~~------~~~~~~~~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
-.. .....+..-|||||++.. ..|++++||||||+|+|||+||..||. ....+ .++ -++ -.++.
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~d--qIi---fmV-GrG~l 610 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRD--QII---FMV-GRGYL 610 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChh--heE---EEe-ccccc
Confidence 322 122334455999999854 468999999999999999999999997 22221 000 000 01110
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
..|.. .....+.+++.+|+..||..++++||.+.+|+..|+++..+
T Consensus 611 --~pd~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 --MPDLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred --Cccch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 01111 11245667889999999999999999999999999988764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=329.41 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=202.0
Q ss_pred HHHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 318 LRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 318 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.|...++||.|..++||+|. ...++.||||++..... +-+.+++|+..++.++||||++++..|..+.+.|+||.||
T Consensus 27 ~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 27 DYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred ceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 34456889999999999998 56789999999976543 2368999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
.+|++.+++..... ..+++..+..|.+++++||.|||++|.+ |||||+.||||+.+|.|||+|||.+......
T Consensus 107 a~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G~I--HRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNGHI--HRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred cCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcCce--ecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999986542 2488999999999999999999999977 9999999999999999999999976543322
Q ss_pred ------CCCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 ------STPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 ------~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
.+..+++.|||||+++. ..|+.|+||||||++..||.+|+.||....+. ..+...+++... .. +
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp-~~-~ 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPP-TL-L 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCC-Cc-c
Confidence 34567888999999543 57999999999999999999999999764321 111122222110 00 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
-..............+.+++..|+..||++|||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0011111222334578899999999999999999999876
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=333.17 Aligned_cols=255 Identities=17% Similarity=0.294 Sum_probs=204.1
Q ss_pred CcCHHHHHHHHhcccccCCceEEEEEEEcCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEe---
Q 037905 311 AFDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYS--- 383 (606)
Q Consensus 311 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~--- 383 (606)
.++.+++.......||+|++|.||+|... |+.||||+++..... .+.+.+|+.++++++||||++++|++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~ 92 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence 45556664444467999999999999984 899999999765333 2567799999999999999999999876
Q ss_pred -CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEe
Q 037905 384 -RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARIS 461 (606)
Q Consensus 384 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~ 461 (606)
....++||||+++|+|.+++... ..+++.....++.+++.||.|||+. +++ ||||||+||++++++.+||+
T Consensus 93 ~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--Hrdlkp~nill~~~~~~kl~ 165 (283)
T PHA02988 93 DLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKII 165 (283)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCCCC--CCcCChhhEEECCCCcEEEc
Confidence 34678999999999999999753 2588999999999999999999985 666 99999999999999999999
Q ss_pred ecccCccCCCC-CCCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccc
Q 037905 462 DFGLAHLASPS-STPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW 538 (606)
Q Consensus 462 DfG~a~~~~~~-~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (606)
|||+++..... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||... +.......+...+.
T Consensus 166 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~------~~~~~~~~i~~~~~ 239 (283)
T PHA02988 166 CHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL------TTKEIYDLIINKNN 239 (283)
T ss_pred ccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhcCC
Confidence 99998765432 23346678999999976 67999999999999999999999999743 22222333322221
Q ss_pred cccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 539 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
.. ..+..+...+.+++.+||+.||++|||++++++.|+.+.
T Consensus 240 ~~----------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 240 SL----------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CC----------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11 111134457889999999999999999999999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=341.90 Aligned_cols=240 Identities=25% Similarity=0.388 Sum_probs=200.6
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHH-HHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-FREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~-~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.++||+|+.|.||.|. ..+++.||||++.......++ +.+|+.+|+..+|+|||.+++.|...++.|+|||||++|+|
T Consensus 278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL 357 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL 357 (550)
T ss_pred hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence 4679999999999997 567899999999876665544 78999999999999999999999989999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+.+... .+++.++..|+.+++.||+|||.+|++ |||||.+|||++.+|.+||+|||++...... .+.
T Consensus 358 TDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~gIi--HrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 358 TDVVTKT------RMTEGQIAAICREILQGLKFLHARGII--HRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred hhhhhcc------cccHHHHHHHHHHHHHHHHHHHhccee--eeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 9999854 389999999999999999999999966 9999999999999999999999998766543 356
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.||+.|||||+.....|+++.||||||++++||+-|++||-.. ..+.. +..+..++ .+.+ ..++.
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE-----~PlrA-lyLIa~ng------~P~l---k~~~k 494 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE-----NPLRA-LYLIATNG------TPKL---KNPEK 494 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-----ChHHH-HHHHhhcC------CCCc---CCccc
Confidence 7899999999999999999999999999999999999999531 11111 11111111 1111 22333
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||..||++||++.|+++|
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 44567788889999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.70 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=198.4
Q ss_pred HHHhcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeC-CceE
Q 037905 319 RASAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSR-DEKL 388 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~ 388 (606)
+...++||+|+||.||+|.. .++..||||+++.... ..+.+.+|+.++.++ +||||++++++|... ...+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 34568899999999999973 2357899999875432 235688999999999 899999999998764 4578
Q ss_pred EEEeecCCCChhhhhhcCCCC---------------------------------------------------------CC
Q 037905 389 LVHDYMPMGSLSALLHGNRGA---------------------------------------------------------GR 411 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~---------------------------------------------------------~~ 411 (606)
+||||+++|+|.+++...... ..
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 999999999999998753210 12
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC------CCCCcccccCcc
Q 037905 412 TPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------TPNRIDGYRAPE 485 (606)
Q Consensus 412 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE 485 (606)
.++++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++...... ...++..|+|||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~~iv--HrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 246 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASRKCI--HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPE 246 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCEE--CCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcH
Confidence 3578889999999999999999999966 99999999999999999999999997653221 122345699999
Q ss_pred ccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHH
Q 037905 486 VTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLA 564 (606)
Q Consensus 486 ~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~ 564 (606)
++.+..++.++|||||||++|||++ |..||...... .........+... ..+......+.+++
T Consensus 247 ~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~~~----------~~~~~~~~~l~~li 310 (338)
T cd05102 247 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN------EEFCQRLKDGTRM----------RAPENATPEIYRIM 310 (338)
T ss_pred HhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHhcCCCC----------CCCCCCCHHHHHHH
Confidence 9998899999999999999999997 99999653211 1111112211110 01122345688999
Q ss_pred HHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 565 INCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 565 ~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.+||+.||++|||+.||++.|+++.+.
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=341.97 Aligned_cols=249 Identities=28% Similarity=0.429 Sum_probs=216.0
Q ss_pred HhcccccCCceEEEEEEEcC-CcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 321 SAEVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
...+||.|-||.||.|.|+. .-.||||.++.....-++|..|..+|+.++|||+|+++|+|..+...|||+|||.+|+|
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNL 350 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNL 350 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccH
Confidence 46789999999999999864 57899999999888899999999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCC----
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP---- 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~---- 475 (606)
.+++.... +..++.-..+.++.||+.||+||..++++ ||||.++|+|+.++..+|++|||+++++......
T Consensus 351 LdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkknFI--HRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 351 LDYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKNFI--HRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred HHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence 99999765 44677788899999999999999999966 9999999999999999999999999988653321
Q ss_pred -CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 476 -NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 476 -~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
.-...|.|||.+....++.|+|||+|||+|||+.| |-.||.+. ++.+ +-..+.+++ ++..+
T Consensus 426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi------dlSq-VY~LLEkgy----------RM~~P 488 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQ-VYGLLEKGY----------RMDGP 488 (1157)
T ss_pred ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc------cHHH-HHHHHhccc----------cccCC
Confidence 11234999999999999999999999999999999 89999653 3333 333444444 23455
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
..|+..+++||+.||++.|.+||++.|+-+.++.|..+
T Consensus 489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 67888999999999999999999999999999999754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.76 Aligned_cols=249 Identities=27% Similarity=0.412 Sum_probs=197.0
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCccC-HHHHHHHHHHHcCCCCCCcccceEEEEeCC--ceEEEEeecC
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS-EKEFREKMEVVGSMDHENLVPLRAYYYSRD--EKLLVHDYMP 395 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~ 395 (606)
...+.||+|+||.||++... +|...|||.+...... .+.+.+|+.++.+++|||||+++|...... ..++.|||++
T Consensus 20 ~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 20 SKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 34678999999999999864 4899999998764222 456899999999999999999999865554 5889999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-CCcEEEeecccCccCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-SYEARISDFGLAHLASP--- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~~--- 471 (606)
+|+|.+++....+ .+++..+++++.||++||+|||++|++ ||||||+|||++. ++.+||+|||+++....
T Consensus 100 ~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g~v--H~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 100 GGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKGIV--HCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred CCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEe--ccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 9999999986542 599999999999999999999999966 9999999999999 79999999999876552
Q ss_pred ----CCCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 472 ----SSTPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 472 ----~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
.....+|+.|||||++... ...+++|||||||++.||+||++||... .....++-.+......+
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P------ 242 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP------ 242 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC------
Confidence 2245678889999999853 3345899999999999999999999753 11122222222211111
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
.-+.....+..+++.+|+..+|++||||.+++++--...
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 111223345677888999999999999999999865543
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=338.55 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=214.6
Q ss_pred CcCHHHHHHHHhcccccCCceEEEEEEEc---C--CcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEe
Q 037905 311 AFDLEDLLRASAEVLGKGTFGTAYKATLE---M--GIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYS 383 (606)
Q Consensus 311 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 383 (606)
.+.+..-.....++||+|-||.||+|..- . ...||||..+... .+.+.|.+|..+|++++||||++++|.|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 34444434456789999999999999742 2 3568999998753 346779999999999999999999999975
Q ss_pred CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeec
Q 037905 384 RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDF 463 (606)
Q Consensus 384 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~Df 463 (606)
...|+|||.++.|.|+++++.+. ..++......++.||+.||+|||++..+ ||||..+|||+....++||+||
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkrfV--HRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKRFV--HRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred -cceeEEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhchh--hhhhhhhheeecCcceeeeccc
Confidence 57899999999999999999764 3588899999999999999999999866 9999999999999999999999
Q ss_pred ccCccCCCCCCCCCc-----ccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcc
Q 037905 464 GLAHLASPSSTPNRI-----DGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEE 537 (606)
Q Consensus 464 G~a~~~~~~~~~~~~-----~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (606)
|+++.......+..+ ..|||||.+.-++++.+||||.|||.+||++. |..||++..+.+. -.++.++
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-------I~~iEnG 608 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-------IGHIENG 608 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-------EEEecCC
Confidence 999988765443333 34999999999999999999999999999998 9999998655441 1112222
Q ss_pred ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 538 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
.+.+.++.|+..++.+|.+||+.+|.+||.+.++...|.++..
T Consensus 609 ----------eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 609 ----------ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ----------CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1345677889999999999999999999999999999999876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.62 Aligned_cols=250 Identities=29% Similarity=0.435 Sum_probs=205.3
Q ss_pred hcccccCCceEEEEEEEcC--C---cEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLEM--G---IVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~--~---~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
.++||+|+||.||+|++.. + ..||||..+... ....+|.+|++++++++|||||+++|++..+...++|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 4789999999999998542 2 238999988522 235689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
+|.||+|.++|+... ..++..++..++.++|.||+|||+++++ ||||.++|+|++.++.+||+|||+++.....
T Consensus 242 l~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k~~I--HRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSKNCI--HRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred ecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHCCCc--chhHhHHHheecCCCeEEeCccccccCCcce
Confidence 999999999999754 2589999999999999999999999966 9999999999999999999999998866522
Q ss_pred CCC----CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 473 STP----NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 473 ~~~----~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
... .-...|+|||.+....|++++|||||||++||+++ |..||.+.. ..+....+..+++...
T Consensus 316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~------~~~v~~kI~~~~~r~~------ 383 (474)
T KOG0194|consen 316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK------NYEVKAKIVKNGYRMP------ 383 (474)
T ss_pred eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC------HHHHHHHHHhcCccCC------
Confidence 111 12345999999999999999999999999999999 889996543 3333333334443322
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
.+...+..+..++.+||..+|++||||.++.+.|+.+.....
T Consensus 384 ----~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 384 ----IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 122345567888889999999999999999999999976544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.28 Aligned_cols=238 Identities=25% Similarity=0.362 Sum_probs=197.1
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCccC----HHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVS----EKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+|++|++|+ ..+++.+|||++.+.... .+.+..|-+.|.+| .||.|++++..|.++...|+|+||++
T Consensus 78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~ 157 (604)
T KOG0592|consen 78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP 157 (604)
T ss_pred hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence 5679999999999998 457999999999765432 24577788888888 89999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+|+|.++|+.. ..+++...+.++.+|+.||+|||+.||+ ||||||+|||+|++|.+||+|||.|+...+.
T Consensus 158 nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~GII--HRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 158 NGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSNGII--HRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred CCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhcCce--eccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999864 3699999999999999999999999966 9999999999999999999999999765331
Q ss_pred --------------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccc
Q 037905 473 --------------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW 538 (606)
Q Consensus 473 --------------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (606)
..+.||..|.+||++.+...++++|+|||||++|.|+.|++||.+.. -.-..+.++.-.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N------eyliFqkI~~l~- 303 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN------EYLIFQKIQALD- 303 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc------HHHHHHHHHHhc-
Confidence 22456777999999999999999999999999999999999997531 111222222221
Q ss_pred cccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 539 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+..+...+..+.+|+.+.|..||.+|+|.++|.+|
T Consensus 304 -----------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 304 -----------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -----------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11122233567788889999999999999999887
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=337.01 Aligned_cols=240 Identities=25% Similarity=0.406 Sum_probs=206.1
Q ss_pred HHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCH---HHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 319 RASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
|+..+.||+|+||.||||+.+ +.+.||+|.+.+....+ +.+++|+++++.++||||+.++++|....+.++|+||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 455677999999999999854 68999999997765444 45889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
.| +|..++.... .++++.+..++.+++.||.|||+.+|. |||+||.|||++..|.+|+||||+|+.+....
T Consensus 84 ~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~ril--hrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~ 155 (808)
T KOG0597|consen 84 VG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNRIL--HRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS 155 (808)
T ss_pred hh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcCcc--cccCCcceeeecCCCceeechhhhhhhcccCce
Confidence 87 9999998654 589999999999999999999999966 99999999999999999999999999877643
Q ss_pred ---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 474 ---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 474 ---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
...||+-|||||...++.|+..+|.||+||++||+++|++||.. ..+...++.+..+...
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a------~si~~Lv~~I~~d~v~----------- 218 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA------RSITQLVKSILKDPVK----------- 218 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH------HHHHHHHHHHhcCCCC-----------
Confidence 34688899999999999999999999999999999999999964 2345555555543211
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+......+.+++...+.+||..|.|..+++.|
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 123445678888889999999999999999876
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=305.75 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=200.6
Q ss_pred HHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 319 RASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
|...+++|+|.||.||+|+ .++|+.||||+++..... .....+|++.++.++|+||+.++++|...+...+|+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 4456789999999999998 578999999999876543 456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST 474 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 474 (606)
+. +|...+++.. ..++...+..++.++++|++|||++.+. ||||||.|+|++.+|.+||+|||+|+.......
T Consensus 84 ~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~Il--HRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 84 PT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKWIL--HRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhhhh--cccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 87 9999998653 4688999999999999999999999866 999999999999999999999999998775432
Q ss_pred ----CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHh-------hcccc---
Q 037905 475 ----PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV-------KEEWT--- 539 (606)
Q Consensus 475 ----~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~--- 539 (606)
...|..|+|||.+.+ +.|+...||||.|||+.||+-|.+-|.+..+- +.+..++ .+.|.
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi------dQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI------DQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH------HHHHHHHHHcCCCCcccCcccc
Confidence 234667999998765 67999999999999999999999888653321 1111111 11111
Q ss_pred --ccccchh----hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 540 --AEVFDLE----LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 540 --~~~~d~~----~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
++.+... .......+.+.....+++..++..+|.+|+|+.|.+++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0111100 00000123344567999999999999999999999876
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=327.26 Aligned_cols=250 Identities=27% Similarity=0.398 Sum_probs=195.1
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 395 (606)
.++||+|.||.||+|+ ..+|+.||+|++..... ...-..+||.+|++++||||+++.+..++. ...|+|+|||+
T Consensus 122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 5689999999999998 67899999999976543 345578999999999999999999998876 68999999998
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP 475 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 475 (606)
. ||.-++... ...++..++..++.|++.||+|+|++|+. |||||.+|||||.+|.+||+|||+|+++......
T Consensus 202 h-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~gvl--HRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 202 H-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRGVL--HRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred c-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcCee--eccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 8 898888743 34699999999999999999999999977 9999999999999999999999999987654432
Q ss_pred -----CCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHh-------hcccc---
Q 037905 476 -----NRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV-------KEEWT--- 539 (606)
Q Consensus 476 -----~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~--- 539 (606)
..|..|+|||.+.+. .|+.+.|+||.||||.||++|++.|++..+-+ .+..++ ..-|.
T Consensus 275 ~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve------Ql~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 275 PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE------QLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH------HHHHHHHHhCCCChhcccccc
Confidence 335569999998774 69999999999999999999999998643322 121111 11111
Q ss_pred -c--cccchhhhcccChH----HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 540 -A--EVFDLELLRYQNVE----EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 540 -~--~~~d~~~~~~~~~~----~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+ ..+.+...-..... ......++|+..+|..||.+|.|+.++++.
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 01111000001111 123456788889999999999999988754
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=337.47 Aligned_cols=240 Identities=25% Similarity=0.375 Sum_probs=206.7
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCc-c---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVT-V---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+-||.|+.|.|-.|+ ..+|+.+|||++.... . ....+.+|+.+|+.+.|||+++++++|.+..+.|+|.||+++
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 5679999999999998 4689999999997652 1 235688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
|-|.+++-.. .++++.++.+++.||..|+.|+|..+++ ||||||+|+|+|...++||+|||+|....+. .
T Consensus 97 GELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH~~~ic--HRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe 169 (786)
T KOG0588|consen 97 GELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCHAFNIC--HRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE 169 (786)
T ss_pred chhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhhhcce--eccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence 9999999753 3689999999999999999999999966 9999999999999999999999999876554 4
Q ss_pred CCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
+.+|.+.|.|||++.+..| +.++||||+|||||.|+||+.||+ +.++..++..+.+..+ ..
T Consensus 170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir~LLlKV~~G~f------------~M 231 (786)
T KOG0588|consen 170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIRVLLLKVQRGVF------------EM 231 (786)
T ss_pred ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------CccHHHHHHHHHcCcc------------cC
Confidence 5678888999999999998 578999999999999999999996 3456666665555432 33
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
+.....+..+|+.+|+..||++|.|++||.+|--
T Consensus 232 Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 232 PSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred CCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 3445566778888999999999999999999843
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=328.86 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=195.1
Q ss_pred HhcccccCCceEEEEEEEcC-----------------CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEE
Q 037905 321 SAEVLGKGTFGTAYKATLEM-----------------GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYY 381 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~ 381 (606)
..+.||+|+||.||++.+++ +..||+|.+..... ...++.+|++++.+++||||+++++++
T Consensus 9 ~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 88 (304)
T cd05096 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVC 88 (304)
T ss_pred eeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE
Confidence 35779999999999997532 34799999876432 245789999999999999999999999
Q ss_pred EeCCceEEEEeecCCCChhhhhhcCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 037905 382 YSRDEKLLVHDYMPMGSLSALLHGNRG--------------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKS 447 (606)
Q Consensus 382 ~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp 447 (606)
...+..++||||+++++|.+++..... .....+++..+..++.||+.||+|||+.+++ ||||||
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv--H~dlkp 166 (304)
T cd05096 89 VDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV--HRDLAT 166 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc--ccCcch
Confidence 999999999999999999999864321 1123478889999999999999999999966 999999
Q ss_pred CCEEecCCCcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCccccc
Q 037905 448 SNILLSKSYEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT--GKAPTQALL 519 (606)
Q Consensus 448 ~Nill~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt--g~~p~~~~~ 519 (606)
+|||++.++.+||+|||+++...... ....+..|+|||++....++.++||||||+++|||++ +..||....
T Consensus 167 ~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 246 (304)
T cd05096 167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246 (304)
T ss_pred hheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence 99999999999999999997653321 1223557999999988889999999999999999987 567776432
Q ss_pred ccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 520 NEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 520 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
.. .....+............ ...+..++..+.+++.+||+.+|++|||+.+|.+.|+
T Consensus 247 ~~---~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 247 DE---QVIENAGEFFRDQGRQVY-------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HH---HHHHHHHHHhhhcccccc-------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 21 111112111111100000 0111234467899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=333.12 Aligned_cols=238 Identities=26% Similarity=0.384 Sum_probs=197.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc------CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV------SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.|+.|.. .+++.||+|++..... ..+.+.+|+.++++++ ||||++++.++......++||||
T Consensus 22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy 101 (370)
T KOG0583|consen 22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY 101 (370)
T ss_pred eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence 56799999999999974 5689999997765311 2345678999999999 99999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-CcEEEeecccCccCC--
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLAS-- 470 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~~~-- 470 (606)
+.+|+|.+++... .++.+..+.+++.|++.|++|||++|++ ||||||+|||++.+ +++||+|||++....
T Consensus 102 ~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H~~gi~--HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~ 174 (370)
T KOG0583|consen 102 CSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCHSRGIV--HRDLKPENILLDGNEGNLKLSDFGLSAISPGE 174 (370)
T ss_pred cCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHHhCCEe--eCCCCHHHEEecCCCCCEEEeccccccccCCC
Confidence 9999999999862 2588899999999999999999999966 99999999999999 999999999998772
Q ss_pred --CCCCCCCcccccCccccCCCC-CC-CcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 471 --PSSTPNRIDGYRAPEVTDARK-VS-QKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 471 --~~~~~~~~~~y~aPE~~~~~~-~~-~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
...+..|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||.. .+.+.....+....+
T Consensus 175 ~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~ki~~~~~-------- 240 (370)
T KOG0583|consen 175 DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRKIRKGEF-------- 240 (370)
T ss_pred CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHHHhcCCc--------
Confidence 245678899999999999987 85 789999999999999999999975 233333333322221
Q ss_pred hhcccChHHH-HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 547 LLRYQNVEEE-MVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~-~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+... ..++..++.+|+..+|.+|+|+.+|..+
T Consensus 241 ----~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 241 ----KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred ----cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 111111 5567888999999999999999999943
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=328.37 Aligned_cols=239 Identities=26% Similarity=0.369 Sum_probs=199.6
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.++||+|+||.||+|. ..+++.||+|++..... ..+++++|+.++.+++++||.+++|.+..+...+++||||.||+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 3679999999999998 45789999999976543 34679999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----CCC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----SST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~~~ 474 (606)
+.+.+.... .+++..+.-+++++..|+.|||.++.+ |||||+.|||+..+|.+|++|||.+..... ..+
T Consensus 98 v~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~ki--HrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t 170 (467)
T KOG0201|consen 98 VLDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEKKI--HRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT 170 (467)
T ss_pred hhhhhccCC-----CCccceeeeehHHHHHHhhhhhhccee--cccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence 999998543 346677777999999999999999977 999999999999999999999999865543 356
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
+.+|+.|||||++....|+.|+||||||++++||.+|.+|+..........+ +.+.. . +....
T Consensus 171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl-------Ipk~~-----P-----P~L~~ 233 (467)
T KOG0201|consen 171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL-------IPKSA-----P-----PRLDG 233 (467)
T ss_pred ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe-------ccCCC-----C-----Ccccc
Confidence 7899999999999999999999999999999999999999987544221111 01110 0 01112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.+.+.+++..|+..+|+.||||.+++++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 455668889999999999999999999876
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=314.39 Aligned_cols=241 Identities=25% Similarity=0.385 Sum_probs=198.6
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||++++.++..+|+|.+........++.+|++++++++||||+++++++......++||||+++|+|.+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 88 (256)
T cd05114 9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN 88 (256)
T ss_pred eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 46799999999999998888899999988766667889999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----CC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-----PN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~ 476 (606)
++.... ..+++..+..++.|++.||+|||+.++. ||||||+||++++++.+||+|||.++....... ..
T Consensus 89 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05114 89 YLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNSFI--HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAK 162 (256)
T ss_pred HHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCC
Confidence 987532 2588999999999999999999999966 999999999999999999999999876533211 12
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+..|+|||++.+..++.++||||||+++|||++ |+.||... +....+..+....... .+..
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~------~~~~~~~~i~~~~~~~-----------~~~~ 225 (256)
T cd05114 163 FPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK------SNYEVVEMISRGFRLY-----------RPKL 225 (256)
T ss_pred CchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHHCCCCCC-----------CCCC
Confidence 2346999999998889999999999999999999 89998642 2222233322221110 0111
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
....+.+++.+||+++|++|||+.++++.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=317.49 Aligned_cols=245 Identities=22% Similarity=0.398 Sum_probs=197.2
Q ss_pred HhcccccCCceEEEEEEEc----CCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
..+.||+|+||.||+|.+. .+..||+|+++..... ...+.+|+..+++++||||+++++++......++||||+
T Consensus 9 ~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 88 (266)
T cd05064 9 IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM 88 (266)
T ss_pred EeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeC
Confidence 4577999999999999753 4678999998765322 356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
++|+|.+++.... ..+++..++.++.|++.||+|||+.+++ ||||||+||+++.++.+|++|||.+.......
T Consensus 89 ~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~ii--H~dikp~nili~~~~~~~l~dfg~~~~~~~~~~ 162 (266)
T cd05064 89 SNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMGYV--HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162 (266)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--eccccHhhEEEcCCCcEEECCCcccccccccch
Confidence 9999999997532 3589999999999999999999999966 99999999999999999999999876532211
Q ss_pred ----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 474 ----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 474 ----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
....+..|+|||++.+..++.++||||||+++||+++ |+.||..... ...+..+ .....
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------~~~~~~~-~~~~~--------- 226 (266)
T cd05064 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------QDVIKAV-EDGFR--------- 226 (266)
T ss_pred hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHH-HCCCC---------
Confidence 1223456999999998899999999999999999876 9999965321 1222222 11111
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.+.+..++..+.+++.+||+.+|++||++.+|.+.|+++
T Consensus 227 -~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 227 -LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111233456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=317.95 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=194.7
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcC--CCCCCcccceEEEEeC----CceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGS--MDHENLVPLRAYYYSR----DEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~~ 395 (606)
.+.||+|.||.||+|.|. |+.||||+|.. .+++.+.+|.++.+. |+|+||+.+++.-..+ .+.+||++|.+
T Consensus 216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s--rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe 292 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSS--RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE 292 (513)
T ss_pred EEEecCccccceeecccc-CCceEEEEecc--cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence 578999999999999998 99999999964 345667777777665 5999999999875433 36799999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----C-CCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-----G-PANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~-~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
.|+|+++|.. ..++....++++..+|.||++||.. | +.|.|||||+.|||+..++.+-|+|+|+|-..
T Consensus 293 ~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h 366 (513)
T KOG2052|consen 293 HGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 366 (513)
T ss_pred CCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence 9999999985 3599999999999999999999963 3 67889999999999999999999999999654
Q ss_pred CC--------CCCCCCcccccCccccCCCC----C--CCcchhHHHHHHHHHHHhC----------CCCcccccccCCCC
Q 037905 470 SP--------SSTPNRIDGYRAPEVTDARK----V--SQKADVYSFGVLLLELLTG----------KAPTQALLNEEGVD 525 (606)
Q Consensus 470 ~~--------~~~~~~~~~y~aPE~~~~~~----~--~~~sDv~slGvvl~elltg----------~~p~~~~~~~~~~~ 525 (606)
.. .....||-.|||||++...- | -..+||||||.|+||+..+ +.||....+.+ ..
T Consensus 367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D-Ps 445 (513)
T KOG2052|consen 367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD-PS 445 (513)
T ss_pred cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC-CC
Confidence 33 23356778899999986531 2 2359999999999999764 34555433322 11
Q ss_pred hhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 526 LPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
+.+..+-+..+. +.|...+.-...+.+..+.++|+.||..+|..|.|+-.|.+.|.++.+.
T Consensus 446 ~eeMrkVVCv~~-----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 446 FEEMRKVVCVQK-----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred HHHHhcceeecc-----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 111111111111 1111111112467889999999999999999999999999999999763
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=332.21 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=197.4
Q ss_pred HHHhcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEE
Q 037905 319 RASAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 389 (606)
+...+.||+|+||.||+|++ .++..||||+++.... ..+.+.+|+.++..+ +||||++++++|...+..++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 34568899999999999973 2466899999975432 345688999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCC------------------------------------------------------------
Q 037905 390 VHDYMPMGSLSALLHGNRGA------------------------------------------------------------ 409 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~------------------------------------------------------------ 409 (606)
||||+++|+|.+++......
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 99999999999998653210
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----
Q 037905 410 ----------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST----- 474 (606)
Q Consensus 410 ----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----- 474 (606)
....+++..+..++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||+++.......
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iv--H~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 274 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCI--HRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG 274 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence 112478889999999999999999999966 999999999999999999999999876543221
Q ss_pred -CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 475 -PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 475 -~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...+..|+|||++.+..++.++||||||+++|||++ |..||...... .........+.... .
T Consensus 275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~~~~----------~ 338 (375)
T cd05104 275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGYRML----------S 338 (375)
T ss_pred CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCccCC----------C
Confidence 122346999999999899999999999999999998 88898643211 11111122221110 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
+.....++.+++.+||+.||++|||+.||++.|++.
T Consensus 339 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111234688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=321.63 Aligned_cols=242 Identities=33% Similarity=0.549 Sum_probs=189.6
Q ss_pred hcccccCCceEEEEEEEc-----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|++. .+..|+||.++.... ..+.+.+|++.+++++||||++++|+|......++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 367999999999999976 368899999965332 2578999999999999999999999999888899999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++|+|.+++.... ...+++..+..|+.||+.||+|||+++++ |+||+++||+++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~ii--H~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNNII--HGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTTEE--EST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccc
Confidence 9999999998752 34689999999999999999999999855 9999999999999999999999998766321
Q ss_pred ----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 473 ----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 473 ----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
........|+|||.+....++.++||||||+++|||++ |+.||... +........ .++...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~-~~~~~~------- 224 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKL-KQGQRL------- 224 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHH-HTTEET-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccc-cccccc-------
Confidence 12233456999999988889999999999999999999 78888543 222233333 222111
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
..+..+...+.+++.+||+.+|++|||+.+|++.|
T Consensus 225 ---~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 ---PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11122345688999999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=301.23 Aligned_cols=237 Identities=23% Similarity=0.290 Sum_probs=196.1
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCc
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDE 386 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 386 (606)
+.+++. ...+.||.|+||.|.+++. .+|..+|+|++.+...- .+...+|-.+++.+.||.++++.+.|.+.+.
T Consensus 41 ~~l~df--e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDF--ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN 118 (355)
T ss_pred cchhhh--hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe
Confidence 444443 2357799999999999985 46899999999775432 2457789999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
.++||||++||-|..+++..+ +++...++.++.+|+.||+|||+.++. +|||||+|||+|.+|.+||+|||.|
T Consensus 119 lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~ii--YRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLDII--YRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcCee--eccCChHHeeeccCCcEEEEeccce
Confidence 999999999999999998654 589999999999999999999999966 9999999999999999999999999
Q ss_pred ccCCC-CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 467 HLASP-SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 467 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
+.+.. ..+.++|+.|+|||++++..|..++|.|||||++|||+.|.+||.... .....+.++....
T Consensus 192 K~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~------~~~iY~KI~~~~v------- 258 (355)
T KOG0616|consen 192 KRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN------PIQIYEKILEGKV------- 258 (355)
T ss_pred EEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC------hHHHHHHHHhCcc-------
Confidence 88765 345689999999999999999999999999999999999999997522 2344455544431
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCC
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNR 575 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R 575 (606)
..++-....+.+|+...++.|-.+|
T Consensus 259 -----~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -----KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1112223346677778888888777
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=328.26 Aligned_cols=237 Identities=23% Similarity=0.293 Sum_probs=192.5
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+.||+|+||.||+++. .+|+.||+|+++.... ....+.+|+.++++++||||+++.+++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 4689999999975422 2245778999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|.+++... ..+++..+..++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~iv--HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~ 153 (323)
T cd05571 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCDVV--YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeE--eCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence 999998753 2588999999999999999999999966 9999999999999999999999998754221 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ..+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~------~~~~~~~~~~~~~------------~~p 215 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEEI------------RFP 215 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC------HHHHHHHHHcCCC------------CCC
Confidence 2356788999999999999999999999999999999999996421 1111222211110 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
......+.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 12335678899999999999999 79998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.48 Aligned_cols=262 Identities=22% Similarity=0.295 Sum_probs=207.8
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEEEcCC-cEEEEEEeccCc-cCHHHHHHHHHHHcCCC-CCCcccceE-EEEe----
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKATLEMG-IVVAVKRLKDVT-VSEKEFREKMEVVGSMD-HENLVPLRA-YYYS---- 383 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~-~~~~---- 383 (606)
|.+......+.+.|.+|||+.||.|+...+ ..+|+|++-... ..-+.+.+|+++|++|+ |+|||.+++ ....
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 444444445568899999999999996555 999999875542 23466889999999996 999999999 3321
Q ss_pred --CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEe
Q 037905 384 --RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARIS 461 (606)
Q Consensus 384 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~ 461 (606)
..+.+|+||||.+|.|-+++.... ...|.+.++++|+.++++|+++||...++|||||||-+||||+.++..|||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 246789999999999999998543 234999999999999999999999999999999999999999999999999
Q ss_pred ecccCccCCCCC-------------CCCCcccccCcccc---CCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCC
Q 037905 462 DFGLAHLASPSS-------------TPNRIDGYRAPEVT---DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVD 525 (606)
Q Consensus 462 DfG~a~~~~~~~-------------~~~~~~~y~aPE~~---~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~ 525 (606)
|||.|....... ....|+-|+|||++ .+...++|+|||||||+||.|+....||+....-
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---- 264 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---- 264 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----
Confidence 999986433221 13456779999987 4677899999999999999999999999752110
Q ss_pred hhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccC
Q 037905 526 LPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQG 596 (606)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~ 596 (606)
.+++-.+. .+..+.....+.+||+.||+++|.+||++.||..++-+|+.....-.
T Consensus 265 ---------------aIlng~Y~-~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 265 ---------------AILNGNYS-FPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred ---------------eEEecccc-CCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 11111111 12225677789999999999999999999999999999986654433
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=313.65 Aligned_cols=245 Identities=28% Similarity=0.434 Sum_probs=200.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|... .+..||+|++........++.+|+++++.++|+||+++++++..+...++||||+++++|.
T Consensus 11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (263)
T cd05052 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90 (263)
T ss_pred eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHH
Confidence 467999999999999854 5889999998866555678999999999999999999999999989999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----C
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-----P 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~ 475 (606)
+++.... ...+++..+..++.|++.||+|||+++++ ||||||+||++++++.+||+|||+++....... .
T Consensus 91 ~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~--H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~ 165 (263)
T cd05052 91 DYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKNFI--HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 165 (263)
T ss_pred HHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEe--ecccCcceEEEcCCCcEEeCCCccccccccceeeccCCC
Confidence 9987543 23589999999999999999999999966 999999999999999999999999876544221 1
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+..|+|||++.+..++.++||||||+++|||++ |..||... +........ ...... ..+.
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~------~~~~~~~~~-~~~~~~----------~~~~ 228 (263)
T cd05052 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------DLSQVYELL-EKGYRM----------ERPE 228 (263)
T ss_pred CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHH-HCCCCC----------CCCC
Confidence 22456999999998899999999999999999998 99998642 122222211 111111 1112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
..+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2345688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=314.14 Aligned_cols=245 Identities=26% Similarity=0.437 Sum_probs=200.3
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
..++||+|+||.||+|...++..||+|.+.......+.+.+|+.++++++|+||+++++++......+++|||+++++|.
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 89 (261)
T cd05072 10 LVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL 89 (261)
T ss_pred EeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHH
Confidence 35789999999999999888889999998765556678999999999999999999999999888999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TP 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~ 475 (606)
+++.... ...+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.++|+|||+++...... ..
T Consensus 90 ~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~i~--H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 164 (261)
T cd05072 90 DFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKNYI--HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA 164 (261)
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--ccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence 9997532 23578899999999999999999999966 99999999999999999999999997654321 11
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+..|+|||++....++.++||||||+++|||+| |+.||...... ..... ....+.. +...
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~------~~~~~-~~~~~~~----------~~~~ 227 (261)
T cd05072 165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS------DVMSA-LQRGYRM----------PRME 227 (261)
T ss_pred ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH------HHHHH-HHcCCCC----------CCCC
Confidence 23456999999988889999999999999999998 99999642211 11111 1111111 1111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
..+..+.+++.+||..+|++|||++++.+.|++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 233568889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=312.46 Aligned_cols=244 Identities=26% Similarity=0.430 Sum_probs=200.8
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|...++..||+|.++......+++.+|+.++++++||||+++++++......++||||+++++|.+
T Consensus 11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 90 (261)
T cd05068 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE 90 (261)
T ss_pred EEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHH
Confidence 57899999999999998778899999998766667889999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC--CCC--
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST--PNR-- 477 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~-- 477 (606)
++.... ...+++..+..++.|++.||.|||+.+++ ||||||+||++++++.+||+|||+++....... ..+
T Consensus 91 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 165 (261)
T cd05068 91 YLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQNYI--HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAK 165 (261)
T ss_pred HHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--eccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCc
Confidence 997543 23589999999999999999999999966 999999999999999999999999876543211 111
Q ss_pred -cccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 478 -IDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 478 -~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
...|+|||++.+..++.++||||||+++|||++ |+.||.... .......+ ...... .....
T Consensus 166 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~~-~~~~~~----------~~~~~ 228 (261)
T cd05068 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT------NAEVLQQV-DQGYRM----------PCPPG 228 (261)
T ss_pred CceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHH-HcCCCC----------CCCCc
Confidence 246999999998899999999999999999999 999996432 11111111 111110 11122
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
....+.+++.+||+.+|++||++.++++.|++
T Consensus 229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 229 CPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 34578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=320.55 Aligned_cols=244 Identities=23% Similarity=0.272 Sum_probs=194.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++.. .+|+.||+|++..... ....+.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05631 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCC
Confidence 46799999999999985 5789999999865432 224577899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
|+|.+++.... ...+++..+..++.|++.||+|||+.+++ ||||||+|||+++++.+||+|||+++..... .
T Consensus 85 g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ii--H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05631 85 GDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRERIV--YRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR 159 (285)
T ss_pred CcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEE--eCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence 99998886432 23588999999999999999999999966 9999999999999999999999999765432 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++|||||||++|||++|+.||....... ....+........ ...+
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~-----------~~~~ 225 (285)
T cd05631 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDRRVKEDQ-----------EEYS 225 (285)
T ss_pred CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHHHhhccc-----------ccCC
Confidence 3456788999999999999999999999999999999999997532211 1111111111100 0111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
......+.+++.+||+.+|++||+ ++++.++
T Consensus 226 ~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 226 EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 223456788999999999999997 7888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.07 Aligned_cols=247 Identities=25% Similarity=0.436 Sum_probs=197.6
Q ss_pred hcccccCCceEEEEEEEcC------CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLEM------GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|.... ...||+|.++.... ....+.+|++.+++++||||+++++++......+++|||
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 89 (283)
T cd05048 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY 89 (283)
T ss_pred hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence 5679999999999998532 26799999875432 235688999999999999999999999988899999999
Q ss_pred cCCCChhhhhhcCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEee
Q 037905 394 MPMGSLSALLHGNRGAG-----------RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISD 462 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~D 462 (606)
+++++|.+++....... ...+++..+..++.|++.||+|||+.++. ||||||+||++++++.+||+|
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~--H~dlkp~Nil~~~~~~~~L~d 167 (283)
T cd05048 90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFV--HRDLAARNCLVGEGLTVKISD 167 (283)
T ss_pred CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCee--ccccccceEEEcCCCcEEECC
Confidence 99999999997542211 14588899999999999999999999966 999999999999999999999
Q ss_pred cccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhh
Q 037905 463 FGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVK 535 (606)
Q Consensus 463 fG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 535 (606)
||+++...... ...++..|+|||++....++.++|||||||++|||++ |..||..... .+.... +.
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~------~~~~~~-i~ 240 (283)
T cd05048 168 FGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN------QEVIEM-IR 240 (283)
T ss_pred CcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HH
Confidence 99987543221 2233566999999988889999999999999999998 9999865322 111211 11
Q ss_pred ccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 536 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
.... ...+..++.++.+++.+||+.+|++||++.+|+++|+.
T Consensus 241 ~~~~----------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 241 SRQL----------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCc----------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111 11123455779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=330.53 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=197.9
Q ss_pred HHHHhcccccCCceEEEEEEE------cCCcEEEEEEeccCccC--HHHHHHHHHHHcCC-CCCCcccceEEEEeCCceE
Q 037905 318 LRASAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVS--EKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKL 388 (606)
Q Consensus 318 ~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 388 (606)
.+...+.||+|+||.||+|.. .++..||+|+++..... ...+.+|+++++.+ +|+||++++++|......+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 344578899999999999873 23457999999754322 34688999999999 8999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCC------------------------------------------------------------
Q 037905 389 LVHDYMPMGSLSALLHGNRG------------------------------------------------------------ 408 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~------------------------------------------------------------ 408 (606)
+||||+++|+|.+++.....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 99999999999999864210
Q ss_pred -----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC------CCCC
Q 037905 409 -----AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------TPNR 477 (606)
Q Consensus 409 -----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------~~~~ 477 (606)
....++++..+.+++.||+.||+|||+++++ ||||||+|||+++++.+||+|||+++...... ....
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gii--HrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI--HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEE--eccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 0112478889999999999999999999966 99999999999999999999999987643321 1123
Q ss_pred cccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 478 IDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 478 ~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
+..|+|||++....++.++|||||||++|||++ |+.||....... . ............ .+...
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~~~~----------~~~~~ 340 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGYQMS----------RPDFA 340 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcccCcc----------CCCCC
Confidence 346999999988899999999999999999997 999997532211 1 111111111100 01112
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
+.++.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 356889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=321.80 Aligned_cols=238 Identities=21% Similarity=0.244 Sum_probs=194.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 85 (291)
T cd05612 6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG 85 (291)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence 467999999999999864 689999999865322 235688899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STP 475 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~ 475 (606)
++|.+++.... .+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++..... ...
T Consensus 86 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (291)
T cd05612 86 GELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKEIV--YRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158 (291)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--ecCCCHHHeEECCCCCEEEEecCcchhccCCcccc
Confidence 99999997532 588899999999999999999999966 9999999999999999999999998765432 234
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||++.+..++.++|||||||++|||++|+.||... +.....+.+..... ..+..
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~------~~~~~~~~i~~~~~------------~~~~~ 220 (291)
T cd05612 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD------NPFGIYEKILAGKL------------EFPRH 220 (291)
T ss_pred cCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCc------------CCCcc
Confidence 5678899999999989999999999999999999999999642 12222222222211 00111
Q ss_pred HHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
....+.+++.+||+.||.+||+ +++++++
T Consensus 221 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 2345788999999999999995 8888876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=323.55 Aligned_cols=235 Identities=22% Similarity=0.293 Sum_probs=190.0
Q ss_pred cccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 325 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
||+|+||.||+|+.. +++.||+|+++... .....+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999864 58899999986532 1234578899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~--HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 153 (312)
T cd05585 81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHKFNVI--YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF 153 (312)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeE--eCCCCHHHeEECCCCcEEEEECcccccCccCCCccccc
Confidence 9999753 2588999999999999999999999966 9999999999999999999999998754321 223
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||++.+..++.++|||||||++|||++|+.||... +.......+..... ..+..
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~------~~~~~~~~~~~~~~------------~~~~~ 215 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE------NVNEMYRKILQEPL------------RFPDG 215 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC------CHHHHHHHHHcCCC------------CCCCc
Confidence 5678899999999999999999999999999999999999642 22222333222211 01122
Q ss_pred HHHHHHHHHHHccCcCCCCCCC---HHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPS---MAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs---~~~v~~~ 584 (606)
....+.+++.+||+.||++||+ +.+++++
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 3356788899999999999985 5566544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=318.51 Aligned_cols=241 Identities=24% Similarity=0.337 Sum_probs=191.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.++||+|+||.||+|+- .+|..+|+|++++.... .+.+..|-.+|...++|.||+++..|.+.+..||||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 57899999999999984 57999999999876543 34578899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC------
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS------ 470 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~------ 470 (606)
||+..+|... ..|+...+..++.+++.|++.+|+.|++ ||||||+|+|||..|++||+|||+++-..
T Consensus 226 GD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH~~gyI--HRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 226 GDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIHQLGYI--HRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred ccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHHHcCcc--cccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999999854 3699999999999999999999999977 99999999999999999999999983110
Q ss_pred -------------C------C--------------------------CCCCCcccccCccccCCCCCCCcchhHHHHHHH
Q 037905 471 -------------P------S--------------------------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLL 505 (606)
Q Consensus 471 -------------~------~--------------------------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl 505 (606)
. . ....||+-|||||++.+..|+..+|+||||||+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 0 0 012345669999999999999999999999999
Q ss_pred HHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCC---HHHHH
Q 037905 506 LELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS---MAEVT 582 (606)
Q Consensus 506 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~~v~ 582 (606)
||||.|.+||.+....+ ....+....... .++.-.....+..+||.+|+. ||++|.. ++||.
T Consensus 379 yEmLvGyPPF~s~tp~~------T~rkI~nwr~~l--------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQE------TYRKIVNWRETL--------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred HHHHhCCCCCCCCCHHH------HHHHHHHHhhhc--------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 99999999998643322 122222111000 011111222566788889998 9999985 66665
Q ss_pred HH
Q 037905 583 SQ 584 (606)
Q Consensus 583 ~~ 584 (606)
+|
T Consensus 444 ~H 445 (550)
T KOG0605|consen 444 KH 445 (550)
T ss_pred cC
Confidence 54
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.11 Aligned_cols=248 Identities=24% Similarity=0.429 Sum_probs=202.9
Q ss_pred HHHHhcccccCCceEEEEEEEcCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 318 LRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 318 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+...+.||+|+||.||+|...++..+|+|++..... ....+..|+.+++.++|+||+++++++......++||||+++
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 3455788999999999999988799999999976544 456789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.... ...+++..+..++.|++.||+|||+.++. ||||||+||+++.++.+||+|||.+.......
T Consensus 87 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~i~--h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 87 GSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQNSI--HRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred CCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--ccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 99999998643 23589999999999999999999999966 99999999999999999999999987654321
Q ss_pred -CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 474 -TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....+..|+|||.+....++.++||||||+++|+|++ |+.||..... ......+. .... ..
T Consensus 162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~------~~~~~~~~-~~~~----------~~ 224 (261)
T cd05148 162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN------HEVYDQIT-AGYR----------MP 224 (261)
T ss_pred cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHH-hCCc----------CC
Confidence 1233456999999988889999999999999999998 8999964321 11111111 1111 11
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
.+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 225 CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 112334568899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=321.04 Aligned_cols=239 Identities=21% Similarity=0.325 Sum_probs=187.6
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..+.||+|+||.||+|+.. +++.||||++..... ....+.+|+++++.++|+||+++++++...+..++||||++++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 3578999999999999854 689999999865432 2456889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|.... ......+..++.||+.||+|||+++++ ||||||+|||+++++.+||+|||+++..... .
T Consensus 158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 226 (353)
T PLN00034 158 SLEGTH---------IADEQFLADVARQILSGIAYLHRRHIV--HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN 226 (353)
T ss_pred cccccc---------cCCHHHHHHHHHHHHHHHHHHHHCCEe--ecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence 986532 245677888999999999999999966 9999999999999999999999998765432 2
Q ss_pred CCCCcccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 474 TPNRIDGYRAPEVTDA-----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
...++..|+|||++.. ...+.++|||||||++|||++|+.||..... .+.......+....
T Consensus 227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~----------- 292 (353)
T PLN00034 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ---GDWASLMCAICMSQ----------- 292 (353)
T ss_pred ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---ccHHHHHHHHhccC-----------
Confidence 3456778999998743 2345689999999999999999999973211 11111111111110
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..........++.+++.+||+.+|++|||+.|++++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112334568899999999999999999999987
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=325.43 Aligned_cols=239 Identities=21% Similarity=0.266 Sum_probs=194.6
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 22 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 101 (329)
T PTZ00263 22 MGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101 (329)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCC
Confidence 3578999999999999864 589999999875422 23568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-ST 474 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~ 474 (606)
+++|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... ..
T Consensus 102 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iv--H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 174 (329)
T PTZ00263 102 GGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKDII--YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT 174 (329)
T ss_pred CChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--ecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence 999999997532 578888999999999999999999966 9999999999999999999999999865442 23
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+++.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+..... ..+.
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~------~~~~~~~i~~~~~------------~~p~ 236 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT------PFRIYEKILAGRL------------KFPN 236 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC------HHHHHHHHhcCCc------------CCCC
Confidence 457788999999999999999999999999999999999996421 1122222222110 0001
Q ss_pred HHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
.....+.+++.+||+.||++||+ +++++++
T Consensus 237 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 237 WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 12245778999999999999997 6888766
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=323.12 Aligned_cols=237 Identities=24% Similarity=0.311 Sum_probs=191.6
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+.||+|+||.||+++. .+|..||+|+++.... ....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999985 4689999999975422 2245678999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|..++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 153 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVV--YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeE--ecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence 9998887432 588999999999999999999999966 9999999999999999999999998753221 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ..+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~------~~~~~~~~~~~~~------------~~p 215 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HERLFELILMEEI------------RFP 215 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCCC------------CCC
Confidence 2356788999999999899999999999999999999999996432 1112222221111 001
Q ss_pred HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
......+.+++.+||+.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 12234678889999999999998 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=308.41 Aligned_cols=242 Identities=26% Similarity=0.372 Sum_probs=197.8
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|+..++..+|+|.+.......+++.+|+.++++++||||+++++++......++||||+.+++|.+
T Consensus 9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 88 (256)
T cd05113 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN 88 (256)
T ss_pred eeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence 46799999999999998777789999988766667889999999999999999999999988888999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----CC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-----PN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~ 476 (606)
++.... ..+++..+..++.||+.||+|||+.+++ |+||||+||+++.++.+||+|||.++....... ..
T Consensus 89 ~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05113 89 YLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQFI--HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK 162 (256)
T ss_pred HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--ccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCc
Confidence 997532 2589999999999999999999999966 999999999999999999999999875543221 12
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+...... ..+..
T Consensus 163 ~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~-----------~~~~~ 225 (256)
T cd05113 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQGLRL-----------YRPHL 225 (256)
T ss_pred cChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhcCCCC-----------CCCCC
Confidence 2346999999988889999999999999999999 9999864321 1122222221110 00111
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
....+.+++.+||+.+|++||++.+|++.|+
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 2457889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=306.89 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=199.5
Q ss_pred HHHhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 319 RASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
+...+.||+|+||.||+|..+++..+|+|.+.......+.+.+|+.++++++|+|++++++++. ....+++|||+++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCc
Confidence 3456789999999999999888889999999876666778999999999999999999999874 566899999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC----
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST---- 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---- 474 (606)
|.+++.... ...+++..+..++.+++.||+|||+.+++ ||||||+||++++++.++|+|||.++.......
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~--H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 161 (260)
T cd05070 87 LLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMNYI--HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ 161 (260)
T ss_pred HHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence 999997532 23589999999999999999999999966 999999999999999999999999876543221
Q ss_pred -CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 475 -PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 475 -~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......... ... .+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~------~~~~~~~~~~-~~~----------~~~ 224 (260)
T cd05070 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN------NREVLEQVER-GYR----------MPC 224 (260)
T ss_pred CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHc-CCC----------CCC
Confidence 122346999999988889999999999999999999 889986421 1122222211 110 011
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
+......+.+++.+||..+|++|||+.++.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12234568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=308.05 Aligned_cols=242 Identities=24% Similarity=0.393 Sum_probs=205.4
Q ss_pred HHHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHH----HHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 318 LRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEK----EFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 318 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~----~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
+|.+.+.||+|.||.|-+|. ...|+.||||.+++..+.++ .+++|+++|..++||||+.++.+|.+.+...+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 45567789999999999997 47799999999987655432 47899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|..+|.|++++.... .+++..+..++.||..|+-|+|+++++ |||||.+|||+|.++++||+|||++-.+...
T Consensus 134 YaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknrVv--HRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 134 YASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNRVV--HRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred ecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhccce--ecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999998654 699999999999999999999999966 9999999999999999999999999776553
Q ss_pred ---CCCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 473 ---STPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
.++.+.+-|.+||++.+..| ++..|.|||||+||-++.|..||++ .+....+.++-...+..
T Consensus 207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG------~Dhk~lvrQIs~GaYrE-------- 272 (668)
T KOG0611|consen 207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG------RDHKRLVRQISRGAYRE-------- 272 (668)
T ss_pred cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC------chHHHHHHHhhcccccC--------
Confidence 35778888999999999998 5789999999999999999999964 45555565555444321
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
+.. +....-||+.++..+|++|-|+.||+.+-
T Consensus 273 -P~~----PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 -PET----PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -CCC----CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 12344567789999999999999999884
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=323.74 Aligned_cols=237 Identities=22% Similarity=0.296 Sum_probs=192.4
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+.||+|+||.||+++. .+|+.||+|++..... ....+.+|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 4689999999975422 2346788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|..++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~iv--HrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~ 153 (328)
T cd05593 81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGKIV--YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK 153 (328)
T ss_pred CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeE--ecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence 999888643 2588999999999999999999999966 9999999999999999999999998753321 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ..+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~------~~~~~~~~~~~~~------------~~p 215 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEDI------------KFP 215 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC------HHHHHHHhccCCc------------cCC
Confidence 2356788999999998899999999999999999999999996421 1122222211110 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
......+.+++.+||..||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 12234678888999999999997 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=307.50 Aligned_cols=248 Identities=28% Similarity=0.436 Sum_probs=199.7
Q ss_pred HHHhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 319 RASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
+.+.++||+|+||.||+|+..++..||+|+++......+.+.+|++++++++|+||+++++++. ....++||||+++++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~ 86 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGS 86 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCc
Confidence 3446789999999999999877778999999876666778999999999999999999999874 456799999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----- 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----- 473 (606)
|.+++.... ...+++..+..++.|++.||+|||+.+++ ||||||+||++++++.++|+|||.++......
T Consensus 87 L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~--H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~ 161 (262)
T cd05071 87 LLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMNYV--HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161 (262)
T ss_pred HHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence 999997532 23578999999999999999999999966 99999999999999999999999987554322
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||+..+..++.++||||||+++|||++ |+.||...... .....+ .... ....
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~-~~~~----------~~~~ 224 (262)
T cd05071 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQV-ERGY----------RMPC 224 (262)
T ss_pred CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHH-hcCC----------CCCC
Confidence 1223456999999988889999999999999999999 88888643211 111111 1110 0111
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
..+.+..+.+++.+||+.+|++||++.++.+.|++..
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 2334567889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=327.87 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=199.6
Q ss_pred HHHHhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceE
Q 037905 318 LRASAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKL 388 (606)
Q Consensus 318 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 388 (606)
.+...++||+|+||.||+|+.. .+..||||+++.... ..+.+.+|+++++++. ||||++++++|......+
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIY 117 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceE
Confidence 3445678999999999999742 235799999975432 2456899999999996 999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCC-----------------------------------------------------------
Q 037905 389 LVHDYMPMGSLSALLHGNRGA----------------------------------------------------------- 409 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------------- 409 (606)
+||||+++|+|.+++..+...
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (400)
T cd05105 118 IITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEA 197 (400)
T ss_pred EEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhh
Confidence 999999999999988653210
Q ss_pred --------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc
Q 037905 410 --------------------------------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE 457 (606)
Q Consensus 410 --------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~ 457 (606)
....+++..+..++.|++.||+|||+.+++ ||||||+|||++.++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv--H~dikp~Nill~~~~~ 275 (400)
T cd05105 198 SKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV--HRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCee--CCCCChHhEEEeCCCE
Confidence 012478888999999999999999999966 9999999999999999
Q ss_pred EEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHH
Q 037905 458 ARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWV 530 (606)
Q Consensus 458 ~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 530 (606)
+||+|||+++...... ...++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~------~~~ 349 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD------STF 349 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh------HHH
Confidence 9999999987543221 1223456999999998889999999999999999997 99998643211 111
Q ss_pred HHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 531 QSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 531 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
......+.. ..........+.+++.+||+.+|++|||+.+|++.|+++.+
T Consensus 350 ~~~~~~~~~----------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YNKIKSGYR----------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHhcCCC----------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111121111 11112344678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=307.72 Aligned_cols=242 Identities=28% Similarity=0.436 Sum_probs=197.9
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
..+.||+|+||.||++.+.++..+|+|.+.........+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 87 (256)
T cd05059 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL 87 (256)
T ss_pred hhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence 45779999999999999877788999998766666778899999999999999999999999889999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----C
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-----P 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~ 475 (606)
+++.... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||.++....... .
T Consensus 88 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 161 (256)
T cd05059 88 NYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNGFI--HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161 (256)
T ss_pred HHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCcc--cccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence 9997532 2589999999999999999999999966 999999999999999999999999876543211 1
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+ ..... ...+.
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~-~~~~~----------~~~~~ 224 (256)
T cd05059 162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS------EVVESV-SAGYR----------LYRPK 224 (256)
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH------HHHHHH-HcCCc----------CCCCC
Confidence 12246999999998899999999999999999999 89998643211 111111 11110 01112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
..+..+.+++.+||..+|++|||+.++++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=311.00 Aligned_cols=248 Identities=23% Similarity=0.397 Sum_probs=198.5
Q ss_pred HHhcccccCCceEEEEEEEc------CCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 391 (606)
...+.||+|+||.||+|... ++..||||+++..... .+.+.+|++++++++|+||+++++++......++||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 87 (280)
T cd05049 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVF 87 (280)
T ss_pred hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEE
Confidence 34578999999999999853 3478999999765433 467999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEee
Q 037905 392 DYMPMGSLSALLHGNRG---------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISD 462 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~D 462 (606)
||+++++|.+++..... .....+++..+..++.|++.|++|||+++++ ||||||+||+++.++.+||+|
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~--h~dlkp~nili~~~~~~kl~d 165 (280)
T cd05049 88 EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV--HRDLATRNCLVGYDLVVKIGD 165 (280)
T ss_pred ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCee--ccccccceEEEcCCCeEEECC
Confidence 99999999999975421 1234578899999999999999999999966 999999999999999999999
Q ss_pred cccCccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhh
Q 037905 463 FGLAHLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVK 535 (606)
Q Consensus 463 fG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 535 (606)
||+++..... .....+..|+|||++.+..++.++||||||+++|||++ |+.||..... ...+..+.
T Consensus 166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~------~~~~~~~~- 238 (280)
T cd05049 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN------EEVIECIT- 238 (280)
T ss_pred cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHH-
Confidence 9998754321 12223456999999999999999999999999999999 9999864322 12222221
Q ss_pred ccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 536 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
.+.... .+......+.+++.+||..+|++||++.||++.|+
T Consensus 239 ~~~~~~----------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 QGRLLQ----------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCCcCC----------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 111110 01123456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=312.61 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=201.2
Q ss_pred HhcccccCCceEEEEEEE------cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 321 SAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
..+.||+|+||.||++.. .++..+|+|.+..... ..+.+.+|++++++++||||+++++++......++||||
T Consensus 9 ~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 88 (288)
T cd05093 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEY 88 (288)
T ss_pred eccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 457799999999999974 2356789998875432 345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeeccc
Q 037905 394 MPMGSLSALLHGNRG--------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGL 465 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~ 465 (606)
+++++|.+++..... .....+++..+..++.|++.||+|||++|++ ||||||+||++++++.+||+|||+
T Consensus 89 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~--H~dlkp~Nili~~~~~~kl~dfg~ 166 (288)
T cd05093 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFV--HRDLATRNCLVGENLLVKIGDFGM 166 (288)
T ss_pred CCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCee--ecccCcceEEEccCCcEEeccCCc
Confidence 999999999874321 1223589999999999999999999999966 999999999999999999999999
Q ss_pred CccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccc
Q 037905 466 AHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEW 538 (606)
Q Consensus 466 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (606)
++...... ...++..|+|||++.+..++.++||||||+++|||++ |..||..... ......+.....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~------~~~~~~i~~~~~ 240 (288)
T cd05093 167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIECITQGRV 240 (288)
T ss_pred cccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCc
Confidence 87553221 1223456999999998899999999999999999999 8999864321 112222222111
Q ss_pred cccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 539 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.. ........+.+++.+||+.+|.+|||+.++.+.|+++.+..
T Consensus 241 -~~----------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 241 -LQ----------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred -CC----------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 00 01122346899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=318.57 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=197.8
Q ss_pred HHHhcccccCCceEEEEEEE------cCCcEEEEEEeccCccC--HHHHHHHHHHHcCC-CCCCcccceEEEEeC-CceE
Q 037905 319 RASAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVS--EKEFREKMEVVGSM-DHENLVPLRAYYYSR-DEKL 388 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~ 388 (606)
+...+.||+|+||.||+|.. .+++.||+|+++..... .+.+.+|++++.++ +|+||++++++|... ...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 45578899999999999963 23578999998754322 34577899999999 899999999988754 5678
Q ss_pred EEEeecCCCChhhhhhcCCCC--------------------------------------------------------CCC
Q 037905 389 LVHDYMPMGSLSALLHGNRGA--------------------------------------------------------GRT 412 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------~~~ 412 (606)
++|||+++++|.+++...... ...
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 999999999999998643210 012
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC------CCCCcccccCccc
Q 037905 413 PLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------TPNRIDGYRAPEV 486 (606)
Q Consensus 413 ~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~ 486 (606)
++++..+..++.||+.||+|||+.+++ ||||||+|||+++++.+||+|||+++...... ...++..|+|||+
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~~iv--HrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~ 246 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASRKCI--HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES 246 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence 588999999999999999999999966 99999999999999999999999998653221 1223456999999
Q ss_pred cCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHH
Q 037905 487 TDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAI 565 (606)
Q Consensus 487 ~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~ 565 (606)
+.+..++.++|||||||++|||++ |..||......+ ............ ..+.....++.+++.
T Consensus 247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~----------~~~~~~~~~~~~l~~ 310 (337)
T cd05054 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTRM----------RAPEYATPEIYSIML 310 (337)
T ss_pred hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCCC----------CCCccCCHHHHHHHH
Confidence 999999999999999999999998 999996532111 111111111110 011223456889999
Q ss_pred HccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 566 NCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 566 ~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
+||+.+|++||++.+|+++|+++.+.
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=323.04 Aligned_cols=246 Identities=20% Similarity=0.255 Sum_probs=196.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|++++..++||||+++++++...+..++||||+++
T Consensus 6 ~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g 85 (333)
T cd05600 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPG 85 (333)
T ss_pred EEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999865 589999999975422 235678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC-CCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP-SSTP 475 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~-~~~~ 475 (606)
++|.+++... ..+++..+..++.|++.||+|||+.+++ ||||||+|||++.++.+||+|||+++.... ....
T Consensus 86 ~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~iv--H~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~ 158 (333)
T cd05600 86 GDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELGYI--HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV 158 (333)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence 9999999743 2588899999999999999999999966 999999999999999999999999976543 2344
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+++.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...... ...+... .....
T Consensus 159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~--~~~~~~~--~~~~~ 228 (333)
T cd05600 159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP------NETWENLKYWKET--LQRPVYD--DPRFN 228 (333)
T ss_pred ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH------HHHHHHHHhcccc--ccCCCCC--ccccc
Confidence 577889999999998999999999999999999999999964321 1111111111100 0000000 00012
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...++.+++.+||..+|++||++.+++++
T Consensus 229 ~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 229 LSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 34567889999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.79 Aligned_cols=244 Identities=20% Similarity=0.314 Sum_probs=192.0
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+++.. +++.||+|+++.... ..+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999854 689999999976432 224577888988888 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
|+|.+++... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~iv--H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERGII--YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT 153 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--ecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence 9999888643 2589999999999999999999999966 999999999999999999999999875321 1
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC--CCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE--GVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||....... ......+..........
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------- 222 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------- 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-----------
Confidence 23456788999999999999999999999999999999999997432211 11122222222221110
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCC------HHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPS------MAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs------~~~v~~~ 584 (606)
..+......+.+++.+||+.||++||| +.+++++
T Consensus 223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 011122346788999999999999997 6677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=310.40 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=187.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCC-----ceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRD-----EKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~ 395 (606)
.+++|+|+||.||+|.. ++++.||||++-.. ++.-.+|+++|+.++|||||++.-+|.... ...+|||||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d---~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD---KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCC---CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 47899999999999985 45799999998543 233457899999999999999998887532 2358999998
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-CcEEEeecccCccCCCCC-
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLASPSS- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~- 473 (606)
. +|.+.++... .....++...+.-+..||.+||+|||+.|++ ||||||.|+|+|.+ |.+||||||.|+......
T Consensus 106 ~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~Ic--HRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHGIC--HRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcCcc--cCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 7 9999988522 1234577778888999999999999999966 99999999999977 899999999998765533
Q ss_pred --CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc----------c
Q 037905 474 --TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT----------A 540 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 540 (606)
.+..+..|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+ .+...++ ++...-. .
T Consensus 182 niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik-~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 182 NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIK-VLGTPTREDIKSMNPNYT 258 (364)
T ss_pred ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHH-HhCCCCHHHHhhcCcccc
Confidence 3445677999998765 679999999999999999999999997632211 1111111 1100000 0
Q ss_pred cccchhhhccc----ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLRYQ----NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.-.+...... .......+.++++.+++..+|.+|.++.|++.+
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111111111 112344678899999999999999999999865
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.11 Aligned_cols=237 Identities=24% Similarity=0.322 Sum_probs=191.4
Q ss_pred cccccCCceEEEEEEE----cCCcEEEEEEeccCcc-----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 323 EVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTV-----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
+.||+|+||.||+++. ..++.||+|+++.... ....+.+|+++++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5699999999999974 3578999999875321 234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
+++++|.+++.... .+.+..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQGII--YRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 99999999987432 478888889999999999999999966 9999999999999999999999998753221
Q ss_pred ---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 ---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~------~~~~~~~~~~~~~----------- 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN------RKKTIDKILKGKL----------- 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCC-----------
Confidence 22356788999999998889999999999999999999999996422 2222222222111
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
..+......+.+++.+||+.+|++|| ++.+++++
T Consensus 218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 00112234678899999999999999 78888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=320.20 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=194.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+++.. +|..+|+|.+..... ..+.+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (331)
T cd06649 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 89 (331)
T ss_pred EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence 467999999999999864 688999999875422 24578999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--CCC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--STP 475 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 475 (606)
|.+++.... .+++..+..++.|++.||.|||++ +++ ||||||+|||++.++.+||+|||+++..... ...
T Consensus 90 L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~iv--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (331)
T cd06649 90 LDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162 (331)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEE--cCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence 999997532 488999999999999999999986 455 9999999999999999999999998765432 233
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc---ccc------------
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE---WTA------------ 540 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~------------ 540 (606)
.++..|+|||++.+..++.++|||||||++|||++|+.||......+ +...+....... ...
T Consensus 163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCccccccccc
Confidence 56778999999999899999999999999999999999996422110 000000000000 000
Q ss_pred ---------------cccchhh--hccc-ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 541 ---------------EVFDLEL--LRYQ-NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 541 ---------------~~~d~~~--~~~~-~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
+..+.-. .... .......++.+++.+||+.||++|||+.+++++-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000 0000 0012345689999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=313.65 Aligned_cols=257 Identities=21% Similarity=0.255 Sum_probs=192.5
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
..+.||+|+||.||+++.. +++.||+|+++.... ..+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (287)
T cd07848 5 VLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEK 84 (287)
T ss_pred EEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCC
Confidence 3567999999999999865 688999999875432 245678999999999999999999999999999999999998
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
+.+..+... ...+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~--H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 85 NMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKNDIV--HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 777655432 23588999999999999999999999966 99999999999999999999999997654321
Q ss_pred --CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCC--------h-hHHHHHHhhccccccc
Q 037905 474 --TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVD--------L-PRWVQSVVKEEWTAEV 542 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~--------~-~~~~~~~~~~~~~~~~ 542 (606)
...++..|+|||++.+..++.++|||||||++|||++|+.||......+... + ................
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 2346778999999998889999999999999999999999997532111000 0 0000000000000000
Q ss_pred cchhhhccc-----ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLRYQ-----NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+...... ........+.+++.+||+.||++|||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 011234568999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=324.66 Aligned_cols=243 Identities=26% Similarity=0.400 Sum_probs=202.2
Q ss_pred HHhcccccCCceEEEEEEEc--CC--cEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 320 ASAEVLGKGTFGTAYKATLE--MG--IVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
...++||+|.||.|++|.|. +| ..||||.++.... .-.+|.+|+..|.+|+|+|+++++|...+ ...++|||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 45688999999999999874 23 5699999987654 35789999999999999999999999887 678899999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
++.|+|.+.|++. ....|.....-+++.|||.||.||.+++.+ ||||.++|+|+.....|||+|||+.+......
T Consensus 192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskrlv--HRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKRLV--HRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhhhh--hhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999973 244688888899999999999999999866 99999999999999999999999999877654
Q ss_pred CCCC-------cccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 474 TPNR-------IDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 474 ~~~~-------~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
.... ...|+|||.+....|+.++|||+|||++|||+| |+.||.+. .-...++.+-..
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~------~g~qIL~~iD~~--------- 331 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC------RGIQILKNIDAG--------- 331 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC------CHHHHHHhcccc---------
Confidence 3221 234999999999999999999999999999999 89999653 222223222211
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.+...+..|.+.++++|++||..+|++||||.+|++.+
T Consensus 332 --erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 332 --ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred --ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 12334567888999999999999999999999998543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=306.92 Aligned_cols=245 Identities=26% Similarity=0.441 Sum_probs=199.5
Q ss_pred HHhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 320 ASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
...++||+|+||.||+|...+++.||+|.+.........+.+|+.++++++|+|++++++++ ..+..+++|||+.+++|
T Consensus 9 ~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~~~~~L 87 (260)
T cd05067 9 KLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSL 87 (260)
T ss_pred eeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcCCCCCH
Confidence 34578999999999999988899999999987776778899999999999999999999886 45678999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----C
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----T 474 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~ 474 (606)
.+++.... ...+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.++|+|||+++...... .
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~i~--H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 162 (260)
T cd05067 88 VDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKNYI--HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162 (260)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCee--cccccHHhEEEcCCCCEEEccCcceeecCCCCcccccC
Confidence 99987543 23588999999999999999999999966 99999999999999999999999987654211 1
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+..|+|||++....++.++||||||+++|||++ |+.||.... ....+... ...... +.+
T Consensus 163 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~-~~~~~~----------~~~ 225 (260)
T cd05067 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT------NPEVIQNL-ERGYRM----------PRP 225 (260)
T ss_pred CcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC------hHHHHHHH-HcCCCC----------CCC
Confidence 223456999999988889999999999999999999 999996432 12222221 111111 111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
...+.++.+++.+||..+|++|||++++++.|++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1223568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=299.29 Aligned_cols=256 Identities=23% Similarity=0.245 Sum_probs=193.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 395 (606)
.+.|++|.||.||+|+. ++++.||+|+++-.... .-.-.+|+.++.+++|||||.+-.+... -+..|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 56799999999999984 57899999999764422 1235789999999999999999888764 367999999998
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST- 474 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 474 (606)
. ||..+++... +++...++..++.|+++|++|||...|. ||||||+|+|+...|.+||+|||+||.++....
T Consensus 161 h-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~wil--HRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 161 H-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNWIL--HRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred h-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhceeE--ecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 7 9999998654 5789999999999999999999999866 999999999999999999999999999887532
Q ss_pred ---CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh--
Q 037905 475 ---PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL-- 548 (606)
Q Consensus 475 ---~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-- 548 (606)
...|..|+|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+....+..+.+-.+.....+...+.+......
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~ 313 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKK 313 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhc
Confidence 234667999999876 56999999999999999999999999764332211111111111111111111111110
Q ss_pred --cccCh--------HH--HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 --RYQNV--------EE--EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 --~~~~~--------~~--~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+ .. -...-++++...+..||++|.|+.|.+++
T Consensus 314 ~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 314 MTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00000 00 12455788889999999999999998775
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=292.05 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=205.3
Q ss_pred HHHHHHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCCcccceEEEEeC-----Cce
Q 037905 315 EDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEK 387 (606)
Q Consensus 315 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~ 387 (606)
.+.+|.+.+.+|+|||+.||+++ ..++..+|+|++.-.. .+.+..++|++..++++|||+++++++...+ .+.
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 33345556789999999999998 5678999999987654 4567789999999999999999999887533 458
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 388 LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
|++++|...|+|.+.+.....+ ...+++.+.+.|+.+|++||.+||+...+.+||||||.|||+.+.+.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999875533 346899999999999999999999999666799999999999999999999999986
Q ss_pred cCCCC-------------CCCCCcccccCccccCCC---CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHH
Q 037905 468 LASPS-------------STPNRIDGYRAPEVTDAR---KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQ 531 (606)
Q Consensus 468 ~~~~~-------------~~~~~~~~y~aPE~~~~~---~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 531 (606)
...-. .....|..|+|||.+... ..++++|||||||++|+|+.|..||+.... .+..+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla---- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA---- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE----
Confidence 54321 123456679999998654 468999999999999999999999986433 222211
Q ss_pred HHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 532 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
..+....+ ..+........+.++++.|++.||.+||++.+++..++++
T Consensus 253 --------LAv~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 --------LAVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------Eeeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111111 1111223567789999999999999999999999999875
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=311.85 Aligned_cols=259 Identities=26% Similarity=0.347 Sum_probs=195.7
Q ss_pred HhcccccCCceEEEEEEE-----cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 391 (606)
..+.||+|+||+||++.. .++..||+|.++.... ....+.+|++++++++||||+++++++... ...++||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (283)
T cd05080 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIM 87 (283)
T ss_pred eceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEe
Confidence 356799999999988653 3578899999876432 356788999999999999999999988754 3578999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+++++|.+++... .+++..+..++.|++.||+|||+++++ ||||||+||++++++.+||+|||+++....
T Consensus 88 e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~i~--H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 88 EYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQHYI--HRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred cCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCee--ccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999742 489999999999999999999999966 999999999999999999999999876543
Q ss_pred CCC-------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 472 SST-------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 472 ~~~-------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
... ..++..|+|||++....++.++||||||+++|||++|..|+....... .................+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence 211 123345999999988889999999999999999999999986432110 000000000000000000000
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
... ..+.+...+..+.+++.+||+++|++|||+++|++.|+++.
T Consensus 239 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000 01112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=316.21 Aligned_cols=250 Identities=19% Similarity=0.249 Sum_probs=189.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|... ++..||+|+++.... ....+.+|+.++++++||||+++++++......++||||+++ +
T Consensus 10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~ 88 (288)
T cd07871 10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-D 88 (288)
T ss_pred eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-C
Confidence 567999999999999854 689999999875322 345678999999999999999999999988899999999985 8
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... ..
T Consensus 89 l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~iv--H~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~ 162 (288)
T cd07871 89 LKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRKIL--HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162 (288)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence 998886432 2478899999999999999999999966 9999999999999999999999998754322 12
Q ss_pred CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc------cccccc-----
Q 037905 475 PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------EWTAEV----- 542 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~----- 542 (606)
..++..|+|||++.+ ..++.++||||+||++|||++|+.||...... ..+..+... .....+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK------EELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCChHHhhccccchh
Confidence 345677999998865 56899999999999999999999999653211 111111100 000000
Q ss_pred ----cchhhhccc---ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 ----FDLELLRYQ---NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ----~d~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+...... .......+..+++.+|+..||.+|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 001123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=316.43 Aligned_cols=248 Identities=23% Similarity=0.399 Sum_probs=196.6
Q ss_pred HhcccccCCceEEEEEEEc-CCc----EEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGI----VVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
..+.||+|+||.||+|++. ++. .||+|+++.... ..+++.+|+.+++.++||||++++|+|... ..++|+||
T Consensus 11 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~ 89 (316)
T cd05108 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQL 89 (316)
T ss_pred eeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeeeec
Confidence 3567999999999999853 333 489999875432 346788999999999999999999999764 56799999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+++|+|.+++.... ..+++..+.+++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ii--H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 163 (316)
T cd05108 90 MPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163 (316)
T ss_pred CCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcCee--ccccchhheEecCCCcEEEccccccccccCCC
Confidence 99999999998542 3578899999999999999999999966 99999999999999999999999998654322
Q ss_pred C------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 T------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 ~------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
. ...+..|+|||++....++.++||||||+++|||++ |+.||.... .... ..+......
T Consensus 164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~------~~~~-~~~~~~~~~------- 229 (316)
T cd05108 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP------ASEI-SSILEKGER------- 229 (316)
T ss_pred cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC------HHHH-HHHHhCCCC-------
Confidence 1 122346999999999899999999999999999998 999986421 1111 112221111
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.+.+..+...+.+++.+||..+|++|||+.+++..|.++.+..
T Consensus 230 ---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 230 ---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0111223356889999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=305.41 Aligned_cols=245 Identities=25% Similarity=0.460 Sum_probs=197.6
Q ss_pred HhcccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
..+.||+|+||.||+|.+. +...||||+++.... ...++.+|+.++++++||||+++++++......++||||+
T Consensus 8 ~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 87 (266)
T cd05033 8 IEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYM 87 (266)
T ss_pred eeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcC
Confidence 3577999999999999864 246899999875433 2456889999999999999999999999889999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
++++|.+++.... ..+++..+..++.|++.||+|||+.+++ ||||||+||++++++.++|+|||+++......
T Consensus 88 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~i~--H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 88 ENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMNYV--HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred CCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 9999999997543 2589999999999999999999999966 99999999999999999999999998764211
Q ss_pred -----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 -----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 -----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
....+..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+ ...+..
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~-~~~~~~------- 227 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN------QDVIKAV-EDGYRL------- 227 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH------HHHHHHH-HcCCCC-------
Confidence 1122356999999998899999999999999999998 9999854221 1111111 111110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
+.+...+..+.+++.+||+.+|++||++.+|+++|+++
T Consensus 228 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 ---PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122345688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=321.20 Aligned_cols=239 Identities=21% Similarity=0.218 Sum_probs=193.2
Q ss_pred HhcccccCCceEEEEEEEcC--CcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATLEM--GIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
..+.||+|+||.||+|.... +..||+|++..... ..+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus 34 ~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~ 113 (340)
T PTZ00426 34 FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV 113 (340)
T ss_pred EEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCC
Confidence 35789999999999998542 36899999865321 2356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-C
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-S 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 473 (606)
++|+|.+++.... .+++..+..++.|++.||+|||+.+++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 114 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iv--HrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~ 186 (340)
T PTZ00426 114 IGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLNIV--YRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY 186 (340)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeE--ccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence 9999999997532 588999999999999999999999966 9999999999999999999999999765432 3
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... .+
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------~~~~~~~i~~~~~~------------~p 248 (340)
T PTZ00426 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE------PLLIYQKILEGIIY------------FP 248 (340)
T ss_pred eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC------HHHHHHHHhcCCCC------------CC
Confidence 3467788999999998889999999999999999999999996421 11112222221110 00
Q ss_pred HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
......+.+++.+|++.+|++|+ +++++.++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11223467888899999999995 89988876
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=327.58 Aligned_cols=252 Identities=26% Similarity=0.427 Sum_probs=210.3
Q ss_pred HHHHHHhcccccCCceEEEEEEE-cC----CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceE
Q 037905 316 DLLRASAEVLGKGTFGTAYKATL-EM----GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKL 388 (606)
Q Consensus 316 ~~~~~~~~~ig~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 388 (606)
|.+....++||+|+||+||+|-| .. ..+||+|++..... +..++.+|+..|.+++|||+++++|+|.... ..
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 33344578999999999999975 22 46799999876543 4678999999999999999999999998655 88
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 389 LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
||++||+.|+|.++++..+ ..+.....+.|..|||+||.|||.+..+ ||||.++|||+.+-..+||.|||+++.
T Consensus 774 lvtq~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qrlV--HrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQRLV--HRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHhcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcchh--hhhhhhhheeecCCCeEEEEecchhhc
Confidence 9999999999999999754 3588899999999999999999999855 999999999999999999999999998
Q ss_pred CCCCCCCC------CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 469 ASPSSTPN------RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 469 ~~~~~~~~------~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
........ ....|||-|.+....|+.++|||||||++||++| |..||++...++ +...++.+.
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~ge--- 917 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGE--- 917 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhccc---
Confidence 76543322 2244999999999999999999999999999999 999998754433 222222221
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
+...++.+..+++.+|.+||..|++.||+|+++..++.++++.
T Consensus 918 -------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 -------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 2345667888999999999999999999999999999999865
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=319.98 Aligned_cols=244 Identities=20% Similarity=0.325 Sum_probs=190.4
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+.. +++.||+|+++.... ..+.+..|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999854 578999999976422 224567788887766 899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
++|..++... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.... .
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~iv--H~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~ 153 (329)
T cd05618 81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERGII--YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 153 (329)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--eCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence 9999888643 2589999999999999999999999966 999999999999999999999999875322 1
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC--CChhHHHHHHhhccccccccchhhhcc
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG--VDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||........ .....++.........
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------- 222 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------- 222 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----------
Confidence 234567889999999999999999999999999999999999964222111 1112222222211110
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCC------HHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPS------MAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs------~~~v~~~ 584 (606)
..+......+.+++.+||+.||++||+ +.+++++
T Consensus 223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 011223346778999999999999998 4676655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.48 Aligned_cols=262 Identities=21% Similarity=0.305 Sum_probs=194.6
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccC---ccCHHHHHHHHHHHcCCCCCCcccceEEEEe-----CCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV---TVSEKEFREKMEVVGSMDHENLVPLRAYYYS-----RDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e 392 (606)
.+.||+|+||.|+.+. ..+|+.||||++... ....+...+|+++++.++|+||+.+.+.+.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 4679999999999997 457999999998743 3345778899999999999999999998865 357899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
+|+. +|...++.+. .+...++..++.|+++||.|+|+.++. ||||||.|+|++.+...||||||+|+.....
T Consensus 107 lMet-DL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAnVi--HRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 107 LMET-DLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSANVI--HRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred HHhh-HHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccccc--ccccchhheeeccCCCEEeccccceeecccc
Confidence 9955 9999998542 489999999999999999999999966 9999999999999999999999999977431
Q ss_pred ------CCCCCcccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccccc--
Q 037905 473 ------STPNRIDGYRAPEVTD-ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF-- 543 (606)
Q Consensus 473 ------~~~~~~~~y~aPE~~~-~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 543 (606)
.....|..|+|||++. ...|+.+.||||.|||+.||++|++-|.+...-....++..+-..........+-
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 2345567799999874 5689999999999999999999999997632211101100000000000000000
Q ss_pred --chhhh----cccC-----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHHHhc
Q 037905 544 --DLELL----RYQN-----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEICRS 591 (606)
Q Consensus 544 --d~~~~----~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~~ 591 (606)
...+. .... .+.....-++|+.+++..||.+|+|++|.+++ |....+.
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 00000 0000 11223456788889999999999999999887 4544433
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=306.72 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=192.7
Q ss_pred hcccccCCceEEEEEEEcC-C--cEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEE
Q 037905 322 AEVLGKGTFGTAYKATLEM-G--IVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 389 (606)
.+.||+|+||.||+|+... + ..+|+|.++..... .+.+..|+++++.++|+||+++++++... ...++
T Consensus 4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 83 (272)
T cd05075 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV 83 (272)
T ss_pred ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence 4679999999999998653 3 36899988754322 35688899999999999999999987532 24689
Q ss_pred EEeecCCCChhhhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 390 VHDYMPMGSLSALLHGNRG-AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
+|||+++|+|.+++..... .....+++..+..++.|++.||+|||+++++ ||||||+|||+++++.+||+|||+++.
T Consensus 84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFI--HRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCee--ccccchhheEEcCCCCEEECCCCcccc
Confidence 9999999999998753221 1234589999999999999999999999966 999999999999999999999999986
Q ss_pred CCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 469 ASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 469 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
..... ....+..|+|||+..+..++.++||||||+++|||++ |+.||..... ...... ...+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~-~~~~~~~- 233 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYDY-LRQGNRL- 233 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH-HHcCCCC-
Confidence 54321 1123456999999999899999999999999999999 8899864221 111111 1211110
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.........+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 234 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 ---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=304.07 Aligned_cols=240 Identities=26% Similarity=0.361 Sum_probs=191.8
Q ss_pred ccccCCceEEEEEEE---cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 324 VLGKGTFGTAYKATL---EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.||+|+||.||+|.+ .++..+|+|+++.... ..+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 3578999999875432 2457889999999999999999999885 45678999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC---
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST--- 474 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 474 (606)
+|.+++... ..+++..+..++.|++.||+|||+++++ ||||||.||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~i~--H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETNFV--HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--ecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999643 2588999999999999999999999966 999999999999999999999999876543221
Q ss_pred ----CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 475 ----PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 475 ----~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
..++..|+|||.+....++.++||||||+++|||++ |+.||..... ...... +..+....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~-i~~~~~~~-------- 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------NEVTQM-IESGERME-------- 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HHCCCCCC--------
Confidence 112356999999988889999999999999999998 9999964321 112222 22211111
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.+...+.++.+++.+||+.+|++||++.+|++.|++.
T Consensus 219 --~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 --CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1122345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=307.68 Aligned_cols=249 Identities=21% Similarity=0.327 Sum_probs=196.9
Q ss_pred HHhcccccCCceEEEEEEEc------CCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 391 (606)
...+.||+|+||.||+|+.. .+..||+|+++..... ...+.+|+.++..++||||+++++++......++++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIF 87 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEE
Confidence 34678999999999999853 3578999999754322 356889999999999999999999999989999999
Q ss_pred eecCCCChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEE
Q 037905 392 DYMPMGSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARI 460 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl 460 (606)
||+.+++|.+++..... .....+++..+..++.|++.||+|||+++++ ||||||+||++++++.+||
T Consensus 88 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~--H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 88 SYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVV--HKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred EcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCcc--ccccchhheEecCCCceEe
Confidence 99999999999853210 1123578889999999999999999999966 9999999999999999999
Q ss_pred eecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHH
Q 037905 461 SDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSV 533 (606)
Q Consensus 461 ~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 533 (606)
+|||+++...... ....++.|+|||++.+..++.++||||||+++|||++ |..||.... ...+...+
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~i 239 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQDVIEMI 239 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHH
Confidence 9999987653321 1223457999999988889999999999999999998 888886421 22223222
Q ss_pred hhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 534 VKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 534 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
...... ..+..++..+.+++.+||+.+|++||++++|+..|+.
T Consensus 240 ~~~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 RNRQVL-----------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HcCCcC-----------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222110 1112344568899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=310.18 Aligned_cols=243 Identities=19% Similarity=0.245 Sum_probs=190.5
Q ss_pred cccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 325 LGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 325 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
||+|+||+||++.. .+++.||+|++...... .+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999985 46899999998654322 24567899999999999999999999988999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----CC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----TP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~ 475 (606)
..++..... ....+++..+..++.||+.||+|||+.+++ ||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 157 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRRII--YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence 988754221 234689999999999999999999999966 99999999999999999999999987554322 23
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||++.+..++.++||||||+++|||++|+.||....... ............. ...+..
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~------------~~~~~~ 223 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQRILNDS------------VTYPDK 223 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHHhhcccC------------CCCccc
Confidence 56778999999999999999999999999999999999996432111 0111111111100 011122
Q ss_pred HHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
....+.+++.+||+.+|++|| ++++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 345678899999999999999 66777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=320.84 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=201.2
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEEEc------CCcEEEEEEeccCccC--HHHHHHHHHHHcCCC-CCCcccceEEEE
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMD-HENLVPLRAYYY 382 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~ 382 (606)
+.+..-.+.+.+.||+|+||.||+|++. .+..||+|+++..... .+.+.+|++++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3333333455788999999999999853 3468999999754322 346889999999997 999999999999
Q ss_pred eCCceEEEEeecCCCChhhhhhcCCC------------------------------------------------------
Q 037905 383 SRDEKLLVHDYMPMGSLSALLHGNRG------------------------------------------------------ 408 (606)
Q Consensus 383 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 408 (606)
.....++||||+.+|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 98999999999999999999975321
Q ss_pred ---------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 037905 409 ---------------------------------------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSN 449 (606)
Q Consensus 409 ---------------------------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~N 449 (606)
.....+++..++.++.|++.||+|||+.+++ ||||||+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv--Hrdlkp~N 269 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV--HRDLAARN 269 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcC--cccCCcce
Confidence 0112467788899999999999999999866 99999999
Q ss_pred EEecCCCcEEEeecccCccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccC
Q 037905 450 ILLSKSYEARISDFGLAHLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522 (606)
Q Consensus 450 ill~~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~ 522 (606)
||+++++.+||+|||+++..... ....++..|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-- 347 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-- 347 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--
Confidence 99999999999999998754321 11234566999999988889999999999999999998 8899864321
Q ss_pred CCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 523 GVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
..........+... ..+......+.+++.+||..+|++||++.+|++.|+++.
T Consensus 348 ----~~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 ----NEQFYNAIKRGYRM----------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ----hHHHHHHHHcCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111112221111 011123457889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=322.24 Aligned_cols=232 Identities=24% Similarity=0.335 Sum_probs=190.8
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
..++||+|+||+|+++..+ +++.+|||++++..+ +.+..+.|-.++... +||.++.++++|.+.++.+.||||+
T Consensus 372 ~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~ 451 (694)
T KOG0694|consen 372 LLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYV 451 (694)
T ss_pred EEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEec
Confidence 3578999999999999864 688999999998643 234566666666555 6999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC----
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS---- 470 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~---- 470 (606)
.||++..+.+. ..+++..+..++..|+.||+|||++||+ +||||.+|||+|.+|.+||+|||+++..-
T Consensus 452 ~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~II--YRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~ 523 (694)
T KOG0694|consen 452 AGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENGII--YRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD 523 (694)
T ss_pred CCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcCce--eeecchhheEEcccCcEEecccccccccCCCCC
Confidence 99996666553 2599999999999999999999999966 99999999999999999999999998653
Q ss_pred CCCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 471 PSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 471 ~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
...+..||+.|||||++.+..|+.++|.|||||+||||+.|+.||.+..+++ ....+.... .
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d~------------~ 585 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVNDE------------V 585 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCC------------C
Confidence 2456789999999999999999999999999999999999999997643322 222222221 1
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSM 578 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 578 (606)
..+.-...+.+++|++.+..+|++|..+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 1223345678889999999999999866
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.29 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=202.3
Q ss_pred HHHHhcccccCCceEEEEEEEc--------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCc
Q 037905 318 LRASAEVLGKGTFGTAYKATLE--------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDE 386 (606)
Q Consensus 318 ~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 386 (606)
.+...+.||+|+||.||++... ....+|+|.++.... ...++.+|+++++++ +||||++++++|...+.
T Consensus 19 ~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (307)
T cd05098 19 RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 98 (307)
T ss_pred HeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 3455678999999999999742 235799999975422 234688899999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGA-----------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS 455 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~ 455 (606)
.++||||+++++|.+++...... ....+++..+.+++.|++.||+|||+.+++ ||||||+||+++.+
T Consensus 99 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~--H~dlkp~Nill~~~ 176 (307)
T cd05098 99 LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI--HRDLAARNVLVTED 176 (307)
T ss_pred eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcc--cccccHHheEEcCC
Confidence 99999999999999999754311 123588999999999999999999999966 99999999999999
Q ss_pred CcEEEeecccCccCCCCC----C--CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhH
Q 037905 456 YEARISDFGLAHLASPSS----T--PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 456 ~~~kl~DfG~a~~~~~~~----~--~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~ 528 (606)
+.+||+|||.++...... . ...+..|+|||++.+..++.++|||||||++|||++ |+.||... ....
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~------~~~~ 250 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------PVEE 250 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC------CHHH
Confidence 999999999987554311 1 112346999999988889999999999999999998 88888542 1212
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
... ........ ..+.....++.+++.+||..+|++|||+.+|++.|+++......
T Consensus 251 ~~~-~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 251 LFK-LLKEGHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN 305 (307)
T ss_pred HHH-HHHcCCCC----------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence 222 11221111 11123345788899999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=303.41 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=198.0
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHc--CCCCCCcccceEEEEeCC----ceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVG--SMDHENLVPLRAYYYSRD----EKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~lv~e~~~ 395 (606)
.+.||+|.||.||||++. ++.||||++... ....|.+|-++.. .|+|+||++++++-.... +.+||++|.+
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~--~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~ 291 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ--EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP 291 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH--HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence 456999999999999987 699999999643 4566777777665 468999999999876544 8899999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-------GPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
.|+|.++|+.+ .++|....+|+..+++||+|||+. .+.|+|||||++|||+..|+.+.|+|||+|..
T Consensus 292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~ 365 (534)
T KOG3653|consen 292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR 365 (534)
T ss_pred CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence 99999999864 599999999999999999999974 35688999999999999999999999999987
Q ss_pred CCCCC------CCCCcccccCccccCCCC-CC-----CcchhHHHHHHHHHHHhCCCCcc-ccccc----------CCCC
Q 037905 469 ASPSS------TPNRIDGYRAPEVTDARK-VS-----QKADVYSFGVLLLELLTGKAPTQ-ALLNE----------EGVD 525 (606)
Q Consensus 469 ~~~~~------~~~~~~~y~aPE~~~~~~-~~-----~~sDv~slGvvl~elltg~~p~~-~~~~~----------~~~~ 525 (606)
+.+.. ...||..|||||++.+.- +. .+.||||+|.|+|||+++..-+. +..++ ....
T Consensus 366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 65432 246788899999987632 22 36899999999999999754432 11111 1122
Q ss_pred hhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 526 LPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
+.+.-.-++++..++.+.+.-.. ...+..+.+.+..||+.||+.|.|+.=+.+++.++.....
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~~-----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWRK-----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhhc-----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 22222233343333333322111 2456778999999999999999999999999999876553
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=301.91 Aligned_cols=241 Identities=23% Similarity=0.371 Sum_probs=193.0
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
+.||+|+||.||+|+. .+++.||+|.+..... ....+.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999986 4689999998865322 245689999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST----- 474 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----- 474 (606)
.+++.... ..+++..+..++.|++.||+|||+.++. ||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~--H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKHCI--HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--ccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99987432 3588999999999999999999999966 999999999999999999999999875432211
Q ss_pred -CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 475 -PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 475 -~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
......|+|||.+.+..++.++||||||+++|||++ |..||...... . ........... ..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~-~~~~~~~~~~~----------~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------Q-TREAIEQGVRL----------PC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------H-HHHHHHcCCCC----------CC
Confidence 111235999999998889999999999999999998 88888643211 1 11111111000 11
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
+...+..+.+++.+||..+|++|||+.+|.+.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=307.99 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=195.3
Q ss_pred HHHhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEE
Q 037905 319 RASAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 390 (606)
+...+.||+|+||.||+|... .+..||+|++..... ...++.+|+.+++.++||||+++++++......++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 344578999999999998743 356799999864322 235688999999999999999999999988899999
Q ss_pred EeecCCCChhhhhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeeccc
Q 037905 391 HDYMPMGSLSALLHGNRGA-----GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGL 465 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~ 465 (606)
|||+++++|.+++...... ....+++..+..++.|++.||+|||+.+++ ||||||+||++++++.++|+|||+
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~v--H~dlkp~Nil~~~~~~~~l~dfg~ 165 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFV--HRDLAARNCMVAEDFTVKIGDFGM 165 (277)
T ss_pred EecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCcchheEEEcCCCCEEECCCCC
Confidence 9999999999998753211 123467888999999999999999999966 999999999999999999999999
Q ss_pred CccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccc
Q 037905 466 AHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEW 538 (606)
Q Consensus 466 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (606)
++...... ....+..|+|||++.+..++.++||||||+++|||++ |..||.... .......+.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~------~~~~~~~~~~~~~ 239 (277)
T cd05062 166 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS------NEQVLRFVMEGGL 239 (277)
T ss_pred ccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCCc
Confidence 87543221 1223456999999998889999999999999999999 788886432 1122222222111
Q ss_pred cccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 539 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
.. .+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 -~~----------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 240 -LD----------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -CC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 10 011234568899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=319.38 Aligned_cols=244 Identities=20% Similarity=0.308 Sum_probs=192.4
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+. .+++.||+|+++.... ..+.+.+|..++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 3699999999999985 4578999999976432 224577888888887 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
++|..++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~iv--HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (327)
T cd05617 81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERGII--YRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT 153 (327)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence 9999888643 2589999999999999999999999966 999999999999999999999999875322 1
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.............++......... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----------~~ 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----------RI 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----------CC
Confidence 2345678899999999999999999999999999999999999754433322333333222221110 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSM------AEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~------~~v~~~ 584 (606)
+......+.+++.+||..||++||++ .++.++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 11123456788899999999999985 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=303.44 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=192.0
Q ss_pred ccccCCceEEEEEEEc---CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 324 VLGKGTFGTAYKATLE---MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.||+|+||.||+|.+. .+..||+|++..... ..+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 356799999876432 2356889999999999999999999875 457899999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC----
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST---- 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---- 474 (606)
|.+++.... ..+++..+.+++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.......
T Consensus 81 L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKNFV--HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcCee--ecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987432 3589999999999999999999999966 999999999999999999999999875433211
Q ss_pred ---CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 475 ---PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 475 ---~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
...+..|+|||++....++.++||||||+++||+++ |+.||..... ..... ....+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~~~---------- 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVMS-FIEQGKRL---------- 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHHH-HHHCCCCC----------
Confidence 112356999999988889999999999999999997 9999965322 11111 11111111
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
..+..+..++.+++.+||..+|++||++.+|.+.|+++
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11123346788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=307.37 Aligned_cols=247 Identities=24% Similarity=0.398 Sum_probs=194.5
Q ss_pred hcccccCCceEEEEEEE-----cCCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|.. ..+..||+|.++..... ...+.+|++++++++||||+++++++......++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 89 (283)
T cd05090 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL 89 (283)
T ss_pred eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence 46799999999999974 34688999999753322 356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEee
Q 037905 395 PMGSLSALLHGNRG------------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISD 462 (606)
Q Consensus 395 ~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~D 462 (606)
++++|.+++..... .....+++..+..++.|++.||+|||+++++ ||||||+|||+++++.+||+|
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~--H~dlkp~nili~~~~~~kl~d 167 (283)
T cd05090 90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFV--HKDLAARNILIGEQLHVKISD 167 (283)
T ss_pred CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCee--hhccccceEEEcCCCcEEecc
Confidence 99999999853211 1123578899999999999999999999966 999999999999999999999
Q ss_pred cccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhh
Q 037905 463 FGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVK 535 (606)
Q Consensus 463 fG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 535 (606)
||+++...... ....+..|+|||++.+..++.++||||||+++|||++ |..||..... ....+.+..
T Consensus 168 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~ 241 (283)
T cd05090 168 LGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------QEVIEMVRK 241 (283)
T ss_pred ccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHc
Confidence 99997653221 2223456999999988889999999999999999999 9999864211 111221211
Q ss_pred ccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 536 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
.... ..+......+.+++.+||+.+|++||++.+|.++|+.
T Consensus 242 ~~~~-----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 242 RQLL-----------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCcC-----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1110 0111233567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.10 Aligned_cols=260 Identities=23% Similarity=0.378 Sum_probs=203.1
Q ss_pred HHHHHHHHhcccccCCceEEEEEEE--------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEE
Q 037905 314 LEDLLRASAEVLGKGTFGTAYKATL--------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYY 382 (606)
Q Consensus 314 ~~~~~~~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 382 (606)
+..-.+...+.||+|+||.||+|+. .++..||+|.++.... ..+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3333445567899999999999973 1345799999875422 235688999999999 8999999999999
Q ss_pred eCCceEEEEeecCCCChhhhhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEE
Q 037905 383 SRDEKLLVHDYMPMGSLSALLHGNRGA-----------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNIL 451 (606)
Q Consensus 383 ~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nil 451 (606)
.....++||||+.+++|.+++...... ....+++..+..++.||+.||+|||++|++ ||||||+||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~giv--H~dlkp~Nil 169 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI--HRDLAARNVL 169 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCee--ecccccceEE
Confidence 999999999999999999999754211 123578899999999999999999999966 9999999999
Q ss_pred ecCCCcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCC
Q 037905 452 LSKSYEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGV 524 (606)
Q Consensus 452 l~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~ 524 (606)
++.++.+||+|||.++...... ....+..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------ 243 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------ 243 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC------
Confidence 9999999999999997654321 1223456999999988889999999999999999998 78888542
Q ss_pred ChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 525 DLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
........+ ...... ..+..+...+.+++.+||..+|++|||+.++++.|+++....
T Consensus 244 ~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 244 PVEELFKLL-KEGHRM----------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred CHHHHHHHH-HcCCcC----------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 222222222 111110 111234467888999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.16 Aligned_cols=244 Identities=27% Similarity=0.433 Sum_probs=196.9
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
..+.||+|+||.||+|....+..+|+|.+.......+.+.+|++++++++|+|++++++++. ....++||||+.+++|.
T Consensus 10 ~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~ 88 (260)
T cd05069 10 LDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLL 88 (260)
T ss_pred eeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHH
Confidence 35679999999999999877778999998766556678899999999999999999998874 45689999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TP 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~ 475 (606)
+++.... ...+++..+..++.|++.||+|||+.+++ |+||||+||++++++.++|+|||.++...... ..
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~--H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 163 (260)
T cd05069 89 DFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMNYI--HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163 (260)
T ss_pred HHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEe--ecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence 9997532 23578999999999999999999999965 99999999999999999999999997653321 12
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+..|+|||+..+..++.++||||||+++|||++ |+.||..... ....... ...... ..+.
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~-~~~~~~----------~~~~ 226 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN------REVLEQV-ERGYRM----------PCPQ 226 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-HcCCCC----------CCCc
Confidence 23456999999988889999999999999999999 8999864321 1111111 111110 1112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
..+..+.+++.+||..+|++||++++|++.|++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 234568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.55 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=199.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. .+++.||||.++.... ....+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 86 (267)
T cd08228 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA 86 (267)
T ss_pred eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence 46799999999999985 4689999998864322 234688899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++..... ....++...+..++.|++.||+|||+++++ |+||||+||+++.++.++|+|||+++......
T Consensus 87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~--H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 163 (267)
T cd08228 87 GDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRRVM--HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred CcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCCee--CCCCCHHHEEEcCCCCEEECccccceeccchhHHH
Confidence 999998864321 123578899999999999999999999966 99999999999999999999999987654322
Q ss_pred -CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 -TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||.+.+..++.++||||||+++|||++|+.||.... .+...+...+...... ...
T Consensus 164 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~~~----------~~~ 229 (267)
T cd08228 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLFSLCQKIEQCDYP----------PLP 229 (267)
T ss_pred hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc----ccHHHHHHHHhcCCCC----------CCC
Confidence 2345667999999988889999999999999999999999985421 1122222221111110 011
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
.......+.+++.+||..+|++||++.+|++.++.+.
T Consensus 230 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 230 TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1234467889999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=305.58 Aligned_cols=248 Identities=23% Similarity=0.371 Sum_probs=196.2
Q ss_pred hcccccCCceEEEEEEEcC----CcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCc------eE
Q 037905 322 AEVLGKGTFGTAYKATLEM----GIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDE------KL 388 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~ 388 (606)
.+.||+|+||.||+|.... +..||+|+++..... ...+.+|++.++.++||||+++++++..... .+
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05035 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM 83 (273)
T ss_pred ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence 4679999999999998542 478999998764333 3468899999999999999999999876544 78
Q ss_pred EEEeecCCCChhhhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 389 LVHDYMPMGSLSALLHGNRG-AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
+++||+++++|..++..... .....+++..+..++.|++.||+|||+.++. ||||||+||++++++.+||+|||+++
T Consensus 84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~--H~dlkp~Nil~~~~~~~kl~dfg~~~ 161 (273)
T cd05035 84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFI--HRDLAARNCMLREDMTVCVADFGLSK 161 (273)
T ss_pred EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCee--ccccchheEEECCCCeEEECCcccee
Confidence 99999999999999865321 1234689999999999999999999999966 99999999999999999999999998
Q ss_pred cCCCCCC------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 468 LASPSST------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 468 ~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
....... ...+..|+|||++.+..++.++||||||+++|||++ |..||..... ............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~-- 233 (273)
T cd05035 162 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYLRHGNR-- 233 (273)
T ss_pred eccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCC--
Confidence 6543221 123456999999988889999999999999999999 8899864321 122222211110
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
...+......+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 234 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 ---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011223456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=317.29 Aligned_cols=237 Identities=24% Similarity=0.316 Sum_probs=189.1
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+.. +++.||+|+++... ...+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 58899999987532 1234566778877765 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
|+|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~iv--H~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKGII--YRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT 153 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeE--eCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence 99999887542 588999999999999999999999966 999999999999999999999999875322 1
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------~~~~~~~i~~~~~~------------~ 215 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN------EDDLFEAILNDEVV------------Y 215 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC------HHHHHHHHhcCCCC------------C
Confidence 23456788999999999899999999999999999999999996432 22223322221110 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSM------AEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~------~~v~~~ 584 (606)
+......+.+++.+||+.||++||++ ++++++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 11123467889999999999999998 555554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=316.55 Aligned_cols=242 Identities=21% Similarity=0.347 Sum_probs=208.4
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCc-eEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDE-KLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~~~ 395 (606)
..+++|+|+||.++.++.+ ++..+++|.+.-...+ ++...+|+.++++++|||||.+.+.|..++. .+|||+|++
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence 3578999999999998753 5788999998765443 3467899999999999999999999998888 899999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
||++.+.+...+ ...++++.+..++.|++.|+.|||++.+. |||||+.|||+..+..|||.|||+|+......
T Consensus 88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~iL--HRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENRVL--HRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhhhh--cccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 999999998765 35689999999999999999999988866 99999999999999999999999999887643
Q ss_pred --CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 474 --TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
+..+|+.||.||.+.+..|..|+|||||||++|||++-+++|.. .++...+..+.+... .+
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a------~~m~~Li~ki~~~~~-----------~P 225 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA------SNMSELILKINRGLY-----------SP 225 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc------cchHHHHHHHhhccC-----------CC
Confidence 46788999999999999999999999999999999999999964 355555655555431 12
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.....++..++..|+..+|+.||++.+++.+
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 334566778899999999999999999999987
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.38 Aligned_cols=237 Identities=22% Similarity=0.328 Sum_probs=190.0
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
++||+|+||.||+|+.. +++.||+|+++.... ....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999864 578999999875421 234566788888755 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|..++.... .+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iv--HrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHGVI--YRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT 153 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHHHeEECCCCCEEEeecccceecccCCccc
Confidence 99999887432 488899999999999999999999966 9999999999999999999999998753321
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+...... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~------~~~~~~~i~~~~~~------------~ 215 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN------EDDLFESILHDDVL------------Y 215 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC------HHHHHHHHHcCCCC------------C
Confidence 22346778999999999899999999999999999999999996432 22223333222110 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCC-------CHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRP-------SMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RP-------s~~~v~~~ 584 (606)
+......+.+++.+||+.+|++|| ++.+++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111234678899999999999999 77888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.32 Aligned_cols=192 Identities=22% Similarity=0.360 Sum_probs=166.3
Q ss_pred HHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 319 RASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
+...+.||+|+||.||++... ++..+|+|.++.... ....+.+|++++++++|+||++++++|...++.++||||++
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 344678999999999999865 688999998875422 23568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
+++|.+++... ..+++..+..++.+++.||.|||+. +++ ||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~~iv--H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 159 (333)
T cd06650 87 GGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA 159 (333)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCEE--ecCCChhhEEEcCCCCEEEeeCCcchhhhhhcc
Confidence 99999999753 2478889999999999999999985 555 9999999999999999999999998754332
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 234567789999999988899999999999999999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=303.62 Aligned_cols=244 Identities=29% Similarity=0.450 Sum_probs=195.9
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEe-CCceEEEEeecCCCCh
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS-RDEKLLVHDYMPMGSL 399 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L 399 (606)
..+.||+|+||.||++... |..||+|.++.. ...+.+.+|+.++++++|+|++++++++.. ....++|+||+++++|
T Consensus 10 ~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 87 (256)
T cd05082 10 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 87 (256)
T ss_pred eeeeecccCCCeEEEEEEc-CCcEEEEEeCCC-chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcH
Confidence 3578999999999999876 888999988653 235678999999999999999999998654 4568999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-CCCCc
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-TPNRI 478 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~ 478 (606)
.+++.... ...+++..+..++.|++.||+|||++++. ||||||+||++++++.+||+|||+++...... ....+
T Consensus 88 ~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 162 (256)
T cd05082 88 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANNFV--HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 162 (256)
T ss_pred HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCEe--ccccchheEEEcCCCcEEecCCccceeccccCCCCccc
Confidence 99987543 23588999999999999999999999966 99999999999999999999999987654322 22334
Q ss_pred ccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHH
Q 037905 479 DGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEM 557 (606)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 557 (606)
..|+|||++....++.++||||||+++|||++ |+.||... ........+ ..++... .....+
T Consensus 163 ~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~------~~~~~~~~~-~~~~~~~----------~~~~~~ 225 (256)
T cd05082 163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRV-EKGYKMD----------APDGCP 225 (256)
T ss_pred eeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHH-hcCCCCC----------CCCCCC
Confidence 56999999998889999999999999999998 99998532 222222222 1111111 112234
Q ss_pred HHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 558 VQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 558 ~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 226 ~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 226 PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 5688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.46 Aligned_cols=252 Identities=25% Similarity=0.411 Sum_probs=200.8
Q ss_pred hcccccCCceEEEEEEEc------CCcEEEEEEeccCccC-HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTVS-EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|+.. ++..+++|.++..... .+.+.+|++.+++++|+||+++++++......++||||+
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (291)
T cd05094 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYM 89 (291)
T ss_pred eeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecC
Confidence 467999999999999742 3567899988754432 357899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeec
Q 037905 395 PMGSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDF 463 (606)
Q Consensus 395 ~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~Df 463 (606)
++++|.+++..... .....+++..++.++.||+.||+|||+++++ ||||||+||+++.++.++|+||
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~--H~dlkp~Nil~~~~~~~~l~df 167 (291)
T cd05094 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFV--HRDLATRNCLVGANLLVKIGDF 167 (291)
T ss_pred CCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCee--ecccCcceEEEccCCcEEECCC
Confidence 99999999975321 1123589999999999999999999999966 9999999999999999999999
Q ss_pred ccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhc
Q 037905 464 GLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKE 536 (606)
Q Consensus 464 G~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (606)
|+++...... ...++..|+|||++.+..++.++||||||+++|||+| |+.||..... ...+... ..
T Consensus 168 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~-~~ 240 (291)
T cd05094 168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIECI-TQ 240 (291)
T ss_pred CcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-hC
Confidence 9987554321 1223456999999999899999999999999999999 9999865322 1112111 11
Q ss_pred cccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 537 EWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 537 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
+.... .....+..+.+++.+||+++|++|||+.+|++.|+++....
T Consensus 241 ~~~~~----------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 241 GRVLE----------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred CCCCC----------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 11110 11123456889999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=302.69 Aligned_cols=245 Identities=28% Similarity=0.452 Sum_probs=201.1
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
..+.||+|+||.||+|..+++..+|||.+.......+++.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus 10 i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 89 (261)
T cd05034 10 LERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLL 89 (261)
T ss_pred eeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHH
Confidence 35679999999999999887889999999877777788999999999999999999999998888999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TP 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~ 475 (606)
+++.... ...+++..+..++.+++.|++|||+++++ |+||||+||++++++.+||+|||.++...... ..
T Consensus 90 ~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~i~--h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 164 (261)
T cd05034 90 DFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRNYI--HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164 (261)
T ss_pred HHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence 9997543 23589999999999999999999999966 99999999999999999999999987654321 11
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+..|+|||.+.+..++.++||||||+++||+++ |+.||.... .......+.. ... ...+.
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~------~~~~~~~~~~-~~~----------~~~~~ 227 (261)
T cd05034 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT------NREVLEQVER-GYR----------MPRPP 227 (261)
T ss_pred CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc-CCC----------CCCCC
Confidence 23346999999998889999999999999999999 999995421 1112222211 110 00111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
..+..+.+++.+||..+|++||+++++.+.|++
T Consensus 228 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 224568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=309.49 Aligned_cols=251 Identities=25% Similarity=0.410 Sum_probs=198.4
Q ss_pred HHhcccccCCceEEEEEEEc------CCcEEEEEEeccCccC--HHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEE
Q 037905 320 ASAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTVS--EKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 390 (606)
...+.||+|+||.||++... ....+|+|.+...... ..++.+|++++.++ +|+||+++++++..+...+++
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 34578999999999999853 2368999998754322 34588899999999 899999999999998999999
Q ss_pred EeecCCCChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEE
Q 037905 391 HDYMPMGSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEAR 459 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~k 459 (606)
|||+++++|.+++..... .....+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+|
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv--H~dlkp~Nil~~~~~~~k 172 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCI--HRDLAARNVLVTEDHVMK 172 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcc--ccccceeeEEEcCCCeEE
Confidence 999999999999864310 1234689999999999999999999999966 999999999999999999
Q ss_pred EeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHH
Q 037905 460 ISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQS 532 (606)
Q Consensus 460 l~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 532 (606)
|+|||.++...... ....+..|+|||++.+..++.++|||||||++|||++ |..||.... .......
T Consensus 173 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~ 246 (293)
T cd05053 173 IADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------VEELFKL 246 (293)
T ss_pred eCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC------HHHHHHH
Confidence 99999998654321 1123456999999988889999999999999999998 999986421 1111111
Q ss_pred HhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 533 VVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 533 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
....... ..+......+.+++.+||..+|++|||+.++++.|+++.
T Consensus 247 -~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 247 -LKEGYRM----------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHcCCcC----------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111100 111223456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.28 Aligned_cols=237 Identities=23% Similarity=0.295 Sum_probs=190.8
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+.||+|+||.||++.. .+|..||+|+++.... ....+..|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999985 4689999999975422 2345678899999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
+|..++... ..+++..+..++.||+.||+|||+ .+++ ||||||+|||++.++.+||+|||+++.....
T Consensus 81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~iv--HrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCEE--ecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 999988643 258999999999999999999997 6765 9999999999999999999999998753221
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~------~~~~~~~i~~~~~------------~~ 215 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD------HEKLFELILMEEI------------RF 215 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC------HHHHHHHHhcCCC------------CC
Confidence 22356788999999999899999999999999999999999996422 1111222111110 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
+......+.+++.+||+.||++|+ ++.+++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111234578889999999999996 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=321.54 Aligned_cols=252 Identities=18% Similarity=0.211 Sum_probs=190.4
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
...+.||+|+||.||++.. .+++.||+|... ...+.+|++++++++||||+++++++......++|+|++. ++
T Consensus 95 ~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~ 168 (391)
T PHA03212 95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TD 168 (391)
T ss_pred EEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CC
Confidence 3457899999999999985 568999999653 3457889999999999999999999999999999999996 58
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-----C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-----S 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~ 473 (606)
|..++... ..+++..++.++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 169 L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~Iv--HrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 169 LYCYLAAK-----RNIAICDILAIERSVLRAIQYLHENRII--HRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCChHhEEEcCCCCEEEEeCCcccccccccccccc
Confidence 88888643 2478999999999999999999999966 9999999999999999999999999753221 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCC-ChhHHHHHHhhcc------ccc------
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGV-DLPRWVQSVVKEE------WTA------ 540 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~------~~~------ 540 (606)
...+|..|+|||++.+..++.++|||||||++|||++|+.||.......+. +....+..++... +..
T Consensus 242 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred cccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHH
Confidence 345788899999999989999999999999999999999887542211111 1111111111100 000
Q ss_pred ----------cccchhh-hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 ----------EVFDLEL-LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ----------~~~d~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.. ..+........++.+++.+||+.||++|||++|++++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0000000 0000112334578899999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=307.33 Aligned_cols=252 Identities=26% Similarity=0.406 Sum_probs=198.6
Q ss_pred HhcccccCCceEEEEEEEc------CCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
..+.||+|+||.||+|... ....+|+|.+...... ...+.+|+.+++.++||||++++++|...+..++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 3567999999999999742 2357899988754332 3568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec
Q 037905 393 YMPMGSLSALLHGNRG-------------------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS 453 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~ 453 (606)
|+.+++|.+++..... ....++++..+..++.|++.||+|||+.+++ ||||||+|||++
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~iv--H~dikp~nill~ 161 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLV--HRDLAARNVLVA 161 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCee--hhhhhhheEEEc
Confidence 9999999999864321 1123588999999999999999999999966 999999999999
Q ss_pred CCCcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCCh
Q 037905 454 KSYEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDL 526 (606)
Q Consensus 454 ~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~ 526 (606)
+++.+||+|||+++...... ....+..|+|||++.+..++.++||||||+++|||++ |..||.... .
T Consensus 162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~ 235 (290)
T cd05045 162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA------P 235 (290)
T ss_pred CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC------H
Confidence 99999999999987543221 1223456999999988889999999999999999999 999986432 1
Q ss_pred hHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 527 PRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 527 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.... ......... ..+......+.+++.+||+.+|++||++.++++.|+++...
T Consensus 236 ~~~~-~~~~~~~~~----------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 ERLF-NLLKTGYRM----------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHH-HHHhCCCCC----------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111 122211111 11122345688999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=301.48 Aligned_cols=244 Identities=30% Similarity=0.474 Sum_probs=199.8
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
..+.||+|+||.||+|... |+.||+|.++......+.+.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 10 ~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 88 (256)
T cd05039 10 LGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88 (256)
T ss_pred ceeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHH
Confidence 3577999999999999876 889999999876545677899999999999999999999999889999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-CCCcc
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-PNRID 479 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~ 479 (606)
+++.... ...+++..+..++.|++.||.|||+.++. ||||||+||+++.++.+||+|||.++....... ...+.
T Consensus 89 ~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~i~--H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 163 (256)
T cd05039 89 DYLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKNFV--HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV 163 (256)
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcc--chhcccceEEEeCCCCEEEcccccccccccccccCCCcc
Confidence 9997543 23589999999999999999999999966 999999999999999999999999987643222 22334
Q ss_pred cccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHH
Q 037905 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV 558 (606)
Q Consensus 480 ~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 558 (606)
.|+|||++....++.++||||||+++|||++ |..||.... ..... ......+... .+...+.
T Consensus 164 ~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~-~~~~~~~~~~----------~~~~~~~ 226 (256)
T cd05039 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVV-PHVEKGYRME----------APEGCPP 226 (256)
T ss_pred cccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC------HHHHH-HHHhcCCCCC----------CccCCCH
Confidence 6999999988889999999999999999998 999986431 11111 1111111111 1122345
Q ss_pred HHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 559 QLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 559 ~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
.+.+++.+||..+|++|||+.++++.|++
T Consensus 227 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 227 EVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 78899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=306.25 Aligned_cols=237 Identities=24% Similarity=0.354 Sum_probs=187.0
Q ss_pred ccccCCceEEEEEEEcC-------------CcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEE
Q 037905 324 VLGKGTFGTAYKATLEM-------------GIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 389 (606)
.||+|+||.||+|.+.. ...||+|.+..... ....+.+|+.+++.++||||+++++++......++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 58999999999997532 23588898765432 23467888999999999999999999999889999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc-------EEEee
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE-------ARISD 462 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~-------~kl~D 462 (606)
||||+++++|..++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++. ++++|
T Consensus 82 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iv--H~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKDLV--HGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCCeE--CCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999998886432 3589999999999999999999999966 9999999999987664 89999
Q ss_pred cccCccCCCCCCCCCcccccCccccC-CCCCCCcchhHHHHHHHHHHH-hCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 463 FGLAHLASPSSTPNRIDGYRAPEVTD-ARKVSQKADVYSFGVLLLELL-TGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 463 fG~a~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDv~slGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
||++..........++..|+|||++. +..++.++|||||||++|||+ +|..|+......+ .........
T Consensus 156 ~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~-- 226 (262)
T cd05077 156 PGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFYEGQC-- 226 (262)
T ss_pred CCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHHhcCc--
Confidence 99987665544555677899999886 467899999999999999998 5888875421111 011111100
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
....+....+.+++.+||+.||++||++.+|+++|
T Consensus 227 ----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 ----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred ----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00111235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=314.54 Aligned_cols=236 Identities=24% Similarity=0.325 Sum_probs=186.9
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcC-CCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGS-MDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+.. +++.||||+++... .....+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999864 57899999997642 123445667777765 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
|+|.+++... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~iv--Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05619 81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKGIV--YRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT 153 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeE--eCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence 9999998743 2578899999999999999999999966 999999999999999999999999875322 1
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~------~~~~~~~i~~~~~------------~~ 215 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD------EEELFQSIRMDNP------------CY 215 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC------------CC
Confidence 23356778999999999899999999999999999999999996432 1122222111110 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMA-EVTS 583 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v~~ 583 (606)
+......+.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111234577889999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=306.77 Aligned_cols=238 Identities=24% Similarity=0.348 Sum_probs=186.0
Q ss_pred ccccCCceEEEEEEEcC-------------------------CcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccc
Q 037905 324 VLGKGTFGTAYKATLEM-------------------------GIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPL 377 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l 377 (606)
.||+|+||.||+|.+.. ...||+|++..... ....+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 24588998865432 23567888999999999999999
Q ss_pred eEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-
Q 037905 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY- 456 (606)
Q Consensus 378 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~- 456 (606)
+++|......++||||+++++|..++.... ..+++..+..++.||+.||+|||+++++ ||||||+||++++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ii--H~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKNLV--HGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCcc--CCCCCcccEEEeccCc
Confidence 999999999999999999999999986432 3578999999999999999999999966 999999999997654
Q ss_pred ------cEEEeecccCccCCCCCCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHH-hCCCCcccccccCCCChhH
Q 037905 457 ------EARISDFGLAHLASPSSTPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELL-TGKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 457 ------~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~ell-tg~~p~~~~~~~~~~~~~~ 528 (606)
.+|++|||.+..........++..|+|||++.+ ..++.++||||||+++|||+ +|+.||....... .
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~-- 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE---K-- 230 (274)
T ss_pred ccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH---H--
Confidence 389999998865544444455677999998865 56899999999999999995 6999986532211 1
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
........ ..+......+.+++.+||+.+|++|||+.+|+++|.
T Consensus 231 --~~~~~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 --ERFYEKKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHHhcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111110 000112246888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=314.78 Aligned_cols=236 Identities=24% Similarity=0.324 Sum_probs=185.2
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcC-CCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGS-MDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+.. +++.||+|+++.... ..+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 578999999975421 22344556666654 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
|+|..++.... .+++..+..++.|++.||+|||+.+++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~iv--H~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKGII--YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA 153 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEE--eCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence 99999987532 588899999999999999999999966 999999999999999999999999875432 1
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+.... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~------~~~~~~~i~~~~------------~~~ 215 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED------EDELFDSILNDR------------PHF 215 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCC------------CCC
Confidence 23356788999999999899999999999999999999999996432 112222221110 000
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMA-EVTS 583 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v~~ 583 (606)
+......+.+++.+||+.+|++||++. ++.+
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111234577888999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=301.68 Aligned_cols=242 Identities=29% Similarity=0.427 Sum_probs=194.0
Q ss_pred cccccCCceEEEEEEEcC----CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLEM----GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
++||+|+||.||+|.... +..+|+|.+..... ..+++.+|+++++.++|+|++++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997432 36899999886554 3567899999999999999999999876 4567999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCC-
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP- 475 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 475 (606)
++|.+++.... .+++..+..++.|++.||+|||..+++ |+||||+||+++.++.+||+|||.++........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~i~--H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKHFV--HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcCee--ccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997532 588999999999999999999999966 9999999999999999999999998765432211
Q ss_pred ------CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 476 ------NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 476 ------~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
.++..|+|||.+.+..++.++||||||+++|||++ |..||..... ......+ ......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~------~~~~~~~-~~~~~~-------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG------AEVIAML-ESGERL-------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHH-HcCCcC--------
Confidence 11245999999998889999999999999999998 9999964321 1222211 111110
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
..+...+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus 218 --~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 --PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111223457889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=308.52 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=196.8
Q ss_pred hcccccCCceEEEEEEEcC-C--cEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLEM-G--IVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~-~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|.... + ..+++|.++.... ..+.+.+|++++.++ +||||+++++++......++|+||++
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (297)
T cd05089 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP 86 (297)
T ss_pred eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence 4679999999999998643 3 3478888874322 235688999999999 79999999999998889999999999
Q ss_pred CCChhhhhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecc
Q 037905 396 MGSLSALLHGNRGA-----------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464 (606)
Q Consensus 396 ~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG 464 (606)
+++|.+++...... ....+++..+..++.|++.||+|||+.+++ ||||||+|||+++++.+||+|||
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iv--H~dlkp~Nill~~~~~~kl~dfg 164 (297)
T cd05089 87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFI--HRDLAARNVLVGENLASKIADFG 164 (297)
T ss_pred CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCcCCcceEEECCCCeEEECCcC
Confidence 99999999753210 123588999999999999999999999966 99999999999999999999999
Q ss_pred cCccCCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 465 LAHLASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 465 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
++...... .....+..|+|||++.+..++.++|||||||++|||++ |..||.... .......... +...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~------~~~~~~~~~~-~~~~ 237 (297)
T cd05089 165 LSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT------CAELYEKLPQ-GYRM 237 (297)
T ss_pred CCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHhc-CCCC
Confidence 98643321 11122345999999988889999999999999999998 999996432 1222222211 1100
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
..+......+.+++.+||+.+|.+|||+.++++.|+++.+..
T Consensus 238 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 238 ----------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111223456889999999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=303.51 Aligned_cols=248 Identities=25% Similarity=0.420 Sum_probs=194.2
Q ss_pred cccccCCceEEEEEEEc-CCc--EEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGI--VVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|... ++. .+|+|.++.... ..+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999864 343 578888874322 345788999999999 899999999999998899999999999
Q ss_pred CChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeeccc
Q 037905 397 GSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGL 465 (606)
Q Consensus 397 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~ 465 (606)
++|.+++..... .....+++..+..++.|++.||+|||+.+++ ||||||+||++++++.+||+|||+
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~--H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI--HRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEe--ecccccceEEEcCCCeEEECCCCC
Confidence 999999975421 1123478999999999999999999999866 999999999999999999999999
Q ss_pred CccCCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 466 AHLASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 466 a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
++..... .....+..|+|||++....++.++||||||+++|||++ |..||.... .......+.. ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~------~~~~~~~~~~-~~~~- 230 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYEKLPQ-GYRL- 230 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC------HHHHHHHHhC-CCCC-
Confidence 8633221 11122446999999988889999999999999999997 999996421 1222222211 1111
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
..+......+.+++.+||..+|.+|||+.++++.|+++.
T Consensus 231 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 ---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 011123356889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=316.92 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=187.8
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeC-----CceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ 391 (606)
..+.||+|+||.||+|.. .++..||||++.... .....+.+|++++++++||||+++++++... ...++||
T Consensus 4 i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~ 83 (338)
T cd07859 4 IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83 (338)
T ss_pred EEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEE
Confidence 357899999999999985 468999999987532 2234688999999999999999999988643 2479999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+. ++|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++....
T Consensus 84 e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 84 ELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTANVF--HRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred ecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9996 5899888743 2589999999999999999999999966 999999999999999999999999875432
Q ss_pred C-------CCCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccC---------CCChhHHHHHH
Q 037905 472 S-------STPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEE---------GVDLPRWVQSV 533 (606)
Q Consensus 472 ~-------~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~ 533 (606)
. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... +.........+
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 1 12346778999999865 678999999999999999999999996422100 00000000000
Q ss_pred hhccccccccchhhhccc-C----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 534 VKEEWTAEVFDLELLRYQ-N----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 534 ~~~~~~~~~~d~~~~~~~-~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.... ....+..-..... . .......+.+++.+||+.+|++|||++|++++
T Consensus 236 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEK-ARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhh-HHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 0000000000000 0 01123457899999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=299.94 Aligned_cols=245 Identities=29% Similarity=0.445 Sum_probs=199.4
Q ss_pred cccccCCceEEEEEEEcC----CcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLEM----GIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|.... +..||+|.++..... .+.+.+|++.++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998653 789999999865443 57789999999999999999999999998999999999999
Q ss_pred CChhhhhhcCCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 397 GSLSALLHGNRGA----GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 397 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
++|.+++...... ....+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||.++.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~--H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFV--HRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcc--cCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999864211 024689999999999999999999999966 9999999999999999999999999766542
Q ss_pred ------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 ------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 ------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
.....+..|+|||.+....++.++||||||+++|||++ |..||.... .......... ...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~-~~~------ 225 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS------NEEVLEYLRK-GYR------ 225 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHc-CCC------
Confidence 22344567999999988889999999999999999999 699996531 1122222211 111
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
...+.....++.+++.+||..+|++|||+.|++++|+
T Consensus 226 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112233567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.81 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=198.5
Q ss_pred hcccccCCceEEEEEEEc-CCc--EEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGI--VVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|... ++. .+|+|.++.... ....+.+|++++.++ +|+||+++++++..++..++||||++
T Consensus 12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (303)
T cd05088 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 91 (303)
T ss_pred eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence 567999999999999864 343 467777764322 345688999999999 89999999999999999999999999
Q ss_pred CCChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecc
Q 037905 396 MGSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464 (606)
Q Consensus 396 ~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG 464 (606)
+++|.+++..... .....+++..++.++.|++.||+|||+.|++ ||||||+|||++.++.+||+|||
T Consensus 92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~--H~dlkp~Nili~~~~~~kl~dfg 169 (303)
T cd05088 92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI--HRDLAARNILVGENYVAKIADFG 169 (303)
T ss_pred CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCcc--ccccchheEEecCCCcEEeCccc
Confidence 9999999975431 1123588999999999999999999999966 99999999999999999999999
Q ss_pred cCccCCCCC---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 465 LAHLASPSS---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 465 ~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
+++...... ....+..|+|||++.+..++.++||||||+++|||+| |..||..... ....... ......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~-~~~~~~ 242 (303)
T cd05088 170 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKL-PQGYRL 242 (303)
T ss_pred cCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh------HHHHHHH-hcCCcC
Confidence 986432211 1122456999999988889999999999999999998 9999964221 1111111 111100
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
..+......+.+++.+||+.+|++||++.+++..|+++.....+.
T Consensus 243 ----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~ 287 (303)
T cd05088 243 ----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287 (303)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhh
Confidence 011123346789999999999999999999999999997666543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=314.68 Aligned_cols=236 Identities=23% Similarity=0.301 Sum_probs=186.6
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcC-CCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGS-MDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+.. +|+.||+|+++... .....+..|..++.. .+||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999864 68899999997542 123446667777764 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
++|..++... ..+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~iv--HrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (316)
T cd05620 81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKGII--YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA 153 (316)
T ss_pred CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--ecCCCHHHeEECCCCCEEeCccCCCeecccCCCce
Confidence 9999998753 2578899999999999999999999966 999999999999999999999999874321 1
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .....+.+.... + ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~------~~~~~~~~~~~~-------~-----~~ 215 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD------EDELFESIRVDT-------P-----HY 215 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCC-------C-----CC
Confidence 23456788999999999999999999999999999999999996432 112222111110 0 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMA-EVTS 583 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v~~ 583 (606)
+.....++.+++.+||+.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111234577889999999999999985 5653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.07 Aligned_cols=244 Identities=23% Similarity=0.251 Sum_probs=194.6
Q ss_pred HhcccccCCceEEEEEEEc-C-CcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-M-GIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..+.||+|+||.||+|... + +..||+|.+..... ....+..|+.+++.++||||++++++|...+..++||||+++|
T Consensus 71 ~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg 150 (478)
T PTZ00267 71 LTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150 (478)
T ss_pred EEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCC
Confidence 3578999999999999743 3 67888887654332 2345788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----- 472 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 472 (606)
+|.+++..... ...++++..+..++.||+.||.|||+.+++ ||||||+|||++.++.+||+|||+++.....
T Consensus 151 ~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv--HrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~ 227 (478)
T PTZ00267 151 DLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRKMM--HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227 (478)
T ss_pred CHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCEE--ECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence 99998864321 234688999999999999999999999966 9999999999999999999999999765432
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....++++|+|||++.+..++.++|||||||++|||++|+.||... .....+..+...... .
T Consensus 228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~------~~~~~~~~~~~~~~~-----------~ 290 (478)
T PTZ00267 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP------SQREIMQQVLYGKYD-----------P 290 (478)
T ss_pred ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC-----------C
Confidence 2234788899999999999999999999999999999999999642 122222222222110 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+......+.+++.+||..+|++||++.+++.+
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111233568889999999999999999998754
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.72 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=187.3
Q ss_pred ccccCCceEEEEEEEcC---CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 324 VLGKGTFGTAYKATLEM---GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.||+|+||.||+|...+ +..+|+|.++.... ....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998643 46799998875432 23468889999999999999999999998889999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----- 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----- 473 (606)
|.+++...........++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||.++......
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~--H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFI--HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEe--ccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999754322233567788889999999999999999966 99999999999999999999999986543221
Q ss_pred -CCCCcccccCccccCCC-------CCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 474 -TPNRIDGYRAPEVTDAR-------KVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~-------~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
...++..|+|||++.+. .++.++||||||+++|||++ |+.||......+ . ....... ......+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~---~~~~~~~-~~~~~~~ 232 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---V---LTYTVRE-QQLKLPK 232 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---H---HHHHhhc-ccCCCCC
Confidence 12234569999998642 35789999999999999997 999996532211 1 1111111 1111111
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
+.. .......+.+++.+|| .+|++|||+++|++.|+
T Consensus 233 ~~~-----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRL-----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred Ccc-----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111 0112345777888999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=315.66 Aligned_cols=237 Identities=24% Similarity=0.307 Sum_probs=187.6
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHH---HcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEV---VGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|.. .+++.||||+++.... ..+.+..|..+ ++.++||||+++++++......++||||
T Consensus 4 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~ 83 (324)
T cd05589 4 LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEY 83 (324)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcC
Confidence 46799999999999985 4689999999975421 12345556554 4667899999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
+++++|..++.. ..+++..+..++.||+.||+|||+.+++ ||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~iv--Hrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 84 AAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENKIV--YRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred CCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCeE--ecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999988863 2489999999999999999999999966 9999999999999999999999998753221
Q ss_pred ---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 ---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+.....
T Consensus 156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~------~~~~~~~i~~~~~----------- 218 (324)
T cd05589 156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD------EEEVFDSIVNDEV----------- 218 (324)
T ss_pred CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC-----------
Confidence 23456778999999999999999999999999999999999996432 1222222222111
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
..+......+.+++.+||+.||++|| ++.+++++
T Consensus 219 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 -RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 01112235678899999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=305.18 Aligned_cols=246 Identities=22% Similarity=0.296 Sum_probs=193.8
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---------------HHHHHHHHHHHcCCCCCCcccceEEEEe
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---------------EKEFREKMEVVGSMDHENLVPLRAYYYS 383 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------~~~~~~e~~~l~~l~h~niv~l~~~~~~ 383 (606)
.+.+.||+|.||.|-+|.. .+++.||||++.+.... .+.+.+|+.+|++++|||||+++.+..+
T Consensus 100 ~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDD 179 (576)
T KOG0585|consen 100 ELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDD 179 (576)
T ss_pred ehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecC
Confidence 3466799999999999984 46999999999653211 2468999999999999999999999875
Q ss_pred C--CceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEe
Q 037905 384 R--DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARIS 461 (606)
Q Consensus 384 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~ 461 (606)
. +..|+|+|||..|.+...-.+ ...++..+++.++.++..||+|||.+|++ ||||||+|+|++++|++||+
T Consensus 180 P~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Qgii--HRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 180 PESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQGII--HRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred cccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcCee--ccccchhheEEcCCCcEEee
Confidence 3 678999999998877644332 22389999999999999999999999966 99999999999999999999
Q ss_pred ecccCccCCCC---------CCCCCcccccCccccCCCC----CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhH
Q 037905 462 DFGLAHLASPS---------STPNRIDGYRAPEVTDARK----VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 462 DfG~a~~~~~~---------~~~~~~~~y~aPE~~~~~~----~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~ 528 (606)
|||.+...... ....||+.|+|||...+.. .+.+.||||+||+||.|+.|+.||.+. ....
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~------~~~~ 326 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD------FELE 326 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc------hHHH
Confidence 99988654221 2357889999999987632 357899999999999999999999642 2222
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
....+..+. + .++..++....+.+|++++|.+||+.|.+..+|..|...-
T Consensus 327 l~~KIvn~p---------L-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 327 LFDKIVNDP---------L-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HHHHHhcCc---------c-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 233332221 1 1222234566788899999999999999999999887543
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=314.53 Aligned_cols=237 Identities=23% Similarity=0.317 Sum_probs=190.0
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|... ++..||+|+++... .....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 57899999997542 1234567788888777 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|..++.... .+++..+..++.|++.||+|||+.+++ ||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~iv--H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERGII--YRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT 153 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeE--ccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence 99999887532 589999999999999999999999966 9999999999999999999999998653221
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ..
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~------~~~~~~~i~~~~~------------~~ 215 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD------EDELFQSILEDEV------------RY 215 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC------HHHHHHHHHcCCC------------CC
Confidence 12346778999999999999999999999999999999999996422 1122222221110 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSM-----AEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~~v~~~ 584 (606)
+......+.+++.+||..||++|||+ .+++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 11223567889999999999999999 777665
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.46 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=199.3
Q ss_pred HhcccccCCceEEEEEEEcC-----CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEe-CCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLEM-----GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYS-RDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 392 (606)
..+.||+|+||.||+|.... +..|++|++..... ..+.+.+|+.++++++|+||+++++++.. ....++++|
T Consensus 10 ~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~ 89 (280)
T cd05043 10 LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYP 89 (280)
T ss_pred EeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEE
Confidence 45789999999999998765 78899999875422 24568899999999999999999999876 467899999
Q ss_pred ecCCCChhhhhhcCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 393 YMPMGSLSALLHGNRGA---GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
|+++++|.+++...... ....+++..+..++.|++.||+|||+.+++ ||||||+||++++++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~--H~di~p~nil~~~~~~~kl~d~g~~~~~ 167 (280)
T cd05043 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVI--HKDIAARNCVIDEELQVKITDNALSRDL 167 (280)
T ss_pred cCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEe--ecccCHhhEEEcCCCcEEECCCCCcccc
Confidence 99999999998754311 124689999999999999999999999966 9999999999999999999999999865
Q ss_pred CCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccc
Q 037905 470 SPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 470 ~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
.... ...++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+.. ........
T Consensus 168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~-~~~~~~~~-- 238 (280)
T cd05043 168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMAA-YLKDGYRL-- 238 (280)
T ss_pred cCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHHH-HHHcCCCC--
Confidence 4321 1233456999999988889999999999999999999 9999964311 11111 11111110
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
.....++..+.+++.+||..+|++|||+.++++.|+++.+
T Consensus 239 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 239 --------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111234568899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.10 Aligned_cols=243 Identities=22% Similarity=0.285 Sum_probs=190.5
Q ss_pred cccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 325 LGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 325 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
||+|+||.||+++. .+|+.||+|++..... ..+.+..|++++++++||||+++.+++....+.++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 4689999999864322 234456799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---TPN 476 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~ 476 (606)
.+++.... ...+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~iv--H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMDIV--YRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRA 155 (277)
T ss_pred HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEE--EccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccC
Confidence 98886432 23588999999999999999999999966 99999999999999999999999987654322 234
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|+|||++.+..++.++|||||||++|||++|+.||....... ............. ... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~-----~~~------~~~~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLEDE-----VKF------EHQNF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhccc-----ccc------ccccC
Confidence 6678999999988889999999999999999999999996432111 1111111111111 000 00123
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
..++.+++.+||+.+|++||+++|+++++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 34678899999999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=301.16 Aligned_cols=238 Identities=26% Similarity=0.412 Sum_probs=189.9
Q ss_pred cccccCCceEEEEEEEcCC-----------cEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEE
Q 037905 323 EVLGKGTFGTAYKATLEMG-----------IVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~-----------~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 391 (606)
+.||+|+||.||+|...+. ..+++|.+.........+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 3589999999999986532 357888876544346788999999999999999999999988 7889999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-------cEEEeecc
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-------EARISDFG 464 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-------~~kl~DfG 464 (606)
||+++++|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+||+++.++ .+||+|||
T Consensus 80 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~--H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 80 EYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKKLV--HGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCCee--cccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999997543 2588999999999999999999999966 999999999999888 79999999
Q ss_pred cCccCCCCCCCCCcccccCccccCCC--CCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 465 LAHLASPSSTPNRIDGYRAPEVTDAR--KVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 465 ~a~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
+++.........+...|+|||++... .++.++||||||+++|||++ |..||....... ... ........
T Consensus 154 ~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~------~~~-~~~~~~~~- 225 (259)
T cd05037 154 IPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE------KER-FYQDQHRL- 225 (259)
T ss_pred cccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh------HHH-HHhcCCCC-
Confidence 99876554444556679999999876 78999999999999999999 577776532111 111 01110000
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
. ......+.+++.+||..+|.+|||+.+|++.|+
T Consensus 226 ---------~--~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 ---------P--MPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---------C--CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 001157889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.44 Aligned_cols=233 Identities=26% Similarity=0.335 Sum_probs=188.7
Q ss_pred cccccCCceEEEEEEE----cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 323 EVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
+.||+|+||.||+++. .+|+.||+|+++.... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999874 3589999999975432 23456789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+++|.+++... ..+++..+..++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~ 154 (318)
T cd05582 82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLGII--YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 154 (318)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--cCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence 99999998643 3589999999999999999999999966 9999999999999999999999998765432
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... .
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~------~~~~~~~i~~~~~------------~ 216 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD------RKETMTMILKAKL------------G 216 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC------HHHHHHHHHcCCC------------C
Confidence 22346778999999998889999999999999999999999996421 1222222222111 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAE 580 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~ 580 (606)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11122346788999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=309.63 Aligned_cols=244 Identities=24% Similarity=0.291 Sum_probs=194.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++.. .+++.||+|++..... ....+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05605 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCC
Confidence 46799999999999985 4689999999865432 224567899999999999999999999988999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.... ...+++..+..++.|++.||+|||+.+++ ||||||+||++++++.++|+|||+++......
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05605 85 GDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRERIV--YRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR 159 (285)
T ss_pred CcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCCcE--ecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence 99998886432 23589999999999999999999999966 99999999999999999999999987654322
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++||||||+++|||++|+.||....... ....+...+... ....+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~-----------~~~~~ 225 (285)
T cd05605 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED-----------QEEYS 225 (285)
T ss_pred cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc-----------ccccC
Confidence 2345678999999998889999999999999999999999997532111 111111111110 00111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
......+.+++.+||..||++|| ++.+++++
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 22345678899999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=301.83 Aligned_cols=252 Identities=20% Similarity=0.322 Sum_probs=200.6
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||.||++.. .++..+|||.+..... ...++.+|+.+++.++|+||+++++++..++..+++|||++
T Consensus 6 ~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecC
Confidence 356799999999999985 5789999998865322 23568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
+++|.+++..... ....+++..+..++.|++.||+|||+.+++ |+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~--H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd08229 86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRRVM--HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 162 (267)
T ss_pred CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence 9999999874321 234589999999999999999999999966 99999999999999999999999987654322
Q ss_pred --CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 474 --TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
...++..|+|||++.+..++.++||||||+++|||++|..||..... .............. + ..
T Consensus 163 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~------~----~~ 228 (267)
T cd08229 163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEQCDY------P----PL 228 (267)
T ss_pred cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhhcCCC------C----CC
Confidence 23456679999999988899999999999999999999999864211 11111111111100 0 00
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
........+.+++.+||..+|++|||+.+|++.++++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11234457889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=299.99 Aligned_cols=242 Identities=28% Similarity=0.425 Sum_probs=195.0
Q ss_pred cccccCCceEEEEEEEcC--C--cEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLEM--G--IVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|++|.||+|.+.. + ..||+|.+..... ..+.+.+|+..+++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 3699999976544 34678899999999999999999999988 888999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++..... ..+++..+..++.|++.||+|||+.++. ||||||+||+++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~--H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKRFI--HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCCcc--ccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999986431 3689999999999999999999999966 99999999999999999999999987654321
Q ss_pred ----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 474 ----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 474 ----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
...++.+|+|||++.+..++.++||||||+++|||++ |+.||.... ..+...........
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~------~~~~~~~~~~~~~~--------- 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS------GSQILKKIDKEGER--------- 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhcCCc---------
Confidence 1234567999999998899999999999999999999 999996432 12222222211110
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.79 Aligned_cols=246 Identities=24% Similarity=0.373 Sum_probs=192.5
Q ss_pred hcccccCCceEEEEEEEc-CCc----EEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGI----VVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|.+. ++. .+++|.+..... ...++..|+..+++++||||+++++++. ....++++||+
T Consensus 12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~ 90 (279)
T cd05111 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLS 90 (279)
T ss_pred ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeC
Confidence 467999999999999863 344 477887754322 2356778888999999999999999875 45678899999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
++|+|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+||++++++.+||+|||+++......
T Consensus 91 ~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ii--H~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 91 PLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHRMV--HRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCEe--ccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 9999999997532 3589999999999999999999999965 99999999999999999999999997653321
Q ss_pred -----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 -----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 -----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...++..|+|||++.+..++.++||||||+++|||++ |+.||...... ........+....
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~------ 231 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGERLA------ 231 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCcCC------
Confidence 1234457999999998889999999999999999998 99999653211 1112222211110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.+..+...+.+++.+||..+|++|||+.|+++.|..+.+.
T Consensus 232 ----~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 232 ----QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 0011234578889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.45 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=188.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+.. +++.||+|++..... ....+.+|+.+++.++||||+++++++.+....++||||+. ++
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~ 88 (303)
T cd07869 10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD 88 (303)
T ss_pred eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence 567999999999999864 689999999875432 23467789999999999999999999999999999999996 58
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++.... ..++...+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++..... ..
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~iv--H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 162 (303)
T cd07869 89 LCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRYIL--HRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162 (303)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCC
Confidence 888776432 3578889999999999999999999966 9999999999999999999999998754321 22
Q ss_pred CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-------cccc----cc
Q 037905 475 PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE-------EWTA----EV 542 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~----~~ 542 (606)
..++..|+|||++.+ ..++.++|||||||++|||++|+.||....+ ....+...... .+.. ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 163 EVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD-----IQDQLERIFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred CcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc-----HHHHHHHHHHHhCCCChhhccchhhccc
Confidence 345677999999865 4578899999999999999999999975321 11111111100 0000 00
Q ss_pred cchhh---hcccChH------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLEL---LRYQNVE------EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~---~~~~~~~------~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.++.. ....... .....+.+++.+|++.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 0000000 012457789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=315.30 Aligned_cols=232 Identities=25% Similarity=0.304 Sum_probs=184.6
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHH-HHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKME-VVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+.. +|+.||+|++..... ....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999864 689999999875322 1233444444 56789999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
|+|..++... ..+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~giv--H~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (323)
T cd05575 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLNII--YRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153 (323)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--eCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence 9999998753 2588899999999999999999999966 9999999999999999999999998753221
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||... +.......+...... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~------------~ 215 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------DTAEMYDNILNKPLR------------L 215 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC------CHHHHHHHHHcCCCC------------C
Confidence 2234677899999999999999999999999999999999999642 222222322222110 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMA 579 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 579 (606)
.......+.+++.+|++.+|++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111234678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=298.62 Aligned_cols=245 Identities=28% Similarity=0.423 Sum_probs=189.7
Q ss_pred cccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEe-CCceEEEEeecC
Q 037905 323 EVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYS-RDEKLLVHDYMP 395 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~ 395 (606)
+.||+|+||.||+|... .+..||+|++..... ..+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999853 246799998854322 24568889999999999999999998764 456789999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
+++|.+++.... ....+..+..++.|++.||+|||+.+++ ||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKKFV--HRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--ccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999997532 2467788889999999999999999866 99999999999999999999999987543211
Q ss_pred ------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhC-CCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 ------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTG-KAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 ------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
....+..|+|||++....++.++||||||+++|||++| .+||... +.............
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~------~~~~~~~~~~~~~~-------- 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVYLLQGRR-------- 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHhcCCC--------
Confidence 12234569999999888899999999999999999995 5666432 12222222211110
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
...+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00111223568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=297.74 Aligned_cols=241 Identities=27% Similarity=0.427 Sum_probs=194.7
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
+.||+|+||.||+|...++..+|+|.+..... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999999988889999999875432 2346889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TP 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~ 475 (606)
+++.... ..+++..+..++.+++.||.|||+.+++ ||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~~--H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESKNCI--HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--ecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9986432 3478999999999999999999999966 99999999999999999999999986543221 11
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+..|+|||++.+..++.++||||||+++||+++ |..||..... ......+ ....... .+.
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~------~~~~~~~-~~~~~~~----------~~~ 217 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN------QQAREQV-EKGYRMS----------CPQ 217 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHH-HcCCCCC----------CCC
Confidence 22456999999998889999999999999999999 9999964321 1111111 1111110 111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
.....+.+++.+||..+|++||++.++++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=298.85 Aligned_cols=241 Identities=27% Similarity=0.444 Sum_probs=197.3
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||++.+.++..+|+|.++........+.+|++++++++|||++++++++......++||||+++++|.+
T Consensus 9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 88 (256)
T cd05112 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD 88 (256)
T ss_pred EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence 46799999999999998778899999998766677889999999999999999999999998899999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~ 476 (606)
++.... ..+++..+..++.+++.|++|||+.+++ ||||||+||+++.++.+||+|||.++...... ...
T Consensus 89 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~--h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 162 (256)
T cd05112 89 YLRAQR----GKFSQETLLGMCLDVCEGMAYLESSNVI--HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTK 162 (256)
T ss_pred HHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccccccceEEEcCCCeEEECCCcceeecccCcccccCCCc
Confidence 987532 2578999999999999999999999966 99999999999999999999999987543321 112
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+.+|+|||++.+..++.++||||||+++|||++ |+.||.... ....+.... .+... ..+ ..
T Consensus 163 ~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~-~~~~~--~~~--------~~ 225 (256)
T cd05112 163 FPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS------NSEVVETIN-AGFRL--YKP--------RL 225 (256)
T ss_pred cchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC------HHHHHHHHh-CCCCC--CCC--------CC
Confidence 3456999999998889999999999999999998 999986421 112222211 11100 000 11
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
....+.+++.+||+.+|++|||+.+++++|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 235688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.13 Aligned_cols=244 Identities=25% Similarity=0.305 Sum_probs=194.4
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCC--------ceE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRD--------EKL 388 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~ 388 (606)
..+.||+|+||.||+|+. .+|+.||||++.....+ ...+.+|+..+..++|+|++++.+.+...+ ..+
T Consensus 36 i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~ 115 (496)
T PTZ00283 36 ISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA 115 (496)
T ss_pred EEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEE
Confidence 357899999999999984 57899999998765433 345788999999999999999887765332 357
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 389 LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
+||||+++|+|.+++..... ....+++..+..++.|++.||.|||+.+++ ||||||+|||++.++.+||+|||+++.
T Consensus 116 lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~Ii--HrDLKP~NILl~~~~~vkL~DFGls~~ 192 (496)
T PTZ00283 116 LVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKHMI--HRDIKSANILLCSNGLVKLGDFGFSKM 192 (496)
T ss_pred EEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCEe--cCCCCHHHEEEeCCCCEEEEecccCee
Confidence 99999999999999875432 234689999999999999999999999966 999999999999999999999999876
Q ss_pred CCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccc
Q 037905 469 ASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 469 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
.... ....+++.|+|||++.+..++.++|||||||++|||++|+.||... +....+.........
T Consensus 193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~------~~~~~~~~~~~~~~~--- 263 (496)
T PTZ00283 193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE------NMEEVMHKTLAGRYD--- 263 (496)
T ss_pred ccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHhcCCCC---
Confidence 5321 2345678899999999989999999999999999999999999642 222333333222110
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 264 --------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 --------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred --------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0112234568889999999999999999999875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=312.03 Aligned_cols=252 Identities=23% Similarity=0.309 Sum_probs=186.3
Q ss_pred HhcccccCCceEEEEEEE-c-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCC---CCCCcccceEEEEe-----CCce
Q 037905 321 SAEVLGKGTFGTAYKATL-E-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSM---DHENLVPLRAYYYS-----RDEK 387 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~ 387 (606)
..+.||+|+||.||+|+. . ++..||+|+++.... ....+.+|+.+++.+ +||||++++++|.. ....
T Consensus 5 ~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 84 (290)
T cd07862 5 CVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKL 84 (290)
T ss_pred eeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcE
Confidence 356799999999999985 2 468899999865422 234566677666554 79999999999862 3467
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 388 LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~ii--H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 85 TLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVV--HRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred EEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--eCCCCHHHEEEcCCCCEEEccccceE
Confidence 99999997 58999987543 23588999999999999999999999966 99999999999999999999999997
Q ss_pred cCCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-------c
Q 037905 468 LASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE-------E 537 (606)
Q Consensus 468 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~ 537 (606)
..... ....++..|+|||.+.+..++.++|||||||++|||++|++||...... ..+..+... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~------~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV------DQLGKILDVIGLPGEED 232 (290)
T ss_pred eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH------HHHHHHHHHhCCCChhh
Confidence 65432 2234577899999998888999999999999999999999999753221 111111110 0
Q ss_pred cccc------ccchhhh--cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 WTAE------VFDLELL--RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ~~~~------~~d~~~~--~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+... .+..... ...........+.+++.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000 0000000 000001233567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=304.18 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=194.7
Q ss_pred HhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
..+.||+|+||.||+|... .+..||+|.+..... ....+.+|+.++++++|+||+++++++......++|||
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 89 (277)
T cd05036 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLE 89 (277)
T ss_pred eeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEe
Confidence 3567999999999999864 357899998864432 24568999999999999999999999998889999999
Q ss_pred ecCCCChhhhhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC---cEEEeecccCc
Q 037905 393 YMPMGSLSALLHGNRGA--GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY---EARISDFGLAH 467 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~---~~kl~DfG~a~ 467 (606)
|+++++|.+++...... ....+++..+..++.||+.||+|||+++++ ||||||+||+++.++ .+||+|||+++
T Consensus 90 ~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv--H~dlkp~nil~~~~~~~~~~kl~dfg~~~ 167 (277)
T cd05036 90 LMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFI--HRDIAARNCLLTCKGPGRVAKIADFGMAR 167 (277)
T ss_pred cCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe--ecccchheEEEeccCCCcceEeccCcccc
Confidence 99999999999754321 123589999999999999999999999965 999999999998765 59999999998
Q ss_pred cCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 468 LASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 468 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+.....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~~-- 239 (277)
T cd05036 168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN------QEVMEFVTGGGR-- 239 (277)
T ss_pred ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCCc--
Confidence 653221 1122346999999988889999999999999999997 9999964322 122222211110
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
...+...+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 240 ---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 ---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0111223457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=312.96 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=196.2
Q ss_pred HHHhcccccCCceEEEEEEE------cCCcEEEEEEeccCccC--HHHHHHHHHHHcCC-CCCCcccceEEEEeC-CceE
Q 037905 319 RASAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVS--EKEFREKMEVVGSM-DHENLVPLRAYYYSR-DEKL 388 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~ 388 (606)
+...+.||+|+||.||+|.. .+++.||||+++..... ...+.+|+.++.++ +||||++++++|... ...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 45578899999999999963 35789999999754322 34688899999999 689999999988754 4578
Q ss_pred EEEeecCCCChhhhhhcCCCC-----------------------------------------------------------
Q 037905 389 LVHDYMPMGSLSALLHGNRGA----------------------------------------------------------- 409 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------------- 409 (606)
+||||+++|+|.+++......
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 999999999999998643210
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC------CCCCccc
Q 037905 410 ---GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------TPNRIDG 480 (606)
Q Consensus 410 ---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------~~~~~~~ 480 (606)
....+++..+..++.|++.||+|||+++++ ||||||+||++++++.+||+|||+++...... ....+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~--H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASRKCI--HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 246 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcc
Confidence 012367888899999999999999999966 99999999999999999999999987643221 1223456
Q ss_pred ccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHH
Q 037905 481 YRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQ 559 (606)
Q Consensus 481 y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~ 559 (606)
|+|||.+.+..++.++||||||+++|||++ |..||...... .........+.... .+......
T Consensus 247 y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~~~----------~~~~~~~~ 310 (343)
T cd05103 247 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTRMR----------APDYTTPE 310 (343)
T ss_pred eECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCCCC----------CCCCCCHH
Confidence 999999988889999999999999999997 99998642111 11111111111110 00112246
Q ss_pred HHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 560 LLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 560 l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
+.+++.+||+.+|++|||+.+|+++|+.+.+.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 88999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=282.07 Aligned_cols=249 Identities=26% Similarity=0.371 Sum_probs=203.3
Q ss_pred CcCHHHHHHHHhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCC
Q 037905 311 AFDLEDLLRASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRD 385 (606)
Q Consensus 311 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 385 (606)
.+++++.. ..+.||+|-||.||.|+. +++-.||+|++.+... ...++.+|+++-..++||||++++++|.+..
T Consensus 18 ~~~l~dfe--igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 18 TWTLDDFE--IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred ccchhhcc--ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 35555442 367899999999999984 5688999999876543 3567999999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeeccc
Q 037905 386 EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGL 465 (606)
Q Consensus 386 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~ 465 (606)
..|+++||...|.+...++... ...++......++.|+|.|+.|+|.++++ ||||||+|+|++.++..||+|||-
T Consensus 96 riyLilEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~VI--hRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKRVI--HRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCCcc--cCCCCHHHhccCCCCCeeccCCCc
Confidence 9999999999999999998654 23577888888999999999999999966 999999999999999999999997
Q ss_pred CccCC--CCCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 466 AHLAS--PSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 466 a~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
+.... ...+..+|.-|.+||...+..++...|+|++|++.||++.|.+||..... ....+.+.+- +..
T Consensus 171 sV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~------~etYkrI~k~----~~~ 240 (281)
T KOG0580|consen 171 SVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH------SETYKRIRKV----DLK 240 (281)
T ss_pred eeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh------HHHHHHHHHc----ccc
Confidence 65443 23456778889999999999999999999999999999999999976431 1122222221 111
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+| ........+++.+|+..+|.+|.+..|++++
T Consensus 241 ~p--------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 241 FP--------STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred CC--------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 11 2233457788889999999999999999876
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=299.30 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=201.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|... +|+.||+|.++.... ..+.+.+|++++++++|+|++++++++...+..++||||+++
T Consensus 7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (267)
T cd08224 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA 86 (267)
T ss_pred eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence 467999999999999865 789999998864221 245788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++..... ....+++..+..++.+++.||+|||+.|++ ||||+|+||+++.++.++|+|||+++......
T Consensus 87 ~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~--h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 163 (267)
T cd08224 87 GDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKRIM--HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 163 (267)
T ss_pred CCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEe--cCCcChhhEEECCCCcEEEeccceeeeccCCCccc
Confidence 999999865321 234588999999999999999999999966 99999999999999999999999987544321
Q ss_pred -CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 -TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||++.+..++.++||||||+++|+|++|+.||.... .+............. .. ..
T Consensus 164 ~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~-~~---------~~ 229 (267)
T cd08224 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEKCDY-PP---------LP 229 (267)
T ss_pred ceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhcCCC-CC---------CC
Confidence 2345667999999998889999999999999999999999985421 222222222111110 00 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
.......+.+++.+||..+|++|||+.+|++.|+++.
T Consensus 230 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1134457889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=307.64 Aligned_cols=258 Identities=23% Similarity=0.379 Sum_probs=200.5
Q ss_pred HHHHHHHhcccccCCceEEEEEEEc--------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEe
Q 037905 315 EDLLRASAEVLGKGTFGTAYKATLE--------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYS 383 (606)
Q Consensus 315 ~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 383 (606)
..-.+...+.||+|+||.||+++.. ....+|+|.++.... ....+.+|+++++++ +||||++++++|..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3334445688999999999999742 246799999875432 234678899999999 69999999999998
Q ss_pred CCceEEEEeecCCCChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe
Q 037905 384 RDEKLLVHDYMPMGSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL 452 (606)
Q Consensus 384 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill 452 (606)
....++||||+++|+|.+++..... .....+++..+..++.|++.||+|||++|++ ||||||+||++
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~--H~dlkp~Nill 167 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI--HRDLAARNVLV 167 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCee--eccccceeEEE
Confidence 8889999999999999999975321 1123588999999999999999999999966 99999999999
Q ss_pred cCCCcEEEeecccCccCCCCCC------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCC
Q 037905 453 SKSYEARISDFGLAHLASPSST------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD 525 (606)
Q Consensus 453 ~~~~~~kl~DfG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~ 525 (606)
+.++.+||+|||.++....... ...+..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~------ 241 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP------ 241 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC------
Confidence 9999999999999976543211 112246999999988889999999999999999999 888885421
Q ss_pred hhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 526 LPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
........ ...... ..+.....++.+++.+||..+|++|||+.++++.|+++...
T Consensus 242 ~~~~~~~~-~~~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 242 VEELFKLL-REGHRM----------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHHHHHH-HcCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11112211 111111 11122345678899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=301.84 Aligned_cols=244 Identities=23% Similarity=0.467 Sum_probs=196.0
Q ss_pred hcccccCCceEEEEEEEc-CC---cEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MG---IVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|... ++ ..+|+|.++.... ..+.+.+|++++++++|+|++++.+++...+..++||||++
T Consensus 10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (268)
T cd05063 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME 89 (268)
T ss_pred eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence 578999999999999864 23 3799999865432 24568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST- 474 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 474 (606)
+++|.+++.... ..+++..+..++.|++.|++|||+.++. ||||||+||+++.++.+||+|||+++.......
T Consensus 90 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~i~--H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 90 NGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMNYV--HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 999999997532 3589999999999999999999999966 999999999999999999999999875543211
Q ss_pred ------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 475 ------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 475 ------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...+..|+|||++....++.++||||||+++|||++ |+.||..... ......+.. ..
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~-~~--------- 227 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAIND-GF--------- 227 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhc-CC---------
Confidence 112235999999988889999999999999999998 9999964321 122222211 11
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
..+........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 228 -~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 -RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111122345688999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=320.71 Aligned_cols=241 Identities=24% Similarity=0.353 Sum_probs=194.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +++.||+|+++... .....+.+|++++..++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (350)
T cd05573 6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG 85 (350)
T ss_pred EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence 467999999999999864 68999999997542 2345688899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++... ..+++..+..++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~gii--H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 86 GDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLGFI--HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 9999999754 3588999999999999999999999966 99999999999999999999999987654322
Q ss_pred ------------------------------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC
Q 037905 474 ------------------------------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG 523 (606)
Q Consensus 474 ------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~ 523 (606)
...++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~---- 234 (350)
T cd05573 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT---- 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC----
Confidence 2346778999999999999999999999999999999999996532
Q ss_pred CChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCC-HHHHHHH
Q 037905 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS-MAEVTSQ 584 (606)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~~v~~~ 584 (606)
.......+.... ... ..+........+.+++.+|+. +|++||+ +++++++
T Consensus 235 --~~~~~~~i~~~~--~~~------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 --LQETYNKIINWK--ESL------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred --HHHHHHHHhccC--Ccc------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 111122221100 000 000001134567888889997 9999999 9999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.77 Aligned_cols=242 Identities=21% Similarity=0.269 Sum_probs=189.8
Q ss_pred hcccccCCceEEEEEEE----cCCcEEEEEEeccCcc-----CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTV-----SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 391 (606)
.+.||+|+||.||+++. .++..||+|++..... ..+.+..|++++..+ +|+||+++++++...+..++||
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (332)
T cd05614 5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL 84 (332)
T ss_pred EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence 56799999999999874 3588999999865321 234577899999999 5999999999999889999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+++|+|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++....
T Consensus 85 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~iv--HrDlkp~Nili~~~~~~kl~DfG~~~~~~~ 157 (332)
T cd05614 85 DYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLGIV--YRDIKLENILLDSEGHVVLTDFGLSKEFLS 157 (332)
T ss_pred eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcE--ecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence 999999999998743 2588999999999999999999999966 999999999999999999999999876432
Q ss_pred C-----CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 472 S-----STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 472 ~-----~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
. ....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ........+.... +
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~-------~ 228 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN--TQSEVSRRILKCD-------P 228 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC--CHHHHHHHHhcCC-------C
Confidence 2 123567889999999865 47889999999999999999999996432111 1111111111110 0
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
..+......+.+++.+||+.||++|| ++++++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 229 -----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01112234578889999999999999 77788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.82 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=192.9
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
...+.||+|+||.||+|+. .+++.||+|++..... ....+.+|+.++++++||||+++++++......++||||++++
T Consensus 12 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~ 91 (267)
T cd06646 12 ELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGG 91 (267)
T ss_pred chhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCC
Confidence 3457799999999999985 5689999999875432 3456788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|.+++... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.++|+|||+++..... .
T Consensus 92 ~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 92 SLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKGKM--HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 999998743 2578999999999999999999999966 9999999999999999999999998765432 1
Q ss_pred CCCCcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 474 TPNRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
...++..|+|||.+. ...++.++||||||+++|||++|+.||......... .......... + ..
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~~----~---~~ 231 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMSKSNFQP----P---KL 231 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh------eeeecCCCCC----C---CC
Confidence 234566799999874 345788999999999999999999998643211100 0000000000 0 00
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.........+.+++.+||..+|++|||+++|+++|
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 232 KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11122345788999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=303.67 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=186.2
Q ss_pred ccccCCceEEEEEEEcC---CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 324 VLGKGTFGTAYKATLEM---GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.||+|+||.||+|+... ...+|+|.+..... ....+.+|++.++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 45788887764332 23467889999999999999999999999899999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC------
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS------ 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------ 472 (606)
|.+++...........++.....++.||+.||+|||+.+++ ||||||+|||+++++.+||+|||+++.....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI--HSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEe--cccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 99999765432233456788899999999999999999966 9999999999999999999999998653221
Q ss_pred CCCCCcccccCccccCC-------CCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 STPNRIDGYRAPEVTDA-------RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~-------~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
.....+..|+|||++.. ..++.++||||||+++|||++ |..||....+. .....+..... ....+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~-~~~~~ 232 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQD-IKLPK 232 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccC-ccCCC
Confidence 11223456999998642 356889999999999999999 78888643211 11222222111 11111
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
+ .........+.+++..|| .||++|||+++|++.|.
T Consensus 233 ~-----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 233 P-----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred C-----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1 111223455677888999 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.52 Aligned_cols=189 Identities=25% Similarity=0.366 Sum_probs=165.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++... +++.||+|++..... ....+.+|+.++.+++|+||+++++.+.+....++||||+++
T Consensus 6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (363)
T cd05628 6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG 85 (363)
T ss_pred eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence 467999999999999854 689999999975322 224578899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
|+|.+++... ..+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~giv--HrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 86 GDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLGFI--HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCeE--ecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 9999999753 2588999999999999999999999966 9999999999999999999999998653211
Q ss_pred -----------------------------------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 473 -----------------------------------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 473 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
....+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 123467889999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=318.59 Aligned_cols=192 Identities=30% Similarity=0.435 Sum_probs=169.1
Q ss_pred HHhcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHHHHHHHHHHcCCC-C-----CCcccceEEEEeCCceEEEEe
Q 037905 320 ASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-H-----ENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~lv~e 392 (606)
...++||+|+||.|-+|. ..+++.||||++++...-..+-..|+.+|..|+ | -|+|+++++|...++.|||+|
T Consensus 189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE 268 (586)
T KOG0667|consen 189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE 268 (586)
T ss_pred EEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence 446789999999999997 567999999999987666667778899998886 3 589999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC--cEEEeecccCccCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY--EARISDFGLAHLAS 470 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~--~~kl~DfG~a~~~~ 470 (606)
.+.. +|+++++.+. +..++...++.++.||+.||.+||+.+++ |+||||+||||.+.+ .+||+|||+|....
T Consensus 269 LL~~-NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l~II--HcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 269 LLST-NLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHELGII--HCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred hhhh-hHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--eccCChhheeeccCCcCceeEEecccccccC
Confidence 9966 9999999775 56699999999999999999999999966 999999999997543 69999999998766
Q ss_pred CC-CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 471 PS-STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 471 ~~-~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
.. .++..+..|+|||++.+..|+.+.||||||||+.||++|.+.|.+
T Consensus 343 q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 343 QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 53 345566679999999999999999999999999999999988876
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=304.21 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=196.3
Q ss_pred HHhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 391 (606)
...+.||+|+||.||+|... .+..||+|.+..... ....+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 88 (277)
T cd05032 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM 88 (277)
T ss_pred eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEE
Confidence 34578999999999999753 247899999875432 2356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 392 DYMPMGSLSALLHGNRGA-----GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
||+++++|.+++...... ....+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||++
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~di~p~nill~~~~~~kl~dfg~~ 166 (277)
T cd05032 89 ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFV--HRDLAARNCMVAEDLTVKIGDFGMT 166 (277)
T ss_pred ecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc--ccccChheEEEcCCCCEEECCcccc
Confidence 999999999998753211 122478899999999999999999999966 9999999999999999999999998
Q ss_pred ccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 467 HLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 467 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
+...... ...++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ........ ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~~-~~~~ 239 (277)
T cd05032 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN------EEVLKFVI-DGGH 239 (277)
T ss_pred hhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH------HHHHHHHh-cCCC
Confidence 7543321 2233567999999988889999999999999999998 9999864221 11111111 1111
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
. ..+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 240 ~----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 240 L----------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1 111223567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.92 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=187.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. .+++.||+|++..... ....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~g 85 (381)
T cd05626 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (381)
T ss_pred EEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 46799999999999985 4689999999975432 234578899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC-----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----- 471 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----- 471 (606)
|+|.+++.... .+++..+..++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||+++....
T Consensus 86 g~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~giv--HrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~ 158 (381)
T cd05626 86 GDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMGFI--HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158 (381)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCee--ecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence 99999987532 478889999999999999999999966 999999999999999999999998753210
Q ss_pred ----------------------------------------------CCCCCCcccccCccccCCCCCCCcchhHHHHHHH
Q 037905 472 ----------------------------------------------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLL 505 (606)
Q Consensus 472 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl 505 (606)
.....+|..|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il 238 (381)
T cd05626 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238 (381)
T ss_pred cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence 0123467789999999988999999999999999
Q ss_pred HHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHH--ccCcCCCCCCCHHHHHH
Q 037905 506 LELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAIN--CTAQYPDNRPSMAEVTS 583 (606)
Q Consensus 506 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~--Cl~~~P~~RPs~~~v~~ 583 (606)
|||++|+.||...... .....+........ .+.......++.+++.+ |+..+|..||++.++++
T Consensus 239 ~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~--------~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 239 FEMLVGQPPFLAPTPT------ETQLKVINWENTLH--------IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHhCCCCCcCCCHH------HHHHHHHccccccC--------CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999653211 11111111100000 00001122345566655 66777778999999988
Q ss_pred H
Q 037905 584 Q 584 (606)
Q Consensus 584 ~ 584 (606)
+
T Consensus 305 h 305 (381)
T cd05626 305 H 305 (381)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=305.26 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=193.2
Q ss_pred HhcccccCCceEEEEEEE-----cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 392 (606)
..+.||+|+||.||++.. .++..||+|+++.... ..+.+.+|++++++++||||+++++++... ...++|||
T Consensus 8 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 87 (284)
T cd05081 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVME 87 (284)
T ss_pred eeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEE
Confidence 357799999999999974 3578999999875433 245788999999999999999999987643 46789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.|++ ||||||+||++++++.+||+|||+++.....
T Consensus 88 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~i~--H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 88 YLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKRYV--HRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred ecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCCce--eccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 999999999997532 3589999999999999999999999966 9999999999999999999999999865432
Q ss_pred CCC-------CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC----C-----CChhHHHHHHhhc
Q 037905 473 STP-------NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE----G-----VDLPRWVQSVVKE 536 (606)
Q Consensus 473 ~~~-------~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~----~-----~~~~~~~~~~~~~ 536 (606)
... .....|+|||++.+..++.++||||||+++|||++|..++....... + .............
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence 211 12234999999988889999999999999999999877654321100 0 0000000011111
Q ss_pred cccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 537 EWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 537 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.. ...........+.+++.+||..+|++|||+.+|++.|+.+
T Consensus 242 ~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 242 NG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CC----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 0011122345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=306.93 Aligned_cols=254 Identities=22% Similarity=0.340 Sum_probs=195.3
Q ss_pred HhcccccCCceEEEEEEEcC-----------------CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEE
Q 037905 321 SAEVLGKGTFGTAYKATLEM-----------------GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYY 381 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~ 381 (606)
..+.||+|+||.||+|+... +..||+|++..... ..+.+.+|++++++++||||++++++|
T Consensus 9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 88 (296)
T cd05051 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVC 88 (296)
T ss_pred ccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 45789999999999987532 25689999875432 345788999999999999999999999
Q ss_pred EeCCceEEEEeecCCCChhhhhhcCCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC
Q 037905 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAG------RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS 455 (606)
Q Consensus 382 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~ 455 (606)
..+...+++|||+.+++|.+++....... ...+++..+..++.|++.||+|||+.+++ ||||||+||+++.+
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~--H~dlkp~Nili~~~ 166 (296)
T cd05051 89 TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV--HRDLATRNCLVGKN 166 (296)
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc--ccccchhceeecCC
Confidence 99899999999999999999997643211 22689999999999999999999999966 99999999999999
Q ss_pred CcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCcccccccCCCChh
Q 037905 456 YEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT--GKAPTQALLNEEGVDLP 527 (606)
Q Consensus 456 ~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt--g~~p~~~~~~~~~~~~~ 527 (606)
+.++|+|||+++...... ....+..|+|||++.+..++.++||||||+++|||++ |..||...... ...
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~---~~~ 243 (296)
T cd05051 167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ---QVI 243 (296)
T ss_pred CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH---HHH
Confidence 999999999987543221 2233557999999988889999999999999999998 67777542211 111
Q ss_pred HHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 528 RWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 528 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
............... ...+...+.++.+++.+||+.+|++|||+.+|++.|+
T Consensus 244 ~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 244 ENAGHFFRDDGRQIY-------LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHhcccccccccc-------CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111000000 0111223457899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=310.38 Aligned_cols=263 Identities=23% Similarity=0.364 Sum_probs=204.3
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEEEc--------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEE
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKATLE--------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAY 380 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~ 380 (606)
+.+....+...+.||+|+||.||+|+.. .+..||+|.++.... ..+++.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3344444556788999999999999742 124789998875432 235788999999999 89999999999
Q ss_pred EEeCCceEEEEeecCCCChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCC
Q 037905 381 YYSRDEKLLVHDYMPMGSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSN 449 (606)
Q Consensus 381 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~N 449 (606)
|......++++||+++|+|.+++..... .....+++..+..++.|++.||+|||+++++ ||||||+|
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~giv--H~dlkp~N 164 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI--HRDLAARN 164 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCee--ccccccce
Confidence 9988899999999999999999875321 1223588999999999999999999999966 99999999
Q ss_pred EEecCCCcEEEeecccCccCCCCCC------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccC
Q 037905 450 ILLSKSYEARISDFGLAHLASPSST------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522 (606)
Q Consensus 450 ill~~~~~~kl~DfG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~ 522 (606)
|+++.++.+||+|||+++....... ...+..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---- 240 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI---- 240 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC----
Confidence 9999999999999999876543211 122345999999999899999999999999999998 88888642
Q ss_pred CCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 523 GVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
+.......+.. .... ..+......+.+++.+||+.+|++|||+.++++.|+++...+.
T Consensus 241 --~~~~~~~~~~~-~~~~----------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 241 --PVEELFKLLKE-GHRM----------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred --CHHHHHHHHHc-CCCC----------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 22222222211 1111 1112234568899999999999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=306.41 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=197.2
Q ss_pred HHHhcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEE
Q 037905 319 RASAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 389 (606)
+...+.||+|+||.||+++. ..+..||+|+++.... ..+.+.+|+++++++ +|+||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 34467899999999999974 2356899999875432 235688999999999 79999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||||+.+++|.++++... ...+++..+..++.|++.||+|||+++++ |+||||+||+++.++.++++|||+++..
T Consensus 117 v~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~iv--H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKNCI--HRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--hhhhccceEEEcCCCeEEECCCcccccc
Confidence 999999999999997533 12389999999999999999999999966 9999999999999999999999998765
Q ss_pred CCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccc
Q 037905 470 SPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 470 ~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
.... ...++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...........+..
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~-- 263 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV------DSKFYKLIKEGYRM-- 263 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc------hHHHHHHHHcCCcC--
Confidence 4322 1223456999999988889999999999999999998 9999864321 11111111111110
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
..+......+.+++.+||..+|++|||+.|+++.|+++
T Consensus 264 --------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 --------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=320.54 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=190.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +++.||||++..... ....+.+|++++..++||||+++++++.+....++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (364)
T cd05599 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG 85 (364)
T ss_pred EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence 467999999999999864 689999999975321 234578899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|+|.+++... ..+++..+..++.|++.||+|||+.+++ ||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~iv--H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 86 GDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLGYI--HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred cHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--eccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 9999998753 2589999999999999999999999966 99999999999999999999999986432110
Q ss_pred ---------------------------------------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 037905 474 ---------------------------------------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514 (606)
Q Consensus 474 ---------------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p 514 (606)
...+|+.|+|||++....++.++|||||||++|||++|+.|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P 238 (364)
T cd05599 159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238 (364)
T ss_pred ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence 12467889999999999999999999999999999999999
Q ss_pred cccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHH
Q 037905 515 TQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS---MAEVTSQ 584 (606)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~~v~~~ 584 (606)
|.... .......+......... +........+.+++.+|+. +|.+|++ +.+++++
T Consensus 239 f~~~~------~~~~~~~i~~~~~~~~~--------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 239 FCSDN------PQETYRKIINWKETLQF--------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCC------HHHHHHHHHcCCCccCC--------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 96432 11112222211100000 0000123456777888886 8999998 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=303.22 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=195.8
Q ss_pred HHHhcccccCCceEEEEEEE-----cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEE
Q 037905 319 RASAEVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLL 389 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l 389 (606)
++..+.||+|+||.||+++. .++..||+|.++.... ....+.+|++++++++|||++++.+++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 34567899999999999974 3578999999875432 235788999999999999999999998765 56789
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++ ||||||+||+++.++.++|+|||+++..
T Consensus 86 v~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~gi~--H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQYV--HRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ecccchheEEEcCCCCEEECCCcccccc
Confidence 999999999999986432 3589999999999999999999999966 9999999999999999999999998765
Q ss_pred CCCC-------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC--------C-CChhHHHHHH
Q 037905 470 SPSS-------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE--------G-VDLPRWVQSV 533 (606)
Q Consensus 470 ~~~~-------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~--------~-~~~~~~~~~~ 533 (606)
.... ...++..|+|||++.+..++.++||||||+++|||++++.|........ . ......+. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 238 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-V 238 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-H
Confidence 4321 1223445999999988889999999999999999999877653211100 0 00111111 1
Q ss_pred hhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 534 VKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 534 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
...+. ..+.....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 239 ~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK----------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc----------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11110 0111122456789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=297.02 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=196.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|... +++.|++|.+.... .....+.+|++++++++|||++++++++......++||||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08529 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENG 84 (256)
T ss_pred eEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCC
Confidence 467999999999999864 68999999986532 23456889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++.... ...+++..+..++.+++.||.|||+.++. |+||||+||+++.++.++|+|||+++......
T Consensus 85 ~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~i~--h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 85 DLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKKIL--HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 9999998642 23688999999999999999999999966 99999999999999999999999987654422
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||+.....++.++||||||+++|||++|+.||..... ......+.... .. ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~----------~~~ 222 (256)
T cd08529 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIRGV-FP----------PVS 222 (256)
T ss_pred ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCC-CC----------CCc
Confidence 22455679999999988899999999999999999999999964321 11111111111 10 111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1334578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=302.14 Aligned_cols=247 Identities=23% Similarity=0.402 Sum_probs=195.5
Q ss_pred hcccccCCceEEEEEEE-cCCc----EEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL-EMGI----VVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.++||+|+||.||+|++ .++. .||+|+++.... ...++.+|+.++..++|+||+++++++.. ...++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~ 90 (279)
T cd05109 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM 90 (279)
T ss_pred eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence 46799999999999985 3444 489999865432 24568899999999999999999999875 4578999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST 474 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 474 (606)
++|+|.+++.... ..+++..++.++.|++.||+|||+.+++ ||||||+|||+++++.+||+|||+++.......
T Consensus 91 ~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~ii--H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 91 PYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVRLV--HRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred CCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 9999999997532 3589999999999999999999999966 999999999999999999999999976543211
Q ss_pred ------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 475 ------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 475 ------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...+..|+|||...+..++.++||||||+++|||++ |..||...... .+.. .+......
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~------- 230 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPD----LLEKGERL------- 230 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHCCCcC-------
Confidence 122356999999998899999999999999999998 89998643211 1111 11111100
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.........+.+++.+||..||++||++.++++.|+++.+..
T Consensus 231 ---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 231 ---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 111223456889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.74 Aligned_cols=244 Identities=20% Similarity=0.357 Sum_probs=191.7
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeC------CceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSR------DEKLLVH 391 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~~~~lv~ 391 (606)
...+.||+|+||.||+|.. .+++.||+|++.........+.+|+.++.++ +|+|++++++++... ...++||
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 88 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 88 (272)
T ss_pred hHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEE
Confidence 3456799999999999985 4688999999976665667889999999988 799999999998753 4578999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+++++ ||||||+||++++++.++|+|||+++....
T Consensus 89 e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~iv--h~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 89 EFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHKVI--HRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCc--cCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 9999999999987532 23588999999999999999999999966 999999999999999999999999875433
Q ss_pred C----CCCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccc
Q 037905 472 S----STPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 472 ~----~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
. ....++..|+|||++. ...++.++|||||||++|||++|+.||...... ... ...... .....
T Consensus 164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~-~~~~~~-~~~~~ 236 (272)
T cd06637 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RAL-FLIPRN-PAPRL 236 (272)
T ss_pred ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHH-HHHhcC-CCCCC
Confidence 2 2234567799999986 345788999999999999999999999643211 010 000010 00000
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||..+|.+|||+.+++++
T Consensus 237 ---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 237 ---------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 011233568899999999999999999999764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=303.28 Aligned_cols=246 Identities=23% Similarity=0.382 Sum_probs=194.8
Q ss_pred hcccccCCceEEEEEEE------cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||++.. .++..+|+|.+..... ....+.+|+++++.++|+||+++++++......+++|||+
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 89 (280)
T cd05092 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89 (280)
T ss_pred ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence 57899999999999963 2467899998875432 3457999999999999999999999999888999999999
Q ss_pred CCCChhhhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecc
Q 037905 395 PMGSLSALLHGNRG----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464 (606)
Q Consensus 395 ~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG 464 (606)
++++|.+++..... .....+++..+..++.|++.|++|||+.+++ ||||||+|||+++++.+||+|||
T Consensus 90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~--H~dlkp~nil~~~~~~~kL~dfg 167 (280)
T cd05092 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFV--HRDLATRNCLVGQGLVVKIGDFG 167 (280)
T ss_pred CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCee--cccccHhhEEEcCCCCEEECCCC
Confidence 99999999875321 1113588999999999999999999999966 99999999999999999999999
Q ss_pred cCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcc
Q 037905 465 LAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEE 537 (606)
Q Consensus 465 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (606)
+++...... ....+..|+|||++.+..++.++|||||||++|||++ |+.||..... ...+.......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~ 241 (280)
T cd05092 168 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------TEAIECITQGR 241 (280)
T ss_pred ceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH------HHHHHHHHcCc
Confidence 987543211 1223456999999998899999999999999999998 8999864321 11122121111
Q ss_pred ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 538 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
. . ..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 242 ~-~----------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 242 E-L----------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred c-C----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0 0 011123356889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=318.14 Aligned_cols=243 Identities=23% Similarity=0.310 Sum_probs=192.4
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
...+.||+|+||.||+++.. ++..||+|++.... .....+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 46 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~ 125 (370)
T cd05596 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYM 125 (370)
T ss_pred EEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCC
Confidence 34578999999999999854 68999999986432 12345778999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++|+|.+++... .++...+..++.|++.||+|||+.+++ ||||||+|||++.++.+||+|||+++.....
T Consensus 126 ~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~iv--HrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~ 197 (370)
T cd05596 126 PGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMGFI--HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM 197 (370)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999998642 377888899999999999999999966 9999999999999999999999998765432
Q ss_pred ---CCCCCcccccCccccCCC----CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 ---STPNRIDGYRAPEVTDAR----KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~----~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....+++.|+|||++.+. .++.++|||||||++|||++|+.||... +.......+........
T Consensus 198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~~~---- 267 (370)
T cd05596 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD------SLVGTYSKIMDHKNSLT---- 267 (370)
T ss_pred ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC------CHHHHHHHHHcCCCcCC----
Confidence 234577889999998653 4789999999999999999999999642 22222233322111000
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDN--RPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~v~~~ 584 (606)
.+........+.+++.+|+..+|++ |||+.+++++
T Consensus 268 ----~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 ----FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1111123356778888999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=301.68 Aligned_cols=254 Identities=23% Similarity=0.365 Sum_probs=197.7
Q ss_pred HHhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 391 (606)
...+.||+|+||.||+|... .+..||+|.+..... ....+.+|+..++.++||||+++++++......++||
T Consensus 9 ~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 88 (288)
T cd05061 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVM 88 (288)
T ss_pred eeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 34578999999999999643 245899998865432 2345788999999999999999999999888999999
Q ss_pred eecCCCChhhhhhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 392 DYMPMGSLSALLHGNRG-----AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
||+++|+|.+++..... .......+..+..++.|++.||+|||++++. ||||||+||++++++.++|+|||++
T Consensus 89 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~--H~dikp~nili~~~~~~~L~Dfg~~ 166 (288)
T cd05061 89 ELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFV--HRDLAARNCMVAHDFTVKIGDFGMT 166 (288)
T ss_pred eCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCc--CCCCChheEEEcCCCcEEECcCCcc
Confidence 99999999999975321 1123457788899999999999999999966 9999999999999999999999998
Q ss_pred ccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 467 HLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 467 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
+...... ....+..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~~~~ 240 (288)
T cd05061 167 RDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLKFVMDGGYL 240 (288)
T ss_pred ccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCC
Confidence 7543321 1122456999999998889999999999999999999 7888864321 1222222111110
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
. .+......+.+++.+||+.+|++|||+.++++.|++.....
T Consensus 241 ~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 241 D-----------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred C-----------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 0 11122357889999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.64 Aligned_cols=238 Identities=22% Similarity=0.272 Sum_probs=187.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCC-CcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHE-NLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. +++.||+|+++... ...+.+..|.+++..++|+ +|+++.+++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (324)
T cd05587 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (324)
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCC
Confidence 467999999999999854 57899999997532 2234577888898888765 57788888888899999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+|+|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~iv--H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 85 GGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKGII--YRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT 157 (324)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--ecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence 99999998743 2578999999999999999999999966 9999999999999999999999998643221
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~i~~~~~------------~ 219 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED------EDELFQSIMEHNV------------S 219 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCC------------C
Confidence 22346788999999999999999999999999999999999996432 1122222221110 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSM-----AEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~~v~~~ 584 (606)
.+......+.+++.+||..+|++||+. +++.++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011123467888999999999999986 566544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=293.72 Aligned_cols=257 Identities=22% Similarity=0.323 Sum_probs=196.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCC-cccceEEEEeCC------ceEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHEN-LVPLRAYYYSRD------EKLLV 390 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~~~lv 390 (606)
.++||+|+||+||+|+. .+|+.||+|++..... ......+|+.++++++|+| |+++.+++.... ..++|
T Consensus 16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 45699999999999984 5789999999976544 2455789999999999999 999999998876 77899
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
+||++. +|..++....... ..++...+..++.||+.||+|||+++|. ||||||.||||+++|.+||+|||+|+...
T Consensus 96 fe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~Il--HRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 96 FEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGIL--HRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred EEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCee--cccCCcceEEECCCCcEeeeccchHHHhc
Confidence 999976 9999998754221 3467788999999999999999999966 99999999999999999999999998665
Q ss_pred CCC----CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh-------ccc
Q 037905 471 PSS----TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK-------EEW 538 (606)
Q Consensus 471 ~~~----~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~ 538 (606)
-+. ....|..|+|||++.+. .|+...||||+||++.||+++++-|.+..+. +....+++ +.|
T Consensus 172 ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~------~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 172 IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI------DQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH------HHHHHHHHHcCCCCccCC
Confidence 322 23455669999998876 7899999999999999999999999764431 11222111 111
Q ss_pred cccc----cchhhhccc---ChHH-H---HHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHH
Q 037905 539 TAEV----FDLELLRYQ---NVEE-E---MVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEI 588 (606)
Q Consensus 539 ~~~~----~d~~~~~~~---~~~~-~---~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i 588 (606)
.... .++...... .... . .....+++..|++.+|.+|.|++..+.+ +.++
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1110 010111111 0111 1 1367888999999999999999999887 4443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=295.74 Aligned_cols=250 Identities=23% Similarity=0.308 Sum_probs=204.9
Q ss_pred HhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeC-CceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSR-DEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 391 (606)
....+-+|.||.||.|-|. +.+.|-||.++.... .-..+..|--++..+.|||+.++.+.+..+ +..++++
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 3456889999999999543 446677888775422 334577888888899999999999998754 5678999
Q ss_pred eecCCCChhhhhhcCCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 392 DYMPMGSLSALLHGNRG---AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
.++..|+|..++...++ ...+.+...+.+.++.|++.|++|||.++++ |.||.++|++||+...+||+|=.++|.
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~Vi--HkDiAaRNCvIdd~LqVkltDsaLSRD 445 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVI--HKDIAARNCVIDDQLQVKLTDSALSRD 445 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcc--cchhhhhcceehhheeEEeccchhccc
Confidence 99999999999984432 2344577788899999999999999999966 999999999999999999999999987
Q ss_pred CCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 469 ASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 469 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
..+.. ..++...||+||.+....|+.++|||||||++|||+| |+.||....+.+ ++..+.+++.
T Consensus 446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE-------m~~ylkdGyR-- 516 (563)
T KOG1024|consen 446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE-------MEHYLKDGYR-- 516 (563)
T ss_pred cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-------HHHHHhccce--
Confidence 76532 3345566999999999999999999999999999999 999997654332 4555555542
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
..++-+|+.+++.+|..||...|++||+++|++..|.+..
T Consensus 517 --------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 517 --------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred --------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 2345678889999999999999999999999999999864
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=305.39 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=195.4
Q ss_pred HHhcccccCCceEEEEEEEc-----------------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEE
Q 037905 320 ASAEVLGKGTFGTAYKATLE-----------------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAY 380 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~ 380 (606)
...+.||+|+||.||++... ++..||+|+++.... ....+.+|++++++++|+||++++++
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~ 87 (296)
T cd05095 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAV 87 (296)
T ss_pred eeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 34567999999999998532 245799999875432 24578999999999999999999999
Q ss_pred EEeCCceEEEEeecCCCChhhhhhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC
Q 037905 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGA------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK 454 (606)
Q Consensus 381 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~ 454 (606)
+...+..++||||+++++|.+++...... ....+++..+..++.|++.||+|||+.+++ ||||||+||+++.
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~--H~dlkp~Nili~~ 165 (296)
T cd05095 88 CITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV--HRDLATRNCLVGK 165 (296)
T ss_pred EecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCee--cccCChheEEEcC
Confidence 99999999999999999999998754311 122478889999999999999999999966 9999999999999
Q ss_pred CCcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCcccccccCCCCh
Q 037905 455 SYEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT--GKAPTQALLNEEGVDL 526 (606)
Q Consensus 455 ~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt--g~~p~~~~~~~~~~~~ 526 (606)
++.++|+|||+++...... ....+..|+|||......++.++|||||||++|||++ |..||......+ .
T Consensus 166 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~---~ 242 (296)
T cd05095 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ---V 242 (296)
T ss_pred CCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH---H
Confidence 9999999999987653321 1122356999999888889999999999999999998 778886432211 1
Q ss_pred hHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 527 PRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 527 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
................ .+.+..++..+.+++.+||+.+|++||++.+|.+.|++
T Consensus 243 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IENTGEFFRDQGRQVY-------LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHHhhcccccc-------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111100000 01112234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=301.88 Aligned_cols=242 Identities=23% Similarity=0.382 Sum_probs=191.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|.. .++..||+|++..... ..+.+.+|++++++++||||+++++++......++||||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 85 (279)
T cd06619 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGS 85 (279)
T ss_pred eeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCC
Confidence 46799999999999984 5689999999865422 23568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--CCCC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--STPN 476 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~ 476 (606)
|..+. .+++..+..++.|++.||+|||+.+++ |+||||+||+++.++.++|+|||++...... ....
T Consensus 86 l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (279)
T cd06619 86 LDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKIL--HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV 154 (279)
T ss_pred hHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEe--eCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence 86542 367888899999999999999999966 9999999999999999999999998755432 2345
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCCh-hHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDL-PRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||++.+..++.++||||||+++|+|++|+.||........... ........... . +.. ....
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~-----~~~----~~~~ 224 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-P-----PVL----PVGQ 224 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-C-----CCC----CCCc
Confidence 67789999999998999999999999999999999999975332221111 11111111110 0 000 0011
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...++.+++.+||+.+|++||++++++++
T Consensus 225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 225 FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 23457889999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=312.94 Aligned_cols=234 Identities=24% Similarity=0.279 Sum_probs=184.2
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHH-HHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKM-EVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+.. +++.||+|++..... ....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999864 578899999875322 122344443 456788999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
++|.+++.... .+....+..++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~gii--HrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~ 153 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLNIV--YRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT 153 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeE--ecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence 99999997532 477888889999999999999999966 999999999999999999999999875422 1
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~------------~~ 215 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN------TAEMYDNILNKPL------------QL 215 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC------HHHHHHHHHhCCc------------CC
Confidence 23457788999999999999999999999999999999999996422 2222222222110 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEV 581 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v 581 (606)
.......+.+++.+|++.+|.+||++.+.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 11223457788889999999999998743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=303.68 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=195.9
Q ss_pred HhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
..+.||+|+||.||+|... ++..||+|+++.... ..+++.+|+.++++++||||+++++++..+...++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (288)
T cd05050 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFE 88 (288)
T ss_pred ecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEe
Confidence 3567999999999999853 468899999875432 24568899999999999999999999998889999999
Q ss_pred ecCCCChhhhhhcCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC
Q 037905 393 YMPMGSLSALLHGNRG-----------------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS 455 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~ 455 (606)
|+++++|.+++..... .....+++..++.++.|++.||+|||+.+++ ||||||+||+++.+
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~--H~dl~p~nil~~~~ 166 (288)
T cd05050 89 YMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV--HRDLATRNCLVGEN 166 (288)
T ss_pred cCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCee--cccccHhheEecCC
Confidence 9999999999974321 1123478889999999999999999999966 99999999999999
Q ss_pred CcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhH
Q 037905 456 YEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 456 ~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~ 528 (606)
+.++|+|||.++...... ....+..|+|||.+.+..++.++|||||||++|||++ |..||.... ...
T Consensus 167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~------~~~ 240 (288)
T cd05050 167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA------HEE 240 (288)
T ss_pred CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------HHH
Confidence 999999999987543221 1223446999999988899999999999999999998 888885422 122
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
....+.... .. ..+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 ~~~~~~~~~-~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 VIYYVRDGN-VL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHhcCC-CC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 222221111 10 0112234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.94 Aligned_cols=232 Identities=25% Similarity=0.314 Sum_probs=183.7
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHH-HHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKM-EVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
++||+|+||.||+|+.. +++.||+|++..... ....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999864 689999999875322 123344554 467889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|..++... ..++...+..++.||+.||+|||+.+++ ||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~iv--H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 153 (321)
T cd05603 81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLNII--YRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT 153 (321)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--eccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence 9999888643 2578888999999999999999999966 9999999999999999999999998753221
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||... +.......+..... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~------------~~ 215 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR------DVSQMYDNILHKPL------------QL 215 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC------CHHHHHHHHhcCCC------------CC
Confidence 2234677899999999889999999999999999999999999642 22222222222110 01
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMA 579 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 579 (606)
+......+.+++.+||+.+|.+||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112334678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=311.61 Aligned_cols=240 Identities=27% Similarity=0.405 Sum_probs=198.2
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccC-ccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV-TVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
-+.||.|+||.||-|+ ..+.++||||++... ..+ =.++..|+..+++++|||++.+.|+|..+...|||||||-|
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG 110 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG 110 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence 4569999999999998 467899999998643 122 25688999999999999999999999988889999999965
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN 476 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 476 (606)
+-.+++.-.+ .++....+..|+.+.+.||+|||+.+.+ |||||+.|||+++.|.|||+|||.|....+..++.
T Consensus 111 -SAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLHS~~~I--HRDiKAGNILLse~g~VKLaDFGSAsi~~PAnsFv 183 (948)
T KOG0577|consen 111 -SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNRI--HRDIKAGNILLSEPGLVKLADFGSASIMAPANSFV 183 (948)
T ss_pred -cHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHHHhhHH--hhhccccceEecCCCeeeeccccchhhcCchhccc
Confidence 6777766432 4688899999999999999999999866 99999999999999999999999999999999999
Q ss_pred CcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 477 RIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 477 ~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
||+.|||||++. .++|+-++||||||++..|+.-.++|+... +....+-.+-++. ++.. ..
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM------NAMSALYHIAQNe-------sPtL---qs 247 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNE-------SPTL---QS 247 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc------hHHHHHHHHHhcC-------CCCC---CC
Confidence 999999999874 467999999999999999999999997532 1222222222221 1111 12
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.++...+.+++..|++.-|.+|||.++++++
T Consensus 248 ~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 248 NEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred chhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 5666778888889999999999999998776
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=299.91 Aligned_cols=245 Identities=30% Similarity=0.428 Sum_probs=193.3
Q ss_pred ccccCCceEEEEEEEcC-------CcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 324 VLGKGTFGTAYKATLEM-------GIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.||+|+||.||+|+..+ +..+|+|.+.... .....+.+|+++++.++||||++++++|......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998542 2679999886543 23567889999999999999999999999889999999999
Q ss_pred CCCChhhhhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-----cEEEeecccCc
Q 037905 395 PMGSLSALLHGNRGA--GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-----EARISDFGLAH 467 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-----~~kl~DfG~a~ 467 (606)
++++|.+++...... ....+++..+..++.|++.||+|||+.+++ |+||||+||+++.++ .++++|||+++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~--H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFI--HRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcc--cCCCChheEEEecCCCCCCcceEECCccccc
Confidence 999999999753211 123478899999999999999999999965 999999999999887 89999999987
Q ss_pred cCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 468 LASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 468 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
...... ....+..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.... .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~-~- 231 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN------QEVLQHVTAGG-R- 231 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH------HHHHHHHhcCC-c-
Confidence 543221 1223456999999998889999999999999999998 9999864221 11111111111 0
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
.......+..+.+++.+||..+|++||++.+|++.|++
T Consensus 232 ---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 ---------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01112234568899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.10 Aligned_cols=233 Identities=24% Similarity=0.312 Sum_probs=184.6
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHH-HHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKME-VVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+. .+|+.||+|++..... ....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999985 4689999999865321 2234455554 56778999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
|+|..++... ..+++..+..++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~giv--H~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 153 (325)
T cd05604 81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSINIV--YRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT 153 (325)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCc
Confidence 9999888643 2588999999999999999999999966 999999999999999999999999875322 1
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||... +.......+..... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~------~~~~~~~~~~~~~~---~~--------- 215 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR------DVAEMYDNILHKPL---VL--------- 215 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC------CHHHHHHHHHcCCc---cC---------
Confidence 2234677899999999999999999999999999999999999642 22222222222110 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAE 580 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~ 580 (606)
.......+.+++.+|++.+|.+||++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 0112345778899999999999998864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=301.71 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=198.3
Q ss_pred hcccccCCceEEEEEEEc-----CCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLE-----MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e 392 (606)
.+.||+|+||.||+|++. ++..+|||+++..... .+.+.+|+++++.++|+||+++++++.. ....++|||
T Consensus 9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 88 (284)
T cd05038 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88 (284)
T ss_pred heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence 478999999999999853 3689999999866553 5679999999999999999999999877 557899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+++ |+||||+||+++.++.++|+|||.+......
T Consensus 89 ~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~i~--H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 89 YLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQRYI--HRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred cCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999997543 2589999999999999999999999966 9999999999999999999999999766532
Q ss_pred CC-------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCC--------ChhHHHHHHhhcc
Q 037905 473 ST-------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGV--------DLPRWVQSVVKEE 537 (606)
Q Consensus 473 ~~-------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~ 537 (606)
.. ......|+|||......++.++||||||+++|||++|+.|+......... .............
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence 11 12234599999998888999999999999999999999998653221100 0001011111111
Q ss_pred ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 538 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
. .......++.++.+++.+||+.+|++|||+.||++.|+++
T Consensus 243 ~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 E----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred C----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0 0111123346789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=304.29 Aligned_cols=239 Identities=26% Similarity=0.408 Sum_probs=188.0
Q ss_pred cccccCCceEEEEEEEcC--------CcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 323 EVLGKGTFGTAYKATLEM--------GIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
+.||+|+||.||+|.... ...+|+|.+..... ..+.+.+|+.+++.++|||++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997532 33488888754332 235688899999999999999999999998999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc--------EEEeeccc
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE--------ARISDFGL 465 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~--------~kl~DfG~ 465 (606)
+.+|+|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ii--H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKGLT--HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997543 2588999999999999999999999966 9999999999987765 69999999
Q ss_pred CccCCCCCCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCC-CCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 466 AHLASPSSTPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGK-APTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 466 a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
+..........++..|+|||++.+ ..++.++||||||+++|||++|. .|+...... ... ......
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~------~~~-~~~~~~------ 221 (258)
T cd05078 155 SITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ------KKL-QFYEDR------ 221 (258)
T ss_pred ccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH------HHH-HHHHcc------
Confidence 877665555567778999999976 45789999999999999999985 555432111 101 011110
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
...+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 222 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0011122346889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=296.95 Aligned_cols=242 Identities=24% Similarity=0.394 Sum_probs=196.1
Q ss_pred HhcccccCCceEEEEEEEcC-CcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 321 SAEVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
..+.||+|+||.||+|.... +..+|+|.+..... .+++.+|++++++++|+||+++++++......++++||+.+++|
T Consensus 7 ~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 85 (256)
T cd06612 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV 85 (256)
T ss_pred hhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcH
Confidence 35679999999999999764 78999999875433 67899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----CC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----TP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~ 475 (606)
.+++.... ..+++..+..++.|++.||.|||+.+++ |+||+|+||+++.++.++|+|||++....... ..
T Consensus 86 ~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~i~--H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (256)
T cd06612 86 SDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNKKI--HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV 159 (256)
T ss_pred HHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence 99987432 3589999999999999999999999966 99999999999999999999999987654432 22
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||++.+..++.++||||||+++|||++|+.||....... ....+.. . .. ........
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~~~~~~-~-~~-------~~~~~~~~ 224 (256)
T cd06612 160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------AIFMIPN-K-PP-------PTLSDPEK 224 (256)
T ss_pred cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------hhhhhcc-C-CC-------CCCCchhh
Confidence 35667999999998899999999999999999999999997532211 0000000 0 00 00111223
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||+.+|++|||+.|++++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 34568899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=317.02 Aligned_cols=242 Identities=20% Similarity=0.310 Sum_probs=192.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++.. .+|+.||+|+++.... ..+.+.+|+.+++.++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (330)
T cd05601 6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85 (330)
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence 46799999999999985 4689999999976432 335688899999999999999999999998999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.... ..+++..+..++.|++.||.|||+.+++ ||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~i~--H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 86 GDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMGYV--HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--cccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 99999997542 3589999999999999999999999966 99999999999999999999999997654322
Q ss_pred --CCCCcccccCccccC------CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 474 --TPNRIDGYRAPEVTD------ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~------~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
...++..|+|||++. ...++.++|||||||++|||++|+.||.... .......+........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~------~~~~~~~i~~~~~~~~---- 229 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT------SAKTYNNIMNFQRFLK---- 229 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC------HHHHHHHHHcCCCccC----
Confidence 234677899999986 4567899999999999999999999996422 1122222222111000
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+........+.+++.+|+. +|++|||+.+++++
T Consensus 230 ----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 ----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred ----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 11111223457788889997 99999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.82 Aligned_cols=240 Identities=22% Similarity=0.303 Sum_probs=192.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|++|.||++.. .++..+|+|.++..... .+.+.+|++++++++||||+++++++..+...++|+||+
T Consensus 7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 86 (263)
T cd06625 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86 (263)
T ss_pred cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence 56799999999999985 46899999998654221 245788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++++|.+++... ..++...+..++.|++.||+|||+.+++ ||||+|+||++++++.++|+|||+++.....
T Consensus 87 ~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~--H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 87 PGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNMIV--HRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred CCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 999999998753 2578889999999999999999999966 9999999999999999999999998754331
Q ss_pred -----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 473 -----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 473 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... .............
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~-------- 225 (263)
T cd06625 160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTN-------- 225 (263)
T ss_pred ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCCC--------
Confidence 122345679999999998899999999999999999999999964211 1111111111110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+......+.+++.+||..+|++|||+.+++++
T Consensus 226 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 --PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 01112334568889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=298.86 Aligned_cols=244 Identities=24% Similarity=0.480 Sum_probs=194.8
Q ss_pred hcccccCCceEEEEEEEc-CC---cEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MG---IVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|... ++ ..||||+++.... ...+|..|+.++++++||||+++.+++......++||||++
T Consensus 9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T cd05065 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME 88 (269)
T ss_pred EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence 567999999999999864 23 4699999875422 24579999999999999999999999998889999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST- 474 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 474 (606)
+++|.+++.... ..+++..+..++.|++.||+|||++|++ |+||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g~~--H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 89 NGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMNYV--HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred CCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--ecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 999999987532 3588999999999999999999999966 999999999999999999999999875433211
Q ss_pred ------CCC--cccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 475 ------PNR--IDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 475 ------~~~--~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
..+ +..|+|||++.+..++.++||||||+++|||++ |..||..... ......+. ....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~------~~~~~~i~-~~~~------ 229 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN------QDVINAIE-QDYR------ 229 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH------HHHHHHHH-cCCc------
Confidence 111 235999999998899999999999999999987 9999864321 11122111 1110
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.+.+.+.+..+.+++.+||..+|++||++.+|+..|+++
T Consensus 230 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ----LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=319.42 Aligned_cols=241 Identities=22% Similarity=0.289 Sum_probs=188.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++.. .+++.||||++..... ..+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g 85 (377)
T cd05629 6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG 85 (377)
T ss_pred eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence 46799999999999985 4689999999865322 234578899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
|+|.+++... ..+++..+..++.|++.||+|||+.|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~giv--HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 86 GDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLGFI--HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 9999999743 2578889999999999999999999966 9999999999999999999999998632110
Q ss_pred -----------------------------------------------CCCCCcccccCccccCCCCCCCcchhHHHHHHH
Q 037905 473 -----------------------------------------------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLL 505 (606)
Q Consensus 473 -----------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl 505 (606)
....+|..|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 238 (377)
T cd05629 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238 (377)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence 012467789999999998999999999999999
Q ss_pred HHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCC---CCHHHHH
Q 037905 506 LELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNR---PSMAEVT 582 (606)
Q Consensus 506 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~~v~ 582 (606)
|||++|+.||..... ......+........ .+........+.+++.+|+. +|.+| +|+.+++
T Consensus 239 ~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~--------~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 239 FECLIGWPPFCSENS------HETYRKIINWRETLY--------FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhcCCCCCCCCCH------HHHHHHHHccCCccC--------CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999964221 111222211100000 01111123457788889997 66665 5999988
Q ss_pred HH
Q 037905 583 SQ 584 (606)
Q Consensus 583 ~~ 584 (606)
++
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 87
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=321.71 Aligned_cols=258 Identities=20% Similarity=0.318 Sum_probs=186.1
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeC--------CceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR--------DEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~lv~ 391 (606)
..+.||+|+||.||+|.. .+++.||||++... .....+|+.+++.++||||+++.+++... ...++||
T Consensus 70 ~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 70 LGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 357899999999999986 46899999988543 23345799999999999999999887532 1356899
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLAS 470 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~ 470 (606)
||+++ +|.+++..... ....+++..+..++.||+.||+|||+++++ ||||||+|||++.++ .+||+|||+++...
T Consensus 147 E~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~Ii--HrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKFIC--HRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred ecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEe--cCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 99985 77776653211 234589999999999999999999999966 999999999999765 69999999998654
Q ss_pred CC---CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc----------
Q 037905 471 PS---STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE---------- 536 (606)
Q Consensus 471 ~~---~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 536 (606)
.. ....+++.|+|||++.+ ..|+.++|||||||++|||++|++||......+ .+...++ ....
T Consensus 223 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~-~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQ-VLGTPTEDQLKEMN 299 (440)
T ss_pred CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHH-HhCCCCHHHHHHhc
Confidence 32 23456778999999865 468999999999999999999999997532211 0111110 0000
Q ss_pred -ccc----ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHHH
Q 037905 537 -EWT----AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEIC 589 (606)
Q Consensus 537 -~~~----~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~ 589 (606)
.+. .......+ ....+.....++.+++.+||..||.+|||+.|++++ ++++.
T Consensus 300 ~~~~~~~~~~~~~~~l-~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 300 PNYADIKFPDVKPKDL-KKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hhhhcccCCccCchhH-HHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 000 00000000 000011223568899999999999999999999866 44443
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=288.29 Aligned_cols=245 Identities=23% Similarity=0.315 Sum_probs=195.6
Q ss_pred HHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 319 RASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
+.+.+.||+|.|+.||++. ..+|+.+|+|++.... .+.+++.+|+.+-+.++||||+++...+......|+|+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 3456779999999999986 4578999999875432 24577899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC---CcEEEeecccCccCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS---YEARISDFGLAHLASP 471 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~---~~~kl~DfG~a~~~~~ 471 (606)
+|++|..-+-.. ..+++..+-..+.||++||+|+|.++|+ |||+||+|+++... .-+||+|||+|..+..
T Consensus 93 ~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~Iv--HRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 93 TGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNGIV--HRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred cchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcCce--eccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999997655432 2467888889999999999999999966 99999999999543 3489999999988774
Q ss_pred C---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 472 S---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 472 ~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
. ....+|++|||||++....|+..+|||+.||+||-++.|.+||.+. +--+..+.+.... .|....
T Consensus 166 g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~------~~~rlye~I~~g~-----yd~~~~ 234 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLYEQIKAGA-----YDYPSP 234 (355)
T ss_pred ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc------cHHHHHHHHhccc-----cCCCCc
Confidence 3 2457899999999999999999999999999999999999999752 2223344443332 222222
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.++...+ +-.+|+++|+..||++|.|+.|.+++
T Consensus 235 ~w~~is~---~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 235 EWDTVTP---EAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ccCcCCH---HHHHHHHHHhccChhhhccHHHHhCC
Confidence 2333344 44566679999999999999988765
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=305.27 Aligned_cols=255 Identities=20% Similarity=0.317 Sum_probs=192.9
Q ss_pred HHhcccccCCceEEEEEEEcC---------------CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATLEM---------------GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYY 382 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~ 382 (606)
...+.||+|+||.||++.... ...||+|+++.... ....+.+|++++++++|+|++++++++.
T Consensus 8 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 87 (295)
T cd05097 8 RLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCV 87 (295)
T ss_pred eehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEc
Confidence 345779999999999987532 23589999875422 2356889999999999999999999999
Q ss_pred eCCceEEEEeecCCCChhhhhhcCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC
Q 037905 383 SRDEKLLVHDYMPMGSLSALLHGNRG-------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS 455 (606)
Q Consensus 383 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~ 455 (606)
.....++||||+.+++|.+++..... .....+++..+..++.|++.||+|||+.+++ ||||||+||+++++
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~--H~dlkp~Nill~~~ 165 (295)
T cd05097 88 SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFV--HRDLATRNCLVGNH 165 (295)
T ss_pred CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCee--ccccChhhEEEcCC
Confidence 99999999999999999999864321 0112478899999999999999999999966 99999999999999
Q ss_pred CcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh--CCCCcccccccCCCChh
Q 037905 456 YEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT--GKAPTQALLNEEGVDLP 527 (606)
Q Consensus 456 ~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt--g~~p~~~~~~~~~~~~~ 527 (606)
+.+||+|||+++...... ....+..|+|||++.+..++.++||||||+++|||++ |..||....... ..
T Consensus 166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~---~~ 242 (295)
T cd05097 166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ---VI 242 (295)
T ss_pred CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH---HH
Confidence 999999999987543321 1122456999999988889999999999999999998 567776432211 11
Q ss_pred HHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 528 RWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 528 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
................ ......+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 243 ~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 243 ENTGEFFRNQGRQIYL-------SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHhhhhccccccC-------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111000000 001122357899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=293.04 Aligned_cols=242 Identities=23% Similarity=0.389 Sum_probs=207.1
Q ss_pred HhcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 321 SAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
..++||+|+||.||+|. .+.|.++|||.+.. ..+-+++..|+.++++++.|++|+++|.|+.+...|+|||||..|+.
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi 115 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI 115 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence 35679999999999997 45799999999865 34567899999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----CCCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----SSTP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~~~~ 475 (606)
.+.++..+ .++.+..+..++...+.||+|||...-+ |||||+.|||++.+|.+||+|||.|..... ..+.
T Consensus 116 SDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~KI--HRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 116 SDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLKKI--HRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred HHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHHHH--HhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 99998653 4799999999999999999999998755 999999999999999999999999876543 3567
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+|+.|||||++..-.|..++||||||++..||..|++||....+.....+ +...+...+..+.+
T Consensus 190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------------IPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------------IPTKPPPTFKKPEE 254 (502)
T ss_pred ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------------ccCCCCCCCCChHh
Confidence 789999999999999999999999999999999999999987544321111 00011123445778
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+..++-+++++|+-..|++|-|+.++.++
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 88899999999999999999999999876
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.07 Aligned_cols=244 Identities=25% Similarity=0.472 Sum_probs=195.4
Q ss_pred hcccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|... .+..+|+|.++.... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (267)
T cd05066 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME 88 (267)
T ss_pred eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence 578999999999999853 234799999875432 23578899999999999999999999998899999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST- 474 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 474 (606)
+++|.+++.... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.++|+|||+++.......
T Consensus 89 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~--h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 89 NGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMGYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--ehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 999999997532 3589999999999999999999999966 999999999999999999999999876543221
Q ss_pred ------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 475 ------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 475 ------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...+..|+|||++.+..++.++||||||+++||+++ |+.||...... .....+. +...
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~------~~~~~~~-~~~~-------- 227 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ------DVIKAIE-EGYR-------- 227 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH------HHHHHHh-CCCc--------
Confidence 111345999999998889999999999999999887 99998653211 1111111 1110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.+.....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 --LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 011122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=316.75 Aligned_cols=242 Identities=22% Similarity=0.299 Sum_probs=189.2
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||.||+++.. +++.+|+|++.... .....+.+|+.+++.++||||+++++++.++...++||||++
T Consensus 47 ~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~ 126 (370)
T cd05621 47 VVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMP 126 (370)
T ss_pred EEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCC
Confidence 3567999999999999864 58899999986432 123457889999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+|+|.+++... .++...+..++.||+.||+|||+++++ ||||||+|||+++++.+||+|||+++.....
T Consensus 127 gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~Iv--HrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 127 GGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMGLI--HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeE--ecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 99999998642 378889999999999999999999966 9999999999999999999999999765432
Q ss_pred --CCCCCcccccCccccCCCC----CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 473 --STPNRIDGYRAPEVTDARK----VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~----~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
....+|..|+|||++.+.. ++.++|||||||++|||++|+.||... +.......+........
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~~----- 267 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD------SLVGTYSKIMDHKNSLN----- 267 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCcccC-----
Confidence 2345788899999987543 788999999999999999999999643 22222222222111000
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDN--RPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~v~~~ 584 (606)
.+........+.+++.+|+..++.+ |||+.|++++
T Consensus 268 ---~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 268 ---FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111122345667777888755543 8899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=295.55 Aligned_cols=243 Identities=25% Similarity=0.460 Sum_probs=196.5
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||++....+..+|+|.++......+.+.+|++++++++|+||+++.+++.. ...+++|||+++++|.+
T Consensus 11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~ 89 (260)
T cd05073 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD 89 (260)
T ss_pred EeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHH
Confidence 57799999999999998778889999987655556778999999999999999999999877 77899999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----CC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-----PN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~ 476 (606)
++.... ...+++..+..++.|++.||+|||+.++. ||||||+||+++.++.+||+|||.++....... ..
T Consensus 90 ~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~i~--H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~ 164 (260)
T cd05073 90 FLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYI--HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 164 (260)
T ss_pred HHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCCcc--ccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCc
Confidence 997532 23578899999999999999999999966 999999999999999999999999875433211 12
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||++....++.++||||||+++|++++ |+.||.... ...... .....+.. +....
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~------~~~~~~-~~~~~~~~----------~~~~~ 227 (260)
T cd05073 165 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEVIR-ALERGYRM----------PRPEN 227 (260)
T ss_pred ccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC------HHHHHH-HHhCCCCC----------CCccc
Confidence 2345999999988889999999999999999999 999996421 111111 11111111 11122
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 34568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.41 Aligned_cols=192 Identities=24% Similarity=0.363 Sum_probs=157.2
Q ss_pred cccccCCceEEEEEEEc---CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g 397 (606)
++||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC-
Confidence 57999999999999854 46889999987543 23457889999999999999999998864 3567899999865
Q ss_pred ChhhhhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe----cCCCcEEEeecccCccC
Q 037905 398 SLSALLHGNRG----AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL----SKSYEARISDFGLAHLA 469 (606)
Q Consensus 398 ~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill----~~~~~~kl~DfG~a~~~ 469 (606)
+|.+++..... .....+++..+..++.||+.||+|||+++++ ||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv--HrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL--HRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEE--cCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 88887753221 1123588999999999999999999999966 99999999999 45678999999999765
Q ss_pred CCC-------CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccc
Q 037905 470 SPS-------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQAL 518 (606)
Q Consensus 470 ~~~-------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~ 518 (606)
... ....++..|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 432 12345778999999876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=305.02 Aligned_cols=240 Identities=25% Similarity=0.353 Sum_probs=193.6
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|.. .++..||+|.+..... ..+.+.+|+.+++.++|+|++++++++....+.++||||+++++|
T Consensus 25 ~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L 104 (296)
T cd06654 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (296)
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCH
Confidence 46799999999999985 4688999999875433 346688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++... .+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++..... ...
T Consensus 105 ~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~gi~--H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 176 (296)
T cd06654 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVI--HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence 9998642 478899999999999999999999966 9999999999999999999999988754332 123
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||++.+..++.++|||||||++|+|++|+.||...... ..+.. ..... ... ...+..
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-----~~~~~-~~~~~-~~~--------~~~~~~ 241 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-----RALYL-IATNG-TPE--------LQNPEK 241 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-----HhHHH-HhcCC-CCC--------CCCccc
Confidence 4566799999998888999999999999999999999999643211 11111 11110 000 011123
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||..+|++|||+.+++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 34568889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=284.45 Aligned_cols=243 Identities=23% Similarity=0.362 Sum_probs=198.1
Q ss_pred HhcccccCCceEEEEEE-EcCCcEEEEEEeccCcc-----C----HHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEE
Q 037905 321 SAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV-----S----EKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 389 (606)
..++||.|..+.|.++. .++|...|+|++..... . .+.-.+|+.+++++ .||+|+.+.++|.++...++
T Consensus 21 pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~Fl 100 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFL 100 (411)
T ss_pred hHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhh
Confidence 35679999999998886 45688899998854311 1 13456789999987 79999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
|+|.|+.|.|.+++.. ...++++...+|+.|+.+|++|||.++|+ ||||||+|||+|+++++||+|||.|...
T Consensus 101 VFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa~~IV--HRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 101 VFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHARNIV--HRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHHhhhh--hcccChhheeeccccceEEeccceeecc
Confidence 9999999999999985 34799999999999999999999999966 9999999999999999999999999888
Q ss_pred CCCC---CCCCcccccCccccCC------CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 470 SPSS---TPNRIDGYRAPEVTDA------RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 470 ~~~~---~~~~~~~y~aPE~~~~------~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
.++. ...+|+||+|||.+.. ..|+...|+||+||++|.++.|.+||.-.. -.-.+..+....+.
T Consensus 174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlMLR~ImeGkyq- 246 (411)
T KOG0599|consen 174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLMLRMIMEGKYQ- 246 (411)
T ss_pred CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHHHHHHHhcccc-
Confidence 7754 4689999999998754 358888999999999999999999996321 11112222222211
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+ +.+.+.+....+.+++.+|++.||.+|.|++|++++
T Consensus 247 -F------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 247 -F------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred -c------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 1 223445566778889999999999999999999886
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=310.15 Aligned_cols=238 Identities=23% Similarity=0.288 Sum_probs=187.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|... ++..||+|+++.... ....+..|..++..+ +|++|+++.+++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 84 (323)
T cd05616 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN 84 (323)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence 467999999999999854 578999999875422 123456677777666 58899999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
+|+|.+++... ..+++..+..++.|++.||+|||+++++ ||||||+|||+++++.+||+|||+++....
T Consensus 85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~iv--HrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 85 GGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKGII--YRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT 157 (323)
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEE--ecCCCHHHeEECCCCcEEEccCCCceecCCCCCc
Confidence 99999998743 2588999999999999999999999966 999999999999999999999999875432
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~------~~~~~~~i~~~~~------------~ 219 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED------EDELFQSIMEHNV------------A 219 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC------------C
Confidence 123456788999999999999999999999999999999999996432 1122222222110 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSM-----AEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~~v~~~ 584 (606)
.+......+.+++.+|++.+|++|++. .++.++
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 111233467888999999999999985 566543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=299.87 Aligned_cols=253 Identities=22% Similarity=0.313 Sum_probs=199.2
Q ss_pred HHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 319 RASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
+...+.||+|+||.||++... +|..||+|++.... ...+.+.+|+++++.++||||+++++++......++||||++
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD 86 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCC
Confidence 345678999999999999854 68899999886542 234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
+++|.+++... ..+++..+..++.+++.||.|||+ .+++ ||||||+||++++++.++|+|||+++.....
T Consensus 87 ~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~~i~--H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~ 159 (284)
T cd06620 87 CGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVHRIM--HRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159 (284)
T ss_pred CCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhcCee--ccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence 99999988643 258999999999999999999997 4655 9999999999999999999999998654322
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC-----CCChhHHHHHHhhccccccccchhh
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE-----GVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||....... ...+..++........ .
T Consensus 160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~------- 231 (284)
T cd06620 160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-P------- 231 (284)
T ss_pred CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-C-------
Confidence 22346678999999988889999999999999999999999997543211 0111222222221110 0
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
. ....+....+.+++.+||+.+|++|||+.|++++.--+
T Consensus 232 -~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 232 -R-LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred -C-CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 0 00122445788999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.53 Aligned_cols=241 Identities=24% Similarity=0.322 Sum_probs=194.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+++.. ++..+|+|.++... ...+.+.+|+.+++.++|+|++++++++.+....++||||+++++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 84 (255)
T cd08219 5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD 84 (255)
T ss_pred EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence 568999999999999854 68999999986432 234668889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----T 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~ 474 (606)
|.+++.... ...++...+..++.|++.||.|||+.++. |+||||+||++++++.++++|||.++...... .
T Consensus 85 l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~i~--H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 85 LMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKRVL--HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred HHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcc--cCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 999886433 23578899999999999999999999966 99999999999999999999999987654322 2
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..++..|+|||++.+..++.++||||||+++|+|++|+.||... +.......+..... . ..+.
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~------~~~~~~~~~~~~~~-~----------~~~~ 222 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN------SWKNLILKVCQGSY-K----------PLPS 222 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC------CHHHHHHHHhcCCC-C----------CCCc
Confidence 34566799999999888999999999999999999999999642 11122222211111 1 0111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+.+++.+||+.+|++|||+.+|+.+
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 233467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=292.53 Aligned_cols=241 Identities=26% Similarity=0.445 Sum_probs=194.3
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
++||+|+||.||++...+++.||+|.+..... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999976699999999876433 3457899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC------
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST------ 474 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~------ 474 (606)
+++.... ..+++..+..++.+++.||+|||+++++ ||||||+||+++.++.+||+|||.++.......
T Consensus 81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~i~--h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKNCI--HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCEe--hhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9987532 2578899999999999999999999966 999999999999999999999999875542111
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+..|+|||.+.+..++.++||||||+++|||+| |..||..... ..... ....... ...+
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------~~~~~-~~~~~~~----------~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN------QQTRE-RIESGYR----------MPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH------HHHHH-HHhcCCC----------CCCC
Confidence 112345999999988889999999999999999999 8888864321 11111 1111110 0111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
...+..+.+++.+||..+|++|||+.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 223457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=300.05 Aligned_cols=244 Identities=24% Similarity=0.278 Sum_probs=192.3
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|.. .+++.||+|.+...... ...+.+|++++++++|+|++++.+++..++..++||||+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (285)
T cd05632 5 YRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84 (285)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccC
Confidence 46799999999999985 46899999998654322 23477899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
++|.+++.... ...+++..+..++.|++.||.|||+.+++ ||||||+||++++++.+||+|||++...... .
T Consensus 85 ~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~ii--H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (285)
T cd05632 85 GDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHRENTV--YRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR 159 (285)
T ss_pred ccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--ecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence 99998886432 23589999999999999999999999966 9999999999999999999999998654322 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++|+||||+++|||++|+.||....... ....+........ . ...
T Consensus 160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~---~~~~~~~~~~~~~--~---------~~~ 225 (285)
T cd05632 160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV---KREEVDRRVLETE--E---------VYS 225 (285)
T ss_pred CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhhhccc--c---------ccC
Confidence 2345678999999998889999999999999999999999997432111 0011111111100 0 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
......+.+++.+||+.+|++||+ +.+++.+
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 123345788999999999999999 6777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=319.70 Aligned_cols=241 Identities=23% Similarity=0.305 Sum_probs=187.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. .+++.||||++..... ....+.+|++++++++|+||+++++.+.+++..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~ 85 (376)
T cd05598 6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG 85 (376)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence 56799999999999985 4689999999865322 235678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC-----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----- 471 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----- 471 (606)
|+|.+++... ..++...+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++....
T Consensus 86 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~iv--HrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 86 GDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMGFI--HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--eCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 9999999753 2478888899999999999999999966 999999999999999999999999742210
Q ss_pred ------------------------------------------CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHH
Q 037905 472 ------------------------------------------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELL 509 (606)
Q Consensus 472 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ell 509 (606)
.....+++.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 01124677899999999999999999999999999999
Q ss_pred hCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCC---CHHHHHHH
Q 037905 510 TGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRP---SMAEVTSQ 584 (606)
Q Consensus 510 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP---s~~~v~~~ 584 (606)
+|+.||..... ......+.... .... .+........+.+++.+|+ .+|++|+ |+.+++++
T Consensus 239 ~G~~Pf~~~~~------~~~~~~i~~~~--~~~~------~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 239 VGQPPFLADTP------AETQLKVINWE--TTLH------IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hCCCCCCCCCH------HHHHHHHhccC--cccc------CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 99999965321 11111111110 0000 0000112334566666765 5999999 89999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.41 Aligned_cols=253 Identities=23% Similarity=0.283 Sum_probs=197.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.++||+|+||.||+|... +|+.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG 86 (932)
T PRK13184 7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG 86 (932)
T ss_pred EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence 468999999999999854 589999999975422 235688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 397 GSLSALLHGNRGA------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 397 g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
++|.+++...... ....+++..+..++.||+.||+|||+++++ ||||||+||+++.++.+||+|||+++...
T Consensus 87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GII--HRDLKPeNILLd~dg~vKLiDFGLAk~i~ 164 (932)
T PRK13184 87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVL--HRDLKPDNILLGLFGEVVILDWGAAIFKK 164 (932)
T ss_pred CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCchheEEEcCCCCEEEEecCcceecc
Confidence 9999998642110 122456778899999999999999999966 99999999999999999999999987541
Q ss_pred C----------------------CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhH
Q 037905 471 P----------------------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 471 ~----------------------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~ 528 (606)
. .....+|+.|+|||++.+..++.++|||||||++|||+||+.||....... ..
T Consensus 165 ~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k---i~- 240 (932)
T PRK13184 165 LEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK---IS- 240 (932)
T ss_pred cccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh---hh-
Confidence 1 011346788999999999999999999999999999999999996521111 10
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHHHhc
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRP-SMAEVTSQIEEICRS 591 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~~ 591 (606)
. .. ...++.. .....+.+..+.+++.+|++.||++|| +++++.+.|+.....
T Consensus 241 --~----~~---~i~~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 241 --Y----RD---VILSPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred --h----hh---hccChhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 00 0000000 001122345678899999999999996 678888888887654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=324.54 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=183.0
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCC------CCCcccceEEEEeC-CceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD------HENLVPLRAYYYSR-DEKLLVH 391 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~-~~~~lv~ 391 (606)
...+.||+|+||.||+|.. ..++.||||+++.......++..|++++..++ |.+++++++++... .+.++||
T Consensus 132 ~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~ 211 (467)
T PTZ00284 132 KILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVM 211 (467)
T ss_pred EEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEE
Confidence 3457899999999999985 45889999999754333445566666666654 45688888888754 5678999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCC--------------
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSY-------------- 456 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~-------------- 456 (606)
|++ +++|.+++... ..+++..+..++.||+.||+|||+ .|++ ||||||+|||++.++
T Consensus 212 ~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~gIi--HrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 212 PKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELHLM--HTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred ecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCee--cCCCCHHHEEEecCCcccccccccccCCC
Confidence 988 66888888643 258999999999999999999998 4866 999999999998765
Q ss_pred --cEEEeecccCccCCC-CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHH
Q 037905 457 --EARISDFGLAHLASP-SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSV 533 (606)
Q Consensus 457 --~~kl~DfG~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (606)
.+||+|||.+..... .....+|..|+|||++.+..|+.++|||||||++|||++|+.||......+ ....+...
T Consensus 284 ~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i~~~ 360 (467)
T PTZ00284 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE---HLHLMEKT 360 (467)
T ss_pred CceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH
Confidence 499999998865433 234567888999999999999999999999999999999999997532211 11111110
Q ss_pred h---hcccc------------------ccccchhhh-c---ccChH--HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 534 V---KEEWT------------------AEVFDLELL-R---YQNVE--EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 534 ~---~~~~~------------------~~~~d~~~~-~---~~~~~--~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. ...+. ....++... . ..... .....+.+|+.+||..||++|||++|+++|
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 0 00000 000011000 0 00000 113457899999999999999999999985
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.16 Aligned_cols=185 Identities=21% Similarity=0.250 Sum_probs=157.0
Q ss_pred HHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 319 RASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+...+.||+|+||.||+|+.. ++..||+|+.... ....|+.++++++|+||+++++++......++|+||+. +
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~ 141 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-S 141 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-C
Confidence 344678999999999999864 5688999975432 23568999999999999999999999999999999996 5
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---CC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---ST 474 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~ 474 (606)
+|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... ..
T Consensus 142 ~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iv--HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 215 (357)
T PHA03209 142 DLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQRII--HRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215 (357)
T ss_pred cHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEECCCCCEEEecCccccccccCccccc
Confidence 8888886432 3589999999999999999999999966 9999999999999999999999998754322 23
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCc
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPT 515 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~ 515 (606)
..++..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 45678899999999989999999999999999999955444
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=316.21 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=185.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. .+++.||+|++..... ....+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~g 85 (382)
T cd05625 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 85 (382)
T ss_pred EEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCC
Confidence 46799999999999985 4688999999875422 234678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC-----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----- 471 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----- 471 (606)
|+|.+++... ..++...+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++....
T Consensus 86 g~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~iv--HrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 86 GDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMGFI--HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 9999998753 2478888999999999999999999966 999999999999999999999999742210
Q ss_pred ----------------------------------------------CCCCCCcccccCccccCCCCCCCcchhHHHHHHH
Q 037905 472 ----------------------------------------------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLL 505 (606)
Q Consensus 472 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl 505 (606)
.....+|..|+|||++.+..++.++|||||||++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 238 (382)
T cd05625 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238 (382)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence 0112467789999999999999999999999999
Q ss_pred HHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCC---HHHHH
Q 037905 506 LELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS---MAEVT 582 (606)
Q Consensus 506 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~~v~ 582 (606)
|||++|+.||..... ......+........ .+.......+..+++.+++ .+|++|++ +.+++
T Consensus 239 ~elltG~~Pf~~~~~------~~~~~~i~~~~~~~~--------~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 239 YEMLVGQPPFLAQTP------LETQMKVINWQTSLH--------IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHhCCCCCCCCCH------HHHHHHHHccCCCcC--------CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999965321 111111111110000 0000111234455555554 58999997 88877
Q ss_pred HH
Q 037905 583 SQ 584 (606)
Q Consensus 583 ~~ 584 (606)
++
T Consensus 304 ~h 305 (382)
T cd05625 304 AH 305 (382)
T ss_pred cC
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=294.17 Aligned_cols=243 Identities=30% Similarity=0.466 Sum_probs=194.1
Q ss_pred HHhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 320 ASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
+..+.||+|+||.||++.. ++..||+|.++.. .....+.+|+.++++++|||++++++++.. +..++||||+.+++|
T Consensus 9 ~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L 85 (254)
T cd05083 9 TLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNL 85 (254)
T ss_pred eeeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCCCCCH
Confidence 3457899999999999975 4788999998653 345678999999999999999999999865 457999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-CCCCc
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-TPNRI 478 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~ 478 (606)
.+++.... ...+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||.++...... .....
T Consensus 86 ~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~~~--H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (254)
T cd05083 86 VNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKKLV--HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP 160 (254)
T ss_pred HHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCCee--ccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence 99997542 23578999999999999999999999966 99999999999999999999999987644321 22234
Q ss_pred ccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHH
Q 037905 479 DGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEM 557 (606)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 557 (606)
..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+ ....... .....+
T Consensus 161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~~~~~-~~~~~~~----------~~~~~~ 223 (254)
T cd05083 161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS------LKEVKECV-EKGYRME----------PPEGCP 223 (254)
T ss_pred ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC------HHHHHHHH-hCCCCCC----------CCCcCC
Confidence 56999999988889999999999999999998 999986432 22222211 1111111 112234
Q ss_pred HHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 558 VQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 558 ~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
..+.+++.+||+.+|++||++.+|++.|++
T Consensus 224 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 224 ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=295.15 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=184.7
Q ss_pred ccccCCceEEEEEEEcCC---cEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 324 VLGKGTFGTAYKATLEMG---IVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.||+|+||.||+|+..++ ..+++|.+..... ..+.+.+|+..++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975433 3466776654322 34678999999999999999999999999899999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC------C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP------S 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~------~ 472 (606)
|.+++...... ....++..+..++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||++..... .
T Consensus 82 L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~i~--H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHNFL--HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCCee--ccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999754321 23467778889999999999999999966 999999999999999999999998864221 1
Q ss_pred CCCCCcccccCccccCC-------CCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 STPNRIDGYRAPEVTDA-------RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~-------~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
....++..|+|||++.. ..++.++||||||+++|||++ |..||.... .......+..+.. ....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~~~~~~~~~~~-~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS------DREVLNHVIKDQQ-VKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhhcc-cccCC
Confidence 22345567999998743 245789999999999999997 567875321 1222332222211 11222
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
+... ......+.+++..|| .+|++||++++|++.|.
T Consensus 232 ~~~~-----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLE-----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccC-----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2111 113345777888999 67999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=301.73 Aligned_cols=244 Identities=25% Similarity=0.288 Sum_probs=192.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++... +++.||+|.+...... ...+.+|+.++++++|+|++++.+.+...+..++||||+++
T Consensus 5 ~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g 84 (285)
T cd05630 5 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84 (285)
T ss_pred eEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCC
Confidence 467999999999999854 6899999998654322 23467899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.... ...+++..+..++.|++.||.|||+.+++ ||||||+||++++++.++|+|||++.......
T Consensus 85 ~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~ii--H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 159 (285)
T cd05630 85 GDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQERIV--YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 159 (285)
T ss_pred CcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEE--eCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence 99999886432 23588999999999999999999999966 99999999999999999999999987544322
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++||||||+++|||++|+.||....... ............ . ....
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~---~~~~~~~~~~~~-~----------~~~~ 225 (285)
T cd05630 160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI---KREEVERLVKEV-Q----------EEYS 225 (285)
T ss_pred CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc---hHHHHHhhhhhh-h----------hhcC
Confidence 2346778999999998899999999999999999999999997532211 001111111100 0 0011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
......+.+++.+||+.||++||| ++|+.++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 123345788899999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=296.31 Aligned_cols=245 Identities=22% Similarity=0.359 Sum_probs=193.1
Q ss_pred HHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 319 RASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+...+.||+|+||.||+|... ++..+++|.+..... ..+.+.+|+++++.++|||++++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 445678999999999999865 578889998865432 345688899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|..++.... .++++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~i~--H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENKII--HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ecCCCcccEEEccCCCEEEcccccccccccccccc
Confidence 99998876422 3589999999999999999999999966 9999999999999999999999998654322
Q ss_pred CCCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 473 STPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
....++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+......... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~~-~~----- 228 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEPP-TL----- 228 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcCCC-CC-----
Confidence 2234667799999974 34578899999999999999999999864321 1111111111100 00
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+......+.+++.+||+.+|.+||++.+++++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 ---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111233568889999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=305.71 Aligned_cols=256 Identities=22% Similarity=0.313 Sum_probs=188.5
Q ss_pred hcccccC--CceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKG--TFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.++||+| +|++||++.. .+|+.||+|++...... .+.+.+|+++++.++||||++++++|..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3579999 6899999975 57899999999754322 3457789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+++|.+++.... ...+++..+..++.|++.||+|||+++++ ||||||+|||++.++.++++||+........
T Consensus 83 ~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~ii--H~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMGYV--HRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEe--cCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999986532 22488999999999999999999999966 9999999999999999999999865332111
Q ss_pred --------CCCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh-------
Q 037905 473 --------STPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK------- 535 (606)
Q Consensus 473 --------~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 535 (606)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCccccccccc
Confidence 11233456999999876 468999999999999999999999996432111 00000000000
Q ss_pred ---ccc----cccccchhh----------------hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 536 ---EEW----TAEVFDLEL----------------LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 536 ---~~~----~~~~~d~~~----------------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.. .....+... ...+........+.+++.+||+.||++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 000000000 0000111234578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=296.37 Aligned_cols=247 Identities=27% Similarity=0.408 Sum_probs=195.5
Q ss_pred HhcccccCCceEEEEEEEcC----CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATLEM----GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
..+.||+|+||.||+|...+ ...||||....... ..+.+.+|+.++++++||||+++++++.+ ...++||||+
T Consensus 10 ~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~ 88 (270)
T cd05056 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELA 88 (270)
T ss_pred eeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcC
Confidence 45789999999999998543 35789998865432 34578999999999999999999998865 5678999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST 474 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 474 (606)
++++|.+++.... ..+++..+..++.+++.||+|||+.+++ ||||||+||+++.++.+||+|||+++.......
T Consensus 89 ~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~--H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 162 (270)
T cd05056 89 PLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKRFV--HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162 (270)
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--ccccChheEEEecCCCeEEccCceeeecccccc
Confidence 9999999997532 2489999999999999999999999966 999999999999999999999999876543211
Q ss_pred -----CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 475 -----PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 475 -----~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
......|+|||.+....++.++||||||+++||+++ |+.||...... .....+ ..+...
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~-~~~~~~-------- 227 (270)
T cd05056 163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN------DVIGRI-ENGERL-------- 227 (270)
T ss_pred eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HcCCcC--------
Confidence 122346999999988889999999999999999996 99999653211 111111 111100
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
..+...+..+.+++.+||.++|++|||+.++++.|+++...
T Consensus 228 --~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 --PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11122345788899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=306.98 Aligned_cols=253 Identities=19% Similarity=0.283 Sum_probs=189.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+.. ++..||+|+++.... ....+.+|++++++++||||+++++++..++..++||||+++ +
T Consensus 11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 89 (309)
T cd07872 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D 89 (309)
T ss_pred EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence 467999999999999854 678899999875432 334677899999999999999999999999999999999986 8
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++.... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++..... ..
T Consensus 90 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~iv--H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 90 LKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRKVL--HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 888876432 3478899999999999999999999966 9999999999999999999999998754322 12
Q ss_pred CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc---ccccc------cc
Q 037905 475 PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE---WTAEV------FD 544 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~------~d 544 (606)
..++..|+|||++.+ ..++.++||||||+++|||+||+.||......+ ....+....... ....+ .+
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED---ELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 345677999998865 468899999999999999999999996532211 101010000000 00000 00
Q ss_pred hhhhcc------cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRY------QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...... ........++.+++.+|+..||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000 0001223467889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=297.41 Aligned_cols=240 Identities=24% Similarity=0.350 Sum_probs=193.8
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
...+.||+|+||.||+|.. .++..||+|.+..... ..+.+.+|++++++++||||+++++++..+...++||||+++
T Consensus 7 ~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06642 7 TKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred HHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCC
Confidence 3456799999999999985 4578999999874432 235688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.. ..+++..+..++.|+++|+.|||+++++ |+||+|+||++++++.++|+|||+++......
T Consensus 87 ~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~iv--H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06642 87 GSALDLLKP------GPLEETYIATILREILKGLDYLHSERKI--HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCCee--ccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence 999999863 2478999999999999999999999966 99999999999999999999999987654322
Q ss_pred -CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 -TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||++.+..++.++||||||+++|||++|+.|+....... .... ...... ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~-~~~~~~----------~~~ 221 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR------VLFL-IPKNSP----------PTL 221 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh------HHhh-hhcCCC----------CCC
Confidence 1235567999999999889999999999999999999999986432111 0110 111100 011
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 12234568899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=310.80 Aligned_cols=254 Identities=25% Similarity=0.329 Sum_probs=187.2
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCC------ceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRD------EKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv 390 (606)
..+.||+|+||.||++.. .+|..||+|++.... .....+.+|+.+++.++||||+++++++.... ..++|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 104 (359)
T cd07876 25 QLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 104 (359)
T ss_pred EEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEE
Confidence 357899999999999985 468999999986532 23456788999999999999999999986443 46999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
|||+.+ +|...+.. .++...+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++...
T Consensus 105 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~iv--HrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 105 MELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred EeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 999976 66666542 378888999999999999999999966 99999999999999999999999997543
Q ss_pred CC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC---------CCChhHHH-------H
Q 037905 471 PS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE---------GVDLPRWV-------Q 531 (606)
Q Consensus 471 ~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~---------~~~~~~~~-------~ 531 (606)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||......+ +.....+. .
T Consensus 175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (359)
T cd07876 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVR 254 (359)
T ss_pred cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 32 22355778999999999999999999999999999999999997532110 00000000 0
Q ss_pred HHhhcccc-cc-ccchhhhcc------cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 532 SVVKEEWT-AE-VFDLELLRY------QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 532 ~~~~~~~~-~~-~~d~~~~~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........ .. ........+ .........+.+++.+||..||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 255 NYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00 000000000 0001123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.51 Aligned_cols=232 Identities=22% Similarity=0.284 Sum_probs=184.6
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|.. .+|+.||+|++..... ..+.+..|..++..+. |++|+++.+++...+..++||||++
T Consensus 5 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~ 84 (323)
T cd05615 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVN 84 (323)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCC
Confidence 36799999999999985 4689999999875321 2345677888888775 5677789999988889999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+|+|.+++... ..+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~iv--HrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 85 GGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRGII--YRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence 99999998743 2589999999999999999999999966 9999999999999999999999998754321
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....++..|+|||++.+..++.++|||||||++|||++|+.||.... .......+..... .
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~------~~~~~~~i~~~~~------------~ 219 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED------EDELFQSIMEHNV------------S 219 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC------------C
Confidence 23346788999999999899999999999999999999999996532 1122222222111 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSM 578 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 578 (606)
.+......+.+++.+||+.+|++|++.
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111223467888999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.58 Aligned_cols=240 Identities=24% Similarity=0.375 Sum_probs=192.0
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC-------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS-------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|...+++.+|+|.+...... ...+.+|++++++++|+||+++++++.+....++|+||+
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (265)
T cd06631 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV 84 (265)
T ss_pred cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence 4679999999999999888999999998643211 245788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC---
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--- 471 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 471 (606)
++++|.+++... .++++..+..++.|++.||+|||+.++. |+||+|+||++++++.++|+|||.++....
T Consensus 85 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 85 PGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNCVV--HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 999999999743 2478899999999999999999999966 999999999999999999999998865421
Q ss_pred -------CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-ccccccc
Q 037905 472 -------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE-EWTAEVF 543 (606)
Q Consensus 472 -------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 543 (606)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||..... ... ....... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~-~~~~~~~~~~~~--- 228 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAA-MFYIGAHRGLMP--- 228 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHH-HHHhhhccCCCC---
Confidence 1123456679999999998899999999999999999999999964211 111 1111110 0000
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+......+.+++.+||+.+|++||++.+++++
T Consensus 229 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 229 -------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1112234567889999999999999999998753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=296.17 Aligned_cols=248 Identities=26% Similarity=0.418 Sum_probs=197.3
Q ss_pred HhcccccCCceEEEEEEEc-CC----cEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 321 SAEVLGKGTFGTAYKATLE-MG----IVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
..+.||+|+||.||+|... +| ..+|+|.+..... ...++.+|+..+++++||||++++++|.. ...++||||
T Consensus 11 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 89 (279)
T cd05057 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQL 89 (279)
T ss_pred EcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEec
Confidence 3578999999999999853 23 3689998875533 23578899999999999999999999987 788999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+++|+|.+++.... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||.++......
T Consensus 90 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~i~--H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 90 MPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCEE--ecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 99999999997543 2489999999999999999999999866 99999999999999999999999997654322
Q ss_pred C------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 T------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 ~------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
. ...+..|+|||.+....++.++||||||+++||+++ |+.||.... .......+.....
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------~~~~~~~~~~~~~-------- 229 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP------AVEIPDLLEKGER-------- 229 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC------HHHHHHHHhCCCC--------
Confidence 1 112346999999988889999999999999999999 999996532 1122221111110
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
...+..+...+.+++.+||..+|++||++.++++.|+++.+..
T Consensus 230 ---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 230 ---LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0111113346788999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.55 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=188.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCC-----ceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRD-----EKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 392 (606)
.+.||+|+||.||++.. .+|+.||+|++..... ..+.+.+|+++++.++|+||+++++++.... +.++|+|
T Consensus 5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 84 (372)
T cd07853 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE 84 (372)
T ss_pred cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence 46799999999999985 4789999999865322 3456889999999999999999999998765 7899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+. ++|.+++... ..+++..+..++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~iv--H~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 85 LMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAGIL--HRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred ccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--CCCCChHHEEECCCCCEEeccccceeecccC
Confidence 997 4788877542 3589999999999999999999999966 9999999999999999999999998754332
Q ss_pred C-----CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc----------
Q 037905 473 S-----TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE---------- 536 (606)
Q Consensus 473 ~-----~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 536 (606)
. ...++..|+|||++.+. .++.++|||||||++|||++|+.||....... ....+......
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~~~~~ 233 (372)
T cd07853 157 ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ---QLDLITDLLGTPSLEAMRSAC 233 (372)
T ss_pred ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhh
Confidence 1 22456779999998774 57899999999999999999999997532111 00000000000
Q ss_pred -----cccccccchh-hh-cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 -----EWTAEVFDLE-LL-RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 -----~~~~~~~d~~-~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+. .. ...........+.+++.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 234 EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 00 000011224567899999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=301.56 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=193.7
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
..+.||+|+||.||++.. .++..||+|.+..... ..+.+.+|+.+++.++|+|++++++++......++||||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (297)
T cd06656 23 RFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (297)
T ss_pred eeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCC
Confidence 457799999999999985 5789999999875433 34568889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----T 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~ 474 (606)
|.+++... .+++..+..++.|++.||.|||+.+++ ||||||+|||++.++.++|+|||.+....... .
T Consensus 103 L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~i~--H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 174 (297)
T cd06656 103 LTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQVI--HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (297)
T ss_pred HHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence 99998642 478889999999999999999999966 99999999999999999999999987544321 2
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||........ .......+ .. ....+.
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------~~~~~~~~-~~--------~~~~~~ 239 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-TP--------ELQNPE 239 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------eeeeccCC-CC--------CCCCcc
Confidence 3456679999999988899999999999999999999999964321110 00000000 00 001112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+.+++.+||..+|++||++.+++++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 233557889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.87 Aligned_cols=254 Identities=21% Similarity=0.296 Sum_probs=192.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||++... ++..+|+|.++.... ....+.+|++++++++||||++++++|..+++.++||||+++++
T Consensus 6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~ 85 (308)
T cd06615 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 85 (308)
T ss_pred EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence 467999999999999854 688899998865322 23568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--CCC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--STP 475 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 475 (606)
|.+++... ..+++..+..++.|++.||+|||+ .+++ ||||||+||+++.++.+||+|||++...... ...
T Consensus 86 L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~--H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (308)
T cd06615 86 LDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 158 (308)
T ss_pred HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhCCEE--ECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence 99999753 358899999999999999999997 4655 9999999999999999999999998754332 233
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc---------------
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA--------------- 540 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------------- 540 (606)
.++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...............
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPPDSPR 235 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCCCccc
Confidence 45678999999988889999999999999999999999986422111 111010000000000
Q ss_pred -----cccchhhh--cccC-hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 541 -----EVFDLELL--RYQN-VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 541 -----~~~d~~~~--~~~~-~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
+..+.... .... .......+.+++.+||..+|++|||+.+++++-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 236 PMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred hhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000 0000 011334688999999999999999999999883
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=291.14 Aligned_cols=242 Identities=25% Similarity=0.354 Sum_probs=196.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||.++. .++..+++|.+..... ..+.+.+|++++++++|+||+++++++.+....+++|||++++
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (256)
T cd08221 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG 84 (256)
T ss_pred eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence 46799999999999874 5688999999865432 2356889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++.... ...+++..+..++.|++.||+|||+.+++ |+||+|+||++++++.+||+|||.++......
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~--h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 85 TLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAGIL--HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred cHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCcc--ccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 9999997542 23588999999999999999999999966 99999999999999999999999987654322
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||+..+..++.++||||||+++|||++|+.||... .....+..+....+.. ..
T Consensus 160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~~~~~~~~-----------~~ 222 (256)
T cd08221 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIVQGNYTP-----------VV 222 (256)
T ss_pred ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCCCCC-----------Cc
Confidence 234567799999998888999999999999999999999998542 2222233332221111 11
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
......+.+++.+||..+|++||++.++++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 22345688899999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=298.47 Aligned_cols=245 Identities=33% Similarity=0.486 Sum_probs=193.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHH---HHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~---~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||+||+++.. +++.+|+|++......... ..+|+.++++++||||+++++++......++||||+.++
T Consensus 4 ~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 83 (260)
T PF00069_consen 4 VKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGG 83 (260)
T ss_dssp EEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTE
T ss_pred eEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccc
Confidence 468999999999999965 4678999999876544332 345899999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC----CCC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS----PSS 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~----~~~ 473 (606)
+|.+++... ..+++..+..++.|+++||++||+.++. |+||||+||++++++.++|+|||.+.... ...
T Consensus 84 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh~~~i~--H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 84 SLQDYLQKN-----KPLSEEEILKIAYQILEALAYLHSKGIV--HRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp BHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHHHTTEE--ESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred ccccccccc-----cccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccc
Confidence 999999832 2589999999999999999999999966 99999999999999999999999987531 122
Q ss_pred CCCCcccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTD-ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~-~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||++. +..++.++||||+|+++|+|++|..||...... +............... ....
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~--------~~~~ 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKRPLPS--------SSQQ 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHTHHHH--------HTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhcccccccc--------cccc
Confidence 345667799999998 888999999999999999999999999753100 1111111111110000 0011
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.+|++|||+.+++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112678999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=293.38 Aligned_cols=240 Identities=23% Similarity=0.352 Sum_probs=195.1
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
...+.||+|+||.||+|... ++..||+|.+..... ....+.+|++++++++|+||+++++++.++...++||||+++
T Consensus 7 ~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 7 TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 34567999999999999864 588999999875432 235688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++... ++++..+..++.|++.||+|||+.+++ |+||+|+||+++.++.++|+|||++.......
T Consensus 87 ~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~iv--H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06640 87 GSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEKKI--HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 158 (277)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcc--CcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence 9999998642 478889999999999999999999966 99999999999999999999999986554322
Q ss_pred -CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 -TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||++.+..++.++|+||||+++|||++|+.||....... ....+ .... ....
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~~-~~~~----------~~~~ 221 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------VLFLI-PKNN----------PPTL 221 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh------Hhhhh-hcCC----------CCCC
Confidence 2234567999999988889999999999999999999999996432111 11111 1000 0112
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 23456678899999999999999999999877
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=294.90 Aligned_cols=241 Identities=23% Similarity=0.351 Sum_probs=195.0
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
...+.||.|+||.||+|... +++.||+|.+..... ....+.+|+++++.++|+|++++++++.++...++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 34567999999999999854 689999999875432 235688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++... .+++..+..++.|++.|+.|||+.+++ |+||+|+||++++++.++|+|||+++.....
T Consensus 84 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~--h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 155 (274)
T cd06609 84 GSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKI--HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR 155 (274)
T ss_pred CcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHEEECCCCCEEEcccccceeeccccccc
Confidence 9999998743 589999999999999999999999966 9999999999999999999999998766543
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++||||||+++|||+||+.||..... ...... ..........+
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~------~~~~~~-~~~~~~~~~~~-------- 220 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP------MRVLFL-IPKNNPPSLEG-------- 220 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch------HHHHHH-hhhcCCCCCcc--------
Confidence 223455679999999988899999999999999999999999964321 111111 11111111100
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||..+|++|||+++++++
T Consensus 221 -~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 221 -NKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred -cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0134568889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=288.60 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=199.6
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCccC-H---HHHHHHHHHHcCCCCCCcccceEEEEeCCc
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS-E---KEFREKMEVVGSMDHENLVPLRAYYYSRDE 386 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 386 (606)
..+..++ ..+.||.|.-|+||+++.. ++..+|+|++.+.... + ...+.|-++|+.++||.+..+++.|..+..
T Consensus 74 l~l~~f~--llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 74 LGLRHFR--LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred cCHHHHH--HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 4444432 3567999999999999975 3589999999876543 2 346778899999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
.|+|||||+||+|..+++.+. ...++...++.++..|+.||+|||..||+ .|||||+||||.++|.+.|+||.++
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHmlGiv--YRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHMLGIV--YRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred eEEEEecCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhhcee--eccCCcceeEEecCCcEEeeecccc
Confidence 999999999999999998765 34689999999999999999999999966 9999999999999999999999876
Q ss_pred ccCCC---------------------------------C-C--------------------------CCCCcccccCccc
Q 037905 467 HLASP---------------------------------S-S--------------------------TPNRIDGYRAPEV 486 (606)
Q Consensus 467 ~~~~~---------------------------------~-~--------------------------~~~~~~~y~aPE~ 486 (606)
..... . . ...||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 31100 0 0 0123344999999
Q ss_pred cCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHH
Q 037905 487 TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAIN 566 (606)
Q Consensus 487 ~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~ 566 (606)
+.+...+.++|+|+|||++|||+.|..||.+..+++ .+ .+++.+. ..++..++......+||++
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl----~NIv~~~----------l~Fp~~~~vs~~akDLIr~ 370 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TL----RNIVGQP----------LKFPEEPEVSSAAKDLIRK 370 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hH----HHHhcCC----------CcCCCCCcchhHHHHHHHH
Confidence 999999999999999999999999999998754433 22 2222221 0122223455678899999
Q ss_pred ccCcCCCCCCC----HHHHHHH
Q 037905 567 CTAQYPDNRPS----MAEVTSQ 584 (606)
Q Consensus 567 Cl~~~P~~RPs----~~~v~~~ 584 (606)
.|.+||.+|.. ++||.+|
T Consensus 371 LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 371 LLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HhccChhhhhccccchHHhhcC
Confidence 99999999998 8888765
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=294.87 Aligned_cols=246 Identities=22% Similarity=0.330 Sum_probs=192.1
Q ss_pred HHHhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 319 RASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+...+.||+|+||.||+|+. .+++.||+|.++.... ....+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 34567899999999999985 4689999999875432 234578899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++... ..+++..+..++.|++.||.|||+.|++ |+||||+||+++.++.++|+|||++......
T Consensus 91 ~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 91 GSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKGKM--HRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 9999998743 2588999999999999999999999966 9999999999999999999999998654322
Q ss_pred CCCCCcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 STPNRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
....++..|+|||++. ...++.++|||||||++|||++|+.||....... .+.............
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~------ 231 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMTKSNFQPPKL------ 231 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhhccCCCCCcc------
Confidence 2235667899999874 4458889999999999999999999985422111 011111111111000
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.........+.+++.+||..+|++|||+.+|+++
T Consensus 232 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 232 -KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred -cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0001123457889999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=302.00 Aligned_cols=192 Identities=24% Similarity=0.360 Sum_probs=156.6
Q ss_pred cccccCCceEEEEEEEc---CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g 397 (606)
..||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence 46999999999999864 45789999987543 23467889999999999999999999864 4567899999875
Q ss_pred ChhhhhhcCCC----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe----cCCCcEEEeecccCccC
Q 037905 398 SLSALLHGNRG----AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL----SKSYEARISDFGLAHLA 469 (606)
Q Consensus 398 ~L~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill----~~~~~~kl~DfG~a~~~ 469 (606)
+|.+++..... .....+++..+..++.||+.||+|||+.+++ ||||||+|||+ +.++.+||+|||+++..
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv--H~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVL--HRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEE--cCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 78777653211 1233588999999999999999999999966 99999999999 56678999999999765
Q ss_pred CCCC-------CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccc
Q 037905 470 SPSS-------TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQAL 518 (606)
Q Consensus 470 ~~~~-------~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~ 518 (606)
.... ...++..|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 4321 2245677999999876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.25 Aligned_cols=244 Identities=22% Similarity=0.293 Sum_probs=189.2
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
...+.||+|+||.||+++.. +++.+|+|++..... ....+.+|+.+++.++||||+++++++......++||||+
T Consensus 46 ~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~ 125 (371)
T cd05622 46 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYM 125 (371)
T ss_pred EEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCC
Confidence 34578999999999999864 688999999864321 2345778999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++|+|.+++... .++...+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++.....
T Consensus 126 ~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~iv--HrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 126 PGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFI--HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred CCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCEE--eCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 999999998642 378888899999999999999999966 9999999999999999999999999765432
Q ss_pred ---CCCCCcccccCccccCCCC----CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 ---STPNRIDGYRAPEVTDARK----VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~~----~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....+|+.|+|||++.... ++.++|||||||++|||++|+.||... +.......+........+
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~~~--- 268 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD------SLVGTYSKIMNHKNSLTF--- 268 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCcccC---
Confidence 2345778899999986543 789999999999999999999999642 222222333221111111
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDN--RPSMAEVTSQI 585 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~v~~~L 585 (606)
+........+.+++.+|+...+.+ ||++.++.++.
T Consensus 269 -----~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 269 -----PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred -----CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111123345677888999743433 78999988864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=298.62 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=193.7
Q ss_pred hcccccCCceEEEEEEEc-CCc----EEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGI----VVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|... +|. .||+|.+...... ..++.+|+.+++.++||||++++++|... ..++++||+
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~ 90 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM 90 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence 467999999999999853 343 5788988654322 34688999999999999999999998754 567999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
++|+|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++......
T Consensus 91 ~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~iv--H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 91 PHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERRLV--HRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcCee--ccccccceeeecCCCceEEccccccccccCccc
Confidence 9999999987532 2578999999999999999999999966 99999999999999999999999997654321
Q ss_pred -----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 -----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 -----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
....+..|+|||++.+..++.++||||||+++|||++ |+.||..... .........+...
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~~------- 230 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-------REIPDLLEKGERL------- 230 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCCC-------
Confidence 1123456999999998899999999999999999998 8999864211 1111122211110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.....+...+.+++.+||..+|++||++.++++.|+++.+..
T Consensus 231 ---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 231 ---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 011123356889999999999999999999999999987554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=309.66 Aligned_cols=251 Identities=19% Similarity=0.227 Sum_probs=190.2
Q ss_pred HHHhcccccCCceEEEEEEEc---CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 319 RASAEVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
+...+.||+|+||.||++... .+..||+|.+... +.+.+|++++++++||||+++++++......++|||++.
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 169 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK 169 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC
Confidence 344678999999999999743 3578999987643 345689999999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
++|.+++... ..+++..++.++.||+.||+|||++|++ ||||||+|||++.++.++|+|||+++......
T Consensus 170 -~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~giv--HrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~ 241 (392)
T PHA03207 170 -CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRGII--HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241 (392)
T ss_pred -CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence 5888888432 3589999999999999999999999966 99999999999999999999999987654321
Q ss_pred ----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc---c---cc----
Q 037905 474 ----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE---E---WT---- 539 (606)
Q Consensus 474 ----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~---~~---- 539 (606)
...++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+..+... . +.
T Consensus 242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS---SSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc---HHHHHHHHHHhccCccccCCccc
Confidence 23567889999999999999999999999999999999999975432211 1111111110 0 00
Q ss_pred ----------ccccchhhhcccCh--HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 540 ----------AEVFDLELLRYQNV--EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 540 ----------~~~~d~~~~~~~~~--~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+........ ......+.+++.+||..||++|||+.+++.+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 0113457788999999999999999999886
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=303.45 Aligned_cols=241 Identities=25% Similarity=0.386 Sum_probs=200.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|.||.||+++.+ +|+.+|+|++.+... +...+.+|+.+|+++. |||||.+.+.|.+....++|||++.
T Consensus 40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~ 119 (382)
T KOG0032|consen 40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE 119 (382)
T ss_pred hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence 467999999999999865 499999999976543 3468999999999998 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC----CcEEEeecccCccCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS----YEARISDFGLAHLASP 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~----~~~kl~DfG~a~~~~~ 471 (606)
||.|.+.+... .+++..+..++.|++.++.|||+.|++ ||||||+|+|+... +.+|++|||++.....
T Consensus 120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvv--HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVV--HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCce--eccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 99999999853 289999999999999999999999966 99999999999643 4799999999988776
Q ss_pred C---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 472 S---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 472 ~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
. ....+|+.|+|||++....|+..+||||+||++|.|++|.+||....... ....+....+ +..
T Consensus 192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~------~~~~i~~~~~-----~f~-- 258 (382)
T KOG0032|consen 192 GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE------IFLAILRGDF-----DFT-- 258 (382)
T ss_pred CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH------HHHHHHcCCC-----CCC--
Confidence 3 34578899999999999999999999999999999999999997643221 1112223222 111
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.+........+++.+++..||.+|+|+.++++|
T Consensus 259 -~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 259 -SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 12233445567778889999999999999999996
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=302.28 Aligned_cols=255 Identities=24% Similarity=0.299 Sum_probs=185.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCC---CCCCcccceEEEEeC-----CceEE
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSM---DHENLVPLRAYYYSR-----DEKLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~~~~l 389 (606)
.+.||+|+||.||+|... +++.||+|.++.... ....+.+|+++++.+ +||||+++++++... ...++
T Consensus 5 ~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~l 84 (288)
T cd07863 5 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTL 84 (288)
T ss_pred eeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEE
Confidence 467999999999999854 689999999875322 223456677666554 799999999988642 45789
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||||+.+ +|.+++.... ...+++..+..++.|++.||+|||++|++ ||||||+||+++.++.+||+|||+++..
T Consensus 85 v~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~iv--H~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 85 VFEHVDQ-DLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANCIV--HRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred EEccccc-CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEECCCCCEEECccCccccc
Confidence 9999985 8988887533 23589999999999999999999999966 9999999999999999999999999765
Q ss_pred CCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHH---hhcccccc--
Q 037905 470 SPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSV---VKEEWTAE-- 541 (606)
Q Consensus 470 ~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~-- 541 (606)
... ....++..|+|||++.+..++.++|||||||++|||++|++||......+ .+....... ....+...
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhhCccccc
Confidence 432 22345677999999988889999999999999999999999996422111 000100000 00000000
Q ss_pred ----ccchhhhc--ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 542 ----VFDLELLR--YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 542 ----~~d~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.+.... ....++....+.+++.+|++.||++|||+.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 237 LPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=309.89 Aligned_cols=242 Identities=27% Similarity=0.383 Sum_probs=196.2
Q ss_pred ccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 324 VLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
+||+|.||+||-|+. .+...+|||-+..... ..+-+..|+.+.++++|.|||+++|.|..+++.-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 699999999999984 4577899999875432 23457889999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec-CCCcEEEeecccCccCCC----CCCCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS-KSYEARISDFGLAHLASP----SSTPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG~a~~~~~----~~~~~ 476 (606)
++...- ++..=++.++-.+..||++||.|||+..|+ |||||-+|||++ ..|.+||+|||-++.... ..++.
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~IV--HRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENKIV--HRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhccee--eccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 998543 333337888889999999999999999866 999999999996 578999999998876543 34567
Q ss_pred CcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 477 RIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 477 ~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
+|..|||||++.. +.|+.++|||||||++.||.||++||-...... ...++-+... ..++.+.
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGmyK-------vHP~iPe 802 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGMYK-------VHPPIPE 802 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhhhhccee-------cCCCCcH
Confidence 8888999999975 468999999999999999999999997543211 1122222211 1133456
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+...+...++.+|..+||.+||+++++++.
T Consensus 803 elsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 667788899999999999999999999763
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=299.42 Aligned_cols=240 Identities=23% Similarity=0.358 Sum_probs=193.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||.|+||.||+|.. .+++.||+|.+..... ..+.+.+|+.+++.++|||++++++++......++|+||+++++|
T Consensus 24 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 103 (296)
T cd06655 24 YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103 (296)
T ss_pred EEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcH
Confidence 46799999999999974 5689999999865433 356788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----CC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----TP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~ 475 (606)
.+++... .+++..+..++.+++.||+|||+.+++ ||||||+||+++.++.+||+|||++....... ..
T Consensus 104 ~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~i~--H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 104 TDVVTET------CMDEAQIAAVCRECLQALEFLHANQVI--HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 9998632 488999999999999999999999966 99999999999999999999999887544321 23
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ......+.... ... ...+..
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~------~~~~~~~~~~~-~~~--------~~~~~~ 240 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNG-TPE--------LQNPEK 240 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-Ccc--------cCCccc
Confidence 456679999999988899999999999999999999999964321 11111111110 000 011122
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||..+|++|||+.+++++
T Consensus 241 ~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 33567889999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=292.25 Aligned_cols=239 Identities=25% Similarity=0.384 Sum_probs=191.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 390 (606)
.+.||+|+||.||+|.. .++..+|+|.+...... .+.+.+|++++++++||||+++++++......++|
T Consensus 5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (267)
T cd06628 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84 (267)
T ss_pred cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence 45799999999999985 45789999988654221 14578899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
|||+++++|.+++... ..+++..+..++.|++.||+|||+.+++ ||||+|+||++++++.++|+|||.++...
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~iv--H~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 85 LEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRGII--HRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcCcc--cccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999743 2578889999999999999999999966 99999999999999999999999987654
Q ss_pred CCC----------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 471 PSS----------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 471 ~~~----------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
... ...++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+..... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~-- 228 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKIGE-NA-- 228 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHHhc-cC--
Confidence 211 12345679999999888899999999999999999999999975321 111111111 00
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. ...+......+.+++.+||+.+|++||++.+|+++
T Consensus 229 ---~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 ---S-----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---C-----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0 01112234568889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.46 Aligned_cols=253 Identities=20% Similarity=0.204 Sum_probs=188.9
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
...+.||+|+||.||++... .++.||||... ...+.+|++++++++|+||+++++++...+..++|||++. ++
T Consensus 172 ~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~ 245 (461)
T PHA03211 172 AIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SD 245 (461)
T ss_pred EEEEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CC
Confidence 34578999999999999864 57889999643 2346789999999999999999999999999999999995 68
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC------
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS------ 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------ 472 (606)
|.+++.... ..+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 246 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~gIv--HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 246 LYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEGII--HRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEE--ECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 888886432 3589999999999999999999999966 9999999999999999999999999765322
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccccccc-CCCChhHHHHHHhhcccc-c-ccc---c--
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNE-EGVDLPRWVQSVVKEEWT-A-EVF---D-- 544 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~-~-~~~---d-- 544 (606)
....+|..|+|||++.+..++.++|||||||++|||++|..|+...... ........+..++..... . +.. .
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 1234678899999999999999999999999999999987665332211 111111112222211100 0 000 0
Q ss_pred --------------hhhhc--ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 --------------LELLR--YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 --------------~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.... +.........+.+++.+||+.||.+|||+.|++++
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 00001112367889999999999999999999875
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=297.17 Aligned_cols=244 Identities=22% Similarity=0.357 Sum_probs=191.8
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
...+.||+|+||.||+|+.. ++..+|+|.+..... ..+.+.+|+++++.++|+|++++++++..+...++||||++++
T Consensus 15 ~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 94 (292)
T cd06644 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGG 94 (292)
T ss_pred hhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCC
Confidence 34677999999999999864 589999999875432 2456888999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|..++.... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||.+...... .
T Consensus 95 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~--H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 168 (292)
T cd06644 95 AVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMKII--HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD 168 (292)
T ss_pred cHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCCee--ecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence 9988876432 2589999999999999999999999966 9999999999999999999999988654322 2
Q ss_pred CCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 474 TPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+....... ...
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~------- 234 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-PPT------- 234 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-Ccc-------
Confidence 234566799999984 34578899999999999999999999864221 11111111110 000
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..........+.+++.+||..+|++||++.+++++
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 -LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01112334568889999999999999999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.44 Aligned_cols=254 Identities=24% Similarity=0.276 Sum_probs=187.7
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv 390 (606)
..+.||+|+||.||++.. ..++.||||++..... ....+.+|+.+++.++||||+++++++... ...++|
T Consensus 21 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 100 (355)
T cd07874 21 NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLV 100 (355)
T ss_pred EEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEE
Confidence 357899999999999984 4688999999875432 235677899999999999999999988643 346899
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
|||+++ +|.+.+.. .+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++...
T Consensus 101 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~giv--HrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 101 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred hhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 999976 67666642 378889999999999999999999966 99999999999999999999999998654
Q ss_pred CC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC---------CChhHH-------HH
Q 037905 471 PS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG---------VDLPRW-------VQ 531 (606)
Q Consensus 471 ~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~---------~~~~~~-------~~ 531 (606)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||......+. .....+ +.
T Consensus 171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (355)
T cd07874 171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_pred CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHH
Confidence 42 223567789999999998999999999999999999999999965321100 000000 00
Q ss_pred HHhhccc-cccccchhhhc-------ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 532 SVVKEEW-TAEVFDLELLR-------YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 532 ~~~~~~~-~~~~~d~~~~~-------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....... ......+.... ..........+.+++.+|++.||++|||+.|++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 00000000000 00011123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=291.91 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=192.6
Q ss_pred hcccccCCceEEEEEEEc----CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCC------ceE
Q 037905 322 AEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRD------EKL 388 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~ 388 (606)
.+.||+|+||.||+|... ++..||||++...... .+++.+|++++++++||||+++++++.... ..+
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 83 (273)
T cd05074 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM 83 (273)
T ss_pred hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence 467999999999999753 4689999998764332 356889999999999999999999886532 247
Q ss_pred EEEeecCCCChhhhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 389 LVHDYMPMGSLSALLHGNRG-AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
+++||+.+|+|.+++..... .....+++.....++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||.++
T Consensus 84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~--H~dikp~nili~~~~~~kl~dfg~~~ 161 (273)
T cd05074 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFI--HRDLAARNCMLNENMTVCVADFGLSK 161 (273)
T ss_pred EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe--ecccchhhEEEcCCCCEEECcccccc
Confidence 88999999999988754321 1223578899999999999999999999966 99999999999999999999999987
Q ss_pred cCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 468 LASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 468 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
...... .......|++||.+....++.++||||||+++|||++ |+.||..... ......+......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~~- 234 (273)
T cd05074 162 KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN------SEIYNYLIKGNRL- 234 (273)
T ss_pred cccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH------HHHHHHHHcCCcC-
Confidence 654321 1223356999999988889999999999999999999 8898864311 1111111111100
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 235 ----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 ----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 01122345789999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=294.85 Aligned_cols=247 Identities=19% Similarity=0.349 Sum_probs=193.8
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
...+.||+|+||.||++... ++..||+|.++.... ....+.+|++++++++|+||+++++++......++||||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 34577999999999999865 789999998875322 235688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 473 (606)
++|..++.... ....+++..+..++.+++.||.|||+. +++ ||||||+||+++.++.+||+|||.++..... .
T Consensus 84 ~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~--H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 84 GSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHNII--HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred CCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEe--eCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 99999887532 123589999999999999999999974 755 9999999999999999999999998765332 2
Q ss_pred CCCCcccccCccccCCC------CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 TPNRIDGYRAPEVTDAR------KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~------~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...++..|+|||++.+. .++.++|||||||++|||++|+.||...... .....+..+.... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~-~-------- 227 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLSAIVDGD-P-------- 227 (286)
T ss_pred cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHHHHhhcC-C--------
Confidence 33456679999998543 3588999999999999999999999642111 1111111111110 0
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+......+.+++.+||..+|++||++.+++++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 --PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11122345678899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=303.49 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=187.4
Q ss_pred HHHhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceE
Q 037905 319 RASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKL 388 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 388 (606)
|...+.||+|+||.||+|.. .++..||||++..... ..+.+.+|++++++++||||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 34467899999999999985 5688999999875422 235577899999999999999999887533 3568
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 389 LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
++++++ +++|.+++.. ..+++..+..++.||+.||+|||+.+++ ||||||+||+++.++.+||+|||+++.
T Consensus 97 ~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~iv--Hrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 97 LVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAGII--HRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred EEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCee--cccCChhhEEECCCCCEEEcCCcccee
Confidence 999987 6799888763 2489999999999999999999999966 999999999999999999999999976
Q ss_pred CCCC-CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc--ccccc--
Q 037905 469 ASPS-STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE--WTAEV-- 542 (606)
Q Consensus 469 ~~~~-~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-- 542 (606)
.... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+..+.... ...+.
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07878 168 ADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY------IDQLKRIMEVVGTPSPEVLK 241 (343)
T ss_pred cCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHH
Confidence 5442 23456778999999876 5689999999999999999999999964211 11111110000 00000
Q ss_pred -cch--------hhhccc--C----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 -FDL--------ELLRYQ--N----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 -~d~--------~~~~~~--~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.. .+.... . .......+.+++.+|+..||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000000 0 00112346789999999999999999999977
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.84 Aligned_cols=236 Identities=22% Similarity=0.272 Sum_probs=181.3
Q ss_pred cccCCceEEEEEEEc-CCcEEEEEEeccCccC----HHHHHHHHHHHcCC---CCCCcccceEEEEeCCceEEEEeecCC
Q 037905 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS----EKEFREKMEVVGSM---DHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 325 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
||+|+||.||+|+.. +++.||||++...... ...+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 6899999998653221 12344555665544 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
|+|..++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~iv--HrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~ 153 (330)
T cd05586 81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYDIV--YRDLKPENILLDATGHIALCDFGLSKANLTDNKTT 153 (330)
T ss_pred ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--eccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCc
Confidence 9999988743 2588999999999999999999999966 999999999999999999999999875422 1
Q ss_pred CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....++..|+|||++.+. .++.++|||||||++|||++|+.||... +.......+...... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~------~~~~~~~~i~~~~~~-------~~~-- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE------DTQQMYRNIAFGKVR-------FPK-- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC------CHHHHHHHHHcCCCC-------CCC--
Confidence 234567889999998754 4899999999999999999999999642 122222222211100 000
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCC----CHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRP----SMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RP----s~~~v~~~ 584 (606)
......+.+++.+||..+|++|| ++.+++++
T Consensus 219 --~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 219 --NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred --ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 11234567888999999999998 45665553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.01 Aligned_cols=241 Identities=23% Similarity=0.302 Sum_probs=186.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++... +++.||+|+++... .....+.+|+.++..++||||+++++.+.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~g 85 (360)
T cd05627 6 LKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPG 85 (360)
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 467999999999999854 68999999997532 1235678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
|+|.+++... ..+++..+..++.|++.||+|||+.|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 86 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~giv--HrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 86 GDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLGFI--HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred ccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--ccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 9999998753 2588999999999999999999999966 9999999999999999999999998643211
Q ss_pred -----------------------------------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 473 -----------------------------------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 473 -----------------------------------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
....+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence 123467789999999999999999999999999999999999964
Q ss_pred ccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHH
Q 037905 518 LLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS---MAEVTSQ 584 (606)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~~v~~~ 584 (606)
... ......+........ +. .. .....++.+++.+++ .+|++|++ +.++.++
T Consensus 239 ~~~------~~~~~~i~~~~~~~~-~p----~~---~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 239 ETP------QETYRKVMNWKETLV-FP----PE---VPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCH------HHHHHHHHcCCCcee-cC----CC---CCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 321 112222221110000 00 00 012234566666665 49999985 6677665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=289.08 Aligned_cols=242 Identities=21% Similarity=0.316 Sum_probs=192.9
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC-CceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR-DEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~ 395 (606)
..+.||+|++|.||++... +++.||+|++..... ..+.+.+|++++++++|+|++++++.+... ...+++|||++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (257)
T cd08223 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83 (257)
T ss_pred EEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccC
Confidence 3578999999999999854 578999999865432 235688899999999999999999887643 45789999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+++|.+++.... ...+++.++..++.+++.|++|||+.+++ ||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~i~--H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 158 (257)
T cd08223 84 GGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKHIL--HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM 158 (257)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence 999999997543 23589999999999999999999999966 9999999999999999999999998755332
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....++..|+|||+..+..++.++||||||++++||++|+.||... +.......+.. +... .
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~------~~~~~~~~~~~-~~~~----------~ 221 (257)
T cd08223 159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK------DMNSLVYRIIE-GKLP----------P 221 (257)
T ss_pred cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHh-cCCC----------C
Confidence 2234566799999999988999999999999999999999998642 22222222211 1110 1
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||+.+|++|||+.+++++
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 112344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=295.74 Aligned_cols=245 Identities=24% Similarity=0.372 Sum_probs=194.1
Q ss_pred HHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 319 RASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.+.+.||+|+||.||++... ++..+|+|.+..... ..+.+.+|++++++++||||+++++++..+...++||||+++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 345677999999999999864 689999999875432 335688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++.... ..+++..+..++.|++.||.|||+.+++ |+||||+||+++.++.++|+|||.+......
T Consensus 87 ~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~i~--h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 87 GALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHKVI--HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 99999987532 3589999999999999999999999966 9999999999999999999999988654332
Q ss_pred CCCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 473 STPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
....++..|+|||++. ...++.++||||||+++|||++|+.||.... ............. .
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~------- 226 (280)
T cd06611 161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN------PMRVLLKILKSEP-P------- 226 (280)
T ss_pred ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC------HHHHHHHHhcCCC-C-------
Confidence 1234567799999874 3457789999999999999999999996431 1111111111110 0
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 -TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001112234567889999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=292.74 Aligned_cols=241 Identities=27% Similarity=0.357 Sum_probs=188.4
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
..||+|+||.||+|.. .++..||+|.+..... ..+.+.+|+++++.++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 4699999999999985 4678899998875433 3457899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-CCcEEEeecccCccCCCC----C
Q 037905 401 ALLHGNRGAGRTPL--NWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-SYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 401 ~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~----~ 473 (606)
+++.... ..+ ++..+..++.||+.||+|||+++++ ||||||+||+++. ++.++|+|||.+...... .
T Consensus 94 ~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~i~--h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 167 (268)
T cd06624 94 ALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQIV--HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE 167 (268)
T ss_pred HHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCCEe--ecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence 9997532 124 7788889999999999999999966 9999999999986 678999999998654321 1
Q ss_pred CCCCcccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 474 TPNRIDGYRAPEVTDAR--KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~--~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
...++..|+|||++... .++.++||||||+++|+|++|+.||....... ...+....... ...
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~~------------~~~ 232 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFKI------------HPE 232 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhcc------------CCC
Confidence 23456779999998654 37889999999999999999999996432111 00000000000 001
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+......+.+++.+||+.+|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 112234568889999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=290.45 Aligned_cols=241 Identities=23% Similarity=0.362 Sum_probs=196.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||++.. .+|+.||+|.+..... ..+++.+|+.++++++||||+++.+++....+.++|+||+.++
T Consensus 5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd08218 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG 84 (256)
T ss_pred EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence 46799999999999985 4689999999865322 2357889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++.... ...+++..+..++.|++.||+|||+.+++ |+||+|+||+++.++.++|+|||.+.......
T Consensus 85 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~--h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 85 DLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRKIL--HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEe--cCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 9999987533 23578899999999999999999999966 99999999999999999999999987654321
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||+..+..++.++||||||+++++|++|+.||... +....+..+...... ..+
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~------~~~~~~~~~~~~~~~-----------~~~ 222 (256)
T cd08218 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG------NMKNLVLKIIRGSYP-----------PVS 222 (256)
T ss_pred hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC------CHHHHHHHHhcCCCC-----------CCc
Confidence 233566799999999888999999999999999999999998632 222233333222110 111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||+.+|++||++.+|+++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2334568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=293.29 Aligned_cols=253 Identities=20% Similarity=0.304 Sum_probs=191.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|... +|+.||+|++..... ..+.+.+|++++++++|+|++++++++......++||||++++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 85 (286)
T cd07847 6 LSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT 85 (286)
T ss_pred eeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCcc
Confidence 467999999999999865 589999999865322 2356789999999999999999999999999999999999998
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
.|..++... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||++.......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~i~--H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07847 86 VLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCHKHNCI--HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT 158 (286)
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCce--ecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence 888876532 2589999999999999999999999966 99999999999999999999999987654432
Q ss_pred CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh------------ccccc
Q 037905 474 TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK------------EEWTA 540 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~ 540 (606)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ......... ..+..
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhcccccccc
Confidence 2334567999999876 4578999999999999999999999975322110 000000000 00000
Q ss_pred cccchhhhcccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLRYQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+....... .......+.+++.+||+.+|++|||+.|++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000000000000 01124568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=297.82 Aligned_cols=246 Identities=23% Similarity=0.358 Sum_probs=189.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEe-----CCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYS-----RDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~~lv~e~~ 394 (606)
.+.||+|+||.||++.. .+++.+|+|++........++.+|+.+++++ +||||+++++++.. +...++||||+
T Consensus 23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 102 (286)
T cd06638 23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC 102 (286)
T ss_pred eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence 46799999999999985 4578999998876444456788999999998 69999999998852 34679999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++++|.+++..... ....+++..+..++.|++.||.|||+.++. ||||||+||++++++.+||+|||+++.....
T Consensus 103 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 179 (286)
T cd06638 103 NGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNKTI--HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 179 (286)
T ss_pred CCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCCcc--ccCCCHHhEEECCCCCEEEccCCceeecccCCC
Confidence 99999998764321 123588899999999999999999999866 9999999999999999999999998754332
Q ss_pred --CCCCCcccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 --STPNRIDGYRAPEVTDA-----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....++..|+|||++.. ..++.++|||||||++|||++|+.||....... . ....... ......
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~-~~~~~~~-~~~~~~-- 250 (286)
T cd06638 180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----A-LFKIPRN-PPPTLH-- 250 (286)
T ss_pred ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----H-Hhhcccc-CCCccc--
Confidence 22346677999998753 457889999999999999999999986432111 0 1100000 000000
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.+......+.+++.+||+.+|++|||+.|++++.
T Consensus 251 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 251 ------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111234688899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=286.53 Aligned_cols=244 Identities=24% Similarity=0.382 Sum_probs=194.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|... +++.+|+|.+..... ..+.+.+|++++++++||||+++++++......+++|||+++++|
T Consensus 8 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l 87 (262)
T cd06613 8 IQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL 87 (262)
T ss_pred EEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcH
Confidence 467999999999999864 578899999875432 356789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++.... ..++...+..++.|++.||+|||+.+++ |+||+|+||++++++.+||+|||.+...... ...
T Consensus 88 ~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~i~--h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 161 (262)
T cd06613 88 QDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETGKI--HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF 161 (262)
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCce--ecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence 99987542 3588999999999999999999999966 9999999999999999999999998765432 123
Q ss_pred CCcccccCccccCCC---CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 476 NRIDGYRAPEVTDAR---KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~---~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
.++..|+|||.+... .++.++||||||+++|||++|+.||....... ............. ....
T Consensus 162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~~~~~~~~~~-------~~~~ 228 (262)
T cd06613 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFLISKSNFPPP-------KLKD 228 (262)
T ss_pred cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccCCCc-------cccc
Confidence 455679999998776 78999999999999999999999996532111 1111111111000 0111
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||..+|.+|||+.+|+.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 229 KEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred hhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 23345678899999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=295.78 Aligned_cols=244 Identities=21% Similarity=0.350 Sum_probs=190.2
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEe------CCceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYS------RDEKLLVH 391 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~ 391 (606)
...+.||+|+||.||+|.. .+++.+|+|++........++..|+.++.++ +|+|++++++++.. ....+++|
T Consensus 19 ~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~ 98 (282)
T cd06636 19 ELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVM 98 (282)
T ss_pred hhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEE
Confidence 3356899999999999985 4689999999876554556788899998888 79999999999863 35679999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+.+++|.+++.... ...+++..+..++.|++.||+|||+.+++ |+||+|+||++++++.++|+|||+++....
T Consensus 99 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~iv--H~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 99 EFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHKVI--HRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 9999999999997543 23578888999999999999999999966 999999999999999999999999875432
Q ss_pred ----CCCCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccc
Q 037905 472 ----SSTPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 472 ----~~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
.....++..|+|||.+. ...++.++|||||||++|||++|+.||....... . ...... ....
T Consensus 174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-----~-~~~~~~-~~~~-- 244 (282)
T cd06636 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-----A-LFLIPR-NPPP-- 244 (282)
T ss_pred cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----h-hhhHhh-CCCC--
Confidence 12234567799999875 3467889999999999999999999996432111 0 000000 0000
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. .........+.+++.+||..+|.+|||+.||+++
T Consensus 245 ---~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 245 ---K----LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---C----CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 0112234578899999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=294.08 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=189.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|+.. ++..||+|+++.... ..+.+.+|+.++++++|||++++++++..+...++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (285)
T cd07861 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-M 83 (285)
T ss_pred eeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-C
Confidence 467999999999999864 689999999865322 23678899999999999999999999999999999999997 5
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++..... ...+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++......
T Consensus 84 ~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~--H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 84 DLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRRVL--HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCCee--ecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 89888865331 24689999999999999999999999966 99999999999999999999999987543221
Q ss_pred CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHh---hcccc--cccc--ch
Q 037905 474 TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV---KEEWT--AEVF--DL 545 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~--d~ 545 (606)
...++..|+|||++.+ ..++.++||||||+++|||+||+.||......+ .......... ...+. .... ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLPDYKN 237 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhHHHHh
Confidence 2234567999998865 457889999999999999999999996422110 0000000000 00000 0000 00
Q ss_pred hhhcc------cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRY------QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..... ........++.+++.+||..||++|||+.+|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 238 TFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 0001133567789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=306.03 Aligned_cols=254 Identities=23% Similarity=0.295 Sum_probs=187.7
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv 390 (606)
..+.||+|+||.||++.. ..++.||||++..... ....+.+|+.+++.++||||+++++++... ...++|
T Consensus 28 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv 107 (364)
T cd07875 28 NLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 107 (364)
T ss_pred EEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEE
Confidence 357899999999999985 4588999999875422 245678899999999999999999987543 356999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
|||+++ +|.+.+.. .+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++...
T Consensus 108 ~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 108 MELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred EeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCee--cCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 999976 77777642 378889999999999999999999966 99999999999999999999999998654
Q ss_pred CC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC---------CCChhHHHHH------
Q 037905 471 PS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE---------GVDLPRWVQS------ 532 (606)
Q Consensus 471 ~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~------ 532 (606)
.. ....++..|+|||++.+..++.++|||||||++|||++|+.||......+ +...+.+...
T Consensus 178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (364)
T cd07875 178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVR 257 (364)
T ss_pred CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHH
Confidence 42 23456778999999999999999999999999999999999996532111 0000000000
Q ss_pred -Hhhccc-cccc-cc---hhhhcc---cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 533 -VVKEEW-TAEV-FD---LELLRY---QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 533 -~~~~~~-~~~~-~d---~~~~~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...... .... .. +..... .........+.+++.+|++.||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 258 TYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 0000 00 000000 0001123467899999999999999999999886
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=288.27 Aligned_cols=242 Identities=30% Similarity=0.466 Sum_probs=195.6
Q ss_pred hcccccCCceEEEEEEEcC-----CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLEM-----GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+++... +..||+|+++.... ..+.+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus 4 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~ 83 (258)
T smart00219 4 GKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYM 83 (258)
T ss_pred cceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEecc
Confidence 4679999999999998653 48899999976544 3567999999999999999999999999989999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST 474 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 474 (606)
++++|.+++..... ..+++..+..++.|++.||+|||+.+++ |+||||+||+++.++.++|+|||.++.......
T Consensus 84 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~~~--h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 84 EGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKNFI--HRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred CCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCCee--ecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999975431 1289999999999999999999999966 999999999999999999999999876544311
Q ss_pred -----CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 475 -----PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 475 -----~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
...+..|+|||.+.+..++.++||||||+++++|++ |+.||... +.....+.+.... ..
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~------~~~~~~~~~~~~~-~~-------- 223 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM------SNEEVLEYLKKGY-RL-------- 223 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------CHHHHHHHHhcCC-CC--------
Confidence 224567999999988889999999999999999998 88888642 2222222222211 11
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.........+.+++.+||..+|++|||+.|+++.|
T Consensus 224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 --PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112445688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=293.99 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=194.5
Q ss_pred hcccccCCceEEEEEEEc------CCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
...||+|+||.||+|+.. ....|++|.+...... .+++.+|++++++++|+||+++++++......++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 89 (275)
T cd05046 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEY 89 (275)
T ss_pred eeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEe
Confidence 467999999999999853 3467999988654332 46789999999999999999999999888899999999
Q ss_pred cCCCChhhhhhcCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 394 MPMGSLSALLHGNRGAG----RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
+++++|.+++....... ...+++..+..++.|++.||+|||+.++. ||||||+||+++.++.++++|||+++..
T Consensus 90 ~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~--H~dlkp~Nili~~~~~~~l~~~~~~~~~ 167 (275)
T cd05046 90 TDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFV--HRDLAARNCLVSSQREVKVSLLSLSKDV 167 (275)
T ss_pred cCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcc--cCcCccceEEEeCCCcEEEccccccccc
Confidence 99999999997543111 12589999999999999999999999966 9999999999999999999999998654
Q ss_pred CCCC-----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 470 SPSS-----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 470 ~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
.... ....+..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...+........ .
T Consensus 168 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~------~~~~~~~~~~~~-~--- 237 (275)
T cd05046 168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------EEVLNRLQAGKL-E--- 237 (275)
T ss_pred CcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch------HHHHHHHHcCCc-C---
Confidence 3211 1223445999999988888999999999999999999 7889864321 112222111111 0
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
.......+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 238 ------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 ------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0011223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=290.86 Aligned_cols=247 Identities=22% Similarity=0.368 Sum_probs=192.9
Q ss_pred hcccccCCceEEEEEEEcC--CcEEEEEEeccCc--------c---CHHHHHHHHHHHcC-CCCCCcccceEEEEeCCce
Q 037905 322 AEVLGKGTFGTAYKATLEM--GIVVAVKRLKDVT--------V---SEKEFREKMEVVGS-MDHENLVPLRAYYYSRDEK 387 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~---~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~ 387 (606)
.+.||+|+||.||+|.... +..+|+|.+.... . ...++.+|+.++.+ ++||||+++++++...+..
T Consensus 5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 84 (269)
T cd08528 5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL 84 (269)
T ss_pred hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence 4679999999999999754 7889999875321 1 12346678887764 7999999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 388 LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++ |+||+|+||+++.++.+||+|||.+
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~--H~dl~~~nil~~~~~~~~l~dfg~~ 161 (269)
T cd08528 85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKRIV--HRDLTPNNIMLGEDDKVTITDFGLA 161 (269)
T ss_pred EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCcee--ecCCCHHHEEECCCCcEEEecccce
Confidence 999999999999998854221 13458899999999999999999996 5655 9999999999999999999999998
Q ss_pred ccCCCCC---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 467 HLASPSS---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 467 ~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
....... ...++..|+|||++.+..++.++||||||+++|||++|+.||... .............+.. .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~-~- 233 (269)
T cd08528 162 KQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------NMLSLATKIVEAVYEP-L- 233 (269)
T ss_pred eecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc------CHHHHHHHHhhccCCc-C-
Confidence 7654432 234566799999999888999999999999999999999998642 1222222222211110 0
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
........+.+++.+||+.+|++||++.|+..++++
T Consensus 234 --------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 234 --------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred --------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 001223568889999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=320.98 Aligned_cols=253 Identities=26% Similarity=0.383 Sum_probs=205.8
Q ss_pred HHhcccccCCceEEEEEEEc--------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceE
Q 037905 320 ASAEVLGKGTFGTAYKATLE--------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKL 388 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 388 (606)
...+.||+|+||.|++|... ....||||.++.... ..+.+..|+++++.+ +|+||+.++|+|...+..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 44568999999999999732 156799999986544 356799999999998 6999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCC---------CCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc
Q 037905 389 LVHDYMPMGSLSALLHGNR---------GAGR--TPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE 457 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~ 457 (606)
+|+||+..|+|.++++..+ .... ..+.....+.++.|||.||+||++...+ ||||.++|||+.++..
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v--HRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV--HRDLAARNVLITKNKV 456 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc--chhhhhhhEEecCCCE
Confidence 9999999999999999766 1111 2388999999999999999999999855 9999999999999999
Q ss_pred EEEeecccCccCCCCCCC-----C--CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHH
Q 037905 458 ARISDFGLAHLASPSSTP-----N--RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRW 529 (606)
Q Consensus 458 ~kl~DfG~a~~~~~~~~~-----~--~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 529 (606)
+||+|||+|+........ . -...|||||.+....|+.++|||||||+||||+| |..||.+.. ...+.
T Consensus 457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~-----~~~~l 531 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP-----PTEEL 531 (609)
T ss_pred EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC-----cHHHH
Confidence 999999999865442221 1 1234999999999999999999999999999999 999996521 01222
Q ss_pred HHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 530 VQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 530 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
++ .++.+. +...+..+..+++++|+.||+.+|++||++.++++.++....
T Consensus 532 ~~-~l~~G~----------r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 532 LE-FLKEGN----------RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HH-HHhcCC----------CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 22 344433 223445567789999999999999999999999999999643
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=299.00 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=188.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+.. ++..||+|.++... .....+.+|+.++++++||||+++++++......++||||+. ++
T Consensus 11 ~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~ 89 (301)
T cd07873 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KD 89 (301)
T ss_pred eeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cC
Confidence 467999999999999854 58899999986532 234567889999999999999999999999999999999997 48
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----T 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~ 474 (606)
|.+++.... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++...... .
T Consensus 90 l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~i~--H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (301)
T cd07873 90 LKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRKVL--HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN 163 (301)
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--CCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence 988887532 3578899999999999999999999966 99999999999999999999999987543221 2
Q ss_pred CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc---cccccccc------
Q 037905 475 PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE---EWTAEVFD------ 544 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d------ 544 (606)
..++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ........... .......+
T Consensus 164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhccccccc
Confidence 234667999998865 457889999999999999999999996532111 00000000000 00000000
Q ss_pred hhhhcc--cC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRY--QN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~--~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...... .. .......+.+++.+|+..||.+|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000 00 01123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=294.04 Aligned_cols=242 Identities=25% Similarity=0.386 Sum_probs=192.8
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
...+.||+|+||.||+|... +++.||+|++..... ..+++.+|+++++.++|||++++.++|...+..++|+||+
T Consensus 18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 97 (307)
T cd06607 18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC 97 (307)
T ss_pred hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhh
Confidence 34577999999999999854 689999999864322 1246889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST 474 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 474 (606)
.+ ++.+++.... ..+++..+..++.|++.||.|||+.+++ ||||+|+||++++++.++|+|||++........
T Consensus 98 ~g-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~i~--H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~ 170 (307)
T cd06607 98 LG-SASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHERI--HRDIKAGNILLTEPGTVKLADFGSASLVSPANS 170 (307)
T ss_pred CC-CHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCCce--ecCCCcccEEECCCCCEEEeecCcceecCCCCC
Confidence 74 7777765322 2589999999999999999999999966 999999999999999999999999987665555
Q ss_pred CCCcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 475 PNRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 475 ~~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
..++..|+|||++. ...++.++||||||+++|||++|+.||.... ............ ... .
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~------~~~~~~~~~~~~-~~~---------~ 234 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQND-SPT---------L 234 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc------HHHHHHHHhcCC-CCC---------C
Confidence 66777899999874 4568899999999999999999999986421 111111111110 000 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||..+|++||++.+|+.+
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 112345678999999999999999999999885
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.03 Aligned_cols=245 Identities=24% Similarity=0.370 Sum_probs=190.6
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeC-----CceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSR-----DEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----~~~~lv~e~~ 394 (606)
.+.||+|+||.||++.. .+++.+|+|++.........+.+|+.+++++ +|||++++++++... ...++||||+
T Consensus 27 ~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~ 106 (291)
T cd06639 27 IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELC 106 (291)
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEEC
Confidence 45799999999999986 4688999999876555567788899999988 899999999998754 3579999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++++|.++++.... ....+++..+..++.|++.||+|||+.+++ ||||||+||++++++.+||+|||.++.....
T Consensus 107 ~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iv--H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 183 (291)
T cd06639 107 NGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNRII--HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL 183 (291)
T ss_pred CCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHHEEEcCCCCEEEeecccchhcccccc
Confidence 99999998864221 123588999999999999999999999966 9999999999999999999999998764432
Q ss_pred --CCCCCcccccCccccCCC-----CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 --STPNRIDGYRAPEVTDAR-----KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~-----~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....++..|+|||++... .++.++|||||||++|||++|+.||..... ...+..+.... ....
T Consensus 184 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~~--- 253 (291)
T cd06639 184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP------VKTLFKIPRNP-PPTL--- 253 (291)
T ss_pred cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH------HHHHHHHhcCC-CCCC---
Confidence 223456679999987543 368899999999999999999999964321 11111111110 0000
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.........+.+++.+||+.+|++||++.+++++
T Consensus 254 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 254 -----LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred -----CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1112234568899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=287.58 Aligned_cols=242 Identities=23% Similarity=0.378 Sum_probs=194.3
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
..+.||+|+||.||++.. .++..+|+|.+..... ..+.+.+|++++++++|||++++++.+......++||||+++
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd08220 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPG 83 (256)
T ss_pred EEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCC
Confidence 356799999999999985 4688999999865432 245688999999999999999999999888999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCCC--
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPSS-- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~-- 473 (606)
++|.+++.... ...+++..+..++.+++.||+|||+++++ |+||+|+||++++++ .+||+|||.++......
T Consensus 84 ~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~i~--h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~ 158 (256)
T cd08220 84 GTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKLIL--HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158 (256)
T ss_pred CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence 99999997543 23578999999999999999999999966 999999999998654 58999999987654322
Q ss_pred -CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 -TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||... +....+......... . .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~------~~~~~~~~~~~~~~~-~----------~ 221 (256)
T cd08220 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA------NLPALVLKIMSGTFA-P----------I 221 (256)
T ss_pred cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC------chHHHHHHHHhcCCC-C----------C
Confidence 234566799999999888999999999999999999999998642 222222222221110 0 1
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+......+.+++.+||..+|++|||+.|++++
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.36 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=186.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+++.. +++.||+|++.... ...+.+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (331)
T cd05597 6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG 85 (331)
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence 467999999999999854 58999999986422 1234588899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|+|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 86 GDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLGYV--HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeE--ECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 99999997422 3588899999999999999999999966 99999999999999999999999987544322
Q ss_pred --CCCCcccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 --TPNRIDGYRAPEVTDA-----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
...++..|+|||++.. ..++.++|||||||++|||++|+.||... ........+........+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~------~~~~~~~~i~~~~~~~~~---- 229 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKEHFQF---- 229 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC------CHHHHHHHHHcCCCcccC----
Confidence 1346788999999863 45788999999999999999999999642 222222222221110000
Q ss_pred hhcccChHHHHHHHHHHHHHccC--cCCCCCCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTA--QYPDNRPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~--~~P~~RPs~~~v~~~ 584 (606)
..........+.+++.+|+. .++..||++.+++++
T Consensus 230 ---~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ---PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ---CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00011123445666667554 444458899999888
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=305.85 Aligned_cols=244 Identities=23% Similarity=0.359 Sum_probs=197.8
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+...||.|+||.||+|..+ .+...|-|++..... .-++|.-|+++|..++||+||++++.|+.++..+++.|||.||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 34667999999999999854 355566777754332 3467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----CC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----SS 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~~ 473 (606)
....++-.-. ..+...++..+++|++.||.|||+++|+ |||||+.|||+.-+|.++|+|||.+..... ..
T Consensus 115 AVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~iI--HRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 115 AVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQNII--HRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred hHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcchh--hhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 9998886543 3589999999999999999999999866 999999999999999999999998765432 45
Q ss_pred CCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 474 TPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
.+.||++|||||+.. ...|++++||||||++|.||..+.+|...... .+.+..+.. . +|+
T Consensus 189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaK-S------ePP-- 253 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAK-S------EPP-- 253 (1187)
T ss_pred cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhh-c------CCC--
Confidence 688999999999875 46799999999999999999999999865322 121111111 1 111
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..-.+..+...+.+++.+|+..+|..||++.+++++
T Consensus 254 TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 112346677889999999999999999999999876
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=290.92 Aligned_cols=239 Identities=22% Similarity=0.320 Sum_probs=185.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc------CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV------SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 392 (606)
.+.||+|+||.||+|.. .++..||+|++..... ....+.+|++++++++||||+++++++... ...++++|
T Consensus 7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e 86 (266)
T cd06651 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME 86 (266)
T ss_pred cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence 46799999999999985 4689999998864321 124578899999999999999999988753 56789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.... .+++.....++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~i~--H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 87 YMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNMIV--HRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCee--eCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 999999999997432 478899999999999999999999866 9999999999999999999999998754321
Q ss_pred -------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 -------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 -------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...+........ .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~-----~- 227 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT-----N- 227 (266)
T ss_pred cccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC-----C-
Confidence 112356679999999988899999999999999999999999964211 111111111110 0
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+......+.+++ +||..+|++||+++||+++
T Consensus 228 ----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 228 ----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 111122234455555 6888999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.77 Aligned_cols=246 Identities=26% Similarity=0.405 Sum_probs=193.0
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCC------ceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRD------EKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~lv~e 392 (606)
..+.||+|+||.||+|... +++.+++|++.......+.+.+|+++++++ .|+||+++++++.... ..++|||
T Consensus 10 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e 89 (275)
T cd06608 10 LVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89 (275)
T ss_pred heeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEE
Confidence 3577999999999999864 578999999887665667899999999998 7999999999997644 4799999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++..... ....+++..+..++.|++.||+|||+.++. |+||+|+||++++++.+||+|||.+......
T Consensus 90 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~i~--H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 166 (275)
T cd06608 90 LCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENKVI--HRDIKGQNILLTKNAEVKLVDFGVSAQLDST 166 (275)
T ss_pred cCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCCcc--cCCCCHHHEEEccCCeEEECCCccceecccc
Confidence 9999999999875321 124688999999999999999999999966 9999999999999999999999998654332
Q ss_pred ----CCCCCcccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 473 ----STPNRIDGYRAPEVTDA-----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 473 ----~~~~~~~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
....++..|+|||++.. ..++.++||||||+++|+|++|+.||...... ......... ...
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~~~--- 236 (275)
T cd06608 167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFKIPRN-PPP--- 236 (275)
T ss_pred hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHHhhcc-CCC---
Confidence 22345667999998753 34778999999999999999999999642111 111111111 000
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...........+.+++.+||..||++|||+.+++++
T Consensus 237 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 237 -----TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -----CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111122345678899999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=306.71 Aligned_cols=241 Identities=25% Similarity=0.387 Sum_probs=192.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccC-----ccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCc--eEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDV-----TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDE--KLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e~ 393 (606)
..+||+|+|-+||+|.. .+|..||.-.++.. ....+.|..|+.+|+.|+||||++++.+|.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 34699999999999974 35777875444321 1223679999999999999999999999987655 6789999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-CCcEEEeecccCccCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-SYEARISDFGLAHLASPS 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~ 472 (606)
+..|+|+.|+...+ .++...+..|++||++||.|||++.++|+|||||-+||||+. .|.|||+|+|+|+....+
T Consensus 125 ~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred ccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999998654 578889999999999999999999999999999999999975 589999999999876553
Q ss_pred --CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 --STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....||+.|||||... ..|++..||||||+.+.||+|+..||....+ ....++.+.... .+..+. +.
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SGi-KP~sl~----kV 268 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSGI-KPAALS----KV 268 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcCC-CHHHhh----cc
Confidence 3457999999999987 6899999999999999999999999986533 223333333322 111111 11
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. ..++.++|.+|+.. .++|||+.|++++
T Consensus 269 ~-----dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 K-----DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred C-----CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1 13577888899999 8999999999875
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=289.97 Aligned_cols=245 Identities=25% Similarity=0.377 Sum_probs=190.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---C--------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---S--------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKL 388 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 388 (606)
..+.||+|+||.||+|.. .+|+.+|+|.++.... . .+.+.+|+++++.++|+|++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 356799999999999974 4689999998853211 0 135778999999999999999999999999999
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 389 LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+.+++ ||||+|+||+++.++.++|+|||+++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKGIL--HRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred EEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCee--ecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999754 3588899999999999999999999966 999999999999999999999999875
Q ss_pred CCCC------CCCCCcccccCccccCCCC--CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 469 ASPS------STPNRIDGYRAPEVTDARK--VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 469 ~~~~------~~~~~~~~y~aPE~~~~~~--~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
.... ....++..|+|||.+.... ++.++||||||+++||+++|..||..... ... ......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~~~~~-~ 230 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAA-MFKLGNKRS-A 230 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHH-HHHhhcccc-C
Confidence 4321 1223556799999987654 78999999999999999999999853211 111 111111110 0
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+.. ....+....+.+++.+||.++|++|||+.+|+++
T Consensus 231 ~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 231 PPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00110 1112234678889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=324.92 Aligned_cols=245 Identities=20% Similarity=0.292 Sum_probs=188.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|... ++..||+|.+...... ...+..|+.++++++||||++++++|... ...++||||++
T Consensus 18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~ 97 (1021)
T PTZ00266 18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD 97 (1021)
T ss_pred EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence 567999999999999854 5788999998754332 35688999999999999999999988653 46899999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCCCCCCCCCCEEecC----------------
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG-----PANSHGNIKSSNILLSK---------------- 454 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~i~HrDlkp~Nill~~---------------- 454 (606)
+++|.+++..... ....+++..++.|+.||+.||+|||+.+ -.|+||||||+||||+.
T Consensus 98 gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n 176 (1021)
T PTZ00266 98 AGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176 (1021)
T ss_pred CCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence 9999999975321 1236899999999999999999999854 12559999999999964
Q ss_pred -CCcEEEeecccCccCCCC---CCCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhH
Q 037905 455 -SYEARISDFGLAHLASPS---STPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 455 -~~~~kl~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~ 528 (606)
.+.+||+|||+++..... ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....
T Consensus 177 g~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-----~~~q 251 (1021)
T PTZ00266 177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-----NFSQ 251 (1021)
T ss_pred CCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-----cHHH
Confidence 335899999999765432 23456788999999854 458899999999999999999999996421 2222
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+..+ .... +.. .......+.+|+..||..+|++||++.|++.+
T Consensus 252 li~~l-k~~p-----~lp------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 252 LISEL-KRGP-----DLP------IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred HHHHH-hcCC-----CCC------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 22211 1110 000 01123568899999999999999999999854
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=296.85 Aligned_cols=239 Identities=22% Similarity=0.344 Sum_probs=191.4
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
..||+|+||.||++.. .++..||+|.+.... ...+.+.+|+.+++.++|||++++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 4699999999999985 468999999986533 23456889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCCC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STPN 476 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~ 476 (606)
.++.. ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++..... ....
T Consensus 107 ~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~iv--H~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 107 DIVSQ------TRLNEEQIATVCESVLQALCYLHSQGVI--HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred HHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 98753 2478999999999999999999999966 9999999999999999999999998654322 2234
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|+|||++.+..++.++||||||+++|||++|+.||..... ...+... ....... .......
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~-~~~~~~~--------~~~~~~~ 243 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP------VQAMKRL-RDSPPPK--------LKNAHKI 243 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-hccCCCC--------ccccCCC
Confidence 56779999999988899999999999999999999999964211 1111111 1110000 0011122
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+.+++.+||+.+|++||++.+++++
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 3457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=301.62 Aligned_cols=244 Identities=22% Similarity=0.263 Sum_probs=187.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.++||+|+||.||+++.. +++.+|+|++.... .....+.+|+.++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~ 85 (332)
T cd05623 6 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVG 85 (332)
T ss_pred EEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCC
Confidence 467999999999999864 57889999986432 1234578899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|+|.+++.... ..+++..+..++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~ii--HrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 86 GDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLHYV--HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--ecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 99999997532 2588999999999999999999999966 99999999999999999999999986543221
Q ss_pred --CCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 --TPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
...++..|+|||++. ...++.++|||||||++|||++|+.||... +.......+........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~------~~~~~~~~i~~~~~~~~----- 228 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKERFQ----- 228 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC------CHHHHHHHHhCCCcccc-----
Confidence 235678899999986 345889999999999999999999999642 22222332222111000
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCC--CCCCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYP--DNRPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P--~~RPs~~~v~~~ 584 (606)
...........+.+++.+|+..++ ..|+++.+++++
T Consensus 229 --~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 --FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred --CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 001112233456777778775444 447899999887
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=287.98 Aligned_cols=246 Identities=23% Similarity=0.348 Sum_probs=196.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||++... +++.+|+|.+..... ..+.+.+|++++++++||||+++++++......++++||+++++
T Consensus 6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (265)
T cd06605 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS 85 (265)
T ss_pred HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence 467999999999999865 689999999876532 34568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--CCC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--STP 475 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 475 (606)
|.+++.... ..++...+..++.|++.||+|||+ .+++ |+||||+||++++++.++|+|||.+...... ...
T Consensus 86 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~--H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 86 LDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHKII--HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred HHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCCee--cCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 999997542 358889999999999999999999 8866 9999999999999999999999998654321 124
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||++.+..++.++||||||+++|+|++|+.||..... ........++....... ... ....
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~-~~~---------~~~~ 228 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIVNEPP-PRL---------PSGK 228 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHhcCCC-CCC---------Chhh
Confidence 456679999999998999999999999999999999999965321 11122222222222110 000 0111
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||..+|++|||+.+++.+
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 229 FSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 44568899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=288.86 Aligned_cols=242 Identities=29% Similarity=0.393 Sum_probs=192.2
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
..+.||+|+||.||+|... ++..||+|.++.... ..+.+.+|++++++++|+||+++++++......++|+||+++
T Consensus 4 ~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06626 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSG 83 (264)
T ss_pred eeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCC
Confidence 3567999999999999854 689999999976544 346788999999999999999999999988999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC--
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-- 474 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 474 (606)
++|.+++... ..+++..+..++.+++.||+|||+.++. |+||+|+||++++++.+||+|||++........
T Consensus 84 ~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~i~--H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 84 GTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHGIV--HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999753 2478889999999999999999999966 999999999999999999999999876543211
Q ss_pred ------CCCcccccCccccCCCC---CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 475 ------PNRIDGYRAPEVTDARK---VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 475 ------~~~~~~y~aPE~~~~~~---~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
..++..|+|||++.+.. ++.++||||||+++|||++|+.||...... ......... ....
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~----- 225 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-----FQIMFHVGA-GHKP----- 225 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-----HHHHHHHhc-CCCC-----
Confidence 23456799999998766 889999999999999999999999643211 011111110 0000
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 583 (606)
. .+........+.+++.+||+.+|++|||+.+++.
T Consensus 226 ~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 P---IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred C---CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0011112456778999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=288.80 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=195.3
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||.|+||.||+|.. .++..+|+|++..... ..+.+.+|++.++.++|+|++++++.+......++|+||+++++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (267)
T cd06610 6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS 85 (267)
T ss_pred eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence 46799999999999985 4688999999865432 34678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC----
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST---- 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---- 474 (606)
|.+++..... ...+++..+..++.|++.||+|||+.+++ ||||+|+||++++++.++|+|||++........
T Consensus 86 l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~i~--h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 161 (267)
T cd06610 86 LLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNGQI--HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161 (267)
T ss_pred HHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHhEEEcCCCCEEEcccchHHHhccCcccccc
Confidence 9999975431 23588999999999999999999999966 999999999999999999999998865543221
Q ss_pred ----CCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 475 ----PNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 475 ----~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
..++..|+|||++... .++.++|+||||+++|||++|+.||...... ........... +....
T Consensus 162 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~~------~~~~~ 229 (267)
T cd06610 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQNDP------PSLET 229 (267)
T ss_pred ccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCCC------CCcCC
Confidence 2356679999998776 7899999999999999999999999643221 11111111110 00000
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..........+.+++.+||..+|++|||+++|+++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 01112344668899999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=287.47 Aligned_cols=239 Identities=25% Similarity=0.376 Sum_probs=193.3
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..+.||+|+||.||+|.. .++..||+|.+..... ..+.+.+|++.+++++||||+++++++..+...++||||++++
T Consensus 8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06641 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 87 (277)
T ss_pred hheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCC
Confidence 456799999999999985 4689999998865432 2356889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++... .+++..+..++.+++.|+.|||+.++. |+||+|+||+++.++.++|+|||++.......
T Consensus 88 ~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~i~--h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 88 SALDLLEPG------PLDETQIATILREILKGLDYLHSEKKI--HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCCee--cCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence 999998632 478999999999999999999999966 99999999999999999999999987554321
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++|||||||++|+|++|..||..... ......+.... .. ...
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~----------~~~ 222 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLIPKNN-PP----------TLE 222 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHHhcCC-CC----------CCC
Confidence 22356679999999888889999999999999999999999964221 11111111110 00 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||+.+|++||++.+++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2234567889999999999999999999996
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=294.51 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=189.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++||||+++++++......++|+||++++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 85 (286)
T cd07846 6 LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85 (286)
T ss_pred eeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCcc
Confidence 467999999999999975 589999999865332 2456889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.++.... ..+++..+..++.|++.||+|||+.++. |+||+|+||++++++.++|+|||+++......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~--h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (286)
T cd07846 86 VLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHNII--HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT 158 (286)
T ss_pred HHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence 998876532 2489999999999999999999999966 99999999999999999999999987653322
Q ss_pred CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh---c-----------c-
Q 037905 474 TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK---E-----------E- 537 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~-----------~- 537 (606)
...++..|+|||++.+ ..++.++||||||+++|||++|++||..... ......+.. . .
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD------IDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch------HHHHHHHHHHhCCCchhhHHHhccch
Confidence 2234567999999875 4478899999999999999999999864221 010100000 0 0
Q ss_pred ccccccchhhhc----ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 WTAEVFDLELLR----YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ~~~~~~d~~~~~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.... ..........+.+++.+||..+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 000000000000 00011234668899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=301.79 Aligned_cols=244 Identities=22% Similarity=0.268 Sum_probs=187.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+++.. +++.||+|++.... .....+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus 6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g 85 (331)
T cd05624 6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG 85 (331)
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence 567999999999999864 57899999986532 1234578899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|+|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~ii--HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 86 GDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLHYV--HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCee--eccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 99999997532 2588899999999999999999999966 99999999999999999999999987654322
Q ss_pred --CCCCcccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 --TPNRIDGYRAPEVTDA-----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
...++.+|+|||++.+ ..++.++||||||+++|||++|+.||... +.......+........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~------~~~~~~~~i~~~~~~~~----- 228 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHEERFQ----- 228 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC------CHHHHHHHHHcCCCccc-----
Confidence 2346788999999875 46788999999999999999999999642 12222222221110000
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDN--RPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~v~~~ 584 (606)
...........+.+++.+|+..++++ |++++++.++
T Consensus 229 --~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 --FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred --CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00111122345777888888765544 5688888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=293.06 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=190.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|... +++.||||+++..... ...+..|++++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (298)
T cd07841 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM 84 (298)
T ss_pred eeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc
Confidence 467999999999999864 6899999999754322 345778999999999999999999999989999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
+++|.+++.... ..+++..+..++.||++||+|||+++++ |+||||+||+++.++.++|+|||+++......
T Consensus 85 -~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~--H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 85 -ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNWIL--HRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred -CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--ecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 889999997532 2589999999999999999999999966 99999999999999999999999987654422
Q ss_pred ---CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-------cc----
Q 037905 474 ---TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE-------EW---- 538 (606)
Q Consensus 474 ---~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~---- 538 (606)
....+..|+|||++.+ ..++.++|||||||++|||++|.+||...... .....+... .+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI------DQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH------HHHHHHHHHcCCCchhhhhhcc
Confidence 1233556999998854 45789999999999999999998887642211 111111100 00
Q ss_pred -cccccchhhhc----ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 539 -TAEVFDLELLR----YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 539 -~~~~~d~~~~~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........... ..........+.+++.+||+++|++|||+.|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 00012234678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=285.03 Aligned_cols=240 Identities=24% Similarity=0.344 Sum_probs=192.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|+++++.++|+||+++++++......++++||+
T Consensus 5 ~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (258)
T cd06632 5 GELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELV 84 (258)
T ss_pred cceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEec
Confidence 467999999999999865 789999999865321 2356889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++++|.+++... ..+++..+..++.|++.||+|||+.+++ |+||+|+||+++.++.+||+|||.+......
T Consensus 85 ~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~ 157 (258)
T cd06632 85 PGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRNTV--HRDIKGANILVDTNGVVKLADFGMAKQVVEFSF 157 (258)
T ss_pred CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence 999999999743 2478999999999999999999999966 9999999999999999999999988754432
Q ss_pred -CCCCCcccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 -STPNRIDGYRAPEVTDARK-VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ..............
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~---------- 221 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELP---------- 221 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCC----------
Confidence 2234566799999987766 89999999999999999999999964321 11111111101010
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+......+.+++.+||+.+|++||++.+++.+
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0111233567889999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=287.67 Aligned_cols=254 Identities=22% Similarity=0.296 Sum_probs=193.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~ 396 (606)
.+.||.|++|.||++.. .+++.+|+|.+..... ....+.+|++++++++||||++++++|... ...++||||+++
T Consensus 6 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 85 (287)
T cd06621 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEG 85 (287)
T ss_pred EEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCC
Confidence 35799999999999986 4589999999875433 345688999999999999999999998654 367999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--CC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--ST 474 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 474 (606)
++|.+++..... ....++...+..++.|++.||+|||+.+++ |+||+|+||+++.++.++|+|||++...... ..
T Consensus 86 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~--H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 162 (287)
T cd06621 86 GSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRKII--HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT 162 (287)
T ss_pred CCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEEecCCeEEEeecccccccccccccc
Confidence 999988764221 234578899999999999999999999966 9999999999999999999999998754432 22
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ............ .......+. .....
T Consensus 163 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~----~~~~~ 236 (287)
T cd06621 163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVN-MPNPELKDE----PGNGI 236 (287)
T ss_pred ccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhc-CCchhhccC----CCCCC
Confidence 345567999999998899999999999999999999999997542211 111111111111 000000000 00001
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+.+++.+||+.+|++|||+.|++++
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 237 KWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred chHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 234568899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=291.16 Aligned_cols=239 Identities=23% Similarity=0.323 Sum_probs=200.1
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|-|+.|-+|+ .-+|+.||||++.+... +...+.+|+.-|+.++|||||+++.+...+...|||.|+-++|
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence 4569999999999997 46799999999987654 4567899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe-cCCCcEEEeecccCccCCCCC---
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill-~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
+|++++.... ..+.+..+.+++.||..|+.|+|+..++ ||||||+||.+ .+-|-+||.|||++-...+..
T Consensus 103 Dl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLHVV--HRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 103 DLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLHVV--HRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred hHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhhhh--cccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 9999997543 3589999999999999999999999866 99999999865 567899999999997776654
Q ss_pred CCCCcccccCccccCCCCCC-CcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTDARKVS-QKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~-~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
+..+...|-|||++.+..|+ ++.||||||||||-+++|++||+...+.+. +..+.... +.-
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------LTmImDCK------------Ytv 238 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------LTMIMDCK------------YTV 238 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------hhhhhccc------------ccC
Confidence 45566679999999999996 679999999999999999999987654432 12222222 223
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.....++.+||..|+..||++|-|.++|+..
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 34556678889999999999999999988764
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=293.54 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=192.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|... +++.||+|.+...... .+.+..|+++++.++|+||+++++++......++||||+.+
T Consensus 6 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (316)
T cd05574 6 IKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPG 85 (316)
T ss_pred eeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCC
Confidence 467999999999999865 4899999999765432 34688899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.... ...+++..+..++.|++.||+|||+.+++ |+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 86 GELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLGIV--YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred CCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCCee--ccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999987432 24589999999999999999999999966 99999999999999999999999876432211
Q ss_pred ------------------------------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC
Q 037905 474 ------------------------------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG 523 (606)
Q Consensus 474 ------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~ 523 (606)
...++..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-- 238 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD-- 238 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH--
Confidence 123456799999999888999999999999999999999999643211
Q ss_pred CChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCC----HHHHHHH
Q 037905 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS----MAEVTSQ 584 (606)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs----~~~v~~~ 584 (606)
.....+..... ...........+.+++.+||..+|++||| +.+++++
T Consensus 239 ----~~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 ----ETFSNILKKEV----------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred ----HHHHHHhcCCc----------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11111111110 00111113467889999999999999999 6666664
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=293.54 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=187.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|... +|+.||+|+++.... ....+.+|++++++++||||+++++++.+....++|+||+.+
T Consensus 5 ~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 83 (284)
T cd07839 5 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ- 83 (284)
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-
Confidence 467999999999999864 689999999865322 235678899999999999999999999999999999999975
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++.... ..+++..+..++.||++||.|||+++++ ||||||+||+++.++.+||+|||+++......
T Consensus 84 ~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~i~--H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (284)
T cd07839 84 DLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHNVL--HRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157 (284)
T ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--cCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence 7888776432 3589999999999999999999999966 99999999999999999999999987654321
Q ss_pred CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc-------c--ccccc
Q 037905 474 TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE-------W--TAEVF 543 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~--~~~~~ 543 (606)
...++..|+|||++.+. .++.++|||||||++|||+||+.|+.... +.......+.... + .....
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC-----CHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 23345679999998764 47899999999999999999988864211 1111111111000 0 00000
Q ss_pred chh-hhcc-------cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLE-LLRY-------QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~-~~~~-------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.. .... .........+.+++.+||+.||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000 0000 0011233567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=288.08 Aligned_cols=243 Identities=22% Similarity=0.351 Sum_probs=192.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||++.. .+++.||+|++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999984 5689999999864331 135688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPS 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~ 472 (606)
+++++|.+++... .++++..+..++.|++.||+|||++|++ |+||+|+||+++.++ .+||+|||.+......
T Consensus 85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~i~--H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 85 MAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQII--HRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred cCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 9999999999743 2578999999999999999999999966 999999999998876 5999999998765432
Q ss_pred C--------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 S--------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 ~--------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
. ...++..|+|||.+.+..++.++||||+|+++++|++|+.||...... ..............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~------ 228 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS---NHLALIFKIASATT------ 228 (268)
T ss_pred cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc---chHHHHHHHhccCC------
Confidence 1 123456799999998888999999999999999999999999642211 11111111111100
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+......+.+++.+||..+|++|||+.+++++
T Consensus 229 ----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 229 ----APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred ----CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 011122344678889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=290.18 Aligned_cols=245 Identities=26% Similarity=0.381 Sum_probs=194.8
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||.||+++. .++..||+|++..... ....+.+|++++++++|||++++++++..+...++||||+.
T Consensus 29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 108 (317)
T cd06635 29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL 108 (317)
T ss_pred hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence 456799999999999985 4689999999864322 12468889999999999999999999999999999999997
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP 475 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 475 (606)
+ +|.+.+.... .++++..+..++.+++.||.|||+.+++ ||||+|+||+++.++.+||+|||++.........
T Consensus 109 g-~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~i~--H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (317)
T cd06635 109 G-SASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNMI--HRDIKAGNILLTEPGQVKLADFGSASIASPANSF 181 (317)
T ss_pred C-CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCcccEEECCCCCEEEecCCCccccCCcccc
Confidence 5 7777775432 3589999999999999999999999966 9999999999999999999999998876655556
Q ss_pred CCcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 476 NRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 476 ~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
.++..|+|||++. ...++.++||||||+++|||++|+.||.... .............. ...
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~~~~~----------~~~ 245 (317)
T cd06635 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNESP----------TLQ 245 (317)
T ss_pred cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHhccCC----------CCC
Confidence 6777899999973 4568899999999999999999999986421 11111111111110 011
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.......+.+++.+||+.+|++||++.+|++++-..
T Consensus 246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 123345688899999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=290.83 Aligned_cols=242 Identities=26% Similarity=0.395 Sum_probs=195.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|... ++..+|+|++.......+.+.+|+++++.++|+|++++++++......++|+||+++++|.
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT 103 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence 456999999999999865 6889999999765445667889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCCC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STPN 476 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~ 476 (606)
+++.... ..+++..+..++.+++.||+|||+.|++ |+||+|+||+++.++.++|+|||.+...... ....
T Consensus 104 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~--H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 177 (286)
T cd06614 104 DIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVI--HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177 (286)
T ss_pred HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCee--eCCCChhhEEEcCCCCEEECccchhhhhccchhhhcccc
Confidence 9998642 3689999999999999999999999966 9999999999999999999999987654332 2233
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|+|||++.+..++.++||||||+++|+|++|+.||..... ......+.... ... .......
T Consensus 178 ~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~------~~~~~~~~~~~-~~~--------~~~~~~~ 242 (286)
T cd06614 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP------LRALFLITTKG-IPP--------LKNPEKW 242 (286)
T ss_pred CCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-CCC--------CcchhhC
Confidence 55679999999888899999999999999999999999864211 11111111111 000 1111223
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+.+++.+||+.+|.+|||+.+++++
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 4568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=289.62 Aligned_cols=244 Identities=23% Similarity=0.385 Sum_probs=186.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC--HHHHHHHHHH-HcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS--EKEFREKMEV-VGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||++... +|+.||+|+++..... ...+..|+.. ++..+||||+++++++..+...++||||++ +
T Consensus 6 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~ 84 (283)
T cd06617 6 IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-T 84 (283)
T ss_pred EEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-c
Confidence 467999999999999864 6899999998765332 3445556654 566789999999999999999999999997 5
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
+|.+++...... ...+++..+..++.|++.||+|||++ ++. ||||||+||+++.++.+||+|||+++......
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~--h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (283)
T cd06617 85 SLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHSKLSVI--HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT 161 (283)
T ss_pred cHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCee--cCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 888887653222 24689999999999999999999987 765 99999999999999999999999987654321
Q ss_pred CCCCcccccCccccCC----CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 474 TPNRIDGYRAPEVTDA----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~----~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..... ....+........ ... .
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~-~~~-----~- 229 (283)
T cd06617 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-----PFQQLKQVVEEPS-PQL-----P- 229 (283)
T ss_pred cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-----CHHHHHHHHhcCC-CCC-----C-
Confidence 2345667999998865 4578899999999999999999999963211 1111111111110 000 0
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+..+.+++.+||..+|++||++.+++++
T Consensus 230 ---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 230 ---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01134568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=291.05 Aligned_cols=240 Identities=24% Similarity=0.368 Sum_probs=190.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
...||+|+||.||++.. .++..||||.+..... ..+.+.+|+..++.++|+|++++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 35699999999999985 4688999999865432 345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++.. ..+++..+..++.||+.||+|||+++++ ||||||+||++++++.++|+|||++...... ...
T Consensus 107 ~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~iv--H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 107 TDIVTH------TRMNEEQIATVCLSVLRALSYLHNQGVI--HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCEe--ecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 998853 2478899999999999999999999966 9999999999999999999999998654321 123
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||++.+..++.++||||||+++|||++|+.||..... ...+.. ......... .....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~-~~~~~~~~~--------~~~~~ 243 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------LQAMRR-IRDNLPPRV--------KDSHK 243 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhcCCCcc--------ccccc
Confidence 456679999999888899999999999999999999999864211 111111 111100000 00112
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||..+|++|||+++++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 23457788889999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=284.31 Aligned_cols=238 Identities=21% Similarity=0.279 Sum_probs=191.6
Q ss_pred cccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 325 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
||.|+||.||+++.. +++.+|+|++..... ..+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999864 489999999875432 235688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---CCCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---STPN 476 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~ 476 (606)
.+++.... .+++..+..++.|++.||+|||+.+++ |+||+|+||+++.++.++|+|||.++..... ....
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~~~--h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~ 153 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRGII--YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC 153 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCcc--cCCCCHHHEEEcCCCCEEEeeCCcccccCccccccccc
Confidence 99997532 478899999999999999999999966 9999999999999999999999998766543 2234
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|+|||.+....++.++|+||||+++|||++|..||..... +.......+..... ....+...
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~----------~~~~~~~~ 219 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKGNG----------KLEFPNYI 219 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhccCC----------CCCCCccc
Confidence 56679999999888899999999999999999999999975321 12222222221110 00111222
Q ss_pred HHHHHHHHHHccCcCCCCCCC-----HHHHHH
Q 037905 557 MVQLLQLAINCTAQYPDNRPS-----MAEVTS 583 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~ 583 (606)
...+.+++.+||..+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 467899999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=298.24 Aligned_cols=250 Identities=20% Similarity=0.355 Sum_probs=195.1
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCC-CCCCcccceEEEEeCCce
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSM-DHENLVPLRAYYYSRDEK 387 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 387 (606)
|.+..-.|...++||+||.+.||++...+...+|+|++.....+ -..|.+|+..|.++ .|.+||++++|-..++..
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 55555567778899999999999999888888999887654443 35699999999999 599999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 388 LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
|+||||=+ .||..+|..... ....| .+..+..|++.|+.++|++||+ |.||||.|+|+-. |.+||+|||+|.
T Consensus 436 YmvmE~Gd-~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~gIV--HSDLKPANFLlVk-G~LKLIDFGIA~ 507 (677)
T KOG0596|consen 436 YMVMECGD-IDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQHGIV--HSDLKPANFLLVK-GRLKLIDFGIAN 507 (677)
T ss_pred EEEeeccc-ccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHhcee--ecCCCcccEEEEe-eeEEeeeechhc
Confidence 99999764 499999986432 22334 7788999999999999999966 9999999998865 589999999998
Q ss_pred cCCCCC------CCCCcccccCccccCCCC-----------CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHH
Q 037905 468 LASPSS------TPNRIDGYRAPEVTDARK-----------VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWV 530 (606)
Q Consensus 468 ~~~~~~------~~~~~~~y~aPE~~~~~~-----------~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~ 530 (606)
...... ...||..||+||.+.... ++.++||||+|||+|+|+.|++||....+ ..
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------~~ 579 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------QI 579 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------HH
Confidence 776643 356888899999875432 56789999999999999999999975321 11
Q ss_pred HHHhhccccccccchhh-hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 531 QSVVKEEWTAEVFDLEL-LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 531 ~~~~~~~~~~~~~d~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. ...+.||.. ..++..+ ...+++++|+.||+.||++|||+.+++++
T Consensus 580 aK------l~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 AK------LHAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HH------HHhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 11 122233321 1111111 12238999999999999999999999876
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=289.26 Aligned_cols=239 Identities=23% Similarity=0.276 Sum_probs=183.7
Q ss_pred ccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHH---HHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 324 VLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKME---VVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
+||+|+||.||++.. .+++.+|+|.+...... ...+.+|.. ++...+|||++.+.+++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999986 45899999998654321 223344443 3334479999999999998899999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--C
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--S 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 473 (606)
+++|.+++... ..+++..+..++.|++.||+|||+.+++ ||||||+||++++++.++|+|||++...... .
T Consensus 81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~iv--H~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 153 (279)
T cd05633 81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRFVV--YRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (279)
T ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcC--CCCCCHHHEEECCCCCEEEccCCcceeccccCcc
Confidence 99999988743 2589999999999999999999999966 9999999999999999999999998654322 2
Q ss_pred CCCCcccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTD-ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~-~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||.+. +..++.++|||||||++|||++|+.||....... . ......... . ....
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~-~~~~~~~~~------~-----~~~~ 218 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---K-HEIDRMTLT------V-----NVEL 218 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---H-HHHHHHhhc------C-----CcCC
Confidence 235677899999986 4568999999999999999999999997532211 1 111111000 0 0111
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
+......+.+++.+||..+|++|| |+++++++
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 123345688889999999999999 59988876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=283.84 Aligned_cols=242 Identities=25% Similarity=0.360 Sum_probs=197.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|++|.||+|+.. ++..||+|++..... ....+.+|+..+.+++|+|++++++++......++||||+++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (264)
T cd06623 6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS 85 (264)
T ss_pred eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence 467999999999999865 589999999876543 35679999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC---
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST--- 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 474 (606)
|.+++... ..++...+..++.|+++|++|||+ .+++ ||||+|+||+++.++.++|+|||.+........
T Consensus 86 L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~--H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 86 LADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRHII--HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCCCc--cCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 99999753 358999999999999999999999 9866 999999999999999999999999876544322
Q ss_pred -CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 475 -PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 475 -~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
..++..|+|||.+....++.++||||||+++|+|++|+.||..... .........+.... .. ...
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~~-~~----------~~~ 224 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ---PSFFELMQAICDGP-PP----------SLP 224 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc---cCHHHHHHHHhcCC-CC----------CCC
Confidence 2345669999999988899999999999999999999999975432 12222222222111 00 011
Q ss_pred HH-HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EE-EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~-~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. .+..+.+++.+||.++|++|||+.+++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11 44678899999999999999999999885
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=291.66 Aligned_cols=241 Identities=24% Similarity=0.356 Sum_probs=192.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
..+.||+|+||.||++.. .++..||+|.+..... ..+.+.+|+.++++++|||++++++++......++|+||+++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 102 (293)
T cd06647 23 RFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGS 102 (293)
T ss_pred eeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCc
Confidence 356799999999999974 4678999999864332 34568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----T 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~ 474 (606)
|.+++... .+++..+..++.|++.||.|||+.+++ ||||||+||+++.++.++|+|||++....... .
T Consensus 103 L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~gi~--H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (293)
T cd06647 103 LTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVI--HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174 (293)
T ss_pred HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCEe--eccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence 99998742 378889999999999999999999966 99999999999999999999999876544322 2
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..++..|+|||.+....++.++||||||+++|++++|+.||........ +....... .. ......
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~--------~~~~~~ 239 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG-TP--------ELQNPE 239 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCC-CC--------CCCCcc
Confidence 2355669999999888899999999999999999999999965322110 00000000 00 011112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+.+++.+||..+|++||++.+++.+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234568889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.34 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=191.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|... +++.||+|+++.... ..+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 85 (288)
T cd07833 6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT 85 (288)
T ss_pred EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence 467999999999999865 588999999875422 2467889999999999999999999999999999999999987
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
.+..+.... ..+++..+..++.||+.||+|||+.+++ |+||+|+||++++++.+||+|||.++......
T Consensus 86 ~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~i~--H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (288)
T cd07833 86 LLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHNII--HRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158 (288)
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHeEECCCCCEEEEeeecccccCCCccccc
Confidence 776655432 2488999999999999999999999966 99999999999999999999999987655432
Q ss_pred -CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHh------------hccc-
Q 037905 474 -TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV------------KEEW- 538 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------------~~~~- 538 (606)
...++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ ......... ....
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFSSNPRF 235 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcccCccc
Confidence 23345679999999887 78999999999999999999999996432110 000000000 0000
Q ss_pred ----cccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 539 ----TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 539 ----~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....++.......+.....++.+++++||..+|++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0000000000000111235678999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=283.82 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=193.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||++.. .++..+|+|++...... .+.+.+|++++++++|+||+++++++.. ....+++|||++
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~ 84 (265)
T cd08217 5 LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCE 84 (265)
T ss_pred eeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhcc
Confidence 46799999999999984 46889999998754332 3467889999999999999999998764 345789999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH-----SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
+++|.+++..... ....+++..++.++.|++.||+||| +.+++ |+||+|+||+++.++.+||+|||+++...
T Consensus 85 ~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~--h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 85 GGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVL--HRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred CCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcce--ecCCCHHHEEEecCCCEEEeccccccccc
Confidence 9999999975421 2346899999999999999999999 77755 99999999999999999999999987654
Q ss_pred CCC----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 471 PSS----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 471 ~~~----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
... ...++..|+|||++.+..++.++||||||+++|+|++|+.||.... .....+.+ ......
T Consensus 162 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~-~~~~~~------ 228 (265)
T cd08217 162 HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN------QLQLASKI-KEGKFR------ 228 (265)
T ss_pred CCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC------HHHHHHHH-hcCCCC------
Confidence 432 2345677999999998889999999999999999999999997532 11112111 111110
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+......+.+++.+||+.+|++||++.+|+++
T Consensus 229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112344678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=284.74 Aligned_cols=241 Identities=24% Similarity=0.341 Sum_probs=193.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||++... +|..+|+|.+.... ...+.+.+|++++++++|+|++++++.+......++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (257)
T cd08225 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG 84 (257)
T ss_pred EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence 467999999999999864 57899999986532 23456889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCCC---
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPSS--- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~--- 473 (606)
+|.+++.... ...+++..+..++.|++.||+|||+.++. |+||||+||++++++ .+||+|||.+.......
T Consensus 85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~i~--H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 85 DLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRKIL--HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcc--cccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 9999997543 23578999999999999999999999966 999999999999886 46999999987654432
Q ss_pred -CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 -TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||+.....++.++||||||+++|||++|+.||... +....+........ .. .
T Consensus 160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~-~~----------~ 222 (257)
T cd08225 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN------NLHQLVLKICQGYF-AP----------I 222 (257)
T ss_pred cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHhcccC-CC----------C
Confidence 224566799999998888999999999999999999999998642 22223332222211 00 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||..+|++|||+.+++++
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11223468889999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=287.47 Aligned_cols=239 Identities=24% Similarity=0.311 Sum_probs=193.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|... ++..||+|.+..... ..+.+.+|++++++++||||+++++++......++|+||+.+
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 84 (258)
T cd05578 5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG 84 (258)
T ss_pred EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence 567999999999999865 689999999975432 245788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
++|.+++... .+++...+..++.|+++||+|||+.+++ |+||+|+||++++++.++|+|||.+...... .
T Consensus 85 ~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~i~--h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 157 (258)
T cd05578 85 GDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKGII--HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT 157 (258)
T ss_pred CCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHHeEEcCCCCEEEeecccccccCCCcccc
Confidence 9999999753 2588999999999999999999999966 9999999999999999999999998765443 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++....++.++|+||||+++|+|++|+.||...... ....+....... ....+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-----------~~~~~ 222 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA-----------DVLYP 222 (258)
T ss_pred ccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc-----------cccCc
Confidence 234556699999998888999999999999999999999999754321 111111111110 01111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCH--HHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSM--AEVT 582 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~--~~v~ 582 (606)
......+.+++.+||+.+|.+||++ +|+.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 2234678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=291.10 Aligned_cols=244 Identities=18% Similarity=0.256 Sum_probs=190.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++... .++.||+|.+..... ..+.+.+|+++++.++||||+++++.+..+++.++||||+++
T Consensus 6 ~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g 85 (305)
T cd05609 6 IKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEG 85 (305)
T ss_pred eeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCC
Confidence 467999999999999854 578999999875432 234678899999999999999999999988999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++.... .+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 86 GDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYGIV--HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 99999997532 588999999999999999999999966 9999999999999999999999988642110
Q ss_pred ---------------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc
Q 037905 473 ---------------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE 537 (606)
Q Consensus 473 ---------------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (606)
....++..|+|||++....++.++||||||+++|||++|..||.... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~------~~~~~~~~~~~~ 232 (305)
T cd05609 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT------PEELFGQVISDD 232 (305)
T ss_pred ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcc
Confidence 01234567999999988889999999999999999999999996421 112222222111
Q ss_pred ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 538 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
. ..+ .........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 233 ~----~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 I----EWP-----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred c----CCC-----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 000 0011234567899999999999999996555544443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=289.02 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=188.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|+.. ++..||||++..... ....+.+|++++++++||||+++++++.+.+..++||||+. +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~ 83 (284)
T cd07860 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-Q 83 (284)
T ss_pred eeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-c
Confidence 467999999999999864 689999999865322 23568899999999999999999999999999999999996 5
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++.... ...+++..+..++.|++.||+|||+.+++ ||||+|+||+++.++.+||+|||+++......
T Consensus 84 ~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~i~--H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 84 DLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHRVL--HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred CHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 8988887543 23589999999999999999999999966 99999999999999999999999987554321
Q ss_pred CCCCcccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccc-cccccchh-----
Q 037905 474 TPNRIDGYRAPEVTDARK-VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW-TAEVFDLE----- 546 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~~----- 546 (606)
...++..|+|||++.+.. ++.++||||||+++|||+||+.||...... ........... ......+.
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI------DQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHHhCCCChhhhhhhhHHH
Confidence 123456799999886644 588999999999999999999999642211 11111110000 00000000
Q ss_pred -----hh--cccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 547 -----LL--RYQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 547 -----~~--~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. .... .......+.+++.+||+.||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00 0000 01123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=283.90 Aligned_cols=239 Identities=21% Similarity=0.268 Sum_probs=186.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc------CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV------SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 392 (606)
.+.||+|+||.||+|.. .++..||+|.+..... ..+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (265)
T cd06652 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86 (265)
T ss_pred eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence 46799999999999985 4589999998853221 124678899999999999999999988653 45789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC-
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP- 471 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 471 (606)
|+++++|.+++... ..+++.....++.|++.||+|||+.+++ |+||||+||+++.++.++|+|||.++....
T Consensus 87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~i~--H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 87 HMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNMIV--HRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEe--cCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 99999999998743 2478888999999999999999999966 999999999999999999999999875432
Q ss_pred ------CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 472 ------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 472 ------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||..... . ...........
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~~~~------- 226 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----M-AAIFKIATQPT------- 226 (265)
T ss_pred cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----H-HHHHHHhcCCC-------
Confidence 1123456679999999888899999999999999999999999964211 1 11111111110
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+......+.+++.+|| .+|++||++++|+++
T Consensus 227 ---~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 227 ---NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred ---CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 01112334456778888998 489999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=290.03 Aligned_cols=250 Identities=22% Similarity=0.334 Sum_probs=187.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|... +++.||+|.+..... ....+.+|++++++++|+||+++++++...+..++||||+.+ +
T Consensus 10 ~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 88 (291)
T cd07844 10 LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-D 88 (291)
T ss_pred EEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-C
Confidence 467999999999999864 689999999865322 234567899999999999999999999999999999999985 8
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++.... ..+++..+..++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||+++..... ..
T Consensus 89 L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~i~--H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 162 (291)
T cd07844 89 LKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRRVL--HRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN 162 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence 999887543 2578999999999999999999999966 9999999999999999999999998654321 12
Q ss_pred CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc------ccc--------
Q 037905 475 PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------EWT-------- 539 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~-------- 539 (606)
...+..|+|||++.+ ..++.++||||||+++|||++|+.||..... ....+..+... ...
T Consensus 163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD-----VEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc-----HHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 234567999999865 4578999999999999999999999964321 11111111000 000
Q ss_pred --c---ccc-chhhhc-ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 540 --A---EVF-DLELLR-YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 540 --~---~~~-d~~~~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. ... ...... .... .....+.+++.+|++.+|++|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRL-DRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccCChhHHHhCcCC-CCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 000 000000 0000 012567889999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=291.83 Aligned_cols=250 Identities=23% Similarity=0.314 Sum_probs=188.4
Q ss_pred cccccC--CceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKG--TFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
..||+| +||+||+++. .+|+.||+|++...... .+.+.+|+.+++.++||||++++++|...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346776 8999999985 47999999998754332 35678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++.... ...+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.++++||+.+......
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~iv--HrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNGYI--HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999987543 23588999999999999999999999966 9999999999999999999999854322110
Q ss_pred -------CCCCCcccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------
Q 037905 473 -------STPNRIDGYRAPEVTDAR--KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------ 537 (606)
Q Consensus 473 -------~~~~~~~~y~aPE~~~~~--~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 537 (606)
.....+..|+|||++.+. .++.++|||||||++|||++|+.||....... .+.......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~ 232 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ------MLLQKLKGPPYSPLD 232 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH------HHHHHhcCCCCCCcc
Confidence 011223459999998763 47899999999999999999999996532110 000000000
Q ss_pred ------------------------------ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 ------------------------------WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ------------------------------~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+. .........+...+.+++.+||..||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSE-RLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccchhhhhhccchhhhhcccccchhccccccccccc-cccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00000000 00111223456778999999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=283.27 Aligned_cols=242 Identities=20% Similarity=0.236 Sum_probs=187.0
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHH-HcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEV-VGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|.. .+++.||+|++...... ...+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4589999999999985 45899999998754321 1223444443 4455899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN 476 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 476 (606)
++|.+++... ..+++..+..++.|++.||.|||+.+++ ||||+|+||++++++.+||+|||+++.........
T Consensus 82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~i~--H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 154 (260)
T cd05611 82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRGII--HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV 154 (260)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHeEECCCCcEEEeecccceeccccccCC
Confidence 9999999753 2578899999999999999999999966 99999999999999999999999987665544556
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|+|||.+.+..++.++||||||+++|||++|..||.... ............... ........
T Consensus 155 ~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~--------~~~~~~~~ 220 (260)
T cd05611 155 GTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET------PDAVFDNILSRRINW--------PEEVKEFC 220 (260)
T ss_pred CCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhcccCC--------CCcccccC
Confidence 6778999999988888999999999999999999999996421 111111111111000 00011123
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
...+.+++.+||+.+|++||++.++.+.|
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 45688999999999999999776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=286.85 Aligned_cols=240 Identities=24% Similarity=0.376 Sum_probs=190.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCC---CCCcccceEEEEeCCceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMD---HENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
..+.||+|+||.||+|.. .++..||+|.+..... ..+++.+|++++++++ |||++++++++......++||||+
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYA 84 (277)
T ss_pred hhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecC
Confidence 346799999999999985 5689999999865422 3456888999988886 999999999999989999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
++++|.+++... .+++..+..++.|++.||.|||+.+++ |+||+|+||++++++.++|+|||.+.......
T Consensus 85 ~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~i~--H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 85 EGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVGVI--HRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred CCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999998632 588999999999999999999999966 99999999999999999999999987654322
Q ss_pred ---CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 474 ---TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 474 ---~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
...++..|+|||++.+ ..++.++||||||+++|+|++|+.||...... ...... ...... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~~-~~~~~~-----~~~- 223 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMMLI-PKSKPP-----RLE- 223 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhcc-ccCCCC-----CCC-
Confidence 2345667999998865 45689999999999999999999999643211 111100 000000 000
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.+|++||++.+++++
T Consensus 224 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 224 ---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 01134578899999999999999999999875
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=290.26 Aligned_cols=248 Identities=23% Similarity=0.332 Sum_probs=187.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||++.. .+++.+|+|++..... ....+.+|+.++.++. |+||+++++++......+++|||+..
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~- 87 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI- 87 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence 46799999999999985 4589999999875432 3456888999999986 99999999999988899999999864
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
++.++...........+++..+..++.+++.||+|||+. +++ ||||||+||+++.++.+||+|||+++..... .
T Consensus 88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~--H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 165 (288)
T cd06616 88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII--HRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKT 165 (288)
T ss_pred CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee--ccCCCHHHEEEccCCcEEEeecchhHHhccCCccc
Confidence 554433211101124589999999999999999999975 755 9999999999999999999999998754332 2
Q ss_pred CCCCcccccCccccCCC---CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 474 TPNRIDGYRAPEVTDAR---KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~---~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
...++..|+|||++... .++.++||||||+++|||++|+.||.... .....+........ +.. ..
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~------~~~-~~ 233 (288)
T cd06616 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDP------PIL-SN 233 (288)
T ss_pred cccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCC------CcC-CC
Confidence 23456779999998765 68999999999999999999999996432 11111111111110 000 01
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.........+.+++.+||+.+|++|||+.+|+++
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1112244578899999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=286.45 Aligned_cols=241 Identities=21% Similarity=0.272 Sum_probs=188.3
Q ss_pred cccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 325 LGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 325 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
||+|+||.||++.. .+|+.+|+|.+..... ....+..|+++++.++|||++++.+.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999975 4689999999865322 234567899999999999999999999988999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---CCCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---STPN 476 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~ 476 (606)
.+++.... ...+++..+..++.|++.||.|||+.+++ ||||+|+||++++++.++|+|||.++..... ....
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~i~--H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQRRIV--YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA 155 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHEEECCCCCEEEccCcchhhhccCCcccccc
Confidence 99997543 23589999999999999999999999966 9999999999999999999999988754432 1233
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|+|||++.+..++.++||||||+++|+|++|+.||....... ........... . ....+...
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~-----~-------~~~~~~~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV--EKEELKRRTLE-----M-------AVEYPDKF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc--cHHHHHhcccc-----c-------cccCCccC
Confidence 4567999999988889999999999999999999999996532211 11111110000 0 00111223
Q ss_pred HHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 557 MVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
...+.+++.+||+.+|++|| ++.+++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 45678899999999999999 55556543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=294.26 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=189.8
Q ss_pred hcccccCCceEEEEEEEc---CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLE---MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 392 (606)
.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus 5 ~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 84 (316)
T cd07842 5 EGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFD 84 (316)
T ss_pred EEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEe
Confidence 467999999999999864 47999999997632 1235678899999999999999999999987 78999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC----CCcEEEeecccCcc
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK----SYEARISDFGLAHL 468 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~----~~~~kl~DfG~a~~ 468 (606)
|+++ +|.+++..........++...+..++.|++.||+|||+.+++ ||||||+||+++. ++.+||+|||+++.
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~--h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~ 161 (316)
T cd07842 85 YAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVL--HRDLKPANILVMGEGPERGVVKIGDLGLARL 161 (316)
T ss_pred CCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEe--eCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence 9975 777776543322233688999999999999999999999966 9999999999999 89999999999876
Q ss_pred CCCCC-------CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhH---HHHHHhhc-
Q 037905 469 ASPSS-------TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPR---WVQSVVKE- 536 (606)
Q Consensus 469 ~~~~~-------~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~- 536 (606)
..... ...++..|+|||++.+ ..++.++||||||++++||++|+.||...........+. .+..++..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (316)
T cd07842 162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVL 241 (316)
T ss_pred cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHh
Confidence 54321 2234567999998866 457899999999999999999999997543322110000 00000000
Q ss_pred --c----c-----cccccc---h-hhhccc--ChH-------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 --E----W-----TAEVFD---L-ELLRYQ--NVE-------EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 --~----~-----~~~~~d---~-~~~~~~--~~~-------~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. + ..+... . ...... ... .....+.+++.+|++.+|++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 242 GTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred CCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0 0 000000 0 000000 001 233568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=288.86 Aligned_cols=238 Identities=21% Similarity=0.265 Sum_probs=192.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++... +++.+|+|+++.... ..+.+.+|++++++++||||+++++++......++||||+++
T Consensus 6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (290)
T cd05580 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG 85 (290)
T ss_pred EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence 467999999999999864 689999999875432 235688899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STP 475 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~ 475 (606)
++|.+++... ..++...+..++.|++.||.|||+.+++ |+||+|+||+++.++.+||+|||+++..... ...
T Consensus 86 ~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~i~--H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~ 158 (290)
T cd05580 86 GELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLDIV--YRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL 158 (290)
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--cCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence 9999998753 3588999999999999999999999966 9999999999999999999999998765443 223
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||.+.+..++.++||||||+++|+|++|+.||.... .....+.+..... ..+..
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~------------~~~~~ 220 (290)
T cd05580 159 CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN------PIQIYEKILEGKV------------RFPSF 220 (290)
T ss_pred CCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCCc------------cCCcc
Confidence 46677999999988888999999999999999999999996422 1111122211110 01111
Q ss_pred HHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
....+.+++.+||..+|.+|| +++|++++
T Consensus 221 ~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred CCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 235678899999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=287.55 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=192.4
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
..+.||+|+||.||+|+. .+|..||+|++..... ..+.+.+|+.++++++||||+++++++......++|+||+ +
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~ 82 (286)
T cd07832 4 ILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-P 82 (286)
T ss_pred EEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-C
Confidence 346799999999999986 4689999999875432 2467889999999999999999999999999999999999 9
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.... ..+++..+..++.||+.||+|||+.++. |+||||+||+++.++.++|+|||.++......
T Consensus 83 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 83 SDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANGIM--HRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 99999987533 3589999999999999999999999966 99999999999999999999999987654322
Q ss_pred --CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc----c--cccccc
Q 037905 474 --TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE----W--TAEVFD 544 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~d 544 (606)
...++..|+|||++.+. .++.++||||+|+++|||++|.+||....+.. ....+....... + ..+..+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcch
Confidence 23456679999998654 46899999999999999999988885422110 000111000000 0 000000
Q ss_pred hhhh-----c----ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELL-----R----YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~-----~----~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.... . .....+....+.+++.+|+..+|++|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 0 00001234678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.98 Aligned_cols=240 Identities=23% Similarity=0.362 Sum_probs=192.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|++|.||++.. .++..+|+|++..... ..+.+.+|+.+++.++|||++++++++...+..++|+||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 46899999999999985 4688999998864432 345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++.. ..+++..+..++.|++.||+|||+.+++ ||||+|+||+++.++.++|+|||.+...... ...
T Consensus 104 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 104 TDIVTH------TRMNEEQIATVCLAVLKALSFLHAQGVI--HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred HHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 999874 2478899999999999999999999966 9999999999999999999999987654322 123
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||...+..++.++||||||+++|||++|+.||.... ....+...... .... ......
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~------~~~~~~~~~~~-~~~~--------~~~~~~ 240 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP------PLQAMKRIRDN-LPPK--------LKNLHK 240 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC------HHHHHHHHHhc-CCCC--------Cccccc
Confidence 45677999999988889999999999999999999999986421 11112211111 0000 001112
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||+.+|++|||+.+++++
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 33568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=278.84 Aligned_cols=242 Identities=28% Similarity=0.435 Sum_probs=196.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|++|.||++... ++..+++|++..... ..+.+.+|++.+++++|+|++++++++......++++||+++++|
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L 84 (253)
T cd05122 5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL 84 (253)
T ss_pred eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence 467999999999999865 689999999976543 456789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---TPN 476 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~ 476 (606)
.+++.... ..+++..+..++.|++.||+|||..+++ |+||+|+||++++++.++|+|||.+....... ...
T Consensus 85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~--h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNGII--HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCEe--cCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 99987542 3589999999999999999999999866 99999999999999999999999987765432 344
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|+|||++.+..++.++||||||+++++|++|+.||..... ......... ...... ......
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~--------~~~~~~ 223 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIAT-NGPPGL--------RNPEKW 223 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHh-cCCCCc--------Cccccc
Confidence 56679999999888899999999999999999999999864311 111111111 111110 011112
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+.+++.+||+.+|++|||+.+++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 4568899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=286.24 Aligned_cols=250 Identities=23% Similarity=0.278 Sum_probs=189.6
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEee
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHDY 393 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 393 (606)
...+.||+|+||.||+|... +++.+|+|.++..... ...+.+|++++++++||||+++.+++... ...++||||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~ 87 (293)
T cd07843 8 EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEY 87 (293)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehh
Confidence 34577999999999999965 5889999999754322 23567899999999999999999999877 889999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
+.+ +|.+++.... ..+++..+..++.|++.||+|||+.+++ |+||||+||+++.++.+||+|||+++.....
T Consensus 88 ~~~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~i~--H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 88 VEH-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNWIL--HRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred cCc-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCee--eccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 975 9998887532 2589999999999999999999999966 9999999999999999999999998765443
Q ss_pred ---CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc------------
Q 037905 473 ---STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------------ 536 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 536 (606)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+...
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~------~~~~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 161 KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI------DQLNKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCchHHHHHh
Confidence 122345679999998764 4688999999999999999999999753211 111111000
Q ss_pred --------cccccccchhhhcccChHH--HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 --------EWTAEVFDLELLRYQNVEE--EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 --------~~~~~~~d~~~~~~~~~~~--~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........... . ..... ....+.+++.+||+.+|++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQL-R-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hccchhcccccccccchhh-h-ccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000 0 00111 24567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=287.92 Aligned_cols=252 Identities=20% Similarity=0.238 Sum_probs=186.6
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.+|.|+++.||+++. +++.||||++.... ...+.+.+|+++++.++|+||+++++++...+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34455666666666655 58999999987542 234578999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC------
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS------ 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------ 472 (606)
|.+++.... ...+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||.+......
T Consensus 86 l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~iv--H~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 86 CEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKGFI--HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999998543 23478889999999999999999999966 9999999999999999999999987644221
Q ss_pred -----CCCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-------cc
Q 037905 473 -----STPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE-------EW 538 (606)
Q Consensus 473 -----~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~ 538 (606)
....++..|+|||++.. ..++.++|||||||++|||++|+.||....... ...+..... ..
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~ 235 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-----MLLEKVRGTVPCLLDKST 235 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhccCccccccCc
Confidence 11234456999999866 358899999999999999999999997532110 111110000 00
Q ss_pred c-------cc----ccchhh---hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 539 T-------AE----VFDLEL---LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 539 ~-------~~----~~d~~~---~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. .. ..++.. ............+.+++.+||..+|++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 00 000000 0001112334568899999999999999999999886
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=287.00 Aligned_cols=251 Identities=22% Similarity=0.290 Sum_probs=186.1
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|.. .+|..||+|++..... ....+.+|+++++.++|+||+++.+++......++|+||+. ++
T Consensus 10 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~ 88 (291)
T cd07870 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TD 88 (291)
T ss_pred EEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CC
Confidence 46799999999999975 4688999999865432 23467889999999999999999999998889999999996 57
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++.... ..+.+..+..++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||+++..... ..
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~--H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 162 (291)
T cd07870 89 LAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQHIL--HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS 162 (291)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence 777765332 2477888889999999999999999966 9999999999999999999999998754321 12
Q ss_pred CCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc----------------c
Q 037905 475 PNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE----------------E 537 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~ 537 (606)
..++..|+|||++.+. .++.++||||||+++|||++|+.||...... ...+..+... .
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-----FEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-----HHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 2346679999998754 5788999999999999999999999753221 1111111000 0
Q ss_pred ccccccc----hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 WTAEVFD----LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ~~~~~~d----~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+...... ...............+.+++.+|+..||++|||+.|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000 0000000000113467889999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.61 Aligned_cols=245 Identities=25% Similarity=0.358 Sum_probs=192.7
Q ss_pred HHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 319 RASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
+...+.||+|+||.||+|... ++..+|+|.+..... ..+++.+|+++++.++|+|++++.+++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 344567999999999999854 578999999864321 234677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+++ ||||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~i~--H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 169 (308)
T cd06634 97 CL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMI--HRDVKAGNILLSEPGLVKLGDFGSASIMAPAN 169 (308)
T ss_pred cC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHhEEECCCCcEEECCcccceeecCcc
Confidence 97 58877775332 3478999999999999999999999966 99999999999999999999999988766555
Q ss_pred CCCCcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 474 TPNRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
...++..|+|||++. ...++.++|||||||++|||++|+.||..... ........... ...
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~--------- 233 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE-SPA--------- 233 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhhcC-CCC---------
Confidence 556777899999874 35678899999999999999999999854211 11111111111 000
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
.........+.+++.+||..+|++||++.+++++-.
T Consensus 234 ~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 011233456888999999999999999999988744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=281.52 Aligned_cols=236 Identities=21% Similarity=0.265 Sum_probs=184.3
Q ss_pred cccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhhhh
Q 037905 325 LGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALL 403 (606)
Q Consensus 325 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l 403 (606)
||+|+||.||++.. .++..+|+|.+........+. +...+ ..+|||++++++++...+..++||||+++++|.+++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~--~~~~~-~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l 100 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEP--MVHQL-MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL 100 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhH--HHHHH-hhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHH
Confidence 69999999999985 468899999987543322211 11111 127999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCCCCCCCccccc
Q 037905 404 HGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPSSTPNRIDGYR 482 (606)
Q Consensus 404 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~y~ 482 (606)
.... .+++..+..++.|++.||.|||+.+++ ||||||+||+++.++ .++|+|||+++.........++..|+
T Consensus 101 ~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~ 173 (267)
T PHA03390 101 KKEG-----KLSEAEVKKIIRQLVEALNDLHKHNII--HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYF 173 (267)
T ss_pred HhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCee--eCCCCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCccc
Confidence 7532 689999999999999999999999965 999999999999998 99999999988766555566778899
Q ss_pred CccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHH
Q 037905 483 APEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQ 562 (606)
Q Consensus 483 aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~ 562 (606)
|||++.+..++.++||||||+++|||++|+.||.....+. .....+.... .. ...........+.+
T Consensus 174 aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~~------------~~~~~~~~~~~~~~ 239 (267)
T PHA03390 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-QK------------KLPFIKNVSKNAND 239 (267)
T ss_pred ChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-cc------------cCCcccccCHHHHH
Confidence 9999998889999999999999999999999997432211 1111111111 00 00111234456888
Q ss_pred HHHHccCcCCCCCCC-HHHHHHH
Q 037905 563 LAINCTAQYPDNRPS-MAEVTSQ 584 (606)
Q Consensus 563 l~~~Cl~~~P~~RPs-~~~v~~~ 584 (606)
++.+||+.+|.+||+ +++++++
T Consensus 240 li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 240 FVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred HHHHHhccChhhCCchHHHHhcC
Confidence 999999999999996 6888753
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=282.04 Aligned_cols=239 Identities=22% Similarity=0.354 Sum_probs=190.3
Q ss_pred cccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 325 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
||+|+||.||++... +|+.+|+|++..... ..+.+.+|++++++++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875433 235688899999999999999999999988999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC------
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------ 473 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------ 473 (606)
.+++.... .+++..+..++.|+++||+|||+.+++ |+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~--H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNGII--HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCee--cCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997532 589999999999999999999999966 99999999999999999999999987543321
Q ss_pred ------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 ------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 ------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...++..|+|||......++.++||||||+++||+++|+.||.... ............. .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~~-----~--- 219 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET------PEEIFQNILNGKI-----E--- 219 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcCCc-----C---
Confidence 1234456999999988889999999999999999999999996432 1111221111110 0
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
..........+.+++.+||+.+|++|||+..+.+.|+
T Consensus 220 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 --WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0000112466889999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=287.02 Aligned_cols=254 Identities=22% Similarity=0.247 Sum_probs=188.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCc-----eEEEE
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDE-----KLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----~~lv~ 391 (606)
.+.||+|+||.||+|... +++.||+|+++.... ....+.+|+.+++.++ |+||+++++++..... .++||
T Consensus 6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~ 85 (295)
T cd07837 6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85 (295)
T ss_pred eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence 467999999999999864 689999998865432 2356888999999995 6999999999887655 79999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-CCcEEEeecccCccCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-SYEARISDFGLAHLAS 470 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~ 470 (606)
||+++ +|.+++..........+++..+..++.||+.||+|||+++++ ||||||+||+++. ++.+||+|||.++...
T Consensus 86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~--H~dl~~~nil~~~~~~~~kl~dfg~~~~~~ 162 (295)
T cd07837 86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVM--HRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162 (295)
T ss_pred eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCee--ecCCChHHEEEecCCCeEEEeecccceecC
Confidence 99986 898888754332234689999999999999999999999966 9999999999998 8899999999987543
Q ss_pred CC----CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------cc
Q 037905 471 PS----STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------WT 539 (606)
Q Consensus 471 ~~----~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~ 539 (606)
.. ....++..|+|||++.+ ..++.++||||||+++|||++|..||..... ......+...- ..
T Consensus 163 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 163 IPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE------LQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred CCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHHhCCCChhhC
Confidence 22 12234567999998865 4578999999999999999999999964211 11111111100 00
Q ss_pred ccccchh----hh--ccc----ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 540 AEVFDLE----LL--RYQ----NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 540 ~~~~d~~----~~--~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....... .. ... ........+.+++.+||.++|++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 00 000 001234568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=273.74 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=195.6
Q ss_pred HHHHHHHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCcc-CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEE
Q 037905 314 LEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV-SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 314 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 390 (606)
++++..-+.+.||+|+|+.|--+. ..+|..+|||++.+... ++..+.+|++++.+. .|+||+++++||.++...|||
T Consensus 75 F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 75 FEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 566666678999999999998886 67899999999987643 567889999999888 599999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc---EEEeecccCc
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE---ARISDFGLAH 467 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~---~kl~DfG~a~ 467 (606)
||-|.||.|..+++... .+++.++.+++.+|+.||.|||.+||. ||||||+|||-.+... +|||||.+..
T Consensus 155 fEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kgIA--HRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKGIA--HRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred EecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcCcc--cccCCccceeecCCCCcCceeeecccccc
Confidence 99999999999998643 699999999999999999999999977 9999999999865443 8999998874
Q ss_pred cCCC--C---------CCCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC-C---Chh
Q 037905 468 LASP--S---------STPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG-V---DLP 527 (606)
Q Consensus 468 ~~~~--~---------~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~-~---~~~ 527 (606)
-... . .++.++..|||||+.. ...|+.++|.||||||+|-|++|.+||.+.=.++- . ...
T Consensus 228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C 307 (463)
T KOG0607|consen 228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC 307 (463)
T ss_pred ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence 3221 1 1233444599999763 34589999999999999999999999986333221 1 122
Q ss_pred HHHHHHh----hccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 528 RWVQSVV----KEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 528 ~~~~~~~----~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+..++.+ +++.. ++.| ..+.....+-.+++...+..++.+|.++.+++++
T Consensus 308 r~CQ~~LFesIQEGkY-eFPd------kdWahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 308 RVCQNKLFESIQEGKY-EFPD------KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHHHHHHhccCC-cCCh------hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 2222221 22211 1111 1122333444556667777999999999998873
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=285.92 Aligned_cols=248 Identities=14% Similarity=0.184 Sum_probs=175.9
Q ss_pred HHhcccccCCceEEEEEEEcC----CcEEEEEEeccCccC---H---------HHHHHHHHHHcCCCCCCcccceEEEEe
Q 037905 320 ASAEVLGKGTFGTAYKATLEM----GIVVAVKRLKDVTVS---E---------KEFREKMEVVGSMDHENLVPLRAYYYS 383 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~---~---------~~~~~e~~~l~~l~h~niv~l~~~~~~ 383 (606)
...+.||+|+||.||+|...+ +..+|+|+....... + .....++..+..+.|+|++++++++..
T Consensus 15 ~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 94 (294)
T PHA02882 15 KIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSF 94 (294)
T ss_pred EEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeE
Confidence 345789999999999998653 345666654322111 1 112233445667799999999987765
Q ss_pred CC----ceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEE
Q 037905 384 RD----EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEAR 459 (606)
Q Consensus 384 ~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~k 459 (606)
.. ..++++|++.. ++.+.+... ...++..+..++.|++.||+|||+.+++ ||||||+|||++.++.++
T Consensus 95 ~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~ii--HrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 95 KRCRMYYRFILLEKLVE-NTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHGIS--HGDIKPENIMVDGNNRGY 166 (294)
T ss_pred ecCCceEEEEEEehhcc-CHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEcCCCcEE
Confidence 43 34677777643 666665532 1356788899999999999999999966 999999999999999999
Q ss_pred EeecccCccCCCC-----------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhH
Q 037905 460 ISDFGLAHLASPS-----------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 460 l~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~ 528 (606)
|+|||+|+..... ....+|..|+|||+..+..++.++|||||||++|||++|+.||....... ....
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~~~~ 244 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--NLIH 244 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--HHHH
Confidence 9999998754321 12346778999999999999999999999999999999999997642211 1111
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
... ..+...+..... ....++..+.+++..||+.+|++||++.++++.+
T Consensus 245 ~~~----~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 245 AAK----CDFIKRLHEGKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HhH----HHHHHHhhhhhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111 000000000000 1122346788999999999999999999999876
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=286.36 Aligned_cols=252 Identities=21% Similarity=0.257 Sum_probs=186.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCC-CCCcccceEEEEeC--CceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMD-HENLVPLRAYYYSR--DEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|.. .++..||+|+++.... ......+|+..+.++. |+|++++++++.+. +..++||||++
T Consensus 4 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (282)
T cd07831 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD 83 (282)
T ss_pred EeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC
Confidence 46799999999999985 4689999999876422 2334457888888885 99999999999887 88999999997
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
+ +|.+++.... ..+++..+..++.|++.||+|||+.+++ ||||+|+||+++. +.+||+|||+++......
T Consensus 84 ~-~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~i~--H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~ 155 (282)
T cd07831 84 M-NLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNGIF--HRDIKPENILIKD-DILKLADFGSCRGIYSKPPY 155 (282)
T ss_pred c-cHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCce--ecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence 5 8888876432 3589999999999999999999999966 9999999999999 999999999997654322
Q ss_pred -CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHh-----------hccccc
Q 037905 474 -TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV-----------KEEWTA 540 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~ 540 (606)
...++..|+|||++.. ..++.++|||||||++|||++|+.||...... +......... ......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 2335667999997644 55788999999999999999999999653211 1111111100 000000
Q ss_pred cccchhhhc---ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLR---YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.... ..........+.+++.+||.++|++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000 00012345779999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=265.27 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=192.3
Q ss_pred CCCCCcCHHHHHHHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEE
Q 037905 307 KGDRAFDLEDLLRASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYY 382 (606)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 382 (606)
...+..++.|+.. ...||+|..|.||+++.. +|..+|||.+....- ..+.+...+.++.+- ..|.||+.+|||.
T Consensus 84 g~r~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi 161 (391)
T KOG0983|consen 84 GQRYQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI 161 (391)
T ss_pred CcccccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence 3345677777744 567999999999999865 589999999976533 234555666655443 4899999999999
Q ss_pred eCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCCCCCCCCCEEecCCCcEEEe
Q 037905 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG-PANSHGNIKSSNILLSKSYEARIS 461 (606)
Q Consensus 383 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~i~HrDlkp~Nill~~~~~~kl~ 461 (606)
.+...++.||.|.. -+..++... ..++++..+-++...+..||.||.++. ++ |||+||+|||+|+.|++|+|
T Consensus 162 ~n~dV~IcMelMs~-C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH~vi--HRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 162 TNTDVFICMELMST-CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKHGVI--HRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred eCchHHHHHHHHHH-HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhccee--ecccCccceEEccCCCEEee
Confidence 99999999999864 455555533 246888888889999999999998764 55 99999999999999999999
Q ss_pred ecccCccCCCCC---CCCCcccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh
Q 037905 462 DFGLAHLASPSS---TPNRIDGYRAPEVTDA---RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK 535 (606)
Q Consensus 462 DfG~a~~~~~~~---~~~~~~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (606)
|||++.+...+. ...+.+.|||||.+.- ..|+.++||||||+.++|+.||+.||.....+ + +.+..+..
T Consensus 235 DFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td----F-e~ltkvln 309 (391)
T KOG0983|consen 235 DFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD----F-EVLTKVLN 309 (391)
T ss_pred cccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc----H-HHHHHHHh
Confidence 999997765543 3455667999999864 46899999999999999999999999753211 1 11222222
Q ss_pred ccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 536 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+. |+...+. ......+.+++..|+..|+.+||...+++++
T Consensus 310 ~e-------PP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 310 EE-------PPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cC-------CCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 0111111 1255678899999999999999999999876
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=284.48 Aligned_cols=251 Identities=21% Similarity=0.267 Sum_probs=189.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|++|.||+|.. .+|..||+|++..... ..+.+.+|++.+++++|||++++++++.+....+++|||++ +
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~ 82 (283)
T cd07835 4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L 82 (283)
T ss_pred heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence 46799999999999985 4799999999875432 23568889999999999999999999999999999999995 5
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|.+++.... ...+++..+..++.|+++||+|||+.+++ ||||+|+||+++.++.++|+|||+++..... .
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~~~--H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 157 (283)
T cd07835 83 DLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHRVL--HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYT 157 (283)
T ss_pred CHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--CCCCCHHHEEEcCCCcEEEeecccccccCCCccccC
Confidence 8999987543 13589999999999999999999999866 9999999999999999999999998754322 1
Q ss_pred CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc---------------
Q 037905 474 TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE--------------- 537 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------------- 537 (606)
...++..|+|||++.+. .++.++||||||+++|||++|+.||...... .....+.+..
T Consensus 158 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 158 HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI------DQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred ccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCChHHhhhhhhch
Confidence 12345679999987654 5788999999999999999999999643211 1011111000
Q ss_pred -ccccccchhhhc-ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 -WTAEVFDLELLR-YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 -~~~~~~d~~~~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
............ ..........+.+++.+||+.+|++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000 00011122567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=283.07 Aligned_cols=240 Identities=23% Similarity=0.371 Sum_probs=191.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
..+||+|+||.||++.. .++..||||++..... ....+.+|+.+++.++|+|++++++++...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 35799999999999986 4689999999864332 345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++... .+++..+..++.|++.||+|||+.|++ |+||+|+||++++++.++|+|||.+...... ...
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~giv--H~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~ 176 (292)
T cd06657 105 TDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVI--HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176 (292)
T ss_pred HHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence 9987532 478899999999999999999999966 9999999999999999999999987654322 123
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++.+|+|||++.+..++.++||||||+++|||++|..||..... ...+... ....... ......
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~------~~~~~~~-~~~~~~~--------~~~~~~ 241 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMI-RDNLPPK--------LKNLHK 241 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH-HhhCCcc--------cCCccc
Confidence 456779999999888889999999999999999999999864211 1111111 1111000 011122
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||+.+|.+||++.+++++
T Consensus 242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 242 VSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 33457788999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=311.92 Aligned_cols=263 Identities=18% Similarity=0.223 Sum_probs=179.2
Q ss_pred HHHhcccccCCceEEEEEEEc--CCcEEEEE------------------EeccCccCHHHHHHHHHHHcCCCCCCcccce
Q 037905 319 RASAEVLGKGTFGTAYKATLE--MGIVVAVK------------------RLKDVTVSEKEFREKMEVVGSMDHENLVPLR 378 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~ 378 (606)
|...+.||+|+||.||++..+ .+..+++| .+.........+.+|+.++++++||||++++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 344678999999999998643 22222222 1111112234678999999999999999999
Q ss_pred EEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcE
Q 037905 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEA 458 (606)
Q Consensus 379 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~ 458 (606)
+++...+..++|++++.+ +|.+++....-..........+..++.||+.||+|||+++++ ||||||+|||++.++.+
T Consensus 230 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIi--HrDLKP~NILl~~~~~v 306 (501)
T PHA03210 230 EILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLI--HRDIKLENIFLNCDGKI 306 (501)
T ss_pred EEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEECCCCCE
Confidence 999999999999999864 777776543211122234566778999999999999999966 99999999999999999
Q ss_pred EEeecccCccCCCCC-----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCC-cccccccCCCChhHHHHH
Q 037905 459 RISDFGLAHLASPSS-----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP-TQALLNEEGVDLPRWVQS 532 (606)
Q Consensus 459 kl~DfG~a~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p-~~~~~~~~~~~~~~~~~~ 532 (606)
||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++|+.+ +..........+...+..
T Consensus 307 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~ 386 (501)
T PHA03210 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDS 386 (501)
T ss_pred EEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHh
Confidence 999999997654321 23567889999999999999999999999999999998754 432111100011111100
Q ss_pred H--hhccccc------cccch-hhh-cccChH------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 533 V--VKEEWTA------EVFDL-ELL-RYQNVE------EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 533 ~--~~~~~~~------~~~d~-~~~-~~~~~~------~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. ....+.. +.++. ... ...... .....+.+++.+|++.||++|||+.|++++
T Consensus 387 ~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 387 LSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred cccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 0000000 00000 000 000000 112346777889999999999999999875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=285.98 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=190.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|++|.||+|+.. +|..||||+++.... ....+.+|++++++++|+||+++++++...+..++||||+++ +
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~ 83 (284)
T cd07836 5 LEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-D 83 (284)
T ss_pred eeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-c
Confidence 467999999999999964 689999999875432 345677899999999999999999999999999999999985 8
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++..... ...+++..+..++.|++.||+|||+.+++ ||||||+||++++++.++|+|||+++..... ..
T Consensus 84 l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~--h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (284)
T cd07836 84 LKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENRVL--HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159 (284)
T ss_pred HHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCCee--eCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence 8888865431 24589999999999999999999999966 9999999999999999999999998754322 12
Q ss_pred CCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc----------------c
Q 037905 475 PNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE----------------E 537 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------------~ 537 (606)
..++..|+|||++.+. .++.++||||||+++|+|++|+.||...... .....+... .
T Consensus 160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE------DQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH------HHHHHHHHHhCCCChhhHHHHhcCch
Confidence 3346679999988654 5688999999999999999999999753221 111111100 0
Q ss_pred ccccccch-hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 WTAEVFDL-ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ~~~~~~d~-~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+....... ........+.....+.+++.+|++.+|++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000 000000012234568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.62 Aligned_cols=250 Identities=24% Similarity=0.298 Sum_probs=189.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|... +++.+|+|++.... .....+.+|++++++++|+|++++++++... ...++|+||++
T Consensus 4 ~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07840 4 IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD 83 (287)
T ss_pred eEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc
Confidence 467999999999999865 48999999997653 2245688999999999999999999999887 78999999997
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
+ +|.+++.... ..+++..+..++.|++.||+|||+.++. |+||+|+||++++++.+||+|||++.......
T Consensus 84 ~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~~~--h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 84 H-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNGIL--HRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred c-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCce--eccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 5 8888886432 3589999999999999999999999966 99999999999999999999999987655432
Q ss_pred ---CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc------ccccccc
Q 037905 474 ---TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------EWTAEVF 543 (606)
Q Consensus 474 ---~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~ 543 (606)
....+..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+..+... .......
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE------LEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHHhCCCchhhccccc
Confidence 1233556999997764 4578999999999999999999999964321 1111111110 0000000
Q ss_pred c--------hhhhcc----cChHH-HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 D--------LELLRY----QNVEE-EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d--------~~~~~~----~~~~~-~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+ +..... ..... +...+.+++.+||..+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0 000000 00011 25678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=282.32 Aligned_cols=239 Identities=23% Similarity=0.282 Sum_probs=183.5
Q ss_pred ccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHH---HHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 324 VLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKM---EVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.||+|+||.||+|.. .+++.||+|.+...... ...+..|. ..++...||||+++.+++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 45899999998654322 12233343 34455689999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--C
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--S 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 473 (606)
+++|.+++... ..+++..+..++.|++.||.|||+.+++ ||||||+||+++.++.+||+|||+++..... .
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~i~--H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 153 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRFVV--YRDLKPANILLDEHGHVRISDLGLACDFSKKKPH 153 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEE--cCCCCHHHEEECCCCCEEEccCcCccccCccCCc
Confidence 99999988643 2589999999999999999999999866 9999999999999999999999998754322 2
Q ss_pred CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||++.+. .++.++||||+|+++|||++|+.||....... ... ....... .+ ...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~---~~~-~~~~~~~------~~-----~~~ 218 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHE-IDRMTLT------MA-----VEL 218 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc---hHH-HHHHhhc------cC-----CCC
Confidence 34567789999998754 68999999999999999999999997532211 111 0000000 00 011
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
+......+.+++.+|+..+|++|| ++.+++++
T Consensus 219 ~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 219 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112245688889999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=283.61 Aligned_cols=242 Identities=27% Similarity=0.404 Sum_probs=190.9
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
...+.||+|+||.||+|+. .++..||+|++..... ....+.+|+++++.++|||++++++++.+....++||||+
T Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 103 (313)
T cd06633 24 VGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC 103 (313)
T ss_pred hcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecC
Confidence 3456799999999999985 4689999999864322 1246788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST 474 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 474 (606)
. +++.+++.... .++++..+..++.|++.|++|||+.|++ |+||+|+||+++.++.+||+|||++........
T Consensus 104 ~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~gi~--H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~ 176 (313)
T cd06633 104 L-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHNMI--HRDIKAGNILLTEPGQVKLADFGSASKSSPANS 176 (313)
T ss_pred C-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCChhhEEECCCCCEEEeecCCCcccCCCCC
Confidence 6 47777776432 3589999999999999999999999966 999999999999999999999999876555445
Q ss_pred CCCcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 475 PNRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 475 ~~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
..++..|+|||++. ...++.++||||||+++|||++|..||.... ....+........ ...
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~------~~~~~~~~~~~~~-~~~--------- 240 (313)
T cd06633 177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNDS-PTL--------- 240 (313)
T ss_pred ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCC-CCC---------
Confidence 56677899999974 4568889999999999999999999986431 1111111111110 000
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||+.+|++||++.+++.+
T Consensus 241 ~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011123457889999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=277.80 Aligned_cols=243 Identities=23% Similarity=0.334 Sum_probs=196.1
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+++. .+++.+|+|.+..... ...++.+|++++++++|+||+++.+++......++|+||++++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd08530 5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG 84 (256)
T ss_pred eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence 46799999999999975 4688999999875432 2346788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--CCC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--STP 475 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~ 475 (606)
+|.+++.... .....+++..+..++.|++.||+|||+.|+. |+||+|+||++++++.+||+|||+++..... ...
T Consensus 85 ~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~--h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~ 161 (256)
T cd08530 85 DLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQKIL--HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ 161 (256)
T ss_pred CHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcc--cCCCCcceEEEecCCcEEEeeccchhhhccCCcccc
Confidence 9999987532 1234689999999999999999999999966 9999999999999999999999998765443 123
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||.+.+..++.++|+||||+++|||++|+.||.... .......+... ... .....
T Consensus 162 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~----------~~~~~ 224 (256)
T cd08530 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS------MQDLRYKVQRG-KYP----------PIPPI 224 (256)
T ss_pred cCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhcC-CCC----------CCchh
Confidence 45667999999999889999999999999999999999996432 11111111111 111 11123
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...++.+++.+||..+|++|||+.+++++
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 225 YSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred hCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 45678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=276.22 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=196.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 395 (606)
.+.||+|++|.||+|... ++..|++|++..... ..+.+.+|++.+++++|+||+++++.+... ...++|+||++
T Consensus 5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 84 (260)
T cd06606 5 GELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVS 84 (260)
T ss_pred eeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecC
Confidence 467999999999999865 689999999876542 356788999999999999999999999887 78999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
+++|.+++.... .+++..+..++.+++.||+|||+.+++ |+||+|+||+++.++.++|+|||.+.......
T Consensus 85 ~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~--h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 85 GGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIV--HRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 999999997532 689999999999999999999999966 99999999999999999999999987655432
Q ss_pred ----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 474 ----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 474 ----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
...++..|+|||......++.++||||||+++++|++|+.||.... +..............
T Consensus 158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~---------- 222 (260)
T cd06606 158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP---------- 222 (260)
T ss_pred ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC----------
Confidence 2345567999999988889999999999999999999999997532 111111111110000
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+......+.+++.+|+..+|++||++.+++++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11112235678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=275.47 Aligned_cols=238 Identities=25% Similarity=0.416 Sum_probs=193.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|++|.||++... +++.|++|.+..... ....+.+|++++++++|+|++++++++.+....+++|||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (254)
T cd06627 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG 84 (254)
T ss_pred eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence 567999999999999854 578999999976543 3456889999999999999999999999989999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC---
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST--- 474 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 474 (606)
+|.+++... ..+++..+..++.|++.||.|||+.|++ ||||+|+||+++.++.++|+|||.+........
T Consensus 85 ~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (254)
T cd06627 85 SLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQGVI--HRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157 (254)
T ss_pred cHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCCcc--cCCCCHHHEEECCCCCEEEeccccceecCCCccccc
Confidence 999998753 3589999999999999999999999966 999999999999999999999999876654322
Q ss_pred -CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 475 -PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 475 -~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
..++..|+|||...+..++.++||||||+++|+|++|+.||.... ...... ....... ...+
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-----~~~~~~-~~~~~~~-----------~~~~ 220 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-----PMAALF-RIVQDDH-----------PPLP 220 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHH-HHhccCC-----------CCCC
Confidence 345667999999988888999999999999999999999986432 111111 1111110 0011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 583 (606)
......+.+++.+||..+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 122456788999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=287.47 Aligned_cols=253 Identities=21% Similarity=0.246 Sum_probs=183.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCC--------ceEE
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRD--------EKLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l 389 (606)
.+.||+|+||.||+|... +++.||||++..... ....+.+|++++++++||||++++++|.... ..++
T Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 96 (310)
T cd07865 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL 96 (310)
T ss_pred EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence 467999999999999864 689999999864322 2345678999999999999999999987654 3499
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||||+.+ +|.+.+.... ..+++..+..++.|++.||+|||+++++ |+||||+||+++.++.+||+|||++...
T Consensus 97 v~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~i~--H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 97 VFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNKIL--HRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred EEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 9999975 8888876432 3589999999999999999999999966 9999999999999999999999998755
Q ss_pred CCCC--------CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh---cc
Q 037905 470 SPSS--------TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK---EE 537 (606)
Q Consensus 470 ~~~~--------~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~ 537 (606)
.... ...++..|+|||++.+. .++.++||||||+++|||++|+.||....... ....+..... ..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 246 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQLCGSITPE 246 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChh
Confidence 3321 12234569999988664 47889999999999999999999986532111 1111111100 00
Q ss_pred ccccccchh----hhccc----C------hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 WTAEVFDLE----LLRYQ----N------VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ~~~~~~d~~----~~~~~----~------~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.. ..... . .......+.+++.+||..+|++|||+++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000000 00000 0 00112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.89 Aligned_cols=253 Identities=23% Similarity=0.272 Sum_probs=188.2
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCH---------------HHHHHHHHHHcCCCCCCcccceEEEEeC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSE---------------KEFREKMEVVGSMDHENLVPLRAYYYSR 384 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------------~~~~~e~~~l~~l~h~niv~l~~~~~~~ 384 (606)
..+.||+|+||.||+|... +++.||||+++...... ..+.+|++++++++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 3567999999999999854 68999999986543221 2477899999999999999999999999
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecc
Q 037905 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464 (606)
Q Consensus 385 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG 464 (606)
+..++||||+. ++|.+++... ..+++.....++.|++.||+|||+.+++ |+||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~i~--H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWYFM--HRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cccccHHHeEECCCCCEEECCcc
Confidence 99999999997 5899998643 2588999999999999999999999966 99999999999999999999999
Q ss_pred cCccCCCC------------------CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCC
Q 037905 465 LAHLASPS------------------STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVD 525 (606)
Q Consensus 465 ~a~~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~ 525 (606)
.++..... ....++..|+|||++.+. .++.++||||||+++|||++|+.||......+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~--- 241 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID--- 241 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 98755410 011235569999998764 46899999999999999999999996532211
Q ss_pred hhHHHHHHhhcc----ccccccchhhh-----cccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 526 LPRWVQSVVKEE----WTAEVFDLELL-----RYQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 526 ~~~~~~~~~~~~----~~~~~~d~~~~-----~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+....... +......+... .... .......+.+++.+||+.+|++|||+.|++.+
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 000010000000 00000000000 0000 11224568899999999999999999999874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.78 Aligned_cols=257 Identities=21% Similarity=0.324 Sum_probs=188.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeC-----CceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 393 (606)
.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+|+.++++++|+||+++++++... ...++|+||
T Consensus 10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 89 (336)
T cd07849 10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL 89 (336)
T ss_pred EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence 56799999999999984 468999999986432 2345678899999999999999999987643 357999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+.+ +|...+.. ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++......
T Consensus 90 ~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~iv--H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 90 MET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSANVL--HRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred ccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 975 88877753 2589999999999999999999999966 99999999999999999999999987543221
Q ss_pred -------CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccc---cccc
Q 037905 474 -------TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW---TAEV 542 (606)
Q Consensus 474 -------~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 542 (606)
...++..|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....+........ ...+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHHh
Confidence 1245667999998754 568999999999999999999999996421100 0000000000000 0000
Q ss_pred cchh---------hhccc----ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHHHh
Q 037905 543 FDLE---------LLRYQ----NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEICR 590 (606)
Q Consensus 543 ~d~~---------~~~~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~ 590 (606)
.+.. ..... ..+.....+.+++.+||+.+|++|||+.+++++ ++....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000 00000 001224568899999999999999999999998 665543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.73 Aligned_cols=250 Identities=25% Similarity=0.313 Sum_probs=187.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|.. .+|+.||+|+++..... ...+.+|+.++++++|+|++++++++... +..++||||+.
T Consensus 12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 91 (309)
T cd07845 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE 91 (309)
T ss_pred eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence 46799999999999986 46899999998754322 23466899999999999999999998755 46799999997
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
+ +|.+++.... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||.++......
T Consensus 92 ~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 92 Q-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENFII--HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred C-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 5 8888887532 3589999999999999999999999966 99999999999999999999999987654321
Q ss_pred --CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc------ccccc---
Q 037905 474 --TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------EWTAE--- 541 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~--- 541 (606)
....+..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+..+... .....
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE------IEQLDLIIQLLGTPNESIWPGFSD 238 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCChhhchhhhc
Confidence 1223556999999865 4578999999999999999999999964321 1111111110 00000
Q ss_pred -----ccchhhhcccCh----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 542 -----VFDLELLRYQNV----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 542 -----~~d~~~~~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.......... ......+.+++.+|+..||++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000 1124567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=281.59 Aligned_cols=253 Identities=21% Similarity=0.268 Sum_probs=192.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|++|.||++... +++.+++|++...... ...+.+|++++++++|+||+++++++......++|+||+++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (283)
T cd05118 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT- 82 (283)
T ss_pred ceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-
Confidence 357999999999999864 6899999998764332 45788899999999999999999999999999999999976
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++.... ..+++..+..++.|++.||+|||+.++. |+||||+||+++.++.++|+|||.+.......
T Consensus 83 ~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~--H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 83 DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHGIL--HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCCee--ecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence 8888887532 3589999999999999999999999966 99999999999999999999999987655432
Q ss_pred CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc---ccccccc-----
Q 037905 474 TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE---WTAEVFD----- 544 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~d----- 544 (606)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+ ............ ......+
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccchhhhhhh
Confidence 12345569999998776 78999999999999999999999996432110 000000000000 0000000
Q ss_pred ------hhh-hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 ------LEL-LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ------~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... ......+.....+.+++.+||+++|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 0001122345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=294.12 Aligned_cols=260 Identities=20% Similarity=0.302 Sum_probs=191.6
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeC-----CceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ 391 (606)
..+.||+|+||.||+|.. .++..||||.++... .....+.+|+.+++.++|+||+++++++... ...++|+
T Consensus 9 ~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07858 9 PIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVY 88 (337)
T ss_pred EEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEE
Confidence 356799999999999985 468999999987532 2345677899999999999999999987643 3579999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+. ++|.+++... ..+++..+..++.|++.||.|||+++++ ||||||+||+++.++.+||+|||+++....
T Consensus 89 e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~i~--H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 89 ELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSANVL--HRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred eCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEe--cCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 9996 5898888643 2589999999999999999999999966 999999999999999999999999876543
Q ss_pred C----CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc---ccccccc
Q 037905 472 S----STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE---EWTAEVF 543 (606)
Q Consensus 472 ~----~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 543 (606)
. ....++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ............ .....+.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChHHhhhcC
Confidence 2 12345567999998764 46889999999999999999999999642110 000000000000 0000000
Q ss_pred chhh-------h---cc---cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHHHhc
Q 037905 544 DLEL-------L---RY---QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEICRS 591 (606)
Q Consensus 544 d~~~-------~---~~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~~ 591 (606)
+... . .. .........+.+++.+||+.+|++|||+++++++ ++.+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 0000 0 00 0011234668899999999999999999999998 7665433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=280.09 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=188.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCC---CCCCcccceEEEEeCCc-----eEE
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSM---DHENLVPLRAYYYSRDE-----KLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----~~l 389 (606)
.+.||+|+||.||+|+.. ++..||+|+++..... ...+.+|+.+++++ +|+|++++++++...+. .++
T Consensus 4 ~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l 83 (287)
T cd07838 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83 (287)
T ss_pred EEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEE
Confidence 467999999999999976 4899999999743222 23466677766554 69999999999987766 899
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
+|||+.+ +|.+++.... ...+++..+..++.|++.||+|||+.+++ |+||+|+||+++.++.+||+|||.++..
T Consensus 84 ~~e~~~~-~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~i~--h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 84 VFEHVDQ-DLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHRIV--HRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred Eehhccc-CHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--eccCChhhEEEccCCCEEEeccCcceec
Confidence 9999975 8988887543 23589999999999999999999999966 9999999999999999999999998765
Q ss_pred CCCC---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc-------cc
Q 037905 470 SPSS---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE-------WT 539 (606)
Q Consensus 470 ~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~ 539 (606)
.... ...++..|+|||++.+..++.++||||||+++|||++|++||...... .....+.... +.
T Consensus 158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA------DQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH------HHHHHHHHHcCCCChHhcC
Confidence 4332 223456699999999888999999999999999999999998653221 1111111100 00
Q ss_pred ccc------cchhhhc--ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 540 AEV------FDLELLR--YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 540 ~~~------~d~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... ....... ..........+.+++.+||+.||++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000 0000000 00112334667899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=285.68 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=186.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|++|.||+|... +|+.||+|++..... ..+.+.+|++++++++||||+++++++......++||||+.+
T Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~- 85 (294)
T PLN00009 7 VEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL- 85 (294)
T ss_pred EEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-
Confidence 467999999999999864 689999999865432 235688999999999999999999999999999999999964
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-CCcEEEeecccCccCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-SYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~---- 472 (606)
+|.+++.... ...+++..+..++.||+.||+|||+++++ ||||+|+||+++. ++.+||+|||+++.....
T Consensus 86 ~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~--H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 86 DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHRVL--HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred cHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCCee--CCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 7888775432 22467888889999999999999999966 9999999999985 457999999998754322
Q ss_pred CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh---cc---cccccc--
Q 037905 473 STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK---EE---WTAEVF-- 543 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~-- 543 (606)
....++..|+|||++.+ ..++.++||||||+++|+|+||+.||...... ..+..+.. .. ......
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI------DELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCCChhhccccccc
Confidence 12234567999998865 45789999999999999999999999642211 11111110 00 000000
Q ss_pred -ch--hhhc--cc----ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 -DL--ELLR--YQ----NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 -d~--~~~~--~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+. .... .. ........+.+++.+|++.+|++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000 00 011223457889999999999999999999874
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=275.70 Aligned_cols=243 Identities=23% Similarity=0.375 Sum_probs=197.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||++... ++..+|+|++..... ..+.+.+|++.++.++|+|++++.+.+......++|+||++++
T Consensus 5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~ 84 (258)
T cd08215 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGG 84 (258)
T ss_pred EeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCC
Confidence 467999999999999864 689999999976433 3467889999999999999999999999989999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++..... ....+++..+..++.+++.||+|||+.++. |+||+|+||++++++.++|+|||.+.......
T Consensus 85 ~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~--H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 161 (258)
T cd08215 85 DLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRKIL--HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK 161 (258)
T ss_pred cHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCCEe--cccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence 99999976421 124689999999999999999999999966 99999999999999999999999987654432
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||...+..++.++||||+|+++++|++|+.||.... ............. . ..+
T Consensus 162 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~----------~~~ 224 (258)
T cd08215 162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKILKGQY-P----------PIP 224 (258)
T ss_pred ceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHhcCCC-C----------CCC
Confidence 2345566999999988889999999999999999999999986421 2222222222110 0 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||..+|++|||+.+++++
T Consensus 225 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=321.13 Aligned_cols=240 Identities=29% Similarity=0.363 Sum_probs=189.4
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..+||.|.||.||-|. ..+|+..|+|-++-.... -+.+.+|+.++..|+|||+|+++|+-..++..+|.||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 4689999999999997 677999999988654332 245788999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+.+...+ -.++.....+..|++.|++|||++||+ ||||||.||+++.+|.+|++|||.|.......
T Consensus 1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~gIV--HRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~ 1392 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHGIV--HRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP 1392 (1509)
T ss_pred cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcCce--ecCCCccceeeecCCcEEeecccceeEecCchhcCC
Confidence 9999998543 245555566889999999999999966 99999999999999999999999998765543
Q ss_pred ----CCCCcccccCccccCCC---CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 ----TPNRIDGYRAPEVTDAR---KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 ----~~~~~~~y~aPE~~~~~---~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
...||+-|||||++.+. .-..+.||||+|||+.||+||++||....++= .+.+ ++.-+.
T Consensus 1393 ~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy---~V~~gh-------- 1458 (1509)
T KOG4645|consen 1393 GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMY---HVAAGH-------- 1458 (1509)
T ss_pred HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHh---HHhccC--------
Confidence 23577889999999653 45668999999999999999999997643321 0000 011111
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.++.+.....+=.+++.+|+..||++|.++.|++++
T Consensus 1459 --~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1459 --KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred --CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 112222233455677779999999999888877654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=290.02 Aligned_cols=254 Identities=24% Similarity=0.290 Sum_probs=187.8
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv 390 (606)
..+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.++++++|+||+++++++... ...++|
T Consensus 20 ~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 99 (353)
T cd07850 20 NLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLV 99 (353)
T ss_pred EEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEE
Confidence 356799999999999985 4689999999864322 235677899999999999999999988643 356999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
|||+.+ +|.+.+.. .++...+..++.|++.||+|||+.|++ ||||||+||+++.++.+||+|||+++...
T Consensus 100 ~e~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~--H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 100 MELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred EeccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCee--eCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 999965 88887752 278888999999999999999999966 99999999999999999999999997654
Q ss_pred CCC---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC---------CCChhHHHH-------
Q 037905 471 PSS---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE---------GVDLPRWVQ------- 531 (606)
Q Consensus 471 ~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~------- 531 (606)
... ...++..|+|||.+.+..++.++|||||||++|+|++|+.||....... +.....+..
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (353)
T cd07850 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR 249 (353)
T ss_pred CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence 322 2345667999999999999999999999999999999999996432100 000000000
Q ss_pred HHhhccccc------cccchhhhc---ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 532 SVVKEEWTA------EVFDLELLR---YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 532 ~~~~~~~~~------~~~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......... ..+...... ..........+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000000000 00011234567899999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=287.08 Aligned_cols=255 Identities=24% Similarity=0.347 Sum_probs=189.1
Q ss_pred HHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCC-CCCCcccceEEEEeC--CceEEEE
Q 037905 319 RASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSM-DHENLVPLRAYYYSR--DEKLLVH 391 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~lv~ 391 (606)
+...+.||+|+||.||+|... ++..+|+|++.... .....+.+|+.+++++ +||||++++++|... ...++||
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 344678999999999999864 58899999886432 2234577899999999 999999999998653 3579999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+.+ +|..++... .+++..+..++.||+.||+|||+.+++ ||||||+||+++.++.+||+|||+++....
T Consensus 89 e~~~~-~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~i~--H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 89 EYMET-DLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGNVI--HRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred ccccc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99974 999888642 478889999999999999999999966 999999999999999999999999875433
Q ss_pred CC---------CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-----
Q 037905 472 SS---------TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE----- 536 (606)
Q Consensus 472 ~~---------~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 536 (606)
.. ...++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~------~~~~~~~~~~~~~ 233 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN------QLEKIIEVIGPPS 233 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHHHhCCCC
Confidence 21 1235667999998755 457889999999999999999999996422111 00000000
Q ss_pred ---------cccccccc----hhhhcc-cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHH
Q 037905 537 ---------EWTAEVFD----LELLRY-QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEI 588 (606)
Q Consensus 537 ---------~~~~~~~d----~~~~~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i 588 (606)
.....+.+ ...... .........+.+++.+||+.+|++|||+.+++++ ++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00000000 000000 0011134678899999999999999999999987 5444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=290.57 Aligned_cols=238 Identities=23% Similarity=0.355 Sum_probs=198.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|.|++|.+|+. .++..||||.+++.... ...+.+|+++|..++|||||+++.+.......|+||||+.+|
T Consensus 61 ~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~g 140 (596)
T KOG0586|consen 61 IKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGG 140 (596)
T ss_pred eeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCc
Confidence 56799999999999984 46999999999876543 245889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---CC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---ST 474 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~ 474 (606)
.+++++.... ......+..++.|+..|++|||+++++ |||||++|||++.++++||+|||++...... .+
T Consensus 141 e~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~k~iv--HrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt 213 (596)
T KOG0586|consen 141 ELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHSKNIV--HRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT 213 (596)
T ss_pred hhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhhccee--ccccchhhcccccccceeeeccccceeecccccccc
Confidence 9999998754 355578889999999999999999866 9999999999999999999999999877653 45
Q ss_pred CCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 475 PNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
..+++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++. ++...-..++...+...+
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~------~lk~Lr~rvl~gk~rIp~----------- 276 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ------NLKELRPRVLRGKYRIPF----------- 276 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc------ccccccchheeeeecccc-----------
Confidence 678888999999999887 68899999999999999999999642 333333333333322111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
-...++.+++++.+-.+|.+|++++++.++
T Consensus 277 -~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 277 -YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 112346678889999999999999999765
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=280.10 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=189.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|... +++.||||++..... ......+|+..+++++ |+|++++++++..++..++||||+ ++
T Consensus 4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 82 (283)
T cd07830 4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG 82 (283)
T ss_pred heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence 467999999999999975 578999999875433 2334567889999998 999999999999999999999999 77
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---T 474 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~ 474 (606)
+|.+++.... ...+++..+..++.|++.+|.|||+++++ |+||+|+||++++++.++|+|||.++...... .
T Consensus 83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~--H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 157 (283)
T cd07830 83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHGFF--HRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD 157 (283)
T ss_pred CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCChhhEEEcCCCCEEEeecccceeccCCCCcCC
Confidence 9999887543 23589999999999999999999999966 99999999999999999999999987654322 2
Q ss_pred CCCcccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC----------CChhHHHHHHhhcccccccc
Q 037905 475 PNRIDGYRAPEVTD-ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG----------VDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 475 ~~~~~~y~aPE~~~-~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~ 543 (606)
..++..|+|||++. ...++.++|+||||++++||++|+.||......+. .....|.............+
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (283)
T cd07830 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRF 237 (283)
T ss_pred CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccc
Confidence 33566799999874 45578999999999999999999999864321100 00000111000000000000
Q ss_pred chhhhc--ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLELLR--YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~~~~--~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...... ..........+.+++.+||+.+|++|||++|++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 238 PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 00001123568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=284.20 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=186.4
Q ss_pred HHhcccccCCceEEEEEEEcC-CcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 320 ASAEVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
...+.||+|+||.||+|.... +..||||.++.... ...++..|+.++.+. .|+||++++++|......++||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 446789999999999999764 89999999975432 234566677766665 59999999999999999999999986
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
+ +|.+++.... ..+++..+..++.|++.||+|||+ .+++ ||||+|+||++++++.+||+|||++.......
T Consensus 98 ~-~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~i~--H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 98 T-CLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHGVI--HRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred c-CHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEe--cCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 4 7777765422 268999999999999999999997 4755 99999999999999999999999987554322
Q ss_pred --CCCCcccccCccccCCCC----CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 --TPNRIDGYRAPEVTDARK----VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~~~----~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...++..|+|||++.+.. ++.++||||||+++|||++|+.||..... .......+..... ..
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~-~~------ 238 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----EFEVLTKILQEEP-PS------ 238 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----HHHHHHHHhcCCC-CC------
Confidence 223456799999987654 78899999999999999999999964211 0111111111110 00
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
..........+.+++.+||..+|++||++.+++++-
T Consensus 239 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 --LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred --CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 000012345688999999999999999999998773
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=278.52 Aligned_cols=257 Identities=26% Similarity=0.312 Sum_probs=197.2
Q ss_pred HHHhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCC--C----CcccceEEEEeCCceEEEE
Q 037905 319 RASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDH--E----NLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~l~~~~~~~~~~~lv~ 391 (606)
+.....+|+|.||.|-++.. +.+..||||+++....-.+...-|++++.++.+ | -++++.++|...++.++|+
T Consensus 91 y~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivf 170 (415)
T KOG0671|consen 91 YEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVF 170 (415)
T ss_pred eehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEE
Confidence 34456799999999999863 457999999998765555667788999998832 2 3778888999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-----------------
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK----------------- 454 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~----------------- 454 (606)
|.+ |-++.+++..+. ..+++..+++.|+.|++++++|||+.+++ |.||||+|||+..
T Consensus 171 ell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~kl~--HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 171 ELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDLKLT--HTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred ecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhccee--ecCCChheEEEeccceEEEeccCCccceec
Confidence 988 559999998754 56799999999999999999999999866 9999999999841
Q ss_pred ---CCcEEEeecccCccCCCC-CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHH
Q 037905 455 ---SYEARISDFGLAHLASPS-STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWV 530 (606)
Q Consensus 455 ---~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~ 530 (606)
+..++++|||.|+...+. .+...|..|+|||++.+..++.++||||+||||+|+.||...|+.-.+.+.. ..+
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHL---aMM 321 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHL---AMM 321 (415)
T ss_pred cCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHH---HHH
Confidence 345899999999887664 3456788899999999999999999999999999999999999864332211 111
Q ss_pred HHHhhc-------------cccccccc------------------hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHH
Q 037905 531 QSVVKE-------------EWTAEVFD------------------LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMA 579 (606)
Q Consensus 531 ~~~~~~-------------~~~~~~~d------------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 579 (606)
+.++.. -+...-+| +-.......+++..+|++|+++++..||.+|+|+.
T Consensus 322 erIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~ 401 (415)
T KOG0671|consen 322 ERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLR 401 (415)
T ss_pred HHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHH
Confidence 111110 00011111 00000112346677899999999999999999999
Q ss_pred HHHHH
Q 037905 580 EVTSQ 584 (606)
Q Consensus 580 ~v~~~ 584 (606)
|++.+
T Consensus 402 EAL~H 406 (415)
T KOG0671|consen 402 EALSH 406 (415)
T ss_pred HHhcC
Confidence 98865
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=291.80 Aligned_cols=252 Identities=22% Similarity=0.320 Sum_probs=186.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEe----CCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYS----RDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|.. .+|..||+|++.... ...+.+.+|+.++++++||||+++.+++.. ....++||||
T Consensus 10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 89 (334)
T cd07855 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL 89 (334)
T ss_pred eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence 46799999999999985 468999999987542 234567789999999999999999988753 3467999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+. ++|.+++... ..+++..+..++.||+.||+|||+.+++ ||||||+||++++++.+||+|||+++......
T Consensus 90 ~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 161 (334)
T cd07855 90 ME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSANVI--HRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161 (334)
T ss_pred hh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence 96 5899888643 2489999999999999999999999966 99999999999999999999999986543211
Q ss_pred --------CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHh----------
Q 037905 474 --------TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV---------- 534 (606)
Q Consensus 474 --------~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------- 534 (606)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ....+....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred cCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChhHhhhh
Confidence 2245567999998765 468899999999999999999999996421110 000000000
Q ss_pred -hccccccccch-hhhcccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 535 -KEEWTAEVFDL-ELLRYQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 535 -~~~~~~~~~d~-~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.........+. ....... .......+.+++.+||+.+|++|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000000 0000000 11234678999999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=283.33 Aligned_cols=238 Identities=23% Similarity=0.280 Sum_probs=190.3
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.++||+|+||.||-++. .+|+.+|.|++.+.+.. +....+|-+++.+++.+.||.+-..|.+.+..++|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 36799999999999984 57999999988665443 34577899999999999999998889999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|||.-+|.... ...+++..++.++.+|+.||++||..+|+ .|||||+|||+|+.|+++|+|+|+|.......
T Consensus 270 GDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~~~iV--YRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~ 344 (591)
T KOG0986|consen 270 GDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHRRRIV--YRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR 344 (591)
T ss_pred CceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHhccee--eccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence 99999998654 34689999999999999999999999866 99999999999999999999999998776543
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+|.||||||+++...|+...|.||+||++|||+.|+.||......... .. +.....+ | ....+
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--eE-vdrr~~~-------~----~~ey~ 410 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--EE-VDRRTLE-------D----PEEYS 410 (591)
T ss_pred cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--HH-HHHHHhc-------c----hhhcc
Confidence 347899999999999999999999999999999999999999753322111 00 1110000 0 01112
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSM 578 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~ 578 (606)
+...++..++.+..+..||++|...
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccC
Confidence 3334455566668888999999743
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=271.18 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=191.9
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHc-CCCCCCcccceEEEEeCCce
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVG-SMDHENLVPLRAYYYSRDEK 387 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~ 387 (606)
|+-++++. ...||.|+||+|+|-.+ +.|+..|||++..... +.+++..|.+... .-+.||||+++|.++.++..
T Consensus 61 F~~~~Lqd--lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc 138 (361)
T KOG1006|consen 61 FTSDNLQD--LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC 138 (361)
T ss_pred cccchHHH--HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence 44444433 46799999999999875 5799999999987654 3456777776544 44799999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 388 LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
|+.||.|.- +|..+-..-.......+++.-.-.|......||.||.+.- .|+|||+||+|||++..|.+||||||++.
T Consensus 139 WiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 139 WICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecCCCEeeecccchH
Confidence 999999964 5544432211112345888888888888999999998763 35599999999999999999999999986
Q ss_pred cCCCC---CCCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccc
Q 037905 468 LASPS---STPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 468 ~~~~~---~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
....+ ....+...|||||.+.. ..|+.+|||||||++|+|+.||+.||.... +.-+.+..+.......-.
T Consensus 217 qLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 217 QLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGDPPILL 291 (361)
T ss_pred hHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCCCCeec
Confidence 55442 22355667999999853 458999999999999999999999997532 233444444443321111
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+ ...-+....+.+++..|+.+|-..||.+.++.++
T Consensus 292 ~~------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FD------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred Cc------ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 1112345678889999999999999999998765
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=280.22 Aligned_cols=246 Identities=22% Similarity=0.257 Sum_probs=191.6
Q ss_pred hcccccCCceEEEEEEE----cCCcEEEEEEeccCcc-----CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTV-----SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 391 (606)
.+.||+|+||.||+++. .+++.||||+++.... ..+.+.+|++++.++ +||||+++.+.+......++||
T Consensus 5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 84 (288)
T cd05583 5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL 84 (288)
T ss_pred EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence 46799999999999974 3578899999875321 235678899999999 5999999999998888999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+.+++|.+++... ..+++..+..++.|+++||+|||+.+++ ||||+|+||+++.++.++|+|||+++....
T Consensus 85 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~~~--H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 85 DYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLGII--YRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred ecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 999999999998643 2588899999999999999999999866 999999999999999999999999876433
Q ss_pred CC-----CCCCcccccCccccCCCC--CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 472 SS-----TPNRIDGYRAPEVTDARK--VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 472 ~~-----~~~~~~~y~aPE~~~~~~--~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
.. ...++..|+|||.+.+.. .+.++||||||+++|||++|..||...... ..............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~------- 228 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSK------- 228 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccC-------
Confidence 22 123566799999987654 788999999999999999999999632111 11111111111110
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
...+......+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 229 -----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 -----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred -----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 011122335678899999999999999998888777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=266.59 Aligned_cols=245 Identities=24% Similarity=0.298 Sum_probs=196.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEe----CCceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYS----RDEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~e~~ 394 (606)
..++||-|-.|.|..+.. .+|+.+|+|++... ...++|+++.-.. .|||||.++++|.+ .....+|||.|
T Consensus 66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 347899999999999874 57899999998653 4466777764433 69999999998863 34567899999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCccCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHLASP 471 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~~~ 471 (606)
+||.|.+.+++.+ ...+.+.++-.|+.||+.|+.|||+.+|. ||||||+|+|... +-.+||+|||.|+....
T Consensus 142 eGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~nIA--HRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 142 EGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMNIA--HRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred cchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcchh--hccCChhheeeecCCCCcceEecccccccccCC
Confidence 9999999999765 34689999999999999999999999977 9999999999964 44689999999987654
Q ss_pred C---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 472 S---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 472 ~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
. .+...|+.|.|||++..+.|+..+|+||+||++|-|++|.+||.... +..+..-++..++.+... +
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h---g~aispgMk~rI~~gqy~-F------ 286 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKRRIRTGQYE-F------ 286 (400)
T ss_pred CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC---CccCChhHHhHhhccCcc-C------
Confidence 3 35677889999999999999999999999999999999999997642 334444444444443221 1
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+.+++..+...++++..++.+|.+|.|+.++.++
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 123456666778888889999999999999999876
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=279.50 Aligned_cols=242 Identities=23% Similarity=0.292 Sum_probs=188.0
Q ss_pred hcccccCCceEEEEEEE----cCCcEEEEEEeccCcc-----CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTV-----SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 391 (606)
.+.||+|+||.||++.. .+|..||+|++..... ..+.+.+|++++.++ +|+||+++.+++..+...++||
T Consensus 5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (290)
T cd05613 5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL 84 (290)
T ss_pred eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence 46799999999999985 3689999999875322 235678899999999 5999999999998888899999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+++++|.+++... ..+++..+..++.|+++||.|||+.+++ ||||+|+|||++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~i~--H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 85 DYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLGII--YRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 999999999998753 2578889999999999999999999966 999999999999999999999999876533
Q ss_pred CC-----CCCCcccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 472 SS-----TPNRIDGYRAPEVTDAR--KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 472 ~~-----~~~~~~~y~aPE~~~~~--~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
.. ...++..|+|||++... .++.++||||||+++|+|++|+.||..... ...............
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~------- 228 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRILKSE------- 228 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhhccC-------
Confidence 21 23356679999998653 467899999999999999999999964211 111222222211111
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
...+......+.+++.+||+.+|++|| ++.++.++
T Consensus 229 -----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 -----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 001112335678899999999999997 66776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=274.22 Aligned_cols=239 Identities=20% Similarity=0.269 Sum_probs=187.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc------cCHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT------VSEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 392 (606)
.+.||+|+||.||+|.. .++..||+|.+.... .....+.+|++++++++|+||+++++++.+. ...++++|
T Consensus 7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e 86 (264)
T cd06653 7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86 (264)
T ss_pred eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence 56799999999999985 468999999875321 1224688899999999999999999998764 45789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++... ..+++..+..++.|++.||.|||+.+++ |+||||+||+++.++.++|+|||+++.....
T Consensus 87 ~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~i~--H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 87 YMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNMIV--HRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred eCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEe--cCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 99999999998743 2478889999999999999999999966 9999999999999999999999998754321
Q ss_pred -------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 -------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 -------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... ....+.........
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~------ 227 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE------AMAAIFKIATQPTK------ 227 (264)
T ss_pred cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC------HHHHHHHHHcCCCC------
Confidence 12345667999999998889999999999999999999999996421 11111111111100
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+......+.+++.+||. +|..||++.+++.+
T Consensus 228 ----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 ----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 11122344568888999998 57999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=290.79 Aligned_cols=255 Identities=22% Similarity=0.321 Sum_probs=194.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCC-----ceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRD-----EKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e 392 (606)
.+.||+|+||.||+|+.. ++..||+|++.... ...+.+.+|+.+++.++|+||+++.+++.... ..++|||
T Consensus 5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 84 (330)
T cd07834 5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE 84 (330)
T ss_pred eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence 467999999999999864 48999999987643 23467889999999999999999999988765 7899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+.+ +|.+++... ..+++..+..++.+++.||+|||+.|++ ||||||+||+++.++.++|+|||.+......
T Consensus 85 ~~~~-~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~gi~--H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 85 LMET-DLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSANVI--HRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred chhh-hHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 9985 898888643 2689999999999999999999999966 9999999999999999999999998765443
Q ss_pred C-------CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc-------
Q 037905 473 S-------TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------- 537 (606)
Q Consensus 473 ~-------~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------- 537 (606)
. ...++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ ....+....
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 157 EDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID------QLNLIVEVLGTPSEED 230 (330)
T ss_pred ccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH------HHHHHHHhcCCCChhH
Confidence 2 22345669999999887 78999999999999999999999996532211 111100000
Q ss_pred -------ccccccch-----hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHHHh
Q 037905 538 -------WTAEVFDL-----ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEICR 590 (606)
Q Consensus 538 -------~~~~~~d~-----~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~ 590 (606)
.....+.. ..............+.+++.+||+++|++|||+.+++++ ++.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000 000000011234568899999999999999999999986 666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=275.27 Aligned_cols=243 Identities=23% Similarity=0.313 Sum_probs=188.0
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCc------cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT------VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
..+.||+|+||.||++... .+..+++|+++... .....+..|+.++++++||||+++++++.+....++|+||
T Consensus 4 i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (260)
T cd08222 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEY 83 (260)
T ss_pred eeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEe
Confidence 3567999999999999854 34456666655322 1233567789999999999999999999988899999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+++++|.+++..... ....+++..+..++.|++.||.|||+.++. |+||+|+||+++. +.++|+|||.++......
T Consensus 84 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~--h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 84 CEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRRIL--HRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred CCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcCcc--ccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999998864321 234689999999999999999999999966 9999999999976 569999999987654322
Q ss_pred ----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 474 ----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 474 ----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
...++..|+|||+..+..++.++|+||||+++|+|++|..||... ............. .
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~-~---------- 222 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ------NFLSVVLRIVEGP-T---------- 222 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHcCC-C----------
Confidence 234566799999998888899999999999999999999998532 1222222221111 0
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+.....++.+++.+||..+|++||++.+++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 01122344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=283.31 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=186.7
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCC----------c
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRD----------E 386 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~ 386 (606)
..+.||+|+||.||+|... +|+.||+|+++... .....+.+|++++++++|||++++++++.+.. .
T Consensus 11 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 90 (302)
T cd07864 11 IIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGA 90 (302)
T ss_pred eeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCc
Confidence 3578999999999999965 58999999986532 22356778999999999999999999987654 7
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
.++|+||+++ ++...+... ...+++..+..++.|++.||+|||+.+++ ||||||+||++++++.+||+|||.+
T Consensus 91 ~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~i~--H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 91 FYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKNFL--HRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred EEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEECCCCcEEeCccccc
Confidence 8999999986 677776543 23589999999999999999999999966 9999999999999999999999998
Q ss_pred ccCCCCC-----CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc---
Q 037905 467 HLASPSS-----TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE--- 537 (606)
Q Consensus 467 ~~~~~~~-----~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 537 (606)
+...... ....+..|+|||.+.+ ..++.++|||||||++|||++|++||...... .....+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLCGSPCPA 240 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChh
Confidence 7654322 1123556999998764 45788999999999999999999999642211 1111111110000
Q ss_pred cccccc--------chhhhc-c---cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 WTAEVF--------DLELLR-Y---QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ~~~~~~--------d~~~~~-~---~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+.+. +..... . ......+..+.+++.+||..+|++|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 000000 0 0001124578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=271.25 Aligned_cols=231 Identities=28% Similarity=0.346 Sum_probs=188.0
Q ss_pred cccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 325 LGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 325 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
||+|+||.||++... +++.+|+|++..... ....+..|++++++++|+|++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999865 589999999876533 234688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++.... .+++..+..++.|++.||.|||+.+++ |+||+|+||+++.++.++|+|||.+...... ...
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~~~--H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLGII--YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF 153 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCce--ecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCC
Confidence 99997532 588999999999999999999999966 9999999999999999999999998765432 223
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||...+...+.++|+||||+++||+++|+.||..... ......+..... ..+..
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~~~~------------~~~~~ 215 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILKDPL------------RFPEF 215 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhcCCC------------CCCCC
Confidence 456679999999888889999999999999999999999964321 111222221110 11111
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAE 580 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~ 580 (606)
....+.+++.+||..+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2456788999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=266.19 Aligned_cols=262 Identities=20% Similarity=0.244 Sum_probs=193.6
Q ss_pred HHhcccccCCceEEEEEEEc---C--CcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEe-CCceEEE
Q 037905 320 ASAEVLGKGTFGTAYKATLE---M--GIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYS-RDEKLLV 390 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv 390 (606)
...++||+|.||.||+|... + ...+|+|+++..... ....-+|+.+++.++|||++.+..++.. +...+++
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 44678999999999999532 2 237999999865321 2457789999999999999999998877 6788999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC----CcEEEeecccC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS----YEARISDFGLA 466 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~----~~~kl~DfG~a 466 (606)
+||.+. +|.+.++-.+......++...+..|+.||+.|+.|||++-+. ||||||.|||+..+ |.|||+|||++
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvl--HRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVL--HRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhhee--eccCCcceEEEeccCCccCeeEeecccHH
Confidence 999988 999998866554456789999999999999999999999755 99999999999776 89999999999
Q ss_pred ccCCCC-------CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCC---CChhHHHHHHhh
Q 037905 467 HLASPS-------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG---VDLPRWVQSVVK 535 (606)
Q Consensus 467 ~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~ 535 (606)
+..... .....|..|+|||.+.+ ..||.+.||||.|||+.||+|-++.|.+...... ..-.+.+..++.
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~ 263 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFE 263 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHH
Confidence 876543 22344667999999876 5699999999999999999999998876432211 112222332221
Q ss_pred cc-ccccccchhhhcccC-----------------hHHH-------HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 536 EE-WTAEVFDLELLRYQN-----------------VEEE-------MVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 536 ~~-~~~~~~d~~~~~~~~-----------------~~~~-------~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
-- ...+..-|.+.+.+. .... ...-++|+.+++..||.+|.|+++.+++
T Consensus 264 vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 264 VLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 10 000000011111100 1111 1226788889999999999999998776
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=278.78 Aligned_cols=238 Identities=25% Similarity=0.380 Sum_probs=191.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||++... ++..||+|++..... ..+.+.+|++++++++ |+||+++++++...+..++||||++
T Consensus 6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd05581 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85 (280)
T ss_pred eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence 467999999999999864 689999999875322 2356888999999998 9999999999999899999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
+++|.+++.... .+++..+..++.|++.||+|||+.++. |+||+|+||+++.++.++++|||++.......
T Consensus 86 ~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~~~--H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 86 NGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKGII--HRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--ecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 999999997532 589999999999999999999999966 99999999999999999999999987543321
Q ss_pred ----------------------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHH
Q 037905 474 ----------------------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQ 531 (606)
Q Consensus 474 ----------------------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 531 (606)
...++..|+|||......++.++||||||++++++++|+.||..... ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~ 232 (280)
T cd05581 159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------YLTFQ 232 (280)
T ss_pred ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------HHHHH
Confidence 11234669999999888899999999999999999999999975321 11111
Q ss_pred HHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCH----HHHHHH
Q 037905 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSM----AEVTSQ 584 (606)
Q Consensus 532 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~----~~v~~~ 584 (606)
...... ...+......+.+++.+||+.+|++|||+ ++++++
T Consensus 233 ~~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 233 KILKLE------------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHhcC------------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 111111 01112224568899999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=281.55 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=186.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEe-CCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYS-RDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|.. .++..||+|++.... ...+.+.+|+++++.++||||+++.++|.. ....++|+||+ +
T Consensus 15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~ 93 (328)
T cd07856 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G 93 (328)
T ss_pred EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence 56799999999999984 478999999886432 224668889999999999999999999875 45789999998 4
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STP 475 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~ 475 (606)
++|.+++... ++++..+..++.|+++||+|||+.+++ ||||+|+||++++++.++|+|||.++..... ...
T Consensus 94 ~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~ii--H~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 165 (328)
T cd07856 94 TDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAGVV--HRDLKPSNILINENCDLKICDFGLARIQDPQMTGY 165 (328)
T ss_pred cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence 5898888632 478888889999999999999999966 9999999999999999999999998755432 223
Q ss_pred CCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCC---------CChhHHHHHHhhccccccccch
Q 037905 476 NRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG---------VDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 476 ~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
.++..|+|||++.+ ..++.++||||||+++|||++|+.||........ ....++................
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (328)
T cd07856 166 VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSL 245 (328)
T ss_pred cccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhc
Confidence 45667999998765 5689999999999999999999999964321100 0000111110000000000000
Q ss_pred hhhcccCh----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNV----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........ ......+.+++.+||+.+|++|||+.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 246 PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 1123678899999999999999999999877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=274.20 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=190.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|+.. +++.+|+|++.... ...+.+..|++++++++|+|++++++++......++|+||+.+
T Consensus 4 ~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~- 82 (282)
T cd07829 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM- 82 (282)
T ss_pred ehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCc-
Confidence 356999999999999865 58999999997643 2245678899999999999999999999998999999999984
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++.... ..+++..+..++.+++.||+|||+.+++ ||||+|+||++++++.++|+|||.++......
T Consensus 83 ~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~--H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (282)
T cd07829 83 DLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHRIL--HRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156 (282)
T ss_pred CHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence 8999998542 3589999999999999999999999966 99999999999999999999999987654322
Q ss_pred CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-------ccc--ccc-
Q 037905 474 TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE-------EWT--AEV- 542 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~--~~~- 542 (606)
....+..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+..+... .+. ...
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE------IDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 12234569999998766 789999999999999999999999964221 1111111000 000 000
Q ss_pred -cchhhhcc------cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 -FDLELLRY------QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 -~d~~~~~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+...... ...+.....+.+++.+||..+|++||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000000 0011124578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-32 Score=280.49 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=187.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 391 (606)
.+.||+|+||.||+|.. .+|+.||+|+++.... ....+.+|+.++++++||||+++++++... ...++|+
T Consensus 20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 99 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99 (342)
T ss_pred EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence 46899999999999985 4689999999875322 235678899999999999999999998654 2458999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+.. +|..++. ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++....
T Consensus 100 e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~i~--H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 100 PYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAGII--HRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 99964 7776652 2478899999999999999999999966 999999999999999999999999876543
Q ss_pred CC-CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------------
Q 037905 472 SS-TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------------ 537 (606)
Q Consensus 472 ~~-~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 537 (606)
.. ...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+..+....
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY------LDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCCHHHHHHhc
Confidence 22 2344567999999866 4688999999999999999999999975211 11111111000
Q ss_pred --ccccccc--hhhhccc---ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHHHh
Q 037905 538 --WTAEVFD--LELLRYQ---NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEICR 590 (606)
Q Consensus 538 --~~~~~~d--~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~ 590 (606)
....... +...+.. ..+.....+.+++.+||++||++||++.+++.+ ++...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0000000 0000000 001123467899999999999999999999977 777654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=288.47 Aligned_cols=265 Identities=23% Similarity=0.305 Sum_probs=193.5
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEe------CCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYS------RDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv~e 392 (606)
.+.||+|+||.||+|+ .++|+.||||.+.... ...+...+|++++++++|+|||++++.-.+ .....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4569999999999999 5689999999997643 235667899999999999999999988543 346689999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe--cCCC--cEEEeecccCcc
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL--SKSY--EARISDFGLAHL 468 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill--~~~~--~~kl~DfG~a~~ 468 (606)
||.+|+|+..+..-.. -..++....+.++.+++.||.|||++||+ ||||||.||++ .++| .-||+|||.|+.
T Consensus 98 yC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn~Iv--HRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRENGIV--HRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHcCce--eccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999986432 23589999999999999999999999966 99999999988 3444 379999999998
Q ss_pred CCCCC---CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 469 ASPSS---TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 469 ~~~~~---~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
..+.. ...||..|.+||.... ..|+..+|.|||||++||.+||..||-.........-..|....-+..-.....+
T Consensus 174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~ 253 (732)
T KOG4250|consen 174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ 253 (732)
T ss_pred CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence 87764 3567888999999985 7788899999999999999999999964322111111111111000000000011
Q ss_pred h--------hh--hccc-ChHHHHHHHHHHHHHccCcCCCCCC--CHHHHHHHHHHHHh
Q 037905 545 L--------EL--LRYQ-NVEEEMVQLLQLAINCTAQYPDNRP--SMAEVTSQIEEICR 590 (606)
Q Consensus 545 ~--------~~--~~~~-~~~~~~~~l~~l~~~Cl~~~P~~RP--s~~~v~~~L~~i~~ 590 (606)
+ .. ..+. ........+-+.+...+..+|++|. .+.+....+.+|.+
T Consensus 254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 1 00 0000 1123344556666677778888888 76666666666654
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=278.86 Aligned_cols=250 Identities=24% Similarity=0.294 Sum_probs=182.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCC--------ceEE
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRD--------EKLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l 389 (606)
.+.||+|+||.||+|... +++.+|+|++..... ....+.+|+++++.++||||+++++++.... ..++
T Consensus 13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l 92 (311)
T cd07866 13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM 92 (311)
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence 467999999999999854 689999999864322 2345778999999999999999999876433 4589
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
|+||+.+ +|...+... ...+++..+..++.|+++||+|||+++++ |+||||+||++++++.++|+|||+++..
T Consensus 93 v~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~i~--H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 93 VTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENHIL--HRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred EEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEECCCCCEEECcCccchhc
Confidence 9999975 677776643 23589999999999999999999999966 9999999999999999999999998754
Q ss_pred CCCCC---------------CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHH
Q 037905 470 SPSST---------------PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSV 533 (606)
Q Consensus 470 ~~~~~---------------~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (606)
..... ..++..|+|||.+.+ ..++.++||||||+++|||++|++||...... ...+.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~------~~~~~~ 239 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI------DQLHLI 239 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence 32211 123456999998765 45889999999999999999999999642211 111111
Q ss_pred hhcc------------ccccccchh-hhc-ccCh----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 534 VKEE------------WTAEVFDLE-LLR-YQNV----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 534 ~~~~------------~~~~~~d~~-~~~-~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.... ......+.. ... .... ......+.+++.+|+..+|++|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 1000 000000000 000 0000 1122568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=299.59 Aligned_cols=239 Identities=22% Similarity=0.316 Sum_probs=175.8
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEe----------------
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYS---------------- 383 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------------- 383 (606)
+.||+||||.||+++.+ +|+.||||++.... .....+.+|+..+.+|+|||||+++..|..
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 56999999999999854 79999999997654 223457889999999999999999554400
Q ss_pred --------------------------------------------------------------C-----------------
Q 037905 384 --------------------------------------------------------------R----------------- 384 (606)
Q Consensus 384 --------------------------------------------------------------~----------------- 384 (606)
.
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence 0
Q ss_pred ------------------------CceEEEEeecCCCChhhhhhcCCCCCCCCC-CHHHHHHHHHHHHHHHHHHHhcCCC
Q 037905 385 ------------------------DEKLLVHDYMPMGSLSALLHGNRGAGRTPL-NWETRSGLALGASRAIAYLHSKGPA 439 (606)
Q Consensus 385 ------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l-~~~~~~~i~~~ia~~L~~LH~~~~~ 439 (606)
...||=||||+..+|+++++.+. .. .....++++.+|++||+|+|++|++
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-----~~~~~d~~wrLFreIlEGLaYIH~~giI 719 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-----FNSQRDEAWRLFREILEGLAYIHDQGII 719 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-----cchhhHHHHHHHHHHHHHHHHHHhCcee
Confidence 01367789998878888877543 11 3667889999999999999999955
Q ss_pred CCCCCCCCCCEEecCCCcEEEeecccCccCC----C------------------CCCCCCcccccCccccCCCC---CCC
Q 037905 440 NSHGNIKSSNILLSKSYEARISDFGLAHLAS----P------------------SSTPNRIDGYRAPEVTDARK---VSQ 494 (606)
Q Consensus 440 i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~----~------------------~~~~~~~~~y~aPE~~~~~~---~~~ 494 (606)
||||||.|||+|++..|||+|||+|+... . .....||.-|+|||.+.+.. |+.
T Consensus 720 --HRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 720 --HRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred --eccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 99999999999999999999999997621 0 01234556699999997654 999
Q ss_pred cchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCC
Q 037905 495 KADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDN 574 (606)
Q Consensus 495 ~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~ 574 (606)
|+|+||+|||++||+ .||...++ ....+ ..++.+..+..- ....+....=.++++.+++.||.+
T Consensus 798 KiDmYSLGIVlFEM~---yPF~TsME-----Ra~iL-~~LR~g~iP~~~-------~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEML---YPFGTSME-----RASIL-TNLRKGSIPEPA-------DFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred hhhhHHHHHHHHHHh---ccCCchHH-----HHHHH-HhcccCCCCCCc-------ccccccchHHHHHHHHHhcCCCcc
Confidence 999999999999998 45653221 11111 122222222210 011233344568888999999999
Q ss_pred CCCHHHHHHH
Q 037905 575 RPSMAEVTSQ 584 (606)
Q Consensus 575 RPs~~~v~~~ 584 (606)
|||+.|+++.
T Consensus 862 RPtA~eLL~s 871 (1351)
T KOG1035|consen 862 RPTATELLNS 871 (1351)
T ss_pred CCCHHHHhhc
Confidence 9999999763
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=281.93 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=182.8
Q ss_pred hcccccCCceEEEEEEEc-C--CcEEEEEEeccCcc---CHHHHHHHHHHHcCC-CCCCcccceEEEEeC----CceEEE
Q 037905 322 AEVLGKGTFGTAYKATLE-M--GIVVAVKRLKDVTV---SEKEFREKMEVVGSM-DHENLVPLRAYYYSR----DEKLLV 390 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~~lv 390 (606)
.+.||+|+||.||++... . +..||+|++..... ..+.+.+|+++++++ .||||+++++++... ...+++
T Consensus 5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 84 (332)
T cd07857 5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY 84 (332)
T ss_pred EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence 467999999999999854 3 77899999865321 245678899999998 599999999875432 456888
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
+||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++ ||||||+||+++.++.+||+|||.++...
T Consensus 85 ~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~giv--H~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 85 EELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSANVL--HRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred Eeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 89886 5899888643 3588999999999999999999999966 99999999999999999999999987543
Q ss_pred CC--------CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccC---------CCChhHHHHH
Q 037905 471 PS--------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEE---------GVDLPRWVQS 532 (606)
Q Consensus 471 ~~--------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~ 532 (606)
.. ....++..|+|||++.+ ..++.++||||||+++|+|++|+.||....... +......+..
T Consensus 157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T cd07857 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236 (332)
T ss_pred cccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 21 11245677999998765 468999999999999999999999986422100 0000000000
Q ss_pred Hhhcc---ccccccchhhhcc-cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 533 VVKEE---WTAEVFDLELLRY-QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 533 ~~~~~---~~~~~~d~~~~~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..... .....-....... .........+.+++.+|++.+|++|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 0000000000000 0001123568899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=281.41 Aligned_cols=248 Identities=22% Similarity=0.317 Sum_probs=181.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeC--------------C
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSR--------------D 385 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------------~ 385 (606)
.+.||+|+||.||+|.. .+|..||+|++..... ..+.+.+|++++++++||||+++++++... .
T Consensus 10 ~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 89 (342)
T cd07854 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89 (342)
T ss_pred EEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccc
Confidence 46799999999999985 4689999999865433 346688999999999999999998776543 3
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-CCcEEEeecc
Q 037905 386 EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-SYEARISDFG 464 (606)
Q Consensus 386 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG 464 (606)
..++||||+. ++|.+++... .+++..+..++.||++||.|||+.|++ ||||||+||+++. ++.+||+|||
T Consensus 90 ~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~giv--H~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 90 SVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSANVL--HRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred eEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHEEEcCCCceEEECCcc
Confidence 5789999997 4898888532 488999999999999999999999966 9999999999974 5578999999
Q ss_pred cCccCCCC-------CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc
Q 037905 465 LAHLASPS-------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE 536 (606)
Q Consensus 465 ~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (606)
.++..... ....++..|+|||++.. ..++.++|||||||++|||++|+.||....... ........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~------~~~~~~~~ 234 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE------QMQLILES 234 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHh
Confidence 98754321 11234566999998654 567889999999999999999999996432110 01100000
Q ss_pred cc------cccc---cchhhh----cc-cC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 EW------TAEV---FDLELL----RY-QN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 ~~------~~~~---~d~~~~----~~-~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. .... ...... .. .. ......++.+++.+||..+|++|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00 0000 000000 00 00 01223567889999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=283.18 Aligned_cols=248 Identities=23% Similarity=0.304 Sum_probs=184.3
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 391 (606)
.+.||+|+||.||+|.. .+++.||+|++..... ..+.+.+|++++++++||||+++.+++... ...++++
T Consensus 22 ~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 101 (345)
T cd07877 22 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101 (345)
T ss_pred EEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEe
Confidence 45799999999999974 5789999999875422 235678899999999999999999988643 3467888
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
+++ +++|.+++... .+++..+..++.|+++||+|||+.+++ ||||||+||++++++.+||+|||+++....
T Consensus 102 ~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~iv--H~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 102 HLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADII--HRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred hhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCee--ecCCChHHEEEcCCCCEEEecccccccccc
Confidence 876 77998887632 488999999999999999999999966 999999999999999999999999876543
Q ss_pred CC-CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------cccccc
Q 037905 472 SS-TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------WTAEVF 543 (606)
Q Consensus 472 ~~-~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 543 (606)
.. ...++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+.... ......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHhhcc
Confidence 32 2345677999998866 5678899999999999999999999954211 11111110000 000000
Q ss_pred ch-------hhhccc--Ch----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DL-------ELLRYQ--NV----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~-------~~~~~~--~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+. .+.... .. ......+.+++.+|++.+|.+|||+.+++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00 000000 00 0123457899999999999999999999877
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=267.26 Aligned_cols=219 Identities=21% Similarity=0.185 Sum_probs=173.0
Q ss_pred CCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhhhhhcC
Q 037905 328 GTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGN 406 (606)
Q Consensus 328 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 406 (606)
|.||.||++.. .+++.+|+|+++... .+.+|...+....||||+++++++......++||||+++++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 89999999985 568999999997643 2334444455567999999999999999999999999999999998743
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCCCCcccccCcc
Q 037905 407 RGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STPNRIDGYRAPE 485 (606)
Q Consensus 407 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE 485 (606)
. .+++..+..++.|+++||+|||+.+++ ||||||+||+++.++.++++|||.+...... .....+..|+|||
T Consensus 80 ~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE 152 (237)
T cd05576 80 L-----NIPEECVKRWAAEMVVALDALHREGIV--CRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPE 152 (237)
T ss_pred c-----CCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCc
Confidence 2 489999999999999999999999966 9999999999999999999999987655432 2233455699999
Q ss_pred ccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHH
Q 037905 486 VTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAI 565 (606)
Q Consensus 486 ~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~ 565 (606)
......++.++||||+|+++|||++|+.|+....... ... .. ...+......+.+++.
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~--~~--------~~~~~~~~~~~~~li~ 210 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH--TT--------LNIPEWVSEEARSLLQ 210 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc--cc--------cCCcccCCHHHHHHHH
Confidence 9988889999999999999999999998875321100 000 00 0011122346788999
Q ss_pred HccCcCCCCCCCHH
Q 037905 566 NCTAQYPDNRPSMA 579 (606)
Q Consensus 566 ~Cl~~~P~~RPs~~ 579 (606)
+|++.||++||++.
T Consensus 211 ~~l~~dp~~R~~~~ 224 (237)
T cd05576 211 QLLQFNPTERLGAG 224 (237)
T ss_pred HHccCCHHHhcCCC
Confidence 99999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=277.24 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=187.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCC------ceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRD------EKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 391 (606)
.+.||+|+||.||++.. .++..||||++...... .+.+.+|++++++++||||+++++++.... ..++||
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07880 20 LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99 (343)
T ss_pred EEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEE
Confidence 46799999999999974 47899999998653222 346789999999999999999999987543 358999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+ +++|.+++.. ..+++..+..++.|++.||+|||+.|++ ||||||+||+++.++.++|+|||+++....
T Consensus 100 e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~gi~--H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 100 PFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 998 6799888763 2488999999999999999999999966 999999999999999999999999876543
Q ss_pred CC-CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------cccccc
Q 037905 472 SS-TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------WTAEVF 543 (606)
Q Consensus 472 ~~-~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 543 (606)
.. ...++..|+|||.+.+ ..++.++|+||||+++|++++|+.||..... ......+.... +...+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH------LDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCCHHHHHhhc
Confidence 32 2345677999998875 4588999999999999999999999964211 11111111000 000000
Q ss_pred ch-------hhhcc--c----ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHH
Q 037905 544 DL-------ELLRY--Q----NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEI 588 (606)
Q Consensus 544 d~-------~~~~~--~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i 588 (606)
.. ..... . ........+.+++.+|+..+|++|||+.+++.+ ++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00 00000 0 001233468899999999999999999999954 4444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=264.53 Aligned_cols=230 Identities=26% Similarity=0.340 Sum_probs=185.2
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCcc-CHHH---HHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV-SEKE---FREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~---~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.++||+|.||.|-+++ ..+|+.+|+|++++... .+++ -..|-.+++..+||.+..+-..|..++..|+||||..|
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 4679999999999998 45799999999987644 3344 34577889999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
|.|.-++...+ .+++...+.+...|..||.|||+++++ .||||.+|.|+|.+|.+||+|||+++..-. .
T Consensus 253 GeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~iv--YRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~ 325 (516)
T KOG0690|consen 253 GELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRNIV--YRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTT 325 (516)
T ss_pred ceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCCee--eeechhhhheeccCCceEeeecccchhccccccee
Confidence 99999987543 578888889999999999999999866 999999999999999999999999986433 3
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
.+..+|+.|+|||++....|+.+.|.|.+|||+|||++|+.||..... ..+-.. +.-+. +.-+..
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeL---Il~ed---------~kFPr~ 390 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFEL---ILMED---------LKFPRT 390 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHH---HHhhh---------ccCCcc
Confidence 467889999999999999999999999999999999999999975322 222221 11111 111122
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCC
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRP 576 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RP 576 (606)
..++.+ .|+...+..||.+|.
T Consensus 391 ls~eAk---tLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 391 LSPEAK---TLLSGLLKKDPKKRL 411 (516)
T ss_pred CCHHHH---HHHHHHhhcChHhhc
Confidence 333433 445588889999996
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=281.66 Aligned_cols=248 Identities=24% Similarity=0.317 Sum_probs=186.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCc------eEEEE
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDE------KLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~ 391 (606)
.+.||+|+||.||+|... ++..||+|++..... ..+.+.+|+.++++++|+|++++.+++...+. .++|+
T Consensus 20 ~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 99 (343)
T cd07851 20 LSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVT 99 (343)
T ss_pred EEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEE
Confidence 467999999999999864 578999999865322 23557789999999999999999988765554 89999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+ +++|.+++.. ..+++..+..++.|+++||+|||+.|++ ||||||+||+++.++.++|+|||++.....
T Consensus 100 e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~gi~--H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 100 HLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAGII--HRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHeEECCCCCEEEccccccccccc
Confidence 998 5699998864 2589999999999999999999999966 999999999999999999999999876543
Q ss_pred C-CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------cccccc
Q 037905 472 S-STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------WTAEVF 543 (606)
Q Consensus 472 ~-~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 543 (606)
. ....++..|+|||.+.. ..++.++||||||+++|||++|+.||..... ...+..+.... +.....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH------IDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHHhcCCCCHHHHhhcc
Confidence 2 23345667999998865 4678899999999999999999999964211 11111111100 000000
Q ss_pred ch---------hhhcccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DL---------ELLRYQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~---------~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. ....... .......+.+++.+||..+|++|||+.+|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00 0000000 01124678899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=287.13 Aligned_cols=243 Identities=22% Similarity=0.361 Sum_probs=202.0
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEE-----eCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYY-----SRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~~~~~~lv~e~~ 394 (606)
.+.||.|.+|.||+++ .++++.+|+|+.......++++..|+++++.. .|||++.++|+|. .+++.|||||||
T Consensus 24 ~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC 103 (953)
T KOG0587|consen 24 IEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFC 103 (953)
T ss_pred EEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeecc
Confidence 4679999999999998 56799999999988777788899999999877 6999999999987 357899999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC---
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--- 471 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 471 (606)
.+|+..++++... ...+.|..+..|++.++.|+.+||...++ |||||-.|||++.++.|||+|||++.....
T Consensus 104 ~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nkvi--HRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g 178 (953)
T KOG0587|consen 104 GGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNKVI--HRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG 178 (953)
T ss_pred CCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhccee--eecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence 9999999998765 34689999999999999999999999866 999999999999999999999999865543
Q ss_pred -CCCCCCcccccCccccCCC-----CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 472 -SSTPNRIDGYRAPEVTDAR-----KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 472 -~~~~~~~~~y~aPE~~~~~-----~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
..+..+|+.|||||++... .|+.++|+||||++..||.-|.+|+....+... +=.+.++. .|
T Consensus 179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra------LF~IpRNP------PP 246 (953)
T KOG0587|consen 179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA------LFLIPRNP------PP 246 (953)
T ss_pred cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh------hccCCCCC------Cc
Confidence 4567888999999998654 377889999999999999999999976443221 00011110 11
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+..+.+++.++|..|+..|.++||++.+++++
T Consensus 247 ---kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 247 ---KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred ---cccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 112356778899999999999999999999988765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=296.81 Aligned_cols=139 Identities=24% Similarity=0.364 Sum_probs=123.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|... +++.||||+++..... ...+..|+.++..++||||+++++++......++||||+.+
T Consensus 9 ~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g 88 (669)
T cd05610 9 VKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIG 88 (669)
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999865 6899999999754321 25688899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
++|.+++... ..+++..++.++.||+.||+|||..+++ ||||||+|||++.++.+||+|||+++
T Consensus 89 ~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~gIi--HrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 89 GDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHGII--HRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEE--eCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999743 2478889999999999999999999865 99999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=279.79 Aligned_cols=241 Identities=24% Similarity=0.279 Sum_probs=187.4
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
...+|.|+|+.|-.+. ..+++..+||++.+. ..+..+|+.++... +||||+++.+.+.+..+.|+|||++.++-+
T Consensus 327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el 403 (612)
T KOG0603|consen 327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL 403 (612)
T ss_pred ccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence 4569999999999887 456888999999765 23344555444443 799999999999999999999999999988
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe-cCCCcEEEeecccCccCCCC-CCCCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPS-STPNR 477 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill-~~~~~~kl~DfG~a~~~~~~-~~~~~ 477 (606)
.+.+...+ .....+..|+.+|+.|+.|||.+|++ ||||||+|||+ +..++++|+|||.++..... .+..-
T Consensus 404 l~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~~gvv--hRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~ 475 (612)
T KOG0603|consen 404 LRRIRSKP------EFCSEASQWAAELVSAVDYLHEQGVV--HRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPAL 475 (612)
T ss_pred HHHHHhcc------hhHHHHHHHHHHHHHHHHHHHhcCee--ecCCChhheeecCCCCcEEEEEechhhhCchhhcccch
Confidence 88876432 22367778999999999999999966 99999999999 68999999999999877665 23456
Q ss_pred cccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHH
Q 037905 478 IDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEM 557 (606)
Q Consensus 478 ~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 557 (606)
|..|.|||+.....|++++||||||++||+|++|+.||..-... ......+....+. ....
T Consensus 476 t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~i~~~~~s--------------~~vS 536 (612)
T KOG0603|consen 476 TLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTRIQMPKFS--------------ECVS 536 (612)
T ss_pred hhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHhhcCCccc--------------cccC
Confidence 67799999999999999999999999999999999999753221 1222211111110 2223
Q ss_pred HHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 558 VQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 558 ~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
....+|+.+||+.||.+||+|.++..+=-.....+
T Consensus 537 ~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~~~~t 571 (612)
T KOG0603|consen 537 DEAKDLLQQLLQVDPALRLGADEIGAHPWFLSHPT 571 (612)
T ss_pred HHHHHHHHHhccCChhhCcChhhhccCcchhcCCC
Confidence 44567777999999999999999988754433333
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=294.07 Aligned_cols=242 Identities=25% Similarity=0.308 Sum_probs=190.9
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccC----ccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
+.++||+|+||.|..++. .++++||+|++.+. .....-|..|-.+|..-+.+=|+.+...|.++.+.|+|||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 357899999999999986 46899999999763 3345668899999988888889999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
||||..++... .+++...+..++..|+.||.-+|+.|++ ||||||+|||+|..|++||+|||.+..+..
T Consensus 159 GGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mgyV--HRDiKPDNvLld~~GHikLADFGsClkm~~dG~V 231 (1317)
T KOG0612|consen 159 GGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMGYV--HRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV 231 (1317)
T ss_pred CchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhccce--eccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence 99999999853 2689999999999999999999999977 999999999999999999999998866653
Q ss_pred -CCCCCCcccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 472 -SSTPNRIDGYRAPEVTDA-----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 472 -~~~~~~~~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
+....|||-|.+||++.. ..|++.+|+||+||++|||+.|..||... .++.-+..+..-....
T Consensus 232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm~hk~~l----- 300 (1317)
T KOG0612|consen 232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIMNHKESL----- 300 (1317)
T ss_pred EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHhchhhhc-----
Confidence 345688999999999853 46889999999999999999999999642 3333333333221111
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCC---HHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS---MAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs---~~~v~~~ 584 (606)
.++.....+....+||.+.+ -+|+.|.. ++++..|
T Consensus 301 ---~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 301 ---SFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ---CCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 11111112233445555544 45888887 8888766
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=271.96 Aligned_cols=250 Identities=23% Similarity=0.350 Sum_probs=193.8
Q ss_pred cCHHHHHHH-HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCc
Q 037905 312 FDLEDLLRA-SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDE 386 (606)
Q Consensus 312 ~~~~~~~~~-~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 386 (606)
.++..+... .++.||+|-||+||-|.. ++|+.||||++.+.+. .+..+++|+.+++++.||.||.+-.-|...+.
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er 637 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER 637 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence 344444332 268899999999999984 5799999999977654 34679999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC---cEEEeec
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY---EARISDF 463 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~---~~kl~Df 463 (606)
.++|||-+.| +..+.+-.+. ...++......++.||+.||.|||.++|+ |+||||+|||+.... ++|||||
T Consensus 638 vFVVMEKl~G-DMLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~knIv--HCDLKPENVLLas~~~FPQvKlCDF 711 (888)
T KOG4236|consen 638 VFVVMEKLHG-DMLEMILSSE---KGRLPERITKFLVTQILVALRYLHFKNIV--HCDLKPENVLLASASPFPQVKLCDF 711 (888)
T ss_pred EEEEehhhcc-hHHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhccee--eccCCchheeeccCCCCCceeeccc
Confidence 9999999976 5544444332 34688888899999999999999999966 999999999997543 6999999
Q ss_pred ccCccCCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 464 GLAHLASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 464 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
|.|+..++. ....+|+.|+|||++..+.|...-|+||.||++|.-++|..||... .++-+.++ +.
T Consensus 712 GfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-----EdIndQIQ----NA--- 779 (888)
T KOG4236|consen 712 GFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-----EDINDQIQ----NA--- 779 (888)
T ss_pred cceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-----cchhHHhh----cc---
Confidence 999988763 4567899999999999999999999999999999999999999752 22222221 11
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 583 (606)
.++- ....+.+.....+++|...++..=.+|-|..+-+.
T Consensus 780 aFMy----Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 780 AFMY----PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred cccc----CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1110 11223444455667777777777777877665443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-31 Score=230.33 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=187.7
Q ss_pred cccccCCceEEEEEE-EcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
++||+|.||+||+|+ +++++.||+|+++....+ .....+|+-+++.++|.|||++++....+....+|+|||.. +
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-d 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-H
Confidence 579999999999998 567899999999765433 35688999999999999999999999889999999999975 8
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----T 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~ 474 (606)
|..+..... ..++...+..++.|+++||.|+|++++. ||||||.|.||+.+|..|++|||+++..+-+. .
T Consensus 87 lkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshnvl--hrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 87 LKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHNVL--HRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhhhh--hccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 888887543 3588999999999999999999999977 99999999999999999999999998765432 2
Q ss_pred CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhc-------cccccccch
Q 037905 475 PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKE-------EWTAEVFDL 545 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~d~ 545 (606)
...|..|++|+++-+ .-|+...|+||-||++.|+.. |++.|.+ .+..+.+..+++. .|...---+
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg------~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG------NDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC------CcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 344667999998876 458999999999999999988 7776754 3333444443321 121100000
Q ss_pred hhhccc------ChHHHHH----HHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQ------NVEEEMV----QLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~------~~~~~~~----~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+..++ .+.+... .=.+++.+.+.-+|..|.++++.+++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 010010 1112211 12455556666679999999987654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=252.73 Aligned_cols=234 Identities=28% Similarity=0.371 Sum_probs=189.0
Q ss_pred CceEEEEEEEc-CCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhhhhhc
Q 037905 329 TFGTAYKATLE-MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHG 405 (606)
Q Consensus 329 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 405 (606)
+||.||+|... +++.+|+|++...... .+.+.+|++.+++++|+|++++++++......++++||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 4899999999765432 57899999999999999999999999998999999999999999999875
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---CCCCCccccc
Q 037905 406 NRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---STPNRIDGYR 482 (606)
Q Consensus 406 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~y~ 482 (606)
.. .+++..+..++.+++.++.|||+.++. |+||+|+||+++.++.++|+|||.+...... ....++..|+
T Consensus 81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~~i~--h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 153 (244)
T smart00220 81 RG-----RLSEDEARFYARQILSALEYLHSNGII--HRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYM 153 (244)
T ss_pred cc-----CCCHHHHHHHHHHHHHHHHHHHHcCee--cCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCC
Confidence 33 278999999999999999999999866 9999999999999999999999998766543 2344566799
Q ss_pred CccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHH
Q 037905 483 APEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQ 562 (606)
Q Consensus 483 aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~ 562 (606)
|||......++.++||||||+++++|++|..||.... +...... ......... ..........+.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~-~~~~~~~~~--------~~~~~~~~~~~~~ 219 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFK-KIGKPKPPF--------PPPEWKISPEAKD 219 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHH-HHhccCCCC--------ccccccCCHHHHH
Confidence 9999988889999999999999999999999986421 1111111 111111000 0000003457889
Q ss_pred HHHHccCcCCCCCCCHHHHHH
Q 037905 563 LAINCTAQYPDNRPSMAEVTS 583 (606)
Q Consensus 563 l~~~Cl~~~P~~RPs~~~v~~ 583 (606)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=257.67 Aligned_cols=231 Identities=23% Similarity=0.302 Sum_probs=181.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC-H---HHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS-E---KEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~---~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+||+|+||.|.+|..+ +.+.+|||++++.... + +--+.|-.+|... +-|.++++..+|..-+..|.||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 467999999999999754 5688999999875331 1 2234455555544 56889999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
||+|-.+++.-. .+.+..++.++..||-||-|||++||+ .||||.+|||+|.+|.+||+|||+++..-.
T Consensus 434 GGDLMyhiQQ~G-----kFKEp~AvFYAaEiaigLFFLh~kgIi--YRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T 506 (683)
T KOG0696|consen 434 GGDLMYHIQQVG-----KFKEPVAVFYAAEIAIGLFFLHSKGII--YRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT 506 (683)
T ss_pred CchhhhHHHHhc-----ccCCchhhhhhHHHHHHhhhhhcCCee--eeeccccceEeccCCceEeeecccccccccCCcc
Confidence 999999998543 477788899999999999999999966 999999999999999999999999986533
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
..+..+|+.|+|||++..+.|+.++|.|||||+||||+.|++||++...+ ...+.+.... ..
T Consensus 507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------elF~aI~ehn------------vs 568 (683)
T KOG0696|consen 507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQAIMEHN------------VS 568 (683)
T ss_pred eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHcc------------Cc
Confidence 34567889999999999999999999999999999999999999764322 2223322221 11
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCC
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPS 577 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs 577 (606)
.+-....+...+.+..+...|.+|..
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCccccC
Confidence 11222344556666778888988853
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=259.93 Aligned_cols=245 Identities=24% Similarity=0.330 Sum_probs=188.3
Q ss_pred cccccCCceEEEEEE-EcCCcEEEEEEeccCccCH--------HHHHHHHHHHcCCCCCCcccceEEEE-eCCceEEEEe
Q 037905 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE--------KEFREKMEVVGSMDHENLVPLRAYYY-SRDEKLLVHD 392 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--------~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 392 (606)
..||+|+|+.||+|. +...+.||||+-.....++ +...+|..+.+.++||.||+++++|. +.+..|-|.|
T Consensus 469 hLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 469 HLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 579999999999997 5568899999865443332 23678999999999999999999987 4567789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCccC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHLA 469 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~ 469 (606)
||+|.+|..+++..+ .+++..++.|+.||+.||.||.+...+|||-||||.|||+.. -|.+||.|||+++.+
T Consensus 549 YceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM 623 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM 623 (775)
T ss_pred ecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence 999999999998654 588999999999999999999999999999999999999954 578999999999876
Q ss_pred CCCC-----------CCCCcccccCccccCCC----CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHh
Q 037905 470 SPSS-----------TPNRIDGYRAPEVTDAR----KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV 534 (606)
Q Consensus 470 ~~~~-----------~~~~~~~y~aPE~~~~~----~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (606)
.... ...+|+.|++||.+.-. ..+.|+||||.||++|..+.|+.||.-... -+.++
T Consensus 624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs---------QQdIL 694 (775)
T KOG1151|consen 624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS---------QQDIL 694 (775)
T ss_pred cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh---------HHHHH
Confidence 5421 24567789999987543 468899999999999999999999964211 11222
Q ss_pred hccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 535 KEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 535 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+.+...-...+... +....+...+|++|++..-++|....+++.+
T Consensus 695 qeNTIlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 695 QENTILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred hhhchhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 2222211111111111 1222344567779999999999988888754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=276.48 Aligned_cols=239 Identities=24% Similarity=0.350 Sum_probs=182.2
Q ss_pred hcccccCCce-EEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFG-TAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+++|.|+.| .||+|..+ |+.||||++-... ..-..+|+..++.- +|||||++++.-.++.+.|+..|.|.. +|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL 589 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SL 589 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hH
Confidence 4569999997 78999997 8899999885422 34467899988876 699999999998899999999999965 99
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---C--CcEEEeecccCccCCCC--
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---S--YEARISDFGLAHLASPS-- 472 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~--~~~kl~DfG~a~~~~~~-- 472 (606)
.+++... +...........+.+..|++.||++||+.+++ ||||||.||||+. + ..++|+|||+++.....
T Consensus 590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iV--HRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLKIV--HRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcccc--cccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 9999864 11111112134567899999999999998866 9999999999976 3 46999999999876542
Q ss_pred -----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 473 -----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 473 -----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
.+..||.||+|||++....-+.++||||+|||+|+.++ |.+||......+ .+++...+....+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~~L--- 735 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLVHL--- 735 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCccceeee---
Confidence 34567889999999998888889999999999999999 589997533221 1122222111110
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....++ +-.+||.+++.++|..||++.+|+.|
T Consensus 736 ----~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 736 ----EPLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ----ccCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111112 56788889999999999999999755
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=235.49 Aligned_cols=203 Identities=24% Similarity=0.382 Sum_probs=161.5
Q ss_pred cCHHHHHHHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCcc--CHHHHHHHHHHH-cCCCCCCcccceEEEEeCCce
Q 037905 312 FDLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV--SEKEFREKMEVV-GSMDHENLVPLRAYYYSRDEK 387 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~ 387 (606)
|.+.+-.......||+|++|.|-+.+ ..+|+..|+|++...-- ..+...+|+.+. +...+|.+|.++|.++.....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 44443333445679999999998887 46799999999975432 334566777654 445799999999999999999
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 388 LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
++.||.|.. +|..+-..--. ....+++...-+|+..+..||.|||++- .++|||+||+|||++.+|++|+||||++.
T Consensus 121 wIcME~M~t-Sldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCCcEEEcccccce
Confidence 999999976 77666543222 2346888889999999999999999983 35599999999999999999999999987
Q ss_pred cCCCCC--C-CCCcccccCccccCC----CCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 468 LASPSS--T-PNRIDGYRAPEVTDA----RKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 468 ~~~~~~--~-~~~~~~y~aPE~~~~----~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
....+. + ..+...|||||.+.. ..|+.++||||||+.++||.+++.||..
T Consensus 198 ~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 665532 1 345566999998854 3799999999999999999999999964
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=248.35 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=185.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEe--------CCceEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYS--------RDEKLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~l 389 (606)
..+||+|.||.||+|+. ++|+.||+|++--.. --.....+|+.++..++|+|++.+++.|.. ....++
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 46799999999999985 457788988753211 123456789999999999999999988753 234799
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||.+|+. +|..++.+. ...++..++.+++.++..||.|+|...+. |||+||.|+||+.++.+||+|||+++..
T Consensus 102 Vf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~kil--HRDmKaaNvLIt~dgilklADFGlar~f 174 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNKIL--HRDMKAANVLITKDGILKLADFGLARAF 174 (376)
T ss_pred eHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhhHH--hhcccHhhEEEcCCceEEeeccccccce
Confidence 9999987 899888754 24689999999999999999999999866 9999999999999999999999999755
Q ss_pred CCCCC--C------CCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHH-Hhhcccc
Q 037905 470 SPSST--P------NRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQS-VVKEEWT 539 (606)
Q Consensus 470 ~~~~~--~------~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 539 (606)
..+.. . ..|..|++||.+.+ +.|+++.|||+-|||+.||+||.+-+++..+.....++..+-. +..+-|.
T Consensus 175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP 254 (376)
T KOG0669|consen 175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP 254 (376)
T ss_pred ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence 43221 1 22566999998866 5799999999999999999999998876443322222221111 1111111
Q ss_pred ccccchh---------hhc--ccChHHHHH------HHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 540 AEVFDLE---------LLR--YQNVEEEMV------QLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 540 ~~~~d~~---------~~~--~~~~~~~~~------~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+...+ +.. .....+..+ +-.+++.+.+..||.+||++.+++++
T Consensus 255 -~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 255 -NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred -CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 000000 000 001112222 46778889999999999999998866
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=276.79 Aligned_cols=252 Identities=20% Similarity=0.201 Sum_probs=160.9
Q ss_pred hcccccCCceEEEEEEEc-C----CcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEE------EEeCCceEEE
Q 037905 322 AEVLGKGTFGTAYKATLE-M----GIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAY------YYSRDEKLLV 390 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~~~~~~~lv 390 (606)
.+.||+|+||.||+|+.. + +..||+|++...... +....| .+....+.++..++.. +....+.++|
T Consensus 137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV 213 (566)
T PLN03225 137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLV 213 (566)
T ss_pred eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence 578999999999999864 4 689999988643221 111111 1122223333332221 2345678999
Q ss_pred EeecCCCChhhhhhcCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-
Q 037905 391 HDYMPMGSLSALLHGNRGA---------------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK- 454 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~- 454 (606)
+||+.+++|.+++...... .........+..++.|++.||+|||+++++ ||||||+|||++.
T Consensus 214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi--HRDLKP~NILl~~~ 291 (566)
T PLN03225 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV--HRDVKPQNIIFSEG 291 (566)
T ss_pred EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE--eCcCCHHHEEEeCC
Confidence 9999999999998753200 000112334567999999999999999966 9999999999986
Q ss_pred CCcEEEeecccCccCCCC-----CCCCCcccccCccccCCC----------------------CCCCcchhHHHHHHHHH
Q 037905 455 SYEARISDFGLAHLASPS-----STPNRIDGYRAPEVTDAR----------------------KVSQKADVYSFGVLLLE 507 (606)
Q Consensus 455 ~~~~kl~DfG~a~~~~~~-----~~~~~~~~y~aPE~~~~~----------------------~~~~~sDv~slGvvl~e 507 (606)
++.+||+|||+|+..... ....+++.|+|||.+... .++.++|||||||++||
T Consensus 292 ~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~e 371 (566)
T PLN03225 292 SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQ 371 (566)
T ss_pred CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHH
Confidence 578999999999754322 234567789999965321 24456799999999999
Q ss_pred HHhCCCCccccc-------ccCCCChhHHHHHHhhccccccccchhhh-cccChHHHHHHHHHHHHHccCcCCCCCCCHH
Q 037905 508 LLTGKAPTQALL-------NEEGVDLPRWVQSVVKEEWTAEVFDLELL-RYQNVEEEMVQLLQLAINCTAQYPDNRPSMA 579 (606)
Q Consensus 508 lltg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 579 (606)
|+++..++.... ...+.+...|....... ..+... .............+|+.+|++.||++|||+.
T Consensus 372 l~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~ 445 (566)
T PLN03225 372 MAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAK 445 (566)
T ss_pred HHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHH
Confidence 999776654211 00011112221111000 000000 0000111223456899999999999999999
Q ss_pred HHHHH
Q 037905 580 EVTSQ 584 (606)
Q Consensus 580 ~v~~~ 584 (606)
|+++|
T Consensus 446 e~L~H 450 (566)
T PLN03225 446 AALAH 450 (566)
T ss_pred HHhCC
Confidence 99987
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-31 Score=264.50 Aligned_cols=239 Identities=20% Similarity=0.249 Sum_probs=193.5
Q ss_pred cccccCCceEEEEEEEcCCc-EEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATLEMGI-VVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..||-|+||.|-+++..... .+|+|++++... ..+.+..|-.+|...+.|.||+++-.|.+....|++||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 45899999999999876433 388898876533 2345778889999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---T 474 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~ 474 (606)
.|...+.+. ..++..+...++..+.+|++|||.+||+ .|||||+|+++|.+|-+||.|||.|+...... +
T Consensus 506 ElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k~iI--YRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT 578 (732)
T KOG0614|consen 506 ELWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRKGII--YRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT 578 (732)
T ss_pred hhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhcCce--eccCChhheeeccCCceEEeehhhHHHhccCCceee
Confidence 999999864 3688889999999999999999999966 99999999999999999999999999887653 5
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
+.+|+.|.|||++.....+.++|.||||+++||+++|.+||.+... ...+..+++.-...+ .+.
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp------mktYn~ILkGid~i~----------~Pr 642 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP------MKTYNLILKGIDKIE----------FPR 642 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch------HHHHHHHHhhhhhhh----------ccc
Confidence 7899999999999999999999999999999999999999976422 222223333211111 112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
...+.-.++|++....+|.+|.. +.||.+|
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 22344567777877899999985 6677666
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=267.01 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=170.5
Q ss_pred hcccccCCceEEEEEEE-----------------cCCcEEEEEEeccCccC-HH--------------HHHHHHHHHcCC
Q 037905 322 AEVLGKGTFGTAYKATL-----------------EMGIVVAVKRLKDVTVS-EK--------------EFREKMEVVGSM 369 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~-~~--------------~~~~e~~~l~~l 369 (606)
.++||+|+||.||+|.. ..++.||||++...... .+ ....|+.++.++
T Consensus 150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l 229 (507)
T PLN03224 150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI 229 (507)
T ss_pred eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence 57899999999999963 23568999998643221 12 233466666667
Q ss_pred CCCCc-----ccceEEEEe--------CCceEEEEeecCCCChhhhhhcCCCC-------------------CCCCCCHH
Q 037905 370 DHENL-----VPLRAYYYS--------RDEKLLVHDYMPMGSLSALLHGNRGA-------------------GRTPLNWE 417 (606)
Q Consensus 370 ~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~ 417 (606)
+|.++ ++++++|.. .++.++||||+++++|.++++...+. ....+++.
T Consensus 230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~ 309 (507)
T PLN03224 230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309 (507)
T ss_pred hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence 66554 677787753 35689999999999999998753210 11235678
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----CCCcccccCccccCCCC-
Q 037905 418 TRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-----PNRIDGYRAPEVTDARK- 491 (606)
Q Consensus 418 ~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~y~aPE~~~~~~- 491 (606)
.+..++.|++.+|.|||+.+++ ||||||+|||++.++.+||+|||+++....... ...++.|+|||.+....
T Consensus 310 ~~~~i~~ql~~aL~~lH~~~iv--HrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~ 387 (507)
T PLN03224 310 VIKGVMRQVLTGLRKLHRIGIV--HRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQS 387 (507)
T ss_pred HHHHHHHHHHHHHHHHHHCCee--cCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCC
Confidence 8899999999999999999966 999999999999999999999999875433211 12356799999875322
Q ss_pred -------------------CC--CcchhHHHHHHHHHHHhCCC-Cccccccc------CCCChhHHHHHHhhcccccccc
Q 037905 492 -------------------VS--QKADVYSFGVLLLELLTGKA-PTQALLNE------EGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 492 -------------------~~--~~sDv~slGvvl~elltg~~-p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
|. .+.||||+||++++|++|.. |+...... ...++..|.. . .....
T Consensus 388 ~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~-----~~~~~ 461 (507)
T PLN03224 388 CPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-Y-----KGQKY 461 (507)
T ss_pred CCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-h-----cccCC
Confidence 11 24799999999999999875 66432110 0011111111 0 00111
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCC---CCCCCHHHHHHH
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYP---DNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P---~~RPs~~~v~~~ 584 (606)
+ +...........+++.+++..+| .+|+|++|+++|
T Consensus 462 ~-----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 462 D-----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred C-----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 1 11122334556777778888765 689999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=241.63 Aligned_cols=237 Identities=20% Similarity=0.311 Sum_probs=184.6
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHH----HHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEK----EFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~----~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+||+|+|+.|..+++ ++.+.+|+|++++.-..++ =++.|-.+..+- +||.+|-+..+|..+...++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 46799999999999985 5688999999987533221 234444444333 79999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
||+|--+++.++ .+++++++.+...|..||.|||++||+ .||||.+|||+|..|.+||.|+|+++....
T Consensus 335 ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rgii--yrdlkldnvlldaeghikltdygmcke~l~~gd~ 407 (593)
T KOG0695|consen 335 GGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERGII--YRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT 407 (593)
T ss_pred Ccceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcCee--eeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence 999999988654 589999999999999999999999966 999999999999999999999999986533
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccc-cCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLN-EEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
..+..+|+.|.|||++.+..|....|.|++||+++||+.|+.||+.... ....+..+++-+++-+.-++.
T Consensus 408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri--------- 478 (593)
T KOG0695|consen 408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI--------- 478 (593)
T ss_pred cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc---------
Confidence 3456788999999999999999999999999999999999999985332 122233344433332221110
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCC
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRP 576 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RP 576 (606)
+.........+++..+.+||.+|.
T Consensus 479 --prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 --PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --cceeehhhHHHHHHhhcCCcHHhc
Confidence 011112334566688899999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-31 Score=244.35 Aligned_cols=189 Identities=27% Similarity=0.407 Sum_probs=159.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeC-----CceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 392 (606)
++.||-|+||.||.++. ++|+.||.|++.... .+.+.+.+|++++..++|.|++..++...-. .+.|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 45699999999999984 579999999987643 3567889999999999999999988776432 46788999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
.|.. +|...+- .+++++...+.-+..||++||.|||+.+|. ||||||.|.|++.+-..||||||+++.....
T Consensus 138 LmQS-DLHKIIV-----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~IL--HRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 138 LMQS-DLHKIIV-----SPQALTPDHVKVFVYQILRGLKYLHTANIL--HRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHh-hhhheec-----cCCCCCcchhhhhHHHHHhhhHHHhhcchh--hccCCCccEEeccCceEEecccccccccchh
Confidence 8854 8888775 256788899999999999999999999966 9999999999999999999999999876654
Q ss_pred CCCC-----CcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccc
Q 037905 473 STPN-----RIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQAL 518 (606)
Q Consensus 473 ~~~~-----~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~ 518 (606)
.... .|..|+|||++++ +.|+.+.||||.||++.|++..+-.|+..
T Consensus 210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq 261 (449)
T KOG0664|consen 210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA 261 (449)
T ss_pred hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc
Confidence 3332 3456999999987 56899999999999999999988888753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-27 Score=228.21 Aligned_cols=206 Identities=33% Similarity=0.514 Sum_probs=180.0
Q ss_pred cccCCceEEEEEEEcC-CcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 325 LGKGTFGTAYKATLEM-GIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 325 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
||+|++|.||++.... ++.+++|++...... .+.+.+|++.++.++|++++++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999999865442 5679999999999999999999999998889999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-CCcEEEeecccCccCCCC----CCCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-SYEARISDFGLAHLASPS----STPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~----~~~~ 476 (606)
++.... ..+++..+..++.++++++++||+.++. |+||+|.||+++. ++.++|+|||.+...... ....
T Consensus 81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~--H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 154 (215)
T cd00180 81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNGII--HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV 154 (215)
T ss_pred HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhccc
Confidence 987532 3588999999999999999999999966 9999999999999 899999999998766543 2234
Q ss_pred CcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
....|++||..... .++.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 55669999999877 788999999999999999
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
..+.+++..|+..+|++||++.++++++
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2477888899999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=252.86 Aligned_cols=191 Identities=26% Similarity=0.382 Sum_probs=162.1
Q ss_pred cccccCCceEEEEEE-EcCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+-||-|+||.|++++ ..+...+|.|.+.+...- ...+..|-.+|..-+.+=||+++..|.+.+..|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 359999999999997 556788999998765432 234677889999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC--------
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA-------- 469 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~-------- 469 (606)
++-.+|.... -+.+..++.++..+..|+++.|..|++ ||||||+|||||.+|.+||.|||++.-.
T Consensus 715 DmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmGFI--HRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 715 DMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMGFI--HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred cHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhccce--ecccCccceEEccCCceeeeeccccccceecccccc
Confidence 9999987543 478888899999999999999999966 9999999999999999999999998421
Q ss_pred -CCCC-------------------------------------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhC
Q 037905 470 -SPSS-------------------------------------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTG 511 (606)
Q Consensus 470 -~~~~-------------------------------------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg 511 (606)
.... ...+|+.|+|||++....|+.-+|.||.|||||||+.|
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence 0000 01345569999999999999999999999999999999
Q ss_pred CCCcccccc
Q 037905 512 KAPTQALLN 520 (606)
Q Consensus 512 ~~p~~~~~~ 520 (606)
+.||-....
T Consensus 868 ~~pf~~~tp 876 (1034)
T KOG0608|consen 868 QPPFLADTP 876 (1034)
T ss_pred CCCccCCCC
Confidence 999976443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=241.85 Aligned_cols=130 Identities=18% Similarity=0.230 Sum_probs=108.6
Q ss_pred HHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHHHHHHHHHHcCCC--------CCCcccceEEEE----eCC
Q 037905 319 RASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD--------HENLVPLRAYYY----SRD 385 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~----~~~ 385 (606)
|...++||-|-|++||++. ..+.+.||+|+.+....=.+....|+++|++++ ..+||+++++|. .+.
T Consensus 80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~ 159 (590)
T KOG1290|consen 80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQ 159 (590)
T ss_pred EEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCc
Confidence 3456789999999999996 566899999999876655667889999999873 356999999997 356
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec
Q 037905 386 EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS 453 (606)
Q Consensus 386 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~ 453 (606)
++++|+|++ |.+|..+|.... ...++...+..|+.||+.||.|||.++ .|||.||||+|||+.
T Consensus 160 HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 160 HVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPENVLLC 222 (590)
T ss_pred EEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcceeeee
Confidence 899999998 568888887653 445899999999999999999999986 344999999999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=222.47 Aligned_cols=252 Identities=17% Similarity=0.251 Sum_probs=186.9
Q ss_pred HHHhcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHHHHHHHHHHcCCC-CCCcccceEEEEeCC--ceEEEEeec
Q 037905 319 RASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HENLVPLRAYYYSRD--EKLLVHDYM 394 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~ 394 (606)
+.+.+++|+|.++.||.|. ..+.+.++||+++.. ..+.+.+|+.++..++ ||||+.+++...+.. -..+|+||+
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV--kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v 117 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV--KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYV 117 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeechH--HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhh
Confidence 3456789999999999997 566899999999864 4678999999999997 999999999987653 457999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-CcEEEeecccCccCCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLASPSS 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~~ 473 (606)
++.+...+-. .+....++.++.+++.||.|+|++||. |||+||.|+++|.. ...+|+|+|+|.++.+..
T Consensus 118 ~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~GIm--HRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 118 NNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMGIM--HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred ccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcCcc--cccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 9877766643 577888999999999999999999977 99999999999965 469999999999887765
Q ss_pred CCC---CcccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc-------ccccc
Q 037905 474 TPN---RIDGYRAPEVTD-ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE-------WTAEV 542 (606)
Q Consensus 474 ~~~---~~~~y~aPE~~~-~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~ 542 (606)
..+ .+..|--||.+- .+.|+..-|+|||||++..|+..+.||-...+.. ..++..+. ++-.. .....
T Consensus 188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkIak-VLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKIAK-VLGTDELYAYLNKYQID 265 (338)
T ss_pred eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHHHH-HhChHHHHHHHHHHccC
Confidence 543 334578899874 4668999999999999999999999985422111 11221111 11000 00111
Q ss_pred cchhhhc---------------ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLR---------------YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~---------------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+|+.... ...-.-...+.++++.+.+..|..+|||++|...+
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 2222111 00001112456778889999999999999998765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=250.67 Aligned_cols=189 Identities=20% Similarity=0.320 Sum_probs=163.6
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHH---------HHHHHHHHHcCCC---CCCcccceEEEEeCCce
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEK---------EFREKMEVVGSMD---HENLVPLRAYYYSRDEK 387 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---------~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~ 387 (606)
+.+.+|+|+||.|+.|..+ +...|+||.+.+.+.-.+ .+-.|+++|..++ |+||++++++|.+++..
T Consensus 565 tlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 565 TLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 4567999999999999864 467799999877643221 2567999999997 99999999999999999
Q ss_pred EEEEeec-CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 388 LLVHDYM-PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 388 ~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
||+||-. ++.+|.+++.-. ..+++..+..|+.||+.|+++||+.||+ |||||-+||.++.+|.+||+|||.|
T Consensus 645 yl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~~iv--hrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQGIV--HRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred EEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccccCce--ecccccccEEEecCCeEEEeeccch
Confidence 9999986 567999999743 3589999999999999999999999966 9999999999999999999999998
Q ss_pred ccCC--CCCCCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcc
Q 037905 467 HLAS--PSSTPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQ 516 (606)
Q Consensus 467 ~~~~--~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~ 516 (606)
.... +-..+.+|.+|.|||++.+..| +..-||||+|++||.++..+.||.
T Consensus 718 a~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 6544 3456789999999999999888 566899999999999999998884
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=256.65 Aligned_cols=243 Identities=23% Similarity=0.345 Sum_probs=195.6
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
...+|+|.||.|||++ ...++..|+|+++.... +-+-+++|+-+++..+||||+.++|.+...+..+++||||.+|+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggsl 99 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSL 99 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcc
Confidence 4569999999999998 45789999999986543 446688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC----CCCCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS----PSSTP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~----~~~~~ 475 (606)
.+.-+.. .++++.++..+++...+|+.|||++|-. |||||-.||++++.|.+|++|||.+.... ....+
T Consensus 100 Qdiy~~T-----gplselqiayvcRetl~gl~ylhs~gk~--hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 100 QDIYHVT-----GPLSELQIAYVCRETLQGLKYLHSQGKI--HRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred cceeeec-----ccchhHHHHHHHhhhhccchhhhcCCcc--cccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 9988753 4789999999999999999999999977 99999999999999999999999876543 34567
Q ss_pred CCcccccCcccc---CCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 476 NRIDGYRAPEVT---DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 476 ~~~~~y~aPE~~---~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
.+|+.|||||+. ....|...+|||++|+...|+---++|-......... .-. ...-+++...+ .
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l------~Lm-----TkS~~qpp~lk--D 239 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL------FLM-----TKSGFQPPTLK--D 239 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH------HHh-----hccCCCCCccc--C
Confidence 899999999986 3457899999999999999998888775443221100 000 11112222211 1
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+-++++.|+..+|++|||++.++.+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 23455668888889999999999999987654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=221.60 Aligned_cols=258 Identities=21% Similarity=0.321 Sum_probs=188.7
Q ss_pred CcCHHHHHHHHhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEE-EEeCCce
Q 037905 311 AFDLEDLLRASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAY-YYSRDEK 387 (606)
Q Consensus 311 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~ 387 (606)
.++++|. +.+.+.+|+|.||.+-+++++ +.+.+++|.++......++|.+|+..--.+ .|.||+..++. |...+..
T Consensus 19 kv~l~d~-y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 19 KVDLEDV-YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred ccchhhh-hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 4555553 456788999999999999864 578899999998777889999999765555 58999987765 5556777
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec--CCCcEEEeeccc
Q 037905 388 LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS--KSYEARISDFGL 465 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~--~~~~~kl~DfG~ 465 (606)
.+++||++.|+|.+-+...+ +-+....+++.|++.|+.|+|+++++ |||||.+||||- +...+||||||.
T Consensus 98 vF~qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHsknlV--HRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKNLV--HRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEeeccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccchh--hcccccceEEEecCCccEEEeeeccc
Confidence 88999999999999988643 67778889999999999999999966 999999999993 234799999999
Q ss_pred CccCCCCCC-CCCcccccCccccCCC-----CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 466 AHLASPSST-PNRIDGYRAPEVTDAR-----KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 466 a~~~~~~~~-~~~~~~y~aPE~~~~~-----~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
++..+.... ...+..|.|||..... ...+.+|||.||+++|.++||+.||+.....+ ..+.+|.+ ..++..
T Consensus 170 t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~Y~~~~~--w~~rk~ 246 (378)
T KOG1345|consen 170 TRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KPYWEWEQ--WLKRKN 246 (378)
T ss_pred ccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-chHHHHHH--HhcccC
Confidence 987664332 2345569999976432 35778999999999999999999998543322 22333322 111111
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
.. .+...........++.++-+.++|++|--..++.+....
T Consensus 247 ~~-------~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 247 PA-------LPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred cc-------CchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 10 011112233456677778999999999555555544433
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=246.35 Aligned_cols=194 Identities=26% Similarity=0.317 Sum_probs=163.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCC------CCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD------HENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
....|+|-|++|.+|.. .-|..||||++.....=.+.=..|+++|++|+ ..|+++++-.|....+.|+|+|.+
T Consensus 437 ~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L 516 (752)
T KOG0670|consen 437 QGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL 516 (752)
T ss_pred EeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh
Confidence 34579999999999974 34789999999887655566678999999984 468999999999999999999998
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPSS 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~ 473 (606)
.. +|.+++...+. ...|....+..++.|+.-||..|...|+. |.||||+|||+++.- .+||||||.|.......
T Consensus 517 sl-NLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~c~vl--HaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene 591 (752)
T KOG0670|consen 517 SL-NLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKKCGVL--HADIKPDNILVNESKNILKLCDFGSASFASENE 591 (752)
T ss_pred hc-hHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHhcCee--ecccCccceEeccCcceeeeccCcccccccccc
Confidence 65 99999987543 33477888999999999999999999966 999999999999865 58999999998877644
Q ss_pred CCC--CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccc
Q 037905 474 TPN--RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLN 520 (606)
Q Consensus 474 ~~~--~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~ 520 (606)
... ....|.|||++.+..|+...|+||.||.|||+.||+-.|.+..+
T Consensus 592 itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 592 ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 322 23349999999999999999999999999999999999877443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-28 Score=229.69 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=183.8
Q ss_pred hcccccCCceEEEEEE-EcCCcEEEEEEeccC---ccCHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEEE
Q 037905 322 AEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV---TVSEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 391 (606)
...+|.|+- .|..+. .-.++.||+|++... ....+...+|...+..+.|+||++++.+|... .+.|+||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 456888888 565554 224889999987543 23456778899999999999999999998743 3679999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
|+|.. +|...+.. .++..++..+..|++.|+.|||+.||. ||||||+||++..+..+||.|||+|+....
T Consensus 101 e~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~Ii--hRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 101 ELMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGII--HRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred Hhhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhccee--ecccCcccceecchhheeeccchhhcccCc
Confidence 99965 99988872 478889999999999999999999966 999999999999999999999999986554
Q ss_pred C---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC------------CCChhHH----HHH
Q 037905 472 S---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE------------GVDLPRW----VQS 532 (606)
Q Consensus 472 ~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~------------~~~~~~~----~~~ 532 (606)
. .....+..|.|||++.+..|.+.+||||.||++.||++|+--|.+...-+ ...+... +..
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~ 250 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRN 250 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHH
Confidence 3 23345566999999999999999999999999999999998876421100 0011111 111
Q ss_pred Hhhccccccccchh-------hhcc-cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 533 VVKEEWTAEVFDLE-------LLRY-QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 533 ~~~~~~~~~~~d~~-------~~~~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+.......+... .... +...-......+++.++|..+|++|.|++++++|
T Consensus 251 yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 251 YVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11111000001100 0000 0011223456788889999999999999999887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=221.27 Aligned_cols=190 Identities=33% Similarity=0.476 Sum_probs=165.4
Q ss_pred hcccccCCceEEEEEEEcC-CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|++|.||++.... ++.+|+|.+..... ..+.+.+|++.+++++|+|++++++++......++++||+++++
T Consensus 4 ~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 83 (225)
T smart00221 4 GKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGD 83 (225)
T ss_pred eeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCC
Confidence 4679999999999999764 89999999976544 35678899999999999999999999998899999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-----C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-----S 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~ 473 (606)
|.+++..... .+++..+..++.+++.++.+||+.++. |+||+|+||+++.++.++|+|||.+...... .
T Consensus 84 L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~--h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 84 LFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLGIV--HRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred HHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 9999985431 178899999999999999999999866 9999999999999999999999998766543 2
Q ss_pred CCCCcccccCcccc-CCCCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 474 TPNRIDGYRAPEVT-DARKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 474 ~~~~~~~y~aPE~~-~~~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
...+...|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 23445569999998 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=215.98 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=191.7
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.-+|.+...|..|+|+|+ |..+++|++.....+ .++|..|+-.++-+.||||++++|.|....+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 346888999999999998 666667887654332 3679999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCCCc
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI 478 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 478 (606)
|+..++... ...++..++++++.++|+|++|||+....|-.--|.+..+++|++..++|. .+-+++..........
T Consensus 274 lynvlhe~t---~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfqe~gr~y~ 349 (448)
T KOG0195|consen 274 LYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQEVGRAYS 349 (448)
T ss_pred HHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeeeccccccC
Confidence 999999754 345788899999999999999999988554456799999999999998875 2223333333344456
Q ss_pred ccccCccccCCCCC---CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 479 DGYRAPEVTDARKV---SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 479 ~~y~aPE~~~~~~~---~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
+.||+||.++..+- -.++|+|||.+++||+.|.+.||....+.+-. + .+--++ .+...++.
T Consensus 350 pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-----m-kialeg----------lrv~ippg 413 (448)
T KOG0195|consen 350 PAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-----M-KIALEG----------LRVHIPPG 413 (448)
T ss_pred cccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----h-hhhhcc----------ccccCCCC
Confidence 77999999976543 45799999999999999999999875543311 0 000111 11122233
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
....+.++|.-|+..||.+||.+..|+-.|+++.
T Consensus 414 is~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 414 ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 4456788888999999999999999999999874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=207.08 Aligned_cols=171 Identities=24% Similarity=0.314 Sum_probs=128.9
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN 476 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 476 (606)
|+|.+++.... ..+++..+..++.||+.||+|||+++ ||+|||++.++.+|+ ||.++...... ..
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~-~~ 65 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ-SR 65 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc-CC
Confidence 68999997532 35999999999999999999999885 999999999999999 99987665432 35
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|||||++.+..++.++|||||||++|||+||+.||..... ....+.............+ .......
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 135 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPADDPRD-----RSNLESV 135 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccCCccc-----cccHHHH
Confidence 67889999999999999999999999999999999999964221 1122222221111000000 0111222
Q ss_pred HH--HHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 557 MV--QLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 557 ~~--~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.. .+.+++.+||..+|++||++.++++++..+....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~ 173 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFAET 173 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence 22 6899999999999999999999999998875443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-25 Score=259.02 Aligned_cols=191 Identities=18% Similarity=0.206 Sum_probs=136.6
Q ss_pred CCCC-CCcccceEEEE-------eCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 037905 368 SMDH-ENLVPLRAYYY-------SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439 (606)
Q Consensus 368 ~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~ 439 (606)
.++| +||++++++|. .....+.++||+ +++|.+++... ...+++..++.++.||++||+|||++|++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3455 57888888772 234566778887 55999999743 23589999999999999999999999966
Q ss_pred CCCCCCCCCCEEecC-------------------CCcEEEeecccCccCCCC--------------------CCCCCccc
Q 037905 440 NSHGNIKSSNILLSK-------------------SYEARISDFGLAHLASPS--------------------STPNRIDG 480 (606)
Q Consensus 440 i~HrDlkp~Nill~~-------------------~~~~kl~DfG~a~~~~~~--------------------~~~~~~~~ 480 (606)
||||||+||||+. ++.+|++|||+++..... ....+|+.
T Consensus 103 --HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 103 --VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred --eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999954 445667777776532110 00234566
Q ss_pred ccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHH
Q 037905 481 YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQL 560 (606)
Q Consensus 481 y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l 560 (606)
|||||++.+..|+.++|||||||++|||++|.+|+.... ...... ... ...+. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~-~~~----~~~~~------~~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSL-RHR----VLPPQ------ILLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHH-HHh----hcChh------hhhcCHHH
Confidence 999999999999999999999999999999988875311 001111 000 01110 01122345
Q ss_pred HHHHHHccCcCCCCCCCHHHHHHH
Q 037905 561 LQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 561 ~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..++.+||+++|.+||+|.|++++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678889999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-25 Score=217.10 Aligned_cols=187 Identities=27% Similarity=0.420 Sum_probs=156.6
Q ss_pred HHhcccccCCceEEEEEEEc----CCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeec
Q 037905 320 ASAEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
...++||+|.|++||++... .++.||+|.+... .....+.+|++++..+ .+.||+++.+++..++...+|+||+
T Consensus 39 ~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t-s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 39 KVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT-SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhhccccccchhhhhhhhHhhhccccceEeeeecccc-cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 34678999999999999743 4688999998653 3456689999999988 5999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-CcEEEeecccCccC----
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLA---- 469 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~~---- 469 (606)
+.....++.. .++...+..++..+..||+++|++||+ ||||||.|+|.+.. +.-.|+|||+|...
T Consensus 118 ~H~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~GIv--HRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~ 187 (418)
T KOG1167|consen 118 EHDRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNGIV--HRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ 187 (418)
T ss_pred CccCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccCcc--ccCCCccccccccccCCceEEechhHHHHHhhh
Confidence 9999988876 377889999999999999999999976 99999999999865 45789999998510
Q ss_pred -------------CC----------------C---------------CCCCCcccccCccccCC-CCCCCcchhHHHHHH
Q 037905 470 -------------SP----------------S---------------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVL 504 (606)
Q Consensus 470 -------------~~----------------~---------------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvv 504 (606)
.+ + ....||+||+|||++.. ..-++++||||.|||
T Consensus 188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccce
Confidence 00 0 01235788999998854 556889999999999
Q ss_pred HHHHHhCCCCccc
Q 037905 505 LLELLTGKAPTQA 517 (606)
Q Consensus 505 l~elltg~~p~~~ 517 (606)
+.-+++++.||-.
T Consensus 268 ~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 268 LLSLLSRRYPFFK 280 (418)
T ss_pred eehhhcccccccc
Confidence 9999999999865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=235.72 Aligned_cols=174 Identities=36% Similarity=0.574 Sum_probs=118.4
Q ss_pred chHHHHHHHhHhhcC--C-CCcCCCCCCCCCcceeEEecC-CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcc
Q 037905 2 ASDRAALLTLRKAIG--G-RTLLWNLTDGPCKWVGVFCTG-ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRG 77 (606)
Q Consensus 2 ~~~~~~l~~~~~~~~--~-~~~~w~~~~~~c~~~~~~c~~-~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 77 (606)
++|+.||++|++.+. . ....|+..++||.|.|+.|.. .+++.|+|++|.|++.+|..|..+++|+.|+|++|++++
T Consensus 28 ~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~ 107 (968)
T PLN00113 28 AEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG 107 (968)
T ss_pred HHHHHHHHHHHHhCCCCcccCCCCCCCCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCC
Confidence 478999999988873 2 234898778999999999974 689999999999999999999999999999999999988
Q ss_pred cCccccc-CCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CC
Q 037905 78 TIPSDFA-KLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LG 155 (606)
Q Consensus 78 ~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~ 155 (606)
.+|..+. .+++|++|+|++|++++.+|. ..+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|. +.
T Consensus 108 ~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~ 185 (968)
T PLN00113 108 PIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLT 185 (968)
T ss_pred cCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhh
Confidence 8887655 777777777777777655553 2344455555555544444444444444444444444444443332 44
Q ss_pred CCCCCCEEEccCCcCcccCCcc
Q 037905 156 AFSSLAQFNVSFNKLNGSIPKR 177 (606)
Q Consensus 156 ~l~~L~~L~l~~N~l~~~~p~~ 177 (606)
++++|+.|+|++|.+++.+|..
T Consensus 186 ~l~~L~~L~L~~n~l~~~~p~~ 207 (968)
T PLN00113 186 NLTSLEFLTLASNQLVGQIPRE 207 (968)
T ss_pred hCcCCCeeeccCCCCcCcCChH
Confidence 4444444444444444444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5e-21 Score=196.93 Aligned_cols=265 Identities=20% Similarity=0.207 Sum_probs=192.0
Q ss_pred HHhcccccCCceEEEEEEEcC--CcEEEEEEeccCccC-HHHHHHHHHHHcCCCC----CCcccceEEE-EeCCceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATLEM--GIVVAVKRLKDVTVS-EKEFREKMEVVGSMDH----ENLVPLRAYY-YSRDEKLLVH 391 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~-~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~lv~ 391 (606)
...+.||+|+||.||++.... ...+|+|........ ...+..|..++..+.+ +++..+++.. ......++||
T Consensus 21 ~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM 100 (322)
T KOG1164|consen 21 KLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVM 100 (322)
T ss_pred EEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEE
Confidence 345789999999999998654 357888877654221 1257777777777752 5888888888 4677889999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-----CcEEEeecccC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-----YEARISDFGLA 466 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-----~~~kl~DfG~a 466 (606)
+.+ |.+|.++..... ...++..++.+|+.|++.+|++||+.|++ ||||||.|+++... ..+.|.|||++
T Consensus 101 ~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G~i--HRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 101 SLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKGFI--HRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred ecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcCcc--cCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 977 679999886543 34689999999999999999999999977 99999999999865 35999999999
Q ss_pred ccCC---C-------C----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHH
Q 037905 467 HLAS---P-------S----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQS 532 (606)
Q Consensus 467 ~~~~---~-------~----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 532 (606)
+... . . ....+|..|++++...+...+.+.|+||++.++.|++.|..||........ ...+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~~ 251 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFEK 251 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHHH
Confidence 8221 1 1 123367789999999999999999999999999999999999965433221 111111
Q ss_pred HhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc-cccCCCCcccc
Q 037905 533 VVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS-LQQGQAHDLEN 603 (606)
Q Consensus 533 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~-~~~~~~~~~~~ 603 (606)
......... .....+ ..+.+++.-+-..+..++|....+...++...... .....+.||+.
T Consensus 252 ~~~~~~~~~-------~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~ 313 (322)
T KOG1164|consen 252 DPRKLLTDR-------FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEV 313 (322)
T ss_pred Hhhhhcccc-------ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccc
Confidence 111110000 011112 33444444555588999999999999999988765 44456777664
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=201.03 Aligned_cols=152 Identities=21% Similarity=0.237 Sum_probs=117.4
Q ss_pred hcccccCCceEEEEEEEc--CCcEEEEEEeccCc------cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE--MGIVVAVKRLKDVT------VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||+||+|... +++.||||++.... .....+.+|++++++++|+|+++.+.. .+..++||||
T Consensus 23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~ 99 (365)
T PRK09188 23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW 99 (365)
T ss_pred ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence 567999999999999864 57888999875331 124568999999999999999863322 2467999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCC-CCCCEEecCCCcEEEeecccCccCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNI-KSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDl-kp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
+++++|... .. .. ...++.++++||+|||++|++ |||| ||+|||++.++.+||+|||+|+.....
T Consensus 100 ~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~gIi--HrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 100 TEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAGIT--HNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred cCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCCCe--eCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 999999632 11 01 135788999999999999966 9999 999999999999999999999865432
Q ss_pred C------------CCCCcccccCccccCCC
Q 037905 473 S------------TPNRIDGYRAPEVTDAR 490 (606)
Q Consensus 473 ~------------~~~~~~~y~aPE~~~~~ 490 (606)
. ...++..|+|||++...
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 2 12234569999988654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-20 Score=180.08 Aligned_cols=254 Identities=18% Similarity=0.229 Sum_probs=186.6
Q ss_pred HHhcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 320 ASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
...++||+|+||..+.|+ +-+++.||||.-.. .....++..|+...+.+ ..+.|..++.|...+-+-.+|+|.+ |-
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccc-cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 446889999999999998 55799999995433 33456678888777666 5688888887777777888999988 66
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-----cEEEeecccCccCCCC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-----EARISDFGLAHLASPS 472 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-----~~kl~DfG~a~~~~~~ 472 (606)
+|.++..-+.+ .++..++..+|.|+..-++|+|++..+ .|||||+|+||...+ .+.++|||+|+.+...
T Consensus 109 SLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~LI--YRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 109 SLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKDLI--YRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred CHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhccee--ecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 88888775542 589999999999999999999999955 999999999997544 4899999999877654
Q ss_pred C-----------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 473 S-----------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 473 ~-----------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
. ...+|..||+-....+++-+.+-|+-|+|-++++.+.|..||++..... ...-.+.+-.......
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t---nK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT---NKEKYEKIGETKRSTP 259 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc---hHHHHHHhccccccCC
Confidence 3 2456778999999999999999999999999999999999999864321 2222222221111110
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
++. --...+++...-+..+++ .+-.+-|...-+..-+.++.+.
T Consensus 260 -i~~---Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 260 -IEV---LCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred -HHH---HHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHHHHHh
Confidence 000 011223444444444443 5566778888888877777654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-22 Score=216.76 Aligned_cols=246 Identities=21% Similarity=0.248 Sum_probs=177.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEecc---CccCH----HHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKD---VTVSE----KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.+|.|++|.|+.... ......+.|.+.. ...+. ..+..|+.+-..+.|+|++..+..+.......-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 46799999997777753 2233344443321 11111 1256677888889999998887777666555556999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
+++ +|..++... ..+....+-.++.|+..|++|+|+.|+. |||+|++|+++..+|.+||+|||.+......
T Consensus 403 ~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~Gia--hrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 403 CPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMGLA--HRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred ccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcCce--eccCccccEEEecCCceEEeecCcceeeccCc
Confidence 999 999999854 2467778888999999999999999977 9999999999999999999999988543322
Q ss_pred -------CCCCCcccccCccccCCCCCCCc-chhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 -------STPNRIDGYRAPEVTDARKVSQK-ADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 -------~~~~~~~~y~aPE~~~~~~~~~~-sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
....+..+|+|||.+.+..|.+. .||||.|+++..|++|+.||......+... .......+.....-
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEG 549 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccC
Confidence 23455667999999999999765 899999999999999999998654433211 00000000000000
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...-....+.....+|.++++.+|.+|.|+++|++.
T Consensus 550 ----~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 550 ----PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ----hHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 011123344567788889999999999999999864
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-20 Score=187.60 Aligned_cols=252 Identities=31% Similarity=0.391 Sum_probs=188.7
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCC-CcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHE-NLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||.|+||.||++... ..+++|.+..... ....+.+|+.++..+.|+ +++++.+++......+++++++.+
T Consensus 5 ~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 5 LRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred EEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 457899999999999876 7889999876533 256789999999999988 799999999777778999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPS--- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~--- 472 (606)
+++.+++...... ..+.......+..|++.++.|+|+.+++ |||+||+||+++..+ .++++|||.++.....
T Consensus 83 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~--hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 83 GSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGII--HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred CcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999777643211 2578889999999999999999999966 999999999999998 7999999998754332
Q ss_pred -------CCCCCcccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccc
Q 037905 473 -------STPNRIDGYRAPEVTDA---RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 473 -------~~~~~~~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
....++..|+|||.+.+ ..+....|+||+|++++++++|..||...... ................ .
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~-~ 234 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP-S 234 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-c
Confidence 33456778999999987 57888999999999999999999997543211 0011111111111110 0
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..... ...........+.+++..|+..+|..|.+..+....
T Consensus 235 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPL-SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccc-CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000 000001223567888889999999999999988776
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=196.12 Aligned_cols=216 Identities=26% Similarity=0.425 Sum_probs=165.0
Q ss_pred HcCCCCCCcccceEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 037905 366 VGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNI 445 (606)
Q Consensus 366 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDl 445 (606)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+... ...+++.....++.+|+.||+|||...+. +|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~-~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSPIG-YHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCcce-eeeee
Confidence 45789999999999999999999999999999999999863 35689999999999999999999998754 79999
Q ss_pred CCCCEEecCCCcEEEeecccCccCCCCCCC------CCcccccCccccCCC-------CCCCcchhHHHHHHHHHHHhCC
Q 037905 446 KSSNILLSKSYEARISDFGLAHLASPSSTP------NRIDGYRAPEVTDAR-------KVSQKADVYSFGVLLLELLTGK 512 (606)
Q Consensus 446 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~------~~~~~y~aPE~~~~~-------~~~~~sDv~slGvvl~elltg~ 512 (606)
++.|+++|....+||+|||+.......... ....-|.|||.+... ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998766431110 111229999998663 1467799999999999999999
Q ss_pred CCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 513 APTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 513 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.||......... .+.+..+ .. .....+.|..... .+....+..++.+||..+|++||++++|...++.+....
T Consensus 156 ~~~~~~~~~~~~--~eii~~~-~~-~~~~~~rP~i~~~---~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 156 GPFDLRNLVEDP--DEIILRV-KK-GGSNPFRPSIELL---NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred CccccccccCCh--HHHHHHH-Hh-cCCCCcCcchhhh---hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 999864333221 1222221 11 1111222222111 133447899999999999999999999999999887654
Q ss_pred c
Q 037905 593 L 593 (606)
Q Consensus 593 ~ 593 (606)
.
T Consensus 229 ~ 229 (484)
T KOG1023|consen 229 S 229 (484)
T ss_pred c
Confidence 4
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=175.01 Aligned_cols=138 Identities=16% Similarity=0.155 Sum_probs=106.5
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccC---H-------HH-----------------HHHHHHHHcCCCCCCcc
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---E-------KE-----------------FREKMEVVGSMDHENLV 375 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~-------~~-----------------~~~e~~~l~~l~h~niv 375 (606)
+.||+|+||.||+|...+|+.||||+++....+ . .. ...|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 579999999999999878999999999754221 0 11 23488999988887764
Q ss_pred cceEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCCCCCCCCCEEecC
Q 037905 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL-HSKGPANSHGNIKSSNILLSK 454 (606)
Q Consensus 376 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~i~HrDlkp~Nill~~ 454 (606)
....+.. ...++||||++++++....... ..++...+..++.|++.+|.|+ |+.|++ ||||||+|||++
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~gii--HrDlkP~NIli~- 152 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCRLV--HADLSEYNLLYH- 152 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHEEEE-
Confidence 4333322 2348999999987776543221 2578899999999999999999 688866 999999999998
Q ss_pred CCcEEEeecccCccCC
Q 037905 455 SYEARISDFGLAHLAS 470 (606)
Q Consensus 455 ~~~~kl~DfG~a~~~~ 470 (606)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.6e-19 Score=196.73 Aligned_cols=130 Identities=34% Similarity=0.541 Sum_probs=104.5
Q ss_pred chHHHHHHHhHhhcCCC-CcCCCCCCCCC-----cceeEEecC------CeEEEEEcCCCCcccccCccccCCCCCcEEE
Q 037905 2 ASDRAALLTLRKAIGGR-TLLWNLTDGPC-----KWVGVFCTG------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVS 69 (606)
Q Consensus 2 ~~~~~~l~~~~~~~~~~-~~~w~~~~~~c-----~~~~~~c~~------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 69 (606)
..|++||+++|+.+... ..+|+. ++| +|.|+.|.. ..++.|+|++|.|+|.+|..|.+|++|+.|+
T Consensus 371 ~~~~~aL~~~k~~~~~~~~~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~ 448 (623)
T PLN03150 371 LEEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSIN 448 (623)
T ss_pred chHHHHHHHHHHhcCCcccCCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEE
Confidence 46899999999887543 348963 345 799999963 1378888888888888888888888888888
Q ss_pred ccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhc
Q 037905 70 LRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNK 133 (606)
Q Consensus 70 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 133 (606)
|++|+|+|.+|..+..+++|+.|+|++|+|++.+|+.+++|++|+.|+|++|+++|.+|..+..
T Consensus 449 Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 449 LSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred CCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence 8888888888888888888888888888888888888888888888888888888888776654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=167.82 Aligned_cols=192 Identities=23% Similarity=0.276 Sum_probs=154.6
Q ss_pred HhcccccCCceEEEEEE-EcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCC-CCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDH-ENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
..++||+|+||.+|.|. ..+|+.||||+-.. ......+..|..+.+.+++ ..|..+..|..+..+-.+||+.+ |.+
T Consensus 19 lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~-~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPs 96 (341)
T KOG1163|consen 19 LVRKIGSGSFGDIYLGISITSGEEVAIKLESS-KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPS 96 (341)
T ss_pred EEEeecCCchhheeeeeeccCCceEEEEeecc-cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Ccc
Confidence 35789999999999997 66799999997543 3344567777777777765 56666777777888889999988 679
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC---CcEEEeecccCccCCCCC--
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS---YEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~-- 473 (606)
|.++..-..+ .++..+++-++-|++.-++|+|.++++ ||||||+|.|+.-+ ..+.++|||+|+.+....
T Consensus 97 LEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~fi--HRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 97 LEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRNFI--HRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred HHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhccc--cccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 9888875542 488899999999999999999999966 99999999999744 358999999998765432
Q ss_pred ---------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccc
Q 037905 474 ---------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLN 520 (606)
Q Consensus 474 ---------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~ 520 (606)
...+|..|.+-....+..-+.+.|+-|+|.++.+.-.|..||++...
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka 226 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA 226 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence 23455668777766666778889999999999999999999997543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-20 Score=176.63 Aligned_cols=163 Identities=15% Similarity=0.166 Sum_probs=126.7
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHH----------HHHHHHHHcCCCCCCcccceEEEEeC-------
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE----------FREKMEVVGSMDHENLVPLRAYYYSR------- 384 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------~~~e~~~l~~l~h~niv~l~~~~~~~------- 384 (606)
.+++|+|+||.||++.. ++..+|||.+.......+. +.+|++.+.++.|++|.....++...
T Consensus 36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~ 114 (232)
T PRK10359 36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY 114 (232)
T ss_pred EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence 57899999999999876 4778999999754332222 57899999999999999998886533
Q ss_pred -CceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeec
Q 037905 385 -DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDF 463 (606)
Q Consensus 385 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~Df 463 (606)
...++||||++|.+|.++.. ++. ....+++.++..+|..|+. |||+||+||+++.++ ++|+||
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~--H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMV--SGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCc--cCCCChHHEEEeCCC-EEEEEC
Confidence 35789999999999988732 222 2456899999999999966 999999999999988 999999
Q ss_pred ccCccCCCCCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHH
Q 037905 464 GLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELL 509 (606)
Q Consensus 464 G~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ell 509 (606)
|..+........ ..+.....|..++|+||||+.+....
T Consensus 179 g~~~~~~e~~a~--------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAK--------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhH--------HHHHHHhHhcccccccceeEeehHHH
Confidence 987655322111 11445556778999999999877654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-19 Score=168.72 Aligned_cols=138 Identities=20% Similarity=0.192 Sum_probs=108.8
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccC---------------------------HHHHHHHHHHHcCCCCCCcc
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---------------------------EKEFREKMEVVGSMDHENLV 375 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~niv 375 (606)
+.||+|+||.||+|...+|+.||||+++..... ...+..|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 569999999999999778999999998754211 11235788889999999875
Q ss_pred cceEEEEeCCceEEEEeecCCCChhhh-hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEec
Q 037905 376 PLRAYYYSRDEKLLVHDYMPMGSLSAL-LHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLS 453 (606)
Q Consensus 376 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~ 453 (606)
....+... ..++||||++++++... +.. ..++......++.+++.++.++|+ .|++ ||||||+||+++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~giv--HrDlkP~NIll~ 152 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAGLV--HGDLSEYNILYH 152 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCCEe--cCCCChhhEEEE
Confidence 54444332 34899999998755433 332 246778889999999999999999 8866 999999999999
Q ss_pred CCCcEEEeecccCccCCC
Q 037905 454 KSYEARISDFGLAHLASP 471 (606)
Q Consensus 454 ~~~~~kl~DfG~a~~~~~ 471 (606)
++.++|+|||+++....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-21 Score=171.04 Aligned_cols=156 Identities=28% Similarity=0.407 Sum_probs=144.6
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++++.|.||+|.|+ .+|+.+.+|.+|+.|++.+|+|+ .+|..+++++.|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 368999999999998 88899999999999999999999 89999999999999999999999 9999999999999999
Q ss_pred cCCCcCC-cccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCcccc---CCCCCcccCCCCCC
Q 037905 118 LAKNNFS-GTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFA---RLPSSAFEGNSLCG 193 (606)
Q Consensus 118 l~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~l~~~~n~l~~ 193 (606)
|++|+++ ..+|+.|-.|..|+.|+|++|.|.-+||+++.+++|+.|.+.+|.+- .+|..++ .+..|++.||.++-
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v 187 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV 187 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee
Confidence 9999986 47899999999999999999999988999999999999999999998 7886655 45568899999998
Q ss_pred CCCc
Q 037905 194 KPLV 197 (606)
Q Consensus 194 ~p~~ 197 (606)
.|+.
T Consensus 188 lppe 191 (264)
T KOG0617|consen 188 LPPE 191 (264)
T ss_pred cChh
Confidence 8765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.1e-19 Score=164.04 Aligned_cols=177 Identities=18% Similarity=0.144 Sum_probs=134.5
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHH-----HHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEK-----EFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
...|++|+||+||.+.. .+.+++.+.+.......+ .+.+|+++++++. |+++.+++++ ...+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 35699999999998876 578888888876554333 5789999999995 5788888886 45699999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCC-CCCCEEecCCCcEEEeecccCccCCCCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNI-KSSNILLSKSYEARISDFGLAHLASPSST 474 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDl-kp~Nill~~~~~~kl~DfG~a~~~~~~~~ 474 (606)
|.+|...+.. ....++.|++.+|.++|++|++ |||| ||+|||++.++.++|+|||+|........
T Consensus 82 G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~GIv--HrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 82 GAAMYQRPPR------------GDLAYFRAARRLLQQLHRCGVA--HNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred CccHHhhhhh------------hhHHHHHHHHHHHHHHHHCcCc--cCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998654321 1134678999999999999966 9999 79999999999999999999985543221
Q ss_pred C-----------------CCcccccCccccCCC-CCC-CcchhHHHHHHHHHHHhCCCCccc
Q 037905 475 P-----------------NRIDGYRAPEVTDAR-KVS-QKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 475 ~-----------------~~~~~y~aPE~~~~~-~~~-~~sDv~slGvvl~elltg~~p~~~ 517 (606)
. ..++.|++|+...-. ..+ .+.+.++.|.-+|.++|++.++..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 123446666643221 222 567899999999999999988754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-20 Score=195.41 Aligned_cols=223 Identities=26% Similarity=0.332 Sum_probs=173.9
Q ss_pred cccCCceEEEEEE----EcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecCC
Q 037905 325 LGKGTFGTAYKAT----LEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 325 ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+|+|+||.|++++ ...|..+|+|++++.... +.....|..++...+ ||.++++...+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999874 334778888888664321 123455667777776 99999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN 476 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 476 (606)
|+|...+.... .+.......+...++-+++++|+.+++ |||+|++||+++.+|.+++.|||+++..-......
T Consensus 82 g~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~ii--yrd~k~enilld~~Ghi~~tdfglske~v~~~~~c 154 (612)
T KOG0603|consen 82 GDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLGIA--YRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIAC 154 (612)
T ss_pred chhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhHHH--HhcccccceeecccCccccCCchhhhHhHhhhhcc
Confidence 99998887543 456666777888999999999999966 99999999999999999999999998776666668
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|||||++. ....++|.||||++++||+||..||.. +.+..+.... ...+.+.
T Consensus 155 gt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~~------------~~~p~~l 210 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKAE------------LEMPREL 210 (612)
T ss_pred cchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhhc------------cCCchhh
Confidence 888999999998 567789999999999999999999975 1122222211 1223334
Q ss_pred HHHHHHHHHHccCcCCCCCCCH
Q 037905 557 MVQLLQLAINCTAQYPDNRPSM 578 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~ 578 (606)
.....+++......+|..|.-.
T Consensus 211 ~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hHHHHHHHHHHHhhCHHHHhcc
Confidence 4445556666777778877654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-19 Score=197.40 Aligned_cols=238 Identities=24% Similarity=0.306 Sum_probs=168.5
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCc--cCHHHHHHHHHH--HcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVT--VSEKEFREKMEV--VGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||++.|=+|.+|+.+.|. |+||++-+.. .+-+.|.++++- ...++|||.+++.-.-..+...|+|=+|...
T Consensus 28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh- 105 (1431)
T KOG1240|consen 28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH- 105 (1431)
T ss_pred ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence 466999999999999988888 7899985542 343444443322 4456899999987776666677888888866
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC--CCC--
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS--PSS-- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~--~~~-- 473 (606)
+|++.+... +-+...+..-|+.|++.||..+|..|++ |+|||.+||||+.=.=+.|+||..-+... +..
T Consensus 106 nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~gVc--HGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 106 NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKLGVC--HGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHcCcc--ccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 899998743 3466667777999999999999999977 99999999999987778999997654321 111
Q ss_pred -------CCCCcccccCccccCCC----------C-CCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHh
Q 037905 474 -------TPNRIDGYRAPEVTDAR----------K-VSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVV 534 (606)
Q Consensus 474 -------~~~~~~~y~aPE~~~~~----------~-~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 534 (606)
+..+-..|.|||.+... . .+++-||||+||++.|+++ |++||.- ..... .
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---------SQL~a--Y 247 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---------SQLLA--Y 247 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---------HHHHh--H
Confidence 11122239999987441 1 5788999999999999999 7888852 11100 0
Q ss_pred hccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 535 KEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 535 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
+. ....+++..-... +...+.+++..|++.||++|.++++.++.-
T Consensus 248 r~---~~~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 248 RS---GNADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred hc---cCccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 00 0011111110000 012478899999999999999999999873
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-18 Score=171.23 Aligned_cols=228 Identities=21% Similarity=0.283 Sum_probs=141.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCC----------CCcccceEEEE----
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDH----------ENLVPLRAYYY---- 382 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h----------~niv~l~~~~~---- 382 (606)
.+.||.|+|+.||.++.. +|+.+|+|++..... ..+++.+|.-....+.+ -.++--++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 357999999999999964 689999999854322 23456666544443322 11221122111
Q ss_pred -----eCC--------ceEEEEeecCCCChhhhhhc---CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCC
Q 037905 383 -----SRD--------EKLLVHDYMPMGSLSALLHG---NRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIK 446 (606)
Q Consensus 383 -----~~~--------~~~lv~e~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlk 446 (606)
... ..+++|+-+. +||.+++.. ... ....+....++.+..|+.+.+++||..|++ |+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlV--Hgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHSYGLV--HGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHHTTEE--EST-S
T ss_pred CcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhhcceE--ecccc
Confidence 110 2356777774 488777542 211 112234455667789999999999999966 99999
Q ss_pred CCCEEecCCCcEEEeecccCccCCCCCC-CCCcccccCccccCC--------CCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 447 SSNILLSKSYEARISDFGLAHLASPSST-PNRIDGYRAPEVTDA--------RKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 447 p~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~y~aPE~~~~--------~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
|+|++++.+|.+.|+||+.....+.... ...+.+|.+||.... -.++++.|.|++|+++|.|++|..||..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 9999999999999999997765554322 233456999997643 2578899999999999999999999975
Q ss_pred ccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCC
Q 037905 518 LLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNR 575 (606)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R 575 (606)
......... +. ..+. +.+..+..|+.+.++++|.+|
T Consensus 253 ~~~~~~~~~-----------------~f----~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPEW-----------------DF----SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSGG-----------------GG----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCccccccc-----------------cc----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 433221110 10 0111 556678888899999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-18 Score=165.85 Aligned_cols=192 Identities=21% Similarity=0.215 Sum_probs=135.3
Q ss_pred CCCCcccceEEEEeC---------------------------CceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHH
Q 037905 370 DHENLVPLRAYYYSR---------------------------DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL 422 (606)
Q Consensus 370 ~h~niv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i 422 (606)
+|||||+++++|.+. ...|+||...+. +|++++..+ ..+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~------~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR------HRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC------CCchHHHHHH
Confidence 699999998887421 134788888765 999999754 3566677779
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCCCCEEe--cCCCc--EEEeecccCccCCCC----------CCCCCcccccCccccC
Q 037905 423 ALGASRAIAYLHSKGPANSHGNIKSSNILL--SKSYE--ARISDFGLAHLASPS----------STPNRIDGYRAPEVTD 488 (606)
Q Consensus 423 ~~~ia~~L~~LH~~~~~i~HrDlkp~Nill--~~~~~--~kl~DfG~a~~~~~~----------~~~~~~~~y~aPE~~~ 488 (606)
+.|+++|+.|||++|+. |||+|++|||+ |+|+. ..|+|||++-..... ...-+....||||+..
T Consensus 347 laQlLEav~hL~~hgvA--hRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVA--HRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHHccch--hhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999988 99999999998 44443 678999976322211 0112223489999986
Q ss_pred CCC------CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHH
Q 037905 489 ARK------VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQ 562 (606)
Q Consensus 489 ~~~------~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~ 562 (606)
... -..|+|.|+.|.+.||+++...||.+..+ ...+...+-+.. -+..++.++..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~Yqe~q---------------LPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRTYQESQ---------------LPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhhhhhhh---------------CCCCcccCChHHHH
Confidence 532 23589999999999999999999976221 111221211111 11223445566788
Q ss_pred HHHHccCcCCCCCCCHHHHHHHHH
Q 037905 563 LAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 563 l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
++...++.||.+|++..-..+.|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 888999999999999876555543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.7e-17 Score=156.83 Aligned_cols=133 Identities=15% Similarity=0.138 Sum_probs=101.9
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCc-cCHHHHHHHHHHHcCC-----CCCCcccceEEEEeCC---ceE-EEE
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVT-VSEKEFREKMEVVGSM-----DHENLVPLRAYYYSRD---EKL-LVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv~ 391 (606)
.+.||+|+||.||. ...++.. +||++.... ...+.+.+|+.+++.+ .||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 35799999999996 3334444 689886532 2456799999999999 6799999999998763 333 789
Q ss_pred ee--cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCCCCCCCCCCEEecCC----CcEEEeecc
Q 037905 392 DY--MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAI-AYLHSKGPANSHGNIKSSNILLSKS----YEARISDFG 464 (606)
Q Consensus 392 e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~i~HrDlkp~Nill~~~----~~~kl~DfG 464 (606)
|| +.+++|.+++... .++.. ..++.+++.++ +|||+++++ ||||||+|||++.. +.++|+||+
T Consensus 85 e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~Iv--hrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 85 DFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNRIV--TMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred cCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCCEe--ecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 99 5579999999642 24444 35677888777 999999966 99999999999743 379999954
Q ss_pred cC
Q 037905 465 LA 466 (606)
Q Consensus 465 ~a 466 (606)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 44
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=6e-18 Score=188.65 Aligned_cols=185 Identities=23% Similarity=0.314 Sum_probs=146.3
Q ss_pred HHhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCC---CCCcccceEEEEeCCceEEEEeecCC
Q 037905 320 ASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD---HENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.+.||+|+||.||+|...+|+.||+|+-+....++-.+.. +++.+|+ -+-|+.+...+...+..++|+||.+.
T Consensus 701 ~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~--q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~ 778 (974)
T KOG1166|consen 701 CISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICL--QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPY 778 (974)
T ss_pred EEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehH--HHHHhhchhhhcchHHHHHHHccCCcceeeeecccc
Confidence 345689999999999999888999999998776555433222 2223333 34455565556667888999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-------CCcEEEeecccCccC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-------SYEARISDFGLAHLA 469 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-------~~~~kl~DfG~a~~~ 469 (606)
|+|.+++..+ ..++|..+..+..|+++-+++||..+|+ |+||||+|.||.. ...++|+|||.+-.+
T Consensus 779 Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~II--HgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 779 GTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMGII--HGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred ccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhccee--cccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 9999999843 3589999999999999999999999966 9999999999942 345899999988543
Q ss_pred C---CCCC---CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCC
Q 037905 470 S---PSST---PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513 (606)
Q Consensus 470 ~---~~~~---~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~ 513 (606)
. .... ...|.++-.+|+..++.++++.|.|.|+-+++-||.|+.
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 2 2212 234566888999999999999999999999999999874
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-17 Score=158.37 Aligned_cols=140 Identities=18% Similarity=0.138 Sum_probs=107.0
Q ss_pred HHhcccccCCceEEEEEE--EcCCcEEEEEEeccCccC-------------------------HHHHHHHHHHHcCCCCC
Q 037905 320 ASAEVLGKGTFGTAYKAT--LEMGIVVAVKRLKDVTVS-------------------------EKEFREKMEVVGSMDHE 372 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~h~ 372 (606)
...+.||+|+||.||+|. ..+|+.||+|+++..... ...+..|++.+.++.+.
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 346789999999999998 568999999998753210 12356789999888653
Q ss_pred C--cccceEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCCCCCCCCC
Q 037905 373 N--LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG-PANSHGNIKSSN 449 (606)
Q Consensus 373 n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~i~HrDlkp~N 449 (606)
. +.+++++ ...++||||+++++|....... ..+.......++.|++.++++||+.| +. ||||||+|
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g~ii--H~Dikp~N 179 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEGELV--HGDLSEYN 179 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcCCEE--eCCCChhh
Confidence 2 3333332 2458999999998887665321 13455567789999999999999999 87 99999999
Q ss_pred EEecCCCcEEEeecccCccCCC
Q 037905 450 ILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 450 ill~~~~~~kl~DfG~a~~~~~ 471 (606)
|+++ ++.++|+|||.+.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 78999999999875443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=2e-16 Score=152.62 Aligned_cols=133 Identities=22% Similarity=0.389 Sum_probs=112.1
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccC---------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
+.||+|++|.||+|.. .|..+++|+....... ...+.+|+.++..+.|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 5778999986543211 23577899999999999998888787777888999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
++|++|.+++... .. .+..++.+++.+|.++|+.++. |+|++|.|||++ ++.++++|||.++.
T Consensus 81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~i~--H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAGII--HGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCCcc--cCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998632 12 7788999999999999999966 999999999999 78899999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2e-16 Score=151.25 Aligned_cols=130 Identities=20% Similarity=0.339 Sum_probs=106.7
Q ss_pred ccccCCceEEEEEEEcCCcEEEEEEeccCcc---------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 324 VLGKGTFGTAYKATLEMGIVVAVKRLKDVTV---------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.||+|+||.||+|.+. |..+++|+...... ....+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999864 78899998654211 1245778999999999888766666666677789999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
+|++|.+++.... . .++.+++.+|.+||+.++. |+|++|.||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~gi~--H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAGIV--HGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCCee--cCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875321 1 6899999999999999966 999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.9e-19 Score=155.21 Aligned_cols=140 Identities=27% Similarity=0.496 Sum_probs=131.2
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCccc-ccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFS-GEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ 117 (606)
.+|+.|+|++|+|+ .+|.+++.|+.|+.|++.-|++. .+|..|+.++.|+.|||++|+++ ..+|+.|.-+..|+.|+
T Consensus 56 ~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 57899999999998 99999999999999999999999 99999999999999999999997 46899999999999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLP 182 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 182 (606)
|++|.+. .+|..++++++|+.|.+..|.+-..|.+++.+..|++|++.+|+++ .+|+.++++.
T Consensus 134 l~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~ 196 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRLT-VLPPELANLD 196 (264)
T ss_pred hcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccceee-ecChhhhhhh
Confidence 9999999 8999999999999999999999988888999999999999999999 7777776653
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=149.87 Aligned_cols=135 Identities=17% Similarity=0.124 Sum_probs=104.8
Q ss_pred HHHhcccccCCceEEEEEEEcCCcEEEEEEeccCcc-----------------------CHHHHHHHHHHHcCCCCCC--
Q 037905 319 RASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV-----------------------SEKEFREKMEVVGSMDHEN-- 373 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~n-- 373 (606)
++..+.||+|+||.||++...+|+.||||++..... ....+..|+..+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 344578999999999999988899999998764321 0123567888888887774
Q ss_pred cccceEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec
Q 037905 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS 453 (606)
Q Consensus 374 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~ 453 (606)
+...++ ....++||||+++++|...... .....++.+++.++.++|+.++. ||||||+||+++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~--H~Dl~p~Nill~ 159 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGII--HGDLSEFNILVD 159 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCC--cCCCCcccEEEc
Confidence 333333 2456899999999998765431 23456889999999999999966 999999999999
Q ss_pred CCCcEEEeecccCccCC
Q 037905 454 KSYEARISDFGLAHLAS 470 (606)
Q Consensus 454 ~~~~~kl~DfG~a~~~~ 470 (606)
+++.++|+|||++....
T Consensus 160 ~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 160 DDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCCcEEEEECCccccCC
Confidence 99999999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.5e-18 Score=172.91 Aligned_cols=163 Identities=23% Similarity=0.283 Sum_probs=141.6
Q ss_pred eeEEecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCC
Q 037905 32 VGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLG 111 (606)
Q Consensus 32 ~~~~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 111 (606)
.|+|-....+++|+|+.|+++..--+++-+|+.|+.||||+|.|....++.+.-.++|++|+||+|+|+...++.|..|.
T Consensus 262 DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~ 341 (873)
T KOG4194|consen 262 DGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLS 341 (873)
T ss_pred CcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHH
Confidence 45666667899999999999977788999999999999999999988899999999999999999999988888899999
Q ss_pred CCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC----CCCCCCCCEEEccCCcCcccCCccccCCCC---C
Q 037905 112 NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD----LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---S 184 (606)
Q Consensus 112 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~----~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l 184 (606)
.|+.|.|++|+|+..-...|..+++|++|||++|.|+..+.+ |..+++|+.|+|.+|+|..+.-.+|..++. |
T Consensus 342 ~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~L 421 (873)
T KOG4194|consen 342 QLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHL 421 (873)
T ss_pred HhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCccccee
Confidence 999999999999977778899999999999999999998875 778999999999999999544456665554 5
Q ss_pred cccCCCCCCC
Q 037905 185 AFEGNSLCGK 194 (606)
Q Consensus 185 ~~~~n~l~~~ 194 (606)
++.+|.+...
T Consensus 422 dL~~NaiaSI 431 (873)
T KOG4194|consen 422 DLGDNAIASI 431 (873)
T ss_pred cCCCCcceee
Confidence 6777776543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.1e-16 Score=170.01 Aligned_cols=131 Identities=20% Similarity=0.312 Sum_probs=106.8
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEE-eccCc--------cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKR-LKDVT--------VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
.+.||+|+||.||+|.+.... +++|+ +.... ...+.+.+|++++..++|++++....++......++|||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 568999999999999876443 44443 22211 112457899999999999999988888877778899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
|+++++|.+++. ....++.+++++|.|||+.+++ ||||||+|||+ +++.++|+|||+++..
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~gii--HrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIV--HGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCc--cCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999998874 2456899999999999999966 99999999999 5778999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.4e-16 Score=163.58 Aligned_cols=118 Identities=25% Similarity=0.361 Sum_probs=101.4
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeeccc
Q 037905 386 EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGL 465 (606)
Q Consensus 386 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~ 465 (606)
..++.|+++...+|.+|+...+. ....++...+.++.|++.|++| ++.+ |||+||.||++..+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~~i--hrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KGLI--HRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---ccch--hhhccccccccccchhhhhhhhhh
Confidence 56899999999999999975442 3456888899999999999999 7766 999999999999999999999998
Q ss_pred CccCCCCC----------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh
Q 037905 466 AHLASPSS----------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT 510 (606)
Q Consensus 466 a~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt 510 (606)
........ ...+|..||+||.+.++.|+.++||||||++++|++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 86554322 2345666999999999999999999999999999997
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.6e-17 Score=168.07 Aligned_cols=159 Identities=25% Similarity=0.329 Sum_probs=122.6
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcc-cccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPS-DFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
..|+.||||+|+|+ ..|..+..-+++-.|+||+|+|. ++|. -|.+|+-|-+||||+|+|. .+|+.+..|.+|++|+
T Consensus 103 ~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 46788888888887 77888888888888888888888 5654 4567888888888888888 7777777777777777
Q ss_pred cCCCcCC-------------------------cccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcc
Q 037905 118 LAKNNFS-------------------------GTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172 (606)
Q Consensus 118 l~~N~l~-------------------------~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~ 172 (606)
|++|.+. ..+|..+..|.+|..+|||.|+|...|..+.++.+|+.|+||+|+|+.
T Consensus 180 Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~ite 259 (1255)
T KOG0444|consen 180 LSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKITE 259 (1255)
T ss_pred cCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCceee
Confidence 7777542 236667777888888888888888554457888899999999998884
Q ss_pred cCC--ccccCCCCCcccCCCCCCCCCcCCC
Q 037905 173 SIP--KRFARLPSSAFEGNSLCGKPLVSCN 200 (606)
Q Consensus 173 ~~p--~~~~~l~~l~~~~n~l~~~p~~~c~ 200 (606)
.-- +.|.++.+|.++.|.|+..|...|.
T Consensus 260 L~~~~~~W~~lEtLNlSrNQLt~LP~avcK 289 (1255)
T KOG0444|consen 260 LNMTEGEWENLETLNLSRNQLTVLPDAVCK 289 (1255)
T ss_pred eeccHHHHhhhhhhccccchhccchHHHhh
Confidence 322 5677888888899999888888775
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.9e-16 Score=170.15 Aligned_cols=199 Identities=24% Similarity=0.325 Sum_probs=132.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.|..|+||.||.++++ ..+.+|+|+-++..+ +++ ++.....|.+| ||=.
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiNkq~li----lRn---ilt~a~npfvv---------------------gDc~ 139 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI----LRN---ILTFAGNPFVV---------------------GDCA 139 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhcccccchh----hhc---cccccCCccee---------------------chhh
Confidence 477999999999999864 467788854332110 000 12111222222 3444
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC---------
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--------- 471 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--------- 471 (606)
..+.... +++... +.+++|||+.|++ |||+||+|.+|..-|.+|+.|||+.+....
T Consensus 140 tllk~~g-----~lPvdm--------vla~Eylh~ygiv--hrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg 204 (1205)
T KOG0606|consen 140 TLLKNIG-----PLPVDM--------VLAVEYLHSYGIV--HRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG 204 (1205)
T ss_pred hhcccCC-----CCcchh--------hHHhHhhccCCee--cCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence 4443221 233322 6789999999966 999999999999999999999998864321
Q ss_pred ----------CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 472 ----------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 472 ----------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
.....+|+.|.|||++..+.|+..+|+|++|+++||.+.|+.||.+...++ ++..++......
T Consensus 205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd~i~w- 277 (1205)
T KOG0606|consen 205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISDDIEW- 277 (1205)
T ss_pred chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhhhccc-
Confidence 122467888999999999999999999999999999999999997643332 222222211000
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCH
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSM 578 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~ 578 (606)
++.......+..+++.+.++++|..|--.
T Consensus 278 --------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 278 --------PEEDEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred --------cccCcCCCHHHHHHHHHHHHhChHhhccc
Confidence 01112233456677778888999999643
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.2e-15 Score=139.39 Aligned_cols=134 Identities=22% Similarity=0.208 Sum_probs=94.7
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHH---H----------------------HHHHHHHcCCCCCC--cc
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE---F----------------------REKMEVVGSMDHEN--LV 375 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~----------------------~~e~~~l~~l~h~n--iv 375 (606)
+.||+|+||.||+|...+++.||||++......... + ..|.+.+.++.+.. +.
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 569999999999999878999999998754321111 1 23444444443332 33
Q ss_pred cceEEEEeCCceEEEEeecCCCChhhh-hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEec
Q 037905 376 PLRAYYYSRDEKLLVHDYMPMGSLSAL-LHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLS 453 (606)
Q Consensus 376 ~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~ 453 (606)
+.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. .+++ ||||||+||+++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~iv--H~Dl~p~Nili~ 149 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAGLV--HGDLSEYNILVD 149 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccCcC--cCCCChhhEEEE
Confidence 33332 346899999999654321 11110 11 5577899999999999999 8866 999999999999
Q ss_pred CCCcEEEeecccCccCC
Q 037905 454 KSYEARISDFGLAHLAS 470 (606)
Q Consensus 454 ~~~~~kl~DfG~a~~~~ 470 (606)
++.++++|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.9e-15 Score=133.75 Aligned_cols=133 Identities=16% Similarity=0.146 Sum_probs=110.0
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCC--CCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDH--ENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
+.||+|.++.||+++.. +..+++|....... ...+.+|+..+..++| .++.++++++...+..++++||+.++.+.
T Consensus 4 ~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~ 81 (155)
T cd05120 4 KLLKGGLTNRVYLLGTK-DEDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD 81 (155)
T ss_pred eecccccccceEEEEec-CCeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence 56999999999999986 47889999866443 5678899999999976 58888888887778899999999887665
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG-PANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
.+ +......++.+++++++++|... ..++|+|++|+||++++.+.++++|||.++..
T Consensus 82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 33 44566778999999999999853 23559999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.9e-14 Score=138.07 Aligned_cols=135 Identities=21% Similarity=0.245 Sum_probs=104.9
Q ss_pred hcccc-cCCceEEEEEEEcCCcEEEEEEeccCc--------------cCHHHHHHHHHHHcCCCCCCc--ccceEEEEeC
Q 037905 322 AEVLG-KGTFGTAYKATLEMGIVVAVKRLKDVT--------------VSEKEFREKMEVVGSMDHENL--VPLRAYYYSR 384 (606)
Q Consensus 322 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~ 384 (606)
...|| .|+.|+||.+... +..++||.+.... .....+.+|++++.+++|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 56788 8999999999886 7788899885321 123457889999999998875 6667665432
Q ss_pred C----ceEEEEeecCC-CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEE
Q 037905 385 D----EKLLVHDYMPM-GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEAR 459 (606)
Q Consensus 385 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~k 459 (606)
. ..++|||++++ .+|.+++... +++.. .+.+++.+|.+||+.|+. ||||||+|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~GI~--HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAGVY--HADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCCCC--CCCCCchhEEEcCCCCEE
Confidence 2 23599999997 6898887632 24433 356899999999999966 999999999999999999
Q ss_pred EeecccCccC
Q 037905 460 ISDFGLAHLA 469 (606)
Q Consensus 460 l~DfG~a~~~ 469 (606)
|+|||.++..
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988754
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-15 Score=149.67 Aligned_cols=167 Identities=26% Similarity=0.333 Sum_probs=122.2
Q ss_pred CCCCCCcc---eeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCC
Q 037905 24 LTDGPCKW---VGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNL 89 (606)
Q Consensus 24 ~~~~~c~~---~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 89 (606)
+....|+- ..|.|.. ...+.|+|..|+|+.+.|.+|..|++|+.|||++|.|+.+-|++|.+|++|
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l 117 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASL 117 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhh
Confidence 33445565 5588976 356789999999997778899999999999999999998889999999998
Q ss_pred CEEeccC-CcccccCCc---------------------------------------------------------------
Q 037905 90 RNLYLQG-NLFSGEIPG--------------------------------------------------------------- 105 (606)
Q Consensus 90 ~~L~Ls~-N~l~~~~p~--------------------------------------------------------------- 105 (606)
.+|-+-+ |+|+ .+|.
T Consensus 118 ~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA 196 (498)
T KOG4237|consen 118 LSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLA 196 (498)
T ss_pred hHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhh
Confidence 7666554 8888 4443
Q ss_pred ------------------------------------------------------------------------cccCCCCC
Q 037905 106 ------------------------------------------------------------------------LLFSLGNL 113 (606)
Q Consensus 106 ------------------------------------------------------------------------~~~~l~~L 113 (606)
.|..|++|
T Consensus 197 ~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L 276 (498)
T KOG4237|consen 197 QNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNL 276 (498)
T ss_pred cCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccc
Confidence 13446677
Q ss_pred cEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCC
Q 037905 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGN 189 (606)
Q Consensus 114 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n 189 (606)
+.|+|++|+|+++-+.+|..+..|+.|+|..|+|...-.. |.++..|+.|+|.+|+|+...|.+|..+.. |.+-+|
T Consensus 277 ~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N 356 (498)
T KOG4237|consen 277 RKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN 356 (498)
T ss_pred eEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccC
Confidence 7777777777777777777777777777777777644433 667777777777777777777766654433 444555
Q ss_pred CC
Q 037905 190 SL 191 (606)
Q Consensus 190 ~l 191 (606)
+|
T Consensus 357 p~ 358 (498)
T KOG4237|consen 357 PF 358 (498)
T ss_pred cc
Confidence 54
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=9.4e-15 Score=150.42 Aligned_cols=160 Identities=26% Similarity=0.278 Sum_probs=109.6
Q ss_pred CCCCCCCcceeEEecC----------------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCC
Q 037905 23 NLTDGPCKWVGVFCTG----------------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKL 86 (606)
Q Consensus 23 ~~~~~~c~~~~~~c~~----------------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 86 (606)
.+.+.+|.-.-..|+. +..+.|||++|.|+.+-+..|.+|++|+.++|..|.|+ .+|......
T Consensus 46 cpa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~s 124 (873)
T KOG4194|consen 46 CPATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHES 124 (873)
T ss_pred CCCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccc
Confidence 4556677666677865 35677999999999888889999999999999999998 788665555
Q ss_pred CCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEc
Q 037905 87 SNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNV 165 (606)
Q Consensus 87 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l 165 (606)
.+|+.|+|.+|.|+..-.+++.-++.|+.||||.|.|+.+.-..|..-.++++|+|++|+|+.+-.. |.++.+|..|-|
T Consensus 125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkL 204 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKL 204 (873)
T ss_pred cceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeec
Confidence 6677777777777755556666666667777766666633333455555666666666666644433 556666666666
Q ss_pred cCCcCcccCCccccCCCC
Q 037905 166 SFNKLNGSIPKRFARLPS 183 (606)
Q Consensus 166 ~~N~l~~~~p~~~~~l~~ 183 (606)
++|+++...+..|.+|++
T Consensus 205 srNrittLp~r~Fk~L~~ 222 (873)
T KOG4194|consen 205 SRNRITTLPQRSFKRLPK 222 (873)
T ss_pred ccCcccccCHHHhhhcch
Confidence 666666444455554443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-15 Score=149.65 Aligned_cols=147 Identities=29% Similarity=0.421 Sum_probs=73.8
Q ss_pred EEEEEcCCCCcccccCccccCCCCCcEE-EccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 41 VTMLRFPGMGLSGQLPIAIGNLTELHTV-SLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 41 l~~L~L~~n~l~~~~p~~l~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
++.++++.|+|. .+|..+..++.+.+. .+++|.+. .+|..++.+++|..|+|++|-+. .+|.+++.+..|+.|+++
T Consensus 390 Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS 466 (565)
T KOG0472|consen 390 VTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLS 466 (565)
T ss_pred eEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccc
Confidence 667777777775 566555444443332 33334443 45555555555555555555555 455555555555555555
Q ss_pred CCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCC
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLC 192 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~ 192 (606)
.|+|. .+|..+..+..|+++-.++|++....++ +.++.+|..|||.+|.|. .+|+.+++|.+ |.+.||+|.
T Consensus 467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 467 FNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 55554 4454444444444444444555444443 444555555555555554 33433333332 344455544
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-15 Score=156.86 Aligned_cols=154 Identities=20% Similarity=0.277 Sum_probs=115.1
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
.+|..+|||.|+|. .+|+.+-++++|+.|+||+|+|+ .+....+...+|++|+||.|+|+ .+|+.++.|+.|+.|++
T Consensus 222 ~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~ 298 (1255)
T KOG0444|consen 222 HNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYA 298 (1255)
T ss_pred hhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHh
Confidence 36777888888887 78888888888888888888888 66667777778888888888888 78888888888888888
Q ss_pred CCCcCC-cccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCCCCC
Q 037905 119 AKNNFS-GTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSLCGK 194 (606)
Q Consensus 119 ~~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l~~~ 194 (606)
.+|+++ ..+|.+++.|.+|+.+..++|.|.-.|..++.+..|+.|.|+.|.|- .+|+++.-|+ .|++..|+---.
T Consensus 299 n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVM 377 (1255)
T KOG0444|consen 299 NNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVM 377 (1255)
T ss_pred ccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccC
Confidence 888765 25777888888888888888888744445888888888888888887 6776654444 455655653333
Q ss_pred CC
Q 037905 195 PL 196 (606)
Q Consensus 195 p~ 196 (606)
|+
T Consensus 378 PP 379 (1255)
T KOG0444|consen 378 PP 379 (1255)
T ss_pred CC
Confidence 33
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.7e-15 Score=160.12 Aligned_cols=243 Identities=25% Similarity=0.305 Sum_probs=177.2
Q ss_pred cccccCCceEEEEEEE--cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATL--EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+|+.|-.... .....+|+|.+..... ..+....|..+-..+. |+|++.+++...+.+..+++++|..+
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 4489999999988764 2345566666654321 2233445666666665 99999999999999999999999999
Q ss_pred CChhhhh-hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCC-C
Q 037905 397 GSLSALL-HGNRGAGRTPLNWETRSGLALGASRAIAYLH-SKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASP-S 472 (606)
Q Consensus 397 g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~-~ 472 (606)
+++.+.+ +... ...+......+..|+..++.|+| ..++. |||+||+|.+++..+ ..+++|||+|..... .
T Consensus 106 ~~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~~~--h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~ 179 (601)
T KOG0590|consen 106 GSLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENGVT--HRDIKPSNSLLDESGSALKIADFGLATAYRNKN 179 (601)
T ss_pred cccccccccCCc----cCCCCcchhhhhhhhccCccccCcccccc--cCCCCCccchhccCCCcccCCCchhhccccccC
Confidence 9999988 4321 13455667789999999999999 88866 999999999999999 999999999976655 2
Q ss_pred C------CCCC-cccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 S------TPNR-IDGYRAPEVTDARK-VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 ~------~~~~-~~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
. ...+ ++.|+|||...+.. ..+..|+||.|+++.-+++|..|+....... .....|......
T Consensus 180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~~--------- 249 (601)
T KOG0590|consen 180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKGR--------- 249 (601)
T ss_pred CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccccc---------
Confidence 1 2345 77799999998854 4678999999999999999999998655443 112222211100
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+........++..+++..+|..|.+.+++...
T Consensus 250 ---~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 250 ---FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred ---cccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 0011112223445677778888999999999887654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-15 Score=149.05 Aligned_cols=156 Identities=28% Similarity=0.394 Sum_probs=137.0
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
..+++|++++|.++ .+|.+++.+..+..|+.++|++. .+|+++..+.+|+.|+.++|.+. .+|+.++.+..|+.|+.
T Consensus 68 ~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~ 144 (565)
T KOG0472|consen 68 ACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDA 144 (565)
T ss_pred cceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhc
Confidence 46899999999998 88999999999999999999999 89999999999999999999999 88888999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCCC---cccCCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSS---AFEGNSLCGKP 195 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l---~~~~n~l~~~p 195 (606)
.+|+++ .+|.++.++.+|..|++.+|+++..+|+.-+++.|++||...|-+. .+|+.++.|.+| ++..|.+...|
T Consensus 145 ~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP 222 (565)
T KOG0472|consen 145 TNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP 222 (565)
T ss_pred cccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC
Confidence 999998 7888899999999999999999988887555888999999999888 777777777764 56778888887
Q ss_pred Cc-CC
Q 037905 196 LV-SC 199 (606)
Q Consensus 196 ~~-~c 199 (606)
.. .|
T Consensus 223 ef~gc 227 (565)
T KOG0472|consen 223 EFPGC 227 (565)
T ss_pred CCCcc
Confidence 65 56
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.43 E-value=5e-15 Score=152.25 Aligned_cols=155 Identities=25% Similarity=0.404 Sum_probs=130.8
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
.|..|.|.+|.|. .+|.++.+|..|+.|||+.|+++ .+|..++.|+ |+.|-+++|+++ .+|+.++.+..|..||.+
T Consensus 99 ~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s 174 (722)
T KOG0532|consen 99 SLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVS 174 (722)
T ss_pred HHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhh
Confidence 4677778888887 78888888888888888888888 7888888876 888888888888 888888888888999999
Q ss_pred CCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCCC---cccCCCCCCCCC
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSS---AFEGNSLCGKPL 196 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l---~~~~n~l~~~p~ 196 (606)
.|.|. .+|..++.+.+|+.|.+..|++...|++++.| .|..||++.|+++ .+|-.|.+|..| .+++|+|...|.
T Consensus 175 ~nei~-slpsql~~l~slr~l~vrRn~l~~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 175 KNEIQ-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred hhhhh-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChH
Confidence 99988 77888888999999999999998888887744 6889999999999 889888877764 678999998887
Q ss_pred cCCCC
Q 037905 197 VSCNG 201 (606)
Q Consensus 197 ~~c~~ 201 (606)
..|..
T Consensus 252 qIC~k 256 (722)
T KOG0532|consen 252 QICEK 256 (722)
T ss_pred HHHhc
Confidence 77754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.7e-11 Score=130.59 Aligned_cols=139 Identities=22% Similarity=0.273 Sum_probs=95.8
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccC---------------------------H--------------HHHHH
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---------------------------E--------------KEFRE 361 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~--------------~~~~~ 361 (606)
+.||+|++|.||+|+..+|+.||||+.+..... . -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 469999999999999999999999998653110 0 01333
Q ss_pred HHHHHcCC----CCCCcccceEEEE-eCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 037905 362 KMEVVGSM----DHENLVPLRAYYY-SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR-AIAYLHS 435 (606)
Q Consensus 362 e~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~~LH~ 435 (606)
|...+.++ +|.+-+.+-..+. .....++||||++|++|.++..... ...+ +..++..++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCCC---HHHHHHHHHHHHHHHHHh
Confidence 44333333 2333333322222 2346789999999999988765321 0122 3446666655 4788899
Q ss_pred cCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 436 ~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
.|+. |+|++|.||++++++.++++|||++....
T Consensus 276 ~g~~--H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFF--HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCce--eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9966 99999999999999999999999986544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.2e-13 Score=147.80 Aligned_cols=99 Identities=23% Similarity=0.347 Sum_probs=48.3
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
+|+.|+|++|.|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. .+|+.|+|+
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 4555555555555 3444332 35555555555555 3444332 24555555555555 4444332 245555555
Q ss_pred CCcCCcccchhhhcCCCcceeeccccccccc
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGS 150 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 150 (606)
+|+|+ .+|..+. ++|+.|+|++|+|+.+
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~L 298 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIRTL 298 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCccccC
Confidence 55555 3443332 3455555555555543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.1e-12 Score=126.97 Aligned_cols=199 Identities=22% Similarity=0.358 Sum_probs=138.0
Q ss_pred HHHcCCCCCCcccceEEEEeC-----CceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037905 364 EVVGSMDHENLVPLRAYYYSR-----DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438 (606)
Q Consensus 364 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 438 (606)
.-+-.+.|.||+++..|+.+. .+..+++|||..|++..+|+.... ....+......+++.||..||.|||+..+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 344455799999999998753 356889999999999999987543 23457777788999999999999999999
Q ss_pred CCCCCCCCCCCEEecCCCcEEEeecccCccC---CC-----CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh
Q 037905 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLA---SP-----SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT 510 (606)
Q Consensus 439 ~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~---~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt 510 (606)
+|+|+++..+-|++..+|-+|+.--.-.... .. .....+.++|.|||+-.....+.++|||+||....||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 9999999999999999998887522111000 00 011123467999999877778889999999999999988
Q ss_pred CCCC-cccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 511 GKAP-TQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 511 g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.-- ........ ++.....- ++- + .. ..=..++..|++..|..||+|.+++.|
T Consensus 278 lEiq~tnseS~~~-------~ee~ia~~----i~~--l---en-----~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 278 LEIQSTNSESKVE-------VEENIANV----IIG--L---EN-----GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred heeccCCCcceee-------hhhhhhhh----eee--c---cC-----ccccCcCcccccCCCCCCcchhhhhcC
Confidence 7643 22211100 00000000 000 0 00 001234558999999999999998765
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.4e-12 Score=144.07 Aligned_cols=148 Identities=24% Similarity=0.403 Sum_probs=118.9
Q ss_pred EEecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCC
Q 037905 34 VFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113 (606)
Q Consensus 34 ~~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 113 (606)
..|...+.+.|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|
T Consensus 173 ~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L 243 (754)
T PRK15370 173 RDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTI 243 (754)
T ss_pred HhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccc
Confidence 4577778899999999999 6777664 58999999999999 7887665 58999999999999 7787654 479
Q ss_pred cEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccc-cCCCCCcccCCCCC
Q 037905 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF-ARLPSSAFEGNSLC 192 (606)
Q Consensus 114 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~l~~~~n~l~ 192 (606)
+.|+|++|+|. .+|..+. ++|+.|++++|+|+.++..+. ++|+.|++++|+|++ +|..+ ..+..|++.+|.+.
T Consensus 244 ~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 244 QEMELSINRIT-ELPERLP--SALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLT 317 (754)
T ss_pred cEEECcCCccC-cCChhHh--CCCCEEECcCCccCccccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCccc
Confidence 99999999998 7787764 589999999999997655453 589999999999995 44433 34566677777776
Q ss_pred CCCC
Q 037905 193 GKPL 196 (606)
Q Consensus 193 ~~p~ 196 (606)
..|.
T Consensus 318 ~LP~ 321 (754)
T PRK15370 318 ALPE 321 (754)
T ss_pred cCCc
Confidence 6553
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-14 Score=147.85 Aligned_cols=155 Identities=26% Similarity=0.387 Sum_probs=142.0
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
...+..||+.|.+. .+|.++..+..|+.|.|++|.|. .+|..+.+|..|++|||+.|+++ .+|..++.|+ |+.|-+
T Consensus 75 tdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~ 150 (722)
T KOG0532|consen 75 TDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIV 150 (722)
T ss_pred cchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEE
Confidence 35677999999998 99999999999999999999999 99999999999999999999999 9999999887 999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCC--CCcccCCCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLP--SSAFEGNSLCGKPL 196 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~l~~~~n~l~~~p~ 196 (606)
++|+++ .+|..++.+.+|..||.+.|.+..+++.++.+.+|+.|++..|++. .+|..+..|+ .|+|+.|++...|.
T Consensus 151 sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi~lDfScNkis~iPv 228 (722)
T KOG0532|consen 151 SNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLIRLDFSCNKISYLPV 228 (722)
T ss_pred ecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCceeeeecccCceeecch
Confidence 999998 8999999999999999999999989999999999999999999999 6777777776 47889999988876
Q ss_pred cCC
Q 037905 197 VSC 199 (606)
Q Consensus 197 ~~c 199 (606)
.-|
T Consensus 229 ~fr 231 (722)
T KOG0532|consen 229 DFR 231 (722)
T ss_pred hhh
Confidence 533
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.31 E-value=8e-12 Score=115.97 Aligned_cols=129 Identities=15% Similarity=0.158 Sum_probs=96.2
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCccc-ceEEEEeCCceEEEEeecCCCChhh
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVP-LRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
+.++.|.++.||+++.. +..+++|...........+..|+..++.+.+.++++ ++.+ .....++||||+++.++..
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~ 80 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT 80 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence 56899999999999876 778999987654333345678888888876655554 4433 2344689999999987754
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC---CCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP---ANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~---~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
.. . ....++.+++++|+.||..++ .++|+|++|.||+++ ++.++++|||.+..
T Consensus 81 ~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 81 ED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 30 0 112356789999999999874 246999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.5e-12 Score=141.11 Aligned_cols=137 Identities=34% Similarity=0.553 Sum_probs=101.9
Q ss_pred CCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccC
Q 037905 89 LRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSF 167 (606)
Q Consensus 89 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~ 167 (606)
++.|+|++|.|+|.+|..+..|++|+.|+|++|+|.|.+|..+..+++|+.|+|++|+|++.+|. ++.+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 67888888888888888888888888888888888888888888888888888888888887775 78888888888888
Q ss_pred CcCcccCCccccCC----CCCcccCCC-CCCCCC-cCCCCCCCCCCCCCCCCCCCceeeehhhHHHHHHHHHHH
Q 037905 168 NKLNGSIPKRFARL----PSSAFEGNS-LCGKPL-VSCNGGGDDDDDDGSNLSGGAIAGIVIGSVIGLLIILVL 235 (606)
Q Consensus 168 N~l~~~~p~~~~~l----~~l~~~~n~-l~~~p~-~~c~~~~~~~~~~~~~~~~~~~~~iv~g~~~~~~~~~~~ 235 (606)
|+|+|.+|..+..+ ..+.+.+|. +|+.|. ..|.. ......+++++++++++++++++.
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~~----------~~~~~~~i~~~~~~~~~~l~~~~~ 563 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGP----------HLSVGAKIGIAFGVSVAFLFLVIC 563 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCCCCCCCcc----------cCCCceEEEEEhHHHHHHHHHHHH
Confidence 88888888776543 345667765 777664 36642 122345667777666554444433
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=5.6e-12 Score=140.42 Aligned_cols=53 Identities=28% Similarity=0.367 Sum_probs=26.7
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCccc
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFS 100 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 100 (606)
+|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++|.|+
T Consensus 223 ~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~N~L~ 275 (788)
T PRK15387 223 HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFSNPLT 275 (788)
T ss_pred CCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccCCchh
Confidence 4556666666665 3443 1355666666666666 34432 133444444444444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.4e-12 Score=119.72 Aligned_cols=123 Identities=27% Similarity=0.347 Sum_probs=41.9
Q ss_pred ccCCCCCcEEEccCCCCcccCccccc-CCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhh-hcCCC
Q 037905 59 IGNLTELHTVSLRFNALRGTIPSDFA-KLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADF-NKLTR 136 (606)
Q Consensus 59 l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~ 136 (606)
+.+...+++|+|++|+|+ .+. .++ .+.+|+.|||++|+|+ .++ .+..|+.|+.|++++|+|+ .++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 445556788888888887 343 454 5677888888888888 454 3667788888888888887 444444 46788
Q ss_pred cceeecccccccccCC--CCCCCCCCCEEEccCCcCcccCC---ccccCCCCCcc
Q 037905 137 LGTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLNGSIP---KRFARLPSSAF 186 (606)
Q Consensus 137 L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~l~~ 186 (606)
|++|++++|+|...-. .+..+++|+.|+|.+|+++...- -.+..+|+|..
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~ 144 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKV 144 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SE
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhhe
Confidence 8888888888875332 25667888888888888873311 23445566543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.30 E-value=7.5e-12 Score=139.45 Aligned_cols=119 Identities=27% Similarity=0.367 Sum_probs=80.3
Q ss_pred EecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCc
Q 037905 35 FCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114 (606)
Q Consensus 35 ~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 114 (606)
.|....-..|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+
T Consensus 197 ~Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~ 265 (788)
T PRK15387 197 ACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLL 265 (788)
T ss_pred HHhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccc
Confidence 355566778999999998 7888775 48999999999999 67753 589999999999999 66753 34667
Q ss_pred EEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCc
Q 037905 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 115 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~ 171 (606)
.|+|++|.|+ .+|..+ .+|+.|++++|+|+.++. .+++|+.|+|++|+|+
T Consensus 266 ~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~LP~---~p~~L~~LdLS~N~L~ 315 (788)
T PRK15387 266 ELSIFSNPLT-HLPALP---SGLCKLWIFGNQLTSLPV---LPPGLQELSVSDNQLA 315 (788)
T ss_pred eeeccCCchh-hhhhch---hhcCEEECcCCccccccc---cccccceeECCCCccc
Confidence 7777777766 444322 334445555555543322 1234455555555444
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.5e-13 Score=144.55 Aligned_cols=148 Identities=26% Similarity=0.339 Sum_probs=113.6
Q ss_pred CeEEEEEcCCCCcccccCcccc--------------------------CCCCCcEEEccCCCCcccCcccccCCCCCCEE
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIG--------------------------NLTELHTVSLRFNALRGTIPSDFAKLSNLRNL 92 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~--------------------------~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (606)
++|++|||..|+|. .+|+.+- ....|+.|+|.+|.|+...=..+.+.+.|+.|
T Consensus 310 ~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVL 388 (1081)
T KOG0618|consen 310 KSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVL 388 (1081)
T ss_pred ceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeee
Confidence 46889999999987 5554221 12337778888888875544567788889999
Q ss_pred eccCCcccccCCc-cccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCc
Q 037905 93 YLQGNLFSGEIPG-LLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 93 ~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~ 171 (606)
+|++|+|. .+|+ .+.+|..|+.|+||+|+++ .+|..+..++.|++|...+|+|...| ++..++.|+.+|++.|.|+
T Consensus 389 hLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 389 HLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNLS 465 (1081)
T ss_pred eecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchhh
Confidence 99999998 5554 5668888999999999998 78888889999999999999998555 8888899999999999888
Q ss_pred ccC-Cccc--cCCCCCcccCCC
Q 037905 172 GSI-PKRF--ARLPSSAFEGNS 190 (606)
Q Consensus 172 ~~~-p~~~--~~l~~l~~~~n~ 190 (606)
... |... .+|+.|++.||.
T Consensus 466 ~~~l~~~~p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 466 EVTLPEALPSPNLKYLDLSGNT 487 (1081)
T ss_pred hhhhhhhCCCcccceeeccCCc
Confidence 433 3222 467778888886
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.1e-11 Score=128.36 Aligned_cols=139 Identities=18% Similarity=0.193 Sum_probs=86.3
Q ss_pred cccccCCceEEEEEEEcC-CcEEEEEEeccCcc---------------------------C--------HHH------HH
Q 037905 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTV---------------------------S--------EKE------FR 360 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---------------------------~--------~~~------~~ 360 (606)
+.||+|++|.||+|+..+ |+.||||+.+.... . .+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 469999999999999877 99999999975310 0 011 22
Q ss_pred HHHHHHcCC----CCCCcccceEEEEe-CCceEEEEeecCCCChhhhhhcC-CCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 037905 361 EKMEVVGSM----DHENLVPLRAYYYS-RDEKLLVHDYMPMGSLSALLHGN-RGAGRTPLNWETRSGLALGASRAIAYLH 434 (606)
Q Consensus 361 ~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~l~~~~~~~i~~~ia~~L~~LH 434 (606)
+|+..+.++ .+.+.+.+-..+.+ ....++||||++|+.+.++-.-. .+.....+....+..++. .++
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~-------Qif 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT-------QVF 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH-------HHH
Confidence 333222222 23333333333322 35678999999999998752211 110011122222222333 344
Q ss_pred hcCCCCCCCCCCCCCEEecCCC----cEEEeecccCccCC
Q 037905 435 SKGPANSHGNIKSSNILLSKSY----EARISDFGLAHLAS 470 (606)
Q Consensus 435 ~~~~~i~HrDlkp~Nill~~~~----~~kl~DfG~a~~~~ 470 (606)
..|+. |+|+||.||+++.++ .++++|||++....
T Consensus 278 ~~Gff--HaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 RDGFF--HADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred hCCee--eCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 57755 999999999999988 89999999986544
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.3e-12 Score=115.05 Aligned_cols=121 Identities=25% Similarity=0.322 Sum_probs=51.8
Q ss_pred eEEEEEcCCCCcccccCcccc-CCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccc-cCCCCCcEEe
Q 037905 40 RVTMLRFPGMGLSGQLPIAIG-NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLL-FSLGNLIRLN 117 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~ 117 (606)
.++.|+|++|.|+ .+ +.++ .|.+|+.|||++|.|+ .++ .+..+++|++|+|++|+|+ .+++.+ ..+++|+.|+
T Consensus 20 ~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE
T ss_pred ccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEE
Confidence 5788999999998 44 3566 5899999999999999 454 5888999999999999999 555444 4689999999
Q ss_pred cCCCcCCcccc-hhhhcCCCcceeecccccccccCCC----CCCCCCCCEEEc
Q 037905 118 LAKNNFSGTIS-ADFNKLTRLGTLYLQENQLTGSIPD----LGAFSSLAQFNV 165 (606)
Q Consensus 118 l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~----~~~l~~L~~L~l 165 (606)
|++|+|...-. ..+..+++|+.|+|.+|+++....- +..+|+|+.||-
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 99999974222 3567899999999999999865331 566888988863
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.3e-13 Score=126.43 Aligned_cols=126 Identities=31% Similarity=0.431 Sum_probs=61.2
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
.|+.||||+|.|+ .+-++..-++.++.|+||+|+|. ++. .+..|++|+.||||+|.|+ .+.+.-..|.+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 3455555555554 44444444555555555555554 222 1444555555555555555 444444444555555555
Q ss_pred CCcCCcccchhhhcCCCcceeecccccccccCC--CCCCCCCCCEEEccCCcCc
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~ 171 (606)
.|.|. .+. ++..|-+|..||+++|+|...-. .+++++-|++|.|.+|+|.
T Consensus 361 ~N~iE-~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 361 QNKIE-TLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhHh-hhh-hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 55554 222 34444555555555555543221 2455555555555555554
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.3e-12 Score=141.74 Aligned_cols=83 Identities=28% Similarity=0.370 Sum_probs=65.3
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
.+++++|+++|.++ .+|+++..+.+|+.|++.+|+|+ .+|..+...++|+.|.+.+|.++ -+|.....+..|++|+|
T Consensus 241 ~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL 317 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDL 317 (1081)
T ss_pred ccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeee
Confidence 57899999999998 66799999999999999999997 67777777777777777777777 56666666777777777
Q ss_pred CCCcCC
Q 037905 119 AKNNFS 124 (606)
Q Consensus 119 ~~N~l~ 124 (606)
..|+|.
T Consensus 318 ~~N~L~ 323 (1081)
T KOG0618|consen 318 QSNNLP 323 (1081)
T ss_pred hhcccc
Confidence 777665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.6e-12 Score=122.66 Aligned_cols=131 Identities=25% Similarity=0.324 Sum_probs=109.9
Q ss_pred cCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcce
Q 037905 60 GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGT 139 (606)
Q Consensus 60 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 139 (606)
...+.|++||||+|.|+ .+.+...-++.++.|++|+|.|. .+-. +..|++|+.||||+|.++ .+.++-..|-++++
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 34677999999999999 78888888899999999999999 5544 889999999999999998 77777788999999
Q ss_pred eecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCC---CcccCCCCCCCC
Q 037905 140 LYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPS---SAFEGNSLCGKP 195 (606)
Q Consensus 140 L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~---l~~~~n~l~~~p 195 (606)
|.|++|.|. ....+..+-+|..||+++|+|..... ..++++|- +.+.+|++.+.|
T Consensus 357 L~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 357 LKLAQNKIE-TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred eehhhhhHh-hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 999999998 45567778899999999999984332 34566665 567889988765
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.2e-10 Score=138.83 Aligned_cols=155 Identities=20% Similarity=0.217 Sum_probs=125.5
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
..+|+.|++.+|.++ .+|..| .+.+|+.|+|++|+|. .+|..+..+++|+.|+|++|..-+.+|. +..+++|+.|+
T Consensus 588 p~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~ 663 (1153)
T PLN03210 588 PPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLK 663 (1153)
T ss_pred CcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEE
Confidence 356888888888887 777777 5789999999999998 7888888999999999998764447774 78889999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCCCcccCCCCCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~~n~l~~~p~ 196 (606)
|++|.....+|..+..+++|+.|++++|.....+|...++++|+.|+|++|...+.+|....++..|++.+|.+...|.
T Consensus 664 L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~lP~ 742 (1153)
T PLN03210 664 LSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPS 742 (1153)
T ss_pred ecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCCccccccccCCcCeeecCCCccccccc
Confidence 9998766688999999999999999986544445543378899999999987776778777788888888888766554
|
syringae 6; Provisional |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=7.2e-10 Score=117.74 Aligned_cols=160 Identities=20% Similarity=0.246 Sum_probs=122.2
Q ss_pred EcCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCH
Q 037905 338 LEMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNW 416 (606)
Q Consensus 338 ~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~ 416 (606)
..++.+|.|...+.... ......+.++.++.+|||||++++..+...+..|+|+|.+. -|..++.. +..
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------l~~ 103 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------LGK 103 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------hHH
Confidence 44688888888876443 23446677889999999999999999999999999999875 46666653 224
Q ss_pred HHHHHHHHHHHHHHHHHHhcC-CCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC----CCCcccccCccccCCCC
Q 037905 417 ETRSGLALGASRAIAYLHSKG-PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST----PNRIDGYRAPEVTDARK 491 (606)
Q Consensus 417 ~~~~~i~~~ia~~L~~LH~~~-~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~----~~~~~~y~aPE~~~~~~ 491 (606)
...-..+.||+.||.|||..+ .+ |++|.-..|++++.|..||++|.++........ ......|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lv--HgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLV--HGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCee--eccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence 455567899999999999665 55 999999999999999999999987754433221 11122377777665433
Q ss_pred CCCcchhHHHHHHHHHHHhC
Q 037905 492 VSQKADVYSFGVLLLELLTG 511 (606)
Q Consensus 492 ~~~~sDv~slGvvl~elltg 511 (606)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-11 Score=126.84 Aligned_cols=91 Identities=23% Similarity=0.228 Sum_probs=39.5
Q ss_pred cccCCCCCcEEEccCCCCcccCcccccCCCC---CCEEeccCCcccc----cCCccccCC-CCCcEEecCCCcCCcc---
Q 037905 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSN---LRNLYLQGNLFSG----EIPGLLFSL-GNLIRLNLAKNNFSGT--- 126 (606)
Q Consensus 58 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~l~~N~l~~~--- 126 (606)
.+.++++|+.|+|++|.+.+..+..+..+.+ |++|+|++|++++ .+...+..+ ++|+.|+|++|.+++.
T Consensus 76 ~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~ 155 (319)
T cd00116 76 GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCE 155 (319)
T ss_pred HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHH
Confidence 3444445555555555554333333333333 5555555555441 111223333 4455555555554421
Q ss_pred -cchhhhcCCCcceeeccccccc
Q 037905 127 -ISADFNKLTRLGTLYLQENQLT 148 (606)
Q Consensus 127 -~p~~~~~l~~L~~L~l~~N~l~ 148 (606)
++..+..+++|++|++++|.++
T Consensus 156 ~~~~~~~~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 156 ALAKALRANRDLKELNLANNGIG 178 (319)
T ss_pred HHHHHHHhCCCcCEEECcCCCCc
Confidence 1223334444555555555544
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.9e-11 Score=126.09 Aligned_cols=248 Identities=21% Similarity=0.216 Sum_probs=171.0
Q ss_pred cCHHHHHHHHhccccc--CCceEEEEEEE---cCCcEEEEEEeccCc---cCHHHHHHHHHHHcCC-CCCCcccceEEEE
Q 037905 312 FDLEDLLRASAEVLGK--GTFGTAYKATL---EMGIVVAVKRLKDVT---VSEKEFREKMEVVGSM-DHENLVPLRAYYY 382 (606)
Q Consensus 312 ~~~~~~~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 382 (606)
++..+......+-+|+ |.+|.||.+.. .++..+|+|+-+.-. .....=.+|+....++ .|+|.++....+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3344443444667999 99999999975 467889998743221 2223334556665555 5999999888888
Q ss_pred eCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCCCCCCCCCCEEecCC-Cc
Q 037905 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR----AIAYLHSKGPANSHGNIKSSNILLSKS-YE 457 (606)
Q Consensus 383 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~i~HrDlkp~Nill~~~-~~ 457 (606)
..+..++-+|++. .+|..+.+.-.. .++....+....+..+ ||.++|..++. |-|+||.||+...+ ..
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~--~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNNIV--HDDLKPANIFTTSDWTS 261 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCccc--ccccchhheecccccce
Confidence 8899999999886 588888775432 2555666666777777 99999999866 99999999999999 88
Q ss_pred EEEeecccCccCCCCCC---------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhH
Q 037905 458 ARISDFGLAHLASPSST---------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 458 ~kl~DfG~a~~~~~~~~---------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~ 528 (606)
.++.|||+......... ..+...|++||...+ .++.+.|+|++|.+..+..++..+....... .
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~ 334 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------S 334 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------C
Confidence 99999998876554321 123344999999876 5788999999999999999987665322111 1
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
|.+ .++.+.. .+ ....-..++...+.++++.+|-.|++.+.+.+.
T Consensus 335 W~~--~r~~~ip----~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 WSQ--LRQGYIP----LE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ccc--cccccCc----hh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 111 1111110 00 011112334457778999999999998877543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.3e-10 Score=136.51 Aligned_cols=57 Identities=19% Similarity=0.246 Sum_probs=25.9
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccC
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQG 96 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 96 (606)
.+|+.|+|+++...+.+| .+..+++|++|+|++|.....+|..+..+++|+.|+|++
T Consensus 634 ~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~ 690 (1153)
T PLN03210 634 TGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSR 690 (1153)
T ss_pred CCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCC
Confidence 345555555443222333 244445555555544432224444444444444444444
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-11 Score=126.60 Aligned_cols=132 Identities=26% Similarity=0.327 Sum_probs=62.9
Q ss_pred eEEEEEcCCCCccc----ccCccccCCCCCcEEEccCCCCcc------cCcccccCCCCCCEEeccCCcccccCCccccC
Q 037905 40 RVTMLRFPGMGLSG----QLPIAIGNLTELHTVSLRFNALRG------TIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS 109 (606)
Q Consensus 40 ~l~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 109 (606)
+|+.|+|+++.++. .++..+..+++|+.|+++.|.+.+ .++..+..+++|+.|+|++|.+.+..+..+..
T Consensus 24 ~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~ 103 (319)
T cd00116 24 CLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLES 103 (319)
T ss_pred hccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHH
Confidence 35555555555532 133344455555555555555441 12233444555555555555555444444433
Q ss_pred CCC---CcEEecCCCcCCc----ccchhhhcC-CCcceeecccccccccCC-----CCCCCCCCCEEEccCCcCc
Q 037905 110 LGN---LIRLNLAKNNFSG----TISADFNKL-TRLGTLYLQENQLTGSIP-----DLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 110 l~~---L~~L~l~~N~l~~----~~p~~~~~l-~~L~~L~l~~N~l~~~~~-----~~~~l~~L~~L~l~~N~l~ 171 (606)
+.+ |+.|++++|+++. .+...+..+ ++|+.|++++|.+++... .+..+.+|+.|++++|.++
T Consensus 104 l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIG 178 (319)
T ss_pred HhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCc
Confidence 333 5555555555542 122233344 555555555555552111 1334445555555555555
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.2e-11 Score=126.39 Aligned_cols=154 Identities=27% Similarity=0.411 Sum_probs=123.7
Q ss_pred CeEEEEEcCCCCcccccCccccCCC-CCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLT-ELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
+.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|.....+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 46899999999998 7777788885 9999999999999 78788899999999999999999 7777666888999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcc--cCCccccCCCCCcccCCCCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG--SIPKRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~l~~~~n~l~~~p 195 (606)
+++|+++ .+|.....+..|++|.+++|++...+..+..+.++..|.+.+|++.. .....+.++..|++.+|.++..+
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~ 271 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSIS 271 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeeccchhccccccceeccccccccccc
Confidence 9999998 77777667777999999999766566667888888888888888874 22234444556777778776654
Q ss_pred C
Q 037905 196 L 196 (606)
Q Consensus 196 ~ 196 (606)
.
T Consensus 272 ~ 272 (394)
T COG4886 272 S 272 (394)
T ss_pred c
Confidence 4
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.2e-10 Score=107.99 Aligned_cols=140 Identities=21% Similarity=0.239 Sum_probs=106.6
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCC--CcccceEEEEeC---CceEEEEeecC
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHE--NLVPLRAYYYSR---DEKLLVHDYMP 395 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 395 (606)
+.|+.|.++.||+++..+|..+++|....... ....+..|+++++.+++. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999987678899998765433 355788999999888663 456667666543 25689999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK--------------------------------------- 436 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------------------------------------- 436 (606)
|.++.+.+.. ..++......++.+++++|.+||+.
T Consensus 84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9888776531 1366677777888888888888842
Q ss_pred ---------------CCCCCCCCCCCCCEEecC--CCcEEEeecccCcc
Q 037905 437 ---------------GPANSHGNIKSSNILLSK--SYEARISDFGLAHL 468 (606)
Q Consensus 437 ---------------~~~i~HrDlkp~Nill~~--~~~~kl~DfG~a~~ 468 (606)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134579999999999998 56689999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.09 E-value=4.4e-11 Score=127.00 Aligned_cols=153 Identities=28% Similarity=0.428 Sum_probs=131.3
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
+|+.|++++|.+. .+|..+..+++|+.|++++|+++ .+|.....+++|+.|++++|+++ .+|.....+..|+.|+++
T Consensus 141 nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 8999999999998 88788999999999999999999 78877778999999999999999 888876667779999999
Q ss_pred CCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCCC
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p~ 196 (606)
+|.+. ..+..+..+.++..|.+.+|++...+..++.+++++.|++++|.++...+ ..+.++..+++++|.+...+.
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeeeccchhccccccceeccccccccccccccccCccCEEeccCccccccch
Confidence 99765 57778999999999999999998665568889999999999999995443 234556667888888766543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.2e-09 Score=100.67 Aligned_cols=135 Identities=15% Similarity=0.125 Sum_probs=95.1
Q ss_pred cccccCCceEEEEEEEcC-------CcEEEEEEeccCcc----------------------C-HHHH----HHHHHHHcC
Q 037905 323 EVLGKGTFGTAYKATLEM-------GIVVAVKRLKDVTV----------------------S-EKEF----REKMEVVGS 368 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~-~~~~----~~e~~~l~~ 368 (606)
..||.|.-+.||.|...+ +..+|||+.+.... + .+.+ .+|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997542 47999998753210 0 1122 378888887
Q ss_pred CCC--CCcccceEEEEeCCceEEEEeecCCCChhh-hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCCCCC
Q 037905 369 MDH--ENLVPLRAYYYSRDEKLLVHDYMPMGSLSA-LLHGNRGAGRTPLNWETRSGLALGASRAIAYL-HSKGPANSHGN 444 (606)
Q Consensus 369 l~h--~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~i~HrD 444 (606)
+.. -++.+.+++ ...++||||+.+..+.. .+.+ ..++......+..+++.+|..| |..|++ |+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~glV--HGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECNLV--HAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCCee--cCC
Confidence 743 345555543 46789999997654422 2221 1244455667889999999998 888866 999
Q ss_pred CCCCCEEecCCCcEEEeecccCccCC
Q 037905 445 IKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 445 lkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
|++.||++++ +.+.|+|||.+....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCC
Confidence 9999999974 689999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.3e-10 Score=84.99 Aligned_cols=18 Identities=39% Similarity=0.508 Sum_probs=6.7
Q ss_pred ccCCCCCcEEEccCCCCc
Q 037905 59 IGNLTELHTVSLRFNALR 76 (606)
Q Consensus 59 l~~l~~L~~L~L~~N~l~ 76 (606)
|.++++|++|+|++|+|+
T Consensus 21 f~~l~~L~~L~l~~N~l~ 38 (61)
T PF13855_consen 21 FSNLPNLETLDLSNNNLT 38 (61)
T ss_dssp TTTGTTESEEEETSSSES
T ss_pred HcCCCCCCEeEccCCccC
Confidence 333333333333333333
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.3e-10 Score=85.02 Aligned_cols=59 Identities=34% Similarity=0.459 Sum_probs=24.4
Q ss_pred CCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCc
Q 037905 64 ELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNN 122 (606)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 122 (606)
+|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444442222334444444444444444443333344444444444444443
|
... |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.1e-08 Score=92.82 Aligned_cols=130 Identities=23% Similarity=0.361 Sum_probs=96.9
Q ss_pred ccccCCceEEEEEEEcCCcEEEEEEe-ccCc----cC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 324 VLGKGTFGTAYKATLEMGIVVAVKRL-KDVT----VS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~~~~vavK~~-~~~~----~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+++|+-+.+|.+.+. |..+++|.= ++.- .+ ...-.+|+.++.+++--.|.--.=+..+.+...++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5889999999999876 555666643 2221 11 234567888888776555554445566778888999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
+|..|.+.+... ...++..+=.-+.-||..|++ |+||.++||++.... +.++|||++...
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~giv--HGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAGIV--HGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcCee--cCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888743 134566666778899999966 999999999998875 999999998743
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.1e-10 Score=115.73 Aligned_cols=146 Identities=25% Similarity=0.336 Sum_probs=121.2
Q ss_pred EEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCC-
Q 037905 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK- 120 (606)
Q Consensus 42 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~- 120 (606)
...|-++-+|+ .+|..+- ..-..|+|..|+|+.+.|++|..+++|+.||||+|+|+.+-|++|.+|.+|..|-+-+
T Consensus 49 ~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~ 125 (498)
T KOG4237|consen 49 GIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGN 125 (498)
T ss_pred ceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcC
Confidence 45678888888 7775543 3567899999999977778999999999999999999999999999999987776655
Q ss_pred CcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCC
Q 037905 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNS 190 (606)
Q Consensus 121 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~ 190 (606)
|+|+...-+.|++|..|+.|.+.-|++..+..+ |..+++|..|.+-+|.+....-..|..+.. +++.-|+
T Consensus 126 NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np 199 (498)
T KOG4237|consen 126 NKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNP 199 (498)
T ss_pred CchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCc
Confidence 999976667899999999999999999987776 899999999999999999443346665544 5666666
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.8e-08 Score=97.33 Aligned_cols=264 Identities=16% Similarity=0.175 Sum_probs=155.3
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEE----E--eCCc-eEEEEeec
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYY----Y--SRDE-KLLVHDYM 394 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~----~--~~~~-~~lv~e~~ 394 (606)
..||+|+-+.+|-.-.- +..| -|+++.-....+ .+.+..|... .||-+-.-+.+= + ++.. .-++|..+
T Consensus 17 r~LgqGgea~ly~l~e~-~d~V-AKIYh~Pppa~~--aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v 92 (637)
T COG4248 17 RPLGQGGEADLYTLGEV-RDQV-AKIYHAPPPAAQ--AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV 92 (637)
T ss_pred ccccCCccceeeecchh-hchh-heeecCCCchHH--HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence 45999999999954321 2233 377765332211 1223333333 566544312110 1 1122 45677776
Q ss_pred CCCC-hhhhhhc-CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 395 PMGS-LSALLHG-NRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 395 ~~g~-L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
.+.- ...+... .++.......|...++.+..+|.+.+.||..|.. -+|+.++|+|+++++.+.|.|=..-......
T Consensus 93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~--vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng 170 (637)
T COG4248 93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHV--VGDVNQNSFLVSDDSKVVLVDSDSFQINANG 170 (637)
T ss_pred CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCc--ccccCccceeeecCceEEEEcccceeeccCC
Confidence 6532 2222221 2223456789999999999999999999999976 8999999999999999999875432222211
Q ss_pred ---CCCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhC-CCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 473 ---STPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTG-KAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
.-..+...|.+||.-. +-.-+...|-|.||+++++++.| ++||.+..-.. +-+.-.+.-+..+.....-
T Consensus 171 ~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~--~ap~p~E~~Ia~g~f~ya~ 248 (637)
T COG4248 171 TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLIS--DAPNPLETDIAHGRFAYAS 248 (637)
T ss_pred ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccC--CCCCcchhhhhcceeeech
Confidence 1234455699999643 33456779999999999999885 99998743211 1111111111111111111
Q ss_pred ch--hhhcc---cChHHHHHHHHHHHHHccCcC--CCCCCCHHHHHHHHHHHHhcccc
Q 037905 544 DL--ELLRY---QNVEEEMVQLLQLAINCTAQY--PDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 544 d~--~~~~~---~~~~~~~~~l~~l~~~Cl~~~--P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
|. .+... ....--...+..+..+|.... +.-|||++.++..|..+.++-..
T Consensus 249 ~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 249 DQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred hccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 10 00000 011222244556666888653 56899999999999988766444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-08 Score=92.35 Aligned_cols=141 Identities=16% Similarity=0.271 Sum_probs=101.7
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEE-eccC--------ccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKR-LKDV--------TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+|-+|+-+.|+++.+. |+...||. +.+. ....+...+|+..+.+++--.|.--.=++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 46889999999999987 77766764 3221 12345677889988887655555444456666777899999
Q ss_pred cCC-CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc---EEEeecccCccC
Q 037905 394 MPM-GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE---ARISDFGLAHLA 469 (606)
Q Consensus 394 ~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~---~kl~DfG~a~~~ 469 (606)
+++ .++.+++...... +........++..|-+.+.-||..+++ |+||..+||++..++. +.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~ndii--HGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDNDII--HGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCCee--cccccccceEEecCCCcCceEEEeecchhcc
Confidence 987 5778887654311 122222356888888899999999966 9999999999976653 589999998643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.6e-10 Score=116.50 Aligned_cols=240 Identities=20% Similarity=0.195 Sum_probs=166.4
Q ss_pred hcccccCCceEEEEEEE--cCCcEEEEEEeccCccC---HHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL--EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
...||.|.|+.|++... .++..+++|.+.+.... +..-..|+.+...+ .|.+++.+...|......++=-||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 35699999999998763 46788999988765332 22223445444444 58899998888877778889999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-CcEEEeecccCccCCC-CC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLASP-SS 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~~~~-~~ 473 (606)
++++...+.. ...++...++++..|++.++.++|+...+ |+|+||+||++..+ +.-++.|||.++.... ..
T Consensus 350 ~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s~~~~--~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~ 422 (524)
T KOG0601|consen 350 GGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHSKLFV--HLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG 422 (524)
T ss_pred CcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccchhhh--cccccccceeeccchhhhhccccccccccceecc
Confidence 9888766631 23477788899999999999999999866 99999999999886 7789999999864332 22
Q ss_pred CCCCcccccC-cccc-CCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 474 TPNRIDGYRA-PEVT-DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 474 ~~~~~~~y~a-PE~~-~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....+.+++| +|++ ....+..+.|+||||.-+.|.+++...-.... .... +..+. +.+.
T Consensus 423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----~~~~-----i~~~~--------~p~~- 483 (524)
T KOG0601|consen 423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----QSLT-----IRSGD--------TPNL- 483 (524)
T ss_pred cccccccccccchhhccccccccccccccccccccccccCcccCcccc-----ccee-----eeccc--------ccCC-
Confidence 3334444552 4444 45567889999999999999999865432110 0000 00000 0011
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~ 589 (606)
......+..+.+....+++..||.+.++..+.+...
T Consensus 484 --~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 484 --PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred --CchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 111244556666777899999999999887766554
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.4e-08 Score=97.19 Aligned_cols=141 Identities=12% Similarity=0.093 Sum_probs=99.6
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCcc------------CHHHHHHHHHHHcCCCCCC--cccceEEEEe----
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV------------SEKEFREKMEVVGSMDHEN--LVPLRAYYYS---- 383 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~---- 383 (606)
.+.+-+.....|++..+. |+.+.||....... ....+.+|+..+.++...+ ..+.+++...
T Consensus 27 ~e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 345555555567777775 78899997743221 1124778888777764333 3344555432
Q ss_pred -CCceEEEEeecCCC-ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-------
Q 037905 384 -RDEKLLVHDYMPMG-SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK------- 454 (606)
Q Consensus 384 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~------- 454 (606)
....++|||++++. +|.+++.... ..+.+...+..++.+++..+.-||..|+. |+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~Gi~--HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAGIN--HRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCcCc--cCCCChhhEEEeccccCCCC
Confidence 23568999999885 7988875321 12345667778999999999999999977 9999999999975
Q ss_pred CCcEEEeecccCcc
Q 037905 455 SYEARISDFGLAHL 468 (606)
Q Consensus 455 ~~~~kl~DfG~a~~ 468 (606)
+..+.++||+.++.
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46799999998754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.1e-09 Score=121.23 Aligned_cols=235 Identities=21% Similarity=0.233 Sum_probs=152.5
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+-+-+|+++.++.++- ..|...++|+...... ..+....+-.++-..+||-++....-+......+|+++|+.++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 3578899999987752 2343344444332211 1122222223333335566666555555567889999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC------
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP------ 471 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~------ 471 (606)
+|...++... ..+..-.......+..+++|||...+. |||++|.|.+...++..++.|||.......
T Consensus 890 ~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~r~--h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 890 DLPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSLRK--HRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CchhhhhcCC-----CcccccccchhHHHHhhhhccccchhh--cccccccchhhcccCCcccCccccccccccccCcCC
Confidence 9999998654 344444455666778889999998755 999999999999999999999983321100
Q ss_pred -----------------------------CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC
Q 037905 472 -----------------------------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE 522 (606)
Q Consensus 472 -----------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~ 522 (606)
.....+++.|.+||...+......+|+|++|++++|.++|.+||+....+.
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 001224566999999999999999999999999999999999998644332
Q ss_pred CCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHH
Q 037905 523 GVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMA 579 (606)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 579 (606)
. .+.+... ++- -...+.+......+++.+-+..+|.+|-.|.
T Consensus 1043 ~------f~ni~~~----~~~-----~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 I------FENILNR----DIP-----WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred h------hhccccC----CCC-----CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1 1111111 000 0111222333445556677778888887765
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.7e-10 Score=96.99 Aligned_cols=133 Identities=24% Similarity=0.211 Sum_probs=96.4
Q ss_pred eEEEEEcCCCCcccccCcccc---CCCCCcEEEccCCCCcccCcccccCC-CCCCEEeccCCcccccCCccccCCCCCcE
Q 037905 40 RVTMLRFPGMGLSGQLPIAIG---NLTELHTVSLRFNALRGTIPSDFAKL-SNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~---~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 115 (606)
.+..+||++++|- .+++... ....|+..+|++|.+. .+|+.|... +.++.|+|++|+|+ .+|.++..++.|+.
T Consensus 28 E~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 28 ELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred Hhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 4667889999885 7776544 4556666799999998 677777654 57899999999999 88888999999999
Q ss_pred EecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCc
Q 037905 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPK 176 (606)
Q Consensus 116 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 176 (606)
|+++.|.|. ..|..+..|.+|-.|+..+|.+..++-++---...-...+.+++|.+.-+.
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCcc
Confidence 999999998 788888888888888888888875444421111112223456666654443
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1e-09 Score=110.51 Aligned_cols=156 Identities=23% Similarity=0.224 Sum_probs=91.2
Q ss_pred CeEEEEEcCCCCcccccC--ccccCCCCCcEEEccCCCCcccCccc-ccCCCCCCEEeccCCcccccC-CccccCCCCCc
Q 037905 39 ERVTMLRFPGMGLSGQLP--IAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEI-PGLLFSLGNLI 114 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~ 114 (606)
.+++.|||++|-|....| .-...|++|+.|+|+.|++..-..+. -..++.|+.|.|+.+.|+-.. -..+..+++|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 467777777776654333 23456777777777777776222111 224566777777777766211 11233567777
Q ss_pred EEecCCCcCCcccchhhhcCCCcceeecccccccccC--CCCCCCCCCCEEEccCCcCcccC-C--------ccccCCCC
Q 037905 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSI--PDLGAFSSLAQFNVSFNKLNGSI-P--------KRFARLPS 183 (606)
Q Consensus 115 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~-p--------~~~~~l~~ 183 (606)
.|+|..|.....-......+..|+.|||++|++.... +..+.++.|+.|+++.+.+.... | ..|..+..
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~ 305 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEY 305 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhccccccee
Confidence 7777777533334444556677777777777776554 34667777777777777766432 2 12444555
Q ss_pred CcccCCCCCCC
Q 037905 184 SAFEGNSLCGK 194 (606)
Q Consensus 184 l~~~~n~l~~~ 194 (606)
|.+..|++...
T Consensus 306 L~i~~N~I~~w 316 (505)
T KOG3207|consen 306 LNISENNIRDW 316 (505)
T ss_pred eecccCccccc
Confidence 55566665443
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=8.2e-08 Score=89.78 Aligned_cols=125 Identities=25% Similarity=0.272 Sum_probs=80.7
Q ss_pred EEEEEEEcCCcEEEEEEeccCccC---------------------------HHHHHHHHHHHcCCCCC--CcccceEEEE
Q 037905 332 TAYKATLEMGIVVAVKRLKDVTVS---------------------------EKEFREKMEVVGSMDHE--NLVPLRAYYY 382 (606)
Q Consensus 332 ~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~--niv~l~~~~~ 382 (606)
.||.|...+|..+|||+.+....+ .....+|++.|.++... ++.+.+.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999888999999987542110 12367799999988765 45555544
Q ss_pred eCCceEEEEeecC--CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCCCCCCCCCCEEecCCCcEE
Q 037905 383 SRDEKLLVHDYMP--MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY-LHSKGPANSHGNIKSSNILLSKSYEAR 459 (606)
Q Consensus 383 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~-LH~~~~~i~HrDlkp~Nill~~~~~~k 459 (606)
....+||||++ |..+..+.... +.......++.+++..+.. +|..|++ |+||.+.||+++++ .+.
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~giv--HGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAGIV--HGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTTEE--ESS-STTSEEEETT-CEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcCce--ecCCChhhEEeecc-eEE
Confidence 25579999998 65554443321 1123345577777775555 5788855 99999999999988 999
Q ss_pred EeecccCccCC
Q 037905 460 ISDFGLAHLAS 470 (606)
Q Consensus 460 l~DfG~a~~~~ 470 (606)
++|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999876544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.7e-10 Score=118.98 Aligned_cols=126 Identities=28% Similarity=0.383 Sum_probs=79.8
Q ss_pred CcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccch-hhhcCCCcceeecc
Q 037905 65 LHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISA-DFNKLTRLGTLYLQ 143 (606)
Q Consensus 65 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~l~ 143 (606)
|.+.+.+.|+|. ...+.+.-++.|+.|||++|+++ ... .+..|+.|++|||++|.+. .+|. ....+. |+.|.++
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-heeeeec
Confidence 555566667776 55666666777777777777777 332 5666777777777777776 4442 233344 7777777
Q ss_pred cccccccCCCCCCCCCCCEEEccCCcCcccCC----ccccCCCCCcccCCCCCCCCC
Q 037905 144 ENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP----KRFARLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 144 ~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p----~~~~~l~~l~~~~n~l~~~p~ 196 (606)
||.++ ..-.+.++++|..||+++|-|.+.-. ..+..|..|.+.||++|-.|+
T Consensus 241 nN~l~-tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~ 296 (1096)
T KOG1859|consen 241 NNALT-TLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPW 296 (1096)
T ss_pred ccHHH-hhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHH
Confidence 77776 33456667777777777776664322 234455566777777765553
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.5e-09 Score=110.81 Aligned_cols=149 Identities=26% Similarity=0.336 Sum_probs=91.3
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
..+++.|+|.+|.|.. +...+..+++|++|+|++|.|+.+. .+..++.|+.|++++|.|+ .+.. +..+..|+.++
T Consensus 94 ~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~-~~~~-~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLIS-DISG-LESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchhh-cccchhhhhcchheecccccccccc--chhhccchhhheeccCcch-hccC-Cccchhhhccc
Confidence 3567778888887773 3333677777888888888777433 3556666778888888877 4432 45577777888
Q ss_pred cCCCcCCcccchh-hhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCcc-ccC--CCCCcccCCCCCC
Q 037905 118 LAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKR-FAR--LPSSAFEGNSLCG 193 (606)
Q Consensus 118 l~~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~--l~~l~~~~n~l~~ 193 (606)
+++|.+. .++.. ...+.+|+.+++.+|.+. .+..+..+..+..+++.+|.++..-+-. +.. ++.+.+.+|++.-
T Consensus 169 l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~-~i~~~~~~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~ 246 (414)
T KOG0531|consen 169 LSYNRIV-DIENDELSELISLEELDLGGNSIR-EIEGLDLLKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISR 246 (414)
T ss_pred CCcchhh-hhhhhhhhhccchHHHhccCCchh-cccchHHHHHHHHhhcccccceeccCcccchhHHHHHHhcccCcccc
Confidence 8888777 33332 467777777777777776 3333333444444466666665333211 111 4455555655543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.2e-10 Score=119.33 Aligned_cols=128 Identities=25% Similarity=0.308 Sum_probs=101.6
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCcccc-CCCCCcEEec
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNL 118 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l 118 (606)
.|...+.+.|.|. ..-.++.-|+.|+.|||++|+++. .. .+..|+.|+.|||++|+|+ .+|..-. .+ .|+.|.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhh-hheeeee
Confidence 5778888999887 666788889999999999999983 33 7888999999999999999 7775322 33 3999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCC--CCCCCCCCCEEEccCCcCcccCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLNGSIP 175 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p 175 (606)
+||.++ .+- ++.+|++|+.||++.|-|++.-. .+..+..|..|+|.+|++. ..|
T Consensus 240 rnN~l~-tL~-gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~-c~p 295 (1096)
T KOG1859|consen 240 RNNALT-TLR-GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC-CAP 295 (1096)
T ss_pred cccHHH-hhh-hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc-cCH
Confidence 999998 333 68899999999999999876432 2556778889999999987 444
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.4e-07 Score=94.73 Aligned_cols=170 Identities=28% Similarity=0.307 Sum_probs=125.2
Q ss_pred CceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEE----eCCceEEEEeecCC-CChhh
Q 037905 329 TFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYY----SRDEKLLVHDYMPM-GSLSA 401 (606)
Q Consensus 329 ~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~ 401 (606)
-..+.|++.. -+|..|++|+++-.+. ....-..-++.++++.|.|+|++..+|. .+...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3467888874 4799999999954322 2223344578889999999999988876 34567899999875 57777
Q ss_pred hhhcCCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 402 LLHGNRGA----------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 402 ~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
.-...... .....++...+.++.|+..||.++|+.|.. .+-|.+.+|+++.+..++|+..|..-...+
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLA--ck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLA--CKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCce--eecccHhHeEeeCcceEEEecccceeeecC
Confidence 65543211 123467788999999999999999999977 799999999999999999998887654443
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCC
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~ 513 (606)
... |-+.. -.+-|.=.||.+++.|.||..
T Consensus 446 d~~----------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT----------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC----------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 221 11111 235788999999999999954
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.9e-07 Score=87.71 Aligned_cols=135 Identities=21% Similarity=0.203 Sum_probs=96.8
Q ss_pred HHHHhcccccCCceEEEEEEEcCCcEEEEEEeccCcc-----------------------CHHHHHHHHHHHcCCCCC--
Q 037905 318 LRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV-----------------------SEKEFREKMEVVGSMDHE-- 372 (606)
Q Consensus 318 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~-- 372 (606)
..++.+.||-|.-+.||.|..+.|.++|||.=+.... +....++|++.|.++.-.
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 4456789999999999999998999999995322111 123467889999887543
Q ss_pred CcccceEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe
Q 037905 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL 452 (606)
Q Consensus 373 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill 452 (606)
.+.+.+++ +...+||||++|--|...- ++....-.++..|++-+.-+-..|++ |+|+.+-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~GiV--HGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRGIV--HGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcCcc--ccCCchheEEE
Confidence 55555543 5678999999986665432 12233334555555556666677866 99999999999
Q ss_pred cCCCcEEEeecccCcc
Q 037905 453 SKSYEARISDFGLAHL 468 (606)
Q Consensus 453 ~~~~~~kl~DfG~a~~ 468 (606)
+++|.+.++||-.+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999976543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=5.3e-09 Score=89.24 Aligned_cols=110 Identities=20% Similarity=0.278 Sum_probs=91.9
Q ss_pred CeEEEEEcCCCCcccccCcccc-CCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIG-NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
..|+.++|++|.+. .+|+.|. .++.++.|+|++|.|+ .+|.++..++.|+.|++++|.|. ..|..+..|.+|-+|+
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 57899999999998 6666655 5679999999999999 89999999999999999999999 8899999999999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP 152 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 152 (606)
..+|.+. .+|-++---+.+-..++.+|.+.+--+
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 9999998 677663222344555678888876544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.7e-08 Score=101.77 Aligned_cols=153 Identities=21% Similarity=0.207 Sum_probs=110.8
Q ss_pred CCeEEEEEcCCCCcccccCcc-ccCCCCCcEEEccCCCCc-ccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcE
Q 037905 38 GERVTMLRFPGMGLSGQLPIA-IGNLTELHTVSLRFNALR-GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 115 (606)
.++|+.|+|+.|.+....... -..+++|+.|.|+.+.|+ ..+-.....+++|+.|+|+.|..-+........+..|+.
T Consensus 171 Lp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~ 250 (505)
T KOG3207|consen 171 LPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQE 250 (505)
T ss_pred cccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhh
Confidence 379999999999997433322 236899999999999998 223344567899999999999633243444556789999
Q ss_pred EecCCCcCCcccc--hhhhcCCCcceeecccccccccC-CCC------CCCCCCCEEEccCCcCcccCC-----ccccCC
Q 037905 116 LNLAKNNFSGTIS--ADFNKLTRLGTLYLQENQLTGSI-PDL------GAFSSLAQFNVSFNKLNGSIP-----KRFARL 181 (606)
Q Consensus 116 L~l~~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~-~~~------~~l~~L~~L~l~~N~l~~~~p-----~~~~~l 181 (606)
|||++|++- ..+ ...+.++.|+.|.++.+.+..+- |+. ..+++|+.|+++.|++.. .+ ..+.++
T Consensus 251 LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~-w~sl~~l~~l~nl 328 (505)
T KOG3207|consen 251 LDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRD-WRSLNHLRTLENL 328 (505)
T ss_pred ccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCcccc-ccccchhhccchh
Confidence 999999987 444 35678999999999999997532 332 568899999999999962 22 123344
Q ss_pred CCCcccCCCCC
Q 037905 182 PSSAFEGNSLC 192 (606)
Q Consensus 182 ~~l~~~~n~l~ 192 (606)
..|.+.+|.|.
T Consensus 329 k~l~~~~n~ln 339 (505)
T KOG3207|consen 329 KHLRITLNYLN 339 (505)
T ss_pred hhhhccccccc
Confidence 44555566654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-08 Score=108.05 Aligned_cols=128 Identities=30% Similarity=0.386 Sum_probs=83.1
Q ss_pred cCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcce
Q 037905 60 GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGT 139 (606)
Q Consensus 60 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 139 (606)
..+..++.++|..|.|. .+-..+..+++|+.|+|.+|+|. .+...+..+++|++|+|++|.|+... .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhh
Confidence 45566666667777776 33344666777777777777777 44444666777777777777776333 3556666777
Q ss_pred eecccccccccCCCCCCCCCCCEEEccCCcCcccCC---ccccCCCCCcccCCCCC
Q 037905 140 LYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP---KRFARLPSSAFEGNSLC 192 (606)
Q Consensus 140 L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~l~~~~n~l~ 192 (606)
|++++|.|+ .++.+..+..|+.+++++|.++..-+ ..+..+..+.+.+|.+.
T Consensus 145 L~l~~N~i~-~~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 145 LNLSGNLIS-DISGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred heeccCcch-hccCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh
Confidence 777777777 44455557777777777777775555 45555555666666543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.7e-06 Score=81.44 Aligned_cols=137 Identities=15% Similarity=0.160 Sum_probs=101.3
Q ss_pred cccCCceEEEEEEEcCCcEEEEEEeccC-------ccCHHHHHHHHHHHcCCCCCC--cccceEEEE-e----CCceEEE
Q 037905 325 LGKGTFGTAYKATLEMGIVVAVKRLKDV-------TVSEKEFREKMEVVGSMDHEN--LVPLRAYYY-S----RDEKLLV 390 (606)
Q Consensus 325 ig~G~~g~Vy~~~~~~~~~vavK~~~~~-------~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~-~----~~~~~lv 390 (606)
-|+||.+.|++...+ |..+-+|+-... ......|.+|+..+.++...+ +.+.. ++. . ....+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 377999999998876 456778876421 235678999999888874322 44444 332 1 1245799
Q ss_pred EeecCC-CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc--EEEeecccCc
Q 037905 391 HDYMPM-GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE--ARISDFGLAH 467 (606)
Q Consensus 391 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~--~kl~DfG~a~ 467 (606)
+|-+.+ .+|.+++.... ..+.+...+..+..+++..++-||..|+. |+|+.+.||+++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~Gv~--Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVNRQ--HGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCCCc--CCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 997753 58888876432 22457777889999999999999999977 9999999999987677 9999998665
Q ss_pred c
Q 037905 468 L 468 (606)
Q Consensus 468 ~ 468 (606)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.41 E-value=3.7e-07 Score=83.40 Aligned_cols=84 Identities=25% Similarity=0.323 Sum_probs=42.9
Q ss_pred CCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccch--hhhcCCCccee
Q 037905 63 TELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISA--DFNKLTRLGTL 140 (606)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L 140 (606)
.+...+||++|.|. -+ ..|..+++|.+|.|++|+|+.+-|.--.-+++|+.|.|.+|+|. .+.+ -+..|++|++|
T Consensus 42 d~~d~iDLtdNdl~-~l-~~lp~l~rL~tLll~nNrIt~I~p~L~~~~p~l~~L~LtnNsi~-~l~dl~pLa~~p~L~~L 118 (233)
T KOG1644|consen 42 DQFDAIDLTDNDLR-KL-DNLPHLPRLHTLLLNNNRITRIDPDLDTFLPNLKTLILTNNSIQ-ELGDLDPLASCPKLEYL 118 (233)
T ss_pred cccceecccccchh-hc-ccCCCccccceEEecCCcceeeccchhhhccccceEEecCcchh-hhhhcchhccCCcccee
Confidence 44555666666555 12 24555556666666666666333333333445666666666554 2211 23455555555
Q ss_pred ecccccccc
Q 037905 141 YLQENQLTG 149 (606)
Q Consensus 141 ~l~~N~l~~ 149 (606)
.+-+|+++.
T Consensus 119 tll~Npv~~ 127 (233)
T KOG1644|consen 119 TLLGNPVEH 127 (233)
T ss_pred eecCCchhc
Confidence 555555553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.7e-06 Score=80.59 Aligned_cols=108 Identities=22% Similarity=0.253 Sum_probs=81.1
Q ss_pred HHHHHHHHHHHcCCCC--CCcccceEEEEeC----CceEEEEeecCC-CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 037905 356 EKEFREKMEVVGSMDH--ENLVPLRAYYYSR----DEKLLVHDYMPM-GSLSALLHGNRGAGRTPLNWETRSGLALGASR 428 (606)
Q Consensus 356 ~~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~ 428 (606)
.....+|+..+..+.. -.+.+.+++.... ...++|+|++++ .+|.+++.... ..+......++.+++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 3456777776666532 2344556665542 245899999987 47999987532 1455667889999999
Q ss_pred HHHHHHhcCCCCCCCCCCCCCEEecCCC---cEEEeecccCccCC
Q 037905 429 AIAYLHSKGPANSHGNIKSSNILLSKSY---EARISDFGLAHLAS 470 (606)
Q Consensus 429 ~L~~LH~~~~~i~HrDlkp~Nill~~~~---~~kl~DfG~a~~~~ 470 (606)
.++-||..|+. |+|+++.|||++.+. .+.++||+-++...
T Consensus 130 ~i~~lH~~gi~--H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 130 LIAKLHDAGIY--HGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHHCcCC--CCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999999977 999999999999887 79999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.4e-07 Score=101.11 Aligned_cols=145 Identities=19% Similarity=0.240 Sum_probs=96.1
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCC-------------CCcccccCccccCCC
Q 037905 424 LGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP-------------NRIDGYRAPEVTDAR 490 (606)
Q Consensus 424 ~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-------------~~~~~y~aPE~~~~~ 490 (606)
.+++.|+.|+|..- .+||+.|.|++|.++..+..||+.|+.+........+ .....|.|||++...
T Consensus 106 ~~v~dgl~flh~sA-k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA-KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hcccchhhhhccCc-ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34558999999763 3559999999999999999999999977544332111 111239999999998
Q ss_pred CCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccC
Q 037905 491 KVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTA 569 (606)
Q Consensus 491 ~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~ 569 (606)
..+.++|+||+|+++|.+.. |+.-+..... .+ .+-.... ..+... .....+.+.++.+=+.+.+.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~----~~-~~~~~~~-------~~~~~~--~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG----LL-SYSFSRN-------LLNAGA--FGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCC----cc-hhhhhhc-------cccccc--ccccccCcHHHHHHHHHHhc
Confidence 88999999999999999985 5544432111 11 0000000 001111 11113344567777778899
Q ss_pred cCCCCCCCHHHHHH
Q 037905 570 QYPDNRPSMAEVTS 583 (606)
Q Consensus 570 ~~P~~RPs~~~v~~ 583 (606)
.++..||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999997776643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.6e-06 Score=91.61 Aligned_cols=140 Identities=19% Similarity=0.229 Sum_probs=87.7
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccC---------------------------H----H----------HHHH
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---------------------------E----K----------EFRE 361 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~----~----------~~~~ 361 (606)
+.|+.++-|.||+|++.+|+.||||+.+..-.. . + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 457789999999999999999999998652110 0 0 1233
Q ss_pred HHHHHcCC----CCCCcccceEEEE-eCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHH-HHHHHh
Q 037905 362 KMEVVGSM----DHENLVPLRAYYY-SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA-IAYLHS 435 (606)
Q Consensus 362 e~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-L~~LH~ 435 (606)
|..-+.++ +...-+++=..|+ ......++|||++|-.+.+...-.. ..++...+ +..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~i---a~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKEL---AELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHHH---HHHHHHHHHHHHHh
Confidence 33322222 2222222222332 3467789999999988888743211 12443332 2222222 333334
Q ss_pred cCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 436 ~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
.|+. |.|..|.||+++.++.+.+.|||+.....+
T Consensus 284 dgff--HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFF--HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCcc--ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 5655 999999999999999999999998865443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.30 E-value=6.7e-06 Score=79.89 Aligned_cols=138 Identities=12% Similarity=0.119 Sum_probs=83.8
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCC--cccceEEEEeCCceEEEEeecCCCC-h
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHEN--LVPLRAYYYSRDEKLLVHDYMPMGS-L 399 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~-L 399 (606)
..||+|..+.||+. . |..+++|..... .......+|+++++.+..-. +.+.+++....+...+|||+++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~--~-~~~~VlR~~~~~-~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--K-TGKWMLKLYNPG-FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--c-CCCEEEEeCCCC-CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 46899999999984 2 456778887653 34566788999888775433 3566777766667789999999863 2
Q ss_pred hhhh---------------------hcCCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHH--hcCCCCCCCCC
Q 037905 400 SALL---------------------HGNRGAGRTPLNWETRSGLAL----------GASR-AIAYLH--SKGPANSHGNI 445 (606)
Q Consensus 400 ~~~l---------------------~~~~~~~~~~l~~~~~~~i~~----------~ia~-~L~~LH--~~~~~i~HrDl 445 (606)
...+ +.-. .....+... ..++.. .+.. ..++|. .....++|+|+
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 1111 1110 001111100 000100 0111 122222 22345679999
Q ss_pred CCCCEEecCCCcEEEeecccCc
Q 037905 446 KSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 446 kp~Nill~~~~~~kl~DfG~a~ 467 (606)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999988 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.1e-06 Score=61.00 Aligned_cols=36 Identities=31% Similarity=0.527 Sum_probs=17.6
Q ss_pred CCcEEEccCCCCcccCcccccCCCCCCEEeccCCccc
Q 037905 64 ELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFS 100 (606)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 100 (606)
+|++|+|++|+|+ .+|..|.+|++|++|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 34444555555555555555554
|
... |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.21 E-value=4.1e-07 Score=89.69 Aligned_cols=154 Identities=16% Similarity=0.187 Sum_probs=101.7
Q ss_pred CeEEEEEcCCCCcccccCcc----ccCCCCCcEEEccCCCCcc----c---------CcccccCCCCCCEEeccCCcccc
Q 037905 39 ERVTMLRFPGMGLSGQLPIA----IGNLTELHTVSLRFNALRG----T---------IPSDFAKLSNLRNLYLQGNLFSG 101 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~----l~~l~~L~~L~L~~N~l~~----~---------~p~~~~~l~~L~~L~Ls~N~l~~ 101 (606)
++|+.||||.|-|....+.. +..++.|++|+|.||.|.. . ......+-+.|+.+..+.|++..
T Consensus 92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccc
Confidence 37888888888876555543 3457888888888888761 1 11223445678888888888872
Q ss_pred c----CCccccCCCCCcEEecCCCcCCc----ccchhhhcCCCcceeecccccccccCC-----CCCCCCCCCEEEccCC
Q 037905 102 E----IPGLLFSLGNLIRLNLAKNNFSG----TISADFNKLTRLGTLYLQENQLTGSIP-----DLGAFSSLAQFNVSFN 168 (606)
Q Consensus 102 ~----~p~~~~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~l~~L~~L~l~~N 168 (606)
. +...|...+.|+.+.+..|.|.. .+-..|..+++|+.|||.+|-|+..-. .+..+++|+.|+++++
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 2 12346667788888888887751 223356788888888888888875322 2566778888888888
Q ss_pred cCcccCC--------ccccCCCCCcccCCCCC
Q 037905 169 KLNGSIP--------KRFARLPSSAFEGNSLC 192 (606)
Q Consensus 169 ~l~~~~p--------~~~~~l~~l~~~~n~l~ 192 (606)
.+...-- ..+.+++.+.+.+|.++
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 8773221 22345566666777654
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 606 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-42 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-25 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-25 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-14 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 6e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 9e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 7e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-08 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-08 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 9e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-07 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 6e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-06 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-06 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-06 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-06 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-06 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-06 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-06 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-06 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-06 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 8e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 9e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-05 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 1e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-05 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-05 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 3e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-05 | ||
| 1p9a_G | 290 | Crystal Structure Of N-terminal Domain Of Human Pla | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 5e-05 | ||
| 3pmh_G | 290 | Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib | 5e-05 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 5e-05 | ||
| 1ook_G | 290 | Crystal Structure Of The Complex Of Platelet Recept | 5e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-05 | ||
| 1p8v_A | 279 | Crystal Structure Of The Complex Of Platelet Recept | 6e-05 | ||
| 1gwb_B | 281 | Structure Of Glycoprotein 1b Length = 281 | 6e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 7e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-04 | ||
| 1sq0_B | 288 | Crystal Structure Of The Complex Of The Wild-Type V | 1e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-04 | ||
| 1m10_B | 290 | Crystal Structure Of The Complex Of Glycoprotein Ib | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 1m0z_A | 290 | Crystal Structure Of The Von Willebrand Factor Bind | 2e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-04 | ||
| 3p72_A | 269 | Structure Of Platelet Glycoprotein 1b Alpha With A | 3e-04 | ||
| 3oja_B | 597 | Crystal Structure Of Lrim1APL1C COMPLEX Length = 59 | 3e-04 | ||
| 1u0n_D | 265 | The Ternary Von Willebrand Factor A1-Glycoprotein I | 3e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-04 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 4e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-04 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 4e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 5e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-04 | ||
| 1p8t_A | 285 | Crystal Structure Of Nogo-66 Receptor Length = 285 | 6e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-04 | ||
| 3o6n_A | 390 | Crystal Structure Of Apl1 Leucine-Rich Repeat Domai | 7e-04 | ||
| 1ozn_A | 285 | 1.5a Crystal Structure Of The Nogo Receptor Ligand | 7e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1P9A|G Chain G, Crystal Structure Of N-terminal Domain Of Human Platelet Receptor Glycoprotein Ib-alpha At 1.7 Angstrom Resolution Length = 290 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3PMH|G Chain G, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib Interaction With Two Distinct Alpha-Thrombin Sites Length = 290 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1OOK|G Chain G, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Human Alpha-thrombin Length = 290 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1P8V|A Chain A, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a Length = 279 | Back alignment and structure |
|
| >pdb|1GWB|B Chain B, Structure Of Glycoprotein 1b Length = 281 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1SQ0|B Chain B, Crystal Structure Of The Complex Of The Wild-Type Von Willebrand Factor A1 Domain And Glycoprotein Ib Alpha At 2.6 Angstrom Resolution Length = 288 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1M10|B Chain B, Crystal Structure Of The Complex Of Glycoprotein Ib Alpha And The Von Willebrand Factor A1 Domain Length = 290 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1M0Z|A Chain A, Crystal Structure Of The Von Willebrand Factor Binding Domain Of Glycoprotein Ib Alpha Length = 290 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3P72|A Chain A, Structure Of Platelet Glycoprotein 1b Alpha With A Bound Peptide Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OJA|B Chain B, Crystal Structure Of Lrim1APL1C COMPLEX Length = 597 | Back alignment and structure |
|
| >pdb|1U0N|D Chain D, The Ternary Von Willebrand Factor A1-Glycoprotein Ibalpha- Botrocetin Complex Length = 265 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O6N|A Chain A, Crystal Structure Of Apl1 Leucine-Rich Repeat Domain Length = 390 | Back alignment and structure |
|
| >pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 8e-79
Identities = 107/287 (37%), Positives = 163/287 (56%), Gaps = 17/287 (5%)
Query: 310 RAFDLEDLLRA-----SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV--SEKEFREK 362
+ F L +L A + +LG+G FG YK L G +VAVKRLK+ E +F+ +
Sbjct: 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77
Query: 363 MEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL 422
+E++ H NL+ LR + + E+LLV+ YM GS+++ L R + PL+W R +
Sbjct: 78 VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE-RPESQPPLDWPKRQRI 136
Query: 423 ALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST--PNRID 479
ALG++R +AYLH P H ++K++NILL + +EA + DFGLA L T +
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196
Query: 480 G---YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA--LLNEEGVDLPRWVQSVV 534
G + APE K S+K DV+ +GV+LLEL+TG+ L N++ V L WV+ ++
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256
Query: 535 KEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
KE+ + D L+ +EE+ QL+Q+A+ CT P RP M+EV
Sbjct: 257 KEKKLEALVD-VDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 3e-70
Identities = 87/293 (29%), Positives = 142/293 (48%), Gaps = 20/293 (6%)
Query: 310 RAFDLEDLLRA-----SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV-SEKEFREKM 363
L DL A ++G G FG YK L G VA+KR + +EF ++
Sbjct: 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86
Query: 364 EVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLA 423
E + H +LV L + R+E +L++ YM G+L L+G ++WE R +
Sbjct: 87 ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEIC 145
Query: 424 LGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-----STPNRI 478
+GA+R + YLH+ A H ++KS NILL +++ +I+DFG++ + ST +
Sbjct: 146 IGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST--VV 201
Query: 479 DG---YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK 535
G Y PE ++++K+DVYSFGV+L E+L ++ L E V+L W
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
++ D L + E + + A+ C A ++RPSM +V ++E
Sbjct: 262 NGQLEQIVD-PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 6e-68
Identities = 89/308 (28%), Positives = 146/308 (47%), Gaps = 39/308 (12%)
Query: 310 RAFDLEDLLRA-----------SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS--- 355
+F +L +G+G FG YK + VAVK+L +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTE 71
Query: 356 --EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTP 413
+++F ++++V+ HENLV L + D+ LV+ YMP GSL L G P
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPP 129
Query: 414 LNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472
L+W R +A GA+ I +LH + H +IKS+NILL +++ A+ISDFGLA +
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN--HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 473 ----STPNRI---DGYRAPE-VTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGV 524
++ RI Y APE + +++ K+D+YSFGV+LLE++TG + E
Sbjct: 188 QTVMTS--RIVGTTAYMAPEALR--GEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQ 241
Query: 525 DLPRWVQSVVKEEWT-AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583
L + + EE T + D ++ + + +A C + + RP + +V
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299
Query: 584 QIEEICRS 591
++E+ S
Sbjct: 300 LLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-59
Identities = 73/314 (23%), Positives = 113/314 (35%), Gaps = 40/314 (12%)
Query: 312 FDLEDLLRAS-----AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVV 366
E+L S EV +G FG +KA L VAVK + ++ +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSL 72
Query: 367 GSMDHENLVPLRAY----YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL 422
M HEN++ + L+ + GSLS L N ++W +
Sbjct: 73 PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHI 126
Query: 423 ALGASRAIAYLHSKGPANS--------HGNIKSSNILLSKSYEARISDFGLAHLASPSST 474
A +R +AYLH P H +IKS N+LL + A I+DFGLA +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 475 PNRID------GYRAPEVTDA-----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG 523
Y APEV + R + D+Y+ G++L EL + ++E
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQ-----NVEEEMVQLLQLAINCTAQYPDNRPSM 578
+ + E EV + R M L + C + R S
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 579 AEVTSQIEEICRSS 592
V +I ++ R +
Sbjct: 307 GCVGERITQMQRLT 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-53
Identities = 79/290 (27%), Positives = 133/290 (45%), Gaps = 34/290 (11%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLRA 379
E +G G+FGT ++A G VAVK L + EF ++ ++ + H N+V
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+V +Y+ GSL LLH + R L+ R +A ++ + YLH++ P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--------TPNRIDGYRAPEVTDARK 491
H N+KS N+L+ K Y ++ DFGL+ L + + TP + APEV
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTP----EWMAPEVLRDEP 215
Query: 492 VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551
++K+DVYSFGV+L EL T + P ++ + V +V + L +
Sbjct: 216 SNEKSDVYSFGVILWELATLQQPW------GNLNPAQVVAAVGFK-------CKRLEIPR 262
Query: 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQAHDL 601
N+ ++ +++ C P RPS A + + + +S++ DL
Sbjct: 263 NLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNRSDL 309
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-52
Identities = 75/285 (26%), Positives = 125/285 (43%), Gaps = 32/285 (11%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHE 372
D +++ EV+G+G FG KA VA+K+++ K F ++ + ++H
Sbjct: 6 DYKEIEVE--EVVGRGAFGVVCKAKW-RAKDVAIKQIES-ESERKAFIVELRQLSRVNHP 61
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
N+V L + LV +Y GSL +LHG L S+ +AY
Sbjct: 62 NIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAY 117
Query: 433 LHSKGPAN-SHGNIKSSNILLSKSYE-ARISDFGLAHLASPSSTPNRIDG---YRAPEVT 487
LHS P H ++K N+LL +I DFG A T N+ G + APEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPEVF 175
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRW-VQSVVKEEWTAEVFDLE 546
+ S+K DV+S+G++L E++T + P + + P + + V
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPF------DEIGGPAFRIMWAVHNGTR-----PP 224
Query: 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
L+ +N+ + + L+ C ++ P RPSM E+ + + R
Sbjct: 225 LI--KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 9e-51
Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 41/285 (14%)
Query: 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSE--------KEFREKMEVVGSMDHEN 373
+ +GKG FG +K L VVA+K L +EF+ ++ ++ +++H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
+V L + +V +++P G L L P+ W + L L + I Y+
Sbjct: 85 IVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYM 138
Query: 434 HSKGPANSHGNIKSSNILLSKSYE-----ARISDFGLAHLASPSSTPNRIDG---YRAPE 485
++ P H +++S NI L E A+++DFGL+ + S + G + APE
Sbjct: 139 QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL--GNFQWMAPE 196
Query: 486 VTDAR--KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543
A ++KAD YSF ++L +LTG+ P + +++ + +E
Sbjct: 197 TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREE------- 245
Query: 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
L ++ + +++ C + P RP + + ++ E+
Sbjct: 246 GLRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 80/292 (27%), Positives = 127/292 (43%), Gaps = 41/292 (14%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLK-----DVTVSEKEFREKMEVVG 367
D +L E++G G FG Y+A G VAVK + D++ + + R++ ++
Sbjct: 5 DFAELTLE--EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 368 SMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
+ H N++ LR LV ++ G L+ +L G R + + A+ +
Sbjct: 62 MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIA 115
Query: 428 RAIAYLHSKGPANS-HGNIKSSNILLSKSYEAR--------ISDFGLAHLASPSSTPNRI 478
R + YLH + H ++KSSNIL+ + E I+DFGLA ++ +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA 175
Query: 479 DGYR--APEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE 536
Y APEV A S+ +DV+S+GVLL ELLTG+ P G+D V
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGIDGLAVAYGVAMN 229
Query: 537 EWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
L L E +L++ +C P +RPS + Q+ I
Sbjct: 230 -------KLALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 8e-49
Identities = 67/192 (34%), Positives = 94/192 (48%), Gaps = 13/192 (6%)
Query: 3 SDRAALLTLRKAIGGRTLL--WNLTDGPC--KWVGVFCTG----ERVTMLRFPGMGLSGQ 54
D+ ALL ++K +G T L W T C W+GV C RV L G+ L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 55 LPI--AIGNLTELHTVSLR-FNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLG 111
PI ++ NL L+ + + N L G IP AKL+ L LY+ SG IP L +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 112 NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQF-NVSFNK 169
L+ L+ + N SGT+ + L L + N+++G+IPD G+FS L +S N+
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 170 LNGSIPKRFARL 181
L G IP FA L
Sbjct: 186 LTGKIPPTFANL 197
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 29/177 (16%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNL-RNLYLQGNLFSGEIPGLLFS 109
LSG LP +I +L L ++ N + G IP + S L ++ + N +G+IP +
Sbjct: 137 LSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196
Query: 110 LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNK 169
L NL ++L++N G S F ++L +N L + +G +L ++ N+
Sbjct: 197 L-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNR 255
Query: 170 LNGSIPK--------------------------RFARLPSSAFEGNS-LCGKPLVSC 199
+ G++P+ R SA+ N LCG PL +C
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 2e-48
Identities = 60/287 (20%), Positives = 106/287 (36%), Gaps = 37/287 (12%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSM 369
D + L L + G +K + G + VK LK S ++F E+ +
Sbjct: 8 DFKQLNFL--TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 370 DHENLVPLRAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
H N++P+ S + +MP GSL +LH ++ AL +
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALDMA 121
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---TPNRIDGYRAP 484
R +A+LH+ P + S ++++ + ARIS + P + AP
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP----AWVAP 177
Query: 485 EVTDARK---VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541
E + + AD++SF VLL EL+T + P + V E
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPF------ADLSNMEIGMKVALE----- 226
Query: 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
L + + +L++ C + P RP + +E++
Sbjct: 227 --GLRPTIPPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKM 268
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-48
Identities = 68/310 (21%), Positives = 116/310 (37%), Gaps = 50/310 (16%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEV--VGSMDHENLVPL--- 377
E++G+G +G YK +L VAVK + + F + + V M+H+N+
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVFS--FANRQNFINEKNIYRVPLMEHDNIARFIVG 75
Query: 378 --RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
R R E LLV +Y P GSL L +W + LA +R +AYLH+
Sbjct: 76 DERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHT 129
Query: 436 KG-------PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID--------- 479
+ PA SH ++ S N+L+ ISDFGL+ + + +
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 480 ---GYRAPEV-------TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLP-- 527
Y APEV D ++ D+Y+ G++ E+ + +
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249
Query: 528 RWVQSVVKEEWTAEVFDLELLR------YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
V + E + E R ++ + L + +C Q + R +
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309
Query: 582 TSQIEEICRS 591
++ E+
Sbjct: 310 EERMAELMMI 319
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-45
Identities = 69/302 (22%), Positives = 116/302 (38%), Gaps = 43/302 (14%)
Query: 310 RAFDLEDLLRASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDV-TVSEKEFREKMEVVG 367
R F DL+ EVLGKG FG A K T E G V+ +K L +++ F ++++V+
Sbjct: 5 RIFRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 368 SMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
++H N++ Y + +Y+ G+L ++ W R A +
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIA 118
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA--------HLASPSSTPNRID 479
+AYLHS H ++ S N L+ ++ ++DFGLA S
Sbjct: 119 SGMAYLHSMNII--HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 480 GYR----------APEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRW 529
R APE+ + R +K DV+SFG++L E++ LPR
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-------LPRT 229
Query: 530 VQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589
+ + L + + C P+ RPS ++ +E +
Sbjct: 230 MDFGLNVR--------GFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281
Query: 590 RS 591
Sbjct: 282 MH 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-45
Identities = 68/300 (22%), Positives = 112/300 (37%), Gaps = 41/300 (13%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAY-- 380
+ +GKG +G + G VAVK + ++ M HEN++ A
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 381 --YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG- 437
S + L+ DY GSL L T L+ ++ LA + + +LH++
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 438 -----PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID--------GYRAP 484
PA +H ++KS NIL+ K+ I+D GLA + I Y P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 485 EVTDAR------KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLP----RWVQSVV 534
EV D + AD+YSFG++L E+ + E LP
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV---EEYQLPYHDLVPSDPSY 272
Query: 535 KEEWTAEVFD---LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
++ + +E + Q+ +L C A P +R + V + ++ S
Sbjct: 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-44
Identities = 66/298 (22%), Positives = 114/298 (38%), Gaps = 43/298 (14%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREK-MEVVGSMDHENLVPLRAY- 380
E +GKG +G ++ + + G VAVK FRE + + HEN++ A
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKS-WFRETELYNTVMLRHENILGFIASD 71
Query: 381 ---YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+S + L+ Y MGSL L T L+ + + L + +A+LH +
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 438 PANS------HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG--------YRA 483
H ++KS NIL+ K+ + I+D GLA + S S+ + Y A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 484 PEV------TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLP----RWVQSV 533
PEV D ++ D+++FG++L E+ + E P
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV---EDYKPPFYDVVPNDPS 242
Query: 534 VKEEWTAEVFD---LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
++ D + + + L +L C Q P R + + + +I
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 75/281 (26%), Positives = 130/281 (46%), Gaps = 35/281 (12%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLRA 379
+ +G G+FGT YK VAVK L + + F+ ++ V+ H N++
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 380 YYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
Y S +L +V + SL LH + + +A +R + YLH+K
Sbjct: 88 Y--STAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------YRAPEV---TDA 489
H ++KS+NI L + +I DFGLA S S ++ + + APEV D+
Sbjct: 142 I--HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 490 RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549
S ++DVY+FG++L EL+TG+ P + N + + ++ V + + ++ +
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLSPDLSKV---- 250
Query: 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590
N + M +L+ C + D RPS + ++IEE+ R
Sbjct: 251 RSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEELAR 288
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 65/302 (21%), Positives = 114/302 (37%), Gaps = 45/302 (14%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEV--VGSMDHENLVPLRA- 379
E +GKG FG ++ G VAVK E+ + + E+ + HEN++ A
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 380 ---YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
+ + LV DY GSL L+ R + E LAL + +A+LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 437 G------PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG--------YR 482
PA +H ++KS NIL+ K+ I+D GLA ++ I Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 483 APEV------TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLP----RWVQS 532
APEV + ++AD+Y+ G++ E+ + + + LP
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ---LPYYDLVPSDP 275
Query: 533 VVKEEWTAEVFD---LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589
V+E + E + + ++ C R + + + ++
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
Query: 590 RS 591
+
Sbjct: 336 QQ 337
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-40
Identities = 58/301 (19%), Positives = 110/301 (36%), Gaps = 52/301 (17%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKATL--EMGIVVAVKRLKDVTVSE---KEFREKMEVVG 367
E L E++GKG FG Y E VA++ + +E K F+ ++
Sbjct: 31 PFEQLEIG--ELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYR 84
Query: 368 SMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
HEN+V S ++ +L +++ + L+ +A
Sbjct: 85 QTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK----IVLDVNKTRQIAQEIV 140
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------- 480
+ + YLH+KG H ++KS N+ + I+DFGL ++ R D
Sbjct: 141 KGMGYLHAKGIL--HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197
Query: 481 --YRAPEV---------TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRW 529
+ APE+ D S+ +DV++ G + EL + P +
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF------KTQPAEAI 251
Query: 530 VQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589
+ + L + +E+ +L C A + RP+ ++ +E++
Sbjct: 252 IWQMGTGM-------KPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKLP 301
Query: 590 R 590
+
Sbjct: 302 K 302
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 6e-40
Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 4/159 (2%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
G + L+ + ++ G F ++ L + N+ SG IP + S+
Sbjct: 596 FQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSM 655
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNK 169
L LNL N+ SG+I + L L L L N+L G IP + A + L + ++S N
Sbjct: 656 PYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN 715
Query: 170 LNGSIPKR--FARLPSSAFEGNS-LCGKPLVSCNGGGDD 205
L+G IP+ F P + F N LCG PL C+ D
Sbjct: 716 LSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNAD 754
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-37
Identities = 49/145 (33%), Positives = 73/145 (50%), Gaps = 2/145 (1%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
LSG +P ++G+L++L + L N L G IP + + L L L N +GEIP L +
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNK 169
NL ++L+ N +G I +L L L L N +G+IP LG SL +++ N
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549
Query: 170 LNGSIPKRFARLPSSAFEGNSLCGK 194
NG+IP + S N + GK
Sbjct: 550 FNGTIPAAMFKQ-SGKIAANFIAGK 573
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-36
Identities = 49/241 (20%), Positives = 82/241 (34%), Gaps = 60/241 (24%)
Query: 1 LASDRAALLTLRKAIGGRTLL--WNLTDGPCKWVGVFCTGERV----------------- 41
L + L++ + + + LL W+ PC + GV C ++V
Sbjct: 10 LYREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAV 69
Query: 42 ---------------------------------TMLRFPGMGLSGQLP--IAIGNLTELH 66
T L LSG + ++G+ + L
Sbjct: 70 SSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLK 129
Query: 67 TVSLRFNALRGTIP-SDFAKLSNLRNLYLQGNLFSGEIPGLLF---SLGNLIRLNLAKNN 122
+++ N L S KL++L L L N SG G L L ++ N
Sbjct: 130 FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK 189
Query: 123 FSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLP 182
SG + ++ L L + N + IP LG S+L ++S NKL+G + +
Sbjct: 190 ISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCT 247
Query: 183 S 183
Sbjct: 248 E 248
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-35
Identities = 50/134 (37%), Positives = 71/134 (52%), Gaps = 1/134 (0%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
+G++P + N +EL ++ L FN L GTIPS LS LR+L L N+ GEIP L +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP-DLGAFSSLAQFNVSFNK 169
L L L N+ +G I + + T L + L N+LTG IP +G +LA +S N
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 170 LNGSIPKRFARLPS 183
+G+IP S
Sbjct: 526 FSGNIPAELGDCRS 539
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 7e-34
Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 9/152 (5%)
Query: 50 GLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPG-LLF 108
LSG AI TEL +++ N G IP L +L+ L L N F+GEIP L
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSG 291
Query: 109 SLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD--LGAFSSLAQFNVS 166
+ L L+L+ N+F G + F + L +L L N +G +P L L ++S
Sbjct: 292 ACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLS 351
Query: 167 FNKLNGSIPKRFARLPSS----AFEGNSLCGK 194
FN+ +G +P+ L +S N+ G
Sbjct: 352 FNEFSGELPESLTNLSASLLTLDLSSNNFSGP 383
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 47/136 (34%), Positives = 62/136 (45%), Gaps = 3/136 (2%)
Query: 51 LSGQLPIAIGN--LTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF 108
SG + + L + L+ N G IP + S L +L+L N SG IP L
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLG 439
Query: 109 SLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSF 167
SL L L L N G I + + L TL L N LTG IP L ++L ++S
Sbjct: 440 SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSN 499
Query: 168 NKLNGSIPKRFARLPS 183
N+L G IPK RL +
Sbjct: 500 NRLTGEIPKWIGRLEN 515
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 37/145 (25%), Positives = 59/145 (40%), Gaps = 6/145 (4%)
Query: 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSG 101
L S +P +G+ + L + + N L G + + L+ L + N F G
Sbjct: 203 EFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
Query: 102 EIPGLLFSLGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPD-LGAFSS 159
IP L +L L+LA+N F+G I L L L N G++P G+ S
Sbjct: 262 PIP--PLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL 319
Query: 160 LAQFNVSFNKLNGSIPK-RFARLPS 183
L +S N +G +P ++
Sbjct: 320 LESLALSSNNFSGELPMDTLLKMRG 344
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-32
Identities = 52/138 (37%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS 109
G +P G+ + L +++L N G +P D K+ L+ L L N FSGE+P L +
Sbjct: 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTN 365
Query: 110 L-GNLIRLNLAKNNFSGTISADF--NKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNV 165
L +L+ L+L+ NNFSG I + N L LYLQ N TG IP L S L ++
Sbjct: 366 LSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHL 425
Query: 166 SFNKLNGSIPKRFARLPS 183
SFN L+G+IP L
Sbjct: 426 SFNYLSGTIPSSLGSLSK 443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-29
Identities = 47/153 (30%), Positives = 64/153 (41%), Gaps = 11/153 (7%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFA-KLSNLRNLYLQGNLFSGEIPGLLFS 109
G +P L L +SL N G IP + L L L GN F G +P S
Sbjct: 259 FVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316
Query: 110 LGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPD-LGAFS-SLAQFNVS 166
L L L+ NNFSG + D K+ L L L N+ +G +P+ L S SL ++S
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376
Query: 167 FNKLNGSIPKRFARLPSSAFE-----GNSLCGK 194
N +G I + P + + N GK
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK 409
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 42/274 (15%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVPLR 378
+G+G+F T YK E + VA L+D +++ E F+E+ E++ + H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 379 AYYYSRDEK----LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ S + +LV + M G+L L + + + + + +LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 146
Query: 435 SKGPANSHGNIKSSNILLS-KSYEARISDFGLAHLASPSS------TPNRIDGYRAPEVT 487
++ P H ++K NI ++ + +I D GLA L S TP + APE+
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE----FMAPEMY 202
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGV-DLPRWVQSVVKEEWTAEVFDLE 546
+ K + DVY+FG+ +LE+ T + P + + R V S VK +V
Sbjct: 203 E-EKYDESVDVYAFGMCMLEMATSEYP---YSECQNAAQIYRRVTSGVKPASFDKVAI-- 256
Query: 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAE 580
E+ ++++ C Q D R S+ +
Sbjct: 257 --------PEVKEIIEG---CIRQNKDERYSIKD 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 62/281 (22%), Positives = 115/281 (40%), Gaps = 37/281 (13%)
Query: 323 EVLGKGTFGTAYKATLEMGIV-VAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVPLRA 379
E +G+G FG + L VAVK ++ + +F ++ ++ H N+V L
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ +V + + G L L +T + A+ + YL SK
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESK--- 232
Query: 440 NS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR-------APEVTDARK 491
H ++ + N L+++ +ISDFG++ + G R APE + +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 492 VSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550
S ++DV+SFG+LL E + G +P L N++ + V K L
Sbjct: 292 YSSESDVWSFGILLWETFSLGASPYPNLSNQQ-T-----REFVEKGGR--------LPCP 337
Query: 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
+ + + +L++ C A P RPS + + +++ I +
Sbjct: 338 ELCPDAVFRLME---QCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 9e-31
Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 29/276 (10%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
LG+G FG + T VA+K LK T+S + F ++ +V+ + HE LV L A
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
S + +V +YM GSL L G G L +A + +AY+ H
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMNYV--H 303
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARKVSQKAD 497
+++++NIL+ ++ +++DFGLA L + R + APE + + K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 498 VYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
V+SFG+LL EL T G+ P ++N E V + V + + E
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNRE-V-----LDQVERGYR--------MPCPPECPES 409
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
+ L+ C + P+ RP+ + + +E+ S+
Sbjct: 410 LHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 64/300 (21%), Positives = 114/300 (38%), Gaps = 70/300 (23%)
Query: 323 EVLGKGTFGTAYKATLEMG-----IVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLV 375
+VLG G FGT YK I VA+K L++ T + KE ++ V+ S+D+ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 376 PLRAYYY---SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
L L+ MP G L + ++ + + + ++ + Y
Sbjct: 81 RL----LGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAKGMNY 132
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR---------- 482
L + H ++ + N+L+ +I+DFGLA L +
Sbjct: 133 LEDRRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYHAEGGKVPIK 184
Query: 483 --APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVDLPRWVQS 532
A E R + ++DV+S+GV + EL+T G P + E+G LP+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 240
Query: 533 VVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
T +V+ + M + C D+RP E+ + ++ R
Sbjct: 241 --PPICTIDVYMI-----------MRK-------CWMIDADSRPKFRELIIEFSKMARDP 280
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-30
Identities = 74/276 (26%), Positives = 125/276 (45%), Gaps = 29/276 (10%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
LG+G FG + T VA+K LK T+S + F ++ +V+ + HE LV L A
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 331
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
S + +V +YM GSL L G G L +A + +AY+ H
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMNYV--H 386
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARKVSQKAD 497
+++++NIL+ ++ +++DFGLA L + R + APE + + K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 498 VYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
V+SFG+LL EL T G+ P ++N E V + V + + E
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNRE-V-----LDQVERGYR--------MPCPPECPES 492
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
+ L+ C + P+ RP+ + + +E+ S+
Sbjct: 493 LHDLM---CQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 69/306 (22%), Positives = 116/306 (37%), Gaps = 65/306 (21%)
Query: 323 EVLGKGTFGTAYKATLEM-----GIVVAVKRLK-DVTVSEKEFREKMEVVGSMDHENLVP 376
LGKG FG+ + G +VAVK+L+ +++F+ +++++ ++ + +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 377 LRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
R Y + LV +Y+P G L L +R L+ + + + YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLG 144
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------------ 482
S+ H ++ + NIL+ +I+DFGLA L P D Y
Sbjct: 145 SRRCV--HRDLAARNILVESEAHVKIADFGLAKL-----LPLDKDYYVVREPGQSPIFWY 197
Query: 483 APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKE----- 536
APE S+++DV+SFGV+L EL T + +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 537 ----------EWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
AEV +L M C A P +RPS + + Q++
Sbjct: 258 EEGQRLPAPPACPAEVHEL-----------MKL-------CWAPSPQDRPSFSALGPQLD 299
Query: 587 EICRSS 592
+ S
Sbjct: 300 MLWSGS 305
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-30
Identities = 73/283 (25%), Positives = 128/283 (45%), Gaps = 31/283 (10%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
LG G +G Y+ + + VAVK LK+ T+ +EF ++ V+ + H NLV L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
++ ++M G+L L R R ++ +A S A+ YL K N
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 442 -HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARKVSQK 495
H N+ + N L+ +++ +++DFGL+ L + + + APE K S K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 496 ADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554
+DV++FGVLL E+ T G +P + + V ++++ D + R +
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEK-------DYRMERPEGCP 445
Query: 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597
E++ +L+ C P +RPS AE+ E + + S +
Sbjct: 446 EKVYELM---RACWQWNPSDRPSFAEIHQAFETMFQESSISDE 485
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-30
Identities = 74/294 (25%), Positives = 121/294 (41%), Gaps = 63/294 (21%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ +G G FG + VA+K +++ +SE++F E+ EV+ + H LV L
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
+ LV ++M G LS L RG ET G+ L +AYL H
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVI--H 127
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI---DGYR------------APEVT 487
++ + N L+ ++ ++SDFG+ R D Y +PEV
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMT----------RFVLDDQYTSSTGTKFPVKWASPEVF 177
Query: 488 DARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD-------LPRWVQSVVKEEWT 539
+ S K+DV+SFGVL+ E+ + GK P + N E V+ L + +
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK------PRLAS 231
Query: 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593
V+ + M C + P++RP+ + + Q+ EI S L
Sbjct: 232 THVYQI-----------MNH-------CWRERPEDRPAFSRLLRQLAEIAESGL 267
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-29
Identities = 69/292 (23%), Positives = 133/292 (45%), Gaps = 45/292 (15%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ LG G FG + AT VAVK +K ++S + F + V+ ++ H+ LV L A
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VV 252
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
+++ ++ ++M GSL L + G + + + +A++ + H
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRNYI--H 307
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARKVSQKAD 497
+++++NIL+S S +I+DFGLA + + R + APE + + K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 498 VYSFGVLLLELLT-GKAPTQALLNEE-------GVDLPRWVQSVVKEEWTAEVFDLELLR 549
V+SFG+LL+E++T G+ P + N E G +PR E E++++
Sbjct: 368 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR------PENCPEELYNI---- 417
Query: 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQAHDL 601
M + C P+ RP+ + S +++ ++ + Q ++
Sbjct: 418 -------M-------MRCWKNRPEERPTFEYIQSVLDDFYTAT--ESQYEEI 453
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 68/313 (21%), Positives = 122/313 (38%), Gaps = 78/313 (24%)
Query: 323 EVLGKGTFGTAYKATLEM-----GIVVAVKRLKDVTVSE-KEFREKMEVVGSMDHENLVP 376
+ LGKG FG+ + G VVAVK+L+ T ++F ++E++ S+ H+N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 377 LRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ YS + L+ +Y+P GSL L ++ ++ + + YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 131
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------------ 482
+K H ++ + NIL+ +I DFGL + P + ++
Sbjct: 132 TKRYI--HRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEFFKVKEPGESPIFWY 184
Query: 483 APEVTDARKVSQKADVYSFGVLLLELLT----------------GKAPTQALLN------ 520
APE K S +DV+SFGV+L EL T G ++
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 521 -EEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMA 579
+ LPR + E++ + M + C + RPS
Sbjct: 245 LKNNGRLPR------PDGCPDEIYMI-----------MTE-------CWNNNVNQRPSFR 280
Query: 580 EVTSQIEEICRSS 592
++ ++++I +
Sbjct: 281 DLALRVDQIRDNM 293
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 66/296 (22%), Positives = 116/296 (39%), Gaps = 48/296 (16%)
Query: 323 EVLGKGTFGTAYKATLEM-----GIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLV 375
LG+G FG + G VAVK LK + + ++++E++ ++ HEN+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 376 PLRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
+ L+ +++P GSL L N+ +N + + A+ + + YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYL 142
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR----------- 482
S+ H ++ + N+L+ ++ +I DFGL + Y
Sbjct: 143 GSRQYV--HRDLAARNVLVESEHQVKIGDFGLTKA-----IETDKEYYTVKDDRDSPVFW 195
Query: 483 -APEVTDARKVSQKADVYSFGVLLLELLT--GKAPTQALLNEEGVDLPRWVQSVVKEEWT 539
APE K +DV+SFGV L ELLT + L + + +V
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV------ 249
Query: 540 AEVFDL-----ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590
+ + L N +E+ QL++ C P NR S + E + +
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMR---KCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-29
Identities = 73/299 (24%), Positives = 122/299 (40%), Gaps = 63/299 (21%)
Query: 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
LG G +G Y+ + + VAVK LK+ T+ +EF ++ V+ + H NLV L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
++ ++M G+L L R R ++ +A S A+ YL K
Sbjct: 79 TREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEKKNFI-- 133
Query: 442 HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI---DGYR------------APEV 486
H ++ + N L+ +++ +++DFGL+ R+ D Y APE
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLS----------RLMTGDTYTAHAGAKFPIKWTAPES 183
Query: 487 TDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD-------LPRWVQSVVKEEW 538
K S K+DV++FGVLL E+ T G +P + + + + R E
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER------PEGC 237
Query: 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597
+V++L M C P +RPS AE+ E + + S +
Sbjct: 238 PEKVYEL-----------MRA-------CWQWNPSDRPSFAEIHQAFETMFQESSISDE 278
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 64/312 (20%), Positives = 114/312 (36%), Gaps = 74/312 (23%)
Query: 323 EVLGKGTFGTAYKATL--------EMGIVVAVKRLKDVTVS-EKEFREKMEVVGSMDHEN 373
E LG+GTF +K V +K L + + F E ++ + H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
LV DE +LV +++ GSL L N+ +N + +A + A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFL 129
Query: 434 HSKGPANSHGNIKSSNILLSKSYEAR--------ISDFGLAHLASPSSTPNRIDGYR--- 482
HGN+ + NILL + + + +SD G++ P D +
Sbjct: 130 EENTLI--HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERI 181
Query: 483 ---APE-VTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDL---------PR 528
PE + + + ++ D +SFG L E+ + G P AL ++ + P+
Sbjct: 182 PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPK 241
Query: 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
AE+ +L + C PD+RPS + + +
Sbjct: 242 A----------AELANL-----------INN-------CMDYEPDHRPSFRAIIRDLNSL 273
Query: 589 CRSSLQQGQAHD 600
L +H
Sbjct: 274 FTPDLVPRGSHH 285
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 43/286 (15%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
E LG G FG + VAVK LK ++S F + ++ + H+ LV L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
+++ ++ +YM GSL L G L +A + +A++ + H
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERNYI--H 132
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YR--APEVTDARKVSQKAD 497
+++++NIL+S + +I+DFGLA L + R + APE + + K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 498 VYSFGVLLLELLT-GKAPTQALLNEEGVD-------LPRWVQSVVKEEWTAEVFDLELLR 549
V+SFG+LL E++T G+ P + N E + + R + E++ L
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPEELYQL---- 242
Query: 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595
M C + P++RP+ + S +E+ ++ Q
Sbjct: 243 -------MRL-------CWKERPEDRPTFDYLRSVLEDFFTATEGQ 274
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 69/309 (22%), Positives = 121/309 (39%), Gaps = 78/309 (25%)
Query: 323 EVLGKGTFGTAYKATLEM-----GIVVAVKRLKDVTVSE-KEFREKMEVVGSMDHENLVP 376
+ LGKG FG+ + G VVAVK+L+ T ++F ++E++ S+ H+N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 377 LRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ YS + L+ +Y+P GSL L ++ ++ + + YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 162
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------------ 482
+K H ++ + NIL+ +I DFGL + P + Y+
Sbjct: 163 TKRYI--HRDLATRNILVENENRVKIGDFGLTKV-----LPQDKEYYKVKEPGESPIFWY 215
Query: 483 APEVTDARKVSQKADVYSFGVLLLELLT----------------GKAPTQALLN------ 520
APE K S +DV+SFGV+L EL T G ++
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 521 -EEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMA 579
+ LPR + E++ + M + C + RPS
Sbjct: 276 LKNNGRLPR------PDGCPDEIYMI-----------MTE-------CWNNNVNQRPSFR 311
Query: 580 EVTSQIEEI 588
++ ++++I
Sbjct: 312 DLALRVDQI 320
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 65/300 (21%), Positives = 115/300 (38%), Gaps = 70/300 (23%)
Query: 323 EVLGKGTFGTAYKATLEMG-----IVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLV 375
+VLG G FGT YK I VA+K L++ T + KE ++ V+ S+D+ ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 376 PLRAYYY---SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
L L+ MP G L + ++ + + + ++ + Y
Sbjct: 81 RL----LGICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNY 132
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR---------- 482
L + H ++ + N+L+ +I+DFGLA L +
Sbjct: 133 LEDRRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGAE------EKEYHAEGGKVPIK 184
Query: 483 --APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVDLPRWVQS 532
A E R + ++DV+S+GV + EL+T G P + E+G LP+
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---- 240
Query: 533 VVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
T +V+ + MV+ C D+RP E+ + ++ R
Sbjct: 241 --PPICTIDVYMI-----------MVK-------CWMIDADSRPKFRELIIEFSKMARDP 280
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 67/284 (23%), Positives = 112/284 (39%), Gaps = 45/284 (15%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ LG G FG VA+K +K+ ++SE EF E+ +V+ ++ HE LV L
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
+ ++ +YM G L L R + + A+ YL SK H
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFL--H 143
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------APEVTDARKVSQKA 496
++ + N L++ ++SDFGL+ G + PEV K S K+
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 497 DVYSFGVLLLELLT-GKAPTQALLNEEGVD-------LPRWVQSVVKEEWTAEVFDLELL 548
D+++FGVL+ E+ + GK P + N E + L R + +V+ +
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR------PHLASEKVYTI--- 253
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
M C + D RP+ + S I ++
Sbjct: 254 --------MYS-------CWHEKADERPTFKILLSNILDVMDEE 282
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 70/294 (23%), Positives = 120/294 (40%), Gaps = 58/294 (19%)
Query: 323 EVLGKGTFGTAYKATLEMG-----IVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLV 375
+VLG G FGT +K I V +K ++D + S + + M +GS+DH ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 376 PLRAYYY---SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
L LV Y+P+GSL + +RG L + + ++ + Y
Sbjct: 79 RL----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYY 130
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------APEV 486
L G H N+ + N+LL + +++DFG+A L P + A E
Sbjct: 131 LEEHGMV--HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 487 TDARKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVDLPRWVQSVVKEEW 538
K + ++DV+S+GV + EL+T G P L E+G L + +
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ------PQIC 242
Query: 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
T +V+ + MV+ C + RP+ E+ ++ + R
Sbjct: 243 TIDVYMV-----------MVK-------CWMIDENIRPTFKELANEFTRMARDP 278
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 63/282 (22%), Positives = 107/282 (37%), Gaps = 45/282 (15%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ LG G FG + VAVK +K+ ++SE EF ++ + + + H LV
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
+V +Y+ G L L + L + +A+L S H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLESHQFI--H 127
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------APEVTDARKVSQKA 496
++ + N L+ + ++SDFG+ G + APEV K S K+
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 497 DVYSFGVLLLELLT-GKAPTQALLNEEGVD-------LPRWVQSVVKEEWTAEVFDLELL 548
DV++FG+L+ E+ + GK P N E V L R + ++ +
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR------PHLASDTIYQI--- 237
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590
M C + P+ RP+ ++ S IE +
Sbjct: 238 --------MYS-------CWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-28
Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 52/304 (17%)
Query: 323 EVLGKGTFGTAYKATLEM-----GIVVAVKRLKD--VTVSEKEFREKMEVVGSMDHENLV 375
LG+G FG + G +VAVK LK ++++++++ ++ HE+++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 376 PLRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
+ LV +Y+P+GSL L + L + A +AYL
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYL 150
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR----------- 482
H++ H ++ + N+LL +I DFGLA P + YR
Sbjct: 151 HAQHYI--HRDLAARNVLLDNDRLVKIGDFGLAKA-----VPEGHEYYRVREDGDSPVFW 203
Query: 483 -APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLN-EEGVDLPRWVQSVVKEEWT 539
APE K +DV+SFGV L ELLT + E + + + +V
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV------ 257
Query: 540 AEVFD-LE----LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594
+ + LE L R E+ L++ NC RP+ + ++ +
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVYHLMK---NCWETEASFRPTFENLIPILKTVHEKY-- 312
Query: 595 QGQA 598
QGQA
Sbjct: 313 QGQA 316
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 43/283 (15%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ +GKG FG G VAVK +K+ + + F + V+ + H NLV L
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 383 SRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
L +V +YM GSL L R GR+ L + +L A+ YL
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV-- 139
Query: 442 HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR--APEVTDARKVSQKADVY 499
H ++ + N+L+S+ A++SDFGL AS + ++ + APE +K S K+DV+
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKFSTKSDVW 198
Query: 500 SFGVLLLELLT-GKAPTQALLNEEGVD-------LPRWVQSVVKEEWTAEVFDLELLRYQ 551
SFG+LL E+ + G+ P + ++ V + + V+++
Sbjct: 199 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA------PDGCPPAVYEV------ 246
Query: 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594
M C RPS ++ Q+E I L
Sbjct: 247 -----MKN-------CWHLDAAMRPSFLQLREQLEHIKTHELH 277
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 74/283 (26%), Positives = 119/283 (42%), Gaps = 43/283 (15%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ +GKG FG G VAVK +K+ + + F + V+ + H NLV L
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 383 SRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
L +V +YM GSL L R GR+ L + +L A+ YL
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV-- 311
Query: 442 HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR--APEVTDARKVSQKADVY 499
H ++ + N+L+S+ A++SDFGL AS + ++ + APE +K S K+DV+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VKWTAPEALREKKFSTKSDVW 370
Query: 500 SFGVLLLELLT-GKAPTQALLNEEGVD-------LPRWVQSVVKEEWTAEVFDLELLRYQ 551
SFG+LL E+ + G+ P + ++ V + + V+D+
Sbjct: 371 SFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA------PDGCPPAVYDV------ 418
Query: 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594
M NC RP+ ++ Q+E I L
Sbjct: 419 -----M-------KNCWHLDAATRPTFLQLREQLEHIRTHELH 449
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 32/216 (14%), Positives = 67/216 (31%), Gaps = 26/216 (12%)
Query: 323 EVLGKGTFGTAYKAT------LEMGIVVAVKRLKDVTVSEKE-FREKMEVVGSMDHENLV 375
+LG+G F Y+AT + +K K E + ME + +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
+ + ++ +LV + G+L ++ + + A+ I +H
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190
Query: 436 KGPANSHGNIKSSNILLSKSYEA-----------RISDFGLAHLASPSSTPNRI------ 478
HG+IK N +L + + D G +
Sbjct: 191 CEII--HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248
Query: 479 DGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
G++ E+ + + + D + + +L G
Sbjct: 249 SGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 53/379 (13%), Positives = 94/379 (24%), Gaps = 68/379 (17%)
Query: 264 KQTEIEIPREKGAGDGENTSSDLSGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAE 323
K+ E I + E + + + + +G+R L E
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLV-------E 68
Query: 324 VLGKGTFGTAYKAT-LEMGIVVAVK----RLKDVTVSEKEFREKMEVVGSMDHENLVPLR 378
L G + +E A+K ++ + E + E+ R
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 379 AY---------------------YYSRDEKLLVHDYMPM----GSLSALLH--GNRGAGR 411
+D+ + + + M L L R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 412 TPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH---- 467
L R A L SKG HG+ N+ + + D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLV--HGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 468 LASPSSTPNRIDGYRAPEVTDARK--VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVD 525
SS P Y E +A + + + G+ + + P +
Sbjct: 247 RGPASSVPVT---YAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 526 LPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQ--LAINCTAQYPDNRPSMAEVTS 583
R V + L + + + L+ L + R E
Sbjct: 304 WKRPSLRVPGTD------SLAFGSCTPLPDFVKTLIGRFLNFD-----RRRRLLPLEAME 352
Query: 584 -----QIEEICRSSLQQGQ 597
Q++ SSL GQ
Sbjct: 353 TPEFLQLQNEISSSLSTGQ 371
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 55/283 (19%), Positives = 101/283 (35%), Gaps = 53/283 (18%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE----FREKMEVVGSMDHENLVPL 377
+G G++G K G ++ K L +++E E E + ++ + H N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSE-VNLLRELKHPNIVRY 70
Query: 378 RAYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGR-----TPLNWETRSGLALGASRAI 430
R L V +Y G L++++ + L T+ LAL
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL------ 124
Query: 431 AYLHSKGPANS---HGNIKSSNILLSKSYEARISDFGLAHLASPSS--------TPNRID 479
H + H ++K +N+ L ++ DFGLA + + + TP
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY--- 181
Query: 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539
Y +PE + ++K+D++S G LL EL P A + +
Sbjct: 182 -YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKELAGKIREG--- 231
Query: 540 AEVFDLELLRYQNVEEEMVQLLQLAIN-CTAQYPDNRPSMAEV 581
+++ + L I +RPS+ E+
Sbjct: 232 ---------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 74/304 (24%), Positives = 121/304 (39%), Gaps = 71/304 (23%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSE----KEFREKMEVVGSMDHENL 374
E LG G+FG + + + VAVK LK +S+ +F ++ + S+DH NL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 375 VPLRAYYY---SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
+ L Y +V + P+GSL L ++G T S A+ + +
Sbjct: 84 IRL----YGVVLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMG 135
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR--------- 482
YL SK H ++ + N+LL+ +I DFGL + D Y
Sbjct: 136 YLESKRFI--HRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHRKVPF 188
Query: 483 ---APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD--------LPRWV 530
APE R S +D + FGV L E+ T G+ P L + + LPR
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-- 246
Query: 531 QSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590
E+ +++++ MVQ C A P++RP+ + + E
Sbjct: 247 ----PEDCPQDIYNV-----------MVQ-------CWAHKPEDRPTFVALRDFLLEAQP 284
Query: 591 SSLQ 594
+ ++
Sbjct: 285 TDMR 288
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 26/204 (12%)
Query: 324 VLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVVGSMDHENLVPL 377
LGKG FG Y A + ++A+K +L+ V + RE E+ + H N++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV-EIQSHLRHPNILRL 74
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
Y++ L+ +Y P+G++ L + + T + + A+ A++Y HSK
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFD-EQRTATYITELAN-ALSYCHSKR 129
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-------TPNRIDGYRAPEVTDAR 490
H +IK N+LL + E +I+DFG + A PSS T + Y PE+ + R
Sbjct: 130 VI--HRDIKPENLLLGSAGELKIADFGWSVHA-PSSRRTDLCGTLD----YLPPEMIEGR 182
Query: 491 KVSQKADVYSFGVLLLELLTGKAP 514
+K D++S GVL E L GK P
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 74/317 (23%), Positives = 118/317 (37%), Gaps = 71/317 (22%)
Query: 316 DLLRASAEVLGKGTFGTAYKATLEMG---IVVAVKRLKDVTVS---EKEFREKMEVVGSM 369
LL + LG G FGT K +M VAVK LK+ + E + V+ +
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75
Query: 370 DHENLVPLRAYYY---SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA 426
D+ +V + + +LV + +G L+ L NR + + L
Sbjct: 76 DNPYIVRM----IGICEAESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQV 126
Query: 427 SRAIAYLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR--- 482
S + YL N H ++ + N+LL + A+ISDFGL+ + Y+
Sbjct: 127 SMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQT 178
Query: 483 ---------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVD 525
APE + K S K+DV+SFGVL+ E + G+ P + + E+G
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 238
Query: 526 LPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585
+ E++DL M C +NRP A V ++
Sbjct: 239 MGC------PAGCPREMYDL-----------MNL-------CWTYDVENRPGFAAVELRL 274
Query: 586 EEICRSSLQQGQAHDLE 602
+ +G H
Sbjct: 275 RNYYYDVVNEGHHHHHH 291
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVVGSMDHENLVPLR 378
LGKG+F Y+A + G+ VA+K + + ++ E +++ + H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE-VKIHCQLKHPSILELY 77
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLN-WETRSGLALGASRAIAYLHSKG 437
Y+ + LV + G ++ L P + E R + + + YLHS G
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIIT-GMLYLHSHG 132
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSS-------TPNRIDGYRAPEVTDA 489
H ++ SN+LL+++ +I+DFGLA L P TPN Y +PE+
Sbjct: 133 IL--HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPN----YISPEIATR 186
Query: 490 RKVSQKADVYSFGVLLLELLTGKAP 514
++DV+S G + LL G+ P
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 68/304 (22%), Positives = 113/304 (37%), Gaps = 61/304 (20%)
Query: 325 LGKGTFGTAYKATLEMG---IVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRA 379
LG G FG+ + M I VA+K LK T +E + +++ +D+ +V L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ +LV + G L L G R + + L S + YL K
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------------APEVT 487
H ++ + N+LL + A+ISDFGL+ Y APE
Sbjct: 133 --HRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLKWYAPECI 185
Query: 488 DARKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVDLPRWVQSVVKEEWT 539
+ RK S ++DV+S+GV + E L+ G+ P + + E+G + E
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC------PPECP 239
Query: 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQAH 599
E++ L M C ++RP V ++ S + + H
Sbjct: 240 PELYAL-----------MSD-------CWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 281
Query: 600 DLEN 603
+
Sbjct: 282 HHHH 285
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE-KEFREKMEVVGSMDHENLVPLRAY 380
VLGKGT+G Y L + +A+K + + + E++ + + H+N+V Y
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV---QY 84
Query: 381 Y--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWE------TR---SGLALGASR 428
+S + + + + +P GSLSALL G + E T+ GL
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIGFYTKQILEGLK----- 136
Query: 429 AIAYLHSKGPANSHGNIKSSNILL-SKSYEARISDFGLA-HLASPSSTPNRIDG---YRA 483
YLH H +IK N+L+ + S +ISDFG + LA + G Y A
Sbjct: 137 ---YLHDNQIV--HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191
Query: 484 PEV--TDARKVSQKADVYSFGVLLLELLTGKAP 514
PE+ R + AD++S G ++E+ TGK P
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 72/319 (22%), Positives = 117/319 (36%), Gaps = 61/319 (19%)
Query: 307 KGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEMG---IVVAVKRLKDVTV--SEKEFRE 361
K + F D L + LG G FG+ + M I VA+K LK T +E
Sbjct: 326 KDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR 385
Query: 362 KMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421
+ +++ +D+ +V L + +LV + G L L G R + +
Sbjct: 386 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAE 440
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGY 481
L S + YL K H N+ + N+LL + A+ISDFGL+ Y
Sbjct: 441 LLHQVSMGMKYLEEKNFV--HRNLAARNVLLVNRHYAKISDFGLSKALGADD-----SYY 493
Query: 482 R------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------E 521
APE + RK S ++DV+S+GV + E L+ G+ P + + E
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
Query: 522 EGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+G + E E++ L M C ++RP V
Sbjct: 554 QGKRMEC------PPECPPELYAL-----------MSD-------CWIYKWEDRPDFLTV 589
Query: 582 TSQIEEICRSSLQQGQAHD 600
++ S + +
Sbjct: 590 EQRMRACYYSLASKVEGGS 608
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 61/296 (20%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
+++G G G L + + VA+K LK ++F + ++G DH N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L ++V +YM GSL L + G G+ G + YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------------AP 484
G H ++ + N+L+ + ++SDFGL+ + D AP
Sbjct: 171 GYV--HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGKIPIRWTAP 223
Query: 485 EVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVDLPRWVQSVVKE 536
E R S +DV+SFGV++ E+L G+ P + N EEG LP
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA------PM 277
Query: 537 EWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
+ L M+ C + RP +++ S ++ + RS
Sbjct: 278 GCPHALHQL-----------MLD-------CWHKDRAQRPRFSQIVSVLDALIRSP 315
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 23/142 (16%), Positives = 47/142 (33%), Gaps = 9/142 (6%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLF--------SGE 102
+ NL +L V + +P+ L ++ + + N +
Sbjct: 237 QYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQ 296
Query: 103 IPGLLFSLGNLIRLNLAKNNF-SGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLA 161
+ + + NN + + K+ +LG L NQL G +P G+ LA
Sbjct: 297 ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLA 356
Query: 162 QFNVSFNKLNGSIPKRFARLPS 183
N+++N++
Sbjct: 357 SLNLAYNQITEIPANFCGFTEQ 378
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-24
Identities = 20/141 (14%), Positives = 49/141 (34%), Gaps = 10/141 (7%)
Query: 52 SGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLG 111
+ + ++ + +L + +N L G +P+ F L +L L N +
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 112 NLIRLNLAKNNFSG-TISADFNKLTRLGTLYLQENQLTGSI--------PDLGAFSSLAQ 162
+ L+ A N D ++ + + N++ P +++
Sbjct: 378 QVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 163 FNVSFNKLNGSIPKRFARLPS 183
N+S N+++ + F+
Sbjct: 438 INLSNNQISKFPKELFSTGSP 458
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 37/211 (17%), Positives = 63/211 (29%), Gaps = 21/211 (9%)
Query: 1 LASDRAALLTLRKAIGGRTL-----------LWNLTDGPCKWV---GVFCTGE-RVTMLR 45
D AL + A+ G+ WN W GV RVT L
Sbjct: 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLS 87
Query: 46 FPGMGLSGQLPIAIGNLTELHTVSLRFNALRG----TIPSDFAKLSNLRNLYLQGNLFSG 101
G G SG++P AIG LTEL ++L + + P + + +
Sbjct: 88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQK 147
Query: 102 EIPGLLF--SLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSS 159
+LI+ + + +I + + N +T + +
Sbjct: 148 TFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTK 207
Query: 160 LAQFNVSFNKLNGSIPKRFARLPSSAFEGNS 190
L QF + + +S +
Sbjct: 208 LRQFYMGNSPFVAENICEAWENENSEYAQQY 238
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 33/185 (17%), Positives = 64/185 (34%), Gaps = 36/185 (19%)
Query: 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALR--------GTIPSDFAKLSNLRNLY 93
T + +LP + L E+ +++ N +D ++ +Y
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 94 LQGN-LFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG--- 149
+ N L + + L + L L N G + A F +L +L L NQ+T
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPA 370
Query: 150 --------------------SIPD---LGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAF 186
IP+ + S ++ + S+N++ K F L + F
Sbjct: 371 NFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 187 EGNSL 191
+G ++
Sbjct: 431 KGINV 435
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 23/148 (15%), Positives = 44/148 (29%), Gaps = 14/148 (9%)
Query: 50 GLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSG-------E 102
L + +++L N + F+ S L ++ L GN+ + +
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 103 IPGLLFSLGNLIRLNLAKNNFSGTI-SADFNKLTRLGTLYLQENQLT------GSIPDLG 155
+ L ++L N + L L + L N + + L
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLK 539
Query: 156 AFSSLAQFNVSFNKLNGSIPKRFARLPS 183
F Q + N+ P+ PS
Sbjct: 540 GFGIRNQRDAQGNRTLREWPEGITLCPS 567
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 25/150 (16%), Positives = 49/150 (32%), Gaps = 29/150 (19%)
Query: 55 LPIAIGNLTELHTVSLRFNALRG-------------------TIPSDFAKLSNLRNLYLQ 95
+ A+ LT+L + + T + L +L ++ +
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257
Query: 96 GNLFSGEIPGLLFSLGNLIRLNLAKNNF--------SGTISADFNKLTRLGTLYLQENQL 147
++P L +L + +N+A N AD ++ +Y+ N L
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
Query: 148 -TGSIP-DLGAFSSLAQFNVSFNKLNGSIP 175
T + L L +N+L G +P
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-21
Identities = 25/144 (17%), Positives = 51/144 (35%), Gaps = 12/144 (8%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-- 108
L G+LP A G+ +L +++L +N + + + NL N IP +
Sbjct: 342 LEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK 399
Query: 109 SLGNLIRLNLAKNNFSG-------TISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSL 160
S+ + ++ + N + K + ++ L NQ++ + S L
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPL 459
Query: 161 AQFNVSFNKLNGSIPKRFARLPSS 184
+ N+ N L +
Sbjct: 460 SSINLMGNMLTEIPKNSLKDENEN 483
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 22/145 (15%), Positives = 38/145 (26%), Gaps = 12/145 (8%)
Query: 50 GLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFA--KLSNLRNLYLQGNLFSGEIPGLL 107
N L ++ LRFN L + DF L L + L N FS P
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532
Query: 108 FSLGNLIRL------NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLA 161
+ L + N L L + N + + + +++
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE-KITPNIS 590
Query: 162 QFNVSFNKLNGSIPKRFARLPSSAF 186
++ N +
Sbjct: 591 VLDIKDNPNISIDLSYVCPYIEAGM 615
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 14/162 (8%), Positives = 42/162 (25%), Gaps = 30/162 (18%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-- 108
+ + + + N + + +L+ LR Y+ + F E +
Sbjct: 171 QQKSIKKSSRITLKDTQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229
Query: 109 -----------------SLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG-- 149
+L +L + + + L + + + N+
Sbjct: 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGE 289
Query: 150 -------SIPDLGAFSSLAQFNVSFNKL-NGSIPKRFARLPS 183
++ D + + +N L + ++
Sbjct: 290 QLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 15/121 (12%), Positives = 39/121 (32%), Gaps = 11/121 (9%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNL------FSGEIPGLLFSL 110
L L + L +N+ P+ S L+ ++ E P +
Sbjct: 507 FRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLC 565
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNK 169
+L +L + N+ ++ + L +++N + + + + ++K
Sbjct: 566 PSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
Query: 170 L 170
Sbjct: 623 T 623
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-12
Identities = 13/101 (12%), Positives = 27/101 (26%), Gaps = 9/101 (8%)
Query: 54 QLPIAIGNLTEL------HTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLL 107
+ P N + L + + N P +L L + N + +
Sbjct: 527 KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI 585
Query: 108 FSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLT 148
N+ L++ N + G L ++
Sbjct: 586 TP--NISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 11/86 (12%), Positives = 22/86 (25%), Gaps = 3/86 (3%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
+ P I L + + N +R + N+ L ++ N +
Sbjct: 554 TLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPY 610
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTR 136
L + D + R
Sbjct: 611 IEAGMYMLFYDKTQDIRGCDALDIKR 636
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-26
Identities = 78/397 (19%), Positives = 142/397 (35%), Gaps = 61/397 (15%)
Query: 221 IVIGSVIGLLIILVLLIGLCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGE 280
+ S+ + L+ G CR +S A ++ ++G
Sbjct: 299 VTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHT 358
Query: 281 NTSSDLSGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKATLEM 340
+ S+ + + D E + +G+G FG ++
Sbjct: 359 VSVSETDDYAEIIDEEDTYTMPSTR---DYEIQRERIELG--RCIGEGQFGDVHQGIYMS 413
Query: 341 G----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394
+ VA+K K+ T ++F ++ + DH ++V L + + ++ +
Sbjct: 414 PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELC 472
Query: 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK 454
+G L + L + L+ + A S A+AYL SK H +I + N+L+S
Sbjct: 473 TLGELRSFLQVRKF----SLDLASLILYAYQLSTALAYLESKRFV--HRDIAARNVLVSS 526
Query: 455 SYEARISDFGLAHL--------ASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLL 506
+ ++ DFGL+ AS P + + APE + R+ + +DV+ FGV +
Sbjct: 527 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---WMAPESINFRRFTSASDVWMFGVCMW 583
Query: 507 ELLT-GKAPTQALLNEE-------GVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV 558
E+L G P Q + N + G LP ++ L M
Sbjct: 584 EILMHGVKPFQGVKNNDVIGRIENGERLPM------PPNCPPTLYSL-----------MT 626
Query: 559 QLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595
+ C A P RP E+ +Q+ I Q
Sbjct: 627 K-------CWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-26
Identities = 33/132 (25%), Positives = 49/132 (37%), Gaps = 3/132 (2%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+ L +L + + + L+ S F L NL L + G+ L +L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 114 IRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLN 171
L +A N+F D F +L L L L + QL P + SSL N+S N
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 172 GSIPKRFARLPS 183
+ L S
Sbjct: 508 SLDTFPYKCLNS 519
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 28/153 (18%), Positives = 47/153 (30%), Gaps = 2/153 (1%)
Query: 41 VTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFS 100
L L + + EL + L ++ + LS+L L L GN
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 101 GEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD--LGAFS 158
G L +L +L + N + + L L L + N + +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 159 SLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSL 191
+L ++S NK+ L SL
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 32/137 (23%), Positives = 48/137 (35%), Gaps = 3/137 (2%)
Query: 51 LSGQLPI-AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS 109
L +L L + + R F LS+L L + GN F +F+
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 110 -LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSF 167
L NL L+L++ FN L+ L L + N +SL + S
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 168 NKLNGSIPKRFARLPSS 184
N + S + PSS
Sbjct: 528 NHIMTSKKQELQHFPSS 544
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 30/128 (23%), Positives = 45/128 (35%), Gaps = 3/128 (2%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS 109
L+ L + + N+ + D F +L NL L L P S
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 110 LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDL--GAFSSLAQFNVSF 167
L +L LN++ NNF + + L L L N + S SSLA N++
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552
Query: 168 NKLNGSIP 175
N +
Sbjct: 553 NDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 35/143 (24%), Positives = 56/143 (39%), Gaps = 4/143 (2%)
Query: 44 LRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEI 103
L G+ G + T L + L FN + T+ S+F L L +L Q +
Sbjct: 354 LSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMS 412
Query: 104 PGLLF-SLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD--LGAFSSL 160
+F SL NLI L+++ + + FN L+ L L + N + +L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 161 AQFNVSFNKLNGSIPKRFARLPS 183
++S +L P F L S
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSS 495
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 28/147 (19%), Positives = 47/147 (31%), Gaps = 6/147 (4%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLF-SGEIPGLLFS 109
+ A L+ L + L L L+ L + NL S ++P +
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 110 LGNLIRLNLAKNNFSGTISADFNKLTRLG----TLYLQENQLTGSIPDLGAFSSLAQFNV 165
L NL L+L+ N D L ++ +L L N + P L + +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207
Query: 166 SFNKLNGSIPKR-FARLPSSAFEGNSL 191
N + ++ K L L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVL 234
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 23/118 (19%), Positives = 34/118 (28%), Gaps = 4/118 (3%)
Query: 67 TVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGT 126
T IP + + +NL L N FS L L+L++
Sbjct: 11 TYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTI 67
Query: 127 ISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
+ L+ L TL L N + SSL + L L +
Sbjct: 68 EDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-17
Identities = 21/120 (17%), Positives = 43/120 (35%), Gaps = 3/120 (2%)
Query: 50 GLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS 109
L P A +L+ L +++ N + L++L+ L N L
Sbjct: 481 QLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQH 540
Query: 110 L-GNLIRLNLAKNNFSGTISAD--FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVS 166
+L LNL +N+F+ T + L ++ ++ + P + N++
Sbjct: 541 FPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-15
Identities = 28/155 (18%), Positives = 45/155 (29%), Gaps = 24/155 (15%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS- 109
+ LT + + SL + DF+ ++L L F L S
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 110 ------------------LGNLIRLNLAKN--NFSGTISADFNKLTRLGTLYLQENQLTG 149
L +L L+L++N +F G S T L L L N +
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
Query: 150 SIPDLGAFSSLAQFNVSFNKLNGSIPKR-FARLPS 183
+ L + + L F L +
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 24/179 (13%), Positives = 45/179 (25%), Gaps = 40/179 (22%)
Query: 51 LSGQLPIAIGNLTELH----TVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGL 106
+ + L ++ ++ L N + P F ++ L L L+ N S +
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT 219
Query: 107 LF----------------------------SLGNLIRLNLAKNNFS------GTISADFN 132
+L L L + + + I FN
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 133 KLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSL 191
LT + + L + + D + K + L F N
Sbjct: 280 CLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKG 337
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 27/143 (18%), Positives = 40/143 (27%), Gaps = 16/143 (11%)
Query: 51 LSGQLP-IAIGNLTELHTVSLRFNALRGTI---PSDFAKLSNLRNLYLQGN------LFS 100
S + I L L L R D + L L NL ++ +
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271
Query: 101 GEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
+I L L N+ +L DF+ L L + SL
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT--LKLKSL 327
Query: 161 AQFNVSFNKLNGSIPKRFARLPS 183
+ + NK + LPS
Sbjct: 328 KRLTFTSNKGGNAFS--EVDLPS 348
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 70/336 (20%), Positives = 126/336 (37%), Gaps = 79/336 (23%)
Query: 293 ESKGSGVKNLVFFGK----GDRAFDLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVK 347
SG +NL F G ++ + + LG+G F L G A+K
Sbjct: 8 HHHSSGRENLYFQGHMVIIDNKHYLFI-------QKLGEGGFSYVDLVEGLHDGHFYALK 60
Query: 348 RLKDVTVSEKEFREKM----EVVGSMDHENLVPLRAYYYSRDEK----LLVHDYMPMGSL 399
R + E++ RE+ ++ +H N++ L AY L+ + G+L
Sbjct: 61 R---ILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTL 117
Query: 400 SALLHGNRGAG-----RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK 454
+ + G L LG R + +H+KG A H ++K +NILL
Sbjct: 118 WNEIERLKDKGNFLTEDQILWL------LLGICRGLEAIHAKGYA--HRDLKPTNILLGD 169
Query: 455 SYEARISDFGLA-----------------HLASPSSTPNRIDGYRAPEVTDARK---VSQ 494
+ + D G A+ T + YRAPE+ + + +
Sbjct: 170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS----YRAPELFSVQSHCVIDE 225
Query: 495 KADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554
+ DV+S G +L ++ G+ P + ++G + VQ+ L + +
Sbjct: 226 RTDVWSLGCVLYAMMFGEGPYDM-VFQKGDSVALAVQN-----------QLSIPQSPRHS 273
Query: 555 EEMVQLLQ--LAINCTAQYPDNRPSMAEVTSQIEEI 588
+ QLL + ++ P RP + + SQ+E +
Sbjct: 274 SALWQLLNSMMTVD-----PHQRPHIPLLLSQLEAL 304
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 28/212 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
E++G G FG +KA G +KR+K +EK RE ++ + +DH N+V +
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK--YNNEKAERE-VKALAKLDHVNIVHYNGCW 73
Query: 382 YSRDEKL----------------LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALG 425
D + ++ G+L + RG L+ L
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQ 130
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YR 482
++ + Y+HSK + ++K SNI L + + +I DFGL R G Y
Sbjct: 131 ITKGVDYIHSKKLI--NRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188
Query: 483 APEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+PE ++ ++ D+Y+ G++L ELL
Sbjct: 189 SPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 26/204 (12%)
Query: 324 VLGKGTFGTAYKA-TLEMGIVVAVK-----RLKDVTVSEKEFREKMEVVGSMDHENLVPL 377
LGKG FG Y A + ++A+K +L+ V + RE E+ + H N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREI-EIQSHLRHPNILRM 79
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
Y++ R L+ ++ P G L L + GR + + + A A+ Y H +
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFD-EQRSATFMEELAD-ALHYCHERK 134
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-------TPNRIDGYRAPEVTDAR 490
H +IK N+L+ E +I+DFG + A PS T + Y PE+ + +
Sbjct: 135 VI--HRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRTMCGTLD----YLPPEMIEGK 187
Query: 491 KVSQKADVYSFGVLLLELLTGKAP 514
+K D++ GVL E L G P
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPP 211
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 50/277 (18%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREK----MEVVGSMDHENLVPL 377
+ +G+G+FG A E G +K + +S KE RE+ + V+ +M H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE-REESRREVAVLANMKHPNIVQY 88
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG---RTPLNWETRSGLALGASRAIAYLH 434
R + +V DY G L ++ +G L+W + LAL ++H
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL------KHVH 142
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--------TPNRIDGYRAPEV 486
+ H +IKS NI L+K ++ DFG+A + + + TP Y +PE+
Sbjct: 143 DRKI--LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPY----YLSPEI 196
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA--EVFD 544
+ + + K+D+++ G +L EL T K +A + V ++ + +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAG------SMKNLVLKIISGSFPPVSLHYS 250
Query: 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+L +V L N P +RPS+ +
Sbjct: 251 YDL-------RSLVSQL-FKRN-----PRDRPSVNSI 274
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 52/206 (25%), Positives = 75/206 (36%), Gaps = 28/206 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM----DHENLVPL 377
LG G++G +K E G + AVKR K+ K+ VGS H V
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV-- 120
Query: 378 RAYYYS--RDEKLLVHDYMPM----GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
+ L Y+ SL A L G A+A
Sbjct: 121 -RLEQAWEEGGIL----YLQTELCGPSLQQHCE----AWGASLPEAQVWGYLRDTLLALA 171
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTD 488
+LHS+G H ++K +NI L ++ DFGL + +G Y APE+
Sbjct: 172 HLHSQGLV--HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL- 228
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAP 514
ADV+S G+ +LE+
Sbjct: 229 QGSYGTAADVFSLGLTILEVACNMEL 254
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 37/265 (13%), Positives = 80/265 (30%), Gaps = 54/265 (20%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK--------------RLKDVTVSEKEFRE------ 361
VLG+ +AT E G V ++K+ + + R
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 362 ---------KMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHG---NRGA 409
++V + ++ +R Y M S + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 410 GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469
L R L L R +A LH G H ++ +I+L + ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLV--HTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 470 SPSSTPNRIDGYRAPEVTDAR-----------KVSQKADVYSFGVLLLELLTGKAP---- 514
+ G+ PE+ R ++ D ++ G+++ + P
Sbjct: 257 GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKD 316
Query: 515 ----TQALLNEEGVDLPRWVQSVVK 535
+ ++P+ V+++++
Sbjct: 317 AALGGSEWIFRSCKNIPQPVRALLE 341
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 61/298 (20%), Positives = 129/298 (43%), Gaps = 47/298 (15%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREK----MEVVGSMDHENLVPL 377
+ +G+G F Y+A L G+ VA+K+++ + + + R ++++ ++H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGR-----TPLNWETRSGLALGASRAIAY 432
A + +E +V + G LS ++ + R T + + AL +
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL------EH 151
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSS-------TPNRIDGYRAP 484
+HS+ H +IK +N+ ++ + ++ D GL +S ++ TP Y +P
Sbjct: 152 MHSRRVM--HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY----YMSP 205
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544
E + K+D++S G LL E+ ++P + ++L + + + ++
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCDYPP---- 257
Query: 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV---TSQIEEICRSSLQQGQAH 599
L + EE+ QL+ + C P+ RP + V ++ SSL+ H
Sbjct: 258 ---LPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-25
Identities = 34/136 (25%), Positives = 51/136 (37%), Gaps = 3/136 (2%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
+S P L L ++L+ N L FA +NL L+L N
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAF---SSLAQFNVSF 167
NLI L+L+ N S T +L L L L N++ + SSL + +S
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 168 NKLNGSIPKRFARLPS 183
N++ P F +
Sbjct: 181 NQIKEFSPGCFHAIGR 196
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 26/127 (20%), Positives = 43/127 (33%), Gaps = 4/127 (3%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNLA 119
+ LH ++L N + F+ L +L L L N E+ G + L N+ + L+
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLS 438
Query: 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPK 176
N + F + L L L+ L F L ++S N +
Sbjct: 439 YNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDD 498
Query: 177 RFARLPS 183
L
Sbjct: 499 MLEGLEK 505
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-24
Identities = 32/147 (21%), Positives = 53/147 (36%), Gaps = 6/147 (4%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
L ++L ++ + FN + P KL L+ L LQ N S
Sbjct: 37 LRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFC 96
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNK 169
NL L+L N+ + F K L TL L N L+ + +L + +S NK
Sbjct: 97 TNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK 156
Query: 170 LNGSIPKRFARLPSSAFE-----GNSL 191
+ + +S+ + N +
Sbjct: 157 IQALKSEELDIFANSSLKKLELSSNQI 183
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 33/124 (26%), Positives = 50/124 (40%), Gaps = 4/124 (3%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
N+T L +L N LR ++F + S L +L + N S P L L L LNL
Sbjct: 26 NITVL---NLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFA 179
N S F T L L+L N + + +L ++S N L+ +
Sbjct: 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 180 RLPS 183
+L +
Sbjct: 143 QLEN 146
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 35/156 (22%), Positives = 53/156 (33%), Gaps = 14/156 (8%)
Query: 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSG 101
TML L+ + L +L L +N ++ L N+R L L+ +
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
Query: 102 EI---------PGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP 152
I L L LN+ N+ G S F L L L L + +
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 153 DLGAFSSLAQ-----FNVSFNKLNGSIPKRFARLPS 183
F SLA N++ NK++ F+ L
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 35/163 (21%), Positives = 54/163 (33%), Gaps = 12/163 (7%)
Query: 33 GVFCTGERVTMLRFPGMGLSGQLPI-AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRN 91
F + +L + +L L + + L +N + FA + +L+
Sbjct: 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQR 458
Query: 92 LYLQGNLFSG--EIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLT- 148
L L+ P L NL L+L+ NN + L +L L LQ N L
Sbjct: 459 LMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLAR 518
Query: 149 --------GSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
G I L S L N+ N + + F L
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 27/134 (20%), Positives = 46/134 (34%), Gaps = 6/134 (4%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF---SLGN 112
+ I + L + L N ++ P F + L L+L + L + +
Sbjct: 164 ELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTS 223
Query: 113 LIRLNLAKNNFSGTISADFN--KLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNK 169
+ L+L+ + S T + F K T L L L N L D L F + +N
Sbjct: 224 IRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNN 283
Query: 170 LNGSIPKRFARLPS 183
+ L +
Sbjct: 284 IQHLFSHSLHGLFN 297
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-21
Identities = 31/135 (22%), Positives = 55/135 (40%), Gaps = 10/135 (7%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFN--------ALRGTIPSDFAKLSNLRNLYLQGNLFSGE 102
++ + L +L + L+ N A G LS+L L L+ N F
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 103 IPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDL--GAFSSL 160
+ L L ++L NN + ++ FN L +L LQ+N +T + AF +L
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNL 611
Query: 161 AQFNVSFNKLNGSIP 175
+ ++ FN + +
Sbjct: 612 TELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-20
Identities = 28/142 (19%), Positives = 45/142 (31%), Gaps = 4/142 (2%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS 109
+S A L L + L N + + + L N+ +YL N +
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452
Query: 110 LGNLIRLNLAKNNFSG--TISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVS 166
+ +L RL L + + + F L L L L N + D L L ++
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512
Query: 167 FNKLNGSIPKRFARLPSSAFEG 188
N L P +G
Sbjct: 513 HNNLARLWKHANPGGPIYFLKG 534
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-20
Identities = 34/181 (18%), Positives = 58/181 (32%), Gaps = 18/181 (9%)
Query: 23 NLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNL--TELHTVSLRFNALRGTIP 80
L + + + + L LS L T L + L +N L
Sbjct: 206 QLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 81 SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTIS---------ADF 131
FA L L +L+ N L L N+ LNL ++ +IS F
Sbjct: 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
Query: 132 NKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNS 190
L L L +++N + G + +L ++S + + L + F +
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT------LTNETFVSLA 379
Query: 191 L 191
Sbjct: 380 H 380
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 26/145 (17%), Positives = 51/145 (35%), Gaps = 7/145 (4%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFA---KLSNLRNLYLQGNLFSGEIPGLL 107
+ P + L + L L ++ +++RNL L + S
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 108 FSLG--NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFN 164
L NL L+L+ NN + + F L +L +L+ N + L ++ N
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLN 302
Query: 165 VSFNKLNGSIPK-RFARLPSSAFEG 188
+ + SI ++ +F+
Sbjct: 303 LKRSFTKQSISLASLPKIDDFSFQW 327
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 27/155 (17%), Positives = 46/155 (29%), Gaps = 9/155 (5%)
Query: 45 RFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIP 104
R G + L+ LH ++L N F L L+ + L N +
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 105 GLLFSLGNLIRLNLAKNNFSGTISADF-NKLTRLGTLYLQENQLTGSIPDLGAFSSLAQF 163
+ + +L LNL KN + F L L ++ N + + F +
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI-- 635
Query: 164 NVSFNKLNGSIPKRFARLPSSAFEGNSLCGKPLVS 198
N + + P G P+
Sbjct: 636 NETHTNIPELSSHYLCNTPP------HYHGFPVRL 664
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 52/292 (17%)
Query: 323 EVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLV 375
+V+G G FG YK L + + VA+K LK + +F + ++G H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L +++ +YM G+L L G + G+ G + + YL +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLAN 165
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDGYR------APEVTD 488
H ++ + NIL++ + ++SDFGL+ L G + APE
Sbjct: 166 MNYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 489 ARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE-------GVDLPRWVQSVVKEEWTA 540
RK + +DV+SFG+++ E++T G+ P L N E G LP + +
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT------PMDCPS 277
Query: 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
++ L M+Q C Q RP A++ S ++++ R+
Sbjct: 278 AIYQL-----------MMQ-------CWQQERARRPKFADIVSILDKLIRAP 311
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 66/298 (22%), Positives = 116/298 (38%), Gaps = 62/298 (20%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
+G+G FG ++ + VA+K K+ T ++F ++ + DH ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L + + ++ + +G L + L + L+ + A S A+AYL SK
Sbjct: 81 LIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK 135
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR-----------APE 485
H +I + N+L+S + ++ DFGL+ S+ Y+ APE
Sbjct: 136 RFV--HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPE 187
Query: 486 VTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE-------GVDLPRWVQSVVKEE 537
+ R+ + +DV+ FGV + E+L G P Q + N + G LP
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------PPN 241
Query: 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595
++ L M + C A P RP E+ +Q+ I Q
Sbjct: 242 CPPTLYSL-----------MTK-------CWAYDPSRRPRFTELKAQLSTILEEEKAQ 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 46/206 (22%), Positives = 80/206 (38%), Gaps = 28/206 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+G+G+FG ++ + G AVK+ V + E + + +VP Y
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKK---VRLEVFRVEE-LVACAGLSSPRIVP---LY 116
Query: 382 --YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+ + + + GSL L+ + L + YLH++
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL-----EGLEYLHTRRI 171
Query: 439 ANSHGNIKSSNILLSKS-YEARISDFGLA-HLASPSSTPNRIDG--------YRAPEVTD 488
HG++K+ N+LLS A + DFG A L + + G + APEV
Sbjct: 172 L--HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAP 514
+ K D++S ++L +L G P
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKR--LKDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
EV+G G A VA+KR L+ S E ++++ + H N+V +
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV---S 77
Query: 380 YY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLAL---GASRAIAYL 433
YY + ++L LV + GS+ ++ G S +A + YL
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR----------- 482
H G H ++K+ NILL + +I+DFG++ A ++ +
Sbjct: 138 HKNG--QIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGDITRNKVRKTFVGTPCWM 193
Query: 483 APEV-TDARKVSQKADVYSFGVLLLELLTGKAP 514
APEV R KAD++SFG+ +EL TG AP
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/207 (27%), Positives = 82/207 (39%), Gaps = 28/207 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVVGSMDHENLVP 376
LGKG F ++ + + V A K L EK E + + S+ H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-ISIHRSLAHQHVVG 105
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLN-WETRSGLALGASRAIAYLHS 435
++ D +V + SL L R L E R L YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELH-----KRRKALTEPEARYYLRQIVL-GCQYLHR 159
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--------TPNRIDGYRAPEVT 487
H ++K N+ L++ E +I DFGLA TPN Y APEV
Sbjct: 160 NRVI--HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIAPEVL 213
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAP 514
+ S + DV+S G ++ LL GK P
Sbjct: 214 SKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 56/284 (19%), Positives = 98/284 (34%), Gaps = 57/284 (20%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRL--KDVTVSEKE---FREKMEVVGSMDHENLVPL 377
+VLG G GT + VAVKR+ + + +++E RE S +H N++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRE------SDEHPNVIRY 83
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
R + + + +L + + L L + +A+LHS
Sbjct: 84 FCTEKDRQFQYIAIELCA-ATLQEYVE-QKDFAHLGLE---PITLLQQTTSGLAHLHSLN 138
Query: 438 PANSHGNIKSSNILLSKSYE-----ARISDFGLA-----------HLASPSSTPNRIDGY 481
H ++K NIL+S A ISDFGL + T G+
Sbjct: 139 IV--HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE----GW 192
Query: 482 RAPEV---TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW 538
APE+ + D++S G + +++ + P +
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH------------PFGKSLQRQANI 240
Query: 539 TAEVFDLELLRY-QNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
L+ L ++ + +L++ A P RPS V
Sbjct: 241 LLGACSLDCLHPEKHEDVIARELIE---KMIAMDPQKRPSAKHV 281
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 67/307 (21%), Positives = 118/307 (38%), Gaps = 76/307 (24%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVP 376
+LG+G FG Y+ I VAVK K ++++F + ++ ++DH ++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 377 LRAYYY---SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
L + ++ + P G L L N+ + L T +L +A+AYL
Sbjct: 78 L----IGIIEEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYL 129
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI----DGYR------- 482
S H +I NIL++ ++ DFGL+ R D Y+
Sbjct: 130 ESINCV--HRDIAVRNILVASPECVKLGDFGLS----------RYIEDEDYYKASVTRLP 177
Query: 483 ----APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVDLPRWV 530
+PE + R+ + +DV+ F V + E+L+ GK P L N E+G LP+
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-- 235
Query: 531 QSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590
+ ++ L M + C P +RP E+ + ++ +
Sbjct: 236 ----PDLCPPVLYTL-----------MTR-------CWDYDPSDRPRFTELVCSLSDVYQ 273
Query: 591 SSLQQGQ 597
Sbjct: 274 MEKDIAM 280
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 67/290 (23%), Positives = 123/290 (42%), Gaps = 51/290 (17%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
+V+G G FG L++ I VA+K LK + ++F + ++G DH N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L ++V +YM GSL + L + G+ G + + YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA----QFTVIQLVGMLRGIASGMKYLSDM 166
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDGYR------APEVTDA 489
G H ++ + NIL++ + ++SDFGL L G + +PE
Sbjct: 167 GYV--HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 490 RKVSQKADVYSFGVLLLELLT-GKAPTQALLN-------EEGVDLPRWVQSVVKEEWTAE 541
RK + +DV+S+G++L E+++ G+ P + N +EG LP + A
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP------PMDCPAA 278
Query: 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
++ L M+ C + +NRP ++ S ++++ R+
Sbjct: 279 LYQL-----------MLD-------CWQKDRNNRPKFEQIVSILDKLIRN 310
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 65/305 (21%), Positives = 115/305 (37%), Gaps = 52/305 (17%)
Query: 323 EVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLV 375
+LGKG FG+ +A L + VAVK LK ++ + F + + DH ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 376 PL------RAYYYSRDEKLLVHDYMPMGSLSALLHGNR-GAGRTPLNWETRSGLALGASR 428
L +++ +M G L A L +R G L +T + +
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------ 482
+ YL S+ H ++ + N +L++ ++DFGL+ D YR
Sbjct: 149 GMEYLSSRNFI--HRDLAARNCMLAEDMTVCVADFGLSRKI------YSGDYYRQGCASK 200
Query: 483 ------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVK 535
A E + +DV++FGV + E++T G+ P + N E + + +
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-------IYNYLI 253
Query: 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595
L + EE+ L+ C + P RPS + ++E I
Sbjct: 254 GGNR-------LKQPPECMEEVYDLMY---QCWSADPKQRPSFTCLRMELENILGHLSVL 303
Query: 596 GQAHD 600
+ D
Sbjct: 304 STSQD 308
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 55/206 (26%), Positives = 81/206 (39%), Gaps = 26/206 (12%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVVGSMDHENLVP 376
LGKG F ++ + + V A K L EK E + + S+ H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME-ISIHRSLAHQHVVG 79
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
++ D +V + SL L + E R L YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEP-EARYYLRQIVL-GCQYLHRN 134
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--------TPNRIDGYRAPEVTD 488
H ++K N+ L++ E +I DFGLA TPN Y APEV
Sbjct: 135 RVI--HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN----YIAPEVLS 188
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAP 514
+ S + DV+S G ++ LL GK P
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 71/308 (23%), Positives = 126/308 (40%), Gaps = 70/308 (22%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSEK-EFREKMEVVGSMDHENLV 375
LG+G FG + A + ++VAVK LKD T++ + +F+ + E++ ++ HE++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS-----------GLAL 424
D ++V +YM G L+ L + ++ + R +A
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR-- 482
+ + YL S+ H ++ + N L+ + +I DFG++ D YR
Sbjct: 141 QIASGMVYLASQHFV--HRDLATRNCLVGANLLVKIGDFGMSRDV------YSTDYYRVG 192
Query: 483 ----------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE-------GV 524
PE RK + ++DV+SFGV+L E+ T GK P L N E G
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 525 DLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584
L R EV+D+ M+ C + P R ++ E+
Sbjct: 253 VLER------PRVCPKEVYDV-----------MLG-------CWQREPQQRLNIKEIYKI 288
Query: 585 IEEICRSS 592
+ + +++
Sbjct: 289 LHALGKAT 296
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 61/300 (20%), Positives = 119/300 (39%), Gaps = 61/300 (20%)
Query: 323 EVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLV 375
++LG+G FG+ + L + VAVK +K S++E F + + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 376 PL-----RAYYYSRDEKLLVHDYMPMGSLSALLHGNR-GAGRTPLNWETRSGLALGASRA 429
L + +++ +M G L L +R G + +T + +
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------- 482
+ YL ++ H ++ + N +L ++DFGL+ D YR
Sbjct: 160 MEYLSNRNFL--HRDLAARNCMLRDDMTVCVADFGLSKKI------YSGDYYRQGRIAKM 211
Query: 483 -----APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKE 536
A E R + K+DV++FGV + E+ T G P + N
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--------------- 256
Query: 537 EWTAEVFDLELLRY-----QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
E++D L + ++ +E+ +++ +C P +RP+ + + Q+E++ S
Sbjct: 257 ----EMYDYLLHGHRLKQPEDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE---KMEVVGSMDHENLVPLR 378
E +GKG+FG +K VVA+K + D+ +E E + ++ V+ D +
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKII-DLEEAEDEIEDIQQEITVLSQCDSPYVT--- 83
Query: 379 AYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
YY Y +D KL ++ +Y+ GS LL PL+ + + + + YLHS
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHS 137
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDARK 491
+ H +IK++N+LLS+ E +++DFG+ L N G + APEV
Sbjct: 138 EK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA 195
Query: 492 VSQKADVYSFGVLLLELLTGKAP 514
KAD++S G+ +EL G+ P
Sbjct: 196 YDSKADIWSLGITAIELARGEPP 218
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 64/315 (20%), Positives = 114/315 (36%), Gaps = 61/315 (19%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENL 374
LG+G+FG Y+ E VA+K + + EF + V+ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNR-----GAGRTPLNWETRSGLALGASRA 429
V L L++ + M G L + L R P + +A +
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR------- 482
+AYL++ H ++ + N ++++ + +I DFG+ D YR
Sbjct: 151 MAYLNANKFV--HRDLAARNCMVAEDFTVKIGDFGMTRDI------YETDYYRKGGKGLL 202
Query: 483 -----APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKE 536
+PE + +DV+SFGV+L E+ T + P Q L NE
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------------- 247
Query: 537 EWTAEVFDLELLRY-----QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
+V + N + + +L++ C P RPS E+ S I+E
Sbjct: 248 ----QVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEMEP 300
Query: 592 SLQQGQAHDLENGSS 606
++ + E
Sbjct: 301 GFREVSFYYSEENKL 315
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 68/289 (23%), Positives = 119/289 (41%), Gaps = 39/289 (13%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
EV+G+G FG Y TL I AVK L +T +F + ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 377 LRAYYYSRDEKLL-VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + L V YM G L + + G L ++ + YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKYLAS 146
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA---HLASPSSTPNRIDG---YR--APEVT 487
K H ++ + N +L + + +++DFGLA + S N+ + A E
Sbjct: 147 KKFV--HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 488 DARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546
+K + K+DV+SFGVLL EL+T G P + + + + +
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQ-------GRR 250
Query: 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595
LL+ + + + +++ C + RPS +E+ S+I I + + +
Sbjct: 251 LLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFSTFIGE 296
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 63/296 (21%), Positives = 113/296 (38%), Gaps = 53/296 (17%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
V+GKG FG Y I A+K L +T + + F + ++ ++H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 377 LRAYYYSRDE-KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + ++ YM G L + + + L +R + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISFGLQVARGMEYLAE 142
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDGYR-------APEVT 487
+ H ++ + N +L +S+ +++DFGLA + + + A E
Sbjct: 143 QKFV--HRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 488 DARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE-------GVDLPRWVQSVVKEEWT 539
+ + K+DV+SFGVLL ELLT G P + + + G LP+ E
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ------PEYCP 254
Query: 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595
++ + M Q C P RP+ + ++E+I + L
Sbjct: 255 DSLYQV-----------MQQ-------CWEADPAVRPTFRVLVGEVEQIVSALLGD 292
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-23
Identities = 57/297 (19%), Positives = 101/297 (34%), Gaps = 68/297 (22%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK--RLKDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
+ LG+G FG ++A A+K RL + ++ ++ +++ + ++H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV---R 67
Query: 380 YYYSRDEKLLVHD---------------YMPMGSLSALLHGNRGAGRTPLNWETRSGLAL 424
Y+ + EK +L ++G + L
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFL 125
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----------- 473
+ A+ +LHSKG H ++K SNI + ++ DFGL
Sbjct: 126 QIAEAVEFLHSKGLM--HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 474 ---------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGV 524
T Y +PE S K D++S G++L ELL P +
Sbjct: 184 YARHTGQVGTKL----YMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRT 236
Query: 525 DLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ V + F + E MVQ + L+ + P RP +
Sbjct: 237 -----LTDVRNLK-----FPPLFTQKYPCEYVMVQDM-LSPS-----PMERPEAINI 277
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 45/224 (20%), Positives = 84/224 (37%), Gaps = 42/224 (18%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM----DHENLVPL 377
E +G G FG+ +K G + A+KR K + + + V + H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV-- 74
Query: 378 RAYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
Y+ ++ D+ + + ++Y GSL+ + N L L R + Y+H
Sbjct: 75 -RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMS-YFKEAELKDLLLQVGRGLRYIH 132
Query: 435 SKGPANSHGNIKSSNILLSKS-------------------YEARISDFGLA-HLASPSS- 473
S H +IK SNI +S++ +I D G ++SP
Sbjct: 133 SMSLV--HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 474 --TPNRIDGYRAPEV-TDARKVSQKADVYSFGVLLLELLTGKAP 514
+ A EV + KAD+++ + ++ +
Sbjct: 191 EGDSR----FLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 18/200 (9%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
E LG+G++G+ YKA E G +VA+K++ V +E +++ ++ D ++V YY
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVV---KYY 90
Query: 382 --YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
Y ++ L +V +Y GS+S ++ L + + + + + YLH
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFMR- 145
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDARKVSQ 494
H +IK+ NILL+ A+++DFG+ L + N + G + APEV +
Sbjct: 146 -KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC 204
Query: 495 KADVYSFGVLLLELLTGKAP 514
AD++S G+ +E+ GK P
Sbjct: 205 VADIWSLGITAIEMAEGKPP 224
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 68/307 (22%), Positives = 121/307 (39%), Gaps = 69/307 (22%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSEK-EFREKMEVVGSMDHENLV 375
LG+G FG + A + ++VAVK LK+ + S + +F+ + E++ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG----------LALG 425
L+V +YM G L+ L + + E + +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR--- 482
+ + YL H ++ + N L+ + +I DFG++ D YR
Sbjct: 167 VAAGMVYLAGLHFV--HRDLATRNCLVGQGLVVKIGDFGMSRDI------YSTDYYRVGG 218
Query: 483 ---------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE-------GVD 525
PE RK + ++DV+SFGV+L E+ T GK P L N E G +
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE 278
Query: 526 LPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585
L R EV+ + M C + P R S+ +V +++
Sbjct: 279 LER------PRACPPEVYAI-----------MRG-------CWQREPQQRHSIKDVHARL 314
Query: 586 EEICRSS 592
+ + ++
Sbjct: 315 QALAQAP 321
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 25/144 (17%), Positives = 46/144 (31%), Gaps = 12/144 (8%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSG--------- 101
++ NL +L V L +P L L++L + N
Sbjct: 479 QYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWT 538
Query: 102 EIPGLLFSLGNLIRLNLAKNNFSG-TISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
+ + + + NN SA K+ +LG L N++ + G L
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKL 597
Query: 161 AQFNVSFNKLNGSIPKRFARLPSS 184
+ +N++ IP+ F
Sbjct: 598 TDLKLDYNQIE-EIPEDFCAFTDQ 620
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 26/160 (16%), Positives = 48/160 (30%), Gaps = 34/160 (21%)
Query: 55 LPIAIGNLTELHTVSLRFNALRG-------------------TIPSDFAKLSNLRNLYLQ 95
+ AI LT+L + + ++ L +L ++ L
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELY 499
Query: 96 GNLFSGEIPGLLFSLGNLIRLNLAKNNFSG---------TISADFNKLTRLGTLYLQENQ 146
++P L+ L L LN+A N ++ D + ++ Y+ N
Sbjct: 500 NCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNN 559
Query: 147 LTGSIPD---LGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
L P L L + NK+ + F
Sbjct: 560 LE-EFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVK 596
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-18
Identities = 34/149 (22%), Positives = 51/149 (34%), Gaps = 16/149 (10%)
Query: 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRG---------TIPSDFAKLSNLRNL 92
T + QLP + +L EL ++++ N + D ++
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 93 YLQGNLFSGEIP--GLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGS 150
Y+ N E P L + L L+ N + A F +L L L NQ+
Sbjct: 554 YMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEI 610
Query: 151 IPDLGAF-SSLAQFNVSFNKLNGSIPKRF 178
D AF + S NKL IP F
Sbjct: 611 PEDFCAFTDQVEGLGFSHNKLK-YIPNIF 638
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 4e-18
Identities = 24/126 (19%), Positives = 38/126 (30%), Gaps = 12/126 (9%)
Query: 53 GQLPIAIGNLTELHTVSLRFNALRGTIPSDFA--KLSNLRNLYLQGNLFSGEIPGLLFSL 110
N L T+ LRFN L ++ DF L L N+ + N FS P +
Sbjct: 718 KPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNS 775
Query: 111 GNLIRLNL------AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFN 164
L + N L L + N + + + L +
Sbjct: 776 SQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDE-KLTPQLYILD 833
Query: 165 VSFNKL 170
++ N
Sbjct: 834 IADNPN 839
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 4e-18
Identities = 28/144 (19%), Positives = 48/144 (33%), Gaps = 18/144 (12%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFS-------GEIPGLLF 108
+ TV+L +N ++ FA S + + L NL + G
Sbjct: 666 SMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYK 725
Query: 109 SLGNLIRLNLAKNNFSGTISAD--FNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNV 165
+ L ++L N + ++S D L L + + N + S P S L F +
Sbjct: 726 NTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGI 783
Query: 166 SF------NKLNGSIPKRFARLPS 183
N++ P PS
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPS 807
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-18
Identities = 18/136 (13%), Positives = 44/136 (32%), Gaps = 11/136 (8%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLI 114
++ + +L + N + F L +L L N EIP + +
Sbjct: 566 SASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVE 622
Query: 115 RLNLAKNNFSG-TISADFNKLTRLGTLYLQENQLTGSIPDLGA------FSSLAQFNVSF 167
L + N + + +G++ N++ ++ + + +S+
Sbjct: 623 GLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682
Query: 168 NKLNGSIPKRFARLPS 183
N++ + FA
Sbjct: 683 NEIQKFPTELFATGSP 698
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 29/149 (19%), Positives = 53/149 (35%), Gaps = 22/149 (14%)
Query: 54 QLPIAIG-NLTELHTVSLRFNALRGTIPSDFA--KLSNLRNLYLQGNLFSGEIPGLLFSL 110
++P ++ + N L+ IP+ F + + ++ N E + S+
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667
Query: 111 G-----NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD---------LGA 156
N + L+ N + F + + T+ L N +T SIP+
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKN 726
Query: 157 FSSLAQFNVSFNKLNGSIPK--RFARLPS 183
L ++ FNKL S+ R LP
Sbjct: 727 TYLLTTIDLRFNKLT-SLSDDFRATTLPY 754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 34/197 (17%), Positives = 61/197 (30%), Gaps = 24/197 (12%)
Query: 3 SDRAALLTLRKAIGGRTL--------------LWNLTDGPCKWV---GVFCTGE-RVTML 44
D AL + +A+ G+ WN W GV RVT L
Sbjct: 269 KDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL 328
Query: 45 RFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIP 104
G G G++P AIG LTEL +S ++ + + + +
Sbjct: 329 SLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYK 388
Query: 105 GLLFS------LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFS 158
+ L +L++ + +N I D + + N++T + +
Sbjct: 389 KMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLT 448
Query: 159 SLAQFNVSFNKLNGSIP 175
L + +
Sbjct: 449 KLQIIYFANSPFTYDNI 465
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 1e-16
Identities = 19/142 (13%), Positives = 42/142 (29%), Gaps = 9/142 (6%)
Query: 53 GQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGN 112
+ + + N + I +L+ L+ +Y + F+ + + +
Sbjct: 415 KPIKKDSRISLKDTQIGNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAV-----D 468
Query: 113 LIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLN 171
N ++ L L + L +PD L L N++ N+
Sbjct: 469 WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528
Query: 172 G--SIPKRFARLPSSAFEGNSL 191
+ + RL G +
Sbjct: 529 SAAQLKADWTRLADDEDTGPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 18/140 (12%), Positives = 44/140 (31%), Gaps = 17/140 (12%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALR-------GTIPSDFAKLSNLRNLYLQGNLFSGEI 103
+ + + T+ L N + ++ L + L+ N +
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLS 744
Query: 104 PGLLFS-LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQE------NQLTGSIPD-LG 155
+ L L ++++ N FS + ++L ++ N++ P +
Sbjct: 745 DDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803
Query: 156 AFSSLAQFNVSFNKLNGSIP 175
SL Q + N + +
Sbjct: 804 TCPSLIQLQIGSNDIR-KVD 822
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 15/122 (12%), Positives = 41/122 (33%), Gaps = 11/122 (9%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNL------FSGEIPGLLFSL 110
L L + + +N + P+ S L+ ++ + P + +
Sbjct: 747 FRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTC 805
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLT-GSIPDLGAFSSLAQFNVSFNK 169
+LI+L + N+ + +L L + +N + + + + + ++K
Sbjct: 806 PSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
Query: 170 LN 171
Sbjct: 863 TQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 1/89 (1%)
Query: 97 NLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGA 156
+++ + L + G + L+LA G + +LT L L + T S G
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 157 FS-SLAQFNVSFNKLNGSIPKRFARLPSS 184
+ +++ K F
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQR 397
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 13/87 (14%), Positives = 25/87 (28%), Gaps = 5/87 (5%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN-LFSGEIPGLLFS 109
+ Q P I L + + N +R + L L + N S ++ +
Sbjct: 794 ILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPY 850
Query: 110 LGNLIRLNLAKNNFSGTISADFNKLTR 136
+ L + D + R
Sbjct: 851 I-EAGMYVLLYDKTQDIRGCDALGIER 876
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 9e-23
Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 38/226 (16%)
Query: 323 EVLGKG--TFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKME----VVGSMDHENLV 375
V+GKG T A G V V+R+ ++ E ++ V +H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 376 PLRAYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
P Y + D +L +V +M GS L+ +N + + G +A+ Y
Sbjct: 90 P---YRATFIADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDY 143
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH-LASPSSTPNRIDGYR--------- 482
+H G H ++K+S+IL+S + +S + S + +
Sbjct: 144 IHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 483 -APEV--TDARKVSQKADVYSFGVLLLELLTGKAP------TQALL 519
+PEV + + K+D+YS G+ EL G P TQ LL
Sbjct: 202 LSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 69/296 (23%), Positives = 118/296 (39%), Gaps = 53/296 (17%)
Query: 323 EVLGKGTFGTAYKATLEMG----IVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
EV+G+G FG Y TL I AVK L +T +F + ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 377 LRAYYYSRDEKLL-VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + L V YM G L + + G L ++ + +L S
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLAS 210
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA---HLASPSSTPNRIDG---YR--APEVT 487
K H ++ + N +L + + +++DFGLA + S N+ + A E
Sbjct: 211 KKFV--HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 488 DARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE-------GVDLPRWVQSVVKEEWT 539
+K + K+DV+SFGVLL EL+T G P + + G L + E
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ------PEYCP 322
Query: 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595
++++ M++ C + RPS +E+ S+I I + + +
Sbjct: 323 DPLYEV-----------MLK-------CWHPKAEMRPSFSELVSRISAIFSTFIGE 360
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVPLR 378
E +G+G GT Y A + G VA++++ ++ K+ E + V+ + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINE-ILVMRENKNPNIV--- 80
Query: 379 AYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
Y Y ++L +V +Y+ GSL+ ++ T ++ + + +A+ +LHS
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS 134
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDARK 491
H +IKS NILL +++DFG A + S + + G + APEV +
Sbjct: 135 NQVI--HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 492 VSQKADVYSFGVLLLELLTGKAP 514
K D++S G++ +E++ G+ P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 58/291 (19%), Positives = 106/291 (36%), Gaps = 47/291 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL-KDVTVSEKE--FREKMEVVGSMDHENLVPLR 378
E LG G FG + + G VA+K+ ++++ +E E ++++ ++H N+V R
Sbjct: 20 ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLE-IQIMKKLNHPNVVSAR 78
Query: 379 AYY------YSRDEKLLVHDYMPMGSLSALL--HGNRGAGRTPLNWETRSGLALGASRAI 430
D LL +Y G L L N + R+ L+ +S A+
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG---PIRTLLSDISS-AL 134
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEAR---ISDFGLAHLASPSS-------TPNRIDG 480
YLH H ++K NI+L + I D G A T
Sbjct: 135 RYLHENRII--HRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ---- 188
Query: 481 YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA----------LLNEEGVDLPRWV 530
Y APE+ + +K + D +SFG L E +TG P + + + +
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248
Query: 531 QSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
++++ + + ++ + LQ + R + +
Sbjct: 249 DLTGAVKFSSVLPT-PNHLSGILAGKLERWLQCMLMWH---QRQRGTDPQN 295
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFRE-KME--VVGS 368
D E + LG G G +K + G+V+A K + + + + E V+
Sbjct: 34 DFEKI-----SELGAGNGGVVFKVSHKPSGLVMARKLI-HLEIKPAIRNQIIRELQVLHE 87
Query: 369 MDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG-LALGAS 427
+ +V +YS E + ++M GSL +L + AGR P E G +++
Sbjct: 88 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIP---EQILGKVSIAVI 141
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRA 483
+ + YL K H ++K SNIL++ E ++ DFG++ L S N G Y +
Sbjct: 142 KGLTYLREKHKIM-HRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMS 198
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
PE S ++D++S G+ L+E+ G+ P
Sbjct: 199 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 66/315 (20%), Positives = 109/315 (34%), Gaps = 61/315 (19%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENL 374
LG G FG Y+ + + VAVK L +V + +F + ++ +H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG--RTPLNWETRSGLALGASRAIAY 432
V + ++ + M G L + L R + L +A + Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEAR---ISDFGLAHLASPSSTPNRIDGYR------- 482
L H +I + N LL+ R I DFG+A R YR
Sbjct: 156 LEENHFI--HRDIAARNCLLTCPGPGRVAKIGDFGMARDI------YRASYYRKGGCAML 207
Query: 483 -----APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKE 536
PE + K D +SFGVLL E+ + G P + N+
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------- 252
Query: 537 EWTAEVFDLELLRY-----QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
EV + +N + +++ C P++RP+ A + +IE +
Sbjct: 253 ----EVLEFVTSGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQD 305
Query: 592 SLQQGQAHDLENGSS 606
A +E G
Sbjct: 306 PDVINTALPIEYGPL 320
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 24/203 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVPLR 378
+G+G+ G A G VAVK + D+ ++ F E + ++ H N+V
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMM-DLRKQQRRELLFNE-VVIMRDYQHFNVV--- 105
Query: 379 AYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
Y Y E+L ++ +++ G+L+ ++ + LN E + + +A+AYLH+
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVS------QVRLNEEQIATVCEAVLQALAYLHA 159
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDARK 491
+G H +IKS +ILL+ ++SDFG A ++ + G + APEV
Sbjct: 160 QGVI--HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL 217
Query: 492 VSQKADVYSFGVLLLELLTGKAP 514
+ + D++S G++++E++ G+ P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP 240
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 27/148 (18%), Positives = 45/148 (30%), Gaps = 5/148 (3%)
Query: 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLF 99
V + + L + L L +PS LS L+ L L N F
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 100 SGEIPGLLFSLGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFS 158
+ +L L++ N + L L L L + + S
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 159 SLAQ---FNVSFNKLNGSIPKRFARLPS 183
+L+ N+S+N+ + F P
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQ 401
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 21/134 (15%), Positives = 33/134 (24%), Gaps = 1/134 (0%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
L L L + L + F L L L N L
Sbjct: 45 LPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGP 104
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNK 169
L L + S + L +LYL N ++ L + N
Sbjct: 105 KALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNA 164
Query: 170 LNGSIPKRFARLPS 183
++ + + L
Sbjct: 165 IHYLSKEDMSSLQQ 178
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-20
Identities = 20/124 (16%), Positives = 34/124 (27%), Gaps = 4/124 (3%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
+ L FN L + F++L NL L L S L L L
Sbjct: 34 STECL---EFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTA 90
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFA 179
N + L L+ + ++ L +L + N ++ +
Sbjct: 91 NPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF 150
Query: 180 RLPS 183
Sbjct: 151 PTEK 154
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 30/137 (21%), Positives = 45/137 (32%), Gaps = 5/137 (3%)
Query: 52 SGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-L 110
S + + NL+ L +++L +N F + L L L + F L
Sbjct: 365 SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNL 424
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD----LGAFSSLAQFNVS 166
L LNL+ + + F+ L L L LQ N L L +S
Sbjct: 425 HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLS 484
Query: 167 FNKLNGSIPKRFARLPS 183
F L+ F L
Sbjct: 485 FCDLSSIDQHAFTSLKM 501
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 32/131 (24%), Positives = 51/131 (38%), Gaps = 3/131 (2%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEI---PGLLFSLGN 112
NL L ++L + L + F L L++L LQGN F L +LG
Sbjct: 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477
Query: 113 LIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172
L L L+ + S F L + + L N+LT S + + N++ N ++
Sbjct: 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHISI 537
Query: 173 SIPKRFARLPS 183
+P L
Sbjct: 538 ILPSLLPILSQ 548
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 34/139 (24%), Positives = 54/139 (38%), Gaps = 7/139 (5%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGN--LFSGEIPGLL 107
I+ N L +S++ N R + + L NLR L L + S L
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 108 FSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FN 164
+L +L LNL+ N + F + +L L L +L F +L N
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ-SPFQNLHLLKVLN 431
Query: 165 VSFNKLNGSIPKRFARLPS 183
+S + L+ S + F LP+
Sbjct: 432 LSHSLLDISSEQLFDGLPA 450
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 26/148 (17%), Positives = 37/148 (25%), Gaps = 7/148 (4%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
L A+ L + + L +LYL N S F
Sbjct: 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPT 152
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLG--TLYLQENQLTGSIPDLGAFSSLAQFNVSFN 168
L L+ N D + L + +L L N + G P + N
Sbjct: 153 EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGT 212
Query: 169 KLNGSIPKRFA-----RLPSSAFEGNSL 191
+ I K L FE
Sbjct: 213 QNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 24/127 (18%), Positives = 41/127 (32%), Gaps = 5/127 (3%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRN---LYLQGNLFSGEIPGLL 107
L L L ++L+ N L L L L S
Sbjct: 437 LDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAF 496
Query: 108 FSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVS 166
SL + ++L+ N + + + L + L L N ++ +P L S N+
Sbjct: 497 TSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLR 555
Query: 167 FNKLNGS 173
N L+ +
Sbjct: 556 QNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 23/101 (22%), Positives = 41/101 (40%), Gaps = 1/101 (0%)
Query: 50 GLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS 109
+ Q ++ L L + L F L F L + ++ L N + L
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 110 LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGS 150
L + LNLA N+ S + + L++ T+ L++N L +
Sbjct: 523 LKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 23/136 (16%), Positives = 45/136 (33%), Gaps = 6/136 (4%)
Query: 53 GQLPIAIGNLTELHTVSLRFNALRGTIPSD--FAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
+ + +++ I + + +L + P + L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 111 G--NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSF 167
++ +NL K+ F S F+ + L L L L+ +P L S+L + +S
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310
Query: 168 NKLNGSIPKRFARLPS 183
NK + PS
Sbjct: 311 NKFENLCQISASNFPS 326
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 26/109 (23%), Positives = 40/109 (36%), Gaps = 1/109 (0%)
Query: 23 NLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSD 82
+ G + T R+ +L LS A +L ++ V L N L +
Sbjct: 460 HFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEA 519
Query: 83 FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADF 131
+ L + L L N S +P LL L +NL +N T S +
Sbjct: 520 LSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 48/217 (22%), Positives = 83/217 (38%), Gaps = 34/217 (15%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK---RLKDVTVSEKEFREKMEVVGSMDHENLVPLR 378
++LG+G ++ + G + A+K + + + + RE EV+ ++H+N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE-FEVLKKLNHKNIVKLF 73
Query: 379 AYYYSRDEKL--LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
A + L+ ++ P GSL +L A P + E L + +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFLIVLRDVVG-GMNHLREN 131
Query: 437 GPANSHGNIKSSNILLSKSYEAR----ISDFGLAHLASPSS-------TPNRIDGYRAPE 485
G H NIK NI+ + + ++DFG A T Y P+
Sbjct: 132 GIV--HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE----YLHPD 185
Query: 486 V--------TDARKVSQKADVYSFGVLLLELLTGKAP 514
+ +K D++S GV TG P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 5e-22
Identities = 32/264 (12%), Positives = 72/264 (27%), Gaps = 53/264 (20%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKME----------------- 364
VLG+ +AT E G V ++M+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 365 ---------VVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM----GSLSALLH--GNRGA 409
+ + + ++ + +L + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 410 GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469
L R L L R +A LH G H ++ +I+L + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLV--HTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 470 SPSSTPNRIDGYRAPEV----------TDARKVSQKADVYSFGVLLLELLTGKAP----- 514
S+ G+ PE ++ D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321
Query: 515 ---TQALLNEEGVDLPRWVQSVVK 535
+ ++P+ V+++++
Sbjct: 322 ALGGSEWIFRSCKNIPQPVRALLE 345
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 50/222 (22%), Positives = 89/222 (40%), Gaps = 39/222 (17%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
VLG+G FG KA A+K+++ ++ ++ S++H+ +V A +
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 382 YSRDEKL-------------LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR 428
R + + +Y G+L L+H + + L
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYWRLFRQILE 127
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------- 480
A++Y+HS+G H ++K NI + +S +I DFGLA S ++D
Sbjct: 128 ALSYIHSQGII--HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 481 ----------YRAPEVTDARKV-SQKADVYSFGVLLLELLTG 511
Y A EV D ++K D+YS G++ E++
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 66/315 (20%), Positives = 109/315 (34%), Gaps = 61/315 (19%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENL 374
LG G FG Y+ + + VAVK L +V + +F + ++ +H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS--GLALGASRAIAY 432
V + ++ + M G L + L R P + +A + Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEAR---ISDFGLAHLASPSSTPNRIDGYR------- 482
L H +I + N LL+ R I DFG+A R YR
Sbjct: 197 LEENHFI--HRDIAARNCLLTCPGPGRVAKIGDFGMARDI------YRAGYYRKGGCAML 248
Query: 483 -----APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKE 536
PE + K D +SFGVLL E+ + G P + N+
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------------- 293
Query: 537 EWTAEVFDLELLRY-----QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
EV + +N + +++ C P++RP+ A + +IE +
Sbjct: 294 ----EVLEFVTSGGRMDPPKNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQD 346
Query: 592 SLQQGQAHDLENGSS 606
A +E G
Sbjct: 347 PDVINTALPIEYGPL 361
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE-KME---VVG 367
DLE+L +G GT G +K + G V+AVK++ + +++E + M+ V+
Sbjct: 26 DLENL-----GEMGSGTCGQVWKMRFRKTGHVIAVKQM-RRSGNKEENKRILMDLDVVLK 79
Query: 368 SMDHENLVPLRAYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLAL 424
S D +V + + + + + + M + L T + +
Sbjct: 80 SHDCPYIV---QCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV-- 134
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---Y 481
+A+ YL K H ++K SNILL + + ++ DFG++ +R G Y
Sbjct: 135 ---KALYYLKEK-HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAY 190
Query: 482 RAPEVTDARKVSQ-----KADVYSFGVLLLELLTGKAP 514
APE D ++ +ADV+S G+ L+EL TG+ P
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 26/217 (11%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE-KMEVVGSM- 369
DL+DL +G+G +G+ K G ++AVKR+ TV EKE ++ M++ M
Sbjct: 23 DLKDL-----GEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMR 76
Query: 370 --DHENLVPLRAYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLAL 424
D +V +Y R+ + + M S + E + L
Sbjct: 77 SSDCPYIV---QFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---Y 481
+A+ +L H +IK SNILL +S ++ DFG++ S R G Y
Sbjct: 133 ATVKALNHLKENLKII-HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPY 191
Query: 482 RAPEVTDARKVSQ----KADVYSFGVLLLELLTGKAP 514
APE D Q ++DV+S G+ L EL TG+ P
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 50/214 (23%), Positives = 93/214 (43%), Gaps = 21/214 (9%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE-KMEVVGSM- 369
DLE + LG+G +G K + G ++AVKR+ TV+ +E + M++ SM
Sbjct: 8 DLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQKRLLMDLDISMR 61
Query: 370 --DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
D V + + + + M P + + +A+
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIV 119
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRAP 484
+A+ +LHSK + H ++K SN+L++ + ++ DFG++ + G Y AP
Sbjct: 120 KALEHLHSKL-SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 485 EVTDARKV----SQKADVYSFGVLLLELLTGKAP 514
E + S K+D++S G+ ++EL + P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 55/211 (26%), Positives = 94/211 (44%), Gaps = 33/211 (15%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-FREKMEVVGSMDHENLVPLRAY 380
LG G FG YKA E G + A K ++ + E E + ++E++ + DH +V
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIV---KL 81
Query: 381 Y--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
Y D KL ++ ++ P G++ A++ L + A+ +LHSK
Sbjct: 82 LGAYYHDGKLWIMIEFCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSS-------TPNRIDGY-RAPEVTD 488
H ++K+ N+L++ + R++DFG+ A TP Y APEV
Sbjct: 138 --IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP-----YWMAPEVVM 190
Query: 489 ARKVSQ-----KADVYSFGVLLLELLTGKAP 514
+ KAD++S G+ L+E+ + P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 71/311 (22%), Positives = 120/311 (38%), Gaps = 66/311 (21%)
Query: 323 EVLGKGTFGTAYKATL--------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSM--- 369
+ LG+G FG A VAVK LK + + +ME+ M
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM---MKMI 131
Query: 370 -DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG------- 421
H+N++ L ++ +Y G+L L R G + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 422 ----LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR 477
A +R + YL SK H ++ + N+L+++ +I+DFGLA +
Sbjct: 192 DLVSCAYQVARGMEYLASKKCI--HRDLAARNVLVTEDNVMKIADFGLARDI------HH 243
Query: 478 IDGYR------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGV 524
ID Y+ APE R + ++DV+SFGVLL E+ T G +P + EE
Sbjct: 244 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
Query: 525 DLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584
L +KE + + N E+ +++ +C P RP+ ++
Sbjct: 304 KL-------LKE-------GHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVED 346
Query: 585 IEEICRSSLQQ 595
++ I + Q
Sbjct: 347 LDRIVALTSNQ 357
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 55/209 (26%), Positives = 97/209 (46%), Gaps = 27/209 (12%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKR-LKDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
+ G+GTFGT G+ VA+K+ ++D +E + M+ + + H N+V L++Y
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQSY 87
Query: 381 YYSRDEK-------LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL--ALGASRAIA 431
+Y+ E+ +V +Y+P +L P + L + R+I
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI---RSIG 143
Query: 432 YLHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLASPSSTPN------RIDGYRAP 484
LH H +IK N+L++++ ++ DFG A SP S PN R YRAP
Sbjct: 144 CLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP-SEPNVAYICSRY--YRAP 200
Query: 485 EV-TDARKVSQKADVYSFGVLLLELLTGK 512
E+ + + D++S G + E++ G+
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 49/247 (19%), Positives = 81/247 (32%), Gaps = 58/247 (23%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKE--FREKMEVVGSMDHENL 374
+G+G++G A + + A+K +++ + + E E + ++ + H N+
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE-VRLMKKLHHPNI 90
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALL--HGNRGAGRTPLNWETRSGLALGASR---- 428
L Y LV + G L L + G+ ++
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 429 -----------------------------AIAYLHSKGPANSHGNIKSSNILLSKSYEAR 459
A+ YLH++G H +IK N L S +
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC--HRDIKPENFLFSTNKSFE 208
Query: 460 --ISDFGLAHLASPSSTPNRID--------GYRAPEV--TDARKVSQKADVYSFGVLLLE 507
+ DFGL+ + + APEV T K D +S GVLL
Sbjct: 209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268
Query: 508 LLTGKAP 514
LL G P
Sbjct: 269 LLMGAVP 275
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 3e-21
Identities = 58/298 (19%), Positives = 104/298 (34%), Gaps = 64/298 (21%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKM--EV---VGSMDHENLVPL 377
++LG G+ GT G VAVKR+ +F + E+ S DH N++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRML------IDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALL--HGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
+ + + +L L+ L + +A+LHS
Sbjct: 75 YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 436 KGPANSHGNIKSSNILLS-------------KSYEARISDFGLA------------HLAS 470
H ++K NIL+S ++ ISDFGL +L +
Sbjct: 134 LKII--HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 471 PSSTPNRIDGYRAPEV-------TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG 523
PS T G+RAPE+ R++++ D++S G + +L+
Sbjct: 192 PSGTS----GWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH--------- 238
Query: 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
P + + +F L+ ++ + + + L P RP+ +V
Sbjct: 239 ---PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 30/132 (22%), Positives = 47/132 (35%), Gaps = 3/132 (2%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+ L EL + + + L+ S F L L L + + G+ L +L
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 114 IRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLN 171
L +A N+F ++ F T L L L + QL L N+S N L
Sbjct: 451 NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLL 510
Query: 172 GSIPKRFARLPS 183
+ +L S
Sbjct: 511 FLDSSHYNQLYS 522
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 30/130 (23%), Positives = 49/130 (37%), Gaps = 2/130 (1%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLI 114
A +L +L + + + + F L++L L + GN F +F+ NL
Sbjct: 417 FSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT 476
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGS 173
L+L+K F+ L RL L + N L SL+ + SFN++ S
Sbjct: 477 FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS 536
Query: 174 IPKRFARLPS 183
S
Sbjct: 537 KGILQHFPKS 546
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-20
Identities = 31/144 (21%), Positives = 49/144 (34%), Gaps = 4/144 (2%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
L + N +EL + L + + L +L NL L GN PG L
Sbjct: 44 LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGL 103
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQF---NVSF 167
+L L + + S +L L L + N + S FS+L ++S+
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH-SCKLPAYFSNLTNLVHVDLSY 162
Query: 168 NKLNGSIPKRFARLPSSAFEGNSL 191
N + L + SL
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSL 186
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-20
Identities = 33/139 (23%), Positives = 52/139 (37%), Gaps = 7/139 (5%)
Query: 48 GMGLSGQLPIAIG-NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGL 106
LS ++P I + + L FN L+ F+ S L+ L L
Sbjct: 20 DQKLS-KVPDDIPSSTKNI---DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKA 75
Query: 107 LFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNV 165
L +L L L N F+ LT L L E +L +G +L + NV
Sbjct: 76 WHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135
Query: 166 SFNKLNG-SIPKRFARLPS 183
+ N ++ +P F+ L +
Sbjct: 136 AHNFIHSCKLPAYFSNLTN 154
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 36/141 (25%), Positives = 58/141 (41%), Gaps = 2/141 (1%)
Query: 33 GVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRN 91
F + E++ L LT L+T+ + N+ + S+ FA +NL
Sbjct: 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF 477
Query: 92 LYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSI 151
L L G+ +L L LN++ NN S+ +N+L L TL N++ S
Sbjct: 478 LDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSK 537
Query: 152 PD-LGAFSSLAQFNVSFNKLN 171
SLA FN++ N +
Sbjct: 538 GILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 34/132 (25%), Positives = 53/132 (40%), Gaps = 9/132 (6%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLG--NLI 114
+L L +++L N +G+I L +L L L N S LG +L
Sbjct: 322 FPTLDLPFLKSLTLTMN--KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLN 171
L+L+ N +SA+F L L L Q + L + + AF SL + ++S+
Sbjct: 380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLK-RVTEFSAFLSLEKLLYLDISYTNTK 437
Query: 172 GSIPKRFARLPS 183
F L S
Sbjct: 438 IDFDGIFLGLTS 449
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-17
Identities = 20/107 (18%), Positives = 30/107 (28%), Gaps = 1/107 (0%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
L N T L + L L F L L+ L + N L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAF 157
+L L+ + N + + L L N + I + F
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEHQKF 566
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-15
Identities = 24/137 (17%), Positives = 42/137 (30%), Gaps = 6/137 (4%)
Query: 52 SGQLPIAIGNLTELHTVSLRFNALRGTIPSDFA--KLSNLRNLYLQGNLFSGEIPGLLFS 109
G + L L + L NAL + ++ ++LR+L L N +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 110 LGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSF 167
L L L+ + F L +L L + +SL ++
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAG 457
Query: 168 NKLNGSIPKR-FARLPS 183
N + FA +
Sbjct: 458 NSFKDNTLSNVFANTTN 474
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 30/146 (20%), Positives = 43/146 (29%), Gaps = 15/146 (10%)
Query: 52 SGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRN----LYLQGNLFSGEIPGLL 107
S +LP NLT L V L +N ++ +D L L + N I
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQA 200
Query: 108 FSLGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTG----SIPDLGAFSSLAQ 162
F L L L N S I L L L + I + L
Sbjct: 201 FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260
Query: 163 -----FNVSFNKLNGSIPKRFARLPS 183
F +++ +F L +
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLAN 286
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 21/137 (15%), Positives = 39/137 (28%), Gaps = 10/137 (7%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEI------PGL 106
+ +LH ++LR N I L+ L L F E P +
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 107 LFSLGNL--IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFN 164
+ L ++ L N F+ L + + L + + D+ +
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLS 313
Query: 165 VSFNKLNGSIPKRFARL 181
+ +L L
Sbjct: 314 IIRCQLKQFPTLDLPFL 330
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 22/131 (16%), Positives = 45/131 (34%), Gaps = 8/131 (6%)
Query: 56 PIAIGNLTELHTVSLRFNALRGT--IPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
P + L ++ R F L+N+ + L G + +
Sbjct: 252 PSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHF-KW 309
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS 173
L++ + + D L +L L N+ + A SL+ ++S N L+ S
Sbjct: 310 QSLSIIRCQLKQFPTLDLPFLK---SLTLTMNKGS-ISFKKVALPSLSYLDLSRNALSFS 365
Query: 174 IPKRFARLPSS 184
++ L ++
Sbjct: 366 GCCSYSDLGTN 376
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 3e-21
Identities = 60/319 (18%), Positives = 111/319 (34%), Gaps = 51/319 (15%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK---RLKDVTVSEKEFREKMEVVGSMDHENLVPLR 378
++LG+G ++ + G + A+K + + + + RE EV+ ++H+N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE-FEVLKKLNHKNIVKLF 73
Query: 379 AYYYSRDEKL--LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
A + L+ ++ P GSL +L A P + E L + +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFLIVLRDVVG-GMNHLREN 131
Query: 437 GPANSHGNIKSSNILLSKSYEAR----ISDFGLAHLASPSS-------TPNRIDGYRAPE 485
G H NIK NI+ + + ++DFG A T Y P+
Sbjct: 132 GIV--HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE----YLHPD 185
Query: 486 V--------TDARKVSQKADVYSFGVLLLELLTGKAP----------TQALLNEEGVDLP 527
+ +K D++S GV TG P + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 528 RWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQY-PDNRPSMAEVTSQIE 586
+ V K E + ++ ++ + LL + + + + ++
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 587 EICR------SSLQQGQAH 599
+I SLQQ AH
Sbjct: 306 DILHRMVIHVFSLQQMTAH 324
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-21
Identities = 63/271 (23%), Positives = 108/271 (39%), Gaps = 36/271 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL---KDVTVSEKEFREKMEVVGSMDHENLVPLR 378
+ LG G +G + A+K + T S + E++ V+ +DH N++ L
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLY 102
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
++ + LV + G L + R N + + + YLH
Sbjct: 103 DFFEDKRNYYLVMECYKGGELF-----DEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNI 157
Query: 439 ANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSSTPNRIDG---YRAPEVTDARKV 492
H ++K N+LL SK +A +I DFGL+ + G Y APEV +K
Sbjct: 158 V--HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKY 214
Query: 493 SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552
+K DV+S GV+L LL G P ++ + ++ V K + + + ++N
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGG-QTDQEI-----LRKVEKGK-----YTFDSPEWKN 263
Query: 553 VEEEMVQLLQ--LAINCTAQYPDNRPSMAEV 581
V E L++ L + R S +
Sbjct: 264 VSEGAKDLIKQMLQFD-----SQRRISAQQA 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 71/308 (23%), Positives = 121/308 (39%), Gaps = 74/308 (24%)
Query: 323 EVLGKGTFGTAYKATL---EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSM-DHENLVP 376
+V+G+G FG KA + + + A+KR+K+ + ++F ++EV+ + H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS-----------GLALG 425
L R L +Y P G+L L +R P S A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR-IDGYR-- 482
+R + YL K H ++ + NIL+ ++Y A+I+DFGL+ R + Y
Sbjct: 151 VARGMDYLSQKQFI--HRDLAARNILVGENYVAKIADFGLS----------RGQEVYVKK 198
Query: 483 ----------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVD------ 525
A E + + +DV+S+GVLL E+++ G P + E +
Sbjct: 199 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 258
Query: 526 -LPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584
L + EV+DL M Q C + P RPS A++
Sbjct: 259 RLEK------PLNCDDEVYDL-----------MRQ-------CWREKPYERPSFAQILVS 294
Query: 585 IEEICRSS 592
+ +
Sbjct: 295 LNRMLEER 302
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 65/312 (20%), Positives = 112/312 (35%), Gaps = 68/312 (21%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMD-HEN 373
+ LG+G FG +A VAVK LK+ + +++++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 374 LVPLRAYYYSRDEKLLV-HDYMPMGSLSALLHGNRGAGRTPLNWETRSGL---------- 422
+V L L+V ++ G+LS L R
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 423 -ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGY 481
+ ++ + +L S+ H ++ + NILLS+ +I DFGLA + Y
Sbjct: 153 YSFQVAKGMEFLASRKCI--HRDLAARNILLSEKNVVKICDFGLARDI------YKDPDY 204
Query: 482 R------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPR 528
APE R + ++DV+SFGVLL E+ + G +P + +E
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------ 258
Query: 529 WVQSVVKEEWTAEVFDLELLRY-----QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583
E EM Q + +C P RP+ +E+
Sbjct: 259 ------------EFCRRLKEGTRMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELVE 303
Query: 584 QIEEICRSSLQQ 595
+ + +++ QQ
Sbjct: 304 HLGNLLQANAQQ 315
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 71/320 (22%), Positives = 124/320 (38%), Gaps = 84/320 (26%)
Query: 323 EVLGKGTFGTAYKATL--------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSM--- 369
+ LG+G FG A + + VAVK LKD + + +ME+ M
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM---MKMI 143
Query: 370 -DHENLVPLRAYYY---SRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG--- 421
H+N++ L ++D L ++ +Y G+L L R G R
Sbjct: 144 GKHKNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 422 --------LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473
+R + YL S+ H ++ + N+L++++ +I+DFGLA
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKCI--HRDLAARNVLVTENNVMKIADFGLARDI---- 253
Query: 474 TPNRIDGYR------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLN 520
N ID Y+ APE R + ++DV+SFGVL+ E+ T G +P +
Sbjct: 254 --NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311
Query: 521 EEGVDLPRWVQSVVKEEWTAEVFDLELLRY-----QNVEEEMVQLLQLAINCTAQYPDNR 575
EE +F L + N E+ +++ +C P R
Sbjct: 312 EE-------------------LFKLLKEGHRMDKPANCTNELYMMMR---DCWHAVPSQR 349
Query: 576 PSMAEVTSQIEEICRSSLQQ 595
P+ ++ ++ I + +
Sbjct: 350 PTFKQLVEDLDRILTLTTNE 369
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 5e-21
Identities = 62/282 (21%), Positives = 111/282 (39%), Gaps = 47/282 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK--------------DVTVSEKEFREKMEVVG 367
LG G +G A+K +K ++ +E ++ ++
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 368 SMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
S+DH N++ L + + LV ++ G L + R + + +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELF-----EQIINRHKFDECDAANIMKQIL 156
Query: 428 RAIAYLHSKGPANSHGNIKSSNILL-SKSYEARI--SDFGLAHLASPSSTPNRIDG---Y 481
I YLH H +IK NILL +K+ I DFGL+ S G Y
Sbjct: 157 SGICYLHKHNIV--HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYY 214
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541
APEV +K ++K DV+S GV++ LL G P N++ + ++ V K +
Sbjct: 215 IAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG-QNDQDI-----IKKVEKGK---- 263
Query: 542 VFDLELLRYQNVEEEMVQLLQ--LAINCTAQYPDNRPSMAEV 581
+ + ++N+ +E +L++ L + + R + E
Sbjct: 264 -YYFDFNDWKNISDEAKELIKLMLTYD-----YNKRCTAEEA 299
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-21
Identities = 72/272 (26%), Positives = 112/272 (41%), Gaps = 37/272 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKM----EVVGSMDHENLVPL 377
VLGKG+FG G AVK + V +K +E + +++ +DH N++ L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
++ + LV + G L + R + + + I Y+H
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELF-----DEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 438 PANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSSTPNRIDG---YRAPEVTDARK 491
H ++K N+LL SKS +A RI DFGL+ S G Y APEV
Sbjct: 147 IV--HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH-GT 203
Query: 492 VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551
+K DV+S GV+L LL+G P NE + ++ V K + + EL +++
Sbjct: 204 YDEKCDVWSTGVILYILLSGCPPFNG-ANEYDI-----LKKVEKGK-----YTFELPQWK 252
Query: 552 NVEEEMVQLLQ--LAINCTAQYPDNRPSMAEV 581
V E L++ L P R S +
Sbjct: 253 KVSESAKDLIRKMLTYV-----PSMRISARDA 279
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 5e-21
Identities = 66/313 (21%), Positives = 108/313 (34%), Gaps = 85/313 (27%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL--KDVTVSEKEFREKMEVVGSM-DHENLVPLR 378
VL +G F Y+A + G A+KRL + + +E + + + H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE-VCFMKKLSGHPNIVQFC 92
Query: 379 AYYYSRDEK--------LLVHDYMPMGSLSALLHGNRGAGRTP----LNWETRSGLALGA 426
+ E+ LL+ + G L L G L
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKI------FYQT 145
Query: 427 SRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------------- 473
RA+ ++H + P H ++K N+LLS ++ DFG A S
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 474 -------TPNRIDGYRAPEVTDARK---VSQKADVYSFGVLLLELLTGKAP-----TQAL 518
TP YR PE+ D + +K D+++ G +L L + P +
Sbjct: 206 EEITRNTTPM----YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261
Query: 519 LNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQ--LAINCTAQYPDNRP 576
+N + P Q L++ L +N P+ R
Sbjct: 262 VNGKYSIPPHDTQY----------------------TVFHSLIRAMLQVN-----PEERL 294
Query: 577 SMAEVTSQIEEIC 589
S+AEV Q++EI
Sbjct: 295 SIAEVVHQLQEIA 307
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 6e-21
Identities = 66/304 (21%), Positives = 106/304 (34%), Gaps = 71/304 (23%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENL 374
E LG+ FG YK L E VA+K LKD +EFR + + + H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS-----------GLA 423
V L ++ Y G L L + R+ L
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 424 LGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYR- 482
+ + YL S H ++ + N+L+ +ISD GL D Y+
Sbjct: 135 AQIAAGMEYLSSHHVV--HKDLATRNVLVYDKLNVKISDLGLFREV------YAADYYKL 186
Query: 483 -----------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE-------G 523
APE K S +D++S+GV+L E+ + G P N++
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR 246
Query: 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583
LP ++ A V+ L M++ C ++P RP ++ S
Sbjct: 247 QVLPC------PDDCPAWVYAL-----------MIE-------CWNEFPSRRPRFKDIHS 282
Query: 584 QIEE 587
++
Sbjct: 283 RLRA 286
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 62/316 (19%), Positives = 110/316 (34%), Gaps = 75/316 (23%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSM----D 370
+ LG G FG +AT + + VAVK LK + +++V + +
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV---LSYLGN 85
Query: 371 HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL-------- 422
H N+V L L++ +Y G L L R +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 423 -----ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR 477
+ ++ +A+L SK H ++ + NILL+ +I DFGLA
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCI--HRDLAARNILLTHGRITKICDFGLARDI------KN 197
Query: 478 IDGYR------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGV 524
Y APE + ++DV+S+G+ L EL + G +P + +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255
Query: 525 DLPRWVQSVVKEEWTAEVFDL-----ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMA 579
+ + + +L ++ EM +++ C P RP+
Sbjct: 256 ----------------KFYKMIKEGFRMLSPEHAPAEMYDIMK---TCWDADPLKRPTFK 296
Query: 580 EVTSQIEEICRSSLQQ 595
++ IE+ S
Sbjct: 297 QIVQLIEKQISESTNH 312
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 27/207 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKME----VVGSMDHENLVPL 377
++G+G G Y+A +VA+K + + S+ FR +M+ G + ++VP+
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 378 RAYYYSRDEKLLVHDYMPM-----GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
+ + + L Y+ M L+A+L + PL + A+
Sbjct: 100 --HDFGEIDGQL---YVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDA 149
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--TPNRIDG---YRAPEVT 487
H+ G H ++K NIL+S A + DFG+A + G Y APE
Sbjct: 150 AHAAGAT--HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAP 514
+ +AD+Y+ +L E LTG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 35/210 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKME-------VVGSMDHENL 374
+G G+FG Y A + VVA+K++ S K+ EK + + + H N
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMS---YSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 375 VPLRAYY--YSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
+ Y Y R+ LV +Y GS S LL ++ PL + + GA + +A
Sbjct: 117 I---QYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQGLA 168
Query: 432 YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----TPNRIDGYRAPEVT 487
YLHS H ++K+ NILLS+ ++ DFG A + +P++ TP + APEV
Sbjct: 169 YLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY----WMAPEVI 222
Query: 488 DARKVSQ---KADVYSFGVLLLELLTGKAP 514
A Q K DV+S G+ +EL K P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 72/315 (22%), Positives = 117/315 (37%), Gaps = 75/315 (23%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENL 374
+ LG+G FG KAT VAVK LK+ ++ + V+ ++H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA-------- 426
+ L LL+ +Y GSL L +R G L +
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 427 -----------SRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP 475
S+ + YL H ++ + NIL+++ + +ISDFGL+
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLV--HRDLAARNILVAEGRKMKISDFGLSRDV------ 200
Query: 476 NRIDGYR------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
D Y A E + ++DV+SFGVLL E++T G P + E
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE- 259
Query: 523 GVDLPRWVQSVVKEEWTAEVFDLELLRY-----QNVEEEMVQLLQLAINCTAQYPDNRPS 577
+F+L + N EEM +L+ C Q PD RP
Sbjct: 260 ------------------RLFNLLKTGHRMERPDNCSEEMYRLML---QCWKQEPDKRPV 298
Query: 578 MAEVTSQIEEICRSS 592
A+++ +E++
Sbjct: 299 FADISKDLEKMMVKR 313
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 60/270 (22%), Positives = 112/270 (41%), Gaps = 37/270 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKME----VVGSMDHENLVPL 377
+ LG G T Y A + I VA+K + ++E ++ E + H+N+V +
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 378 RAYYYSRDEKL--LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
++ LV +Y+ +LS + + PL+ +T I + H
Sbjct: 77 --IDVDEEDDCYYLVMEYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHD 129
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--TPNRIDG---YRAPEVTDAR 490
H +IK NIL+ + +I DFG+A S +S N + G Y +PE
Sbjct: 130 MRIV--HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 491 KVSQKADVYSFGVLLLELLTGKAP-------TQAL--LNEEGVDLPRWVQSVVKEEWTAE 541
+ D+YS G++L E+L G+ P + A+ + + ++ V+ + + +
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247
Query: 542 VF-----DLELLRYQNVEEEMVQLLQLAIN 566
+ D RY+ + +EM L ++
Sbjct: 248 ILRATEKDKA-NRYKTI-QEMKDDLSSVLH 275
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 69/316 (21%), Positives = 120/316 (37%), Gaps = 76/316 (24%)
Query: 323 EVLGKGTFGTAYKATL--------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSM--- 369
+ LG+G FG A + + VAVK LKD + + +ME+ M
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEM---MKMI 97
Query: 370 -DHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG------- 421
H+N++ L ++ +Y G+L L R G R
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 422 ----LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR 477
+R + YL S+ H ++ + N+L++++ +I+DFGLA N
Sbjct: 158 DLVSCTYQLARGMEYLASQKCI--HRDLAARNVLVTENNVMKIADFGLARDI------NN 209
Query: 478 IDGYR------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGV 524
ID Y+ APE R + ++DV+SFGVL+ E+ T G +P + E
Sbjct: 210 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266
Query: 525 DLPRWVQSVVKEEWTAEVFDLELLRY-----QNVEEEMVQLLQLAINCTAQYPDNRPSMA 579
E+F L + N E+ +++ +C P RP+
Sbjct: 267 ----------------ELFKLLKEGHRMDKPANCTNELYMMMR---DCWHAVPSQRPTFK 307
Query: 580 EVTSQIEEICRSSLQQ 595
++ ++ I + +
Sbjct: 308 QLVEDLDRILTLTTNE 323
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 52/289 (17%), Positives = 103/289 (35%), Gaps = 62/289 (21%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVPLRA 379
+ +G G ++ E + A+K + + +R ++ + + + +R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 380 YYYSRDEKLLVHDYMPM----GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
Y Y ++ + YM M L++ L + ++ R A+ +H
Sbjct: 94 YDYEITDQYI---YMVMECGNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIHQ 145
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA----------HLASPSSTPNRIDGYRAPE 485
G H ++K +N L+ ++ DFG+A S T N Y PE
Sbjct: 146 HGIV--HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN----YMPPE 198
Query: 486 V-----------TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV 534
K+S K+DV+S G +L + GK P Q ++N+ + +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------ISKLH 250
Query: 535 KEEWTAEVFDLELLRYQNVEEEMVQLLQ--LAINCTAQYPDNRPSMAEV 581
+ E+++ +L+ L + P R S+ E+
Sbjct: 251 AIIDPNHEIEF----PDIPEKDLQDVLKCCLKRD-----PKQRISIPEL 290
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 2e-20
Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 23/286 (8%)
Query: 239 LCRRKRDRQRSSKDVAPAATATATAKQTEIEIPREKG-AGDGENTSSDLSGVVKGESKGS 297
+ K + + + AP K+ E+G G+ T S +
Sbjct: 83 IAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQ 142
Query: 298 GVKNLVFFGKGD--RAFDLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV 354
V +D+ E LG G FG ++ T G A K +
Sbjct: 143 YYPQPVEIKHDHVLDHYDIH-------EELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195
Query: 355 SEKE-FREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTP 413
S+KE R++++ + + H LV L + +E ++++++M G L +
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---- 251
Query: 414 LNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARI--SDFGLAHLASP 471
++ + + + ++H H ++K NI+ + + DFGL P
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYV--HLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
Query: 472 SSTPNRIDG---YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+ G + APEV + + V D++S GVL LL+G +P
Sbjct: 310 KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 31/208 (14%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKR-LKDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
+V+G G+FG Y+A L + G +VA+K+ L+D + RE ++++ +DH N+V LR +
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNRE-LQIMRKLDHCNIVRLRYF 115
Query: 381 YYSRDEKL------LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL--ALGASRAIAY 432
+YS EK LV DY+P ++ + A +T + + R++AY
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF---RSLAY 171
Query: 433 LHSKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSSTPN------RIDGYRAPE 485
+HS G H +IK N+LL + ++ DFG A PN R YRAPE
Sbjct: 172 IHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSRY--YRAPE 226
Query: 486 VT-DARKVSQKADVYSFGVLLLELLTGK 512
+ A + DV+S G +L ELL G+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVP---- 376
E++G GT+G YK ++ G + A+K + E+E ++++ ++ H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 377 -LRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
++ D++L LV ++ GS++ L+ +G L E + + R +++LH
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLH 146
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGL-AHLASPSSTPNRIDG---YRAPEVTDAR 490
H +IK N+LL+++ E ++ DFG+ A L N G + APEV
Sbjct: 147 QHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD 204
Query: 491 KVSQ-----KADVYSFGVLLLELLTGKAP 514
+ K+D++S G+ +E+ G P
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 63/312 (20%), Positives = 119/312 (38%), Gaps = 71/312 (22%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSM----D 370
+ LG G FG +AT + + VAVK LK ++ + ++++ M
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI---MSHLGQ 108
Query: 371 HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL-------- 422
HEN+V L L++ +Y G L L T + +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 423 -ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGY 481
+ ++ +A+L SK H ++ + N+LL+ + A+I DFGLA Y
Sbjct: 169 FSSQVAQGMAFLASKNCI--HRDVAARNVLLTNGHVAKIGDFGLARDI------MNDSNY 220
Query: 482 R------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPR 528
APE + ++DV+S+G+LL E+ + G P +L
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------ 274
Query: 529 WVQSVVKEEWTAEVFDL-----ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583
+ + L ++ + + + ++Q C A P +RP+ ++ S
Sbjct: 275 ------------KFYKLVKDGYQMAQPAFAPKNIYSIMQ---ACWALEPTHRPTFQQICS 319
Query: 584 QIEEICRSSLQQ 595
++E + ++
Sbjct: 320 FLQEQAQEDRRE 331
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 43/221 (19%), Positives = 78/221 (35%), Gaps = 45/221 (20%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE----FREKMEVVGSMDHENLVPLR 378
+ +G G ++ E + A+K + + E + + + + +R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE-IAYLNKLQQHSDKIIR 73
Query: 379 AYYYSRDEKLLVHDYMPM----GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
Y Y ++ + YM M L++ L + ++ R A+ +H
Sbjct: 74 LYDYEITDQYI---YMVMECGNIDLNSWLK-KKK----SIDPWERKSYWKNMLEAVHTIH 125
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLA----------HLASPSSTPNRIDGYRAP 484
G H ++K +N L+ ++ DFG+A S T N Y P
Sbjct: 126 QHGIV--HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN----YMPP 178
Query: 485 EV-----------TDARKVSQKADVYSFGVLLLELLTGKAP 514
E K+S K+DV+S G +L + GK P
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 7e-20
Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 32/209 (15%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEF--REKMEVVGSMDHENLVPLRAY 380
+V+G G+FG ++A L VA+K++ +K F RE ++++ + H N+V L+A+
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVL----QDKRFKNRE-LQIMRIVKHPNVVDLKAF 100
Query: 381 YYSRDEKL------LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL--ALGASRAIAY 432
+YS +K LV +Y+P ++ +T + + L R++AY
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAY 156
Query: 433 LHSKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSSTPN------RIDGYRAPE 485
+HS G H +IK N+LL S ++ DFG A + PN R YRAPE
Sbjct: 157 IHSIGIC--HRDIKPQNLLLDPPSGVLKLIDFGSAKILIA-GEPNVSYICSRY--YRAPE 211
Query: 486 VT-DARKVSQKADVYSFGVLLLELLTGKA 513
+ A + D++S G ++ EL+ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQP 240
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-20
Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 46/276 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVPLR 378
+LGKG+FG K AVK + + K+ ++E++ +DH N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 379 AYYYSRDEKLLVHDYMPMGSL--SALLHGN---RGAGRTPLNWETRSGLALGASRAIAYL 433
+V + G L + A R + I Y+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQVF-----SGITYM 137
Query: 434 HSKGPANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSSTPNRIDG---YRAPEVT 487
H H ++K NILL SK + +I DFGL+ ++ G Y APEV
Sbjct: 138 HKHNIV--HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL 195
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547
+K DV+S GV+L LL+G P NE + ++ V + + +L
Sbjct: 196 R-GTYDEKCDVWSAGVILYILLSGTPPFYG-KNEYDI-----LKRVETGK-----YAFDL 243
Query: 548 LRYQNVEEEMVQLLQ--LAINCTAQYPDNRPSMAEV 581
+++ + ++ L++ L + P R + +
Sbjct: 244 PQWRTISDDAKDLIRKMLTFH-----PSLRITATQC 274
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 39/195 (20%), Positives = 67/195 (34%), Gaps = 19/195 (9%)
Query: 34 VFCTGER----------VTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSD- 82
C V + ++ + L +L + + I ++
Sbjct: 15 AICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT 74
Query: 83 FAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNLAKNNF-SGTISAD-FNKLTRLGT 139
F LS+L L L N F ++ F L NL L L + N +S + F LT L
Sbjct: 75 FRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM 133
Query: 140 LYLQENQLTGSIPDLGAFSSLAQF---NVSFNKLNGSIPKRFARLPSSAFEGNSLCGKPL 196
L L++N + I F ++ +F +++FNK+ + F L L
Sbjct: 134 LVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITL 192
Query: 197 VSCNGGGDDDDDDGS 211
N + G+
Sbjct: 193 QDMNEYWLGWEKCGN 207
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 3e-15
Identities = 32/103 (31%), Positives = 47/103 (45%), Gaps = 8/103 (7%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNL 118
+ T+L ++L N + I + F L++L L L N I +F +L L L+L
Sbjct: 297 HFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDL 354
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
+ N+ + F L L L L NQL S+PD G F L
Sbjct: 355 SYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPD-GIFDRL 394
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 27/146 (18%), Positives = 44/146 (30%), Gaps = 19/146 (13%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLG--NLIRLN 117
LT L + LR N ++ P+ F + L L N L + + L
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186
Query: 118 LAKNN--------FSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLA-------Q 162
L+ + K T + TL L N F ++A
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK-ESMAKRFFDAIAGTKIQSLI 245
Query: 163 FNVSFNKLNGSIPKRFARLPSSAFEG 188
+ S+N + F + F+G
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKG 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 22/142 (15%), Positives = 46/142 (32%), Gaps = 22/142 (15%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL---- 116
L+ + + L + K +++ L L GN F + F ++
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 117 ---------NLAKNNFSGTISADFNKL--TRLGTLYLQENQLTGSIPDLGAFSSLAQ--- 162
+ NF + F L + + T L ++++ ++ FS
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLK-SVFSHFTDLEQ 303
Query: 163 FNVSFNKLNGSIPKR-FARLPS 183
++ N++N I F L
Sbjct: 304 LTLAQNEIN-KIDDNAFWGLTH 324
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 19/65 (29%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNL 118
NL +L + L +N +R + F L NL+ L L N +P +F L +L ++ L
Sbjct: 345 NLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWL 402
Query: 119 AKNNF 123
N +
Sbjct: 403 HTNPW 407
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 41/228 (17%), Positives = 73/228 (32%), Gaps = 59/228 (25%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE----FREKMEVVGSMDHENLVPLR 378
+ +G G ++ E + A+K + + E + + + + +R
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE-IAYLNKLQQHSDKIIR 120
Query: 379 AYYYSRDEKLLVHDYMPM----GSLSALLHGNRGAGRTPLNWETRSGLALGASR------ 428
Y Y ++ + YM M L++ L
Sbjct: 121 LYDYEITDQYI---YMVMECGNIDLNSWLKKK---KSIDPWE---------RKSYWKNML 165
Query: 429 -AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA----------HLASPSSTPNR 477
A+ +H G H ++K +N L+ ++ DFG+A S N
Sbjct: 166 EAVHTIHQHGIV--HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVN- 221
Query: 478 IDGYRAPEV-----------TDARKVSQKADVYSFGVLLLELLTGKAP 514
Y PE K+S K+DV+S G +L + GK P
Sbjct: 222 ---YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 65/318 (20%), Positives = 105/318 (33%), Gaps = 80/318 (25%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSM----D 370
+VLG G FG AT + I VAVK LK+ S + ++++ M
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM---MTQLGS 107
Query: 371 HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA- 429
HEN+V L L+ +Y G L L R
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 430 -------------IA----YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472
+A +L K H ++ + N+L++ +I DFGLA
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKSCV--HRDLAARNVLVTHGKVVKICDFGLARDI--- 222
Query: 473 STPNRIDGYR------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALL 519
Y APE + K+DV+S+G+LL E+ + G P +
Sbjct: 223 ---MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279
Query: 520 NEEGVDLPRWVQSVVKEEWTAEVFDL-----ELLRYQNVEEEMVQLLQLAINCTAQYPDN 574
+ + L ++ + EE+ ++Q +C A
Sbjct: 280 VDA------------------NFYKLIQNGFKMDQPFYATEEIYIIMQ---SCWAFDSRK 318
Query: 575 RPSMAEVTSQIEEICRSS 592
RPS +TS + +
Sbjct: 319 RPSFPNLTSFLGCQLADA 336
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 36/227 (15%), Positives = 76/227 (33%), Gaps = 49/227 (21%)
Query: 324 VLGKGTFGTAYKATLEMGIVVAVK-------------------RLKDVTVSEKEFREKME 364
L +G F + A+K ++ + + E ++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNE-LQ 95
Query: 365 VVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLAL 424
++ + +E + + DE ++++YM S+ L+ + +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF-----VLDKNYTCFIPI 150
Query: 425 GASR--------AIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473
+ + +Y+H+ K H ++K SNIL+ K+ ++SDFG +
Sbjct: 151 QVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK 208
Query: 474 ----TPNRIDGYRAPEVTDARKV--SQKADVYSFGVLLLELLTGKAP 514
T + PE K D++S G+ L + P
Sbjct: 209 GSRGTYE----FMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 52/218 (23%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL-KDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
EVLG G F + G + A+K + K + ++ V+ + HEN+V L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 381 YYSRDEKLLVHDYMPMGSL---------------SALLHGNRGAGRTPLNWETRSGLALG 425
Y S LV + G L S ++ + L+
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVI-------QQVLS---------- 117
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILL-SKSYEAR--ISDFGLAHLASPSS------TPN 476
A+ YLH G H ++K N+L + ++ I+DFGL+ + TP
Sbjct: 118 ---AVKYLHENGIV--HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTP- 171
Query: 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
GY APEV + S+ D +S GV+ LL G P
Sbjct: 172 ---GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 53/210 (25%), Positives = 82/210 (39%), Gaps = 31/210 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL--KDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
LG G FG + G+ +K + V ++ ++EV+ S+DH N++ +
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 380 YYYSRDEKLLVHDYMPMGSL------SALLHGN---RGAGRTPLNWETRSGLALGASRAI 430
+ +V + G L + + + A+
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-----MKQMMN-----AL 137
Query: 431 AYLHSKGPANSHGNIKSSNILL-SKSYEARI--SDFGLAHLASPSSTPNRIDG---YRAP 484
AY HS+ H ++K NIL S + I DFGLA L G Y AP
Sbjct: 138 AYFHSQHVV--HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAP 514
EV R V+ K D++S GV++ LLTG P
Sbjct: 196 EVFK-RDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 61/315 (19%), Positives = 117/315 (37%), Gaps = 75/315 (23%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENL 374
+G+G FG ++A E +VAVK LK+ ++ +F+ + ++ D+ N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL------------ 422
V L L+ +YM G L+ L L+ S
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 423 -------ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP 475
A + +AYL + H ++ + N L+ ++ +I+DFGL+
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFV--HRDLATRNCLVGENMVVKIADFGLSRNI------ 224
Query: 476 NRIDGYR------------APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEE 522
D Y+ PE + + ++DV+++GV+L E+ + G P + +E
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 283
Query: 523 GVDLPRWVQSVVKEEWTAEVFDLELLRY-----QNVEEEMVQLLQLAINCTAQYPDNRPS 577
EV +N E+ L++ C ++ P +RPS
Sbjct: 284 ------------------EVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADRPS 322
Query: 578 MAEVTSQIEEICRSS 592
+ ++ +C +
Sbjct: 323 FCSIHRILQRMCERA 337
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 56/213 (26%), Positives = 89/213 (41%), Gaps = 41/213 (19%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-FREKMEVVGSMDHENLVPLRAY 380
E+LG G FG +K G+ +A K +K + +KE + ++ V+ +DH NL+ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALG---ASR-------AI 430
+ S+++ +LV +Y+ G L + L I
Sbjct: 155 FESKNDIVLVMEYVDGGEL--------------FDRIIDESYNLTELDTILFMKQICEGI 200
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARI--SDFGLAHLASPSS-------TPNRIDGY 481
++H H ++K NIL +I DFGLA P TP +
Sbjct: 201 RHMHQMYIL--HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP----EF 254
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
APEV + VS D++S GV+ LL+G +P
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 30/229 (13%)
Query: 302 LVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFR 360
++F G + + + D + S +VLG G G + G A+K L D S K +
Sbjct: 14 VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD---SPKARQ 70
Query: 361 EKMEVVGSMDHENLVPLRAYY----YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNW 416
E + ++V + Y + + L++ + M G L +R R +
Sbjct: 71 EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF-----SRIQERGDQAF 125
Query: 417 ETR--SGLALGASRAIAYLHSKGPANSHGNIKSSNILL-SKSYEA--RISDFGLA----- 466
R + + AI +LHS A H ++K N+L SK +A +++DFG A
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHNIA--HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
Query: 467 -HLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
L +P TP Y APEV K + D++S GV++ LL G P
Sbjct: 184 NALQTPCYTP----YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 35/214 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKME----VVGSMDHENLV-- 375
E+LG G + A L VAVK L+ + F + +++H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 376 --------PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
P Y +V +Y+ +L ++H P+ + + A
Sbjct: 78 YDTGEAETPAGPLPY------IVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADAC 126
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP----NRIDG--- 480
+A+ + H G H ++K +NI++S + ++ DFG+A + S + G
Sbjct: 127 QALNFSHQNGII--HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 481 YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
Y +PE V ++DVYS G +L E+LTG+ P
Sbjct: 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 41/109 (37%), Positives = 53/109 (48%), Gaps = 6/109 (5%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
LP+ L L + + FN L ++P L L+ LYL+GN PGLL L
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 114 IRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLA 161
+L+LA NN + + A N L L TL LQEN L +IP G F S
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPK-GFFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 31/134 (23%), Positives = 52/134 (38%), Gaps = 14/134 (10%)
Query: 55 LPIAI-GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
LP + + T LH L N L + + L L L + ++ + +L L
Sbjct: 25 LPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVL 79
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKL 170
L+L+ N ++ L L L + N+LT S+P GA L + + N+L
Sbjct: 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPL-GALRGLGELQELYLKGNEL 136
Query: 171 NGSIPKR-FARLPS 183
++P P
Sbjct: 137 K-TLPPGLLTPTPK 149
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 23/101 (22%), Positives = 41/101 (40%), Gaps = 5/101 (4%)
Query: 83 FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYL 142
+K+++ + + +P L + L+L++N A TRL L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 143 QENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
+LT + G L ++S N+L S+P LP+
Sbjct: 63 DRAELT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPA 101
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 45/213 (21%), Positives = 80/213 (37%), Gaps = 41/213 (19%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-FREKMEVVGSMDHENLVPLRAY 380
E LG G FG ++ G V K + +K + ++ ++ + H L+ L
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALG---ASR-------AI 430
+ + E +L+ +++ G L + + +
Sbjct: 117 FEDKYEMVLILEFLSGGEL--------------FDRIAAEDYKMSEAEVINYMRQACEGL 162
Query: 431 AYLHSKGPANSHGNIKSSNILLS--KSYEARISDFGLAHLASPSS-------TPNRIDGY 481
++H H +IK NI+ K+ +I DFGLA +P T +
Sbjct: 163 KHMHEHSIV--HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA----EF 216
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
APE+ D V D+++ GVL LL+G +P
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 43/218 (19%), Positives = 79/218 (36%), Gaps = 52/218 (23%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
E LG+G FG ++ K +K + ++++ ++ H N++ L +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 382 YSRDEKLLVHDYMPMGSL----------------SALLHGNRGAGRTPLNWETRSGLALG 425
S +E +++ +++ + + +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYV-------HQVCE---------- 113
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLS--KSYEARISDFGLAHLASPSS-------TPN 476
A+ +LHS H +I+ NI+ +S +I +FG A P P
Sbjct: 114 ---ALQFLHSHNIG--HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP- 167
Query: 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
Y APEV VS D++S G L+ LL+G P
Sbjct: 168 ---EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 52/202 (25%), Positives = 81/202 (40%), Gaps = 18/202 (8%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL--KDVTVSEKE-FREKMEVVGSMDHENLVPLR 378
+LGKG+FG K AVK + + ++E++ +DH N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+V + G L + R + + + I Y+H
Sbjct: 88 EILEDSSSFYIVGELYTGGELF-----DEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142
Query: 439 ANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSSTPNRIDG---YRAPEVTDARKV 492
H ++K NILL SK + +I DFGL+ ++ G Y APEV
Sbjct: 143 V--HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTY 199
Query: 493 SQKADVYSFGVLLLELLTGKAP 514
+K DV+S GV+L LL+G P
Sbjct: 200 DEKCDVWSAGVILYILLSGTPP 221
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 29/139 (20%), Positives = 47/139 (33%), Gaps = 4/139 (2%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
+ + EL + L ++ + LS+L L L GN G L +L +
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 104
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQF---NVSFNKLNG 172
L + N + + L L L + N + S FS+L ++S NK+
Sbjct: 105 LVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 173 SIPKRFARLPSSAFEGNSL 191
L SL
Sbjct: 164 IYCTDLRVLHQMPLLNLSL 182
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 37/135 (27%), Positives = 57/135 (42%), Gaps = 9/135 (6%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+ L +L + + + L+ S F L NL L + G+ L +L
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSL 447
Query: 114 IRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNK 169
L +A N+F D F +L L L L + QL + AF+SL+ N++ N+
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP-TAFNSLSSLQVLNMASNQ 505
Query: 170 LNGSIPKR-FARLPS 183
L S+P F RL S
Sbjct: 506 LK-SVPDGIFDRLTS 519
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 32/126 (25%), Positives = 48/126 (38%), Gaps = 7/126 (5%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
+ L L FN LR F L+ L L G SL +L L L
Sbjct: 29 STKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPD--LGAFSSLAQFNVSFNKLN-GSIPKR 177
N F+ L+ L L E L S+ + +G +L + NV+ N + +P+
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 178 FARLPS 183
F+ L +
Sbjct: 145 FSNLTN 150
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 7e-14
Identities = 34/145 (23%), Positives = 55/145 (37%), Gaps = 8/145 (5%)
Query: 50 GLSGQLPIAIGNLTELHTVSLRFNALR-GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF 108
L+ IG+L L +++ N ++ +P F+ L+NL +L L N L
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR 170
Query: 109 SLGNL----IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFN 164
L + + L+L+ N + I K RL L L+ N + ++ LA
Sbjct: 171 VLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMK-TCIQGLAGLE 228
Query: 165 VSFNKLNGSIP-KRFARLPSSAFEG 188
V L + SA EG
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEG 253
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 27/102 (26%), Positives = 40/102 (39%), Gaps = 1/102 (0%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
L+ L + + N+ + D F +L NL L L P SL +L L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 499
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFS 158
N+A N F++LT L ++L N S P + S
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 541
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 28/129 (21%), Positives = 40/129 (31%), Gaps = 10/129 (7%)
Query: 52 SGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRN----LYLQGNLFSGEIPGLL 107
S +LP NLT L + L N ++ +D L + L L N + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 108 FSLGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTG----SIPDLGAFSSLAQ 162
F L +L L N S + L L L + D A L
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 163 FNVSFNKLN 171
+ +L
Sbjct: 257 LTIEEFRLA 265
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 27/159 (16%), Positives = 50/159 (31%), Gaps = 14/159 (8%)
Query: 30 KWVGVFCTGERVTMLRFPGMGLSGQLPIAI-GNLTELHTVSLRFNALRGTIPSDFAKLSN 88
+ +F V+ + + + L V+ +F KL +
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP------TLKLKS 326
Query: 89 LRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN--NFSGTISADFNKLTRLGTLYLQENQ 146
L+ L N + L +L L+L++N +F G S T L L L N
Sbjct: 327 LKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 147 LTGSIPDLGAFSSLAQFNVSFNKLNGSIPKR--FARLPS 183
+ + L + + L + + F L +
Sbjct: 385 VITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRN 422
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 27/148 (18%), Positives = 40/148 (27%), Gaps = 11/148 (7%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEI------PGL 106
+ LH ++LR N + L+ L L F E
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 107 LFSLGNLI--RLNLAKNNFSGT-ISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQF 163
L L NL LA ++ I FN LT + + L + + D
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHL 309
Query: 164 NVSFNKLNGSIPKRFARLPSSAFEGNSL 191
+ K + L F N
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKG 337
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 18/74 (24%), Positives = 29/74 (39%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114
LP L L + L L P+ F LS+L+ L + N G+ L +L
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQ 521
Query: 115 RLNLAKNNFSGTIS 128
++ L N + +
Sbjct: 522 KIWLHTNPWDCSCP 535
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 51/211 (24%), Positives = 90/211 (42%), Gaps = 30/211 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-------RLKDVTVSEKEFREKMEVVGSMDHENL 374
E LG G F K G A K VS +E ++ ++ + H N+
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ L + ++ + +L+ + + G L + A + L + + + YLH
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELF-----DFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 435 SKGPANSHGNIKSSNILL-SKSYEA---RISDFGLAHLASPSS-------TPNRIDGYRA 483
SK A H ++K NI+L K+ ++ DFG+AH + TP + A
Sbjct: 126 SKRIA--HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP----EFVA 179
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
PE+ + + +AD++S GV+ LL+G +P
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-------RLKDVTVSEKEFREKMEVVGSMDHENL 374
E LG G F K G+ A K R VS +E ++ ++ + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ L Y +R + +L+ + + G L + A + L+ E + + YLH
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 435 SKGPANSHGNIKSSNILL-SKSYEA---RISDFGLAHLASPSS-------TPNRIDGYRA 483
+K A H ++K NI+L K+ ++ DFGLAH TP + A
Sbjct: 133 TKKIA--HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP----EFVA 186
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
PE+ + + +AD++S GV+ LL+G +P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 7/127 (5%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ +LT LH + N + P A ++ L +L + N + P L +L L L
Sbjct: 193 SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWL 248
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPK 176
+ N S I+A LT+L L + NQ++ I L S L ++ N+L +
Sbjct: 249 EIGTNQIS-DINA-VKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDME 305
Query: 177 RFARLPS 183
L +
Sbjct: 306 VIGGLTN 312
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 4e-17
Identities = 32/127 (25%), Positives = 58/127 (45%), Gaps = 8/127 (6%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ NL +L + + N + T S L+NLR LYL + S P L +L + L
Sbjct: 82 SPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSL 137
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPK 176
NL N+ +S + +T L L + E+++ + + + L ++++N++ P
Sbjct: 138 NLGANHNLSDLSP-LSNMTGLNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQIEDISP- 194
Query: 177 RFARLPS 183
A L S
Sbjct: 195 -LASLTS 200
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 9e-16
Identities = 27/114 (23%), Positives = 48/114 (42%), Gaps = 5/114 (4%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ NL++L + + N + + + L+ L+ L + N S +I L +L L L
Sbjct: 237 SPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQIS-DISVL-NNLSQLNSL 292
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
L N LT L TL+L +N +T I L + S + + + +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT-DIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 36/126 (28%), Positives = 54/126 (42%), Gaps = 8/126 (6%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
I LT L ++L N + P + L L NLY+ N + +I L +L NL L
Sbjct: 61 GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISAL-QNLTNLRELY 116
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKR 177
L ++N S IS LT++ +L L N + L + L V+ +K+ P
Sbjct: 117 LNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP-- 172
Query: 178 FARLPS 183
A L
Sbjct: 173 IANLTD 178
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 2e-15
Identities = 26/119 (21%), Positives = 50/119 (42%), Gaps = 7/119 (5%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+ N+T L+ +++ + ++ P A L++L +L L N P L SL +L
Sbjct: 146 SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSL 201
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172
N + +TRL +L + N++T + L S L + N+++
Sbjct: 202 HYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT-DLSPLANLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 29/128 (22%), Positives = 47/128 (36%), Gaps = 8/128 (6%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
+ L + + + + L+NL L L GN + P L +L L
Sbjct: 37 VVTQEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTN 92
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
L + N + ISA LT L LYL E+ ++ I L + + N+ N S
Sbjct: 93 LYIGTNKIT-DISA-LQNLTNLRELYLNEDNIS-DISPLANLTKMYSLNLGANHN-LSDL 148
Query: 176 KRFARLPS 183
+ +
Sbjct: 149 SPLSNMTG 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 25/119 (21%), Positives = 50/119 (42%), Gaps = 7/119 (5%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+L E L+ ++ + +L ++ L + G + I G + L NL L
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
NL N + + L +L LY+ N++T I L ++L + ++ + ++ P
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNLTNLRELYLNEDNISDISP 127
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 20/91 (21%), Positives = 41/91 (45%), Gaps = 4/91 (4%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
A+ +LT+L +++ N + + S LS L +L+L N E ++ L NL L
Sbjct: 260 AVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLF 317
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLT 148
L++N+ + L+++ + +
Sbjct: 318 LSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 44/150 (29%), Positives = 61/150 (40%), Gaps = 15/150 (10%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNL 118
LT LH++ L N L I S+ F + NLR L L N + LFS L L L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAF------SSLAQFNVSFNKLN 171
N+ + + F + +L LYL +NQ++ P L ++S NKL
Sbjct: 120 YNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV-ELIKDGNKLPKLMLLDLSSNKLK 176
Query: 172 GSIPKRFARLPSSAFEGNSLCGKPLV-SCN 200
+LP+ G L PL C
Sbjct: 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 27/123 (21%), Positives = 44/123 (35%), Gaps = 13/123 (10%)
Query: 67 TVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNLAKNNFSG 125
+S L +P S L L N S + L NL L L+ N+ +
Sbjct: 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN- 77
Query: 126 TISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKR-FAR 180
IS++ F + L L L N L ++ + FS L + N + + + F
Sbjct: 78 FISSEAFVPVPNLRYLDLSSNHLH-TLDE-FLFSDLQALEVLLLYNNHIV-VVDRNAFED 134
Query: 181 LPS 183
+
Sbjct: 135 MAQ 137
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 32/135 (23%), Positives = 50/135 (37%), Gaps = 9/135 (6%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN-LFSGEIPGLLFS-LG 111
+P I + + L N L+ F KL+ L L L N L
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 112 NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFN 168
+L L+L+ N T+S++F L +L L Q + L + + F SL ++S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHT 136
Query: 169 KLNGSIPKRFARLPS 183
+ F L S
Sbjct: 137 HTRVAFNGIFNGLSS 151
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 31/129 (24%), Positives = 50/129 (38%), Gaps = 10/129 (7%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNLA 119
T L + L FN + T+ S+F L L +L Q + +F L NLI L+++
Sbjct: 76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134
Query: 120 KNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIP 175
+ FN L+ L L + N + F+ L ++S +L +
Sbjct: 135 HTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLP-DIFTELRNLTFLDLSQCQLE-QLS 191
Query: 176 KR-FARLPS 183
F L S
Sbjct: 192 PTAFNSLSS 200
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 28/118 (23%), Positives = 47/118 (39%), Gaps = 11/118 (9%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNL 118
L+ L + + N+ + D F +L NL L L ++ F+ L +L LN+
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAF----SSLAQFNVSFNKLN 171
+ NNF ++ + L L L N + + SSLA N++ N
Sbjct: 207 SHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKK-QELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 7/101 (6%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS 109
LP L L + L L + F LS+L+ L + N F + +
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
Query: 110 -LGNLIRLNLAKNNFSGTISAD--FNKLTRLGTLYLQENQL 147
L +L L+ + N+ T + + L L L +N
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 22/95 (23%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 92 LYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSI 151
+ + +P + S + RL L N F+KLT+L L L N L+
Sbjct: 12 IRCNSKGLT-SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 152 PDLGAF---SSLAQFNVSFNKLNGSIPKRFARLPS 183
+ +SL ++SFN + ++ F L
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 102
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 6e-18
Identities = 49/208 (23%), Positives = 87/208 (41%), Gaps = 32/208 (15%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-FREKMEVVGSMDHENLVPLRAY 380
+G+G++G A I A K++ V + + F++++E++ S+DH N++ L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 381 YYSRDEKLLVHDYMPMGSL--SALLHGN---RGAG---RTPLNWETRSGLALGASRAIAY 432
+ + LV + G L + A + L+ A+AY
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS-------------AVAY 121
Query: 433 LHSKGPANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSSTPNRIDG---YRAPEV 486
H A H ++K N L + S ++ ++ DFGLA P G Y +P+V
Sbjct: 122 CHKLNVA--HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKAP 514
+ + D +S GV++ LL G P
Sbjct: 180 LE-GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-------RLKDVTVSEKEFREKMEVVGSMDHENL 374
E LG G F K G+ A K R V +E ++ ++ + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ L Y +R + +L+ + + G L + A + L+ E + + YLH
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELF-----DFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 435 SKGPANSHGNIKSSNILL-SKSYEA---RISDFGLAHLASPSS-------TPNRIDGYRA 483
+K A H ++K NI+L K+ ++ DFGLAH TP + A
Sbjct: 133 TKKIA--HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP----EFVA 186
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
PE+ + + +AD++S GV+ LL+G +P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 47/225 (20%), Positives = 87/225 (38%), Gaps = 56/225 (24%)
Query: 318 LRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HENLV 375
L + LG+G+F K + AVK + + +E + + + H N+V
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-RMEANTQKE-ITALKLCEGHPNIV 69
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSL---------------SALLHGNRGAGRTPLNWETRS 420
L ++ + LV + + G L S ++ R ++
Sbjct: 70 KLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM-------RKLVS----- 117
Query: 421 GLALGASRAIAYLHSKGPANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSS---- 473
A++++H G H ++K N+L ++ +I DFG A L P +
Sbjct: 118 --------AVSHMHDVGVV--HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
Query: 474 ----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
T Y APE+ + + D++S GV+L +L+G+ P
Sbjct: 168 TPCFTL----HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 1e-17
Identities = 58/206 (28%), Positives = 83/206 (40%), Gaps = 25/206 (12%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL---KDVTVSEKEFREKMEVVGSMDHENLVPLR 378
E LGKG F + G+ A K + K ++ + + + H N+V L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
LV D + G L R + S +IAY HS G
Sbjct: 72 DSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 439 ANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSS-------TPNRIDGYRAPEVTD 488
H N+K N+LL SK+ A +++DFGLA + S TP GY +PEV
Sbjct: 127 V--HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP----GYLSPEVLK 180
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAP 514
S+ D+++ GV+L LL G P
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPP 206
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 52/226 (23%), Positives = 85/226 (37%), Gaps = 60/226 (26%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVV-------GSMDHENL 374
E LG G F K G+ A K +K E + + H N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSL---------------SALLHGNRGAGRTPLNWETR 419
+ L Y ++ + +L+ + + G L + L + LN
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL-------KQILN---- 125
Query: 420 SGLALGASRAIAYLHSKGPANSHGNIKSSNILL-SKSYEA---RISDFGLAHLASPSS-- 473
+ YLHS A H ++K NI+L ++ +I DFGLAH +
Sbjct: 126 ---------GVYYLHSLQIA--HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174
Query: 474 -----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
TP + APE+ + + +AD++S GV+ LL+G +P
Sbjct: 175 KNIFGTP----EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 30/136 (22%), Positives = 51/136 (37%), Gaps = 7/136 (5%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ N L V L +N L I F K+ L LY+ N + + L L
Sbjct: 243 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG-SIP 175
+L+ N+ + + + RL LYL N + ++ L +L +S N + S+
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDCNSLR 357
Query: 176 KRFARLPSSAFEGNSL 191
F + A +
Sbjct: 358 ALFRNVARPAVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 28/139 (20%), Positives = 53/139 (38%), Gaps = 9/139 (6%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ + ++ ++L + I + FA ++ LY+ N P + ++ L L
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122
Query: 117 NLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQF---NVSFNKLNG 172
L +N+ S ++ F+ +L TL + N L I D F + +S N+L
Sbjct: 123 VLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIED-DTFQATTSLQNLQLSSNRLTH 179
Query: 173 SIPKRFARLPSSAFEGNSL 191
L + N L
Sbjct: 180 VDLSLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 25/138 (18%), Positives = 44/138 (31%), Gaps = 9/138 (6%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIR 115
+ EL + L+ N L T + L + L N +I F + L R
Sbjct: 220 VRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLER 276
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP-DLGAFSSLAQFNVSFNKLNGSI 174
L ++ N ++ + L L L N L + + F L + N + ++
Sbjct: 277 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TL 333
Query: 175 PKR-FARLPSSAFEGNSL 191
L + N
Sbjct: 334 KLSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 8e-13
Identities = 25/125 (20%), Positives = 40/125 (32%), Gaps = 14/125 (11%)
Query: 60 GNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
N +L T+S+ N L I D F ++L+NL L N + + L +L N+
Sbjct: 138 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIP--SLFHANV 193
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
+ N S + L N + + L + N L
Sbjct: 194 SYNLLS-----TLAIPIAVEELDASHNSIN-VVRG-PVNVELTILKLQHNNLT-DTAW-L 244
Query: 179 ARLPS 183
P
Sbjct: 245 LNYPG 249
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 21/135 (15%), Positives = 44/135 (32%), Gaps = 11/135 (8%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNL 113
+ + + V + + L+N + + + + ++P L +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 114 IRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNK 169
LNL I F + LY+ N + +P F ++ + N
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPP-HVFQNVPLLTVLVLERND 128
Query: 170 LNGSIPKR-FARLPS 183
L+ S+P+ F P
Sbjct: 129 LS-SLPRGIFHNTPK 142
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 15/94 (15%), Positives = 28/94 (29%), Gaps = 6/94 (6%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
L + + L + L N L + + + L NLYL N + L
Sbjct: 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH--TL 341
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQL 147
L L+ N++ + + +
Sbjct: 342 KNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQ 373
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 16/110 (14%), Positives = 37/110 (33%), Gaps = 7/110 (6%)
Query: 78 TIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRL 137
I S+ ++++ +L N + + +A + ++
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 138 GTLYLQENQLTGSIPDLGAF---SSLAQFNVSFNKLNGSIPKR-FARLPS 183
L L + Q+ I AF ++ + + FN + +P F +P
Sbjct: 72 ELLNLNDLQIE-EIDT-YAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL 118
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-17
Identities = 33/157 (21%), Positives = 53/157 (33%), Gaps = 23/157 (14%)
Query: 34 VFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNL 92
T + + R P + T+ L LR TIPS F+ L N+ +
Sbjct: 16 FRVTCKDIQ--RIPSL------------PPSTQTLKLIETHLR-TIPSHAFSNLPNISRI 60
Query: 93 YLQGNLFSGEIPGLLFS-LGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGS 150
Y+ ++ ++ F L + + + I D +L L L + L
Sbjct: 61 YVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-M 119
Query: 151 IPDLGAFSSLA---QFNVSFNKLNGSIPKR-FARLPS 183
PDL S ++ N SIP F L +
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCN 156
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 7e-12
Identities = 23/109 (21%), Positives = 42/109 (38%), Gaps = 7/109 (6%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSN-LRNLYLQGNLFSGEIPGLLFSLGNLIR 115
+ + + + N +IP + F L N L L N F+ + G F+ L
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183
Query: 116 LNLAKNNFSGTISAD-FNKL-TRLGTLYLQENQLTGSIPDLGAFSSLAQ 162
+ L KN + I D F + + L + + +T ++P L +
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPS-KGLEHLKE 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPL 377
+G G +G+ A G VA+K+L +++ +RE + ++ M HEN++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE-LLLLKHMQHENVIGL 88
Query: 378 R-----AYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
A LV +M L ++ + E L + +
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-------GLKFSEEKIQYLVYQMLKGLK 140
Query: 432 YLHSKGPAN-SHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP---NRIDGYRAPEV- 486
Y+HS A H ++K N+ +++ E +I DFGLA A T R YRAPEV
Sbjct: 141 YIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--YRAPEVI 195
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKA 513
+Q D++S G ++ E+LTGK
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 5e-17
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 31/208 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPL 377
+ +G G G A + VA+K+L T +++ +RE + ++ ++H+N++ L
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE-LVLMKCVNHKNIISL 126
Query: 378 R-----AYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
+ + LV + M +L ++ + L+ E S L I
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGIK 178
Query: 432 YLHSKGPAN-SHGNIKSSNILLSKSYEARISDFGLAHLASPSS--TP---NRIDGYRAPE 485
+LHS A H ++K SNI++ +I DFGLA A S TP R YRAPE
Sbjct: 179 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--YRAPE 233
Query: 486 VTDARKVSQKADVYSFGVLLLELLTGKA 513
V + D++S G ++ E++ K
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 5e-17
Identities = 32/147 (21%), Positives = 54/147 (36%), Gaps = 8/147 (5%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ N L V L +N L I F K+ L LY+ N + + L L
Sbjct: 249 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 306
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG-SIP 175
+L+ N+ + + + RL LYL N + ++ L +L +S N + S+
Sbjct: 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDCNSLR 363
Query: 176 KRFARLPSSAFEGNSL-CGKPLVSCNG 201
F + A + C +G
Sbjct: 364 ALFRNVARPAVDDADQHCKIDYQLEHG 390
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 3e-14
Identities = 29/140 (20%), Positives = 54/140 (38%), Gaps = 11/140 (7%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIR 115
+ + ++ ++L + I + FA ++ LY+ N +P +F + L
Sbjct: 70 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 127
Query: 116 LNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLN 171
L L +N+ S ++ F+ +L TL + N L I D F + +S N+L
Sbjct: 128 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIED-DTFQATTSLQNLQLSSNRLT 184
Query: 172 GSIPKRFARLPSSAFEGNSL 191
L + N L
Sbjct: 185 HVDLSLIPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 7e-13
Identities = 25/137 (18%), Positives = 43/137 (31%), Gaps = 7/137 (5%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIR 115
+ EL + L+ N L T + L + L N +I F + L R
Sbjct: 226 VRGPVNVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLER 282
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
L ++ N ++ + L L L N L + F L + N + ++
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV-TLK 340
Query: 176 KR-FARLPSSAFEGNSL 191
L + N
Sbjct: 341 LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 26/137 (18%), Positives = 48/137 (35%), Gaps = 13/137 (9%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIR 115
N+ L + L N L ++P F L L + N I F +L
Sbjct: 118 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQN 175
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
L L+ N + D + + L + N L+ ++ ++ + + S N +N +
Sbjct: 176 LQLSSNRLT---HVDLSLIPSLFHANVSYNLLS-TLAIP---IAVEELDASHNSIN-VVR 227
Query: 176 KR-FARLPSSAFEGNSL 191
L + N+L
Sbjct: 228 GPVNVELTILKLQHNNL 244
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 4e-11
Identities = 21/135 (15%), Positives = 44/135 (32%), Gaps = 11/135 (8%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNL 113
+ + + V + + L+N + + + + ++P L +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 114 IRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNK 169
LNL I F + LY+ N + +P F ++ + N
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPP-HVFQNVPLLTVLVLERND 134
Query: 170 LNGSIPKR-FARLPS 183
L+ S+P+ F P
Sbjct: 135 LS-SLPRGIFHNTPK 148
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 18/93 (19%), Positives = 32/93 (34%), Gaps = 5/93 (5%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
L + + L + L N L + + + L NLYL N + L
Sbjct: 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHH--TL 347
Query: 114 IRLNLAKNNFSGT-ISADFNKLTRLGTLYLQEN 145
L L+ N++ + A F + R ++
Sbjct: 348 KNLTLSHNDWDCNSLRALFRNVARPAVDDADQH 380
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 16/112 (14%), Positives = 42/112 (37%), Gaps = 11/112 (9%)
Query: 78 TIPSDFAKLSNLRNLYLQGNLFSGEIPGLL--FSLGNLIRLNLAKNNFSGTISADFNKLT 135
I S+ ++++ ++ + ++ +L N + + +A +
Sbjct: 18 CIDSNLQYDCVFYDVHI--DMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFR 75
Query: 136 RLGTLYLQENQLTGSIPDLGAF---SSLAQFNVSFNKLNGSIPKR-FARLPS 183
++ L L + Q+ I AF ++ + + FN + +P F +P
Sbjct: 76 QVELLNLNDLQIE-EIDT-YAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPL 124
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 5e-17
Identities = 36/142 (25%), Positives = 56/142 (39%), Gaps = 11/142 (7%)
Query: 48 GMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLL 107
L+ Q+P + L L FN +R S F L L+ L L I
Sbjct: 13 FCNLT-QVPQVLNTTERLL---LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68
Query: 108 F-SLGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFS---SLAQ 162
F +L NL L+L + + D F L L L L L+ ++ G F +L +
Sbjct: 69 FRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTR 127
Query: 163 FNVSFNKLNG-SIPKRFARLPS 183
++S N++ + F +L S
Sbjct: 128 LDLSKNQIRSLYLHPSFGKLNS 149
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 33/136 (24%), Positives = 52/136 (38%), Gaps = 12/136 (8%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
L +L ++L +N + F L NL+ L L NL + L +
Sbjct: 283 SRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAY 342
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
++L KN+ + F L +L TL L++N LT + S+ +S NKL
Sbjct: 343 IDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPDIFLSGNKLV---- 394
Query: 176 KRFARLPSSAFEGNSL 191
LP N +
Sbjct: 395 ----TLPKINLTANLI 406
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 5e-14
Identities = 32/138 (23%), Positives = 52/138 (37%), Gaps = 9/138 (6%)
Query: 61 NLTELHTVSLRFNALRGTIPSD--FAKLSNLRNLYLQGNLFSG----EIPGLLFS-LGNL 113
+ L + L N + D ++ +L L+L N+ E+ +F L +L
Sbjct: 424 RVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL 482
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS 173
L L N + F+ LT L L L N+LT + ++L ++S N+L
Sbjct: 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQLLAP 541
Query: 174 IPKRFARLPSSAFEGNSL 191
P F L N
Sbjct: 542 NPDVFVSLSVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 28/139 (20%), Positives = 49/139 (35%), Gaps = 7/139 (5%)
Query: 50 GLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKL--SNLRNLYLQGNLFSGEIPGLL 107
+S ++ + F+ ++ + FA L S++R+L L +
Sbjct: 227 AISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVF 286
Query: 108 FSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFS---SLAQFN 164
+L +L LNLA N + F L L L L N L + F +A +
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYS-SNFYGLPKVAYID 344
Query: 165 VSFNKLNGSIPKRFARLPS 183
+ N + + F L
Sbjct: 345 LQKNHIAIIQDQTFKFLEK 363
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 33/135 (24%), Positives = 50/135 (37%), Gaps = 20/135 (14%)
Query: 65 LHTVSLRFNALRG-TIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNLAKNN 122
+ + L N L I ++ +L+ L L N FS S +L +L L +N
Sbjct: 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENM 462
Query: 123 FSGTISAD-----FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSI 174
+ F L+ L LYL N L S+P G FS L +++ N+L
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPP-GVFSHLTALRGLSLNSNRLT--- 517
Query: 175 PKRFARLPSSAFEGN 189
L + N
Sbjct: 518 -----VLSHNDLPAN 527
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-11
Identities = 28/137 (20%), Positives = 39/137 (28%), Gaps = 14/137 (10%)
Query: 61 NLTELHTVSLRFNALRGTI--PSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLN 117
L L + L F L + F L L L L N F L +L ++
Sbjct: 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSID 154
Query: 118 LAKNNFSGTISADFNKLT--RLGTLYLQENQLTGSIPDLGAFSSLAQF--------NVSF 167
+ N + L L L N L S + + F +VS
Sbjct: 155 FSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY-SRVSVDWGKCMNPFRNMVLEILDVSG 213
Query: 168 NKLNGSIPKRFARLPSS 184
N I F+ S
Sbjct: 214 NGWTVDITGNFSNAISK 230
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 36/200 (18%), Positives = 65/200 (32%), Gaps = 17/200 (8%)
Query: 45 RFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIP 104
+ L+ L + L N L P F+ L+ LR L L N + +
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLS 520
Query: 105 GLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFN 164
NL L++++N + D L L + N+ +L F +
Sbjct: 521 HNDL-PANLEILDISRNQLL-APNPDV--FVSLSVLDITHNKFICEC-ELSTFINWLNHT 575
Query: 165 VSFNKLNGSIPKRFARLPSSAFEGNSLCGKPLVSCNGGGDDDDDDGSNLSGGAIAGIVIG 224
N +I A + + S G L S + + D+ L + ++
Sbjct: 576 ------NVTIAGPPADIYCVYPD--SFSGVSLFSLS---TEGCDEEEVLKSLKFSLFIVC 624
Query: 225 SVIGLLIILVLLIGLCRRKR 244
+V L ++ +L R
Sbjct: 625 TVTLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 23/155 (14%), Positives = 46/155 (29%), Gaps = 27/155 (17%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLS--NLRNLYLQGNLFSGEIPGLLFSLG 111
L + G L L ++ N + + L L L N +
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198
Query: 112 NLIR------LNLAKNNFSGTISADFNK------------LTRLGTLYLQENQLTGSIPD 153
N R L+++ N ++ I+ +F+ + + + PD
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK--DPD 256
Query: 154 LGAFSSLAQ-----FNVSFNKLNGSIPKRFARLPS 183
F+ LA+ ++S + + F L
Sbjct: 257 QNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKD 291
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 63/284 (22%), Positives = 101/284 (35%), Gaps = 45/284 (15%)
Query: 253 VAPAATATATAKQTEIEIPREKGAGDGENTSSDLSGVVKGESKGSGVKNLVFFGKGDRAF 312
++ + + P + + + + VK+ + K
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNA--- 58
Query: 313 DLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDH 371
+ D + +++VLG G G + A+K L+D K RE +
Sbjct: 59 -IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQC 114
Query: 372 ENLVPLRAYY----YSRDEKLLVHDYMPMGSL----SALLHGN---RGAGRTPLNWETRS 420
++V + Y R L+V + + G L R A S
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA----------S 164
Query: 421 GLALGASRAIAYLHSKGPANSHGNIKSSNILL-SKSYEA--RISDFGLA-------HLAS 470
+ AI YLHS A H ++K N+L SK A +++DFG A L +
Sbjct: 165 EIMKSIGEAIQYLHSINIA--HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 222
Query: 471 PSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
P TP Y APEV K + D++S GV++ LL G P
Sbjct: 223 PCYTP----YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 28/206 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVG-SMDHENLVPLRAY 380
E +G G++ + + AVK + S+++ E++E++ H N++ L+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDK---SKRDPTEEIEILLRYGQHPNIITLKDV 84
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
Y +V + M G L ++ + + S + ++ + YLH++G
Sbjct: 85 YDDGKYVYVVTELMKGGELL-----DKILRQKFFSEREASAVLFTITKTVEYLHAQGVV- 138
Query: 441 SHGNIKSSNILL-SKSYEA---RISDFGLAHLASPSS--------TPNRIDGYRAPEVTD 488
H ++K SNIL +S RI DFG A + T + APEV +
Sbjct: 139 -HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTA----NFVAPEVLE 193
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAP 514
+ D++S GVLL +LTG P
Sbjct: 194 RQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 57/235 (24%), Positives = 94/235 (40%), Gaps = 53/235 (22%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+ LG G+FG + +E G A+K K + + RE ++++ +DH N++ L Y+
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALK--KVLQDPRYKNRE-LDIMKVLDHVNIIKLVDYF 69
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTP--------------------------LN 415
Y+ ++ P N L
Sbjct: 70 YTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLK 129
Query: 416 WETRSGLALGAS----------RAIAYLHSKGPANSHGNIKSSNILL-SKSYEARISDFG 464
RSG ++ + RA+ ++HS G H +IK N+L+ SK ++ DFG
Sbjct: 130 SFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC--HRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 465 LAHLASPSSTPN------RIDGYRAPEVT-DARKVSQKADVYSFGVLLLELLTGK 512
A PS P+ R YRAPE+ A + + D++S G + EL+ GK
Sbjct: 188 SAKKLIPS-EPSVAYICSRF--YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 61/313 (19%), Positives = 102/313 (32%), Gaps = 81/313 (25%)
Query: 241 RRKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLSGVVKGESKGSGVK 300
R +R S P+ +A A+ ++ + KG + S + +
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93
Query: 301 NLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVK--RLKDVTVSEK 357
V+G+G + G AVK + +S +
Sbjct: 94 QKYDPKD----------------VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPE 137
Query: 358 EFREKMEVVGS--------MDHENLVPLRAYYYSRDEKLLVHDYMPMGSL---------- 399
+ E E H +++ L Y S LV D M G L
Sbjct: 138 QLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVAL 197
Query: 400 -----SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK 454
+++ R+ L A+++LH+ H ++K NILL
Sbjct: 198 SEKETRSIM-------RSLLE-------------AVSFLHANNIV--HRDLKPENILLDD 235
Query: 455 SYEARISDFGLAHLASPSS-------TPNRIDGYRAPEV------TDARKVSQKADVYSF 501
+ + R+SDFG + P TP GY APE+ ++ D+++
Sbjct: 236 NMQIRLSDFGFSCHLEPGEKLRELCGTP----GYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 502 GVLLLELLTGKAP 514
GV+L LL G P
Sbjct: 292 GVILFTLLAGSPP 304
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 9e-17
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 35/215 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREK---------MEVVGSMDHE 372
+ LG G G A + VA++ + + RE +E++ ++H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
++ ++ ++ + D +V + M G L ++ G L T A+ Y
Sbjct: 201 CIIKIKNFFDAED-YYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 433 LHSKGPANSHGNIKSSNILL-SKSYEAR--ISDFGLAHLASPSS-------TPNRIDGYR 482
LH G H ++K N+LL S+ + I+DFG + + +S TP Y
Sbjct: 255 LHENGII--HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP----TYL 308
Query: 483 APEV---TDARKVSQKADVYSFGVLLLELLTGKAP 514
APEV ++ D +S GV+L L+G P
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 38/131 (29%), Positives = 55/131 (41%), Gaps = 14/131 (10%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNL 118
L L+T+ L N L IPS F LS LR L+L+ N IP F+ + +L+RL+L
Sbjct: 121 GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDL 178
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKR 177
+ IS F L L L L + +P+L L + +S N
Sbjct: 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHF------- 230
Query: 178 FARLPSSAFEG 188
+ +F G
Sbjct: 231 -PEIRPGSFHG 240
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 32/131 (24%), Positives = 49/131 (37%), Gaps = 16/131 (12%)
Query: 63 TELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNN 122
+ ++L N ++ F L +L L L N G L +L L L N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 123 FSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNV----SFNKLNGSIPKR 177
+ I + F L++L L+L+ N + SIP AF+ + KL
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPS-YAFNRVPSLMRLDLGELKKL------- 184
Query: 178 FARLPSSAFEG 188
+ AFEG
Sbjct: 185 -EYISEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 36/135 (26%), Positives = 53/135 (39%), Gaps = 14/135 (10%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIP-GLLFSLGNL 113
+L L + L N++R I F L++L L L N + IP G L L
Sbjct: 92 ADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKL 149
Query: 114 IRLNLAKNNFSGTISAD-FNKLTRLGTLYLQE-NQLTGSIPDLGAF---SSLAQFNVSFN 168
L L N +I + FN++ L L L E +L I + GAF +L N+
Sbjct: 150 RELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISE-GAFEGLFNLKYLNLGMC 206
Query: 169 KLNGSIPKRFARLPS 183
+ +P L
Sbjct: 207 NIK-DMPN-LTPLVG 219
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 28/101 (27%), Positives = 44/101 (43%), Gaps = 6/101 (5%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
L L ++L ++ +P + L L L + GN F PG L +L +L +
Sbjct: 194 GLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMN 251
Query: 121 NNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
+ S I + F+ L L L L N L+ S+P F+ L
Sbjct: 252 SQVS-LIERNAFDGLASLVELNLAHNNLS-SLPH-DLFTPL 289
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 29/105 (27%), Positives = 39/105 (37%), Gaps = 16/105 (15%)
Query: 87 SNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQ 146
+ + S E+P + S N LNL +NN + F L L L L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 147 LTGSIPDLGAF---SSLAQFNVSFNKLNGSIPKRFARLPSSAFEG 188
+ I GAF +SL + N L +PS AFE
Sbjct: 111 IR-QIEV-GAFNGLASLNTLELFDNWL--------TVIPSGAFEY 145
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 17/67 (25%), Positives = 30/67 (44%), Gaps = 2/67 (2%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRL 116
+ L+ L + + + + + F L++L L L N S +P LF L L+ L
Sbjct: 237 SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVEL 295
Query: 117 NLAKNNF 123
+L N +
Sbjct: 296 HLHHNPW 302
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 19/115 (16%), Positives = 41/115 (35%), Gaps = 2/115 (1%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
I L+ L + + + + + L++L L + + I + +L + ++
Sbjct: 83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172
L+ N I L L +L +Q + + + F L Q + G
Sbjct: 143 LSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DYRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 22/113 (19%), Positives = 44/113 (38%), Gaps = 2/113 (1%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
I + +++ P + LSNL L + G + + L L +L L++
Sbjct: 62 IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
+ + +I N L ++ ++ L N I L L N+ F+ ++
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 18/99 (18%), Positives = 35/99 (35%), Gaps = 3/99 (3%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
++ + LT L + + +A +I + L + ++ L N +I L +L
Sbjct: 100 VTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP-LKTL 158
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG 149
L LN+ + +L LY + G
Sbjct: 159 PELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 20/120 (16%), Positives = 44/120 (36%), Gaps = 5/120 (4%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
I + L ++L + T + N+++L + + P + L NL R
Sbjct: 37 NITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLER 92
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGS-IPDLGAFSSLAQFNVSFNKLNGSI 174
L + + + + + LT L L + + S + + + ++S+N I
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLVP 376
E +G+GT+G YKA G +VA+KR++ +E E RE + ++ + H N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIR--LDAEDEGIPSTAIRE-ISLLKELHHPNIVS 83
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L +S LV ++M L +L N+ L R +A+ H
Sbjct: 84 LIDVIHSERCLTLVFEFMEK-DLKKVLDENKT----GLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAPEV-TD 488
H ++K N+L++ +++DFGLA P R YRAP+V
Sbjct: 139 RIL--HRDLKPQNLLINSDGALKLADFGLARA---FGIPVRSYTHEVVTLWYRAPDVLMG 193
Query: 489 ARKVSQKADVYSFGVLLLELLTGKA 513
++K S D++S G + E++TGK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGKP 218
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 50/208 (24%), Positives = 89/208 (42%), Gaps = 31/208 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPL 377
+ +G G G A + VA+K+L T +++ +RE + ++ ++H+N++ L
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE-LVLMKCVNHKNIIGL 89
Query: 378 RAYYYSRDEKL------LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
+ + +V + M +L ++ + L+ E S L I
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGIK 141
Query: 432 YLHSKGPAN-SHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPE 485
+LHS A H ++K SNI++ +I DFGLA A S YRAPE
Sbjct: 142 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 196
Query: 486 VTDARKVSQKADVYSFGVLLLELLTGKA 513
V + D++S G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 27/134 (20%), Positives = 47/134 (35%), Gaps = 14/134 (10%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114
+ N + ++L+ + S N++ L L GN S L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSI 174
LNL+ N + D L+ L TL L N + + S+ + + N ++
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG---PSIETLHAANNNIS--- 112
Query: 175 PKRFARLPSSAFEG 188
R+ S +G
Sbjct: 113 -----RVSCSRGQG 121
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 27/132 (20%), Positives = 48/132 (36%), Gaps = 8/132 (6%)
Query: 54 QLPIAIG-NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN-LFSGEIPGLLFSLG 111
++ + G ++ L N + D S ++ L L+ N + + L S
Sbjct: 113 RVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 112 NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
L LNL N + +L TL L N+L P+ + + + ++ NKL
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV 227
Query: 172 GSIPKRFARLPS 183
I K +
Sbjct: 228 -LIEKALRFSQN 238
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 26/150 (17%), Positives = 45/150 (30%), Gaps = 9/150 (6%)
Query: 34 VFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLY 93
+ G R + + L L + + + L N L +D A + L L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 94 LQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD 153
L N+ E L SL L L+L N + + TL+ N ++ +
Sbjct: 65 LSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS- 115
Query: 154 LGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
++ NK+
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSR 145
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 23/150 (15%), Positives = 45/150 (30%), Gaps = 33/150 (22%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
+ +L+ L T+ L N + + ++ L+ N S + +
Sbjct: 75 DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIY 126
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTG------------------------SIPD 153
LA N + D +R+ L L+ N++ +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG 186
Query: 154 LGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
F+ L ++S NKL + F
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAG 215
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 19/145 (13%), Positives = 40/145 (27%), Gaps = 8/145 (5%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+ L ++L++N + + + L+ L L N + + S +
Sbjct: 160 NFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSNKLA-FMGPEFQSAAGV 216
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS 173
++L N I L L+ N FS + +
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKK 274
Query: 174 IP---KRFARLPSSAFEGNSLCGKP 195
+ + +P+ G C
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDL 299
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 19/101 (18%), Positives = 33/101 (32%), Gaps = 3/101 (2%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+ + + +SLR N L I NL + L+GN F FS
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDL 154
++ +AK ++ + + TL +P
Sbjct: 264 VQ-TVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAP 302
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 49/217 (22%), Positives = 79/217 (36%), Gaps = 36/217 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL---KDVTVSEKEFREKMEVVGS--------MD 370
E+LG+G + AVK + + S +E +E E
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 371 HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAI 430
H N++ L+ Y + LV D M G L + + L+ + + I
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELF-----DYLTEKVTLSEKETRKIMRALLEVI 137
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-------TPNRIDGYRA 483
LH H ++K NILL +++DFG + P TP Y A
Sbjct: 138 CALHKLNIV--HRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTP----SYLA 191
Query: 484 PEV------TDARKVSQKADVYSFGVLLLELLTGKAP 514
PE+ + ++ D++S GV++ LL G P
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 13/136 (9%)
Query: 55 LPIAI-GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGN 112
+P + + L L N + SD + NL+ L L N + I FS LG+
Sbjct: 46 IPSGLTEAVKSLD---LSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGS 101
Query: 113 LIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFS---SLAQFNVSFN 168
L L+L+ N S +S+ F L+ L L L N ++ + FS L V
Sbjct: 102 LEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNM 159
Query: 169 KLNGSIPKR-FARLPS 183
I ++ FA L
Sbjct: 160 DTFTKIQRKDFAGLTF 175
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-14
Identities = 30/130 (23%), Positives = 46/130 (35%), Gaps = 11/130 (8%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNL 118
+L L + L +N L + S F LS+L L L GN + LFS L L L +
Sbjct: 98 SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSI 174
+ I F LT L L + + L S + S+ + + +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEP-KSLKSIQNVSHLILHMKQHI-LL 213
Query: 175 PKR-FARLPS 183
+ S
Sbjct: 214 LEIFVDVTSS 223
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 23/134 (17%), Positives = 46/134 (34%), Gaps = 13/134 (9%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
+LT+L + + I FA L+ L L + + P L S+ N+ L L
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 120 KNNFSGTISADFNKLTRLGTLYLQENQLTG----SIPDLGAFSSLAQF------NVSFNK 169
+ + + + L L++ L + G +SL + ++
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-GETNSLIKKFTFRNVKITDES 265
Query: 170 LNGSIPKRFARLPS 183
L + K ++
Sbjct: 266 LF-QVMKLLNQISG 278
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 27/156 (17%), Positives = 49/156 (31%), Gaps = 16/156 (10%)
Query: 42 TMLRFPGMGLSGQL----PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN 97
T L+ +G LT L + + + L+ P + N+ +L L
Sbjct: 149 TKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208
Query: 98 LFSGEIPGLLFS-LGNLIRLNLAKNNFSGT--------ISADFNKLTRLGTLYLQENQLT 148
+ + ++ L L + + K + + + L
Sbjct: 209 QHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
Query: 149 GSIPDLGAFSSLAQFNVSFNKLNGSIPKR-FARLPS 183
+ L S L + S N+L S+P F RL S
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTS 302
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 12/64 (18%), Positives = 23/64 (35%), Gaps = 3/64 (4%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNLA 119
V + +L + ++S L L N +P +F L +L ++ L
Sbjct: 252 KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLH 309
Query: 120 KNNF 123
N +
Sbjct: 310 TNPW 313
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 48/249 (19%), Positives = 84/249 (33%), Gaps = 48/249 (19%)
Query: 291 KGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRL 349
G +NL F + + +++ LG+G F + G A K L
Sbjct: 7 HSSGVDLGTENLYFQSMEN----FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFL 62
Query: 350 ---KDVTVSEKEFREKMEVVGSMDH-ENLVPLRAYYYSRDEKLLVHDYMPMGSL----SA 401
+ E ++ V+ ++ L Y + E +L+ +Y G +
Sbjct: 63 KKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP 122
Query: 402 LLHGN------RGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL-SK 454
L + L + YLH H ++K NILL S
Sbjct: 123 ELAEMVSENDVIRLIKQILE-------------GVYYLHQNNIV--HLDLKPQNILLSSI 167
Query: 455 SYEARI--SDFGLAHLASPSS-------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLL 505
I DFG++ + TP Y APE+ + ++ D+++ G++
Sbjct: 168 YPLGDIKIVDFGMSRKIGHACELREIMGTP----EYLAPEILNYDPITTATDMWNIGIIA 223
Query: 506 LELLTGKAP 514
LLT +P
Sbjct: 224 YMLLTHTSP 232
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 36/154 (23%), Positives = 57/154 (37%), Gaps = 13/154 (8%)
Query: 36 CTGERVTMLRFPGMGLSGQLPIAI-GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYL 94
C E P GL +P+ I + L N + + F NL L+L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPAASQRIF---LHGNRISHVPAASFRACRNLTILWL 63
Query: 95 QGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPD 153
N+ + L L +L+L+ N ++ F+ L RL TL+L L +
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122
Query: 154 LGAFS---SLAQFNVSFNKLNGSIPKR-FARLPS 183
G F +L + N L ++P F L +
Sbjct: 123 -GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGN 154
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 6/102 (5%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
L L + L+ NAL+ +P D F L NL +L+L GN S L +L RL L
Sbjct: 127 GLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 120 KNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
+N + + F L RL TLYL N L+ ++P A + L
Sbjct: 186 QNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPT-EALAPL 224
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 65/298 (21%), Positives = 110/298 (36%), Gaps = 45/298 (15%)
Query: 242 RKRDRQRSSKDVAPAATATATAKQTEIEIPREKGAGDGENTSSDLSGVVKGESKGSGVKN 301
++ S + +A + ++P + E +L G V + S
Sbjct: 113 IMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFT 172
Query: 302 LVFFGK---GDRAFDLED--LLRASAEVLGKGTFGTAY----KATLEMGIVVAVKRL-KD 351
K + + D + R ++G+G FG Y T +M A+K L K
Sbjct: 173 RFCQWKNVELNIHLTMNDFSVHR----IIGRGGFGEVYGCRKADTGKM---YAMKCLDKK 225
Query: 352 VTVSEKEFREKM------EVVGSMDHENLVPLRAYYYSRDEKL-LVHDYMPMGSLSALLH 404
++ + +V + D +V + +Y + +KL + D M G L L
Sbjct: 226 RIKMKQGETLALNERIMLSLVSTGDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL- 283
Query: 405 GNRGAGRTPLNWETRSG-----LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEAR 459
G E + L + ++H++ + ++K +NILL + R
Sbjct: 284 --SQHGVFS---EADMRFYAAEIIL----GLEHMHNRFVV--YRDLKPANILLDEHGHVR 332
Query: 460 ISDFGLAHLASPSSTPNRI--DGYRAPEV-TDARKVSQKADVYSFGVLLLELLTGKAP 514
ISD GLA S + GY APEV AD +S G +L +LL G +P
Sbjct: 333 ISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 53/211 (25%), Positives = 80/211 (37%), Gaps = 27/211 (12%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK--RLKDVTVSEKEFREKME----VVGSMDHENLV 375
EV+GKG F + E G AVK + T S E ++ + + H ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSL-SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
L Y S +V ++M L ++ R + S A+ Y H
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVK--RADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 435 SKGPANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSS--------TPNRIDGYRA 483
H ++K +LL SK A ++ FG+A S TP + A
Sbjct: 148 DNNII--HRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP----HFMA 201
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
PEV + DV+ GV+L LL+G P
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 38/237 (16%)
Query: 324 VLGKGTFGTAYKATL-EMGIVVAVKRL-KDVTVSEKE----FREKMEVVGSMDHENLVPL 377
+LG+G+F T A A+K L K + E + RE+ +V+ +DH V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER-DVMSRLDHPFFVKL 95
Query: 378 RAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETR---SGLALGASRAIAYL 433
+ + DEKL Y G L + R G TR + + A+ YL
Sbjct: 96 Y-FTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFD-ETCTRFYTAEIVS----ALEYL 146
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID---G---YRAPEVT 487
H KG H ++K NILL++ +I+DFG A + SP S R + G Y +PE+
Sbjct: 147 HGKGII--HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAP---------TQALLNEEGVDLPRWVQSVVK 535
+ + +D+++ G ++ +L+ G P Q ++ E D P +
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE-YDFPEKFFPKAR 260
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 53/218 (24%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
LG+G Y+ A+K LK TV +K R ++ V+ + H N++ L+ +
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKK-TVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 382 YSRDEKLLVHDYMPMGSL---------------SALLHGNRGAGRTPLNWETRSGLALGA 426
+ E LV + + G L + + + L
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV-------KQILE----------- 159
Query: 427 SRAIAYLHSKGPANSHGNIKSSNILL-SKSYEAR--ISDFGLAHLASPSS-------TPN 476
A+AYLH G H ++K N+L + + +A I+DFGL+ + TP
Sbjct: 160 --AVAYLHENGIV--HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTP- 214
Query: 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
GY APE+ + D++S G++ LL G P
Sbjct: 215 ---GYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 29/131 (22%), Positives = 48/131 (36%), Gaps = 2/131 (1%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
LP +I NL L ++ +R + L + L L L L+G P + L
Sbjct: 197 SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPL 255
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNG 172
RL L + T+ D ++LT+L L L+ +P + + V +
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315
Query: 173 SIPKRFARLPS 183
R P+
Sbjct: 316 LDQHRPVARPA 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 30/139 (21%), Positives = 53/139 (38%), Gaps = 13/139 (9%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN---------LFSGEIPG 105
LP + L T++L N LR +P+ A L+ LR L ++ L S + G
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 106 LLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFN 164
L NL L L ++ A L L +L ++ + L+ ++ + L + +
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235
Query: 165 VSFNKLNGSIPKRFARLPS 183
+ + P F
Sbjct: 236 LRGCTALRNYPPIFGGRAP 254
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 32/189 (16%), Positives = 60/189 (31%), Gaps = 19/189 (10%)
Query: 8 LLTLRKAIGGRTLLWNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTE--L 65
L + +N + G L + + T+
Sbjct: 25 LRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGR 83
Query: 66 HTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSG 125
+ LR L P +LS+L+++ + E+P + L L LA+N
Sbjct: 84 VALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR- 140
Query: 126 TISADFNKLTRLGTLYLQE-NQLTGSIPD----------LGAFSSLAQFNVSFNKLNGSI 174
+ A L RL L ++ +LT +P+ +L + + + S+
Sbjct: 141 ALPASIASLNRLRELSIRACPELT-ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SL 198
Query: 175 PKRFARLPS 183
P A L +
Sbjct: 199 PASIANLQN 207
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 22/138 (15%), Positives = 43/138 (31%), Gaps = 5/138 (3%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPS-DFAKLSNLRNLYLQGNLFSGEIPGLLFSLGN 112
N + AL+ T + A L L+ + P F L +
Sbjct: 47 HSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSH 105
Query: 113 LIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLN 171
L + + + + L TL L N L ++P + + + L + ++
Sbjct: 106 LQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163
Query: 172 GSIPKRFARLPSSAFEGN 189
+P+ A +S
Sbjct: 164 TELPEPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 31/140 (22%), Positives = 55/140 (39%), Gaps = 14/140 (10%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSDFAK---------LSNLRNLYLQGNLFSGEIPG 105
LP +I +L L +S+R +P A L NL++L L+ +P
Sbjct: 142 LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPA 200
Query: 106 LLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFN 164
+ +L NL L + + S + + L +L L L+ + P G + L +
Sbjct: 201 SIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259
Query: 165 VS-FNKLNGSIPKRFARLPS 183
+ + L ++P RL
Sbjct: 260 LKDCSNL-LTLPLDIHRLTQ 278
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 8e-04
Identities = 17/120 (14%), Positives = 28/120 (23%), Gaps = 24/120 (20%)
Query: 86 LSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTI---------SADFNKLT- 135
S NLY QG+ +L + + + + + L
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKA 70
Query: 136 -----------RLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
L L+ L PD S L + L +P +
Sbjct: 71 TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAG 128
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 34/120 (28%), Positives = 52/120 (43%), Gaps = 7/120 (5%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
+ NLT L + + N + + S AKL+NL +L N S P L L NL
Sbjct: 170 LKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDE 225
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
L+L N I LT L L L NQ++ ++ L + L + + N+++ P
Sbjct: 226 LSLNGNQLKD-IGT-LASLTNLTDLDLANNQIS-NLAPLSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 38/119 (31%), Positives = 47/119 (39%), Gaps = 7/119 (5%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+G LT L +SL N L A L+NL +L L N S P L L L L
Sbjct: 215 TPLGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
L N S LT L L L ENQL I + +L + FN ++ P
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLE-DISPISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 30/119 (25%), Positives = 51/119 (42%), Gaps = 7/119 (5%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ LT+L + L N + P A L+ L NL L N P + +L NL L
Sbjct: 259 APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
L NN S + LT+L L+ N+++ + L +++ + N+++ P
Sbjct: 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVS-DVSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 24/117 (20%), Positives = 46/117 (39%), Gaps = 7/117 (5%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
++ +L ++ T+ + L+NL + N + P L +L L+
Sbjct: 39 TVSQTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 94
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172
+ + N + LT L L L NQ+T I L ++L + +S N ++
Sbjct: 95 ILMNNNQIADITP--LANLTNLTGLTLFNNQIT-DIDPLKNLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 35/116 (30%), Positives = 58/116 (50%), Gaps = 8/116 (6%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ NLT L+ + L N + S + L++L+ L GN + P L +L L RL
Sbjct: 128 DPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERL 182
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172
+++ N S IS KLT L +L NQ++ I LG ++L + +++ N+L
Sbjct: 183 DISSNKVSD-ISV-LAKLTNLESLIATNNQIS-DITPLGILTNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 23/119 (19%), Positives = 40/119 (33%), Gaps = 7/119 (5%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
L E L + T+ L + L I G + L NL ++
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQI 73
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
N + N + LT+L + + NQ+ I L ++L + N++ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITPLANLTNLTGLTLFNNQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 18/115 (15%), Positives = 42/115 (36%), Gaps = 5/115 (4%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ +LT+L + N + + S A L+N+ L N S P L +L + +L
Sbjct: 325 SPVSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
L ++ ++ + + + S + ++++N +
Sbjct: 381 GLNDQAWT-NAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS 434
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 20/121 (16%), Positives = 39/121 (32%), Gaps = 6/121 (4%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
++ NLT ++ +S N + P A L+ + L L ++ N+
Sbjct: 346 VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNY---KANVSI 400
Query: 116 LNLAKNNFSGTIS-ADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSI 174
N KN I+ A + + N + + FS +G++
Sbjct: 401 PNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTV 460
Query: 175 P 175
Sbjct: 461 T 461
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 3e-16
Identities = 50/283 (17%), Positives = 89/283 (31%), Gaps = 55/283 (19%)
Query: 323 EVLGKGTFGTAYKA--TLEMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVPLR 378
+ G G Y A G V +K L +E + + + + H ++V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 379 AYYYSRDEKLLVHDYMPM-----GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
+ D Y+ M SL L L A++YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYL 198
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----TPNRIDGYRAPEVTDA 489
HS G + ++K NI+L++ + ++ D G + TP G++APE+
Sbjct: 199 HSIGLV--YNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTP----GFQAPEI--V 249
Query: 490 R-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548
R + D+Y+ G L L + T + + L
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPTRNG-------RYVDGLPEDDPVLKTYDSYGRLLR 302
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRP-SMAEVTSQIEEICR 590
R P R + E+++Q+ + R
Sbjct: 303 R-----------------AIDPDPRQRFTTAEEMSAQLTGVLR 328
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 4e-16
Identities = 24/125 (19%), Positives = 48/125 (38%), Gaps = 6/125 (4%)
Query: 56 PIAIGNLTELHTVSLRFNALRG-TIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114
+ G + + + L+ N + A L +L LQ N ++ G + L
Sbjct: 137 DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV-FAKLK 194
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGS 173
L+L+ N + + +F + + L+ N+L I L +L F++ N +
Sbjct: 195 TLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252
Query: 174 IPKRF 178
+ F
Sbjct: 253 TLRDF 257
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 27/130 (20%), Positives = 46/130 (35%), Gaps = 14/130 (10%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
N + ++L+ + S N++ L L GN S L L LNL
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
+ N + D L+ L TL L N + + S+ + + N ++
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVG---PSIETLHAANNNIS------- 112
Query: 179 ARLPSSAFEG 188
R+ S +G
Sbjct: 113 -RVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 25/150 (16%), Positives = 45/150 (30%), Gaps = 9/150 (6%)
Query: 34 VFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLY 93
+ G R + + L L + + + L N L +D A + L L
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 94 LQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD 153
L N+ + L SL L L+L N + + TL+ N ++ +
Sbjct: 65 LSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVS- 115
Query: 154 LGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
++ NK+
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSR 145
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 26/128 (20%), Positives = 43/128 (33%), Gaps = 4/128 (3%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSG-EIPGLLFSLGNLIR 115
++ + L N + D S ++ L L+ N L S L
Sbjct: 114 VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
LNL N + +L TL L N+L P+ + + + ++ NKL I
Sbjct: 174 LNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 176 KRFARLPS 183
K +
Sbjct: 231 KALRFSQN 238
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 23/150 (15%), Positives = 45/150 (30%), Gaps = 33/150 (22%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
+ +L+ L T+ L N + + ++ L+ N S + +
Sbjct: 75 DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIY 126
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTG------------------------SIPD 153
LA N + D +R+ L L+ N++ +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG 186
Query: 154 LGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
F+ L ++S NKL + F
Sbjct: 187 QVVFAKLKTLDLSSNKLA-FMGPEFQSAAG 215
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 21/138 (15%), Positives = 34/138 (24%), Gaps = 4/138 (2%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+ + + +SLR N L I NL + L+GN F FS
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS 173
++ +AK + + T + L + L
Sbjct: 264 VQ-TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL--PAPFADRLIALKRKEHALLSG 320
Query: 174 IPKRFARLPSSAFEGNSL 191
RL
Sbjct: 321 QGSETERLECERENQARQ 338
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 13/82 (15%), Positives = 28/82 (34%), Gaps = 3/82 (3%)
Query: 103 IPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLA 161
I + + + ++ +++ + L L N L+ L F+ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 162 QFNVSFNKLNGSIPKRFARLPS 183
N+S N L ++ L +
Sbjct: 62 LLNLSSNVLYETLD--LESLST 81
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 12/111 (10%), Positives = 23/111 (20%), Gaps = 1/111 (0%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
E +S + + + + + R + + I + I L K
Sbjct: 311 KRKEHALLSGQGSETER-LECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKK 369
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
+S L Q S L +
Sbjct: 370 KALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 17/158 (10%), Positives = 37/158 (23%), Gaps = 28/158 (17%)
Query: 55 LPIAIGNLTELHTVSLRFNALR-GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS---- 109
+ A+ L LR N GT+ F+K ++ + Q +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288
Query: 110 ---------------LGNLIRLNLAKN-------NFSGTISADFNKLTRLGTLYLQENQL 147
LI L ++ + + + + R + + Q
Sbjct: 289 GHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQY 348
Query: 148 TGSIPDLGA-FSSLAQFNVSFNKLNGSIPKRFARLPSS 184
I + + L+ +
Sbjct: 349 RTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAEL 386
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 9/96 (9%), Positives = 21/96 (21%), Gaps = 1/96 (1%)
Query: 53 GQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGN 112
+L N + R I + L + ++ +
Sbjct: 326 ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAE 385
Query: 113 LIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLT 148
L L + + + + L L +
Sbjct: 386 L-DGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 55/243 (22%), Positives = 90/243 (37%), Gaps = 67/243 (27%)
Query: 313 DLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE--FREKMEVVGSM 369
ED+ + +VLG+G L AVK ++ + FRE V +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE----VEML 64
Query: 370 ----DHENLVPLRAYYYSRDEKLLVHDYMPMGSL---------------SALLHGNRGAG 410
H N++ L ++ D LV + M GS+ S ++
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV------- 117
Query: 411 RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL-SKSYEA--RISDFGLAH 467
+ + A+ +LH+KG A H ++K NIL + + +I DF L
Sbjct: 118 QDVAS-------------ALDFLHNKGIA--HRDLKPENILCEHPNQVSPVKICDFDLGS 162
Query: 468 LASPSSTPNRID-----------GYRAPEV-----TDARKVSQKADVYSFGVLLLELLTG 511
+ + I Y APEV +A ++ D++S GV+L LL+G
Sbjct: 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
Query: 512 KAP 514
P
Sbjct: 223 YPP 225
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL----KDVTVSEKEFREKMEVVGSMDHENLVPL 377
+G G +G+ A + G+ VAVK+L + + +++ +RE + ++ M HEN++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE-LRLLKHMKHENVIGL 93
Query: 378 R-----AYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
A + LV M L+ ++ L + L R +
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQ------KLTDDHVQFLIYQILRGLK 146
Query: 432 YLHSKGPAN-SHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP---NRIDGYRAPEV- 486
Y+HS A+ H ++K SN+ +++ E +I DFGLA + T R YRAPE+
Sbjct: 147 YIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--YRAPEIM 201
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKA 513
+ +Q D++S G ++ ELLTG+
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 36/139 (25%), Positives = 54/139 (38%), Gaps = 11/139 (7%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
L L+ + L N + I F+ L L+ LY+ N EIP L S +L+ L
Sbjct: 73 DFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNLPS--SLVEL 128
Query: 117 NLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFS--SLAQFNVSFNKLNGS 173
+ N + F+ L + + + N L S + GAF L +S KL
Sbjct: 129 RIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-G 186
Query: 174 IPKR-FARLPSSAFEGNSL 191
IPK L + N +
Sbjct: 187 IPKDLPETLNELHLDHNKI 205
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 35/134 (26%), Positives = 48/134 (35%), Gaps = 15/134 (11%)
Query: 61 NLTELHTVSLRFNALRGTIPS-DFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNL 118
L ELH L N ++ I D + S L L L N I S L L L+L
Sbjct: 194 TLNELH---LDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHL 248
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG----SI 174
N S + A L L +YL N +T + F + F V NG +
Sbjct: 249 DNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGV-NDFCPV-GFGVKRAYYNGISLFNN 304
Query: 175 PKRFARLPSSAFEG 188
P + + + F
Sbjct: 305 PVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 31/149 (20%), Positives = 56/149 (37%), Gaps = 33/149 (22%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGN-LFSGEIPGLLFSLGNLIRLNL 118
+L EL + N +R +P F+ L N+ + + GN L + F L L +
Sbjct: 124 SLVELR---IHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI 179
Query: 119 AKNNFSG--------------------TISA-DFNKLTRLGTLYLQENQLTGSIPDLGAF 157
++ +G I D + ++L L L NQ+ I + G+
Sbjct: 180 SEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIEN-GSL 237
Query: 158 ---SSLAQFNVSFNKLNGSIPKRFARLPS 183
+L + ++ NKL+ +P L
Sbjct: 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKL 265
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 23/111 (20%), Positives = 40/111 (36%), Gaps = 11/111 (9%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ ++L+ + L N +R I + + L LR L+L N S +P L L L +
Sbjct: 212 DLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVV 269
Query: 117 NLAKNNFSGTISAD-------FNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
L NN + + + K + L N + F +
Sbjct: 270 YLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCV 319
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 5e-09
Identities = 16/98 (16%), Positives = 32/98 (32%), Gaps = 11/98 (11%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-------L 110
++ L L + L N L +P+ L L+ +YL N + ++ F
Sbjct: 236 SLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKR 293
Query: 111 GNLIRLNLAKNNFS-GTISAD-FNKLTRLGTLYLQENQ 146
++L N + F +T + +
Sbjct: 294 AYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 28/118 (23%), Positives = 43/118 (36%), Gaps = 23/118 (19%)
Query: 88 NLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQL 147
+LR + +P + + L+L N+ S DF L L L L N++
Sbjct: 34 HLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 148 TGSIPDLGAFS---SLAQFNVSFNKLNGSIPK--------------RFARLPSSAFEG 188
+ I + AFS L + +S N L IP R ++P F G
Sbjct: 91 S-KIHE-KAFSPLRKLQKLYISKNHLV-EIPPNLPSSLVELRIHDNRIRKVPKGVFSG 145
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 10/77 (12%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSD-------FAKLSNLRNLYLQGN-LFSGEIPG 105
++P + +L L V L N + + + K + + L N + E+
Sbjct: 255 RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 106 LLFS-LGNLIRLNLAKN 121
F + + + +
Sbjct: 314 ATFRCVTDRLAIQFGNY 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 35/149 (23%), Positives = 60/149 (40%), Gaps = 23/149 (15%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
NL LHT+ L N + P FA L L LYL N E+P + L L
Sbjct: 71 DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELR 127
Query: 118 LAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFS---SLAQFNVSFNKLNGS 173
+ +N + + FN L ++ + L N L S + GAF L+ ++ + +
Sbjct: 128 VHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 185
Query: 174 IPK--------------RFARLPSSAFEG 188
IP+ + ++ +++ +G
Sbjct: 186 IPQGLPPSLTELHLDGNKITKVDAASLKG 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 28/129 (21%), Positives = 51/129 (39%), Gaps = 13/129 (10%)
Query: 61 NLTELHTVSLRFNALR-GTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
L ++ V L N L+ I + F + L + + + IP L +L L+L
Sbjct: 143 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPP--SLTELHL 199
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAF---SSLAQFNVSFNKLNGSI 174
N + + A L L L L N ++ ++ + G+ L + +++ NKL +
Sbjct: 200 DGNKIT-KVDAASLKGLNNLAKLGLSFNSIS-AVDN-GSLANTPHLRELHLNNNKLV-KV 255
Query: 175 PKRFARLPS 183
P A
Sbjct: 256 PGGLADHKY 264
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 28/136 (20%), Positives = 48/136 (35%), Gaps = 19/136 (13%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
+LTELH L N + + + L+NL L L N S G L + +L L+L
Sbjct: 193 SLTELH---LDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 120 KNNFSGTISADFNKLTRLGTLYLQENQLT----GSIPDLGAFSSLAQFNV---SFNKLNG 172
N + + +YL N ++ G + A ++ N +
Sbjct: 249 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV-- 305
Query: 173 SIPKRFARLPSSAFEG 188
++ + S F
Sbjct: 306 ----QYWEIQPSTFRC 317
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 26/120 (21%), Positives = 40/120 (33%), Gaps = 14/120 (11%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
L L + L FN++ A +LR L+L N ++PG L + + L
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 121 NNFSGTISAD-------FNKLTRLGTLYLQENQLT-GSIPDLGAFS---SLAQFNVSFNK 169
NN S I ++ K + L N + I F A + K
Sbjct: 273 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQP-STFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 11/97 (11%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-------SL 110
++ N L + L N L +P A ++ +YL N S I F
Sbjct: 235 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKK 292
Query: 111 GNLIRLNLAKNNFSGT-ISAD-FNKLTRLGTLYLQEN 145
+ ++L N I F + + L
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 77.9 bits (193), Expect = 4e-16
Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 27/205 (13%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLVP 376
E +G+GT+G YKA G A+K+++ E E RE + ++ + H N+V
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR--LEKEDEGIPSTTIRE-ISILKELKHSNIVK 64
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L +++ +LV +++ L LL G L T L IAY H +
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR 119
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAPEV-TD 488
H ++K N+L+++ E +I+DFGLA P R YRAP+V
Sbjct: 120 RVL--HRDLKPQNLLINREGELKIADFGLARA---FGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 489 ARKVSQKADVYSFGVLLLELLTGKA 513
++K S D++S G + E++ G
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTP 199
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 27/207 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL--KDVTVSEKE--FREKMEVVGSMDHENLVPL 377
E LGKG F + G+ A K + K ++ + + RE + + H N+V L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE-ARICRKLQHPNIVRL 93
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
LV D + G L R + S +IAY HS G
Sbjct: 94 HDSIQEESFHYLVFDLVTGGELF-----EDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 438 PANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSS-------TPNRIDGYRAPEVT 487
H N+K N+LL SK+ A +++DFGLA + S TP GY +PEV
Sbjct: 149 IV--HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP----GYLSPEVL 202
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAP 514
S+ D+++ GV+L LL G P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 45/246 (18%), Positives = 79/246 (32%), Gaps = 42/246 (17%)
Query: 355 SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH---DYMPMGSLSALLHGNRGAGR 411
S + MD + K+ ++ +L + NR
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM--NRRCSL 158
Query: 412 TPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA----H 467
+ + + A+ +LHSKG H ++K SNI + ++ DFGL
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLM--HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
Query: 468 LASPSSTPNRIDG------------YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPT 515
+ + Y +PE S K D++S G++L ELL +
Sbjct: 217 DEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
Query: 516 QALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNR 575
+ + V + F L + E MVQ + L+ + P R
Sbjct: 277 MERVRI--------ITDVRNLK-----FPLLFTQKYPQEHMMVQDM-LSPS-----PTER 317
Query: 576 PSMAEV 581
P ++
Sbjct: 318 PEATDI 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 11/77 (14%), Positives = 35/77 (45%), Gaps = 3/77 (3%)
Query: 323 EVLGKGTFGTAYKATLEM-GIVVAVKR--LKDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
+ +G+G FG ++A ++ A+KR L + ++ ++ +++ + ++H +V
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 380 YYYSRDEKLLVHDYMPM 396
+ + + +
Sbjct: 72 AWLETPPEKWQEEMDEI 88
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 29/207 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPL 377
+ +G G +G A G VA+K+L +++ +RE + ++ M HEN++ L
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE-LRLLKHMRHENVIGL 89
Query: 378 R------AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
+ LV +M L L+ L + L + +
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHE------KLGEDRIQFLVYQMLKGLR 142
Query: 432 YLHSKGPAN-SHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP---NRIDGYRAPEV- 486
Y+H+ A H ++K N+ +++ E +I DFGLA A T R YRAPEV
Sbjct: 143 YIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--YRAPEVI 197
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKA 513
+ + +Q D++S G ++ E++TGK
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKT 224
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)
Query: 325 LGKGTFGTAYKA---TLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLR-AY 380
+G+GT+G YKA + A+K+++ +S RE + ++ + H N++ L+ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE-IALLRELKHPNVISLQKVF 87
Query: 381 YYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS----------RA 429
D K+ L+ DY L ++ +R + + + L
Sbjct: 88 LSHADRKVWLLFDYAEH-DLWHIIKFHRASKA------NKKPVQLPRGMVKSLLYQILDG 140
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEAR----ISDFGLAHL-ASPSSTPNRIDG---- 480
I YLH+ H ++K +NIL+ R I+D G A L SP +D
Sbjct: 141 IHYLHANWVL--HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 198
Query: 481 --YRAPEV-TDARKVSQKADVYSFGVLLLELLTGKA 513
YRAPE+ AR ++ D+++ G + ELLT +
Sbjct: 199 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 32/134 (23%), Positives = 54/134 (40%), Gaps = 8/134 (5%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNL 118
+L+ L T+ L N ++ ++ F+ LS+L+ L + + L L LN+
Sbjct: 74 SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNV 131
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKR 177
A N + F+ LT L L L N++ SI L Q + L+ S+
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC-TDLRVLHQMPLLNLSLDLSLNP- 188
Query: 178 FARLPSSAFEGNSL 191
+ AF+ L
Sbjct: 189 MNFIQPGAFKEIRL 202
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 31/129 (24%), Positives = 45/129 (34%), Gaps = 13/129 (10%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
+ L L FN LR F L+ L L G SL +L L L
Sbjct: 29 STKNLD---LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTG 85
Query: 121 NNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPK 176
N +++ F+ L+ L L E L S+ + L NV+ N + S
Sbjct: 86 NPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLEN-FPIGHLKTLKELNVAHNLIQ-SFKL 141
Query: 177 R--FARLPS 183
F+ L +
Sbjct: 142 PEYFSNLTN 150
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 30/129 (23%), Positives = 44/129 (34%), Gaps = 32/129 (24%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGN-LFSGEIPGLLFSLGNLIRLNL 118
L+ L + L ++ + L L+ L + N + S ++P +L NL L+L
Sbjct: 98 GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 119 AKNNFSGTISADFNKLT---------------------------RLGTLYLQENQLTGSI 151
+ N D L RL L L NQL S+
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SV 215
Query: 152 PDLGAFSSL 160
PD G F L
Sbjct: 216 PD-GIFDRL 223
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 26/106 (24%), Positives = 37/106 (34%), Gaps = 15/106 (14%)
Query: 87 SNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQEN 145
+ +NL L N FS L L+L++ TI + L+ L TL L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 146 QLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKRFARLPSSAFEG 188
+ S+ GAFS L+ L A L +
Sbjct: 87 PIQ-SLAL-GAFSGLSSLQKLVAVETNL--------ASLENFPIGH 122
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-16
Identities = 44/134 (32%), Positives = 56/134 (41%), Gaps = 11/134 (8%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNL 113
P A NL L T+ LR N L+ IP F LSNL L + N + +F L NL
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNL 130
Query: 114 IRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFS---SLAQFNVSFNK 169
L + N+ IS F+ L L L L++ LT SIP A S L +
Sbjct: 131 KSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPT-EALSHLHGLIVLRLRHLN 187
Query: 170 LNGSIPKRFARLPS 183
+N F RL
Sbjct: 188 INAIRDYSFKRLYR 201
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 38/151 (25%), Positives = 58/151 (38%), Gaps = 13/151 (8%)
Query: 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNL 98
+L + + L + L N + + F L NLR L L+ N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNR 91
Query: 99 FSGEIPGLLFS-LGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGA 156
IP +F+ L NL +L++++N + F L L +L + +N L I A
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISH-RA 147
Query: 157 FS---SLAQFNVSFNKLNGSIPKR-FARLPS 183
FS SL Q + L SIP + L
Sbjct: 148 FSGLNSLEQLTLEKCNLT-SIPTEALSHLHG 177
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 28/136 (20%), Positives = 51/136 (37%), Gaps = 17/136 (12%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIR 115
A L L ++L L +IP++ + L L L L+ + I F L L
Sbjct: 147 AFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKV 204
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNG 172
L ++ + T++ + L +L + LT ++P A L N+S+N +
Sbjct: 205 LEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY-LAVRHLVYLRFLNLSYNPI-- 260
Query: 173 SIPKRFARLPSSAFEG 188
+ + S
Sbjct: 261 ------STIEGSMLHE 270
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 41/156 (26%), Positives = 57/156 (36%), Gaps = 24/156 (15%)
Query: 34 VFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLY 93
V C +R +P I TE + L N ++ +FA +L L
Sbjct: 16 VLCHRKRFV-----------AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELE 62
Query: 94 LQGNLFSGEIPGLLFS-LGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSI 151
L N+ S + F+ L NL L L N I F L+ L L + EN++ +
Sbjct: 63 LNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-IL 119
Query: 152 PDLGAFSSLAQ---FNVSFNKLNGSIPKR-FARLPS 183
D F L V N L I R F+ L S
Sbjct: 120 LD-YMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNS 153
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 30/128 (23%), Positives = 50/128 (39%), Gaps = 7/128 (5%)
Query: 22 WNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPS 81
W D G +T L L+ +A+ +L L ++L +N + S
Sbjct: 210 WPYLDTMT---PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGS 266
Query: 82 DFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNLAKNNFSGTISAD-FNKLTRLGT 139
+L L+ + L G + + F L L LN++ N + T+ F+ + L T
Sbjct: 267 MLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLET 324
Query: 140 LYLQENQL 147
L L N L
Sbjct: 325 LILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 28/103 (27%), Positives = 39/103 (37%), Gaps = 11/103 (10%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNL 118
NLT L + L +P L LR L L N S I G + L L + L
Sbjct: 225 NLTSLS---ITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQL 279
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
+ + F L L L + NQLT ++ + F S+
Sbjct: 280 VGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEE-SVFHSV 319
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 7e-06
Identities = 19/66 (28%), Positives = 28/66 (42%), Gaps = 4/66 (6%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNL 118
L L + L L + F L+ LR L + GN + + +F S+GNL L L
Sbjct: 270 ELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLIL 327
Query: 119 AKNNFS 124
N +
Sbjct: 328 DSNPLA 333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-15
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 28/208 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-------FREKMEVVGSMDHENL 374
E LG GT+ T YK G+ VA+K +K + E RE + ++ + HEN+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSEEGTPSTAIRE-ISLMKELKHENI 65
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALL-HGNRGAGRTPLNWETRSGLALGASRAIAYL 433
V L ++ ++ LV ++M L + G L + +A+
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAPEV 486
H H ++K N+L++K + ++ DFGLA P YRAP+V
Sbjct: 125 HENKIL--HRDLKPQNLLINKRGQLKLGDFGLARA---FGIPVNTFSSEVVTLWYRAPDV 179
Query: 487 -TDARKVSQKADVYSFGVLLLELLTGKA 513
+R S D++S G +L E++TGK
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKP 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 51/222 (22%), Positives = 79/222 (35%), Gaps = 56/222 (25%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL--KDVTVSEKE-FREKMEVVGSMDHENLVPLR 378
E LGKG F + + G A + K ++ + + + + + H N+V L
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76
Query: 379 AYYYSRDEKLLVHDYMPMGSL---------------SALLHGNRGAGRTPLNWETRSGLA 423
L+ D + G L S + + L
Sbjct: 77 DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCI-------QQILE-------- 121
Query: 424 LGASRAIAYLHSKGPANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSS------- 473
A+ + H G H N+K N+LL SK A +++DFGLA
Sbjct: 122 -----AVLHCHQMGVV--HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA 174
Query: 474 -TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
TP GY +PEV + D+++ GV+L LL G P
Sbjct: 175 GTP----GYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 53/223 (23%), Positives = 85/223 (38%), Gaps = 46/223 (20%)
Query: 316 DLLRASAEVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKEFR----EKMEVV 366
R VLG+G FG + KAT ++ A K+L K K ++ EK +++
Sbjct: 188 LDFR----VLGRGGFGEVFACQMKATGKL---YACKKLNKKRLKKRKGYQGAMVEK-KIL 239
Query: 367 GSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS------ 420
+ +V L + ++ + LV M G + H P E R+
Sbjct: 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 421 -GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------ 473
L +LH + + ++K N+LL RISD GLA
Sbjct: 298 IVSGLE------HLHQRNII--YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY 349
Query: 474 --TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
TP G+ APE+ + D ++ GV L E++ + P
Sbjct: 350 AGTP----GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 58/231 (25%), Positives = 95/231 (41%), Gaps = 44/231 (19%)
Query: 307 KGDRAFDLED--LLRASAEVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKE- 358
+ + + +LR +GKG+FG T + A+K + K V E
Sbjct: 7 DENEDVNFDHFEILR----AIGKGSFGKVCIVQKNDT---KKMYAMKYMNKQKCVERNEV 59
Query: 359 ---FREKMEVVGSMDHENLVPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPL 414
F+E +++ ++H LV L Y + +E + +V D + G L L +
Sbjct: 60 RNVFKEL-QIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFK- 113
Query: 415 NWETRSG-----LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469
E L + A+ YL ++ H ++K NILL + I+DF +A +
Sbjct: 114 --EETVKLFICELVM----ALDYLQNQRII--HRDMKPDNILLDEHGHVHITDFNIAAML 165
Query: 470 SPSSTPNRIDG---YRAPEVTDARKV---SQKADVYSFGVLLLELLTGKAP 514
+ + G Y APE+ +RK S D +S GV ELL G+ P
Sbjct: 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 69/263 (26%), Positives = 111/263 (42%), Gaps = 68/263 (25%)
Query: 307 KGDRAFDLED--LLRASAEVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKEF 359
+G D LL+ VLG+G+FG + + + + A+K L K
Sbjct: 16 EGHEKADPSQFELLK----VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV 71
Query: 360 REKME--VVGSMDHENLVPLRAYYYS--RDEKL-LVHDYMPMGSLSALLHGNRGAGRTPL 414
R KME ++ ++H +V L +Y+ + KL L+ D++ G L ++
Sbjct: 72 RTKMERDILVEVNHPFIVKL---HYAFQTEGKLYLILDFLRGGDL--FTRLSK-EVMFT- 124
Query: 415 NWETRSG-----LALGASRAIAYLHSKGPANSHGNI-----KSSNILLSKSYEARISDFG 464
E LAL A+ +LHS G I K NILL + +++DFG
Sbjct: 125 --EEDVKFYLAELAL----ALDHLHSLG-------IIYRDLKPENILLDEEGHIKLTDFG 171
Query: 465 LAHLASPSS--------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP-- 514
L+ + T Y APEV + R +Q AD +SFGVL+ E+LTG P
Sbjct: 172 LSKESIDHEKKAYSFCGTVE----YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
Query: 515 -------TQALLNEEGVDLPRWV 530
+L + + +P+++
Sbjct: 228 GKDRKETMTMILKAK-LGMPQFL 249
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 36/216 (16%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE-------------FREKMEVVGSM 369
+ G++G GI VA+KR+ + + RE + ++
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE-IRLLNHF 86
Query: 370 DHENLVPL----RAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLAL 424
H N++ L + KL LV + M L+ ++H R ++ +
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH----DQRIVISPQHIQYFMY 141
Query: 425 GASRAIAYLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSS--TP---NRI 478
+ LH A H ++ NILL+ + + I DF LA + + T +R
Sbjct: 142 HILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198
Query: 479 DGYRAPEV-TDARKVSQKADVYSFGVLLLELLTGKA 513
YRAPE+ + ++ D++S G ++ E+ KA
Sbjct: 199 --YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 33/127 (25%), Positives = 50/127 (39%), Gaps = 10/127 (7%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
+TE+ L N ++ P F+ LR + L N S P L +L L L
Sbjct: 33 TITEIR---LEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKR 177
N + + F L L L L N++ + AF L ++ NKL +I K
Sbjct: 90 NKITELPKSLFEGLFSLQLLLLNANKIN-CLRV-DAFQDLHNLNLLSLYDNKLQ-TIAKG 146
Query: 178 -FARLPS 183
F+ L +
Sbjct: 147 TFSPLRA 153
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 27/111 (24%), Positives = 46/111 (41%), Gaps = 11/111 (9%)
Query: 78 TIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISAD-FNKLTR 136
IP++ + + L+ N PG L R++L+ N S ++ D F L
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 137 LGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKR-FARLPS 183
L +L L N++T +P F L ++ NK+N + F L +
Sbjct: 82 LNSLVLYGNKIT-ELPK-SLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHN 129
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 23/86 (26%), Positives = 37/86 (43%), Gaps = 4/86 (4%)
Query: 62 LTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN-LFSGEIPGLLF-SLGNLIRLNLA 119
L L+++ L N + S F L +L+ L L N + + F L NL L+L
Sbjct: 79 LRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC--LRVDAFQDLHNLNLLSLY 136
Query: 120 KNNFSGTISADFNKLTRLGTLYLQEN 145
N F+ L + T++L +N
Sbjct: 137 DNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 6e-05
Identities = 18/64 (28%), Positives = 25/64 (39%), Gaps = 2/64 (3%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
L L + L N + + D F L NL L L N G L + ++LA
Sbjct: 102 GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160
Query: 120 KNNF 123
+N F
Sbjct: 161 QNPF 164
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 3e-15
Identities = 56/214 (26%), Positives = 90/214 (42%), Gaps = 42/214 (19%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVVGSMDHENLVP 376
+ LG GTFG G VAVK +++ + V K RE ++ + H +++
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE-IQNLKLFRHPHIIK 75
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR-------- 428
L + + +V +Y+ G L + + GR + +R
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKH---GR----------VEEMEARRLFQQILS 122
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-------TPNRIDGY 481
A+ Y H H ++K N+LL A+I+DFGL+++ S +PN Y
Sbjct: 123 AVDYCHRHMVV--HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----Y 176
Query: 482 RAPEVTDARK-VSQKADVYSFGVLLLELLTGKAP 514
APEV R + D++S GV+L LL G P
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 56/211 (26%), Positives = 84/211 (39%), Gaps = 37/211 (17%)
Query: 324 VLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKEFREKM---EVVGSMDHENLV 375
VLGKG FG +AT +M A K+L K K + +++ ++ +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKM---YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVV 247
Query: 376 PLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR------ 428
L AY Y + L LV M G L H + ++G +
Sbjct: 248 SL-AYAYETKDALCLVLTLMNGGDL--KFH---------IYHMGQAGFPEARAVFYAAEI 295
Query: 429 --AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRA 483
+ LH + + ++K NILL RISD GLA T G Y A
Sbjct: 296 CCGLEDLHRERIV--YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
PEV + + D ++ G LL E++ G++P
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 47/225 (20%)
Query: 316 DLLRASAEVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKE---FREKMEVVG 367
++L+ V+G+G FG K V A+K L K + E FRE+ +V+
Sbjct: 77 EILK----VIGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLV 129
Query: 368 SMDHENLVPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETR---SGLA 423
+ D + + L Y + D L LV DY G L LL ++ R P R + +
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL--SKFEDRLPEEM-ARFYLAEMV 185
Query: 424 LGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---------T 474
+ AI +H H +IK NIL+ + R++DFG T
Sbjct: 186 I----AIDSVHQLHYV--HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 475 PNRIDGYRAPEVTDARKVSQK-----ADVYSFGVLLLELLTGKAP 514
P+ Y +PE+ A + + D +S GV + E+L G+ P
Sbjct: 240 PD----YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 50/211 (23%), Positives = 83/211 (39%), Gaps = 34/211 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLV 375
LG+GT+G YKA VA+KR++ E+E RE + ++ + H N++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIRE-VSLLKELQHRNII 96
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L++ + L+ +Y L + N ++ + + HS
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHS 150
Query: 436 KGPANSHGNIKSSNILLSKSYEAR-----ISDFGLAHLASPSSTPNRIDG-------YRA 483
+ H ++K N+LLS S + I DFGLA P R YR
Sbjct: 151 RRCL--HRDLKPQNLLLSVSDASETPVLKIGDFGLARA---FGIPIRQFTHEIITLWYRP 205
Query: 484 PEV-TDARKVSQKADVYSFGVLLLELLTGKA 513
PE+ +R S D++S + E+L
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 53/209 (25%), Positives = 97/209 (46%), Gaps = 29/209 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK---DVTVSEKEFREKMEVVGSMDHENLVPL- 377
+G+G +G A + VA+K++ T ++ RE ++++ HEN++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE-IKILLRFRHENIIGIN 91
Query: 378 ---RAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
RA + + + +V D M L LL L+ + R + Y+
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQ------HLSNDHICYFLYQILRGLKYI 144
Query: 434 HSKGPAN-SHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI-------DGYRAPE 485
HS AN H ++K SN+LL+ + + +I DFGLA +A P YRAPE
Sbjct: 145 HS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 486 VT-DARKVSQKADVYSFGVLLLELLTGKA 513
+ +++ ++ D++S G +L E+L+ +
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRP 230
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 40/218 (18%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLV 375
+G+GTFG +KA + G VA+K++ +EKE RE ++++ + HEN+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALRE-IKILQLLKHENVV 79
Query: 376 PLR-------AYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
L + Y + LV D+ L+ LL +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS----NVLVKFTLSEIKRVMQMLL 134
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------- 480
+ Y+H H ++K++N+L+++ +++DFG LA S
Sbjct: 135 NGLYYIHRNKIL--HRDMKAANVLITRDGVLKLADFG---LARAFSLAKNSQPNRYTNRV 189
Query: 481 ----YRAPEV-TDARKVSQKADVYSFGVLLLELLTGKA 513
YR PE+ R D++ G ++ E+ T
Sbjct: 190 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 227
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 5e-15
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 28/207 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLV 375
E +G+GT+GT +KA E +VA+KR++ + E RE + ++ + H+N+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALRE-ICLLKELKHKNIV 64
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L +S + LV ++ L G L+ E + + + HS
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHS 119
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAPEV-T 487
+ H ++K N+L++++ E ++++FGLA P R YR P+V
Sbjct: 120 RNVL--HRDLKPQNLLINRNGELKLANFGLARA---FGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAP 514
A+ S D++S G + EL P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 50/215 (23%), Positives = 88/215 (40%), Gaps = 35/215 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKME----VVGSMDHE 372
+ LG G G A + VA+K + + E + +E ++ ++H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
++ ++ ++ + D +V + M G L ++ G L T A+ Y
Sbjct: 76 CIIKIKNFFDAED-YYIVLELMEGGELF-----DKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 433 LHSKGPANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSS-------TPNRIDGYR 482
LH G H ++K N+LL S+ + +I+DFG + + +S TP Y
Sbjct: 130 LHENGII--HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP----TYL 183
Query: 483 APEV---TDARKVSQKADVYSFGVLLLELLTGKAP 514
APEV ++ D +S GV+L L+G P
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 37/129 (28%), Positives = 51/129 (39%), Gaps = 12/129 (9%)
Query: 61 NLTELHTVSL-RFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+ L + L L I F LSNLR L L EIP L L L L+L
Sbjct: 158 RIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPNLT-PLIKLDELDL 214
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQF---NVSFNKLNGSIP 175
+ N+ S F L L L++ ++Q+ I AF +L N++ N L +P
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIER-NAFDNLQSLVEINLAHNNLT-LLP 271
Query: 176 KR-FARLPS 183
F L
Sbjct: 272 HDLFTPLHH 280
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 39/137 (28%), Positives = 57/137 (41%), Gaps = 12/137 (8%)
Query: 54 QLPIAI-GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGN 112
++P I N L +L N ++ + F L +L L L N G L N
Sbjct: 57 EVPDGISTNTRLL---NLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLAN 113
Query: 113 LIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
L L L N + TI F L++L L+L+ N + SIP AF+ + L+
Sbjct: 114 LNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPS-YAFNRIPSLRR----LD 166
Query: 172 GSIPKRFARLPSSAFEG 188
KR + + AFEG
Sbjct: 167 LGELKRLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 25/92 (27%), Positives = 40/92 (43%), Gaps = 4/92 (4%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRL 116
+ L +L + L N L P F L +L+ L++ + I F L +L+ +
Sbjct: 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEI 260
Query: 117 NLAKNNFSGTISAD-FNKLTRLGTLYLQENQL 147
NLA NN + + D F L L ++L N
Sbjct: 261 NLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 6e-15
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK---DVTVSEKEFREKMEVVGSMDHENLVPL- 377
+LG+G +G AT G +VA+K+++ + + RE ++++ HEN++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE-IKILKHFKHENIITIF 75
Query: 378 ---RAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
R + ++ ++ + M L ++ L+ + RA+ L
Sbjct: 76 NIQRPDSFENFNEVYIIQELMQT-DLHRVISTQ------MLSDDHIQYFIYQTLRAVKVL 128
Query: 434 HSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------------ 480
H +N H ++K SN+L++ + + ++ DFGLA + S+ N
Sbjct: 129 HG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 481 --YRAPEV-TDARKVSQKADVYSFGVLLLELLTGKA 513
YRAPEV + K S+ DV+S G +L EL +
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRP 221
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-15
Identities = 37/153 (24%), Positives = 53/153 (34%), Gaps = 23/153 (15%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALR--GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF 108
+ G L T+ L N LR L NL +L + N F +P
Sbjct: 349 EYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407
Query: 109 SLGNLIRLNLAKNNFSG-----------------TISADFNKLTRLGTLYLQENQLTGSI 151
+ LNL+ + + L RL LY+ N+L ++
Sbjct: 408 WPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK-TL 466
Query: 152 PDLGAFSSLAQFNVSFNKLNGSIPKR-FARLPS 183
PD F L +S N+L S+P F RL S
Sbjct: 467 PDASLFPVLLVMKISRNQLK-SVPDGIFDRLTS 498
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 32/142 (22%), Positives = 57/142 (40%), Gaps = 12/142 (8%)
Query: 48 GMGLSGQLPIAI-GNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGL 106
+ +P + + L L FN + D +NL+ L L+ + +
Sbjct: 14 SRSFT-SIPSGLTAAMKSL---DLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69
Query: 107 LFSLGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ--- 162
+SLG+L L+L+ N+ S ++S+ F L+ L L L N ++ F +L
Sbjct: 70 FYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTNLQT 127
Query: 163 FNVSFNKLNGSIPKR-FARLPS 183
+ + I + FA L S
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTS 149
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 4e-14
Identities = 29/130 (22%), Positives = 48/130 (36%), Gaps = 5/130 (3%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ L + L+ + + TI D F L +L +L L N S L +L L
Sbjct: 45 DLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYL 103
Query: 117 NLAKNNFSG-TISADFNKLTRLGTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLNGS 173
NL N + +++ F LT L TL + + I D +SL + + L
Sbjct: 104 NLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163
Query: 174 IPKRFARLPS 183
+ +
Sbjct: 164 QSQSLKSIRD 173
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 25/143 (17%), Positives = 50/143 (34%), Gaps = 5/143 (3%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGN 112
+ NLT L T+ + I DFA L++L L ++ L S+ +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 113 LIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLT----GSIPDLGAFSSLAQFNVSFN 168
+ L L + + + + L+ + L L++ L +P S + + +
Sbjct: 174 IHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233
Query: 169 KLNGSIPKRFARLPSSAFEGNSL 191
L +L E + +
Sbjct: 234 VLTDESFNELLKLLRYILELSEV 256
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 23/138 (16%), Positives = 43/138 (31%), Gaps = 8/138 (5%)
Query: 44 LRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGE 102
L P L L L ++ +++ + + +P L +L L L NL E
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEE 349
Query: 103 I---PGLLFSLGNLIRLNLAKNNFS--GTISADFNKLTRLGTLYLQENQLTGSIPDLGAF 157
+ +L L L++N+ L L +L + N
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWP 409
Query: 158 SSLAQFNVSFNKLNGSIP 175
+ N+S + +
Sbjct: 410 EKMRFLNLSSTGIR-VVK 426
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 27/145 (18%), Positives = 48/145 (33%), Gaps = 16/145 (11%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLS--------NLRNLYLQGNLFSGEIPG 105
+L I L+E+ N L PS+ +S +R L++ ++
Sbjct: 245 KLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLST 304
Query: 106 LLFSLGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPD----LGAFSSL 160
+ L + R+ + + + L L L L EN + GA+ SL
Sbjct: 305 VYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSL 363
Query: 161 AQFNVSFNKLN--GSIPKRFARLPS 183
+S N L + L +
Sbjct: 364 QTLVLSQNHLRSMQKTGEILLTLKN 388
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 18/147 (12%), Positives = 49/147 (33%), Gaps = 19/147 (12%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
++ ++ ++H ++L + + LS++R L L+ + L
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLT-----------------GSIPDLGA-- 156
+ S FN+L +L L+ +++ + +LG
Sbjct: 225 MKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE 284
Query: 157 FSSLAQFNVSFNKLNGSIPKRFARLPS 183
++ + ++ L + ++ L
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEK 311
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 14/70 (20%), Positives = 28/70 (40%), Gaps = 5/70 (7%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+ + L EL+ + N L+ T+P + L + + N G+ L +L
Sbjct: 445 SFSLFLPRLQELY---ISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499
Query: 114 IRLNLAKNNF 123
++ L N +
Sbjct: 500 QKIWLHTNPW 509
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 13/159 (8%)
Query: 32 VGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALR--GTIPSDFAKLSNL 89
+ L F L+ + G+LTEL T+ L+ N L+ I ++ +L
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL 376
Query: 90 RNLYLQGNLFSGEIPGLLFS-LGNLIRLNLAKNNFSGTISADFNKLTR-LGTLYLQENQL 147
+ L + N S + S +L+ LN++ N + F L + L L N++
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT---DTIFRCLPPRIKVLDLHSNKI 433
Query: 148 TGSIPDLGAF--SSLAQFNVSFNKLNGSIPKR-FARLPS 183
SIP +L + NV+ N+L S+P F RL S
Sbjct: 434 K-SIPK-QVVKLEALQELNVASNQLK-SVPDGIFDRLTS 469
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 9e-15
Identities = 28/134 (20%), Positives = 42/134 (31%), Gaps = 10/134 (7%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
T L+ + N + SD LS LR L + N + L L+L+
Sbjct: 22 KTTILN---ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKR 177
N + L L L N ++P F +++Q +S L S
Sbjct: 79 NKLV---KISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLP 134
Query: 178 FARLPSSAFEGNSL 191
A L S
Sbjct: 135 IAHLNISKVLLVLG 148
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 27/120 (22%), Positives = 44/120 (36%), Gaps = 6/120 (5%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
I +L++L + + N ++ S F L L L N +I NL L+
Sbjct: 40 DILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLD 96
Query: 118 LAKNNF-SGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPK 176
L+ N F + I +F +++L L L L S + + L V K
Sbjct: 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS--SVLPIAHLNISKVLLVLGETYGEK 154
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 27/149 (18%), Positives = 54/149 (36%), Gaps = 8/149 (5%)
Query: 41 VTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFS 100
++ ++ G + +L L + + + SN+ + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVS-GT 312
Query: 101 GEIPGLLFS-LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDL-GAF- 157
+ L S + + L+ + N + T+ + LT L TL LQ NQL + +
Sbjct: 313 RMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTT 371
Query: 158 --SSLAQFNVSFNKLNGSIPKR-FARLPS 183
SL Q ++S N ++ K + S
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKS 400
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 27/120 (22%), Positives = 42/120 (35%), Gaps = 10/120 (8%)
Query: 67 TVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGT 126
V N L +P D + L + N S + SL L L ++ N
Sbjct: 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-Y 59
Query: 127 ISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP--KRFARLPS 183
+ F L L L N+L I +L ++SFN + ++P K F +
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KIS-CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQ 116
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 16/131 (12%), Positives = 37/131 (28%), Gaps = 11/131 (8%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFA--KLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+ +++ D++ L L + ++F + N+ N
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIP 175
+ +K++ L N LT L + + N+L +
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTV-FENCGHLTELETLILQMNQLK-ELS 364
Query: 176 KR---FARLPS 183
K ++ S
Sbjct: 365 KIAEMTTQMKS 375
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 19/126 (15%), Positives = 40/126 (31%), Gaps = 5/126 (3%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
L + T F + + ++ N+ LQG L + SL L +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQF---NVSFNKLNGSIPKR 177
+ F S + + + + + + S ++ F + S N L ++ +
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSGTR--MVHMLCPSKISPFLHLDFSNNLLTDTVFEN 343
Query: 178 FARLPS 183
L
Sbjct: 344 CGHLTE 349
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 16/64 (25%), Positives = 28/64 (43%), Gaps = 6/64 (9%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNLA 119
+ L L N ++ +IP KL L+ L + N +P +F L +L ++ L
Sbjct: 422 RIKVLD---LHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLH 476
Query: 120 KNNF 123
N +
Sbjct: 477 TNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 21/133 (15%), Positives = 35/133 (26%), Gaps = 6/133 (4%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIP--SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114
I+ L + L FNA +P +F +S L+ L L + L
Sbjct: 84 ISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLT-GSIPDLGAFSSLAQFNVSFNKLNGS 173
L + + L T L T + S N+ + +
Sbjct: 143 VLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCV 200
Query: 174 IPKRFARLPSSAF 186
+ S
Sbjct: 201 LEDNKCSYFLSIL 213
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 56/221 (25%), Positives = 87/221 (39%), Gaps = 49/221 (22%)
Query: 324 VLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKE---FREKMEVVGSMDHENLV 375
V+G+G F K T G V A+K + K + E FRE+ +V+ + D +
Sbjct: 68 VIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 376 PLRAYYYS--RDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETR---SGLALGASRA 429
L +++ + L LV +Y G L LL ++ R P R + + + A
Sbjct: 125 QL---HFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEM-ARFYLAEIVM----A 174
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---------TPNRIDG 480
I +H G H +IK NILL + R++DFG TP+
Sbjct: 175 IDSVHRLGYV--HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPD---- 228
Query: 481 YRAPEVTDARKVSQKADVY-------SFGVLLLELLTGKAP 514
Y +PE+ A Y + GV E+ G+ P
Sbjct: 229 YLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 30/207 (14%), Positives = 58/207 (28%), Gaps = 37/207 (17%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKME----VVGSMDHENLVPL 377
G ++A + VA+ + V + ++ + +D + +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
++R L+V +++ GSL + T + + A H G
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQKAD 497
A S + +S G LA P + + D
Sbjct: 150 VA--LSIDHPSRVR--------VSIDGDVVLAYP--------ATMPD-------ANPQDD 184
Query: 498 VYSFGVLLLELLTGKAPTQALLNEEGV 524
+ G L LL + P G+
Sbjct: 185 IRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLV 375
++G+G++G K + G +VA+K+ + + + RE ++++ + HENLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLES--DDDKMVKKIAMRE-IKLLKQLRHENLV 87
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + LV +++ ++ L L+++ I + HS
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHS 142
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSST-PNRIDG--YRAPEV-TDAR 490
H +IK NIL+S+S ++ DFG A LA+P + + YRAPE+
Sbjct: 143 HNII--HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 491 KVSQKADVYSFGVLLLELLTGKA 513
K + DV++ G L+ E+ G+
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEP 223
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 36/102 (35%), Positives = 47/102 (46%), Gaps = 6/102 (5%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNL 118
L L + L N L+ ++P F L+ L L L N +P +F L +L L L
Sbjct: 107 QLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRL 164
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
N F+KLT L TL L NQL +P+ GAF SL
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPE-GAFDSL 204
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 14/129 (10%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNLA 119
+ +L L+ N L F +L+ LR LYL N +P +F L NL L +
Sbjct: 38 DTKKLD---LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVT 93
Query: 120 KNNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIP 175
N + F++L L L L NQL S+P F SL + ++ +N+L S+P
Sbjct: 94 DNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPP-RVFDSLTKLTYLSLGYNELQ-SLP 149
Query: 176 KR-FARLPS 183
K F +L S
Sbjct: 150 KGVFDKLTS 158
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 4/87 (4%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNL 118
+LT+L +SL +N L+ ++P F KL++L+ L L N +P F L L L L
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKL 188
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQEN 145
N F+ L +L L LQEN
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 25/80 (31%), Positives = 37/80 (46%), Gaps = 13/80 (16%)
Query: 112 NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFN 168
+ +L+L N S S F++LT+L LYL +N+L ++P G F L V+ N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPA-GIFKELKNLETLWVTDN 95
Query: 169 KLNGSIPKRFARLPSSAFEG 188
KL LP F+
Sbjct: 96 KL--------QALPIGVFDQ 107
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 43/213 (20%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVK---RLKDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
LG+G +G A VAVK + V E +E + + ++HEN+V +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYGH 73
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR--------AIAY 432
+ + L +Y G L + E G+ ++ + Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-------------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----------TPNRIDGYR 482
LH G H +IK N+LL + +ISDFGLA + ++ T Y
Sbjct: 121 LHGIGIT--HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP----YV 174
Query: 483 APEVTDARK-VSQKADVYSFGVLLLELLTGKAP 514
APE+ R+ ++ DV+S G++L +L G+ P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 27/207 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK-DVTVSEKE------FREKMEVVGSMDHENL 374
+ LG+G F T YKA +VA+K++K K+ RE ++++ + H N+
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE-IKLLQELSHPNI 74
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ L + + LV D+M L ++ N L L + + YLH
Sbjct: 75 IGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLH 129
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAPEV- 486
H ++K +N+LL ++ +++DFG LA +PNR YRAPE+
Sbjct: 130 QHWIL--HRDLKPNNLLLDENGVLKLADFG---LAKSFGSPNRAYTHQVVTRWYRAPELL 184
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKA 513
AR D+++ G +L ELL
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRVP 211
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 43/212 (20%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVVGSMDHENLVPLR 378
+GKG F A + G VA+K +L ++ +K FRE + ++ ++H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLFRE-VRIMKILNHPNIVKLF 80
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR--------AI 430
+ L+ +Y G + L + GR + +R A+
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAH---GR----------MKEKEARSKFRQIVSAV 127
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-------TPNRIDGYRA 483
Y H K H ++K+ N+LL +I+DFG ++ + P Y A
Sbjct: 128 QYCHQKRIV--HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP----YAA 181
Query: 484 PEVTDARK-VSQKADVYSFGVLLLELLTGKAP 514
PE+ +K + DV+S GV+L L++G P
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 53/223 (23%), Positives = 85/223 (38%), Gaps = 52/223 (23%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVV------GSMD 370
+LGKG FGT + L + VA+K R+ + +EV
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 371 HENLVPLRAYYYSRDEKLLVHDY-MPMGSLSALL--HGNRGAGRTPLNWETRSGLALGAS 427
H ++ L ++ +++ +LV + +P L + G L G S
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---------------LGEGPS 141
Query: 428 R--------AIAYLHSKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSS----- 473
R AI + HS+G H +IK NIL+ + A++ DFG L
Sbjct: 142 RCFFGQVVAAIQHCHSRGVV--HRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD 199
Query: 474 -TPNRIDGYRAPEVTDARK-VSQKADVYSFGVLLLELLTGKAP 514
T Y PE + + A V+S G+LL +++ G P
Sbjct: 200 GTRV----YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 32/212 (15%)
Query: 323 EVLGKGTFGTAYKA--TLEMGIVVAVKRLKDVTVSEKE------FRE--KMEVVGSMDHE 372
+G+G +G +KA G VA+KR++ + +E RE + + + +H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 373 NLVPLR----AYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
N+V L R+ KL LV +++ L+ L G ET +
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT---ETIKDMMFQLL 130
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------Y 481
R + +LHS H ++K NIL++ S + +++DFGLA S + Y
Sbjct: 131 RGLDFLHSHRVV--HRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWY 185
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
RAPEV + D++S G + E+ K
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 38/218 (17%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL--KDVTVSEKEFREKMEVVGSMDHENLVPLR- 378
+ LG G G + A + VA+K++ D + RE ++++ +DH+N+V +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-IKIIRRLDHDNIVKVFE 75
Query: 379 -------------AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALG 425
+ +V +YM L+ +L PL E
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQG------PLLEEHARLFMYQ 128
Query: 426 ASRAIAYLHSKGPAN-SHGNIKSSNILL-SKSYEARISDFGLAHLASPSSTPNRI----- 478
R + Y+HS AN H ++K +N+ + ++ +I DFGLA + P +
Sbjct: 129 LLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 479 --DGYRAPEVT-DARKVSQKADVYSFGVLLLELLTGKA 513
YR+P + ++ D+++ G + E+LTGK
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 39/120 (32%), Positives = 51/120 (42%), Gaps = 4/120 (3%)
Query: 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFS 100
T L L LT L + L N L+ ++P+ F KL++L L L N
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 101 GEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
G+ L L L L N F+KLT+L L L +NQL S+PD G F L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPD-GVFDRL 147
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 6e-14
Identities = 58/214 (27%), Positives = 89/214 (41%), Gaps = 42/214 (19%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVVGSMDHENLVP 376
+ LG GTFG G VAVK +++ + V K RE ++ + H +++
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE-IQNLKLFRHPHIIK 80
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR-------- 428
L + + +V +Y+ G L + N GR L SR
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKN---GR----------LDEKESRRLFQQILS 127
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-------TPNRIDGY 481
+ Y H H ++K N+LL A+I+DFGL+++ S +PN Y
Sbjct: 128 GVDYCHRHMVV--HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN----Y 181
Query: 482 RAPEVTDARK-VSQKADVYSFGVLLLELLTGKAP 514
APEV R + D++S GV+L LL G P
Sbjct: 182 AAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 43/213 (20%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVK---RLKDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
LG+G +G A VAVK + V E +E + + ++HEN+V +
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE-ICINKMLNHENVVKFYGH 73
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR--------AIAY 432
+ + L +Y G L + E G+ ++ + Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-------------EPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----------TPNRIDGYR 482
LH G H +IK N+LL + +ISDFGLA + ++ T Y
Sbjct: 121 LHGIGIT--HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP----YV 174
Query: 483 APEVTDARK-VSQKADVYSFGVLLLELLTGKAP 514
APE+ R+ ++ DV+S G++L +L G+ P
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 29/130 (22%), Positives = 44/130 (33%), Gaps = 15/130 (11%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+LP +L + N L + L L +Y N ++P +L
Sbjct: 167 KLPDLPPSLEFIA---AGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPD---LPLSL 217
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS 173
+ N + L L T+Y N L ++PDL SL NV N L
Sbjct: 218 ESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDL--PPSLEALNVRDNYLT-D 271
Query: 174 IPKRFARLPS 183
+P+ L
Sbjct: 272 LPELPQSLTF 281
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-13
Identities = 27/171 (15%), Positives = 45/171 (26%), Gaps = 41/171 (23%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPS---------------DFAKLSNLRNLYLQGNLF 99
LP +L L + AL P + S L+ + + N
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSL 165
Query: 100 SGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG---------- 149
++P +L + N + + L L +Y N L
Sbjct: 166 K-KLPD---LPPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKKLPDLPLSLES 219
Query: 150 ---------SIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSL 191
+P+L L N L ++P L + N L
Sbjct: 220 IVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYL 269
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 22/157 (14%), Positives = 40/157 (25%), Gaps = 35/157 (22%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLS-------------NLRNLYLQGNLFS 100
++P+ N+ ++ P + L L S
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 101 GEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG----------- 149
+P +L L + N+ + + L L L+
Sbjct: 85 -SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVS 139
Query: 150 -----SIPDLGAFSSLAQFNVSFNKLNGSIPKRFARL 181
+P+L S L +V N L +P L
Sbjct: 140 NNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSL 175
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 31/130 (23%), Positives = 45/130 (34%), Gaps = 19/130 (14%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
LP +LT L F+ L P NL L N + L +L
Sbjct: 271 DLPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIR-SLCDL---PPSL 319
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS 173
LN++ N + A +L R L N L +P+L +L Q +V +N L
Sbjct: 320 EELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPEL--PQNLKQLHVEYNPLR-E 371
Query: 174 IPKRFARLPS 183
P +
Sbjct: 372 FPDIPESVED 381
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 17/111 (15%), Positives = 34/111 (30%), Gaps = 24/111 (21%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKL----------------SNLRNLYLQGN 97
++P NL +LH + +N LR P + NL+ L+++ N
Sbjct: 351 EVPELPQNLKQLH---VEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETN 406
Query: 98 LFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLT 148
E P + ++ L + +L + +
Sbjct: 407 PLR-EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 20/117 (17%), Positives = 36/117 (30%), Gaps = 29/117 (24%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL--- 110
+LP L L FN L +P NL+ L+++ N E P + S+
Sbjct: 331 ELPALPPRLERLI---ASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDL 382
Query: 111 -------------GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDL 154
NL +L++ N + L + ++ +
Sbjct: 383 RMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVV-DPYEF 434
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 52/214 (24%), Positives = 85/214 (39%), Gaps = 34/214 (15%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKM------EV-----VGSMD 370
+G G +GT YKA G VA+K ++ + + EV + + +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 371 HENLVPLR----AYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALG 425
H N+V L R+ K+ LV +++ L L G ET L
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA---ETIKDLMRQ 128
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG----- 480
R + +LH+ H ++K NIL++ +++DFGLA + S +
Sbjct: 129 FLRGLDFLHANCIV--HRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTPVVVTL 183
Query: 481 -YRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
YRAPEV + D++S G + E+ K
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 51/207 (24%), Positives = 74/207 (35%), Gaps = 48/207 (23%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+VLG G G + A+K L+D K RE + ++V + Y
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVY 80
Query: 382 ----YSRDEKLLVHDYMPMGSL----SALLHGN---RGAGRTPLNWETRSGLALGASRAI 430
R L+V + + G L R A S + AI
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA----------SEIMKSIGEAI 130
Query: 431 AYLHSKGPANSHGNIKSSNILL-SKSYEA--RISDFGLAHLASPSSTPNRIDGYRAPEVT 487
YLHS A H ++K N+L SK A +++DFG A E T
Sbjct: 131 QYLHSINIA--HRDVKPENLLYTSKRPNAILKLTDFGFA-----------------KETT 171
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAP 514
K + D++S GV++ LL G P
Sbjct: 172 -GEKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-14
Identities = 32/161 (19%), Positives = 57/161 (35%), Gaps = 23/161 (14%)
Query: 29 CKWVGVFCTGERVTMLRFPGMGLSGQLPIAI-GNLTELHTVSLRFNALRGTIPSD-FAKL 86
C+ V C+ +++ ++P I EL L N + F KL
Sbjct: 11 CEGTTVDCSNQKLN-----------KIPEHIPQYTAELR---LNNNEFTVLEATGIFKKL 56
Query: 87 SNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQ 146
LR + N + G + + L N F L L TL L+ N+
Sbjct: 57 PQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNR 116
Query: 147 LTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKR-FARLPS 183
+T + + +F L+ ++ N++ ++ F L S
Sbjct: 117 IT-CVGN-DSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 23/64 (35%), Positives = 32/64 (50%), Gaps = 2/64 (3%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
L L T+ LR N + + +D F LS++R L L N + PG +L +L LNL
Sbjct: 103 GLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLL 161
Query: 120 KNNF 123
N F
Sbjct: 162 ANPF 165
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-------FREKMEVVGSMDHENL 374
+ LG+GT+ T YK +VA+K ++ E E RE + ++ + H N+
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIR----LEHEEGAPCTAIRE-VSLLKDLKHANI 62
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
V L ++ LV +Y+ L L +N R +AY H
Sbjct: 63 VTLHDIIHTEKSLTLVFEYLDK-DLKQYLD----DCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------YRAPEV- 486
+ H ++K N+L+++ E +++DFGLA S P + YR P++
Sbjct: 118 RQKVL--HRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDIL 172
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKA 513
+ S + D++ G + E+ TG+
Sbjct: 173 LGSTDYSTQIDMWGVGCIFYEMATGRP 199
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 72/300 (24%), Positives = 112/300 (37%), Gaps = 63/300 (21%)
Query: 266 TEIEIPREKGAGDGENTSSDLSGVVKGESKGSGVKNLVFFGKGDRAFDLED--LLRASAE 323
T I+ + SG S ++ + K + + L+
Sbjct: 101 TAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSL--AKPKHRVTMNEFEYLK---- 154
Query: 324 VLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKEFR----EKMEVVGSMDHENL 374
+LGKGTFG KAT G A+K L K+V V++ E E V+ + H L
Sbjct: 155 LLGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTEN-RVLQNSRHPFL 210
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS-------GLALGAS 427
L+ + + D V +Y G L H +R E R+ AL
Sbjct: 211 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFS---EDRARFYGAEIVSALD-- 262
Query: 428 RAIAYLHSKGPANSHGNI----KSSNILLSKSYEARISDFGLAHLA-SPSSTPNRIDG-- 480
YLHS+ + K N++L K +I+DFGL +T G
Sbjct: 263 ----YLHSE-----KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 313
Query: 481 -YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP---------TQALLNEEGVDLPRWV 530
Y APEV + + D + GV++ E++ G+ P + +L EE + PR +
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRFPRTL 372
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 48/224 (21%)
Query: 316 DLLRASAEVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKE---FREKMEVVG 367
++++ V+G+G FG K+T V A+K L K + + F E+ +++
Sbjct: 72 EVVK----VIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124
Query: 368 SMDHENLVPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETR---SGLA 423
+ +V L Y + D L +V +YMP G L L+ P W R + +
Sbjct: 125 FANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS----NYDVPEKW-ARFYTAEVV 178
Query: 424 LGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---------T 474
L A+ +HS G H ++K N+LL KS +++DFG + T
Sbjct: 179 L----ALDAIHSMGFI--HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 475 PNRIDGYRAPEVTDARKVSQK----ADVYSFGVLLLELLTGKAP 514
P+ Y +PEV ++ D +S GV L E+L G P
Sbjct: 233 PD----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 48/230 (20%), Positives = 85/230 (36%), Gaps = 62/230 (26%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE--KMEV-------------V 366
LG G F T + A + VA+K ++ +K + E + E+
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVR----GDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 367 GSMDHENLVPLRAYYYSRDEKL----LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL 422
SM +++ L ++ + +V + + +L AL+ G+
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEH-----------RGI 128
Query: 423 ALGASRAIA--------YLHSKGPANS-HGNIKSSNILLS------KSYEARISDFGLA- 466
L + I+ Y+H + H +IK N+L+ + +I+D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 467 ----HLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGK 512
H + T YR+PEV AD++S L+ EL+TG
Sbjct: 187 WYDEHYTNSIQTRE----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 44/130 (33%), Positives = 58/130 (44%), Gaps = 6/130 (4%)
Query: 33 GVFCTGERVTMLRFPGMGLSGQLPIAI-GNLTELHTVSLRFNALRGTIPSD-FAKLSNLR 90
+T L G L LP + LT L + L N L+ ++P F KL+NL
Sbjct: 79 SALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLT 136
Query: 91 NLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGS 150
L L N G+ L NL L+L+ N F+KLT+L L L +NQL S
Sbjct: 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK-S 195
Query: 151 IPDLGAFSSL 160
+PD G F L
Sbjct: 196 VPD-GVFDRL 204
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 15/102 (14%), Positives = 32/102 (31%), Gaps = 19/102 (18%)
Query: 90 RNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG 149
L+ + + L ++ ++ ++ L + L L N+L
Sbjct: 22 IKANLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNKLH- 76
Query: 150 SIPDLGAFSSLAQ---FNVSFNKLNGSIPKRFARLPSSAFEG 188
D+ A L ++ N+L LP+ F+
Sbjct: 77 ---DISALKELTNLTYLILTGNQL--------QSLPNGVFDK 107
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 64/254 (25%), Positives = 102/254 (40%), Gaps = 49/254 (19%)
Query: 306 GKGDRAFDLED--LLRASAEVLGKGTFG----TAYKATLEMGIVVAVKRL-KDVTVSEKE 358
L D L VLGKG+FG + K T E+ AVK L KDV + + +
Sbjct: 332 NGNRDRMKLTDFNFLM----VLGKGSFGKVMLSERKGTDEL---YAVKILKKDVVIQDDD 384
Query: 359 FR----EKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPL 414
EK + L L + + + D V +Y+ G L + GR
Sbjct: 385 VECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFK- 440
Query: 415 NWETRSGL-ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473
E + A + + +L SKG + ++K N++L +I+DFG+
Sbjct: 441 --EPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 496
Query: 474 --------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP---------TQ 516
TP+ Y APE+ + + D ++FGVLL E+L G+AP Q
Sbjct: 497 VTTKTFCGTPD----YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
Query: 517 ALLNEEGVDLPRWV 530
+++ V P+ +
Sbjct: 553 SIMEHN-VAYPKSM 565
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 28/206 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE------FREKMEVVGSMDHENLV 375
+G+G++G +K + G +VA+K+ + + RE + ++ + H NLV
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLE--SEDDPVIKKIALRE-IRMLKQLKHPNLV 65
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + + LV +Y ++ L + + + +A+ + H
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHK 120
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI--DG-----YRAPEV-T 487
H ++K NIL++K ++ DFG A L + P+ D YR+PE+
Sbjct: 121 HNCI--HRDVKPENILITKHSVIKLCDFGFARL---LTGPSDYYDDEVATRWYRSPELLV 175
Query: 488 DARKVSQKADVYSFGVLLLELLTGKA 513
+ DV++ G + ELL+G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGVP 201
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 21/116 (18%), Positives = 31/116 (26%), Gaps = 5/116 (4%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLI 114
P+ L L + G + A L+ L L N L
Sbjct: 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
LNL+ KL+ L L N+L P + ++ N
Sbjct: 257 SLNLSFTGLKQVPKGLPAKLS---VLDLSYNRLD-RNPSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 35/171 (20%), Positives = 49/171 (28%), Gaps = 14/171 (8%)
Query: 19 TLLWNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLP----IAIGNLTELHTVSLRFNA 74
TL G + TG + +L + + + + L +S+
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 75 LRGTIPSDFAKLSNLRNLYLQGNLFSGEI-------PGLLFSLGNLIRLNLAKNNFSGTI 127
L L L N GE P +L L N SG
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVC 220
Query: 128 SADFNKLTRLGTLYLQENQLTGSIPDLGAF--SSLAQFNVSFNKLNGSIPK 176
SA +L L L N L + S L N+SF L +PK
Sbjct: 221 SALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK 270
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 23/177 (12%), Positives = 43/177 (24%), Gaps = 16/177 (9%)
Query: 23 NLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSD 82
+ + L + ++G P + T L +
Sbjct: 79 RIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA 138
Query: 83 FA------KLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTI----SADFN 132
+ L+ L + + L L+L+ N G +
Sbjct: 139 WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPL 198
Query: 133 KLTRLGTLYLQENQLTGSIPD-----LGAFSSLAQFNVSFNKLNGSIPKRFARLPSS 184
K L L L+ + + A L ++S N L + PS
Sbjct: 199 KFPTLQVLALRNAGME-TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQ 254
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 24/101 (23%), Positives = 38/101 (37%), Gaps = 6/101 (5%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRNLYLQGNLFSGEIPGLLFS 109
SG +L + L N+LR S L +L L ++P L +
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA 274
Query: 110 LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGS 150
L L+L+ N S ++L ++G L L+ N S
Sbjct: 275 --KLSVLDLSYNRLDRNPS--PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 33/186 (17%), Positives = 60/186 (32%), Gaps = 26/186 (13%)
Query: 23 NLTDGPCKWVGVF-CTGERVTMLRFPGMGLSGQLPIAIGNL--------TELHTVSLRFN 73
N +D W F C G + G G S + + + + ++SL+
Sbjct: 16 NFSDPKPDWSSAFNCLG--AADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRL 73
Query: 74 ALRGTIPSD--------FAKLSNLRNLYLQGNLFSGEIP--GLLFSLGNLIRLNLAKNNF 123
+R +S L+ L L+ +G P L + +L LNL ++
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 124 SGTISADFN----KLTRLGTLYLQENQLTG-SIPDLGAFSSLAQFNVSFNKLNGSIPKRF 178
+ + L L + + S + F +L+ ++S N G
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 179 ARLPSS 184
A P
Sbjct: 194 ALCPLK 199
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 55/210 (26%), Positives = 82/210 (39%), Gaps = 40/210 (19%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRL-KDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+G G FG A +VAVK + + + E RE + S+ H N+V +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE-IINHRSLRHPNIVRFKEVIL 86
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR--------AIAYLH 434
+ ++ +Y G L + AGR + +R ++Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERI---CNAGR----------FSEDEARFFFQQLLSGVSYCH 133
Query: 435 SKGPANSHGNIKSSNILLSKSYEAR--ISDFGLAHLASPSS-------TPNRIDGYRAPE 485
S H ++K N LL S R I DFG + + S TP Y APE
Sbjct: 134 SMQIC--HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA----YIAPE 187
Query: 486 VTDARK-VSQKADVYSFGVLLLELLTGKAP 514
V ++ + ADV+S GV L +L G P
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 32/158 (20%), Positives = 52/158 (32%), Gaps = 25/158 (15%)
Query: 34 VFCTGERVTMLRFPGMGLSGQLPIAI-GNLTELHTVSLRFNALRGTIPSD-FAKLSNLRN 91
C +VT ++P + N EL LR I F+ +L
Sbjct: 14 FLCQESKVT-----------EIPSDLPRNAIEL---RFVLTKLR-VIQKGAFSGFGDLEK 58
Query: 92 LYLQGNLFSGEIPGLLFS-LGNLIRLNLAKNNFSGTISAD-FNKLTRLGTLYLQENQLTG 149
+ + N I +FS L L + + K N I+ + F L L L + +
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK- 117
Query: 150 SIPDLGAFSSLAQ---FNVSFNKLNGSIPKR-FARLPS 183
+PD Q ++ N +I + F L
Sbjct: 118 HLPD-VHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF 154
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 24/146 (16%), Positives = 49/146 (33%), Gaps = 12/146 (8%)
Query: 58 AIGNLT-ELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLI 114
+ L+ E + L N ++ I + F N E+P +F +
Sbjct: 148 SFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPV 205
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSI 174
L++++ S L +L L +P L +L + ++++ S
Sbjct: 206 ILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPTLEKLVALMEASLTYP----SH 258
Query: 175 PKRFARLPSSAFEGNSLCGKPLVSCN 200
FA E + +C K ++
Sbjct: 259 CCAFANWRRQISELHPICNKSILRQE 284
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 18/101 (17%), Positives = 32/101 (31%), Gaps = 8/101 (7%)
Query: 88 NLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQL 147
+ R Q + + EIP L N I L F+ L + + +N +
Sbjct: 10 SNRVFLCQESKVT-EIPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66
Query: 148 TGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEG 188
I FS+L +++ + AF+
Sbjct: 67 LEVIEA-DVFSNL----PKLHEIRIEKANNLLYINPEAFQN 102
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 24/113 (21%), Positives = 48/113 (42%), Gaps = 7/113 (6%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
+ L L + L+ N + T + L+ + L L GN + + L ++ L+
Sbjct: 58 GVQYLNNLIGLELKDNQI--TDLAPLKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLD 113
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
L + ++ L+ L LYL NQ+T +I L ++L ++ ++
Sbjct: 114 LTSTQIT-DVTP-LAGLSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQV 163
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 31/113 (27%), Positives = 54/113 (47%), Gaps = 7/113 (6%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
AI L + T+ L + T + A LSNL+ LYL N + I L L NL L+
Sbjct: 102 AIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQIT-NISPLA-GLTNLQYLS 157
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
+ S ++ L++L TL +N+++ I L + +L + ++ N++
Sbjct: 158 IGNAQVS-DLTP-LANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQI 207
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 22/111 (19%), Positives = 44/111 (39%), Gaps = 7/111 (6%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
L ++ + + T+ A L + L G + I G+ L NLI L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQ-YLNNLIGLELKD 72
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
N + ++ LT++ L L N L ++ + S+ +++ ++
Sbjct: 73 NQIT-DLAP-LKNLTKITELELSGNPLK-NVSAIAGLQSIKTLDLTSTQIT 120
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 50/219 (22%), Positives = 82/219 (37%), Gaps = 46/219 (21%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVV--GSMDHE-- 372
+LG G FG+ Y + + VA+K R+ D R MEVV +
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 373 NLVPLRAYYYSRDEKLLVHDY-MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR--- 428
++ L ++ D +L+ + P+ L + G L +R
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GA----------LQEELARSFF 155
Query: 429 -----AIAYLHSKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSS------TPN 476
A+ + H+ G H +IK NIL+ E ++ DFG L + T
Sbjct: 156 WQVLEAVRHCHNCGVL--HRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRV 213
Query: 477 RIDGYRAPEVTDARK-VSQKADVYSFGVLLLELLTGKAP 514
Y PE + + A V+S G+LL +++ G P
Sbjct: 214 ----YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 4e-13
Identities = 37/159 (23%), Positives = 58/159 (36%), Gaps = 26/159 (16%)
Query: 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN 97
+T L P L+ LP L L + N L ++P L L
Sbjct: 60 PAHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQLT-SLPVLPPGLLELSIFSNPLT 114
Query: 98 LFSGEIPGLLF-------------SLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQE 144
GL L L+++ N + ++ A ++L + L+
Sbjct: 115 HLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLA-SLPALPSELCK---LWAYN 170
Query: 145 NQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
NQLT S+P L S L + +VS N+L S+P + L
Sbjct: 171 NQLT-SLPML--PSGLQELSVSDNQLA-SLPTLPSELYK 205
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 4e-12
Identities = 29/140 (20%), Positives = 51/140 (36%), Gaps = 17/140 (12%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
LP L +L + R +L S L+ L + GN + +P L
Sbjct: 195 SLPTLPSELYKLWAYNNRLTSLPALP-------SGLKELIVSGNRLT-SLPV---LPSEL 243
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNG 172
L ++ N + ++ + L L + NQLT +P+ L SS N+ N L+
Sbjct: 244 KELMVSGNRLT-SLPMLPSGLLS---LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298
Query: 173 SIPKRFARLPSSAFEGNSLC 192
+ + S+ +
Sbjct: 299 RTLQALREITSAPGYSGPII 318
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 43/214 (20%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKEFREKMEVVGSMDHENLVP 376
E LG+G+FG AT + VA+K LK + + RE + + + H +++
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVERE-ISYLKLLRHPHIIK 73
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR-------- 428
L + + ++V +Y G L + R + R
Sbjct: 74 LYDVITTPTDIVMVIEYAG-GELFDYIVEK---KR----------MTEDEGRRFFQQIIC 119
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-------TPNRIDGY 481
AI Y H H ++K N+LL + +I+DFGL+++ + + +PN Y
Sbjct: 120 AIEYCHRHKIV--HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN----Y 173
Query: 482 RAPEVTDARK-VSQKADVYSFGVLLLELLTGKAP 514
APEV + + + DV+S G++L +L G+ P
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 44/215 (20%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE--KMEV-----VGSMDHE-- 372
+V+GKG+FG KA ++ VA+K ++ +EK F E+ + D +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR----NEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 373 -NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
N++ + + R+ + + + M +L L+ N+ G +L R A
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKF-----------QGFSLPLVRKFA 206
Query: 432 --------YLHSKGPANSHGNIKSSNILL--SKSYEARISDFGLAHLASPSSTP---NRI 478
LH H ++K NILL ++ DFG + +R
Sbjct: 207 HSILQCLDALHKNRII--HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF 264
Query: 479 DGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
YRAPEV + D++S G +L ELLTG
Sbjct: 265 --YRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 62/354 (17%), Positives = 111/354 (31%), Gaps = 104/354 (29%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMD-HEN 373
+ LG+G FG +A VAVK LK+ + +++++ + H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 374 LVPLRAYYYSRDEKLLV-HDYMPMGSLSALLHGNRGAGRTPL------------------ 414
+V L L+V ++ G+LS L R
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 415 -----------NWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE------ 457
+ + S + + P + + + + L+ S++
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 458 ------------------------ARISDFGLAHLASPSSTPNRIDGYR----------- 482
+I DFGLA + Y
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI------YKDPDYVRKGDARLPLKW 261
Query: 483 -APEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540
APE R + ++DV+SFGVLL E+ + G +P GV + +KE
Sbjct: 262 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDEEFCRRLKEGTR- 314
Query: 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594
+ EM Q + +C P RP+ +E+ + + +++ Q
Sbjct: 315 ------MRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.3 bits (168), Expect = 1e-12
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 57/230 (24%)
Query: 312 FDLED--LLRASAEVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKEFR---- 360
+ L+D +LR LG G+FG + + G A+K L K++ V K+
Sbjct: 3 YSLQDFQILR----TLGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQVEHTND 55
Query: 361 EKMEVVGSMDHENLVPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETR 419
E++ ++ + H ++ + + +++ ++ DY+ G L +LL R + R P
Sbjct: 56 ERL-MLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFP---NPV 107
Query: 420 SG-----LALGASRAIAYLHSKGPANSHGNI-----KSSNILLSKSYEARISDFGLAHLA 469
+ + L A+ YLHSK +I K NILL K+ +I+DFG A
Sbjct: 108 AKFYAAEVCL----ALEYLHSK-------DIIYRDLKPENILLDKNGHIKITDFGFAKYV 156
Query: 470 SPSS-----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
+ TP+ Y APEV + ++ D +SFG+L+ E+L G P
Sbjct: 157 PDVTYTLCGTPD----YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 67/248 (27%), Positives = 101/248 (40%), Gaps = 60/248 (24%)
Query: 316 DLLRASAEVLGKGTFG----TAYKATLEMGIVVAVKRL-KDVTVSEKEFR----EKMEVV 366
D L+ +LGKGTFG KAT G A+K L K+V +++ E E V+
Sbjct: 8 DYLK----LLGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESR-VL 59
Query: 367 GSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS------ 420
+ H L L+ + + D V +Y G L H +R E R+
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFT---EERARFYGAE 113
Query: 421 -GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------ 473
AL YLHS+ + +IK N++L K +I+DFGL
Sbjct: 114 IVSALE------YLHSRDVV--YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 474 --TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP---------TQALLNEE 522
TP Y APEV + + D + GV++ E++ G+ P + +L EE
Sbjct: 166 CGTPE----YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE 221
Query: 523 GVDLPRWV 530
+ PR +
Sbjct: 222 -IRFPRTL 228
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 1e-12
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 7/112 (6%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+ NL L + L N ++ + S L L++L L+ N S +I G L L L L L
Sbjct: 83 LTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYL 138
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
N + I+ ++LT+L TL L++NQ++ I L + L +S N +
Sbjct: 139 GNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI 187
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 31/112 (27%), Positives = 47/112 (41%), Gaps = 7/112 (6%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
I L + + L N L I L NL L+L N ++ L L L L+L
Sbjct: 61 IQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSL 116
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
N S I+ L +L +LYL N++T I L + L ++ N++
Sbjct: 117 EHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQI 165
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 26/114 (22%), Positives = 49/114 (42%), Gaps = 7/114 (6%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ L + + + ++ ++ L N+ L+L GN + +I L +L NL L
Sbjct: 37 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWL 92
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
L +N +S+ L +L +L L+ N ++ I L L + NK+
Sbjct: 93 FLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKI 143
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 30/119 (25%), Positives = 51/119 (42%), Gaps = 9/119 (7%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
+ +L +L ++ L N + T + ++L+ L L L+ N S +I L L L L
Sbjct: 126 GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 181
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPK 176
L+KN+ S + A L L L L + + S+L N + +GS+
Sbjct: 182 LSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPIN--HQSNLVVPN-TVKNTDGSLVT 235
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 28/114 (24%), Positives = 44/114 (38%), Gaps = 5/114 (4%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
+ LT+L T+SL N + I A L+ L+NLYL N S ++ L L NL L
Sbjct: 148 VLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRAL-AGLKNLDVLE 203
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
L + L T+ + L + + + NV ++
Sbjct: 204 LFSQECLNKPINHQSNLVVPNTVKNTDGSLV-TPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 5e-06
Identities = 11/83 (13%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 89 LRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLT 148
+ +I + I+ NL K + + ++ N+L + + + +
Sbjct: 1 MGETITVSTPIK-QIFPDD-AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 149 GSIPDLGAFSSLAQFNVSFNKLN 171
S+ + ++ + ++ NKL
Sbjct: 57 -SVQGIQYLPNVTKLFLNGNKLT 78
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 71/277 (25%), Positives = 109/277 (39%), Gaps = 58/277 (20%)
Query: 272 REKGAGDGENTSSDLSGVVKGESKGSGVKNL--VFFGKGDRAFDLED--LLRASAEVLGK 327
E+G G + G GE + L +E+ LL+ VLG
Sbjct: 9 EEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK----VLGT 64
Query: 328 GTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKEFRE--KME--VVGSMDHEN-LVPL 377
G +G + + + G + A+K L K V + + E + E V+ + LV L
Sbjct: 65 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 124
Query: 378 RAYYYS--RDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG-----LALGASRA 429
+Y+ + KL L+ DY+ G L H ++ R E + L A
Sbjct: 125 ---HYAFQTETKLHLILDYINGGEL--FTHLSQ-RERFT---EHEVQIYVGEIVL----A 171
Query: 430 IAYLHSKGPANSHGNI-----KSSNILLSKSYEARISDFGLA--HLASPSSTPNRIDG-- 480
+ +LH G I K NILL + ++DFGL+ +A + G
Sbjct: 172 LEHLHKLG-------IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 481 -YRAPEV-TDARKVSQKA-DVYSFGVLLLELLTGKAP 514
Y AP++ KA D +S GVL+ ELLTG +P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 63/268 (23%), Positives = 103/268 (38%), Gaps = 76/268 (28%)
Query: 307 KGDRAFDLED--LLRASAEVLGKGTFG-------TAYKATLEMGIVVAVKRL-KDVTVSE 356
+G E LLR VLGKG +G T G + A+K L K + V
Sbjct: 9 RGPEKIRPECFELLR----VLGKGGYGKVFQVRKVTGANT---GKIFAMKVLKKAMIVRN 61
Query: 357 KEFRE--KME--VVGSMDHENLVPLRAYYYS--RDEKL-LVHDYMPMGSLSALLHGNRGA 409
+ K E ++ + H +V L Y+ KL L+ +Y+ G L + R
Sbjct: 62 AKDTAHTKAERNILEEVKHPFIVDL---IYAFQTGGKLYLILEYLSGGEL--FMQLER-E 115
Query: 410 GRTPLNWETRSG-----LALGASRAIAYLHSKGPANSHGNI-----KSSNILLSKSYEAR 459
G E + +++ A+ +LH KG I K NI+L+ +
Sbjct: 116 GIFM---EDTACFYLAEISM----ALGHLHQKG-------IIYRDLKPENIMLNHQGHVK 161
Query: 460 ISDFGLAHLASPSS--------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTG 511
++DFGL + T Y APE+ ++ D +S G L+ ++LTG
Sbjct: 162 LTDFGLCKESIHDGTVTHTFCGTIE----YMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217
Query: 512 KAP---------TQALLNEEGVDLPRWV 530
P +L + ++LP ++
Sbjct: 218 APPFTGENRKKTIDKILKCK-LNLPPYL 244
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 50/222 (22%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL------KDVTVSEKEFREKMEVVGSMDHENLV 375
++LG+G++G + E AVK L + +E ++++ + H+N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE-IQLLRRLRHKNVI 69
Query: 376 PLRAYYYSRDEKLLVHDYMPM----GSLSALLHGNRGAGRTPLNWETR-------SGLAL 424
L Y+ +++ + YM M + +L + R P+ + G
Sbjct: 70 QLVDVLYNEEKQKM---YMVMEYCVCGMQEMLD-SVPEKRFPV-CQAHGYFCQLIDG--- 121
Query: 425 GASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----------T 474
+ YLHS+G H +IK N+LL+ +IS G+A P + +
Sbjct: 122 -----LEYLHSQGIV--HKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGS 174
Query: 475 PNRIDGYRAPEVTDARKV--SQKADVYSFGVLLLELLTGKAP 514
P ++ PE+ + K D++S GV L + TG P
Sbjct: 175 PA----FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 33/120 (27%), Positives = 48/120 (40%), Gaps = 5/120 (4%)
Query: 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFS 100
+L ++ P +L L + L N L +P F L+ L L L N +
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 101 GEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
+ L +L L + N + + +LT L L L +NQL SIP GAF L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPH-GAFDRL 158
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 37/125 (29%), Positives = 53/125 (42%), Gaps = 14/125 (11%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
+ T + S R ++ IP++ + LYL N + PG+ SL NL L L
Sbjct: 20 SGTTVDCRSKRHASVPAGIPTN------AQILYLHDNQITKLEPGVFDSLINLKELYLGS 73
Query: 121 NNFSGTISAD-FNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPK 176
N + F+ LT+L L L NQLT +P F L + NKL +P+
Sbjct: 74 NQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPS-AVFDRLVHLKELFMCCNKLT-ELPR 129
Query: 177 RFARL 181
RL
Sbjct: 130 GIERL 134
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 31/116 (26%), Positives = 51/116 (43%), Gaps = 5/116 (4%)
Query: 33 GVFCTGERVTMLRFPGMGLSGQLPIAI-GNLTELHTVSLRFNALRGTIPSDFAKLSNLRN 91
GVF + + L L LP+ + +LT+L + L N L + F +L +L+
Sbjct: 58 GVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKE 116
Query: 92 LYLQGN-LFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQ 146
L++ N L +P + L +L L L +N F++L+ L YL N
Sbjct: 117 LFMCCNKLTE--LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNP 170
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 69/281 (24%), Positives = 105/281 (37%), Gaps = 77/281 (27%)
Query: 293 ESKGSGVKNLVFFGKGDRAFDLED--LLRASAEVLGKGTFG----TAYKATLEMGIVVAV 346
+ + + + D L+ V+GKG+FG +KA + AV
Sbjct: 16 APPPAPSQQINLGPSSNPHAKPSDFHFLK----VIGKGSFGKVLLARHKAE---EVFYAV 68
Query: 347 KRL-KDVTVSEKEFR----EKMEVVGSMDHENLVPLRAYYYS--RDEKL-LVHDYMPMGS 398
K L K + +KE + E+ ++ ++ H LV L ++S +KL V DY+ G
Sbjct: 69 KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL---HFSFQTADKLYFVLDYINGGE 125
Query: 399 LSALLHGNRGAGRTPLNWETRS-------GLALGASRAIAYLHSKGPANSHGNI-----K 446
L H R E R+ ALG YLHS I K
Sbjct: 126 L--FYHLQR-ERCFL---EPRARFYAAEIASALG------YLHSLN-------IVYRDLK 166
Query: 447 SSNILLSKSYEARISDFGLA--HLASPSS------TPNRIDGYRAPEVTDARKVSQKADV 498
NILL ++DFGL ++ S+ TP Y APEV + + D
Sbjct: 167 PENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPE----YLAPEVLHKQPYDRTVDW 222
Query: 499 YSFGVLLLELLTGKAP---------TQALLNEEGVDLPRWV 530
+ G +L E+L G P +LN+ + L +
Sbjct: 223 WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQLKPNI 262
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 56/235 (23%), Positives = 100/235 (42%), Gaps = 51/235 (21%)
Query: 306 GKGDRAFDLED--LLRASAEVLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKE 358
GK + L+D LLR V+G+G++ K T + A++ + K++ +++
Sbjct: 43 GKASSSLGLQDFDLLR----VIGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDED 95
Query: 359 ----FREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPL 414
EK + +H LV L + + + V +Y+ G L + H R + P
Sbjct: 96 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP- 151
Query: 415 NWETRS-------GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA- 466
E + LAL YLH +G + ++K N+LL +++D+G+
Sbjct: 152 --EEHARFYSAEISLALN------YLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK 201
Query: 467 -HLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
L + TPN Y APE+ D ++ GVL+ E++ G++P
Sbjct: 202 EGLRPGDTTSTFCGTPN----YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 27/97 (27%), Positives = 44/97 (45%), Gaps = 17/97 (17%)
Query: 429 AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--------TPNRIDG 480
I YLH + H +IK SN+L+ + +I+DFG+++ S TP
Sbjct: 149 GIEYLHYQKII--HRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPA---- 202
Query: 481 YRAPEVTDARKVS---QKADVYSFGVLLLELLTGKAP 514
+ APE + + DV++ GV L + G+ P
Sbjct: 203 FMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 51/214 (23%), Positives = 88/214 (41%), Gaps = 47/214 (21%)
Query: 324 VLGKGTFGTAY----KATLEMGIVVAVKRL-KDVTVSEKE----FREKMEVVGSMDHENL 374
LG G+FG K + G A+K L K V K+ EK ++ +++ L
Sbjct: 48 TLGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQIEHTLNEKR-ILQAVNFPFL 103
Query: 375 VPLRAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETR---SGLALGASRAI 430
V L + + + L +V +Y+ G + + L R GR R + + L
Sbjct: 104 VKLE-FSFKDNSNLYMVMEYVAGGEMFSHL---RRIGRFSEPH-ARFYAAQIVL----TF 154
Query: 431 AYLHSKGPANSHGNI-----KSSNILLSKSYEARISDFGLAHLASPSS-----TPNRIDG 480
YLHS ++ K N+L+ + +++DFG A + TP
Sbjct: 155 EYLHSL-------DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPE---- 203
Query: 481 YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
APE+ ++ ++ D ++ GVL+ E+ G P
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 7/112 (6%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+ NL L + L N ++ + S L L++L L+ N S +I GL+ L L L L
Sbjct: 86 LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DINGLV-HLPQLESLYL 141
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
N + I+ ++LT+L TL L++NQ++ I L + L +S N +
Sbjct: 142 GNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 32/112 (28%), Positives = 48/112 (42%), Gaps = 7/112 (6%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
I L + + L N L I A L NL L+L N ++ L L L L+L
Sbjct: 64 IQYLPNVTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSL 119
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
N S I+ L +L +LYL N++T I L + L ++ N++
Sbjct: 120 EHNGIS-DING-LVHLPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQI 168
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 26/114 (22%), Positives = 49/114 (42%), Gaps = 7/114 (6%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ L + + + ++ ++ L N+ L+L GN + +I L +L NL L
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWL 95
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
L +N +S+ L +L +L L+ N ++ I L L + NK+
Sbjct: 96 FLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKI 146
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 30/117 (25%), Positives = 51/117 (43%), Gaps = 9/117 (7%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
+ +L +L ++ L N + T + ++L+ L L L+ N S +I L L L L
Sbjct: 129 GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLY 184
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSI 174
L+KN+ S + A L L L L + + S+L N + +GS+
Sbjct: 185 LSKNHIS-DLRA-LAGLKNLDVLELFSQECLN--KPINHQSNLVVPN-TVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 31/116 (26%), Positives = 45/116 (38%), Gaps = 9/116 (7%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
+ LT+L T+SL N + I A L+ L+NLYL N S ++ L L NL L
Sbjct: 151 VLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHIS-DLRAL-AGLKNLDVLE 206
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTG--SIPDLGAFSSLAQFNVSFNKLN 171
L + L T+ + L I D G + NV ++
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP---NVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 13/90 (14%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 81 SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTL 140
+ L+ + + L ++ ++ ++ ++ L + L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKL 73
Query: 141 YLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
+L N+LT I L +L + NK+
Sbjct: 74 FLNGNKLT-DIKPLANLKNLGWLFLDENKV 102
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 10/63 (15%), Positives = 28/63 (44%), Gaps = 3/63 (4%)
Query: 109 SLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFN 168
+ I+ NL K + + ++ N+L + + + + S+ + ++ + ++ N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGN 78
Query: 169 KLN 171
KL
Sbjct: 79 KLT 81
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 3e-12
Identities = 63/248 (25%), Positives = 107/248 (43%), Gaps = 59/248 (23%)
Query: 316 DLLRASAEVLGKGTFG----TAYKATLEMGIVVAVKRL-KDVTVSEKEFR----EKMEVV 366
L + +LGKG+FG +K T A+K L KDV + + + EK +
Sbjct: 20 ILHK----MLGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLS 72
Query: 367 GSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRS------ 420
+ +H L + + +++ V +Y+ G L + H + +R+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQS-CHKFD---LSRATFYAAE 126
Query: 421 -GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA--HLASPSS---- 473
L L +LHSKG + ++K NILL K +I+DFG+ ++ +
Sbjct: 127 IILGLQ------FLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF 178
Query: 474 --TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP---------TQALLNEE 522
TP+ Y APE+ +K + D +SFGVLL E+L G++P ++ +
Sbjct: 179 CGTPD----YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 234
Query: 523 GVDLPRWV 530
PRW+
Sbjct: 235 -PFYPRWL 241
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 39/243 (16%), Positives = 81/243 (33%), Gaps = 68/243 (27%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPL 377
++G+G++G Y A VA+K++ + ++ RE + ++ + + ++ L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE-ITILNRLKSDYIIRL 90
Query: 378 RAYYYSRDEKL-----LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS----- 427
D +V + L L ++ + L
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADS-DLKKLF---------------KTPIFLTEEHIKTI 134
Query: 428 -----RAIAYLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG- 480
++H + H ++K +N LL++ ++ DFGLA + N ++
Sbjct: 135 LYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 481 -------------------------YRAPEV-TDARKVSQKADVYSFGVLLLELLTGKAP 514
YRAPE+ ++ D++S G + ELL
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 515 TQA 517
Sbjct: 252 HIN 254
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 55/233 (23%), Positives = 97/233 (41%), Gaps = 51/233 (21%)
Query: 308 GDRAFDLED--LLRASAEVLGKGTFGTA----YKATLEMGIVVAVKRL-KDVTVSEKE-- 358
L+D LLR V+G+G++ K T + A+K + K++ +++
Sbjct: 2 AMDPLGLQDFDLLR----VIGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDID 54
Query: 359 --FREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNW 416
EK + +H LV L + + + V +Y+ G L + H R + P
Sbjct: 55 WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLP--- 108
Query: 417 ETRS-------GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA--H 467
E + LAL YLH +G + ++K N+LL +++D+G+
Sbjct: 109 EEHARFYSAEISLALN------YLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160
Query: 468 LASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
L + TPN Y APE+ D ++ GVL+ E++ G++P
Sbjct: 161 LRPGDTTSTFCGTPN----YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-12
Identities = 28/93 (30%), Positives = 42/93 (45%), Gaps = 5/93 (5%)
Query: 70 LRFNALRGTIPSD--FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTI 127
L N L I SD F +L +L L L+ N +G P ++ L L +N
Sbjct: 36 LNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEIS 94
Query: 128 SADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
+ F L +L TL L +NQ++ + G+F L
Sbjct: 95 NKMFLGLHQLKTLNLYDNQIS-CVMP-GSFEHL 125
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 27/112 (24%), Positives = 42/112 (37%), Gaps = 8/112 (7%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+ T L + L N + + S L+ L L + N + G+ L RL L
Sbjct: 59 MQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFL 113
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
N L L L ++ N+L SI LG S L ++ N++
Sbjct: 114 DNNELR-DTD-SLIHLKNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEI 162
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 23/112 (20%), Positives = 46/112 (41%), Gaps = 8/112 (7%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
L +L ++ T +LS ++N + + G + NL L+L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
+ N S +S LT+L L + N+L ++ + + L++ + N+L
Sbjct: 71 SHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGI-PSACLSRLFLDNNEL 118
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 19/88 (21%), Positives = 29/88 (32%), Gaps = 9/88 (10%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
L+ L L N L L NL L ++ N I L L L L+L
Sbjct: 107 CLSRLF---LDNNEL--RDTDSLIHLKNLEILSIRNNKLK-SIVMLG-FLSKLEVLDLHG 159
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLT 148
N + +L ++ + L +
Sbjct: 160 NEIT-NTG-GLTRLKKVNWIDLTGQKCV 185
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 67/259 (25%), Positives = 109/259 (42%), Gaps = 61/259 (23%)
Query: 307 KGDRAFDLED--LLRASAEVLGKGTFG----TAYKATLEMGIVVAVKRL-KDVTVSEKE- 358
+++ +R VLGKG+FG K T G + AVK L KDV + + +
Sbjct: 15 NSSNRLGIDNFEFIR----VLGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDV 67
Query: 359 ---FREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLN 415
EK + + +H L L + + D V +++ G L + H + + R
Sbjct: 68 ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQK-SRRFD-- 122
Query: 416 WETRS-------GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA-- 466
E R+ AL +LH KG + ++K N+LL +++DFG+
Sbjct: 123 -EARARFYAAEIISALM------FLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173
Query: 467 HLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP------ 514
+ + + TP+ Y APE+ D ++ GVLL E+L G AP
Sbjct: 174 GICNGVTTATFCGTPD----YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229
Query: 515 ---TQALLNEEGVDLPRWV 530
+A+LN+E V P W+
Sbjct: 230 DDLFEAILNDE-VVYPTWL 247
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 37/116 (31%), Positives = 50/116 (43%), Gaps = 7/116 (6%)
Query: 70 LRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISA 129
L+ L + F L+ L L L N G+ L L L LA N +
Sbjct: 42 LQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLG 101
Query: 130 DFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKR-FARL 181
F+ LT+L LYL NQL S+P G F L + ++ N+L SIP F +L
Sbjct: 102 VFDHLTQLDKLYLGGNQLK-SLPS-GVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 40/100 (40%), Positives = 48/100 (48%), Gaps = 4/100 (4%)
Query: 62 LTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
LTEL T+ L N L ++P F L+ L LYL GN G+ L L L L
Sbjct: 82 LTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNT 140
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
N + F+KLT L TL L NQL S+P GAF L
Sbjct: 141 NQLQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPH-GAFDRL 178
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 6e-09
Identities = 39/108 (36%), Positives = 47/108 (43%), Gaps = 15/108 (13%)
Query: 79 IPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISAD-FNKLTRL 137
IP+D L LQ + L L LNL N T+SA F+ LT L
Sbjct: 33 IPAD------TEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTEL 85
Query: 138 GTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKR-FARL 181
GTL L NQL S+P G F L Q + N+L S+P F RL
Sbjct: 86 GTLGLANNQLA-SLPL-GVFDHLTQLDKLYLGGNQLK-SLPSGVFDRL 130
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 4/88 (4%)
Query: 61 NLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNL 118
+LT+L + L N L+ ++PS F +L+ L+ L L N IP F L NL L+L
Sbjct: 105 HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSL 162
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQ 146
+ N F++L +L T+ L NQ
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 44/211 (20%), Positives = 82/211 (38%), Gaps = 41/211 (19%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE--------KEFREKMEVVGSMDHEN 373
LG+G + ++A + V VK LK V + + R N
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR---------GGPN 92
Query: 374 LVPLRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPL-NWETRSGL--ALGASR 428
++ L + LV +++ L L +++ R + L +
Sbjct: 93 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEIL---K 141
Query: 429 AIAYLHSKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSSTPN-RIDG--YRAP 484
A+ Y HS G H ++K N+++ + + R+ D+GLA P N R+ ++ P
Sbjct: 142 ALDYCHSMGIM--HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 199
Query: 485 EV-TDARKVSQKADVYSFGVLLLELLTGKAP 514
E+ D + D++S G +L ++ K P
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 23/116 (19%), Positives = 41/116 (35%), Gaps = 11/116 (9%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
+ + T+L T+ FN + + D ++ L L N + ++ L L
Sbjct: 163 KLDVTPQTQLTTLDCSFNKIT-EL--DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF 216
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
L+ + N + D LT+L N LT + + S L + L
Sbjct: 217 LDCSSNKLT---EIDVTPLTQLTYFDCSVNPLT-ELD-VSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 31/135 (22%), Positives = 49/135 (36%), Gaps = 10/135 (7%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
I + + T+L + N D + L L N + E+ + L RL
Sbjct: 142 IDVSHNTQLTELDCHLNKK--ITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRL 196
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPK 176
N NN + D N+ +L L N+LT I D+ + L F+ S N L
Sbjct: 197 NCDTNNIT---KLDLNQNIQLTFLDCSSNKLT-EI-DVTPLTQLTYFDCSVNPLTELDVS 251
Query: 177 RFARLPSSAFEGNSL 191
++L + L
Sbjct: 252 TLSKLTTLHCIQTDL 266
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 27/118 (22%), Positives = 44/118 (37%), Gaps = 11/118 (9%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
I LT L + N + T+ D ++ +NL L N + + + L L LN
Sbjct: 59 GIEKLTGLTKLICTSNNIT-TL--DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLN 112
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
N + D ++ L L N LT I D+ + L + + NK +
Sbjct: 113 CDTNKLT---KLDVSQNPLLTYLNCARNTLT-EI-DVSHNTQLTELDCHLNKKITKLD 165
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 19/114 (16%), Positives = 37/114 (32%), Gaps = 9/114 (7%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
I + + T+L + R D + L L Q + E+ L L+ L
Sbjct: 269 IDLTHNTQLIY--FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYL 323
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
L + + D + T+L +L + +G +L + +
Sbjct: 324 YLNNTELT-EL--DVSHNTKLKSLSCVNAHIQ-DFSSVGKIPALNNNFEAEGQT 373
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 25/114 (21%), Positives = 43/114 (37%), Gaps = 10/114 (8%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116
+ + LT+L ++ N L D ++ L L N + EI + L L
Sbjct: 100 LDVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTEL 153
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
+ N + D T+L TL N++T + D+ L + N N +
Sbjct: 154 DCHLNKKITKL--DVTPQTQLTTLDCSFNKIT-EL-DVSQNKLLNRLNCDTNNI 203
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 24/112 (21%), Positives = 43/112 (38%), Gaps = 10/112 (8%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+ T L ++ N L + L+ L L N + ++ + L LN
Sbjct: 81 LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNC 134
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
A+N + D + T+L L N+ + D+ + L + SFNK+
Sbjct: 135 ARNTLT---EIDVSHNTQLTELDCHLNKKI-TKLDVTPQTQLTTLDCSFNKI 182
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 24/117 (20%), Positives = 37/117 (31%), Gaps = 11/117 (9%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+ LT+L N L + + LS L L+ EI L LI
Sbjct: 229 VTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQA 282
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP 175
+ D T+L L Q +T + DL L ++ +L +
Sbjct: 283 EGCRKIKEL--DVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT-ELD 334
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 25/127 (19%), Positives = 48/127 (37%), Gaps = 7/127 (5%)
Query: 65 LHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFS 124
+ ++ T +L+ L +L + + ++ G+ L L +L NN +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNIT 77
Query: 125 GTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSS 184
+ D ++ T L L N+LT ++ + + L N NKL + L
Sbjct: 78 ---TLDLSQNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYL 132
Query: 185 AFEGNSL 191
N+L
Sbjct: 133 NCARNTL 139
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 19/118 (16%), Positives = 44/118 (37%), Gaps = 9/118 (7%)
Query: 56 PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115
+ + + T+L+ + + + + D ++ L LYL + E+ + L
Sbjct: 290 ELDVTHNTQLYLLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKS 343
Query: 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS 173
L+ + S+ K+ L + E Q ++P ++ VS + L+
Sbjct: 344 LSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQF 398
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 10/64 (15%), Positives = 21/64 (32%), Gaps = 1/64 (1%)
Query: 107 LFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVS 166
F N A T + +L L +L + +T + + + L + +
Sbjct: 14 WFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICT 72
Query: 167 FNKL 170
N +
Sbjct: 73 SNNI 76
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 29/135 (21%), Positives = 44/135 (32%), Gaps = 28/135 (20%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN----LFSGEIPGL 106
+ + L L T+ L+ N L+ N+ +L L S
Sbjct: 365 FTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423
Query: 107 LFSLGNLIRLNLAKNNFSG---------------------TISADFNKLTRLGTLYLQEN 145
+++ LNL+ N +G +I D L L L + N
Sbjct: 424 CAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASN 483
Query: 146 QLTGSIPDLGAFSSL 160
QL S+PD G F L
Sbjct: 484 QLK-SVPD-GVFDRL 496
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 29/131 (22%), Positives = 45/131 (34%), Gaps = 9/131 (6%)
Query: 63 TELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLNLAKN 121
+SL N++ D + LS LR L L N + +F +L L+++ N
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110
Query: 122 NFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKRF 178
IS + L L L N +P F +L + +S K
Sbjct: 111 RLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV 166
Query: 179 ARLPSSAFEGN 189
A L S +
Sbjct: 167 AHLHLSCILLD 177
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 23/155 (14%), Positives = 51/155 (32%), Gaps = 7/155 (4%)
Query: 33 GVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNL 92
++ + + + + + ++ N ++ + L L+ L
Sbjct: 323 ALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTL 382
Query: 93 YLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTR----LGTLYLQENQLT 148
LQ N + N+ L + + S +++ + L L N LT
Sbjct: 383 ILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLT 441
Query: 149 GSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
GS+ + ++ N++ SIPK L +
Sbjct: 442 GSVFR-CLPPKVKVLDLHNNRIM-SIPKDVTHLQA 474
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 8e-09
Identities = 24/130 (18%), Positives = 40/130 (30%), Gaps = 13/130 (10%)
Query: 62 LTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121
E++ L + S+ L N+F+ + +L L L L +N
Sbjct: 328 FAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRN 387
Query: 122 NFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ-------FNVSFNKLNGSI 174
+ +L + L S+ A+ N+S N L GS+
Sbjct: 388 GLK-NFFKVALMTKNMSSLETLDVSLN-SLNS-HAYDRTCAWAESILVLNLSSNMLTGSV 444
Query: 175 PKRFARLPSS 184
F LP
Sbjct: 445 ---FRCLPPK 451
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 29/139 (20%), Positives = 50/139 (35%), Gaps = 6/139 (4%)
Query: 57 IAIGNLTELHTVSLRFNALRGTIP--SDFAKLSNLRNLYLQGN-LFSGEIPGLLFSLGNL 113
I+ + L + L FN +P +F L+ L L L ++ + +
Sbjct: 115 ISCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSC 173
Query: 114 IRLNLAKNNFSGTISADFNKL-TRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172
I L+L + G + T + L N L S+ + ++L +S KLN
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF-SVQVNMSVNALGHLQLSNIKLND 232
Query: 173 SIPKRFARLPSSAFEGNSL 191
+R S G +L
Sbjct: 233 ENCQRLMTFLSELTRGPTL 251
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 16/99 (16%), Positives = 34/99 (34%), Gaps = 5/99 (5%)
Query: 88 NLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQL 147
N+ NL + + E +L +L+ ++ F + A ++ + L +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 148 TGSIPDLGAFSSLAQF---NVSFNKLNGSIPKRFARLPS 183
I S + F N + N S+ + + L
Sbjct: 342 P-FIHM-VCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKR 378
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 37/146 (25%), Positives = 58/146 (39%), Gaps = 20/146 (13%)
Query: 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN 97
++T+L L LP +L L N L T+P ++L++L + N
Sbjct: 79 PPQITVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLPEL---PASLKHLDVDNN 130
Query: 98 LFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAF 157
+ +P L L +N N ++ T L L ++ NQLT +P+L
Sbjct: 131 QLT-MLPEL---PALLEYINADNNQ----LTMLPELPTSLEVLSVRNNQLT-FLPEL--P 179
Query: 158 SSLAQFNVSFNKLNGSIPKRFARLPS 183
SL +VS N L S+P R
Sbjct: 180 ESLEALDVSTNLLE-SLPAVPVRNHH 204
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 23/131 (17%), Positives = 44/131 (33%), Gaps = 13/131 (9%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110
A + N + ++ L L S +P L
Sbjct: 25 TYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPDNLPP- 80
Query: 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKL 170
+ L + +N ++ L L +N+L+ ++P+L +SL +V N+L
Sbjct: 81 -QITVLEITQNALI-SLPELPASLEY---LDACDNRLS-TLPEL--PASLKHLDVDNNQL 132
Query: 171 NGSIPKRFARL 181
+P+ A L
Sbjct: 133 T-MLPELPALL 142
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 18/103 (17%), Positives = 30/103 (29%), Gaps = 12/103 (11%)
Query: 86 LSNLRNLYLQGNLFS-------GEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLG 138
L N L N F + +N + + +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFS 62
Query: 139 TLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARL 181
L L L+ S+PD + ++ N L S+P+ A L
Sbjct: 63 ELQLNRLNLS-SLPD-NLPPQITVLEITQNAL-ISLPELPASL 102
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 64/259 (24%), Positives = 102/259 (39%), Gaps = 61/259 (23%)
Query: 307 KGDRAFDLED--LLRASAEVLGKGTFG----TAYKATLEMGIVVAVKRL-KDVTVSEKEF 359
L D L VLGKG+FG + K T + AVK L KDV + + +
Sbjct: 12 GNRDRMKLTDFNFLM----VLGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDV 64
Query: 360 R----EKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLN 415
EK + L L + + + D V +Y+ G L + H + GR
Sbjct: 65 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQ-VGRFK-- 119
Query: 416 WETRS-------GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468
E + + L +L SKG + ++K N++L +I+DFG+
Sbjct: 120 -EPHAVFYAAEIAIGLF------FLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170
Query: 469 ASPSS--------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP------ 514
TP+ Y APE+ + + D ++FGVLL E+L G+AP
Sbjct: 171 NIWDGVTTKTFCGTPD----YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226
Query: 515 ---TQALLNEEGVDLPRWV 530
Q+++ V P+ +
Sbjct: 227 DELFQSIMEHN-VAYPKSM 244
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 8e-12
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 16/110 (14%)
Query: 79 IPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISAD-FNKLTRL 137
IP D + LYL GN F+ +P L + +L ++L+ N S T+S F+ +T+L
Sbjct: 29 IPRD------VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80
Query: 138 GTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKR-FARLPS 183
TL L N+L IP F L ++ N ++ +P+ F L +
Sbjct: 81 LTLILSYNRLR-CIPP-RTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSA 127
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 27/96 (28%), Positives = 41/96 (42%), Gaps = 4/96 (4%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLF-SLG 111
+P + N L + L N + T+ + F+ ++ L L L N IP F L
Sbjct: 45 LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLK 102
Query: 112 NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQL 147
+L L+L N+ S FN L+ L L + N L
Sbjct: 103 SLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 45/252 (17%), Positives = 87/252 (34%), Gaps = 73/252 (28%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPL 377
++G G++G +A VVA+K++ V ++ RE + ++ ++H+++V +
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE-IAILNRLNHDHVVKV 117
Query: 378 ----RAYYYSRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS----- 427
+ ++L +V + L R+ + L
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADS-DFKKLF---------------RTPVYLTELHIKTL 161
Query: 428 -----RAIAYLHSKGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG- 480
+ Y+HS A H ++K +N L+++ ++ DFGLA N
Sbjct: 162 LYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 481 ------------------------------YRAPEV-TDARKVSQKADVYSFGVLLLELL 509
YRAPE+ ++ DV+S G + ELL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 510 TGKAPTQALLNE 521
A +
Sbjct: 279 NMIKENVAYHAD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 54/215 (25%), Positives = 90/215 (41%), Gaps = 42/215 (19%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE--KMEV-----VGSMDHEN- 373
++GKG+FG KA VA+K +K ++K F ++EV + D E
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIK----NKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 374 --LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA 431
+V L+ ++ R+ LV + + +L LL G++L +R A
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTN-----------FRGVSLNLTRKFA 163
Query: 432 --------YLHSKGPANSHGNIKSSNILL--SKSYEARISDFGLAHLASPSSTP---NRI 478
+L + + H ++K NILL K +I DFG + +R
Sbjct: 164 QQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF 223
Query: 479 DGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
YR+PEV D++S G +L+E+ TG+
Sbjct: 224 --YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.2 bits (158), Expect = 3e-11
Identities = 26/119 (21%), Positives = 43/119 (36%), Gaps = 7/119 (5%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNL 113
+ + ++ + L L T+ +L + +L L N +P L +L L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488
Query: 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG--SIPDLGAFSSLAQFNVSFNKL 170
L + N + L RL L L N+L +I L + L N+ N L
Sbjct: 489 EVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.2 bits (145), Expect = 1e-09
Identities = 25/98 (25%), Positives = 34/98 (34%), Gaps = 7/98 (7%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+ L + + L N LR +P A L L L N + G+ +L L L L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVA-NLPRLQELLL 515
Query: 119 AKNNFSGTISA--DFNKLTRLGTLYLQENQLTGSIPDL 154
N +A RL L LQ N L +
Sbjct: 516 CNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC-QEEGI 551
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 3e-09
Identities = 22/112 (19%), Positives = 42/112 (37%), Gaps = 8/112 (7%)
Query: 88 NLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQL 147
++R L+L + + L L + L+L+ N + L L L +N L
Sbjct: 442 DVRVLHLAHKDLT-VLCHL-EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498
Query: 148 TGSIPDLGAFSSLAQFNVSFNKLNG-SIPKRFARLPSSA---FEGNSLCGKP 195
++ + L + + N+L + + P +GNSLC +
Sbjct: 499 E-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 2e-05
Identities = 21/73 (28%), Positives = 29/73 (39%), Gaps = 5/73 (6%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGL--LFSLG 111
LP A+ L L + NAL + A L L+ L L N + + L S
Sbjct: 477 ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCP 533
Query: 112 NLIRLNLAKNNFS 124
L+ LNL N+
Sbjct: 534 RLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 30/126 (23%), Positives = 47/126 (37%), Gaps = 10/126 (7%)
Query: 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
A+ L F+ L+ P A L +LR+ +L E L ++ L+
Sbjct: 394 ALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL------ENSVLKMEYADVRVLH 447
Query: 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKR 177
LA + + + +L + L L N+L P L A L S N L ++
Sbjct: 448 LAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG- 503
Query: 178 FARLPS 183
A LP
Sbjct: 504 VANLPR 509
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 44/220 (20%), Positives = 78/220 (35%), Gaps = 48/220 (21%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVK-----RLKDVTVSEKE-----FREKMEVVGSMDH 371
LG G FG + A E V VK ++ + E E + ++ ++H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLE-IAILSRVEH 88
Query: 372 ENLVPLRAYYYSRDEKLLV-HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASR-- 428
N++ + + ++ LV + L A + + L +
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI-------------DRHPRLDEPLASYI 135
Query: 429 ------AIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-------TP 475
A+ YL K H +IK NI++++ + ++ DFG A T
Sbjct: 136 FRQLVSAVGYLRLKDII--HRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTI 193
Query: 476 NRIDGYRAPEVTDARK-VSQKADVYSFGVLLLELLTGKAP 514
Y APEV + +++S GV L L+ + P
Sbjct: 194 E----YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 63.2 bits (153), Expect = 6e-11
Identities = 19/93 (20%), Positives = 31/93 (33%), Gaps = 5/93 (5%)
Query: 78 TIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNLAKNNFSGTISAD-FNKLT 135
NL LY++ + LG L L + K+ ++ D F+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 136 RLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFN 168
RL L L N L S+ L+ + +
Sbjct: 81 RLSRLNLSFNALE-SLSW-KTVQGLSLQELVLS 111
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 2e-06
Identities = 21/111 (18%), Positives = 34/111 (30%), Gaps = 18/111 (16%)
Query: 29 CKW-VGVFCTGERVTML--RFPGM------GLSGQLPI------AIGNLTELHTVSLRFN 73
G+ CT + PG + Q + + L EL +++ +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 74 ALRGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNF 123
LR + D F L L L N + +L L L+ N
Sbjct: 67 GLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-11
Identities = 32/91 (35%), Positives = 40/91 (43%), Gaps = 2/91 (2%)
Query: 70 LRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISA 129
L N L+ F KL+ L L L N G+ L L L L +N +
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNG 94
Query: 130 DFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
F+KLT+L L L NQL S+PD G F L
Sbjct: 95 VFDKLTQLKELALDTNQLK-SVPD-GIFDRL 123
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 37/109 (33%), Positives = 51/109 (46%), Gaps = 13/109 (11%)
Query: 79 IPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLG 138
IPS L L+ N G+ L L +L+L++N F+KLT+L
Sbjct: 26 IPSS------ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT 79
Query: 139 TLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLNGSIPKR-FARLPS 183
LYL EN+L S+P+ G F L Q + N+L S+P F RL S
Sbjct: 80 ILYLHENKLQ-SLPN-GVFDKLTQLKELALDTNQLK-SVPDGIFDRLTS 125
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 62/225 (27%), Positives = 97/225 (43%), Gaps = 44/225 (19%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPL 377
+ LGKG +G +K+ G VVAVK++ D T +++ FRE M + HEN+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 378 RAYYYSRDEK--LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
+ +++ LV DYM L A++ N L + + + I YLHS
Sbjct: 75 LNVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHS 127
Query: 436 KGPANS-HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-------------- 480
H ++K SNILL+ +++DFGL+
Sbjct: 128 ---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 481 -----------YRAPEV-TDARKVSQKADVYSFGVLLLELLTGKA 513
YRAPE+ + K ++ D++S G +L E+L GK
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 46/277 (16%), Positives = 81/277 (29%), Gaps = 93/277 (33%)
Query: 389 LVHDYMPMG-SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKS 447
+V + +G L + + G L + + + YLH+K H +IK
Sbjct: 122 MVFE--VLGHHLLKWIIKSNYQG---LPLPCVKKIIQQVLQGLDYLHTKCRI-IHTDIKP 175
Query: 448 SNILL-------------------------------------------------SKSYEA 458
NILL ++ +
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 459 RISDFGLAHLAS-PSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517
+I+D G A + + YR+ EV + AD++S + EL TG +
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEP 295
Query: 518 LLNEEGVD--------------LPR-WVQSVVKEEWTAEVFD----------------LE 546
EE +PR + +++ E F E
Sbjct: 296 HSGEEYTRDEDHIALIIELLGKVPRKLIV---AGKYSKEFFTKKGDLKHITKLKPWGLFE 352
Query: 547 LL--RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+L +Y+ +EE + P+ R + AE
Sbjct: 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-09
Identities = 25/113 (22%), Positives = 43/113 (38%), Gaps = 7/113 (6%)
Query: 61 NLTELHTVSL--RFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
TE V L + + + + L ++L L N +I L + NL L+L
Sbjct: 21 VATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISSLS-GMENLRILSL 77
Query: 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
+N I L L++ NQ+ S+ + +L +S NK+
Sbjct: 78 GRNLIK-KIENLDAVADTLEELWISYNQIA-SLSGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 8e-06
Identities = 25/117 (21%), Positives = 38/117 (32%), Gaps = 26/117 (22%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114
+ + L ++L N + I S + + NLR L L NL +I L L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 115 RLNLAKNNFS-----------GTISADFNK------------LTRLGTLYLQENQLT 148
L ++ N + + NK L +L L L N L
Sbjct: 97 ELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.3 bits (140), Expect = 5e-09
Identities = 55/357 (15%), Positives = 104/357 (29%), Gaps = 113/357 (31%)
Query: 282 TSSDLSGVVKGESKGSGVKNL--VFFGKGDRAFD--LEDLLRASAEVLGKGTFGTAYKAT 337
+ ++ ++ + SG L K + +E++LR + + L + K
Sbjct: 47 SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLM-----SPIK-- 99
Query: 338 LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLL-----VHD 392
+ ++ + + E+ + + + + Y SR + L + +
Sbjct: 100 ---------TEQRQPSMMTRMYIEQRDRL----YNDNQVFAKYNVSRLQPYLKLRQALLE 146
Query: 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH----GNIKSS 448
P ++ L+ G G+G+T W +AL + + K N S
Sbjct: 147 LRPAKNV--LIDGVLGSGKT---W-----VALDVCLSYK-VQCKMDFKIFWLNLKNCNSP 195
Query: 449 NILLSK--SYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLL 506
+L +I + S+ RI + L
Sbjct: 196 ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH-----SIQAE---------------LR 235
Query: 507 ELLTGKAPTQALLNEEGV--DLPRWVQSVVKEEWTAEVFDLE---LL--RYQNV------ 553
LL K LL V + V+ F+L LL R++ V
Sbjct: 236 RLLKSKPYENCLL----VLLN--------VQNAKAWNAFNLSCKILLTTRFKQVTDFLSA 283
Query: 554 ----------------EEEMVQLLQLAINCTAQYPDNRPSMAEVT----SQIEEICR 590
+E+ LL ++C Q D + S I E R
Sbjct: 284 ATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQ--DLPREVLTTNPRRLSIIAESIR 338
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 4e-06
Identities = 73/606 (12%), Positives = 160/606 (26%), Gaps = 156/606 (25%)
Query: 81 SDFAK--LSN--LRNLYLQGNLFSGEIPGLLFSLGNLIRL--NLAKNNFSGTISADFNKL 134
D K LS + ++ + + + G L L+ + + + ++ L
Sbjct: 39 QDMPKSILSKEEIDHIIMSKD----AVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL 94
Query: 135 -TRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFE------ 187
+ + T Q + +T + L N F K N S + + +L + E
Sbjct: 95 MSPIKTEQRQPSMMTRMYIE--QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKN 152
Query: 188 -------GNSLCGKP-LVS--CNGGGDDDDDDGSNLSGGAIAGIVIGSVIGLLIILVLLI 237
G GK + C + I + + + +L +L
Sbjct: 153 VLIDGVLG---SGKTWVALDVCL-----SYKVQCKMDFK-IFWLNLKNCNSPETVLEMLQ 203
Query: 238 GLCRRKRDRQRSSKDVAPAATATATAKQTEI-EIPREKGAGDGEN--------------- 281
L + S D + + Q E+ + + K EN
Sbjct: 204 KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK---PYENCLLVLLNVQNAKAWN 260
Query: 282 ----------TSSDLSGVVKGESKGSGVKNLVFFGKGDRAFDLEDLLRASAEVLGKGTFG 331
T+ V + + + +++ + L
Sbjct: 261 AFNLSCKILLTTRF-KQVT--DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD 317
Query: 332 TAYKAT----LEMGIVVAVKRLKDVTVSEKEFR----EKMEVVGSMDHENLVP--LRAYY 381
+ + I+ ++D + ++ +K+ + L P R +
Sbjct: 318 LPREVLTTNPRRLSIIAE--SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF 375
Query: 382 YS-----RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNW---------------ETRSG 421
+ P LS + W S
Sbjct: 376 DRLSVFPPSAHI------PTILLSLI-------------WFDVIKSDVMVVVNKLHKYSL 416
Query: 422 LALGASRAIAYLHS-----KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN 476
+ + + S K N + + + Y F L P
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLE---NEYALHRSIVDHYNIP-KTFDSDDL-----IPP 467
Query: 477 RIDGYRAPEVTDARKVSQKADVYS-FGVLLLEL--LTGK--APTQALLNEEGV-----DL 526
+D Y + K + + + F ++ L+ L K + A + L
Sbjct: 468 YLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQL 527
Query: 527 PRWVQSVVKEEWTAEVFDLELLRY-QNVEEEMVQ-----LLQLAINCTAQYPDNRPSMAE 580
+ + + E +L + +EE ++ LL++A+ ++ E
Sbjct: 528 KFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALM-----AEDEAIFEE 582
Query: 581 VTSQIE 586
Q++
Sbjct: 583 AHKQVQ 588
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 48/235 (20%), Positives = 77/235 (32%), Gaps = 62/235 (26%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFRE--KMEV-----VGSMDHE-- 372
+G GTFG ++ AVK ++++ K++ K+E + + D
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNN 96
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIA- 431
N+V + D L+ + + SL ++ N +G + +
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITRNN-----------YNGFHIEDIKLYCI 144
Query: 432 -------YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR------- 477
YL H ++K NILL Y + R
Sbjct: 145 EILKALNYLRKMSLT--HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 478 -ID-G-----------------YRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
ID G YRAPEV +D++SFG +L EL TG
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 45/231 (19%), Positives = 75/231 (32%), Gaps = 58/231 (25%)
Query: 323 EVLGKGTFGTAYKA--TLEMGIVVAVKRLKDVTVSEKEFRE--KMEV-----VGSMDHEN 373
LG+GTFG + VA+K +++V ++RE ++E+ + D EN
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKEN 80
Query: 374 ---LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAI 430
V + ++ + + + + L N L R +
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLKENN-----------FQPYPLPHVRHM 128
Query: 431 A--------YLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN--RID- 479
A +LH H ++K NIL S + + + + D
Sbjct: 129 AYQLCHALRFLHENQLT--HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 480 G-----------------YRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
G YR PEV +Q DV+S G +L E G
Sbjct: 187 GSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 22/89 (24%), Positives = 43/89 (48%), Gaps = 4/89 (4%)
Query: 85 KLSNLRNLYLQGNLFS-GEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQ 143
S+++ L L + + G++ GL L L+ + +I+ + KL +L L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 144 ENQLTGSIPDLG-AFSSLAQFNVSFNKLN 171
+N+++G + L +L N+S NK+
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 22/104 (21%), Positives = 35/104 (33%), Gaps = 7/104 (6%)
Query: 61 NLTELHTVSLRFNAL-RGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
+++ + L + G + + L L + I L L L +L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLP-KLNKLKKLELS 72
Query: 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQF 163
N SG + K L L L N+ I DL L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNK----IKDLSTIEPLKKL 112
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-06
Identities = 26/91 (28%), Positives = 39/91 (42%), Gaps = 3/91 (3%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
EL +S L +I ++ KL+ L+ L L N SG + L NL LNL
Sbjct: 38 TDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLT 148
+ N + + KL L +L L ++T
Sbjct: 96 SGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 49/231 (21%), Positives = 80/231 (34%), Gaps = 58/231 (25%)
Query: 323 EVLGKGTFGTAYKA--TLEMGIVVAVKRLKDVTVSEKEFRE--KMEV-----VGSMDHEN 373
+ LG+G FG + G VAVK +K+V + E + E+ + + D +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNS 75
Query: 374 ---LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAI 430
V + ++ +V + + + S + N L R +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENG-----------FLPFRLDHIRKM 123
Query: 431 A--------YLHSKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSSTPNR-ID- 479
A +LHS H ++K NIL Y + + + + +D
Sbjct: 124 AYQICKSVNFLHSNKLT--HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 480 G-----------------YRAPEVTDARKVSQKADVYSFGVLLLELLTGKA 513
G YRAPEV A SQ DV+S G +L+E G
Sbjct: 182 GSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-07
Identities = 20/88 (22%), Positives = 33/88 (37%), Gaps = 4/88 (4%)
Query: 85 KLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQE 144
R L L+G I L +L ++ + +N + F L RL TL +
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFS-DNEIRKLD-GFPLLRRLKTLLVNN 73
Query: 145 NQLTGSIPDLG-AFSSLAQFNVSFNKLN 171
N++ L A L + ++ N L
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 21/90 (23%), Positives = 33/90 (36%), Gaps = 5/90 (5%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
L + + N +R + F L L+ L + N GL +L +L L L
Sbjct: 40 TLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97
Query: 121 NNFS--GTISADFNKLTRLGTLYLQENQLT 148
N+ G + L L L + N +T
Sbjct: 98 NSLVELGDLDP-LASLKSLTYLCILRNPVT 126
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 26/91 (28%), Positives = 38/91 (41%), Gaps = 3/91 (3%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
L +SL L ++ S+ KL L+ L L N G + L L NL LNL
Sbjct: 45 TAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102
Query: 119 AKNNFSGTISAD-FNKLTRLGTLYLQENQLT 148
+ N + + KL L +L L ++T
Sbjct: 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-06
Identities = 25/101 (24%), Positives = 34/101 (33%), Gaps = 4/101 (3%)
Query: 61 NLTELHTVSLRFNALR-GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119
+ + L G I A+ NL L L + L L L +L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLP-KLPKLKKLELS 79
Query: 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
+N G + KL L L L N+L I L L
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKL 119
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 27/88 (30%), Positives = 40/88 (45%), Gaps = 4/88 (4%)
Query: 86 LSNLRNLYLQGN-LFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQE 144
+ +R L L G+I GL NL L+L ++S + KL +L L L E
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELSE 80
Query: 145 NQLTGSIPDLG-AFSSLAQFNVSFNKLN 171
N++ G + L +L N+S NKL
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 35/155 (22%), Positives = 57/155 (36%), Gaps = 27/155 (17%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVK---RLKDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
+G G FG L VA+K E+R ++ +P + Y
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG----IP-QVY 71
Query: 381 YYSRDEKLLVHDYMPM---G-SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
Y+ K ++ M + G SL L RT + +T +A+ + Y+HSK
Sbjct: 72 YFGPCGK---YNAMVLELLGPSLEDLF---DLCDRT-FSLKTVLMIAIQLISRMEYVHSK 124
Query: 437 GPANSHGNIKSSNILLSKSYEAR-----ISDFGLA 466
+ ++K N L+ + I DF LA
Sbjct: 125 NLI--YRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 5e-06
Identities = 30/106 (28%), Positives = 41/106 (38%), Gaps = 28/106 (26%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114
+P I T+ + L N + P F L NL+ LY N + G+
Sbjct: 27 VPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGV-------- 76
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
F+KLT+L L L +N L SIP GAF +L
Sbjct: 77 ----------------FDKLTQLTQLDLNDNHLK-SIPR-GAFDNL 104
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-05
Identities = 26/73 (35%), Positives = 34/73 (46%), Gaps = 7/73 (9%)
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLN 171
RL L N + F+ L L LY N+LT +IP G F L Q +++ N L
Sbjct: 37 RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPT-GVFDKLTQLTQLDLNDNHLK 94
Query: 172 GSIPKR-FARLPS 183
SIP+ F L S
Sbjct: 95 -SIPRGAFDNLKS 106
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 30/106 (28%), Positives = 41/106 (38%), Gaps = 28/106 (26%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114
+P I T + L N + P F +L+ L L L N + G+
Sbjct: 24 VPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGV-------- 73
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
F+KLT+L L L +NQL SIP GAF +L
Sbjct: 74 ----------------FDKLTQLTQLSLNDNQLK-SIPR-GAFDNL 101
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 26/73 (35%), Positives = 36/73 (49%), Gaps = 7/73 (9%)
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQ---FNVSFNKLN 171
L L N + F++LT+L L L NQLT +P G F L Q +++ N+L
Sbjct: 34 VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPA-GVFDKLTQLTQLSLNDNQLK 91
Query: 172 GSIPKR-FARLPS 183
SIP+ F L S
Sbjct: 92 -SIPRGAFDNLKS 103
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 41/234 (17%), Positives = 80/234 (34%), Gaps = 46/234 (19%)
Query: 325 LGKGTFGTAYKAT---------LEMGIVVAVK------RLKDVTVSEKEFREKMEVVGSM 369
+ G Y+A ++K RL + + + ++V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 370 DHENL----VPLRAYYYSRDEK---LLVHDYMPMG-SLSALLHGNRGAGRTPLNWETRSG 421
+ +P + + LV + G SL + L + + L+ +
Sbjct: 110 KLYSTPLLAIP-TCMGFGVHQDKYRFLVLPSL--GRSLQSALDVS---PKHVLSERSVLQ 163
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARI--SDFGLAHLASPSST--PNR 477
+A A+ +LH HGN+ + NI + ++++ + +G A PS
Sbjct: 164 VACRLLDALEFLHENEYV--HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 478 IDGYRAPEVTDAR----------KVSQKADVYSFGVLLLELLTGKAPTQALLNE 521
+G R+P D S+++D+ S G +L+ L G P L
Sbjct: 222 -EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 50/223 (22%), Positives = 84/223 (37%), Gaps = 44/223 (19%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK---DVTVSEKEFREKMEVVGSMDHENLVPLR 378
+G+G+FG ++ T L VA+K D E+R + G +P
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG----IP-N 70
Query: 379 AYYYSRDEKLLVHDYMPM---G-SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
YY+ ++ H+ + + G SL LL GR + +T + A + +H
Sbjct: 71 VYYFGQEGL---HNVLVIDLLGPSLEDLL---DLCGRK-FSVKTVAMAAKQMLARVQSIH 123
Query: 435 SKGPANSHGNIKSSNILLSKSYEAR-----ISDFGLAHLASPSSTPNRIDGYRAPEVTD- 488
K + +IK N L+ + + DFG+ T I YR E +
Sbjct: 124 EKSLV--YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP-YR--EKKNL 178
Query: 489 ---AR----------KVSQKADVYSFGVLLLELLTGKAPTQAL 518
AR + S++ D+ + G + + L G P Q L
Sbjct: 179 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 46/231 (19%), Positives = 77/231 (33%), Gaps = 40/231 (17%)
Query: 325 LGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKE----FRE--------KMEVVGSMDHE 372
+G+G FG Y A + V V V + F E K E +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 373 NLVPLRA---YYYSRDEKLLVHDY----MPM-G-SLSALLHGNRGAGRTPLNWETRSGLA 423
+ Y+ S Y M G L + N + + +T L+
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEAN---AKR-FSRKTVLQLS 158
Query: 424 LGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARI--SDFGLAHLASPSSTPNRID-G 480
L + Y+H HG+IK+SN+LL+ ++ D+GLA+ P
Sbjct: 159 LRILDILEYIHEHEYV--HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 481 YRAPEVTDAR----------KVSQKADVYSFGVLLLELLTGKAPTQALLNE 521
+ S++ D+ G +++ LTG P + L +
Sbjct: 217 PKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 56/216 (25%), Positives = 79/216 (36%), Gaps = 36/216 (16%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS 383
+G G+FG Y T + G VA+K T + E ++ M +P +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIES-KIYKMMQGGVGIP-TIRWCG 74
Query: 384 RDEKLLVHDYMPM---G-SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ ++ M M G SL L R + +T LA I Y+HSK
Sbjct: 75 AEGD---YNVMVMELLGPSLEDLF---NFCSRK-FSLKTVLLLADQMISRIEYIHSKNFI 127
Query: 440 NSHGNIKSSNILL---SKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTD----ARKV 492
H ++K N L+ K I DFGLA + T I YR E + AR
Sbjct: 128 --HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIP-YR--ENKNLTGTARYA 182
Query: 493 SQKA----------DVYSFGVLLLELLTGKAPTQAL 518
S D+ S G +L+ G P Q L
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218
|
| >1qzv_F Plant photosystem I: subunit PSAF; photosynthesis,plant photosynthetic reaction center, peripheral antenna; HET: CL1 PQN; 4.44A {Pisum sativum} SCOP: i.5.1.1 Length = 154 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 2e-04
Identities = 8/33 (24%), Positives = 20/33 (60%), Gaps = 3/33 (9%)
Query: 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
E++ ++ LQ ++ A D+ P++A + + +E
Sbjct: 18 EKQALKKLQASLKLYA--DDSAPALA-IKATME 47
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 44/229 (19%), Positives = 76/229 (33%), Gaps = 39/229 (17%)
Query: 325 LGKGTFGTAYKAT-LEMGIVVAVKRLK-DVTVSEKEFRE--------KMEVVGSMDHENL 374
+G G FG Y A A +K + + F E K + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 375 VPLRA---YYYSRDEKLLVHDY----MPM-G-SLSALLHGNRGAGRTPLNWETRSGLALG 425
+ +Y S + Y M G L + N T L +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-----TFKKSTVLQLGIR 159
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARI--SDFGLAHLASPSSTPNRID-GYR 482
+ Y+H HG+IK++N+LL ++ +D+GL++ P+ + R
Sbjct: 160 MLDVLEYIHENEYV--HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPR 217
Query: 483 APEVTDAR----------KVSQKADVYSFGVLLLELLTGKAPTQALLNE 521
+S+++DV G +L L GK P + L +
Sbjct: 218 KGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 606 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.89 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.87 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.82 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.82 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.82 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.82 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.82 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.81 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.8 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.8 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.8 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.79 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.79 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.79 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.78 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.78 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.78 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.78 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.78 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.78 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.77 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.77 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.77 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.77 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.77 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.77 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.76 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.76 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.76 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.76 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.75 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.75 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.75 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.75 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.74 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.74 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.74 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.74 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.74 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.73 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.73 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.73 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.73 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.73 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.73 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.73 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.72 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.72 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.72 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.72 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.72 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.72 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.72 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.72 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.71 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.71 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.71 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.71 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.71 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.7 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.7 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.7 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.7 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.7 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.7 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.7 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.69 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.69 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.69 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.68 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.67 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.66 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.66 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.66 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.64 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.63 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.62 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.61 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.61 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.61 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.61 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.61 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.61 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.6 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.6 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.59 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.59 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.58 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.57 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.54 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.53 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.53 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.53 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.53 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.52 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.51 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.5 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.49 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.49 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.48 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.43 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.35 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.33 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.27 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.26 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.22 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.13 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.1 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.0 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.89 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.81 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.7 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.69 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.68 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.67 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.66 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.66 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.66 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.6 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.49 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.43 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.4 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.29 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.2 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.19 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.84 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.8 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.8 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.78 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.74 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.72 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.62 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.54 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.52 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.51 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.44 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.24 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.22 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.21 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.12 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.12 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.08 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.06 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.81 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.77 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.7 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.69 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.68 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.59 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.4 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.19 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 95.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.5 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 91.24 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.75 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 89.62 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.99 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=435.43 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=202.9
Q ss_pred hcccccCCceEEEEEEEc------CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.++||+|+||.||+|++. +++.||||+++.... ..++|.+|++++++++|||||+++|+|.+....++|||||
T Consensus 46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 125 (329)
T 4aoj_A 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM 125 (329)
T ss_dssp EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 578999999999999864 478999999976543 3467999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecc
Q 037905 395 PMGSLSALLHGNRG----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464 (606)
Q Consensus 395 ~~g~L~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG 464 (606)
++|+|.++++.... ....+++|..+++|+.|||.||+|||+++++ ||||||+|||+++++.+||+|||
T Consensus 126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii--HRDLKp~NILl~~~~~~Ki~DFG 203 (329)
T 4aoj_A 126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFV--HRDLATRNCLVGQGLVVKIGDFG 203 (329)
T ss_dssp TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEEETTTEEEECCCC
T ss_pred CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCee--cccccHhhEEECCCCcEEEcccc
Confidence 99999999976432 1234699999999999999999999999966 99999999999999999999999
Q ss_pred cCccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcc
Q 037905 465 LAHLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEE 537 (606)
Q Consensus 465 ~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (606)
+|+..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.... ....+..+....
T Consensus 204 la~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~------~~~~~~~i~~g~ 277 (329)
T 4aoj_A 204 MSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS------NTEAIDCITQGR 277 (329)
T ss_dssp ----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC------HHHHHHHHHHTC
T ss_pred cceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCC
Confidence 99865432 23457788999999999999999999999999999999 899997532 222233322221
Q ss_pred ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 538 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
. ...+..++.++.++|.+||+.||++||||+||+++|+.+.+.
T Consensus 278 -~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 278 -E----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp -C----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -C----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 1 111233456788999999999999999999999999999765
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=429.03 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=206.4
Q ss_pred hcccccCCceEEEEEEEc------CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|++. ++..||||+++.... ..++|.+|++++++++|||||+++|+|.+.+..++|||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~ 97 (299)
T 4asz_A 18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM 97 (299)
T ss_dssp EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence 578999999999999863 478999999976543 3567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 395 PMGSLSALLHGNR--------GAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 395 ~~g~L~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
++|+|.++++... +.....++|..+++|+.|||.||+|||+++++ ||||||+|||+++++.+||+|||+|
T Consensus 98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii--HRDlKp~NILl~~~~~~Ki~DFGla 175 (299)
T 4asz_A 98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFV--HRDLATRNCLVGENLLVKIGDFGMS 175 (299)
T ss_dssp TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECGGGCEEECCCSCH
T ss_pred CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCccCHhhEEECCCCcEEECCcccc
Confidence 9999999997532 12345699999999999999999999999966 9999999999999999999999999
Q ss_pred ccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 467 HLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 467 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
+..... ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.... ....+..+.....
T Consensus 176 ~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~------~~~~~~~i~~~~~- 248 (299)
T 4asz_A 176 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS------NNEVIECITQGRV- 248 (299)
T ss_dssp HHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHHTCC-
T ss_pred eecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHcCCC-
Confidence 765432 12346778999999999999999999999999999999 899997532 2223333322211
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
...+..++.++.++|.+||+.||++||||+||++.|+++.+..
T Consensus 249 ----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 249 ----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp ----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1112334567889999999999999999999999999997654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=427.26 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=204.3
Q ss_pred hcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|++. +++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+.+..++||||
T Consensus 31 ~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey 110 (308)
T 4gt4_A 31 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 110 (308)
T ss_dssp EEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEc
Confidence 467999999999999863 468999999975432 457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEee
Q 037905 394 MPMGSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISD 462 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~D 462 (606)
|++|+|.+++..... .....++|..+.+|+.|||.||+|||+++++ ||||||+|||+++++.+||+|
T Consensus 111 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii--HRDLK~~NILl~~~~~~Ki~D 188 (308)
T 4gt4_A 111 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVV--HKDLATRNVLVYDKLNVKISD 188 (308)
T ss_dssp CSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECGGGCEEECC
T ss_pred CCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCC--CCCccccceEECCCCCEEECC
Confidence 999999999975321 1124589999999999999999999999966 999999999999999999999
Q ss_pred cccCccCCC------CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhh
Q 037905 463 FGLAHLASP------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVK 535 (606)
Q Consensus 463 fG~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 535 (606)
||+|+.... .....+|+.|||||++.+..|+.++|||||||++|||+| |+.||.... ....+..+..
T Consensus 189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~------~~~~~~~i~~ 262 (308)
T 4gt4_A 189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQDVVEMIRN 262 (308)
T ss_dssp SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC------HHHHHHHHHT
T ss_pred cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc
Confidence 999986532 123456788999999999999999999999999999999 899997532 2233333322
Q ss_pred ccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 536 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.. . .+.+..++..+.++|.+||+.||++||||.||+++|+.+
T Consensus 263 ~~-~----------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 263 RQ-V----------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TC-C----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CC-C----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 21 1 112234556789999999999999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-52 Score=418.87 Aligned_cols=249 Identities=29% Similarity=0.427 Sum_probs=198.7
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||+||+|++. ..||||+++....+ .+.|.+|++++++++|||||+++|+|. ++..++|||||++|+
T Consensus 41 ~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGs 117 (307)
T 3omv_A 41 STRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSS 117 (307)
T ss_dssp EEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCB
T ss_pred eeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCC
Confidence 578999999999999875 35899998754433 357999999999999999999999885 467899999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC------
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS------ 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------ 472 (606)
|.++++... ..+++..+..|+.|||.||+|||+++++ ||||||+|||+++++.+||+|||+|+.....
T Consensus 118 L~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~Ii--HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 118 LYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKNII--HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTTCB--CSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--CCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 999997543 3599999999999999999999999855 9999999999999999999999999865431
Q ss_pred CCCCCcccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 STPNRIDGYRAPEVTDA---RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
....+|+.|||||++.+ ..|+.++|||||||++|||+||+.||.... ....+......+... +..
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~------~~~~~~~~~~~~~~~----p~~-- 259 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN------NRDQIIFMVGRGYAS----PDL-- 259 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC------CHHHHHHHHHTTCCC----CCS--
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC------hHHHHHHHHhcCCCC----CCc--
Confidence 23468899999999854 358999999999999999999999996432 122222233222211 110
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
...+..++..+.++|.+||+.||++||||.||+++|+.+..+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 011233456788999999999999999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=418.59 Aligned_cols=258 Identities=23% Similarity=0.293 Sum_probs=198.2
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCC----ceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRD----EKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|++. |+.||||+++........+..|+..+.+++|||||+++|+|..++ ..++|||||++|
T Consensus 8 ~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEEECSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 578999999999999985 899999999764433333445666677889999999999998654 579999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG------PANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
+|.++++.. .++|..+.+++.|++.||+|||+++ ..|+||||||+|||++.++.+||+|||+|+....
T Consensus 87 sL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 999999753 4899999999999999999999871 2356999999999999999999999999976533
Q ss_pred CC--------CCCCcccccCccccCCC------CCCCcchhHHHHHHHHHHHhCCCCcccccccCC---------CChhH
Q 037905 472 SS--------TPNRIDGYRAPEVTDAR------KVSQKADVYSFGVLLLELLTGKAPTQALLNEEG---------VDLPR 528 (606)
Q Consensus 472 ~~--------~~~~~~~y~aPE~~~~~------~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~---------~~~~~ 528 (606)
.. ...+|+.|||||++.+. .|+.++|||||||++|||+||++||........ .....
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~ 240 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence 21 23578899999999764 467899999999999999999888754322111 11111
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
....+..+. .++.........+....+.++|.+||+.||++||||.||++.|+++.++
T Consensus 241 ~~~~~~~~~-----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 241 MRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhccc-----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 111122221 1221111112235667899999999999999999999999999998765
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=416.29 Aligned_cols=246 Identities=21% Similarity=0.250 Sum_probs=202.1
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..|+||||+++|+|.
T Consensus 63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~ 138 (336)
T 4g3f_A 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred CcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence 46799999999999986 4689999999976433 246899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCC-------
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPS------- 472 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~------- 472 (606)
+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++ .+||+|||+|+.....
T Consensus 139 ~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~Ii--HRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 139 QLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRRIL--HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTTEE--CSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCce--ecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 9998543 589999999999999999999999955 999999999999998 5999999999865432
Q ss_pred --CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 --STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....||+.|||||++.+..|+.++|||||||++|||+||+.||....... + ...+....... .
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~---~~~i~~~~~~~---------~ 276 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---L---CLKIASEPPPI---------R 276 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---C---HHHHHHSCCGG---------G
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---H---HHHHHcCCCCc---------h
Confidence 22468899999999999999999999999999999999999997532221 1 22222221100 0
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
..+......+.+++.+||+.||++|||+.|++++|..+.....
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 1112334567888999999999999999999999999876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=406.75 Aligned_cols=242 Identities=24% Similarity=0.417 Sum_probs=193.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEe----CCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYS----RDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 393 (606)
.++||+|+||.||+|.. .++..||+|++...... .+.|.+|++++++++|||||+++++|.+ +...++||||
T Consensus 31 ~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy 110 (290)
T 3fpq_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeC
Confidence 35699999999999986 46899999999765433 3568999999999999999999999875 2457999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec-CCCcEEEeecccCccCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS-KSYEARISDFGLAHLASPS 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 472 (606)
|++|+|.+++.... .+++..+..++.||+.||+|||+++..|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 111 ~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999998543 58999999999999999999999985556999999999997 4789999999999865432
Q ss_pred --CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 --STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
.+..||+.|||||++.+ .|+.++|||||||++|||+||+.||.... ........+ ..+......+
T Consensus 186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~~i-~~~~~~~~~~------ 252 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRV-TSGVKPASFD------ 252 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHH-TTTCCCGGGG------
T ss_pred ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----cHHHHHHHH-HcCCCCCCCC------
Confidence 34568999999999875 69999999999999999999999996421 122222222 2221111010
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....++.+++.+||+.||++|||++|+++|
T Consensus 253 ---~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 253 ---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122357889999999999999999999864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=418.23 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=206.3
Q ss_pred HhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCC-CCcccceEEEEeC-CceEEE
Q 037905 321 SAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDH-ENLVPLRAYYYSR-DEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-~~~~lv 390 (606)
..+.||+|+||.||+|++. .++.||||+++.... ..++|.+|++++.+++| ||||+++|+|... ...++|
T Consensus 68 l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV 147 (353)
T 4ase_A 68 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 147 (353)
T ss_dssp EEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred EeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEE
Confidence 3578999999999999854 246899999976543 24579999999999965 8999999999764 568999
Q ss_pred EeecCCCChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEE
Q 037905 391 HDYMPMGSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEAR 459 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~k 459 (606)
||||++|+|.++++.... .....+++..+..++.|||+||+|||+++++ ||||||+|||+++++.+|
T Consensus 148 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~ii--HRDLK~~NILl~~~~~vK 225 (353)
T 4ase_A 148 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI--HRDLAARNILLSEKNVVK 225 (353)
T ss_dssp EECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECGGGCEE
T ss_pred EEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCee--cCccCccceeeCCCCCEE
Confidence 999999999999975421 1134589999999999999999999999966 999999999999999999
Q ss_pred EeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHH
Q 037905 460 ISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQS 532 (606)
Q Consensus 460 l~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 532 (606)
|+|||+|+...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.... ....+..
T Consensus 226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~------~~~~~~~ 299 (353)
T 4ase_A 226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEFCR 299 (353)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC------CSHHHHH
T ss_pred ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC------HHHHHHH
Confidence 99999998764432 2345678999999999999999999999999999998 999996532 1222333
Q ss_pred HhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 533 VVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 533 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
.+..+... ..+..++.++.++|.+||+.||++||||.||+++|+++.++..++
T Consensus 300 ~i~~g~~~----------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~~q 352 (353)
T 4ase_A 300 RLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 352 (353)
T ss_dssp HHHHTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC--
T ss_pred HHHcCCCC----------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhhCC
Confidence 33333211 112234457889999999999999999999999999998776554
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-51 Score=416.71 Aligned_cols=242 Identities=23% Similarity=0.350 Sum_probs=198.0
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
..+.||+|+||.||+|+. .+|+.||||++...... .+.+.+|++++++++|||||++++++.+++..|+||||+++
T Consensus 28 ~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~g 107 (350)
T 4b9d_A 28 RLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107 (350)
T ss_dssp EEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 357899999999999985 46999999999765443 35689999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
|+|.+++.... ...+++..++.++.||+.||+|||++||+ ||||||+|||++.++.+||+|||+|+.....
T Consensus 108 g~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~Ii--HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 108 GDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRKIL--HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTTCE--ETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred CcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--eccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 99999997543 23578999999999999999999999966 9999999999999999999999999876542
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....+|+.|||||++.+..|+.++|||||||++|||+||+.||.. .+....+..+....+.. .
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~------~~~~~~~~~i~~~~~~~-----------~ 245 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA------GSMKNLVLKIISGSFPP-----------V 245 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC------SSHHHHHHHHHHTCCCC-----------C
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC------cCHHHHHHHHHcCCCCC-----------C
Confidence 234588999999999999999999999999999999999999964 23444444444433211 1
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.....++.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11233567889999999999999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=412.69 Aligned_cols=240 Identities=23% Similarity=0.359 Sum_probs=200.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+|++++++++|||||+++++|.+++..|+|||||++|+|
T Consensus 79 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L 158 (346)
T 4fih_A 79 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 158 (346)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEH
T ss_pred eEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999864 699999999975433 345688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+|+..... .+.
T Consensus 159 ~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~Ii--HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 159 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQGVI--HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred HHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCcc--cccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 9999743 489999999999999999999999965 9999999999999999999999999866432 345
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+|+.|||||++.+..|+.++|||||||++|||++|+.||... +....+..+... .... ...+..
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i~~~-~~~~--------~~~~~~ 295 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKMIRDN-LPPR--------LKNLHK 295 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHS-SCCC--------CSCGGG
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcC-CCCC--------CCcccc
Confidence 7899999999999999999999999999999999999999642 222223322221 1111 111222
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...++.+++.+||..||++|||++|++++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 34567889999999999999999999875
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=400.83 Aligned_cols=239 Identities=21% Similarity=0.302 Sum_probs=201.2
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||+||+|+. .+|+.||||++.+.. ...+.+.+|++++++++|||||++++++.+++..|+||||++
T Consensus 36 i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~ 115 (311)
T 4aw0_A 36 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 115 (311)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 357899999999999985 579999999997532 235679999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+|+|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+|+.....
T Consensus 116 gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~Ii--HRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 116 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKGII--HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCc--cCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 999999998543 589999999999999999999999966 9999999999999999999999999865422
Q ss_pred ---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 ---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
.+..||+.|||||++.+..|+.++||||+||++|||++|+.||... +.......+......
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i~~~~~~---------- 252 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG------NEGLIFAKIIKLEYD---------- 252 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCC----------
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCC----------
Confidence 2457899999999999999999999999999999999999999642 333444444433211
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.....++.+++.+||..||++|||++|+..+
T Consensus 253 --~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 253 --FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp --CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred --CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 011123457788999999999999999997544
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=391.53 Aligned_cols=237 Identities=22% Similarity=0.335 Sum_probs=187.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|++++++++|||||++++++.+++..++||||+ +
T Consensus 18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~ 96 (275)
T 3hyh_A 18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G 96 (275)
T ss_dssp EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence 57899999999999985 5699999999976432 2457899999999999999999999999999999999999 6
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
|+|.+++... ..+++..+..++.||+.||+|||++|++ ||||||+|||+++++.+||+|||+|+..... .
T Consensus 97 g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~Ii--HRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~ 169 (275)
T 3hyh_A 97 NELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHKIV--HRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLK 169 (275)
T ss_dssp EEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--cccCChHHeEECCCCCEEEeecCCCeecCCCCccC
Confidence 7999998754 2599999999999999999999999966 9999999999999999999999999876542 3
Q ss_pred CCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
+..+|+.|||||++.+..| +.++||||+||++|||+||+.||... +.......+...... .
T Consensus 170 ~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~------~~~~~~~~i~~~~~~------------~ 231 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE------SIPVLFKNISNGVYT------------L 231 (275)
T ss_dssp -----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCC------------C
T ss_pred CeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCCCC------------C
Confidence 4578999999999998876 57999999999999999999999642 333333333332211 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.....++.+++.+||+.||++|||++|++++
T Consensus 232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11123457788999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=413.87 Aligned_cols=240 Identities=23% Similarity=0.356 Sum_probs=199.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|+.++++++|||||+++++|.+.+..|+|||||++|+|
T Consensus 156 ~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L 235 (423)
T 4fie_A 156 FIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235 (423)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999986 4699999999975433 345689999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++... .+++..+..++.||+.||+|||++||+ ||||||+|||++.+|.+||+|||+|+..... .+.
T Consensus 236 ~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~Ii--HRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 236 TDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQGVI--HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCCee--cccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 9999743 489999999999999999999999965 9999999999999999999999999865432 345
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.||+.|||||++.+..|+.++|||||||++|||++|+.||... +....+..+.... ... ...+..
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~------~~~~~~~~i~~~~-~~~--------~~~~~~ 372 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE------PPLKAMKMIRDNL-PPR--------LKNLHK 372 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSC-CCC--------CSCTTS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHcCC-CCC--------Cccccc
Confidence 6889999999999999999999999999999999999999642 2222233222211 111 011122
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+|+.+||..||++|||+.|+++|
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 33467888999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=398.10 Aligned_cols=240 Identities=25% Similarity=0.325 Sum_probs=192.1
Q ss_pred HHhcccccCCceEEEEEEE----cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 320 ASAEVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
...+.||+|+||+||+|+. .+++.||||+++.... ....+.+|++++++++|||||++++++.+++..|+|||
T Consensus 27 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 106 (304)
T 3ubd_A 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILD 106 (304)
T ss_dssp EEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEEC
T ss_pred EEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEE
Confidence 3457899999999999985 2478999999975432 23468889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC-
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP- 471 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 471 (606)
|+++|+|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+|+....
T Consensus 107 y~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~Ii--HRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 107 FLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLGII--YRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp CCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTCC--CSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCc--CCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 999999999998543 589999999999999999999999966 999999999999999999999999986533
Q ss_pred ---CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 472 ---SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 472 ---~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
..+..+|+.|||||++.+..|+.++|||||||++|||+||+.||... +.......+......
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~~~~~~--------- 244 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK------DRKETMTMILKAKLG--------- 244 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC---------
T ss_pred CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc------CHHHHHHHHHcCCCC---------
Confidence 23457899999999999999999999999999999999999999642 333334444332211
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSM-----AEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~~v~~~ 584 (606)
.+.....++.+++.+||+.||++|||+ +|+++|
T Consensus 245 ---~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 245 ---MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred ---CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 111223467889999999999999985 566543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=386.18 Aligned_cols=240 Identities=20% Similarity=0.309 Sum_probs=183.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCC------------c
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRD------------E 386 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------------~ 386 (606)
.+.||+|+||.||+|+. .+|+.||||+++.... ..+.+.+|++++++++|||||+++++|.+.+ .
T Consensus 10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~ 89 (299)
T 4g31_A 10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY 89 (299)
T ss_dssp EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence 47899999999999986 4689999999975432 3467899999999999999999999987544 3
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
.|+||||+++|+|.+++.... .....++..++.++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+|
T Consensus 90 l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~Ii--HRDlKp~NILl~~~~~vKl~DFGla 165 (299)
T 4g31_A 90 LYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKGLM--HRDLKPSNIFFTMDDVVKVGDFGLV 165 (299)
T ss_dssp EEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCcCc--cccCcHHHeEECCCCcEEEccCccc
Confidence 689999999999999998543 223456778899999999999999999966 9999999999999999999999999
Q ss_pred ccCCCCC----------------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHH
Q 037905 467 HLASPSS----------------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWV 530 (606)
Q Consensus 467 ~~~~~~~----------------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~ 530 (606)
+...... ...||+.|||||++.+..|+.++|||||||++|||++ ||....+ ....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~-----~~~~~ 237 (299)
T 4g31_A 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME-----RVRTL 237 (299)
T ss_dssp --------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HHHHH
T ss_pred eecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH-----HHHHH
Confidence 8654321 2357889999999999999999999999999999996 7753211 11111
Q ss_pred HHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 531 QSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 531 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+.... . ++...+....+.+++.+||+.||++|||+.|++++
T Consensus 238 ~~~~~~~-~----------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 238 TDVRNLK-F----------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHTTC-C----------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHhcCC-C----------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111110 0 11123334556789999999999999999999874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=380.06 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=192.9
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv 390 (606)
..+.||+|+||.||+|+. .+|+.||||+++..... .+.+.+|+++|++++|||||++++++... ...|+|
T Consensus 58 ~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~iv 137 (398)
T 4b99_A 58 IIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 137 (398)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEE
T ss_pred EEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEE
Confidence 357899999999999986 47999999999765433 35688999999999999999999997642 568999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
||||+ |+|.+++... ..+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+|+...
T Consensus 138 mE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~ii--HRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 138 LDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQVI--HRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp EECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCcCc--CCCcCccccccCCCCCEEEeecceeeecc
Confidence 99996 6899999753 3699999999999999999999999966 99999999999999999999999998653
Q ss_pred C--------CCCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc-
Q 037905 471 P--------SSTPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA- 540 (606)
Q Consensus 471 ~--------~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 540 (606)
. ..+..+|+.|||||++.+. .|+.++||||+||++|||++|++||.+. +....+..+.......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~------~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK------NYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS------SHHHHHHHHHHHHCCCC
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC------CHHHHHHHHHHhcCCCC
Confidence 2 2245788999999998875 4699999999999999999999999653 2222222222111000
Q ss_pred -cccc--------hh---hh-ccc-Ch----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 -EVFD--------LE---LL-RYQ-NV----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 -~~~d--------~~---~~-~~~-~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.... .. .. ... .. .....++.+|+.+||..||++|||+.|+++|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00 00 000 00 1123467889999999999999999999876
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=373.48 Aligned_cols=185 Identities=24% Similarity=0.427 Sum_probs=161.6
Q ss_pred hcccccCCceEEEEEEEc----CCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||+||+|+.+ +++.||||++.... ....+.+|+++++.+ +||||+++++++.+.++.++||||+++
T Consensus 26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g 104 (361)
T 4f9c_A 26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH 104 (361)
T ss_dssp EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence 568999999999999753 47899999986543 456788999999888 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-CcEEEeecccCccCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLASPS--- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~--- 472 (606)
|+|.+++. .+++..+..++.||+.||+|||++|++ ||||||+|||++.+ +.+||+|||+|+.....
T Consensus 105 ~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~gIi--HRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 105 ESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFGIV--HRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred ccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCCeE--eCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 99999984 388999999999999999999999966 99999999999877 79999999999754321
Q ss_pred -----------------------------CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 473 -----------------------------STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 473 -----------------------------~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
.+..+|+.|||||++.+. .|+.++||||+||++|||++|+.||..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 123578899999999775 589999999999999999999999954
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=358.79 Aligned_cols=266 Identities=30% Similarity=0.511 Sum_probs=222.0
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|+..+++.||||++..... ..+.+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 44 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 123 (321)
T 2qkw_B 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123 (321)
T ss_dssp CCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTG
T ss_pred cceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHH
Confidence 467999999999999988899999999876543 3567999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC------CC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS------ST 474 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------~~ 474 (606)
+++..... ....+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++..... ..
T Consensus 124 ~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~iv--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 200 (321)
T 2qkw_B 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRAII--HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV 200 (321)
T ss_dssp GGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred HHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCCee--cCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence 99975432 234689999999999999999999999966 9999999999999999999999999764322 12
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..++..|+|||++.+..++.++||||||+++|||++|+.||......+......|.............+++... .....
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 279 (321)
T 2qkw_B 201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA-DKIRP 279 (321)
T ss_dssp CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT-TCSCH
T ss_pred cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc-cccCH
Confidence 23577899999998889999999999999999999999999876555555566555544444444444444332 22346
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
+....+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 7788899999999999999999999999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=387.06 Aligned_cols=241 Identities=23% Similarity=0.273 Sum_probs=194.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHH---HHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEF---REKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|+. .+|+.||||++.+... ....+ ..++.+++.++|||||+++++|.+.+..|+||||
T Consensus 194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy 273 (689)
T 3v5w_A 194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273 (689)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence 46899999999999986 4699999999965322 22233 3446778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC--
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP-- 471 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 471 (606)
++||+|.+++.... .+++..+..++.||+.||+|||++||+ ||||||+|||++.+|.+||+|||+|+....
T Consensus 274 ~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~gIi--HRDLKPeNILld~~G~vKL~DFGlA~~~~~~~ 346 (689)
T 3v5w_A 274 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRFVV--YRDLKPANILLDEHGHVRISDLGLACDFSKKK 346 (689)
T ss_dssp CCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence 99999999998543 589999999999999999999999966 999999999999999999999999987654
Q ss_pred CCCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 472 SSTPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
..+..||+.|||||++.. ..|+.++|||||||++|||++|++||...... +.......+.....
T Consensus 347 ~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~---~~~~i~~~i~~~~~------------ 411 (689)
T 3v5w_A 347 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDRMTLTMAV------------ 411 (689)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC---CHHHHHHHHHHCCC------------
T ss_pred CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhhcCCCC------------
Confidence 345679999999999964 57999999999999999999999999753222 22222222222111
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
..+.....++.+++.+||..||++|++ ++||.+|
T Consensus 412 ~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 011122345778889999999999998 6888765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=387.65 Aligned_cols=244 Identities=20% Similarity=0.333 Sum_probs=200.9
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
+.+.||+|+||.||+|+. .+|+.||+|++..... ..+.+.+|+++|+.++|||||+++++|.+....++|||||++|+
T Consensus 161 i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~ 240 (573)
T 3uto_A 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240 (573)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 357899999999999986 4699999999976543 35678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC--CcEEEeecccCccCCCCC---
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS--YEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~--~~~kl~DfG~a~~~~~~~--- 473 (606)
|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.+ +.+||+|||+|+......
T Consensus 241 L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~ii--HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 241 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENNYV--HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp HHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred HHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--eccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 999996432 3589999999999999999999999966 99999999999854 789999999998776533
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+|+.|||||++.+..|+.++|||||||++|||++|+.||.+. +....+..+....+... + ...
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~------~~~~~~~~i~~~~~~~~--~------~~~ 380 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE------NDDETLRNVKSCDWNMD--D------SAF 380 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHTTCCCCC--S------GGG
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc------CHHHHHHHHHhCCCCCC--c------ccc
Confidence 346788999999999999999999999999999999999999643 22333333333221110 0 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+|+.+||..||++|||+.|+++|
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223457788999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=360.52 Aligned_cols=257 Identities=27% Similarity=0.350 Sum_probs=203.1
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCC----ceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRD----EKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~ 396 (606)
..+.||+|+||.||+|+.. ++.||||++.........+..|+.++++++||||+++++++.... ..++||||+++
T Consensus 28 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 28 LLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hhheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 3578999999999999876 899999999765555566777999999999999999999998754 36999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK----------GPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
|+|.+++... .+++..+..++.|++.||+|||+. +++ ||||||+|||++.++.+||+|||++
T Consensus 107 g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~iv--H~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 107 GSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAIS--HRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEE--CSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEE--eCCCChHhEEECCCCeEEEccCCcc
Confidence 9999999753 489999999999999999999998 855 9999999999999999999999999
Q ss_pred ccCCCC------CCCCCcccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChh--------
Q 037905 467 HLASPS------STPNRIDGYRAPEVTDA-----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLP-------- 527 (606)
Q Consensus 467 ~~~~~~------~~~~~~~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~-------- 527 (606)
+..... ....++..|+|||++.+ ..++.++|||||||++|||+||+.||............
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 754432 22456788999999986 35667899999999999999999999765433222211
Q ss_pred --HHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 528 --RWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 528 --~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.+.......... +..............+.+++.+||+.||++|||+.||++.|+++.+.
T Consensus 259 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 259 LEDMQEVVVHKKKR-----PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHTTSCCC-----CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCC-----CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111111 11111111234567799999999999999999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=343.72 Aligned_cols=248 Identities=26% Similarity=0.406 Sum_probs=208.1
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|...++..||+|++.......+++.+|++++++++||||+++++++.+....++||||+++++|.+
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 94 (269)
T 4hcu_A 15 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 94 (269)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred eheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHH
Confidence 57899999999999998889999999999877788899999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-----CCCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-----STPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~ 476 (606)
++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++..... ....
T Consensus 95 ~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~--H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 168 (269)
T 4hcu_A 95 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVI--HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 168 (269)
T ss_dssp HHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred HHHhcC----cccCHHHHHHHHHHHHHHHHHHHhCCee--cCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence 997543 3589999999999999999999999966 9999999999999999999999999765432 2334
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.... .. ..+..
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~------~~~~~~~~~~~~-~~----------~~~~~ 231 (269)
T 4hcu_A 169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS------NSEVVEDISTGF-RL----------YKPRL 231 (269)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTC-CC----------CCCTT
T ss_pred cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC------HHHHHHHHhcCc-cC----------CCCCc
Confidence 4567999999998899999999999999999999 999996432 222222222211 00 01111
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
....+.+++.+||+.+|++|||+.+++++|+++.++.
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g 268 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 268 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence 2346888999999999999999999999999998754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.21 Aligned_cols=256 Identities=29% Similarity=0.445 Sum_probs=198.2
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCH---HHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..+.||+|+||.||+|+.. |..||||++....... +.+.+|++++++++||||+++++++......++||||++++
T Consensus 41 i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 119 (309)
T 3p86_A 41 IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119 (309)
T ss_dssp EEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTC
T ss_pred eeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCC
Confidence 3578999999999999874 8899999997654433 46889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|.+++.... ....+++..+..++.|++.||+|||++|..++||||||+|||++.++.+||+|||+++..... .
T Consensus 120 ~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 197 (309)
T 3p86_A 120 SLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK 197 (309)
T ss_dssp BHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred cHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence 9999998532 112489999999999999999999999933449999999999999999999999999754432 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++||||||+++|||++|+.||.... .......+...... ...+
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~------~~~~~~~~~~~~~~----------~~~~ 261 (309)
T 3p86_A 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN------PAQVVAAVGFKCKR----------LEIP 261 (309)
T ss_dssp ----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC------HHHHHHHHHHSCCC----------CCCC
T ss_pred cCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhcCCC----------CCCC
Confidence 3456788999999999999999999999999999999999996532 11222222111111 0111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
......+.+++.+||+.+|++|||+.++++.|+.+.++...+
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 223356889999999999999999999999999998876554
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=354.94 Aligned_cols=274 Identities=38% Similarity=0.634 Sum_probs=222.7
Q ss_pred CcCHHHHHHHH-----hcccccCCceEEEEEEEcCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEe
Q 037905 311 AFDLEDLLRAS-----AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYS 383 (606)
Q Consensus 311 ~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 383 (606)
.|++.++.... .+.||+|+||.||+|+..+|+.||||++..... ....+.+|+++++.++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 45556554433 467999999999999988899999999976432 23368999999999999999999999999
Q ss_pred CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---CCCCCCCCCCCCCEEecCCCcEEE
Q 037905 384 RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK---GPANSHGNIKSSNILLSKSYEARI 460 (606)
Q Consensus 384 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---~~~i~HrDlkp~Nill~~~~~~kl 460 (606)
....++||||+++++|.+++..... ....+++..+..++.|++.||+|||++ +++ ||||||+|||++.++.+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~iv--H~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKII--HRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEE--CCCCSGGGEEECTTCCEEE
T ss_pred CCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE--eCCCchhhEEECCCCCEEe
Confidence 9999999999999999999986542 234599999999999999999999999 855 9999999999999999999
Q ss_pred eecccCccCCCC-----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccccc--ccCCCChhHHHHHH
Q 037905 461 SDFGLAHLASPS-----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALL--NEEGVDLPRWVQSV 533 (606)
Q Consensus 461 ~DfG~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~ 533 (606)
+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||.... .........++...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 999999765432 22347888999999988889999999999999999999999997432 22333455555555
Q ss_pred hhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 534 VKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 534 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
..........+.... .....+....+.+++.+||+.||++|||+.||+++|+..
T Consensus 256 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 256 LKEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TSSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 554444444443332 234567788999999999999999999999999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=348.74 Aligned_cols=249 Identities=25% Similarity=0.419 Sum_probs=203.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 94 (310)
T 3s95_A 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94 (310)
T ss_dssp EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence 578999999999999864 68999999886543 3456799999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC------
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------ 473 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------ 473 (606)
.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~iv--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 168 (310)
T 3s95_A 95 RGIIKSMD----SQYPWSQRVSFAKDIASGMAYLHSMNII--HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168 (310)
T ss_dssp HHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSTTSEEECTTSCEEECCCTTCEECC---------
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--CCCCCcCeEEECCCCCEEEeecccceeccccccccccc
Confidence 99998642 3589999999999999999999999965 99999999999999999999999997653321
Q ss_pred ------------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 474 ------------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 474 ------------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
...+|+.|+|||++.+..++.++||||||+++|||++|..|+........... .........
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-~~~~~~~~~----- 242 (310)
T 3s95_A 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-LNVRGFLDR----- 242 (310)
T ss_dssp -----------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-BCHHHHHHH-----
T ss_pred ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-hhhhccccc-----
Confidence 33577889999999999999999999999999999999999875332221100 001111000
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
..+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus 243 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 243 ---------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp ---------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 01112234588899999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=357.70 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=204.7
Q ss_pred HhcccccCCceEEEEEEE--------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEE
Q 037905 321 SAEVLGKGTFGTAYKATL--------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 389 (606)
..+.||+|+||.||+|+. .++..||||+++.... ..+.+.+|+++++++ +||||++++++|...+..++
T Consensus 85 ~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 164 (370)
T 2psq_A 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 164 (370)
T ss_dssp EEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEE
Confidence 357899999999999985 2457899999976532 235689999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcE
Q 037905 390 VHDYMPMGSLSALLHGNRGA-----------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEA 458 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~ 458 (606)
||||+++|+|.+++...... ....+++..++.++.||+.||+|||+++++ ||||||+|||++.++.+
T Consensus 165 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~~~~ 242 (370)
T 2psq_A 165 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI--HRDLAARNVLVTENNVM 242 (370)
T ss_dssp EEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEECTTCCE
T ss_pred EEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee--ccccchhhEEECCCCCE
Confidence 99999999999999864311 123589999999999999999999999965 99999999999999999
Q ss_pred EEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHH
Q 037905 459 RISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQ 531 (606)
Q Consensus 459 kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (606)
||+|||+++...... ...++..|+|||++.+..++.++|||||||++|||++ |+.||..... .....
T Consensus 243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~------~~~~~ 316 (370)
T 2psq_A 243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------EELFK 316 (370)
T ss_dssp EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHH
T ss_pred EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH
Confidence 999999998654321 1234567999999999899999999999999999999 9999975321 11121
Q ss_pred HHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 532 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
. +..+... ..+..+...+.+++.+||+.+|++|||+.|++++|+++......
T Consensus 317 ~-~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 317 L-LKEGHRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp H-HHTTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred H-HhcCCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 1 1111111 11123345688999999999999999999999999999765443
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-42 Score=369.16 Aligned_cols=251 Identities=25% Similarity=0.455 Sum_probs=208.4
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|...++..||||+++......+.|.+|+.++++++||||+++++++. ....++||||+++|+|.+
T Consensus 193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~ 271 (454)
T 1qcf_A 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLD 271 (454)
T ss_dssp EEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHH
T ss_pred EEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHH
Confidence 5789999999999999988899999999887777889999999999999999999999986 667899999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-----CCCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-----STPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~ 476 (606)
++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... ....
T Consensus 272 ~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~iv--HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~ 346 (454)
T 1qcf_A 272 FLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYI--HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 346 (454)
T ss_dssp HHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTCC--CSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSS
T ss_pred HHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcc--CCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCc
Confidence 997542 12478899999999999999999999966 9999999999999999999999999865431 2233
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||++....++.++||||||+++|||+| |+.||.... .......+.. +.. .+.+..
T Consensus 347 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~------~~~~~~~i~~-~~~----------~~~~~~ 409 (454)
T 1qcf_A 347 FPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS------NPEVIRALER-GYR----------MPRPEN 409 (454)
T ss_dssp SCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHH-TCC----------CCCCTT
T ss_pred ccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc-CCC----------CCCCCC
Confidence 4567999999988889999999999999999999 999996432 2222222222 111 111223
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
++..+.++|.+||+.||++|||+.+|++.|+++......+
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~~ 449 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATESQ 449 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCCS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccccc
Confidence 4467889999999999999999999999999987665544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=340.50 Aligned_cols=247 Identities=25% Similarity=0.366 Sum_probs=204.5
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+++..++..||+|+++......+++.+|++++++++||||+++++++......++||||+++++|.+
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (283)
T 3gen_A 29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 108 (283)
T ss_dssp EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHH
T ss_pred HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHH
Confidence 57899999999999999888899999999877788899999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC-----CCCCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP-----SSTPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~-----~~~~~ 476 (606)
++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.... .....
T Consensus 109 ~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 182 (283)
T 3gen_A 109 YLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQFL--HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 182 (283)
T ss_dssp HHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTT
T ss_pred HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCCcc--CCCCccceEEEcCCCCEEEccccccccccccccccccCCc
Confidence 997532 2589999999999999999999999966 999999999999999999999999976543 12334
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.... .. ..+..
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~------~~~~~~~~~~~~-~~----------~~~~~ 245 (283)
T 3gen_A 183 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT------NSETAEHIAQGL-RL----------YRPHL 245 (283)
T ss_dssp SCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHTTC-CC----------CCCTT
T ss_pred cCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC------hhHHHHHHhccc-CC----------CCCCc
Confidence 5567999999998889999999999999999998 999996532 122222222111 00 01111
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
....+.+++.+||+.+|++|||+.+++++|+++.+.
T Consensus 246 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 246 ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 234688899999999999999999999999998754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=342.65 Aligned_cols=240 Identities=25% Similarity=0.349 Sum_probs=198.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 25 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (297)
T 3fxz_A 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (297)
T ss_dssp CEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred eeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCH
Confidence 46799999999999984 578999999986543 3467789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++... .+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++..... ...
T Consensus 105 ~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 176 (297)
T 3fxz_A 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVI--HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (297)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCce--eCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence 9999753 488999999999999999999999966 9999999999999999999999998765432 234
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+++.|+|||++.+..++.++||||||+++|||++|+.||.... .......+..... .. ...+..
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~~~~~~~~~~-~~--------~~~~~~ 241 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN------PLRALYLIATNGT-PE--------LQNPEK 241 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHHCS-CC--------CSCGGG
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCC-CC--------CCCccc
Confidence 57788999999999999999999999999999999999996421 1121222211111 00 111223
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 34568889999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=363.17 Aligned_cols=248 Identities=28% Similarity=0.440 Sum_probs=203.7
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCC-ceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRD-EKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|+.. |+.||||+++... ..+.|.+|+.++++++||||+++++++.... ..++||||+++|+|.
T Consensus 198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~ 275 (450)
T 1k9a_A 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275 (450)
T ss_dssp EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence 578999999999999986 7899999998654 5577999999999999999999999988765 789999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCCCCcc
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STPNRID 479 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 479 (606)
+++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... .....+.
T Consensus 276 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~iv--HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 350 (450)
T 1k9a_A 276 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFV--HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 350 (450)
T ss_dssp HHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEECTTSCEEECCCTTCEECC------CCCT
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--CCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCc
Confidence 9998643 23478999999999999999999999965 9999999999999999999999999865432 2234566
Q ss_pred cccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHH
Q 037905 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV 558 (606)
Q Consensus 480 ~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 558 (606)
.|+|||++.+..++.++||||||+++|||+| |+.||...... .....+ ..+.. ...+..++.
T Consensus 351 ~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i-~~~~~----------~~~p~~~~~ 413 (450)
T 1k9a_A 351 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRV-EKGYK----------MDAPDGCPP 413 (450)
T ss_dssp TTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT------THHHHH-HTTCC----------CCCCTTCCH
T ss_pred ceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHH-HcCCC----------CCCCCcCCH
Confidence 7999999999999999999999999999999 99999753221 112222 22211 111223456
Q ss_pred HHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 559 QLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 559 ~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
.+.++|.+||+.||++|||+.+|++.|+++....+
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~l 448 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhhc
Confidence 78899999999999999999999999999976543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=339.57 Aligned_cols=246 Identities=24% Similarity=0.358 Sum_probs=205.5
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|+..++..||+|+++......+++.+|++++++++||||+++++++......++||||+++++|.+
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (268)
T 3sxs_A 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN 92 (268)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHH
T ss_pred eeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHH
Confidence 56799999999999999888899999998877788899999999999999999999999998899999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~ 476 (606)
++.... ..+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++...... ...
T Consensus 93 ~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 166 (268)
T 3sxs_A 93 YLRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQFI--HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK 166 (268)
T ss_dssp HHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEE--ESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCC
T ss_pred HHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCC
Confidence 997642 2489999999999999999999999966 99999999999999999999999997654432 233
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||.+.+..++.++||||||+++|||++ |+.||.... ............... .+..
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~~~~~-----------~~~~ 229 (268)
T 3sxs_A 167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT------NSEVVLKVSQGHRLY-----------RPHL 229 (268)
T ss_dssp CCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC------HHHHHHHHHTTCCCC-----------CCTT
T ss_pred cCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC------hHHHHHHHHcCCCCC-----------CCCc
Confidence 4556999999998889999999999999999999 999996432 122222222111100 0111
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
....+.+++.+||+.+|++|||+.+++++|+.+.+
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 230 ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 23468889999999999999999999999998754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=347.33 Aligned_cols=238 Identities=21% Similarity=0.320 Sum_probs=198.6
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|+. .+|+.||||++...... .+.+.+|+++++.++||||+++++++......++||||++++
T Consensus 20 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~ 99 (328)
T 3fe3_A 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99 (328)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCC
Confidence 57899999999999986 57999999999765433 356889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---CC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---ST 474 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~ 474 (606)
+|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++..... ..
T Consensus 100 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~iv--HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 172 (328)
T 3fe3_A 100 EVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKRIV--HRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA 172 (328)
T ss_dssp BHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEe--ccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence 9999997543 589999999999999999999999966 9999999999999999999999999765432 34
Q ss_pred CCCcccccCccccCCCCCC-CcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 475 PNRIDGYRAPEVTDARKVS-QKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~-~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
..+++.|+|||++.+..++ .++|||||||++|||++|+.||... +.......+....... +
T Consensus 173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~~------------p 234 (328)
T 3fe3_A 173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ------NLKELRERVLRGKYRI------------P 234 (328)
T ss_dssp TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCCC------------C
T ss_pred ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCC------------C
Confidence 5678889999999887775 7899999999999999999999642 3333333333322110 1
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||..||++|||++|++++
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1123457889999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=347.76 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=202.3
Q ss_pred hcccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|... .+..||||+++.... ..+.+.+|++++++++||||+++++++......++||||++
T Consensus 54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 133 (325)
T 3kul_A 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME 133 (325)
T ss_dssp EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence 578999999999999863 456799999976432 34678999999999999999999999998889999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST- 474 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 474 (606)
+++|.+++.... ..+++..+..++.|++.||+|||+.+++ ||||||+|||++.++.+||+|||+++.......
T Consensus 134 ~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iv--H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 134 NGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLSDLGYV--HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred CCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCee--CCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 999999997532 3589999999999999999999999965 999999999999999999999999986644221
Q ss_pred ------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 475 ------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 475 ------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.....
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~------~~~~~~~~~~~~~--------- 272 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT------NRDVISSVEEGYR--------- 272 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC------HHHHHHHHHTTCC---------
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC------HHHHHHHHHcCCC---------
Confidence 223456999999998889999999999999999999 999996432 2222222222111
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
...+......+.+++.+||..||++|||+.+|++.|+.+.+....
T Consensus 273 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 273 --LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred --CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 111123345688999999999999999999999999999866443
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=365.51 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=206.1
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|.+..+..||||+++......++|.+|++++++++||||+++++++.. ...++||||+++|+|.+
T Consensus 189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~ 267 (452)
T 1fmk_A 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 267 (452)
T ss_dssp EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHH
T ss_pred eeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHH
Confidence 56899999999999999878889999998776778899999999999999999999999865 67899999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~ 476 (606)
++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++...... ...
T Consensus 268 ~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iv--HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 342 (452)
T 1fmk_A 268 FLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYV--HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 342 (452)
T ss_dssp HHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECGGGCEEECCCCTTC--------------
T ss_pred HHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--CCCCChhhEEECCCCCEEECCCccceecCCCceecccCCc
Confidence 997532 13489999999999999999999999966 99999999999999999999999998654321 223
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+ ..+.. .+.+..
T Consensus 343 ~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~------~~~~~~~i-~~~~~----------~~~~~~ 405 (452)
T 1fmk_A 343 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV------NREVLDQV-ERGYR----------MPCPPE 405 (452)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHH-HTTCC----------CCCCTT
T ss_pred ccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC------HHHHHHHH-HcCCC----------CCCCCC
Confidence 4567999999988899999999999999999999 999996532 12222222 22111 111223
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccCCC
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQA 598 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~~~ 598 (606)
++..+.++|.+||+.+|++|||+.+|++.|+++..+...+.++
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~~~~ 448 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 448 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCccccc
Confidence 4567889999999999999999999999999988766555444
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=333.83 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=207.3
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|...++..||+|++.......+.+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 92 (267)
T 3t9t_A 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD 92 (267)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHH
T ss_pred eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHH
Confidence 56799999999999998888999999998877778899999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-----CCCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-----STPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~ 476 (606)
++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++..... ....
T Consensus 93 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 166 (267)
T 3t9t_A 93 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVI--HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 166 (267)
T ss_dssp HHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred HHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence 997543 3589999999999999999999999966 9999999999999999999999999765431 2234
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||.+.+..++.++||||||+++|||++ |+.||... ........+... ... ..+..
T Consensus 167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~------~~~~~~~~i~~~-~~~----------~~~~~ 229 (267)
T 3t9t_A 167 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR------SNSEVVEDISTG-FRL----------YKPRL 229 (267)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTT-CCC----------CCCTT
T ss_pred ccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC------CHHHHHHHHhcC-CcC----------CCCcc
Confidence 4567999999988889999999999999999999 89999642 222222222221 110 00111
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
....+.+++.+||+.+|++|||+.+++++|+++.++.
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 2346888999999999999999999999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.17 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=204.7
Q ss_pred CcCHHHHHHHHh---------------cccccCCceEEEEEEEc-CCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCC
Q 037905 311 AFDLEDLLRASA---------------EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHEN 373 (606)
Q Consensus 311 ~~~~~~~~~~~~---------------~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~n 373 (606)
.++.+++..++. +.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 477777776653 36999999999999975 79999999997543 34577899999999999999
Q ss_pred cccceEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec
Q 037905 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS 453 (606)
Q Consensus 374 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~ 453 (606)
|+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||+|||+.+++ ||||||+|||++
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~iv--H~Dlkp~NIll~ 175 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQGVI--HRDIKSDSILLT 175 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEC
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEEC
Confidence 999999999999999999999999999998632 489999999999999999999999965 999999999999
Q ss_pred CCCcEEEeecccCccCCCC----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHH
Q 037905 454 KSYEARISDFGLAHLASPS----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRW 529 (606)
Q Consensus 454 ~~~~~kl~DfG~a~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~ 529 (606)
.++.+||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||.... ....
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~------~~~~ 249 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS------PVQA 249 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHH
T ss_pred CCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHH
Confidence 9999999999998765432 23467888999999999999999999999999999999999996421 1222
Q ss_pred HHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 530 VQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 530 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+.... .... .........+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~~~~~-~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 MKRLRDSP-PPKL--------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHSS-CCCC--------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhcCC-CCCc--------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 22221111 1000 0111223467889999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=338.01 Aligned_cols=271 Identities=31% Similarity=0.522 Sum_probs=215.0
Q ss_pred CCcCHHHHHHHHh-----------cccccCCceEEEEEEEcCCcEEEEEEeccCc-----cCHHHHHHHHHHHcCCCCCC
Q 037905 310 RAFDLEDLLRASA-----------EVLGKGTFGTAYKATLEMGIVVAVKRLKDVT-----VSEKEFREKMEVVGSMDHEN 373 (606)
Q Consensus 310 ~~~~~~~~~~~~~-----------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~n 373 (606)
..|+++++..++. +.||+|+||.||+|.. +++.||||++.... ...+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4578888877653 5799999999999987 48899999986532 22467899999999999999
Q ss_pred cccceEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec
Q 037905 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS 453 (606)
Q Consensus 374 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~ 453 (606)
|+++++++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+++++ ||||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~i~--H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENHHI--HRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCee--cCCCCHHHEEEc
Confidence 99999999998999999999999999999975432 34689999999999999999999999966 999999999999
Q ss_pred CCCcEEEeecccCccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChh
Q 037905 454 KSYEARISDFGLAHLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLP 527 (606)
Q Consensus 454 ~~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~ 527 (606)
.++.+||+|||+++..... ....++..|+|||.+.+ .++.++||||||+++|||++|+.||....... .+.
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLL 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BTT
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HHH
Confidence 9999999999998765432 22356788999999876 58899999999999999999999997643322 122
Q ss_pred HHHHHHhhcc-ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 528 RWVQSVVKEE-WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 528 ~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
.+........ .....++... ..........+.+++.+||+.+|++|||+.+|+++|+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2222221111 1112222111 12345667889999999999999999999999999999854
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=343.32 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=192.2
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcC--CCCCCcccceEEEEeC----CceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGS--MDHENLVPLRAYYYSR----DEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+. +++.||||++... ....+..|.+++.. ++||||+++++++... ...++||||++
T Consensus 13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~ 89 (301)
T 3q4u_A 13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSR--DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE 89 (301)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred EEeeccCCCcEEEEEEE-CCEEEEEEEeccc--cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence 47899999999999988 5899999999754 34445555555544 8999999999997653 45789999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH--------SKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
+|+|.+++.. ..+++..+..++.|++.||+||| +.+++ ||||||+|||++.++.+||+|||+++
T Consensus 90 ~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv--H~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 90 MGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA--HRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp TCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEE--CSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCee--cCCCChHhEEEcCCCCEEEeeCCCee
Confidence 9999999963 25899999999999999999999 77755 99999999999999999999999986
Q ss_pred cCCCC--------CCCCCcccccCccccCCC------CCCCcchhHHHHHHHHHHHhC----------CCCcccccccCC
Q 037905 468 LASPS--------STPNRIDGYRAPEVTDAR------KVSQKADVYSFGVLLLELLTG----------KAPTQALLNEEG 523 (606)
Q Consensus 468 ~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~sDv~slGvvl~elltg----------~~p~~~~~~~~~ 523 (606)
..... ....+|..|+|||++.+. .+++++||||||+++|||++| +.||.......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~- 240 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND- 240 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS-
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC-
Confidence 54332 223678889999999876 455799999999999999999 77876533222
Q ss_pred CChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
................. ..............+.+++.+||+.||++|||+.+|++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQQRP-----NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCHHHHHHHHTTSCCCC-----CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchhhhhHHHhccCCCC-----CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 11111111111111111 1111112245667899999999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=356.33 Aligned_cols=247 Identities=24% Similarity=0.379 Sum_probs=201.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|++++++++||||++++++|...+..++||||+++|+
T Consensus 119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~ 198 (377)
T 3cbl_A 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 198 (377)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence 578999999999999975 789999999875432 22468899999999999999999999998889999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----- 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----- 473 (606)
|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 199 L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~iv--HrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 199 FLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLESKCCI--HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp HHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcC--CcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 999997532 2589999999999999999999999965 99999999999999999999999997644321
Q ss_pred -CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 474 -TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 474 -~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....+..|+|||.+.+..++.++||||||+++|||++ |+.||..... .. +......+.. .+
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------~~-~~~~~~~~~~----------~~ 335 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------QQ-TREFVEKGGR----------LP 335 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------HH-HHHHHHTTCC----------CC
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHHcCCC----------CC
Confidence 1123456999999988889999999999999999999 9999965322 11 1112222111 11
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.+..++..+.++|.+||+.||++|||+.+|++.|+++.+.
T Consensus 336 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 1122345688999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=339.80 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=206.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. .+++.||+|++..... ..+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 95 (294)
T 4eqm_A 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEG 95 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCC
Confidence 57899999999999985 4689999999864322 235688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++.... ++++..+..++.|++.||+|||++|++ ||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 96 PTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMRIV--HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 99999997542 589999999999999999999999966 9999999999999999999999999865432
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....+++.|+|||++.+..++.++||||||+++|||++|+.||.... .............. .... .
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~~----~~~~---~ 235 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET------AVSIAIKHIQDSVP----NVTT---D 235 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC------HHHHHHHHHSSCCC----CHHH---H
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhhccCC----Ccch---h
Confidence 22346788999999999999999999999999999999999996432 11212222221110 0000 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHHHhcccccCCCCccc
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRP-SMAEVTSQIEEICRSSLQQGQAHDLE 602 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~~~~~~~~~~~~~ 602 (606)
.....+..+.+++.+||+.||++|| +++++.+.|+.+.......++..+..
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~~~~~~ 287 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELD 287 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCCCCC--
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcchhhhh
Confidence 0112345688899999999999999 99999999999887766666665544
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.27 Aligned_cols=256 Identities=24% Similarity=0.359 Sum_probs=206.0
Q ss_pred HhcccccCCceEEEEEEEc--------CCcEEEEEEeccCccC--HHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEE
Q 037905 321 SAEVLGKGTFGTAYKATLE--------MGIVVAVKRLKDVTVS--EKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 389 (606)
..+.||+|+||.||+|+.. .+..||||+++..... .+.+.+|+++++++ +||||++++++|...+..++
T Consensus 73 i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~l 152 (382)
T 3tt0_A 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 152 (382)
T ss_dssp EEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEE
Confidence 3578999999999999852 3468999999765332 36688999999999 99999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcE
Q 037905 390 VHDYMPMGSLSALLHGNRGA-----------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEA 458 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~ 458 (606)
||||+++|+|.+++...... ....+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+
T Consensus 153 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~ 230 (382)
T 3tt0_A 153 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI--HRDLAARNVLVTEDNVM 230 (382)
T ss_dssp EEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTCCE
T ss_pred EEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEe--cCCCCcceEEEcCCCcE
Confidence 99999999999999864311 123589999999999999999999999966 99999999999999999
Q ss_pred EEeecccCccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHH
Q 037905 459 RISDFGLAHLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQ 531 (606)
Q Consensus 459 kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (606)
||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++ |+.||... .......
T Consensus 231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~------~~~~~~~ 304 (382)
T 3tt0_A 231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV------PVEELFK 304 (382)
T ss_dssp EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC------CHHHHHH
T ss_pred EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC------CHHHHHH
Confidence 99999999865432 12234567999999999999999999999999999999 99999643 2222222
Q ss_pred HHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 532 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
.+.. .... ..+......+.+++.+||+.+|++|||+.||+++|+++......+
T Consensus 305 ~~~~-~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 305 LLKE-GHRM----------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHT-TCCC----------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred HHHc-CCCC----------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence 2222 1111 111223456889999999999999999999999999998665444
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=335.76 Aligned_cols=244 Identities=28% Similarity=0.417 Sum_probs=189.4
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCcc-----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV-----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|... +..||||+++.... ..+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 90 (271)
T 3dtc_A 12 EEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTT
T ss_pred eeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCC
Confidence 467999999999999976 89999999875432 236789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CCCCCCCCCCEEecC--------CCcEEEeecccCc
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA-NSHGNIKSSNILLSK--------SYEARISDFGLAH 467 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~-i~HrDlkp~Nill~~--------~~~~kl~DfG~a~ 467 (606)
++|.+++.. ..+++..+..++.|++.||+|||++++. ++||||||+||+++. ++.+||+|||+++
T Consensus 91 ~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 91 GPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp EEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred CCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 999999863 2589999999999999999999999943 669999999999986 6789999999997
Q ss_pred cCCCC--CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 468 LASPS--STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 468 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~----- 233 (271)
T 3dtc_A 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNKLAL----- 233 (271)
T ss_dssp -----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSCCCC-----
T ss_pred ccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCCCCC-----
Confidence 65442 234567889999999988899999999999999999999999965321 11111111111111
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
..+......+.+++.+||+.+|++|||+.|++++|+++
T Consensus 234 -----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 234 -----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11122345688999999999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=350.54 Aligned_cols=248 Identities=25% Similarity=0.457 Sum_probs=194.0
Q ss_pred hcccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. .+..||||+++.... ..+++.+|+.++++++||||+++++++......++||||++
T Consensus 50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 129 (373)
T 2qol_A 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME 129 (373)
T ss_dssp CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence 578999999999999864 578899999976432 34579999999999999999999999998899999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST- 474 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 474 (606)
+++|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++.......
T Consensus 130 ~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 130 NGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMGYV--HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp TCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--CCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 999999997532 3589999999999999999999999966 999999999999999999999999986543221
Q ss_pred ------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 475 ------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 475 ------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
..++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+.. +..
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~------~~~~~~~i~~-~~~-------- 268 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS------NQDVIKAVDE-GYR-------- 268 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC------HHHHHHHHHT-TEE--------
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc-CCC--------
Confidence 122456999999998899999999999999999998 999996432 1222222211 111
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
...+..++..+.+++.+||+.+|++||++.+|++.|+++.+..
T Consensus 269 --~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 269 --LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp --CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred --CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 1111233457889999999999999999999999999997653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=366.93 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=206.6
Q ss_pred hcccccCCceEEEEEEEcC-CcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|.+.. +..||||+++......++|.+|+.++++++||||++++++|......++||||+++|+|.
T Consensus 225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~ 304 (495)
T 1opk_A 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304 (495)
T ss_dssp EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHH
Confidence 5789999999999999764 889999999877777889999999999999999999999999989999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TP 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~ 475 (606)
+++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++...... ..
T Consensus 305 ~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~iv--HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 379 (495)
T 1opk_A 305 DYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFI--HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 379 (495)
T ss_dssp HHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTC
T ss_pred HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCChhhEEECCCCcEEEeecccceeccCCceeecCCC
Confidence 9998643 34589999999999999999999999965 99999999999999999999999998654321 22
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
.++..|+|||++....++.++|||||||++|||++ |+.||..... ..... .+..... ...+.
T Consensus 380 ~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~------~~~~~-~~~~~~~----------~~~~~ 442 (495)
T 1opk_A 380 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYE-LLEKDYR----------MERPE 442 (495)
T ss_dssp CCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHH-HHHTTCC----------CCCCT
T ss_pred cCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH------HHHHH-HHHcCCC----------CCCCC
Confidence 33457999999988889999999999999999999 9999975322 11111 1222111 11122
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.++..+.++|.+||+.||++|||+.+|++.|+.+...
T Consensus 443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 3445788999999999999999999999999987543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=331.21 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=201.3
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +..||||+++..... .+.+.+|+.++++++||||+++++++.+. ...++||||+++
T Consensus 15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (271)
T 3kmu_A 15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY 93 (271)
T ss_dssp EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence 568999999999999986 899999999865433 35689999999999999999999999876 778999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN 476 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 476 (606)
++|.+++.... ...+++..+..++.|++.||+|||+++..++||||||+||+++.++.++|+|||++..... ....
T Consensus 94 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-~~~~ 169 (271)
T 3kmu_A 94 GSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-PGRM 169 (271)
T ss_dssp CBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-TTCB
T ss_pred CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-cCcc
Confidence 99999998643 2358999999999999999999999994455999999999999999999999988765332 3456
Q ss_pred CcccccCccccCCCCCCC---cchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 477 RIDGYRAPEVTDARKVSQ---KADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~---~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
+++.|+|||.+.+..++. ++||||||+++|||++|+.||.... ................ .+
T Consensus 170 ~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~----------~~ 233 (271)
T 3kmu_A 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEGLRPT----------IP 233 (271)
T ss_dssp SCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC------HHHHHHHHHHSCCCCC----------CC
T ss_pred CCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC------hHHHHHHHHhcCCCCC----------CC
Confidence 678899999998765544 7999999999999999999996432 2222222222221111 11
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
......+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 2234568899999999999999999999999998854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=339.58 Aligned_cols=254 Identities=25% Similarity=0.418 Sum_probs=198.8
Q ss_pred hcccccCCceEEEEEEE-----cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e~ 393 (606)
.+.||+|+||.||+|++ .+++.||||++..... ..+.+.+|++++++++||||+++++++... ...++||||
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 94 (295)
T 3ugc_A 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY 94 (295)
T ss_dssp EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence 57899999999999984 3689999999976433 246789999999999999999999998653 558999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+++ ||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (295)
T 3ugc_A 95 LPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKRYI--HRDLATRNILVENENRVKIGDFGLTKVLPQDK 168 (295)
T ss_dssp CTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred CCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCCcc--cCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence 99999999998643 2489999999999999999999999966 99999999999999999999999998654321
Q ss_pred -------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccccccc------CCCC---hhHHHHHHhhcc
Q 037905 474 -------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNE------EGVD---LPRWVQSVVKEE 537 (606)
Q Consensus 474 -------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~------~~~~---~~~~~~~~~~~~ 537 (606)
...++..|+|||.+.+..++.++||||||+++|||++|..|+...... .... ....+.......
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (295)
T 3ugc_A 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 248 (295)
T ss_dssp -------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred ceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhcc
Confidence 223445699999999889999999999999999999999998643211 0000 000011111111
Q ss_pred ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 538 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
. +...+..++..+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 249 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 249 G----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C----------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0 1112233456788999999999999999999999999999764
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=341.16 Aligned_cols=238 Identities=25% Similarity=0.308 Sum_probs=197.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccC----ccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +|+.||+|+++.. ......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~g 89 (337)
T 1o6l_A 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 467999999999999864 6899999999753 22456788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----S 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~ 472 (606)
|+|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 90 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 162 (337)
T 1o6l_A 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVV--YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--cCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence 99999997543 589999999999999999999999966 999999999999999999999999986432 2
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+...... .
T Consensus 163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~~------------~ 224 (337)
T 1o6l_A 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHERLFELILMEEIR------------F 224 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------C
T ss_pred cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC------CHHHHHHHHHcCCCC------------C
Confidence 2345788899999999999999999999999999999999999642 222233333322110 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
+......+.+++.+||+.||++|| +++||+++
T Consensus 225 p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112234678889999999999999 89999876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=351.66 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=202.4
Q ss_pred hcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|++. ++..||||+++.... ....+.+|+.++++++||||+++++++......++||||
T Consensus 76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 155 (367)
T 3l9p_A 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL 155 (367)
T ss_dssp EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence 578999999999999843 467899999975432 345688999999999999999999999998899999999
Q ss_pred cCCCChhhhhhcCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC---cEEEeecccCcc
Q 037905 394 MPMGSLSALLHGNRG--AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY---EARISDFGLAHL 468 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~---~~kl~DfG~a~~ 468 (606)
+++|+|.+++..... .....+++..++.++.||+.||+|||++|++ ||||||+|||++.++ .+||+|||+++.
T Consensus 156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~~~~~~~kL~DFG~a~~ 233 (367)
T 3l9p_A 156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI--HRDIAARNCLLTCPGPGRVAKIGDFGMARD 233 (367)
T ss_dssp CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCee--CCCCChhhEEEecCCCCceEEECCCccccc
Confidence 999999999986432 1224589999999999999999999999966 999999999999555 599999999874
Q ss_pred CC------CCCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 469 AS------PSSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 469 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
.. ......++..|+|||++.+..++.++|||||||++|||++ |+.||.... .......+......
T Consensus 234 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~------~~~~~~~i~~~~~~-- 305 (367)
T 3l9p_A 234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQEVLEFVTSGGRM-- 305 (367)
T ss_dssp HHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTTCCC--
T ss_pred cccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHcCCCC--
Confidence 32 1222345678999999988899999999999999999998 999996532 22222222222110
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
..+......+.+++.+||+.+|++|||+.+|+++|+.+.+...
T Consensus 306 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 306 ---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 1112233568899999999999999999999999999976543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=345.12 Aligned_cols=242 Identities=23% Similarity=0.346 Sum_probs=198.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|+.. +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~ 96 (361)
T 2yab_A 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96 (361)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence 568999999999999864 689999999976432 357899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC----cEEEeecccCccC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY----EARISDFGLAHLA 469 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~----~~kl~DfG~a~~~ 469 (606)
+++|+|.+++... ..+++..+..++.||+.||+|||++|++ ||||||+|||++.++ .+||+|||+++..
T Consensus 97 ~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~giv--HrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 97 VSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKKIA--HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp CCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 9999999999743 3589999999999999999999999966 999999999998877 7999999999876
Q ss_pred CCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 470 SPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 470 ~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||... +.......+....+. +++.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~------~~~~~~~~i~~~~~~---~~~~ 240 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANITAVSYD---FDEE 240 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHTTCCC---CCHH
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhcCCC---CCch
Confidence 543 3346788899999999999999999999999999999999999642 222223333222110 1111
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. +......+.+++.+||..||++|||+.|++++
T Consensus 241 ~-----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 241 F-----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp H-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred h-----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 11223467889999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=368.13 Aligned_cols=255 Identities=28% Similarity=0.424 Sum_probs=209.8
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
..+.||+|+||.||+|++..+..||||+++......++|.+|++++++++||||+++++++.. ...++||||+++|+|.
T Consensus 271 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~ 349 (535)
T 2h8h_A 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLL 349 (535)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHH
T ss_pred hheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHH
Confidence 357899999999999999888889999998777778899999999999999999999999865 6789999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-----CCC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-----STP 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~ 475 (606)
+++.... ...+++..++.++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... ...
T Consensus 350 ~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iv--HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~ 424 (535)
T 2h8h_A 350 DFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYV--HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 424 (535)
T ss_dssp HHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred HHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--CCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence 9997532 12489999999999999999999999966 9999999999999999999999999865431 223
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
.++..|+|||++....++.++|||||||++|||++ |+.||..... ......+ ..+... ..+.
T Consensus 425 ~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~i-~~~~~~----------~~~~ 487 (535)
T 2h8h_A 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQV-ERGYRM----------PCPP 487 (535)
T ss_dssp TSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHHH-HTTCCC----------CCCT
T ss_pred cCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-HcCCCC----------CCCC
Confidence 34567999999988899999999999999999999 9999965321 2222222 222111 1112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccCCC
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQA 598 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~~~ 598 (606)
.+...+.++|.+||+.||++|||+.+|++.|+++......+.++
T Consensus 488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~~~~ 531 (535)
T 2h8h_A 488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 531 (535)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCSSCC
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcccCc
Confidence 34457889999999999999999999999999987766555443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=345.65 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=202.3
Q ss_pred hcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 131 (343)
T 1luf_A 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 131 (343)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence 568999999999999864 358999999976432 245789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC
Q 037905 394 MPMGSLSALLHGNRGA-------------------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK 454 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~ 454 (606)
+++++|.+++...... ....+++..++.++.||+.||+|||+++++ ||||||+|||++.
T Consensus 132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv--H~Dlkp~NIl~~~ 209 (343)
T 1luf_A 132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV--HRDLATRNCLVGE 209 (343)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECG
T ss_pred CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCcceEEECC
Confidence 9999999999864211 124689999999999999999999999966 9999999999999
Q ss_pred CCcEEEeecccCccCCC------CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChh
Q 037905 455 SYEARISDFGLAHLASP------SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLP 527 (606)
Q Consensus 455 ~~~~kl~DfG~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~ 527 (606)
++.+||+|||+++.... .....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ..
T Consensus 210 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~------~~ 283 (343)
T 1luf_A 210 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA------HE 283 (343)
T ss_dssp GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC------HH
T ss_pred CCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC------hH
Confidence 99999999999865432 223445677999999988889999999999999999999 999996432 22
Q ss_pred HHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 528 RWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 528 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.....+.... .. ..+......+.+++.+||+.+|++|||+.+|+++|+++....
T Consensus 284 ~~~~~~~~~~-~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 284 EVIYYVRDGN-IL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp HHHHHHHTTC-CC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred HHHHHHhCCC-cC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 2222222211 11 011223456889999999999999999999999999987654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.96 Aligned_cols=264 Identities=16% Similarity=0.176 Sum_probs=209.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|.. .+++.||||++.... ..+.+.+|+.+++.+ +|+|++++++++......++||||+ +++|
T Consensus 15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 92 (298)
T 1csn_A 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL 92 (298)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCH
Confidence 46799999999999985 579999999986532 334678899999988 7999999999999999999999999 8999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc-----EEEeecccCccCCCC--
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE-----ARISDFGLAHLASPS-- 472 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~-----~kl~DfG~a~~~~~~-- 472 (606)
.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+||+++.++. +||+|||+++.....
T Consensus 93 ~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iv--H~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~ 166 (298)
T 1csn_A 93 EDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLV--YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166 (298)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTTEE--CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred HHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCEe--cCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence 99998542 3589999999999999999999999966 9999999999988776 999999999765432
Q ss_pred ---------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 473 ---------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 473 ---------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
....++..|+|||++.+..++.++||||||+++|||++|+.||...... ........+........
T Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~-- 241 (298)
T 1csn_A 167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA---TNKQKYERIGEKKQSTP-- 241 (298)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC---CHHHHHHHHHHHHHHSC--
T ss_pred cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc---ccHHHHHHHHhhccCcc--
Confidence 2335678899999999999999999999999999999999999764221 11222222211110000
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc-cCCCCcccc
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ-QGQAHDLEN 603 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~-~~~~~~~~~ 603 (606)
... .....+..+.+++.+||+.+|++|||+.+|++.|+++.+.... ...+.||+.
T Consensus 242 -~~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 242 -LRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp -HHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred -HHH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 000 0012345788999999999999999999999999999876443 466677764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=337.67 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=192.5
Q ss_pred HHhcccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 320 ASAEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
...+.||+|+||.||+|... .+..||+|+++.... ..+.+.+|+.++++++||||+++++++ .++..++||||
T Consensus 18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 96 (281)
T 1mp8_A 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMEL 96 (281)
T ss_dssp EEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred EEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEec
Confidence 34678999999999999863 356799999875432 245688999999999999999999997 45678999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+++++|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 97 CTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKRFV--HRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp CTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEEEETTEEEECC-----------
T ss_pred CCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cccccHHHEEECCCCCEEECccccccccCccc
Confidence 99999999997542 3589999999999999999999999966 99999999999999999999999997654422
Q ss_pred -----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 -----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 -----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+......
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~------~~~~~i~~~~~~-------- 236 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERL-------- 236 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCCC--------
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH------HHHHHHHcCCCC--------
Confidence 1234567999999988889999999999999999997 99999753221 122222221110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
..+......+.+++.+||+.||++|||+.+++++|+++.++.
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111223456888999999999999999999999999997654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.60 Aligned_cols=243 Identities=22% Similarity=0.317 Sum_probs=200.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|... +++.||+|++.........+.+|+++++.++||||+++++++.+.+..++||||+++++|.
T Consensus 10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~ 89 (321)
T 1tki_A 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF 89 (321)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHH
Confidence 467999999999999864 6899999999866555677899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC--CCcEEEeecccCccCCCCCC---C
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK--SYEARISDFGLAHLASPSST---P 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~---~ 475 (606)
+++.... ..+++..+..++.||+.||+|||++|++ ||||||+|||++. ++.+||+|||+++....... .
T Consensus 90 ~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~giv--H~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 163 (321)
T 1tki_A 90 ERINTSA----FELNEREIVSYVHQVCEALQFLHSHNIG--HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163 (321)
T ss_dssp HHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEE
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCC--cCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccc
Confidence 9997532 3589999999999999999999999966 9999999999987 78999999999987654322 3
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+++.|+|||++.+..++.++||||||+++|||++|+.||... ........+....... +.. ....
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~~---~~~-----~~~~ 229 (321)
T 1tki_A 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE------TNQQIIENIMNAEYTF---DEE-----AFKE 229 (321)
T ss_dssp ESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCCCC---CHH-----HHTT
T ss_pred cCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC------CHHHHHHHHHcCCCCC---Chh-----hhcc
Confidence 4677899999999988999999999999999999999999642 2223333333322110 000 0112
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||..||++|||+.|++++
T Consensus 230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 230 ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 23568889999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=341.11 Aligned_cols=255 Identities=26% Similarity=0.363 Sum_probs=195.7
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcC--CCCCCcccceEEEEeC----CceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGS--MDHENLVPLRAYYYSR----DEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~ 394 (606)
..+.||+|+||.||+|+.. ++.||||++.... ...+..|.+++.. ++||||+++++++... ...++||||+
T Consensus 41 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 117 (337)
T 3mdy_A 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117 (337)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCC
T ss_pred EEeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEecc
Confidence 4578999999999999986 8999999986543 3444455555554 4999999999999877 6789999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK--------GPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~--------~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
++|+|.+++... .+++..+..++.|++.||+|||++ +++ ||||||+|||++.++.+||+|||++
T Consensus 118 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv--H~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 118 ENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA--HRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEE--CSCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEE--ecccchHHEEECCCCCEEEEeCCCc
Confidence 999999999743 489999999999999999999998 755 9999999999999999999999999
Q ss_pred ccCCCCC--------CCCCcccccCccccCCCCCCCc------chhHHHHHHHHHHHhC----------CCCcccccccC
Q 037905 467 HLASPSS--------TPNRIDGYRAPEVTDARKVSQK------ADVYSFGVLLLELLTG----------KAPTQALLNEE 522 (606)
Q Consensus 467 ~~~~~~~--------~~~~~~~y~aPE~~~~~~~~~~------sDv~slGvvl~elltg----------~~p~~~~~~~~ 522 (606)
+...... ...++..|+|||++.+..++.+ +|||||||++|||++| +.||.......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 269 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCC
Confidence 7554321 3357788999999988766665 9999999999999999 55554432211
Q ss_pred CCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 523 GVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
... ............. +.........++...+.+++.+||+.||++|||+.+|+++|+++.++.
T Consensus 270 -~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 270 -PSY-EDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp -CCH-HHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -Cch-hhhHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 111 1111111111111 111111112367788999999999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=336.53 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=196.9
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||+++++|.+
T Consensus 13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~ 88 (307)
T 2eva_A 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 88 (307)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHH
T ss_pred eeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHH
Confidence 568999999999999986 789999998653 34567999999999999999999999875 46899999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---cCCCCCCCCCCCCCEEecCCCc-EEEeecccCccCCCC-CCCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS---KGPANSHGNIKSSNILLSKSYE-ARISDFGLAHLASPS-STPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~---~~~~i~HrDlkp~Nill~~~~~-~kl~DfG~a~~~~~~-~~~~ 476 (606)
++.... ....+++..+..++.|+++||+|||+ ++++ ||||||+|||++.++. +||+|||+++..... ....
T Consensus 89 ~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~iv--H~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (307)
T 2eva_A 89 VLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI--HRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK 164 (307)
T ss_dssp HHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCC--CCCCSGGGEEEETTTTEEEECCCCC------------
T ss_pred HHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCee--cCCCChhHEEEeCCCCEEEEcccccccccccccccCC
Confidence 998543 12347889999999999999999999 6755 9999999999998886 799999999765432 2345
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|+|||++.+..++.++||||||+++|||++|+.||..... ............ ... ......
T Consensus 165 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~-~~~----------~~~~~~ 229 (307)
T 2eva_A 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIMWAVHNG-TRP----------PLIKNL 229 (307)
T ss_dssp CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS----SHHHHHHHHHTT-CCC----------CCBTTC
T ss_pred CCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc----cHHHHHHHHhcC-CCC----------Cccccc
Confidence 77889999999999999999999999999999999999964321 111111111111 111 111223
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccCCC
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQA 598 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~~~ 598 (606)
...+.+++.+||+.||++|||+.++++.|+.+.+.......+
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 356888999999999999999999999999998765544433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=335.52 Aligned_cols=264 Identities=19% Similarity=0.273 Sum_probs=205.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCC--ceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRD--EKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 396 (606)
.++||+|+||.||+|+.. +++.||||++.... ...+.+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~ 93 (319)
T 4euu_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (319)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTT
T ss_pred EEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCC
Confidence 467999999999999865 58999999997543 24577889999999999999999999998765 77999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe----cCCCcEEEeecccCccCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL----SKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill----~~~~~~kl~DfG~a~~~~~~ 472 (606)
++|.+++..... ...+++..+..++.||+.||+|||+++++ ||||||+|||+ +.++.+||+|||+++.....
T Consensus 94 ~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~iv--H~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~ 169 (319)
T 4euu_A 94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENGIV--HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (319)
T ss_dssp CBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred CCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEe--cCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence 999999986432 23489999999999999999999999966 99999999999 78888999999999876543
Q ss_pred C---CCCCcccccCccccC--------CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc--
Q 037905 473 S---TPNRIDGYRAPEVTD--------ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT-- 539 (606)
Q Consensus 473 ~---~~~~~~~y~aPE~~~--------~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 539 (606)
. ...++..|+|||++. +..++.++|||||||++|||++|+.||....... .....+..+......
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSGA 247 (319)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHHHHCCTTC
T ss_pred CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHhcCCCccc
Confidence 2 345778899999875 5678999999999999999999999997532211 122222222221110
Q ss_pred -ccc-------cc--hhh-hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 540 -AEV-------FD--LEL-LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 540 -~~~-------~d--~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
... ++ ... ............+.+++.+||+.||++|||++|++++..+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 000 00 000 01122356677889999999999999999999999999986543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=333.43 Aligned_cols=253 Identities=27% Similarity=0.433 Sum_probs=204.8
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|...++..||||+++......+.+.+|++++++++||||+++++++. .+..++||||+++++|.+
T Consensus 18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 96 (279)
T 1qpc_A 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD 96 (279)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHH
Confidence 5789999999999999888889999999877777888999999999999999999999976 456899999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~ 476 (606)
++.... ...+++..+..++.|++.||+|||++|++ ||||||+||++++++.+||+|||+++...... ...
T Consensus 97 ~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 171 (279)
T 1qpc_A 97 FLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI--HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171 (279)
T ss_dssp HTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred HHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCC
Confidence 997432 12589999999999999999999999966 99999999999999999999999997654321 223
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||.+.+..++.++||||||+++|||++ |+.||.... .......+.. .... ..+..
T Consensus 172 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~-~~~~----------~~~~~ 234 (279)
T 1qpc_A 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT------NPEVIQNLER-GYRM----------VRPDN 234 (279)
T ss_dssp CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHHHHHT-TCCC----------CCCTT
T ss_pred CccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC------HHHHHHHHhc-ccCC----------CCccc
Confidence 4567999999988889999999999999999999 999996432 2222222211 1110 01112
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccCC
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~~ 597 (606)
....+.+++.+||+.+|++|||+.++++.|+++......+.+
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 276 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQ 276 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-----
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCCCC
Confidence 335688999999999999999999999999999877655443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=347.41 Aligned_cols=266 Identities=17% Similarity=0.206 Sum_probs=200.4
Q ss_pred hcccccCCceEEEEEEEcC------CcEEEEEEeccCccC------------HHHHHHHHHHHcCCCCCCcccceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLEM------GIVVAVKRLKDVTVS------------EKEFREKMEVVGSMDHENLVPLRAYYYS 383 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~niv~l~~~~~~ 383 (606)
.+.||+|+||.||+|.... ++.||||++...... ...+..|+..+..++||||+++++++..
T Consensus 40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~ 119 (364)
T 3op5_A 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH 119 (364)
T ss_dssp EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence 4679999999999998754 478999998754311 1234456667888899999999999876
Q ss_pred C----CceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec--CCCc
Q 037905 384 R----DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS--KSYE 457 (606)
Q Consensus 384 ~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~--~~~~ 457 (606)
. ...++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++ .++.
T Consensus 120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~ii--HrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 120 DKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHEYV--HGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEEESSCTTC
T ss_pred ccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--EecCCHHHEEEecCCCCe
Confidence 4 4579999999 999999998642 3589999999999999999999999966 999999999999 8899
Q ss_pred EEEeecccCccCCCC-----------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCCh
Q 037905 458 ARISDFGLAHLASPS-----------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDL 526 (606)
Q Consensus 458 ~kl~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~ 526 (606)
+||+|||+++..... ....+|..|+|||++.+..++.++|||||||++|||++|+.||....... ..
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~--~~ 270 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP--KY 270 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH--HH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH--HH
Confidence 999999999754321 12337888999999999999999999999999999999999998532211 11
Q ss_pred hHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc-CCCCcc
Q 037905 527 PRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ-GQAHDL 601 (606)
Q Consensus 527 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~-~~~~~~ 601 (606)
.......... .....++..+.. ...+..+.+++..||+.+|++||++.+|++.|+++.+..... +...+|
T Consensus 271 ~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw 341 (364)
T 3op5_A 271 VRDSKIRYRE-NIASLMDKCFPA----ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDL 341 (364)
T ss_dssp HHHHHHHHHH-CHHHHHHHHSCT----TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC
T ss_pred HHHHHHHhhh-hHHHHHHHhccc----ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccce
Confidence 1111111111 111111111100 122456889999999999999999999999999998765443 344444
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=339.22 Aligned_cols=254 Identities=24% Similarity=0.362 Sum_probs=192.0
Q ss_pred HHhcccccCCceEEEEEEEcC-C---cEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCce-----
Q 037905 320 ASAEVLGKGTFGTAYKATLEM-G---IVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEK----- 387 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~-~---~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~----- 387 (606)
...+.||+|+||.||+|+... + ..||||+++... ...+.+.+|++++++++||||+++++++......
T Consensus 26 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (323)
T 3qup_A 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPI 105 (323)
T ss_dssp EEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------C
T ss_pred EEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCc
Confidence 345789999999999998543 2 379999997642 2346789999999999999999999999876654
Q ss_pred -EEEEeecCCCChhhhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeeccc
Q 037905 388 -LLVHDYMPMGSLSALLHGNRG-AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGL 465 (606)
Q Consensus 388 -~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~ 465 (606)
++||||+++++|.+++..... .....+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+
T Consensus 106 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~iv--H~Dikp~NIli~~~~~~kl~Dfg~ 183 (323)
T 3qup_A 106 PMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFI--HRDLAARNCMLAEDMTVCVADFGL 183 (323)
T ss_dssp EEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECTTSCEEECCCCC
T ss_pred cEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcc--cCCCCcceEEEcCCCCEEEeeccc
Confidence 999999999999999965331 1223589999999999999999999999966 999999999999999999999999
Q ss_pred CccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccc
Q 037905 466 AHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEW 538 (606)
Q Consensus 466 a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (606)
++...... ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.....
T Consensus 184 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~~~ 257 (323)
T 3qup_A 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA------EIYNYLIGGNR 257 (323)
T ss_dssp -----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTCC
T ss_pred cccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH------HHHHHHhcCCC
Confidence 97654322 2234567999999998899999999999999999999 99999753221 22222222111
Q ss_pred cccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 539 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
. ..+......+.+++.+||+.||++|||+.++++.|+++....
T Consensus 258 ~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 258 L-----------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp C-----------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred C-----------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1 111223456889999999999999999999999999997653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=340.02 Aligned_cols=262 Identities=16% Similarity=0.157 Sum_probs=206.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+++++++ +||||+++++++......++||||+ +++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (330)
T 2izr_A 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL 91 (330)
T ss_dssp EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence 46799999999999985 578999999987543 234688999999999 9999999999999999999999999 8999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc-----EEEeecccCccCCCC--
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE-----ARISDFGLAHLASPS-- 472 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~-----~kl~DfG~a~~~~~~-- 472 (606)
.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++. +||+|||+++.....
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ii--HrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 92 EDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKNLI--YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred HHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 99998542 3589999999999999999999999965 9999999999999887 999999999764332
Q ss_pred ---------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 473 ---------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 473 ---------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
....+|..|+|||++.+..++.++||||||+++|||++|+.||..... ......+..+.......
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~---~~~~~~~~~i~~~~~~~--- 239 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA---DTLKERYQKIGDTKRAT--- 239 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC---SSHHHHHHHHHHHHHHS---
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc---ccHHHHHHHHHhhhccC---
Confidence 234577889999999999999999999999999999999999976422 22322222222111000
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc-cCCCCccc
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ-QGQAHDLE 602 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~-~~~~~~~~ 602 (606)
..... . ...+ .+.+++..||+.+|.+||++.+|++.|+++.+.... .+...+|+
T Consensus 240 ~~~~~-~---~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 240 PIEVL-C---ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp CHHHH-T---TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred CHHHH-h---ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 00000 0 0122 788999999999999999999999999999765433 23344554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=338.51 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=198.8
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEE
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 391 (606)
...+.||+|+||.||+|... +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 14 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 93 (326)
T 2y0a_A 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93 (326)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred EeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 34578999999999999864 689999999875432 3678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC----cEEEeecccCc
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY----EARISDFGLAH 467 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~----~~kl~DfG~a~ 467 (606)
||+++++|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++ .+||+|||+++
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~iv--H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 94 ELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQIA--HFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp ECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCCeE--cCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 999999999999743 3589999999999999999999999966 999999999999887 79999999998
Q ss_pred cCCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 468 LASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 468 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
..... ....+++.|+|||++.+..++.++||||||+++|||++|+.||.... .......+...... ..
T Consensus 167 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~~---~~ 237 (326)
T 2y0a_A 167 KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANVSAVNYE---FE 237 (326)
T ss_dssp ECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHHTCCC---CC
T ss_pred ECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC------HHHHHHHHHhcCCC---cC
Confidence 66432 23457888999999999999999999999999999999999996421 22222222221110 00
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... .......+.+++.+||..||++|||+.|++++
T Consensus 238 ~~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 238 DEY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHH-----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccc-----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 11223567889999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.50 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=201.0
Q ss_pred hcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCc-eEEEE
Q 037905 322 AEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDE-KLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~-~~lv~ 391 (606)
.+.||+|+||.||+|++ .+++.||||+++.... ..+.+.+|++++.++ +||||++++++|...+. .++||
T Consensus 27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~ 106 (359)
T 3vhe_A 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV 106 (359)
T ss_dssp EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence 57899999999999974 3468999999976433 235689999999999 79999999999987554 89999
Q ss_pred eecCCCChhhhhhcCCCCC-------------------------------------------------------------
Q 037905 392 DYMPMGSLSALLHGNRGAG------------------------------------------------------------- 410 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~------------------------------------------------------------- 410 (606)
||+++|+|.+++.......
T Consensus 107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (359)
T 3vhe_A 107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186 (359)
T ss_dssp ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence 9999999999998653210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC------CCCCcccccCc
Q 037905 411 RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS------TPNRIDGYRAP 484 (606)
Q Consensus 411 ~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aP 484 (606)
...+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++...... ...++..|+||
T Consensus 187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~iv--H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aP 264 (359)
T 3vhe_A 187 KDFLTLEHLICYSFQVAKGMEFLASRKCI--HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264 (359)
T ss_dssp TTCBCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCH
T ss_pred ccccCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeECh
Confidence 12288999999999999999999999966 99999999999999999999999998654322 23455679999
Q ss_pred cccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHH
Q 037905 485 EVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQL 563 (606)
Q Consensus 485 E~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l 563 (606)
|++.+..++.++||||||+++|||++ |+.||..... ...+........... .+......+.++
T Consensus 265 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~~~~~~~~----------~~~~~~~~l~~l 328 (359)
T 3vhe_A 265 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DEEFCRRLKEGTRMR----------APDYTTPEMYQT 328 (359)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------SHHHHHHHHHTCCCC----------CCTTCCHHHHHH
T ss_pred hhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch------hHHHHHHHHcCCCCC----------CCCCCCHHHHHH
Confidence 99998899999999999999999998 9999965321 111222222211111 111233468889
Q ss_pred HHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 564 AINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 564 ~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
+.+||+.||++|||+.||+++|+++.+..
T Consensus 329 i~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 329 MLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999997653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=336.54 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=202.9
Q ss_pred HhcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
..+.||+|+||.||+|+. .++..||||+++.... ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 106 (314)
T 2ivs_A 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVE 106 (314)
T ss_dssp EEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEe
Confidence 457899999999999985 2458999999976432 23678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec
Q 037905 393 YMPMGSLSALLHGNRGA-------------------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS 453 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~ 453 (606)
|+++++|.+++...... ....+++..+..++.||+.||+|||+++++ ||||||+||+++
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv--H~dikp~NIli~ 184 (314)
T 2ivs_A 107 YAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV--HRDLAARNILVA 184 (314)
T ss_dssp CCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEE
T ss_pred ecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc--ccccchheEEEc
Confidence 99999999999864321 123488999999999999999999999965 999999999999
Q ss_pred CCCcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCCh
Q 037905 454 KSYEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDL 526 (606)
Q Consensus 454 ~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~ 526 (606)
.++.+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 185 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----- 259 (314)
T 2ivs_A 185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE----- 259 (314)
T ss_dssp TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-----
T ss_pred CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 99999999999997654321 2334567999999988889999999999999999999 99999653221
Q ss_pred hHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 527 PRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 527 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
... ......... ..+......+.+++.+||+.||++|||+.+++++|+++...
T Consensus 260 -~~~-~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 260 -RLF-NLLKTGHRM----------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp -GHH-HHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -HHH-HHhhcCCcC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 111 111111111 11122345688999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.14 Aligned_cols=240 Identities=18% Similarity=0.305 Sum_probs=191.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCC-------------
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRD------------- 385 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------------- 385 (606)
.+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|++++++++||||++++++|....
T Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~ 90 (332)
T 3qd2_B 11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL 90 (332)
T ss_dssp EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence 578999999999999975 79999999997433 24577999999999999999999999986543
Q ss_pred --------------------------------------------ceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHH
Q 037905 386 --------------------------------------------EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421 (606)
Q Consensus 386 --------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~ 421 (606)
..++||||+++++|.+++.... ......+..+..
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ 168 (332)
T 3qd2_B 91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREHGVCLH 168 (332)
T ss_dssp -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCHHHHHH
T ss_pred ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--CccchhhHHHHH
Confidence 2799999999999999998654 233467778899
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----------------CCCCCcccccCcc
Q 037905 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----------------STPNRIDGYRAPE 485 (606)
Q Consensus 422 i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----------------~~~~~~~~y~aPE 485 (606)
++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... ....++..|+|||
T Consensus 169 i~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 246 (332)
T 3qd2_B 169 IFIQIAEAVEFLHSKGLM--HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246 (332)
T ss_dssp HHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred HHHHHHHHHHHHHhCCee--ecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence 999999999999999965 9999999999999999999999999765442 2234678899999
Q ss_pred ccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHH
Q 037905 486 VTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAI 565 (606)
Q Consensus 486 ~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~ 565 (606)
++.+..++.++||||||+++|||++|..|+.... ...... .... ...........+.+++.
T Consensus 247 ~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~~~~-~~~~----------~~~~~~~~~~~~~~li~ 307 (332)
T 3qd2_B 247 QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RIITDV-RNLK----------FPLLFTQKYPQEHMMVQ 307 (332)
T ss_dssp HHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHHHHH-HTTC----------CCHHHHHHCHHHHHHHH
T ss_pred HhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHHHHh-hccC----------CCcccccCChhHHHHHH
Confidence 9999999999999999999999999988764311 111111 1100 00112334456789999
Q ss_pred HccCcCCCCCCCHHHHHHH
Q 037905 566 NCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 566 ~Cl~~~P~~RPs~~~v~~~ 584 (606)
+||+.||++|||+.|++++
T Consensus 308 ~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 308 DMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHCSSGGGSCCHHHHHHS
T ss_pred HHccCCCCcCCCHHHHhhc
Confidence 9999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=344.21 Aligned_cols=244 Identities=21% Similarity=0.277 Sum_probs=192.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+++.. +++.||||++.......+.+.+|+.+++.++||||+++++++.+....++||||+++|+|.
T Consensus 25 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~ 104 (361)
T 3uc3_A 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY 104 (361)
T ss_dssp EEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred EEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHH
Confidence 578999999999999865 7899999999876666678999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc--EEEeecccCccCCC---CCCC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE--ARISDFGLAHLASP---SSTP 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~--~kl~DfG~a~~~~~---~~~~ 475 (606)
+++.... .+++..+..++.|++.||+|||++|++ ||||||+|||++.++. +||+|||+++.... ....
T Consensus 105 ~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~iv--H~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 177 (361)
T 3uc3_A 105 ERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQIC--HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177 (361)
T ss_dssp HHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--SCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred HHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCC
Confidence 9997533 589999999999999999999999966 9999999999987765 99999999874332 2334
Q ss_pred CCcccccCccccCCCCCCCc-chhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQK-ADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~-sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
.+++.|+|||++.+..++.+ +|||||||++|||++|+.||...... ......+..+....... +...
T Consensus 178 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~~~~~~~~~~----------~~~~ 245 (361)
T 3uc3_A 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP--RDYRKTIQRILSVKYSI----------PDDI 245 (361)
T ss_dssp ---CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C--CCHHHHHHHHHTTCCCC----------CTTS
T ss_pred cCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhcCCCCC----------CCcC
Confidence 67888999999988777655 89999999999999999999754322 22333333332222110 0001
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+.+++.+||..||++|||+.|++++
T Consensus 246 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 246 RISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 123467889999999999999999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=331.95 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=204.4
Q ss_pred cccccCCceEEEEEEEc---CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+.||+|+||.||+|... ++..||||+++.... ..+.+.+|++++++++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 37999999999999753 578899999986432 346789999999999999999999999 556789999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++... ...+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++......
T Consensus 95 ~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 168 (287)
T 1u59_A 95 PLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFV--HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168 (287)
T ss_dssp EHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCCEe--eCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence 999999743 23589999999999999999999999966 99999999999999999999999997654321
Q ss_pred ---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 474 ---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 474 ---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
...++..|+|||++.+..++.++||||||+++|||++ |+.||..... ......+.... ..
T Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~i~~~~-~~--------- 232 (287)
T 1u59_A 169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMAFIEQGK-RM--------- 232 (287)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT------HHHHHHHHTTC-CC---------
T ss_pred ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHhcCC-cC---------
Confidence 2234567999999988889999999999999999999 9999965321 22222221111 11
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccCCC
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQA 598 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~~~ 598 (606)
..+......+.+++.+||+.+|++|||+.+++++|+.+..+.......
T Consensus 233 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~ 280 (287)
T 1u59_A 233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280 (287)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSS
T ss_pred -CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccC
Confidence 111233457889999999999999999999999999998877665433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=363.58 Aligned_cols=247 Identities=26% Similarity=0.366 Sum_probs=201.1
Q ss_pred ccccCCceEEEEEEEc---CCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 324 VLGKGTFGTAYKATLE---MGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.||+|+||.||+|.+. ++..||||+++... ...+++.+|++++++++||||++++++|.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 6999999999999863 56789999997643 346789999999999999999999999975 56899999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC----
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST---- 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---- 474 (606)
|.+++... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++.......
T Consensus 422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ii--HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKNFV--HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCEE--cCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 99999753 23589999999999999999999999966 999999999999999999999999987543211
Q ss_pred ---CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 475 ---PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 475 ---~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
..++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+. .+.. .
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~~~~~i~-~~~~----------~ 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG------PEVMAFIE-QGKR----------M 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS------HHHHHHHH-TTCC----------C
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH------HHHHHHHH-cCCC----------C
Confidence 123457999999998899999999999999999998 9999975322 22222222 2111 1
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
..+..++..+.++|.+||+.+|++|||+.+|++.|+.+..+...
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 11223456788999999999999999999999999999766544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=348.74 Aligned_cols=244 Identities=22% Similarity=0.265 Sum_probs=197.4
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
...+.||+|+||.||+|.. .+|+.+|+|++...... .+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 14 ~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~ 93 (444)
T 3soa_A 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93 (444)
T ss_dssp EEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCB
T ss_pred EEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCC
Confidence 3457899999999999985 46899999999765432 3568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec---CCCcEEEeecccCccCCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS---KSYEARISDFGLAHLASPS 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~ 472 (606)
+|+|.+.+.... .+++..+..++.||+.||+|||++|++ ||||||+|||++ .++.+||+|||+++.....
T Consensus 94 gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~giv--HrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 94 GGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMGVV--HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 999999997542 589999999999999999999999966 999999999998 4678999999999766543
Q ss_pred ----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 473 ----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 473 ----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
....+++.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+....... ..
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~--~~---- 234 (444)
T 3soa_A 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE------DQHRLYQQIKAGAYDF--PS---- 234 (444)
T ss_dssp CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCCCC--CT----
T ss_pred CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc------cHHHHHHHHHhCCCCC--Cc----
Confidence 2346788899999999999999999999999999999999999642 2222233332221110 00
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+........+.+++.+||+.||++|||+.|++++
T Consensus 235 --~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 --PEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp --TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0111233567889999999999999999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=341.29 Aligned_cols=244 Identities=23% Similarity=0.298 Sum_probs=198.5
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
...+.||+|+||.||+|... +|+.||+|++...... .+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 32 ~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 111 (362)
T 2bdw_A 32 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111 (362)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 34678999999999999864 6899999999765443 3568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC---cEEEeecccCccCCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY---EARISDFGLAHLASPS 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~---~~kl~DfG~a~~~~~~ 472 (606)
+|+|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++ .+||+|||+++.....
T Consensus 112 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~iv--H~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 112 GGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNGIV--HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp SCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--eccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999998743 3589999999999999999999999966 999999999998654 5999999999876543
Q ss_pred C---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 S---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ~---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
. ...+++.|+|||++.+..++.++|||||||++|||++|+.||... +.......+....... ..
T Consensus 185 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~------~~~~~~~~i~~~~~~~--~~----- 251 (362)
T 2bdw_A 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLYAQIKAGAYDY--PS----- 251 (362)
T ss_dssp CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCC--CT-----
T ss_pred cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCCCCC--Cc-----
Confidence 2 346788899999999989999999999999999999999999642 2222233222221110 00
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.........+.+++.+||..||++|||+.|++++
T Consensus 252 -~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 252 -PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0112233567889999999999999999999876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=333.43 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=207.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|... ++..||+|++.......+.+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 97 (288)
T 3kfa_A 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97 (288)
T ss_dssp EEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHH
T ss_pred EeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHH
Confidence 567999999999999975 4889999999876666788999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----C
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-----P 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~ 475 (606)
+++.... ...+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++....... .
T Consensus 98 ~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~--H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 172 (288)
T 3kfa_A 98 DYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFI--HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 172 (288)
T ss_dssp HHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHTCC--CSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred HHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCCcc--CCCCCcceEEEcCCCCEEEccCccceeccCCccccccCC
Confidence 9998643 34589999999999999999999999966 999999999999999999999999986654321 2
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
.++..|+|||++.+..++.++||||||+++|+|++ |..||..... ....... ...... ..+.
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~------~~~~~~~-~~~~~~----------~~~~ 235 (288)
T 3kfa_A 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL------SQVYELL-EKDYRM----------ERPE 235 (288)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG------GGHHHHH-HTTCCC----------CCCT
T ss_pred ccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHH-hccCCC----------CCCC
Confidence 23456999999988899999999999999999999 9999965321 1111111 111111 1112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
..+..+.+++.+||..||++|||+.++++.|+.+.....
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 234568899999999999999999999999999976543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=335.16 Aligned_cols=238 Identities=23% Similarity=0.304 Sum_probs=199.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +|+.||+|+++... ...+.+.+|..+++.++||||+++++++.+....++||||+++
T Consensus 11 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~g 90 (318)
T 1fot_A 11 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90 (318)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCC
Confidence 467999999999999864 68999999997542 2346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STP 475 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~ 475 (606)
|+|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++..... ...
T Consensus 91 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~ 163 (318)
T 1fot_A 91 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKDII--YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 163 (318)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTTEE--CCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCChheEEEcCCCCEEEeecCcceecCCccccc
Confidence 99999998542 589999999999999999999999966 9999999999999999999999999865442 345
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+|+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+...... .+..
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~------~~~~~~~~i~~~~~~------------~p~~ 225 (318)
T 1fot_A 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS------NTMKTYEKILNAELR------------FPPF 225 (318)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHCCCC------------CCTT
T ss_pred cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCC------------CCCC
Confidence 6788999999999999999999999999999999999999642 222333333332210 0111
Q ss_pred HHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
....+.+++.+||..||++|| ++++++++
T Consensus 226 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 226 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 234678889999999999999 89999865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=333.99 Aligned_cols=239 Identities=21% Similarity=0.308 Sum_probs=188.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---------------------------HHHHHHHHHHHcCCCCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---------------------------EKEFREKMEVVGSMDHEN 373 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------------------------~~~~~~e~~~l~~l~h~n 373 (606)
.+.||+|+||.||+|+. .+++.||||++...... .+.+.+|++++++++|||
T Consensus 18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 97 (298)
T 2zv2_A 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97 (298)
T ss_dssp EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence 57799999999999985 46899999998654321 245889999999999999
Q ss_pred cccceEEEEe--CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEE
Q 037905 374 LVPLRAYYYS--RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNIL 451 (606)
Q Consensus 374 iv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nil 451 (606)
|+++++++.+ ....++||||+++++|.+++.. ..+++..+..++.||+.||+|||+++++ ||||||+|||
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~Dlkp~Nil 169 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQKII--HRDIKPSNLL 169 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEE
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHHHEE
Confidence 9999999986 5678999999999999887642 3589999999999999999999999965 9999999999
Q ss_pred ecCCCcEEEeecccCccCCCC----CCCCCcccccCccccCCCC---CCCcchhHHHHHHHHHHHhCCCCcccccccCCC
Q 037905 452 LSKSYEARISDFGLAHLASPS----STPNRIDGYRAPEVTDARK---VSQKADVYSFGVLLLELLTGKAPTQALLNEEGV 524 (606)
Q Consensus 452 l~~~~~~kl~DfG~a~~~~~~----~~~~~~~~y~aPE~~~~~~---~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~ 524 (606)
++.++.+||+|||+++..... ....++..|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------ 243 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE------ 243 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS------
T ss_pred ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc------
Confidence 999999999999999765432 2346788899999997755 477899999999999999999999642
Q ss_pred ChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 525 DLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+...... .+........+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 244 RIMCLHSKIKSQALE----------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SHHHHHHHHHHCCCC----------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred cHHHHHHHHhcccCC----------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 222222222211110 00111223468889999999999999999999764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=344.81 Aligned_cols=248 Identities=21% Similarity=0.277 Sum_probs=198.7
Q ss_pred HHHhcccccCCceEEEEEEE-cCCcEEEEEEeccC------ccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEE
Q 037905 319 RASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDV------TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 319 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 391 (606)
|...+.||+|+||.||+|.. .+|+.||||++... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 105 (351)
T 3c0i_A 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 105 (351)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 44567899999999999986 46899999998642 124678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc---EEEeecccCcc
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE---ARISDFGLAHL 468 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~---~kl~DfG~a~~ 468 (606)
||+++++|.+.+..... ....+++..+..++.||+.||+|||+++++ ||||||+|||++.++. +||+|||+++.
T Consensus 106 e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~iv--HrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 106 EFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNNII--HRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp ECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCce--eccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 99999999888764321 123589999999999999999999999966 9999999999987655 99999999977
Q ss_pred CCCC----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 469 ASPS----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 469 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
.... ....+|+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+...... ..
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-------~~~~~~i~~~~~~---~~ 252 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-------ERLFEGIIKGKYK---MN 252 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-------HHHHHHHHHTCCC---CC
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-------HHHHHHHHcCCCC---CC
Confidence 6543 23457888999999999999999999999999999999999996521 1222222222111 01
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.. .......+.+++.+||..||++|||+.|++++
T Consensus 253 ~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 253 PRQ-----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHH-----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 01223568889999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=339.68 Aligned_cols=246 Identities=24% Similarity=0.410 Sum_probs=194.6
Q ss_pred hcccccCCceEEEEEEEc-CCc----EEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGI----VVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|+.. +++ +||+|.+.... ...+.+.+|+.++++++||||++++++|... ..++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~ 98 (327)
T 3poz_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 98 (327)
T ss_dssp EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECC
T ss_pred ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEec
Confidence 478999999999999853 343 46888876432 3457899999999999999999999999865 478999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
.+|+|.+++.... ..+++..++.++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~iv--H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 99 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp TTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCee--CCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 9999999998643 3589999999999999999999999966 99999999999999999999999997654322
Q ss_pred -----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 -----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 -----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...++..|+|||++.+..++.++||||||+++|||++ |+.||....... +.........
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~~-------- 237 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGER-------- 237 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTCC--------
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHHcCCC--------
Confidence 1234567999999999999999999999999999999 999997532211 1111211110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
...+..+...+.+++.+||+.+|++|||+.+++++|+++.+.
T Consensus 238 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 238 --LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred --CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 111122345688999999999999999999999999999754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=344.89 Aligned_cols=244 Identities=20% Similarity=0.342 Sum_probs=193.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCH----HHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSE----KEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. +++.||+|+++...... +.+..|..++.++ +||||+++++++.+....++||||++
T Consensus 57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~ 136 (396)
T 4dc2_A 57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 136 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence 578999999999999865 58899999998654322 3477888888776 89999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
+|+|..++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 137 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~giv--HrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 209 (396)
T 4dc2_A 137 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGII--YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 209 (396)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEE--eccCCHHHEEECCCCCEEEeecceeeecccCCCc
Confidence 999999998543 589999999999999999999999966 999999999999999999999999986322
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC--CChhHHH-HHHhhccccccccchhhh
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG--VDLPRWV-QSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~d~~~~ 548 (606)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+. ......+ +.+.....
T Consensus 210 ~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 279 (396)
T 4dc2_A 210 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 279 (396)
T ss_dssp BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----------
T ss_pred cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----------
Confidence 2345678889999999999999999999999999999999999964322111 1111212 22222111
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSM------AEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~~v~~~ 584 (606)
..+......+.+++.+||+.||++||++ .||+++
T Consensus 280 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 280 --RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred --CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1111233467889999999999999996 566554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=337.44 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=193.4
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+..+|+.||+|++...... .+.+.+|++++++++||||+++++++.+....++||||+++ +
T Consensus 26 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~ 104 (311)
T 3niz_A 26 LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-D 104 (311)
T ss_dssp EEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-E
T ss_pred hhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-C
Confidence 4679999999999999888999999999754332 36788999999999999999999999999999999999985 8
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++.... ..+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++..... ..
T Consensus 105 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~iv--H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 178 (311)
T 3niz_A 105 LKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHRIL--HRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178 (311)
T ss_dssp HHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence 888887543 3589999999999999999999999966 9999999999999999999999999765432 23
Q ss_pred CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccc---ccchhh---
Q 037905 475 PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE---VFDLEL--- 547 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~d~~~--- 547 (606)
..++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+........... ..+...
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 255 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQELPLWKQ 255 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGTTSHHHHS
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhhccchhhh
Confidence 456788999999876 568999999999999999999999997543221 1111111111100000 000000
Q ss_pred ---h--cccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 548 ---L--RYQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 548 ---~--~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. .... ......++.+++.+||+.||++|||++|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 0000 01123567899999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=329.54 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=195.3
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC--H------HHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS--E------KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~------~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
.+.||+|+||.||+|+. .+++.||+|++...... . +.+.+|++++++++||||+++++++.+ ..++|||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~lv~e 101 (287)
T 4f0f_A 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVME 101 (287)
T ss_dssp EEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT--TTEEEEE
T ss_pred hhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC--CCeEEEE
Confidence 46799999999999986 47899999998654321 1 678999999999999999999999854 3479999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc-----EEEeecccCc
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE-----ARISDFGLAH 467 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~-----~kl~DfG~a~ 467 (606)
|+++++|.+++.... ..+++..+..++.|++.||+|||+++..++||||||+|||++.++. +||+|||+++
T Consensus 102 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~ 177 (287)
T 4f0f_A 102 FVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177 (287)
T ss_dssp CCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred ecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence 999999999887542 3589999999999999999999999933449999999999988776 9999999997
Q ss_pred cCCCC-CCCCCcccccCccccC--CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 468 LASPS-STPNRIDGYRAPEVTD--ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 468 ~~~~~-~~~~~~~~y~aPE~~~--~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
..... ....++..|+|||++. ...++.++||||||+++|||++|+.||..... ................
T Consensus 178 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~---- 249 (287)
T 4f0f_A 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY----GKIKFINMIREEGLRP---- 249 (287)
T ss_dssp CCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC----CHHHHHHHHHHSCCCC----
T ss_pred cccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc----cHHHHHHHHhccCCCC----
Confidence 65443 2345778899999984 45678999999999999999999999965321 1112222222222111
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
..+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 250 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 250 ------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp ------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ------CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11122345688999999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=329.63 Aligned_cols=264 Identities=20% Similarity=0.195 Sum_probs=207.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEE-eCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY-SRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|+. .+|+.||||++.... ..+.+.+|+.+++.++|++++..+.++. .....++||||+ +++|
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L 91 (296)
T 3uzp_A 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL 91 (296)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCH
Confidence 46799999999999985 579999999986543 3346889999999999999887777664 556779999999 8899
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe---cCCCcEEEeecccCccCCCC----
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL---SKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~---- 472 (606)
.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||+ +.++.+||+|||+++.....
T Consensus 92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iv--H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (296)
T 3uzp_A 92 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKNFI--HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165 (296)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCCee--eCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccc
Confidence 99997432 3589999999999999999999999966 99999999999 48889999999999765432
Q ss_pred -------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 -------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 -------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....++..|+|||.+.+..++.++||||||+++|||++|+.||..............+........ .
T Consensus 166 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~ 239 (296)
T 3uzp_A 166 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------I 239 (296)
T ss_dssp BCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC------H
T ss_pred ccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc------h
Confidence 234567789999999999999999999999999999999999986443322222221111100000 0
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc-cCCCCcccc
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ-QGQAHDLEN 603 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~-~~~~~~~~~ 603 (606)
.. .....+..+.+++.+||+.||++|||+.+|++.|+++...... .+++.|||.
T Consensus 240 ~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 240 EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred HH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 00 0011235688999999999999999999999999999876554 466788874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=338.59 Aligned_cols=237 Identities=22% Similarity=0.323 Sum_probs=193.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|.. .+++.||||++.... .....+.+|+.+++.++||||+++++++......++||||+ +
T Consensus 14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~ 92 (336)
T 3h4j_B 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence 57899999999999996 578999999986532 22357899999999999999999999999999999999999 6
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
|+|.+++.... .+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 93 g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~giv--H~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 93 GELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHKIV--HRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHTCC--CCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeE--ecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence 79999887542 589999999999999999999999966 9999999999999999999999999865443 3
Q ss_pred CCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...+++.|+|||++.+..+ ++++||||||+++|+|++|+.||....... + ...+ ... ....
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~---~~~i-~~~-----------~~~~ 227 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---L---FKKV-NSC-----------VYVM 227 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---C---BCCC-CSS-----------CCCC
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---H---HHHH-HcC-----------CCCC
Confidence 4567888999999988776 789999999999999999999997532211 0 0000 000 0001
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+......+.+++.+||..||++|||++|++++
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11223467889999999999999999999876
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=343.29 Aligned_cols=238 Identities=23% Similarity=0.302 Sum_probs=194.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. +|+.||||+++... ...+.+.+|..++..+ +||||+++++++.+.+..++||||++
T Consensus 28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 107 (353)
T 3txo_A 28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107 (353)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence 578999999999999864 68999999997532 2345678899999887 79999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
+|+|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 108 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~giv--HrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~ 180 (353)
T 3txo_A 108 GGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKGII--YRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT 180 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCc--ccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence 999999997543 589999999999999999999999966 999999999999999999999999986432
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+......
T Consensus 181 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~~------------ 242 (353)
T 3txo_A 181 TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE------NEDDLFEAILNDEVV------------ 242 (353)
T ss_dssp -----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------
T ss_pred ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCC------------
Confidence 22346788899999999888999999999999999999999999643 223333333332211
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSM------AEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~~v~~~ 584 (606)
.+......+.+++.+||+.+|++||++ .|++++
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 011123457888999999999999998 677654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=335.04 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=204.5
Q ss_pred HhcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 391 (606)
..+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 27 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 106 (313)
T 1t46_A 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (313)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEE
Confidence 357899999999999985 3578999999976532 346789999999999 9999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcE
Q 037905 392 DYMPMGSLSALLHGNRGA-------------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEA 458 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~ 458 (606)
||+++|+|.+++...... ....+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+
T Consensus 107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~ 184 (313)
T 1t46_A 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI--HRDLAARNILLTHGRIT 184 (313)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEEETTTEE
T ss_pred ecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCccceEEEcCCCCE
Confidence 999999999999864321 122589999999999999999999999966 99999999999999999
Q ss_pred EEeecccCccCCCCCC------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHH
Q 037905 459 RISDFGLAHLASPSST------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQ 531 (606)
Q Consensus 459 kl~DfG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (606)
||+|||+++....... ..++..|+|||++.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~ 258 (313)
T 1t46_A 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV------DSKFY 258 (313)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS------SHHHH
T ss_pred EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc------hhHHH
Confidence 9999999986654322 233457999999988889999999999999999999 9999965321 11122
Q ss_pred HHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 532 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
......... ..+......+.+++.+||+.||++|||+.+++++|+++..+.
T Consensus 259 ~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 259 KMIKEGFRM----------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHTCCC----------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHhccCCCC----------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 222221111 011223356888999999999999999999999999987654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=333.51 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=196.2
Q ss_pred hcccccCCceEEEEEEEc-CC-------cEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLE-MG-------IVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
.+.||+|+||.||+|... ++ ..||+|++.... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 92 (289)
T 4fvq_A 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE 92 (289)
T ss_dssp EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence 567999999999999854 23 579999986543 345779999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc--------EEEeecc
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE--------ARISDFG 464 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~--------~kl~DfG 464 (606)
|+++++|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++. +||+|||
T Consensus 93 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~iv--H~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg 166 (289)
T 4fvq_A 93 FVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENTLI--HGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166 (289)
T ss_dssp CCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred CCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCCeE--CCCcCcceEEEecCCcccccccceeeeccCc
Confidence 999999999998643 2489999999999999999999999966 9999999999998887 9999999
Q ss_pred cCccCCCCCCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCC-CcccccccCCCChhHHHHHHhhccccccc
Q 037905 465 LAHLASPSSTPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKA-PTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 465 ~a~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
+++.........++..|+|||++.+ ..++.++||||||+++|||++|.. |+... ................
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~------~~~~~~~~~~~~~~~~-- 238 (289)
T 4fvq_A 167 ISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL------DSQRKLQFYEDRHQLP-- 238 (289)
T ss_dssp SCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS------CHHHHHHHHHTTCCCC--
T ss_pred ccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc------chHHHHHHhhccCCCC--
Confidence 9976655444456778999999987 678999999999999999999654 44321 1111111111110000
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
......+.+++.+||+.||++|||+.+++++|+++..+..+.
T Consensus 239 -----------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 239 -----------APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp -----------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred -----------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 111235788999999999999999999999999987765553
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.19 Aligned_cols=245 Identities=22% Similarity=0.334 Sum_probs=180.0
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
+.||+|+||.||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++++|.
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 67999999999999864 6899999999653 3567889999999997 999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC---cEEEeecccCccCCCC----C
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY---EARISDFGLAHLASPS----S 473 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~---~~kl~DfG~a~~~~~~----~ 473 (606)
+++... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++ .+||+|||+++..... .
T Consensus 95 ~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~iv--H~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 167 (325)
T 3kn6_A 95 ERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVGVV--HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167 (325)
T ss_dssp HHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCe--ecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence 999854 2589999999999999999999999966 999999999998766 7999999999865432 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC-CChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG-VDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||++.+..++.++||||||+++|||++|+.||........ .........+....... . ...
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~---~-----~~~ 239 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF---E-----GEA 239 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC---C-----SHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC---C-----ccc
Confidence 34457789999999999999999999999999999999999976433211 12222222222221100 0 001
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||..||++|||+.|++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12234568899999999999999999998754
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=343.69 Aligned_cols=242 Identities=24% Similarity=0.336 Sum_probs=193.8
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
+.||+|+||.||+|.. .+|+.||+|+++.... ..+.+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~ 174 (373)
T 2x4f_A 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF 174 (373)
T ss_dssp EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence 5699999999999986 4689999999986543 4567999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe--cCCCcEEEeecccCccCCCC---CCC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL--SKSYEARISDFGLAHLASPS---STP 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill--~~~~~~kl~DfG~a~~~~~~---~~~ 475 (606)
+++.... ..+++..+..++.||+.||+|||+.+++ ||||||+|||+ +.++.+||+|||+++..... ...
T Consensus 175 ~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~ 248 (373)
T 2x4f_A 175 DRIIDES----YNLTELDTILFMKQICEGIRHMHQMYIL--HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN 248 (373)
T ss_dssp HHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCC
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--cccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccc
Confidence 9887532 3589999999999999999999999955 99999999999 56788999999999876543 234
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+++.|+|||++.+..++.++|||||||++|||++|+.||... +....+..+....+... . .....
T Consensus 249 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~------~~~~~~~~i~~~~~~~~--~------~~~~~ 314 (373)
T 2x4f_A 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD------NDAETLNNILACRWDLE--D------EEFQD 314 (373)
T ss_dssp CSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCCCSC--S------GGGTT
T ss_pred cCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhccCCCC--h------hhhcc
Confidence 5788899999999989999999999999999999999999643 22233333333322110 0 01112
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||+.||++|||+.|++++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 23568889999999999999999999885
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.06 Aligned_cols=241 Identities=21% Similarity=0.290 Sum_probs=192.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|... +++.||||++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+++++
T Consensus 12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~ 91 (323)
T 3tki_A 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91 (323)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence 468999999999999865 789999999865432 23568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC------C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP------S 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~------~ 472 (606)
|.+++... ..+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++.... .
T Consensus 92 L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~giv--H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 92 LFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIGIT--HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp GGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 99999743 3589999999999999999999999966 999999999999999999999999975432 1
Q ss_pred CCCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 STPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....++..|+|||++.+..+ +.++||||||+++|||++|+.||....... .. .......... ..
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~-~~~~~~~~~~----------~~ 229 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QE-YSDWKEKKTY----------LN 229 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS----HH-HHHHHTTCTT----------ST
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH----HH-HHHHhccccc----------CC
Confidence 24567888999999987765 778999999999999999999997532211 11 1111111100 00
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112233467789999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=342.61 Aligned_cols=251 Identities=26% Similarity=0.405 Sum_probs=192.9
Q ss_pred hcccccCCceEEEEEEEc--C--CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEe-CCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE--M--GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYS-RDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|+.. + +..||||.++.... ..+.+.+|+.++++++||||++++++|.. ++..++||||+
T Consensus 94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~ 173 (373)
T 3c1x_A 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173 (373)
T ss_dssp EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence 467999999999999853 2 34689999875432 34679999999999999999999999764 45789999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++|+|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++.....
T Consensus 174 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 174 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKKFV--HRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTCCEEECCC-----------
T ss_pred CCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCEe--cCccchheEEECCCCCEEEeecccccccccccc
Confidence 9999999997532 3578999999999999999999999966 9999999999999999999999999755322
Q ss_pred ------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 ------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 ------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....++..|+|||++.+..++.++||||||+++|||++ |.+||...... .... .+..... .
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~---~~~~~~~-~----- 315 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITV---YLLQGRR-L----- 315 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHH---HHHTTCC-C-----
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHH---HHHcCCC-C-----
Confidence 12234567999999998899999999999999999999 67777643221 1211 1111110 0
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
..+..++..+.+++.+||+.+|++|||+.+++++|+++.......
T Consensus 316 -----~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 316 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 011223356889999999999999999999999999998765543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.62 Aligned_cols=238 Identities=19% Similarity=0.212 Sum_probs=198.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +|+.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus 46 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 125 (350)
T 1rdq_E 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence 467999999999999864 68999999996542 2346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STP 475 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~ 475 (606)
|+|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++..... ...
T Consensus 126 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~ 198 (350)
T 1rdq_E 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLI--YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--cccCccceEEECCCCCEEEcccccceeccCCcccc
Confidence 99999998542 489999999999999999999999966 9999999999999999999999999866543 345
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+|+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+...... .+..
T Consensus 199 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~~------------~p~~ 260 (350)
T 1rdq_E 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD------QPIQIYEKIVSGKVR------------FPSH 260 (350)
T ss_dssp EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------CCTT
T ss_pred cCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC------CHHHHHHHHHcCCCC------------CCCC
Confidence 6788899999999999999999999999999999999999642 222333333322110 0112
Q ss_pred HHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
....+.+++.+||+.||++||+ ++||.++
T Consensus 261 ~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 2356788999999999999998 8888765
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=338.09 Aligned_cols=241 Identities=25% Similarity=0.390 Sum_probs=197.2
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||.||+|+. .+|+.||||++...... .+.+.+|++++++++||||+++++++...+..++||||+.
T Consensus 58 ~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 137 (348)
T 1u5q_A 58 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137 (348)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred eeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC
Confidence 356899999999999985 57899999999754322 2468899999999999999999999999999999999997
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP 475 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 475 (606)
|+|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++........
T Consensus 138 -g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 210 (348)
T 1u5q_A 138 -GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHNMI--HRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF 210 (348)
T ss_dssp -EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCC
T ss_pred -CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCee--eCCCCHHHEEECCCCCEEEeeccCceecCCCCcc
Confidence 58888876432 3589999999999999999999999966 9999999999999999999999999887776677
Q ss_pred CCcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 476 NRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 476 ~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
.+++.|+|||++. ...++.++|||||||++|||++|+.||... +....+..+..... ... .
T Consensus 211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~------~~~~~~~~~~~~~~-~~~---------~ 274 (348)
T 1u5q_A 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNES-PAL---------Q 274 (348)
T ss_dssp CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCC-CCC---------C
T ss_pred cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC------ChHHHHHHHHhcCC-CCC---------C
Confidence 8899999999984 567899999999999999999999999642 12222222222211 100 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.+|++|||+.+++++
T Consensus 275 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223457889999999999999999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.43 Aligned_cols=265 Identities=20% Similarity=0.222 Sum_probs=206.3
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEE-EeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY-YSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~~~g~ 398 (606)
..+.||+|+||.||+|+. .+++.||||++.... ....+.+|+++++.++|++++..++++ ......++||||+ +++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~ 90 (296)
T 4hgt_A 13 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPS 90 (296)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCC
Confidence 357899999999999985 578999999875532 223578899999999999888877766 4567789999999 889
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe---cCCCcEEEeecccCccCCCC---
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL---SKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~--- 472 (606)
|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||+ +.++.+||+|||+++.....
T Consensus 91 L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iv--H~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~ 164 (296)
T 4hgt_A 91 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKNFI--HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp HHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred HHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence 999997532 3589999999999999999999999965 99999999999 78899999999999765432
Q ss_pred --------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 --------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 --------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
....++..|+|||.+.+..++.++||||||+++|||++|+.||..............+. ...... .
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~~~~---~ 238 (296)
T 4hgt_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS---EKKMST---P 238 (296)
T ss_dssp CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH---HHHHHS---C
T ss_pred ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh---cccccc---h
Confidence 23456778999999999999999999999999999999999998654333222222111 111000 0
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc-CCCCcccc
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ-GQAHDLEN 603 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~-~~~~~~~~ 603 (606)
.... ....+..+.+++.+||+.+|++|||+.+|++.|+++.+..... ..+.|||.
T Consensus 239 ~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 239 IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp HHHH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred hhhh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 0000 0112356889999999999999999999999999998776554 56678875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=334.44 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=199.7
Q ss_pred hcccccCCceEEEEEEEcC-----CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLEM-----GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|.... +..||||+++.... ....+.+|+.++++++||||+++++++......++||||+
T Consensus 49 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 128 (333)
T 1mqb_A 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128 (333)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCC
Confidence 4789999999999998542 34699999976432 2456889999999999999999999999889999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
++++|.+++.... ..+++..+..++.||+.||+|||++|++ ||||||+||+++.++.+||+|||+++......
T Consensus 129 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 129 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMNYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred CCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--CCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 9999999997532 3589999999999999999999999966 99999999999999999999999997654321
Q ss_pred ------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 ------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 ------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
...++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+......
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~------~~~~~~~~~~~~~~------- 269 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS------NHEVMKAINDGFRL------- 269 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTTCCC-------
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC------HHHHHHHHHCCCcC-------
Confidence 1123557999999998899999999999999999999 999996432 12222222211110
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccCCC
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQA 598 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~~~ 598 (606)
..+......+.+++.+||+.+|++||++.++++.|+++.+........
T Consensus 270 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~~ 317 (333)
T 1mqb_A 270 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 317 (333)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGSB
T ss_pred ----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhhh
Confidence 111223456889999999999999999999999999998665544333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=326.18 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=198.0
Q ss_pred hcccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCce-EEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEK-LLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv~e~~ 394 (606)
.++||+|+||.||+|+.. ++..||+|++..... ..+.+.+|+.++++++||||+++++++...+.. ++||||+
T Consensus 26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 105 (298)
T 3pls_A 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM 105 (298)
T ss_dssp EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence 478999999999999853 234799999975433 236788999999999999999999999876655 9999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC---
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--- 471 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 471 (606)
.+++|.+++.... ..+++..+..++.|++.||+|||++|++ ||||||+||+++.++.+||+|||+++....
T Consensus 106 ~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~--H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 106 CHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQKFV--HRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred cCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 9999999997532 3588999999999999999999999966 999999999999999999999999975432
Q ss_pred -----CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 472 -----SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 472 -----~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+.... +.......+.... ..
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~-----~~~~~~~~~~~~~-~~------ 247 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-----DPFDLTHFLAQGR-RL------ 247 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-----CGGGHHHHHHTTC-CC------
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccC-----CHHHHHHHhhcCC-CC------
Confidence 123345677999999999999999999999999999999655543211 1111111111111 00
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
..+......+.+++.+||+.+|++|||+.++++.|+++......
T Consensus 248 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 248 ----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11112335688999999999999999999999999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.09 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=192.8
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEe-----CCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS-----RDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. +++.||||++............|+..+..++||||+++++++.. ....++||||+++
T Consensus 18 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 96 (336)
T 3g2f_A 18 LELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN 96 (336)
T ss_dssp EEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTT
T ss_pred eeecccCCCeEEEEEEE-CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCC
Confidence 46799999999999987 48999999997543222223334444556899999999987653 2256899999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK---------GPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
|+|.+++... ..++..+..++.||+.||+|||+. +++ ||||||+|||++.++.+||+|||+++
T Consensus 97 g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~iv--H~Dikp~Nill~~~~~~kL~DFG~a~ 168 (336)
T 3g2f_A 97 GSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS--HRDLNSRNVLVKNDGTCVISDFGLSM 168 (336)
T ss_dssp CBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEE--CSSCSGGGEEECTTSCEEECCCTTCE
T ss_pred CcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhcccccccccee--ecccccceEEEcCCCcEEEeecccee
Confidence 9999999753 358899999999999999999999 855 99999999999999999999999997
Q ss_pred cCCCC------------CCCCCcccccCccccCC-------CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCCh--
Q 037905 468 LASPS------------STPNRIDGYRAPEVTDA-------RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDL-- 526 (606)
Q Consensus 468 ~~~~~------------~~~~~~~~y~aPE~~~~-------~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~-- 526 (606)
..... ....+|..|+|||++.+ ..++.++|||||||++|||++|..||...........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 248 (336)
T 3g2f_A 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248 (336)
T ss_dssp ECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTT
T ss_pred ecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhh
Confidence 65321 12347788999999987 4567789999999999999999877643222111100
Q ss_pred ---------hHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 527 ---------PRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 527 ---------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
................+.. ...........+.+++.+||+.||++|||++|+++.|+++.......
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 249 QTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 0001111111100000000 11122345667999999999999999999999999999998776654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=328.51 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=193.0
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+..+|+.||+|++..... ..+.+.+|++++++++||||+++++++...+..++||||+++ +
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (288)
T 1ob3_A 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-D 85 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred hhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-C
Confidence 467999999999999988899999999975433 236788999999999999999999999999999999999986 9
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++.... ..+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++..... ..
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 86 LKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRRVL--HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp HHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred HHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 999987542 3588999999999999999999999966 9999999999999999999999998754322 23
Q ss_pred CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc---c----cc----ccc
Q 037905 475 PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE---E----WT----AEV 542 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~----~~----~~~ 542 (606)
..++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ...+..+... . +. ...
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHHCCCChhhchhhhcccc
Confidence 356788999999876 4589999999999999999999999965321 1111111110 0 00 000
Q ss_pred cchhhhcc------cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLRY------QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~~------~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.++..... .........+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 01000000 0011233567889999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.64 Aligned_cols=245 Identities=21% Similarity=0.326 Sum_probs=194.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC----HHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS----EKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. +++.||+|+++..... .+.+.+|..++.++ +||||+++++++.+....++||||++
T Consensus 14 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~ 93 (345)
T 3a8x_A 14 LRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 93 (345)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999964 6899999999765332 34578899999887 89999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
+|+|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++....
T Consensus 94 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~ 166 (345)
T 3a8x_A 94 GGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGII--YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 166 (345)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCce--ecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence 999999997542 589999999999999999999999966 999999999999999999999999986432
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCC--ChhHHHHHHhhccccccccchhhhc
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGV--DLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||......... .....+...+.....
T Consensus 167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~---------- 236 (345)
T 3a8x_A 167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---------- 236 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC----------
T ss_pred ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC----------
Confidence 23456788899999999999999999999999999999999999653221110 111111111111110
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCH------HHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSM------AEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~------~~v~~~ 584 (606)
..+......+.+++.+||+.||++||++ .|++++
T Consensus 237 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 237 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 0111223467889999999999999996 566654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=334.15 Aligned_cols=238 Identities=22% Similarity=0.303 Sum_probs=189.0
Q ss_pred hcccccCCceEEEEEEE----cCCcEEEEEEeccCcc-----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTV-----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
.+.||+|+||.||+++. .+|+.||+|+++.... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 101 (327)
T 3a62_A 22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101 (327)
T ss_dssp EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence 57899999999999986 4789999999976432 23457889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~iv--H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 102 YLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKGII--YRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred CCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEE--cccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 999999999997543 588999999999999999999999966 9999999999999999999999998754322
Q ss_pred ----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 473 ----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 473 ----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
....++..|+|||++.+..++.++||||||+++|||++|+.||... +.......+.....
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~------~~~~~~~~i~~~~~---------- 238 (327)
T 3a62_A 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE------NRKKTIDKILKCKL---------- 238 (327)
T ss_dssp ----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCC----------
T ss_pred CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCCC----------
Confidence 2345788899999999989999999999999999999999999642 22223333332211
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
..+......+.+++.+||+.||++|| ++.+++++
T Consensus 239 --~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 239 --NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred --CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 01112235678899999999999999 77788765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=339.75 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=194.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. +|+.||||+++... .....+..|..++..+ +||||+++++++.+....++||||++
T Consensus 22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 101 (345)
T 1xjd_A 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 101 (345)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence 478999999999999964 68999999997542 2445678888888766 89999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
+|+|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 102 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 174 (345)
T 1xjd_A 102 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKGIV--YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 174 (345)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeE--eCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence 999999997542 589999999999999999999999966 999999999999999999999999986432
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+......
T Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~~------------ 236 (345)
T 1xjd_A 175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ------DEEELFHSIRMDNPF------------ 236 (345)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------
T ss_pred ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC------CHHHHHHHHHhCCCC------------
Confidence 23456788899999999999999999999999999999999999642 222223333222110
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMA-EVTS 583 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v~~ 583 (606)
.+......+.+++.+||..||++||++. +|.+
T Consensus 237 ~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 0111234678889999999999999997 6654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=332.55 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=198.8
Q ss_pred hcccccCCceEEEEEEE-----cCCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 392 (606)
.+.||+|+||.||+|++ .+++.||||+++... ...+.+.+|++++++++||||+++++++... ...++|||
T Consensus 26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 105 (302)
T 4e5w_A 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105 (302)
T ss_dssp EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence 57899999999999984 468999999997543 2457799999999999999999999999876 66899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 106 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 106 FLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQYV--HRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp CCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred eCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCCcc--cCCCchheEEEcCCCCEEECcccccccccCC
Confidence 999999999996543 3589999999999999999999999966 9999999999999999999999999765442
Q ss_pred C-------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccccccc--------CCCChhHHHHHHhhcc
Q 037905 473 S-------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNE--------EGVDLPRWVQSVVKEE 537 (606)
Q Consensus 473 ~-------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 537 (606)
. ...++..|+|||++.+..++.++||||||+++|||++|+.|+...... ........+.......
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEG 259 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTT
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhcc
Confidence 2 234556699999998888999999999999999999999987542110 0000000111111111
Q ss_pred ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 538 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
. ....+......+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 260 ~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~ 302 (302)
T 4e5w_A 260 K----------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302 (302)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred C----------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 0 011122334578899999999999999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=344.76 Aligned_cols=257 Identities=22% Similarity=0.299 Sum_probs=194.8
Q ss_pred HhcccccC--CceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 321 SAEVLGKG--TFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
..+.||+| +||.||+|+.. +|+.||||++...... .+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 29 ~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 108 (389)
T 3gni_B 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108 (389)
T ss_dssp EEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEcc
Confidence 35789999 99999999965 6999999999765433 356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC---
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--- 471 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 471 (606)
++++|.+++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||.+.....
T Consensus 109 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~iv--HrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~ 183 (389)
T 3gni_B 109 AYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMGYV--HRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183 (389)
T ss_dssp TTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred CCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence 9999999997643 23589999999999999999999999965 999999999999999999999998753211
Q ss_pred --------CCCCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc----
Q 037905 472 --------SSTPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE---- 537 (606)
Q Consensus 472 --------~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 537 (606)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .+...+.......
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 261 (389)
T 3gni_B 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTS 261 (389)
T ss_dssp ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC------------
T ss_pred cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCcccccc
Confidence 122356777999999987 679999999999999999999999997532211 0000000000000
Q ss_pred ------------------ccccccc--------hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 ------------------WTAEVFD--------LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ------------------~~~~~~d--------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....... ...............+.+++.+||+.||++|||+.|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 262 TIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000 0000001112234568899999999999999999999876
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=337.62 Aligned_cols=242 Identities=21% Similarity=0.298 Sum_probs=183.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|+.. +++.||||+++... ..+.+.+|++++++++||||++++++|......++||||+++++|.
T Consensus 58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 136 (349)
T 2w4o_A 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF 136 (349)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHH
Confidence 568999999999999975 57899999997643 4567889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCccCCCC---CC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHLASPS---ST 474 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~---~~ 474 (606)
+++... ..+++..+..++.|++.||+|||+.+++ ||||||+|||++. ++.+||+|||+++..... ..
T Consensus 137 ~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~iv--H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 209 (349)
T 2w4o_A 137 DRIVEK-----GYYSERDAADAVKQILEAVAYLHENGIV--HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT 209 (349)
T ss_dssp HHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEESSSSTTCCEEECCCC-------------
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeE--ecCCCcccEEEecCCCCCCEEEccCccccccCccccccc
Confidence 999753 2589999999999999999999999966 9999999999975 889999999999865442 23
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+++.|+|||++.+..++.++|||||||++|||++|+.||..... .......+....... .. +...
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~i~~~~~~~--~~------~~~~ 276 (349)
T 2w4o_A 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-----DQFMFRRILNCEYYF--IS------PWWD 276 (349)
T ss_dssp ---CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-----HHHHHHHHHTTCCCC--CT------TTTT
T ss_pred ccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-----cHHHHHHHHhCCCcc--CC------chhh
Confidence 4567889999999998999999999999999999999999964221 111222222221110 00 1112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+.+++.+||+.||++|||+.|++++
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234568889999999999999999999875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=327.89 Aligned_cols=248 Identities=28% Similarity=0.424 Sum_probs=189.5
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+.. ..||||+++..... .+.+.+|++++++++||||+++++++ .....++||||+++++
T Consensus 29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~ 105 (289)
T 3og7_A 29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS 105 (289)
T ss_dssp EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence 578999999999999864 35999999765433 35689999999999999999999965 5567899999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC------
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS------ 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------ 472 (606)
|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 106 L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~i~--H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 106 LYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKSII--HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp HHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--cccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 999997532 3589999999999999999999999966 9999999999999999999999998754421
Q ss_pred CCCCCcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 STPNRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
....++..|+|||.+. +..++.++||||||+++|||++|+.||..... ...+..............
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~----- 248 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIEMVGRGSLSPDLS----- 248 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC------HHHHHHHHHHTSCCCCTT-----
T ss_pred cccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch------HHHHHHHhcccccCcchh-----
Confidence 2235678899999986 56788899999999999999999999965321 111222222211111000
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
.....++..+.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 249 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 249 -KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0112334678899999999999999999999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.03 Aligned_cols=256 Identities=22% Similarity=0.381 Sum_probs=202.5
Q ss_pred HhcccccCCceEEEEEEE--------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEE
Q 037905 321 SAEVLGKGTFGTAYKATL--------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 389 (606)
..+.||+|+||.||+|+. .++..||||+++.... ..+.+.+|+++++++ +||||+++++++...+..++
T Consensus 39 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 118 (334)
T 2pvf_A 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYV 118 (334)
T ss_dssp EEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEE
T ss_pred EeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEE
Confidence 357899999999999986 3467899999976432 235688999999999 89999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcE
Q 037905 390 VHDYMPMGSLSALLHGNRGA-----------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEA 458 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~ 458 (606)
||||+++++|.+++...... ....+++..+..++.||+.||+|||+++++ ||||||+||+++.++.+
T Consensus 119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~ 196 (334)
T 2pvf_A 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCI--HRDLAARNVLVTENNVM 196 (334)
T ss_dssp EEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCE
T ss_pred EEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCee--CCCCccceEEEcCCCCE
Confidence 99999999999999864321 123489999999999999999999999965 99999999999999999
Q ss_pred EEeecccCccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHH
Q 037905 459 RISDFGLAHLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQ 531 (606)
Q Consensus 459 kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (606)
||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ......
T Consensus 197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~ 270 (334)
T 2pvf_A 197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------VEELFK 270 (334)
T ss_dssp EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHH
T ss_pred EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC------HHHHHH
Confidence 99999999765432 12234567999999988889999999999999999999 999996432 222222
Q ss_pred HHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 532 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
.+... ... ..+......+.+++.+||+.+|++|||+.+++++|+++.......
T Consensus 271 ~~~~~-~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 271 LLKEG-HRM----------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp HHHHT-CCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HHhcC-CCC----------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 22111 111 111223456889999999999999999999999999998655443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=330.16 Aligned_cols=253 Identities=22% Similarity=0.365 Sum_probs=193.3
Q ss_pred HHhcccccCCceEEEEEEEc----CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCC-----ce
Q 037905 320 ASAEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRD-----EK 387 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 387 (606)
...+.||+|+||.||+|+.. ++..||+|+++..... .+.+.+|+.++++++||||+++++++.... ..
T Consensus 37 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 116 (313)
T 3brb_A 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKP 116 (313)
T ss_dssp EEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CE
T ss_pred eeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCccc
Confidence 34578999999999999753 3568999999765433 356889999999999999999999998654 34
Q ss_pred EEEEeecCCCChhhhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 388 LLVHDYMPMGSLSALLHGNRG-AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
++||||+++++|.+++..... .....+++..+..++.||+.||.|||+++++ ||||||+||+++.++.+||+|||++
T Consensus 117 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~dikp~NIli~~~~~~kl~Dfg~~ 194 (313)
T 3brb_A 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFL--HRDLAARNCMLRDDMTVCVADFGLS 194 (313)
T ss_dssp EEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCC--CCCCSGGGEEECTTSCEEECSCSCC
T ss_pred EEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCcceEEEcCCCcEEEeecCcc
Confidence 999999999999999854321 1234689999999999999999999999966 9999999999999999999999999
Q ss_pred ccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 467 HLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 467 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
+..... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .......... .
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~~-~ 267 (313)
T 3brb_A 195 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH------EMYDYLLHGH-R 267 (313)
T ss_dssp ----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG------GHHHHHHTTC-C
T ss_pred eecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHHcCC-C
Confidence 765432 12334567999999999899999999999999999999 88998653221 1122221111 1
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
. ..+......+.+++.+||..+|++|||+.+++++|+++.+.
T Consensus 268 ~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 268 L----------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp C----------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C----------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0 11122345688999999999999999999999999999764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.16 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=199.8
Q ss_pred ccccCCceEEEEEEE---cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 324 VLGKGTFGTAYKATL---EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.||+|+||.||+|.. .+++.||||+++.... ..+.+.+|+++++.++||||+++++++ ..+..++||||++++
T Consensus 24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 102 (291)
T 1xbb_A 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG 102 (291)
T ss_dssp EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence 799999999999964 3478999999976432 246789999999999999999999999 567789999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC---
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST--- 474 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~--- 474 (606)
+|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.......
T Consensus 103 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~--H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 175 (291)
T 1xbb_A 103 PLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFV--HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175 (291)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCCeE--cCCCCcceEEEeCCCcEEEccCCcceeeccCCCccc
Confidence 9999998542 589999999999999999999999966 999999999999999999999999976543221
Q ss_pred ----CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 475 ----PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 475 ----~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
..++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ...... .......
T Consensus 176 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~-~~~~~~~--------- 239 (291)
T 1xbb_A 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAM-LEKGERM--------- 239 (291)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHH-HHTTCCC---------
T ss_pred ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHHH-HHcCCCC---------
Confidence 233467999999988889999999999999999999 9999965321 111211 1111111
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccCC
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~~ 597 (606)
..+......+.+++.+||+.||++|||+.++++.|+++........+
T Consensus 240 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~ 286 (291)
T 1xbb_A 240 -GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286 (291)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhhccc
Confidence 11122345688999999999999999999999999999876655433
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=340.14 Aligned_cols=240 Identities=23% Similarity=0.307 Sum_probs=195.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+++++.++||||++++++|.+....++||||+.+
T Consensus 20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g 99 (384)
T 4fr4_A 20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG 99 (384)
T ss_dssp EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence 578999999999999864 58999999986532 2346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
|+|.+++... ..+++..+..++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 100 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~giv--HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 172 (384)
T 4fr4_A 100 GDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQRII--HRDMKPDNILLDEHGHVHITDFNIAAMLPRETQIT 172 (384)
T ss_dssp EEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCce--eccCcHHHeEECCCCCEEEeccceeeeccCCCcee
Confidence 9999999853 3589999999999999999999999966 9999999999999999999999999865432 3
Q ss_pred CCCCcccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 474 TPNRIDGYRAPEVTDA---RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
...+|+.|+|||++.. ..|+.++|||||||++|||++|+.||...... ............. .
T Consensus 173 ~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~~~~~~~~~------------~ 237 (384)
T 4fr4_A 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST---SSKEIVHTFETTV------------V 237 (384)
T ss_dssp CCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS---CHHHHHHHHHHCC------------C
T ss_pred ccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc---cHHHHHHHHhhcc------------c
Confidence 4567888999999864 45899999999999999999999999643221 2222222221111 0
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCC-HHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPS-MAEVTS 583 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-~~~v~~ 583 (606)
..+......+.+++.+||+.||++||+ +++|.+
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111223456889999999999999998 666655
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=328.85 Aligned_cols=248 Identities=28% Similarity=0.421 Sum_probs=194.9
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeC-CceEEEEeecCCCCh
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR-DEKLLVHDYMPMGSL 399 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~g~L 399 (606)
..+.||+|+||.||+++.. |+.||||+++... ..+.+.+|++++++++||||+++++++... +..++||||+++++|
T Consensus 25 ~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred EEeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 3578999999999999875 8899999997643 457799999999999999999999997654 478999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCCCCc
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STPNRI 478 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~ 478 (606)
.+++.... ...+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++..... ....++
T Consensus 103 ~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 177 (278)
T 1byg_A 103 VDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFV--HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177 (278)
T ss_dssp HHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred HHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCCcc--ccCCCcceEEEeCCCcEEEeeccccccccccccCCCcc
Confidence 99997542 12378899999999999999999999966 9999999999999999999999998765442 233456
Q ss_pred ccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHH
Q 037905 479 DGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEM 557 (606)
Q Consensus 479 ~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 557 (606)
..|+|||.+.+..++.++||||||+++|||++ |+.||..... ......+. ..... ..+....
T Consensus 178 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~-~~~~~----------~~~~~~~ 240 (278)
T 1byg_A 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVE-KGYKM----------DAPDGCP 240 (278)
T ss_dssp TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG------GGHHHHHT-TTCCC----------CCCTTCC
T ss_pred ccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHh-cCCCC----------CCcccCC
Confidence 77999999988889999999999999999998 9999965321 11222221 11111 1112234
Q ss_pred HHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 558 VQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 558 ~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
..+.+++.+||+.||++|||+.++++.|+++....
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 56889999999999999999999999999997654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.27 Aligned_cols=238 Identities=22% Similarity=0.281 Sum_probs=196.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. +|+.||||+++... ...+.+..|..++..+ +||||+++++++.+.+..++||||++
T Consensus 25 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~ 104 (353)
T 2i0e_A 25 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 104 (353)
T ss_dssp EEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCC
Confidence 468999999999999975 47899999997542 2356688899999887 89999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
+|+|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 105 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~giv--HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 177 (353)
T 2i0e_A 105 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKGII--YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177 (353)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEE--eccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence 999999997542 589999999999999999999999966 999999999999999999999999986432
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+......
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~~------------ 239 (353)
T 2i0e_A 178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELFQSIMEHNVA------------ 239 (353)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------
T ss_pred cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC------CHHHHHHHHHhCCCC------------
Confidence 23456788899999999999999999999999999999999999642 222333333332211
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
.+......+.+++.+||..||++||+ +++|.++
T Consensus 240 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 240 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01122346788999999999999995 5777655
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=336.20 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=201.6
Q ss_pred hcccccCCceEEEEEEEc-----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeC--CceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLE-----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSR--DEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 392 (606)
.+.||+|+||.||++.+. +++.||||+++.... ..+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus 36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 115 (318)
T 3lxp_A 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115 (318)
T ss_dssp EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence 578999999999998642 689999999986532 245689999999999999999999999874 56799999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++... .+++..+..++.|++.||+|||+.+++ ||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~iv--H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 116 YVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQHYI--HRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp CCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred cccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCCcc--CCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999753 389999999999999999999999965 9999999999999999999999999866542
Q ss_pred C-------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC----CCC--hhH--HHHHHhhcc
Q 037905 473 S-------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE----GVD--LPR--WVQSVVKEE 537 (606)
Q Consensus 473 ~-------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~----~~~--~~~--~~~~~~~~~ 537 (606)
. ...++..|+|||++.+..++.++||||||+++|||++|+.||....... ... ... .+.......
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 2 2345566999999998889999999999999999999999997532110 000 000 001111111
Q ss_pred ccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 538 WTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 538 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
. ....+......+.+++.+||+.||++|||+.++++.|+.+.+...
T Consensus 268 ~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 268 E----------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred c----------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 0 111123344678999999999999999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=337.24 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=194.5
Q ss_pred hcccccCCceEEEEEEEc-CCc----EEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGI----VVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|+.. +++ +||+|.+.... .....+.+|+.++++++||||+++++++. ....++||||+
T Consensus 18 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 96 (325)
T 3kex_A 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYL 96 (325)
T ss_dssp EEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECC
T ss_pred eeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeC
Confidence 578999999999999853 344 37888875432 22356778999999999999999999885 56789999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
.+|+|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 97 ~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 97 PLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHGMV--HRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp TTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTTCC--CSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred CCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCCCC--CCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 9999999997542 3588899999999999999999999966 99999999999999999999999998764322
Q ss_pred -----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 -----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 -----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...++..|+|||++.+..++.++||||||+++|||++ |+.||...... .... ........
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~~~------- 236 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA------EVPD-LLEKGERL------- 236 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT------HHHH-HHHTTCBC-------
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH------HHHH-HHHcCCCC-------
Confidence 2234567999999998899999999999999999999 99999753211 1111 11111110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
..+..+...+.+++.+||..||++|||+.+++++|+++.+.
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 237 ---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00111233577899999999999999999999999999754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=343.90 Aligned_cols=190 Identities=24% Similarity=0.356 Sum_probs=168.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCC-----CCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-----HENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+. .+++.||||+++......+.+..|+++++.++ ||||+++++++...+..++||||+
T Consensus 40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~- 118 (360)
T 3llt_A 40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL- 118 (360)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence 57899999999999986 46899999999765555667788999988886 999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---------------------
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK--------------------- 454 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~--------------------- 454 (606)
+++|.+++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.
T Consensus 119 ~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iv--HrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~ 193 (360)
T 3llt_A 119 GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMSLT--HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193 (360)
T ss_dssp CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--eCCCCcccEEEccccccccccchhcccccccccc
Confidence 889999998643 23589999999999999999999999966 9999999999975
Q ss_pred ----CCcEEEeecccCccCCC-CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 455 ----SYEARISDFGLAHLASP-SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 455 ----~~~~kl~DfG~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
++.+||+|||+++.... .....++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 194 ~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp EEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 78899999999986544 3345678889999999999999999999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=363.83 Aligned_cols=244 Identities=25% Similarity=0.335 Sum_probs=198.3
Q ss_pred cccccCCceEEEEEEEc---CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|.+. .++.||||+++.... ..+++.+|++++++++||||++++++|. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 468899999976433 3578999999999999999999999986 4568899999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|+|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~ii--HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESNFV--HRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--CCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999753 2589999999999999999999999966 99999999999999999999999997654322
Q ss_pred ----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 474 ----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 474 ----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
...++..|+|||++.+..++.++|||||||++|||++ |+.||..... ...... +..+...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~------~~~~~~-i~~~~~~-------- 591 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAM-LEKGERM-------- 591 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHH-HHTTCCC--------
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH-HHcCCCC--------
Confidence 1233466999999998899999999999999999999 9999965322 122222 2222111
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
..+..++..+.++|.+||+.||++|||+.+|++.|+++..+
T Consensus 592 --~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 592 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11223446788999999999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=327.36 Aligned_cols=251 Identities=22% Similarity=0.260 Sum_probs=191.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|+.. +++.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 7 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 85 (292)
T 3o0g_A 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred eeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-
Confidence 467999999999999864 6899999999754332 36788999999999999999999999999999999999986
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
++.+.+.... ..+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 86 ~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~iv--H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 86 DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRNVL--HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 6666555422 3589999999999999999999999966 9999999999999999999999999765432 2
Q ss_pred CCCCcccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc------ccc---
Q 037905 474 TPNRIDGYRAPEVTDARK-VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA------EVF--- 543 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~--- 543 (606)
...++..|+|||++.+.. ++.++|||||||++|||++|..||... .+....+..+....... ...
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~-----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-----NDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC-----SSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC-----CCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 345678899999997765 899999999999999999988886421 12222222221110000 000
Q ss_pred -------ch-hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 -------DL-ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 -------d~-~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+ ..............+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 000000112234567889999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=347.94 Aligned_cols=241 Identities=22% Similarity=0.298 Sum_probs=196.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +++.||+|+++... .....+.+|+.+++.++||||++++++|.+....++||||+++
T Consensus 74 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~g 153 (410)
T 3v8s_A 74 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG 153 (410)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 467999999999999865 58999999996532 1234588999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
|+|.+++... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 154 g~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~giv--HrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 225 (410)
T 3v8s_A 154 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFI--HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225 (410)
T ss_dssp EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred CcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCCeE--eccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence 9999999743 488999999999999999999999965 9999999999999999999999999765542
Q ss_pred -CCCCCcccccCccccCCCC----CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 473 -STPNRIDGYRAPEVTDARK----VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~----~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
....+|+.|+|||++.+.. ++.++|||||||++|||++|+.||... +.......+........
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~~------ 293 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD------SLVGTYSKIMNHKNSLT------ 293 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTHHHHCC------
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC------ChhhHHHHHHhcccccc------
Confidence 2456889999999997655 889999999999999999999999642 23333333332211100
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDN--RPSMAEVTSQ 584 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~v~~~ 584 (606)
.+........+.+++.+||..+|++ ||+++||++|
T Consensus 294 --~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 --FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp --CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred --CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1111122346788888999988988 9999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=326.85 Aligned_cols=250 Identities=27% Similarity=0.409 Sum_probs=196.9
Q ss_pred hcccccCCceEEEEEEEcC----CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEe-CCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLEM----GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYS-RDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|+... +..+|+|.+..... ..+.+.+|+.++++++||||++++++|.. +...++||||+
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~ 109 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence 5789999999999998532 34689999876432 24668899999999999999999999754 45779999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++++|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 110 ~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~i~--H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 110 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKKFV--HRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp TTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCcc--CCCCchheEEECCCCCEEECcccccccccccch
Confidence 9999999997532 3578999999999999999999999966 9999999999999999999999999765331
Q ss_pred ------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 ------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 ------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....++..|+|||.+.+..++.++||||||+++|||++ |.+||...... .. ..........
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~---~~~~~~~~~~------ 251 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DI---TVYLLQGRRL------ 251 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTT---TH---HHHHHTTCCC------
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHH---HH---HHHHhcCCCC------
Confidence 22344567999999998899999999999999999999 55666432211 11 1111111110
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
..+......+.+++.+||+.+|++|||+.++++.|+++......
T Consensus 252 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 252 -----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred -----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 00111234688999999999999999999999999999876544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=339.95 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=198.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|... +|+.||+|++..... ....+.+|+++++.++||||+++++++.+....++||||+++++|
T Consensus 56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L 135 (387)
T 1kob_A 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135 (387)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence 567999999999999864 689999999876432 345789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC--CCcEEEeecccCccCCCCC---C
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK--SYEARISDFGLAHLASPSS---T 474 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~~---~ 474 (606)
.+++.... ..+++..+..++.||+.||+|||++|++ ||||||+|||++. ++.+||+|||+++...... .
T Consensus 136 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giv--HrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~ 209 (387)
T 1kob_A 136 FDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHSIV--HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 209 (387)
T ss_dssp HHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCee--ecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence 99997532 3589999999999999999999999965 9999999999974 4679999999998765432 2
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+|..|+|||++.+..++.++|||||||++|||++|+.||... +....+..+....+.. + .....
T Consensus 210 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~------~~~~~~~~i~~~~~~~---~-----~~~~~ 275 (387)
T 1kob_A 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE------DDLETLQNVKRCDWEF---D-----EDAFS 275 (387)
T ss_dssp ECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHHCCCCC---C-----SSTTT
T ss_pred eccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCC---C-----ccccc
Confidence 35778899999999999999999999999999999999999642 2222333332222111 0 01112
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+.+++.+||..||++|||+.|++++
T Consensus 276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 234568889999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.68 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=199.9
Q ss_pred HhcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 391 (606)
..+.||+|+||.||+|+. .++..||||+++.... ..+.+.+|+.+++++ +||||+++++++...+..++||
T Consensus 49 ~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~ 128 (344)
T 1rjb_A 49 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 128 (344)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred eeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEE
Confidence 357899999999999985 2467899999975432 346789999999999 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec
Q 037905 392 DYMPMGSLSALLHGNRGA------------------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS 453 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~ 453 (606)
||+++|+|.+++...... ....+++..+..++.||+.||+|||++|++ ||||||+|||++
T Consensus 129 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dikp~NIll~ 206 (344)
T 1rjb_A 129 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV--HRDLAARNVLVT 206 (344)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE--ETTCSGGGEEEE
T ss_pred ecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCChhhEEEc
Confidence 999999999999864321 012478999999999999999999999966 999999999999
Q ss_pred CCCcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCCh
Q 037905 454 KSYEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDL 526 (606)
Q Consensus 454 ~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~ 526 (606)
.++.+||+|||+++...... ...++..|+|||.+.+..++.++||||||+++|||+| |+.||.....
T Consensus 207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------ 280 (344)
T 1rjb_A 207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV------ 280 (344)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------
T ss_pred CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc------
Confidence 99999999999997654322 1233557999999988889999999999999999998 9999965321
Q ss_pred hHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 527 PRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 527 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
...+.......... ..+......+.+++.+||+.||++|||+.+|+++|+.+.....
T Consensus 281 ~~~~~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 281 DANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp SHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred HHHHHHHHhcCCCC----------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 11122222222111 1112234568889999999999999999999999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=332.01 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=193.3
Q ss_pred hcccccCCceEEEEEEEc-CCc----EEEEEEeccC--ccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGI----VVAVKRLKDV--TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|... +++ +||+|.+... ....+.+.+|+.++++++||||++++++|... ..++|+||+
T Consensus 20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~~ 98 (327)
T 3lzb_A 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM 98 (327)
T ss_dssp EEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECCC
T ss_pred EEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEec
Confidence 478999999999999853 344 4677877543 23567899999999999999999999999865 478999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
.+|+|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 99 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp SSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCCc--CCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 9999999998643 3589999999999999999999999966 99999999999999999999999998654322
Q ss_pred -----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 -----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 -----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...++..|+|||++.+..++.++||||||+++|||++ |+.||....... .. ........
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~-~~~~~~~~-------- 237 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------IS-SILEKGER-------- 237 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HH-HHHHTTCC--------
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HH-HHHHcCCC--------
Confidence 1234557999999999999999999999999999999 999997532221 11 11111110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
...+......+.+++.+||+.||++|||+.|+++.|+++.+.
T Consensus 238 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 238 --LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 011122344688999999999999999999999999999754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=339.13 Aligned_cols=254 Identities=18% Similarity=0.242 Sum_probs=190.7
Q ss_pred hcccccCCceEEEEEEEc----CCcEEEEEEeccCcc------------CHHHHHHHHHHHcCCCCCCcccceEEEEe--
Q 037905 322 AEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV------------SEKEFREKMEVVGSMDHENLVPLRAYYYS-- 383 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~-- 383 (606)
.+.||+|+||.||+|... ++..+|||++..... ....+.+|+..++.++||||+++++++..
T Consensus 42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~ 121 (345)
T 2v62_A 42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF 121 (345)
T ss_dssp EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence 568999999999999975 578999999875432 11346678889999999999999999987
Q ss_pred --CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC--cEE
Q 037905 384 --RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY--EAR 459 (606)
Q Consensus 384 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~--~~k 459 (606)
....++||||+ +++|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++ .+|
T Consensus 122 ~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 122 KGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENEYV--HGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp SSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEESSSTTSEE
T ss_pred CCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCee--CCCcCHHHEEEccCCCCcEE
Confidence 67889999999 999999997543 589999999999999999999999966 999999999999887 999
Q ss_pred EeecccCccCCCC-----------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhH
Q 037905 460 ISDFGLAHLASPS-----------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 460 l~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~ 528 (606)
|+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||....... ....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP--VAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH--HHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc--HHHH
Confidence 9999999765321 22356778999999999899999999999999999999999996421111 0011
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
........ . +.............+..+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 272 ~~~~~~~~----~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 272 TAKTNLLD----E-LPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHH----T-TTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHhhcc----c-ccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111110 0 011110000001234578899999999999999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=330.44 Aligned_cols=255 Identities=24% Similarity=0.322 Sum_probs=186.8
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..+.||+|+||.||+|.. .+|+.||+|+++.... ..+.+.+|++++++++||||+++++++...+..++||||++ +
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~ 87 (317)
T 2pmi_A 9 QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-N 87 (317)
T ss_dssp ----------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-C
T ss_pred EeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-C
Confidence 457799999999999985 4689999999975432 34678899999999999999999999999999999999998 5
Q ss_pred ChhhhhhcCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 398 SLSALLHGNRG-AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 398 ~L~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
+|.+++..... .....+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv--H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (317)
T 2pmi_A 88 DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKIL--HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165 (317)
T ss_dssp BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCC
T ss_pred CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCee--eCCCChHHeEEcCCCCEEECcCccceecCCCcccC
Confidence 99998865321 1233589999999999999999999999966 9999999999999999999999999765432
Q ss_pred CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc------cccccc---
Q 037905 473 STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------EWTAEV--- 542 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~--- 542 (606)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+..+... ......
T Consensus 166 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~~~~~~~~~~~~ 239 (317)
T 2pmi_A 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE------EQLKLIFDIMGTPNESLWPSVTKL 239 (317)
T ss_dssp CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHHHCSCCTTTCGGGGGC
T ss_pred CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHHhCCCChhHhhhhhhh
Confidence 23456788999999876 46899999999999999999999999653221 111111110 000000
Q ss_pred --cchhh-----------hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 --FDLEL-----------LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 --~d~~~-----------~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+.. ............+.+++.+||+.||++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp TTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00000 0000001223568899999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=347.61 Aligned_cols=238 Identities=24% Similarity=0.365 Sum_probs=197.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +|+.||||++.... .....+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g 100 (476)
T 2y94_A 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100 (476)
T ss_dssp EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 567999999999999865 79999999997542 2346789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
|+|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 101 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~giv--HrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 173 (476)
T 2y94_A 101 GELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHMVV--HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173 (476)
T ss_dssp EEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTTEE--CSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBC
T ss_pred CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCC--cccccHHHEEEecCCCeEEEeccchhhcccccccc
Confidence 9999999753 3589999999999999999999999966 9999999999999999999999999876443 3
Q ss_pred CCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...+++.|+|||++.+..+ +.++|||||||++|||++|+.||... ........+...... .
T Consensus 174 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~------~~~~~~~~i~~~~~~------------~ 235 (476)
T 2y94_A 174 TSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD------HVPTLFKKICDGIFY------------T 235 (476)
T ss_dssp CCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS------SSHHHHHHHHTTCCC------------C
T ss_pred ccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC------CHHHHHHHHhcCCcC------------C
Confidence 4567888999999988766 68999999999999999999999642 223333333222110 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+......+.+++.+||..||++|||+.|++++
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11123457889999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=331.08 Aligned_cols=254 Identities=24% Similarity=0.413 Sum_probs=200.7
Q ss_pred hcccccCCceEEEEEEEc-CCcE--EEEEEeccCc--cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIV--VAVKRLKDVT--VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~--vavK~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. ++.. +|+|+++... ...+.+.+|+++++++ +||||+++++++...+..++||||++
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~ 109 (327)
T 1fvr_A 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 109 (327)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence 578999999999999853 4554 4999987532 2345689999999999 99999999999999999999999999
Q ss_pred CCChhhhhhcCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecc
Q 037905 396 MGSLSALLHGNR-----------GAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464 (606)
Q Consensus 396 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG 464 (606)
+++|.+++.... ......+++..+..++.||+.||+|||+++++ ||||||+||+++.++.+||+|||
T Consensus 110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~dlkp~NIl~~~~~~~kL~Dfg 187 (327)
T 1fvr_A 110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI--HRDLAARNILVGENYVAKIADFG 187 (327)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECGGGCEEECCTT
T ss_pred CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcc--CCCCccceEEEcCCCeEEEcccC
Confidence 999999997542 01124689999999999999999999999966 99999999999999999999999
Q ss_pred cCccCCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 465 LAHLASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 465 ~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
+++..... ....++..|+|||++.+..++.++||||||+++|||++ |+.||... ........+.. +...
T Consensus 188 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~------~~~~~~~~~~~-~~~~ 260 (327)
T 1fvr_A 188 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYEKLPQ-GYRL 260 (327)
T ss_dssp CEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHGGG-TCCC
T ss_pred cCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC------cHHHHHHHhhc-CCCC
Confidence 98754321 22344567999999988889999999999999999998 99999643 22222222211 1110
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
..+......+.+++.+||..+|++|||+.+++++|+++......
T Consensus 261 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 261 ----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred ----------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 11112335688999999999999999999999999999876544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=332.25 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=199.7
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcC--CCCCCcccceEEEEeCC----ceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGS--MDHENLVPLRAYYYSRD----EKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lv~e~~ 394 (606)
..+.||+|+||.||+|+.. |+.||||++... ....+.+|.+++.. ++||||+++++++.... ..++||||+
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~ 122 (342)
T 1b6c_B 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122 (342)
T ss_dssp EEEEEEEETTEEEEEEEET-TEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCC
T ss_pred EEeeecCCCCcEEEEEEEc-CccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeec
Confidence 3578999999999999985 899999999653 35667778887766 79999999999998765 789999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH--------SKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
++|+|.+++... .+++..+..++.|++.||+||| +.+++ ||||||+|||++.++.+||+|||++
T Consensus 123 ~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv--H~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 123 EHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA--HRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp TTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEE--CSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCee--eCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999999743 4899999999999999999999 77755 9999999999999999999999999
Q ss_pred ccCCCC--------CCCCCcccccCccccCCC------CCCCcchhHHHHHHHHHHHhC----------CCCcccccccC
Q 037905 467 HLASPS--------STPNRIDGYRAPEVTDAR------KVSQKADVYSFGVLLLELLTG----------KAPTQALLNEE 522 (606)
Q Consensus 467 ~~~~~~--------~~~~~~~~y~aPE~~~~~------~~~~~sDv~slGvvl~elltg----------~~p~~~~~~~~ 522 (606)
+..... ....++..|+|||++.+. .++.++||||||+++|||++| +.||.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~ 274 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 274 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence 754432 234577889999998775 234689999999999999999 67775432211
Q ss_pred CCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 523 GVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.....+...+.......... ......+....+.+++.+||+.||++|||+.+|+++|+++.++.
T Consensus 275 -~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 275 -PSVEEMRKVVCEQKLRPNIP-----NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp -CCHHHHHHHHTTSCCCCCCC-----GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred -ccHHHHHHHHHHHHhCCCCc-----ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 12222222222221111111 00012356678999999999999999999999999999997654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=327.16 Aligned_cols=256 Identities=19% Similarity=0.329 Sum_probs=195.1
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|.. .+|+.||||+++.... ....+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 116 (310)
T 2wqm_A 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116 (310)
T ss_dssp EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence 57899999999999985 5789999999975322 245688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++..... ....+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 117 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~--H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 193 (310)
T 2wqm_A 117 GDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRRVM--HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA 193 (310)
T ss_dssp CBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTSCEEECCC-------------
T ss_pred CCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCCee--CCCCcHHHEEEcCCCCEEEEeccceeeecCCCccc
Confidence 999999874221 123589999999999999999999999966 9999999999999999999999998765432
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++||||||+++|||++|+.||.... .........+....+.. . .
T Consensus 194 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~-~---------~ 259 (310)
T 2wqm_A 194 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEQCDYPP-L---------P 259 (310)
T ss_dssp -----CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHHHHHTTCSCC-C---------C
T ss_pred cccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hhHHHHHHHhhcccCCC-C---------c
Confidence 22346778999999999899999999999999999999999996421 12222222222211110 0 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
.......+.+++.+||+.||++|||+.+|++.|+++......
T Consensus 260 ~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 260 SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 012234688899999999999999999999999999755444
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=326.91 Aligned_cols=251 Identities=20% Similarity=0.279 Sum_probs=193.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +++.||+|++...... .+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 118 (309)
T 2h34_A 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING 118 (309)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence 578999999999999864 6899999999764332 36688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 119 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 119 VDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAGAT--HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCcCC--cCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 99999998542 589999999999999999999999966 9999999999999999999999998765432
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... ..+......... .+. .
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~----~~~----~ 256 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIP----RPS----T 256 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCC----CGG----G
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCC----Ccc----c
Confidence 233567789999999998999999999999999999999999964221 112222221110 000 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHHHhcccc
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRP-SMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~~~~~ 594 (606)
.....+..+.+++.+||+.||++|| |++++++.|+.+......
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 0112234688899999999999999 999999999988655543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=346.47 Aligned_cols=239 Identities=24% Similarity=0.291 Sum_probs=190.0
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||.||+|+. .+|+.||||+++... .....+.+|+.+++.++||||++++++|...+..++||||++
T Consensus 152 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 231 (446)
T 4ejn_A 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYAN 231 (446)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCS
T ss_pred EeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCC
Confidence 357899999999999985 468999999997532 223457789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 471 (606)
+|+|.+++.... .+++..+..++.||+.||+|||+ .|++ ||||||+|||++.++.+||+|||+++....
T Consensus 232 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~gii--HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 304 (446)
T 4ejn_A 232 GGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVV--YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA 304 (446)
T ss_dssp SCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTCCC--CCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEE--ECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence 999999997543 58999999999999999999998 8866 999999999999999999999999976432
Q ss_pred -CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 472 -SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 472 -~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+......
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~------~~~~~~~~i~~~~~~----------- 367 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHEKLFELILMEEIR----------- 367 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC-----------
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC------CHHHHHHHHHhCCCC-----------
Confidence 23456788899999999999999999999999999999999999642 222233333222210
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
.+......+.+++.+||+.||++|| |++|++++
T Consensus 368 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 368 -FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0111234678899999999999999 99999875
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.00 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=198.8
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
..+.||+|+||.||+|+.. +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 16 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (321)
T 2a2a_A 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILE 95 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEE
Confidence 4678999999999999864 689999999975432 36789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC----cEEEeecccCcc
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY----EARISDFGLAHL 468 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~----~~kl~DfG~a~~ 468 (606)
|+++++|.+++... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++ .+||+|||+++.
T Consensus 96 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~iv--H~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 96 LVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKKIA--HFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp CCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 99999999999753 3589999999999999999999999966 999999999999888 799999999976
Q ss_pred CCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 469 ASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 469 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
.... ....+++.|+|||++.+..++.++||||||+++|||++|+.||.... .......+..... ..++
T Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~---~~~~ 239 (321)
T 2a2a_A 169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------KQETLANITSVSY---DFDE 239 (321)
T ss_dssp CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS------HHHHHHHHHTTCC---CCCH
T ss_pred cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhccc---ccCh
Confidence 6543 23457788999999999999999999999999999999999996421 2222222222111 0111
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. .......+.+++.+||..||++|||+.|++++
T Consensus 240 ~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 240 EF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HH-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hh-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 01123467889999999999999999999875
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=334.87 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=200.2
Q ss_pred hcccccCCceEEEEEEE-----cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|++ .+++.||||++..... ..+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 107 (327)
T 3lxl_A 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY 107 (327)
T ss_dssp EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence 57899999999999984 4689999999976533 34568999999999999999999999874 4568899999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+++++|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 108 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~iv--H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 181 (327)
T 3lxl_A 108 LPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRRCV--HRDLAARNILVESEAHVKIADFGLAKLLPLDK 181 (327)
T ss_dssp CTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEEETTEEEECCGGGCEECCTTC
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCcc--CCCCChhhEEECCCCCEEEcccccceecccCC
Confidence 99999999997532 2589999999999999999999999966 99999999999999999999999998654322
Q ss_pred -------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccC--------CCChhHHHHHHhhccc
Q 037905 474 -------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE--------GVDLPRWVQSVVKEEW 538 (606)
Q Consensus 474 -------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~--------~~~~~~~~~~~~~~~~ 538 (606)
...++..|+|||++.+..++.++||||||+++|||++|+.||....... .......+......+.
T Consensus 182 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3lxl_A 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261 (327)
T ss_dssp SEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred ccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence 2345566999999988889999999999999999999999986532210 0001111111111111
Q ss_pred cccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 539 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
....+......+.+++.+||+.||++|||+.+++++|+.+.....
T Consensus 262 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 262 ----------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred ----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 011122344678899999999999999999999999999865443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=330.29 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=190.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCc----eEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDE----KLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e 392 (606)
.+.||+|+||.||+|+. .+++.||||+++..... ...+.+|++++++++||||+++++++..... .++|||
T Consensus 17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e 96 (311)
T 3ork_A 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence 57899999999999985 57899999999765332 2468899999999999999999999876544 399999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++.....
T Consensus 97 ~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 97 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGII--HRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCC--cCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 999999999997542 589999999999999999999999966 9999999999999999999999999765432
Q ss_pred C-------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 S-------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 ~-------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
. ...++..|+|||++.+..++.++||||||+++|||++|+.||.... .............. .+
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~------~~~~~~~~~~~~~~----~~ 239 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPI----PP 239 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCC----CH
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcCCCC----Cc
Confidence 1 2346788999999999899999999999999999999999996422 22222222222111 11
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHH-HHHHHHHHHh
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAE-VTSQIEEICR 590 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~-v~~~L~~i~~ 590 (606)
.. .. ......+.+++.+||+.||++||++.+ +...+.++..
T Consensus 240 ~~-~~---~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 240 SA-RH---EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HH-HS---TTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cc-cc---CCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 00 00 112356888999999999999996555 5556666543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=331.00 Aligned_cols=257 Identities=24% Similarity=0.364 Sum_probs=202.1
Q ss_pred HhcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCC-ceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRD-EKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lv 390 (606)
..+.||+|+||.||+|+. .+++.||||+++.... ..+.+.+|+.++.++ +||||+++++++...+ ..++|
T Consensus 31 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv 110 (316)
T 2xir_A 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110 (316)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEE
T ss_pred eeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEE
Confidence 357899999999999974 3568999999976533 235688999999999 7999999999987654 48999
Q ss_pred EeecCCCChhhhhhcCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEE
Q 037905 391 HDYMPMGSLSALLHGNRGAG-----------RTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEAR 459 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~k 459 (606)
|||+++++|.+++....... ...+++..+..++.|++.||.|||+++++ ||||||+||+++.++.+|
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~--H~dikp~Nil~~~~~~~k 188 (316)
T 2xir_A 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI--HRDLAARNILLSEKNVVK 188 (316)
T ss_dssp EECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECGGGCEE
T ss_pred EEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcc--cccCccceEEECCCCCEE
Confidence 99999999999998643210 12378999999999999999999999966 999999999999999999
Q ss_pred EeecccCccCCCCCC------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHH
Q 037905 460 ISDFGLAHLASPSST------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQS 532 (606)
Q Consensus 460 l~DfG~a~~~~~~~~------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 532 (606)
|+|||+++....... ..++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...+..
T Consensus 189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~ 262 (316)
T 2xir_A 189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DEEFCR 262 (316)
T ss_dssp ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------SHHHHH
T ss_pred ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch------hHHHHH
Confidence 999999986543322 234567999999988899999999999999999998 9999965321 111212
Q ss_pred HhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 533 VVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 533 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
....+.... .+......+.+++.+||+.+|++|||+.+|+++|+++.+....+
T Consensus 263 ~~~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 315 (316)
T 2xir_A 263 RLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQQ 315 (316)
T ss_dssp HHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred HhccCccCC----------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhccC
Confidence 222211110 11122346888999999999999999999999999998765543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=323.11 Aligned_cols=239 Identities=27% Similarity=0.409 Sum_probs=195.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|... ++..||+|++.... .....+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 93 (279)
T 3fdn_A 14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93 (279)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence 578999999999999864 57899999986532 2346789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--CC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--ST 474 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~ 474 (606)
++|.+++.... .+++..+..++.|++.||+|||+.|++ ||||||+||+++.++.+||+|||++...... ..
T Consensus 94 ~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~i~--H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~ 166 (279)
T 3fdn_A 94 GTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKRVI--HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD 166 (279)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTTCE--ECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEe--cccCChHhEEEcCCCCEEEEeccccccCCcccccc
Confidence 99999997543 589999999999999999999999966 9999999999999999999999988655432 23
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..++..|+|||.+.+..++.++||||||+++|||++|+.||... ........+..... ..+.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~------------~~~~ 228 (279)
T 3fdn_A 167 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQETYKRISRVEF------------TFPD 228 (279)
T ss_dssp -CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCC------------CCCT
T ss_pred cCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC------cHHHHHHHHHhCCC------------CCCC
Confidence 45678899999999999999999999999999999999999642 22222222222111 0111
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.....+.+++.+||+.+|++|||+.|++++-
T Consensus 229 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 229 FVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred cCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 2234678899999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=339.44 Aligned_cols=265 Identities=18% Similarity=0.268 Sum_probs=207.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCC--ceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRD--EKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|++++++++||||+++++++.... ..++||||+++
T Consensus 14 ~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~ 93 (396)
T 4eut_A 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93 (396)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTT
T ss_pred EEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCC
Confidence 567999999999999865 58999999997543 24577889999999999999999999998755 67999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe----cCCCcEEEeecccCccCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL----SKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill----~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+|.+++..... ...+++..+..++.||+.||+|||+++++ ||||||+|||+ +.++.+||+|||+++.....
T Consensus 94 g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~ 169 (396)
T 4eut_A 94 GSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENGIV--HRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169 (396)
T ss_dssp EEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred CCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCEE--ECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence 999999986432 22489999999999999999999999955 99999999999 77788999999999866543
Q ss_pred ---CCCCCcccccCccccCC--------CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 473 ---STPNRIDGYRAPEVTDA--------RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~--------~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... .....+..+........
T Consensus 170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~--~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKIITGKPSGA 247 (396)
T ss_dssp GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTT--TCHHHHHHHHHSCCTTC
T ss_pred CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCccc--chHHHHHHHhcCCCccc
Confidence 23457788999999864 467889999999999999999999997533221 22222333322211000
Q ss_pred ---c-------cc--hhh-hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 542 ---V-------FD--LEL-LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 542 ---~-------~d--~~~-~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
. ++ ... ............+.+++.+||+.||++|||+.|+++.++++....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 0 00 000 011123566778899999999999999999999999999997653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=332.42 Aligned_cols=255 Identities=22% Similarity=0.342 Sum_probs=203.3
Q ss_pred HhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
..+.||+|+||.||+|... .+..||||++..... ....+.+|+.++++++||||+++++++......++|||
T Consensus 29 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 108 (322)
T 1p4o_A 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 108 (322)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEE
Confidence 3578999999999999754 478899999975433 23568899999999999999999999998899999999
Q ss_pred ecCCCChhhhhhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 393 YMPMGSLSALLHGNRG-----AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
|+++++|.+++..... .....+++..+..++.||+.||+|||++|++ ||||||+||+++.++.+||+|||+++
T Consensus 109 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dikp~NIli~~~~~~kl~Dfg~~~ 186 (322)
T 1p4o_A 109 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV--HRDLAARNCMVAEDFTVKIGDFGMTR 186 (322)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB--CSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred eCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCc--cCCCccceEEEcCCCeEEECcCcccc
Confidence 9999999999875321 1123578999999999999999999999966 99999999999999999999999997
Q ss_pred cCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 468 LASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 468 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
...... ...++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~~~~~~~- 259 (322)
T 1p4o_A 187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFVMEGGLL- 259 (322)
T ss_dssp GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHHHHHTTCCC-
T ss_pred ccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------HHHHHHHHHcCCcC-
Confidence 553321 2234567999999988889999999999999999999 899986432 22222222222110
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
..+......+.+++.+||+.+|++|||+.|++++|+++......
T Consensus 260 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~ 303 (322)
T 1p4o_A 260 ----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 303 (322)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence 01122345688899999999999999999999999988655443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.17 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=187.0
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHH-cCCCCCCcccceEEEEe----CCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVV-GSMDHENLVPLRAYYYS----RDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~ 396 (606)
++||+|+||.||++... +|+.||||+++. ...+.+|++++ +..+||||++++++|.. ....++||||+++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g 143 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence 57999999999999864 689999999964 24567788776 44589999999999875 5578999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCccCCCC-
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHLASPS- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~- 472 (606)
|+|.+++.... ...+++..+..++.||+.||+|||+.+++ ||||||+|||++. ++.+||+|||+++.....
T Consensus 144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~iv--HrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIA--HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 99999998643 23589999999999999999999999965 9999999999998 788999999999865432
Q ss_pred --CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 --STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....+|..|+|||++.+..|+.++|||||||++|||++|+.||......... ......+....+.. ..
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~i~~~~~~~--~~------ 288 (400)
T 1nxk_A 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQYEF--PN------ 288 (400)
T ss_dssp --------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHHHHHHHTCCCC--CT------
T ss_pred ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHHHHHHcCcccC--CC------
Confidence 2345678899999999999999999999999999999999999754322110 01111111111100 00
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.........+.+++.+||..||++|||+.|++++-
T Consensus 289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 01122345688899999999999999999999873
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=323.20 Aligned_cols=246 Identities=25% Similarity=0.396 Sum_probs=196.5
Q ss_pred hcccccCCceEEEEEEEcC----CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLEM----GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|.... +..||+|+++.... ..+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 95 (281)
T 3cc6_A 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-EEPTWIIMELYP 95 (281)
T ss_dssp EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCCEEEEecCC
Confidence 5789999999999998542 35699999876432 3467899999999999999999999975 456789999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
+++|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++......
T Consensus 96 ~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 96 YGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESINCV--HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp TCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred CCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 999999997542 3589999999999999999999999966 99999999999999999999999997654322
Q ss_pred ---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 474 ---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 474 ---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
...++..|+|||++.+..++.++||||||+++|||++ |+.||....... .......... .
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~------~~~~~~~~~~-~--------- 233 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------VIGVLEKGDR-L--------- 233 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG------HHHHHHHTCC-C---------
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH------HHHHHhcCCC-C---------
Confidence 2334567999999988889999999999999999998 999996432211 1111111110 0
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
..+......+.+++.+||..+|++|||+.|++++|+++.+.
T Consensus 234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 234 -PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 11112335688999999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=331.31 Aligned_cols=247 Identities=25% Similarity=0.307 Sum_probs=190.7
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCc-cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT-VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
+.||+|+||.||+|.. .+++.||||++.... .....+.+|++++.++ +||||+++++++.+.+..++||||+++++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5699999999999984 468999999997653 3467789999999884 799999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc---EEEeecccCccCCCC----
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE---ARISDFGLAHLASPS---- 472 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~---- 472 (606)
.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++. +||+|||+++.....
T Consensus 99 ~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iv--H~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 99 LSHIHKRR-----HFNELEASVVVQDVASALDFLHNKGIA--HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp HHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred HHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCce--eCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 99997543 589999999999999999999999966 9999999999998776 999999998754321
Q ss_pred -------CCCCCcccccCccccCC-----CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCCh---------hHHHH
Q 037905 473 -------STPNRIDGYRAPEVTDA-----RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDL---------PRWVQ 531 (606)
Q Consensus 473 -------~~~~~~~~y~aPE~~~~-----~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~---------~~~~~ 531 (606)
....++..|+|||++.. ..++.++||||||+++|||++|+.||......+.... .....
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence 12346788999999865 4588999999999999999999999976432211000 00111
Q ss_pred HHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 532 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+..... ..... ........+.+++.+||+.||++|||+.|++++
T Consensus 252 ~i~~~~~--~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 252 SIQEGKY--EFPDK------DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHCCC--CCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhccCc--ccCch------hcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1111110 00000 001123568899999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=334.94 Aligned_cols=265 Identities=16% Similarity=0.150 Sum_probs=203.6
Q ss_pred hcccccCCceEEEEEEEc---------CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCccc---------------c
Q 037905 322 AEVLGKGTFGTAYKATLE---------MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVP---------------L 377 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------------l 377 (606)
.+.||+|+||.||+|+.. +++.||+|++... +.+.+|++++++++||||++ +
T Consensus 47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~ 122 (352)
T 2jii_A 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122 (352)
T ss_dssp EEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence 577999999999999865 3789999998754 46888999999999999988 6
Q ss_pred eEEEEe-CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC
Q 037905 378 RAYYYS-RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY 456 (606)
Q Consensus 378 ~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~ 456 (606)
++++.. ....++||||+ +++|.+++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.++
T Consensus 123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iv--H~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENEYV--HGNVTAENIFVDPED 196 (352)
T ss_dssp CEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCB--CSCCCGGGEEEETTE
T ss_pred hhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCCcc--CCCCCHHHEEEcCCC
Confidence 777776 67889999999 999999998642 23589999999999999999999999966 999999999999998
Q ss_pred --cEEEeecccCccCCCC-----------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC
Q 037905 457 --EARISDFGLAHLASPS-----------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG 523 (606)
Q Consensus 457 --~~kl~DfG~a~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~ 523 (606)
.+||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 275 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT- 275 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-
T ss_pred CceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH-
Confidence 8999999999765321 22356778999999999999999999999999999999999997642111
Q ss_pred CChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc-cCCCCccc
Q 037905 524 VDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ-QGQAHDLE 602 (606)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~-~~~~~~~~ 602 (606)
..+.......... .....+.. .........+.+++.+||+.||++|||+.+|++.|+++.+.... ..++.+|+
T Consensus 276 ~~~~~~~~~~~~~--~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~ 349 (352)
T 2jii_A 276 EDIMKQKQKFVDK--PGPFVGPC----GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLP 349 (352)
T ss_dssp HHHHHHHHHHHHS--CCCEECTT----SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCC
T ss_pred HHHHHHHHhccCC--hhhhhhhc----cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCc
Confidence 0111111111110 01111100 00011235688899999999999999999999999999876544 46667766
Q ss_pred c
Q 037905 603 N 603 (606)
Q Consensus 603 ~ 603 (606)
.
T Consensus 350 ~ 350 (352)
T 2jii_A 350 M 350 (352)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=322.92 Aligned_cols=245 Identities=27% Similarity=0.351 Sum_probs=191.7
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..+.||+|+||.||+++. .++..||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||++++
T Consensus 26 ~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 105 (285)
T 3is5_A 26 FKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105 (285)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCC
T ss_pred ecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCC
Confidence 357899999999999986 468999999987543 34678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe---cCCCcEEEeecccCccCCCC--
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL---SKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~-- 472 (606)
+|.+++..... ....+++..+..++.|++.||+|||+++++ ||||||+||++ +.++.+||+|||+++.....
T Consensus 106 ~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv--H~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~ 182 (285)
T 3is5_A 106 ELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQHVV--HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182 (285)
T ss_dssp BHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred cHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCCEE--ECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc
Confidence 99999864321 123589999999999999999999999966 99999999999 45678999999999765432
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....++..|+|||++. ..++.++||||||+++|||++|+.||.... .................
T Consensus 183 ~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~--------- 246 (285)
T 3is5_A 183 STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS------LEEVQQKATYKEPNYAV--------- 246 (285)
T ss_dssp ----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCCCC---------
T ss_pred CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC------HHHHHhhhccCCccccc---------
Confidence 2345678899999986 468999999999999999999999996432 22222211111110000
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||+.||++|||+.|++++
T Consensus 247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000123467789999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=321.72 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=196.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|... +++.||+|++...... .+.+.+|+.++++++||||+++++++......++||||++++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~ 90 (284)
T 3kk8_A 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90 (284)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred hhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCC
Confidence 467999999999999864 5899999999765443 356789999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc---EEEeecccCccCCCCC-
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE---ARISDFGLAHLASPSS- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~~- 473 (606)
+|.+.+.... .+++..+..++.|++.||+|||+++++ ||||||+||+++.++. +||+|||++.......
T Consensus 91 ~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 91 ELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNGIV--HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp BHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcC--cCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 9999887543 589999999999999999999999965 9999999999987655 9999999997655432
Q ss_pred --CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 474 --TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
...+++.|+|||++.+..++.++||||||+++|+|++|+.||... ........+........ . .
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~------~~~~~~~~~~~~~~~~~--~------~ 229 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE------DQHRLYAQIKAGAYDYP--S------P 229 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCCC--T------T
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC------chhHHHHHHHhccccCC--c------h
Confidence 345778899999999999999999999999999999999999642 12222222222211100 0 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||+.||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 230 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111223568889999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=334.52 Aligned_cols=245 Identities=15% Similarity=0.178 Sum_probs=196.5
Q ss_pred hcccccCCceEEEEEE------EcCCcEEEEEEeccCccCHHHHHHHHHHHcCCC---CCCcccceEEEEeCCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKAT------LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD---HENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e 392 (606)
.+.||+|+||.||+|. ..+++.||||+++.. ...++..|++++..++ |+||+++++++...+..++|||
T Consensus 70 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e 147 (365)
T 3e7e_A 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147 (365)
T ss_dssp EEEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEEC
T ss_pred EEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEe
Confidence 4679999999999993 456899999999754 4567778888877776 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-----------CCcEEEe
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-----------SYEARIS 461 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-----------~~~~kl~ 461 (606)
|+++|+|.+++..........+++..+..++.||+.||+|||+++++ ||||||+|||++. ++.+||+
T Consensus 148 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~iv--HrDiKp~NIll~~~~~~~~~~~~~~~~~kl~ 225 (365)
T 3e7e_A 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEII--HGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225 (365)
T ss_dssp CCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEE--CCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred ccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCee--cCCCCHHHEEecccccCccccccccCCEEEe
Confidence 99999999999753322344699999999999999999999999955 9999999999998 8999999
Q ss_pred ecccCccCC---C---CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh
Q 037905 462 DFGLAHLAS---P---SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK 535 (606)
Q Consensus 462 DfG~a~~~~---~---~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (606)
|||+++... . .....+|.+|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------------- 292 (365)
T 3e7e_A 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE------------- 292 (365)
T ss_dssp CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------------
T ss_pred eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------------
Confidence 999996532 1 133467889999999999999999999999999999999999996532211
Q ss_pred ccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCC-CCHHHHHHHHHHHHhcc
Q 037905 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNR-PSMAEVTSQIEEICRSS 592 (606)
Q Consensus 536 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R-Ps~~~v~~~L~~i~~~~ 592 (606)
+.. .....+.. ....+.+++..|++.+|.+| |+++++.+.|+++....
T Consensus 293 --~~~---~~~~~~~~----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 --CKP---EGLFRRLP----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp --EEE---CSCCTTCS----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --eee---chhccccC----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 000 00001111 12345677779999999988 68899999999887654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=334.46 Aligned_cols=233 Identities=22% Similarity=0.294 Sum_probs=193.4
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 390 (606)
..+.||+|+||.||+|.. .+++.||||+++.... ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 28 ~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv 107 (335)
T 3dls_A 28 TMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLV 107 (335)
T ss_dssp EEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred EEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEE
Confidence 357899999999999985 5689999999976532 223577899999999999999999999999999999
Q ss_pred EeecCCC-ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 391 HDYMPMG-SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 391 ~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
|||+..| +|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++..
T Consensus 108 ~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iv--H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 108 MEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKDII--HRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeE--EeccCHHHEEEcCCCcEEEeecccceEC
Confidence 9999776 9999997532 589999999999999999999999965 9999999999999999999999999876
Q ss_pred CCCC---CCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 470 SPSS---TPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 470 ~~~~---~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
.... ...++..|+|||++.+..+ +.++||||||+++|||++|+.||....... ... ..
T Consensus 181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------~~~-----~~- 242 (335)
T 3dls_A 181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------EAA-----IH- 242 (335)
T ss_dssp CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------------TTC-----CC-
T ss_pred CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------------hhc-----cC-
Confidence 5433 2346788999999988776 789999999999999999999996532111 000 00
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+......+.+++.+||+.||++|||+.+++++
T Consensus 243 ------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 243 ------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001123458889999999999999999999986
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=331.42 Aligned_cols=240 Identities=19% Similarity=0.320 Sum_probs=189.2
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCC--CCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDH--ENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++...+++.||||++...... .+.+.+|+.++.+++| +||+++++++......++||| +.+
T Consensus 14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 92 (343)
T 3dbq_A 14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 92 (343)
T ss_dssp EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence 5789999999999999888999999999765433 3568899999999976 999999999999999999999 457
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++ ++.+||+|||+++......
T Consensus 93 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~ii--HrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 164 (343)
T 3dbq_A 93 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIV--HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 164 (343)
T ss_dssp EEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEEE-TTEEEECCCSSSCCC-------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCcceEEEE-CCcEEEeecccccccCcccccc
Confidence 79999998542 589999999999999999999999966 999999999997 5789999999998664322
Q ss_pred ---CCCCcccccCccccCC-----------CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 474 ---TPNRIDGYRAPEVTDA-----------RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 474 ---~~~~~~~y~aPE~~~~-----------~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...............
T Consensus 165 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~ 239 (343)
T 3dbq_A 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHE 239 (343)
T ss_dssp -----CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHCTTSC
T ss_pred cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHhcCCcc
Confidence 3457888999999854 678999999999999999999999996422 111222222211111
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.. .+......+.+++.+||+.||++|||+.|++++-
T Consensus 240 ~~----------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 240 IE----------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp CC----------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cC----------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 10 0111124678899999999999999999998773
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=335.93 Aligned_cols=234 Identities=24% Similarity=0.296 Sum_probs=185.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC----HHHHHHHHHH-HcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS----EKEFREKMEV-VGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. +++.||||+++..... ...+..|..+ ++.++||||+++++++.+.+..++||||++
T Consensus 43 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 122 (373)
T 2r5t_A 43 LKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122 (373)
T ss_dssp EEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCC
Confidence 578999999999999965 5889999999765432 2345666665 567899999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
+|+|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 123 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~giv--HrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~ 195 (373)
T 2r5t_A 123 GGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLNIV--YRDLKPENILLDSQGHIVLTDFGLCKENIEHNST 195 (373)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCce--ecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence 999999997543 588999999999999999999999966 999999999999999999999999976322
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||... +.......+......
T Consensus 196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~------~~~~~~~~i~~~~~~------------ 257 (373)
T 2r5t_A 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR------NTAEMYDNILNKPLQ------------ 257 (373)
T ss_dssp CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS------BHHHHHHHHHHSCCC------------
T ss_pred cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHhcccC------------
Confidence 23446788899999999999999999999999999999999999642 222333333332110
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAE 580 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~ 580 (606)
.+......+.+++.+||+.||++||++.+
T Consensus 258 ~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 258 LKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp CCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred CCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 00112345788889999999999999853
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=319.48 Aligned_cols=254 Identities=22% Similarity=0.354 Sum_probs=201.6
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
..+.||+|+||.||+|+.. +++.||+|+++.... ..+.+.+|+.++++++||||+++++++......++|||
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 88 (283)
T 3bhy_A 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILE 88 (283)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEe
Confidence 3578999999999999975 689999999875422 36789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC----cEEEeecccCcc
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY----EARISDFGLAHL 468 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~----~~kl~DfG~a~~ 468 (606)
|+++++|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+||+++.++ .+||+|||+++.
T Consensus 89 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 89 LVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKRIA--HFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred ecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcc--CCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 999999999997532 589999999999999999999999966 999999999999877 799999999976
Q ss_pred CCCCC---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 469 ASPSS---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 469 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
..... ...++..|+|||++.+..++.++||||||+++|||++|+.||.... .......+...... .+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~~---~~~ 232 (283)
T 3bhy_A 162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET------KQETLTNISAVNYD---FDE 232 (283)
T ss_dssp CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCCC---CCH
T ss_pred ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc------hHHHHHHhHhcccC---Ccc
Confidence 54432 3356778999999999899999999999999999999999996432 11222222111100 011
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHHHhccccc
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEICRSSLQQ 595 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~~~~~~ 595 (606)
.. .......+.+++.+||..||++|||+.+++++ ++.+.+....+
T Consensus 233 ~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~ 279 (283)
T 3bhy_A 233 EY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRG 279 (283)
T ss_dssp HH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC--
T ss_pred hh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhhhc
Confidence 00 11223568889999999999999999999985 66666555443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=344.61 Aligned_cols=244 Identities=22% Similarity=0.272 Sum_probs=195.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.++||+|+||.||+|+.. +++.||+|+++.... ....+.+|..++..++||||++++++|.+....++||||+++
T Consensus 79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g 158 (437)
T 4aw2_A 79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG 158 (437)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence 468999999999999975 478999999975321 223488999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|+|.+++.... ..+++..+..++.||+.||+|||+.+++ ||||||+|||++.++.+||+|||+++......
T Consensus 159 g~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~gii--HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 159 GDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLHYV--HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp CBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeE--ecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 99999998532 3589999999999999999999999965 99999999999999999999999997654322
Q ss_pred --CCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 --TPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
...+|+.|+|||++. ...|+.++|||||||++|||++|+.||... +.......+........+
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~------~~~~~~~~i~~~~~~~~~---- 302 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE------SLVETYGKIMNHKERFQF---- 302 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTHHHHCCC----
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC------ChhHHHHhhhhccccccC----
Confidence 246788999999986 567899999999999999999999999642 223333333322110000
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCC--CCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDN--RPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~--RPs~~~v~~~ 584 (606)
+.........+.+++.+|+..+|++ ||+++|++++
T Consensus 303 ---p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 ---PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0011112345778888999888888 9999999876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.88 Aligned_cols=242 Identities=22% Similarity=0.292 Sum_probs=196.4
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
..+.||+|+||.||+|... ++..||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (277)
T 3f3z_A 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE 92 (277)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCB
T ss_pred eeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCc
Confidence 4578999999999999864 47789999987643 356789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe---cCCCcEEEeecccCccCCCC---
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL---SKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~--- 472 (606)
|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+||++ +.++.+||+|||+++.....
T Consensus 93 L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~ 165 (277)
T 3f3z_A 93 LFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLNVA--HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM 165 (277)
T ss_dssp HHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--CCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence 999987543 589999999999999999999999966 99999999999 78889999999999765443
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....+++.|+|||++.+. ++.++||||||+++|||++|+.||.... .......+....... ... .
T Consensus 166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~--~~~------~ 230 (277)
T 3f3z_A 166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT------DSEVMLKIREGTFTF--PEK------D 230 (277)
T ss_dssp CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCC--CHH------H
T ss_pred hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCCC--Cch------h
Confidence 234577889999998764 8999999999999999999999996532 122222222211100 000 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.||++|||+.+++++
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01224568899999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=323.39 Aligned_cols=239 Identities=23% Similarity=0.391 Sum_probs=177.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (278)
T 3cok_A 16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95 (278)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence 46799999999999986 5789999999965322 246789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 96 GEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHGIL--HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred CcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 99999998542 3589999999999999999999999966 9999999999999999999999999765432
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ......... ...
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~------------~~~ 231 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN------TLNKVVLAD------------YEM 231 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSC------------CCC
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH------HHHHHhhcc------------cCC
Confidence 23456778999999998889999999999999999999999997532211 111111100 001
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+......+.+++.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11223467889999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=328.78 Aligned_cols=238 Identities=21% Similarity=0.223 Sum_probs=185.6
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCH---HHHHHHHHHHcC-CCCCCcccceEEEEeCCceEEEEeec
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSE---KEFREKMEVVGS-MDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
...++||+|+||+||+|+.. +|+.||||++....... ..+..|+..+.+ .+||||++++++|......++||||+
T Consensus 60 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~ 139 (311)
T 3p1a_A 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC 139 (311)
T ss_dssp EEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc
Confidence 34578999999999999975 79999999987644332 234445544444 48999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
+++|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++.....
T Consensus 140 -~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 140 -GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQGLV--HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp -CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred -CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--cCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 669998887543 3589999999999999999999999955 9999999999999999999999998766442
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....+|.+|+|||++.+ .++.++|||||||++|||++|..|+..... .... .... ..+..
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~-~~~~----~~~~~---- 273 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQL-RQGY----LPPEF---- 273 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHH-TTTC----CCHHH----
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHH-hccC----CCccc----
Confidence 23457888999999886 789999999999999999999766543111 1111 1111 11111
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.||++|||+.|++++
T Consensus 274 -~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 274 -TAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -ccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 11223568899999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.96 Aligned_cols=242 Identities=21% Similarity=0.351 Sum_probs=197.4
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEe----------------
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS---------------- 383 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~---------------- 383 (606)
..+.||+|+||.||+|... +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (284)
T 2a19_B 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91 (284)
T ss_dssp EEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCE
T ss_pred eeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccC
Confidence 3578999999999999975 78999999997543 457789999999999999999998864
Q ss_pred CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeec
Q 037905 384 RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDF 463 (606)
Q Consensus 384 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~Df 463 (606)
....++||||+++++|.+++.... ...+++..+..++.|++.||.|||+++++ ||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~kl~Df 166 (284)
T 2a19_B 92 TKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKKLI--NRDLKPSNIFLVDTKQVKIGDF 166 (284)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEEETTEEEECCC
T ss_pred cceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--eccCCHHHEEEcCCCCEEECcc
Confidence 345789999999999999997543 23589999999999999999999999965 9999999999999999999999
Q ss_pred ccCccCCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 464 GLAHLASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 464 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
|+++..... ....++..|+|||++.+..++.++||||||+++|||++|..|+.... ..... .......
T Consensus 167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~-~~~~~~~ 237 (284)
T 2a19_B 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTD-LRDGIIS 237 (284)
T ss_dssp TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHH-HHTTCCC
T ss_pred hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHH-hhccccc
Confidence 998765443 23456788999999999899999999999999999999999875321 11111 1111111
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
......+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus 238 -------------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 238 -------------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp -------------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred -------------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 112245778899999999999999999999999986553
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=328.65 Aligned_cols=251 Identities=23% Similarity=0.274 Sum_probs=190.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc------CHHHHHHHHHHHcCC---CCCCcccceEEEEeCC-----c
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV------SEKEFREKMEVVGSM---DHENLVPLRAYYYSRD-----E 386 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~-----~ 386 (606)
.+.||+|+||.||+|+. .+++.||||++..... ....+.+|+++++.+ +||||++++++|.... .
T Consensus 14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~ 93 (308)
T 3g33_A 14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK 93 (308)
T ss_dssp EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence 57899999999999985 5689999999864321 234667777777666 4999999999998755 4
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccC
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLA 466 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a 466 (606)
.++||||+. ++|.+++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||++
T Consensus 94 ~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~iv--H~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 94 VTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANCIV--HRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp EEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCTTTEEECTTSCEEECSCSCT
T ss_pred EEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEEcCCCCEEEeeCccc
Confidence 789999997 59999998643 23489999999999999999999999966 9999999999999999999999999
Q ss_pred ccCCCCCC---CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-------
Q 037905 467 HLASPSST---PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------- 536 (606)
Q Consensus 467 ~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 536 (606)
+....... ..+|+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+...
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE------ADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH------HHHHHHHHHHHCCCCTT
T ss_pred cccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCChh
Confidence 86654322 3467789999999988999999999999999999999999965321 1122222111
Q ss_pred cccccccchh--hh-c-ccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 EWTAEVFDLE--LL-R-YQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 ~~~~~~~d~~--~~-~-~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+......+. .. . ... ..+....+.+++.+||+.||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 0000000000 00 0 000 01233568889999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=329.67 Aligned_cols=255 Identities=23% Similarity=0.330 Sum_probs=198.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCCcccceEEEEe----CCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPLRAYYYS----RDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+++. .+++.||||++.... ...+.+.+|+++++.++||||+++++++.. ....++||||++
T Consensus 34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 113 (317)
T 2buj_A 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK 113 (317)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence 57899999999999986 578999999986543 245678999999999999999999999873 347789999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC--
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
+++|.+++..... ....+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++......
T Consensus 114 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv--H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~ 190 (317)
T 2buj_A 114 RGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKGYA--HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190 (317)
T ss_dssp TCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred CCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence 9999999875321 134689999999999999999999999966 99999999999999999999999887543211
Q ss_pred -----------CCCCcccccCccccCCCC---CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 474 -----------TPNRIDGYRAPEVTDARK---VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 474 -----------~~~~~~~y~aPE~~~~~~---~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
...++..|+|||++.+.. ++.++||||||+++|||++|+.||....... ...... ......
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~----~~~~~~ 265 (317)
T 2buj_A 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALA----VQNQLS 265 (317)
T ss_dssp HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHH----HHCC--
T ss_pred ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHH----hhccCC
Confidence 112467799999987654 6899999999999999999999997532221 111111 111100
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
.+........+.+++.+||+.||++|||+.+++++|+.+......
T Consensus 266 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 266 ----------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred ----------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 011112335688999999999999999999999999988654443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=334.42 Aligned_cols=248 Identities=22% Similarity=0.253 Sum_probs=192.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCc------cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT------VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
..+.||+|+||.||+|.. .++..||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 30 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 109 (345)
T 3hko_A 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMEL 109 (345)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeC
Confidence 467899999999999986 468899999986532 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 037905 394 MPMGSLSALLHGNRGA-----------------------------------GRTPLNWETRSGLALGASRAIAYLHSKGP 438 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~ 438 (606)
+++|+|.+++...... ....+++..+..++.||+.||+|||++++
T Consensus 110 ~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 189 (345)
T 3hko_A 110 CHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGI 189 (345)
T ss_dssp CCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred CCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9999999998521100 01123567788899999999999999995
Q ss_pred CCCCCCCCCCCEEecCCC--cEEEeecccCccCCC--------CCCCCCcccccCccccCC--CCCCCcchhHHHHHHHH
Q 037905 439 ANSHGNIKSSNILLSKSY--EARISDFGLAHLASP--------SSTPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLL 506 (606)
Q Consensus 439 ~i~HrDlkp~Nill~~~~--~~kl~DfG~a~~~~~--------~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~ 506 (606)
+ ||||||+|||++.++ .+||+|||+++.... .....+++.|+|||++.+ ..++.++||||||+++|
T Consensus 190 v--H~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 267 (345)
T 3hko_A 190 C--HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267 (345)
T ss_dssp E--CCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHH
T ss_pred c--ccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHH
Confidence 5 999999999998776 899999999975422 123456788999999865 67899999999999999
Q ss_pred HHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 507 ELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 507 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
||++|+.||.... .......+........ . +........+.+++.+||+.+|++|||+.+++++
T Consensus 268 el~~g~~pf~~~~------~~~~~~~~~~~~~~~~--~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 268 LLLMGAVPFPGVN------DADTISQVLNKKLCFE--N------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHSSCSSCCSS------HHHHHHHHHHCCCCTT--S------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHCCCCCCCCC------hHHHHHHHHhcccccC--C------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9999999996432 2222333332221110 0 1111233568889999999999999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.18 Aligned_cols=242 Identities=24% Similarity=0.402 Sum_probs=191.6
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEe----CCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYS----RDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|.. .++..||+|++...... .+.+.+|+.++++++||||+++++++.. ....++||||
T Consensus 31 ~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~ 110 (290)
T 1t4h_A 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 110 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEe
Confidence 45799999999999986 46889999999765433 3568899999999999999999999875 3457999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec-CCCcEEEeecccCccCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS-KSYEARISDFGLAHLASPS 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 472 (606)
+++++|.+++.... .+++..+..++.|++.||+|||+.+..++||||||+||+++ .++.+||+|||+++.....
T Consensus 111 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~ 185 (290)
T 1t4h_A 111 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred cCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence 99999999997532 58999999999999999999999983344999999999997 7899999999999765443
Q ss_pred C--CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 S--TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 ~--~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
. ...++..|+|||++.+ .++.++||||||+++|+|++|+.||.... ........... .......
T Consensus 186 ~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~-~~~~~~~------- 251 (290)
T 1t4h_A 186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTS-GVKPASF------- 251 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTT-TCCCGGG-------
T ss_pred ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-----cHHHHHHHHhc-cCCcccc-------
Confidence 2 2456788999998875 58999999999999999999999996422 12222222211 1111100
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.||++|||+.|++++
T Consensus 252 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 252 --DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp --GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred --CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01112458899999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.68 Aligned_cols=239 Identities=19% Similarity=0.321 Sum_probs=189.5
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCC--CCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMD--HENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|....++.||||++...... .+.+.+|++++++++ ||||+++++++...+..++||| +.+
T Consensus 61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~ 139 (390)
T 2zmd_A 61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 139 (390)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence 5789999999999999878999999999765433 356899999999986 5999999999999999999999 567
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++.... .+++..+..++.||+.||.|||+++++ ||||||+|||++ ++.+||+|||+++.....
T Consensus 140 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~iv--HrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 140 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIV--HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTTCC--CCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--ecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 89999998542 588899999999999999999999966 999999999996 578999999999866432
Q ss_pred --CCCCCcccccCccccCC-----------CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 473 --STPNRIDGYRAPEVTDA-----------RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~-----------~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.... .....+..+......
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~~~~~~ 286 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAIIDPNHE 286 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHHCTTSC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHhCcccc
Confidence 23457888999999865 368899999999999999999999996432 111222222221111
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. .+......+.+++.+||+.||++|||+.|++++
T Consensus 287 ~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 287 IE----------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CC----------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC----------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 10 001113467889999999999999999999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.38 Aligned_cols=247 Identities=23% Similarity=0.266 Sum_probs=186.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 391 (606)
.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|+.+++.++||||+++++++... .+.++||
T Consensus 67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 146 (464)
T 3ttj_A 67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 146 (464)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence 57899999999999985 4689999999976432 345688999999999999999999999654 3569999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+++ +|.+.+.. .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 147 E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~ii--HrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 147 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp ECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 99986 56666642 388999999999999999999999966 999999999999999999999999987654
Q ss_pred C---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc------------
Q 037905 472 S---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------------ 536 (606)
Q Consensus 472 ~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 536 (606)
. ....+|+.|+|||++.+..|+.++|||||||++|||++|+.||.+.. ....+..+...
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~------~~~~~~~i~~~lg~p~~~~~~~~ 290 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD------YIDQWNKVIEQLGTPCPEFMKKL 290 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCSCCHHHHTTS
T ss_pred CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHHHHHHc
Confidence 3 23467888999999999999999999999999999999999996532 12222211110
Q ss_pred ----------cccccccch------hhhccc--ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 ----------EWTAEVFDL------ELLRYQ--NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 ----------~~~~~~~d~------~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......... ...... ........+.+++.+||..||++|||++|++++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 000000 011225678999999999999999999999886
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=335.77 Aligned_cols=248 Identities=27% Similarity=0.363 Sum_probs=182.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCC-CCCcccceEEEEeCC--ceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMD-HENLVPLRAYYYSRD--EKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~e~~ 394 (606)
.+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+.+++++. ||||+++++++...+ ..++||||+
T Consensus 14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~ 93 (388)
T 3oz6_A 14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93 (388)
T ss_dssp EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence 46899999999999985 4689999999865432 2456778999999997 999999999998554 689999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC---
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--- 471 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 471 (606)
+ ++|..++... .+++..+..++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||+++....
T Consensus 94 ~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~iv--HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 94 E-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGGLL--HRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp S-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred C-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCEE--eCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 8 5899998753 488999999999999999999999965 999999999999999999999999975432
Q ss_pred ----------------------CCCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhH
Q 037905 472 ----------------------SSTPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 472 ----------------------~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~ 528 (606)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~------~~~ 238 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS------TMN 238 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC------HHH
Confidence 112357788999999876 678999999999999999999999996532 122
Q ss_pred HHHHHhhccccc--------------------------------cccc---hhhhcccChHHHHHHHHHHHHHccCcCCC
Q 037905 529 WVQSVVKEEWTA--------------------------------EVFD---LELLRYQNVEEEMVQLLQLAINCTAQYPD 573 (606)
Q Consensus 529 ~~~~~~~~~~~~--------------------------------~~~d---~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~ 573 (606)
.+..+....... ..+. ...............+.+++.+||..||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 222221100000 0000 00000000002235688999999999999
Q ss_pred CCCCHHHHHHH
Q 037905 574 NRPSMAEVTSQ 584 (606)
Q Consensus 574 ~RPs~~~v~~~ 584 (606)
+|||+.|++++
T Consensus 319 ~R~t~~e~l~H 329 (388)
T 3oz6_A 319 KRISANDALKH 329 (388)
T ss_dssp GSCCHHHHTTS
T ss_pred cCCCHHHHhCC
Confidence 99999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=329.49 Aligned_cols=253 Identities=20% Similarity=0.306 Sum_probs=191.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|+.. +|+.||||++...... .+.+.+|++++++++||||+++++++...+..++||||++++
T Consensus 8 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (311)
T 4agu_A 8 IGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT 87 (311)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCc
Confidence 467999999999999865 5899999998765433 356789999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|.+++.... .+++..+..++.|++.||+|||++|++ ||||||+||+++.++.+||+|||+++..... .
T Consensus 88 ~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~iv--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (311)
T 4agu_A 88 VLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHNCI--HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160 (311)
T ss_dssp HHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred hHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCCc--CCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence 9999887432 489999999999999999999999966 9999999999999999999999999765532 2
Q ss_pred CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHh------------hccccc
Q 037905 474 TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV------------KEEWTA 540 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------------~~~~~~ 540 (606)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....+.... ...+..
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD---QLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhcccccccccccccccccc
Confidence 3456778999999875 668999999999999999999999996532211 000011100 000000
Q ss_pred cccchhhhcccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLRYQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+....... .......+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000000 01234568899999999999999999999876
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=329.73 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=200.4
Q ss_pred HhcccccCCceEEEEEEE-----cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCC--ceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRD--EKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 392 (606)
..+.||+|+||.||+++. .+++.||||++..... ..+.+.+|++++++++||||+++++++...+ ..++|||
T Consensus 45 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 124 (326)
T 2w1i_A 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124 (326)
T ss_dssp EEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEEC
T ss_pred eeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEE
Confidence 357899999999999984 3689999999976433 3467999999999999999999999987543 6799999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 125 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 125 YLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKRYI--HRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred CCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCEe--ccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 999999999998643 3589999999999999999999999966 9999999999999999999999999866443
Q ss_pred C-------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccccccc------CCCC---hhHHHHHHhhc
Q 037905 473 S-------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNE------EGVD---LPRWVQSVVKE 536 (606)
Q Consensus 473 ~-------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~------~~~~---~~~~~~~~~~~ 536 (606)
. ...++..|+|||.+.+..++.++||||||+++|||++|..|+...... .... ....+...+..
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN 278 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence 2 223455699999998888999999999999999999999998642110 0000 00001111111
Q ss_pred cccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 537 EWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 537 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.. ....+...+..+.+++.+||+.+|++|||+.+|++.|+.+.++
T Consensus 279 ~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 279 NG----------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp TC----------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC----------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 10 0111223446788999999999999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=348.14 Aligned_cols=244 Identities=24% Similarity=0.265 Sum_probs=198.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +|+.||+|++.... .....+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 189 ~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 268 (576)
T 2acx_A 189 YRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268 (576)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCC
Confidence 467999999999999864 69999999996532 2356688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
|+|.+++.... ...+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++..... .
T Consensus 269 g~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~gIv--HrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 343 (576)
T 2acx_A 269 GDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRERIV--YRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343 (576)
T ss_dssp CBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred CcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEe--ccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence 99999997543 23489999999999999999999999965 9999999999999999999999999876543 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+|+.|+|||++.+..|+.++|||||||++|||++|+.||....... ........+..... ..+
T Consensus 344 ~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~i~~~~~------------~~p 409 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERLVKEVPE------------EYS 409 (576)
T ss_dssp CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHHHHHCCC------------CCC
T ss_pred ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHHhhcccc------------cCC
Confidence 3467888999999999899999999999999999999999997532211 11111111111110 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
......+.+++.+||..||++|| ++.||++|
T Consensus 410 ~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 410 ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 12235678899999999999999 78888875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.53 Aligned_cols=245 Identities=18% Similarity=0.256 Sum_probs=198.1
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+.||+|+||.||+|+.. +|+.||+|++.... .....+.+|++++++++||||+++++++.+....++||||+++|
T Consensus 191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg 270 (543)
T 3c4z_A 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG 270 (543)
T ss_dssp EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence 56999999999999974 69999999996542 23467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|.+++..... ....+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++......
T Consensus 271 ~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~gIv--HrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 347 (543)
T 3c4z_A 271 DIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRNII--YRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK 347 (543)
T ss_dssp BHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBC
T ss_pred CHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcCCc--ccCCChHHEEEeCCCCEEEeecceeeeccCCCcccc
Confidence 99999875432 234689999999999999999999999965 99999999999999999999999998654432
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+|+.|+|||++.+..|+.++|||||||++|||++|+.||...... .........+..... ..+
T Consensus 348 ~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--~~~~~~~~~i~~~~~------------~~p 413 (543)
T 3c4z_A 348 GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQRVLEQAV------------TYP 413 (543)
T ss_dssp CCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--CCHHHHHHHHHHCCC------------CCC
T ss_pred cccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--hhHHHHHHHHhhccc------------CCC
Confidence 346788999999999999999999999999999999999999753211 122222333322211 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSM-----AEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~-----~~v~~~ 584 (606)
......+.+++.+||+.||++||++ .+|.++
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 1223567888999999999999975 566653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=345.53 Aligned_cols=237 Identities=15% Similarity=0.165 Sum_probs=182.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc----cCHHHHHHHH---HHHcCCCCCCcccce-------EEEEeCC-
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT----VSEKEFREKM---EVVGSMDHENLVPLR-------AYYYSRD- 385 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~~~~~- 385 (606)
.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+ +.+++++||||++++ +++...+
T Consensus 78 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 157 (377)
T 3byv_A 78 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157 (377)
T ss_dssp EEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTS
T ss_pred cceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCC
Confidence 46799999999999995 569999999997432 2346788999 566667899999998 6665443
Q ss_pred ----------------ceEEEEeecCCCChhhhhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 037905 386 ----------------EKLLVHDYMPMGSLSALLHGNRGA--GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKS 447 (606)
Q Consensus 386 ----------------~~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp 447 (606)
..++||||+ +|+|.+++...... ....+++..+..++.||+.||+|||+++++ ||||||
T Consensus 158 ~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv--HrDikp 234 (377)
T 3byv_A 158 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV--HTYLRP 234 (377)
T ss_dssp CSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCG
T ss_pred ccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee--cCCCCH
Confidence 278999999 57999999853211 112345688889999999999999999955 999999
Q ss_pred CCEEecCCCcEEEeecccCccCCCC-CCCCCcccccCccccCCC-----------CCCCcchhHHHHHHHHHHHhCCCCc
Q 037905 448 SNILLSKSYEARISDFGLAHLASPS-STPNRIDGYRAPEVTDAR-----------KVSQKADVYSFGVLLLELLTGKAPT 515 (606)
Q Consensus 448 ~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~-----------~~~~~sDv~slGvvl~elltg~~p~ 515 (606)
+|||++.++.+||+|||+++..... ....+ ..|+|||++.+. .++.++|||||||++|||++|+.||
T Consensus 235 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf 313 (377)
T 3byv_A 235 VDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC
T ss_pred HHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999865442 23345 789999999887 8999999999999999999999999
Q ss_pred ccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 516 QALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 516 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......... . .+.. .. ......+.+++.+||+.||++|||+.|++++
T Consensus 314 ~~~~~~~~~---~---~~~~-------------~~---~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 314 TKDAALGGS---E---WIFR-------------SC---KNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp ------CCS---G---GGGS-------------SC---CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred cccccccch---h---hhhh-------------hc---cCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 753322110 0 0000 00 1123467889999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=343.17 Aligned_cols=242 Identities=22% Similarity=0.289 Sum_probs=197.2
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccC---ccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDV---TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
..+.||+|+||.||+|... +++.||||++... ......+.+|++++++++||||+++++++.+....++||||+.+
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~ 105 (486)
T 3mwu_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (486)
T ss_dssp EEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCC
Confidence 4678999999999999864 7899999998643 23467899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec---CCCcEEEeecccCccCCCC-
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS---KSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~- 472 (606)
++|.+.+.... .+++..+..++.||+.||.|||++|++ ||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~iv--H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~ 178 (486)
T 3mwu_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHNIV--HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (486)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeE--eccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence 99999887543 589999999999999999999999966 999999999995 4567999999999865443
Q ss_pred --CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 --STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....+++.|+|||++.+ .|+.++|||||||++|+|++|+.||... .....+..+.........
T Consensus 179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~~~~-------- 243 (486)
T 3mwu_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK------NEYDILKRVETGKYAFDL-------- 243 (486)
T ss_dssp ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCSCS--------
T ss_pred ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCCCC--------
Confidence 23467888999999876 5899999999999999999999999643 222233333222211110
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+........+.+++.+||..+|++|||+.|++++
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112233567889999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=338.57 Aligned_cols=243 Identities=21% Similarity=0.261 Sum_probs=193.5
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+++.. +|+.||||++++... ..+.+.+|..++..++||||++++++|.+.+..++||||+++
T Consensus 66 ~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~g 145 (412)
T 2vd5_A 66 LKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVG 145 (412)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCC
Confidence 467999999999999974 699999999975322 123478899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|+|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 146 g~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~gii--HrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 146 GDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLGYV--HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp CBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 99999997532 2589999999999999999999999965 99999999999999999999999997665432
Q ss_pred --CCCCcccccCccccC-------CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 474 --TPNRIDGYRAPEVTD-------ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~-------~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
...+|+.|+|||++. ...|+.++|||||||++|||++|+.||... +.......+.........
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~~~~-- 291 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD------STAETYGKIVHYKEHLSL-- 291 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTHHHHCCC--
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC------CHHHHHHHHHhcccCcCC--
Confidence 346788999999986 456899999999999999999999999642 222223333221100000
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCC---CCHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNR---PSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~R---Ps~~~v~~~ 584 (606)
.........++.+++.+||. +|++| |+++||+++
T Consensus 292 -----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 292 -----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00011233567888899998 99998 589998776
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=345.74 Aligned_cols=243 Identities=25% Similarity=0.332 Sum_probs=198.9
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccC----ccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDV----TVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
...+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.++++++||||+++++++......++||||+
T Consensus 29 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 108 (484)
T 3nyv_A 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVY 108 (484)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecC
Confidence 34678999999999999865 7899999998654 234678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe---cCCCcEEEeecccCccCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL---SKSYEARISDFGLAHLASP 471 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill---~~~~~~kl~DfG~a~~~~~ 471 (606)
.+++|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||+ +.++.+||+|||+++....
T Consensus 109 ~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~iv--H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 109 TGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNKIV--HRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp CSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--eCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 999999998753 2589999999999999999999999966 99999999999 5678999999999976654
Q ss_pred CCC---CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 472 SST---PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 472 ~~~---~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
... ..+++.|+|||++.+ .++.++|||||||++|+|++|++||... +....+..+........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~~~------- 247 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA------NEYDILKKVEKGKYTFE------- 247 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCCCC-------
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC------CHHHHHHHHHcCCCCCC-------
Confidence 332 357888999999876 6999999999999999999999999653 22223333333221111
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.+......+.+++.+||+.+|++|||+.|++++
T Consensus 248 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 -LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 01112234567889999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=328.64 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=197.9
Q ss_pred hcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|+. .++..||||++..... ....+.+|+.++++++||||+++++++......++||||
T Consensus 35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (327)
T 2yfx_A 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL 114 (327)
T ss_dssp EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence 57799999999999973 3577899999975432 345688999999999999999999999998899999999
Q ss_pred cCCCChhhhhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCcc
Q 037905 394 MPMGSLSALLHGNRGA--GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHL 468 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~ 468 (606)
+++++|.+++...... ....+++..+..++.|++.||.|||+++++ ||||||+|||++. +..+||+|||+++.
T Consensus 115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~--H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~ 192 (327)
T 2yfx_A 115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFI--HRDIAARNCLLTCPGPGRVAKIGDFGMARD 192 (327)
T ss_dssp CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEESCSSTTCCEEECCCHHHHH
T ss_pred CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCee--cCcCCHhHEEEecCCCcceEEECccccccc
Confidence 9999999999865321 124589999999999999999999999966 9999999999984 44699999999864
Q ss_pred CCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 469 ASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 469 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
.... ....++..|+|||++.+..++.++||||||+++|||++ |+.||.... .......+..... .
T Consensus 193 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------~~~~~~~~~~~~~-~- 264 (327)
T 2yfx_A 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS------NQEVLEFVTSGGR-M- 264 (327)
T ss_dssp HHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTTCC-C-
T ss_pred cccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC------HHHHHHHHhcCCC-C-
Confidence 3221 12334667999999988889999999999999999998 999996432 1222222222111 0
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
..+......+.+++.+||+.||++|||+.+|+++|+.+.....
T Consensus 265 ---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 265 ---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred ---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 0111233568899999999999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=318.00 Aligned_cols=242 Identities=21% Similarity=0.285 Sum_probs=194.6
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..+.||+|+||.||+|... +++.||||++.... ...+.+.+|+.+++.++||||+++++++......++||||++++
T Consensus 11 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (276)
T 2yex_A 11 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG 90 (276)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTE
T ss_pred EEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCC
Confidence 3578999999999999865 68999999986543 23467899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC------
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP------ 471 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~------ 471 (606)
+|.+++... ..+++..+..++.|++.||+|||++|++ ||||||+||+++.++.+||+|||.++....
T Consensus 91 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 91 ELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIGIT--HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp EGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCCee--ccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 999998743 3589999999999999999999999966 999999999999999999999999875432
Q ss_pred CCCCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 472 SSTPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
.....++..|+|||.+.+..+ +.++||||||+++|||++|+.||....... .. ......... ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~~~~~~---~~------- 228 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC----QE-YSDWKEKKT---YL------- 228 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS----HH-HHHHHTTCT---TS-------
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH----HH-HHHhhhccc---cc-------
Confidence 223456788999999987765 778999999999999999999997532211 11 111111100 00
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.........+.+++.+||+.||++|||+.|++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0111223467889999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=320.88 Aligned_cols=243 Identities=23% Similarity=0.338 Sum_probs=195.4
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
..+.||+|+||.||+++.. +|+.||+|+++.... ..+.+.+|+.++++++||||+++++++......++||||+++++
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 92 (304)
T 2jam_A 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGE 92 (304)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred eeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCcc
Confidence 3578999999999999864 689999999976533 34568899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe---cCCCcEEEeecccCccCCCCC--
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL---SKSYEARISDFGLAHLASPSS-- 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~-- 473 (606)
|.+++.... .+++..+..++.|++.||+|||++|++ ||||||+||++ +.++.+||+|||+++......
T Consensus 93 L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (304)
T 2jam_A 93 LFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENGIV--HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165 (304)
T ss_dssp HHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence 999987543 589999999999999999999999966 99999999999 788899999999987654322
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...++..|+|||++.+..++.++||||||+++|||++|+.||.... .......+....... . ....
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~---~-----~~~~ 231 (304)
T 2jam_A 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET------ESKLFEKIKEGYYEF---E-----SPFW 231 (304)
T ss_dssp HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHCCCCC---C-----TTTT
T ss_pred cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHcCCCCC---C-----cccc
Confidence 1236778999999999999999999999999999999999996422 222222222221110 0 0011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||..||++|||+.|++++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 232 DDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 2233568889999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-39 Score=322.14 Aligned_cols=241 Identities=21% Similarity=0.266 Sum_probs=194.1
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||.||+|... +++.||+|+++... ....++.+|+..+..+ +||||+++++++.+.+..++||||++
T Consensus 15 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 94 (289)
T 1x8b_A 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94 (289)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred hhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecC
Confidence 3578999999999999875 79999999997542 2346688899988888 99999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-------------------C
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-------------------Y 456 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-------------------~ 456 (606)
+++|.+++..... ....+++..+..++.||+.||+|||+++++ ||||||+||+++.+ .
T Consensus 95 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~iv--H~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~ 171 (289)
T 1x8b_A 95 GGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMSLV--HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171 (289)
T ss_dssp TCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEC--------------------CC
T ss_pred CCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCCEe--ecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence 9999999975421 113589999999999999999999999966 99999999999844 4
Q ss_pred cEEEeecccCccCCCCCCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh
Q 037905 457 EARISDFGLAHLASPSSTPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK 535 (606)
Q Consensus 457 ~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (606)
.+||+|||.++.........++..|+|||++.+. .+++++||||||+++|||++|.+|+.... ....+..
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------~~~~~~~ 242 (289)
T 1x8b_A 172 MFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------QWHEIRQ 242 (289)
T ss_dssp CEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------HHHHHHT
T ss_pred EEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------HHHHHHc
Confidence 7999999999887776667788999999999775 56789999999999999999988764211 1111111
Q ss_pred ccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 536 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.... .+......+.+++.+||+.||++|||+.|++++
T Consensus 243 -~~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 243 -GRLPR----------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -TCCCC----------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -CCCCC----------CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11111 011223468889999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=332.20 Aligned_cols=244 Identities=22% Similarity=0.308 Sum_probs=192.4
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
..+.||+|+||.||+|... +|+.||||+++.... ...+|++++.++ +||||+++++++.+....++||||+++|+
T Consensus 26 ~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 26 VKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 4578999999999999864 689999999976432 234677777776 79999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC----CcEEEeecccCccCCCC--
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS----YEARISDFGLAHLASPS-- 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~----~~~kl~DfG~a~~~~~~-- 472 (606)
|.+++... ..+++..+..++.||+.||+|||++|++ ||||||+|||+.++ +.+||+|||+++.....
T Consensus 103 L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~giv--HrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 103 LLDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQGVV--HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp HHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcE--eccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99999753 2589999999999999999999999966 99999999998543 34999999999865432
Q ss_pred --CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 --STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... .........+........ .
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~~~~i~~~~~~~~--------~ 244 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD---DTPEEILARIGSGKFSLS--------G 244 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---SCHHHHHHHHHHCCCCCC--------S
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc---CCHHHHHHHHccCCcccC--------c
Confidence 234567889999999888899999999999999999999999974211 122233333322221100 0
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
..+......+.+++.+||..||++|||+.+++++-
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 01122335678899999999999999999998863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=318.85 Aligned_cols=238 Identities=23% Similarity=0.339 Sum_probs=196.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. ++..||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+++
T Consensus 19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 98 (284)
T 2vgo_A 19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98 (284)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence 578999999999999865 57899999986532 2356789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC--CCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--SST 474 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~~ 474 (606)
++|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||++..... ...
T Consensus 99 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (284)
T 2vgo_A 99 GELYKELQKHG-----RFDEQRSATFMEELADALHYCHERKVI--HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT 171 (284)
T ss_dssp EEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTTEE--CCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCC
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCce--ecCCCHHHEEEcCCCCEEEecccccccCccccccc
Confidence 99999997543 589999999999999999999999966 999999999999999999999999865543 233
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..++..|+|||++.+..++.++||||||+++|||++|+.||.... .......+..... ..+.
T Consensus 172 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~------------~~~~ 233 (284)
T 2vgo_A 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS------HTETHRRIVNVDL------------KFPP 233 (284)
T ss_dssp CCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCC------------CCCT
T ss_pred ccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC------HhHHHHHHhcccc------------CCCC
Confidence 457788999999999999999999999999999999999996422 1222222221110 0011
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+.+++.+||+.||++|||+.+++++
T Consensus 234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 123467889999999999999999999985
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.81 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=182.5
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCC-CCCcccceEEEEe--------CCceE
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMD-HENLVPLRAYYYS--------RDEKL 388 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--------~~~~~ 388 (606)
...+.||+|+||.||+|+. .+++.||||++..... ..+.+.+|+.++.++. ||||+++++++.. ....+
T Consensus 31 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~ 110 (337)
T 3ll6_A 31 RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110 (337)
T ss_dssp EEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEE
T ss_pred EEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEE
Confidence 3467899999999999996 4689999999865432 3467889999999996 9999999999953 23478
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 389 LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
+||||+. |+|.+++..... ...+++..+..++.||+.||+|||+++..++||||||+|||++.++.+||+|||+++.
T Consensus 111 lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 111 LLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred EEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 9999996 699998865321 2358999999999999999999999983344999999999999999999999999976
Q ss_pred CCCCC----------------CCCCcccccCcccc---CCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHH
Q 037905 469 ASPSS----------------TPNRIDGYRAPEVT---DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRW 529 (606)
Q Consensus 469 ~~~~~----------------~~~~~~~y~aPE~~---~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~ 529 (606)
..... ...++..|+|||++ .+..++.++||||||+++|||++|+.||....... .
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~ 261 (337)
T 3ll6_A 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR------I 261 (337)
T ss_dssp CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------------
T ss_pred ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH------h
Confidence 54321 22367779999998 56678999999999999999999999996432111 0
Q ss_pred HHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 530 VQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 530 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
. ...... .........+.+++.+||+.||++|||+.|++++|+++....
T Consensus 262 ~----~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 262 V----NGKYSI----------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --------CCC----------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred h----cCcccC----------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 111000 000111234778899999999999999999999999997643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=334.49 Aligned_cols=253 Identities=24% Similarity=0.362 Sum_probs=200.7
Q ss_pred hcccccCCceEEEEEEEcC------CcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLEM------GIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 392 (606)
.+.||+|+||.||+|.... ...||+|+++.... ..+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus 51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 130 (333)
T 2i1m_A 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE 130 (333)
T ss_dssp EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence 5789999999999998642 24899999976532 346688999999999 89999999999999999999999
Q ss_pred ecCCCChhhhhhcCCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeec
Q 037905 393 YMPMGSLSALLHGNRG---------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDF 463 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~Df 463 (606)
|+++|+|.+++..... .....+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+||
T Consensus 131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~Dlkp~NIl~~~~~~~kl~Df 208 (333)
T 2i1m_A 131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCI--HRDVAARNVLLTNGHVAKIGDF 208 (333)
T ss_dssp CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGCEEEGGGEEEBCCC
T ss_pred cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcc--cCCcccceEEECCCCeEEECcc
Confidence 9999999999875321 0123579999999999999999999999966 9999999999999999999999
Q ss_pred ccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhc
Q 037905 464 GLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKE 536 (606)
Q Consensus 464 G~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (606)
|+++...... ...++..|+|||++.+..++.++||||||+++|||+| |..||..... ..........
T Consensus 209 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~------~~~~~~~~~~ 282 (333)
T 2i1m_A 209 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV------NSKFYKLVKD 282 (333)
T ss_dssp GGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS------SHHHHHHHHH
T ss_pred ccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch------hHHHHHHHhc
Confidence 9997553321 2234567999999988889999999999999999999 9999965321 1112222222
Q ss_pred cccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 537 EWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 537 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.... ..+......+.+++.+||+.+|++|||+.+|++.|+++....
T Consensus 283 ~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 283 GYQM----------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCC----------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 2111 011112356888999999999999999999999999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.43 Aligned_cols=253 Identities=20% Similarity=0.309 Sum_probs=194.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|... ++..||+|++..... ..+.+.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 117 (360)
T 3eqc_A 38 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117 (360)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCC
Confidence 467999999999999865 689999999976432 34678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC--CCCC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--SSTP 475 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~~~ 475 (606)
|.+++.... .+++..+..++.|++.||+|||++ +++ ||||||+|||++.++.+||+|||+++.... ....
T Consensus 118 L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~i~--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 190 (360)
T 3eqc_A 118 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190 (360)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCC--CSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCEE--cCCccHHHEEECCCCCEEEEECCCCcccccccccCC
Confidence 999997543 588999999999999999999996 866 999999999999999999999999864322 2344
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------------------
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------------------ 537 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------------ 537 (606)
.++..|+|||++.+..++.++||||||+++|||++|+.||....... +...........
T Consensus 191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (360)
T 3eqc_A 191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE---LELMFGCQVEGDAAETPPRPRTPGRPLNKF 267 (360)
T ss_dssp CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH---HHHHHC------------------------
T ss_pred CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccCCCCCCCcccCCCccccc
Confidence 67888999999999999999999999999999999999996422110 000000000000
Q ss_pred --------ccccccchhhhc--c-cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 --------WTAEVFDLELLR--Y-QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 --------~~~~~~d~~~~~--~-~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+..+..... . .........+.+++.+||+.||++|||+.|++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000000000000 0 0001123568899999999999999999999886
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.41 Aligned_cols=258 Identities=21% Similarity=0.253 Sum_probs=196.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCC--------CCCcccceEEEE----eCCce
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD--------HENLVPLRAYYY----SRDEK 387 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~----~~~~~ 387 (606)
..+.||+|+||.||+|+. .+++.||||+++......+.+.+|+.+++.++ |+||+++++++. .....
T Consensus 41 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~ 120 (397)
T 1wak_A 41 VIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHI 120 (397)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEE
T ss_pred EEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceE
Confidence 357899999999999985 46899999999865555677889999998885 788999999987 45678
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCC----------
Q 037905 388 LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSY---------- 456 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~---------- 456 (606)
++||||+ +++|.+.+.... ...+++..+..++.||+.||+|||++ |++ ||||||+|||++.++
T Consensus 121 ~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~giv--HrDikp~NIll~~~~~~~~~~~~~~ 194 (397)
T 1wak_A 121 CMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEA 194 (397)
T ss_dssp EEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCEE--CCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred EEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCCEe--cCCCCHHHeeEeccchhhhhhhhhh
Confidence 9999999 556666665432 23589999999999999999999998 866 999999999999775
Q ss_pred ---------------------------------------cEEEeecccCccCCCC-CCCCCcccccCccccCCCCCCCcc
Q 037905 457 ---------------------------------------EARISDFGLAHLASPS-STPNRIDGYRAPEVTDARKVSQKA 496 (606)
Q Consensus 457 ---------------------------------------~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~s 496 (606)
.+||+|||+++..... ....+|..|+|||++.+..++.++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 274 (397)
T 1wak_A 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA 274 (397)
T ss_dssp C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence 7999999999765443 344678889999999998999999
Q ss_pred hhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh------------ccccccccch------------------h
Q 037905 497 DVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK------------EEWTAEVFDL------------------E 546 (606)
Q Consensus 497 Dv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~d~------------------~ 546 (606)
|||||||++|||++|+.||..............+..+.. ..+....+.. -
T Consensus 275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (397)
T 1wak_A 275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354 (397)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence 999999999999999999975433221111111111110 0000000000 0
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+....+.+++.+||+.||++|||+.|++++
T Consensus 355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 01112345667889999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=314.92 Aligned_cols=238 Identities=23% Similarity=0.344 Sum_probs=190.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+.. +|+.||||++.... ...+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 95 (276)
T 2h6d_A 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95 (276)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence 467999999999999975 68999999986532 2346788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++......
T Consensus 96 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~ 168 (276)
T 2h6d_A 96 GELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHMVV--HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168 (276)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHCSS--CCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred CcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCc--cCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence 99999997542 589999999999999999999999966 99999999999999999999999997665432
Q ss_pred CCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 474 TPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
...++..|+|||.+.+..+ +.++||||||+++|||++|+.||... ........+..... ..
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~------~~~~~~~~~~~~~~------------~~ 230 (276)
T 2h6d_A 169 TSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE------HVPTLFKKIRGGVF------------YI 230 (276)
T ss_dssp --------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC------------CC
T ss_pred cccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC------cHHHHHHHhhcCcc------------cC
Confidence 3346778999999988765 68999999999999999999999642 22222222211110 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+......+.+++.+||+.||++|||+.|++++
T Consensus 231 ~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11123467889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.20 Aligned_cols=243 Identities=23% Similarity=0.309 Sum_probs=185.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 390 (606)
..+.||+|+||.||+|.. .+++.||||++..... ....+.+|++++++++||||+++++++. ....++|
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv 217 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIV 217 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEE
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEE
Confidence 357899999999999985 4689999999875421 1124789999999999999999999975 4568999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC---cEEEeecccCc
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY---EARISDFGLAH 467 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~---~~kl~DfG~a~ 467 (606)
|||+++++|.+++... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++ .+||+|||+++
T Consensus 218 ~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~iv--HrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 218 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENGII--HRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred EEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCChHhEEEecCCCcceEEEeecccce
Confidence 9999999999998753 3589999999999999999999999966 999999999997544 59999999998
Q ss_pred cCCCC---CCCCCcccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 468 LASPS---STPNRIDGYRAPEVTDA---RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 468 ~~~~~---~~~~~~~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
..... ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+... .......
T Consensus 291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~----i~~~~~~- 363 (419)
T 3i6u_A 291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQ----ITSGKYN- 363 (419)
T ss_dssp SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHH----HHTTCCC-
T ss_pred ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHH----HhcCCCC-
Confidence 76543 23457888999999853 56788999999999999999999999753221 112111 1111100
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+. ........+.+++.+||+.||++|||+.|++++
T Consensus 364 -~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 364 -FIPE-----VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp -CCHH-----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCch-----hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000 011224568899999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.42 Aligned_cols=191 Identities=24% Similarity=0.332 Sum_probs=165.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCC------CCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSM------DHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|... +++.||||+++......+.+.+|+.+++.+ +|+||+++++++......++||||+
T Consensus 102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 181 (429)
T 3kvw_A 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL 181 (429)
T ss_dssp EEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred EEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence 578999999999999854 589999999987554556677788777665 6789999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc--EEEeecccCccCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE--ARISDFGLAHLASPS 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~ 472 (606)
. ++|.+++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||++.++. +||+|||+++.....
T Consensus 182 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~iv--HrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~ 255 (429)
T 3kvw_A 182 S-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNRII--HCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255 (429)
T ss_dssp C-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHTEE--CSCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred C-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHeEEccCCCcceEEeecccceecCCc
Confidence 6 59999988643 23589999999999999999999999955 9999999999999987 999999999765443
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQAL 518 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~ 518 (606)
....+++.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 256 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 256 VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 3456788899999999999999999999999999999999999753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=324.87 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=192.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|+.. +|+.||||++...... .+.+.+|++++++++||||+++++++......++||||++++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 109 (331)
T 4aaa_A 30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT 109 (331)
T ss_dssp EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence 578999999999999865 5899999998665433 355789999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+|.+++... ..+++..+..++.|++.||+|||+.|++ ||||||+||+++.++.+||+|||+++..... .
T Consensus 110 ~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~iv--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 182 (331)
T 4aaa_A 110 ILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHNII--HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182 (331)
T ss_dssp HHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred hHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCEE--ccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence 998887643 2589999999999999999999999966 9999999999999999999999999765432 2
Q ss_pred CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHH----------HHh-hcccccc
Q 037905 474 TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQ----------SVV-KEEWTAE 541 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~----------~~~-~~~~~~~ 541 (606)
...++..|+|||++.+. .++.++||||||+++|||++|+.||......+ .+..... ... .......
T Consensus 183 ~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (331)
T 4aaa_A 183 DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFNKNPVFAG 260 (331)
T ss_dssp -CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHHHCGGGTT
T ss_pred CCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhhhcccccc
Confidence 34567789999999775 78999999999999999999999996532211 0000000 000 0000000
Q ss_pred ccchhhhcccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 542 VFDLELLRYQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 542 ~~d~~~~~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+....... .......+.+++.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 261 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 01234678899999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=325.86 Aligned_cols=243 Identities=19% Similarity=0.250 Sum_probs=194.7
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
+.||+|+||.||+|... +++.||+|+++... .....+.+|+.++..+ .||||+++++++......++||||++++
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~ 114 (327)
T 3lm5_A 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114 (327)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence 78999999999999865 68999999987543 2367889999999988 5699999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCccCCCC--
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~-- 472 (606)
+|.+++.... ...+++..+..++.|++.||+|||++|++ ||||||+|||++. ++.+||+|||+++.....
T Consensus 115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~giv--H~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 189 (327)
T 3lm5_A 115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNNIV--HLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189 (327)
T ss_dssp EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEESCBTTBCCEEECCGGGCEEC-----
T ss_pred cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCee--cCcCChHHEEEecCCCCCcEEEeeCccccccCCccc
Confidence 9999986532 24589999999999999999999999965 9999999999998 789999999999876543
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....+++.|+|||++.+..++.++||||||+++|||++|+.||.... .......+....... ...
T Consensus 190 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~--------~~~ 255 (327)
T 3lm5_A 190 LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED------NQETYLNISQVNVDY--------SEE 255 (327)
T ss_dssp ----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCC--------CTT
T ss_pred cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------chHHHHHHHhccccc--------Cch
Confidence 23457888999999999999999999999999999999999996432 122222221111000 001
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||+.||++|||+++++++
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 112234568889999999999999999999875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=320.27 Aligned_cols=238 Identities=23% Similarity=0.317 Sum_probs=196.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 99 (294)
T 2rku_A 20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99 (294)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence 467999999999999865 588999999875432 245688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 100 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNRVI--HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 99999987532 589999999999999999999999966 9999999999999999999999999765422
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||.+.+..++.++||||||+++|||++|+.||.... .......+..... ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~------------~~ 234 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC------LKETYLRIKKNEY------------SI 234 (294)
T ss_dssp CCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS------HHHHHHHHHTTCC------------CC
T ss_pred ccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHhhccC------------CC
Confidence 23456778999999999889999999999999999999999996422 2222222222111 00
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+......+.+++.+||+.||++|||+.|++++
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11223467889999999999999999999986
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=329.31 Aligned_cols=248 Identities=23% Similarity=0.309 Sum_probs=186.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCC------ceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRD------EKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 391 (606)
.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|+++++.++||||+++++++.... ..++||
T Consensus 30 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~ 109 (367)
T 1cm8_A 30 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 109 (367)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred eEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEE
Confidence 56799999999999986 46899999999654332 356889999999999999999999997653 459999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+ +++|.+++... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 110 e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~iv--H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 110 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 999 78999999752 489999999999999999999999966 999999999999999999999999987654
Q ss_pred C-CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc------cccc
Q 037905 472 S-STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT------AEVF 543 (606)
Q Consensus 472 ~-~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 543 (606)
. ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+..+...... ..+.
T Consensus 181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD------HLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHhcCCCCHHHHHHhh
Confidence 3 33467888999999876 679999999999999999999999997532 12222221110000 0000
Q ss_pred ch-------hhh-----c-ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DL-------ELL-----R-YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~-------~~~-----~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. .+. . ..........+.+++.+||..||++|||+.|++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 000 0 00011224568889999999999999999999886
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=321.04 Aligned_cols=239 Identities=25% Similarity=0.361 Sum_probs=197.1
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++.++||||+++++++......++||||+++++
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 106 (303)
T 3a7i_A 27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS 106 (303)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence 46799999999999985 468999999997543 345789999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++.. ..+++..+..++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||+++..... ..
T Consensus 107 L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 178 (303)
T 3a7i_A 107 ALDLLEP------GPLDETQIATILREILKGLDYLHSEKKI--HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT 178 (303)
T ss_dssp HHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCc--cCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence 9999864 2589999999999999999999999966 9999999999999999999999999765432 23
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..++..|+|||++.+..++.++||||||+++|||++|+.||..... ......+... .... ...
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~----------~~~ 241 (303)
T 3a7i_A 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLFLIPKN-NPPT----------LEG 241 (303)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS-CCCC----------CCS
T ss_pred cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHHHhhcC-CCCC----------Ccc
Confidence 4567789999999999999999999999999999999999964321 1111111111 1110 011
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.....+.+++.+||+.+|++|||+.+++++.
T Consensus 242 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 242 NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 2234588899999999999999999998864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=320.32 Aligned_cols=245 Identities=19% Similarity=0.265 Sum_probs=194.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. +++.||+|++...... .+.+.+|++++++++||||+++++++.. ....++||||++
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 90 (279)
T 2w5a_A 11 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90 (279)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCT
T ss_pred ehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCC
Confidence 467999999999999864 6899999999765433 3568899999999999999999998864 467899999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG-----PANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
+++|.+++..... ....+++..+..++.|++.||+|||+.+ ++ ||||||+||+++.++.+||+|||+++...
T Consensus 91 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iv--H~dl~p~NIl~~~~~~~kl~dfg~~~~~~ 167 (279)
T 2w5a_A 91 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL--HRDLKPANVFLDGKQNVKLGDFGLARILN 167 (279)
T ss_dssp TEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------C--CCCCSGGGEEECSSSCEEECCCCHHHHC-
T ss_pred CCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeE--EeccchhhEEEcCCCCEEEecCchheeec
Confidence 9999999975431 2335899999999999999999999998 66 99999999999999999999999987654
Q ss_pred CCC----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 471 PSS----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 471 ~~~----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
... ...++..|+|||.+.+..++.++||||||+++|||++|+.||.... .......+.... ...
T Consensus 168 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~~~-~~~----- 235 (279)
T 2w5a_A 168 HDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS------QKELAGKIREGK-FRR----- 235 (279)
T ss_dssp --CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTC-CCC-----
T ss_pred cccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC------HHHHHHHHhhcc-ccc-----
Confidence 432 1245677999999998889999999999999999999999996532 122222222211 110
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~ 586 (606)
.+......+.+++.+||+.+|++|||+.||++++.
T Consensus 236 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 236 -----IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -----CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 11123356888999999999999999999998764
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=329.01 Aligned_cols=242 Identities=22% Similarity=0.348 Sum_probs=194.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--C-------HHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEE
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--S-------EKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~-------~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 390 (606)
.+.||+|+||.||+|+.. +|+.||||++..... . .+.+.+|+.+++++ +||||+++++++......++|
T Consensus 99 ~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 178 (365)
T 2y7j_A 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178 (365)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEE
T ss_pred ceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEE
Confidence 378999999999999975 799999999875431 1 34578899999998 799999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
|||+++++|.+++... ..+++..+..++.||+.||.|||+.|++ ||||||+|||++.++.+||+|||++....
T Consensus 179 ~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~gi~--H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 179 FDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANNIV--HRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp ECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 9999999999999753 2589999999999999999999999965 99999999999999999999999987655
Q ss_pred CC---CCCCCcccccCccccCC------CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 471 PS---STPNRIDGYRAPEVTDA------RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 471 ~~---~~~~~~~~y~aPE~~~~------~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
.. ....+++.|+|||++.+ ..++.++||||||+++|||++|+.||.... .......+.......
T Consensus 252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~------~~~~~~~i~~~~~~~- 324 (365)
T 2y7j_A 252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR------QILMLRMIMEGQYQF- 324 (365)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCC-
T ss_pred CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHhCCCCC-
Confidence 43 23467888999998853 358899999999999999999999996421 112222222211100
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+. .......+.+++.+||+.||++|||+.+++++
T Consensus 325 -~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 325 -SSPE------WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -CHHH------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCcc------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 01123568889999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.10 Aligned_cols=254 Identities=20% Similarity=0.240 Sum_probs=198.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcc-cceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLV-PLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.++||+|+||.||+|+. .+++.||||++.... ...++.+|+++++.++|++.+ .+..++...+..++||||+ +++|
T Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL 89 (483)
T 3sv0_A 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL 89 (483)
T ss_dssp CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence 46799999999999985 568999999876533 234588899999999875544 5555566778889999999 8899
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe---cCCCcEEEeecccCccCCCCC---
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL---SKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
.+++.... ..+++..++.++.||+.||+|||+++++ ||||||+|||+ +.++.+||+|||+++......
T Consensus 90 ~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~gIv--HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (483)
T 3sv0_A 90 EDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFL--HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163 (483)
T ss_dssp HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCC
T ss_pred HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEe--ecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccc
Confidence 99997532 3589999999999999999999999955 99999999999 688899999999997654322
Q ss_pred --------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 474 --------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 474 --------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
...++..|+|||++.+..++.++|||||||++|||++|+.||...... .....+..+....... .+.
T Consensus 164 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~---~~~~~~~~i~~~~~~~-~~~- 238 (483)
T 3sv0_A 164 HIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG---TKKQKYEKISEKKVAT-SIE- 238 (483)
T ss_dssp BCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS---SHHHHHHHHHHHHHHS-CHH-
T ss_pred ccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch---hHHHHHHHHhhccccc-cHH-
Confidence 345678899999999999999999999999999999999999764322 1222222222111100 000
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
. .......++.+++..||+.+|++||++.+|++.|+++.....
T Consensus 239 ~-----l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 239 A-----LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp H-----HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred H-----HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 0 001223578899999999999999999999999999976543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=327.46 Aligned_cols=238 Identities=23% Similarity=0.316 Sum_probs=196.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 125 (335)
T 2owb_A 46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125 (335)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence 578999999999999864 578999999875432 345688999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
++|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++.....
T Consensus 126 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~iv--H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 126 RSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNRVI--HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp CBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred CCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCCE--ecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 99999987532 589999999999999999999999966 9999999999999999999999999765432
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....++..|+|||++.+..++.++||||||+++|||++|+.||... ........+...... .
T Consensus 199 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~~------------~ 260 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS------CLKETYLRIKKNEYS------------I 260 (335)
T ss_dssp CCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCCC------------C
T ss_pred cccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCC------CHHHHHHHHhcCCCC------------C
Confidence 2345677899999999888999999999999999999999999642 222222222221110 0
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+......+.+++.+||+.||++|||+.|++++
T Consensus 261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 261 PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123457889999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=336.58 Aligned_cols=246 Identities=13% Similarity=0.027 Sum_probs=175.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHHHH---HHHHcCCCCCCcccce-------EEEEeC--
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFREK---MEVVGSMDHENLVPLR-------AYYYSR-- 384 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~e---~~~l~~l~h~niv~l~-------~~~~~~-- 384 (606)
.+.||+|+||.||+|+.. +|+.||||++..... ..+.+.+| +..++. +||||++++ +++...
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~ 145 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ 145 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence 568999999999999964 789999999987543 23456777 456666 799988754 455433
Q ss_pred ---------------CceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCCCC
Q 037905 385 ---------------DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETR------SGLALGASRAIAYLHSKGPANSHG 443 (606)
Q Consensus 385 ---------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~~LH~~~~~i~Hr 443 (606)
...++||||++ ++|.+++..... .+.+..+ ..++.||+.||+|||+++++ ||
T Consensus 146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv--Hr 218 (371)
T 3q60_A 146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF----VYVFRGDEGILALHILTAQLIRLAANLQSKGLV--HG 218 (371)
T ss_dssp CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE--ET
T ss_pred CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc----ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc--cC
Confidence 23799999999 799999986421 2344445 67889999999999999955 99
Q ss_pred CCCCCCEEecCCCcEEEeecccCccCCCCC-CCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccc
Q 037905 444 NIKSSNILLSKSYEARISDFGLAHLASPSS-TPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLN 520 (606)
Q Consensus 444 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~ 520 (606)
||||+|||++.++.+||+|||+++...... ...++..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 298 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTP 298 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCc
Confidence 999999999999999999999998766543 4455688999999987 6799999999999999999999999986532
Q ss_pred cCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 521 EEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......... ......... ..+........+.+++.+||+.||++|||+.+++++
T Consensus 299 ~~~~~~~~~~---~~~~~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 299 GIKGSWKRPS---LRVPGTDSL------AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp TCTTCCCBCC---TTSCCCCSC------CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred ccccchhhhh---hhhcccccc------chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 2111000000 000000000 011111234568889999999999999999999753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=319.10 Aligned_cols=243 Identities=25% Similarity=0.344 Sum_probs=193.0
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+||+|+||.||+|.. .+++.||||++..... ..+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999985 4688999999976533 3567899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-CCcEEEeecccCccCCCC----CCC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-SYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
+++.... ....+++..+..++.|++.||+|||+++++ ||||||+||+++. ++.+||+|||+++..... ...
T Consensus 108 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 183 (295)
T 2clq_A 108 ALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQIV--HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183 (295)
T ss_dssp HHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCC
T ss_pred HHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCCEE--ccCCChhhEEEECCCCCEEEeecccccccCCCCCccccc
Confidence 9998643 233567889999999999999999999966 9999999999987 899999999999765432 234
Q ss_pred CCcccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 476 NRIDGYRAPEVTDAR--KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~--~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
.++..|+|||++.+. .++.++||||||+++|||++|+.||....... ..... ....... ...+
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~-~~~~~~~----------~~~~ 248 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFK-VGMFKVH----------PEIP 248 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHH-HHHHCCC----------CCCC
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHh-hcccccc----------cccc
Confidence 567889999998664 37899999999999999999999996532110 01011 0000000 0111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||+.||++|||+.+++++
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 249 ESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp TTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2233567889999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=342.59 Aligned_cols=241 Identities=23% Similarity=0.306 Sum_probs=193.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc--------------cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCc
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--------------VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDE 386 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 386 (606)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 120 (504)
T 3q5i_A 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120 (504)
T ss_dssp EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 578999999999999864 58899999997543 224678899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC---cEEEeec
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY---EARISDF 463 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~---~~kl~Df 463 (606)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++ .+||+||
T Consensus 121 ~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iv--H~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 121 FYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHNIV--HRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeE--eCCCcHHHEEEecCCCCccEEEEEC
Confidence 999999999999999987543 589999999999999999999999965 999999999998876 6999999
Q ss_pred ccCccCCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 464 GLAHLASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 464 G~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
|+++..... ....+++.|+|||++.+ .++.++|||||||++|+|++|+.||... .....+..+.......
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~------~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ------NDQDIIKKVEKGKYYF 266 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCCC
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCCCC
Confidence 999866543 33467888999999875 6999999999999999999999999653 2223333332222111
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.. .+......+.+++.+||..||++|||+.|++++
T Consensus 267 ---~~~-----~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 267 ---DFN-----DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp ---CHH-----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---Ccc-----ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000 011223568889999999999999999999876
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=340.80 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=195.2
Q ss_pred HHhcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 320 ASAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
...+.||+|+||.||+|+.. ++..||+|++.... .....+.+|+.+++.++||||++++++|.+....++||||++
T Consensus 40 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 119 (494)
T 3lij_A 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYK 119 (494)
T ss_dssp EEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCC
Confidence 34678999999999999864 68999999997643 234678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC---CcEEEeecccCccCCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS---YEARISDFGLAHLASPS 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~ 472 (606)
+|+|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.. +.+||+|||+++.....
T Consensus 120 ~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iv--H~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 120 GGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHNIV--HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCce--eccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999887542 589999999999999999999999965 99999999999764 45999999999765432
Q ss_pred ---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 ---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
....+|+.|+|||++.+ .|+.++|||||||++|+|++|+.||.... .......+........ .+
T Consensus 193 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~i~~~~~~~~--~~---- 259 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT------DQEILRKVEKGKYTFD--SP---- 259 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCCC--SG----
T ss_pred ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHhCCCCCC--ch----
Confidence 33467888999999874 69999999999999999999999996532 2223333322221110 00
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEIC 589 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~ 589 (606)
........+.+++.+||+.+|++|||+.|++++ +.++.
T Consensus 260 --~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 260 --EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp --GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred --hcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 111223467889999999999999999999876 55543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.94 Aligned_cols=244 Identities=23% Similarity=0.285 Sum_probs=194.0
Q ss_pred HhcccccCCceEEEEEEE----cCCcEEEEEEeccCc-----cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL----EMGIVVAVKRLKDVT-----VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 390 (606)
..+.||+|+||.||+|+. .+++.||||+++... ...+.+.+|+++++++ +||||+++++++......++|
T Consensus 58 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv 137 (355)
T 1vzo_A 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLI 137 (355)
T ss_dssp EEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEE
T ss_pred EEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEE
Confidence 357899999999999986 468999999987532 2345677889999988 699999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
|||+++++|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++...
T Consensus 138 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~iv--H~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 138 LDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLGII--YRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred eecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999997542 589999999999999999999999966 99999999999999999999999987543
Q ss_pred CC-----CCCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 471 PS-----STPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 471 ~~-----~~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
.. ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||...... .........+....
T Consensus 211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~------ 282 (355)
T 1vzo_A 211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE------ 282 (355)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC--CCHHHHHHHHHHCC------
T ss_pred cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc--chHHHHHHHHhccC------
Confidence 21 22357788999999985 35789999999999999999999999743221 12222222222111
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCC-----CHHHHHHHH
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRP-----SMAEVTSQI 585 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~L 585 (606)
...+......+.+++.+||..||++|| |+.|++++.
T Consensus 283 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred ------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011122335678899999999999999 999998864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=327.61 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=196.2
Q ss_pred hcccccCCceEEEEEEE--cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCC------CcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL--EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHE------NLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|.. .+++.||||+++......+.+.+|+++++.++|+ +++++++++...+..++||||
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 98 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFEL 98 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcC
Confidence 57799999999999986 3689999999976554556788899888887655 499999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-------------------
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK------------------- 454 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~------------------- 454 (606)
+ +++|.+++.... ..++++..+..++.||+.||+|||+++++ ||||||+|||++.
T Consensus 99 ~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~ 172 (339)
T 1z57_A 99 L-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNKLT--HTDLKPENILFVQSDYTEAYNPKIKRDERTLI 172 (339)
T ss_dssp C-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred C-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCCCc--CCCCCHHHEEEeccccccccCCcccccccccc
Confidence 9 789999997643 23588999999999999999999999966 9999999999987
Q ss_pred CCcEEEeecccCccCCCC-CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHH
Q 037905 455 SYEARISDFGLAHLASPS-STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSV 533 (606)
Q Consensus 455 ~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (606)
++.+||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||......+ ....+...
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~ 249 (339)
T 1z57_A 173 NPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE---HLAMMERI 249 (339)
T ss_dssp CCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH---HHHHHHHH
T ss_pred CCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHH
Confidence 668999999999865543 34567888999999999999999999999999999999999997532211 11111111
Q ss_pred hhc--------cccccc---------------------cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 534 VKE--------EWTAEV---------------------FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 534 ~~~--------~~~~~~---------------------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... ...... ..+..............+.+++.+||+.||++|||+.|++++
T Consensus 250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 000 000000 000000011123456789999999999999999999999865
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=321.98 Aligned_cols=250 Identities=26% Similarity=0.409 Sum_probs=189.5
Q ss_pred hcccccCCceEEEEEEEc--CC--cEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE--MG--IVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|++. ++ ..||||+++.... ..+.+.+|++++++++||||+++++++... ..++||||
T Consensus 23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~ 101 (291)
T 1u46_A 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTEL 101 (291)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEEC
T ss_pred eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-CceeeEec
Confidence 578999999999999853 23 3689999875422 246788999999999999999999998765 48899999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+++++|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++......
T Consensus 102 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 175 (291)
T 1u46_A 102 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFI--HRDLAARNLLLATRDLVKIGDFGLMRALPQND 175 (291)
T ss_dssp CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred ccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCchheEEEcCCCCEEEccccccccccccc
Confidence 99999999997542 3589999999999999999999999966 99999999999999999999999997664422
Q ss_pred -------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 474 -------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 474 -------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
...++..|+|||++.+..++.++||||||+++|||++ |+.||.... ....+..+.......
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~~~~~~----- 244 (291)
T 1u46_A 176 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN------GSQILHKIDKEGERL----- 244 (291)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHTSCCCC-----
T ss_pred cchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC------HHHHHHHHHccCCCC-----
Confidence 2234557999999988889999999999999999999 999996432 222233222221111
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
.........+.+++.+||+.+|++|||+.++++.|+++......
T Consensus 245 -----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 288 (291)
T 1u46_A 245 -----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288 (291)
T ss_dssp -----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred -----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence 11122345688999999999999999999999999998655443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=333.05 Aligned_cols=259 Identities=19% Similarity=0.271 Sum_probs=179.7
Q ss_pred hcccccCCceEEEEEEEc---CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~ 396 (606)
.++||+|+||.||+|+.. +++.||||++..... ...+.+|+.++++++||||+++++++.. ....++||||+.+
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~ 104 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 104 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC
Confidence 457999999999999965 578999999976433 3468899999999999999999999965 5678999999975
Q ss_pred CChhhhhhcCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe----cCCCcEEEeecccCcc
Q 037905 397 GSLSALLHGNR----GAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL----SKSYEARISDFGLAHL 468 (606)
Q Consensus 397 g~L~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill----~~~~~~kl~DfG~a~~ 468 (606)
+|.+++.... ......+++..+..++.||+.||+|||+++++ ||||||+|||+ +.++.+||+|||+++.
T Consensus 105 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv--H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 181 (405)
T 3rgf_A 105 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL--HRDLKPANILVMGEGPERGRVKIADMGFARL 181 (405)
T ss_dssp -EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred -CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEe--CCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence 8888775321 11223589999999999999999999999966 99999999999 7788999999999986
Q ss_pred CCCC-------CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCC---CChhHHHHHHhhcc
Q 037905 469 ASPS-------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG---VDLPRWVQSVVKEE 537 (606)
Q Consensus 469 ~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~---~~~~~~~~~~~~~~ 537 (606)
.... ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||........ ......+..+...-
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~ 261 (405)
T 3rgf_A 182 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261 (405)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHH
T ss_pred cCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhh
Confidence 5432 23456788999999887 4589999999999999999999999975332110 00111111111100
Q ss_pred ccc------cc------------cchhhhcccChH--------HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 WTA------EV------------FDLELLRYQNVE--------EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ~~~------~~------------~d~~~~~~~~~~--------~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... .+ +........... .....+.+|+.+||..||++|||++|++++
T Consensus 262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000 00 000000000000 013467899999999999999999999886
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=331.45 Aligned_cols=253 Identities=20% Similarity=0.275 Sum_probs=187.6
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCH--HHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+.. +++.||||++....... ..+.+|++++++++||||+++++++......++||||+++ +
T Consensus 7 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~ 85 (324)
T 3mtl_A 7 LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-D 85 (324)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSE-E
T ss_pred EEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccccc-C
Confidence 467999999999999865 68999999997543221 2356799999999999999999999999999999999985 9
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
|.+++.... ..+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++..... ..
T Consensus 86 l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~iv--H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 86 LKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCHRQKVL--HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEE--ESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--CCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 999887543 3589999999999999999999999965 9999999999999999999999998765432 22
Q ss_pred CCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccc---cccccc-hhhhc
Q 037905 475 PNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW---TAEVFD-LELLR 549 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d-~~~~~ 549 (606)
..++..|+|||++.+ ..++.++||||||+++|||++|+.||......+ ....+........ ...... .....
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 345778999999876 568999999999999999999999996532111 1111111110000 000000 00000
Q ss_pred -------cc----ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 -------YQ----NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 -------~~----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. ........+.+++.+||+.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 001123567899999999999999999999885
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=337.65 Aligned_cols=183 Identities=23% Similarity=0.367 Sum_probs=146.3
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeC-----CceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ 391 (606)
..+.||+|+||.||+|... +++.||||++...... .+.+.+|++++++++||||+++++++... ...++||
T Consensus 57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~ 136 (458)
T 3rp9_A 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136 (458)
T ss_dssp ECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEE
T ss_pred EeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEE
Confidence 3578999999999999854 6899999999764332 45688999999999999999999998543 4689999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+. ++|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ii--HrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 137 EIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAGIL--HRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred eccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcC--CCCCChhhEEECCCCCEeecccccchhccC
Confidence 9985 6999998743 3589999999999999999999999966 999999999999999999999999986542
Q ss_pred C-------------------------------CCCCCcccccCcccc-CCCCCCCcchhHHHHHHHHHHHhC
Q 037905 472 S-------------------------------STPNRIDGYRAPEVT-DARKVSQKADVYSFGVLLLELLTG 511 (606)
Q Consensus 472 ~-------------------------------~~~~~~~~y~aPE~~-~~~~~~~~sDv~slGvvl~elltg 511 (606)
. ....+|+.|+|||++ ....|+.++|||||||++|||++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 1 122457789999976 566799999999999999999993
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.04 Aligned_cols=241 Identities=23% Similarity=0.376 Sum_probs=192.8
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+.++++++||||+++++++......++||||+++++|.
T Consensus 34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 112 (314)
T 3com_A 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS 112 (314)
T ss_dssp EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHH
Confidence 467999999999999865 58999999997643 3467889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCCC
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STPN 476 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~~ 476 (606)
+++.... ..+++..+..++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||+++..... ....
T Consensus 113 ~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 186 (314)
T 3com_A 113 DIIRLRN----KTLTEDEIATILQSTLKGLEYLHFMRKI--HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI 186 (314)
T ss_dssp HHHHHHT----CCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCC
T ss_pred HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCCc--CCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccC
Confidence 9987432 3589999999999999999999999966 9999999999999999999999999765432 2345
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|+|||++.+..++.++||||||+++|||++|+.||..... .......... ..... ..+...
T Consensus 187 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~-~~~~~--------~~~~~~ 251 (314)
T 3com_A 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIPTN-PPPTF--------RKPELW 251 (314)
T ss_dssp SCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHS-CCCCC--------SSGGGS
T ss_pred CCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcC-CCccc--------CCcccC
Confidence 67789999999998999999999999999999999999964321 1111111111 10100 111223
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...+.+++.+||..||++|||+.+++++
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 4568899999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=325.07 Aligned_cols=249 Identities=19% Similarity=0.221 Sum_probs=185.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|.. .+++.||||+++..... .+.+.+|++++++++||||+++++++......++||||+++
T Consensus 39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~- 117 (329)
T 3gbz_A 39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117 (329)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSE-
T ss_pred EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCC-
Confidence 57899999999999985 47899999999754332 34578999999999999999999999999999999999985
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec-----CCCcEEEeecccCccCCCC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS-----KSYEARISDFGLAHLASPS 472 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~-----~~~~~kl~DfG~a~~~~~~ 472 (606)
+|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++ .++.+||+|||+++.....
T Consensus 118 ~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~iv--H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 118 DLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRRCL--HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEE--CCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 9999997543 489999999999999999999999966 999999999994 5556999999999765422
Q ss_pred ----CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccc-ccch-
Q 037905 473 ----STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE-VFDL- 545 (606)
Q Consensus 473 ----~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~d~- 545 (606)
....++..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..+........ ..-+
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~ 264 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE------IDQLFKIFEVLGLPDDTTWPG 264 (329)
T ss_dssp ---------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH------HHHHHHHHHHhCCCchhhhhh
Confidence 233457889999999774 489999999999999999999999965321 111222111100000 0000
Q ss_pred ---------hhh--cccCh-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ---------ELL--RYQNV-----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ---------~~~--~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... ..... ......+.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 00000 0123567899999999999999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.10 Aligned_cols=253 Identities=24% Similarity=0.347 Sum_probs=179.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|.. .+++.||||++.... ...+++.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 99 (303)
T 2vwi_A 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS 99 (303)
T ss_dssp EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence 57899999999999984 468999999986542 234678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 399 LSALLHGNR---GAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 399 L~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
|.+++.... ......+++..+..++.||+.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 177 (303)
T 2vwi_A 100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI--HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177 (303)
T ss_dssp HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCSGGGEEECTTCCEEECCCHHHHHCC-----
T ss_pred hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCC--CCCCChhhEEEcCCCCEEEEeccchheeccCCCc
Confidence 999987411 11234589999999999999999999999966 9999999999999999999999988654321
Q ss_pred ------CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 ------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 ------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ........... ... ..
T Consensus 178 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~-~~~-~~ 249 (303)
T 2vwi_A 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM------KVLMLTLQNDP-PSL-ET 249 (303)
T ss_dssp ----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG------GHHHHHHTSSC-CCT-TC
T ss_pred cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh------hHHHHHhccCC-Ccc-cc
Confidence 22356778999999865 56899999999999999999999999753221 11111111110 000 00
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..............+.+++.+||+.||++|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000001111223568889999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=321.80 Aligned_cols=242 Identities=21% Similarity=0.358 Sum_probs=190.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEe------CCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYS------RDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|+. .+|+.||||++.......+.+.+|+.+++++ +||||+++++++.. ....++||||
T Consensus 29 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~ 108 (326)
T 2x7f_A 29 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEEC
T ss_pred EEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEc
Confidence 57899999999999986 4689999999987666678899999999998 89999999999986 4578999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
+++++|.+++.... ...+++..+..++.||+.||+|||++|++ ||||||+||+++.++.+||+|||+++.....
T Consensus 109 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iv--H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 183 (326)
T 2x7f_A 109 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHKVI--HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183 (326)
T ss_dssp CTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred CCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence 99999999998643 23588999999999999999999999966 9999999999999999999999998765432
Q ss_pred ---CCCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 ---STPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
....++..|+|||++. ...++.++||||||+++|||++|+.||.... .......+..... ....
T Consensus 184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~~~- 255 (326)
T 2x7f_A 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------PMRALFLIPRNPA-PRLK- 255 (326)
T ss_dssp -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC-CCCS-
T ss_pred cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc------HHHHHHHhhcCcc-ccCC-
Confidence 2345678899999987 5678999999999999999999999996422 1111111111111 1000
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||..||++|||+.+++++
T Consensus 256 --------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 256 --------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp --------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 01123468889999999999999999999875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=326.73 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=191.2
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccC------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
..+.||+|+||.||+|+.. +|+.||||++...... .+.+.+|++++++++||||+++++++......++||||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 93 (346)
T 1ua2_A 14 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 93 (346)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred EEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEc
Confidence 4578999999999999864 5899999999753221 23578999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
+++ +|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 94 MET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHWIL--HRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp CSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred CCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCCEE--CCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 986 8988887532 3578889999999999999999999966 9999999999999999999999999865432
Q ss_pred ---CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc------ccc
Q 037905 473 ---STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT------AEV 542 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 542 (606)
....+++.|+|||++.+. .++.++|||||||++|||++|.+||.... ....+..+...... ...
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~------~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS------DLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC------HHHHHHHHHHHcCCCChhhhhhh
Confidence 234567889999998654 58999999999999999999999986532 12222222211000 000
Q ss_pred cc-hhhh---cc-cC-----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FD-LELL---RY-QN-----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d-~~~~---~~-~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.. +... .. .. .......+.+++.+||..||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00 0000 00 00 01223578899999999999999999999886
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=350.04 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=199.2
Q ss_pred HHhcccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 320 ASAEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
...+.||+|+||.||+|... .+..||||+++.... ..+.+.+|+.++++++||||+++++++. ++..++||||
T Consensus 393 ~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~ 471 (656)
T 2j0j_A 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMEL 471 (656)
T ss_dssp EEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred EEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEc
Confidence 34578999999999999863 256899999875432 2367899999999999999999999984 5678999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+++|+|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 472 ~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giv--HrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 472 CTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKRFV--HRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp CTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred CCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--ccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 99999999997542 3589999999999999999999999966 99999999999999999999999998765432
Q ss_pred C-----CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 T-----PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 ~-----~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
. ..++..|+|||++.+..++.++||||||+++|||++ |..||.... .......+......
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~------~~~~~~~i~~~~~~-------- 611 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK------NNDVIGRIENGERL-------- 611 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHHTCCC--------
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHHcCCCC--------
Confidence 1 234467999999988899999999999999999997 999996532 22222222221110
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
..+...+..+.+++.+||+.||++|||+.+|++.|+++.+.
T Consensus 612 ---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 612 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 11123345788999999999999999999999999998754
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=315.90 Aligned_cols=244 Identities=20% Similarity=0.314 Sum_probs=180.1
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCH---HHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|+. .+|+.||+|+++...... +.+.++...++.++||||+++++++...+..++||||+++
T Consensus 12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~- 90 (290)
T 3fme_A 12 IMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT- 90 (290)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-
T ss_pred HHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-
Confidence 46799999999999986 578999999997643322 2344555668889999999999999999999999999985
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
+|.+++..... ....+++..+..++.|++.||+|||++ |++ ||||||+||+++.++.+||+|||+++......
T Consensus 91 ~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (290)
T 3fme_A 91 SLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLSVI--HRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD 167 (290)
T ss_dssp EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSCCC--CCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred chHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCCee--cCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence 88777754211 124689999999999999999999998 866 99999999999999999999999997654432
Q ss_pred CCCCcccccCcccc----CCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 474 TPNRIDGYRAPEVT----DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 474 ~~~~~~~y~aPE~~----~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
...++..|+|||++ .+..++.++||||||+++|||++|+.||.... .....+...........
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~-------- 234 (290)
T 3fme_A 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-----TPFQQLKQVVEEPSPQL-------- 234 (290)
T ss_dssp --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS-----CHHHHHHHHHHSCCCCC--------
T ss_pred ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC-----chHHHHHHHhccCCCCc--------
Confidence 23577889999996 55678999999999999999999999996421 11111222222211100
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||+.||++|||+.|++++
T Consensus 235 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 235 --PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp --CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred --ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 011233568899999999999999999999884
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=317.54 Aligned_cols=242 Identities=23% Similarity=0.366 Sum_probs=191.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 103 (302)
T 2j7t_A 24 VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103 (302)
T ss_dssp EEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEH
T ss_pred cceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcH
Confidence 567999999999999975 58999999987543 3457889999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC----CCCCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS----PSSTP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~----~~~~~ 475 (606)
.+++.... ..+++..+..++.|++.||.|||+.|++ ||||||+||+++.++.+||+|||++.... .....
T Consensus 104 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 177 (302)
T 2j7t_A 104 DAIMLELD----RGLTEPQIQVVCRQMLEALNFLHSKRII--HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF 177 (302)
T ss_dssp HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhcCCcc--cCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence 99987532 3589999999999999999999999966 99999999999999999999999875321 12334
Q ss_pred CCcccccCcccc-----CCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 476 NRIDGYRAPEVT-----DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 476 ~~~~~y~aPE~~-----~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
.++..|+|||++ ....++.++||||||+++|||++|+.||.... ............. ...
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~~~-~~~-------- 242 (302)
T 2j7t_A 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIAKSDP-PTL-------- 242 (302)
T ss_dssp -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC-CCC--------
T ss_pred cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC------HHHHHHHHhccCC-ccc--------
Confidence 577889999988 46678999999999999999999999996432 2222222222111 100
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.........+.+++.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1112234568899999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.05 Aligned_cols=187 Identities=21% Similarity=0.347 Sum_probs=158.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC-----CceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e 392 (606)
.+.||+|+||.||+|.. .+++.||||++..... ..+.+.+|++++++++||||+++++++... ...++|||
T Consensus 31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e 110 (432)
T 3n9x_A 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110 (432)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence 57899999999999985 4689999999976433 246788999999999999999999998765 56899999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+. ++|.+++... ..+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 111 ~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~giv--HrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 111 IAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESGII--HRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp CCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred cCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCC--CCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 987 4999999753 3589999999999999999999999965 9999999999999999999999999865432
Q ss_pred --------------------------CCCCCcccccCcccc-CCCCCCCcchhHHHHHHHHHHHhCCCCcc
Q 037905 473 --------------------------STPNRIDGYRAPEVT-DARKVSQKADVYSFGVLLLELLTGKAPTQ 516 (606)
Q Consensus 473 --------------------------~~~~~~~~y~aPE~~-~~~~~~~~sDv~slGvvl~elltg~~p~~ 516 (606)
....+|..|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 234567889999986 56679999999999999999998665554
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.29 Aligned_cols=253 Identities=20% Similarity=0.257 Sum_probs=190.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC--------CceEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR--------DEKLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~l 389 (606)
.+.||+|+||.||+|+. .+|+.||||++..... ....+.+|+++++.++||||+++++++... +..++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l 101 (351)
T 3mi9_A 22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 101 (351)
T ss_dssp EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence 57899999999999986 5789999999865432 245788999999999999999999999863 46799
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||||+++ +|.+.+.... ..+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++..
T Consensus 102 v~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iv--H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 102 VFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNKIL--HRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp EEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCee--CCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 9999986 7877776532 3589999999999999999999999966 9999999999999999999999999765
Q ss_pred CCC--------CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc---
Q 037905 470 SPS--------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE--- 537 (606)
Q Consensus 470 ~~~--------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 537 (606)
... ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+.......
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSITPE 251 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTT
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChh
Confidence 321 22345778999999876 458999999999999999999999997532211 111111110000
Q ss_pred ccccccchh--------hhcccChHHH------HHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 WTAEVFDLE--------LLRYQNVEEE------MVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ~~~~~~d~~--------~~~~~~~~~~------~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......... ........+. ...+.+++.+||+.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000000000 0000011111 2458899999999999999999999886
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=351.35 Aligned_cols=238 Identities=22% Similarity=0.283 Sum_probs=196.1
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+.. +++.||||+++... ...+.+..|..++..+ +||+|+++++++.+.+..++||||++
T Consensus 346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~ 425 (674)
T 3pfq_A 346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN 425 (674)
T ss_dssp EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence 468999999999999864 68899999997532 2345678889999887 79999999999999899999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP---- 471 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 471 (606)
+|+|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++....
T Consensus 426 gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~gIi--HrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~ 498 (674)
T 3pfq_A 426 GGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKGII--YRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 498 (674)
T ss_dssp SCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTSEE--CCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeE--eccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence 999999998643 589999999999999999999999965 999999999999999999999999985432
Q ss_pred CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 472 SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 472 ~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
.....+|+.|+|||++.+..|+.++|||||||++|||++|+.||... +.....+.+......
T Consensus 499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~------------ 560 (674)
T 3pfq_A 499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE------DEDELFQSIMEHNVA------------ 560 (674)
T ss_dssp BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHSSCCC------------
T ss_pred cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC------CHHHHHHHHHhCCCC------------
Confidence 23456788999999999999999999999999999999999999652 223333444332211
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCH-----HHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSM-----AEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~-----~~v~~~ 584 (606)
.+.....++.+++.+||+.||++||++ +||.++
T Consensus 561 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 561 YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 111233567889999999999999998 666654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=325.53 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=185.8
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC------------HHHHHHHHHHHcCCCCCCcccceEEEEeC-----
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS------------EKEFREKMEVVGSMDHENLVPLRAYYYSR----- 384 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 384 (606)
.+.||+|+||.||+|...+|..||||++...... .+.+.+|++++++++||||+++++++...
T Consensus 27 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 106 (362)
T 3pg1_A 27 QRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAM 106 (362)
T ss_dssp EEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTC
T ss_pred eEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCc
Confidence 4689999999999999888999999998643221 26789999999999999999999998653
Q ss_pred CceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecc
Q 037905 385 DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464 (606)
Q Consensus 385 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG 464 (606)
...++||||+. |+|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~Dlkp~NIl~~~~~~~kl~Dfg 179 (362)
T 3pg1_A 107 HKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAGVV--HRDLHPGNILLADNNDITICDFN 179 (362)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTCCEEECCTT
T ss_pred ceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCcCE--ecCCChHHEEEcCCCCEEEEecC
Confidence 25799999998 58888887432 3589999999999999999999999966 99999999999999999999999
Q ss_pred cCccCCCC---CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 465 LAHLASPS---STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 465 ~a~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
+++..... ....++..|+|||++.+ ..++.++||||||+++|||++|+.||.... .......+.......
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST------FYNQLNKIVEVVGTP 253 (362)
T ss_dssp C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCC
T ss_pred cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHcCCC
Confidence 99754432 23456777999999876 678999999999999999999999996532 111122111100000
Q ss_pred c--------------ccchhhhc--ccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 E--------------VFDLELLR--YQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~--------------~~d~~~~~--~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. ........ ... .......+.+++.+||+.||++|||+.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 0 00000000 000 11223568899999999999999999999886
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=322.98 Aligned_cols=247 Identities=22% Similarity=0.260 Sum_probs=185.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCC------ceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRD------EKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 391 (606)
.+.||+|+||.||+|.. .+++.||||++...... .+.+.+|+.+++.++||||+++++++.... ..++||
T Consensus 30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~ 109 (371)
T 2xrw_A 30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM 109 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence 57899999999999985 46899999999764332 356889999999999999999999997654 679999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+++ +|.+.+.. .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 110 e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~iv--H~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 110 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp ECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCCee--cccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 99975 78888852 388999999999999999999999966 999999999999999999999999986654
Q ss_pred C---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc------------
Q 037905 472 S---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------------ 536 (606)
Q Consensus 472 ~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 536 (606)
. ....++..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+...
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~ 253 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH------IDQWNKVIEQLGTPCPEFMKKL 253 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHC-CCCCCHHHHTTS
T ss_pred ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHHh
Confidence 2 234567889999999999999999999999999999999999975321 1111111110
Q ss_pred ----------cccccccc-----hhhhccc---ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 ----------EWTAEVFD-----LELLRYQ---NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 ----------~~~~~~~d-----~~~~~~~---~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........ +...... ........+.+++.+||..||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 0000000 012335678999999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.08 Aligned_cols=246 Identities=19% Similarity=0.245 Sum_probs=190.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCC-CCCcccceEEEEe--CCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HENLVPLRAYYYS--RDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|.. .+++.||||+++. ...+.+.+|++++++++ ||||+++++++.. ....++||||+.++
T Consensus 41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 118 (330)
T 3nsz_A 41 VRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 118 (330)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred EEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence 57899999999999985 5789999999974 34678999999999997 9999999999987 56789999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCC---C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPS---S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~---~ 473 (606)
+|.+++. .++...+..++.|++.||+|||++|++ ||||||+|||++.++ .+||+|||+++..... .
T Consensus 119 ~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~ 188 (330)
T 3nsz_A 119 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIM--HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN 188 (330)
T ss_dssp CHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCC
T ss_pred hHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCCee--eCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccc
Confidence 9999985 378899999999999999999999965 999999999999777 8999999999865443 2
Q ss_pred CCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh---ccccc-------cc
Q 037905 474 TPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK---EEWTA-------EV 542 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-------~~ 542 (606)
...++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+..+.. ..... ..
T Consensus 189 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-----~~~~l~~~~~~~~~~~~~~~~~~~~~~ 263 (330)
T 3nsz_A 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-----NYDQLVRIAKVLGTEDLYDYIDKYNIE 263 (330)
T ss_dssp SCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS-----HHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred cccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc-----hHHHHHHHHHhcCCchhhhHHHHhccc
Confidence 3456777999999877 6789999999999999999999999953211 1111110000 00000 00
Q ss_pred cchh---------------hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLE---------------LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~---------------~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.++. .............+.+++.+||+.||++|||++|++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 00001111234678899999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=326.30 Aligned_cols=248 Identities=23% Similarity=0.300 Sum_probs=175.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 391 (606)
.+.||+|+||.||+|.. .+|+.||||++..... ..+.+.+|+.+++.++||||+++++++... ...++|+
T Consensus 34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~ 113 (367)
T 2fst_X 34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113 (367)
T ss_dssp EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence 57899999999999985 5689999999975433 245688999999999999999999998754 5679999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+ +++|.+++.. ..+++..+..++.||+.||+|||+.|++ ||||||+|||++.++.+||+|||+++....
T Consensus 114 e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~giv--H~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 114 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSADII--HRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp ECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTCCEEECC---------
T ss_pred ccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCee--eCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 999 6799998864 2489999999999999999999999966 999999999999999999999999986544
Q ss_pred C-CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------cccccc
Q 037905 472 S-STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------WTAEVF 543 (606)
Q Consensus 472 ~-~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 543 (606)
. ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||.... ....+..+.... ....+.
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~------~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 185 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD------HIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 33467788999999877 678999999999999999999999996532 122222211100 000000
Q ss_pred chh-------hhc--ccCh----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLE-------LLR--YQNV----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~-------~~~--~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... +.. .... ......+.+++.+||..||++|||+.|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 000 0000 1123567899999999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=327.61 Aligned_cols=257 Identities=18% Similarity=0.263 Sum_probs=194.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCC-----------CCCcccceEEEEeCC----
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-----------HENLVPLRAYYYSRD---- 385 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~~---- 385 (606)
.+.||+|+||.||+|+. .+++.||||++.......+.+.+|++++++++ |+||+++++++....
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 103 (373)
T 1q8y_A 24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV 103 (373)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred EEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence 57899999999999985 56899999999866555677889999888775 899999999998654
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEec------CCCcE
Q 037905 386 EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLS------KSYEA 458 (606)
Q Consensus 386 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~------~~~~~ 458 (606)
..++||||+ +++|.+++.... ...+++..+..++.||+.||+|||++ |++ ||||||+|||++ ..+.+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~iv--H~Dikp~NIll~~~~~~~~~~~~ 177 (373)
T 1q8y_A 104 HVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQI 177 (373)
T ss_dssp EEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCEE--CSCCSGGGEEEEEEETTTTEEEE
T ss_pred eEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCCEE--ecCCChHHeEEeccCCCcCcceE
Confidence 689999999 889999998643 23489999999999999999999998 866 999999999994 44479
Q ss_pred EEeecccCccCCCC-CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc
Q 037905 459 RISDFGLAHLASPS-STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE 537 (606)
Q Consensus 459 kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (606)
||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||..............+..+...-
T Consensus 178 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (373)
T 1q8y_A 178 KIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 257 (373)
T ss_dssp EECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHH
T ss_pred EEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhc
Confidence 99999999766543 34467888999999999899999999999999999999999997543221111111111111000
Q ss_pred ------------cc----------cccc--------chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 ------------WT----------AEVF--------DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ------------~~----------~~~~--------d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+. ..+. +........+......+.+++.+||+.||++|||+.|++++
T Consensus 258 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 258 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp CSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence 00 0000 00001112335667889999999999999999999999885
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=324.66 Aligned_cols=252 Identities=16% Similarity=0.255 Sum_probs=196.4
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC------------------HHHHHHHHHHHcCCCCCCcccceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS------------------EKEFREKMEVVGSMDHENLVPLRAYYYS 383 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~e~~~l~~l~h~niv~l~~~~~~ 383 (606)
.+.||+|+||.||+|.. +|+.||||++...... .+.+.+|++++++++||||+++++++.+
T Consensus 36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 114 (348)
T 2pml_X 36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN 114 (348)
T ss_dssp EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence 57899999999999998 8999999998653221 1789999999999999999999999999
Q ss_pred CCceEEEEeecCCCChhhh------hhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCC
Q 037905 384 RDEKLLVHDYMPMGSLSAL------LHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSY 456 (606)
Q Consensus 384 ~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~ 456 (606)
.+..++||||+++++|.++ +.... ...+++..+..++.|++.||+|||+ .|++ ||||||+||+++.++
T Consensus 115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~--H~dl~p~Nil~~~~~ 189 (348)
T 2pml_X 115 YDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNEKNIC--HRDVKPSNILMDKNG 189 (348)
T ss_dssp SSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHTSCEE--CCCCCGGGEEECTTS
T ss_pred CCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhccCCEe--ecCCChHhEEEcCCC
Confidence 9999999999999999999 54321 3468999999999999999999999 8866 999999999999999
Q ss_pred cEEEeecccCccCCCC--CCCCCcccccCccccCCC-CCCC-cchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHH
Q 037905 457 EARISDFGLAHLASPS--STPNRIDGYRAPEVTDAR-KVSQ-KADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQS 532 (606)
Q Consensus 457 ~~kl~DfG~a~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~-~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 532 (606)
.+||+|||.++..... ....++..|+|||.+.+. .++. ++||||||+++|||++|+.||..... .......
T Consensus 190 ~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~ 264 (348)
T 2pml_X 190 RVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS-----LVELFNN 264 (348)
T ss_dssp CEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC-----SHHHHHH
T ss_pred cEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHH
Confidence 9999999999765432 344577889999999887 6666 99999999999999999999975322 1222222
Q ss_pred Hhhccccccc----cchhhhc---ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 533 VVKEEWTAEV----FDLELLR---YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 533 ~~~~~~~~~~----~d~~~~~---~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+......... ....... ..........+.+++.+||+.||++|||+.|++++
T Consensus 265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2221110000 0000000 00012234578899999999999999999999874
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=314.70 Aligned_cols=242 Identities=20% Similarity=0.291 Sum_probs=194.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----------CHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEE
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----------SEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 389 (606)
.+.||+|+||.||+|... +|+.||||++..... ..+.+.+|+++++++. ||||+++++++......++
T Consensus 22 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l 101 (298)
T 1phk_A 22 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101 (298)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred eeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEE
Confidence 467999999999999864 689999999975421 1345788999999995 9999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||||+++++|.+++... ..+++..+..++.||+.||+|||++|++ ||||||+||+++.++.+||+|||+++..
T Consensus 102 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 102 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLNIV--HRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999753 2589999999999999999999999966 9999999999999999999999999765
Q ss_pred CCC---CCCCCcccccCccccC------CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 470 SPS---STPNRIDGYRAPEVTD------ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 470 ~~~---~~~~~~~~y~aPE~~~------~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
... ....++..|+|||++. ...++.++||||||+++|||++|+.||.... .......+.......
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK------QMLMLRMIMSGNYQF 248 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHTCCCC
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc------HHHHHHHHhcCCccc
Confidence 432 2345677899999874 4568899999999999999999999996421 222222222221110
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. .+........+.+++.+||+.||++|||+.|++++
T Consensus 249 ~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 249 G--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp C--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C--------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 0 01112234568899999999999999999999763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=329.29 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=188.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeC----------------
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR---------------- 384 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------------- 384 (606)
.+.||+|+||.||+|+. .+|+.||||++.... ....+|+++++.++||||++++++|...
T Consensus 12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~ 88 (383)
T 3eb0_A 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK 88 (383)
T ss_dssp EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence 57899999999999985 578999999986542 2234799999999999999999998543
Q ss_pred ----------------------CceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCC
Q 037905 385 ----------------------DEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442 (606)
Q Consensus 385 ----------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~H 442 (606)
...++||||+++ +|.+.+..... ....+++..+..++.||+.||+|||++|++ |
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~--H 164 (383)
T 3eb0_A 89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLGIC--H 164 (383)
T ss_dssp ---------------------CCEEEEEECCCSE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTTEE--C
T ss_pred ccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCcCc--c
Confidence 237899999985 87777753211 123689999999999999999999999966 9
Q ss_pred CCCCCCCEEec-CCCcEEEeecccCccCCCC---CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 443 GNIKSSNILLS-KSYEARISDFGLAHLASPS---STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 443 rDlkp~Nill~-~~~~~kl~DfG~a~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
|||||+|||++ .++.+||+|||+++..... ....++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 99999999998 6889999999999865432 234567789999998764 589999999999999999999999975
Q ss_pred ccccCCCChhHHHHHHhhccc-------------cccccchhhhccc-----ChHHHHHHHHHHHHHccCcCCCCCCCHH
Q 037905 518 LLNEEGVDLPRWVQSVVKEEW-------------TAEVFDLELLRYQ-----NVEEEMVQLLQLAINCTAQYPDNRPSMA 579 (606)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~d~~~~~~~-----~~~~~~~~l~~l~~~Cl~~~P~~RPs~~ 579 (606)
... .+.+..+..... .....-+. .... .+......+.+++.+||+.||++|||+.
T Consensus 245 ~~~------~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 245 ETS------IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPT-LKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSH------HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCC-CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCh------HHHHHHHHHHhCCCCHHHHHHhCcccccccCCc-cCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 321 111221111000 00000000 0000 0112345688999999999999999999
Q ss_pred HHHHH--HHHHHh
Q 037905 580 EVTSQ--IEEICR 590 (606)
Q Consensus 580 ~v~~~--L~~i~~ 590 (606)
|++++ ++++..
T Consensus 318 e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 318 EAMAHPFFDHLRN 330 (383)
T ss_dssp HHHTSGGGHHHHH
T ss_pred HHhcCHHHHHHHh
Confidence 99875 444443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=322.60 Aligned_cols=247 Identities=24% Similarity=0.320 Sum_probs=188.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCce------EEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDEK------LLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~lv~ 391 (606)
.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|+.+++.++||||+++++++...... ++||
T Consensus 47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 126 (371)
T 4exu_A 47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence 56799999999999985 46899999999765433 36788999999999999999999999876554 9999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+. ++|.+++.. .+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 127 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 127 PFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAGVV--HRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp ECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred cccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCCCc--CCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 9997 588888742 389999999999999999999999966 999999999999999999999999986554
Q ss_pred C-CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccc------ccccc
Q 037905 472 S-STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW------TAEVF 543 (606)
Q Consensus 472 ~-~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 543 (606)
. ....++..|+|||++.+ ..++.++||||||+++|||++|+.||.... ....+..+..... .....
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------YLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCcHHHHHHhh
Confidence 3 33467888999999877 678999999999999999999999996532 1222222111000 00000
Q ss_pred ch-------hhhc--ccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DL-------ELLR--YQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~-------~~~~--~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+. .... ... .......+.+++.+||+.||++|||+.|++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 0000 000 01224578899999999999999999999886
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.13 Aligned_cols=241 Identities=23% Similarity=0.354 Sum_probs=186.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEe-------------CCce
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS-------------RDEK 387 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------------~~~~ 387 (606)
.+.||+|+||.||+|+. .+++.||||++.......+.+.+|+.++++++||||+++++++.. ....
T Consensus 11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (303)
T 1zy4_A 11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTL 90 (303)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEE
T ss_pred hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCce
Confidence 57899999999999986 478999999997654455778999999999999999999999865 3467
Q ss_pred EEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 388 LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 388 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+++++ ||||||+||+++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~--H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 91 FIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQGII--HRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp EEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred EEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCCee--cccCCHHhEEEcCCCCEEEeeCcchh
Confidence 89999999999999998532 3578899999999999999999999966 99999999999999999999999987
Q ss_pred cCCCC------------------CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhH
Q 037905 468 LASPS------------------STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPR 528 (606)
Q Consensus 468 ~~~~~------------------~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~ 528 (606)
..... ....++..|+|||++.+. .++.++||||||+++|||++ ||..... ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-----~~~ 236 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-----RVN 236 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-----HHH
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-----HHH
Confidence 65421 123456779999999764 68999999999999999998 4432111 111
Q ss_pred HHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 529 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......... . .. ..........+.+++.+||+.||++|||+.+++++
T Consensus 237 ~~~~~~~~~~--~-~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 237 ILKKLRSVSI--E-FP-----PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHSTTC--C-CC-----TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHhcccccc--c-cC-----ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1111111100 0 00 01112234567889999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=323.37 Aligned_cols=248 Identities=20% Similarity=0.299 Sum_probs=190.1
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+... .+|+|+++.... ..+.+.+|+.++++++||||+++++++......++||||+++++
T Consensus 38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 5689999999999998753 489999875432 23457889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC-------
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP------- 471 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~------- 471 (606)
|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+||+++ ++.+||+|||+++....
T Consensus 116 L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~i~--H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~ 188 (319)
T 2y4i_B 116 LYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKGIL--HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE 188 (319)
T ss_dssp HHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcc--ccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence 999997532 3588999999999999999999999966 999999999998 67999999999865422
Q ss_pred --CCCCCCcccccCccccCC---------CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 472 --SSTPNRIDGYRAPEVTDA---------RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 472 --~~~~~~~~~y~aPE~~~~---------~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
.....++..|+|||++.. ..++.++||||||+++|||++|+.||.... .......+.. ....
T Consensus 189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~-~~~~ 261 (319)
T 2y4i_B 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP------AEAIIWQMGT-GMKP 261 (319)
T ss_dssp CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC------HHHHHHHHHT-TCCC
T ss_pred cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHhcc-CCCC
Confidence 112346778999999864 357889999999999999999999996432 1122222211 1111
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
.... ......+.+++.+||..+|++|||+.++++.|+++.+....
T Consensus 262 ~~~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 262 NLSQ---------IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp CCCC---------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CCCc---------CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1100 01223578899999999999999999999999998765433
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=313.80 Aligned_cols=239 Identities=23% Similarity=0.359 Sum_probs=190.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc-----cCHHHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT-----VSEKEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 393 (606)
.+.||+|+||.||++.. .+++.||+|+++... ...+.+.+|++++++++||||+++++++.. ....++||||
T Consensus 10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (305)
T 2wtk_C 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89 (305)
T ss_dssp CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence 46799999999999986 468999999997542 234678999999999999999999999853 4578999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
++++ |.+++.... ...+++..+..++.||+.||+|||+++++ ||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~--H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 90 CVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQGIV--HKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp CSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred ccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCCee--ecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 9876 777776543 24689999999999999999999999966 9999999999999999999999999765431
Q ss_pred -----CCCCCcccccCccccCCCC--CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 -----STPNRIDGYRAPEVTDARK--VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 -----~~~~~~~~y~aPE~~~~~~--~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....++..|+|||++.+.. ++.++||||||+++|||++|+.||... ........+.....
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~i~~~~~------- 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD------NIYKLFENIGKGSY------- 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHCCC-------
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc------hHHHHHHHHhcCCC-------
Confidence 2345678899999987644 377999999999999999999999642 22222322222211
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+......+.+++.+||+.||++|||+.|++++
T Consensus 231 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 -----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0111233467889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=329.36 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=184.8
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCc------eEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDE------KLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~e~~ 394 (606)
..+.||+|+||.||+|+...+..||+|++..... ...+|+++++.++||||++++++|..... .++||||+
T Consensus 44 ~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~---~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~ 120 (394)
T 4e7w_A 44 NCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR---FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV 120 (394)
T ss_dssp EEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT---SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECC
T ss_pred EeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc---hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeecc
Confidence 3578999999999999987677799998864322 23368999999999999999999975443 78999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec-CCCcEEEeecccCccCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS-KSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~- 472 (606)
+++.+........ ....+++..+..++.||+.||+|||++|++ ||||||+|||++ .++.+||+|||+++.....
T Consensus 121 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv--HrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~ 196 (394)
T 4e7w_A 121 PETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIGIC--HRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196 (394)
T ss_dssp SEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred CccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCcc--CCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence 8754443332111 123589999999999999999999999965 999999999999 7899999999999865432
Q ss_pred --CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-------------
Q 037905 473 --STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------------- 536 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------- 536 (606)
....++..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..+...
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG------IDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHHHHC
T ss_pred CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHhhC
Confidence 234567889999998764 589999999999999999999999975321 1111111110
Q ss_pred -cccccccchhhhcccC-----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 -EWTAEVFDLELLRYQN-----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 -~~~~~~~d~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+....+. . ..... .......+.+++.+||+.||++|||+.|++++
T Consensus 271 ~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFP-Q-IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCC-C-CCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccc-c-ccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000 0 00000 01133578899999999999999999999876
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=308.53 Aligned_cols=242 Identities=21% Similarity=0.280 Sum_probs=194.5
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCc---cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT---VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
..+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++++++||||+++++++......++||||+++
T Consensus 26 i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 105 (287)
T 2wei_A 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105 (287)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred eeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCC
Confidence 3578999999999999865 68999999986543 3467899999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC---CcEEEeecccCccCCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS---YEARISDFGLAHLASPSS 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~---~~~kl~DfG~a~~~~~~~ 473 (606)
++|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+||+++.+ +.+||+|||+++......
T Consensus 106 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~i~--H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~ 178 (287)
T 2wei_A 106 GELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHNIV--HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178 (287)
T ss_dssp CBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence 99999887543 589999999999999999999999966 99999999999764 469999999987665432
Q ss_pred C---CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 474 T---PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 474 ~---~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
. ..++..|+|||.+.+ .++.++||||||+++|+|++|+.||.... .......+.........
T Consensus 179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~-------- 243 (287)
T 2wei_A 179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN------EYDILKRVETGKYAFDL-------- 243 (287)
T ss_dssp SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHHCCCCCCS--------
T ss_pred ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCCCCCCc--------
Confidence 2 234567999999876 48999999999999999999999996432 22222222222111100
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+........+.+++.+||..+|++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0111223568889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=322.27 Aligned_cols=257 Identities=22% Similarity=0.308 Sum_probs=180.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCc-------eEEEEee
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDE-------KLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------~~lv~e~ 393 (606)
.+.||+|+||.||+|+. .+|+.||||++.........+.++++.+..++||||++++++|..... .++||||
T Consensus 28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~ 107 (360)
T 3e3p_A 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107 (360)
T ss_dssp C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence 46799999999999986 468999999987655545566778888888899999999999976443 7899999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCCCCCCCCCCEEecC-CCcEEEeecccCccCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH--SKGPANSHGNIKSSNILLSK-SYEARISDFGLAHLAS 470 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~i~HrDlkp~Nill~~-~~~~kl~DfG~a~~~~ 470 (606)
+++ +|...+..... ....+++..+..++.|++.||.||| +.+++ ||||||+|||++. ++.+||+|||+++...
T Consensus 108 ~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~iv--H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~ 183 (360)
T 3e3p_A 108 VPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVC--HRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183 (360)
T ss_dssp CSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCB--CSCCCGGGEEEETTTTEEEECCCTTCBCCC
T ss_pred ccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCCee--cCcCCHHHEEEeCCCCcEEEeeCCCceecC
Confidence 987 55544432111 1345889999999999999999999 88855 9999999999997 8999999999998765
Q ss_pred CCC---CCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc---------
Q 037905 471 PSS---TPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE--------- 537 (606)
Q Consensus 471 ~~~---~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 537 (606)
... ...++..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..+....
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3e3p_A 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS------AGQLHEIVRVLGCPSREVLR 257 (360)
T ss_dssp TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCCCHHHHH
T ss_pred CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh------HHHHHHHHHHcCCCCHHHHH
Confidence 432 34567889999998664 489999999999999999999999975321 11121111100
Q ss_pred -ccccccchhhh----------cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHH
Q 037905 538 -WTAEVFDLELL----------RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEI 588 (606)
Q Consensus 538 -~~~~~~d~~~~----------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i 588 (606)
......+.... ...........+.+++.+||+.||++|||+.|++++ ++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 321 (360)
T 3e3p_A 258 KLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321 (360)
T ss_dssp HHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence 00000000000 000111235678999999999999999999999986 4444
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=328.17 Aligned_cols=192 Identities=24% Similarity=0.332 Sum_probs=162.4
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCC-CC-----CcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HE-----NLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.+.||+|+||.||+|... +++.||||+++.......++..|+.+++.++ |+ +|+++++++...+..++||||+
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 138 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence 578999999999999854 6889999999865544566778888877764 44 4999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec--CCCcEEEeecccCccCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS--KSYEARISDFGLAHLASPS 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~--~~~~~kl~DfG~a~~~~~~ 472 (606)
.+ +|.+++.... ...+++..+..++.|++.||.|||++...|+||||||+|||++ .++.+||+|||+++.....
T Consensus 139 ~~-~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~ 214 (382)
T 2vx3_A 139 SY-NLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214 (382)
T ss_dssp CC-BHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred CC-CHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc
Confidence 65 9999998643 2358999999999999999999995322355999999999994 5778999999999876543
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
....+++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 215 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 215 IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 345678889999999999999999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=320.40 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=188.2
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc---------CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEE
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV---------SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 390 (606)
..+.||+|+||.||+|... +++.||||++..... ....+.+|++++++++||||+++++++... ..++|
T Consensus 14 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~lv 92 (322)
T 2ycf_A 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIV 92 (322)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred EeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-ceEEE
Confidence 4578999999999999864 589999999865421 123488999999999999999999998655 48999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc---EEEeecccCc
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE---ARISDFGLAH 467 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~---~kl~DfG~a~ 467 (606)
|||+++++|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++. +||+|||+++
T Consensus 93 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~iv--H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 93 LELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENGII--HRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp EECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCee--ccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 9999999999998743 3589999999999999999999999966 9999999999987664 9999999998
Q ss_pred cCCCCC---CCCCcccccCccccC---CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccc
Q 037905 468 LASPSS---TPNRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541 (606)
Q Consensus 468 ~~~~~~---~~~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (606)
...... ...++..|+|||++. ...++.++||||||+++|||++|+.||....... .+...+ ..+...
T Consensus 166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~----~~~~~~- 238 (322)
T 2ycf_A 166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI----TSGKYN- 238 (322)
T ss_dssp ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH----HHTCCC-
T ss_pred ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH----HhCccc-
Confidence 765432 224677899999863 5678999999999999999999999997532211 121111 111100
Q ss_pred ccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 542 ~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+.. .......+.+++.+||..||++|||+.+++++
T Consensus 239 -~~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 239 -FIPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -CCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -cCchh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 00000 11224568899999999999999999999853
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=322.63 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=190.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeC-----CceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 393 (606)
.+.||+|+||.||+|... +++.||||++..... ..+.+.+|++++++++||||+++++++... ...++||||
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~ 111 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL 111 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence 578999999999999854 688999999975332 236788999999999999999999999754 367999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
+.+ +|.+++... .+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 112 ~~~-~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 112 MET-DLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVL--HRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp CSE-EHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred cCc-CHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 975 999998743 489999999999999999999999966 9999999999999999999999999765432
Q ss_pred ------CCCCCcccccCccccC-CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccc---cccc
Q 037905 473 ------STPNRIDGYRAPEVTD-ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW---TAEV 542 (606)
Q Consensus 473 ------~~~~~~~~y~aPE~~~-~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 542 (606)
....+++.|+|||++. ...++.++||||||+++|||++|+.||......+ ....+........ ....
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HHHHHHHHHCSCCHHHHHTC
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHh
Confidence 2346788899999865 4558999999999999999999999996532211 1111111000000 0000
Q ss_pred cchh-------hh--cccC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLE-------LL--RYQN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~-------~~--~~~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.. .. .... .......+.+++.+||+.||++|||+.|++++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00 0000 01123568899999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.04 Aligned_cols=250 Identities=25% Similarity=0.324 Sum_probs=185.3
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCC------ceEEEEee
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRD------EKLLVHDY 393 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~e~ 393 (606)
..+.||+|+||.||+|+.. +|+.||||++.... ....+|++++++++||||++++++|.... ..++||||
T Consensus 58 ~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc---hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 3578999999999999974 68999999986532 23447899999999999999999986432 25789999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-CcEEEeecccCccCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLASPS 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~~~~~ 472 (606)
+++ +|.+.+.... .....+++..+..++.||++||+|||+++++ ||||||+|||++.+ +.+||+|||+++.....
T Consensus 135 ~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iv--HrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 135 VPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp CCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEE--CSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCCcc--ccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 986 6666654311 1134689999999999999999999999965 99999999999965 56899999999865432
Q ss_pred ---CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc------------
Q 037905 473 ---STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE------------ 536 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 536 (606)
....++..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..++..
T Consensus 211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~------~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG------VDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCSCCHHHHHHH
T ss_pred CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHHhCCCCHHHHHhh
Confidence 234667889999998764 789999999999999999999999975321 1112211110
Q ss_pred -cccccccchhhhcccCh-----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 -EWTAEVFDLELLRYQNV-----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 -~~~~~~~d~~~~~~~~~-----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......-+.. ....+ ......+.+|+.+||..||++|||+.|++++
T Consensus 285 ~~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 285 NPNYTEFKFPQI-KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp CSCCCCCCCCCC-CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhhhhccCcc-CCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000000000 00000 1123568899999999999999999999875
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=322.93 Aligned_cols=254 Identities=23% Similarity=0.283 Sum_probs=193.0
Q ss_pred hcccccCCceEEEEEEEc-CC-cEEEEEEeccCccCHHHHHHHHHHHcCCCCCC------cccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE-MG-IVVAVKRLKDVTVSEKEFREKMEVVGSMDHEN------LVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|... ++ ..||+|+++......+.+.+|+.++++++|++ ++.+.+++......++||||
T Consensus 24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 103 (355)
T 2eu9_A 24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFEL 103 (355)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEEC
T ss_pred EEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEec
Confidence 578999999999999864 34 78999999865555677888999988887665 88999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEe-------------------cC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILL-------------------SK 454 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill-------------------~~ 454 (606)
+ +++|.+++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||+ +.
T Consensus 104 ~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~iv--H~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~ 177 (355)
T 2eu9_A 104 L-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQLT--HTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177 (355)
T ss_dssp C-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTTEE--CCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred c-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEEEecccccccccccccccccccC
Confidence 9 557777776532 23589999999999999999999999966 99999999999 56
Q ss_pred CCcEEEeecccCccCCCC-CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHH
Q 037905 455 SYEARISDFGLAHLASPS-STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSV 533 (606)
Q Consensus 455 ~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (606)
++.+||+|||+++..... ....++..|+|||++.+..++.++||||||+++|||++|+.||....... ....+...
T Consensus 178 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~ 254 (355)
T 2eu9_A 178 NTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE---HLVMMEKI 254 (355)
T ss_dssp CCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred CCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 789999999999865443 34567888999999999999999999999999999999999997532211 11111111
Q ss_pred hhcc---c-----cccc---------------------cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 534 VKEE---W-----TAEV---------------------FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 534 ~~~~---~-----~~~~---------------------~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.... + .... ..+..............+.+++.+||+.||++|||+.|++++
T Consensus 255 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 0 0000 000000001122345678999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=318.19 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=173.0
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC--HHHHHHHHH-HHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS--EKEFREKME-VVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|... +|+.||||+++..... ..++..|+. +++.++||||+++++++...+..++||||+.+
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~- 105 (327)
T 3aln_A 27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST- 105 (327)
T ss_dssp -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence 467999999999999874 6899999999765322 334555555 77888999999999999999999999999986
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
+|.+++..........+++..+..++.|++.||.|||+. +++ ||||||+||+++.++.+||+|||+++......
T Consensus 106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~iv--H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 183 (327)
T 3aln_A 106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKII--HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT 183 (327)
T ss_dssp EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCC--CSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEe--ECCCCHHHEEEcCCCCEEEccCCCceecccccccc
Confidence 888777632111134689999999999999999999998 966 99999999999999999999999997654422
Q ss_pred CCCCcccccCcccc----CCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 474 TPNRIDGYRAPEVT----DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 474 ~~~~~~~y~aPE~~----~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
...++..|+|||++ .+..++.++||||||+++|||++|+.||....... ..+....... .... .
T Consensus 184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~-~~~~------~ 251 (327)
T 3aln_A 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQVVKGD-PPQL------S 251 (327)
T ss_dssp ----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCSC-CCCC------C
T ss_pred cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHHHhcCC-CCCC------C
Confidence 23567789999998 45678999999999999999999999996532110 0011111100 0000 0
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..........+.+++.+||+.||++|||+.+++++
T Consensus 252 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 00011233568899999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=315.03 Aligned_cols=251 Identities=23% Similarity=0.303 Sum_probs=190.2
Q ss_pred hcccccCCceEEEEEEE--cCCcEEEEEEeccCccC---HHHHHHHHHHHcCC---CCCCcccceEEEE-----eCCceE
Q 037905 322 AEVLGKGTFGTAYKATL--EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSM---DHENLVPLRAYYY-----SRDEKL 388 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~~~~~~ 388 (606)
.+.||+|+||.||+|+. .+|+.||+|+++..... ...+.+|+.+++.+ +||||+++++++. .....+
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 95 (326)
T 1blx_A 16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95 (326)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence 56899999999999997 46899999998653321 23466677666655 8999999999987 456789
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 389 LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
+||||+. ++|.+++.... ...+++..+..++.|++.||+|||++|++ ||||||+||+++.++.+||+|||+++.
T Consensus 96 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~gi~--H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 96 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVV--HRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCCce--eccCCHHHeEEcCCCCEEEecCccccc
Confidence 9999998 59999997643 23489999999999999999999999966 999999999999999999999999976
Q ss_pred CCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-------cc
Q 037905 469 ASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE-------EW 538 (606)
Q Consensus 469 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~ 538 (606)
.... ....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...+..+... .+
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~ 243 (326)
T 1blx_A 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------VDQLGKILDVIGLPGEEDW 243 (326)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCGGGS
T ss_pred ccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHHcCCCCcccC
Confidence 5432 234567789999999998999999999999999999999999975321 1112222110 01
Q ss_pred cccccchh--hh------cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 539 TAEVFDLE--LL------RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 539 ~~~~~d~~--~~------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+. .. ...........+.+++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 00 000011234567889999999999999999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.11 Aligned_cols=244 Identities=21% Similarity=0.265 Sum_probs=167.2
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEe----CCceEEEEeecCCC
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS----RDEKLLVHDYMPMG 397 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~g 397 (606)
++||+|+||.||+|... +|+.||||++.......+ +....++.++||||+++++++.. ....++||||+++|
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg 111 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG 111 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence 56999999999999865 689999999976432222 22334556689999999999876 34579999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCccCCCC--
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~-- 472 (606)
+|.+++.... ...+++..+..++.|++.||+|||++|++ ||||||+|||++. ++.+||+|||+++.....
T Consensus 112 ~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~iv--H~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~ 186 (336)
T 3fhr_A 112 ELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHNIA--HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL 186 (336)
T ss_dssp EHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCee--cCCCCHHHEEEEecCCCceEEEeccccceecccccc
Confidence 9999998643 24689999999999999999999999965 9999999999976 455999999999765432
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....+++.|+|||++.+..++.++||||||+++|||++|+.||........ ............. .. ....
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~-~~------~~~~ 256 (336)
T 3fhr_A 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLGQY-GF------PNPE 256 (336)
T ss_dssp -----------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CC------CTTT
T ss_pred ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhcccc-cc------Cchh
Confidence 234567889999999888899999999999999999999999975432210 0000000000000 00 0011
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.||++|||+.|++++
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12234568889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.73 Aligned_cols=240 Identities=20% Similarity=0.320 Sum_probs=188.2
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC---HHHHHHHHHHHcCCC--CCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMD--HENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||++...+++.||||++...... .+.+.+|++++.+++ |+||+++++++......++||| +.+
T Consensus 33 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~ 111 (313)
T 3cek_A 33 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN 111 (313)
T ss_dssp EEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred EEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCC
Confidence 4689999999999999888999999999754433 356889999999997 5999999999999999999999 567
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
++|.+++.... .+++..+..++.|++.||.|||+++++ ||||||+|||+++ +.+||+|||+++......
T Consensus 112 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~iv--H~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~ 183 (313)
T 3cek_A 112 IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHGIV--HSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183 (313)
T ss_dssp EEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCce--ecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence 89999998542 589999999999999999999999966 9999999999975 799999999998654322
Q ss_pred ---CCCCcccccCccccCC-----------CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccc
Q 037905 474 ---TPNRIDGYRAPEVTDA-----------RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWT 539 (606)
Q Consensus 474 ---~~~~~~~y~aPE~~~~-----------~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (606)
...++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ....+.........
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~ 258 (313)
T 3cek_A 184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPNHE 258 (313)
T ss_dssp ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTTSC
T ss_pred cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHhcccc
Confidence 2346788999999875 4688899999999999999999999964321 11122222221111
Q ss_pred ccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 540 AEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 540 ~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.. .+......+.+++.+||+.||++|||+.|++++-
T Consensus 259 ~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 259 IE----------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp CC----------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred cC----------CcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 10 0011134678899999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.92 Aligned_cols=245 Identities=22% Similarity=0.294 Sum_probs=182.8
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+....++||||+. |+|.
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~ 96 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQ 96 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHH
Confidence 4679999999998776677999999998653 245678899999875 89999999999999999999999996 5999
Q ss_pred hhhhcCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-------------CcEEEeeccc
Q 037905 401 ALLHGNRGAGR--TPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-------------YEARISDFGL 465 (606)
Q Consensus 401 ~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-------------~~~kl~DfG~ 465 (606)
+++........ ....+..+..++.||+.||+|||+++++ ||||||+|||++.+ +.+||+|||+
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv--HrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~ 174 (434)
T 2rio_A 97 DLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII--HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174 (434)
T ss_dssp HHHHTC------------CCHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred HHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCcc--ccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence 99986432111 0112334578999999999999999965 99999999999754 4799999999
Q ss_pred CccCCCCC--------CCCCcccccCccccCC-------CCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHH
Q 037905 466 AHLASPSS--------TPNRIDGYRAPEVTDA-------RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRW 529 (606)
Q Consensus 466 a~~~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 529 (606)
++...... ...+|++|+|||++.+ ..++.++|||||||++|||++ |+.||...... .
T Consensus 175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~----~--- 247 (434)
T 2rio_A 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR----E--- 247 (434)
T ss_dssp CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----H---
T ss_pred ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----H---
Confidence 98665421 2357788999999875 568999999999999999999 99999642111 0
Q ss_pred HHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 530 VQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 530 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+......... ............+.+++.+||+.||++|||+.+|+++
T Consensus 248 -~~i~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 -SNIIRGIFSLDE-----MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -HHHHHTCCCCCC-----CTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHhcCCCCccc-----ccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 111111111100 0111124456778999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=320.57 Aligned_cols=247 Identities=24% Similarity=0.311 Sum_probs=188.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCCc------eEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRDE------KLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lv~ 391 (606)
.+.||+|+||.||+|.. .+|+.||||++...... .+.+.+|+.+++.++||||+++++++..... .++||
T Consensus 29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~ 108 (353)
T 3coi_A 29 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred eeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEe
Confidence 46799999999999986 46899999999764433 3568899999999999999999999976543 49999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+. ++|.+++.. .+++..+..++.||+.||+|||++|++ ||||||+||+++.++.+||+|||+++....
T Consensus 109 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~iv--H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 109 PFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAGVV--HRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp ECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCC--CSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred cccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcc--cCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 9997 588888742 389999999999999999999999966 999999999999999999999999986543
Q ss_pred C-CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------cccccc
Q 037905 472 S-STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------WTAEVF 543 (606)
Q Consensus 472 ~-~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 543 (606)
. ....++..|+|||++.+ ..++.++||||||+++|||++|+.||.... ....+..+.... +.....
T Consensus 179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD------YLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC------HHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2 23456788999999877 678999999999999999999999997532 111122111100 000000
Q ss_pred chh------------hhc-ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLE------------LLR-YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~------------~~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+.. ... ..........+.+++.+||..||++|||+.+++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 000 00112334678899999999999999999999876
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=313.48 Aligned_cols=248 Identities=21% Similarity=0.299 Sum_probs=182.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEE--------------eCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYY--------------SRD 385 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~--------------~~~ 385 (606)
.+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++||||+++++++. ...
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 95 (320)
T 2i6l_A 16 LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELN 95 (320)
T ss_dssp EEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCS
T ss_pred EEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccC
Confidence 467999999999999975 489999999875432 3467889999999999999999999873 335
Q ss_pred ceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec-CCCcEEEeecc
Q 037905 386 EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS-KSYEARISDFG 464 (606)
Q Consensus 386 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG 464 (606)
..++||||++ |+|.+++.. ..+++..+..++.|++.||+|||++|++ ||||||+||+++ +++.+||+|||
T Consensus 96 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 96 SVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSANVL--HRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp EEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCSGGGEEEETTTTEEEECCCT
T ss_pred ceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCCEe--cCCCCHHHEEEcCCCCeEEEccCc
Confidence 7799999998 599999863 2488999999999999999999999966 999999999997 56799999999
Q ss_pred cCccCCCC-------CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc
Q 037905 465 LAHLASPS-------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE 536 (606)
Q Consensus 465 ~a~~~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (606)
+++..... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ......+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~~~ 240 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE------LEQMQLILES 240 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHHh
Confidence 99865432 11234667999998765 6789999999999999999999999975321 1111111111
Q ss_pred ccc-------------ccccchhhhcccC-----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 537 EWT-------------AEVFDLELLRYQN-----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 537 ~~~-------------~~~~d~~~~~~~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... ............. .......+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000 0000000000000 01234568899999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=319.51 Aligned_cols=248 Identities=21% Similarity=0.293 Sum_probs=188.7
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeC-----CceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~ 393 (606)
.+.||+|+||.||+|+.. +|+.||||++..... ....+.+|++++++++||||+++++++... ...++||||
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~ 95 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL 95 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEec
Confidence 467999999999999865 689999999965332 245678999999999999999999988654 678999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
+. ++|.+++... .+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~iv--H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 96 MQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSNVI--HRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred cC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCee--cCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 97 5999998742 489999999999999999999999966 9999999999999999999999999765421
Q ss_pred -------------CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh---
Q 037905 473 -------------STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK--- 535 (606)
Q Consensus 473 -------------~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 535 (606)
....++..|+|||++.. ..++.++||||||+++|||++|+.||..... ......+..
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~ 240 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY------RHQLLLIFGIIG 240 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHC
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhC
Confidence 12345778999998754 6789999999999999999999999975321 111111100
Q ss_pred ccc----cccccchh-------hhcc--cC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 536 EEW----TAEVFDLE-------LLRY--QN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 536 ~~~----~~~~~d~~-------~~~~--~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... ........ .... .. .......+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 00000000 0000 00 01234567899999999999999999999885
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.46 Aligned_cols=232 Identities=21% Similarity=0.351 Sum_probs=188.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC-------HHHHHHHHHHHcCCC--CCCcccceEEEEeCCceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS-------EKEFREKMEVVGSMD--HENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 391 (606)
.+.||+|+||.||+|.. .+++.||||++...... ...+.+|+.++++++ |+||+++++++...+..++|+
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~ 127 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 127 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence 57899999999999985 46899999999764322 245677888988885 599999999999999999999
Q ss_pred eecCC-CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec-CCCcEEEeecccCccC
Q 037905 392 DYMPM-GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS-KSYEARISDFGLAHLA 469 (606)
Q Consensus 392 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG~a~~~ 469 (606)
|++.+ ++|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++ +++.+||+|||+++..
T Consensus 128 e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~iv--H~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 128 ERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCGVL--HRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp ECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCcE--eCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 99976 89999997532 589999999999999999999999966 999999999999 7889999999999766
Q ss_pred CCC--CCCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 470 SPS--STPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 470 ~~~--~~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
... ....++..|+|||++.+..+ +.++||||||+++|||++|+.||..... ....... .
T Consensus 201 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~~~~~---~--- 262 (320)
T 3a99_A 201 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQVF---F--- 262 (320)
T ss_dssp CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCCCC---C---
T ss_pred ccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhccccc---c---
Confidence 543 23457788999999877665 6789999999999999999999964211 1111100 0
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.||++|||+.||+++
T Consensus 263 ------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 263 ------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01123467889999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=307.48 Aligned_cols=242 Identities=23% Similarity=0.330 Sum_probs=174.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCH---HHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|... +|+.||||++....... +.+.++..+++.++||||+++++++...+..++||||+ ++
T Consensus 30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 108 (318)
T 2dyl_A 30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT 108 (318)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence 568999999999999974 68999999997654322 23445556788889999999999999999999999999 44
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~ 473 (606)
.+..+.... ...+++..+..++.|++.||+|||++ +++ ||||||+||+++.++.+||+|||+++..... .
T Consensus 109 ~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~--H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (318)
T 2dyl_A 109 CAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHGVI--HRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182 (318)
T ss_dssp EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHCCC--CCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred cHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCCEE--eCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence 555555432 23589999999999999999999995 866 9999999999999999999999998765432 2
Q ss_pred CCCCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 474 TPNRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
...++..|+|||++. ...++.++||||||+++|||++|+.||.... ................ .
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~-~------ 250 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK-----TDFEVLTKVLQEEPPL-L------ 250 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHHHSCCCC-C------
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC-----ccHHHHHHHhccCCCC-C------
Confidence 335677899999984 4568899999999999999999999996421 1222233332221110 0
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
+........+.+++.+||+.||.+|||+.+++++
T Consensus 251 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 251 --PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp --CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0001123467889999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.42 Aligned_cols=239 Identities=23% Similarity=0.264 Sum_probs=179.0
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.++||+|+||+||.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....++||||+. |+|.
T Consensus 29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~ 105 (432)
T 3p23_A 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ 105 (432)
T ss_dssp EEEEEECGGGCEEEEEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred CCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence 467999999997655556799999999965432 2356789999988 89999999999999999999999997 5999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-----CCcEEEeecccCccCCCC---
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-----SYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-----~~~~kl~DfG~a~~~~~~--- 472 (606)
+++..... ......+..++.||+.||+|||+++++ ||||||+|||++. ...+||+|||+++.....
T Consensus 106 ~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~iv--HrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~ 179 (432)
T 3p23_A 106 EYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLNIV--HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179 (432)
T ss_dssp HHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTTCC--CCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------
T ss_pred HHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCcCE--eCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc
Confidence 99986432 233445678999999999999999966 9999999999953 235889999999765432
Q ss_pred ----CCCCCcccccCccccC---CCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 ----STPNRIDGYRAPEVTD---ARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 ----~~~~~~~~y~aPE~~~---~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
....+|+.|+|||++. ...++.++|||||||++|||++ |..||..... ...... ..........
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-------~~~~~~-~~~~~~~~~~ 251 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-------RQANIL-LGACSLDCLH 251 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-------HHHHHH-TTCCCCTTSC
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-------HHHHHH-hccCCccccC
Confidence 2345788899999997 4567889999999999999999 9999853211 111111 1111111111
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........+.+++.+||+.||++|||+.+++++
T Consensus 252 -------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 252 -------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 112234457889999999999999999999853
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=300.92 Aligned_cols=228 Identities=13% Similarity=0.062 Sum_probs=177.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|... +++.||||++...... .+.+.+|+..+.+++||||+++++++...+..++||||+++
T Consensus 36 ~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g 115 (286)
T 3uqc_A 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRG 115 (286)
T ss_dssp EEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCE
T ss_pred EEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCC
Confidence 467999999999999965 4899999999765433 26789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN 476 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 476 (606)
++|.+++... .....+.+++.|++.||+|||++|++ ||||||+|||++.++.+||+++|
T Consensus 116 ~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~giv--H~Dikp~NIll~~~g~~kl~~~~------------ 174 (286)
T 3uqc_A 116 GSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAGVA--LSIDHPSRVRVSIDGDVVLAYPA------------ 174 (286)
T ss_dssp EEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCSGGGEEEETTSCEEECSCC------------
T ss_pred CCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCCCc--cCCCCcccEEEcCCCCEEEEecc------------
Confidence 9999999531 34557888999999999999999966 99999999999999999998543
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
|++| ++.++||||||+++|||+||+.||........... ...... .....+.... ...
T Consensus 175 ----~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~----~~~~~~~~~~----~~~ 232 (286)
T 3uqc_A 175 ----TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTA----GQPIEPADID----RDI 232 (286)
T ss_dssp ----CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTT----SCBCCHHHHC----TTS
T ss_pred ----ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhc----cCCCChhhcc----cCC
Confidence 4443 68899999999999999999999976433221100 000000 0000000000 122
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccc
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~ 593 (606)
...+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 233 ~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 233 PFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp CHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 3568899999999999999 99999999999876543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.46 Aligned_cols=233 Identities=24% Similarity=0.355 Sum_probs=183.9
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC-------HHHHHHHHHHHcCC----CCCCcccceEEEEeCCceE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS-------EKEFREKMEVVGSM----DHENLVPLRAYYYSRDEKL 388 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l----~h~niv~l~~~~~~~~~~~ 388 (606)
..+.||+|+||.||+|+. .+++.||||+++..... ...+.+|+.++.++ +||||+++++++...+..+
T Consensus 35 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~ 114 (312)
T 2iwi_A 35 LGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114 (312)
T ss_dssp EEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CE
T ss_pred EeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEE
Confidence 357899999999999985 46899999999754321 22355688887777 8999999999999889999
Q ss_pred EEEee-cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec-CCCcEEEeecccC
Q 037905 389 LVHDY-MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS-KSYEARISDFGLA 466 (606)
Q Consensus 389 lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG~a 466 (606)
+|+|| +.+++|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+||+++ .++.+||+|||++
T Consensus 115 ~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 115 LVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRGVV--HRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp EEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHTEE--CCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred EEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--ecCCChhhEEEeCCCCeEEEEEcchh
Confidence 99999 78999999998532 589999999999999999999999966 999999999999 8899999999998
Q ss_pred ccCCCC--CCCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcccccccc
Q 037905 467 HLASPS--STPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543 (606)
Q Consensus 467 ~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (606)
+..... ....++..|+|||++.+..+ +.++||||||+++|||++|+.||..... ......
T Consensus 188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~~~~----- 250 (312)
T 2iwi_A 188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------ILEAEL----- 250 (312)
T ss_dssp EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHTCC-----
T ss_pred hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------Hhhhcc-----
Confidence 765442 23456778999999876665 4589999999999999999999964210 111100
Q ss_pred chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.........+.+++.+||+.+|++|||+.|++++
T Consensus 251 -------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 251 -------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011223467889999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=335.51 Aligned_cols=234 Identities=20% Similarity=0.258 Sum_probs=190.1
Q ss_pred hcccccCCceEEEEEEEc--CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCc-----eEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLE--MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDE-----KLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~e 392 (606)
.+.||+|+||.||+|... +|+.||||++..... ....+.+|++++++++||||+++++++...+. .++|||
T Consensus 85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E 164 (681)
T 2pzi_A 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164 (681)
T ss_dssp EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence 568999999999999875 589999999865432 23568899999999999999999999987665 699999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.. .+++..+..++.||+.||.|||++|++ ||||||+|||++.+ .+||+|||+++.....
T Consensus 165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~gii--HrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIGLV--YNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCCCe--ecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 9999999987752 489999999999999999999999955 99999999999986 8999999999887766
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....+|++|+|||++.+. ++.++|||||||++|||++|..||....... +. ....
T Consensus 235 ~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---~~---------------------~~~~ 289 (681)
T 2pzi_A 235 GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG---LP---------------------EDDP 289 (681)
T ss_dssp SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS---CC---------------------TTCH
T ss_pred CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc---cc---------------------cccc
Confidence 667789999999998764 4889999999999999999999886432111 00 0000
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHHHh
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRP-SMAEVTSQIEEICR 590 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~ 590 (606)
.......+.+++.+||+.||++|| +++++...|..+.+
T Consensus 290 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 290 VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 112335688999999999999999 56777777777654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=331.54 Aligned_cols=264 Identities=22% Similarity=0.249 Sum_probs=198.1
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEe------CCceEEE
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYS------RDEKLLV 390 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lv 390 (606)
...+.||+|+||.||+|.. .+|+.||||+++.... ..+.+.+|++++++++||||+++++++.. .+..++|
T Consensus 17 ~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LV 96 (676)
T 3qa8_A 17 EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96 (676)
T ss_dssp CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCE
T ss_pred EEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEE
Confidence 3457899999999999985 4689999999875422 24568899999999999999999998754 5677999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc---EEEeecccCc
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE---ARISDFGLAH 467 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~---~kl~DfG~a~ 467 (606)
|||+++++|.+++..... ...+++..+..++.|++.||+|||+.|++ ||||||+||+++.++. +||+|||+++
T Consensus 97 mEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs~gIV--HrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 97 MEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHENRII--HRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp EECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHHTTBC--CCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCc--cCCCCHHHeEeecCCCceeEEEccccccc
Confidence 999999999999986432 23588889999999999999999999966 9999999999997765 9999999998
Q ss_pred cCCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc--------
Q 037905 468 LASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE-------- 536 (606)
Q Consensus 468 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 536 (606)
..... ....++..|+|||++.+..++.++||||||+++|||++|+.||..... ...|.......
T Consensus 173 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 173 ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp BTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------CCSC
T ss_pred ccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchhhhhh
Confidence 76543 234567889999999999999999999999999999999999964211 01110000000
Q ss_pred cccccccc--hhhhc-ccChHHHHHHHHHHHHHccCcCCCCCCCHHH-----HHHHHHHHHhcc
Q 037905 537 EWTAEVFD--LELLR-YQNVEEEMVQLLQLAINCTAQYPDNRPSMAE-----VTSQIEEICRSS 592 (606)
Q Consensus 537 ~~~~~~~d--~~~~~-~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~-----v~~~L~~i~~~~ 592 (606)
........ ..... ..........+.+++.+||..||++|||+.+ +.+.++++....
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000000 00000 0112335577899999999999999999988 667788876543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.46 Aligned_cols=225 Identities=22% Similarity=0.292 Sum_probs=173.3
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHH-cCCCCCCcccceEEEEe----CCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVV-GSMDHENLVPLRAYYYS----RDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|.. .+++.||+|+++. ...+.+|++++ +..+||||+++++++.. ....++||||+++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~ 99 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 99 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence 5699999999999986 5689999999965 34567788777 56699999999999876 6678999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCccCCCCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHLASPSS 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~~ 473 (606)
++|.+++.... ...+++..+..++.|++.||+|||+++++ ||||||+||+++. ++.+||+|||+++...
T Consensus 100 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~--H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 100 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIA--HRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 99999998643 23589999999999999999999999966 9999999999998 7889999999986433
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
+..++.++||||||+++|||++|+.||.......... ............... ...
T Consensus 172 ---------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~~~~~~~~~~~~~---~~~ 226 (299)
T 3m2w_A 172 ---------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKTRIRMGQYEFPN---PEW 226 (299)
T ss_dssp ---------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSCCSSCTTCCSSCH---HHH
T ss_pred ---------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHHHHHhhccccCCc---hhc
Confidence 2356789999999999999999999996532211000 000000000000000 000
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||+.||++|||+.|++++
T Consensus 227 ~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 1234568899999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=312.52 Aligned_cols=236 Identities=16% Similarity=0.141 Sum_probs=172.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc----CHHHHHHHHHHHcCCCC-CCcccc---------eE-------
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV----SEKEFREKMEVVGSMDH-ENLVPL---------RA------- 379 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h-~niv~l---------~~------- 379 (606)
.+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|+.+++.++| +|.... ..
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 46799999999999994 5799999999874322 24678999999999877 222111 11
Q ss_pred -----EEEe-----CCceEEEEeecCCCChhhhhhcCC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCC
Q 037905 380 -----YYYS-----RDEKLLVHDYMPMGSLSALLHGNR--GAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKS 447 (606)
Q Consensus 380 -----~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp 447 (606)
++.. ....+++|+++ +++|.+++.... ......+++..+..++.||+.||+|||+++++ ||||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii--HrDiKp 239 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV--HTYLRP 239 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCG
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCCccc
Confidence 1111 12346677765 579998885210 01123578889999999999999999999955 999999
Q ss_pred CCEEecCCCcEEEeecccCccCCCC-CCCCCcccccCcccc----------CCCCCCCcchhHHHHHHHHHHHhCCCCcc
Q 037905 448 SNILLSKSYEARISDFGLAHLASPS-STPNRIDGYRAPEVT----------DARKVSQKADVYSFGVLLLELLTGKAPTQ 516 (606)
Q Consensus 448 ~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~y~aPE~~----------~~~~~~~~sDv~slGvvl~elltg~~p~~ 516 (606)
+|||++.++.+||+|||+++..... ....+ ..|+|||++ ....++.++|||||||++|||++|+.||.
T Consensus 240 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~ 318 (413)
T 3dzo_A 240 VDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318 (413)
T ss_dssp GGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCC
T ss_pred ceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999999999999998765543 23345 889999999 66678999999999999999999999997
Q ss_pred cccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 037905 517 ALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583 (606)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 583 (606)
........ ..+.. ... ..+..+.+++.+||+.||++|||+.++++
T Consensus 319 ~~~~~~~~------~~~~~-------------~~~---~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 319 DDAALGGS------EWIFR-------------SCK---NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp TTGGGSCS------GGGGS-------------SCC---CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CcchhhhH------HHHHh-------------hcc---cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 54322210 00000 001 11246888999999999999999877744
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=302.88 Aligned_cols=241 Identities=15% Similarity=0.127 Sum_probs=180.3
Q ss_pred HHHHhcccccCCceEEEEEEEcCCcEEEEEEeccCcc---------CHHHHHHHHHHHcCCC---------CCCcccceE
Q 037905 318 LRASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV---------SEKEFREKMEVVGSMD---------HENLVPLRA 379 (606)
Q Consensus 318 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------~~~~~~~e~~~l~~l~---------h~niv~l~~ 379 (606)
.+...+.||+|+||.||+|+. +|+.||||+++.... ..+.+.+|+.+++.++ ||||+++.+
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~ 99 (336)
T 2vuw_A 21 KLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNS 99 (336)
T ss_dssp HHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEE
T ss_pred cchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcc
Confidence 456678999999999999998 589999999975432 2367888988888775 777766666
Q ss_pred EEE-----------------e-------------CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 037905 380 YYY-----------------S-------------RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRA 429 (606)
Q Consensus 380 ~~~-----------------~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~ 429 (606)
.+. + ....++||||+++|++.+.+.. ..+++..+..++.||+.|
T Consensus 100 ~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 100 VHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHH
T ss_pred eeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHH
Confidence 543 2 6788999999999977776643 247999999999999999
Q ss_pred HHHHH-hcCCCCCCCCCCCCCEEecCCC--------------------cEEEeecccCccCCCCCCCCCcccccCccccC
Q 037905 430 IAYLH-SKGPANSHGNIKSSNILLSKSY--------------------EARISDFGLAHLASPSSTPNRIDGYRAPEVTD 488 (606)
Q Consensus 430 L~~LH-~~~~~i~HrDlkp~Nill~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~ 488 (606)
|+||| +++++ ||||||+|||++.++ .+||+|||+|+..... ...+|+.|+|||++.
T Consensus 174 L~~lH~~~~iv--HrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 174 LAVAEASLRFE--HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHHCCB--CSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGC
T ss_pred HHHHHHhCCEe--ECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhc
Confidence 99999 89966 999999999999887 8999999999876542 346788899999998
Q ss_pred CCCCCCcchhHHHHHH-HHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHc
Q 037905 489 ARKVSQKADVYSFGVL-LLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINC 567 (606)
Q Consensus 489 ~~~~~~~sDv~slGvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~C 567 (606)
+.. +.++|||||+++ .+++++|..||..... ................. ...........++.+++.+|
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~-----~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-----LHYLTDKMLKQMTFKTK-----CNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-----HHHHHHHHHHTCCCSSC-----CCSHHHHHHHHHHHHHHHHG
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcchhh-----hhHHHHhhhhhhccCcc-----cchhhhhhcCHHHHHHHHHH
Confidence 766 889999998777 7788999999854210 00011111111000000 00112345667899999999
Q ss_pred cCcCCCCCCCHHHHH-HH
Q 037905 568 TAQYPDNRPSMAEVT-SQ 584 (606)
Q Consensus 568 l~~~P~~RPs~~~v~-~~ 584 (606)
|+.| |++|++ ++
T Consensus 320 L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 320 LNFS-----SATDLLCQH 332 (336)
T ss_dssp GGSS-----SHHHHHHHC
T ss_pred hccC-----CHHHHHhcC
Confidence 9865 899887 53
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-29 Score=273.34 Aligned_cols=181 Identities=15% Similarity=0.052 Sum_probs=127.3
Q ss_pred ccccCCceEEEEEE-EcCCcEEEEEEeccCcc-----------CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEE
Q 037905 324 VLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTV-----------SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-----------~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 390 (606)
..+.|++|.+..++ .-.|+.+|+|++..... ..++|.+|+++|+++ .|+||+++++++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35667777776654 33589999999975421 135699999999999 799999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCC
Q 037905 391 HDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLAS 470 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~ 470 (606)
|||++|++|.+++.... +++.. +|+.||+.||+|+|++||+ ||||||+|||+++++.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~~~~-----~l~~~---~I~~QIl~AL~ylH~~GII--HRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE-----EIDRE---KILGSLLRSLAALEKQGFW--HDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHHTTC-----CCCHH---HHHHHHHHHHHHHHHTTCE--ESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHHhCC-----CCCHH---HHHHHHHHHHHHHHHCCce--eccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999998542 45543 5899999999999999966 99999999999999999999999998765
Q ss_pred CCCC----CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCc
Q 037905 471 PSST----PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPT 515 (606)
Q Consensus 471 ~~~~----~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~ 515 (606)
.... ..+|++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 4332 246788999999986 4677899999999988887765554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=244.74 Aligned_cols=195 Identities=34% Similarity=0.606 Sum_probs=176.2
Q ss_pred chHHHHHHHhHhhcCC--CCcCCCCCCCCCc--ceeEEecC----CeEEEEEcCCCCccc--ccCccccCCCCCcEEEcc
Q 037905 2 ASDRAALLTLRKAIGG--RTLLWNLTDGPCK--WVGVFCTG----ERVTMLRFPGMGLSG--QLPIAIGNLTELHTVSLR 71 (606)
Q Consensus 2 ~~~~~~l~~~~~~~~~--~~~~w~~~~~~c~--~~~~~c~~----~~l~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~ 71 (606)
+.|++||++||+.+.+ ....|+.+++||. |.||.|.. .+|+.|+|++|+|++ .+|..|.++++|++|+|+
T Consensus 5 ~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~ 84 (313)
T 1ogq_A 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIG 84 (313)
T ss_dssp HHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEE
T ss_pred HHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCC
Confidence 5789999999888744 3459987779998 99999985 689999999999999 899999999999999999
Q ss_pred C-CCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeeccccccccc
Q 037905 72 F-NALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGS 150 (606)
Q Consensus 72 ~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 150 (606)
+ |.+.+.+|..|.++++|++|+|++|++++.+|..|..+++|++|+|++|+|++.+|..|..+++|++|++++|+|++.
T Consensus 85 ~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 164 (313)
T 1ogq_A 85 GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA 164 (313)
T ss_dssp EETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEE
T ss_pred CCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCc
Confidence 5 999999999999999999999999999999999999999999999999999999999999999999999999999977
Q ss_pred CCC-CCCCC-CCCEEEccCCcCcccCCccccC--CCCCcccCCCCCCCCC
Q 037905 151 IPD-LGAFS-SLAQFNVSFNKLNGSIPKRFAR--LPSSAFEGNSLCGKPL 196 (606)
Q Consensus 151 ~~~-~~~l~-~L~~L~l~~N~l~~~~p~~~~~--l~~l~~~~n~l~~~p~ 196 (606)
+|. +..++ +|+.|++++|++++.+|..+.. +..|++.+|.+.+.+.
T Consensus 165 ~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l~~~~~ 214 (313)
T 1ogq_A 165 IPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS 214 (313)
T ss_dssp CCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCG
T ss_pred CCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcccCcCC
Confidence 774 88887 9999999999999999987765 4556778888876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.5e-26 Score=248.34 Aligned_cols=177 Identities=14% Similarity=0.181 Sum_probs=143.8
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccC---------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS---------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
.+.||+|+||.||+|+.. +..+++|+....... .+.+.+|++++++++||||+++..++...++.++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 568999999999999654 788899986443211 2447899999999999999987777778888999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.. +..++.|+++||+|||+++++ ||||||+|||++. .+||+|||+++.....
T Consensus 420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~gIi--HrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKNDVI--HNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTTEE--CTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCcCc--cCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 9999999999873 457999999999999999955 9999999999999 9999999999877652
Q ss_pred C-----------CCCCcccccCccccCC--CCCCCcchhHHHHHHHHHHHhCCCCcc
Q 037905 473 S-----------TPNRIDGYRAPEVTDA--RKVSQKADVYSFGVLLLELLTGKAPTQ 516 (606)
Q Consensus 473 ~-----------~~~~~~~y~aPE~~~~--~~~~~~sDv~slGvvl~elltg~~p~~ 516 (606)
. ...+|+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 1 2356788999999976 568888999999999999888877763
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=239.87 Aligned_cols=192 Identities=22% Similarity=0.344 Sum_probs=139.9
Q ss_pred chHHHHHHHhHhhc--CCCCcCCCCCCCCCcceeEEecCCeEEEEEcCCCCcccc---cC--------------------
Q 037905 2 ASDRAALLTLRKAI--GGRTLLWNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQ---LP-------------------- 56 (606)
Q Consensus 2 ~~~~~~l~~~~~~~--~~~~~~w~~~~~~c~~~~~~c~~~~l~~L~L~~n~l~~~---~p-------------------- 56 (606)
++|++||++||+.+ |....+|+.+++||+|.||.|+..+|+.|+|+++.+.|. +|
T Consensus 11 ~~~~~all~~k~~~~~~~~l~~W~~~~~~C~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~ 90 (768)
T 3rgz_A 11 YREIHQLISFKDVLPDKNLLPDWSSNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHIN 90 (768)
T ss_dssp HHHHHHHHHHHTTCSCTTSSTTCCTTSCGGGSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCEE
T ss_pred HHHHHHHHHHHhhCCCcccccCCCCCCCCcCCcceEECCCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCcC
Confidence 47899999999886 443459987789999999999988999999999999886 43
Q ss_pred ---ccccCCCCCcEEEccCCCCcccCcc--cccCCCCCCEEeccCCcccccCCccc-cCCCCCcEEecCCCcCCcccchh
Q 037905 57 ---IAIGNLTELHTVSLRFNALRGTIPS--DFAKLSNLRNLYLQGNLFSGEIPGLL-FSLGNLIRLNLAKNNFSGTISAD 130 (606)
Q Consensus 57 ---~~l~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~~ 130 (606)
..|..+++|++|+|++|.+++.+|. .++++++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..|..
T Consensus 91 ~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~ 170 (768)
T 3rgz_A 91 GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170 (768)
T ss_dssp ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHH
T ss_pred CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChh
Confidence 5678889999999999999988888 88999999999999999988887765 67888888888888888777765
Q ss_pred ---hhcCCCcceeeccccccc----------------------ccCCCCCCCCCCCEEEccCCcCcccCCccccCCCC--
Q 037905 131 ---FNKLTRLGTLYLQENQLT----------------------GSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS-- 183 (606)
Q Consensus 131 ---~~~l~~L~~L~l~~N~l~----------------------~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-- 183 (606)
+.++++|++|++++|.++ +.+|.+..+++|+.|++++|++++.+|..+..+++
T Consensus 171 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~ 250 (768)
T 3rgz_A 171 WVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELK 250 (768)
T ss_dssp HHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHHHHTTTCSSCC
T ss_pred hhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCcccHHHhcCCCCC
Confidence 455555555555555444 44444444555555555555555544544433333
Q ss_pred -CcccCCCCCC
Q 037905 184 -SAFEGNSLCG 193 (606)
Q Consensus 184 -l~~~~n~l~~ 193 (606)
|++.+|.+.+
T Consensus 251 ~L~Ls~n~l~~ 261 (768)
T 3rgz_A 251 LLNISSNQFVG 261 (768)
T ss_dssp EEECCSSCCEE
T ss_pred EEECCCCcccC
Confidence 3344555443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.5e-24 Score=244.81 Aligned_cols=190 Identities=23% Similarity=0.345 Sum_probs=164.5
Q ss_pred hHHHHHHHhHhhcCCCCcCCCCCC-----CC--Ccc------------eeEEecC-CeEEEEEcCCCCcccccCccccCC
Q 037905 3 SDRAALLTLRKAIGGRTLLWNLTD-----GP--CKW------------VGVFCTG-ERVTMLRFPGMGLSGQLPIAIGNL 62 (606)
Q Consensus 3 ~~~~~l~~~~~~~~~~~~~w~~~~-----~~--c~~------------~~~~c~~-~~l~~L~L~~n~l~~~~p~~l~~l 62 (606)
+|++||++|++.+.+. .|+..+ +| |+| .||.|+. .+|+.|+|++|+|+|.+|++|++|
T Consensus 269 ~d~~ALl~~k~~l~~~--~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~~l~~L 346 (876)
T 4ecn_A 269 KDYKALKAIWEALDGK--NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346 (876)
T ss_dssp HHHHHHHHHHHHTTGG--GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECGGGGGC
T ss_pred HHHHHHHHHHHHcCCC--CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCchHHhcc
Confidence 6899999999988543 897554 56 999 9999984 789999999999999999999999
Q ss_pred CCCcEEEc-cCCCCccc---------------------------------------------------------------
Q 037905 63 TELHTVSL-RFNALRGT--------------------------------------------------------------- 78 (606)
Q Consensus 63 ~~L~~L~L-~~N~l~~~--------------------------------------------------------------- 78 (606)
++|++|+| ++|.+.|.
T Consensus 347 ~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~ 426 (876)
T 4ecn_A 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426 (876)
T ss_dssp TTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCC
T ss_pred ccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchh
Confidence 99999999 77765443
Q ss_pred -------------CcccccCCCCCCEEeccCCcccc-----------------cCCcccc--CCCCCcEEecCCCcCCcc
Q 037905 79 -------------IPSDFAKLSNLRNLYLQGNLFSG-----------------EIPGLLF--SLGNLIRLNLAKNNFSGT 126 (606)
Q Consensus 79 -------------~p~~~~~l~~L~~L~Ls~N~l~~-----------------~~p~~~~--~l~~L~~L~l~~N~l~~~ 126 (606)
+|..|++|++|++|+|++|+|++ .+|..++ ++++|+.|+|++|++.+.
T Consensus 427 ~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~ 506 (876)
T 4ecn_A 427 DTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506 (876)
T ss_dssp TTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCS
T ss_pred hceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCcc
Confidence 78899999999999999999997 3899887 999999999999999999
Q ss_pred cchhhhcCCCcceeeccccc-ccc-cCCC-C-------CCCCCCCEEEccCCcCcccCCc--cccCCCC---CcccCCCC
Q 037905 127 ISADFNKLTRLGTLYLQENQ-LTG-SIPD-L-------GAFSSLAQFNVSFNKLNGSIPK--RFARLPS---SAFEGNSL 191 (606)
Q Consensus 127 ~p~~~~~l~~L~~L~l~~N~-l~~-~~~~-~-------~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~---l~~~~n~l 191 (606)
+|..|.+|++|++|+|++|+ |++ .+|. + ..+++|+.|+|++|.|+ .+|. .|.++++ |++.+|.+
T Consensus 507 iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l 585 (876)
T 4ecn_A 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKV 585 (876)
T ss_dssp CCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCC
T ss_pred ChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCc
Confidence 99999999999999999998 887 4442 3 34569999999999999 7787 6766555 57888988
Q ss_pred CCCC
Q 037905 192 CGKP 195 (606)
Q Consensus 192 ~~~p 195 (606)
...|
T Consensus 586 ~~lp 589 (876)
T 4ecn_A 586 RHLE 589 (876)
T ss_dssp CBCC
T ss_pred ccch
Confidence 8665
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.2e-24 Score=236.74 Aligned_cols=189 Identities=25% Similarity=0.396 Sum_probs=162.1
Q ss_pred hHHHHHHHhHhhcCC-----------CCcCCCCCCCCCcc---eeEEecC-CeEEEEEcCCCCcccccCccccCCCCCcE
Q 037905 3 SDRAALLTLRKAIGG-----------RTLLWNLTDGPCKW---VGVFCTG-ERVTMLRFPGMGLSGQLPIAIGNLTELHT 67 (606)
Q Consensus 3 ~~~~~l~~~~~~~~~-----------~~~~w~~~~~~c~~---~~~~c~~-~~l~~L~L~~n~l~~~~p~~l~~l~~L~~ 67 (606)
+|+.||.+++..+.+ ...+|+..+++|.| .||.|+. .+|+.|+|++|+++|.+|++|++|++|++
T Consensus 30 ~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L~~ 109 (636)
T 4eco_A 30 KDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEV 109 (636)
T ss_dssp HHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTCCE
T ss_pred HHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccceE
Confidence 589999999777522 12379888899999 9999975 58999999999999999999999999999
Q ss_pred EEccCC--------------------------------------------------------------------------
Q 037905 68 VSLRFN-------------------------------------------------------------------------- 73 (606)
Q Consensus 68 L~L~~N-------------------------------------------------------------------------- 73 (606)
|+|++|
T Consensus 110 L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~ 189 (636)
T 4eco_A 110 LALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189 (636)
T ss_dssp EESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTT
T ss_pred EECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhc
Confidence 999988
Q ss_pred ----CCcccCcccccCCCCCCEEeccCCccccc-----------------CCcccc--CCCCCcEEecCCCcCCcccchh
Q 037905 74 ----ALRGTIPSDFAKLSNLRNLYLQGNLFSGE-----------------IPGLLF--SLGNLIRLNLAKNNFSGTISAD 130 (606)
Q Consensus 74 ----~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~p~~ 130 (606)
+|++ +|..|+++++|++|+|++|+|++. +|..+. ++++|++|+|++|++.+.+|..
T Consensus 190 ~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~ 268 (636)
T 4eco_A 190 QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTF 268 (636)
T ss_dssp CCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTT
T ss_pred cccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHH
Confidence 4445 788999999999999999999975 999988 9999999999999999999999
Q ss_pred hhcCCCcceeeccccc-ccc-cCC-CCCCC------CCCCEEEccCCcCcccCCc--cccCCCC---CcccCCCCCC
Q 037905 131 FNKLTRLGTLYLQENQ-LTG-SIP-DLGAF------SSLAQFNVSFNKLNGSIPK--RFARLPS---SAFEGNSLCG 193 (606)
Q Consensus 131 ~~~l~~L~~L~l~~N~-l~~-~~~-~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~---l~~~~n~l~~ 193 (606)
|.++++|++|++++|+ +++ .+| .++.+ ++|+.|++++|+++ .+|. .+.++++ |++.+|.+.|
T Consensus 269 l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g 344 (636)
T 4eco_A 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEG 344 (636)
T ss_dssp TTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEE
T ss_pred HhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCcc
Confidence 9999999999999998 887 455 36555 89999999999999 7777 6665554 5678888873
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-23 Score=216.52 Aligned_cols=190 Identities=16% Similarity=0.232 Sum_probs=161.0
Q ss_pred CchHHHHHHHhHhhc---CCC-CcCC----CCCCCCCcceeEEecC----------CeEEEEEcCCCCcccccCccccCC
Q 037905 1 LASDRAALLTLRKAI---GGR-TLLW----NLTDGPCKWVGVFCTG----------ERVTMLRFPGMGLSGQLPIAIGNL 62 (606)
Q Consensus 1 ~~~~~~~l~~~~~~~---~~~-~~~w----~~~~~~c~~~~~~c~~----------~~l~~L~L~~n~l~~~~p~~l~~l 62 (606)
+.+|++||++|+..+ +.. ...| +...++|.|.|+.|.. .+|+.|+|++|.|+ .+|..+.++
T Consensus 25 ~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l 103 (328)
T 4fcg_A 25 LRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRL 103 (328)
T ss_dssp CCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGG
T ss_pred CchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhC
Confidence 357899999998865 333 3488 3456899999999952 78999999999998 888889999
Q ss_pred CCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhc---------
Q 037905 63 TELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNK--------- 133 (606)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~--------- 133 (606)
++|++|+|++|.|+ .+|..|.++++|++|+|++|+|+ .+|..+..+++|++|+|++|++.+.+|..+..
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 99999999999999 89999999999999999999999 88999999999999999999888889887654
Q ss_pred CCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCCCCC
Q 037905 134 LTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSLCGK 194 (606)
Q Consensus 134 l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l~~~ 194 (606)
+++|++|+|++|+|+.++..+..+++|+.|+|++|++++ +|..+..++ .|++.+|.+.+.
T Consensus 182 l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~ 244 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRN 244 (328)
T ss_dssp STTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCB
T ss_pred CCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhh
Confidence 999999999999999555568899999999999999995 554565544 467788877664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-22 Score=198.63 Aligned_cols=155 Identities=26% Similarity=0.320 Sum_probs=132.1
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
.+++.|+|++|.|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 46888999999999888888999999999999999999777778899999999999999999777778889999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSLCG 193 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l~~ 193 (606)
++|+|++..+..|..+++|++|+|++|+|++.++. |..+++|+.|+|++|+|++..+..|..++ .+++.+|++..
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCT
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeC
Confidence 99999977776788899999999999999988874 88899999999999999977776665554 45678888753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.9e-22 Score=193.10 Aligned_cols=154 Identities=21% Similarity=0.192 Sum_probs=130.8
Q ss_pred CCCCCCCCCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCC
Q 037905 21 LWNLTDGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNL 89 (606)
Q Consensus 21 ~w~~~~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 89 (606)
.|...+..|+|+++.|+. ++|++|+|++|.|++..|..|.++++|++|+|++|+|+...+..|..+++|
T Consensus 11 ~~~~~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L 90 (229)
T 3e6j_A 11 AACPSQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90 (229)
T ss_dssp CCCCTTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC
T ss_pred ccCCCCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCc
Confidence 454678999999999975 468889999999998888889999999999999999985555667889999
Q ss_pred CEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCC
Q 037905 90 RNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFN 168 (606)
Q Consensus 90 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N 168 (606)
++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++.++. +..+++|+.|+|++|
T Consensus 91 ~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 169 (229)
T 3e6j_A 91 TVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169 (229)
T ss_dssp CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCC
Confidence 99999999999666677888999999999999998 7788888999999999999999877765 788889999999999
Q ss_pred cCcccCC
Q 037905 169 KLNGSIP 175 (606)
Q Consensus 169 ~l~~~~p 175 (606)
++.+..+
T Consensus 170 ~~~c~c~ 176 (229)
T 3e6j_A 170 PWDCECR 176 (229)
T ss_dssp CBCTTBG
T ss_pred CccCCcc
Confidence 8885543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=3.1e-22 Score=228.92 Aligned_cols=118 Identities=36% Similarity=0.614 Sum_probs=93.2
Q ss_pred CCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEE
Q 037905 86 LSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFN 164 (606)
Q Consensus 86 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~ 164 (606)
+++|++|||++|+|+|.+|..|+++++|+.|+|++|+|+|.+|..|+.+++|+.|||++|+++|.+|. +..+++|+.|+
T Consensus 631 l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ 710 (768)
T 3rgz_A 631 NGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEID 710 (768)
T ss_dssp SBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEE
T ss_pred cccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEE
Confidence 35567777777777777787888888888888888888888888888888888888888888887775 77888888888
Q ss_pred ccCCcCcccCCc--cccCCCCCcccCCC-CCCCCCcCCCCCC
Q 037905 165 VSFNKLNGSIPK--RFARLPSSAFEGNS-LCGKPLVSCNGGG 203 (606)
Q Consensus 165 l~~N~l~~~~p~--~~~~l~~l~~~~n~-l~~~p~~~c~~~~ 203 (606)
+++|+|+|.+|. .|..++.+.+.||+ +||.|...|....
T Consensus 711 ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~~~~ 752 (768)
T 3rgz_A 711 LSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSN 752 (768)
T ss_dssp CCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCCSCC
T ss_pred CcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCCCCc
Confidence 888888888884 46677777888886 8998888886543
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-22 Score=202.02 Aligned_cols=139 Identities=15% Similarity=0.167 Sum_probs=113.5
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCcc-------------------CHHHHHHHHHHHcCCCCCCcccceEEEEe
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV-------------------SEKEFREKMEVVGSMDHENLVPLRAYYYS 383 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 383 (606)
+.||+|+||.||+|...+|+.||+|+++.... ....+.+|++++++++ | +++.+++.
T Consensus 96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~- 171 (282)
T 1zar_A 96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA- 171 (282)
T ss_dssp EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE-
T ss_pred CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe-
Confidence 78999999999999997799999999964321 2456889999999998 5 67777554
Q ss_pred CCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeec
Q 037905 384 RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDF 463 (606)
Q Consensus 384 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~Df 463 (606)
.+..++||||+++++|.+ +.. .....++.|++.||+|||+.|++ ||||||+|||++ ++.+||+||
T Consensus 172 ~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~gii--HrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 172 WEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRGIV--HGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTTEE--CSCCSTTSEEEE-TTEEEECCC
T ss_pred ccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCCCE--eCCCCHHHEEEE-CCcEEEEEC
Confidence 356699999999999998 421 12346999999999999999966 999999999999 999999999
Q ss_pred ccCccCCCCCCCCCcccccCccccCC
Q 037905 464 GLAHLASPSSTPNRIDGYRAPEVTDA 489 (606)
Q Consensus 464 G~a~~~~~~~~~~~~~~y~aPE~~~~ 489 (606)
|+|+.. ..|+|||++..
T Consensus 237 G~a~~~---------~~~~a~e~l~r 253 (282)
T 1zar_A 237 PQSVEV---------GEEGWREILER 253 (282)
T ss_dssp TTCEET---------TSTTHHHHHHH
T ss_pred CCCeEC---------CCCCHHHHHHH
Confidence 998743 23788998753
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.3e-21 Score=193.35 Aligned_cols=158 Identities=25% Similarity=0.276 Sum_probs=137.0
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
+|+.|+|++|.|++..+..|.++++|++|+|++|+|+...+..|.++++|++|+|++|++++..+..|..+++|+.|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 58899999999997777789999999999999999995555667889999999999999997777778899999999999
Q ss_pred CCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCC---CCCcccCCCCCCCC
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARL---PSSAFEGNSLCGKP 195 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l---~~l~~~~n~l~~~p 195 (606)
+|++++..+..|..+++|++|+|++|+|++.++. |..+++|+.|+|++|++++..+..|..+ ..|++.+|.+.+.|
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCC
Confidence 9999988888899999999999999999988776 8889999999999999998777666554 44678889988776
Q ss_pred Cc
Q 037905 196 LV 197 (606)
Q Consensus 196 ~~ 197 (606)
..
T Consensus 198 ~~ 199 (270)
T 2o6q_A 198 EG 199 (270)
T ss_dssp TT
T ss_pred HH
Confidence 53
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.1e-21 Score=187.59 Aligned_cols=164 Identities=25% Similarity=0.238 Sum_probs=141.8
Q ss_pred CCCCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEec
Q 037905 26 DGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYL 94 (606)
Q Consensus 26 ~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 94 (606)
...|.|.++.|.. ++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 4 ~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 83 (208)
T 2o6s_A 4 RCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83 (208)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEEC
Confidence 4568899999975 36899999999999777778999999999999999999666667899999999999
Q ss_pred cCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCccc
Q 037905 95 QGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGS 173 (606)
Q Consensus 95 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~ 173 (606)
++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|++++|+|++.++. +..+++|+.|++++|++.+.
T Consensus 84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 163 (208)
T 2o6s_A 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT 163 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC
T ss_pred CCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC
Confidence 99999977677789999999999999999977777789999999999999999988876 88899999999999998865
Q ss_pred CCccccCCCCCcccCCCCCC
Q 037905 174 IPKRFARLPSSAFEGNSLCG 193 (606)
Q Consensus 174 ~p~~~~~l~~l~~~~n~l~~ 193 (606)
.| .+..+.+.+|.+.|
T Consensus 164 ~~----~l~~L~~~~n~~~g 179 (208)
T 2o6s_A 164 CP----GIRYLSEWINKHSG 179 (208)
T ss_dssp TT----TTHHHHHHHHHCTT
T ss_pred CC----CHHHHHHHHHhCCc
Confidence 43 44455566676665
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.85 E-value=1.3e-21 Score=199.46 Aligned_cols=155 Identities=25% Similarity=0.426 Sum_probs=118.6
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCC-CCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLS-NLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
.++|++|+|++|.|++.+|..|..+++|++|+|++|+|++.+|..+..++ +|++|+|++|++++.+|..+..+. |+.|
T Consensus 124 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L 202 (313)
T 1ogq_A 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFV 202 (313)
T ss_dssp CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEE
T ss_pred CCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEE
Confidence 36788888888888888888888888888888888888888888888887 888888888888888887777776 7777
Q ss_pred ecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCCC
Q 037905 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLCG 193 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~~ 193 (606)
+|++|++++.+|..|..+++|+.|+|++|++++.++.+..+++|+.|+|++|+|++.+|..|..+++ |++.+|.+++
T Consensus 203 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 282 (313)
T 1ogq_A 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282 (313)
T ss_dssp ECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEE
T ss_pred ECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccc
Confidence 7777777777777777777777777777777766666666777777777777777667766554443 4456666654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=5.8e-21 Score=184.28 Aligned_cols=146 Identities=23% Similarity=0.313 Sum_probs=81.1
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCc
Q 037905 43 MLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNN 122 (606)
Q Consensus 43 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 122 (606)
.+++++|+++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3455555555 4444333 456666666666664444455566666666666666665555556666666666666666
Q ss_pred CCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCC
Q 037905 123 FSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSL 191 (606)
Q Consensus 123 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l 191 (606)
|+...+..|..+++|++|+|++|+|++.++. |..+++|+.|+|++|+|++..+..|..+++ +++.+|++
T Consensus 92 l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~ 164 (220)
T 2v9t_B 92 ITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164 (220)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE
T ss_pred CCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc
Confidence 6544444455566666666666666655543 555566666666666666555544443333 34455554
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.2e-20 Score=182.15 Aligned_cols=147 Identities=21% Similarity=0.234 Sum_probs=107.2
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCc-ccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCC
Q 037905 43 MLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121 (606)
Q Consensus 43 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 121 (606)
.|++++|.|+ .+|..+. ..+++|+|++|+|++..| ..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 6777777776 4665553 345788888888875544 34777888888888888888666667778888888888888
Q ss_pred cCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCC
Q 037905 122 NFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLC 192 (606)
Q Consensus 122 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~ 192 (606)
+|++..+..|..+++|++|+|++|+|++.+|. |..+++|+.|+|++|+|++..|..|..+++ |++.+|++.
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 88776676777788888888888888777664 777788888888888888777766665544 456777664
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=8.3e-21 Score=197.55 Aligned_cols=169 Identities=24% Similarity=0.253 Sum_probs=145.6
Q ss_pred CCCCCCcceeEEecC-----------CeEEEEEcCCCCcccccCcccc-CCCCCcEEEccCCCCcccCcccccCCCCCCE
Q 037905 24 LTDGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIG-NLTELHTVSLRFNALRGTIPSDFAKLSNLRN 91 (606)
Q Consensus 24 ~~~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 91 (606)
+....|.+..+.|.. ..++.|+|++|.|++..+..|. ++++|++|+|++|+|++..|..|.++++|++
T Consensus 13 p~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~ 92 (361)
T 2xot_A 13 PANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRY 92 (361)
T ss_dssp CTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred CCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCE
Confidence 444566788888865 3588999999999987777887 9999999999999999777788999999999
Q ss_pred EeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-C---CCCCCCCEEEccC
Q 037905 92 LYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-L---GAFSSLAQFNVSF 167 (606)
Q Consensus 92 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~---~~l~~L~~L~l~~ 167 (606)
|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|+++++. | ..+++|+.|+|++
T Consensus 93 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~ 172 (361)
T 2xot_A 93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSS 172 (361)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCS
T ss_pred EECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCC
Confidence 99999999977777899999999999999999988899999999999999999999987776 4 5799999999999
Q ss_pred CcCcccCCccccCCCC-----CcccCCCCC
Q 037905 168 NKLNGSIPKRFARLPS-----SAFEGNSLC 192 (606)
Q Consensus 168 N~l~~~~p~~~~~l~~-----l~~~~n~l~ 192 (606)
|+|++..+..|..++. |++.+|++.
T Consensus 173 N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 173 NKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp SCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 9999766677776654 677888763
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.82 E-value=9.1e-20 Score=181.91 Aligned_cols=154 Identities=30% Similarity=0.298 Sum_probs=130.4
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.|++. +.+..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|++|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 46899999999999853 4788999999999999999977777788999999999999999977777788999999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLCG 193 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~~ 193 (606)
|++|+|++..+..|..+++|++|++++|+|++.++. +..+++|+.|++++|++++..|..|..+++ |++.+|++.+
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccc
Confidence 999999977777788999999999999999987776 688999999999999999887766655544 5678887754
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.82 E-value=9e-20 Score=183.67 Aligned_cols=157 Identities=23% Similarity=0.222 Sum_probs=137.5
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++++.|+|++|.|++..|..|.++++|++|+|++|+|++ ++.. ..+++|++|+|++|+|+ .+|..+..+++|+.|+|
T Consensus 31 ~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l 107 (290)
T 1p9a_G 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (290)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEEC
Confidence 578999999999998888899999999999999999994 4433 78999999999999999 88888999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccC---CCCCcccCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFAR---LPSSAFEGNSLCGK 194 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~---l~~l~~~~n~l~~~ 194 (606)
++|+|++..|..|..+++|++|+|++|+|++.++. |..+++|+.|+|++|+|++..+..|.. +..|++.+|.+...
T Consensus 108 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~i 187 (290)
T 1p9a_G 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI 187 (290)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred CCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCcc
Confidence 99999977778899999999999999999988876 788999999999999999776666554 45567899999877
Q ss_pred CCcC
Q 037905 195 PLVS 198 (606)
Q Consensus 195 p~~~ 198 (606)
|...
T Consensus 188 p~~~ 191 (290)
T 1p9a_G 188 PKGF 191 (290)
T ss_dssp CTTT
T ss_pred Chhh
Confidence 6653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=8.2e-20 Score=183.48 Aligned_cols=155 Identities=21% Similarity=0.241 Sum_probs=90.3
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCc-ccccCCccccCCCCCcEEec
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNL-FSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~l 118 (606)
+|+.|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+ +....|..|..+++|+.|+|
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 55666666666665555556666666666666666665555666666666666666665 55444555666666666666
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSLCGK 194 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l~~~ 194 (606)
++|++++..|..|..+++|++|++++|++++.++. +..+++|+.|+|++|++++..+..|..++ .|++.+|.+.+.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 66666655555566666666666666666655544 55566666666666666644444443332 334555555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.82 E-value=4.7e-20 Score=181.74 Aligned_cols=165 Identities=27% Similarity=0.294 Sum_probs=135.5
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 46899999999999988888899999999999999999977778899999999999999999977777789999999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCc------cccCC--CCCcccC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPK------RFARL--PSSAFEG 188 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~------~~~~l--~~l~~~~ 188 (606)
|++|+|++..+..|..+++|++|+|++|+|++.++. +..+++|+.|+|++|+|++.... .+..- ......+
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~~~~~~~~~~~~~~~~ 217 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRCEILYLSQWIRENSNKVKDGTG 217 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTSTTHHHHHHHHHHSGGGBCC---
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCccccHHHHHHHHhcccceeeccC
Confidence 999999977777899999999999999999988885 88999999999999999866332 11111 1123456
Q ss_pred CCCCCCCCc-CCCCC
Q 037905 189 NSLCGKPLV-SCNGG 202 (606)
Q Consensus 189 n~l~~~p~~-~c~~~ 202 (606)
+.+++.|.. .|..+
T Consensus 218 ~~~~~~~~~~~C~~~ 232 (251)
T 3m19_A 218 QNLHESPDGVTCSDG 232 (251)
T ss_dssp ----CCGGGCBBTTS
T ss_pred cccccCCCcCccCCC
Confidence 777777765 77654
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-19 Score=182.52 Aligned_cols=159 Identities=25% Similarity=0.296 Sum_probs=144.5
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCC-CcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNA-LRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
.++|++|+|++|.|++..|.+|.++++|++|+|++|+ ++...|..|..+++|++|+|++|++++..|..|..+++|++|
T Consensus 55 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 134 (285)
T 1ozn_A 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYL 134 (285)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEE
Confidence 3689999999999998889999999999999999997 886668899999999999999999998888899999999999
Q ss_pred ecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCC
Q 037905 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLC 192 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~ 192 (606)
+|++|++++..+..|..+++|++|+|++|+|++.++. +..+++|+.|++++|.+++..|..|..+++ |++.+|.+.
T Consensus 135 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~ 214 (285)
T 1ozn_A 135 YLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (285)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred ECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCC
Confidence 9999999977777799999999999999999988886 899999999999999999988888765554 678899998
Q ss_pred CCCC
Q 037905 193 GKPL 196 (606)
Q Consensus 193 ~~p~ 196 (606)
+.|.
T Consensus 215 ~~~~ 218 (285)
T 1ozn_A 215 ALPT 218 (285)
T ss_dssp CCCH
T ss_pred cCCH
Confidence 8764
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-19 Score=174.11 Aligned_cols=151 Identities=20% Similarity=0.245 Sum_probs=136.1
Q ss_pred CCCCCcceeEEecC-----------CeEEEEEcCCCCcccccC-ccccCCCCCcEEEccCCCCcccCcccccCCCCCCEE
Q 037905 25 TDGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLP-IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNL 92 (606)
Q Consensus 25 ~~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (606)
....|.|..+.|+. ..++.|+|++|.|++..| ..|..+++|++|+|++|+|++..+..|.++++|++|
T Consensus 7 ~~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L 86 (220)
T 2v70_A 7 EKCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI 86 (220)
T ss_dssp TTCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred CCCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence 34557788888865 357899999999997755 458999999999999999998778899999999999
Q ss_pred eccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCc
Q 037905 93 YLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 93 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~ 171 (606)
+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++.+|. |..+++|+.|+|++|+|+
T Consensus 87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 9999999988888899999999999999999988899999999999999999999998775 899999999999999999
Q ss_pred ccCC
Q 037905 172 GSIP 175 (606)
Q Consensus 172 ~~~p 175 (606)
+..+
T Consensus 167 c~c~ 170 (220)
T 2v70_A 167 CNCY 170 (220)
T ss_dssp CSGG
T ss_pred CCCc
Confidence 6654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.4e-19 Score=180.36 Aligned_cols=156 Identities=24% Similarity=0.236 Sum_probs=138.1
Q ss_pred cCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 37 TGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
..++|++|+|++|.|+...+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|+.|
T Consensus 59 ~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 138 (270)
T 2o6q_A 59 RLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL 138 (270)
T ss_dssp SCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEE
Confidence 34789999999999996666678999999999999999997667788999999999999999998888889999999999
Q ss_pred ecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCC
Q 037905 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLC 192 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~ 192 (606)
+|++|+|++..+..|..+++|++|+|++|+|++.++. |..+++|+.|+|++|+|++..+..|..+++ |++.+|++.
T Consensus 139 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 139 SLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence 9999999977777799999999999999999988876 889999999999999999777766665554 667888773
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=174.79 Aligned_cols=149 Identities=23% Similarity=0.266 Sum_probs=136.2
Q ss_pred CCCCCCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEE
Q 037905 24 LTDGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNL 92 (606)
Q Consensus 24 ~~~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (606)
+....|.|..+.|.+ ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus 6 P~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L 85 (220)
T 2v9t_B 6 PAACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL 85 (220)
T ss_dssp CTTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEE
T ss_pred CCCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEE
Confidence 344567899999975 368999999999998777899999999999999999998889999999999999
Q ss_pred eccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCc
Q 037905 93 YLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 93 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~ 171 (606)
+|++|+|+...+..|..+++|+.|+|++|+|++..|..|..+++|++|+|++|+|++.++. |..+++|+.|+|++|+|.
T Consensus 86 ~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 86 VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 9999999966666688999999999999999988899999999999999999999998886 889999999999999998
Q ss_pred c
Q 037905 172 G 172 (606)
Q Consensus 172 ~ 172 (606)
.
T Consensus 166 c 166 (220)
T 2v9t_B 166 C 166 (220)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=6.2e-20 Score=183.45 Aligned_cols=158 Identities=18% Similarity=0.194 Sum_probs=127.8
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|+.|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 36889999999998777778889999999999999998766778888999999999999998777788888999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeeccccccccc-CC-CCCCCCCCCEEEccCCcCcccCCccccC---CC----CCcccCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGS-IP-DLGAFSSLAQFNVSFNKLNGSIPKRFAR---LP----SSAFEGN 189 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~---l~----~l~~~~n 189 (606)
++|++.+..+..+..+++|++|++++|++++. +| .+..+++|+.|++++|++++..+..|.. ++ .+++.+|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n 187 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCC
Confidence 99998876666788889999999999998873 24 4888889999999999988776665543 33 4556677
Q ss_pred CCCCCCC
Q 037905 190 SLCGKPL 196 (606)
Q Consensus 190 ~l~~~p~ 196 (606)
.+.+.+.
T Consensus 188 ~l~~~~~ 194 (276)
T 2z62_A 188 PMNFIQP 194 (276)
T ss_dssp CCCEECT
T ss_pred cccccCc
Confidence 7766543
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.3e-20 Score=188.81 Aligned_cols=153 Identities=23% Similarity=0.300 Sum_probs=134.7
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccC--------
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-------- 109 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-------- 109 (606)
.++|++|+|++|.|+ .+|..|.++++|++|+|++|+|+ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus 103 l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~ 180 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQ 180 (328)
T ss_dssp GTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEE
T ss_pred CCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhc
Confidence 368999999999998 88999999999999999999999 88999999999999999998888889887664
Q ss_pred -CCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCC---Cc
Q 037905 110 -LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SA 185 (606)
Q Consensus 110 -l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~ 185 (606)
+++|+.|+|++|+|+ .+|..+..+++|++|+|++|++++.++.+..+++|+.|+|++|.+.+.+|..|..+++ |+
T Consensus 181 ~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~ 259 (328)
T 4fcg_A 181 GLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLI 259 (328)
T ss_dssp ESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEE
T ss_pred cCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEE
Confidence 999999999999998 8888899999999999999999987777888999999999999999999987766555 56
Q ss_pred ccCCCCCC
Q 037905 186 FEGNSLCG 193 (606)
Q Consensus 186 ~~~n~l~~ 193 (606)
+.+|.+.+
T Consensus 260 L~~n~~~~ 267 (328)
T 4fcg_A 260 LKDCSNLL 267 (328)
T ss_dssp CTTCTTCC
T ss_pred CCCCCchh
Confidence 77776654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=8.9e-20 Score=203.73 Aligned_cols=158 Identities=18% Similarity=0.175 Sum_probs=138.0
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
.++++|||++|.|++..|.+|.++++|++|+|++|+|++..|++|.+|++|++|+|++|+|++..+..|.+|++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 47899999999999777889999999999999999999777888999999999999999999777788999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccC-CC-CCCCCCCCEEEccCCcCcccCCccccCCCC-------CcccCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSI-PD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS-------SAFEGN 189 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-------l~~~~n 189 (606)
++|+|++..+..|+++++|++|+|++|.|++.. |. +..+++|+.|++++|+|++..|..|..+.. +.+..|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 999999777778999999999999999998643 44 788999999999999999988887765443 335566
Q ss_pred CCCCCCC
Q 037905 190 SLCGKPL 196 (606)
Q Consensus 190 ~l~~~p~ 196 (606)
.+...+.
T Consensus 212 ~l~~i~~ 218 (635)
T 4g8a_A 212 PMNFIQP 218 (635)
T ss_dssp CCCEECT
T ss_pred cccccCc
Confidence 6665443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.9e-20 Score=190.50 Aligned_cols=172 Identities=20% Similarity=0.240 Sum_probs=140.6
Q ss_pred CCCCCCCCCcceeEEecC-------------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCC
Q 037905 21 LWNLTDGPCKWVGVFCTG-------------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLS 87 (606)
Q Consensus 21 ~w~~~~~~c~~~~~~c~~-------------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 87 (606)
.|......|.|.++ |.. ++|++|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.+++
T Consensus 22 ~~~~~~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 100 (353)
T 2z80_A 22 SSNQASLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLG 100 (353)
T ss_dssp -----CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred CCCccCCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCC
Confidence 45566788999887 532 4799999999999977667899999999999999999987788899999
Q ss_pred CCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccc-hhhhcCCCcceeecccc-cccccCCC-CCCCCCCCEEE
Q 037905 88 NLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTIS-ADFNKLTRLGTLYLQEN-QLTGSIPD-LGAFSSLAQFN 164 (606)
Q Consensus 88 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N-~l~~~~~~-~~~l~~L~~L~ 164 (606)
+|++|+|++|+|++..+..|..+++|++|+|++|++++..+ ..|..+++|++|++++| .++..++. +..+++|+.|+
T Consensus 101 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~ 180 (353)
T 2z80_A 101 SLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180 (353)
T ss_dssp TCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEE
T ss_pred CCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEE
Confidence 99999999999995555558899999999999999984443 37889999999999999 47777664 88999999999
Q ss_pred ccCCcCcccCCccccCCCC---CcccCCCCCC
Q 037905 165 VSFNKLNGSIPKRFARLPS---SAFEGNSLCG 193 (606)
Q Consensus 165 l~~N~l~~~~p~~~~~l~~---l~~~~n~l~~ 193 (606)
+++|++++..|..|..+++ |++.+|.+..
T Consensus 181 l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~ 212 (353)
T 2z80_A 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHIL 212 (353)
T ss_dssp EEETTCCEECTTTTTTCSEEEEEEEECSCSTT
T ss_pred CCCCCcCccCHHHHhccccCCeecCCCCcccc
Confidence 9999999888888877665 4567776643
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.9e-19 Score=173.44 Aligned_cols=156 Identities=26% Similarity=0.317 Sum_probs=135.3
Q ss_pred ceeEEecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCC
Q 037905 31 WVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSL 110 (606)
Q Consensus 31 ~~~~~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 110 (606)
+..-.|+ .+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+
T Consensus 14 ~~~~~Cs---~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l 87 (229)
T 3e6j_A 14 PSQCSCS---GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSL 87 (229)
T ss_dssp CTTCEEE---TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCCEEe---CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccC
Confidence 3346676 456899999998 7776654 899999999999998889999999999999999999996666778999
Q ss_pred CCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCC---Cccc
Q 037905 111 GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFE 187 (606)
Q Consensus 111 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~ 187 (606)
++|+.|+|++|+|++..+..|..+++|++|+|++|+|+.++..+..+++|+.|+|++|+|++..+..|..+++ |++.
T Consensus 88 ~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 167 (229)
T 3e6j_A 88 TQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF 167 (229)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECT
T ss_pred CCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEee
Confidence 9999999999999977777789999999999999999977777999999999999999999777766765554 5678
Q ss_pred CCCCC
Q 037905 188 GNSLC 192 (606)
Q Consensus 188 ~n~l~ 192 (606)
+|++.
T Consensus 168 ~N~~~ 172 (229)
T 3e6j_A 168 GNPWD 172 (229)
T ss_dssp TSCBC
T ss_pred CCCcc
Confidence 88875
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-19 Score=180.96 Aligned_cols=153 Identities=27% Similarity=0.247 Sum_probs=135.8
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 36899999999999988888899999999999999999977777799999999999999999977777789999999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCCCcccCCCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSLCGK 194 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~~n~l~~~ 194 (606)
|++|+|++..+..|..+++|++|++++|+|++.++. +..+++|+.|++++|++.+..| ++..+.+.+|.++|.
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~----~l~~l~~~~n~~~g~ 237 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP----GIRYLSEWINKHSGV 237 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT----TTHHHHHHHHHTGGG
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc----HHHHHHHHHHhCCCc
Confidence 999999988887889999999999999999998886 7899999999999999986654 344455566666653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.79 E-value=5.8e-19 Score=177.72 Aligned_cols=152 Identities=28% Similarity=0.290 Sum_probs=133.9
Q ss_pred ecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcE
Q 037905 36 CTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115 (606)
Q Consensus 36 c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 115 (606)
...++|++|+|++|.|++..+ ...+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|+.
T Consensus 52 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~ 128 (290)
T 1p9a_G 52 MPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQE 128 (290)
T ss_dssp TTCTTCCEEECTTSCCCEEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCE
T ss_pred hcCCCCCEEECCCCccCcccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCE
Confidence 345789999999999996544 389999999999999999 88999999999999999999999777788999999999
Q ss_pred EecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccC---CCCCcccCCCC
Q 037905 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFAR---LPSSAFEGNSL 191 (606)
Q Consensus 116 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~---l~~l~~~~n~l 191 (606)
|+|++|+|++..+..|..+++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|..+.. +..+.+.+|++
T Consensus 129 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred EECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCc
Confidence 99999999987777889999999999999999988876 688999999999999999 56655544 44566788876
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=5.4e-19 Score=179.37 Aligned_cols=168 Identities=19% Similarity=0.181 Sum_probs=119.2
Q ss_pred CCCCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcc--cCcccccCCCCCCEE
Q 037905 26 DGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRG--TIPSDFAKLSNLRNL 92 (606)
Q Consensus 26 ~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L 92 (606)
...|.|.++.|+. ++|++|+|++|.|+...+..|.++++|++|+|++|+|+. ..|..+..+++|++|
T Consensus 4 ~C~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L 83 (306)
T 2z66_A 4 RCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYL 83 (306)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEE
T ss_pred CCeeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEE
Confidence 3558899999975 478999999999985544568899999999999999873 235666777778888
Q ss_pred eccCCcccccCCccccCCCCCcEEecCCCcCCcccc-hhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcC
Q 037905 93 YLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTIS-ADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKL 170 (606)
Q Consensus 93 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l 170 (606)
+|++|.++ .+|..+..+++|+.|+|++|++++..+ ..+..+++|++|++++|++++.++. +..+++|+.|++++|.+
T Consensus 84 ~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 162 (306)
T 2z66_A 84 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162 (306)
T ss_dssp ECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEE
T ss_pred ECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcc
Confidence 88777777 566667777777777777777764443 4566777777777777777766654 66667777777777777
Q ss_pred cc-cCCccccCCC---CCcccCCCCCCC
Q 037905 171 NG-SIPKRFARLP---SSAFEGNSLCGK 194 (606)
Q Consensus 171 ~~-~~p~~~~~l~---~l~~~~n~l~~~ 194 (606)
++ ..|..+..++ .|++.+|.+.+.
T Consensus 163 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~ 190 (306)
T 2z66_A 163 QENFLPDIFTELRNLTFLDLSQCQLEQL 190 (306)
T ss_dssp GGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred ccccchhHHhhCcCCCEEECCCCCcCCc
Confidence 65 4555444433 345666666654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.79 E-value=4.3e-19 Score=180.06 Aligned_cols=159 Identities=21% Similarity=0.231 Sum_probs=134.6
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCc-ccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
..+|++|+|++|.++ .+|..+..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..|..|..+++|+.|
T Consensus 77 ~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 155 (306)
T 2z66_A 77 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 155 (306)
T ss_dssp CSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred ccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence 368999999999998 677789999999999999999985444 578899999999999999998888889999999999
Q ss_pred ecCCCcCCc-ccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccC---CCCCcccCCCC
Q 037905 117 NLAKNNFSG-TISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFAR---LPSSAFEGNSL 191 (606)
Q Consensus 117 ~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~---l~~l~~~~n~l 191 (606)
+|++|++.+ .+|..|..+++|++|++++|+|++.+|. +..+++|+.|+|++|++++..+..|.. +..|++.+|.+
T Consensus 156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCC
T ss_pred ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCC
Confidence 999999986 5788899999999999999999988765 888999999999999999777766654 44567888988
Q ss_pred CCCCCc
Q 037905 192 CGKPLV 197 (606)
Q Consensus 192 ~~~p~~ 197 (606)
.+.+..
T Consensus 236 ~~~~~~ 241 (306)
T 2z66_A 236 MTSKKQ 241 (306)
T ss_dssp CBCSSS
T ss_pred cccCHH
Confidence 876543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=4.8e-19 Score=191.31 Aligned_cols=166 Identities=19% Similarity=0.220 Sum_probs=146.8
Q ss_pred ceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcc
Q 037905 31 WVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLF 99 (606)
Q Consensus 31 ~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 99 (606)
|..+.|.. .+++.|+|++|.|++..|..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+|
T Consensus 13 ~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l 92 (477)
T 2id5_A 13 DRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92 (477)
T ss_dssp TTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcC
Confidence 56788864 4789999999999988889999999999999999999988899999999999999999999
Q ss_pred cccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccc
Q 037905 100 SGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRF 178 (606)
Q Consensus 100 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~ 178 (606)
++..+..|.++++|+.|+|++|++.+..|..|..+++|++|+|++|++++..+. |..+++|+.|+|++|++++..+..|
T Consensus 93 ~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l 172 (477)
T 2id5_A 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEAL 172 (477)
T ss_dssp CSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHH
T ss_pred CccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHh
Confidence 966666789999999999999999988899999999999999999999988775 8999999999999999997766666
Q ss_pred cCCC---CCcccCCCCCCCCC
Q 037905 179 ARLP---SSAFEGNSLCGKPL 196 (606)
Q Consensus 179 ~~l~---~l~~~~n~l~~~p~ 196 (606)
..++ .|++.+|.+.+.+.
T Consensus 173 ~~l~~L~~L~l~~n~i~~~~~ 193 (477)
T 2id5_A 173 SHLHGLIVLRLRHLNINAIRD 193 (477)
T ss_dssp TTCTTCCEEEEESCCCCEECT
T ss_pred cccCCCcEEeCCCCcCcEeCh
Confidence 5554 46678888776543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.78 E-value=5e-19 Score=196.59 Aligned_cols=174 Identities=18% Similarity=0.147 Sum_probs=152.2
Q ss_pred CCCCCCCCCc----ceeEEecC------------------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCccc
Q 037905 21 LWNLTDGPCK----WVGVFCTG------------------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGT 78 (606)
Q Consensus 21 ~w~~~~~~c~----~~~~~c~~------------------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 78 (606)
.|.....||. |.++.|.. .+++.|+|++|.++...+..|.++++|++|+|++|.|++.
T Consensus 11 ~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~ 90 (597)
T 3oja_B 11 PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 90 (597)
T ss_dssp CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEE
T ss_pred CCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCC
Confidence 6766556664 66666541 4689999999999866666789999999999999999988
Q ss_pred CcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCC
Q 037905 79 IPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAF 157 (606)
Q Consensus 79 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l 157 (606)
.|..|..+++|++|+|++|.|++..|..|.++++|++|+|++|+|++.++..|.++++|++|+|++|.|++.+|. |..+
T Consensus 91 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 170 (597)
T 3oja_B 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQAT 170 (597)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTC
T ss_pred ChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcC
Confidence 888999999999999999999988888899999999999999999966666689999999999999999998886 8999
Q ss_pred CCCCEEEccCCcCcccCCccccCCCCCcccCCCCCCC
Q 037905 158 SSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSLCGK 194 (606)
Q Consensus 158 ~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~~n~l~~~ 194 (606)
++|+.|+|++|.|++..+..+.++..|++.+|.+.+.
T Consensus 171 ~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l 207 (597)
T 3oja_B 171 TSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTL 207 (597)
T ss_dssp TTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEE
T ss_pred CcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccc
Confidence 9999999999999988778888888888888887664
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-18 Score=178.28 Aligned_cols=169 Identities=21% Similarity=0.265 Sum_probs=144.3
Q ss_pred CCCCCCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEE
Q 037905 24 LTDGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNL 92 (606)
Q Consensus 24 ~~~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (606)
+....|.++.+.|.. ++|+.|+|++|.|++..|..|.++++|++|+|++|+|++..|..|.++++|++|
T Consensus 28 p~~c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 107 (332)
T 2ft3_A 28 PFGCHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKL 107 (332)
T ss_dssp CSSCEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEE
T ss_pred CCCCcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEE
Confidence 333457899999974 478999999999998878899999999999999999998889999999999999
Q ss_pred eccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccc--cCCC-CCCCCCCCEEEccCCc
Q 037905 93 YLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG--SIPD-LGAFSSLAQFNVSFNK 169 (606)
Q Consensus 93 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~-~~~l~~L~~L~l~~N~ 169 (606)
+|++|+++ .+|..+. ++|++|++++|++.+..+..|..+++|++|++++|.++. ..+. +..+ +|+.|++++|+
T Consensus 108 ~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~ 183 (332)
T 2ft3_A 108 YISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAK 183 (332)
T ss_dssp ECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSB
T ss_pred ECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCC
Confidence 99999999 6776665 799999999999997777789999999999999999964 5554 6666 89999999999
Q ss_pred CcccCCccccCCCCCcccCCCCCCCCC
Q 037905 170 LNGSIPKRFARLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 170 l~~~~p~~~~~l~~l~~~~n~l~~~p~ 196 (606)
+++.....+.++..|++.+|.+.+.+.
T Consensus 184 l~~l~~~~~~~L~~L~l~~n~i~~~~~ 210 (332)
T 2ft3_A 184 LTGIPKDLPETLNELHLDHNKIQAIEL 210 (332)
T ss_dssp CSSCCSSSCSSCSCCBCCSSCCCCCCT
T ss_pred CCccCccccCCCCEEECCCCcCCccCH
Confidence 986554555678888899988887653
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=6e-19 Score=196.42 Aligned_cols=159 Identities=17% Similarity=0.123 Sum_probs=144.5
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
+++++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 47899999999999888999999999999999999999888999999999999999999999888999999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccC-CCCCCCCCCCEEEccCCcCcccCCccccCCCC-----CcccCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSI-PDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS-----SAFEGNSLC 192 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-----l~~~~n~l~ 192 (606)
++|+|++..|..|.++++|++|++++|++++.. |.+..+++|+.|++++|++++..|..|..++. +++.+|.+.
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 999999777888999999999999999999854 66777999999999999999888877776664 457889988
Q ss_pred CCCCc
Q 037905 193 GKPLV 197 (606)
Q Consensus 193 ~~p~~ 197 (606)
+.+..
T Consensus 193 ~~~~~ 197 (606)
T 3t6q_A 193 GIEPG 197 (606)
T ss_dssp EECTT
T ss_pred ccChh
Confidence 76654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1e-18 Score=187.51 Aligned_cols=163 Identities=22% Similarity=0.230 Sum_probs=121.8
Q ss_pred ceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcc
Q 037905 31 WVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLF 99 (606)
Q Consensus 31 ~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 99 (606)
+..+.|.. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 56788865 4689999999999988899999999999999999999988889999999999999999999
Q ss_pred cccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcce-------------------------eecccccccccCCCC
Q 037905 100 SGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGT-------------------------LYLQENQLTGSIPDL 154 (606)
Q Consensus 100 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~-------------------------L~l~~N~l~~~~~~~ 154 (606)
++..+..|..+++|++|+|++|+|....+..|..+++|++ |+|++|+|++. |.+
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~ 214 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNL 214 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCC
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccc
Confidence 9777777889999999999999998655545555555554 45555555432 345
Q ss_pred CCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCCCC
Q 037905 155 GAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLCGK 194 (606)
Q Consensus 155 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~~~ 194 (606)
..+++|+.|+|++|+|++..|..|..+++ |++.+|.+.+.
T Consensus 215 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (452)
T 3zyi_A 215 TPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257 (452)
T ss_dssp TTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred cccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence 55555666666666666555555544443 34555665554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=7.4e-19 Score=188.55 Aligned_cols=170 Identities=21% Similarity=0.289 Sum_probs=147.6
Q ss_pred CCCccee--EEecC----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccC-cccccCCCCCCEEe
Q 037905 27 GPCKWVG--VFCTG----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTI-PSDFAKLSNLRNLY 93 (606)
Q Consensus 27 ~~c~~~~--~~c~~----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 93 (606)
..|.+.+ +.|.. ++|++|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 4555555 77865 46999999999999888999999999999999999997555 67899999999999
Q ss_pred ccCCcccccCCccccCCCCCcEEecCCCcCCcccchh--hhcCCCcceeecccccccccCCC--CCCCCCCCEEEccCCc
Q 037905 94 LQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISAD--FNKLTRLGTLYLQENQLTGSIPD--LGAFSSLAQFNVSFNK 169 (606)
Q Consensus 94 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~~--~~~l~~L~~L~l~~N~ 169 (606)
|++|++++..|..|.++++|++|+|++|++++..|.. |..+++|++|+|++|++++..|. +..+++|+.|++++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 9999999888999999999999999999999766665 99999999999999999998775 7899999999999999
Q ss_pred CcccCCccccCCC-----CCcccCCCCCCCCC
Q 037905 170 LNGSIPKRFARLP-----SSAFEGNSLCGKPL 196 (606)
Q Consensus 170 l~~~~p~~~~~l~-----~l~~~~n~l~~~p~ 196 (606)
+++..|..+..+. .+.+.+|.+.+.+.
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~ 197 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNE 197 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCST
T ss_pred ccccChhhhhccccccccccccccCcccccch
Confidence 9999888876653 45677787776543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.3e-19 Score=197.54 Aligned_cols=159 Identities=18% Similarity=0.184 Sum_probs=143.4
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 57999999999999888889999999999999999999888999999999999999999999888999999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccc-cCC-CCCCCCCCCEEEccCCcCcccCCccccCCC-------CCcccCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTG-SIP-DLGAFSSLAQFNVSFNKLNGSIPKRFARLP-------SSAFEGN 189 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~-------~l~~~~n 189 (606)
++|++++..+..|+++++|++|++++|++++ .+| .+.++++|+.|++++|++++..|..|..+. .+++.+|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 9999997777889999999999999999986 334 599999999999999999998887765443 4678889
Q ss_pred CCCCCCCc
Q 037905 190 SLCGKPLV 197 (606)
Q Consensus 190 ~l~~~p~~ 197 (606)
.+.+.|..
T Consensus 192 ~l~~~~~~ 199 (606)
T 3vq2_A 192 PIDFIQDQ 199 (606)
T ss_dssp CCCEECTT
T ss_pred CcceeCcc
Confidence 88876654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=8.5e-19 Score=166.00 Aligned_cols=150 Identities=18% Similarity=0.286 Sum_probs=128.9
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|+.|+|++|.|+ .+| .+..+++|++|+|++|.++ . +..+..+++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 44 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 47999999999998 666 7999999999999999887 3 448999999999999999999888999999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeeccccc-ccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQ-LTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCG 193 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~ 193 (606)
++|++++..|..+..+++|++|++++|+ ++ .++.+..+++|+.|++++|++++..+ ..+.+|..|++.+|++.+
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIMPLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCGGGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC----
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccHhhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCcccCC
Confidence 9999998889999999999999999998 66 45578899999999999999996532 344556667888898753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=164.37 Aligned_cols=131 Identities=26% Similarity=0.346 Sum_probs=118.5
Q ss_pred EEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcc-cccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCC
Q 037905 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPS-DFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120 (606)
Q Consensus 42 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 120 (606)
++|++++|+|+ .+|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 57899999997 78876654 999999999999965554 489999999999999999988899999999999999999
Q ss_pred CcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCC
Q 037905 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIP 175 (606)
Q Consensus 121 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p 175 (606)
|+|++..|..|..+++|++|+|++|+|++.+|. +..+++|+.|+|++|+|++..+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 999988888899999999999999999998775 8899999999999999997655
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-19 Score=169.73 Aligned_cols=166 Identities=22% Similarity=0.237 Sum_probs=130.0
Q ss_pred CCCCcceeEEecC-----------CeEEEEEcCCCCcccccCc-cccCCCCCcEEEccCCCCcccCcccccCCCCCCEEe
Q 037905 26 DGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPI-AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLY 93 (606)
Q Consensus 26 ~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 93 (606)
...|.|+.+.|+. .+|+.|+|++|.|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 5 ~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 84 (192)
T 1w8a_A 5 MCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEE
Confidence 4567788888875 3789999999999966664 499999999999999999988899999999999999
Q ss_pred ccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCccc
Q 037905 94 LQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS 173 (606)
Q Consensus 94 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~ 173 (606)
|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|++++..+-..-...++...+..+.....
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBC
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCC
Confidence 99999998888889999999999999999999999999999999999999999987554200001122223334444444
Q ss_pred CCccccCCCCCcccCCCC
Q 037905 174 IPKRFARLPSSAFEGNSL 191 (606)
Q Consensus 174 ~p~~~~~l~~l~~~~n~l 191 (606)
.|..+...+-.++..+.+
T Consensus 165 ~P~~l~~~~l~~l~~~~~ 182 (192)
T 1w8a_A 165 APSKVRDVQIKDLPHSEF 182 (192)
T ss_dssp SSTTTTTSBGGGSCTTTC
T ss_pred CChHHcCCChhhCcHhhc
Confidence 555555444444444443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.4e-19 Score=195.92 Aligned_cols=154 Identities=20% Similarity=0.261 Sum_probs=135.9
Q ss_pred CCcceeEEecC-------------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEec
Q 037905 28 PCKWVGVFCTG-------------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYL 94 (606)
Q Consensus 28 ~c~~~~~~c~~-------------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 94 (606)
.|.|.++ |.. ++|++|+|++|.|++..|.+|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5888887 753 37999999999999888899999999999999999999888899999999999999
Q ss_pred cCCcccccCCccccCCCCCcEEecCCCcCCc-ccchhhhcCCCcceeeccccc-ccccCC-CCCCCCCCCEEEccCCcCc
Q 037905 95 QGNLFSGEIPGLLFSLGNLIRLNLAKNNFSG-TISADFNKLTRLGTLYLQENQ-LTGSIP-DLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 95 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~-l~~~~~-~~~~l~~L~~L~l~~N~l~ 171 (606)
++|++++..|..|.++++|++|+|++|++++ ..|..|.++++|++|++++|+ +...++ .+..+++|+.|++++|.++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~ 161 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR 161 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCccc
Confidence 9999997777779999999999999999986 356789999999999999999 555554 4899999999999999999
Q ss_pred ccCCccccCCC
Q 037905 172 GSIPKRFARLP 182 (606)
Q Consensus 172 ~~~p~~~~~l~ 182 (606)
+..|..+..++
T Consensus 162 ~~~~~~l~~l~ 172 (549)
T 2z81_A 162 NYQSQSLKSIR 172 (549)
T ss_dssp EECTTTTTTCS
T ss_pred ccChhhhhccc
Confidence 98887765544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.8e-19 Score=173.05 Aligned_cols=156 Identities=15% Similarity=0.150 Sum_probs=133.9
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCC-CcccCcccccCCCCCCEEeccC-CcccccCCccccCCCCCcEE
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNA-LRGTIPSDFAKLSNLRNLYLQG-NLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 116 (606)
.+|++|+|++|+|++..+..|.++++|++|+|++|+ ++...+..|.++++|++|+|++ |+|++..+..|.++++|+.|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 589999999999997777789999999999999997 9866667899999999999999 99997777889999999999
Q ss_pred ecCCCcCCcccchhhhcCCCcc---eeecccc-cccccCCC-CCCCCCCC-EEEccCCcCcccCCcccc--CCCCCcccC
Q 037905 117 NLAKNNFSGTISADFNKLTRLG---TLYLQEN-QLTGSIPD-LGAFSSLA-QFNVSFNKLNGSIPKRFA--RLPSSAFEG 188 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~---~L~l~~N-~l~~~~~~-~~~l~~L~-~L~l~~N~l~~~~p~~~~--~l~~l~~~~ 188 (606)
+|++|++++ +|. |..+++|+ +|++++| ++++.++. |..+++|+ .|++++|+++...+..|. ++..|++.+
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~ 188 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNK 188 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTT
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCC
Confidence 999999995 665 88888888 9999999 99988876 88999999 999999999954444443 355577888
Q ss_pred CC-CCCCCC
Q 037905 189 NS-LCGKPL 196 (606)
Q Consensus 189 n~-l~~~p~ 196 (606)
|+ +...|.
T Consensus 189 n~~l~~i~~ 197 (239)
T 2xwt_C 189 NKYLTVIDK 197 (239)
T ss_dssp CTTCCEECT
T ss_pred CCCcccCCH
Confidence 85 876554
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.77 E-value=1e-18 Score=183.66 Aligned_cols=156 Identities=19% Similarity=0.180 Sum_probs=139.7
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++++.|+|++|.++...+..|..+++|++|+|++|.|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 57899999999998555556899999999999999999777789999999999999999999888888999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCCCcccCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSLCGK 194 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~~n~l~~~ 194 (606)
++|+|+...+..|..+++|++|++++|++++.++. +..+++|+.|++++|++++.....+.++..+++.+|.+.+.
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~ 201 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTL 201 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEE
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeeccccccccc
Confidence 99999955555579999999999999999988886 89999999999999999987777888888888888887664
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.77 E-value=5e-18 Score=162.06 Aligned_cols=149 Identities=26% Similarity=0.331 Sum_probs=129.3
Q ss_pred EEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCC
Q 037905 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121 (606)
Q Consensus 42 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 121 (606)
+.+++++++++ .+|..+ .++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 57899999998 666555 469999999999999766677899999999999999999766677899999999999999
Q ss_pred cCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCCCC
Q 037905 122 NFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSLCG 193 (606)
Q Consensus 122 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l~~ 193 (606)
+|++..+..|..+++|++|++++|+|++.++. +..+++|+.|+|++|+|++..+..|..++ .|++.+|++.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 162 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 162 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence 99977777789999999999999999988886 78999999999999999987776665554 46788888754
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=172.98 Aligned_cols=160 Identities=23% Similarity=0.229 Sum_probs=130.1
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 46899999999999877777899999999999999999977778899999999999999999976666788999999999
Q ss_pred cCCCcCCcc-cchhhhcCCCcceeecccccccccCCC-CCCCCCCC----EEEccCCcCcccCCcccc--CCCCCcccCC
Q 037905 118 LAKNNFSGT-ISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLA----QFNVSFNKLNGSIPKRFA--RLPSSAFEGN 189 (606)
Q Consensus 118 l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~----~L~l~~N~l~~~~p~~~~--~l~~l~~~~n 189 (606)
|++|++.+. +|..|..+++|++|++++|+|++.++. +..+.+|+ .|++++|++++..+..+. ++..|++.+|
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n 210 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTN 210 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSS
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCC
Confidence 999999863 588899999999999999999887664 55555555 788888888866665544 4556677888
Q ss_pred CCCCCCCc
Q 037905 190 SLCGKPLV 197 (606)
Q Consensus 190 ~l~~~p~~ 197 (606)
.+.+.|..
T Consensus 211 ~l~~~~~~ 218 (276)
T 2z62_A 211 QLKSVPDG 218 (276)
T ss_dssp CCSCCCTT
T ss_pred ceeecCHh
Confidence 88776653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.8e-18 Score=176.04 Aligned_cols=168 Identities=21% Similarity=0.270 Sum_probs=139.1
Q ss_pred CCCCCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEe
Q 037905 25 TDGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLY 93 (606)
Q Consensus 25 ~~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 93 (606)
....|.++.+.|.. ++++.|+|++|.|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+
T Consensus 27 ~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 27 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 34567899999964 4789999999999987777999999999999999999987799999999999999
Q ss_pred ccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccc--cCCC-CCCCCCCCEEEccCCcC
Q 037905 94 LQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG--SIPD-LGAFSSLAQFNVSFNKL 170 (606)
Q Consensus 94 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~-~~~l~~L~~L~l~~N~l 170 (606)
|++|+|+ .+|..+. ++|+.|++++|++.+..+..|..+++|++|++++|+++. ..+. +..+++|+.|++++|.+
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l 183 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCC
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcc
Confidence 9999999 6776654 689999999999987777788889999999999998863 4443 77788888888888888
Q ss_pred cccCCccccCCCCCcccCCCCCCCC
Q 037905 171 NGSIPKRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 171 ~~~~p~~~~~l~~l~~~~n~l~~~p 195 (606)
+......+.++..|++.+|.+.+.+
T Consensus 184 ~~l~~~~~~~L~~L~l~~n~l~~~~ 208 (330)
T 1xku_A 184 TTIPQGLPPSLTELHLDGNKITKVD 208 (330)
T ss_dssp CSCCSSCCTTCSEEECTTSCCCEEC
T ss_pred ccCCccccccCCEEECCCCcCCccC
Confidence 8544444566777778888776653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=3e-18 Score=183.16 Aligned_cols=141 Identities=23% Similarity=0.262 Sum_probs=108.2
Q ss_pred ceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcc
Q 037905 31 WVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLF 99 (606)
Q Consensus 31 ~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 99 (606)
+..+.|.. ++++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 56788865 4688999999999988888999999999999999999977788999999999999999999
Q ss_pred cccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccc-cccccCCC-CCCCCCCCEEEccCCcCc
Q 037905 100 SGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQEN-QLTGSIPD-LGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 100 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~~-~~~l~~L~~L~l~~N~l~ 171 (606)
++..+..|..+++|+.|+|++|+|....+..|..+++|++|+|++| .+...++. |..+++|+.|+|++|+|+
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~ 198 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS
T ss_pred CeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc
Confidence 9666667889999999999999888666656666666666666653 33333332 455555555555555554
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.8e-18 Score=185.61 Aligned_cols=155 Identities=21% Similarity=0.263 Sum_probs=130.7
Q ss_pred CeEEEEEcCCCCcccccCccccC---------------------------------------CCCCcEEEccCCCCcccC
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGN---------------------------------------LTELHTVSLRFNALRGTI 79 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~---------------------------------------l~~L~~L~L~~N~l~~~~ 79 (606)
++|++|+|++|.+++..|..+.. .++|++|+|++|++++..
T Consensus 212 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 291 (455)
T 3v47_A 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALL 291 (455)
T ss_dssp CEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEEC
T ss_pred ceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccc
Confidence 57889999999887766654422 268999999999999888
Q ss_pred cccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCC
Q 037905 80 PSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFS 158 (606)
Q Consensus 80 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~ 158 (606)
|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|+|.+..|..|..+++|++|+|++|+|++.+|. +..++
T Consensus 292 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 371 (455)
T 3v47_A 292 KSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLP 371 (455)
T ss_dssp TTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred hhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccc
Confidence 88999999999999999999988888899999999999999999988888899999999999999999988774 88899
Q ss_pred CCCEEEccCCcCcccCCccccCC---CCCcccCCCCCC
Q 037905 159 SLAQFNVSFNKLNGSIPKRFARL---PSSAFEGNSLCG 193 (606)
Q Consensus 159 ~L~~L~l~~N~l~~~~p~~~~~l---~~l~~~~n~l~~ 193 (606)
+|+.|+|++|+|++..+..|..+ ..|++.+|++.+
T Consensus 372 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 409 (455)
T 3v47_A 372 NLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 409 (455)
T ss_dssp TCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred cccEEECCCCccccCCHhHhccCCcccEEEccCCCccc
Confidence 99999999999997776665554 446778888864
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.76 E-value=6.3e-19 Score=179.51 Aligned_cols=154 Identities=21% Similarity=0.209 Sum_probs=71.8
Q ss_pred CeEEEEEcCCCCcccccCccccCC-----CCCcEEEccCCCCcccCcccccCCCCCCEEeccCCccccc--CCccc--cC
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNL-----TELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGE--IPGLL--FS 109 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~--~~ 109 (606)
++|++|+|++|.|++. |..+..+ ++|++|+|++|+|++..|..|.++++|++|+|++|++.+. +|..+ ..
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 3445555555555433 4444443 4555555555555444444455555555555555554432 12222 44
Q ss_pred CCCCcEEecCCCcCCc---ccchhhhcCCCcceeecccccccccCC--CCCCCCCCCEEEccCCcCcccCCccc-cCCCC
Q 037905 110 LGNLIRLNLAKNNFSG---TISADFNKLTRLGTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLNGSIPKRF-ARLPS 183 (606)
Q Consensus 110 l~~L~~L~l~~N~l~~---~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~ 183 (606)
+++|+.|+|++|+|++ .....+..+++|++|+|++|+|++.+| .+..+++|+.|+|++|+|+ .+|..+ .++..
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~~~L~~ 278 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSV 278 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCCSEEEE
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhccCCceE
Confidence 5555555555555541 111223344555555555555555442 2344455555555555555 333333 23444
Q ss_pred CcccCCCCCCC
Q 037905 184 SAFEGNSLCGK 194 (606)
Q Consensus 184 l~~~~n~l~~~ 194 (606)
|++++|.+.+.
T Consensus 279 L~Ls~N~l~~~ 289 (312)
T 1wwl_A 279 LDLSYNRLDRN 289 (312)
T ss_dssp EECCSSCCCSC
T ss_pred EECCCCCCCCC
Confidence 55555555544
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=195.10 Aligned_cols=158 Identities=22% Similarity=0.202 Sum_probs=142.5
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.|++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 47999999999999877778999999999999999999888999999999999999999999655567999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccc-----cCCCCCcccCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRF-----ARLPSSAFEGNSLC 192 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~-----~~l~~l~~~~n~l~ 192 (606)
++|++++..|..|.++++|++|++++|++++.++. +..+++|+.|++++|.+++..+..+ .++..|++.+|.+.
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 99999987778999999999999999999988876 8899999999999999998877654 45677889999988
Q ss_pred CCCC
Q 037905 193 GKPL 196 (606)
Q Consensus 193 ~~p~ 196 (606)
+.+.
T Consensus 185 ~~~~ 188 (680)
T 1ziw_A 185 EFSP 188 (680)
T ss_dssp CBCT
T ss_pred ccCh
Confidence 7654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.4e-18 Score=159.84 Aligned_cols=127 Identities=22% Similarity=0.297 Sum_probs=116.9
Q ss_pred EEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCC
Q 037905 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121 (606)
Q Consensus 42 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 121 (606)
+.+++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 46899999998 7777653 68999999999999 88899999999999999999999888888999999999999999
Q ss_pred cCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcc
Q 037905 122 NFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNG 172 (606)
Q Consensus 122 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~ 172 (606)
+|++..|..|..+++|++|+|++|+|+..++. |..+++|+.|+|++|+|..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 99988888999999999999999999988886 8899999999999999974
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.75 E-value=4.4e-18 Score=182.52 Aligned_cols=158 Identities=24% Similarity=0.218 Sum_probs=127.3
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCc------------
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPG------------ 105 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~------------ 105 (606)
.++|+.|+|++|.|++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|++|+|+...+.
T Consensus 98 l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 177 (452)
T 3zyi_A 98 LHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLD 177 (452)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEe
Confidence 36788888888888877777888888888888888888865566678888888888888887744432
Q ss_pred -------------cccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCc
Q 037905 106 -------------LLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 106 -------------~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~ 171 (606)
.|.++++|+.|+|++|+|+ .+| .+..+++|++|+|++|+|++.+|. |..+++|+.|+|++|+++
T Consensus 178 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~ 255 (452)
T 3zyi_A 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS 255 (452)
T ss_dssp CCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCCCccccChhhccCCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCc
Confidence 3556777777888888887 344 478899999999999999998875 999999999999999999
Q ss_pred ccCCccccCCCC---CcccCCCCCCCCCc
Q 037905 172 GSIPKRFARLPS---SAFEGNSLCGKPLV 197 (606)
Q Consensus 172 ~~~p~~~~~l~~---l~~~~n~l~~~p~~ 197 (606)
+..|..|..+++ |++.+|.+.+.|..
T Consensus 256 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 284 (452)
T 3zyi_A 256 LIERNAFDGLASLVELNLAHNNLSSLPHD 284 (452)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred eECHHHhcCCCCCCEEECCCCcCCccChH
Confidence 998887766555 67899999887754
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.8e-19 Score=179.74 Aligned_cols=156 Identities=18% Similarity=0.178 Sum_probs=92.6
Q ss_pred CeEEEEEcCCCCcccccCccc--cCCCCCcEEEccCCCCcccCcccccCC-----CCCCEEeccCCcccccCCccccCCC
Q 037905 39 ERVTMLRFPGMGLSGQLPIAI--GNLTELHTVSLRFNALRGTIPSDFAKL-----SNLRNLYLQGNLFSGEIPGLLFSLG 111 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~~l~ 111 (606)
++|++|+|++|.|++.+|..+ ..+++|++|+|++|+|++. |..+..+ ++|++|+|++|+|++..|..|..++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~ 173 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence 456666666666666666654 6666666666666666644 5555555 6666666666666655556666666
Q ss_pred CCcEEecCCCcCCcc--cchhh--hcCCCcceeecccccccccC---CC-CCCCCCCCEEEccCCcCcccCC-ccc---c
Q 037905 112 NLIRLNLAKNNFSGT--ISADF--NKLTRLGTLYLQENQLTGSI---PD-LGAFSSLAQFNVSFNKLNGSIP-KRF---A 179 (606)
Q Consensus 112 ~L~~L~l~~N~l~~~--~p~~~--~~l~~L~~L~l~~N~l~~~~---~~-~~~l~~L~~L~l~~N~l~~~~p-~~~---~ 179 (606)
+|+.|+|++|++.+. .|..+ ..+++|++|+|++|+|++.+ .. +..+++|+.|+|++|+|++..| ..+ .
T Consensus 174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 666666666666543 23333 56666666666666666322 12 3455666666666666665553 222 3
Q ss_pred CCCCCcccCCCCCCCC
Q 037905 180 RLPSSAFEGNSLCGKP 195 (606)
Q Consensus 180 ~l~~l~~~~n~l~~~p 195 (606)
++..|++++|.+...|
T Consensus 254 ~L~~L~Ls~N~l~~ip 269 (312)
T 1wwl_A 254 QLNSLNLSFTGLKQVP 269 (312)
T ss_dssp TCCEEECTTSCCSSCC
T ss_pred CCCEEECCCCccChhh
Confidence 4445556666665443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=159.99 Aligned_cols=131 Identities=23% Similarity=0.210 Sum_probs=117.4
Q ss_pred CeEEEEEcCCCCcc-cccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLS-GQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
++|+.|+|++|.|+ +.+|..+..+++|++|+|++|.|++. ..|..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57999999999998 78888899999999999999999954 7899999999999999999977888888899999999
Q ss_pred cCCCcCCcccc-hhhhcCCCcceeecccccccccCC----CCCCCCCCCEEEccCCcCc
Q 037905 118 LAKNNFSGTIS-ADFNKLTRLGTLYLQENQLTGSIP----DLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 118 l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~----~~~~l~~L~~L~l~~N~l~ 171 (606)
|++|+|++..+ ..+..+++|++|++++|++++.++ .+..+++|+.|++++|.+.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 99999985432 688999999999999999998887 4888999999999999987
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=5.6e-18 Score=181.06 Aligned_cols=155 Identities=23% Similarity=0.233 Sum_probs=105.2
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.|++..+.+|.++++|++|+|++|+|+...+..|..+++|++|+|++|+|+...+..|..+++|+.|+
T Consensus 87 l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 166 (440)
T 3zyj_A 87 LRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLD 166 (440)
T ss_dssp CSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeC
Confidence 36788899999999877778888899999999999998865556788888899999998888866666677777777777
Q ss_pred cCCC-cCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCCC
Q 037905 118 LAKN-NFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLCG 193 (606)
Q Consensus 118 l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~~ 193 (606)
|++| .+....+..|.++++|++|+|++|+|+. +|.+..+++|+.|+|++|+|++..|..|..+++ |++.+|.+.+
T Consensus 167 l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 245 (440)
T 3zyj_A 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245 (440)
T ss_dssp CCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred CCCCCCcceeCcchhhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE
Confidence 7763 3443333356666666666666666663 334555566666666666666555554443333 3344444443
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.74 E-value=8.4e-18 Score=174.78 Aligned_cols=164 Identities=20% Similarity=0.232 Sum_probs=140.2
Q ss_pred CCCCcceeEEecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCccccc-CCCCCCEEeccCCcccccCC
Q 037905 26 DGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFA-KLSNLRNLYLQGNLFSGEIP 104 (606)
Q Consensus 26 ~~~c~~~~~~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p 104 (606)
...|.- .-.|.. +.+++++|+|+ .+|..+. +.|+.|+|++|+|++..+..|. ++++|++|+|++|+|++..|
T Consensus 9 ~~~Cp~-~C~C~~---~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~ 81 (361)
T 2xot_A 9 VVSCPA-NCLCAS---NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISS 81 (361)
T ss_dssp CTTCCT-TCEEET---TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECT
T ss_pred CCCCCC-CCEECC---CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccCh
Confidence 356764 456764 47899999998 6787664 4689999999999977777787 99999999999999998888
Q ss_pred ccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccc-----
Q 037905 105 GLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRF----- 178 (606)
Q Consensus 105 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~----- 178 (606)
..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+. |..+++|+.|+|++|+|++..+..|
T Consensus 82 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~ 161 (361)
T 2xot_A 82 EAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNK 161 (361)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----
T ss_pred hhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCccc
Confidence 8899999999999999999987777899999999999999999998775 9999999999999999997655543
Q ss_pred -cCCCCCcccCCCCCCCCC
Q 037905 179 -ARLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 179 -~~l~~l~~~~n~l~~~p~ 196 (606)
.+|..|++.+|.|...|.
T Consensus 162 l~~L~~L~L~~N~l~~l~~ 180 (361)
T 2xot_A 162 LPKLMLLDLSSNKLKKLPL 180 (361)
T ss_dssp CTTCCEEECCSSCCCCCCH
T ss_pred CCcCCEEECCCCCCCccCH
Confidence 456667889999987763
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.5e-18 Score=167.89 Aligned_cols=158 Identities=17% Similarity=0.084 Sum_probs=136.4
Q ss_pred CCeEEEEEcCCCC-cccccCccccCCCCCcEEEccC-CCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCc-
Q 037905 38 GERVTMLRFPGMG-LSGQLPIAIGNLTELHTVSLRF-NALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI- 114 (606)
Q Consensus 38 ~~~l~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~- 114 (606)
.++|++|+|++|. +++..+..|.++++|++|+|++ |+|++..+..|.++++|++|+|++|++++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 3689999999997 9867677899999999999998 99997667889999999999999999994 776 88999998
Q ss_pred --EEecCCC-cCCcccchhhhcCCCcc-eeecccccccccCCCCCCCCCCCEEEccCCc-CcccCCccccCC----CCCc
Q 037905 115 --RLNLAKN-NFSGTISADFNKLTRLG-TLYLQENQLTGSIPDLGAFSSLAQFNVSFNK-LNGSIPKRFARL----PSSA 185 (606)
Q Consensus 115 --~L~l~~N-~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~l~ 185 (606)
.|++++| ++++..+..|..+++|+ +|++++|+++.+++.....++|+.|++++|+ +++..+..|..+ ..|+
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~ 211 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEE
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEE
Confidence 9999999 99977777899999999 9999999999777764344899999999995 997777777655 4567
Q ss_pred ccCCCCCCCCCc
Q 037905 186 FEGNSLCGKPLV 197 (606)
Q Consensus 186 ~~~n~l~~~p~~ 197 (606)
+.+|.+.+.|..
T Consensus 212 l~~N~l~~l~~~ 223 (239)
T 2xwt_C 212 VSQTSVTALPSK 223 (239)
T ss_dssp CTTCCCCCCCCT
T ss_pred CCCCccccCChh
Confidence 889999887654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.4e-18 Score=176.74 Aligned_cols=160 Identities=19% Similarity=0.139 Sum_probs=128.7
Q ss_pred ecCCeEEEEEcCCCCcccccC----ccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCccccc--C--Cccc
Q 037905 36 CTGERVTMLRFPGMGLSGQLP----IAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGE--I--PGLL 107 (606)
Q Consensus 36 c~~~~l~~L~L~~n~l~~~~p----~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~ 107 (606)
....+|++|+|++|.|++..| ..+..+++|++|+|++|+|++..|..|..+++|++|+|++|++.+. + +..+
T Consensus 114 ~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 193 (310)
T 4glp_A 114 ATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCP 193 (310)
T ss_dssp CCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCT
T ss_pred ccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhh
Confidence 344689999999999997665 3456899999999999999987788999999999999999998742 2 2334
Q ss_pred cCCCCCcEEecCCCcCCcccch----hhhcCCCcceeecccccccccCC-CCCCC---CCCCEEEccCCcCcccCCcccc
Q 037905 108 FSLGNLIRLNLAKNNFSGTISA----DFNKLTRLGTLYLQENQLTGSIP-DLGAF---SSLAQFNVSFNKLNGSIPKRFA 179 (606)
Q Consensus 108 ~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~~-~~~~l---~~L~~L~l~~N~l~~~~p~~~~ 179 (606)
..+++|++|+|++|+|+ .++. .+..+++|++|+|++|+|++..| .+..+ ++|+.|+|++|+|+...+..+.
T Consensus 194 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~ 272 (310)
T 4glp_A 194 HKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLPA 272 (310)
T ss_dssp TSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCCS
T ss_pred hcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhcC
Confidence 68899999999999997 4444 35788999999999999998844 46555 6999999999999944334446
Q ss_pred CCCCCcccCCCCCCCCC
Q 037905 180 RLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 180 ~l~~l~~~~n~l~~~p~ 196 (606)
++..|++++|.+.+.|.
T Consensus 273 ~L~~L~Ls~N~l~~~~~ 289 (310)
T 4glp_A 273 KLRVLDLSSNRLNRAPQ 289 (310)
T ss_dssp CCSCEECCSCCCCSCCC
T ss_pred CCCEEECCCCcCCCCch
Confidence 78888999999988654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.9e-18 Score=188.65 Aligned_cols=112 Identities=24% Similarity=0.316 Sum_probs=97.2
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.|++..|..|..+++|++|+|++|.|++..|..|.++++|++|+|++|.|++..+..|.++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 57899999999998877788999999999999999999777778899999999999999999555566788999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeeccccccccc
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGS 150 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 150 (606)
++|.|++..|..|..+++|++|+|++|.|++.
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 186 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 186 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCc
Confidence 99999888888888899999999999888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=2.3e-18 Score=170.24 Aligned_cols=132 Identities=16% Similarity=0.132 Sum_probs=101.8
Q ss_pred hcccccCCceEEEEEEE-cCCcE--EEEEEeccCccC-------------------------HHHHHHHHHHHcCCCCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIV--VAVKRLKDVTVS-------------------------EKEFREKMEVVGSMDHEN 373 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~-------------------------~~~~~~e~~~l~~l~h~n 373 (606)
.+.||+|+||.||+|.. .+|+. ||||+++..... ...+.+|+..+.++.|++
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 131 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAG 131 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCC
Confidence 36799999999999997 67988 999987543211 135788999999998876
Q ss_pred cc--cceEEEEeCCceEEEEeecCC-C----ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCCCCCC
Q 037905 374 LV--PLRAYYYSRDEKLLVHDYMPM-G----SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH-SKGPANSHGNI 445 (606)
Q Consensus 374 iv--~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~i~HrDl 445 (606)
+. ..+++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.|++ ||||
T Consensus 132 i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~giv--HrDl 197 (258)
T 1zth_A 132 VSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAELV--HADL 197 (258)
T ss_dssp CCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSCEE--CSSC
T ss_pred CCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCCEE--eCCC
Confidence 52 33322 367899999942 3 66666432 223456789999999999999 89855 9999
Q ss_pred CCCCEEecCCCcEEEeecccCccC
Q 037905 446 KSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 446 kp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.9e-18 Score=196.22 Aligned_cols=165 Identities=22% Similarity=0.175 Sum_probs=144.2
Q ss_pred cceeEEecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccC-cccccCCCCCCEEeccCCcccccCCcccc
Q 037905 30 KWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTI-PSDFAKLSNLRNLYLQGNLFSGEIPGLLF 108 (606)
Q Consensus 30 ~~~~~~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 108 (606)
.+..|.+..++|++|||++|.|++..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+|++..|..|.
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~ 94 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence 34444444478999999999999888999999999999999999665555 88999999999999999999988899999
Q ss_pred CCCCCcEEecCCCcCCcccchh--hhcCCCcceeecccccccccCC--CCCCCCCCCEEEccCCcCcccCCccc-----c
Q 037905 109 SLGNLIRLNLAKNNFSGTISAD--FNKLTRLGTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLNGSIPKRF-----A 179 (606)
Q Consensus 109 ~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~~-----~ 179 (606)
++++|++|+|++|++++.+|.. |.++++|++|+|++|.+++..+ .|+++++|+.|+|++|.+++..|..+ .
T Consensus 95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~ 174 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK 174 (844)
T ss_dssp SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHC
T ss_pred CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCC
Confidence 9999999999999999877765 8999999999999999998765 38999999999999999998888776 4
Q ss_pred CCCCCcccCCCCCCC
Q 037905 180 RLPSSAFEGNSLCGK 194 (606)
Q Consensus 180 ~l~~l~~~~n~l~~~ 194 (606)
++..|++.+|.+.+.
T Consensus 175 ~L~~L~L~~n~l~~~ 189 (844)
T 3j0a_A 175 TLSFFSLAANSLYSR 189 (844)
T ss_dssp SSCCCEECCSBSCCC
T ss_pred ccceEECCCCccccc
Confidence 566677888887663
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=9e-19 Score=198.12 Aligned_cols=191 Identities=17% Similarity=0.172 Sum_probs=128.4
Q ss_pred chHHHHHHHhHhhcC----CCCcCCCCCC-CCCcceeEEecCCeE------------------EEEEcCCCCccc-----
Q 037905 2 ASDRAALLTLRKAIG----GRTLLWNLTD-GPCKWVGVFCTGERV------------------TMLRFPGMGLSG----- 53 (606)
Q Consensus 2 ~~~~~~l~~~~~~~~----~~~~~w~~~~-~~c~~~~~~c~~~~l------------------~~L~L~~n~l~~----- 53 (606)
.++.++|+++..... .....|.... ..+.|.++.++.+++ ..++|++|.|.+
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~~~ 210 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDDIE 210 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCcchhhHhhcCccCcccccCccccc
Confidence 356778888843331 1222553222 455566655554333 334444444433
Q ss_pred ----ccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccch
Q 037905 54 ----QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISA 129 (606)
Q Consensus 54 ----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 129 (606)
..|..|..+++|+.|+|++|+|. .+|..+.++++|++|+|++|.|+ .+|..|.+|++|+.|+|++|+|+ .+|.
T Consensus 211 n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~ 287 (727)
T 4b8c_D 211 NRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPA 287 (727)
T ss_dssp -----------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCS
T ss_pred cceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccCh
Confidence 33667889999999999999999 78888889999999999999999 89999999999999999999999 7899
Q ss_pred hhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCC----CcccCCCCCCCC
Q 037905 130 DFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS----SAFEGNSLCGKP 195 (606)
Q Consensus 130 ~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~----l~~~~n~l~~~p 195 (606)
.|.+|++|++|+|++|.|+.++..|..+++|+.|+|++|+|++.+|..+..+.. +.+.+|.+.+..
T Consensus 288 ~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~ 357 (727)
T 4b8c_D 288 ELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPL 357 (727)
T ss_dssp SGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred hhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcC
Confidence 999999999999999999977667999999999999999999999987755432 456778887753
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=5.8e-18 Score=182.79 Aligned_cols=156 Identities=24% Similarity=0.203 Sum_probs=136.3
Q ss_pred cCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 37 TGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
..++|++|+|++|.|++..|.+|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|+.|
T Consensus 54 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 133 (477)
T 2id5_A 54 SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133 (477)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEE
Confidence 34689999999999998889999999999999999999996555678999999999999999998888899999999999
Q ss_pred ecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCC
Q 037905 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLC 192 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~ 192 (606)
+|++|++.+..|..|..+++|++|+|++|++++.++. +..+++|+.|+|++|.+++..+..|..+++ |++.+|.+.
T Consensus 134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~ 213 (477)
T 2id5_A 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213 (477)
T ss_dssp EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTC
T ss_pred ECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccc
Confidence 9999999988888999999999999999999987765 888999999999999999887777766554 456666543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=5.8e-18 Score=186.88 Aligned_cols=159 Identities=18% Similarity=0.166 Sum_probs=140.6
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
+++++|+|++|.|++..+.+|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 47999999999999888889999999999999999999877889999999999999999999888899999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeeccccccccc-CC-CCCCCCCCCEEEccCCcCcccCCccccCCCC-------CcccCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGS-IP-DLGAFSSLAQFNVSFNKLNGSIPKRFARLPS-------SAFEGN 189 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~-------l~~~~n 189 (606)
++|++++..+..|+.+++|++|++++|.+++. +| .+.++++|+.|++++|++++..|..+..++. +++.+|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 99999966665799999999999999999873 34 5999999999999999999888876655443 467888
Q ss_pred CCCCCCCc
Q 037905 190 SLCGKPLV 197 (606)
Q Consensus 190 ~l~~~p~~ 197 (606)
.+.+.+..
T Consensus 188 ~l~~~~~~ 195 (570)
T 2z63_A 188 PMNFIQPG 195 (570)
T ss_dssp CCCEECTT
T ss_pred CceecCHH
Confidence 88776543
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-18 Score=194.83 Aligned_cols=159 Identities=21% Similarity=0.330 Sum_probs=142.2
Q ss_pred cCCeEEEEEcCCCCcccc-----------------cCcccc--CCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCC
Q 037905 37 TGERVTMLRFPGMGLSGQ-----------------LPIAIG--NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN 97 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~~-----------------~p~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 97 (606)
..++|++|+|++|.|++. +|.+++ ++++|++|+|++|++.+.+|..|.++++|++|+|++|
T Consensus 204 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n 283 (636)
T 4eco_A 204 RLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN 283 (636)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred cccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence 347899999999999985 999999 9999999999999999999999999999999999999
Q ss_pred c-ccc-cCCccccCC------CCCcEEecCCCcCCcccch--hhhcCCCcceeecccccccccCCCCCCCCCCCEEEccC
Q 037905 98 L-FSG-EIPGLLFSL------GNLIRLNLAKNNFSGTISA--DFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSF 167 (606)
Q Consensus 98 ~-l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~ 167 (606)
+ +++ .+|..+..+ ++|+.|+|++|+++ .+|. .|..+++|++|++++|+++|.+|.+..+++|+.|++++
T Consensus 284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~ 362 (636)
T 4eco_A 284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAY 362 (636)
T ss_dssp TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCS
T ss_pred CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCC
Confidence 8 998 899988876 99999999999999 8888 89999999999999999997777888899999999999
Q ss_pred CcCcccCCccccC----CCCCcccCCCCCCCCCc
Q 037905 168 NKLNGSIPKRFAR----LPSSAFEGNSLCGKPLV 197 (606)
Q Consensus 168 N~l~~~~p~~~~~----l~~l~~~~n~l~~~p~~ 197 (606)
|+++ .+|..+.. +..|++.+|.+...|..
T Consensus 363 N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~ 395 (636)
T 4eco_A 363 NQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNI 395 (636)
T ss_dssp SEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSC
T ss_pred Cccc-cccHhhhhhcccCcEEEccCCcCcccchh
Confidence 9999 77766654 55567888998876643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.73 E-value=4.9e-18 Score=183.65 Aligned_cols=156 Identities=20% Similarity=0.148 Sum_probs=91.4
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcc----------------cccCCCCCCEEeccCCccccc
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPS----------------DFAKLSNLRNLYLQGNLFSGE 102 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~----------------~~~~l~~L~~L~Ls~N~l~~~ 102 (606)
++|++|+|++|.|++..| |..+++|++|+|++|.|++..+. ....+++|+.|+|++|+|++.
T Consensus 58 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~~~~L~~L~L~~N~l~~~~~~~l~~L~~L~L~~N~l~~~ 135 (487)
T 3oja_A 58 TKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITML 135 (487)
T ss_dssp TTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCCCEEECCCSSCEEEECCSSCCCSG
T ss_pred CCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCCCCCcCEEECcCCcCCCCCccccCCCCEEECCCCCCCCC
Confidence 445555555555554333 55555555555555544421110 011234455555555555555
Q ss_pred CCccccCCCCCcEEecCCCcCCcccchhhh-cCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCc--ccc
Q 037905 103 IPGLLFSLGNLIRLNLAKNNFSGTISADFN-KLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPK--RFA 179 (606)
Q Consensus 103 ~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~--~~~ 179 (606)
.|..|..+++|+.|+|++|+|++.+|..+. .+++|++|+|++|.|++.++ +..+++|+.|+|++|.|++.+|. .+.
T Consensus 136 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~ 214 (487)
T 3oja_A 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAFMGPEFQSAA 214 (487)
T ss_dssp GGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-CCCCTTCCEEECCSSCCCEECGGGGGGT
T ss_pred CchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc-cccCCCCCEEECCCCCCCCCCHhHcCCC
Confidence 566666777777777777777766666665 67777777777777776533 34577777788888877765443 223
Q ss_pred CCCCCcccCCCCCCCCCc
Q 037905 180 RLPSSAFEGNSLCGKPLV 197 (606)
Q Consensus 180 ~l~~l~~~~n~l~~~p~~ 197 (606)
+|..|++++|.+++.|..
T Consensus 215 ~L~~L~Ls~N~l~~lp~~ 232 (487)
T 3oja_A 215 GVTWISLRNNKLVLIEKA 232 (487)
T ss_dssp TCSEEECTTSCCCEECTT
T ss_pred CccEEEecCCcCcccchh
Confidence 444566777777765543
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-17 Score=175.39 Aligned_cols=112 Identities=24% Similarity=0.316 Sum_probs=89.9
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.|++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|+++...+..|..+++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 57888888888888777778888888888888888888766777888888888888888888444444678888888888
Q ss_pred CCCcCCcccchhhhcCCCcceeeccccccccc
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGS 150 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 150 (606)
++|++.+..|..|..+++|++|++++|++++.
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 180 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHV 180 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCcc
Confidence 88888877777788888888888888887754
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=2.1e-17 Score=153.49 Aligned_cols=131 Identities=28% Similarity=0.344 Sum_probs=114.2
Q ss_pred EEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCC
Q 037905 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121 (606)
Q Consensus 42 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 121 (606)
+.+++++|+++ .+|..+ .++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 45667778887 566544 379999999999999766677899999999999999999776777899999999999999
Q ss_pred cCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCC
Q 037905 122 NFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIP 175 (606)
Q Consensus 122 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p 175 (606)
+|++..+..|..+++|++|++++|+|++.++. +..+++|+.|+|++|++++..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 99977777789999999999999999988876 6889999999999999997665
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=7.6e-18 Score=187.49 Aligned_cols=157 Identities=22% Similarity=0.211 Sum_probs=93.3
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCc-ccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
++|++|+|++|.++ .+|..|..+++|++|+|++|++.+..| ..|..+++|++|+|++|++++..|..+..+++|+.|+
T Consensus 376 ~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 454 (606)
T 3vq2_A 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLK 454 (606)
T ss_dssp SCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred CcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEE
Confidence 34555555555554 344555566666666666666665444 4556666666666666666655666666666666666
Q ss_pred cCCCcCCc-ccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCC
Q 037905 118 LAKNNFSG-TISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLC 192 (606)
Q Consensus 118 l~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~ 192 (606)
|++|++.+ .+|..|..+++|++|++++|++++.+|. +..+++|+.|+|++|++++..|..|..+++ |++.+|.+.
T Consensus 455 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 534 (606)
T 3vq2_A 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534 (606)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred CCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence 66666665 3555666666666666666666665554 566666666666666666665655554433 455666665
Q ss_pred CCCC
Q 037905 193 GKPL 196 (606)
Q Consensus 193 ~~p~ 196 (606)
..|.
T Consensus 535 ~~p~ 538 (606)
T 3vq2_A 535 TSKG 538 (606)
T ss_dssp CEES
T ss_pred ccCH
Confidence 5443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.3e-18 Score=171.89 Aligned_cols=160 Identities=16% Similarity=0.088 Sum_probs=132.5
Q ss_pred CeEEEEEcCCCCcccccCccc--cCCCCCcEEEccCCCCcccCc----ccccCCCCCCEEeccCCcccccCCccccCCCC
Q 037905 39 ERVTMLRFPGMGLSGQLPIAI--GNLTELHTVSLRFNALRGTIP----SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGN 112 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 112 (606)
++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..| ..+..+++|++|+|++|++++..|..|..+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 469999999999999999888 899999999999999996555 44567999999999999999888889999999
Q ss_pred CcEEecCCCcCCcc--cc--hhhhcCCCcceeecccccccccCCC----CCCCCCCCEEEccCCcCcccCCcccc-----
Q 037905 113 LIRLNLAKNNFSGT--IS--ADFNKLTRLGTLYLQENQLTGSIPD----LGAFSSLAQFNVSFNKLNGSIPKRFA----- 179 (606)
Q Consensus 113 L~~L~l~~N~l~~~--~p--~~~~~l~~L~~L~l~~N~l~~~~~~----~~~l~~L~~L~l~~N~l~~~~p~~~~----- 179 (606)
|++|+|++|++.+. ++ ..+..+++|++|+|++|+|+..++. +..+++|+.|+|++|+|++..|..+.
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~ 250 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWS 250 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCc
Confidence 99999999998752 22 2347899999999999999754432 46789999999999999988775553
Q ss_pred -CCCCCcccCCCCCCCCCcC
Q 037905 180 -RLPSSAFEGNSLCGKPLVS 198 (606)
Q Consensus 180 -~l~~l~~~~n~l~~~p~~~ 198 (606)
++..|++++|.+...|...
T Consensus 251 ~~L~~L~Ls~N~l~~lp~~~ 270 (310)
T 4glp_A 251 SALNSLNLSFAGLEQVPKGL 270 (310)
T ss_dssp TTCCCEECCSSCCCSCCSCC
T ss_pred CcCCEEECCCCCCCchhhhh
Confidence 5566788999998776654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.72 E-value=2.7e-17 Score=167.00 Aligned_cols=150 Identities=22% Similarity=0.311 Sum_probs=116.0
Q ss_pred cCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 37 TGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
..++|++|+|++|.|++..+ +..+++|++|+|++|+|++ +| .+..+++|++|+|++|++++ +|. +..+++|+.|
T Consensus 61 ~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L 134 (308)
T 1h6u_A 61 YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVL 134 (308)
T ss_dssp GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEE
T ss_pred ccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEE
Confidence 34678888888888885444 8888888888888888884 44 68888888888888888884 443 7888888888
Q ss_pred ecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCC
Q 037905 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p 195 (606)
+|++|++++..+ +..+++|++|++++|++++.++ +..+++|+.|++++|++++..+ ..+.++..|++.+|.+.+.+
T Consensus 135 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 135 YLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp ECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCG
T ss_pred ECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCccc
Confidence 888888885443 7888888888888888886655 7888888888888888886554 23445555677888887754
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.72 E-value=5.5e-18 Score=152.69 Aligned_cols=127 Identities=24% Similarity=0.216 Sum_probs=110.7
Q ss_pred CeEEEEEcCCCCcc-cccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLS-GQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
++|+.|+|++|.++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 57899999999998 78888889999999999999999854 7889999999999999999977888888899999999
Q ss_pred cCCCcCCcc-cchhhhcCCCcceeecccccccccCC----CCCCCCCCCEEEccC
Q 037905 118 LAKNNFSGT-ISADFNKLTRLGTLYLQENQLTGSIP----DLGAFSSLAQFNVSF 167 (606)
Q Consensus 118 l~~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~----~~~~l~~L~~L~l~~ 167 (606)
+++|+|++. .+..+..+++|++|++++|++++.++ .+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999853 34788999999999999999998877 377889999998864
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=2e-17 Score=184.57 Aligned_cols=150 Identities=21% Similarity=0.254 Sum_probs=129.8
Q ss_pred EEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcC
Q 037905 44 LRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNF 123 (606)
Q Consensus 44 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 123 (606)
.+-++.+|+ .+|..+. +++++|||++|+|++..|..|.++++|++|+|++|+|++..|+.|.+|++|++|+|++|+|
T Consensus 36 ~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l 112 (635)
T 4g8a_A 36 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 112 (635)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence 466777787 6776553 5799999999999977778999999999999999999987888999999999999999999
Q ss_pred CcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCccc-CCccccC---CCCCcccCCCCCCCCC
Q 037905 124 SGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGS-IPKRFAR---LPSSAFEGNSLCGKPL 196 (606)
Q Consensus 124 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~-~p~~~~~---l~~l~~~~n~l~~~p~ 196 (606)
++..+..|.+|++|++|+|++|+|+++++. |+.+++|+.|+|++|.+++. .|..+.. +..|++.+|.+.+.+.
T Consensus 113 ~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 190 (635)
T 4g8a_A 113 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 190 (635)
T ss_dssp CEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred CCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCcccccccc
Confidence 977778899999999999999999988875 89999999999999999864 4655554 5556789999877653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=4.3e-18 Score=194.59 Aligned_cols=157 Identities=20% Similarity=0.305 Sum_probs=139.6
Q ss_pred cCCeEEEEEcCCCCccc-----------------ccCcccc--CCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCC
Q 037905 37 TGERVTMLRFPGMGLSG-----------------QLPIAIG--NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN 97 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~-----------------~~p~~l~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 97 (606)
..++|++|+|++|.|++ .+|..++ ++++|++|+|++|++.+.+|..|.+|++|++|+|++|
T Consensus 446 ~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N 525 (876)
T 4ecn_A 446 RLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN 525 (876)
T ss_dssp GCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred cCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence 34789999999999998 3899988 9999999999999999999999999999999999999
Q ss_pred c-ccc-cCCccccCCC-------CCcEEecCCCcCCcccch--hhhcCCCcceeecccccccccCCCCCCCCCCCEEEcc
Q 037905 98 L-FSG-EIPGLLFSLG-------NLIRLNLAKNNFSGTISA--DFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVS 166 (606)
Q Consensus 98 ~-l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~ 166 (606)
+ |++ .+|..+..++ +|+.|+|++|+|+ .+|. .|.++++|++|+|++|+|+ .+|.+..+++|+.|+|+
T Consensus 526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp~~~~L~~L~~L~Ls 603 (876)
T 4ecn_A 526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLD 603 (876)
T ss_dssp TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCCCCCTTSEESEEECC
T ss_pred CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cchhhcCCCcceEEECc
Confidence 8 998 7887666554 9999999999999 8888 8999999999999999999 55589999999999999
Q ss_pred CCcCcccCCccccC----CCCCcccCCCCCCCCC
Q 037905 167 FNKLNGSIPKRFAR----LPSSAFEGNSLCGKPL 196 (606)
Q Consensus 167 ~N~l~~~~p~~~~~----l~~l~~~~n~l~~~p~ 196 (606)
+|+|+ .+|..+.. |..|++.+|.+...|.
T Consensus 604 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~ 636 (876)
T 4ecn_A 604 YNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPN 636 (876)
T ss_dssp SSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCS
T ss_pred CCccc-cchHHHhhccccCCEEECcCCCCCcCch
Confidence 99999 78866654 5557789999886664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.4e-17 Score=167.96 Aligned_cols=155 Identities=20% Similarity=0.237 Sum_probs=134.3
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCc--ccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALR--GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
++|++|+|++|.|++..+..|.++++|++|+|++|.++ +..+..|.++++|++|+|++|+++ .+|..+. ++|+.|
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L 197 (330)
T 1xku_A 121 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTEL 197 (330)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEE
T ss_pred ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEE
Confidence 57999999999999777778999999999999999996 367888999999999999999999 5676554 789999
Q ss_pred ecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCCC
Q 037905 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSLC 192 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l~ 192 (606)
+|++|++++..|..|..+++|++|++++|++++.++. +..+++|+.|+|++|+++ .+|..+..++ .|++.+|.++
T Consensus 198 ~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~ 276 (330)
T 1xku_A 198 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276 (330)
T ss_dssp ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCC
Confidence 9999999988888999999999999999999988874 888999999999999999 6776665554 4678889998
Q ss_pred CCCCc
Q 037905 193 GKPLV 197 (606)
Q Consensus 193 ~~p~~ 197 (606)
+.|..
T Consensus 277 ~~~~~ 281 (330)
T 1xku_A 277 AIGSN 281 (330)
T ss_dssp CCCTT
T ss_pred ccChh
Confidence 87765
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-17 Score=192.95 Aligned_cols=61 Identities=26% Similarity=0.434 Sum_probs=33.3
Q ss_pred hhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcC----------------------cccCCccccCCCCCccc
Q 037905 131 FNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKL----------------------NGSIPKRFARLPSSAFE 187 (606)
Q Consensus 131 ~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l----------------------~~~~p~~~~~l~~l~~~ 187 (606)
|.++++|+.|+|++|+|++.+|. |..+++|+.|+|++|+| ++..|..|.++..+++.
T Consensus 476 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~ 555 (844)
T 3j0a_A 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAPNPDVFVSLSVLDIT 555 (844)
T ss_dssp SSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCEEEEEEECCCCCCSCCCSSCCEEEEE
T ss_pred hcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccEEECCCCcCCCCChhHhCCcCEEEec
Confidence 33445555555555555555544 44555555555555555 44555555566666666
Q ss_pred CCCC
Q 037905 188 GNSL 191 (606)
Q Consensus 188 ~n~l 191 (606)
+|++
T Consensus 556 ~Np~ 559 (844)
T 3j0a_A 556 HNKF 559 (844)
T ss_dssp EECC
T ss_pred CCCc
Confidence 6664
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.7e-17 Score=167.06 Aligned_cols=149 Identities=28% Similarity=0.365 Sum_probs=110.1
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.|++..| +.++++|++|+|++|+|++ +| .+..+++|++|+|++|++++ + +.+..+++|+.|+
T Consensus 67 l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~ 140 (291)
T 1h6t_A 67 LPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY 140 (291)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred CCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence 3678888888888875444 8888888888888888873 44 47888888888888888884 3 3577788888888
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCC---CCCcccCCCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARL---PSSAFEGNSLCGK 194 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l---~~l~~~~n~l~~~ 194 (606)
|++|++++. ..+..+++|++|++++|+|++.++ +..+++|+.|++++|.|++. |. +..+ ..|++.+|+++..
T Consensus 141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~l-~~-l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL-RA-LAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC-GG-GTTCTTCSEEEEEEEEEECC
T ss_pred ccCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCCC-hh-hccCCCCCEEECcCCcccCC
Confidence 888888744 467888888888888888887665 77888888888888888753 32 4444 4456677777665
Q ss_pred CCc
Q 037905 195 PLV 197 (606)
Q Consensus 195 p~~ 197 (606)
|..
T Consensus 216 ~~~ 218 (291)
T 1h6t_A 216 PIN 218 (291)
T ss_dssp CEE
T ss_pred ccc
Confidence 443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=3.3e-17 Score=182.31 Aligned_cols=157 Identities=20% Similarity=0.210 Sum_probs=93.7
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcc-cccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPS-DFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
++|++|+|++|.+++..|..|..+++|++|+|++|++++..|. .|..+++|++|+|++|.+++..|..+..+++|+.|+
T Consensus 376 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 455 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455 (606)
T ss_dssp TTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEE
Confidence 4566666666666655555666666666666666666544433 255666666666666666655566666666666666
Q ss_pred cCCCcCCcc---cchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCCC--cccCCCC
Q 037905 118 LAKNNFSGT---ISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPSS--AFEGNSL 191 (606)
Q Consensus 118 l~~N~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l--~~~~n~l 191 (606)
|++|++.+. .+..+..+++|++|++++|++++.+|. |..+++|+.|+|++|++++..|..|.+++.| ++.+|.+
T Consensus 456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~L~L~~N~l 535 (606)
T 3t6q_A 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535 (606)
T ss_dssp CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSCEEECCSSCC
T ss_pred CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCcccccEEECcCCcc
Confidence 666666542 223456666666666666666665553 5666666666666666666666666555543 3455666
Q ss_pred CCCC
Q 037905 192 CGKP 195 (606)
Q Consensus 192 ~~~p 195 (606)
.+.|
T Consensus 536 ~~~~ 539 (606)
T 3t6q_A 536 SIIL 539 (606)
T ss_dssp CCCC
T ss_pred cccC
Confidence 5543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=6.4e-18 Score=175.11 Aligned_cols=159 Identities=19% Similarity=0.213 Sum_probs=137.9
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCc--cccCCCCCcE
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPG--LLFSLGNLIR 115 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~ 115 (606)
.++|++|+|++|.|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+|. .|..+++|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 378999999999999888889999999999999999999555555999999999999999999 5554 7899999999
Q ss_pred EecCCC-cCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCcc---ccCCCCCcccCCC
Q 037905 116 LNLAKN-NFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKR---FARLPSSAFEGNS 190 (606)
Q Consensus 116 L~l~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~---~~~l~~l~~~~n~ 190 (606)
|++++| .+....+..|..+++|++|++++|++++.+|. +..+++|+.|++++|+++...+.. +.++..|++.+|.
T Consensus 154 L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~ 233 (353)
T 2z80_A 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233 (353)
T ss_dssp EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCB
T ss_pred EECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCc
Confidence 999999 57767778899999999999999999998775 899999999999999997444332 4566678899999
Q ss_pred CCCCCCc
Q 037905 191 LCGKPLV 197 (606)
Q Consensus 191 l~~~p~~ 197 (606)
+.+.+..
T Consensus 234 l~~~~~~ 240 (353)
T 2z80_A 234 LDTFHFS 240 (353)
T ss_dssp CTTCCCC
T ss_pred ccccccc
Confidence 9876543
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.3e-17 Score=180.04 Aligned_cols=153 Identities=24% Similarity=0.238 Sum_probs=111.4
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcc--cCcccccCCCCCCEEeccCCcccccCCc-cccCCCCCc
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRG--TIPSDFAKLSNLRNLYLQGNLFSGEIPG-LLFSLGNLI 114 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~ 114 (606)
.++|++|+|++|.|++.+|..+.++++|++|+|++|+|++ .+|..+..+++|++|+|++|++++.+|. .+..+++|+
T Consensus 323 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~ 402 (520)
T 2z7x_B 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL 402 (520)
T ss_dssp CCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCC
T ss_pred CCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCC
Confidence 3578888888888887777788888888888888888875 4556778888888888888888864554 367778888
Q ss_pred EEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCC
Q 037905 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSL 191 (606)
Q Consensus 115 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l 191 (606)
.|+|++|++++..|..+. ++|++|++++|+|+.+++.+..+++|+.|+|++|+|+...+..|..++ .+++.+|++
T Consensus 403 ~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~ 480 (520)
T 2z7x_B 403 SLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480 (520)
T ss_dssp EEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred EEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCC
Confidence 888888888766665543 678888888888885555566788888888888888843333354443 456677776
Q ss_pred C
Q 037905 192 C 192 (606)
Q Consensus 192 ~ 192 (606)
.
T Consensus 481 ~ 481 (520)
T 2z7x_B 481 D 481 (520)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.8e-17 Score=167.73 Aligned_cols=155 Identities=21% Similarity=0.272 Sum_probs=103.5
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccc--cCCccccCC------
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSG--EIPGLLFSL------ 110 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l------ 110 (606)
++|++|+|++|.|+ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.++. ..|..+..+
T Consensus 102 ~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~ 178 (332)
T 2ft3_A 102 RKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLR 178 (332)
T ss_dssp TTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCB
T ss_pred CCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEE
Confidence 45556666666555 3443332 455555555555553333345555555555555555531 223322221
Q ss_pred --------------CCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCC
Q 037905 111 --------------GNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIP 175 (606)
Q Consensus 111 --------------~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p 175 (606)
++|+.|+|++|++++..+..|..+++|++|++++|+|++.++. +..+++|+.|+|++|+|+ .+|
T Consensus 179 l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp 257 (332)
T 2ft3_A 179 ISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257 (332)
T ss_dssp CCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCC
T ss_pred CcCCCCCccCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecC
Confidence 5788888888999877778899999999999999999988774 888899999999999998 677
Q ss_pred ccccCCC---CCcccCCCCCCCCCc
Q 037905 176 KRFARLP---SSAFEGNSLCGKPLV 197 (606)
Q Consensus 176 ~~~~~l~---~l~~~~n~l~~~p~~ 197 (606)
..+..++ .|++.+|.+++.|..
T Consensus 258 ~~l~~l~~L~~L~l~~N~l~~~~~~ 282 (332)
T 2ft3_A 258 AGLPDLKLLQVVYLHTNNITKVGVN 282 (332)
T ss_dssp TTGGGCTTCCEEECCSSCCCBCCTT
T ss_pred hhhhcCccCCEEECCCCCCCccChh
Confidence 6665544 467888998887655
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.1e-17 Score=152.31 Aligned_cols=127 Identities=26% Similarity=0.348 Sum_probs=112.9
Q ss_pred CCCCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEec
Q 037905 26 DGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYL 94 (606)
Q Consensus 26 ~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 94 (606)
...|+|.++.|.. ++|+.|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 4 ~C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 83 (177)
T 2o6r_A 4 RCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYL 83 (177)
T ss_dssp TCEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEEC
Confidence 3567899999964 47899999999999777778999999999999999999666677899999999999
Q ss_pred cCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCC
Q 037905 95 QGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP 152 (606)
Q Consensus 95 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~ 152 (606)
++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|++|+|++|++.+..+
T Consensus 84 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 84 HENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999997777778999999999999999997666667899999999999999987654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.70 E-value=2.8e-17 Score=166.89 Aligned_cols=151 Identities=24% Similarity=0.383 Sum_probs=128.1
Q ss_pred cCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 37 TGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
..++|++|+|++|.|++. +.+..+++|++|+|++|+|++ +|. +..+++|++|+|++|++++. +. +..+++|+.|
T Consensus 83 ~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L 156 (308)
T 1h6u_A 83 NLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNI-SP-LAGLTNLQYL 156 (308)
T ss_dssp TCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCC-GG-GGGCTTCCEE
T ss_pred cCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcC-cc-ccCCCCccEE
Confidence 347899999999999853 379999999999999999995 553 99999999999999999954 44 8899999999
Q ss_pred ecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCC
Q 037905 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p 195 (606)
+|++|++++ ++. +..+++|+.|++++|++++.++ +..+++|+.|+|++|++++..| ..+.++..|++.+|++++.|
T Consensus 157 ~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 157 SIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp ECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEECCC
T ss_pred EccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeecCC
Confidence 999999995 443 9999999999999999997665 8889999999999999997664 22334455678899998765
Q ss_pred C
Q 037905 196 L 196 (606)
Q Consensus 196 ~ 196 (606)
.
T Consensus 234 ~ 234 (308)
T 1h6u_A 234 V 234 (308)
T ss_dssp E
T ss_pred e
Confidence 4
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.70 E-value=4.6e-17 Score=153.44 Aligned_cols=123 Identities=25% Similarity=0.304 Sum_probs=112.0
Q ss_pred CCCCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEec
Q 037905 26 DGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYL 94 (606)
Q Consensus 26 ~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 94 (606)
...|.+..+.|+. ++|+.|+|++|.|+ .+|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 7 ~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~L 85 (193)
T 2wfh_A 7 ECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL 85 (193)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEEC
Confidence 4556778888864 47899999999998 78899999999999999999999877888999999999999
Q ss_pred cCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccc
Q 037905 95 QGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG 149 (606)
Q Consensus 95 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 149 (606)
++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 86 s~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 86 SYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 9999998888899999999999999999997777779999999999999999974
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.70 E-value=5.4e-17 Score=178.94 Aligned_cols=154 Identities=20% Similarity=0.239 Sum_probs=126.5
Q ss_pred cCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcc--cCcccccCCCCCCEEeccCCcccccCCc-cccCCCCC
Q 037905 37 TGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRG--TIPSDFAKLSNLRNLYLQGNLFSGEIPG-LLFSLGNL 113 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L 113 (606)
..++|++|+|++|.|++.+|..+.++++|++|+|++|+|++ .+|..|.++++|++|+|++|++++.+|. .+..+++|
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 34689999999999998889999999999999999999985 3356789999999999999999974554 57889999
Q ss_pred cEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCC
Q 037905 114 IRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNS 190 (606)
Q Consensus 114 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~ 190 (606)
+.|+|++|+|++..|..+. ++|++|+|++|+|+.+++.+..+++|+.|+|++|+|++..+..|..++ .+++.+|+
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~ 508 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCC
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCC
Confidence 9999999999877766543 789999999999997777777899999999999999954443355544 45678888
Q ss_pred CC
Q 037905 191 LC 192 (606)
Q Consensus 191 l~ 192 (606)
+.
T Consensus 509 ~~ 510 (562)
T 3a79_B 509 WD 510 (562)
T ss_dssp BC
T ss_pred cC
Confidence 75
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-17 Score=169.79 Aligned_cols=155 Identities=20% Similarity=0.156 Sum_probs=90.4
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcc----------------cccCCCCCCEEeccCCcccc
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPS----------------DFAKLSNLRNLYLQGNLFSG 101 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~----------------~~~~l~~L~~L~Ls~N~l~~ 101 (606)
.++|++|+|++|.|++..| |..+++|++|+|++|+|++..+. ....+++|++|+|++|++++
T Consensus 57 l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~N~l~~ 134 (317)
T 3o53_A 57 FTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKITM 134 (317)
T ss_dssp CTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECCCSSCEEEECCSSCCCS
T ss_pred CCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccccCCCCEEECCCCCCCC
Confidence 3456666666666654433 56666666666666655521100 01123344555555555554
Q ss_pred cCCccccCCCCCcEEecCCCcCCcccchhh-hcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCcccc-
Q 037905 102 EIPGLLFSLGNLIRLNLAKNNFSGTISADF-NKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFA- 179 (606)
Q Consensus 102 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~- 179 (606)
..|..+..+++|+.|+|++|+|++..+..+ ..+++|++|+|++|+|++.+ ....+++|+.|+|++|+|++..+. +.
T Consensus 135 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N~l~~l~~~-~~~ 212 (317)
T 3o53_A 135 LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLAFMGPE-FQS 212 (317)
T ss_dssp GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCCEECGG-GGG
T ss_pred ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCCcCCcchhh-hcc
Confidence 445566666777777777777776555555 35677777777777777553 333467777777777777754443 43
Q ss_pred --CCCCCcccCCCCCCCCC
Q 037905 180 --RLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 180 --~l~~l~~~~n~l~~~p~ 196 (606)
++..|++.+|.+...|.
T Consensus 213 l~~L~~L~L~~N~l~~l~~ 231 (317)
T 3o53_A 213 AAGVTWISLRNNKLVLIEK 231 (317)
T ss_dssp GTTCSEEECTTSCCCEECT
T ss_pred cCcccEEECcCCcccchhh
Confidence 44445677777776554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.9e-17 Score=179.55 Aligned_cols=157 Identities=23% Similarity=0.249 Sum_probs=122.9
Q ss_pred CCCCCCCCC-----cceeE-EecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEec
Q 037905 21 LWNLTDGPC-----KWVGV-FCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYL 94 (606)
Q Consensus 21 ~w~~~~~~c-----~~~~~-~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 94 (606)
.|.....+| .|.++ .|..++|+.|+|++|+|++ +|..+ +++|++|+|++|+|+ .+| ..+++|++|+|
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~L 107 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDA 107 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEEC
T ss_pred HHhccCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEc
Confidence 686666788 78888 7887889999999999986 77766 378999999999998 677 45788999999
Q ss_pred cCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccC
Q 037905 95 QGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSI 174 (606)
Q Consensus 95 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~ 174 (606)
++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|+++++ .+++|+.|+|++|+|++ +
T Consensus 108 s~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~-l 175 (571)
T 3cvr_A 108 CDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF-L 175 (571)
T ss_dssp CSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-C
T ss_pred cCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-c
Confidence 9999995 776 655 88888888888885 555 67888888888888887544 56788888888888886 4
Q ss_pred CccccCCCCCcccCCCCCCCCC
Q 037905 175 PKRFARLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 175 p~~~~~l~~l~~~~n~l~~~p~ 196 (606)
|.-..+|..|++++|.|...|.
T Consensus 176 p~l~~~L~~L~Ls~N~L~~lp~ 197 (571)
T 3cvr_A 176 PELPESLEALDVSTNLLESLPA 197 (571)
T ss_dssp CCCCTTCCEEECCSSCCSSCCC
T ss_pred chhhCCCCEEECcCCCCCchhh
Confidence 4422456667777887776654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=3.8e-17 Score=154.58 Aligned_cols=130 Identities=15% Similarity=0.203 Sum_probs=115.3
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.++ .+..+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|+.|+
T Consensus 65 l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~ 142 (197)
T 4ezg_A 65 AHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142 (197)
T ss_dssp CTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEE
T ss_pred CCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEE
Confidence 368999999999776 335899999999999999999987899999999999999999999988899999999999999
Q ss_pred cCCCc-CCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcc
Q 037905 118 LAKNN-FSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172 (606)
Q Consensus 118 l~~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~ 172 (606)
|++|+ +. .+| .+..+++|++|++++|++++.+ .+..+++|+.|++++|++.+
T Consensus 143 L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 143 LSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC----
T ss_pred ccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCcccCC
Confidence 99998 66 666 7999999999999999999754 78899999999999999864
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.70 E-value=2.1e-17 Score=178.70 Aligned_cols=148 Identities=21% Similarity=0.089 Sum_probs=125.7
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCcccc-CCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 117 (606)
++|++|+|++|.|++..+. .+++|++|+|++|.|++..|..|..+++|++|+|++|.|++..|..+. .+++|+.|+
T Consensus 99 ~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~ 175 (487)
T 3oja_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (487)
T ss_dssp TTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEe
Confidence 5677788888888765543 468899999999999988888999999999999999999988888886 799999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccC---CCCCcccCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFAR---LPSSAFEGNSLC 192 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---l~~l~~~~n~l~ 192 (606)
|++|.|++..+ +..+++|++|+|++|+|++.+|.+..+++|+.|+|++|.|++ +|..+.. +..+++.+|++.
T Consensus 176 Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 176 LQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred cCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 99999996533 446999999999999999998889999999999999999996 5655654 445678888875
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.69 E-value=3.6e-17 Score=180.48 Aligned_cols=157 Identities=24% Similarity=0.299 Sum_probs=114.5
Q ss_pred CeEEEEEcCCCCccccc--CccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCC-ccccCCCCCcE
Q 037905 39 ERVTMLRFPGMGLSGQL--PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIP-GLLFSLGNLIR 115 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~ 115 (606)
++|+.|+|++|.+++.. |..+..+++|++|+|++|.+++ +|..+..+++|++|+|++|++.+..| ..+..+++|+.
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccc-ccccccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 57888888888887544 5677778888888888888874 44447778888888888888776555 45677778888
Q ss_pred EecCCCcCCcccchhhhcCCCcceeeccccccc-ccCC-CCCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCC
Q 037905 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLT-GSIP-DLGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNS 190 (606)
Q Consensus 116 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~ 190 (606)
|+|++|++.+..|..|..+++|++|++++|+++ +.+| .+..+++|+.|+|++|++++..|..|..+++ |++.+|.
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 505 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence 888888877777777777888888888888776 3333 4777778888888888887777766655444 5667777
Q ss_pred CCCCCC
Q 037905 191 LCGKPL 196 (606)
Q Consensus 191 l~~~p~ 196 (606)
+.+.|.
T Consensus 506 l~~~~~ 511 (570)
T 2z63_A 506 LKSVPD 511 (570)
T ss_dssp CSCCCT
T ss_pred CCCCCH
Confidence 777654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=4.5e-17 Score=161.44 Aligned_cols=147 Identities=20% Similarity=0.311 Sum_probs=123.3
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|+.|+|++|.|+ .+| .+..+++|++|+|++|+|++ +|. +.++++|++|+|++|+|++ +|... . ++|+.|+
T Consensus 40 l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~ 112 (263)
T 1xeu_A 40 LSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLF 112 (263)
T ss_dssp HTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEE
T ss_pred cCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEE
Confidence 368999999999998 556 79999999999999999995 454 9999999999999999994 55433 3 8999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccC---CCCCcccCCCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFAR---LPSSAFEGNSLCGK 194 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---l~~l~~~~n~l~~~ 194 (606)
|++|+|++ ++ .+..+++|+.|++++|+|++. +.+..+++|+.|++++|++++. ..+.. +..|++.+|+++..
T Consensus 113 L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 113 LDNNELRD-TD-SLIHLKNLEILSIRNNKLKSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred ccCCccCC-Ch-hhcCcccccEEECCCCcCCCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 99999995 44 699999999999999999976 4688899999999999999976 44444 44567888888765
Q ss_pred CC
Q 037905 195 PL 196 (606)
Q Consensus 195 p~ 196 (606)
|.
T Consensus 188 ~~ 189 (263)
T 1xeu_A 188 PV 189 (263)
T ss_dssp CE
T ss_pred cc
Confidence 43
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=8.5e-17 Score=181.51 Aligned_cols=156 Identities=22% Similarity=0.217 Sum_probs=80.0
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCc--ccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALR--GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
++|++|+|++|.+++..+..|..+++|+.|+|++|.++ +.+|..|..+++|++|+|++|+|++..|..|.++++|+.|
T Consensus 430 ~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L 509 (680)
T 1ziw_A 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEIL 509 (680)
T ss_dssp TTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEE
Confidence 46777777777776555555555555555555555554 3445555555555555555555554444445555555555
Q ss_pred ecCCCcCCcccc--------hhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccC---CCCC
Q 037905 117 NLAKNNFSGTIS--------ADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFAR---LPSS 184 (606)
Q Consensus 117 ~l~~N~l~~~~p--------~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~---l~~l 184 (606)
+|++|++++..+ ..|.++++|++|+|++|+|+.+++. |..+++|+.|+|++|+|++..+..|.. +..|
T Consensus 510 ~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 589 (680)
T 1ziw_A 510 DLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSL 589 (680)
T ss_dssp ECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred eCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEE
Confidence 555555543211 1144455555555555555544332 455555555555555555444433322 2223
Q ss_pred cccCCCCCCC
Q 037905 185 AFEGNSLCGK 194 (606)
Q Consensus 185 ~~~~n~l~~~ 194 (606)
++.+|.+++.
T Consensus 590 ~L~~N~l~~~ 599 (680)
T 1ziw_A 590 NLQKNLITSV 599 (680)
T ss_dssp ECTTSCCCBC
T ss_pred ECCCCcCCcc
Confidence 4444544443
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.69 E-value=9.7e-17 Score=161.54 Aligned_cols=148 Identities=23% Similarity=0.335 Sum_probs=126.7
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|+.|++++|.|+.. | .+..+++|++|+|++|+|++ ++. +.++++|++|+|++|++++ +|. +..+++|+.|+|
T Consensus 46 ~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L 119 (291)
T 1h6t_A 46 NSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSL 119 (291)
T ss_dssp HTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEEC
T ss_pred CcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEEC
Confidence 5799999999999844 4 58999999999999999995 444 9999999999999999994 444 999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p 195 (606)
++|+|++ + ..+..+++|++|++++|++++. +.+..+++|+.|++++|++++..| ..+.+|..|++.+|.+.+.|
T Consensus 120 ~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~l~ 194 (291)
T 1h6t_A 120 EHNGISD-I-NGLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLR 194 (291)
T ss_dssp TTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCG
T ss_pred CCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc-hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCCCh
Confidence 9999995 4 4789999999999999999976 678999999999999999997665 22334455678899988764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.69 E-value=7.7e-17 Score=178.01 Aligned_cols=153 Identities=27% Similarity=0.342 Sum_probs=127.4
Q ss_pred ecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcE
Q 037905 36 CTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115 (606)
Q Consensus 36 c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 115 (606)
...++|+.|+|++|.|++..| |..+++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++ + +.+..|++|+.
T Consensus 62 ~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~ 135 (605)
T 1m9s_A 62 QYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLES 135 (605)
T ss_dssp GGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSE
T ss_pred ccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCE
Confidence 344789999999999986555 8999999999999999984 44 78999999999999999995 4 35889999999
Q ss_pred EecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCcccc---CCCCCcccCCCCC
Q 037905 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFA---RLPSSAFEGNSLC 192 (606)
Q Consensus 116 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~l~~~~n~l~ 192 (606)
|+|++|+|++. ..|..|++|+.|+|++|+|++.+| +..+++|+.|+|++|+|++. | .+. +|..|++.+|+++
T Consensus 136 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l-~-~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 136 LYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp EECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEECCSEEEE
T ss_pred EECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEccCCcCc
Confidence 99999999854 578999999999999999998877 88999999999999999865 3 344 4455678889888
Q ss_pred CCCCcCC
Q 037905 193 GKPLVSC 199 (606)
Q Consensus 193 ~~p~~~c 199 (606)
+.|...+
T Consensus 211 ~~p~~~~ 217 (605)
T 1m9s_A 211 NKPINHQ 217 (605)
T ss_dssp CCCCCCC
T ss_pred CCccccc
Confidence 7765543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=147.07 Aligned_cols=136 Identities=21% Similarity=0.139 Sum_probs=118.0
Q ss_pred cCCCCCcEEEccCCCCc-ccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcc
Q 037905 60 GNLTELHTVSLRFNALR-GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLG 138 (606)
Q Consensus 60 ~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 138 (606)
...++|++|+|++|+|+ +.+|..+..+++|++|+|++|.|++. ..+..+++|+.|+|++|++++.+|..+..+++|+
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 34588999999999998 78898999999999999999999955 7899999999999999999977998888999999
Q ss_pred eeecccccccccC--CCCCCCCCCCEEEccCCcCcccCC---ccccCCCC---CcccCCCCCCCCCc
Q 037905 139 TLYLQENQLTGSI--PDLGAFSSLAQFNVSFNKLNGSIP---KRFARLPS---SAFEGNSLCGKPLV 197 (606)
Q Consensus 139 ~L~l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~---l~~~~n~l~~~p~~ 197 (606)
+|++++|+|++.+ +.+..+++|+.|++++|++++..+ ..+..+++ |++.+|.+...|..
T Consensus 99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 165 (168)
T 2ell_A 99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDS 165 (168)
T ss_dssp EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCSS
T ss_pred EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcccc
Confidence 9999999999865 468999999999999999997665 35555554 56777888776654
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.68 E-value=6.4e-17 Score=164.98 Aligned_cols=148 Identities=21% Similarity=0.100 Sum_probs=90.6
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCcccc-CCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF-SLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ 117 (606)
++|++|+|++|.|++..+. .+++|++|+|++|+|++..|..|..+++|++|+|++|++++..|..+. .+++|+.|+
T Consensus 99 ~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 4555566666666544332 256677777777777755555666677777777777777755555553 566777777
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccC---CCCCcccCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFAR---LPSSAFEGNSLC 192 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---l~~l~~~~n~l~ 192 (606)
|++|+|++. |. ...+++|++|+|++|+|++.++.+..+++|+.|+|++|+|+ .+|..+.. +..+++.+|++.
T Consensus 176 L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~ 250 (317)
T 3o53_A 176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250 (317)
T ss_dssp CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCB
T ss_pred CCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCcc
Confidence 777776633 32 23466777777777777766666666667777777777776 34444433 333456666654
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=6.7e-17 Score=176.42 Aligned_cols=150 Identities=20% Similarity=0.218 Sum_probs=122.6
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+ .+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence 57889999999998777778899999999999999998777888999999999999999998 56665 7889999999
Q ss_pred CCCcCCc-ccchhhhcCCCcceeecccccccccCCCCCCCCCC--CEEEccCCcC--cccCCccccCCC----CCcccCC
Q 037905 119 AKNNFSG-TISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL--AQFNVSFNKL--NGSIPKRFARLP----SSAFEGN 189 (606)
Q Consensus 119 ~~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L--~~L~l~~N~l--~~~~p~~~~~l~----~l~~~~n 189 (606)
++|+|++ .+|..|+.+++|++|++++|+|++ ..+..+++| +.|++++|.+ .+..|..+..+. .+.+.+|
T Consensus 98 ~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n 175 (520)
T 2z7x_B 98 SFNAFDALPICKEFGNMSQLKFLGLSTTHLEK--SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175 (520)
T ss_dssp CSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG--GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSS
T ss_pred cCCccccccchhhhccCCcceEEEecCcccch--hhccccccceeeEEEeecccccccccccccccccccceEEEEeccC
Confidence 9999886 467888999999999999998876 346667777 8999999988 778888877766 2445666
Q ss_pred CCCC
Q 037905 190 SLCG 193 (606)
Q Consensus 190 ~l~~ 193 (606)
.+.+
T Consensus 176 ~~~~ 179 (520)
T 2z7x_B 176 KEFH 179 (520)
T ss_dssp SCCC
T ss_pred cchh
Confidence 6554
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=174.90 Aligned_cols=138 Identities=22% Similarity=0.235 Sum_probs=81.2
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
+|++|+|++|.|++..|.+|.++++|++|+|++|+|++..|+.|.++++|++|+|++|+|+ .+|.. .+++|++|+|+
T Consensus 53 ~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls 129 (562)
T 3a79_B 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLS 129 (562)
T ss_dssp TCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECC
T ss_pred CcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECC
Confidence 5566666666666555556666666666666666666555666666666666666666666 44444 56666666666
Q ss_pred CCcCCcc-cchhhhcCCCcceeecccccccccCCCCCCCCCC--CEEEccCCcC--cccCCccccCCC
Q 037905 120 KNNFSGT-ISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSL--AQFNVSFNKL--NGSIPKRFARLP 182 (606)
Q Consensus 120 ~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L--~~L~l~~N~l--~~~~p~~~~~l~ 182 (606)
+|+|++. +|..|.++++|++|++++|+|++ ..+..+++| +.|++++|.+ ++..|..+..+.
T Consensus 130 ~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~--~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~ 195 (562)
T 3a79_B 130 FNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ--LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195 (562)
T ss_dssp SSCCSBCCCCGGGGGCTTCCEEEEECSBCCT--TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECC
T ss_pred CCCccccCchHhhcccCcccEEecCCCcccc--CchhhhhhceeeEEEeecccccccccCcccccccC
Confidence 6666542 24566666666666666666654 223334444 6666666666 555555555544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=7.2e-17 Score=177.32 Aligned_cols=159 Identities=19% Similarity=0.205 Sum_probs=139.0
Q ss_pred ecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCccccc-CCccccCCCCCc
Q 037905 36 CTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGE-IPGLLFSLGNLI 114 (606)
Q Consensus 36 c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~ 114 (606)
...++|++|+|++|.|++..|.+|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++. .|..+.++++|+
T Consensus 47 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 126 (549)
T 2z81_A 47 RACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126 (549)
T ss_dssp SSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCC
T ss_pred hcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCcc
Confidence 3447899999999999988889999999999999999999977777899999999999999999963 577899999999
Q ss_pred EEecCCCcCCcccc-hhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCc----cccCCCCCcccC
Q 037905 115 RLNLAKNNFSGTIS-ADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPK----RFARLPSSAFEG 188 (606)
Q Consensus 115 ~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~l~~~~ 188 (606)
.|++++|++.+.+| ..|.++++|++|++++|++++..|. +..+++|+.|++++|.+.. +|. .+.++..|++.+
T Consensus 127 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~-~~~~~~~~l~~L~~L~L~~ 205 (549)
T 2z81_A 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF-LLEIFADILSSVRYLELRD 205 (549)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTT-HHHHHHHSTTTBSEEEEES
T ss_pred EEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccc-cchhhHhhcccccEEEccC
Confidence 99999999544555 6899999999999999999997775 8999999999999999874 443 246677788999
Q ss_pred CCCCCCC
Q 037905 189 NSLCGKP 195 (606)
Q Consensus 189 n~l~~~p 195 (606)
|.+.+.+
T Consensus 206 n~l~~~~ 212 (549)
T 2z81_A 206 TNLARFQ 212 (549)
T ss_dssp CBCTTCC
T ss_pred Ccccccc
Confidence 9998864
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=148.28 Aligned_cols=132 Identities=19% Similarity=0.243 Sum_probs=110.8
Q ss_pred ecCCeEEEEEcCCCCcccccCccccCCC-CCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCc
Q 037905 36 CTGERVTMLRFPGMGLSGQLPIAIGNLT-ELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114 (606)
Q Consensus 36 c~~~~l~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 114 (606)
....+|+.|+|++|+|+ .+|. +..+. +|++|+|++|.|++. ..|..+++|++|+|++|+|++..|..|..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 34468999999999998 4554 55554 999999999999954 6899999999999999999965556568999999
Q ss_pred EEecCCCcCCcccch--hhhcCCCcceeecccccccccCCC----CCCCCCCCEEEccCCcCcc
Q 037905 115 RLNLAKNNFSGTISA--DFNKLTRLGTLYLQENQLTGSIPD----LGAFSSLAQFNVSFNKLNG 172 (606)
Q Consensus 115 ~L~l~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~----~~~l~~L~~L~l~~N~l~~ 172 (606)
.|+|++|+|. .+|. .+..+++|+.|++++|+++..++. +..+++|+.|++++|.+..
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 9999999997 6665 788999999999999999876653 7789999999999998763
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.65 E-value=3.9e-16 Score=167.97 Aligned_cols=125 Identities=25% Similarity=0.333 Sum_probs=67.5
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|+.|+|++|.+++. +.+..+++|++|+|++|.+++..| +..+++|++|+|++|++++..| +..+++|+.|+|
T Consensus 221 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 294 (466)
T 1o6v_A 221 TNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 294 (466)
T ss_dssp TTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEc
Confidence 4566666666666532 245556666666666666653322 5555556666666665553222 555555555555
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcc
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~ 172 (606)
++|++.+..+ +..+++|+.|++++|++++.+| +..+++|+.|++++|++++
T Consensus 295 ~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNNKVSD 345 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred CCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCCccCC
Confidence 5555553332 4555555555555555554443 4455555555555555554
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=2.2e-16 Score=142.11 Aligned_cols=123 Identities=18% Similarity=0.186 Sum_probs=109.6
Q ss_pred CCCCCcEEEccCCCCc-ccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcce
Q 037905 61 NLTELHTVSLRFNALR-GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGT 139 (606)
Q Consensus 61 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 139 (606)
..++|+.|+|++|.++ +.+|..+..+++|++|+|++|++++. ..+..+++|+.|+|++|+|++.+|..+..+++|++
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3578999999999998 78999999999999999999999965 77999999999999999999779988989999999
Q ss_pred eecccccccccC--CCCCCCCCCCEEEccCCcCcccCC---ccccCCCCCc
Q 037905 140 LYLQENQLTGSI--PDLGAFSSLAQFNVSFNKLNGSIP---KRFARLPSSA 185 (606)
Q Consensus 140 L~l~~N~l~~~~--~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~l~ 185 (606)
|++++|++++.+ ..+..+++|+.|++++|++++..+ ..+..+++|.
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~ 143 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLT 143 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcc
Confidence 999999999864 568999999999999999997766 4666666653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.3e-16 Score=172.91 Aligned_cols=150 Identities=22% Similarity=0.323 Sum_probs=128.9
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
..+|+.|+|++|.|+ .+| .|..|++|+.|+|++|+|++..| +..|++|+.|+|++|+|++ +| .+..|++|+.|+
T Consensus 42 L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~ 115 (605)
T 1m9s_A 42 LNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSLS 115 (605)
T ss_dssp HTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEEE
T ss_pred CCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEEE
Confidence 367999999999998 444 69999999999999999995444 9999999999999999994 55 689999999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p~ 196 (606)
|++|+|.+ ++ .+..|++|+.|+|++|+|++. +.+..+++|+.|+|++|.|++..| ..+.+|..|++.+|.+.+.|.
T Consensus 116 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~l~~ 192 (605)
T 1m9s_A 116 LEHNGISD-IN-GLVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRA 192 (605)
T ss_dssp CTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC-GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCGG
T ss_pred ecCCCCCC-Cc-cccCCCccCEEECCCCccCCc-hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCCChH
Confidence 99999995 44 699999999999999999976 678999999999999999998766 223445556789999987643
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.63 E-value=6.6e-16 Score=159.73 Aligned_cols=170 Identities=17% Similarity=0.115 Sum_probs=123.2
Q ss_pred CCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCc-ccccCCCCCCE-Eec
Q 037905 28 PCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRN-LYL 94 (606)
Q Consensus 28 ~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L 94 (606)
-|++..|.|+. .+++.|+|++|+|+.+.+.+|.+|++|++|+|++|++.+.+| ..|.++++|++ +++
T Consensus 8 ~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 8 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp EEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred EeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 47888899964 468999999999996656689999999999999999876665 56889988765 677
Q ss_pred cCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCC--------------------------Ccceeeccccccc
Q 037905 95 QGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLT--------------------------RLGTLYLQENQLT 148 (606)
Q Consensus 95 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--------------------------~L~~L~l~~N~l~ 148 (606)
++|+|+...|+.|..+++|++|++++|+|....+..+.... .|+.|+|++|+|+
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 78999977788899999999999999988755443333322 3555666666666
Q ss_pred ccCCCCCCCCCCCEEEccC-CcCcccCCcccc---CCCCCcccCCCCCCCCCc
Q 037905 149 GSIPDLGAFSSLAQFNVSF-NKLNGSIPKRFA---RLPSSAFEGNSLCGKPLV 197 (606)
Q Consensus 149 ~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~---~l~~l~~~~n~l~~~p~~ 197 (606)
.+++......+|+.|++++ |.++...++.|. +|..|++++|.|+..|..
T Consensus 168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~ 220 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 220 (350)
T ss_dssp EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSS
T ss_pred CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChh
Confidence 5555544455666666653 455533334443 344466777887777654
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.62 E-value=9.5e-16 Score=158.17 Aligned_cols=151 Identities=21% Similarity=0.271 Sum_probs=121.7
Q ss_pred cCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 37 TGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
..++|+.|+|++|.+++..+ +..+++|+.|++++|.+++..+ +..+++|++|+|++|++++ +|. +..+++|+.|
T Consensus 175 ~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L 248 (347)
T 4fmz_A 175 NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-LSP-LANLSQLTWL 248 (347)
T ss_dssp GCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEE
T ss_pred cCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCC-Ccc-hhcCCCCCEE
Confidence 34689999999999985433 8889999999999999984433 8888999999999999984 444 8889999999
Q ss_pred ecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCCCC
Q 037905 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSLCG 193 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l~~ 193 (606)
++++|++++ + ..+..+++|++|++++|++++. +.+..+++|+.|++++|++++..|..|..++ .|++.+|++++
T Consensus 249 ~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 249 EIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp ECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred ECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 999999884 4 3688889999999999998865 5678888999999999999888777665554 45678888877
Q ss_pred CCC
Q 037905 194 KPL 196 (606)
Q Consensus 194 ~p~ 196 (606)
.+.
T Consensus 326 ~~~ 328 (347)
T 4fmz_A 326 IRP 328 (347)
T ss_dssp CGG
T ss_pred ccC
Confidence 644
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.7e-18 Score=164.07 Aligned_cols=150 Identities=25% Similarity=0.340 Sum_probs=128.3
Q ss_pred CeEEEEEcCCCCcccccCc------cccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCC
Q 037905 39 ERVTMLRFPGMGLSGQLPI------AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGN 112 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 112 (606)
..++.++|+.+.+++..|. .|..+++|++|+|++|+|++ +| .+.++++|++|+|++|+|+ .+|..+..+++
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~ 94 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADT 94 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCc
Confidence 4677777888888777776 89999999999999999995 77 9999999999999999999 78888888899
Q ss_pred CcEEecCCCcCCcccchhhhcCCCcceeecccccccccCC--CCCCCCCCCEEEccCCcCcccCCcc----------ccC
Q 037905 113 LIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLNGSIPKR----------FAR 180 (606)
Q Consensus 113 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~----------~~~ 180 (606)
|+.|+|++|+|++ +| .+..+++|++|++++|+|+..++ .+..+++|+.|++++|++++..|.. +..
T Consensus 95 L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~ 172 (198)
T 1ds9_A 95 LEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKR 172 (198)
T ss_dssp CSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHH
T ss_pred CCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHh
Confidence 9999999999995 56 79999999999999999997654 4889999999999999999876653 667
Q ss_pred CCCCc-ccCCCCCC
Q 037905 181 LPSSA-FEGNSLCG 193 (606)
Q Consensus 181 l~~l~-~~~n~l~~ 193 (606)
+++|. +++|+++.
T Consensus 173 l~~L~~Ld~~~i~~ 186 (198)
T 1ds9_A 173 LPNLKKLDGMPVDV 186 (198)
T ss_dssp CSSCSEECCGGGTT
T ss_pred CCCcEEECCcccCH
Confidence 77764 45666543
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.61 E-value=4.6e-17 Score=184.18 Aligned_cols=143 Identities=22% Similarity=0.215 Sum_probs=122.9
Q ss_pred EecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCc
Q 037905 35 FCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114 (606)
Q Consensus 35 ~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 114 (606)
+.....|+.|+|++|.|. .+|..+.+|++|++|+|++|+|+ .+|..|.+|++|++|+|++|+|+ .+|..|.+|++|+
T Consensus 220 ~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~ 296 (727)
T 4b8c_D 220 KYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLK 296 (727)
T ss_dssp --CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCS
T ss_pred hccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCC
Confidence 444578999999999998 88888889999999999999999 89999999999999999999999 8899999999999
Q ss_pred EEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCC-CCCEEEccCCcCcccCCccccCC
Q 037905 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFS-SLAQFNVSFNKLNGSIPKRFARL 181 (606)
Q Consensus 115 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~-~L~~L~l~~N~l~~~~p~~~~~l 181 (606)
+|+|++|.|+ .+|..|..|++|++|+|++|+|++.+|. +..+. .+..|+|++|.+++.+|..+..+
T Consensus 297 ~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~~l 364 (727)
T 4b8c_D 297 YFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERRFI 364 (727)
T ss_dssp EEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----
T ss_pred EEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcccccee
Confidence 9999999998 7888899999999999999999988875 33221 12347899999999998765543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.6e-15 Score=159.74 Aligned_cols=145 Identities=19% Similarity=0.214 Sum_probs=95.4
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.|++. | +|..+++|++|+|++|+|++ +| +..+++|++|+|++|+|++ +| +..+++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 5677777777777753 4 57777777777777777774 34 7777777777777777774 33 667777777777
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKPL 196 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p~ 196 (606)
++|++++ +| +..+++|++|++++|+|++. .+..+++|+.|++++|+..+.++ ..+.++..|++.+|.+.+.|.
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~l~l 187 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELDV 187 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCCCCC
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccceecc
Confidence 7777774 44 66777777777777777764 25666666666666664333332 233444445566666666553
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.7e-15 Score=150.07 Aligned_cols=128 Identities=22% Similarity=0.275 Sum_probs=112.6
Q ss_pred ecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcE
Q 037905 36 CTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115 (606)
Q Consensus 36 c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 115 (606)
+...+|+.|+|++|.|++..| +.++++|++|+|++|+|++ +|.. .. ++|++|+|++|+|++ +| .+..+++|+.
T Consensus 60 ~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~ 132 (263)
T 1xeu_A 60 QFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGI-PS-ACLSRLFLDNNELRD-TD-SLIHLKNLEI 132 (263)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTC-CC-SSCCEEECCSSCCSB-SG-GGTTCTTCCE
T ss_pred hhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcc-cc-CcccEEEccCCccCC-Ch-hhcCcccccE
Confidence 344789999999999996554 9999999999999999994 5543 33 899999999999995 44 5899999999
Q ss_pred EecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCccc
Q 037905 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS 173 (606)
Q Consensus 116 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~ 173 (606)
|+|++|+|++ ++ .+..+++|++|++++|+|++. +.+..+++|+.|++++|++++.
T Consensus 133 L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 133 LSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp EECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred EECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 9999999995 45 799999999999999999987 6799999999999999999865
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.5e-15 Score=166.77 Aligned_cols=104 Identities=24% Similarity=0.278 Sum_probs=49.7
Q ss_pred CcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeeccc
Q 037905 65 LHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQE 144 (606)
Q Consensus 65 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 144 (606)
|+.|+|++|+|+ .+|. |..+++|+.|+|++|+|+ .+|..|..|++|+.|+|++|+|++ +| .|..|++|++|+|++
T Consensus 443 L~~L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCC-CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCC
Confidence 444555555554 2343 444455555555555554 444444455555555555555542 33 444455555555555
Q ss_pred ccccccC-C-CCCCCCCCCEEEccCCcCccc
Q 037905 145 NQLTGSI-P-DLGAFSSLAQFNVSFNKLNGS 173 (606)
Q Consensus 145 N~l~~~~-~-~~~~l~~L~~L~l~~N~l~~~ 173 (606)
|+|++.+ | .+..+++|+.|+|++|+|++.
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~ 548 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 548 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence 5554442 2 244444555555555555433
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.61 E-value=1.6e-15 Score=139.84 Aligned_cols=108 Identities=24% Similarity=0.329 Sum_probs=77.0
Q ss_pred EEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCC
Q 037905 41 VTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120 (606)
Q Consensus 41 l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 120 (606)
.+.|++++|+|+ .+|..+ .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 356788888887 566655 37778888888888866677777777777777777777755555667777777777777
Q ss_pred CcCCcccchhhhcCCCcceeecccccccccC
Q 037905 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSI 151 (606)
Q Consensus 121 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 151 (606)
|+|++..+..|..+++|++|+|++|+++...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 7777555555667777777777777666443
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.61 E-value=5.2e-15 Score=158.49 Aligned_cols=145 Identities=19% Similarity=0.128 Sum_probs=97.7
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.|++. | ++++++|++|+|++|+|++ +| +..+++|++|+|++|+|++ ++ +..+++|+.|+
T Consensus 84 l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~ 154 (457)
T 3bz5_A 84 NTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELD 154 (457)
T ss_dssp CTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEE
T ss_pred CCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEE
Confidence 46889999999999864 3 8889999999999999985 55 8888899999999999885 33 66666777777
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCCCcccCCCCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~~n~l~~~p 195 (606)
+++|+..+.+ .+..+++|++|++++|+|++.+ +..+++|+.|++++|++++..-..+.++..|++.+|.+.+.|
T Consensus 155 l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~~l~~l~~L~~L~Ls~N~l~~ip 228 (457)
T 3bz5_A 155 CHLNKKITKL--DVTPQTQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLTEID 228 (457)
T ss_dssp CTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC--CTTCTTCCEEECCSSCCSCCCCTTCTTCSEEECCSSCCSCCC
T ss_pred CCCCCccccc--ccccCCcCCEEECCCCccceec--cccCCCCCEEECcCCcCCeeccccCCCCCEEECcCCcccccC
Confidence 7776444444 2556666666666666666532 555556666666666665442223333444455555555554
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.60 E-value=1.1e-15 Score=169.03 Aligned_cols=156 Identities=24% Similarity=0.308 Sum_probs=112.7
Q ss_pred CCCCCCCCCcceeE--------EecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEE
Q 037905 21 LWNLTDGPCKWVGV--------FCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNL 92 (606)
Q Consensus 21 ~w~~~~~~c~~~~~--------~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (606)
.|.....+|.|++. .|...+++.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|
T Consensus 14 ~W~~~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L 86 (622)
T 3g06_A 14 AWRRAAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTL 86 (622)
T ss_dssp HHHHTCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEE
T ss_pred HHHhcCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEE
Confidence 67666788888663 334456889999999998 7777665 78899999999888 5665 56888888
Q ss_pred eccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcc
Q 037905 93 YLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172 (606)
Q Consensus 93 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~ 172 (606)
+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|++++|+|+++++. +++|+.|+|++|+|++
T Consensus 87 ~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N~l~~ 155 (622)
T 3g06_A 87 EVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDNQLAS 155 (622)
T ss_dssp EECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSC
T ss_pred EcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCCcCCC
Confidence 88888888 5665 67788888888888884 443 567778888888887765543 3677777777777774
Q ss_pred cCCccccCCCCCcccCCCCCCCC
Q 037905 173 SIPKRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 173 ~~p~~~~~l~~l~~~~n~l~~~p 195 (606)
+|..+.++..|.+.+|.+++.|
T Consensus 156 -l~~~~~~L~~L~L~~N~l~~l~ 177 (622)
T 3g06_A 156 -LPALPSELCKLWAYNNQLTSLP 177 (622)
T ss_dssp -CCCCCTTCCEEECCSSCCSCCC
T ss_pred -cCCccCCCCEEECCCCCCCCCc
Confidence 4445555655666666555544
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.6e-15 Score=138.90 Aligned_cols=107 Identities=25% Similarity=0.407 Sum_probs=78.2
Q ss_pred EEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCC
Q 037905 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121 (606)
Q Consensus 42 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 121 (606)
+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 56888888886 6676654 77888888888888666777888888888888888888555555677777777777777
Q ss_pred cCCcccchhhhcCCCcceeecccccccccC
Q 037905 122 NFSGTISADFNKLTRLGTLYLQENQLTGSI 151 (606)
Q Consensus 122 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 151 (606)
+|++..+..|..+++|++|+|++|++...+
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccc
Confidence 777555545777777777777777766443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.60 E-value=2.4e-15 Score=155.20 Aligned_cols=149 Identities=21% Similarity=0.311 Sum_probs=116.4
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|++++|.+++..+ +..+++|++|+|++|.+++ ++. +..+++|+.|++++|.+++..+ +..+++|+.|+
T Consensus 154 l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~ 227 (347)
T 4fmz_A 154 MTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred CCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEE
Confidence 3678899999998885443 8888999999999999884 443 8888899999999999885444 78888999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p 195 (606)
|++|++++..+ +..+++|++|++++|.+++. +.+..+++|+.|++++|++++... ..+.++..|++.+|.+.+.+
T Consensus 228 l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 228 IGNNKITDLSP--LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCGGG
T ss_pred ccCCccCCCcc--hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCCChhhcCCCCCCEEECcCCcCCCcC
Confidence 99999885443 88889999999999988864 568888899999999998886421 23445556778888877654
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.60 E-value=4.1e-15 Score=137.02 Aligned_cols=107 Identities=27% Similarity=0.344 Sum_probs=97.9
Q ss_pred CcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeeccc
Q 037905 65 LHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQE 144 (606)
Q Consensus 65 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 144 (606)
.+.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 578999999999 6887764 8999999999999988899999999999999999999977777789999999999999
Q ss_pred ccccccCCC-CCCCCCCCEEEccCCcCcccC
Q 037905 145 NQLTGSIPD-LGAFSSLAQFNVSFNKLNGSI 174 (606)
Q Consensus 145 N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~ 174 (606)
|+|++.++. |..+++|+.|+|++|+|++..
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 999998886 899999999999999998544
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2e-16 Score=162.77 Aligned_cols=132 Identities=14% Similarity=0.125 Sum_probs=93.7
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCcc---------------CHHHH--------HHHHHHHcCCCCCCcccce
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV---------------SEKEF--------REKMEVVGSMDHENLVPLR 378 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~~--------~~e~~~l~~l~h~niv~l~ 378 (606)
.+.||+|+||.||+|...+|+.||||+++.... ..... ..|+..+.++.+.++.-..
T Consensus 100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~ 179 (397)
T 4gyi_A 100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE 179 (397)
T ss_dssp EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence 467999999999999988899999998764211 01112 2345555555333332111
Q ss_pred EEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCc-
Q 037905 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYE- 457 (606)
Q Consensus 379 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~- 457 (606)
-+. ....++||||+++++|..+... .....++.|++.+|.+||+.|++ ||||||.|||+++++.
T Consensus 180 p~~--~~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~gIV--HrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 180 PIA--QSRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHGLI--HGDFNEFNILIREEKDA 244 (397)
T ss_dssp EEE--EETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTTEE--CSCCSTTSEEEEEEECS
T ss_pred eee--ccCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCCCc--CCCCCHHHEEEeCCCCc
Confidence 111 1234799999999888766431 12346789999999999999955 9999999999988763
Q ss_pred ---------EEEeecccCcc
Q 037905 458 ---------ARISDFGLAHL 468 (606)
Q Consensus 458 ---------~kl~DfG~a~~ 468 (606)
+.|+||+.+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 89999997754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.59 E-value=3.7e-15 Score=160.36 Aligned_cols=151 Identities=30% Similarity=0.391 Sum_probs=128.3
Q ss_pred ecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcE
Q 037905 36 CTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115 (606)
Q Consensus 36 c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 115 (606)
+..++|++|+|++|.+++..| +..+++|++|+|++|++++ + ..+..+++|+.|+|++|++++..| +..+++|+.
T Consensus 196 ~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 269 (466)
T 1o6v_A 196 AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 269 (466)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred ccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCccc-c-hhhhcCCCCCEEECCCCccccchh--hhcCCCCCE
Confidence 344789999999999987665 7889999999999999984 4 368899999999999999996554 889999999
Q ss_pred EecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCC
Q 037905 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGK 194 (606)
Q Consensus 116 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~ 194 (606)
|++++|++++..+ +..+++|+.|++++|++++.++ +..+++|+.|++++|++++..| ..+.++..|++.+|.+.+.
T Consensus 270 L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 270 LKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred EECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 9999999996544 8899999999999999997665 8889999999999999998766 3445666678899998876
Q ss_pred C
Q 037905 195 P 195 (606)
Q Consensus 195 p 195 (606)
+
T Consensus 347 ~ 347 (466)
T 1o6v_A 347 S 347 (466)
T ss_dssp G
T ss_pred h
Confidence 4
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.2e-15 Score=161.71 Aligned_cols=139 Identities=25% Similarity=0.246 Sum_probs=115.5
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.|+ .+| ..+++|++|+|++|+|++ +|. |.+ +|++|+|++|+|++ +|. .+++|+.|+|
T Consensus 80 ~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 80 PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 57999999999998 677 568999999999999995 777 665 99999999999995 776 6889999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCC-------CCCcccCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARL-------PSSAFEGNSL 191 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-------~~l~~~~n~l 191 (606)
++|+|++ +|. .+++|++|+|++|+|+++++ +. ++|+.|+|++|+|+ .+|....++ ..|++.+|.|
T Consensus 148 s~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~~~~~L~~~~~~L~~L~Ls~N~l 219 (571)
T 3cvr_A 148 DNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCCCC--------CCEEEECCSSCC
T ss_pred CCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhhHHHhhhcccccceEEecCCCcc
Confidence 9999995 665 67899999999999998655 65 89999999999999 555522355 6678899999
Q ss_pred CCCCCc
Q 037905 192 CGKPLV 197 (606)
Q Consensus 192 ~~~p~~ 197 (606)
+..|..
T Consensus 220 ~~lp~~ 225 (571)
T 3cvr_A 220 THIPEN 225 (571)
T ss_dssp CCCCGG
T ss_pred eecCHH
Confidence 887754
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.58 E-value=7.2e-15 Score=135.91 Aligned_cols=106 Identities=24% Similarity=0.332 Sum_probs=96.7
Q ss_pred CcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeeccc
Q 037905 65 LHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQE 144 (606)
Q Consensus 65 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~ 144 (606)
-+.+++++|+|+ .+|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 378999999998 7888775 8999999999999988899999999999999999999976666789999999999999
Q ss_pred ccccccCCC-CCCCCCCCEEEccCCcCccc
Q 037905 145 NQLTGSIPD-LGAFSSLAQFNVSFNKLNGS 173 (606)
Q Consensus 145 N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~ 173 (606)
|+|+++++. |..+++|+.|+|++|+|...
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 999988886 89999999999999999843
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.58 E-value=9.9e-15 Score=156.20 Aligned_cols=122 Identities=20% Similarity=0.312 Sum_probs=60.2
Q ss_pred CCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeec
Q 037905 63 TELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYL 142 (606)
Q Consensus 63 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l 142 (606)
++|++|+|++|++++ +| .|.++++|++|+|++|++++ +|..+ .+|++|++++|++++ +| .|..+++|++|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 455555555555553 44 35555555555555555552 44322 355555555555553 33 3555555555555
Q ss_pred cccccccc-------------------CCCCCCCCCCCEEEccCCcCcccCCccccCCCCCcccCCCCCC
Q 037905 143 QENQLTGS-------------------IPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSLCG 193 (606)
Q Consensus 143 ~~N~l~~~-------------------~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~~n~l~~ 193 (606)
++|++++. +|.+..+++|+.|++++|++++ +|..+.++..|++.+|.+.+
T Consensus 203 ~~N~l~~l~~~~~~L~~L~l~~n~l~~lp~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~N~l~~ 271 (454)
T 1jl5_A 203 DNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTD 271 (454)
T ss_dssp CSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSC
T ss_pred CCCcCCcCCCCcCcccEEECcCCcCCcccccCCCCCCCEEECCCCcCCc-ccccccccCEEECCCCcccc
Confidence 55555442 2234444455555555555542 33333444444444444444
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.57 E-value=4.4e-15 Score=137.60 Aligned_cols=130 Identities=17% Similarity=0.116 Sum_probs=107.6
Q ss_pred ccccCCCCCcEEEccCCCCcccCcccccCCC-CCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCC
Q 037905 57 IAIGNLTELHTVSLRFNALRGTIPSDFAKLS-NLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLT 135 (606)
Q Consensus 57 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 135 (606)
..+.++.+|++|+|++|+|+ .+|. +..+. +|++|+|++|+|++. ..|..+++|+.|+|++|+|++..+..|..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 35778999999999999999 5665 55554 999999999999965 6799999999999999999966656679999
Q ss_pred CcceeecccccccccCC--CCCCCCCCCEEEccCCcCcccCCc----cccCCCC---CcccCCCC
Q 037905 136 RLGTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLNGSIPK----RFARLPS---SAFEGNSL 191 (606)
Q Consensus 136 ~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~----~~~~l~~---l~~~~n~l 191 (606)
+|++|++++|+|+..++ .+..+++|+.|++++|+++. .|. .+..++. |++.+|..
T Consensus 89 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 89 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCH
Confidence 99999999999987665 58899999999999999984 454 3555554 45555654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.54 E-value=3.2e-14 Score=152.21 Aligned_cols=141 Identities=21% Similarity=0.195 Sum_probs=109.2
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.+++ +|.. +++|++|+|++|++++ +|.. .++|++|+|++|++++ +| .|.++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 578888888888875 5643 3788888888888883 4432 1688899999999884 77 5888889999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCCCcccCCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~~~~n~l~~~p 195 (606)
++|++++ +|.. ..+|++|++++|++++. |.+..+++|+.|++++|++++ +|....++..|++.+|.+...|
T Consensus 161 ~~N~l~~-lp~~---~~~L~~L~L~~n~l~~l-~~~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~n~l~~lp 231 (454)
T 1jl5_A 161 DNNSLKK-LPDL---PPSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNNSLKK-LPDLPLSLESIVAGNNILEELP 231 (454)
T ss_dssp CSSCCSC-CCCC---CTTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCSS-CCCCCTTCCEEECCSSCCSSCC
T ss_pred CCCcCcc-cCCC---cccccEEECcCCcCCcC-ccccCCCCCCEEECCCCcCCc-CCCCcCcccEEECcCCcCCccc
Confidence 9998884 5543 35888999999998874 578888899999999998885 5666667888888888887665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-15 Score=166.86 Aligned_cols=121 Identities=23% Similarity=0.230 Sum_probs=105.4
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
.|+.|+|++|.|++ +|. |..+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|..|++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 58889999999985 676 999999999999999999 889999999999999999999995 67 78999999999999
Q ss_pred CCcCCccc-chhhhcCCCcceeecccccccccCCCCC----CCCCCCEEEc
Q 037905 120 KNNFSGTI-SADFNKLTRLGTLYLQENQLTGSIPDLG----AFSSLAQFNV 165 (606)
Q Consensus 120 ~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~~----~l~~L~~L~l 165 (606)
+|+|++.. |..|..|++|+.|+|++|+|++.+|.+. .+++|+.|++
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99999776 8899999999999999999998887543 3788888864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-15 Score=158.23 Aligned_cols=155 Identities=24% Similarity=0.269 Sum_probs=101.9
Q ss_pred CeEEEEEcCCCCcccccC----ccccCCC-CCcEEEccCCCCcccCcccccCC-----CCCCEEeccCCcccccCCcccc
Q 037905 39 ERVTMLRFPGMGLSGQLP----IAIGNLT-ELHTVSLRFNALRGTIPSDFAKL-----SNLRNLYLQGNLFSGEIPGLLF 108 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~~p~~~~ 108 (606)
.+|++|+|++|.|++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++|++|+|++|+|++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 457778888887775555 5667777 78888888887776666666654 7788888888887765555333
Q ss_pred ----CC-CCCcEEecCCCcCCcccchhhhc-----CCCcceeecccccccccCCC-----CCCCC-CCCEEEccCCcCcc
Q 037905 109 ----SL-GNLIRLNLAKNNFSGTISADFNK-----LTRLGTLYLQENQLTGSIPD-----LGAFS-SLAQFNVSFNKLNG 172 (606)
Q Consensus 109 ----~l-~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~~~~-----~~~l~-~L~~L~l~~N~l~~ 172 (606)
.+ ++|+.|+|++|+|++..+..+.. .++|++|+|++|+|+..... +..++ +|+.|+|++|+|++
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~ 181 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCch
Confidence 33 67788888888777655554433 25777888888777743221 23343 77777777777776
Q ss_pred cCCccc--------cCCCCCcccCCCCCC
Q 037905 173 SIPKRF--------ARLPSSAFEGNSLCG 193 (606)
Q Consensus 173 ~~p~~~--------~~l~~l~~~~n~l~~ 193 (606)
..+..+ .++..|++++|.+..
T Consensus 182 ~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 182 KNCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp SCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred hhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 555322 255556677777643
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.1e-15 Score=156.98 Aligned_cols=129 Identities=24% Similarity=0.275 Sum_probs=77.1
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCccc-CcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGT-IPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.+++.|+|++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|++++..|..+..+++|+.|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4566666666666644443 44566666666666666543 555666666666666666666655666666666666666
Q ss_pred cCCC-cCCc-ccchhhhcCCCcceeecccc-ccccc-CC-CCCCCC-CCCEEEccCC
Q 037905 118 LAKN-NFSG-TISADFNKLTRLGTLYLQEN-QLTGS-IP-DLGAFS-SLAQFNVSFN 168 (606)
Q Consensus 118 l~~N-~l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~-~~-~~~~l~-~L~~L~l~~N 168 (606)
|++| .+++ .++..+..+++|++|++++| .+++. ++ .+..++ +|+.|++++|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~ 205 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGY 205 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSC
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCC
Confidence 6666 4553 24555666666666666666 66542 12 244555 6666666666
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.53 E-value=9.9e-16 Score=160.60 Aligned_cols=157 Identities=17% Similarity=0.207 Sum_probs=106.0
Q ss_pred cCCeEEEEEcCCCCccc----ccCccccCCCCCcEEEccCCCCcccCcccc----cCC---------CCCCEEeccCCcc
Q 037905 37 TGERVTMLRFPGMGLSG----QLPIAIGNLTELHTVSLRFNALRGTIPSDF----AKL---------SNLRNLYLQGNLF 99 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~----~~l---------~~L~~L~Ls~N~l 99 (606)
..++|++|+|++|.|++ .+|..+..+++|++|+|++|.|+...+..+ ..+ ++|++|+|++|+|
T Consensus 92 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l 171 (386)
T 2ca6_A 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171 (386)
T ss_dssp TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCC
T ss_pred hCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCC
Confidence 34678888888888876 467777888888888888888864333333 333 7788888888887
Q ss_pred c-ccCC---ccccCCCCCcEEecCCCcCC--c---ccchhhhcCCCcceeeccccccc----ccCC-CCCCCCCCCEEEc
Q 037905 100 S-GEIP---GLLFSLGNLIRLNLAKNNFS--G---TISADFNKLTRLGTLYLQENQLT----GSIP-DLGAFSSLAQFNV 165 (606)
Q Consensus 100 ~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----~~~~-~~~~l~~L~~L~l 165 (606)
+ +.+| ..+..+++|+.|+|++|+|+ + ..|..+..+++|++|+|++|.|+ ..+| .+..+++|+.|+|
T Consensus 172 ~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L 251 (386)
T 2ca6_A 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 251 (386)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEEC
Confidence 6 3444 35566777888888887776 2 33446677777778888777774 3333 3666777777777
Q ss_pred cCCcCccc----CCcc-----ccCCCCCcccCCCCCC
Q 037905 166 SFNKLNGS----IPKR-----FARLPSSAFEGNSLCG 193 (606)
Q Consensus 166 ~~N~l~~~----~p~~-----~~~l~~l~~~~n~l~~ 193 (606)
++|.|++. +|.. +.++..|++.+|.+++
T Consensus 252 ~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 252 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred CCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 77777754 3333 3445556677777765
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=8.1e-16 Score=161.28 Aligned_cols=158 Identities=19% Similarity=0.291 Sum_probs=127.2
Q ss_pred cCCeEEEEEcCCC---CcccccCccc-------cCCCCCcEEEccCCCCcc----cCcccccCCCCCCEEeccCCccccc
Q 037905 37 TGERVTMLRFPGM---GLSGQLPIAI-------GNLTELHTVSLRFNALRG----TIPSDFAKLSNLRNLYLQGNLFSGE 102 (606)
Q Consensus 37 ~~~~l~~L~L~~n---~l~~~~p~~l-------~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~ 102 (606)
..++|++|+|++| .+++.+|..+ ..+++|++|+|++|+|++ .+|..+..+++|++|+|++|.|+..
T Consensus 58 ~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~ 137 (386)
T 2ca6_A 58 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 137 (386)
T ss_dssp TCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHH
T ss_pred hCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHH
Confidence 3478999999996 4555666655 789999999999999996 4788899999999999999999755
Q ss_pred CCcccc----CC---------CCCcEEecCCCcCC-cccc---hhhhcCCCcceeeccccccc--c---cCC-CCCCCCC
Q 037905 103 IPGLLF----SL---------GNLIRLNLAKNNFS-GTIS---ADFNKLTRLGTLYLQENQLT--G---SIP-DLGAFSS 159 (606)
Q Consensus 103 ~p~~~~----~l---------~~L~~L~l~~N~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~~-~~~~l~~ 159 (606)
.+..+. .+ ++|+.|+|++|+|+ ..+| ..+..+++|++|+|++|+|+ + ..+ .+..+++
T Consensus 138 ~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~ 217 (386)
T 2ca6_A 138 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQE 217 (386)
T ss_dssp HHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTT
T ss_pred HHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCC
Confidence 444443 34 89999999999997 4555 46788999999999999998 3 445 6888999
Q ss_pred CCEEEccCCcCc----ccCCcccc---CCCCCcccCCCCCCC
Q 037905 160 LAQFNVSFNKLN----GSIPKRFA---RLPSSAFEGNSLCGK 194 (606)
Q Consensus 160 L~~L~l~~N~l~----~~~p~~~~---~l~~l~~~~n~l~~~ 194 (606)
|+.|+|++|.|+ +.+|..+. +|..|++.+|.+.+.
T Consensus 218 L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~ 259 (386)
T 2ca6_A 218 LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 259 (386)
T ss_dssp CCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred ccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchh
Confidence 999999999996 56666554 455567888988653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.51 E-value=7e-14 Score=154.60 Aligned_cols=97 Identities=25% Similarity=0.329 Sum_probs=67.7
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|+.|+|++|.|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|+|
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEEC
Confidence 56888888888887 5554 5678888888888887 5665 6677888888888887 4554 4566777777
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSI 151 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 151 (606)
++|+|+ .+|.. +++|++|+|++|+|++++
T Consensus 129 ~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~l~ 157 (622)
T 3g06_A 129 FGNQLT-SLPVL---PPGLQELSVSDNQLASLP 157 (622)
T ss_dssp CSSCCS-CCCCC---CTTCCEEECCSSCCSCCC
T ss_pred CCCCCC-cCCCC---CCCCCEEECcCCcCCCcC
Confidence 777776 34432 366777777777776543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.50 E-value=6.4e-15 Score=153.05 Aligned_cols=153 Identities=21% Similarity=0.214 Sum_probs=128.0
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCc----ccccCCC-CCCEEeccCCcccccCCccccCC-----CC
Q 037905 43 MLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP----SDFAKLS-NLRNLYLQGNLFSGEIPGLLFSL-----GN 112 (606)
Q Consensus 43 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 112 (606)
.++|++|++++.+|..+...++|++|+|++|.|++..+ ..|..++ +|++|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 47899999999999888888889999999999996666 7888999 99999999999998878777765 99
Q ss_pred CcEEecCCCcCCcccchhhhc----C-CCcceeecccccccccCCC-----CCC-CCCCCEEEccCCcCcccCCccc---
Q 037905 113 LIRLNLAKNNFSGTISADFNK----L-TRLGTLYLQENQLTGSIPD-----LGA-FSSLAQFNVSFNKLNGSIPKRF--- 178 (606)
Q Consensus 113 L~~L~l~~N~l~~~~p~~~~~----l-~~L~~L~l~~N~l~~~~~~-----~~~-l~~L~~L~l~~N~l~~~~p~~~--- 178 (606)
|+.|+|++|+|++..+..+.. + ++|++|+|++|+|+...+. +.. .++|+.|+|++|.|++..+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999999777775544 4 8999999999999977653 334 3699999999999996544332
Q ss_pred -----cCCCCCcccCCCCCCCC
Q 037905 179 -----ARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 179 -----~~l~~l~~~~n~l~~~p 195 (606)
.++..|++.+|.+.+..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~ 183 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKN 183 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSC
T ss_pred HhcCCccccEeeecCCCCchhh
Confidence 36778899999987654
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.49 E-value=7.4e-15 Score=150.66 Aligned_cols=152 Identities=22% Similarity=0.228 Sum_probs=127.9
Q ss_pred CeEEEEEcCCCCcccc-cCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCC-ccccc-CCccccCCCCCcE
Q 037905 39 ERVTMLRFPGMGLSGQ-LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN-LFSGE-IPGLLFSLGNLIR 115 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~ 115 (606)
.+|++|+|++|.+++. +|..+..+++|++|+|++|.+++..|..+..+++|++|+|++| .+++. +|..+..+++|+.
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 6899999999999866 8888999999999999999999888999999999999999999 68853 6777889999999
Q ss_pred EecCCC-cCCcc-cchhhhcCC-Ccceeeccccc--cc-ccCC-CCCCCCCCCEEEccCCc-CcccCCccccCCCC---C
Q 037905 116 LNLAKN-NFSGT-ISADFNKLT-RLGTLYLQENQ--LT-GSIP-DLGAFSSLAQFNVSFNK-LNGSIPKRFARLPS---S 184 (606)
Q Consensus 116 L~l~~N-~l~~~-~p~~~~~l~-~L~~L~l~~N~--l~-~~~~-~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~---l 184 (606)
|+|++| ++++. ++..+..++ +|++|++++|. ++ +.++ .+..+++|+.|++++|. +++..+..+..+++ |
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L 252 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 252 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEe
Confidence 999999 99854 677889999 99999999994 44 2333 36678999999999999 77777766665554 5
Q ss_pred cccCCC
Q 037905 185 AFEGNS 190 (606)
Q Consensus 185 ~~~~n~ 190 (606)
++.+|.
T Consensus 253 ~l~~~~ 258 (336)
T 2ast_B 253 SLSRCY 258 (336)
T ss_dssp ECTTCT
T ss_pred eCCCCC
Confidence 677774
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.49 E-value=6.5e-14 Score=144.72 Aligned_cols=163 Identities=12% Similarity=0.100 Sum_probs=128.8
Q ss_pred CcceeEEecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCC-ccc
Q 037905 29 CKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIP-GLL 107 (606)
Q Consensus 29 c~~~~~~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~ 107 (606)
|.-.--.|+. ++++.++++|+ .+|..+ .++|++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|
T Consensus 2 Cp~~~C~C~~---~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f 75 (350)
T 4ay9_X 2 CHHRICHCSN---RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 75 (350)
T ss_dssp CCCSSSEEET---TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSB
T ss_pred CCCCccEeeC---CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHh
Confidence 4333356765 35789999998 778776 4789999999999995555679999999999999999876665 468
Q ss_pred cCCCCCcE-EecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccC-CcCcccCCccccCCC--
Q 037905 108 FSLGNLIR-LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSF-NKLNGSIPKRFARLP-- 182 (606)
Q Consensus 108 ~~l~~L~~-L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~-- 182 (606)
.++++|.. +.+++|+|+...|..|..+++|++|++++|+|+..++. +....++..|++.+ |.+....+..|..+.
T Consensus 76 ~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~ 155 (350)
T 4ay9_X 76 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 155 (350)
T ss_dssp CSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSS
T ss_pred hcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchh
Confidence 89998775 67778999988888999999999999999999977764 56667788888865 677766666666554
Q ss_pred --CCcccCCCCCCCCCc
Q 037905 183 --SSAFEGNSLCGKPLV 197 (606)
Q Consensus 183 --~l~~~~n~l~~~p~~ 197 (606)
.|++.+|.+...|..
T Consensus 156 l~~L~L~~N~i~~i~~~ 172 (350)
T 4ay9_X 156 SVILWLNKNGIQEIHNS 172 (350)
T ss_dssp CEEEECCSSCCCEECTT
T ss_pred hhhhccccccccCCChh
Confidence 367788888766543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.48 E-value=8.7e-14 Score=143.51 Aligned_cols=103 Identities=24% Similarity=0.216 Sum_probs=87.1
Q ss_pred EEcCCC-CcccccCccccCCCCCcEEEccC-CCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCC
Q 037905 44 LRFPGM-GLSGQLPIAIGNLTELHTVSLRF-NALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121 (606)
Q Consensus 44 L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 121 (606)
++++++ +|+ .+|. |..+++|++|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 456666 787 5777 99999999999996 9999777788999999999999999999888888999999999999999
Q ss_pred cCCcccchhhhcCCCcceeecccccccc
Q 037905 122 NFSGTISADFNKLTRLGTLYLQENQLTG 149 (606)
Q Consensus 122 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 149 (606)
+|++..+..|..++ |+.|+|++|+|..
T Consensus 91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred ccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 99866666666665 8888888888874
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.45 E-value=4.8e-16 Score=147.10 Aligned_cols=130 Identities=18% Similarity=0.231 Sum_probs=114.1
Q ss_pred EecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCc
Q 037905 35 FCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114 (606)
Q Consensus 35 ~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 114 (606)
++..++|++|+|++|.|++ +| .+.++++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++ +| .+..+++|+
T Consensus 44 ~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~ 118 (198)
T 1ds9_A 44 LSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLR 118 (198)
T ss_dssp HHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSS
T ss_pred HhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCC
Confidence 3445789999999999996 77 8999999999999999999 788888888999999999999995 56 688999999
Q ss_pred EEecCCCcCCcccc-hhhhcCCCcceeecccccccccCCC-----------CCCCCCCCEEEccCCcCc
Q 037905 115 RLNLAKNNFSGTIS-ADFNKLTRLGTLYLQENQLTGSIPD-----------LGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 115 ~L~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~-----------~~~l~~L~~L~l~~N~l~ 171 (606)
.|+|++|+|++..+ ..+..+++|++|++++|++++.+|. +..+++|+.|+ +|.++
T Consensus 119 ~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp EEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred EEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 99999999995333 4789999999999999999887665 67889999887 77776
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.43 E-value=3.2e-13 Score=139.23 Aligned_cols=106 Identities=24% Similarity=0.232 Sum_probs=95.5
Q ss_pred cEEEccCC-CCcccCcccccCCCCCCEEeccC-CcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecc
Q 037905 66 HTVSLRFN-ALRGTIPSDFAKLSNLRNLYLQG-NLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQ 143 (606)
Q Consensus 66 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~ 143 (606)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 35689988 999 6888 99999999999996 99998888899999999999999999999999999999999999999
Q ss_pred cccccccCCC-CCCCCCCCEEEccCCcCcccC
Q 037905 144 ENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSI 174 (606)
Q Consensus 144 ~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~ 174 (606)
+|+|+++++. +..++ |+.|+|++|+|....
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHCSC 119 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCCCG
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccCCC
Confidence 9999998887 44454 999999999998543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.35 E-value=5.5e-14 Score=150.68 Aligned_cols=157 Identities=18% Similarity=0.125 Sum_probs=124.3
Q ss_pred CCeEEEEEcCCCCccccc-----CccccCCCCCcEEEccCCCCccc----CcccccCCCCCCEEeccCCcccccCCcccc
Q 037905 38 GERVTMLRFPGMGLSGQL-----PIAIGNLTELHTVSLRFNALRGT----IPSDFAKLSNLRNLYLQGNLFSGEIPGLLF 108 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~-----p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 108 (606)
.++|++|+|++|.|++.. +..+..+++|++|+|++|+|+.. ++..+..+++|++|+|++|.+++..+..+.
T Consensus 226 ~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~ 305 (461)
T 1z7x_W 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLC 305 (461)
T ss_dssp CTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHH
T ss_pred CCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHH
Confidence 478999999999997543 23344689999999999999953 678888899999999999999855444443
Q ss_pred -----CCCCCcEEecCCCcCCcc----cchhhhcCCCcceeecccccccccCCC-CC-----CCCCCCEEEccCCcCcc-
Q 037905 109 -----SLGNLIRLNLAKNNFSGT----ISADFNKLTRLGTLYLQENQLTGSIPD-LG-----AFSSLAQFNVSFNKLNG- 172 (606)
Q Consensus 109 -----~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~-----~l~~L~~L~l~~N~l~~- 172 (606)
..++|+.|+|++|.+++. ++..+..+++|++|++++|+++...+. +. ..++|+.|+|++|++++
T Consensus 306 ~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~ 385 (461)
T 1z7x_W 306 ETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385 (461)
T ss_dssp HHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred HHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChh
Confidence 236999999999999865 567788899999999999999865432 22 26799999999999996
Q ss_pred ---cCCccc---cCCCCCcccCCCCCCC
Q 037905 173 ---SIPKRF---ARLPSSAFEGNSLCGK 194 (606)
Q Consensus 173 ---~~p~~~---~~l~~l~~~~n~l~~~ 194 (606)
.+|..+ .++..|++.+|++.+.
T Consensus 386 ~~~~l~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 386 SCSSLAATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp HHHHHHHHHHHCCCCCEEECCSSSCCHH
T ss_pred hHHHHHHHHHhCCCccEEECCCCCCCHH
Confidence 666554 5566678899988653
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.33 E-value=8.1e-14 Score=149.40 Aligned_cols=155 Identities=17% Similarity=0.130 Sum_probs=115.2
Q ss_pred CeEEEEEcCCCCcccccCcccc-----CCCCCcEEEccCCCCccc----CcccccCCCCCCEEeccCCcccccC-----C
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIG-----NLTELHTVSLRFNALRGT----IPSDFAKLSNLRNLYLQGNLFSGEI-----P 104 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~-----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~-----p 104 (606)
++|++|+|++|.++...+..+. .+++|++|+|++|.+++. ++..+..+++|++|+|++|++++.. +
T Consensus 170 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~ 249 (461)
T 1z7x_W 170 PDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCP 249 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHH
T ss_pred CCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHH
Confidence 6899999999998765555443 367899999999999853 5777888899999999999887532 2
Q ss_pred ccccCCCCCcEEecCCCcCCcc----cchhhhcCCCcceeecccccccccCCC-C-----CCCCCCCEEEccCCcCccc-
Q 037905 105 GLLFSLGNLIRLNLAKNNFSGT----ISADFNKLTRLGTLYLQENQLTGSIPD-L-----GAFSSLAQFNVSFNKLNGS- 173 (606)
Q Consensus 105 ~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~-~-----~~l~~L~~L~l~~N~l~~~- 173 (606)
..+..+++|+.|+|++|+|+.. ++..+..+++|++|++++|.++...+. + ...++|+.|++++|.+++.
T Consensus 250 ~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~ 329 (461)
T 1z7x_W 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC 329 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG
T ss_pred HHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH
Confidence 3334688999999999998853 677788889999999999988754321 1 2336888889998888865
Q ss_pred ---CCccc---cCCCCCcccCCCCCC
Q 037905 174 ---IPKRF---ARLPSSAFEGNSLCG 193 (606)
Q Consensus 174 ---~p~~~---~~l~~l~~~~n~l~~ 193 (606)
++..+ .++..|++++|.+.+
T Consensus 330 ~~~l~~~l~~~~~L~~L~Ls~n~i~~ 355 (461)
T 1z7x_W 330 CSHFSSVLAQNRFLLELQISNNRLED 355 (461)
T ss_dssp HHHHHHHHHHCSSCCEEECCSSBCHH
T ss_pred HHHHHHHHhhCCCccEEEccCCcccc
Confidence 23333 456667788887654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.27 E-value=9.3e-12 Score=127.28 Aligned_cols=84 Identities=17% Similarity=0.160 Sum_probs=55.3
Q ss_pred CCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCC-EEEccCCcCcccCCccccCCCCC---
Q 037905 110 LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLA-QFNVSFNKLNGSIPKRFARLPSS--- 184 (606)
Q Consensus 110 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~l--- 184 (606)
+++|+.|+|++|+++.+.+..|.+|++|+.|+|.+| ++.+.+. |.++.+|+ .|++.+ .++...+.+|.++++|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 567777777777777555566777777777777776 6655554 77777777 777777 6665666677666553
Q ss_pred cccCCCCCCCC
Q 037905 185 AFEGNSLCGKP 195 (606)
Q Consensus 185 ~~~~n~l~~~p 195 (606)
.+.+|.+...+
T Consensus 303 ~l~~n~i~~I~ 313 (329)
T 3sb4_A 303 LATGDKITTLG 313 (329)
T ss_dssp EECSSCCCEEC
T ss_pred EeCCCccCccc
Confidence 44556655443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=126.65 Aligned_cols=145 Identities=15% Similarity=0.100 Sum_probs=120.2
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCccccc---------------------------------
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFA--------------------------------- 84 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--------------------------------- 84 (606)
.++|+.|+|++ .++.+-+.+|.++++|+.|+|++|.+....+.+|.
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 46899999999 88866677899999999999999876321111110
Q ss_pred ---------------------------------------------CCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 85 ---------------------------------------------KLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 85 ---------------------------------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
.+++|++|+|++|+++...+..|.++.+|+.|+|.
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~ 258 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP 258 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence 26799999999999996667789999999999999
Q ss_pred CCcCCcccchhhhcCCCcc-eeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCCCc
Q 037905 120 KNNFSGTISADFNKLTRLG-TLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPSSA 185 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~ 185 (606)
+| +..+.+.+|.+|++|+ .|++.+ +++.+.+. |.++++|+.|++++|.++...+.+|.++++|.
T Consensus 259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~ 324 (329)
T 3sb4_A 259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSK 324 (329)
T ss_dssp TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCC
T ss_pred cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchh
Confidence 98 8877778899999999 999999 78767665 99999999999999999988888998887764
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.22 E-value=4.1e-13 Score=139.52 Aligned_cols=155 Identities=18% Similarity=0.153 Sum_probs=110.4
Q ss_pred CeEEEEEcCCCCcccccCccccC-----CCCCcEEEccCCCCcccCcccc-cCCCCCCEEeccCCcccccCCccc-----
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGN-----LTELHTVSLRFNALRGTIPSDF-AKLSNLRNLYLQGNLFSGEIPGLL----- 107 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~----- 107 (606)
++|+.|+|++|.|+......|.. .++|++|+|++|.|+..-...+ ..+++|+.|+|++|+|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 57889999999987654444333 3789999999999874333333 345688999999999875444433
Q ss_pred cCCCCCcEEecCCCcCCc----ccchhhhcCCCcceeecccccccccC----C-CCCCCCCCCEEEccCCcCcccCC---
Q 037905 108 FSLGNLIRLNLAKNNFSG----TISADFNKLTRLGTLYLQENQLTGSI----P-DLGAFSSLAQFNVSFNKLNGSIP--- 175 (606)
Q Consensus 108 ~~l~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~----~-~~~~l~~L~~L~l~~N~l~~~~p--- 175 (606)
...++|+.|+|++|.|+. .++..+..+++|++|+|++|.|+... . .+...++|+.|+|++|.|+....
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 246789999999999864 24455677889999999999987532 1 25566789999999999885332
Q ss_pred -ccc---cCCCCCcccCCCCCC
Q 037905 176 -KRF---ARLPSSAFEGNSLCG 193 (606)
Q Consensus 176 -~~~---~~l~~l~~~~n~l~~ 193 (606)
..+ ..+..|++++|.+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHhCCCCCEEeccCCCCCH
Confidence 222 567778888888754
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=2.5e-12 Score=133.55 Aligned_cols=142 Identities=14% Similarity=0.163 Sum_probs=110.4
Q ss_pred CeEEEEEcCCCCcccccCcccc-CCCCCcEEEccCCCCcccCcccc-----cCCCCCCEEeccCCcccc----cCCcccc
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIG-NLTELHTVSLRFNALRGTIPSDF-----AKLSNLRNLYLQGNLFSG----EIPGLLF 108 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~ 108 (606)
.+|+.|+|++|.|+......+. .+++|+.|+|++|+|+..-...+ ...++|++|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 5899999999999765444443 46789999999999985434444 356899999999999974 2445567
Q ss_pred CCCCCcEEecCCCcCCcc----cchhhhcCCCcceeecccccccccCC-----CCCCCCCCCEEEccCCcCcccCCcccc
Q 037905 109 SLGNLIRLNLAKNNFSGT----ISADFNKLTRLGTLYLQENQLTGSIP-----DLGAFSSLAQFNVSFNKLNGSIPKRFA 179 (606)
Q Consensus 109 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~l~~L~~L~l~~N~l~~~~p~~~~ 179 (606)
.+++|++|+|++|+|... ++..+..+++|++|+|++|.|+.... .+...++|+.|+|++|.|+......+.
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~ 260 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR 260 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence 889999999999999743 35667788999999999999975322 244568999999999999866555554
Q ss_pred C
Q 037905 180 R 180 (606)
Q Consensus 180 ~ 180 (606)
.
T Consensus 261 ~ 261 (372)
T 3un9_A 261 D 261 (372)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=1.7e-10 Score=113.78 Aligned_cols=134 Identities=13% Similarity=0.035 Sum_probs=103.5
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCc-cCHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVT-VSEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
..++.|+++.||++... +..+++|+..... .....+.+|+++++.+. +..+.++++++...+..++||||++|.+|.
T Consensus 20 ~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 98 (263)
T 3tm0_A 20 KDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCS 98 (263)
T ss_dssp ECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHH
T ss_pred eeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehh
Confidence 45677888999999865 6889999986532 22345888888888774 677888999998888899999999999998
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG------------------------------------------- 437 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------------------- 437 (606)
+.+.. ......++.+++++|+.||+..
T Consensus 99 ~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (263)
T 3tm0_A 99 EEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPR 168 (263)
T ss_dssp HHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHH
T ss_pred hccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHH
Confidence 76421 1123468889999999999810
Q ss_pred --------------CCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 438 --------------PANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 438 --------------~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
..++|+|++|.||+++++..+.|+||+.+.
T Consensus 169 ~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 169 ELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 346799999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.00 E-value=5e-10 Score=109.92 Aligned_cols=127 Identities=13% Similarity=0.071 Sum_probs=94.5
Q ss_pred ccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCC--cccceEEEEeCCceEEEEeecCCCChhhhh
Q 037905 326 GKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHEN--LVPLRAYYYSRDEKLLVHDYMPMGSLSALL 403 (606)
Q Consensus 326 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l 403 (606)
+.|..+.||++...+|..+++|+.... ....+..|+.+++.+.+.+ +.+++++....+..++||||++|.+|. .
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~ 104 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S 104 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c
Confidence 355669999998777888999987654 2345778888887775444 455888887777889999999998884 2
Q ss_pred hcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 037905 404 HGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG---------------------------------------------- 437 (606)
Q Consensus 404 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---------------------------------------------- 437 (606)
.. .. ...++.++++.|+.||+..
T Consensus 105 ~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 105 SH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp SC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred Cc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 11 11 1256777888888888643
Q ss_pred ----------CCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 438 ----------PANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 438 ----------~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
..++|+|++|.||++++++.+.|+||+.+.
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 127799999999999887667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.96 E-value=1.2e-09 Score=112.88 Aligned_cols=138 Identities=14% Similarity=0.200 Sum_probs=102.8
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEec--cCc--cCHHHHHHHHHHHcCCC--CCCcccceEEEEeC---CceEEEEee
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLK--DVT--VSEKEFREKMEVVGSMD--HENLVPLRAYYYSR---DEKLLVHDY 393 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~--~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e~ 393 (606)
+.|+.|.++.||+.+.. +..+++|+.. ... .+...+.+|+.+++.+. +..+.+++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 45889999999999876 4577888776 332 23456888998888876 45577888888665 347999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK------------------------------------- 436 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------- 436 (606)
++|..+.+.. ...++...+..++.++++.|+.||+.
T Consensus 123 v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 123 VSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred cCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9997775421 12367888889999999999999973
Q ss_pred -------------------CCCCCCCCCCCCCEEecCCCc--EEEeecccCcc
Q 037905 437 -------------------GPANSHGNIKSSNILLSKSYE--ARISDFGLAHL 468 (606)
Q Consensus 437 -------------------~~~i~HrDlkp~Nill~~~~~--~kl~DfG~a~~ 468 (606)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 145789999999999997753 68999998864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.89 E-value=1.3e-10 Score=128.54 Aligned_cols=156 Identities=12% Similarity=0.082 Sum_probs=114.7
Q ss_pred CeEEEEEcC-----------CCCcccccCcc-ccCCCCCcEEEccCCCCcccCcccccC-CCCCCEEecc----CCcccc
Q 037905 39 ERVTMLRFP-----------GMGLSGQLPIA-IGNLTELHTVSLRFNALRGTIPSDFAK-LSNLRNLYLQ----GNLFSG 101 (606)
Q Consensus 39 ~~l~~L~L~-----------~n~l~~~~p~~-l~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~ 101 (606)
++|++|+|+ .|.+++..... +..+++|++|+|+.|.+++..+..+.. +++|+.|+|+ .|.+++
T Consensus 342 ~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~ 421 (592)
T 3ogk_B 342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD 421 (592)
T ss_dssp TTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSS
T ss_pred CCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccC
Confidence 679999999 36676543223 456899999999999998777777765 8899999996 778885
Q ss_pred c-----CCccccCCCCCcEEecCCC--cCCcccchhhhc-CCCcceeecccccccc-cCCC-CCCCCCCCEEEccCCcCc
Q 037905 102 E-----IPGLLFSLGNLIRLNLAKN--NFSGTISADFNK-LTRLGTLYLQENQLTG-SIPD-LGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 102 ~-----~p~~~~~l~~L~~L~l~~N--~l~~~~p~~~~~-l~~L~~L~l~~N~l~~-~~~~-~~~l~~L~~L~l~~N~l~ 171 (606)
. ++..+.++++|+.|+|++| .+++..+..+.. +++|++|++++|++++ .++. +..+++|+.|+|++|+++
T Consensus 422 ~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~ 501 (592)
T 3ogk_B 422 LPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS 501 (592)
T ss_dssp CCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred chHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence 3 3344667899999999753 366555555544 8889999999999875 2233 567889999999999987
Q ss_pred ccCCc----cccCCCCCcccCCCCCCC
Q 037905 172 GSIPK----RFARLPSSAFEGNSLCGK 194 (606)
Q Consensus 172 ~~~p~----~~~~l~~l~~~~n~l~~~ 194 (606)
+.... .+.+|..|++.+|+++..
T Consensus 502 ~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 502 ERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 54332 345677788888887654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.86 E-value=2.9e-10 Score=125.69 Aligned_cols=152 Identities=11% Similarity=0.078 Sum_probs=112.5
Q ss_pred eEEEEEcCCCC-ccc-ccCccccCCCCCcEEEccCCCCccc----CcccccCCCCCCEEeccCCccc----ccCCccccC
Q 037905 40 RVTMLRFPGMG-LSG-QLPIAIGNLTELHTVSLRFNALRGT----IPSDFAKLSNLRNLYLQGNLFS----GEIPGLLFS 109 (606)
Q Consensus 40 ~l~~L~L~~n~-l~~-~~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~ 109 (606)
+|++|+|++|. ++. .++..+.++++|++|+|++|.+++. ++..+..+++|++|+|++|.++ +.++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 49999999986 221 1223345789999999999998755 4445678899999999999997 344555678
Q ss_pred CCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccc----cCCCCCCCCCCCEEEccCCcCcccCCcc---ccCCC
Q 037905 110 LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTG----SIPDLGAFSSLAQFNVSFNKLNGSIPKR---FARLP 182 (606)
Q Consensus 110 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~---~~~l~ 182 (606)
+++|+.|+|++|.+. .+|..+..+++|++|+++.+.... ....+..+++|+.|+++++... .+|.. +.++.
T Consensus 219 ~~~L~~L~L~~~~~~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~ 296 (592)
T 3ogk_B 219 CRSLVSVKVGDFEIL-ELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIR 296 (592)
T ss_dssp CTTCCEEECSSCBGG-GGHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCC
T ss_pred CCCCcEEeccCccHH-HHHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCc
Confidence 899999999999998 477889999999999998643321 1123677888999998886443 44543 34666
Q ss_pred CCcccCCCCCC
Q 037905 183 SSAFEGNSLCG 193 (606)
Q Consensus 183 ~l~~~~n~l~~ 193 (606)
.|++.+|.+.+
T Consensus 297 ~L~Ls~~~l~~ 307 (592)
T 3ogk_B 297 KLDLLYALLET 307 (592)
T ss_dssp EEEETTCCCCH
T ss_pred EEecCCCcCCH
Confidence 77788877644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.81 E-value=1.3e-09 Score=109.94 Aligned_cols=180 Identities=19% Similarity=0.200 Sum_probs=118.3
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCC-CCC--cccceEEEEeCC---ceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HEN--LVPLRAYYYSRD---EKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~~~ 396 (606)
+.++.|.+..||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++.+..... ..|+||++++|
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G 100 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG 100 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence 458899999999863 45788876532 23466888999887763 332 233444332222 34889999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG--------------------------------------- 437 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--------------------------------------- 437 (606)
.+|...... .++...+..++.++++.++.||+..
T Consensus 101 ~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 101 VPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred eECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 888754321 3667777888888888888888611
Q ss_pred -----------------CCCCCCCCCCCCEEecC--CCcEEEeecccCccCCCCCCC----C----Ccc--------cc-
Q 037905 438 -----------------PANSHGNIKSSNILLSK--SYEARISDFGLAHLASPSSTP----N----RID--------GY- 481 (606)
Q Consensus 438 -----------------~~i~HrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~~~~----~----~~~--------~y- 481 (606)
..++|+|++|.||++++ ...+.|+||+.+....+.... . ... +|
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 24679999999999998 456889999988654321100 0 000 02
Q ss_pred -cC-ccccCCCCCCCcchhHHHHHHHHHHHhCCCCcc
Q 037905 482 -RA-PEVTDARKVSQKADVYSFGVLLLELLTGKAPTQ 516 (606)
Q Consensus 482 -~a-PE~~~~~~~~~~sDv~slGvvl~elltg~~p~~ 516 (606)
.. |+.... .....+.|+++.++|.+.+|..+|-
T Consensus 254 ~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 254 HKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 11 222111 1123689999999999999988774
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.70 E-value=3.8e-09 Score=103.46 Aligned_cols=117 Identities=20% Similarity=0.299 Sum_probs=72.5
Q ss_pred EcCCCCcccccCc-cccCCCCCcE--EEccCCCCcccCcc----cccCCCCCCEEeccCCcccc--cCCccccCCCCCcE
Q 037905 45 RFPGMGLSGQLPI-AIGNLTELHT--VSLRFNALRGTIPS----DFAKLSNLRNLYLQGNLFSG--EIPGLLFSLGNLIR 115 (606)
Q Consensus 45 ~L~~n~l~~~~p~-~l~~l~~L~~--L~L~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~ 115 (606)
....|..++.++- .|...+.|.. ++++.|+.. .++. ...++++|+.|+|++|+|++ .+|..+..+++|+.
T Consensus 122 ~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~ 200 (267)
T 3rw6_A 122 SKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKI 200 (267)
T ss_dssp HHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCE
T ss_pred HhccchhccccCHHHcCCCcchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCE
Confidence 3344444443332 2455555655 667777544 2332 22457788888888888875 34456667788888
Q ss_pred EecCCCcCCcccchhhhcCC--CcceeecccccccccCCC--------CCCCCCCCEEE
Q 037905 116 LNLAKNNFSGTISADFNKLT--RLGTLYLQENQLTGSIPD--------LGAFSSLAQFN 164 (606)
Q Consensus 116 L~l~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~~~--------~~~l~~L~~L~ 164 (606)
|+|++|+|++. ..+..+. +|++|+|++|++.+..|+ +..+++|+.||
T Consensus 201 L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 201 LNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp EECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 88888888744 2344444 788888888888765542 44577777765
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.69 E-value=4.6e-08 Score=102.36 Aligned_cols=149 Identities=13% Similarity=0.113 Sum_probs=116.7
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
.+|+.+.|..+ ++.+-..+|.++++|+.|+|..| ++..-..+|.+ .+|+.+.|. |.++..-+..|.++++|+.+++
T Consensus 203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECTTTTTTCTTCCEEEE
T ss_pred cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEEChhHhhCCCCCCEEEe
Confidence 57899999855 77666778999999999999986 56455677777 789999994 5577566788999999999999
Q ss_pred CCCcCC-----cccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCC--CCCcccCCC
Q 037905 119 AKNNFS-----GTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARL--PSSAFEGNS 190 (606)
Q Consensus 119 ~~N~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l--~~l~~~~n~ 190 (606)
.+|.+. ...+..|.+|++|+.++|. |.++.+... |.++.+|+.+.|.+| ++...+.+|.++ ..+.+.+|.
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTT 356 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSS
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCC
Confidence 988775 4667789999999999999 457766654 889999999999665 765666777655 445677776
Q ss_pred CCC
Q 037905 191 LCG 193 (606)
Q Consensus 191 l~~ 193 (606)
+..
T Consensus 357 ~~~ 359 (401)
T 4fdw_A 357 PPQ 359 (401)
T ss_dssp CCB
T ss_pred Ccc
Confidence 544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.68 E-value=5.1e-08 Score=102.03 Aligned_cols=139 Identities=16% Similarity=0.138 Sum_probs=101.4
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
+|+.++|.+ .++.+-+.+|.++++|+.++|++|+++......|. +.+|+.+.|.+| ++..-...|.++++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 588888886 67766677899999999999999999843344454 688999999855 775667788888899999988
Q ss_pred CCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCc-----ccCCccccCCCCC
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLN-----GSIPKRFARLPSS 184 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~l 184 (606)
+| ++..-..+|.+ .+|+.+.+ .|.++.+... |.++++|+.+++.+|.+. ...+.+|..+++|
T Consensus 235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L 302 (401)
T 4fdw_A 235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKL 302 (401)
T ss_dssp TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTC
T ss_pred CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccC
Confidence 75 55455566766 67888888 4556655553 777888888888777665 3445566655544
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.67 E-value=2e-09 Score=105.40 Aligned_cols=160 Identities=18% Similarity=0.191 Sum_probs=103.8
Q ss_pred CCCcceeEEecCC--eEEEEEcCC---CCcccccC-ccccCCCCCcEEEccCCCCcccCc-ccccCCCCCCE--EeccCC
Q 037905 27 GPCKWVGVFCTGE--RVTMLRFPG---MGLSGQLP-IAIGNLTELHTVSLRFNALRGTIP-SDFAKLSNLRN--LYLQGN 97 (606)
Q Consensus 27 ~~c~~~~~~c~~~--~l~~L~L~~---n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~--L~Ls~N 97 (606)
..|.|.|+.|... .+..+-..+ ..+.+.++ +.+..++. .|...+|..++.++ +.|...+.|.. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 5788999999754 555554433 22333332 23333332 23334444443333 22555555655 788888
Q ss_pred cccccCCc----cccCCCCCcEEecCCCcCCc--ccchhhhcCCCcceeecccccccccCCCCCCCC--CCCEEEccCCc
Q 037905 98 LFSGEIPG----LLFSLGNLIRLNLAKNNFSG--TISADFNKLTRLGTLYLQENQLTGSIPDLGAFS--SLAQFNVSFNK 169 (606)
Q Consensus 98 ~l~~~~p~----~~~~l~~L~~L~l~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~--~L~~L~l~~N~ 169 (606)
+.. .++. ...++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. .++..+. +|+.|+|++|+
T Consensus 154 ~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~~l~~l~~l~L~~L~L~~Np 231 (267)
T 3rw6_A 154 RRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-RELDKIKGLKLEELWLDGNS 231 (267)
T ss_dssp SHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-GGGGGGTTSCCSEEECTTST
T ss_pred HHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-hhhhhcccCCcceEEccCCc
Confidence 654 4443 23568999999999999997 4557788999999999999999976 3333333 99999999999
Q ss_pred CcccCCc-------cccCCCCCcc-cCCC
Q 037905 170 LNGSIPK-------RFARLPSSAF-EGNS 190 (606)
Q Consensus 170 l~~~~p~-------~~~~l~~l~~-~~n~ 190 (606)
+++.+|. .+..+|+|.. +|..
T Consensus 232 l~~~~~~~~~y~~~il~~~P~L~~LDg~~ 260 (267)
T 3rw6_A 232 LCDTFRDQSTYISAIRERFPKLLRLDGHE 260 (267)
T ss_dssp TGGGCSSHHHHHHHHHHHCTTCCEESSCB
T ss_pred CccccCcchhHHHHHHHHCcccCeECCcC
Confidence 9987763 3567777653 4433
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.66 E-value=7.6e-10 Score=122.30 Aligned_cols=152 Identities=13% Similarity=0.141 Sum_probs=99.6
Q ss_pred CeEEEEEc---------CCCCcccccCcccc-CCCCCcEEEccCCCCcccCccccc-CCCCCCEEecc--C----Ccccc
Q 037905 39 ERVTMLRF---------PGMGLSGQLPIAIG-NLTELHTVSLRFNALRGTIPSDFA-KLSNLRNLYLQ--G----NLFSG 101 (606)
Q Consensus 39 ~~l~~L~L---------~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~ 101 (606)
++|+.|+| +.+.+++.....+. .+++|+.|+++.|.+++..+..+. .+++|+.|+|+ + |.++.
T Consensus 338 ~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~ 417 (594)
T 2p1m_B 338 KDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL 417 (594)
T ss_dssp TTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTC
T ss_pred CCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccC
Confidence 67888888 33455544333343 478888888888888765555554 57888888888 4 55652
Q ss_pred c-----CCccccCCCCCcEEecCCCcCCcccchhhhc-CCCcceeecccccccccCC-CC-CCCCCCCEEEccCCcCccc
Q 037905 102 E-----IPGLLFSLGNLIRLNLAKNNFSGTISADFNK-LTRLGTLYLQENQLTGSIP-DL-GAFSSLAQFNVSFNKLNGS 173 (606)
Q Consensus 102 ~-----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~~-~~-~~l~~L~~L~l~~N~l~~~ 173 (606)
. ++..+..+++|+.|+|++ +++...+..+.. +++|+.|+|++|.+++... .+ ..+++|+.|+|++|++++.
T Consensus 418 ~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 418 EPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp CCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred CchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 1 112255677888888876 666555555554 7888888888888764332 22 4577888888888888644
Q ss_pred CCc----cccCCCCCcccCCCC
Q 037905 174 IPK----RFARLPSSAFEGNSL 191 (606)
Q Consensus 174 ~p~----~~~~l~~l~~~~n~l 191 (606)
.+. .+.+|..|++.+|++
T Consensus 497 ~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 497 ALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHHHHhCCCCCEEeeeCCCC
Confidence 332 345666677777766
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.66 E-value=4.2e-09 Score=116.33 Aligned_cols=130 Identities=15% Similarity=0.117 Sum_probs=82.9
Q ss_pred CeEEEEEcCCCCcccccCcccc-CCCCCcEEEccCC-CCccc-CcccccCCCCCCEEeccCCcccccCCcccc----CCC
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIG-NLTELHTVSLRFN-ALRGT-IPSDFAKLSNLRNLYLQGNLFSGEIPGLLF----SLG 111 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l~ 111 (606)
++|++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 5788888888887766666665 5788888888887 55422 444455778888888888887754443333 566
Q ss_pred CCcEEecCCCc--CCc-ccchhhhcCCCcceeecccc-cccccCCCCCCCCCCCEEEccCC
Q 037905 112 NLIRLNLAKNN--FSG-TISADFNKLTRLGTLYLQEN-QLTGSIPDLGAFSSLAQFNVSFN 168 (606)
Q Consensus 112 ~L~~L~l~~N~--l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~~~~~~~l~~L~~L~l~~N 168 (606)
+|+.|+|++|. +.. .++..+.++++|++|++++| .+.+.+..+..+++|+.|+++.+
T Consensus 185 ~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~ 245 (594)
T 2p1m_B 185 SLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGY 245 (594)
T ss_dssp CCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBC
T ss_pred cCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccc
Confidence 88888888876 221 12222345688888888877 44442222455666666664433
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.66 E-value=7.1e-09 Score=96.38 Aligned_cols=113 Identities=19% Similarity=0.226 Sum_probs=49.5
Q ss_pred ccCCCCCcEEEccCC-CCcc----cCcccccCCCCCCEEeccCCccccc----CCccccCCCCCcEEecCCCcCCcc---
Q 037905 59 IGNLTELHTVSLRFN-ALRG----TIPSDFAKLSNLRNLYLQGNLFSGE----IPGLLFSLGNLIRLNLAKNNFSGT--- 126 (606)
Q Consensus 59 l~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~--- 126 (606)
+...++|++|+|++| .|.. .+...+...++|++|+|++|+|... +...+...++|++|+|++|+|...
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 344444555555554 4431 1223333444455555555554421 122233334455555555555421
Q ss_pred -cchhhhcCCCcceeec--ccccccccC-----CCCCCCCCCCEEEccCCcCc
Q 037905 127 -ISADFNKLTRLGTLYL--QENQLTGSI-----PDLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 127 -~p~~~~~l~~L~~L~l--~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~ 171 (606)
+...+...++|++|+| ++|.|...- ..+...++|+.|+|++|.+.
T Consensus 112 ~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2333444455555555 445554311 01223345556666655554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.60 E-value=7.5e-09 Score=96.21 Aligned_cols=112 Identities=16% Similarity=0.155 Sum_probs=88.7
Q ss_pred cCCeEEEEEcCCC-Ccccc----cCccccCCCCCcEEEccCCCCcc----cCcccccCCCCCCEEeccCCccccc----C
Q 037905 37 TGERVTMLRFPGM-GLSGQ----LPIAIGNLTELHTVSLRFNALRG----TIPSDFAKLSNLRNLYLQGNLFSGE----I 103 (606)
Q Consensus 37 ~~~~l~~L~L~~n-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~ 103 (606)
..++|++|+|++| .|... +...+...++|++|+|++|.|.. .+...+...++|++|+|++|.|... +
T Consensus 34 ~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l 113 (185)
T 1io0_A 34 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 113 (185)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHH
Confidence 3468999999999 88643 44567788999999999999973 2345566678999999999999843 4
Q ss_pred CccccCCCCCcEEec--CCCcCCcc----cchhhhcCCCcceeeccccccc
Q 037905 104 PGLLFSLGNLIRLNL--AKNNFSGT----ISADFNKLTRLGTLYLQENQLT 148 (606)
Q Consensus 104 p~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 148 (606)
...+...++|+.|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 114 ~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 114 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 556777889999999 88999743 3445667799999999999985
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.49 E-value=5e-08 Score=100.41 Aligned_cols=151 Identities=15% Similarity=0.175 Sum_probs=98.4
Q ss_pred CeEEEEEcCCCCcc---------cccCccccCCCCCcEEEccCCC-CcccCcccccCCCCCCEEeccCCcccccCCcccc
Q 037905 39 ERVTMLRFPGMGLS---------GQLPIAIGNLTELHTVSLRFNA-LRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLF 108 (606)
Q Consensus 39 ~~l~~L~L~~n~l~---------~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 108 (606)
++|+.|.+.++... +.++..+..+++|+.|+|++|. +. ++. +. +++|+.|+|..|.+.......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~ 214 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSVVEDIL 214 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHHHHHHH
Confidence 57888888765431 1234456778899999998873 32 333 43 78899999998888744434444
Q ss_pred --CCCCCcEEecCC--CcCCcc-----cchhh--hcCCCcceeecccccccccCCC----CCCCCCCCEEEccCCcCccc
Q 037905 109 --SLGNLIRLNLAK--NNFSGT-----ISADF--NKLTRLGTLYLQENQLTGSIPD----LGAFSSLAQFNVSFNKLNGS 173 (606)
Q Consensus 109 --~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~L~l~~N~l~~~~~~----~~~l~~L~~L~l~~N~l~~~ 173 (606)
.+++|+.|+|+. |...+. +...+ ..+++|++|+|++|.+...... ...+++|+.|+|+.|.|.+.
T Consensus 215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~ 294 (362)
T 2ra8_A 215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDE 294 (362)
T ss_dssp HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHH
T ss_pred HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChH
Confidence 688999998853 222111 11122 2478999999999888743221 23578899999999998863
Q ss_pred C----C---ccccCCCCCcccCCCCCC
Q 037905 174 I----P---KRFARLPSSAFEGNSLCG 193 (606)
Q Consensus 174 ~----p---~~~~~l~~l~~~~n~l~~ 193 (606)
- + ..+.+|..|++.+|.+..
T Consensus 295 G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 295 GARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp HHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred HHHHHHhhcccCCcceEEECCCCcCCH
Confidence 2 2 234567777787776643
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.43 E-value=9.8e-08 Score=98.22 Aligned_cols=82 Identities=17% Similarity=0.192 Sum_probs=38.0
Q ss_pred cccCCCCCcEEEccCCCCc---------ccCcccccCCCCCCEEeccCCc-ccccCCccccCCCCCcEEecCCCcCCccc
Q 037905 58 AIGNLTELHTVSLRFNALR---------GTIPSDFAKLSNLRNLYLQGNL-FSGEIPGLLFSLGNLIRLNLAKNNFSGTI 127 (606)
Q Consensus 58 ~l~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 127 (606)
++..+++|+.|.+..+... +.++..+..+++|+.|+|++|. ++ ++. + .+++|+.|+|..|.+....
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~-~~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-K-PRPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-C-BCTTCSEEEEECSBCCHHH
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-c-cCCCCcEEEEecCCCChHH
Confidence 3445555555555443221 1123334455556666665552 21 222 2 2555666666555554322
Q ss_pred chhhh--cCCCcceeecc
Q 037905 128 SADFN--KLTRLGTLYLQ 143 (606)
Q Consensus 128 p~~~~--~l~~L~~L~l~ 143 (606)
...+. .+++|+.|+|+
T Consensus 210 l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp HHHHHHSBCTTCCEEEEE
T ss_pred HHHHHHccCCCCcEEEEe
Confidence 22332 45556665553
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=2.2e-06 Score=86.17 Aligned_cols=134 Identities=18% Similarity=0.118 Sum_probs=91.0
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCC---CcccceEEEE-eCCceEEEEeecCCCC
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHE---NLVPLRAYYY-SRDEKLLVHDYMPMGS 398 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~g~ 398 (606)
+.++.|....||+. |..+++|+... ......+..|+++++.+.+. .+.+.+.++. ..+..++||||++|..
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45788888999988 55677887532 22346788999999888653 2455666664 3455789999999988
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK------------------------------------------ 436 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------ 436 (606)
+...... .++......++.++++.|+.||+.
T Consensus 100 l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 100 LGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred Cchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 8763221 134444555555555555555542
Q ss_pred ----------------CCCCCCCCCCCCCEEecC---CCc-EEEeecccCcc
Q 037905 437 ----------------GPANSHGNIKSSNILLSK---SYE-ARISDFGLAHL 468 (606)
Q Consensus 437 ----------------~~~i~HrDlkp~Nill~~---~~~-~kl~DfG~a~~ 468 (606)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 124579999999999987 455 48999997753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.21 E-value=4.1e-06 Score=82.40 Aligned_cols=133 Identities=15% Similarity=0.183 Sum_probs=92.1
Q ss_pred ccccCCce-EEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 324 VLGKGTFG-TAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 324 ~ig~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+..|..| .||+.... ++..+++|+-... ...++..|...++.+. +--+.++++++.+.+..++|||+++|.++.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 35556665 68988754 4567888986543 3456788888877663 333667888888888999999999998877
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-------------------------------------------- 436 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-------------------------------------------- 436 (606)
+...... .....+..+++..|+.||..
T Consensus 109 ~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 109 QVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 6543211 12233455555555555531
Q ss_pred ------------CCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 437 ------------GPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 437 ------------~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
..+++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1236799999999999988777899998775
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=4.1e-06 Score=86.06 Aligned_cols=79 Identities=10% Similarity=0.077 Sum_probs=53.5
Q ss_pred ccc-ccCCceEEEEEEEc-------CCcEEEEEEeccCc---c-CHHHHHHHHHHHcCCCC---CCcccceEEEEeC---
Q 037905 323 EVL-GKGTFGTAYKATLE-------MGIVVAVKRLKDVT---V-SEKEFREKMEVVGSMDH---ENLVPLRAYYYSR--- 384 (606)
Q Consensus 323 ~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~-~~~~~~~e~~~l~~l~h---~niv~l~~~~~~~--- 384 (606)
+.| +.|....+|+.... ++..+++|+..... . ....+..|+.+++.+.. -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 88889999998754 26778889865432 1 22456777777776632 3466677776544
Q ss_pred CceEEEEeecCCCChhh
Q 037905 385 DEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 385 ~~~~lv~e~~~~g~L~~ 401 (606)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999876653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=3.8e-05 Score=78.06 Aligned_cols=140 Identities=19% Similarity=0.261 Sum_probs=78.6
Q ss_pred ccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCC-----CCCCcccce-E--EEEeCCceEEEEeecC
Q 037905 324 VLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-----DHENLVPLR-A--YYYSRDEKLLVHDYMP 395 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~e~~~ 395 (606)
.|+.|..+.||+....+|. +++|+... ....+..|+.+++.+ ..|.++... | +....+..++||+|++
T Consensus 39 ~l~gG~~n~~~~v~~~~~~-~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~ 114 (346)
T 2q83_A 39 VIQGNQMALVWKVHTDSGA-VCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE 114 (346)
T ss_dssp ECC----CEEEEEEETTEE-EEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred eccccccCcEEEEEeCCCC-EEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence 4666778999999877554 88998875 233444444444433 334444321 1 1234567789999999
Q ss_pred CCChh--------------hhhhcC-CCCC-C-------CCCCHHHH-------------------------------HH
Q 037905 396 MGSLS--------------ALLHGN-RGAG-R-------TPLNWETR-------------------------------SG 421 (606)
Q Consensus 396 ~g~L~--------------~~l~~~-~~~~-~-------~~l~~~~~-------------------------------~~ 421 (606)
|..+. ..++.. .+.. . ..-.|... ..
T Consensus 115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (346)
T 2q83_A 115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG 194 (346)
T ss_dssp CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence 86542 111111 0000 0 01123211 01
Q ss_pred HHHHHHHHHHHHHh-----------cCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 422 LALGASRAIAYLHS-----------KGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 422 i~~~ia~~L~~LH~-----------~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
+...+..++++|+. ....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11223446667763 24567799999999999888899999998764
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.84 E-value=4.6e-05 Score=79.35 Aligned_cols=114 Identities=10% Similarity=0.118 Sum_probs=82.5
Q ss_pred ccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhc
Q 037905 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNK 133 (606)
Q Consensus 54 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 133 (606)
.-..+|.++.+|+.+.+.++..+ .-..+|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++.+-..+|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 33456778888888888776655 556778888888888886 4555455667888888888888754 66555667888
Q ss_pred CCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCc
Q 037905 134 LTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 134 l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~ 171 (606)
|.+|+.+.+..+ ++.+... |.++.+|+.+++.+|...
T Consensus 333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 888888888654 5544443 788888888888877543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.80 E-value=8.6e-05 Score=76.76 Aligned_cols=125 Identities=11% Similarity=0.060 Sum_probs=71.0
Q ss_pred ccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhc
Q 037905 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNK 133 (606)
Q Consensus 54 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 133 (606)
.....+....+|+.+.+..+ ++..-...|.++..|+.+.+..+ ++..-...|.++.+|+.+.+..+ +.......|.+
T Consensus 208 i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~ 284 (379)
T 4h09_A 208 VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSG 284 (379)
T ss_dssp ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTT
T ss_pred Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccc
Confidence 33445566666666666554 23244555666666666666655 44344455666666666666543 44344445666
Q ss_pred CCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCC
Q 037905 134 LTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLP 182 (606)
Q Consensus 134 l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 182 (606)
+.+|+.+.+.+|.++.+... |.++.+|+.+.|.++ ++..-..+|.++.
T Consensus 285 c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 333 (379)
T 4h09_A 285 CSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCK 333 (379)
T ss_dssp CTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCT
T ss_pred ccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCC
Confidence 66666666666666644443 666666666666544 4434445554443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.80 E-value=5.4e-05 Score=78.80 Aligned_cols=127 Identities=13% Similarity=0.155 Sum_probs=93.1
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
..|+.+.+.++..+ +...+|.++++|+.+.+. +.++..-..+|.++.+|+.++|.+| ++..-...|.++.+|+.+.|
T Consensus 265 ~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 265 AYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 46777888766543 666789999999999996 5566455678999999999999876 66466778999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCc
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~ 171 (606)
..+ ++..-..+|.+|++|+.+++.+|.... ..+..+.+|+.+.+..|.+.
T Consensus 342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp CTT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC-----------
T ss_pred Ccc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCCCEE
Confidence 755 775667789999999999999987642 34667788998888777653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=7.4e-05 Score=77.82 Aligned_cols=73 Identities=10% Similarity=0.091 Sum_probs=46.9
Q ss_pred cccccCCceEEEEEEEc-CCcEEEEEEeccCc--------cCHHHHHHHHHHHcCCCC--CCcc-cceEEEEeCCceEEE
Q 037905 323 EVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT--------VSEKEFREKMEVVGSMDH--ENLV-PLRAYYYSRDEKLLV 390 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~lv 390 (606)
+.||.|.++.||+++.. ++..++||...... .....+..|.++++.+.. +..+ +++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 46899999999999753 46789999764321 123446678877776532 3333 44433 45567899
Q ss_pred EeecCCC
Q 037905 391 HDYMPMG 397 (606)
Q Consensus 391 ~e~~~~g 397 (606)
|||+++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00011 Score=76.56 Aligned_cols=137 Identities=17% Similarity=0.151 Sum_probs=76.7
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
..|+.+.+..+ ++.....+|..+.+|+.+.+..|... .....|..+..|+.+.+..+.+. ...|..+.+|+.+.+
T Consensus 230 ~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l 304 (394)
T 4fs7_A 230 TGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKL 304 (394)
T ss_dssp CCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEE
T ss_pred CCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccccccccc
Confidence 35666666544 33344456777777887777776554 44556666666666666554432 234555666666666
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 183 (606)
.+| +..+-..+|.++.+|+.++|.++ ++.+... |.++.+|+.+.+..| ++..-..+|.++.+
T Consensus 305 ~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~ 367 (394)
T 4fs7_A 305 LDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCIN 367 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTT
T ss_pred ccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCC
Confidence 543 44344445666666666666433 4433332 556666666666555 44444455554443
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.72 E-value=1.8e-05 Score=71.76 Aligned_cols=82 Identities=10% Similarity=0.006 Sum_probs=41.1
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCC-CcccCcccccCC----CCCCEEeccCCc-ccccCCccccCCCCC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNA-LRGTIPSDFAKL----SNLRNLYLQGNL-FSGEIPGLLFSLGNL 113 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~L 113 (606)
.|+.|||+++.|+..--..+..+++|++|+|+++. |+..--..+..+ ++|++|+|+++. ++..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 46666666666654433445566666666666653 442222233332 245555555543 443222234455555
Q ss_pred cEEecCCC
Q 037905 114 IRLNLAKN 121 (606)
Q Consensus 114 ~~L~l~~N 121 (606)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.62 E-value=2e-05 Score=71.47 Aligned_cols=93 Identities=10% Similarity=0.110 Sum_probs=71.0
Q ss_pred ccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCc-ccccCCccccCC----CCCcEEecCCCc-CCccc
Q 037905 54 QLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNL-FSGEIPGLLFSL----GNLIRLNLAKNN-FSGTI 127 (606)
Q Consensus 54 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~ 127 (606)
.+|.....--+|++|||+++.|+..--..+.++++|+.|+|+++. ++..--..+..+ ++|+.|+|+++. |+..-
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 445544444579999999999985444567899999999999995 775444456664 379999999974 87544
Q ss_pred chhhhcCCCcceeeccccc
Q 037905 128 SADFNKLTRLGTLYLQENQ 146 (606)
Q Consensus 128 p~~~~~l~~L~~L~l~~N~ 146 (606)
-..+..+++|++|+|++..
T Consensus 132 l~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HHHGGGCTTCCEEEEESCT
T ss_pred HHHHhcCCCCCEEECCCCC
Confidence 4467889999999999975
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00045 Score=71.76 Aligned_cols=122 Identities=13% Similarity=0.038 Sum_probs=62.5
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
.++.+.+..+..+ .....|..+..|+.+.+..+.+. ...|..+.+|+.+.+.+| ++..-...|.++.+|+.++|.
T Consensus 254 ~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp 328 (394)
T 4fs7_A 254 DLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLP 328 (394)
T ss_dssp SCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCC
T ss_pred cceeEEcCCCcce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeC
Confidence 4555555554332 44445555556665555544322 234555556666665544 442334455555666666664
Q ss_pred CCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCC
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFN 168 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N 168 (606)
++ ++..-..+|.+|.+|+.+.+..| ++.+... |.++.+|+.+++..|
T Consensus 329 ~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 329 YL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp TT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred Cc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 33 44344445556666666665544 4433332 555566666655433
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00066 Score=70.00 Aligned_cols=137 Identities=10% Similarity=0.039 Sum_probs=89.4
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
+|+.+.+..+ ++.....+|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ +...-...|.++.+|+.+.+.
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~ 294 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMD 294 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEEC
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccc
Confidence 4555555444 44344556777788888888765 55345667777888888888654 553555667778888888888
Q ss_pred CCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCC
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARL 181 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l 181 (606)
+|.++.+.+..|.+|.+|+.+.|.+| ++.+... |.++.+|+.+.+..+ ++..-..+|.+.
T Consensus 295 ~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 295 NSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred ccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 77777566667888888888888654 5544443 777778887776544 443334444443
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.51 E-value=5.2e-05 Score=70.10 Aligned_cols=62 Identities=19% Similarity=0.208 Sum_probs=28.6
Q ss_pred CeEEEEEcCCC-Cccc----ccCccccCCCCCcEEEccCCCCcc----cCcccccCCCCCCEEeccCCccc
Q 037905 39 ERVTMLRFPGM-GLSG----QLPIAIGNLTELHTVSLRFNALRG----TIPSDFAKLSNLRNLYLQGNLFS 100 (606)
Q Consensus 39 ~~l~~L~L~~n-~l~~----~~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 100 (606)
..|+.|+|++| +|.. .+.+++..-+.|+.|+|++|+|.. .+-+.+..-+.|+.|+|++|+|.
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 45555555553 4432 123344445555555555555541 11222223344555555555554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00052 Score=68.71 Aligned_cols=74 Identities=16% Similarity=0.103 Sum_probs=57.9
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCC---CCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD---HENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
+.|+.|.+..+|+.... +..+++|+.... ....+..|+..++.+. ...+.++++++...+..++||||+++..+
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 45888999999999864 667888987643 3567888988887763 35677888888777889999999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00094 Score=69.99 Aligned_cols=75 Identities=11% Similarity=0.124 Sum_probs=48.0
Q ss_pred CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCC-----CcccccCccccCCCC---CCCcchhHHHHHHHHHH
Q 037905 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN-----RIDGYRAPEVTDARK---VSQKADVYSFGVLLLEL 508 (606)
Q Consensus 437 ~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~-----~~~~y~aPE~~~~~~---~~~~sDv~slGvvl~el 508 (606)
...++|+|++|.|||++.++ ++++||+.+....+..... ....|++|+...... -....++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 35577999999999999876 9999999886543221110 012366666554211 12235566788888887
Q ss_pred HhCC
Q 037905 509 LTGK 512 (606)
Q Consensus 509 ltg~ 512 (606)
++++
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.22 E-value=0.002 Score=64.78 Aligned_cols=142 Identities=15% Similarity=0.091 Sum_probs=80.6
Q ss_pred ccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCC--CcccceEE-----EEeCCceEEEEeecCC
Q 037905 324 VLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHE--NLVPLRAY-----YYSRDEKLLVHDYMPM 396 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~~~ 396 (606)
.++ |....||+....+|+.+++|.......+...+..|..++..+... .+.+++.. ....+..++||+|++|
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G 111 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 111 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCC
Confidence 355 777899998877777889999875444566777777776655311 13333332 1224566789999987
Q ss_pred CChhh-----h---------hhcC----CCCCCCCCCHHHH----HHH---------------HHHHHHHHHHHHh----
Q 037905 397 GSLSA-----L---------LHGN----RGAGRTPLNWETR----SGL---------------ALGASRAIAYLHS---- 435 (606)
Q Consensus 397 g~L~~-----~---------l~~~----~~~~~~~l~~~~~----~~i---------------~~~ia~~L~~LH~---- 435 (606)
..+.. . ++.. ........++... ..+ ...+...++.+..
T Consensus 112 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 191 (328)
T 1zyl_A 112 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 191 (328)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhh
Confidence 54321 0 1110 0000112222211 001 1111122333332
Q ss_pred -cCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 436 -KGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 436 -~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
....++|+|+++.||+++ + .+.++||+.+..
T Consensus 192 ~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 192 DFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred cCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234467999999999999 4 899999987753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00049 Score=59.32 Aligned_cols=35 Identities=26% Similarity=0.227 Sum_probs=15.4
Q ss_pred CcEEecCCCcCCcccchhhhcCCCcceeecccccc
Q 037905 113 LIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQL 147 (606)
Q Consensus 113 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 147 (606)
|+.|+|++|+|+...+..|..+++|++|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433333344444444444444444
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0015 Score=64.60 Aligned_cols=73 Identities=16% Similarity=0.211 Sum_probs=51.6
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCC---CcccceEEEEeCCceEEEEeecCCCC
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHE---NLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
+.+|.|..+.||+.+..+|+.|.+|+..... .....|..|+..|+.+.-. -+.+++++ +..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeecccC
Confidence 4589999999999999999999999875433 2345678888887766322 23344443 23478999988754
Q ss_pred h
Q 037905 399 L 399 (606)
Q Consensus 399 L 399 (606)
.
T Consensus 97 ~ 97 (288)
T 3f7w_A 97 P 97 (288)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00068 Score=58.40 Aligned_cols=35 Identities=34% Similarity=0.431 Sum_probs=17.0
Q ss_pred CCEEeccCCcccccCCccccCCCCCcEEecCCCcC
Q 037905 89 LRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNF 123 (606)
Q Consensus 89 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 123 (606)
|+.|+|++|+|+...++.|..+++|+.|+|++|.+
T Consensus 33 l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 33 TTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp CSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred CCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 44444444444433333444555555555555544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00015 Score=67.03 Aligned_cols=113 Identities=12% Similarity=0.110 Sum_probs=65.5
Q ss_pred cccCCCCCcEEEccCC-CCcc----cCcccccCCCCCCEEeccCCcccccC----CccccCCCCCcEEecCCCcCCcc--
Q 037905 58 AIGNLTELHTVSLRFN-ALRG----TIPSDFAKLSNLRNLYLQGNLFSGEI----PGLLFSLGNLIRLNLAKNNFSGT-- 126 (606)
Q Consensus 58 ~l~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~-- 126 (606)
.+.+-+.|++|+|++| +|.. .+-+.+..-+.|+.|+|++|+|...- -+.+..-+.|+.|+|+.|.|...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 4456678888888875 7752 23444555677888888888887322 22344456788888888887632
Q ss_pred --cchhhhcCCCcceeecccccc---ccc----C-CCCCCCCCCCEEEccCCcC
Q 037905 127 --ISADFNKLTRLGTLYLQENQL---TGS----I-PDLGAFSSLAQFNVSFNKL 170 (606)
Q Consensus 127 --~p~~~~~l~~L~~L~l~~N~l---~~~----~-~~~~~l~~L~~L~l~~N~l 170 (606)
+-..+..-+.|++|+|++|.. ... + ..+..-++|+.|+++.|.+
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 222333445677777765432 211 0 0123345666666665543
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00088 Score=66.72 Aligned_cols=70 Identities=7% Similarity=-0.012 Sum_probs=41.0
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCc-ccceEEEEeCCceEEEEeec-CCCCh
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENL-VPLRAYYYSRDEKLLVHDYM-PMGSL 399 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~L 399 (606)
+.|+.|....+|+. ..+++|+............+|+..++.+....+ .+++++ +.+..++|+||+ ++.++
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 45888999999998 457788876432111122456666555432223 344443 344567899999 66544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0055 Score=61.40 Aligned_cols=143 Identities=12% Similarity=0.137 Sum_probs=76.4
Q ss_pred cccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCC-----CCCCcccce-E--EEEeCCceEEEEeec
Q 037905 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-----DHENLVPLR-A--YYYSRDEKLLVHDYM 394 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lv~e~~ 394 (606)
+.|+.|....+|+....+| .+++|+.... .....+..|+.++..+ .-|.++... | +....+..+++++|+
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l 105 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 105 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeC
Confidence 3477788899999987766 5778988652 1223455566655544 233333221 1 112345678999999
Q ss_pred CCCChhh--------------hhhcCC-CCCCC---CC---CHHHHHH------------HHHHHHHHHHHHHhc-----
Q 037905 395 PMGSLSA--------------LLHGNR-GAGRT---PL---NWETRSG------------LALGASRAIAYLHSK----- 436 (606)
Q Consensus 395 ~~g~L~~--------------~l~~~~-~~~~~---~l---~~~~~~~------------i~~~ia~~L~~LH~~----- 436 (606)
+|..+.. .++... +-... .. .|..... +...+...+++++..
T Consensus 106 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~ 185 (322)
T 2ppq_A 106 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 185 (322)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred CCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccC
Confidence 8865321 012110 00000 01 1222110 011244556666532
Q ss_pred CCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 437 GPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 437 ~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
...++|+|+.+.||+++.+..+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 1346799999999999987666899998664
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0045 Score=62.43 Aligned_cols=32 Identities=22% Similarity=0.251 Sum_probs=26.8
Q ss_pred CCCCCCCCCCCCEEecCC----CcEEEeecccCccC
Q 037905 438 PANSHGNIKSSNILLSKS----YEARISDFGLAHLA 469 (606)
Q Consensus 438 ~~i~HrDlkp~Nill~~~----~~~kl~DfG~a~~~ 469 (606)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 457799999999999875 67999999987643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.70 E-value=0.018 Score=53.52 Aligned_cols=101 Identities=13% Similarity=0.123 Sum_probs=67.1
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCCCC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH-SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPN 476 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 476 (606)
+|.++|.... .++++.+++.++.|.+.+|.-+- .+... .+=+.|..|++..+|.|...+ +.+. .
T Consensus 34 SL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~~~~~~--~~i~~~~~i~l~~dG~V~f~~-~~s~--------~ 98 (229)
T 2yle_A 34 SLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAARRRQPR--HRVRSAAQIRVWRDGAVTLAP-AADD--------A 98 (229)
T ss_dssp EHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCC--CCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhhcccCC--ceecCCcceEEecCCceeccc-cccc--------c
Confidence 7888888643 57999999999999999887762 22212 333557999999999998764 1111 1
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCC
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAP 514 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p 514 (606)
....+.|||... ...+.+.-|||+|+++|..+--..|
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 122367888764 3456789999999999999874433
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0046 Score=63.53 Aligned_cols=141 Identities=15% Similarity=0.162 Sum_probs=80.5
Q ss_pred cccccCCceEEEEEEEc--------CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCc-ccceEEEEeCCceEEEEee
Q 037905 323 EVLGKGTFGTAYKATLE--------MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENL-VPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 393 (606)
+.|..|-...+|+.... ++..+++|+..........+.+|..+++.+.-.++ .++++++. + .+||||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e~ 131 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQY 131 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEEC
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEEE
Confidence 34677888899998864 24788999875433345666788888876642223 45665553 2 289999
Q ss_pred cCCCChhhh-----------------hhcCCCCCCCCCC--HHHHHHHHHHHH-------------------HHHHHHH-
Q 037905 394 MPMGSLSAL-----------------LHGNRGAGRTPLN--WETRSGLALGAS-------------------RAIAYLH- 434 (606)
Q Consensus 394 ~~~g~L~~~-----------------l~~~~~~~~~~l~--~~~~~~i~~~ia-------------------~~L~~LH- 434 (606)
++|.+|..- ++...-....+.. +.++.++..++. ..+.+|.
T Consensus 132 i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~ 211 (379)
T 3feg_A 132 IPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRK 211 (379)
T ss_dssp CSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHH
T ss_pred ecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHH
Confidence 998655311 1111100011122 445555544332 1233332
Q ss_pred ---hc--CCCCCCCCCCCCCEEecCC----CcEEEeecccCc
Q 037905 435 ---SK--GPANSHGNIKSSNILLSKS----YEARISDFGLAH 467 (606)
Q Consensus 435 ---~~--~~~i~HrDlkp~Nill~~~----~~~kl~DfG~a~ 467 (606)
.. ..+++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 212 ~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 212 LLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 2457799999999999876 689999998764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0016 Score=66.87 Aligned_cols=73 Identities=11% Similarity=0.060 Sum_probs=41.5
Q ss_pred cccccCCceEEEEEEEcC---------CcEEEEEEeccCccCHHHHHHHHHHHcCCCCCC-cccceEEEEeCCceEEEEe
Q 037905 323 EVLGKGTFGTAYKATLEM---------GIVVAVKRLKDVTVSEKEFREKMEVVGSMDHEN-LVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 392 (606)
+.|+.|....+|+....+ +..+++|+.........+...|..+++.+...+ ..++++.. ..++|||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~e 114 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIEE 114 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEEE
Confidence 357788889999998754 267888987543211112345666666553233 33555443 2368999
Q ss_pred ecCCCCh
Q 037905 393 YMPMGSL 399 (606)
Q Consensus 393 ~~~~g~L 399 (606)
|++|..+
T Consensus 115 ~i~G~~l 121 (369)
T 3c5i_A 115 WLYGDPL 121 (369)
T ss_dssp CCCSEEC
T ss_pred EecCCcC
Confidence 9987543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0027 Score=66.62 Aligned_cols=72 Identities=13% Similarity=0.158 Sum_probs=47.9
Q ss_pred cccccCCceEEEEEEEcC--------CcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCc-ccceEEEEeCCceEEEEee
Q 037905 323 EVLGKGTFGTAYKATLEM--------GIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENL-VPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 393 (606)
+.|+.|-...+|++...+ +..+++|+.... .....+..|+.+++.+...++ .++++.+. + .+|+||
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~ 153 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEY 153 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEE
Confidence 357888889999998753 478899988542 222456678888777643334 45665542 2 389999
Q ss_pred cCCCCh
Q 037905 394 MPMGSL 399 (606)
Q Consensus 394 ~~~g~L 399 (606)
++|.+|
T Consensus 154 l~G~~l 159 (429)
T 1nw1_A 154 IPSRPL 159 (429)
T ss_dssp CCEEEC
T ss_pred eCCccc
Confidence 986444
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.59 E-value=0.0058 Score=64.56 Aligned_cols=73 Identities=8% Similarity=0.083 Sum_probs=45.0
Q ss_pred cccccCCceEEEEEEEcC-CcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCc-ccceEEEEeCCceEEEEeecCCCCh
Q 037905 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENL-VPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
+.|+.|-...+|+....+ +..+++|+........-+-..|+.+++.+...++ .++++++ .+ .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 457888889999998764 4788899875432111112467777776654445 4566665 22 359999987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0065 Score=61.55 Aligned_cols=31 Identities=23% Similarity=0.309 Sum_probs=26.8
Q ss_pred CCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 438 PANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 438 ~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
..++|+|+.+.||++++++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4577999999999999888899999987653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.02 Score=59.71 Aligned_cols=73 Identities=7% Similarity=0.048 Sum_probs=44.4
Q ss_pred cccccCCceEEEEEEEcC--------CcEEEEEEeccCccCHHHHHHHHHHHcCCCCCC-cccceEEEEeCCceEEEEee
Q 037905 323 EVLGKGTFGTAYKATLEM--------GIVVAVKRLKDVTVSEKEFREKMEVVGSMDHEN-LVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 393 (606)
+.+..|-...+|+....+ +..+++|+........-+..+|..+++.+.-.+ ..++++.+ ..+.|+||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ef 151 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEEF 151 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEEC
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEEE
Confidence 346678888999998753 578889987543211112245666665553222 34455433 23789999
Q ss_pred cCCCCh
Q 037905 394 MPMGSL 399 (606)
Q Consensus 394 ~~~g~L 399 (606)
++|.+|
T Consensus 152 I~G~~l 157 (424)
T 3mes_A 152 IDGEPL 157 (424)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 998654
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=95.19 E-value=0.0074 Score=39.05 Aligned_cols=33 Identities=30% Similarity=0.634 Sum_probs=23.8
Q ss_pred CCCCCCCceeeehhhHHHHHHHHHHHHhhhhhc
Q 037905 210 GSNLSGGAIAGIVIGSVIGLLIILVLLIGLCRR 242 (606)
Q Consensus 210 ~~~~~~~~~~~iv~g~~~~~~~~~~~~~~~~~~ 242 (606)
+++++.+.+.|+++|.++++.+++.++++++||
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 345677888999999888887777666655443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.50 E-value=0.23 Score=51.33 Aligned_cols=30 Identities=27% Similarity=0.375 Sum_probs=24.8
Q ss_pred CCCCCCCCCCCCEEe------cCCCcEEEeecccCc
Q 037905 438 PANSHGNIKSSNILL------SKSYEARISDFGLAH 467 (606)
Q Consensus 438 ~~i~HrDlkp~Nill------~~~~~~kl~DfG~a~ 467 (606)
++++|+|+.+.|||+ +++..+.++||..|.
T Consensus 244 ~vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 244 VVFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 456799999999999 456679999998764
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.24 E-value=0.23 Score=33.12 Aligned_cols=27 Identities=26% Similarity=0.396 Sum_probs=10.6
Q ss_pred ceeeehhhHHHHHHHHHHHHhhhhhcc
Q 037905 217 AIAGIVIGSVIGLLIILVLLIGLCRRK 243 (606)
Q Consensus 217 ~~~~iv~g~~~~~~~~~~~~~~~~~~~ 243 (606)
.+++.++|.++++++++.+.+++.||+
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr 38 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRR 38 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhh
Confidence 344444443333333333333333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.75 E-value=0.21 Score=33.22 Aligned_cols=10 Identities=50% Similarity=0.581 Sum_probs=4.0
Q ss_pred ceeeehhhHH
Q 037905 217 AIAGIVIGSV 226 (606)
Q Consensus 217 ~~~~iv~g~~ 226 (606)
.+++.++|.+
T Consensus 11 aIA~gVVgGv 20 (44)
T 2l2t_A 11 LIAAGVIGGL 20 (44)
T ss_dssp HHHHHHHHHH
T ss_pred eEEEeehHHH
Confidence 3444444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=89.62 E-value=0.16 Score=33.72 Aligned_cols=26 Identities=27% Similarity=0.388 Sum_probs=11.9
Q ss_pred ceeeehhhHHHHHHHHHHHHhhhhhc
Q 037905 217 AIAGIVIGSVIGLLIILVLLIGLCRR 242 (606)
Q Consensus 217 ~~~~iv~g~~~~~~~~~~~~~~~~~~ 242 (606)
.+++.++|+++++++.+.+++++.||
T Consensus 13 ~Ia~~vVGvll~vi~~l~~~~~~RRR 38 (44)
T 2jwa_A 13 SIISAVVGILLVVVLGVVFGILIKRR 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHHHHhheehh
Confidence 45666677443333333333333333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.99 E-value=1.1 Score=41.57 Aligned_cols=125 Identities=12% Similarity=0.109 Sum_probs=80.8
Q ss_pred HHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCC
Q 037905 362 KMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441 (606)
Q Consensus 362 e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~ 441 (606)
|+.++.. .||+.++. ..-...+...+.++.-+ ....+-.- ...+...+++++..|+....+++.. .
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~~r--~-- 101 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNRTR--Y-- 101 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGGSS--E--
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhcCc--e--
Confidence 3444433 68888866 44455555555454433 23333221 1377889999999998887655544 4
Q ss_pred CCCCCCCCEEecCCCcEEEeecccCccCCCCCCCCCcccccCccccCCCCCCCcchhH-HHHHHHHHHHhCCCCccccc
Q 037905 442 HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVTDARKVSQKADVY-SFGVLLLELLTGKAPTQALL 519 (606)
Q Consensus 442 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~-slGvvl~elltg~~p~~~~~ 519 (606)
|--|.|+|++++.++.+++.=.|+...+. |. .++ ..|.| .+=+++..+++++..|....
T Consensus 102 tf~L~P~NL~f~~~~~p~i~~RGik~~l~-------------P~-----~~~-ee~fL~qyKAliiall~~K~~Fe~l~ 161 (215)
T 4ann_A 102 TFVLAPDELFFTRDGLPIAKTRGLQNVVD-------------PL-----PVS-EAEFLTRYKALVICAFNEKQSFDALV 161 (215)
T ss_dssp ECCCSGGGEEECTTSCEEESCCEETTTBS-------------CC-----CCC-HHHHHHHHHHHHHHHHCTTCCHHHHH
T ss_pred EEEEecceEEEcCCCCEEEEEccCccCCC-------------CC-----CCC-HHHHHHHHHHHHHHHHcCCCCHHHHH
Confidence 77899999999999999999777643222 21 111 22333 57788899999999987643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 606 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-57 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-53 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-51 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-50 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-49 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-48 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-48 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-47 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-46 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-44 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-43 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-42 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-39 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-38 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-35 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-34 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-34 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-34 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-34 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-32 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-30 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-28 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-13 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 4e-06 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 6e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 1e-57
Identities = 71/275 (25%), Positives = 128/275 (46%), Gaps = 27/275 (9%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
E LG G FG + VAVK LK ++S F + ++ + H+ LV L A
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
+++ ++ +YM GSL L G L +A + +A++ + H
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERNYI--H 132
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAPEVTDARKVSQKAD 497
+++++NIL+S + +I+DFGLA L + R + APE + + K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 498 VYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEM 557
V+SFG+LL E++T G+ P +Q++ + ++R N EE+
Sbjct: 193 VWSFGILLTEIVTHGRIP-----YPGMTNPEVIQNLER--------GYRMVRPDNCPEEL 239
Query: 558 VQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
QL++L C + P++RP+ + S +E+ ++
Sbjct: 240 YQLMRL---CWKERPEDRPTFDYLRSVLEDFFTAT 271
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-54
Identities = 70/281 (24%), Positives = 121/281 (43%), Gaps = 33/281 (11%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLRA 379
+ +G G+FGT YK VAVK L + + F+ ++ V+ H N++
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
Y + + +V + SL LH +A ++ + YLH+K
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKSII 126
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID------GYRAPEV---TDAR 490
H ++KS+NI L + +I DFGLA + S S ++ + + APEV D
Sbjct: 127 --HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 491 KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550
S ++DVY+FG++L EL+TG+ P ++ + +V + +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSPDLS---KVR 235
Query: 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
N + M +L+ C + D RP ++ + IE + RS
Sbjct: 236 SNCPKAMKRLMAE---CLKKKRDERPLFPQILASIELLARS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-53
Identities = 62/274 (22%), Positives = 115/274 (41%), Gaps = 27/274 (9%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ +G G FG + VA+K +++ +SE++F E+ EV+ + H LV L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
+ LV ++M G LS L R ET G+ L +AYL H
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEEACVI--H 124
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAPEVTDARKVSQKAD 497
++ + N L+ ++ ++SDFG+ + + +PEV + S K+D
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 498 VYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEM 557
V+SFGVL+ E+ + + ++ + + L + + +
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNS--EVVEDIST-----------GFRLYKPRLASTHV 231
Query: 558 VQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
Q++ C + P++RP+ + + Q+ EI S
Sbjct: 232 YQIMNH---CWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 4e-53
Identities = 72/268 (26%), Positives = 114/268 (42%), Gaps = 25/268 (9%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ +GKG FG G VAVK +K+ + + F + V+ + H NLV L
Sbjct: 13 QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 383 SRDEKL-LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
L +V +YM GSL L GR+ L + +L A+ YL
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNNFV-- 125
Query: 442 HGNIKSSNILLSKSYEARISDFGLAHLASPS-STPNRIDGYRAPEVTDARKVSQKADVYS 500
H ++ + N+L+S+ A++SDFGL AS + T + APE +K S K+DV+S
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 185
Query: 501 FGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQL 560
FG+LL E+ + + L V V K ++ + ++
Sbjct: 186 FGILLWEIYSFGRV-----PYPRIPLKDVVPRVEK--------GYKMDAPDGCPPAVYEV 232
Query: 561 LQLAINCTAQYPDNRPSMAEVTSQIEEI 588
++ NC RPS ++ Q+E I
Sbjct: 233 MK---NCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 1e-52
Identities = 65/272 (23%), Positives = 113/272 (41%), Gaps = 29/272 (10%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
+ LG G FG VA+K +K+ ++SE EF E+ +V+ ++ HE LV L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
+ ++ +YM G L L R + + A+ YL SK H
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFL--H 123
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAPEVTDARKVSQKAD 497
++ + N L++ ++SDFGL+ + + + PEV K S K+D
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 498 VYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
+++FGVL+ E+ + GK P E + + + L L R E+
Sbjct: 184 IWAFGVLMWEIYSLGKMP------YERFTNSETAEHIAQ--------GLRLYRPHLASEK 229
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
+ ++ C + D RP+ + S I ++
Sbjct: 230 VYTIMYS---CWHEKADERPTFKILLSNILDV 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-51
Identities = 59/298 (19%), Positives = 109/298 (36%), Gaps = 35/298 (11%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
E +GKG FG ++ G VAVK ++ + HEN++ A
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 383 SRDEKL----LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG- 437
+ LV DY GSL L+ R + E LAL + +A+LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 438 -----PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID--------GYRAP 484
PA +H ++KS NIL+ K+ I+D GLA ++ I Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 485 EV------TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEE----GVDLPRWVQSVV 534
EV + ++AD+Y+ G++ E+ + + + + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 535 KEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
++ + + E + + ++ C R + + + ++ +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (443), Expect = 9e-51
Identities = 71/276 (25%), Positives = 124/276 (44%), Gaps = 27/276 (9%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
LG G +G Y+ + + VAVK LK+ T+ +EF ++ V+ + H NLV L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
++ ++M G+L L R ++ +A S A+ YL K
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEKKNFI-- 137
Query: 442 HGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAPEVTDARKVSQKA 496
H ++ + N L+ +++ +++DFGL+ L + + + APE K S K+
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 497 DVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
DV++FGVLL E+ T G+DL + + + K D + R + E+
Sbjct: 198 DVWAFGVLLWEIATYGMSP-----YPGIDLSQVYELLEK--------DYRMERPEGCPEK 244
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
+ +L++ C P +RPS AE+ E + + S
Sbjct: 245 VYELMRA---CWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 1e-50
Identities = 72/280 (25%), Positives = 121/280 (43%), Gaps = 27/280 (9%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYY 382
LG+G FG + T VA+K LK T+S + F ++ +V+ + HE LV L A
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 81
Query: 383 SRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSH 442
S + +V +YM GSL L G G L +A + +AY+ H
Sbjct: 82 SEEPIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMNYV--H 136
Query: 443 GNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAPEVTDARKVSQKAD 497
+++++NIL+ ++ +++DFGLA L + R + APE + + K+D
Sbjct: 137 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 196
Query: 498 VYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEM 557
V+SFG+LL EL T + ++ V+ + E +
Sbjct: 197 VWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGYRMPCPPECPE------------- 241
Query: 558 VQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597
L L C + P+ RP+ + + +E+ S+ Q Q
Sbjct: 242 -SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (430), Expect = 9e-49
Identities = 59/285 (20%), Positives = 124/285 (43%), Gaps = 39/285 (13%)
Query: 323 EVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
+V+G G FG L + I VA+K LK + ++F + ++G DH N++
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L +++ ++M GSL + L N G G+ G + + YL
Sbjct: 92 LEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADM 147
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID---------GYRAPEVT 487
H ++ + NIL++ + ++SDFGL+ ++ + APE
Sbjct: 148 NYV--HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 488 DARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546
RK + +DV+S+G+++ E+++ G+ P + N++ + ++ + D
Sbjct: 206 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD------VINAIEQ--------DYR 251
Query: 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
L + + QL+ C + ++RP ++ + ++++ R+
Sbjct: 252 LPPPMDCPSALHQLMLD---CWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-48
Identities = 67/302 (22%), Positives = 120/302 (39%), Gaps = 37/302 (12%)
Query: 309 DRAFDLEDLLRASAEVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTVSE--KEFREK 362
L+ EV+G+G FG Y TL I AVK L +T +F +
Sbjct: 19 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78
Query: 363 MEVVGSMDHENLVPLRAYYYSRDEK-LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSG 421
++ H N++ L + L+V YM G L + + G
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIG 134
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-- 479
L ++ + +L SK H ++ + N +L + + +++DFGLA + +
Sbjct: 135 FGLQVAKGMKFLASKKFV--HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKT 192
Query: 480 ------GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSV 533
+ A E +K + K+DV+SFGVLL EL+T AP V+ +
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYL 247
Query: 534 VKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSL 593
++ LL+ + + + +++ C + RPS +E+ S+I I + +
Sbjct: 248 LQGR--------RLLQPEYCPDPLYEVMLK---CWHPKAEMRPSFSELVSRISAIFSTFI 296
Query: 594 QQ 595
+
Sbjct: 297 GE 298
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-48
Identities = 66/270 (24%), Positives = 115/270 (42%), Gaps = 32/270 (11%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVPLR 378
+G+G+F T YK E + VA L+D +++ E F+E+ E++ + H N+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 379 AYYYS----RDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ S + +LV + M G+L L + + + + + +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129
Query: 435 SKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSSTPNRID--GYRAPEVTDARK 491
++ P H ++K NI + + +I D GLA L S I + APE+ + K
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EK 188
Query: 492 VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551
+ DVY+FG+ +LE+ T + P N + R V S VK +V E
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGVKPASFDKVAIPE----- 241
Query: 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ ++ C Q D R S+ ++
Sbjct: 242 --------VKEIIEGCIRQNKDERYSIKDL 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-48
Identities = 72/281 (25%), Positives = 116/281 (41%), Gaps = 38/281 (13%)
Query: 310 RAFDLED--LLRASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREK 362
R + LED + R LGKG FG Y A + ++A+K L + E + R +
Sbjct: 1 RQWALEDFEIGR----PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 56
Query: 363 MEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGL 422
+E+ + H N++ L Y++ L+ +Y P+G++ L + + +
Sbjct: 57 VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATY 111
Query: 423 ALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI--DG 480
+ A++Y HSK H +IK N+LL + E +I+DFG + A S
Sbjct: 112 ITELANALSYCHSKRVI--HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLD 169
Query: 481 YRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540
Y PE+ + R +K D++S GVL E L GK P E + + + E+T
Sbjct: 170 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF------EANTYQETYKRISRVEFTF 223
Query: 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
V E L+ P RP + EV
Sbjct: 224 P---------DFVTEGARDLIS---RLLKHNPSQRPMLREV 252
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 1e-47
Identities = 62/267 (23%), Positives = 109/267 (40%), Gaps = 31/267 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKM----EVVGSMDHENLVPL 377
+G G+FG Y A + VVA+K++ E + + + + H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
R Y LV +Y + L + PL + + GA + +AYLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEV---TDARKVSQ 494
H ++K+ NILLS+ ++ DFG A + +P+++ + APEV D +
Sbjct: 136 MI--HRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDG 193
Query: 495 KADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554
K DV+S G+ +EL K P ++ + + + E A L+ +
Sbjct: 194 KVDVWSLGITCIELAERKPPLF------NMNAMSALYHIAQNESPA-------LQSGHWS 240
Query: 555 EEMVQLLQLAINCTAQYPDNRPSMAEV 581
E + +C + P +RP+ +
Sbjct: 241 EYFRNFVD---SCLQKIPQDRPTSEVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-47
Identities = 69/301 (22%), Positives = 120/301 (39%), Gaps = 38/301 (12%)
Query: 312 FDLEDLLRASAEVLGKGTFGTAYKATLEM---GIVVAVKRLKDVTVSE--KEFREKMEVV 366
++LL A E LG G FG+ + M I VA+K LK T +E + +++
Sbjct: 5 LKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 63
Query: 367 GSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGA 426
+D+ +V L + +LV + G L L G R + + L
Sbjct: 64 HQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQV 118
Query: 427 SRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID------- 479
S + YL K H ++ + N+LL + A+ISDFGL+ +
Sbjct: 119 SMGMKYLEEKNF--VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 176
Query: 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEW 538
+ APE + RK S ++DV+S+GV + E L+ G+ P + + E + +++ + E
Sbjct: 177 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGKRMEC 233
Query: 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQA 598
E+ L+ C ++RP V ++ S + +
Sbjct: 234 P-----------PECPPELYALMSD---CWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279
Query: 599 H 599
H
Sbjct: 280 H 280
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (419), Expect = 3e-47
Identities = 58/300 (19%), Positives = 114/300 (38%), Gaps = 51/300 (17%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENL 374
+G+G FG ++A E +VAVK LK+ + + +F+ + ++ D+ N+
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRG-------------------AGRTPLN 415
V L L+ +YM G L+ L G PL+
Sbjct: 79 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138
Query: 416 WETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP 475
+ +A + +AYL + H ++ + N L+ ++ +I+DFGL+ +
Sbjct: 139 CAEQLCIARQVAAGMAYLSERKFV--HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 476 NRID------GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRW 529
+ PE + + ++DV+++GV+L E+ + + E V
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV----- 251
Query: 530 VQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEIC 589
+ V E ++L L C ++ P +RPS + ++ +C
Sbjct: 252 IYYVRDGN-----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 8e-47
Identities = 49/290 (16%), Positives = 109/290 (37%), Gaps = 37/290 (12%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK--DVTVSEKEFREKMEVVGSMDHENLVPLRA 379
LG G G +K + G+V+A K + + +++V+ + +V
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+YS E + ++M GSL +L + + +++ + + YL K
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK- 125
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI--DGYRAPEVTDARKVSQKAD 497
H ++K SNIL++ E ++ DFG++ S + + Y +PE S ++D
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSD 185
Query: 498 VYSFGVLLLELLTGKAP------------TQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545
++S G+ L+E+ G+ P + + + P ++ + + +
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 546 ELLRYQNVEEEMV--------------QLLQLAINCTAQYPDNRPSMAEV 581
+ + + +V + C + P R + ++
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 8e-47
Identities = 60/283 (21%), Positives = 116/283 (40%), Gaps = 36/283 (12%)
Query: 323 EVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLV 375
+V+G G FG YK L + + VA+K LK +F + ++G H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L +++ +YM G+L L G + G+ G + + YL +
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLAN 128
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-------GYRAPEVTD 488
H ++ + NIL++ + ++SDFGL+ + + APE
Sbjct: 129 MN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 489 ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548
RK + +DV+SFG+++ E++T L+ ++ + + +
Sbjct: 187 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIN--------------DGF 230
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
R + + QL + C Q RP A++ S ++++ R+
Sbjct: 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-46
Identities = 49/272 (18%), Positives = 101/272 (37%), Gaps = 31/272 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE---FREKMEVVGSMDHENLVPLR 378
+G G++G K G ++ K L +++E E ++ ++ + H N+V
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 379 AYYYSRDEKLL--VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
R L V +Y G L++++ R L+ E + + A+ H +
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRR 128
Query: 437 GPANS---HGNIKSSNILLSKSYEARISDFGLAHLASP----SSTPNRIDGYRAPEVTDA 489
H ++K +N+ L ++ DFGLA + + + Y +PE +
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188
Query: 490 RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549
++K+D++S G LL EL P + + ++
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPF------TAFSQKELAGKIREGKF--------RRI 234
Query: 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+E+ +++ +RPS+ E+
Sbjct: 235 PYRYSDELNEIIT---RMLNLKDYHRPSVEEI 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-46
Identities = 60/283 (21%), Positives = 116/283 (40%), Gaps = 33/283 (11%)
Query: 310 RAFDLEDLLRASAEVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE-KEFREKMEVVG 367
R + ED LG G FG YKA E ++ A K + + E +++ +++++
Sbjct: 6 RDLNPEDFWEII-GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILA 64
Query: 368 SMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
S DH N+V L +Y + ++ ++ G++ A++ PL +
Sbjct: 65 SCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTL 120
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNR----IDGYRA 483
A+ YLH H ++K+ NIL + + +++DFG++ + + + A
Sbjct: 121 DALNYLHDNKII--HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 178
Query: 484 PEV-----TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW 538
PEV + R KADV+S G+ L+E+ + P ++ R + + K E
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH------ELNPMRVLLKIAKSEP 232
Query: 539 TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
L + L+ C + D R + +++
Sbjct: 233 ------PTLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQL 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 4e-46
Identities = 62/286 (21%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 323 EVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTVSE--KEFREKMEVVGSM-DHENLVP 376
+V+G+G FG KA ++ + + A+KR+K+ + ++F ++EV+ + H N++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGN-----------RGAGRTPLNWETRSGLALG 425
L R L +Y P G+L L + + + L+ + A
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 426 ASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YR 482
+R + YL K H ++ + NIL+ ++Y A+I+DFGL+ +
Sbjct: 136 VARGMDYLSQKQFI--HRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWM 193
Query: 483 APEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542
A E + + +DV+S+GVLL E+++ G+ + + +
Sbjct: 194 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-----YCGMTCAELYEKLPQ------- 241
Query: 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
L + N ++E+ L++ C + P RPS A++ + +
Sbjct: 242 -GYRLEKPLNCDDEVYDLMRQ---CWREKPYERPSFAQILVSLNRM 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-46
Identities = 69/288 (23%), Positives = 113/288 (39%), Gaps = 39/288 (13%)
Query: 324 VLGKGTFGTAYKATLEM---GIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPL 377
LG G FGT K +M VAVK LK+ E + V+ +D+ +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ +LV + +G L+ L NR + + L S + YL
Sbjct: 74 IGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN 127
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-------GYRAPEVTDAR 490
H ++ + N+LL + A+ISDFGL+ + + APE +
Sbjct: 128 FV--HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 491 KVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549
K S K+DV+SFGVL+ E + G+ P + + E V +++++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGCPA----- 233
Query: 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQ 597
EM L+ L C +NRP A V ++ + +G
Sbjct: 234 --GCPREMYDLMNL---CWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 9e-46
Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 45/298 (15%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLK--DVTVSEKEFREKMEVVGSM-DHEN 373
+ LG G FG +AT + + VAVK LK + +++V+ + +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGA-------------GRTPLNWETRS 420
+V L L++ +Y G L L R + L+ E
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 421 GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID- 479
+ ++ +A+L SK H ++ + NILL+ +I DFGLA S
Sbjct: 149 SFSYQVAKGMAFLASKNCI--HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 480 -----GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV 534
+ APE + ++DV+S+G+ L EL + + G+ + ++
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFYKMI 261
Query: 535 KEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
KE +L ++ EM +++ C P RP+ ++ IE+ S
Sbjct: 262 KE-------GFRMLSPEHAPAEMYDIMKT---CWDADPLKRPTFKQIVQLIEKQISES 309
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 162 bits (410), Expect = 2e-45
Identities = 55/266 (20%), Positives = 112/266 (42%), Gaps = 27/266 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-FREKMEVVGSMDHENLVPLRAY 380
E LG G FG ++ T G A K + S+KE R++++ + + H LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+ +E ++++++M G L + ++ + + + ++H
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYV- 146
Query: 441 SHGNIKSSNILLS--KSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDARKVSQK 495
H ++K NI+ + +S E ++ DFGL P + G + APEV + + V
Sbjct: 147 -HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 496 ADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555
D++S GVL LL+G +P G + +++V +W ++ + + E
Sbjct: 206 TDMWSVGVLSYILLSGLSPFG------GENDDETLRNVKSCDWN-----MDDSAFSGISE 254
Query: 556 EMVQLLQLAINCTAQYPDNRPSMAEV 581
+ ++ P+ R ++ +
Sbjct: 255 DGKDFIR---KLLLADPNTRMTIHQA 277
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-44
Identities = 66/298 (22%), Positives = 112/298 (37%), Gaps = 52/298 (17%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSM-DHEN 373
+VLG G FG AT + I VAVK LK+ S + +++++ + HEN
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102
Query: 374 LVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRG------------------AGRTPLN 415
+V L L+ +Y G L L R L
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 416 WETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTP 475
+E A ++ + +L K H ++ + N+L++ +I DFGLA S
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFKSCV--HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 476 NRID------GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPR 528
+ APE + K+DV+S+G+LL E+ + G P G+ +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------YPGIPVDA 274
Query: 529 WVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIE 586
+++ ++ + EE+ ++Q C A RPS +TS +
Sbjct: 275 NFYKLIQN-------GFKMDQPFYATEEIYIIMQS---CWAFDSRKRPSFPNLTSFLG 322
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 8e-44
Identities = 69/282 (24%), Positives = 118/282 (41%), Gaps = 39/282 (13%)
Query: 323 EVLGKGTFGTAYKATLEM----GIVVAVKRLKDVTVSEKEFREKM----EVVGSMDHENL 374
E LG G+FG + + + VAVK LK +S+ E + + S+DH NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ L + K+ V + P+GSL L ++G T S A+ + + YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLE 128
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-------GYRAPEVT 487
SK H ++ + N+LL+ +I DFGL + + + APE
Sbjct: 129 SKRFI--HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186
Query: 488 DARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546
R S +D + FGV L E+ T G+ P G++ + + + KE
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEP------WIGLNGSQILHKIDKE-------GER 233
Query: 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
L R ++ +++ ++ C A P++RP+ + + E
Sbjct: 234 LPRPEDCPQDIYNVMVQ---CWAHKPEDRPTFVALRDFLLEA 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-43
Identities = 53/269 (19%), Positives = 105/269 (39%), Gaps = 32/269 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL--KDVTVSEKEFREKMEVVGSMDHENLVPLRA 379
+ LG+G +G A VAVK + K + ++++ + ++HEN+V
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+ + + L +Y G L + + G + + YLH G
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID------GYRAPEV-TDARKV 492
H +IK N+LL + +ISDFGLA + ++ ++ Y APE+
Sbjct: 126 --HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 493 SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552
++ DV+S G++L +L G+ ++ + W + L ++
Sbjct: 184 AEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEK-----------KTYLNPWKK 231
Query: 553 VEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
++ + LL + P R ++ ++
Sbjct: 232 IDSAPLALLH---KILVENPSARITIPDI 257
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-42
Identities = 61/265 (23%), Positives = 109/265 (41%), Gaps = 29/265 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-FREKMEVVGSMDHENLVPLRAY 380
E +G+G GT Y A + G VA++++ +KE ++ V+ + N+V
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
Y DE +V +Y+ GSL+ ++ T ++ + + +A+ +LHS
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSNQVI- 138
Query: 441 SHGNIKSSNILLSKSYEARISDFGLAHLASP----SSTPNRIDGYRAPEVTDARKVSQKA 496
H +IKS NILL +++DFG +P ST + APEV + K
Sbjct: 139 -HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 497 DVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
D++S G++ +E++ G+ P + R + + EL + +
Sbjct: 198 DIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGT------PELQNPEKLSAI 245
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEV 581
L C + R S E+
Sbjct: 246 FRDFLN---RCLDMDVEKRGSAKEL 267
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 3e-42
Identities = 61/282 (21%), Positives = 120/282 (42%), Gaps = 38/282 (13%)
Query: 323 EVLGKGTFGTAYKATL-----EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLV 375
+VLG G FGT YK ++ I VA+K L++ T + KE ++ V+ S+D+ ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + +L+ MP G L + ++ + + + ++ + YL
Sbjct: 75 RLLGICLTSTVQLIT-QLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLED 129
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG------YRAPEVTDA 489
+ H ++ + N+L+ +I+DFGLA L +G + A E
Sbjct: 130 RRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 490 RKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548
R + ++DV+S+GV + EL+T G P + E + S++++ L
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEK-------GERLP 233
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590
+ ++ ++ C D+RP E+ + ++ R
Sbjct: 234 QPPICTIDVYMIMVK---CWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 153 bits (388), Expect = 3e-42
Identities = 54/266 (20%), Positives = 104/266 (39%), Gaps = 27/266 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRL-KDVTVSEKEFREKMEVVGSMDHENLVPLRAY 380
E LG G FG ++ G V K + + + + ++ ++ + H L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+ + E +L+ +++ G L + ++ A + ++H
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHSIV- 149
Query: 441 SHGNIKSSNILLSKSYEARI--SDFGLAHLASPSSTPNRIDG---YRAPEVTDARKVSQK 495
H +IK NI+ + + DFGLA +P + APE+ D V
Sbjct: 150 -HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 208
Query: 496 ADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555
D+++ GVL LL+G +P G D +Q+V + +W FD + + +V
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFA------GEDDLETLQNVKRCDWE---FDEDA--FSSVSP 257
Query: 556 EMVQLLQLAINCTAQYPDNRPSMAEV 581
E ++ N + P R ++ +
Sbjct: 258 EAKDFIK---NLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-42
Identities = 54/265 (20%), Positives = 109/265 (41%), Gaps = 26/265 (9%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
E LG+G FG ++ K +K + ++++ ++ H N++ L +
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
S +E +++ +++ + ++ + LN A+ +LHS
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHNIG-- 124
Query: 442 HGNIKSSNILLS--KSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDARKVSQKA 496
H +I+ NI+ +S +I +FG A P + Y APEV VS
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 497 DVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
D++S G L+ LL+G P A N++ +++++ E+T FD E ++ + E
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYT---FDEEA--FKEISIE 233
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEV 581
+ + + +R + +E
Sbjct: 234 AMDFVD---RLLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-42
Identities = 61/297 (20%), Positives = 115/297 (38%), Gaps = 44/297 (14%)
Query: 323 EVLGKGTFGTAYKAT------LEMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENL 374
+ LG+G FG +A VAVK LK+ + +++++ + H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 375 VPLRAYYYSRDEK--LLVHDYMPMGSLSALLHGNRG-----------AGRTPLNWETRSG 421
V ++ +++ ++ G+LS L R + L E
Sbjct: 79 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138
Query: 422 LALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-- 479
+ ++ + +L S+ H ++ + NILLS+ +I DFGLA R
Sbjct: 139 YSFQVAKGMEFLASRKC--IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 480 ----GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK 535
+ APE R + ++DV+SFGVLL E+ + A GV + +K
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCRRLK 251
Query: 536 EEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592
E R + + ++ Q ++C P RP+ +E+ + + +++
Sbjct: 252 EG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-41
Identities = 58/292 (19%), Positives = 116/292 (39%), Gaps = 37/292 (12%)
Query: 323 EVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENL 374
LG+G+FG Y+ E VA+K + + EF + V+ + ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG-----RTPLNWETRSGLALGASRA 429
V L L++ + M G L + L R A P + +A +
Sbjct: 86 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145
Query: 430 IAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID------GYRA 483
+AYL++ H ++ + N ++++ + +I DFG+ + + + +
Sbjct: 146 MAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVF 543
PE + +DV+SFGV+L E+ T +G+ + ++ V++
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQP-----YQGLSNEQVLRFVMEGGL----- 253
Query: 544 DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595
L + N + + +L+++ C P RPS E+ S I+E ++
Sbjct: 254 ---LDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 66/288 (22%), Positives = 120/288 (41%), Gaps = 40/288 (13%)
Query: 323 EVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVP 376
+G+G FG ++ + VA+K K+ T ++F ++ + DH ++V
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
L + + ++ + +G L + L + L+ + A S A+AYL SK
Sbjct: 73 LIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK 127
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG-----YRAPEVTDARK 491
H +I + N+L+S + ++ DFGL+ S+ G + APE + R+
Sbjct: 128 RFV--HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR 185
Query: 492 VSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550
+ +DV+ FGV + E+L G P Q + N + + + E L
Sbjct: 186 FTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGE--------RLPMP 231
Query: 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQA 598
N + L+ C A P RP E+ +Q+ I L++ +A
Sbjct: 232 PNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTI----LEEEKA 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 4e-39
Identities = 55/270 (20%), Positives = 99/270 (36%), Gaps = 29/270 (10%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+VLG G G + A+K L+D + +E ++V + Y
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDVY 74
Query: 382 YSRDEK----LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ L+V + + G L + + G S + AI YLHS
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 438 PANSHGNIKSSNILLSKSYE---ARISDFGLAHLASPSSTPNRID---GYRAPEVTDARK 491
+H ++K N+L + +++DFG A + ++ Y APEV K
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 189
Query: 492 VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551
+ D++S GV++ LL G P + + + +K ++ +
Sbjct: 190 YDKSCDMWSLGVIMYILLCGYPPFYS-------NHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
V EE+ L++ N P R ++ E
Sbjct: 243 EVSEEVKMLIR---NLLKTEPTQRMTITEF 269
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (358), Expect = 7e-39
Identities = 47/280 (16%), Positives = 85/280 (30%), Gaps = 42/280 (15%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-----------D 370
E+LG+G + AVK + E E+ +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 371 HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAI 430
H N++ L+ Y + LV D M G L L L+ + + I
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVI 123
Query: 431 AYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---------Y 481
LH H ++K NILL +++DFG + P + G
Sbjct: 124 CALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 181
Query: 482 RAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAE 541
+ ++ D++S GV++ LL G P ++ ++
Sbjct: 182 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRMIMSGN---- 231
Query: 542 VFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ + + + + L+ P R + E
Sbjct: 232 -YQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-39
Identities = 63/294 (21%), Positives = 113/294 (38%), Gaps = 46/294 (15%)
Query: 323 EVLGKGTFGTAYKATL--------EMGIVVAVKRLKDVTVSE--KEFREKMEVVGSM-DH 371
+ LG+G FG A VAVK LK + + +ME++ + H
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 372 ENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAG-----------RTPLNWETRS 420
+N++ L ++ +Y G+L L R G L+ +
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 421 GLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID- 479
A +R + YL SK H ++ + N+L+++ +I+DFGLA +
Sbjct: 139 SCAYQVARGMEYLASKKCI--HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 480 -----GYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVV 534
+ APE R + ++DV+SFGVLL E+ T + E + ++
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------ELFKLL 250
Query: 535 KEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
KE + + N E+ +++ C P RP+ ++ ++ I
Sbjct: 251 KE-------GHRMDKPSNCTNELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 8e-39
Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 36/270 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE----FREKMEVVGSMDHENLVPL 377
++LG+G+F T A L A+K L+ + ++ + +V+ +DH V L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ ++ Y G L + + A+ YLH KG
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG 128
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID------GYRAPEVTDARK 491
H ++K NILL++ +I+DFG A + SP S R + Y +PE+ +
Sbjct: 129 II--HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186
Query: 492 VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551
+ +D+++ G ++ +L+ G P + + Q ++K E+ +
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEYDFP---------E 231
Query: 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ L++ R E+
Sbjct: 232 KFFPKARDLVE---KLLVLDATKRLGCEEM 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (356), Expect = 3e-38
Identities = 57/268 (21%), Positives = 102/268 (38%), Gaps = 30/268 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK--DVTVSEKEFREKMEVVGSMDHENLVPLRA 379
+VLG G F A +VA+K + + E ++ V+ + H N+V L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
Y S L+ + G L + S L A+ YLH
Sbjct: 75 IYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHD--LG 127
Query: 440 NSHGNIKSSNILLS---KSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDARKVS 493
H ++K N+L + + ISDFGL+ + P S + G Y APEV + S
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 494 QKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553
+ D +S GV+ LL G P + + + ++K E ++ + + ++
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQILKAE-----YEFDSPYWDDI 236
Query: 554 EEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ ++ + + P+ R + +
Sbjct: 237 SDSAKDFIR---HLMEKDPEKRFTCEQA 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 142 bits (359), Expect = 4e-38
Identities = 57/277 (20%), Positives = 106/277 (38%), Gaps = 35/277 (12%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-------FREKMEVVGSMDHENL 374
++G+G FG Y + G + A+K L + K+ R + +V + D +
Sbjct: 10 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
V + +++ D+ + D M G L L + + A + ++H
Sbjct: 70 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMH 124
Query: 435 SKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID--GYRAPEV-TDARK 491
++ + ++K +NILL + RISD GLA S + GY APEV
Sbjct: 125 NRFVV--YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVA 182
Query: 492 VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551
AD +S G +L +LL G +P + ++ ++ R ++ E
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------------D 230
Query: 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
+ E+ LL+ + + R +E+
Sbjct: 231 SFSPELRSLLE---GLLQRDVNRRLGCLGRG--AQEV 262
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 8e-37
Identities = 68/285 (23%), Positives = 111/285 (38%), Gaps = 36/285 (12%)
Query: 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+V+G G+FG Y+A L + G +VA+K++ ++ +++++ +DH N+V LR ++
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ---DKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 382 YSRDEK------LLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
YS EK LV DY+P H +R + L R++AY+HS
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHS 140
Query: 436 KGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSS---TPNRIDGYRAP-EVTDAR 490
G H +IK N+LL + ++ DFG A + YRAP + A
Sbjct: 141 FGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 491 KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV-------- 542
+ DV+S G +L ELL G+ + + V E E+
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258
Query: 543 ------FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ E + L P R + E
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEA 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 1e-35
Identities = 59/306 (19%), Positives = 105/306 (34%), Gaps = 42/306 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYY 381
+G G+FG Y T + G VA+K T + E ++ M +P +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIE-SKIYKMMQGGVGIPTIRWC 71
Query: 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANS 441
+ + ++ + SL L + + +T LA I Y+HSK
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFI-- 125
Query: 442 HGNIKSSNILLS---KSYEARISDFGLAHLASPSSTPNRID-----------GYRAPEVT 487
H ++K N L+ K I DFGLA + T I Y +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547
+ S++ D+ S G +L+ G P Q L + + ++
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT-------KRQKYERISEKKMSTPIE 238
Query: 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQAHD------- 600
+ + E L C + D++P + + + +QG ++D
Sbjct: 239 VLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNLFH---RQGFSYDYVFDWNM 292
Query: 601 LENGSS 606
L+ G+S
Sbjct: 293 LKFGAS 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (334), Expect = 2e-35
Identities = 46/287 (16%), Positives = 89/287 (31%), Gaps = 36/287 (12%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVP-LRAY 380
+G+G+FG ++ T L VA+K + R++ + +P + +
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 381 YYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPAN 440
+LV D + L R + +T + A + +H K
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEKSLV- 123
Query: 441 SHGNIKSSNILLSK-----SYEARISDFGLAHLASPSSTPNRID-----------GYRAP 484
+ +IK N L+ + + + DFG+ T I Y +
Sbjct: 124 -YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 485 EVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544
R+ S++ D+ + G + + L G P Q G+ Q + +
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ------GLKAATNKQKYERIGEKKQSTP 236
Query: 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591
L L EE + + D P + ++
Sbjct: 237 LRELC-AGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-35
Identities = 59/274 (21%), Positives = 105/274 (38%), Gaps = 36/274 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLK-------DVTVSEKEFREKMEVVGSMDHENL 374
E LG G F K G+ A K +K VS ++ ++ ++ + H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLH 434
+ L Y ++ + +L+ + + G L L L E + + YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLH 130
Query: 435 SKGPANSHGNIKSSNILLSKSYEAR----ISDFGLAHLASPSSTPNRIDG---YRAPEVT 487
S A H ++K NI+L + I DFGLAH + I G + APE+
Sbjct: 131 SLQIA--HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIV 188
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547
+ + +AD++S GV+ LL+G +P +E +A ++ E
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-----------TLANVSAVNYEFED 237
Query: 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ N ++ + P R ++ +
Sbjct: 238 EYFSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (331), Expect = 4e-35
Identities = 58/283 (20%), Positives = 115/283 (40%), Gaps = 38/283 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKM----EVVGSMDHENLVPL 377
E+LG G + A L + VAVK L+ + F + + +++H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 378 RAYYYSRDEKL----LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
+ +V +Y+ +L ++H P+ + + A +A+ +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFS 127
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-------GYRAPEV 486
H G H ++K +NI++S + ++ DFG+A + S Y +PE
Sbjct: 128 HQNGII--HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546
V ++DVYS G +L E+LTG+ P G V+E+
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVREDPI-----PP 234
Query: 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRP-SMAEVTSQIEEI 588
R++ + ++ ++ A+ P+NR + AE+ + + +
Sbjct: 235 SARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 131 bits (329), Expect = 7e-35
Identities = 56/281 (19%), Positives = 107/281 (38%), Gaps = 32/281 (11%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLRA 379
E +G+GT+G YKA G A+K+++ E ++ ++ + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 380 YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPA 439
+++ +LV +++ L L T L IAY H +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 440 NSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID----GYRAPEV-TDARKVSQ 494
H ++K N+L+++ E +I+DFGLA + YRAP+V ++K S
Sbjct: 123 --HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 495 KADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR----- 549
D++S G + E++ G + + + + + V +L
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240
Query: 550 ---------YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ ++E + LL P+ R + +
Sbjct: 241 YEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQA 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-34
Identities = 61/268 (22%), Positives = 104/268 (38%), Gaps = 35/268 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHENLVP 376
++LGKG+FG + A + A+K LK V + EK + + +H L
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 377 LRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK 436
+ + +++ V +Y+ G L + + + A + +LHSK
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSK 122
Query: 437 GPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRI----DGYRAPEVTDARKV 492
G + ++K NILL K +I+DFG+ Y APE+ +K
Sbjct: 123 GIV--YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 493 SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552
+ D +SFGVLL E+L G++P G D S+ + +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPF------HGQDEEELFHSIRMDNPFYP---------RW 225
Query: 553 VEEEMVQLLQLAINCTAQYPDNRPSMAE 580
+E+E LL + P+ R +
Sbjct: 226 LEKEAKDLLV---KLFVREPEKRLGVRG 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 57/280 (20%), Positives = 100/280 (35%), Gaps = 23/280 (8%)
Query: 323 EVLGKGTFGTAYKAT--LEMGIVVAVKRLKDVTVSEKE----FREK--MEVVGSMDHENL 374
+G+G +G +KA G VA+KR++ T E RE + + + +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 375 VPLRAYYYSRDEKLLVHDYMPMGSLS-ALLHGNRGAGRTPLNWETRSGLALGASRAIAYL 433
V L + + L + ET + R + +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 434 HSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDAR 490
HS H ++K NIL++ S + +++DFGLA + S + YRAPEV
Sbjct: 133 HSHRVV--HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS 190
Query: 491 KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550
+ D++S G + E+ K + + + + V + EE L +
Sbjct: 191 SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 250
Query: 551 QNVEEEMV---------QLLQLAINCTAQYPDNRPSMAEV 581
+ + + L + C P R S
Sbjct: 251 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 52/290 (17%), Positives = 109/290 (37%), Gaps = 42/290 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE--KEFREKMEVVGSMDHENLVPLRA 379
+G+G +G A + VA+K++ + +++++ HEN++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 380 YYYSRDEKLLVHDYMPM----GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
+ + + Y+ L LL L+ + R + Y+HS
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIHS 127
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-------GYRAPEV-T 487
H ++K SN+LL+ + + +I DFGLA +A P YRAPE+
Sbjct: 128 AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 488 DARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547
+++ ++ D++S G +L E+L+ + + ++ + +E + +L+
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 548 LRYQ----------------NVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
Y N + + + LL P R + +
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 6e-34
Identities = 58/284 (20%), Positives = 108/284 (38%), Gaps = 35/284 (12%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE------KEFREKMEVVGSMDHENLV 375
+ LG+G F T YKA +VA+K++K SE + +++++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 376 PLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
L + + LV D+M + + L L + + YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEV-TDAR 490
H ++K +N+LL ++ +++DFGLA SP+ YRAPE+ AR
Sbjct: 119 HWIL--HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 491 KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL-- 548
D+++ G +L ELL + + + EE ++ L
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 549 -----------RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ ++++ L+Q P R + +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQA 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (322), Expect = 1e-33
Identities = 56/267 (20%), Positives = 107/267 (40%), Gaps = 30/267 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE----KEFREKMEVVGSMDHENLVPL 377
LG G+FG + G A+K LK V + ++ ++ + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ + ++ DY+ G L +LL ++ A A+ YLHSK
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD 124
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDGYRAPEVTDARKVSQKA 496
+ ++K NILL K+ +I+DFG A ++ + T Y APEV + ++
Sbjct: 125 II--YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 497 DVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
D +SFG+L+ E+L G P + + + ++ E E+
Sbjct: 183 DWWSFGILIYEMLAGYTPFY------DSNTMKTYEKILNAELR---------FPPFFNED 227
Query: 557 MVQLLQ--LAINCTAQYPDNRPSMAEV 581
+ LL + + + + + + +V
Sbjct: 228 VKDLLSRLITRDLSQRLGNLQNGTEDV 254
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 5e-33
Identities = 54/282 (19%), Positives = 107/282 (37%), Gaps = 32/282 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLR 378
E +G+GT+G YKA G VVA+K+++ T +E ++ ++ ++H N+V L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
++ ++ LV +++ + + + +A+ HS
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSHRV 123
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID----GYRAPEV-TDARKVS 493
H ++K N+L++ +++DFGLA + YRAPE+ + S
Sbjct: 124 L--HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 494 QKADVYSFGVLLLELLTGKAP-----TQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548
D++S G + E++T +A L L + V + +
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241
Query: 549 RY---------QNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
++ ++E+ LL P+ R S
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 5e-33
Identities = 59/273 (21%), Positives = 101/273 (36%), Gaps = 44/273 (16%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEF-----REKMEVV----GSMDHE 372
+LG G FG+ Y + + VA+K ++ +S+ R MEVV S
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
++ L ++ D +L+ + RG L E A+ +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125
Query: 433 LHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHLASPSSTPNRI--DGYRAPEVTDA 489
H+ G H +IK NIL+ + E ++ DFG L + + Y PE
Sbjct: 126 CHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRY 183
Query: 490 RKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548
+ + A V+S G+LL +++ G P + E+ ++
Sbjct: 184 HRYHGRSAAVWSLGILLYDMVCGDIPFEH---------------------DEEIIRGQVF 222
Query: 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
Q V E L++ C A P +RP+ E+
Sbjct: 223 FRQRVSSECQHLIR---WCLALRPSDRPTFEEI 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 22/278 (7%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLR 378
+ +G G +G A G VA+K+L SE K ++ ++ M HEN++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+ + D+ + G L + L + + Y+H+ G
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAG- 141
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDGYRAPEV-TDARKVSQKA 496
H ++K N+ +++ E +I DFGLA S + YRAPEV + + +Q
Sbjct: 142 -IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTV 200
Query: 497 DVYSFGVLLLELLTGKAP---------TQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547
D++S G ++ E++TGK + ++ G +VQ + +E + L
Sbjct: 201 DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPE 260
Query: 548 LRYQNVEEEMVQLLQLAIN----CTAQYPDNRPSMAEV 581
L ++ + LA+N + R + E
Sbjct: 261 LEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (301), Expect = 2e-30
Identities = 49/265 (18%), Positives = 104/265 (39%), Gaps = 26/265 (9%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREK----MEVVGSMDHENLVPL 377
+ LG G+FG E G A+K L V + + E ++ +++ LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ +V +Y+ G + + L + A YLHS
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDGYRAPEVTDARKVSQKA 496
+ ++K N+L+ + +++DFG A + + T APE+ ++ ++
Sbjct: 162 LI--YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 497 DVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556
D ++ GVL+ E+ G P A + + + +++++ DL
Sbjct: 220 DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL----------- 268
Query: 557 MVQLLQLAINCTAQYPDNRPSMAEV 581
+ LLQ ++ T ++ + + + ++
Sbjct: 269 LRNLLQ--VDLTKRFGNLKNGVNDI 291
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 3e-30
Identities = 63/275 (22%), Positives = 100/275 (36%), Gaps = 36/275 (13%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKM----EVVGSMDHENLVPL 377
++LGKGTFG G A+K L+ + K+ V+ + H L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 378 RAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG 437
+ + + D V +Y G L L R E A+ YLHS+
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD 125
Query: 438 PANSHGNIKSSNILLSKSYEARISDFGLA-HLASPSSTPNRIDG---YRAPEVTDARKVS 493
+ +IK N++L K +I+DFGL S +T G Y APEV +
Sbjct: 126 VV--YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 494 QKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553
+ D + GV++ E++ G+ P D R + ++ EE + +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPF------YNQDHERLFELILMEEIRFP---------RTL 228
Query: 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588
E LL + P R +E+
Sbjct: 229 SPEAKSLLA---GLLKKDPKQRLGGGPSD--AKEV 258
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 5e-29
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 22/278 (7%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLR 378
+G G +G+ A + G+ VAVK+L S K ++ ++ M HEN++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+ +D + L N + L + L R + Y+HS
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD- 141
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLAS-PSSTPNRIDGYRAPEVT-DARKVSQKA 496
H ++K SN+ +++ E +I DFGLA + YRAPE+ + +Q
Sbjct: 142 -IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 497 DVYSFGVLLLELLTGKAP---------TQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547
D++S G ++ ELLTG+ + +L G ++ + E + L
Sbjct: 201 DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQ 260
Query: 548 LRYQNVEEEMVQLLQLAIN----CTAQYPDNRPSMAEV 581
+ N + LA++ D R + A+
Sbjct: 261 MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 8e-29
Identities = 58/283 (20%), Positives = 103/283 (36%), Gaps = 34/283 (12%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLR 378
E +G+GT+GT +KA E +VA+KR++ E ++ ++ + H+N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 379 AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+S + LV ++ N L+ E + + + HS+
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN- 121
Query: 439 ANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG----YRAPEV-TDARKVS 493
H ++K N+L++++ E ++++FGLA + YR P+V A+ S
Sbjct: 122 -VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 494 QKADVYSFGVLLLELLTGKAPT----------QALLNEEGVDLPRWVQSVVKEEWTAEVF 543
D++S G + EL P + + G S+ K
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 544 DLELLR-----YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEV 581
+ LLQ N P R S E
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEA 280
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 51/289 (17%), Positives = 97/289 (33%), Gaps = 32/289 (11%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLR 378
+G+GTFG +KA + G VA+K++ E +++++ + HEN+V L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 379 AYYYSRDEKLLVHD---YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS 435
++ Y+ L G + + Y+H
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135
Query: 436 KGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID--------GYRAPEV- 486
H ++K++N+L+++ +++DFGLA S + YR PE+
Sbjct: 136 NK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 487 TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546
R D++ G ++ E+ T Q + + L + + E V + E
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253
Query: 547 LLRYQNVEEEMV--------------QLLQLAINCTAQYPDNRPSMAEV 581
L + + L L P R +
Sbjct: 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 112 bits (280), Expect = 7e-28
Identities = 48/288 (16%), Positives = 99/288 (34%), Gaps = 41/288 (14%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSM-DHENLVPLRAY 380
LG+G + ++A + V VK LK V +K+ + +++++ ++ N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILK--PVKKKKIKREIKILENLRGGPNIITLADI 98
Query: 381 YYSRDEKL--LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGP 438
+ LV +++ L L +A+ Y HS G
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 149
Query: 439 ANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVT-DARKVS 493
H ++K N+++ + + R+ D+GLA P N ++ PE+ D +
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYD 208
Query: 494 QKADVYSFGVLLLELLTGKAP--------------TQALLNEEGVDLPRWVQSVVKEEWT 539
D++S G +L ++ K P + L E+ D + +
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 540 AEVFDLELLRYQNVEEEMV------QLLQLAINCTAQYPDNRPSMAEV 581
+ R++ + L +R + E
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 7e-27
Identities = 63/285 (22%), Positives = 102/285 (35%), Gaps = 40/285 (14%)
Query: 323 EVLGKGTFGTAYKATL----EMGIVVAVKRLKDVTVSEKE-----FREKMEVVGSMDHE- 372
+VLG G +G + + G + A+K LK T+ +K R + +V+ +
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 373 NLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
LV L + + + L+ DY+ G L L R A+ +
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEH 144
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRID-----GYRAPEV- 486
LH G + +IK NILL + ++DFGL+ T D Y AP++
Sbjct: 145 LHKLGII--YRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 487 -TDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545
+ D +S GVL+ ELLTG +P + + E + +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-----------SQAEISRRILKS 251
Query: 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590
E Q + L+Q + P R +EI
Sbjct: 252 EPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGPRD--ADEIKE 291
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 7e-24
Identities = 57/301 (18%), Positives = 105/301 (34%), Gaps = 57/301 (18%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLR 378
+ +G G G A + VA+K+L ++ K ++ ++ ++H+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 379 AYYYSRD------EKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAY 432
+ + + LV + M + + E S L I +
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIKH 134
Query: 433 LHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDG---YRAPEVTDA 489
LHS G H ++K SNI++ +I DFGLA A S YRAPEV
Sbjct: 135 LHSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 490 RKVSQKADVYSFGVLLLELLTGKAP---------------------------TQALLNEE 522
+ D++S G ++ E++ K Q +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 523 GVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQ--LAINCTAQYPDNRPSMAE 580
+ P++ + + +F + + + LL L I+ P R S+ +
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID-----PAKRISVDD 307
Query: 581 V 581
Sbjct: 308 A 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.4 bits (241), Expect = 1e-22
Identities = 34/211 (16%), Positives = 73/211 (34%), Gaps = 20/211 (9%)
Query: 323 EVLGKGTFGTAYKAT-LEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRA-- 379
LG G F T + A + VA+K ++ V + ++++++ ++ + +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 380 ---------YYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAI 430
++ + + + LL + + ++ +
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 431 AYLHSKGPANSHGNIKSSNILL-SKSYEARISDFGLAHLASPSSTPNRID------GYRA 483
Y+H + H +IK N+L+ + +A L + YR+
Sbjct: 139 DYMHRRCGII-HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 484 PEVTDARKVSQKADVYSFGVLLLELLTGKAP 514
PEV AD++S L+ EL+TG
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.0 bits (193), Expect = 1e-16
Identities = 53/162 (32%), Positives = 78/162 (48%), Gaps = 11/162 (6%)
Query: 3 SDRAALLTLRKAIGGRTLL--WNLTDGPC--KWVGVFCTGE----RVTMLRFPGMGLSGQ 54
D+ ALL ++K +G T L W T C W+GV C + RV L G+ L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 55 LPI--AIGNLTELHTVSLRFNA-LRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLG 111
PI ++ NL L+ + + L G IP AKL+ L LY+ SG IP L +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 112 NLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD 153
L+ L+ + N SGT+ + L L + N+++G+IPD
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 67.1 bits (162), Expect = 1e-12
Identities = 21/83 (25%), Positives = 28/83 (33%), Gaps = 20/83 (24%)
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPK 176
+L N GT+ +L L +L + N L G IP G + NK
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC------ 303
Query: 177 RFARLPSSAFEGNSLCGKPLVSC 199
LCG PL +C
Sbjct: 304 --------------LCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 3e-10
Identities = 17/58 (29%), Positives = 25/58 (43%), Gaps = 1/58 (1%)
Query: 66 HTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNF 123
+ + LR N + GT+P +L L +L + N GEIP +L A N
Sbjct: 247 NGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.0 bits (141), Expect = 4e-10
Identities = 20/66 (30%), Positives = 25/66 (37%), Gaps = 1/66 (1%)
Query: 87 SNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQ 146
NL L L+ N G +P L L L LN++ NN G I L R N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 147 LTGSIP 152
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.1 bits (136), Expect = 2e-09
Identities = 15/54 (27%), Positives = 21/54 (38%), Gaps = 1/54 (1%)
Query: 51 LSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIP 104
+ G LP + L LH++++ FN L G IP L N P
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (186), Expect = 6e-16
Identities = 40/176 (22%), Positives = 59/176 (33%)
Query: 18 RTLLWNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRG 77
TL + G+F + L L +L L + L N +
Sbjct: 108 HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167
Query: 78 TIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRL 137
F L +L L L N + P LG L+ L L NN S + L L
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227
Query: 138 GTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSLCG 193
L L +N ++ L +F S +++ S+P+R A N L G
Sbjct: 228 QYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 6e-06
Identities = 28/109 (25%), Positives = 38/109 (34%), Gaps = 1/109 (0%)
Query: 75 LRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKL 134
LR P+ F L L L+L PGL L L L L N F L
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 135 TRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLP 182
L L+L N+++ SL + + N++ P F L
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 33/164 (20%), Positives = 48/164 (29%), Gaps = 32/164 (19%)
Query: 67 TVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGT 126
T S L+ +P + + ++L GN S + NL L L N +
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 127 I-------------------------SADFNKLTRLGTLYLQENQLTGSIPDLGA-FSSL 160
A F+ L RL TL+L L P L ++L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 161 AQFNVSFNKLNGSIPKRF---ARLPSSAFEGNSLCGKPLVSCNG 201
+ N L F L GN + P + G
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRG 175
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 1e-15
Identities = 34/169 (20%), Positives = 56/169 (33%), Gaps = 29/169 (17%)
Query: 35 FCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYL 94
+ L G L + +LT L + L N + P + L+ L L L
Sbjct: 215 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270
Query: 95 QGNLFSGEIPGLLFS--------------------LGNLIRLNLAKNNFSGTISADFNKL 134
N S P + L NL L L NN S + L
Sbjct: 271 GANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSL 328
Query: 135 TRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
T+L L+ N+++ + L +++ + N+++ P A L
Sbjct: 329 TKLQRLFFANNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTR 374
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.5 bits (166), Expect = 6e-13
Identities = 39/166 (23%), Positives = 57/166 (34%), Gaps = 27/166 (16%)
Query: 23 NLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP-- 80
+L K +G + +T L +S P+ LT+L + L N + P
Sbjct: 225 SLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPL--SGLTKLTELKLGANQISNISPLA 282
Query: 81 ------------------SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNN 122
S + L NL L L N S P + SL L RL A N
Sbjct: 283 GLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNK 340
Query: 123 FSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFN 168
S S LT + L NQ++ P L + + Q ++
Sbjct: 341 VSDVSS--LANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.0 bits (144), Expect = 3e-10
Identities = 20/101 (19%), Positives = 36/101 (35%), Gaps = 6/101 (5%)
Query: 21 LWNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP 80
L + + + + +T L +S + +LT+L + N +
Sbjct: 289 NLELNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD--V 344
Query: 81 SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121
S A L+N+ L N S P L +L + +L L
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 2e-04
Identities = 16/81 (19%), Positives = 27/81 (33%), Gaps = 6/81 (7%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
L E L + T+ L + L I G+ + L NL ++N +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEY-LNNLTQINFSN 75
Query: 121 NNFSGTISADFNKLTRLGTLY 141
N + LT+L +
Sbjct: 76 NQLTDITP--LKNLTKLVDIL 94
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 5e-04
Identities = 15/83 (18%), Positives = 25/83 (30%), Gaps = 5/83 (6%)
Query: 86 LSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQEN 145
L+ L + + L + L + +I L L + N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 76
Query: 146 QLTGSIPDLGAFSSLAQFNVSFN 168
QLT P L + L ++ N
Sbjct: 77 QLTDITP-LKNLTKLVDILMNNN 98
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.3 bits (166), Expect = 7e-14
Identities = 28/203 (13%), Positives = 58/203 (28%), Gaps = 35/203 (17%)
Query: 323 EVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEK-----------EFREKMEVVGSMDH 371
+++G+G + E VK K S K F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 372 ENLVPLR----AYYYSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGAS 427
L L+ Y+ + ++ + + + E +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKE------------LYRVRVENPDEVLDMIL 113
Query: 428 RAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSSTPNRIDGYRAPEVT 487
+A + +G HG++ N+L+S+ I DF + ++ R
Sbjct: 114 EEVAKFYHRGIV--HGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILE--RDVRNI 168
Query: 488 DA---RKVSQKADVYSFGVLLLE 507
R + D+ S +L+
Sbjct: 169 ITYFSRTYRTEKDINSAIDRILQ 191
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 69.3 bits (168), Expect = 2e-13
Identities = 36/188 (19%), Positives = 57/188 (30%), Gaps = 36/188 (19%)
Query: 29 CKWVGVFCTGER-----------VTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRG 77
C V C+ +L ++ NL LHT+ L N +
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 78 TIPSDFAKLSNLRNLYLQGNLFSGEIPGL------LFSLGN-----------------LI 114
P FA L L LYL N + L N ++
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSI 174
L SG + F + +L + + + +T +IP G SL + ++ NK+
Sbjct: 130 ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ-GLPPSLTELHLDGNKITKVD 187
Query: 175 PKRFARLP 182
L
Sbjct: 188 AASLKGLN 195
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.5 bits (153), Expect = 1e-11
Identities = 37/180 (20%), Positives = 60/180 (33%), Gaps = 7/180 (3%)
Query: 21 LWNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP 80
N K V V L + SG A + +L + + + TIP
Sbjct: 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP 166
Query: 81 SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTL 140
+L L+L GN + L L NL +L L+ N+ S + L L
Sbjct: 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLREL 224
Query: 141 YLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPS----SAFEGNSLCGKPL 196
+L N+L L + + N ++ F +++ G SL P+
Sbjct: 225 HLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPV 284
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.8 bits (130), Expect = 1e-08
Identities = 20/91 (21%), Positives = 32/91 (35%), Gaps = 11/91 (12%)
Query: 70 LRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISA 129
NA I S +L L + N E+P L RL + N+ + +
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPE 321
Query: 130 DFNKLTRLGTLYLQENQLTGSIPDLGAFSSL 160
L L+++ N L PD+ S+
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDI--PESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 3e-07
Identities = 23/91 (25%), Positives = 34/91 (37%), Gaps = 8/91 (8%)
Query: 93 YLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP 152
N S EI L +L LN++ N + A +L R L N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVP 320
Query: 153 DLGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183
+L +L Q +V +N L P +
Sbjct: 321 EL--PQNLKQLHVEYNPLR-EFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.1 bits (97), Expect = 1e-04
Identities = 20/75 (26%), Positives = 28/75 (37%), Gaps = 4/75 (5%)
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFAR 180
N S I + + L L + N+L +P L L + SFN L +P+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL--PPRLERLIASFNHLA-EVPELPQN 325
Query: 181 LPSSAFEGNSLCGKP 195
L E N L P
Sbjct: 326 LKQLHVEYNPLREFP 340
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.1 bits (119), Expect = 3e-08
Identities = 27/120 (22%), Positives = 39/120 (32%), Gaps = 10/120 (8%)
Query: 69 SLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTIS 128
L L T+ +L + +L L N P L +L L L + N
Sbjct: 4 HLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60
Query: 129 ADFNKLTRLGTLYLQENQLTG--SIPDLGAFSSLAQFNVSFNKL---NGSIPKRFARLPS 183
+ L L N+L +I L + L N+ N L G + LPS
Sbjct: 61 VANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 5e-08
Identities = 17/89 (19%), Positives = 29/89 (32%), Gaps = 6/89 (6%)
Query: 88 NLRNLYLQGNLFSGE-IPGLLFSLGNLIRLNLAKNNFSG----TISADFNKLTRLGTLYL 142
++++L +Q S LL L + L + IS+ L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 143 QENQLTGSIPDLGAFSSLAQFNVSFNKLN 171
+ N+L L + KL+
Sbjct: 63 RSNELGDVGVHCVL-QGLQTPSCKIQKLS 90
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 9/77 (11%)
Query: 87 SNLRNLYLQGNLFSGE----IPGLLFSLGNLIRLNLAKNNFSGTISADF-----NKLTRL 137
S LR L+L S + L + +L L+L+ N L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 138 GTLYLQENQLTGSIPDL 154
L L + + + D
Sbjct: 429 EQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 13/93 (13%), Positives = 27/93 (29%), Gaps = 10/93 (10%)
Query: 64 ELHTVSLRFNALRGTIPSD-FAKLSNLRNLYLQGNLFSGE----IPGLLFSLGNLIRLNL 118
++ ++ ++ L ++ L + + L + I L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 119 AKNNFSGT-----ISADFNKLTRLGTLYLQENQ 146
N + ++ L LQ
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 18/136 (13%), Positives = 34/136 (25%), Gaps = 15/136 (11%)
Query: 22 WNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGT--- 78
F +++ R G+ + L + L + +
Sbjct: 328 CCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCS 387
Query: 79 -IPSDFAKLSNLRNLYLQGNLFSGEIP-----GLLFSLGNLIRLNLAKNNFSGTISADFN 132
+ + +LR L L N + L +L L +S +
Sbjct: 388 SLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM----- 442
Query: 133 KLTRLGTLYLQENQLT 148
RL L + L
Sbjct: 443 -EDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 2e-05
Identities = 12/76 (15%), Positives = 26/76 (34%), Gaps = 6/76 (7%)
Query: 112 NLIRLNLAKNNFSGT-ISADFNKLTRLGTLYLQENQLTGSIPD-----LGAFSSLAQFNV 165
++ L++ S + L + + L + LT + L +LA+ N+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 166 SFNKLNGSIPKRFARL 181
N+L +
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 4e-04
Identities = 11/76 (14%), Positives = 18/76 (23%), Gaps = 4/76 (5%)
Query: 54 QLPIAIGNLTELHTVSLRFNALRG----TIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS 109
+ + L + V L L I S L L L+ N +
Sbjct: 18 RWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ 77
Query: 110 LGNLIRLNLAKNNFSG 125
+ K +
Sbjct: 78 GLQTPSCKIQKLSLQN 93
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 13/63 (20%), Positives = 29/63 (46%), Gaps = 3/63 (4%)
Query: 109 SLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFN 168
+L N I++ K+N + T++ L + TL +T +I + ++L + N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDN 73
Query: 169 KLN 171
++
Sbjct: 74 QIT 76
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 6e-06
Identities = 19/97 (19%), Positives = 32/97 (32%), Gaps = 4/97 (4%)
Query: 22 WNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPS 81
L + + + + NL++L T+ N + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 82 DFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
A L NL ++L+ N S P L + NL + L
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.001
Identities = 15/63 (23%), Positives = 24/63 (38%), Gaps = 4/63 (6%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
L ++ + + T+ A L + L G + I G+ + L NLI L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEGVQY-LNNLIGLELKD 72
Query: 121 NNF 123
N
Sbjct: 73 NQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.001
Identities = 15/60 (25%), Positives = 24/60 (40%), Gaps = 3/60 (5%)
Query: 107 LFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVS 166
L +L L L N S L L ++L+ NQ++ P L S+L ++
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT 225
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 4e-06
Identities = 18/64 (28%), Positives = 30/64 (46%), Gaps = 5/64 (7%)
Query: 110 LGNLIRLNLAKNNFSGTIS-ADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFN 168
L ++ L K N + T+S D +++T TL + SI + ++L Q N S N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQTDLDQVT---TLQADRLGIK-SIDGVEYLNNLTQINFSNN 72
Query: 169 KLNG 172
+L
Sbjct: 73 QLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 6e-04
Identities = 14/72 (19%), Positives = 24/72 (33%), Gaps = 2/72 (2%)
Query: 21 LWNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIP 80
L L + ++ + + NLT L + + N +
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--I 187
Query: 81 SDFAKLSNLRNL 92
S AKL+NL +L
Sbjct: 188 SVLAKLTNLESL 199
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 4e-06
Identities = 17/79 (21%), Positives = 25/79 (31%), Gaps = 5/79 (6%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+ + V+ L +P D K + L+L NL L L +LNL
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 119 AKNNFSGTISADFNKLTRL 137
+ T L L
Sbjct: 63 --DRAELTKLQVDGTLPVL 79
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 12/65 (18%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 82 DFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLY 141
+ +K+++ + + +P L + L+L++N A TRL L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 142 LQENQ 146
L +
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 6e-04
Identities = 17/71 (23%), Positives = 27/71 (38%), Gaps = 1/71 (1%)
Query: 29 CKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSN 88
G+ ++ L L+ + L L T+ L+ N+L TIP F
Sbjct: 138 TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHL 196
Query: 89 LRNLYLQGNLF 99
L +L GN +
Sbjct: 197 LPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 23/75 (30%), Positives = 28/75 (37%)
Query: 97 NLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGA 156
N PGLL L +L+LA NN + + N L L TL LQEN L
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFG 193
Query: 157 FSSLAQFNVSFNKLN 171
L + N
Sbjct: 194 SHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.001
Identities = 31/126 (24%), Positives = 44/126 (34%), Gaps = 1/126 (0%)
Query: 22 WNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPS 81
+ + T +T+L L+ A+ L EL + L+ N L+ P
Sbjct: 83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142
Query: 82 DFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLY 141
L L L N + GLL L NL L L +N+ TI F L +
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201
Query: 142 LQENQL 147
L N
Sbjct: 202 LHGNPW 207
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 1e-05
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSG--EIPGLLFSLGNLIRL 116
+ ++ R + + T+ + L +L L N ++ ++ NL L
Sbjct: 38 LVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD 153
NL+ N D K +L L+L N L+ + D
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 7e-05
Identities = 21/123 (17%), Positives = 41/123 (33%), Gaps = 9/123 (7%)
Query: 79 IPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLG 138
+ +K + L P L+ + + LN +++ + T+ + L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGLR-SDPDLV-AQNIDVVLNR-RSSMAATLRIIEENIPELL 68
Query: 139 TLYLQENQLTGSIP---DLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSA---FEGNSLC 192
+L L N+L + +L N+S N+L + +GNSL
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 193 GKP 195
Sbjct: 129 DTF 131
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 23/80 (28%), Positives = 30/80 (37%), Gaps = 2/80 (2%)
Query: 55 LPIAIGNLTELHTVSLRFNALRGT--IPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGN 112
L I N+ EL +++L N L + S K NL+ L L GN E
Sbjct: 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116
Query: 113 LIRLNLAKNNFSGTISADFN 132
L L L N+ S T
Sbjct: 117 LEELWLDGNSLSDTFRDQST 136
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 3e-05
Identities = 18/115 (15%), Positives = 32/115 (27%), Gaps = 3/115 (2%)
Query: 81 SDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTL 140
+ + R L L+G I L +L ++ + N F L RL TL
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 141 YLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSLCGKP 195
+ N++ L + N + + + P
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 1e-04
Identities = 23/129 (17%), Positives = 34/129 (26%), Gaps = 10/129 (7%)
Query: 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAK 120
N + LR + I + A L + N ++ G L L L +
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 72
Query: 121 NNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQF------NVSFNKLNGSI 174
N L L L L N L + DL +SL
Sbjct: 73 NRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYR 131
Query: 175 PKRFARLPS 183
++P
Sbjct: 132 LYVIYKVPQ 140
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (97), Expect = 4e-05
Identities = 27/150 (18%), Positives = 40/150 (26%), Gaps = 14/150 (9%)
Query: 63 TELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFS-LGNLIRLNLAKN 121
+ + NL LY++ + LG L L + K+
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 122 NFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGS-------- 173
F+ RL L L N L SL + +S N L+ S
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 174 -IPKRFARLPSSAF---EGNSLCGKPLVSC 199
+ +P L P SC
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNASC 156
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 8e-05
Identities = 10/64 (15%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 109 SLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFN 168
+ I+ NL K + + ++ N+L + + + + S+ + ++ + ++ N
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQGIQYLPNVTKLFLNGN 78
Query: 169 KLNG 172
KL
Sbjct: 79 KLTD 82
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 38/185 (20%), Positives = 57/185 (30%), Gaps = 14/185 (7%)
Query: 29 CKWVGVFCTGER-----------VTMLRFPGMGLSGQLPIAI-GNLTELHTVSLRFNALR 76
C+ V CTG T L L + G L L + L+ N L
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 77 GTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTR 136
G P+ F S+++ L L N + L L LNL N S + F L
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 137 LGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSAFEGNSL-CGKP 195
L +L L N + L + +++ P + + + C
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSE 187
Query: 196 -LVSC 199
C
Sbjct: 188 NSEGC 192
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 3e-04
Identities = 8/44 (18%), Positives = 13/44 (29%), Gaps = 1/44 (2%)
Query: 76 RGTIPSD-FAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118
+P+D F S L + L +L L +
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 4e-04
Identities = 10/55 (18%), Positives = 19/55 (34%), Gaps = 4/55 (7%)
Query: 101 GEIPGLLFS-LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDL 154
E+P +F + L++++ S L +L L +P L
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLPTL 241
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 6e-04
Identities = 14/87 (16%), Positives = 25/87 (28%), Gaps = 4/87 (4%)
Query: 21 LWNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPI-AIGNLTELHTVSLRFNALRGTI 79
LW +G + G ++ L +LP + + + +
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 80 PSDFAKLSNLRNLYLQGNLFSGEIPGL 106
L LR NL ++P L
Sbjct: 218 SYGLENLKKLRARSTY-NL--KKLPTL 241
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 17/105 (16%), Positives = 30/105 (28%), Gaps = 10/105 (9%)
Query: 22 WNLTDGPCKWVGVFCTGERVTMLRFPGMGLSGQLPIA----IGNLTELHTVSLRFNALRG 77
+L R L + G + L T+ L++N +
Sbjct: 228 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 287
Query: 78 TIPSDFA-----KLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117
K+ +L L L GN FS E ++ + +
Sbjct: 288 DAVRTLKTVIDEKMPDLLFLELNGNRFSEE-DDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 6e-04
Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 8/91 (8%)
Query: 65 LHTVSLRFNALRG----TIPSDFAKLSNLRNLYLQGNLFSGE----IPGLLFSLGNLIRL 116
+ SL+ +A+ ++ + + +++ + L GN E + + S +L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQL 147
+ L L L+ +L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.002
Identities = 12/79 (15%), Positives = 19/79 (24%), Gaps = 11/79 (13%)
Query: 93 YLQGNLFSGEIPGLLF------SLGNLIRLNLAKNNFSGTI-----SADFNKLTRLGTLY 141
L L S + L L L N + K+ L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 142 LQENQLTGSIPDLGAFSSL 160
L N+ + + +
Sbjct: 309 LNGNRFSEEDDVVDEIREV 327
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 606 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.81 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.74 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.73 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.73 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.69 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.67 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.65 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.64 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.62 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.6 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.59 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.57 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.53 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.51 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.49 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.47 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.46 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.46 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.46 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.32 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.1 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.98 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.91 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.89 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.77 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.72 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.57 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.51 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.48 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.39 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.99 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.94 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.65 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.38 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.29 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.95 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.11 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.5 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=405.33 Aligned_cols=247 Identities=26% Similarity=0.410 Sum_probs=200.3
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|++.++..||||+++......++|.+|++++++++||||++++|+|...+..++||||+++|+|.+
T Consensus 10 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 10 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 46799999999999999888999999998877788999999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~ 476 (606)
++.... ..+++..+..++.|||.||+|||+++++ ||||||+|||+++++.+||+|||+++...... ...
T Consensus 90 ~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~ii--HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 163 (263)
T d1sm2a_ 90 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEEACVI--HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 163 (263)
T ss_dssp HHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTTCC--CTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred Hhhccc----cCCCHHHHHHHHHHHHHHHHhhhcccee--ecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence 987542 4589999999999999999999999966 99999999999999999999999998654322 234
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhC-CCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTG-KAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
+|..|+|||++.+..|+.++|||||||++|||+|+ ++||.. ......+..+... ... ..+..
T Consensus 164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~------~~~~~~~~~i~~~-~~~----------~~p~~ 226 (263)
T d1sm2a_ 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN------RSNSEVVEDISTG-FRL----------YKPRL 226 (263)
T ss_dssp -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS------CCHHHHHHHHHHT-CCC----------CCCTT
T ss_pred cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC------CCHHHHHHHHHhc-CCC----------CCccc
Confidence 56779999999999999999999999999999995 555532 2222233322221 111 11122
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
+..++.+++.+||+.||++||||+||+++|++++++
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 345688999999999999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=398.62 Aligned_cols=249 Identities=28% Similarity=0.401 Sum_probs=197.7
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||.||+|+++ ..||||+++.... ..+.|.+|++++++++|||||++++++. .+..++||||+++|+
T Consensus 13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~ 89 (276)
T d1uwha_ 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS 89 (276)
T ss_dssp CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence 467999999999999865 3599999975432 3467999999999999999999999875 457899999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC------
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS------ 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~------ 472 (606)
|.+++.... ..+++..+..++.|||.||+|||+++++ ||||||+|||++.++.+||+|||+|+.....
T Consensus 90 L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~iv--HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 90 LYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKSII--HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCCEe--ccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 999997543 3589999999999999999999999966 9999999999999999999999999765432
Q ss_pred CCCCCcccccCccccCCC---CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 STPNRIDGYRAPEVTDAR---KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~---~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
....+|+.|||||++.+. .|+.++|||||||++|||+||+.||..... ...+......+.... ...
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~------~~~~~~~~~~~~~~p----~~~- 232 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------RDQIIFMVGRGYLSP----DLS- 232 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHHTSCCC----CGG-
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcCCCCC----cch-
Confidence 234578889999998643 589999999999999999999999965321 112222222221111 110
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.....++..+.+++.+||+.||++||||+||+++|+.+.++
T Consensus 233 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 233 -KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11123446788999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=400.68 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=204.0
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||.||+|+++++..||||+++......++|.+|++++++++|||||+++|++. ++..++||||+++|+|.+
T Consensus 18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~ 96 (272)
T d1qpca_ 18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD 96 (272)
T ss_dssp EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHH
Confidence 5779999999999999988899999999887778889999999999999999999999875 467799999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-----CCCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-----STPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~ 476 (606)
++.... ...+++..+++++.||++||+|||+++++ ||||||+|||+++++.+||+|||+|+..... ....
T Consensus 97 ~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~iv--HrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (272)
T d1qpca_ 97 FLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYI--HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171 (272)
T ss_dssp HTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred HHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcc--cCccchhheeeecccceeeccccceEEccCCccccccccC
Confidence 876543 23589999999999999999999999955 9999999999999999999999999876542 2345
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEE 556 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 556 (606)
++..|||||++.+..++.++|||||||++|||+||..|+... .........+.. +... ..+...
T Consensus 172 gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~-----~~~~~~~~~i~~-~~~~----------~~p~~~ 235 (272)
T d1qpca_ 172 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-----MTNPEVIQNLER-GYRM----------VRPDNC 235 (272)
T ss_dssp CCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT-----CCHHHHHHHHHT-TCCC----------CCCTTC
T ss_pred CcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC-----CCHHHHHHHHHh-cCCC----------CCcccC
Confidence 667899999999889999999999999999999965554321 122222222222 1111 111223
Q ss_pred HHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 557 MVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 557 ~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
+..+.+++.+||+.||++||||.+|++.|+++..+
T Consensus 236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 45688999999999999999999999999998754
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=392.75 Aligned_cols=244 Identities=25% Similarity=0.383 Sum_probs=206.3
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChhh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLSA 401 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 401 (606)
.+.||+|+||+||+|+++++..||||+++.....+++|.+|++++++++||||++++|+|.+++..++||||+++|+|..
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~ 88 (258)
T d1k2pa_ 9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88 (258)
T ss_dssp CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHH
T ss_pred eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHH
Confidence 46799999999999999888999999999888888999999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----CCC
Q 037905 402 LLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----TPN 476 (606)
Q Consensus 402 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~ 476 (606)
++.... ..+++..+.+++.|+++||+|||++|++ ||||||+|||+++++.+||+|||+++...... ...
T Consensus 89 ~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~ii--H~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~ 162 (258)
T d1k2pa_ 89 YLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQFL--HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 162 (258)
T ss_dssp HHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTTBC--CSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSC
T ss_pred hhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcCcc--cccccceeEEEcCCCcEEECcchhheeccCCCceeecccC
Confidence 987543 3588999999999999999999999966 99999999999999999999999997654322 234
Q ss_pred CcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 477 RIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 477 ~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
++..|+|||++.+..++.++|||||||++|||+| |+.||..... ......+ ..+... ..+..
T Consensus 163 ~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~~~i-~~~~~~----------~~p~~ 225 (258)
T d1k2pa_ 163 FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHI-AQGLRL----------YRPHL 225 (258)
T ss_dssp CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHH-HTTCCC----------CCCTT
T ss_pred CCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH------HHHHHHH-HhCCCC----------CCccc
Confidence 5677999999999999999999999999999998 8999975322 2222222 222111 11122
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.+..+.+++.+||+.||++||||++|+++|.+|
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 335788999999999999999999999999753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.4e-50 Score=400.89 Aligned_cols=250 Identities=27% Similarity=0.410 Sum_probs=207.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||+||+|+.. +++.||||+++......++|.+|++++++++|||||+++++|.+.+..++||||+++|+|.
T Consensus 22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~ 101 (287)
T d1opja_ 22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101 (287)
T ss_dssp EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchH
Confidence 567999999999999975 5889999999887777889999999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-----C
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST-----P 475 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-----~ 475 (606)
+++.... ...+++..+..++.||+.||+|||+++++ ||||||+|||+++++.+||+|||+|+....... .
T Consensus 102 ~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~ii--HrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~ 176 (287)
T d1opja_ 102 DYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKNFI--HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176 (287)
T ss_dssp HHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTE
T ss_pred HHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCCcc--cCccccCeEEECCCCcEEEccccceeecCCCCceeeccc
Confidence 9997543 34689999999999999999999999966 999999999999999999999999987654322 2
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.++..|+|||++.+..|+.++|||||||++|||++|+.|+... .+... +...+..+... ..+..
T Consensus 177 ~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~-----~~~~~-~~~~i~~~~~~----------~~~~~ 240 (287)
T d1opja_ 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-----IDLSQ-VYELLEKDYRM----------ERPEG 240 (287)
T ss_dssp EECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT-----CCHHH-HHHHHHTTCCC----------CCCTT
T ss_pred cccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc-----chHHH-HHHHHhcCCCC----------CCCcc
Confidence 3456799999999999999999999999999999977665421 12222 22222222211 11122
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.+..+.+++.+||+.||++||||.||++.|+.+.++.
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 3456889999999999999999999999999886543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=393.18 Aligned_cols=239 Identities=28% Similarity=0.417 Sum_probs=200.7
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 10 i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~ 89 (263)
T d2j4za1 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89 (263)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred EEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4578999999999999864 68999999986432 345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--C
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--S 473 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~ 473 (606)
+|+|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+|+..... .
T Consensus 90 ~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~iv--HrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 162 (263)
T d2j4za1 90 LGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKRVI--HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT 162 (263)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred CCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCee--eeeeccccceecCCCCEeecccceeeecCCCccc
Confidence 999999997543 589999999999999999999999966 9999999999999999999999999876543 2
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+|+.|||||++.+..|+.++|||||||++|||++|+.||... +.......+...... .+
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~------------~p 224 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN------TYQETYKRISRVEFT------------FP 224 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHTTCCC------------CC
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC------CHHHHHHHHHcCCCC------------CC
Confidence 346788999999999999999999999999999999999999642 223333333322211 11
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....++.+++.+||+.||++|||++|++++
T Consensus 225 ~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 225 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1223467888999999999999999999874
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-49 Score=399.30 Aligned_cols=247 Identities=23% Similarity=0.456 Sum_probs=195.3
Q ss_pred hcccccCCceEEEEEEEc-C---CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-M---GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.++||+|+||+||+|+.. + ...||||++..... ..++|.+|++++++++|||||+++|+|...+..++||||++
T Consensus 31 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~ 110 (299)
T d1jpaa_ 31 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFME 110 (299)
T ss_dssp EEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecC
Confidence 467999999999999864 2 24689998875433 34579999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC-
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST- 474 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 474 (606)
+|+|.+++.... ..+++..+..++.|||+||+|||+++++ ||||||+|||++.++.+||+|||+|+.......
T Consensus 111 ~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH~~~ii--HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 111 NGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLADMNYV--HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp TEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHhhCCCc--cCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 999999887543 3589999999999999999999999966 999999999999999999999999986543211
Q ss_pred --------CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 475 --------PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 475 --------~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
..+++.|||||++.+..++.++|||||||++|||+| |+.||.... ....+..+.. +..
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~------~~~~~~~i~~-~~~------ 251 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT------NQDVINAIEQ-DYR------ 251 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHHHHHT-TCC------
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC------HHHHHHHHHc-CCC------
Confidence 234667999999999999999999999999999998 899996532 2222222222 111
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.+.+.+++..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 252 ----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 252 ----LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 111223456788999999999999999999999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=394.02 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=201.7
Q ss_pred ccccCCceEEEEEEEc---CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 324 VLGKGTFGTAYKATLE---MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 324 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
+||+|+||.||+|.+. ++..||||+++.... ..++|.+|++++++++|||||+++|+|.+ +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 4999999999999753 456899999976432 34679999999999999999999999864 56899999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS----- 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----- 473 (606)
|.+++.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+|+......
T Consensus 95 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~ii--HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (285)
T d1u59a_ 95 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKNFV--HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 168 (285)
T ss_dssp HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred HHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCCee--cCcCchhheeeccCCceeeccchhhhccccccccccc
Confidence 999986432 3699999999999999999999999965 99999999999999999999999998654321
Q ss_pred --CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 474 --TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 474 --~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+....+ ..+...
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~------~~~~~~~i-~~~~~~---------- 231 (285)
T d1u59a_ 169 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------GPEVMAFI-EQGKRM---------- 231 (285)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------THHHHHHH-HTTCCC----------
T ss_pred ccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC------HHHHHHHH-HcCCCC----------
Confidence 2345677999999998899999999999999999998 999997532 22222222 222211
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
..+..++.++.+++.+||+.+|++||||.+|++.|+.+..+..++
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 112234467889999999999999999999999999887654443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=394.97 Aligned_cols=247 Identities=25% Similarity=0.340 Sum_probs=198.9
Q ss_pred cccccCCceEEEEEEEc---CCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATLE---MGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
++||+|+||.||+|.++ .++.||||+++.... ..++|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 357899999975432 24679999999999999999999999864 567899999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|+|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~ii--HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFV--HRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCCcc--cCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 99999998543 589999999999999999999999955 99999999999999999999999998654322
Q ss_pred ----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 474 ----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 474 ----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
...+|+.|||||.+.+..++.++|||||||++|||+| |+.||.... ...... .+..+...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~------~~~~~~-~i~~~~~~-------- 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK------GSEVTA-MLEKGERM-------- 229 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC------HHHHHH-HHHTTCCC--------
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC------HHHHHH-HHHcCCCC--------
Confidence 2346678999999999899999999999999999998 899997532 222222 22222111
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ 594 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~ 594 (606)
+.+..++.++.+++.+||+.||++||||++|++.|+....+...
T Consensus 230 --~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 230 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred --CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcCC
Confidence 11223445788999999999999999999999999987655443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=391.43 Aligned_cols=240 Identities=25% Similarity=0.356 Sum_probs=199.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc-cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT-VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|+. .+|+.||||+++... ...+.+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 25 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L 104 (293)
T d1yhwa1 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104 (293)
T ss_dssp CEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcH
Confidence 46799999999999985 579999999997543 3567799999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----STP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~~ 475 (606)
.+++... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+|+..... ...
T Consensus 105 ~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~ii--HrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 105 TDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVI--HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp HHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred HHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCCCc--ccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 9988743 489999999999999999999999965 9999999999999999999999999865432 334
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+|+.|+|||++.+..|+.++|||||||++|||++|+.||... +....+..+...... . ...+..
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~~~~~~~~-~--------~~~~~~ 241 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE------NPLRALYLIATNGTP-E--------LQNPEK 241 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHHCSC-C--------CSSGGG
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC------CHHHHHHHHHhCCCC-C--------CCCccc
Confidence 6788999999999999999999999999999999999999642 222222223222211 0 111122
Q ss_pred HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....+.+++.+||+.||++|||+.|++++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 34567889999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=386.18 Aligned_cols=242 Identities=24% Similarity=0.411 Sum_probs=193.3
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEe----CCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYS----RDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 393 (606)
.++||+|+||+||+|+.. +++.||+|++...... .+.+.+|++++++++|||||+++++|.+ +...++||||
T Consensus 14 ~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~ 93 (270)
T d1t4ha_ 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTEL 93 (270)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEEC
T ss_pred eeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeC
Confidence 356999999999999864 6889999999765433 3568899999999999999999999875 3457899999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec-CCCcEEEeecccCccCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS-KSYEARISDFGLAHLASPS 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~-~~~~~kl~DfG~a~~~~~~ 472 (606)
+++|+|.+++.... .+++..+..++.||+.||+|||+++..|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 94 ~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 94 MTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp CCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 99999999997543 58999999999999999999999985556999999999996 5789999999999865443
Q ss_pred --CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 --STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....+|+.|||||++.+ .|+.++|||||||++|||++|+.||.... +.......+.. +.....++
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~~i~~-~~~~~~~~------ 235 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTS-GVKPASFD------ 235 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTT-TCCCGGGG------
T ss_pred ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----cHHHHHHHHHc-CCCCcccC------
Confidence 24568899999999876 59999999999999999999999996421 22222222222 11111000
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....++.+++.+||+.||++|||++|++++
T Consensus 236 ---~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 236 ---KVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp ---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ---ccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1122357889999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=388.62 Aligned_cols=249 Identities=23% Similarity=0.419 Sum_probs=196.8
Q ss_pred hcccccCCceEEEEEEEcCC-----cEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLEMG-----IVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.++||+|+||.||+|.++.. ..||||+++.... ...+|.+|++++++++|||||+++|+|.+....++||||+
T Consensus 12 ~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~ 91 (283)
T d1mqba_ 12 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91 (283)
T ss_dssp EEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred eeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEec
Confidence 46799999999999986532 4799999975433 2356899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
.++++.+++.... ..+++..+.+++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~ii--HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 92 ENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMNYV--HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp TTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred ccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhccccccc--cCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 9999999887543 3589999999999999999999999966 99999999999999999999999998654321
Q ss_pred ------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 ------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 ------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...+|..|||||++.+..++.++|||||||++|||++|..|+... ......+.. +..+..
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~-----~~~~~~~~~-i~~~~~-------- 231 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE-----LSNHEVMKA-INDGFR-------- 231 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT-----CCHHHHHHH-HHTTCC--------
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc-----CCHHHHHHH-HhccCC--------
Confidence 124567799999999999999999999999999999966555321 112222222 222211
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.+.+..++..+.+++.+||+.+|++||||.||++.|+++.+..
T Consensus 232 --~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 232 --LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp --CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 1112234456889999999999999999999999999998754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=391.80 Aligned_cols=257 Identities=27% Similarity=0.369 Sum_probs=206.2
Q ss_pred HHhcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 320 ASAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
...+.||+|+||.||+|+..++..||||+++......+.|.+|+.++++++|||||+++|+|. ++..++||||+++|+|
T Consensus 20 ~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l 98 (285)
T d1fmka3 20 RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSL 98 (285)
T ss_dssp EEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBH
T ss_pred EEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCch
Confidence 346789999999999999988889999999887778889999999999999999999999984 5678999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-----C
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS-----T 474 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~ 474 (606)
.+++.... ...++|..++.++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++...... .
T Consensus 99 ~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~iv--H~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~ 173 (285)
T d1fmka3 99 LDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMNYV--HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173 (285)
T ss_dssp HHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECGGGCEEECCCCTTC------------
T ss_pred hhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhhee--cccccceEEEECCCCcEEEcccchhhhccCCCceeecc
Confidence 99987543 23589999999999999999999999966 99999999999999999999999998654322 2
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+++.|+|||++....++.++|||||||++|||++|+.|+... ......+..+.. +... +.+.
T Consensus 174 ~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~-----~~~~~~~~~i~~-~~~~----------~~~~ 237 (285)
T d1fmka3 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG-----MVNREVLDQVER-GYRM----------PCPP 237 (285)
T ss_dssp --CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT-----CCHHHHHHHHHT-TCCC----------CCCT
T ss_pred ccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC-----CCHHHHHHHHHh-cCCC----------CCCc
Confidence 34677899999999999999999999999999999976665421 122222322222 1111 1122
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccccCCC
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQGQA 598 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~~~~ 598 (606)
.+..++.+++.+||+.||++||||++|++.|++...+...+.++
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 33457889999999999999999999999999987666554444
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=390.19 Aligned_cols=240 Identities=21% Similarity=0.281 Sum_probs=193.2
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||+||+|+. .+|+.||||++..... ..+.+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~ 89 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence 47899999999999986 4689999999975432 34568999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC------C
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP------S 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~------~ 472 (606)
|.+++... ..+++..+..++.||+.||+|||++|++ ||||||+|||+++++.+||+|||+|+.... .
T Consensus 90 L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~Ii--HrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 90 LFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIGIT--HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp GGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcCCc--cCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 99999743 3689999999999999999999999955 999999999999999999999999986532 2
Q ss_pred CCCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 STPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....+|+.|||||++.+..+ +.++|||||||++|||+||+.||....... ............. .
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~-----~~~~~~~~~~~~~----------~ 227 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTYL----------N 227 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS-----HHHHHHHTTCTTS----------T
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcCCCCC----------C
Confidence 34568899999999988776 578999999999999999999996532211 1111111111000 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTS 583 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~ 583 (606)
.......++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11122345778899999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=388.63 Aligned_cols=245 Identities=19% Similarity=0.279 Sum_probs=189.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCH---HHHHHHHHHHcCCCCCCcccceEEEEe--CCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSE---KEFREKMEVVGSMDHENLVPLRAYYYS--RDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|+. .+|+.||||++......+ +.+.+|++++++++||||+++++++.+ ....++||||++
T Consensus 9 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~ 88 (269)
T d2java1 9 LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88 (269)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCT
T ss_pred eEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCC
Confidence 46899999999999986 468999999997655433 458899999999999999999999875 356799999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---CCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG---PANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~---~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
+|+|.+++..... ....+++..++.++.||+.||+|||+++ ..|+||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 167 (269)
T d2java1 89 GGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167 (269)
T ss_dssp TEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---
T ss_pred CCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccC
Confidence 9999999864321 1246999999999999999999999976 12559999999999999999999999999875442
Q ss_pred ----CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 473 ----STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 473 ----~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
....+|+.|||||++.+..|+.++|||||||++|||+||+.||... +.......+...... .
T Consensus 168 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~------~~~~~~~~i~~~~~~-~------- 233 (269)
T d2java1 168 TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKELAGKIREGKFR-R------- 233 (269)
T ss_dssp --------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHTCCC-C-------
T ss_pred CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC------CHHHHHHHHHcCCCC-C-------
Confidence 2356788999999999999999999999999999999999999642 222333333222211 1
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+.....++.+++.+||+.||++|||+.|++++
T Consensus 234 ---~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 234 ---IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011233468889999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.6e-48 Score=391.59 Aligned_cols=242 Identities=24% Similarity=0.354 Sum_probs=200.1
Q ss_pred HHhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 320 ASAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 320 ~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
...+.||+|+||.||+|+. .+|+.||||+++..... .+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 18 ~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 97 (309)
T d1u5ra_ 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97 (309)
T ss_dssp EEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEec
Confidence 3457899999999999985 57899999999765432 246889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCCC
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSST 474 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 474 (606)
.+|+|..++... ..+++..+..++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+|+.......
T Consensus 98 ~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~ii--HrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (309)
T d1u5ra_ 98 LGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHNMI--HRDVKAGNILLSEPGLVKLGDFGSASIMAPANS 170 (309)
T ss_dssp SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCSGGGEEEETTTEEEECCCTTCBSSSSBCC
T ss_pred CCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCCEe--ccCCCcceEEECCCCCEEEeecccccccCCCCc
Confidence 999998776543 3589999999999999999999999966 999999999999999999999999998877777
Q ss_pred CCCcccccCccccCC---CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 475 PNRIDGYRAPEVTDA---RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~---~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
..+|+.|||||++.+ ..|+.++|||||||++|||++|+.||... .....+..+..... ....
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~------~~~~~~~~i~~~~~-~~~~-------- 235 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM------NAMSALYHIAQNES-PALQ-------- 235 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS------CHHHHHHHHHHSCC-CCCS--------
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC------CHHHHHHHHHhCCC-CCCC--------
Confidence 889999999999864 45899999999999999999999999642 22222333332221 1110
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.......+.+++.+||+.||++|||++|++++
T Consensus 236 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11223468889999999999999999999763
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=388.42 Aligned_cols=242 Identities=23% Similarity=0.358 Sum_probs=198.5
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
.+.||+|+||.||+|+. .+|+.||||+++.... ..+.+.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus 17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L 96 (288)
T d2jfla1 17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence 46799999999999986 4689999999976433 346789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC----CCCC
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP----SSTP 475 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~----~~~~ 475 (606)
.+++.... ..+++..+..++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+|+.... ....
T Consensus 97 ~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~iv--HrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~ 170 (288)
T d2jfla1 97 DAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNKII--HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170 (288)
T ss_dssp HHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCC
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCEE--EeecChhheeECCCCCEEEEechhhhccCCCccccccc
Confidence 99986532 3589999999999999999999999955 999999999999999999999999975432 2356
Q ss_pred CCcccccCccccC-----CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 476 NRIDGYRAPEVTD-----ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 476 ~~~~~y~aPE~~~-----~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
.+|+.|||||++. ...|+.++|||||||++|||+||+.||..... ...+..+...... . .
T Consensus 171 ~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~------~~~~~~i~~~~~~-~--------~ 235 (288)
T d2jfla1 171 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP------MRVLLKIAKSEPP-T--------L 235 (288)
T ss_dssp CSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG------GGHHHHHHHSCCC-C--------C
T ss_pred ccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCC-C--------C
Confidence 7888999999984 45689999999999999999999999975322 2223333322211 0 1
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..+.....++.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122334568889999999999999999999764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=381.90 Aligned_cols=246 Identities=29% Similarity=0.446 Sum_probs=194.5
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEe-CCceEEEEeecCCCChh
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYS-RDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~ 400 (606)
.+.||+|+||.||+|++. |+.||||+++.. ...+++.+|++++++++||||++++|+|.+ .+..++||||+++|+|.
T Consensus 12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~ 89 (262)
T d1byga_ 12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89 (262)
T ss_dssp EEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred eEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence 577999999999999986 889999999764 345779999999999999999999999865 45679999999999999
Q ss_pred hhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCCCCcc
Q 037905 401 ALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STPNRID 479 (606)
Q Consensus 401 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~ 479 (606)
+++.... ...+++..+++++.||+.||.|||+.+++ ||||||+|||++.++.+||+|||+++..... ....++.
T Consensus 90 ~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~iv--H~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~ 164 (262)
T d1byga_ 90 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNNFV--HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 164 (262)
T ss_dssp HHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECTTSCEEECCCCC------------CCT
T ss_pred HHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCcee--ccccchHhheecCCCCEeecccccceecCCCCccccccc
Confidence 9997532 23589999999999999999999999966 9999999999999999999999999875543 2345567
Q ss_pred cccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHHHHH
Q 037905 480 GYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEEEMV 558 (606)
Q Consensus 480 ~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~ 558 (606)
.|+|||++.+..+++++|||||||++|||+| |++||.... ..+....+ .++.... .+.....
T Consensus 165 ~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~------~~~~~~~i-~~~~~~~----------~~~~~~~ 227 (262)
T d1byga_ 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRV-EKGYKMD----------APDGCPP 227 (262)
T ss_dssp TTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC------GGGHHHHH-TTTCCCC----------CCTTCCH
T ss_pred cCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC------HHHHHHHH-HcCCCCC----------CCccCCH
Confidence 8999999998899999999999999999998 688876432 22222222 2222111 1222335
Q ss_pred HHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 559 QLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 559 ~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
++.+++.+||+.||++||||.+|+++|+++...
T Consensus 228 ~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 688999999999999999999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-48 Score=393.96 Aligned_cols=189 Identities=23% Similarity=0.371 Sum_probs=168.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||+||+|+. .+|+.||+|+++... .....+.+|+.++++++|||||+++++|.+.++.++||||+++|+
T Consensus 11 ~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~ 90 (322)
T d1s9ja_ 11 ISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90 (322)
T ss_dssp EEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred EEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCc
Confidence 46799999999999986 478999999997543 235678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC--CCCC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSK-GPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--SSTP 475 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--~~~~ 475 (606)
|.+++.... .+++..+..++.|++.||.|||++ +++ ||||||+|||++.++.+||+|||+|+.... ..+.
T Consensus 91 L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~Ii--HRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 163 (322)
T d1s9ja_ 91 LDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIM--HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 163 (322)
T ss_dssp HHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCC--CSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred HHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCEE--ccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence 999997543 589999999999999999999975 766 999999999999999999999999986532 3456
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCccc
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQA 517 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~ 517 (606)
.+|+.|||||++.+..|+.++||||+||++|||++|+.||..
T Consensus 164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 789999999999999999999999999999999999999965
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=393.43 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=198.5
Q ss_pred HhcccccCCceEEEEEEEcC------CcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATLEM------GIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 391 (606)
..+.||+|+||+||+|+... ...||||++..... ....+.+|+.++.++ +|||||+++++|.+.+..++||
T Consensus 41 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 120 (325)
T d1rjba_ 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120 (325)
T ss_dssp EEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEE
Confidence 35789999999999998642 24799999865432 345788999999988 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec
Q 037905 392 DYMPMGSLSALLHGNRGA------------------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS 453 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~ 453 (606)
||+++|+|.++++..... ....+++..++.++.||+.||+|||+++++ ||||||+|||++
T Consensus 121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~Ii--HRDlKp~Nill~ 198 (325)
T d1rjba_ 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV--HRDLAARNVLVT 198 (325)
T ss_dssp ECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE--ETTCSGGGEEEE
T ss_pred EcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCee--eccCchhccccc
Confidence 999999999999764321 123589999999999999999999999955 999999999999
Q ss_pred CCCcEEEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCCh
Q 037905 454 KSYEARISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDL 526 (606)
Q Consensus 454 ~~~~~kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~ 526 (606)
.++.+||+|||+|+...... ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.....
T Consensus 199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~------ 272 (325)
T d1rjba_ 199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV------ 272 (325)
T ss_dssp TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC------
T ss_pred cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH------
Confidence 99999999999998654432 2335778999999999999999999999999999998 8999965321
Q ss_pred hHHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHH
Q 037905 527 PRWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEE 587 (606)
Q Consensus 527 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~ 587 (606)
...+..++..+... +.+..++.++.++|.+||+.||++||||+||+++|..
T Consensus 273 ~~~~~~~~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DANFYKLIQNGFKM----------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHHHHHHHHTTCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCC----------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 12223333333211 1122334578899999999999999999999999963
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-47 Score=385.90 Aligned_cols=243 Identities=24% Similarity=0.352 Sum_probs=186.4
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
..+.||+|+||+||+|+.. +|+.||||++..... ..+.+.+|++++++++||||+++++++.+++..++||||+++|
T Consensus 13 ~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg 92 (307)
T d1a06a_ 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92 (307)
T ss_dssp EEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred EEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCC
Confidence 3578999999999999864 689999999976533 2456889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec---CCCcEEEeecccCccCCCC--
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS---KSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~-- 472 (606)
+|.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||+. +++.+||+|||+|+.....
T Consensus 93 ~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~ii--HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 93 ELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLGIV--HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp BHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred cHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhceee--eEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 999999753 3599999999999999999999999966 999999999994 5789999999999866443
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....+|+.|||||++.+..|++++|||||||++|||++|+.||... ........+........ .+
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~i~~~~~~~~--------~~ 231 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE------NDAKLFEQILKAEYEFD--------SP 231 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHTTCCCCC--------TT
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC------CHHHHHHHHhccCCCCC--------Cc
Confidence 2346788999999999999999999999999999999999999642 22233333333221110 01
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....+..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 112233567889999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=382.01 Aligned_cols=240 Identities=22% Similarity=0.296 Sum_probs=198.9
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
..+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 12 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~ 91 (288)
T d1uu3a_ 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAK 91 (288)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccC
Confidence 357899999999999986 468999999997532 234679999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+|+|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+|||+++++.+||+|||+|+.....
T Consensus 92 gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~ii--HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 92 NGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKGII--HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp TEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhccccEE--cCcCCccccccCCCceEEecccccceecccCCcc
Confidence 999999987543 589999999999999999999999966 9999999999999999999999999865432
Q ss_pred ---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhc
Q 037905 473 ---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLR 549 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 549 (606)
....+|+.|||||++.+..|+.++|||||||++|||++|+.||... +.......+......
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~i~~~~~~---------- 228 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG------NEYLIFQKIIKLEYD---------- 228 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHTTCCC----------
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc------CHHHHHHHHHcCCCC----------
Confidence 2346889999999999999999999999999999999999999642 222333333332210
Q ss_pred ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHH
Q 037905 550 YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQI 585 (606)
Q Consensus 550 ~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L 585 (606)
.+......+.+++.+||+.||++|||++|+.++-
T Consensus 229 --~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~ 262 (288)
T d1uu3a_ 229 --FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 262 (288)
T ss_dssp --CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH
T ss_pred --CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH
Confidence 0112234578899999999999999999986653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=380.96 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=200.4
Q ss_pred hcccccCCceEEEEEEEcC----CcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeC-CceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLEM----GIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSR-DEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~ 394 (606)
.++||+|+||+||+|++.. ...||||+++.... ..++|.+|++++++++||||++++|+|... ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 3579999999999998643 24699999975322 336799999999999999999999998764 5789999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
++|+|.+++.... ..+++..+++++.|++.||.|||+.+++ ||||||+|||+++++.+||+|||+++......
T Consensus 112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH~~~ii--HrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLASKKFV--HRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhcccCcc--cCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999988543 3578889999999999999999999966 99999999999999999999999998654321
Q ss_pred -------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchh
Q 037905 474 -------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLE 546 (606)
Q Consensus 474 -------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 546 (606)
...++..|+|||.+....++.++||||||+++|||+||+.||..... ..+....+.... ..
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-----~~~~~~~i~~g~-~~------ 253 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYLLQGR-RL------ 253 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTC-CC------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC-----HHHHHHHHHcCC-CC------
Confidence 13456779999999999999999999999999999998888754221 111222222221 11
Q ss_pred hhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 547 LLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 547 ~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
..+..+...+.++|.+||+.||++||||.||+++|+++..+...+
T Consensus 254 ----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 254 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred ----CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 111223356889999999999999999999999999998765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=383.99 Aligned_cols=259 Identities=24% Similarity=0.280 Sum_probs=195.8
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCC----ceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRD----EKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~~~g 397 (606)
.+.||+|+||.||+|+.. |+.||||+++.........+.|+..+.+++||||++++++|.+.+ ..++||||+++|
T Consensus 8 ~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 8 QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEECCSSSEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEeeCCCeEEEEEEEC-CEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 467999999999999975 899999999754332333444555666789999999999998654 578999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKG------PANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
+|.++++.. .++|..+.+++.|+|.||+|||+.. ..|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 999999853 4899999999999999999999741 1245999999999999999999999999976533
Q ss_pred C--------CCCCCcccccCccccCCCC------CCCcchhHHHHHHHHHHHhCCCCcccccccCCC--------ChhHH
Q 037905 472 S--------STPNRIDGYRAPEVTDARK------VSQKADVYSFGVLLLELLTGKAPTQALLNEEGV--------DLPRW 529 (606)
Q Consensus 472 ~--------~~~~~~~~y~aPE~~~~~~------~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~--------~~~~~ 529 (606)
. ....+|++|+|||++.+.. ++.++|||||||++|||+||..||......... .....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHH
Confidence 2 2345788999999987643 577899999999999999999887543221110 01111
Q ss_pred HHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 530 VQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 530 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
....... ...++.........+....+.+++.+||+.||++||||.||+++|+++.++
T Consensus 241 ~~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 241 MRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 1111111 111111111112345667799999999999999999999999999998754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.6e-47 Score=383.33 Aligned_cols=250 Identities=22% Similarity=0.384 Sum_probs=201.6
Q ss_pred hcccccCCceEEEEEEEc------CCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|++. +++.||||+++..... .++|.+|++++++++||||++++++|......++||||
T Consensus 18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~ 97 (301)
T d1lufa_ 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY 97 (301)
T ss_dssp EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence 577999999999999864 4578999999764332 46799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC
Q 037905 394 MPMGSLSALLHGNRG-------------------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK 454 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~ 454 (606)
+++|+|.+++..... .....+++..++.++.|++.||+|||+++++ ||||||+|||++.
T Consensus 98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv--HrDlKp~NILld~ 175 (301)
T d1lufa_ 98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV--HRDLATRNCLVGE 175 (301)
T ss_dssp CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECG
T ss_pred cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE--eeEEcccceEECC
Confidence 999999999974321 1123588999999999999999999999966 9999999999999
Q ss_pred CCcEEEeecccCccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCC-CCcccccccCCCChh
Q 037905 455 SYEARISDFGLAHLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGK-APTQALLNEEGVDLP 527 (606)
Q Consensus 455 ~~~~kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~-~p~~~~~~~~~~~~~ 527 (606)
++.+||+|||+|+..... ....+++.|+|||++.+..|+.++|||||||++|||++|. +||... +..
T Consensus 176 ~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~------~~~ 249 (301)
T d1lufa_ 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM------AHE 249 (301)
T ss_dssp GGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS------CHH
T ss_pred CCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC------CHH
Confidence 999999999998754321 2345667799999999999999999999999999999985 677543 222
Q ss_pred HHHHHHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 528 RWVQSVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 528 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
..+..+.. +... ..+...+.++.+++.+||+.+|++||||.||++.|++|++
T Consensus 250 e~~~~v~~-~~~~----------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 250 EVIYYVRD-GNIL----------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHHHHHHT-TCCC----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHHHHHHc-CCCC----------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 22332222 2111 1112234568899999999999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=376.11 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=192.8
Q ss_pred HhcccccCCceEEEEEEEc----CCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 321 SAEVLGKGTFGTAYKATLE----MGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
..+.||+|+||.||+|+.. .+..||||+++.... ..+.|.+|++++++++||||++++++|. ++..++||||+
T Consensus 11 l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~ 89 (273)
T d1mp8a_ 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELC 89 (273)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred EEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEec
Confidence 3578999999999999863 246799999865433 2467999999999999999999999985 56789999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC--
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 472 (606)
++|+|.+++.... ..+++..++.++.||++||+|||+++++ ||||||+||+++.++.+||+|||+|+.....
T Consensus 90 ~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~ii--HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 90 TLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKRFV--HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp TTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEEEETTEEEECC------------
T ss_pred cCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhcccCee--ccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 9999999876543 3589999999999999999999999966 9999999999999999999999999865432
Q ss_pred ---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhhh
Q 037905 473 ---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELL 548 (606)
Q Consensus 473 ---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 548 (606)
....+|+.|+|||++.+..|+.++|||||||++|||+| |.+||...... .....+.... ..
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~------~~~~~i~~~~-~~-------- 228 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGE-RL-------- 228 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG------GHHHHHHTTC-CC--------
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC-CC--------
Confidence 22345678999999999999999999999999999998 89999754322 2222222211 11
Q ss_pred cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 549 RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 549 ~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
+.+...+..+.+++.+||+.||++|||+.||+++|+++.+.
T Consensus 229 --~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 --PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11223345788999999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=377.18 Aligned_cols=243 Identities=23% Similarity=0.336 Sum_probs=199.2
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCc-------cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT-------VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
..+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++|||||+++++|.+.+..++|||
T Consensus 14 ~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (293)
T d1jksa_ 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILE 93 (293)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357899999999999996 578999999986532 235789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC----cEEEeecccCcc
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY----EARISDFGLAHL 468 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~----~~kl~DfG~a~~ 468 (606)
|+++|+|.+++.... .+++..+..++.|++.||+|||+++++ ||||||+|||++.++ .+|++|||+|+.
T Consensus 94 ~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~iv--HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 94 LVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQIA--HFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred cCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhccee--ecccccceEEEecCCCcccceEecchhhhhh
Confidence 999999999997543 589999999999999999999999966 999999999998876 499999999987
Q ss_pred CCCC---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 469 ASPS---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 469 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
.... ....+++.|+|||++.+..++.++|||||||++|||++|+.||... +.......+....... ..
T Consensus 167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~~~~~~~i~~~~~~~---~~ 237 (293)
T d1jksa_ 167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD------TKQETLANVSAVNYEF---ED 237 (293)
T ss_dssp CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHTTCCCC---CH
T ss_pred cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC------CHHHHHHHHHhcCCCC---Cc
Confidence 6442 3456778899999999999999999999999999999999999643 2222233332221110 00
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. .+......+.+++.+||+.||++|||++|++++
T Consensus 238 ~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 238 E-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp H-----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h-----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 011223567889999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.7e-46 Score=384.50 Aligned_cols=244 Identities=21% Similarity=0.328 Sum_probs=200.9
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
..+.||+|+||.||+|.. .+|+.||||+++.... ..+.+.+|++++++++|||||+++++|.+++..++||||+++|+
T Consensus 33 i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 112 (352)
T d1koba_ 33 ILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112 (352)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCB
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCh
Confidence 357899999999999986 5799999999976543 34678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEec--CCCcEEEeecccCccCCCCC---
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLS--KSYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~--~~~~~kl~DfG~a~~~~~~~--- 473 (606)
|.+++... ...+++..+..++.||+.||+|||++|++ ||||||+|||++ .++.+||+|||+|+......
T Consensus 113 L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~ii--HRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 113 LFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHSIV--HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp HHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCee--ecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 99887643 23599999999999999999999999966 999999999998 67899999999998776533
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+++.|+|||++.+..|+.++|||||||++|||+||+.||... +.......+........ ....
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~i~~~~~~~~--------~~~~ 252 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE------DDLETLQNVKRCDWEFD--------EDAF 252 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS------SHHHHHHHHHHCCCCCC--------SSTT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCCC--------cccc
Confidence 246778899999999999999999999999999999999999642 22333333333221110 0111
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.....++.+++.+||+.||++|||+.|++++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2233567889999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-46 Score=385.27 Aligned_cols=244 Identities=20% Similarity=0.326 Sum_probs=201.0
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCcc-CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV-SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
..+.||+|+||.||+|+. .+|+.||||++..... ..+.+.+|++++++++|||||++++++.+++..++||||+++|+
T Consensus 30 i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 109 (350)
T d1koaa2 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109 (350)
T ss_dssp EEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCC
Confidence 357899999999999986 4799999999976543 34678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC--CCcEEEeecccCccCCCCC---
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK--SYEARISDFGLAHLASPSS--- 473 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~--~~~~kl~DfG~a~~~~~~~--- 473 (606)
|.+++.... ..+++..+..++.||+.||+|||++|++ ||||||+|||++. ++.+||+|||+|+......
T Consensus 110 L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~ii--HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 110 LFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENNYV--HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp HHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred HHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcCCe--eeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 999986432 3599999999999999999999999966 9999999999964 5789999999998765433
Q ss_pred CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccCh
Q 037905 474 TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNV 553 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 553 (606)
...+|+.|||||++.+..|+.++|||||||++|||++|+.||... +....+..+....+.... ...
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~------~~~~~~~~i~~~~~~~~~--------~~~ 249 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE------NDDETLRNVKSCDWNMDD--------SAF 249 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCSCC--------GGG
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCCCc--------ccc
Confidence 246788899999999999999999999999999999999999642 233334444333221110 011
Q ss_pred HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 554 EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 554 ~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+.+++.+||..||++|||++|++++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1223467889999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-46 Score=379.70 Aligned_cols=246 Identities=24% Similarity=0.411 Sum_probs=197.0
Q ss_pred hcccccCCceEEEEEEEc-CCc----EEEEEEeccCc--cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATLE-MGI----VVAVKRLKDVT--VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 394 (606)
.++||+|+||+||+|.+. +|+ +||+|+++... ...++|.+|++++++++|||||+++|+|.+ +..++++||+
T Consensus 14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~~ 92 (317)
T d1xkka_ 14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLM 92 (317)
T ss_dssp EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEec
Confidence 478999999999999864 343 68999886532 346789999999999999999999999976 4667889999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS- 473 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 473 (606)
.+|+|.+++.... ..+++..+++++.|||.||+|||+++++ ||||||+|||++.++.+||+|||+|+......
T Consensus 93 ~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~ii--HrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 93 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRRLV--HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp TTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred cCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcCcc--cCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 9999999887543 4689999999999999999999999966 99999999999999999999999998654322
Q ss_pred -----CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccchhh
Q 037905 474 -----TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLEL 547 (606)
Q Consensus 474 -----~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 547 (606)
...+|..|+|||++.+..|+.++|||||||++|||+| |++||......+ +...+..+..
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~-------~~~~i~~~~~-------- 231 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGER-------- 231 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG-------HHHHHHHTCC--------
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCC--------
Confidence 1245778999999999999999999999999999999 788986532211 1222222211
Q ss_pred hcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 548 LRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 548 ~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.+.+..++..+.+++.+||+.||++|||+.||+++|+.+.+.
T Consensus 232 --~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 232 --LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp --CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred --CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 111223445688999999999999999999999999998654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.1e-46 Score=375.35 Aligned_cols=238 Identities=23% Similarity=0.304 Sum_probs=200.3
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 88 (316)
T d1fota_ 9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 88 (316)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence 57899999999999996 569999999997532 2356789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STP 475 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~ 475 (606)
|+|..++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+|+..... ...
T Consensus 89 g~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ii--HrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~ 161 (316)
T d1fota_ 89 GELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKDII--YRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL 161 (316)
T ss_dssp CBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTTEE--CCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred ccccccccccc-----cccccHHHHHHHHHHHhhhhhccCcEE--ccccCchheeEcCCCCEEEecCccceEeccccccc
Confidence 99999988643 578889999999999999999999955 9999999999999999999999999876543 346
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+|+.|||||++.+..|+.++|||||||++|||++|+.||... +.......+...... .+..
T Consensus 162 ~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~i~~~~~~------------~p~~ 223 (316)
T d1fota_ 162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS------NTMKTYEKILNAELR------------FPPF 223 (316)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHCCCC------------CCTT
T ss_pred cCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc------CHHHHHHHHHcCCCC------------CCCC
Confidence 7889999999999999999999999999999999999999642 233333333332211 0111
Q ss_pred HHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
....+.+++.+||..||++|| |++++++|
T Consensus 224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 234578889999999999996 89999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=377.24 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=190.8
Q ss_pred HhcccccCCceEEEEEEEc------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeC-CceEEE
Q 037905 321 SAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSR-DEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~lv 390 (606)
..+.||+|+||.||+|+.. +++.||||+++.... ..+.+.+|...+.++ +|+||+.+++++... ...++|
T Consensus 17 ~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv 96 (299)
T d1ywna1 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 96 (299)
T ss_dssp EEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEE
T ss_pred EeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEE
Confidence 3578999999999999853 357899999975432 245677787777666 689999999998764 467999
Q ss_pred EeecCCCChhhhhhcCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEE
Q 037905 391 HDYMPMGSLSALLHGNRG-----------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEAR 459 (606)
Q Consensus 391 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~k 459 (606)
|||+++|+|.+++..... .....+++..++.++.||++||+|||+++++ ||||||+|||++.++.+|
T Consensus 97 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iv--HrDlKp~NILl~~~~~~K 174 (299)
T d1ywna1 97 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI--HRDLAARNILLSEKNVVK 174 (299)
T ss_dssp EECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECGGGCEE
T ss_pred EEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCc--CCcCCccceeECCCCcEE
Confidence 999999999999975431 1123589999999999999999999999966 999999999999999999
Q ss_pred EeecccCccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhC-CCCcccccccCCCChhHHHHH
Q 037905 460 ISDFGLAHLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTG-KAPTQALLNEEGVDLPRWVQS 532 (606)
Q Consensus 460 l~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~ 532 (606)
|+|||+|+..... ....+|+.|||||++.+..++.++|||||||++|||+|| .+||.... ....+..
T Consensus 175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~------~~~~~~~ 248 (299)
T d1ywna1 175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK------IDEEFCR 248 (299)
T ss_dssp ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------CSHHHHH
T ss_pred EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC------HHHHHHH
Confidence 9999999865432 223567889999999999999999999999999999996 46775421 1222333
Q ss_pred HhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc
Q 037905 533 VVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS 591 (606)
Q Consensus 533 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~ 591 (606)
.+..+.... .+...+.++.+++.+||+.||++|||+.||+++|+++.++
T Consensus 249 ~~~~~~~~~----------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 249 RLKEGTRMR----------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHTCCCC----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhcCCCCC----------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 333332211 1122345688999999999999999999999999999765
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=376.04 Aligned_cols=238 Identities=25% Similarity=0.309 Sum_probs=199.1
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. .+|+.||||++++.. ...+.+.+|+.++++++||||+++++++.+.+..++||||+++
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g 89 (337)
T d1o6la_ 10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89 (337)
T ss_dssp EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence 57899999999999986 579999999997542 2356788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS---- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---- 472 (606)
|+|.+++.... .+++..++.++.||+.||+|||++|++ ||||||+|||++.+|.+||+|||+|+.....
T Consensus 90 g~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~ii--HRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~ 162 (337)
T d1o6la_ 90 GELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVV--YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 162 (337)
T ss_dssp CBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred Cchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcCcc--ccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence 99999998643 588999999999999999999999966 9999999999999999999999999865432
Q ss_pred CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccC
Q 037905 473 STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQN 552 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 552 (606)
....+|+.|+|||++.+..|+.++|||||||++|||++|++||... +.....+.+...... .
T Consensus 163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~------~~~~~~~~i~~~~~~------------~ 224 (337)
T d1o6la_ 163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ------DHERLFELILMEEIR------------F 224 (337)
T ss_dssp CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------C
T ss_pred ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc------CHHHHHHHHhcCCCC------------C
Confidence 2356788999999999999999999999999999999999999653 223333333332210 1
Q ss_pred hHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 553 VEEEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 553 ~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
+.....++.+++.+||+.||++||+ ++|+++|
T Consensus 225 p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1122345778899999999999995 8888875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-46 Score=375.54 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=200.4
Q ss_pred hcccccCCceEEEEEEEc-CCc--EEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGI--VVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||.||+|++. +|. .||||+++.... ..++|.+|+++++++ +||||++++|+|.+.+..++||||++
T Consensus 15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~ 94 (309)
T d1fvra_ 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 94 (309)
T ss_dssp EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence 578999999999999865 343 578888764322 345799999999998 79999999999999999999999999
Q ss_pred CCChhhhhhcCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecc
Q 037905 396 MGSLSALLHGNR-----------GAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFG 464 (606)
Q Consensus 396 ~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG 464 (606)
+|+|.++++... ......+++..+++++.|||.||.|||+++++ ||||||+|||++.++.+||+|||
T Consensus 95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~ii--HrDlkp~NIL~~~~~~~kl~DfG 172 (309)
T d1fvra_ 95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFI--HRDLAARNILVGENYVAKIADFG 172 (309)
T ss_dssp TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECGGGCEEECCTT
T ss_pred CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCcc--ccccccceEEEcCCCceEEcccc
Confidence 999999997541 11234699999999999999999999999965 99999999999999999999999
Q ss_pred cCccCCCCC---CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCC-CCcccccccCCCChhHHHHHHhhccccc
Q 037905 465 LAHLASPSS---TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGK-APTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 465 ~a~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
+++...... ...+|..|+|||.+....|+.++|||||||++|||++|. +||... +.......+.. +...
T Consensus 173 ~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~------~~~~~~~~i~~-~~~~ 245 (309)
T d1fvra_ 173 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYEKLPQ-GYRL 245 (309)
T ss_dssp CEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHGGG-TCCC
T ss_pred ccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC------CHHHHHHHHHh-cCCC
Confidence 997654322 335677899999999999999999999999999999975 566432 23333333322 2111
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
..+.....++.+++.+||+.||++||||+||+++|+++.++.
T Consensus 246 ----------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 246 ----------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ----------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ----------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 111223456888999999999999999999999999998654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=371.72 Aligned_cols=244 Identities=27% Similarity=0.411 Sum_probs=190.7
Q ss_pred hcccccCCceEEEEEEEc--C--CcEEEEEEeccCcc----CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE--M--GIVVAVKRLKDVTV----SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|+.. + ...||||+++.... ..++|.+|+.++++++||||++++|+|.+ ...++||||
T Consensus 13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~ 91 (273)
T d1u46a_ 13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL 91 (273)
T ss_dssp EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence 467999999999999853 2 34789999875422 23578999999999999999999999965 567899999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS 473 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 473 (606)
+++|++.+++.... ..+++..++.++.|||.||.|||+++++ ||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~ii--HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 92 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKRFI--HRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred ecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCCEe--eeeecHHHhccccccceeeccchhhhhcccCC
Confidence 99999999887543 3599999999999999999999999955 99999999999999999999999998764432
Q ss_pred -------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 474 -------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 474 -------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
...++..|+|||++.+..++.++|||||||++|||+| |+.||... +....+..+...+....
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~------~~~~~~~~i~~~~~~~~---- 235 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKIDKEGERLP---- 235 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTSCCCCC----
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc------CHHHHHHHHHhCCCCCC----
Confidence 1234567999999999999999999999999999998 89999643 33333444444332211
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEI 588 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i 588 (606)
.+...+..+.+++.+||+.||++||||.+|.+.|+++
T Consensus 236 ------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 ------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122335688999999999999999999999999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-45 Score=367.67 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=197.4
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----HHHHHHHHHHHcCCCCCCcccceEEEEeCCc----eEEEEe
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----EKEFREKMEVVGSMDHENLVPLRAYYYSRDE----KLLVHD 392 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lv~e 392 (606)
.+.||+|+||.||+|+. .+|+.||||+++..... .+.+.+|+++++.++||||+++++++...+. .|+|||
T Consensus 12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE 91 (277)
T d1o6ya_ 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence 57899999999999985 57999999999764332 3468899999999999999999999986543 789999
Q ss_pred ecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC
Q 037905 393 YMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS 472 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 472 (606)
|+++++|.+++.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.++++|||.++.....
T Consensus 92 ~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ii--HrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 92 YVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGII--HRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp CCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred CCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCCcc--CccccCcccccCccccceeehhhhhhhhccc
Confidence 999999999987543 589999999999999999999999966 9999999999999999999999988654321
Q ss_pred -------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 473 -------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 473 -------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
....+|+.|||||++.+..+++++|||||||++|||+||+.||... +.......+....... +
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~------~~~~~~~~~~~~~~~~----~ 234 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD------SPVSVAYQHVREDPIP----P 234 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS------SHHHHHHHHHHCCCCC----G
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc------CHHHHHHHHHhcCCCC----C
Confidence 2345788899999999999999999999999999999999999642 2223333333332211 1
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCC-CHHHHHHHHHHHHh
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRP-SMAEVTSQIEEICR 590 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RP-s~~~v~~~L~~i~~ 590 (606)
.. .. ...+..+.+++.+||+.||++|| |++++.+.|.++.+
T Consensus 235 ~~-~~---~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 235 SA-RH---EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp GG-TS---SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred ch-hc---cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence 10 11 12235678889999999999999 89999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=374.51 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=197.2
Q ss_pred HhcccccCCceEEEEEEEc--------CCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEE
Q 037905 321 SAEVLGKGTFGTAYKATLE--------MGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 389 (606)
..+.||+|+||.||+|+.. ++..||||+++.... ...++.+|...+.++ +|||||+++++|.+++..++
T Consensus 17 l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~ 96 (299)
T d1fgka_ 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV 96 (299)
T ss_dssp EEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred EeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEE
Confidence 4578999999999999742 235799999976543 236788888888877 89999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcE
Q 037905 390 VHDYMPMGSLSALLHGNRGA-----------GRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEA 458 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~ 458 (606)
||||+++|+|.+++...... ....+++..++.++.||+.||+|||+++++ ||||||+|||++.++.+
T Consensus 97 v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~iv--HrDiKp~NiLl~~~~~~ 174 (299)
T d1fgka_ 97 IVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCI--HRDLAARNVLVTEDNVM 174 (299)
T ss_dssp EECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEECTTCCE
T ss_pred EEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEE--eeeecccceeecCCCCe
Confidence 99999999999999754311 134689999999999999999999999966 99999999999999999
Q ss_pred EEeecccCccCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHH
Q 037905 459 RISDFGLAHLASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQ 531 (606)
Q Consensus 459 kl~DfG~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (606)
||+|||+++..... ....+++.|+|||.+.+..|++++|||||||++|||++ |++||.... ... +.
T Consensus 175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~------~~~-~~ 247 (299)
T d1fgka_ 175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------VEE-LF 247 (299)
T ss_dssp EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHH-HH
T ss_pred EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC------HHH-HH
Confidence 99999999865432 22346677999999999999999999999999999998 788886422 222 22
Q ss_pred HHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHh
Q 037905 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICR 590 (606)
Q Consensus 532 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~ 590 (606)
..+..+.... .+...+..+.+++.+||+.||++||||.||++.|+++..
T Consensus 248 ~~i~~~~~~~----------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 248 KLLKEGHRMD----------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHTTCCCC----------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCC----------CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2222222111 112233568899999999999999999999999999864
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=374.26 Aligned_cols=256 Identities=22% Similarity=0.335 Sum_probs=205.7
Q ss_pred HhcccccCCceEEEEEEEc------CCcEEEEEEeccCccC--HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEe
Q 037905 321 SAEVLGKGTFGTAYKATLE------MGIVVAVKRLKDVTVS--EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHD 392 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 392 (606)
..+.||+|+||.||+|.+. +++.||||+++..... ...|.+|++++++++||||++++++|..+...++|||
T Consensus 24 l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 103 (308)
T d1p4oa_ 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIME 103 (308)
T ss_dssp EEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEe
Confidence 4578999999999999863 3578999999764332 3458999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 393 YMPMGSLSALLHGNRG-----AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 393 ~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
|+++|+|.+++..... .....+++..+.+++.|+|+||.|||+++++ ||||||+|||+++++.+||+|||+|+
T Consensus 104 ~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~iv--HrDlk~~NiLld~~~~~Kl~DFGla~ 181 (308)
T d1p4oa_ 104 LMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV--HRDLAARNCMVAEDFTVKIGDFGMTR 181 (308)
T ss_dssp CCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB--CSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred ecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCee--eceEcCCceeecCCceEEEeecccce
Confidence 9999999999864311 1233578999999999999999999999866 99999999999999999999999998
Q ss_pred cCCCC------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCC-CCcccccccCCCChhHHHHHHhhccccc
Q 037905 468 LASPS------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGK-APTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 468 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
..... ....+++.|+|||.+.+..++.++||||||+++|||+||. +||... +.......+..... .
T Consensus 182 ~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~~~~~-~ 254 (308)
T d1p4oa_ 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVMEGGL-L 254 (308)
T ss_dssp GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHHTTCC-C
T ss_pred eccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHHHHHhCCC-C
Confidence 65432 2234567799999999999999999999999999999984 777542 23333333332221 1
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhccccc
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQQ 595 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~~ 595 (606)
..+..++..+.++|.+||+.+|++||||.+|+++|++..+....+
T Consensus 255 ----------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 255 ----------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp ----------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred ----------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence 111223457899999999999999999999999999887665544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=371.99 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=203.7
Q ss_pred HhcccccCCceEEEEEEE------cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCC-CCCCcccceEEEEeCCceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATL------EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSM-DHENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 391 (606)
..+.||+|+||.||+|++ .+++.||||+++.... ...++.+|+.+++++ +|||||+++++|.+....++||
T Consensus 27 l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvm 106 (311)
T d1t46a_ 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVIT 106 (311)
T ss_dssp EEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred EeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEE
Confidence 357899999999999985 3467999999976443 345789999999998 6999999999999999999999
Q ss_pred eecCCCChhhhhhcCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcE
Q 037905 392 DYMPMGSLSALLHGNRG-------------AGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEA 458 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~ 458 (606)
||+++|+|.++++.... .....+++..+..++.||+.||+|||+++++ ||||||+||+++.++.+
T Consensus 107 E~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~iv--HrDLKp~NIl~~~~~~~ 184 (311)
T d1t46a_ 107 EYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCI--HRDLAARNILLTHGRIT 184 (311)
T ss_dssp ECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCSGGGEEEETTTEE
T ss_pred EcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCee--ecccccccccccccCcc
Confidence 99999999999975432 1233589999999999999999999999966 99999999999999999
Q ss_pred EEeecccCccCCCCC------CCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHh-CCCCcccccccCCCChhHHHH
Q 037905 459 RISDFGLAHLASPSS------TPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLT-GKAPTQALLNEEGVDLPRWVQ 531 (606)
Q Consensus 459 kl~DfG~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (606)
|++|||.++...... ...+++.|+|||++.+..++.++|||||||++|||+| |.+||.... ....+.
T Consensus 185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~------~~~~~~ 258 (311)
T d1t46a_ 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP------VDSKFY 258 (311)
T ss_dssp EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC------SSHHHH
T ss_pred cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC------HHHHHH
Confidence 999999998765432 2345677999999999999999999999999999999 555554321 112233
Q ss_pred HHhhccccccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcc
Q 037905 532 SVVKEEWTAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSS 592 (606)
Q Consensus 532 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~ 592 (606)
.++..+.... .+...+..+.+|+.+||+.||++||||.||++.|+++..++
T Consensus 259 ~~i~~~~~~~----------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 259 KMIKEGFRML----------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp HHHHHTCCCC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhcCCCCC----------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 3333332211 11223456889999999999999999999999999876553
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.1e-45 Score=374.90 Aligned_cols=238 Identities=19% Similarity=0.216 Sum_probs=199.9
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCc----cCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVT----VSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPM 396 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 396 (606)
.+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+++++.++||||+++++++.+....++||||+.+
T Consensus 46 ~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~ 125 (350)
T d1rdqe_ 46 IKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125 (350)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred EEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccc
Confidence 57899999999999986 479999999986432 2346789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-CCC
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS-STP 475 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~ 475 (606)
|+|.+++.... .+++..+..++.||+.||.|||+++++ ||||||+|||++.++.+||+|||+|+..... ...
T Consensus 126 g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~ii--HRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 198 (350)
T d1rdqe_ 126 GEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLI--YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL 198 (350)
T ss_dssp CBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred cchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEe--cCcCCHHHcccCCCCCEEeeeceeeeecccccccc
Confidence 99999997543 589999999999999999999999955 9999999999999999999999999876543 345
Q ss_pred CCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChHH
Q 037905 476 NRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVEE 555 (606)
Q Consensus 476 ~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 555 (606)
.+|+.|||||++.+..|+.++|||||||++|||+||+.||... +.......+...... .+..
T Consensus 199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~------~~~~~~~~i~~~~~~------------~p~~ 260 (350)
T d1rdqe_ 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD------QPIQIYEKIVSGKVR------------FPSH 260 (350)
T ss_dssp EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCCC------------CCTT
T ss_pred cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc------CHHHHHHHHhcCCCC------------CCcc
Confidence 6888999999999999999999999999999999999999642 233333333332211 1112
Q ss_pred HHHHHHHHHHHccCcCCCCCC-----CHHHHHHH
Q 037905 556 EMVQLLQLAINCTAQYPDNRP-----SMAEVTSQ 584 (606)
Q Consensus 556 ~~~~l~~l~~~Cl~~~P~~RP-----s~~~v~~~ 584 (606)
...++.+++.+||..||++|+ |++|+++|
T Consensus 261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 334678899999999999994 89999874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=375.63 Aligned_cols=244 Identities=21% Similarity=0.307 Sum_probs=200.8
Q ss_pred HhcccccCCceEEEEEEEc-CCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCCh
Q 037905 321 SAEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGSL 399 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 399 (606)
..+.||+|+||+||+|... +|+.||||+++........+.+|+++++.++||||+++++++.+++..|+||||+++|+|
T Consensus 9 i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L 88 (321)
T d1tkia_ 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88 (321)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBH
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcH
Confidence 3578999999999999864 689999999987666667789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC--CcEEEeecccCccCCCCC---C
Q 037905 400 SALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS--YEARISDFGLAHLASPSS---T 474 (606)
Q Consensus 400 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~--~~~kl~DfG~a~~~~~~~---~ 474 (606)
.+++.... ..+++..+..++.||+.||+|||++|++ ||||||+|||++.+ ..+||+|||+++...... .
T Consensus 89 ~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~ii--HrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~ 162 (321)
T d1tkia_ 89 FERINTSA----FELNEREIVSYVHQVCEALQFLHSHNIG--HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162 (321)
T ss_dssp HHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcCCC--cccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence 99997532 3589999999999999999999999966 99999999999854 479999999998765432 2
Q ss_pred CCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcccChH
Q 037905 475 PNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQNVE 554 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 554 (606)
..+++.|+|||...+..|+.++|||||||++|||++|+.||... +....+..+....... +... ..
T Consensus 163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~------~~~~~~~~i~~~~~~~---~~~~-----~~ 228 (321)
T d1tkia_ 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE------TNQQIIENIMNAEYTF---DEEA-----FK 228 (321)
T ss_dssp EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS------SHHHHHHHHHHTCCCC---CHHH-----HT
T ss_pred cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC------CHHHHHHHHHhCCCCC---Chhh-----cc
Confidence 35677899999999999999999999999999999999999643 2223333333322111 0000 01
Q ss_pred HHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 555 EEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 555 ~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
....++.+++.+||..||++|||+.|++++
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123457889999999999999999999885
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.3e-45 Score=362.12 Aligned_cols=242 Identities=20% Similarity=0.293 Sum_probs=197.0
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC----------HHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS----------EKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l 389 (606)
.+.||+|+||+||+|+. .+|+.||||+++..... .+.+.+|+.++++++ ||||+++++++.+++..|+
T Consensus 8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i 87 (277)
T d1phka_ 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87 (277)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence 57899999999999986 57899999999764321 235789999999997 9999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||||+++|+|.+++.... .+++..++.++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+++..
T Consensus 88 vmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~iv--HrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 88 VFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLNIV--HRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCc--ccccccceEEEcCCCCeEEccchheeEc
Confidence 999999999999997543 589999999999999999999999955 9999999999999999999999999876
Q ss_pred CCC---CCCCCcccccCccccC------CCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc
Q 037905 470 SPS---STPNRIDGYRAPEVTD------ARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA 540 (606)
Q Consensus 470 ~~~---~~~~~~~~y~aPE~~~------~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (606)
... ....+|..|+|||++. ...++.++||||+||++|||++|+.||... +.......+.......
T Consensus 161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~------~~~~~~~~i~~~~~~~ 234 (277)
T d1phka_ 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR------KQMLMLRMIMSGNYQF 234 (277)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHTCCCC
T ss_pred cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCC------CHHHHHHHHHhCCCCC
Confidence 543 3345778899999875 345788999999999999999999999753 2222233333332211
Q ss_pred cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 ~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. .........++.+++.+||+.||++|||++||+++
T Consensus 235 ~--------~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 235 G--------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp C--------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred C--------CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0 01112233568889999999999999999998764
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=373.81 Aligned_cols=243 Identities=23% Similarity=0.316 Sum_probs=191.0
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcC-CCCCCcccceEEEEe----CCceEEEEeecCC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGS-MDHENLVPLRAYYYS----RDEKLLVHDYMPM 396 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~lv~e~~~~ 396 (606)
+.||+|+||.||+|+. .+++.||||+++. .+.+.+|++++.+ .+||||++++++|.+ +...|+|||||++
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 5699999999999985 5789999999965 3457788887654 589999999999875 3568999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCccCCCC-
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHLASPS- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~- 472 (606)
|+|.+++.... ...+++..+..++.||+.||+|||++|++ ||||||+|||++. ++.+||+|||+|+.....
T Consensus 94 g~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~ii--HRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 94 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSINIA--HRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp EEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcCCc--cccccccccccccccccccccccccceeeeccCCC
Confidence 99999997532 34699999999999999999999999966 9999999999986 457999999999865442
Q ss_pred --CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 --STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....+|+.|||||++.+..|+.++|||||||++|||+||+.||....... ....+...... ...+. ..
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~---~~~~~~~~i~~----~~~~~---~~ 238 (335)
T d2ozaa1 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKTRIRM----GQYEF---PN 238 (335)
T ss_dssp CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS----CSSSC---CT
T ss_pred ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH---HHHHHHHHHhc----CCCCC---CC
Confidence 34567889999999999999999999999999999999999997643221 11111111110 00000 00
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........++.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122345678899999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.9e-45 Score=374.78 Aligned_cols=241 Identities=23% Similarity=0.261 Sum_probs=192.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCcc----CHHHHH---HHHHHHcCCCCCCcccceEEEEeCCceEEEEee
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTV----SEKEFR---EKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 393 (606)
.+.||+|+||.||+|+.. +|+.||||++..... ....+. +|+.+++.++|||||++++++.+.+..++||||
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~ 88 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence 478999999999999864 699999999865322 223333 447788889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC-
Q 037905 394 MPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS- 472 (606)
Q Consensus 394 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 472 (606)
+++|+|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+|+.....
T Consensus 89 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~ii--HrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 89 MNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRFVV--YRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp CCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred cCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCCcc--ceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 99999999997543 578999999999999999999999966 9999999999999999999999999866543
Q ss_pred -CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhcc
Q 037905 473 -STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRY 550 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 550 (606)
....+|+.|+|||++.. ..|+.++|||||||++|||+||+.||...... ............. .
T Consensus 162 ~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~~~~~~~~~------------~ 226 (364)
T d1omwa3 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK---DKHEIDRMTLTMA------------V 226 (364)
T ss_dssp CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS---CHHHHHHHSSSCC------------C
T ss_pred ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcccCC------------C
Confidence 34568899999999864 56899999999999999999999999753221 1111111111110 0
Q ss_pred cChHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 551 QNVEEEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 551 ~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
..+.....++.+++.+||+.||++||| ++|+++|
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 011122345788999999999999999 6888765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=368.49 Aligned_cols=249 Identities=21% Similarity=0.270 Sum_probs=189.4
Q ss_pred cccccCCceEEEEEEE-cCCcEEEEEEeccCccC------HHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 323 EVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS------EKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
++||+|+||+||+|+. .+|+.||||+++..... .+.+.+|++++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 6799999999999985 46899999998654322 2358899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
++++..+.... ..+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~ii--HrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHWIL--HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhcccee--cccCCcceEEecCCCccccccCccccccCCCccc
Confidence 98777666532 3588889999999999999999999966 9999999999999999999999999765442
Q ss_pred -CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc---cc---cccccc
Q 037905 473 -STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE---EW---TAEVFD 544 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~d 544 (606)
....+|+.|+|||++.. ..|+.++|||||||++|||++|++||....+. +.+..+... .. ......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~------~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL------DQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCTTTSSSTTS
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH------HHHHHHHHhcCCCChhhccchhc
Confidence 23457788999999865 45799999999999999999999999653221 111111110 00 000000
Q ss_pred h----hhhcc-cC-----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 545 L----ELLRY-QN-----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 545 ~----~~~~~-~~-----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. ..... .. .......+.+++.+||+.||++|||++|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 00000 00 01123568899999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-45 Score=368.97 Aligned_cols=237 Identities=24% Similarity=0.339 Sum_probs=193.2
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCc----cCHHHHHHHHHHHc-CCCCCCcccceEEEEeCCceEEEEeecC
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVT----VSEKEFREKMEVVG-SMDHENLVPLRAYYYSRDEKLLVHDYMP 395 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~~~ 395 (606)
.+.||+|+||+||+|+.. +|+.||||+++... ...+.+..|..++. .++||||+++++++.+++..|+||||++
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~ 86 (320)
T d1xjda_ 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86 (320)
T ss_dssp EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence 578999999999999864 69999999997532 23445666666654 6899999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC---
Q 037905 396 MGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 396 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 472 (606)
+|+|.+++.... .+++..+..++.||+.||+|||+++++ ||||||+|||+++++.+||+|||+++.....
T Consensus 87 ~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~ii--HrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~ 159 (320)
T d1xjda_ 87 GGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKGIV--YRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159 (320)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCB--CCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred CCcHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCee--eccCcccceeecCCCceeccccchhhhccccccc
Confidence 999999998543 588999999999999999999999966 9999999999999999999999999865432
Q ss_pred -CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccchhhhccc
Q 037905 473 -STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDLELLRYQ 551 (606)
Q Consensus 473 -~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 551 (606)
....+|+.|+|||++.+..|+.++|||||||++|||++|+.||.+. +.......+..... .
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~------~~~~~~~~i~~~~~------------~ 221 (320)
T d1xjda_ 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ------DEEELFHSIRMDNP------------F 221 (320)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS------SHHHHHHHHHHCCC------------C
T ss_pred ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC------CHHHHHHHHHcCCC------------C
Confidence 2346788899999999999999999999999999999999999642 22222333322211 0
Q ss_pred ChHHHHHHHHHHHHHccCcCCCCCCCHH-HHHH
Q 037905 552 NVEEEMVQLLQLAINCTAQYPDNRPSMA-EVTS 583 (606)
Q Consensus 552 ~~~~~~~~l~~l~~~Cl~~~P~~RPs~~-~v~~ 583 (606)
.+......+.+++.+||..||++|||+. ++++
T Consensus 222 ~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 222 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111234578899999999999999996 6754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=359.33 Aligned_cols=251 Identities=22% Similarity=0.292 Sum_probs=189.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|++++++++||||+++++++.+.++.++||||+.++
T Consensus 7 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~ 86 (298)
T d1gz8a_ 7 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86 (298)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred ccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc
Confidence 46899999999999986 5799999999965432 2467899999999999999999999999999999999999764
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----C
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----S 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~ 473 (606)
+..++.... ...+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+||+|||.|+..... .
T Consensus 87 -~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~~Ii--HrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 87 -LKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSHRVL--HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp -HHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred -hhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcCCEE--ccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 444443322 23589999999999999999999999966 9999999999999999999999999765432 2
Q ss_pred CCCCcccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------ccccc----
Q 037905 474 TPNRIDGYRAPEVTDARK-VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------WTAEV---- 542 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~---- 542 (606)
...+++.|+|||.+.... ++.++|||||||++|+|++|+.||..... ...+..+.... .....
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE------IDQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH------HHHHHHHHHhcCCCchhhcccccccc
Confidence 346778899999877655 57899999999999999999999964321 11111111100 00000
Q ss_pred -cchhhhcc--cC----hHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 -FDLELLRY--QN----VEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 -~d~~~~~~--~~----~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
........ .. .......+.+++.+||..||++|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 00 01223567889999999999999999999886
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-45 Score=361.14 Aligned_cols=233 Identities=21% Similarity=0.348 Sum_probs=188.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC-------HHHHHHHHHHHcCCC--CCCcccceEEEEeCCceEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS-------EKEFREKMEVVGSMD--HENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 390 (606)
+.+.||+|+||.||+|+. .+|+.||||+++..... ...+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus 8 i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv 87 (273)
T d1xwsa_ 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 87 (273)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEE
T ss_pred EeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEE
Confidence 357899999999999986 47899999999754321 234678999998886 89999999999999999999
Q ss_pred EeecCC-CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCC-CcEEEeecccCcc
Q 037905 391 HDYMPM-GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKS-YEARISDFGLAHL 468 (606)
Q Consensus 391 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~-~~~kl~DfG~a~~ 468 (606)
|||+.+ +++.+++... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.+ +.+||+|||+|+.
T Consensus 88 ~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~ii--HrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 88 LERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCGVL--HRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp EECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCc--cccCcccceEEecCCCeEEECcccccee
Confidence 999976 6788887653 2589999999999999999999999966 99999999999854 7899999999986
Q ss_pred CCCC--CCCCCcccccCccccCCCCC-CCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccch
Q 037905 469 ASPS--STPNRIDGYRAPEVTDARKV-SQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFDL 545 (606)
Q Consensus 469 ~~~~--~~~~~~~~y~aPE~~~~~~~-~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 545 (606)
.... ....+|+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .+...... +.
T Consensus 161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~~~~---~~- 224 (273)
T d1xwsa_ 161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVF---FR- 224 (273)
T ss_dssp CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHCCCC---CS-
T ss_pred cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhcccC---CC-
Confidence 5443 34568899999999987665 577999999999999999999996421 11111110 00
Q ss_pred hhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 546 ELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 546 ~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. ..+.++.+++.+||+.||++|||++|++++
T Consensus 225 -----~---~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 225 -----Q---RVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -----S---CCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----C---CCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 1 122457888999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-43 Score=351.60 Aligned_cols=250 Identities=21% Similarity=0.278 Sum_probs=192.2
Q ss_pred hcccccCCceEEEEEEEcCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCCC
Q 037905 322 AEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
.+.||+|+||+||+|+..+|+.||||+++.... ..+.+.+|+.++++++||||++++++|.+.+..+++|||+.++.
T Consensus 7 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~ 86 (286)
T d1ob3a_ 7 LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDL 86 (286)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEH
T ss_pred ccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhh
Confidence 467999999999999998999999999976432 24679999999999999999999999999999999999998877
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCC----CC
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPS----ST 474 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----~~ 474 (606)
+..+.... ..+++..+..++.||+.||+|||+++++ ||||||+|||++.++.+|++|||.+...... ..
T Consensus 87 ~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~Iv--HrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 87 KKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRRVL--HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp HHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred HHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCcEE--ecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 77666532 3699999999999999999999999966 9999999999999999999999998765432 23
Q ss_pred CCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc------ccccc-----
Q 037905 475 PNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE------WTAEV----- 542 (606)
Q Consensus 475 ~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~----- 542 (606)
..+++.|+|||.+.+. .++.++|||||||++|||++|+.||..... .+....+.... .....
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~------~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE------ADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH------HHHHHHHHHhhCCCChhhccchhhhhh
Confidence 3467779999998754 568999999999999999999999965321 11111111000 00000
Q ss_pred cchhhhc------ccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 543 FDLELLR------YQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 543 ~d~~~~~------~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.+..... ..........+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 00011223567889999999999999999999764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=351.55 Aligned_cols=251 Identities=23% Similarity=0.276 Sum_probs=187.0
Q ss_pred hcccccCCceEEEEEEE-cC-CcEEEEEEeccCcc---CHHHHHHHHHHHcCC---CCCCcccceEEEEe-----CCceE
Q 037905 322 AEVLGKGTFGTAYKATL-EM-GIVVAVKRLKDVTV---SEKEFREKMEVVGSM---DHENLVPLRAYYYS-----RDEKL 388 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~ 388 (606)
.+.||+|+||+||+|+. .+ ++.||||+++.... ....+.+|+.+++.+ +||||++++++|.. ....+
T Consensus 12 ~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~ 91 (305)
T d1blxa_ 12 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT 91 (305)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred EEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEE
Confidence 56899999999999986 34 67899999865322 223466777766554 89999999999863 24678
Q ss_pred EEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCcc
Q 037905 389 LVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHL 468 (606)
Q Consensus 389 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~ 468 (606)
++|||+.++.+....... ...+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~iv--HrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 92 LVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHRVV--HRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred EEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEE--ecCCCccEEEEcCCCCeeecchhhhhh
Confidence 999999987776555432 23589999999999999999999999966 999999999999999999999999876
Q ss_pred CCC---CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhc-------cc
Q 037905 469 ASP---SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKE-------EW 538 (606)
Q Consensus 469 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------~~ 538 (606)
... .....+|+.|+|||++.+..|+.++||||+||++|||++|++||..... ...+..+... .+
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~------~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD------VDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCGGGS
T ss_pred hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH------HHHHHHHHHhhCCCchhcc
Confidence 543 2356778899999999999999999999999999999999999975322 1111111110 00
Q ss_pred cccccchhhh--------cccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 539 TAEVFDLELL--------RYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 539 ~~~~~d~~~~--------~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......+... ...........+.+|+.+||+.||++|||++|+++|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 000011223457788999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-43 Score=351.99 Aligned_cols=264 Identities=20% Similarity=0.228 Sum_probs=197.1
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEE-EEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAY-YYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-~~~~~~~~lv~e~~~~g~ 398 (606)
+.+.||+|+||.||+|+. .+|+.||||++.... ..+++..|+++++.++|+|++..++. +...+..++||||+. ++
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~ 88 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PS 88 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CB
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cc
Confidence 357899999999999986 568999999887543 33468889999999988876666554 456778889999995 46
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC---CCcEEEeecccCccCCCC---
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK---SYEARISDFGLAHLASPS--- 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~---~~~~kl~DfG~a~~~~~~--- 472 (606)
|...+.... ..+++..+..++.|++.||+|||++|++ ||||||+|||++. +..+||+|||+|+.....
T Consensus 89 l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ii--HrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 89 LEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKNFI--HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTTEE--CSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred hhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHHHCCee--eccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 666655332 3589999999999999999999999955 9999999999864 457999999999865432
Q ss_pred --------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 473 --------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 473 --------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
....+|+.|||||.+.+..+++++|||||||++|||+||+.||........... +........ . ..
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~---~~~~~~~~~-~--~~ 236 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK---YERISEKKM-S--TP 236 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC----------HHHHHHHHH-H--SC
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH---HHHhhcccC-C--CC
Confidence 233578889999999999999999999999999999999999976433221111 111100000 0 00
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhc-ccccCCCCccc
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRS-SLQQGQAHDLE 602 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~-~~~~~~~~~~~ 602 (606)
.... ....+.++.+++.+||+.+|++||++.++.+.|+++... ....++++||+
T Consensus 237 ~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~ 291 (299)
T d1ckia_ 237 IEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN 291 (299)
T ss_dssp HHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHH
T ss_pred hhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCch
Confidence 0000 012335688999999999999999999999999998643 44556677765
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.2e-42 Score=344.05 Aligned_cols=264 Identities=16% Similarity=0.184 Sum_probs=204.3
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCC-CCcccceEEEEeCCceEEEEeecCCCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDH-ENLVPLRAYYYSRDEKLLVHDYMPMGS 398 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~ 398 (606)
+.+.||+|+||+||+|+. .+|+.||||++.... ....+.+|++.++.++| +|++.+++++......++||||+ +++
T Consensus 9 i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~ 86 (293)
T d1csna_ 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPS 86 (293)
T ss_dssp EEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCB
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCC
Confidence 357899999999999995 468999999886532 33457788888888865 89999999999999999999998 679
Q ss_pred hhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecC-----CCcEEEeecccCccCCCC-
Q 037905 399 LSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSK-----SYEARISDFGLAHLASPS- 472 (606)
Q Consensus 399 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~-----~~~~kl~DfG~a~~~~~~- 472 (606)
|.+++.... ..+++..+..++.|++.||+|||++|++ ||||||+|||++. ++.+||+|||+|+.....
T Consensus 87 l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH~~gii--HrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 87 LEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHEKSLV--YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp HHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHTTTEE--CCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred HHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHHHCCce--eccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 999987543 3589999999999999999999999955 9999999999974 567999999999765321
Q ss_pred ----------CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccc
Q 037905 473 ----------STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEV 542 (606)
Q Consensus 473 ----------~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (606)
....+|+.|||||++.+..+++++|||||||++|||+||+.||....... .......+.......
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~---~~~~~~~i~~~~~~~-- 235 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT---NKQKYERIGEKKQST-- 235 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC---HHHHHHHHHHHHHHS--
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh---HHHHHHHHHhccCCC--
Confidence 23457889999999999999999999999999999999999997533221 111121111111000
Q ss_pred cchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHHHHHHHhcccc-cCCCCccc
Q 037905 543 FDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQIEEICRSSLQ-QGQAHDLE 602 (606)
Q Consensus 543 ~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~L~~i~~~~~~-~~~~~~~~ 602 (606)
...-. ....+.++.+++..||+.+|++||+++.+.+.|+++.+.... ..++.||+
T Consensus 236 -~~~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 236 -PLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp -CHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred -ChHHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence 00000 011235688899999999999999999999999998765433 45567776
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=352.18 Aligned_cols=255 Identities=25% Similarity=0.339 Sum_probs=187.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~e~~ 394 (606)
.++||+|+||+||+|+. .+|+.||||+++.... .+.+|++++++++||||++++++|... .+.++||||+
T Consensus 25 ~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred eeEEeeCcCeEEEEEEECCCCCEEEEEEECccch---HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 46799999999999996 4699999999976432 234799999999999999999998643 3468999999
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCC-
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPS- 472 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~- 472 (606)
+++.+..+..... ....+++..++.++.||+.||+|||++|++ ||||||+|||++.++ .+||+|||+++.....
T Consensus 102 ~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~Ii--HrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 102 PETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp SEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTTEE--CCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred CCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCc--ccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 8764444333211 234699999999999999999999999966 999999999999775 8999999999865442
Q ss_pred --CCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh--------------
Q 037905 473 --STPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK-------------- 535 (606)
Q Consensus 473 --~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------------- 535 (606)
.+..++..|+|||.+.+ ..|+.++||||+||++|||++|+.||...... +....+..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~------~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV------DQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH------HHHHHHHHHHCCCCHHHHHHHC
T ss_pred ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH------HHHHHHHHHhCCChHHhhhhhc
Confidence 34467788999998765 57899999999999999999999999653221 11111110
Q ss_pred ccc----cccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHHHh
Q 037905 536 EEW----TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEICR 590 (606)
Q Consensus 536 ~~~----~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i~~ 590 (606)
... ........... ........++.+|+.+||..||++|||+.|++++ ++++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp C---CCCCCCCCCCCGGG-TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred cchhhccccccccCchhh-hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 000 00000000000 0011223467888999999999999999999976 555543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=345.69 Aligned_cols=253 Identities=19% Similarity=0.233 Sum_probs=185.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEe--------CCceEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYS--------RDEKLL 389 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~l 389 (606)
.+.||+|+||+||+|+. .+|+.||||++..... ..+.+.+|++++++++||||+++++++.. ..+.++
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~i 94 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL 94 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEE
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEE
Confidence 47899999999999996 5799999999865422 34678899999999999999999999864 346799
Q ss_pred EEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccC
Q 037905 390 VHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLA 469 (606)
Q Consensus 390 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~ 469 (606)
||||+.++.+...... ...++...+..++.||+.||.|||++|++ ||||||+|||++.++.+||+|||+++..
T Consensus 95 v~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~iv--HrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 95 VFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNKIL--HRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp EEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCCEE--ecCcCchheeecCCCcEEeeecceeeec
Confidence 9999988766655442 23588899999999999999999999966 9999999999999999999999999754
Q ss_pred CC--------CCCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhcc---
Q 037905 470 SP--------SSTPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEE--- 537 (606)
Q Consensus 470 ~~--------~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 537 (606)
.. .....+|+.|+|||.+.+. .|++++|||||||++|||++|+.||....+.. ....+.......
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLCGSITPE 244 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTT
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH---HHHHHHHhcCCCChh
Confidence 42 1224578889999998765 68999999999999999999999996532111 111111111000
Q ss_pred ccccc--------cchhhhcccChHH------HHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 538 WTAEV--------FDLELLRYQNVEE------EMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 538 ~~~~~--------~d~~~~~~~~~~~------~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
..... ............+ ....+.+|+.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 0000000001111 12456789999999999999999999865
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-41 Score=345.99 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=186.6
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeCC------ceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSRD------EKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lv~ 391 (606)
.+.||+|+||+||+|.. .+|+.||||+++..... .+.+.+|++++++++|||||+++++|...+ +.++||
T Consensus 23 i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~ 102 (346)
T d1cm8a_ 23 LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102 (346)
T ss_dssp EEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEE
Confidence 57899999999999985 46999999999764433 356889999999999999999999997654 569999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+ +.+|..+.... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+|++|||+|+....
T Consensus 103 e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~Ii--HrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 103 PFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGII--HRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp ECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCCCc--ccccCcchhhcccccccccccccceeccCC
Confidence 999 55788877642 499999999999999999999999966 999999999999999999999999987655
Q ss_pred C-CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccc-----------
Q 037905 472 S-STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW----------- 538 (606)
Q Consensus 472 ~-~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 538 (606)
. ....+++.|+|||.+.+. .++.++||||+||++|||++|+.||...... ...........
T Consensus 174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL------DQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH------HHHHHHHhccCCCcHHHHhhhc
Confidence 3 335678889999998764 5689999999999999999999999653211 11111000000
Q ss_pred ----------cccccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH--HHHH
Q 037905 539 ----------TAEVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ--IEEI 588 (606)
Q Consensus 539 ----------~~~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~--L~~i 588 (606)
.......... .........+.+|+.+||..||++|||++|++++ ++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred chhhhhhhccCCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000000 0011123457789999999999999999999987 5554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-41 Score=344.84 Aligned_cols=252 Identities=19% Similarity=0.283 Sum_probs=184.8
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc--CHHHHHHHHHHHcCCCCCCcccceEEEEeCC----ceEEEEeec
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV--SEKEFREKMEVVGSMDHENLVPLRAYYYSRD----EKLLVHDYM 394 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~e~~ 394 (606)
.+.||+|+||+||+|+. .+|+.||||++..... ..+.+.+|++++++++||||+++++++.... ..+++++|+
T Consensus 13 ~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~ 92 (345)
T d1pmea_ 13 LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHL 92 (345)
T ss_dssp EEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred EEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEee
Confidence 57899999999999985 5799999999975432 2457889999999999999999999987543 235566677
Q ss_pred CCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC---
Q 037905 395 PMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP--- 471 (606)
Q Consensus 395 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 471 (606)
.+|+|.+++... .+++..+..++.|++.||+|||++|++ ||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~ii--HRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 93 MGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVL--HRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp CCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred cCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCc--CCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 799999999743 489999999999999999999999966 999999999999999999999999975433
Q ss_pred ----CCCCCCcccccCccccCC-CCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccc---ccccc
Q 037905 472 ----SSTPNRIDGYRAPEVTDA-RKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEW---TAEVF 543 (606)
Q Consensus 472 ----~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 543 (606)
.....+++.|+|||++.. ..++.++||||+||++|||++|+.||......+ ............. .....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHTCC
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChhhhhhhh
Confidence 223456778999999854 567899999999999999999999996532111 0000000000000 00000
Q ss_pred chh-------h--hcccCh----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLE-------L--LRYQNV----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~-------~--~~~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... . ...... .....++.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 0 000000 0112357889999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-41 Score=335.78 Aligned_cols=251 Identities=22% Similarity=0.255 Sum_probs=193.7
Q ss_pred hcccccCCceEEEEEEE-cCCcEEEEEEeccCcc---CHHHHHHHHHHHcCCCCCCcccceEEEEeCCceEEEEeecCCC
Q 037905 322 AEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTV---SEKEFREKMEVVGSMDHENLVPLRAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 397 (606)
.+.||+|+||+||+|+. .+|+.||||+++.... ....+.+|+.+++.++||||++++++|.+....++|+|++.++
T Consensus 7 i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~ 86 (292)
T d1unla_ 7 LEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86 (292)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEE
T ss_pred eeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccc
Confidence 46899999999999995 5789999999975433 2467899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCCCC----
Q 037905 398 SLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASPSS---- 473 (606)
Q Consensus 398 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 473 (606)
+|..++... ..+++..+..++.|++.||+|||+++++ ||||||+|||++.++.+||+|||.++......
T Consensus 87 ~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~Iv--HrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~ 159 (292)
T d1unla_ 87 LKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRNVL--HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp HHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred ccccccccc-----cccchhHHHHHHHHHHHHHHHhhcCCEe--eecccCcccccccCCceeeeecchhhcccCCCccce
Confidence 998887743 3578999999999999999999999965 99999999999999999999999998765432
Q ss_pred CCCCcccccCccccCCCC-CCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc------------
Q 037905 474 TPNRIDGYRAPEVTDARK-VSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA------------ 540 (606)
Q Consensus 474 ~~~~~~~y~aPE~~~~~~-~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 540 (606)
...++..|+|||.+.... ++.++|||||||++|||++|+.||... .+..+....+.......
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-----NDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC-----SSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC-----CCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 233456699999987655 689999999999999999999997431 22222222211100000
Q ss_pred -----cccchhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 541 -----EVFDLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 541 -----~~~d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
...................+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000001112223467888999999999999999998764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-40 Score=338.16 Aligned_cols=250 Identities=18% Similarity=0.233 Sum_probs=188.7
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCC-CCCcccceEEEEeC--CceEEEEeecCC
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-HENLVPLRAYYYSR--DEKLLVHDYMPM 396 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e~~~~ 396 (606)
..+.||+|+||+||+|+. .+|+.||||+++.. ..+.+.+|++++++++ ||||++++++|... ...++||||+.+
T Consensus 39 i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~ 116 (328)
T d3bqca1 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN 116 (328)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCS
T ss_pred EEEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCC
Confidence 457899999999999986 57999999999753 4677899999999985 99999999999754 468999999999
Q ss_pred CChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCC-cEEEeecccCccCCCC---
Q 037905 397 GSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSY-EARISDFGLAHLASPS--- 472 (606)
Q Consensus 397 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~--- 472 (606)
++|..+.+ .+++..+..++.||+.||+|||++|++ ||||||+|||++.++ .+||+|||+|+.....
T Consensus 117 ~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~gIv--HrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 117 TDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIM--HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp CBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTTEE--CCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred CcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcccc--cccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 99987643 489999999999999999999999965 999999999998655 5999999999866543
Q ss_pred CCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh---------c-cc--c
Q 037905 473 STPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK---------E-EW--T 539 (606)
Q Consensus 473 ~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~-~~--~ 539 (606)
....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||....... +....+..... . .. .
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhH--HHHHHHHHHHCCchhhhhhhhcccccC
Confidence 344567889999998765 57999999999999999999999996432110 00000000000 0 00 0
Q ss_pred cccc----------chhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 540 AEVF----------DLELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 540 ~~~~----------d~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
.... ...............++.+|+.+||..||++|||++|+++|
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 00000011112233567889999999999999999999763
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=342.83 Aligned_cols=242 Identities=24% Similarity=0.290 Sum_probs=191.6
Q ss_pred hcccccCCceEEEEEEE----cCCcEEEEEEeccCc-----cCHHHHHHHHHHHcCCCC-CCcccceEEEEeCCceEEEE
Q 037905 322 AEVLGKGTFGTAYKATL----EMGIVVAVKRLKDVT-----VSEKEFREKMEVVGSMDH-ENLVPLRAYYYSRDEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~-----~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 391 (606)
.+.||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++| |||+++++++.+....++||
T Consensus 29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~ 108 (322)
T d1vzoa_ 29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108 (322)
T ss_dssp EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence 57899999999999974 258999999986532 234568899999999977 89999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+.+|+|.+++.... .++...+..++.||+.||+|||+++++ ||||||+|||++.++.+||+|||+++....
T Consensus 109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~iv--HrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLGII--YRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCCEE--eccCCccceeecCCCCEEEeeccchhhhcc
Confidence 9999999999998654 467889999999999999999999966 999999999999999999999999976543
Q ss_pred C-----CCCCCcccccCccccCCC--CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccccccc
Q 037905 472 S-----STPNRIDGYRAPEVTDAR--KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTAEVFD 544 (606)
Q Consensus 472 ~-----~~~~~~~~y~aPE~~~~~--~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 544 (606)
. ....+++.|+|||.+.+. .++.++|||||||++|||++|+.||....... .............
T Consensus 182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~--~~~~i~~~~~~~~------- 252 (322)
T d1vzoa_ 182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE------- 252 (322)
T ss_dssp GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCC-------
T ss_pred cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcccCC-------
Confidence 2 234567779999998764 46889999999999999999999997643222 1111111111111
Q ss_pred hhhhcccChHHHHHHHHHHHHHccCcCCCCCCC-----HHHHHHH
Q 037905 545 LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPS-----MAEVTSQ 584 (606)
Q Consensus 545 ~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs-----~~~v~~~ 584 (606)
...+.....++.+++.+||.+||++||| ++|+++|
T Consensus 253 -----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 253 -----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1111234457888999999999999995 7888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=336.84 Aligned_cols=253 Identities=23% Similarity=0.271 Sum_probs=182.9
Q ss_pred hcccccCCceEEEEEEEc-CCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeC------CceEEEE
Q 037905 322 AEVLGKGTFGTAYKATLE-MGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSR------DEKLLVH 391 (606)
Q Consensus 322 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lv~ 391 (606)
.++||+|+||+||+|... +|+.||||+++..... .+.+.+|+.++++++||||++++++|... .+.|+||
T Consensus 22 ~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~ 101 (355)
T d2b1pa1 22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101 (355)
T ss_dssp EEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred EEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEE
Confidence 468999999999999864 6999999999765433 34688999999999999999999999643 5789999
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
||+.++.+. .+. ..+++..++.++.||+.||.|||++|++ ||||||+|||++.++.+|++|||+++....
T Consensus 102 Ey~~~~l~~-~~~-------~~~~~~~i~~~~~qil~gl~~LH~~gii--HrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 102 ELMDANLCQ-VIQ-------MELDHERMSYLLYQMLCGIKHLHSAGII--HRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp ECCSEEHHH-HHT-------SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CSCCCGGGEEECTTCCEEECCCCC------
T ss_pred eccchHHHH-hhh-------cCCCHHHHHHHHHHHHHHHHHhhhcccc--cccCCccccccccccceeeechhhhhcccc
Confidence 999775444 443 1488999999999999999999999966 999999999999999999999999876544
Q ss_pred C---CCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCC---------CChh-------HHHHH
Q 037905 472 S---STPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEG---------VDLP-------RWVQS 532 (606)
Q Consensus 472 ~---~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~---------~~~~-------~~~~~ 532 (606)
. ....+|+.|+|||++.+..+++++||||+||+++||++|+.||.+...... .... .....
T Consensus 172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (355)
T d2b1pa1 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251 (355)
T ss_dssp ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence 2 234567889999999999999999999999999999999999964221100 0000 00000
Q ss_pred Hhhcccccc------ccchhhhccc--ChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 533 VVKEEWTAE------VFDLELLRYQ--NVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 533 ~~~~~~~~~------~~d~~~~~~~--~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
......... .+........ ........+.+|+.+|+..||++|||++|+++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 011100000 0000000000 123445678999999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-40 Score=338.06 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=186.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccC---HHHHHHHHHHHcCCCCCCcccceEEEEeC-----CceEEEE
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVS---EKEFREKMEVVGSMDHENLVPLRAYYYSR-----DEKLLVH 391 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~ 391 (606)
..+.||+|+||+||+|+. .+|+.||||+++....+ .+.+.+|++++++++|||++++++++... ...++++
T Consensus 22 i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~ 101 (348)
T d2gfsa1 22 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101 (348)
T ss_dssp EEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEE
T ss_pred EEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEE
Confidence 357899999999999985 57999999999765433 35688999999999999999999998643 3346777
Q ss_pred eecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEeecccCccCCC
Q 037905 392 DYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARISDFGLAHLASP 471 (606)
Q Consensus 392 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 471 (606)
+|+.+|+|.+++... .+++..+..++.||+.||+|||++|++ ||||||+|||++.++.+|++|||.+.....
T Consensus 102 ~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~gii--HrDiKp~NILi~~~~~~kl~dfg~a~~~~~ 173 (348)
T d2gfsa1 102 THLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADII--HRDLKPSNLAVNEDCELKILDFGLARHTDD 173 (348)
T ss_dssp EECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred EeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCCCc--ccccCCccccccccccccccccchhcccCc
Confidence 888899999999632 489999999999999999999999966 999999999999999999999999876543
Q ss_pred -CCCCCCcccccCccccCCC-CCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhhccccc--c----cc
Q 037905 472 -SSTPNRIDGYRAPEVTDAR-KVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVKEEWTA--E----VF 543 (606)
Q Consensus 472 -~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~----~~ 543 (606)
.....++..|+|||...+. .++.++|||||||++|+|++|+.||.+... ......+....... + ..
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~------~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH------IDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHHhcCCCChHHhhhcc
Confidence 2345567779999987665 468999999999999999999999964221 11111111110000 0 00
Q ss_pred chh-------hhc--ccCh----HHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 544 DLE-------LLR--YQNV----EEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 544 d~~-------~~~--~~~~----~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
... ... .... ......+.+|+.+||..||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000 000 0000 1123457889999999999999999999875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-36 Score=313.31 Aligned_cols=260 Identities=17% Similarity=0.234 Sum_probs=186.5
Q ss_pred HhcccccCCceEEEEEEE-cCCcEEEEEEeccCccCHHHHHHHHHHHcCCC-----------CCCcccceEEEEeC--Cc
Q 037905 321 SAEVLGKGTFGTAYKATL-EMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD-----------HENLVPLRAYYYSR--DE 386 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~--~~ 386 (606)
..++||+|+||+||+|+. .+|+.||||+++......+.+.+|+++++.++ |+||+++++++... ..
T Consensus 17 i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~ 96 (362)
T d1q8ya_ 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 96 (362)
T ss_dssp EEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTE
T ss_pred EEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccc
Confidence 357899999999999986 57999999999876555677888998887764 57899999988643 45
Q ss_pred eEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCCCCCCCCCCEEecCCCc------EE
Q 037905 387 KLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHS-KGPANSHGNIKSSNILLSKSYE------AR 459 (606)
Q Consensus 387 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~i~HrDlkp~Nill~~~~~------~k 459 (606)
.+++++++..+.......... ....+++..+..++.||+.||+|||+ .|++ ||||||+|||++.++. ++
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~Iv--HrDlKp~NIll~~~~~~~~~~~~k 172 (362)
T d1q8ya_ 97 VHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIK 172 (362)
T ss_dssp EEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEE--CSCCSGGGEEEEEEETTTTEEEEE
T ss_pred eeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhcCcc--cccCChhHeeeeccCcccccceee
Confidence 566777765544333322222 23468889999999999999999998 7755 9999999999987653 99
Q ss_pred EeecccCccCCC-CCCCCCcccccCccccCCCCCCCcchhHHHHHHHHHHHhCCCCcccccccCCCChhHHHHHHhh---
Q 037905 460 ISDFGLAHLASP-SSTPNRIDGYRAPEVTDARKVSQKADVYSFGVLLLELLTGKAPTQALLNEEGVDLPRWVQSVVK--- 535 (606)
Q Consensus 460 l~DfG~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDv~slGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 535 (606)
++|||.+..... .....+++.|+|||++....++.++||||+||+++||++|+.||....................
T Consensus 173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg 252 (362)
T d1q8ya_ 173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252 (362)
T ss_dssp ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence 999999876543 3345678889999999999999999999999999999999999975432221111111111100
Q ss_pred --------c-cccccccc------------------hhhhcccChHHHHHHHHHHHHHccCcCCCCCCCHHHHHHH
Q 037905 536 --------E-EWTAEVFD------------------LELLRYQNVEEEMVQLLQLAINCTAQYPDNRPSMAEVTSQ 584 (606)
Q Consensus 536 --------~-~~~~~~~d------------------~~~~~~~~~~~~~~~l~~l~~~Cl~~~P~~RPs~~~v~~~ 584 (606)
. .......+ ...............+.+|+.+|+..||.+|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 00000000 0001122235667889999999999999999999999876
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=5.6e-29 Score=251.75 Aligned_cols=114 Identities=34% Similarity=0.635 Sum_probs=95.7
Q ss_pred chHHHHHHHhHhhcC--CCCcCCCCCCCCC--cceeEEecCC----eEEEEEcCCCCccc--ccCccccCCCCCcEEEcc
Q 037905 2 ASDRAALLTLRKAIG--GRTLLWNLTDGPC--KWVGVFCTGE----RVTMLRFPGMGLSG--QLPIAIGNLTELHTVSLR 71 (606)
Q Consensus 2 ~~~~~~l~~~~~~~~--~~~~~w~~~~~~c--~~~~~~c~~~----~l~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~ 71 (606)
++|++||++||+.+. .....|..+++|| +|.||.|... +|+.|+|++|+++| .+|.+|++|++|++|+|+
T Consensus 5 ~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls 84 (313)
T d1ogqa_ 5 PQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIG 84 (313)
T ss_dssp HHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEE
T ss_pred HHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccc
Confidence 689999999999874 4445998888999 5999999753 69999999999998 578999999999999998
Q ss_pred C-CCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcE
Q 037905 72 F-NALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115 (606)
Q Consensus 72 ~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 115 (606)
+ |+++|.+|..|++|++|++|+|++|+|.+..|..+..+..|+.
T Consensus 85 ~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 85 GINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp EETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred cccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 6 8999999999999999999999999988765543333333333
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=6.1e-23 Score=191.37 Aligned_cols=161 Identities=15% Similarity=0.119 Sum_probs=117.3
Q ss_pred HhcccccCCceEEEEEEEcCCcEEEEEEeccCccC-------------------HHHHHHHHHHHcCCCCCCcccceEEE
Q 037905 321 SAEVLGKGTFGTAYKATLEMGIVVAVKRLKDVTVS-------------------EKEFREKMEVVGSMDHENLVPLRAYY 381 (606)
Q Consensus 321 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~~~~e~~~l~~l~h~niv~l~~~~ 381 (606)
..+.||+|+||.||+|...+|+.||||+++....+ ......|+..+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 35789999999999999888999999987532110 12345678888899999998877653
Q ss_pred EeCCceEEEEeecCCCChhhhhhcCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCCCCCCCCCCEEecCCCcEEEe
Q 037905 382 YSRDEKLLVHDYMPMGSLSALLHGNRGAGRTPLNWETRSGLALGASRAIAYLHSKGPANSHGNIKSSNILLSKSYEARIS 461 (606)
Q Consensus 382 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~i~HrDlkp~Nill~~~~~~kl~ 461 (606)
..+++|||+++..+.. ++......++.|++++|+|||++|++ ||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~gii--HrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRGIV--HGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTTEE--CSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCCEE--EccCChhheeeeCC-CEEEE
Confidence 3479999998865543 22334567899999999999999966 99999999999976 58999
Q ss_pred ecccCccCCCCCCCCCcccccC------ccccCCCCCCCcchhHHHHHHH
Q 037905 462 DFGLAHLASPSSTPNRIDGYRA------PEVTDARKVSQKADVYSFGVLL 505 (606)
Q Consensus 462 DfG~a~~~~~~~~~~~~~~y~a------PE~~~~~~~~~~sDv~slGvvl 505 (606)
|||.|+....... ..|.. .+.+ .+.|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~----~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGW----REILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTH----HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCc----HHHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999876543211 11211 1112 24678899999976433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.81 E-value=8.4e-21 Score=176.84 Aligned_cols=129 Identities=26% Similarity=0.349 Sum_probs=98.2
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCCCCcccC-cccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCC
Q 037905 43 MLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTI-PSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121 (606)
Q Consensus 43 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 121 (606)
.++.++++|+ .+|..+. ++|++|+|++|+|++.+ +..|.++++|+.|+|++|++.+..+..|..+++|+.|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4666777777 6666553 67888888888886534 456777888888888888888777777888888888888888
Q ss_pred cCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccC
Q 037905 122 NFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSI 174 (606)
Q Consensus 122 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~ 174 (606)
+|+...|..|.++++|++|+|++|+|++++++ |..+++|+.|+|++|++....
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccccc
Confidence 88877777788888888888888888877775 777888888888888877443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.2e-19 Score=174.10 Aligned_cols=156 Identities=22% Similarity=0.208 Sum_probs=134.1
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|.|++..+.+|.++++|++|+|++|+|+ .+| .+..+++|++|+|++|+|+ ..|..+..+++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 47999999999999777788999999999999999998 555 4678999999999999999 67788999999999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNSLCGK 194 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~l~~~ 194 (606)
++|.+....+..+..+.+|++|++++|.++..++. +..+++|+.|++++|+|++..+..|..++ .|++.+|.|...
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~l 187 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI 187 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCccc
Confidence 99999877788888899999999999999887776 67788999999999999987776665544 567888988877
Q ss_pred CCc
Q 037905 195 PLV 197 (606)
Q Consensus 195 p~~ 197 (606)
|..
T Consensus 188 p~~ 190 (266)
T d1p9ag_ 188 PKG 190 (266)
T ss_dssp CTT
T ss_pred Chh
Confidence 654
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=1.5e-18 Score=161.36 Aligned_cols=167 Identities=22% Similarity=0.233 Sum_probs=141.3
Q ss_pred CCCCCcceeEEecC-----------CeEEEEEcCCCCccccc-CccccCCCCCcEEEccCCCCcccCcccccCCCCCCEE
Q 037905 25 TDGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQL-PIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNL 92 (606)
Q Consensus 25 ~~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 92 (606)
....|++..|.|++ +++++|+|++|.|++.+ +..|.++++|+.|+|++|.+....+..|..+++|++|
T Consensus 4 ~~C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L 83 (192)
T d1w8aa_ 4 AMCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TTSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccccee
Confidence 34557788999974 47899999999998655 5578999999999999999998888999999999999
Q ss_pred eccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcc
Q 037905 93 YLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNG 172 (606)
Q Consensus 93 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~ 172 (606)
+|++|+|+...|..|.++++|+.|+|++|+|++..|..|..+++|++|+|++|.+....+...-...++.+.+..|.++.
T Consensus 84 ~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c 163 (192)
T d1w8aa_ 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARC 163 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBB
T ss_pred eeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEe
Confidence 99999999888889999999999999999999888889999999999999999998654321112345666778888888
Q ss_pred cCCccccCCCCCcccCCCC
Q 037905 173 SIPKRFARLPSSAFEGNSL 191 (606)
Q Consensus 173 ~~p~~~~~l~~l~~~~n~l 191 (606)
..|..+..++-+++..|.|
T Consensus 164 ~~p~~l~~~~l~~L~~n~l 182 (192)
T d1w8aa_ 164 GAPSKVRDVQIKDLPHSEF 182 (192)
T ss_dssp CSSTTTTTSBGGGSCTTTC
T ss_pred CCChhhcCCEeeecCHhhC
Confidence 8888887777777777776
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=4.7e-18 Score=166.51 Aligned_cols=153 Identities=27% Similarity=0.285 Sum_probs=134.9
Q ss_pred EecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCc
Q 037905 35 FCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLI 114 (606)
Q Consensus 35 ~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 114 (606)
+...++|++|+|++|+|+ .+| .++.+++|++|+|++|+|+ ..+..+.++++|++|+|++|.+....+..+..+.+|+
T Consensus 51 f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~ 127 (266)
T d1p9ag_ 51 LMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127 (266)
T ss_dssp GTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCC
T ss_pred hhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccc
Confidence 445578999999999998 444 4688999999999999999 6788999999999999999999988888889999999
Q ss_pred EEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCC---CCcccCCC
Q 037905 115 RLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLP---SSAFEGNS 190 (606)
Q Consensus 115 ~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~---~l~~~~n~ 190 (606)
.|++++|.+....+..+..+++|+.|++++|+|++.++. |..+++|+.|+|++|+|+ .+|..+..++ .|.+.||+
T Consensus 128 ~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np 206 (266)
T d1p9ag_ 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (266)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred cccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCC
Confidence 999999999977788889999999999999999998886 889999999999999999 7776665554 45677777
Q ss_pred C
Q 037905 191 L 191 (606)
Q Consensus 191 l 191 (606)
+
T Consensus 207 ~ 207 (266)
T d1p9ag_ 207 W 207 (266)
T ss_dssp B
T ss_pred C
Confidence 6
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.3e-17 Score=164.85 Aligned_cols=158 Identities=22% Similarity=0.259 Sum_probs=124.3
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCccc-------------------------CcccccCCCCCCEEe
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGT-------------------------IPSDFAKLSNLRNLY 93 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-------------------------~p~~~~~l~~L~~L~ 93 (606)
+++++|+|++|.|+...+.+|.++++|++|++++|+|... .|..|.++++|++|+
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~ 111 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEe
Confidence 3678999999999966667899999999999999987532 245566777888888
Q ss_pred ccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcc
Q 037905 94 LQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNG 172 (606)
Q Consensus 94 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~ 172 (606)
|++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|++++|+|++.++. |..+++|+.+++++|++++
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred cCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 888888766666777788888888888888866667788888888888888888877765 7778888888888888888
Q ss_pred cCCccccCCCC---CcccCCCCCCCCC
Q 037905 173 SIPKRFARLPS---SAFEGNSLCGKPL 196 (606)
Q Consensus 173 ~~p~~~~~l~~---l~~~~n~l~~~p~ 196 (606)
..|..|..+++ |++.+|.+.+.+.
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~~~~~ 218 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLSALPT 218 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred cChhHhhhhhhcccccccccccccccc
Confidence 77877765554 5667788777654
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.73 E-value=1.2e-17 Score=166.96 Aligned_cols=171 Identities=23% Similarity=0.290 Sum_probs=135.0
Q ss_pred CCCCCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEe
Q 037905 25 TDGPCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLY 93 (606)
Q Consensus 25 ~~~~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 93 (606)
...-|.+..+.|++ ++|++|+|++|+|+...+.+|.++++|++|++++|.+....|..|..+++|++|+
T Consensus 6 ~~c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~ 85 (305)
T d1xkua_ 6 FRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85 (305)
T ss_dssp TTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence 34557899999975 4688999999999955556899999999999999999977788999999999999
Q ss_pred ccCCcccccCCcc------------------------------------------------ccC----------------
Q 037905 94 LQGNLFSGEIPGL------------------------------------------------LFS---------------- 109 (606)
Q Consensus 94 Ls~N~l~~~~p~~------------------------------------------------~~~---------------- 109 (606)
|++|+|+ .+|.. +..
T Consensus 86 l~~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~ 164 (305)
T d1xkua_ 86 LSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT 164 (305)
T ss_dssp CCSSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred ccCCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccc
Confidence 9999987 34321 111
Q ss_pred -----CCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC
Q 037905 110 -----LGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS 183 (606)
Q Consensus 110 -----l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 183 (606)
+++|+.|++++|.+.+..+..|.+++.++.|++++|.+++.++. +..+++|+.|+|++|+|+ .+|..|.++++
T Consensus 165 l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~ 243 (305)
T d1xkua_ 165 IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243 (305)
T ss_dssp CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSS
T ss_pred cCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccC
Confidence 34456666666666666777788889999999999999888775 778899999999999998 55666665554
Q ss_pred ---CcccCCCCCCCCCc
Q 037905 184 ---SAFEGNSLCGKPLV 197 (606)
Q Consensus 184 ---l~~~~n~l~~~p~~ 197 (606)
|++++|++...+..
T Consensus 244 L~~L~Ls~N~i~~i~~~ 260 (305)
T d1xkua_ 244 IQVVYLHNNNISAIGSN 260 (305)
T ss_dssp CCEEECCSSCCCCCCTT
T ss_pred CCEEECCCCccCccChh
Confidence 56788888876544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=2.6e-17 Score=162.68 Aligned_cols=154 Identities=25% Similarity=0.305 Sum_probs=126.8
Q ss_pred CeEEEEEc-CCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 39 ERVTMLRF-PGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 39 ~~l~~L~L-~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
..+..++. ..|.++...|.+|.++++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+
T Consensus 80 ~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~ 159 (284)
T d1ozna_ 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (284)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcc
Confidence 45666655 46677766677899999999999999998866677788888999999999999966677788889999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCccccCCCC---CcccCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPKRFARLPS---SAFEGNSLC 192 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~ 192 (606)
|++|+|++..+..|.++++|+.|++++|++++..|. |..+++|+.|++++|++++..|..|..+++ +++.+|++.
T Consensus 160 l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred cccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCC
Confidence 999999877788888999999999999999888775 888899999999999999887777766554 567788764
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.67 E-value=1.1e-16 Score=136.88 Aligned_cols=117 Identities=23% Similarity=0.257 Sum_probs=90.6
Q ss_pred EEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCC
Q 037905 42 TMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121 (606)
Q Consensus 42 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 121 (606)
++|||++|+|+ .++ .+..+++|++|+|++|+|+ .+|..|..+++|+.|++++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 46889999998 555 4888899999999999998 67778888999999999999998 555 3888889999999999
Q ss_pred cCCcccc-hhhhcCCCcceeecccccccccCCC----CCCCCCCCEE
Q 037905 122 NFSGTIS-ADFNKLTRLGTLYLQENQLTGSIPD----LGAFSSLAQF 163 (606)
Q Consensus 122 ~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~----~~~l~~L~~L 163 (606)
+|+.... ..+..+++|++|++++|+++....- +..+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 8884432 4678888888888888888754321 2335666654
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.65 E-value=4.2e-17 Score=163.57 Aligned_cols=162 Identities=32% Similarity=0.553 Sum_probs=117.9
Q ss_pred CCeEEEEEcCC-CCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 38 GERVTMLRFPG-MGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 38 ~~~l~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
.++|++|+|++ |+++|.+|.+|++|++|++|+|++|+|.+..|..+..+.+|+.|++++|++.+.+|..+.+++.|+.+
T Consensus 75 L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l 154 (313)
T d1ogqa_ 75 LPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154 (313)
T ss_dssp CTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEE
T ss_pred CccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCccccee
Confidence 36889999986 88988899999999999999999888876555555555555555554444444444444444444444
Q ss_pred ecCC------------------------------------------------------------------------CcCC
Q 037905 117 NLAK------------------------------------------------------------------------NNFS 124 (606)
Q Consensus 117 ~l~~------------------------------------------------------------------------N~l~ 124 (606)
++++ |++.
T Consensus 155 ~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~ 234 (313)
T d1ogqa_ 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234 (313)
T ss_dssp ECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC
T ss_pred eccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3333 3333
Q ss_pred cccchhhhcCCCcceeecccccccccCCC-CCCCCCCCEEEccCCcCcccCCc--cccCCCCCcccCCC-CCCCCCcCCC
Q 037905 125 GTISADFNKLTRLGTLYLQENQLTGSIPD-LGAFSSLAQFNVSFNKLNGSIPK--RFARLPSSAFEGNS-LCGKPLVSCN 200 (606)
Q Consensus 125 ~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~l~~~~n~-l~~~p~~~c~ 200 (606)
+.+| .+..+++|+.|+|++|+|++.+|. ++.+++|+.|+|++|+|+|.+|. .+.++..+++.+|+ +||.|+.+|.
T Consensus 235 ~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 235 FDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp CBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred cccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCCC
Confidence 2222 455578899999999999987775 99999999999999999999985 35566667888987 8999988884
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.64 E-value=5.1e-16 Score=144.76 Aligned_cols=148 Identities=26% Similarity=0.408 Sum_probs=116.4
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
.++++|++++|+|+. + +.+..+++|++|+|++|+|++ ++ .+.++++|++|++++|.+. .++. +.+++.|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~-~~-~l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccC-cc-cccCCcccccccccccccc-cccc-cccccccccccc
Confidence 578889999999884 3 357889999999999999984 44 3888999999999999988 5553 788899999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p 195 (606)
++|.+.. ++ .+..+++|+.|++++|++.. ++.+..+++|+.|++++|++++..+ ..+.++..|++.+|+++..+
T Consensus 114 ~~~~~~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i~~i~ 188 (199)
T d2omxa2 114 FNNQITD-ID-PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDIS 188 (199)
T ss_dssp CSSCCCC-CG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCCG
T ss_pred ccccccc-cc-ccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccCCccccCCCCCCEEECCCCCCCCCc
Confidence 9988874 33 47788999999999999874 4568888899999999999886543 33455566778888887654
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.9e-16 Score=141.06 Aligned_cols=106 Identities=22% Similarity=0.300 Sum_probs=52.5
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
+++.|||++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|+.|+|+
T Consensus 19 ~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 19 RDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp SCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred cCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 4455555555554 33444445555555555555555 232 34555555555555555553333333445555555555
Q ss_pred CCcCCcccc--hhhhcCCCcceeecccccccc
Q 037905 120 KNNFSGTIS--ADFNKLTRLGTLYLQENQLTG 149 (606)
Q Consensus 120 ~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~ 149 (606)
+|+|+ .++ ..+..+++|++|++++|+++.
T Consensus 96 ~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 96 NNSLV-ELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp SCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccccc-ccccccccccccccchhhcCCCcccc
Confidence 55554 222 234455555555555555543
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.60 E-value=3.3e-15 Score=139.12 Aligned_cols=136 Identities=32% Similarity=0.419 Sum_probs=116.4
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.|++..| +.++++|++|++++|.+. .++ .+.++++|+.|++++|.+.. ++ .+..+++|+.|+
T Consensus 61 l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~ 134 (199)
T d2omxa2 61 LNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLE 134 (199)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred CCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccccccccccc-cc-ccchhhhhHHhh
Confidence 4789999999999996543 999999999999999998 555 48999999999999999984 33 488999999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCCC
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSS 184 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l 184 (606)
+++|++. .++ .+..+++|+.|++++|++++. +.+.++++|+.|++++|++++. + .+..+++|
T Consensus 135 l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L 196 (199)
T d2omxa2 135 LSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-KPLANLTTLERLDISSNKVSDI-S-VLAKLTNL 196 (199)
T ss_dssp CCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCC-G-GGGGCTTC
T ss_pred hhhhhhc-ccc-cccccccccccccccccccCC-ccccCCCCCCEEECCCCCCCCC-c-cccCCCCC
Confidence 9999998 455 688999999999999999965 4589999999999999999853 3 45666554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=1.7e-15 Score=129.47 Aligned_cols=103 Identities=24% Similarity=0.287 Sum_probs=92.3
Q ss_pred cEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccc
Q 037905 66 HTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQEN 145 (606)
Q Consensus 66 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N 145 (606)
++|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|+.|..+++|+.|++++|+|+ .+| .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 58999999999 666 5899999999999999999 78888999999999999999999 555 5999999999999999
Q ss_pred cccccCC--CCCCCCCCCEEEccCCcCccc
Q 037905 146 QLTGSIP--DLGAFSSLAQFNVSFNKLNGS 173 (606)
Q Consensus 146 ~l~~~~~--~~~~l~~L~~L~l~~N~l~~~ 173 (606)
+|+..+. .+..+++|+.|++++|+++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 9997654 378899999999999999843
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.59 E-value=3.2e-15 Score=140.54 Aligned_cols=147 Identities=24% Similarity=0.349 Sum_probs=99.8
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
+|+.|++++|.|+.. + .+..+++|++|+|++|+|++ ++ .+..+++|++|+|++|+|+ .+| .+..+++|+.|+++
T Consensus 47 ~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~ 120 (210)
T d1h6ta2 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLE 120 (210)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECT
T ss_pred CccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccccccc
Confidence 577778888877743 2 36777788888888887774 43 3677778888888888877 444 46777778888888
Q ss_pred CCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCC
Q 037905 120 KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 120 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p 195 (606)
+|.+. .++ .+..+++|+.+++++|.++. ++.+..+++|+.+++++|++++..+ ..+.++..|++++|.++..|
T Consensus 121 ~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~-~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~~l~ 194 (210)
T d1h6ta2 121 HNGIS-DIN-GLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLR 194 (210)
T ss_dssp TSCCC-CCG-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCBCG
T ss_pred ccccc-ccc-cccccccccccccccccccc-cccccccccccccccccccccccccccCCCCCCEEECCCCCCCCCh
Confidence 77776 333 56777777777777777764 3345667777777777777775433 23344455567777776543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=8.9e-16 Score=137.84 Aligned_cols=125 Identities=18% Similarity=0.108 Sum_probs=106.3
Q ss_pred cccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCc
Q 037905 58 AIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRL 137 (606)
Q Consensus 58 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 137 (606)
.+.+..+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+ .++ .|..+++|+.|+|++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 5678889999999999999 67877788999999999999999 554 48899999999999999996666667889999
Q ss_pred ceeecccccccccCC--CCCCCCCCCEEEccCCcCcccCC---ccccCCCCCc
Q 037905 138 GTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLNGSIP---KRFARLPSSA 185 (606)
Q Consensus 138 ~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p---~~~~~l~~l~ 185 (606)
++|++++|+|+.... .+..+++|+.|++++|+++.... ..+..+|+|.
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~ 142 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVR 142 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCS
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcC
Confidence 999999999986543 47889999999999999984331 2466677765
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.57 E-value=8.6e-15 Score=137.50 Aligned_cols=137 Identities=28% Similarity=0.369 Sum_probs=116.8
Q ss_pred CCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEe
Q 037905 38 GERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLN 117 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 117 (606)
.++|++|+|++|.|++.. .+..+++|++|+|++|+|+ .+| .+..+++|+.|++++|.+. .++ .+..++.|+.++
T Consensus 67 l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~ 140 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLY 140 (210)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEE
T ss_pred CCCCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccc-cccccccccccc
Confidence 368999999999999643 4789999999999999999 566 6899999999999999998 444 588999999999
Q ss_pred cCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccCCCCCc
Q 037905 118 LAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFARLPSSA 185 (606)
Q Consensus 118 l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~l~ 185 (606)
+++|.++. . ..+..+++|+++++++|++++.+ .+.++++|+.|+|++|+|+. +| .|..+++|.
T Consensus 141 ~~~n~l~~-~-~~~~~l~~L~~l~l~~n~l~~i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~ 203 (210)
T d1h6ta2 141 LGNNKITD-I-TVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLD 203 (210)
T ss_dssp CCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCS
T ss_pred cccccccc-c-ccccccccccccccccccccccc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCC
Confidence 99999983 3 35789999999999999999654 58899999999999999985 44 466666553
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.53 E-value=2.2e-14 Score=142.83 Aligned_cols=151 Identities=19% Similarity=0.228 Sum_probs=108.6
Q ss_pred CeEEEEEcCCCCcc--cccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 39 ERVTMLRFPGMGLS--GQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 39 ~~l~~L~L~~n~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
..+..++...|... ...+..+..+++|+.+++++|.++ .+|..+ +++|+.|++++|.+++..+..|..++.++.|
T Consensus 124 ~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L 200 (305)
T d1xkua_ 124 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL 200 (305)
T ss_dssp TTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred ccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccc
Confidence 34556777766443 334556777888888888888887 566443 5678888888888887777778888888888
Q ss_pred ecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCcccc---------CCCCCccc
Q 037905 117 NLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFA---------RLPSSAFE 187 (606)
Q Consensus 117 ~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~---------~l~~l~~~ 187 (606)
++++|.+.+..+..|.++++|++|+|++|+|+.+++.+..+++|+.|+|++|+|+......|. ++..+.+.
T Consensus 201 ~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~ 280 (305)
T d1xkua_ 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280 (305)
T ss_dssp ECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECC
T ss_pred ccccccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECC
Confidence 888888887777778888888888888888886666677788888888888888754433332 23345567
Q ss_pred CCCCC
Q 037905 188 GNSLC 192 (606)
Q Consensus 188 ~n~l~ 192 (606)
+|++.
T Consensus 281 ~N~~~ 285 (305)
T d1xkua_ 281 SNPVQ 285 (305)
T ss_dssp SSSSC
T ss_pred CCcCc
Confidence 77664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=3.5e-14 Score=136.17 Aligned_cols=169 Identities=17% Similarity=0.158 Sum_probs=117.4
Q ss_pred CCcceeEEecC-----------CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccC-cccccCCCCCCEEecc
Q 037905 28 PCKWVGVFCTG-----------ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTI-PSDFAKLSNLRNLYLQ 95 (606)
Q Consensus 28 ~c~~~~~~c~~-----------~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls 95 (606)
-|+...+.|+. .++++|+|++|.|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++.
T Consensus 7 ~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 7 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp EECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 35677788863 37899999999998655668999999999999999987544 4568888888888875
Q ss_pred -CCcccccCCccccCCCCCcEEecCCCcCCcccc-------------------------hhhhcCC-Ccceeeccccccc
Q 037905 96 -GNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTIS-------------------------ADFNKLT-RLGTLYLQENQLT 148 (606)
Q Consensus 96 -~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p-------------------------~~~~~l~-~L~~L~l~~N~l~ 148 (606)
.|++....+..|.++++|+.|++++|++....+ ..|..++ .++.|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 467776777778888888888888887753222 1122222 4666777777777
Q ss_pred ccCCCCCCCCCCCEE-EccCCcCcccCCccccCCCC---CcccCCCCCCCCC
Q 037905 149 GSIPDLGAFSSLAQF-NVSFNKLNGSIPKRFARLPS---SAFEGNSLCGKPL 196 (606)
Q Consensus 149 ~~~~~~~~l~~L~~L-~l~~N~l~~~~p~~~~~l~~---l~~~~n~l~~~p~ 196 (606)
.+.+......++..+ ++++|+|+...+..|..+++ |++.+|++...|.
T Consensus 167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 218 (242)
T d1xwdc1 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218 (242)
T ss_dssp EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence 666554445555444 46777777554555554444 5667777776554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.49 E-value=8.7e-14 Score=132.15 Aligned_cols=149 Identities=20% Similarity=0.327 Sum_probs=88.8
Q ss_pred eEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecC
Q 037905 40 RVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLA 119 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 119 (606)
+|+.|++.+|+|+. ++ .+..+++|++|+|++|+|++..| +.++++|++|++++|.++ .++ .+.++++|+.|+++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~ 115 (227)
T d1h6ua2 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLT 115 (227)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECT
T ss_pred CcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccc
Confidence 45555555555552 32 35555555555555555553222 555555555555555555 332 24455555555555
Q ss_pred CCcCCccc--------------------chhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccc
Q 037905 120 KNNFSGTI--------------------SADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRF 178 (606)
Q Consensus 120 ~N~l~~~~--------------------p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~ 178 (606)
+|.+.+.. ...+.++++|++|++++|.++.. +.+..+++|+.|+|++|++++..+ ..+
T Consensus 116 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~Ls~n~l~~l~~l~~l 194 (227)
T d1h6ua2 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDL-TPLANLSKLTTLKADDNKISDISPLASL 194 (227)
T ss_dssp TSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCCGGGGGC
T ss_pred cccccccchhccccchhhhhchhhhhchhhhhccccccccccccccccccc-hhhcccccceecccCCCccCCChhhcCC
Confidence 44433211 12356778888888888888743 347788889999999998886433 234
Q ss_pred cCCCCCcccCCCCCCCC
Q 037905 179 ARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 179 ~~l~~l~~~~n~l~~~p 195 (606)
.+|..|++.+|+++..+
T Consensus 195 ~~L~~L~Ls~N~lt~i~ 211 (227)
T d1h6ua2 195 PNLIEVHLKNNQISDVS 211 (227)
T ss_dssp TTCCEEECTTSCCCBCG
T ss_pred CCCCEEECcCCcCCCCc
Confidence 55566778888887654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.47 E-value=2.6e-16 Score=146.40 Aligned_cols=129 Identities=24% Similarity=0.348 Sum_probs=106.4
Q ss_pred EEEEEcCCC--CcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 41 VTMLRFPGM--GLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 41 l~~L~L~~n--~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++.++|.++ .++ .+|.+|..|++|++|+|++|+|+ .++ .|.++++|++|+|++|+|+ .+|..+..+++|+.|++
T Consensus 25 ~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l 100 (198)
T d1m9la_ 25 AEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWI 100 (198)
T ss_dssp CSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEEC
T ss_pred cceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccc
Confidence 444566554 344 56678999999999999999999 555 5899999999999999999 67776666778999999
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCC--CCCCCCCCCEEEccCCcCcccCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIP--DLGAFSSLAQFNVSFNKLNGSIP 175 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p 175 (606)
++|+|+ .++ .+..+++|++|++++|+|+.... .+..+++|+.|+|++|++....+
T Consensus 101 ~~N~i~-~l~-~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 101 SYNQIA-SLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEECC-CHH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccc-ccc-cccccccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 999998 444 58899999999999999986543 47889999999999999986554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=2.8e-14 Score=127.06 Aligned_cols=103 Identities=22% Similarity=0.150 Sum_probs=59.9
Q ss_pred EEEcCCCCcccccCccccCCCCCcEEEccCC-CCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCC
Q 037905 43 MLRFPGMGLSGQLPIAIGNLTELHTVSLRFN-ALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKN 121 (606)
Q Consensus 43 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 121 (606)
.++.+++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 3555666665 45556666666666666544 366444455666666666666666666555555666666666666666
Q ss_pred cCCcccchhhhcCCCcceeecccccc
Q 037905 122 NFSGTISADFNKLTRLGTLYLQENQL 147 (606)
Q Consensus 122 ~l~~~~p~~~~~l~~L~~L~l~~N~l 147 (606)
+|+...+..|. ..+|++|+|++|++
T Consensus 91 ~l~~l~~~~~~-~~~l~~L~L~~Np~ 115 (156)
T d2ifga3 91 ALESLSWKTVQ-GLSLQELVLSGNPL 115 (156)
T ss_dssp CCSCCCSTTTC-SCCCCEEECCSSCC
T ss_pred CCcccChhhhc-cccccccccCCCcc
Confidence 66633332332 23455555555555
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.46 E-value=9.4e-14 Score=142.35 Aligned_cols=146 Identities=23% Similarity=0.287 Sum_probs=106.5
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
.+|+.|++++|.++. + +.+..+++|+.|++++|++++.. .+..+++|++|++++|++++..+ +..++.++.+++
T Consensus 219 ~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~ 292 (384)
T d2omza2 219 TNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISP--LAGLTALTNLEL 292 (384)
T ss_dssp TTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCc--cccccccccccc
Confidence 578999999999984 3 46888999999999999998533 38889999999999999984432 667777777777
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCccccC---CCCCcccCCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPKRFAR---LPSSAFEGNSLCGKP 195 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~---l~~l~~~~n~l~~~p 195 (606)
++|++++ ++ .+..+++|+.|++++|+|++.+ .+..+++|+.|++++|+|++. + .|.+ |..|++.+|++++.+
T Consensus 293 ~~n~l~~-~~-~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~ 367 (384)
T d2omza2 293 NENQLED-IS-PISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLT 367 (384)
T ss_dssp CSSCCSC-CG-GGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCG
T ss_pred ccccccc-cc-ccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCCh
Confidence 7777763 32 4667777777777777777653 366677777777777777642 2 3443 444566777776654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.46 E-value=1.7e-13 Score=130.02 Aligned_cols=139 Identities=21% Similarity=0.327 Sum_probs=113.8
Q ss_pred cCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCC------------
Q 037905 37 TGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIP------------ 104 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p------------ 104 (606)
..++|++|+|++|.|++..| +..+++|++|++++|.++ .++ .+.++++|++|++++|...+..+
T Consensus 61 ~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~ 136 (227)
T d1h6ua2 61 YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136 (227)
T ss_dssp GCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEEC
T ss_pred cCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhc
Confidence 45799999999999986543 899999999999999998 454 68889999999999998774322
Q ss_pred --------ccccCCCCCcEEecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCCc
Q 037905 105 --------GLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIPK 176 (606)
Q Consensus 105 --------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 176 (606)
..+..+++|+.|++++|.+.... .+.++++|++|+|++|+++++ +.+..+++|++|+|++|+|++..|
T Consensus 137 ~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt~i~~- 212 (227)
T d1h6ua2 137 DLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQISDVSP- 212 (227)
T ss_dssp CSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCCBCGG-
T ss_pred hhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCCCCcc-
Confidence 13566788999999999998433 488999999999999999864 558899999999999999996544
Q ss_pred cccCCCCC
Q 037905 177 RFARLPSS 184 (606)
Q Consensus 177 ~~~~l~~l 184 (606)
+.+++.|
T Consensus 213 -l~~l~~L 219 (227)
T d1h6ua2 213 -LANTSNL 219 (227)
T ss_dssp -GTTCTTC
T ss_pred -cccCCCC
Confidence 5555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.6e-13 Score=121.97 Aligned_cols=110 Identities=20% Similarity=0.109 Sum_probs=97.0
Q ss_pred CCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCC-cccccCCccccCCCCCcEEecCCCcCCcccchhhhcCCCcce
Q 037905 61 NLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGN-LFSGEIPGLLFSLGNLIRLNLAKNNFSGTISADFNKLTRLGT 139 (606)
Q Consensus 61 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 139 (606)
.....+.++.+++.+. ..|..+.++++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|..|..+++|++
T Consensus 6 ~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~ 84 (156)
T d2ifga3 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (156)
T ss_dssp CCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccc
Confidence 3455677999999998 78889999999999999766 599666788999999999999999999888889999999999
Q ss_pred eecccccccccCCCCCCCCCCCEEEccCCcCc
Q 037905 140 LYLQENQLTGSIPDLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 140 L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~ 171 (606)
|+|++|+|+.+++.+....+|+.|+|++|+|.
T Consensus 85 L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 85 LNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EECCSSCCSCCCSTTTCSCCCCEEECCSSCCC
T ss_pred eeccCCCCcccChhhhccccccccccCCCccc
Confidence 99999999988877545557999999999996
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.38 E-value=9.2e-13 Score=134.79 Aligned_cols=148 Identities=30% Similarity=0.405 Sum_probs=95.5
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
.++..|++++|.+++..| +...++|++|++++|+++ .+| .+..+++|+.|++++|++++..+ +..+++|+.|++
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l 270 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKL 270 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEEC
T ss_pred cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCC-Ccc-hhhcccccchhccccCccCCCCc--ccccccCCEeec
Confidence 456677777777765443 445667777777777776 333 56667777777777777774332 666777777777
Q ss_pred CCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCCC
Q 037905 119 AKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGKP 195 (606)
Q Consensus 119 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~p 195 (606)
++|++++.. .+..++.++.+++.+|.+++ ++.+..+++++.|++++|++++..+ ..+.+|..|++.+|.+++.+
T Consensus 271 ~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~~~~~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~l~ 345 (384)
T d2omza2 271 GANQISNIS--PLAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDVS 345 (384)
T ss_dssp CSSCCCCCG--GGTTCTTCSEEECCSSCCSC-CGGGGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCCG
T ss_pred cCcccCCCC--cccccccccccccccccccc-ccccchhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCCCh
Confidence 777776433 25667777777777777764 3345666777777777777776543 44555566667777766654
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=3.1e-15 Score=138.99 Aligned_cols=123 Identities=19% Similarity=0.243 Sum_probs=102.0
Q ss_pred cCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEE
Q 037905 37 TGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRL 116 (606)
Q Consensus 37 ~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 116 (606)
...+|++|+|++|+|+ .++ .|..|++|++|+|++|+|+ .+|..+..+++|++|++++|+|+ .++ .+..+++|+.|
T Consensus 46 ~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L 120 (198)
T d1m9la_ 46 TLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVL 120 (198)
T ss_dssp HTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEE
T ss_pred cccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccccccccc
Confidence 3478999999999998 454 5999999999999999998 67766666778999999999999 444 48889999999
Q ss_pred ecCCCcCCcccc-hhhhcCCCcceeecccccccccCCCC-----------CCCCCCCEEE
Q 037905 117 NLAKNNFSGTIS-ADFNKLTRLGTLYLQENQLTGSIPDL-----------GAFSSLAQFN 164 (606)
Q Consensus 117 ~l~~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~-----------~~l~~L~~L~ 164 (606)
+|++|+|+.... ..+..|++|++|+|++|++....+.. ..+++|+.||
T Consensus 121 ~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp EESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 999999984322 46899999999999999998766542 3466777665
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=4.3e-12 Score=121.30 Aligned_cols=163 Identities=12% Similarity=0.143 Sum_probs=126.8
Q ss_pred CcceeEEecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccC-Cccc
Q 037905 29 CKWVGVFCTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEI-PGLL 107 (606)
Q Consensus 29 c~~~~~~c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~ 107 (606)
|.-..-.|.. +.++.++++++ .+|..+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|
T Consensus 1 ~~~~~C~C~~---~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f 74 (242)
T d1xwdc1 1 CHHRICHCSN---RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74 (242)
T ss_dssp CCCSSEEECS---SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSE
T ss_pred CcCCcCCCcC---CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccc
Confidence 4445566764 56888999998 7887663 68999999999999555567999999999999999987654 4568
Q ss_pred cCCCCCcEEecC-CCcCCcccchhhhcCCCcceeecccccccccCCC--CCCCCCCCEEEccCCcCcccCCccccCCCC-
Q 037905 108 FSLGNLIRLNLA-KNNFSGTISADFNKLTRLGTLYLQENQLTGSIPD--LGAFSSLAQFNVSFNKLNGSIPKRFARLPS- 183 (606)
Q Consensus 108 ~~l~~L~~L~l~-~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~--~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~- 183 (606)
.+++.++.|.+. .|++....+..|.++++|++|++++|.+...++. +..+..+..+..+++.+....+..|..++.
T Consensus 75 ~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~ 154 (242)
T d1xwdc1 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 154 (242)
T ss_dssp ESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSS
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccccc
Confidence 899999999986 4788878888899999999999999999865442 445566666777888888777777765543
Q ss_pred ---CcccCCCCCCCCCc
Q 037905 184 ---SAFEGNSLCGKPLV 197 (606)
Q Consensus 184 ---l~~~~n~l~~~p~~ 197 (606)
+.+.+|.+...+..
T Consensus 155 l~~L~l~~n~l~~i~~~ 171 (242)
T d1xwdc1 155 SVILWLNKNGIQEIHNC 171 (242)
T ss_dssp CEEEECCSSCCCEECTT
T ss_pred ceeeecccccccccccc
Confidence 56777887765543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.10 E-value=2e-10 Score=115.33 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=103.5
Q ss_pred ecCCeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcE
Q 037905 36 CTGERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIR 115 (606)
Q Consensus 36 c~~~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 115 (606)
|...+++.|||++|+|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.. .+.|++
T Consensus 35 c~~~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~ 102 (353)
T d1jl5a_ 35 CLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEY 102 (353)
T ss_dssp HHHHTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCE
T ss_pred HHHcCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccc
Confidence 43457899999999998 67854 578999999999999 788664 57999999999999 55532 146999
Q ss_pred EecCCCcCCcccchhhhcCCCcceeecccccccccCCCCCCCCCCCEEEccCCcCcccCC-ccccCCCCCcccCCCCCCC
Q 037905 116 LNLAKNNFSGTISADFNKLTRLGTLYLQENQLTGSIPDLGAFSSLAQFNVSFNKLNGSIP-KRFARLPSSAFEGNSLCGK 194 (606)
Q Consensus 116 L~l~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~l~~~~n~l~~~ 194 (606)
|++++|.|. .+|. ++.+++|++|++++|.+...+.. ...+..+.+.++....... ..+..+..+.+.+|.+...
T Consensus 103 L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~---~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 103 LGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDL---PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp EECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSC
T ss_pred ccccccccc-cccc-hhhhccceeeccccccccccccc---cccccchhhccccccccccccccccceeccccccccccc
Confidence 999999998 5663 68899999999999999865543 3455666666665543221 2233334455555555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.98 E-value=2e-09 Score=107.68 Aligned_cols=77 Identities=18% Similarity=0.218 Sum_probs=64.6
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEec
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNL 118 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 118 (606)
++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .++.. .+.|++|+|++|.++ .+|. +..+++|+.|++
T Consensus 58 ~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l 127 (353)
T d1jl5a_ 58 PHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDV 127 (353)
T ss_dssp TTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEEC
T ss_pred CCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhhh---ccccccccccccccc-cccc-hhhhccceeecc
Confidence 57999999999999 77865 468999999999998 55532 146999999999999 6775 678999999999
Q ss_pred CCCcCCc
Q 037905 119 AKNNFSG 125 (606)
Q Consensus 119 ~~N~l~~ 125 (606)
++|.+..
T Consensus 128 ~~~~~~~ 134 (353)
T d1jl5a_ 128 DNNSLKK 134 (353)
T ss_dssp CSSCCSC
T ss_pred ccccccc
Confidence 9998873
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.91 E-value=2.5e-10 Score=111.62 Aligned_cols=150 Identities=23% Similarity=0.241 Sum_probs=98.0
Q ss_pred CeEEEEEcCCCCcccc-cCccccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccC-Cccccc-CCccccCCCCCcE
Q 037905 39 ERVTMLRFPGMGLSGQ-LPIAIGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQG-NLFSGE-IPGLLFSLGNLIR 115 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~-~p~~~~~l~~L~~ 115 (606)
.+|++|||+++.++.. ++..+.++++|++|+|+++.+++..+..+.++++|++|+|++ +.++.. +...+.++++|+.
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4688999998887643 344577889999999999988877778888889999999988 456532 2223456788899
Q ss_pred EecCCC-cCCc-ccchhhhc-CCCcceeecccc--ccccc-CCC-CCCCCCCCEEEccCC-cCcccCCccccCCCC---C
Q 037905 116 LNLAKN-NFSG-TISADFNK-LTRLGTLYLQEN--QLTGS-IPD-LGAFSSLAQFNVSFN-KLNGSIPKRFARLPS---S 184 (606)
Q Consensus 116 L~l~~N-~l~~-~~p~~~~~-l~~L~~L~l~~N--~l~~~-~~~-~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~---l 184 (606)
|+|+++ +++. .+...+.. .++|+.|++++. .++.. +.. +..+++|+.|++++| .+++.....+.++++ |
T Consensus 126 L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L 205 (284)
T d2astb2 126 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHL 205 (284)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEE
T ss_pred cccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEE
Confidence 998885 4442 12223333 367888887753 23321 111 245677888888775 466555555554444 4
Q ss_pred cccC
Q 037905 185 AFEG 188 (606)
Q Consensus 185 ~~~~ 188 (606)
.+.+
T Consensus 206 ~L~~ 209 (284)
T d2astb2 206 SLSR 209 (284)
T ss_dssp ECTT
T ss_pred ECCC
Confidence 4555
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.89 E-value=3e-10 Score=111.03 Aligned_cols=146 Identities=16% Similarity=0.199 Sum_probs=102.0
Q ss_pred CeEEEEEcCCCCcccccCccccCCCCCcEEEccC-CCCccc-CcccccCCCCCCEEeccCC-ccccc-CCcccc-CCCCC
Q 037905 39 ERVTMLRFPGMGLSGQLPIAIGNLTELHTVSLRF-NALRGT-IPSDFAKLSNLRNLYLQGN-LFSGE-IPGLLF-SLGNL 113 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~-~l~~L 113 (606)
++|++|+|+++.+++..+..+..+++|++|+|++ +.++.. +..-+.++++|++|+|+++ .++.. +...+. ..++|
T Consensus 71 ~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L 150 (284)
T d2astb2 71 SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 150 (284)
T ss_dssp CCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhccccccc
Confidence 6899999999999888888999999999999998 467621 2333467899999999985 45421 222233 34678
Q ss_pred cEEecCCC--cCCc-ccchhhhcCCCcceeeccccc-ccccC-CCCCCCCCCCEEEccC-CcCcccCCccccCCCCC
Q 037905 114 IRLNLAKN--NFSG-TISADFNKLTRLGTLYLQENQ-LTGSI-PDLGAFSSLAQFNVSF-NKLNGSIPKRFARLPSS 184 (606)
Q Consensus 114 ~~L~l~~N--~l~~-~~p~~~~~l~~L~~L~l~~N~-l~~~~-~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~l~~l 184 (606)
+.|++++. .++. .+...+.++++|++|++++|. ++... ..+..+++|+.|+|++ +.+++.....++++++|
T Consensus 151 ~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L 227 (284)
T d2astb2 151 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTL 227 (284)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTC
T ss_pred chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCC
Confidence 88888864 3442 233334678888888888864 55433 3477788888888888 46776555555555543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=1.7e-10 Score=102.72 Aligned_cols=92 Identities=21% Similarity=0.144 Sum_probs=49.2
Q ss_pred ccCCCCCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccC--CccccCCCCCcEEecCCCcCCcccchhhhcCCC
Q 037905 59 IGNLTELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEI--PGLLFSLGNLIRLNLAKNNFSGTISADFNKLTR 136 (606)
Q Consensus 59 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 136 (606)
+..+..+..|++.+|.+. .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+...+-.+.....
T Consensus 38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 333444444444444443 34444455666666666666666321 233455666666666666666333323334445
Q ss_pred cceeecccccccccC
Q 037905 137 LGTLYLQENQLTGSI 151 (606)
Q Consensus 137 L~~L~l~~N~l~~~~ 151 (606)
|+.|++++|+++...
T Consensus 117 L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 117 LEELWLDGNSLSDTF 131 (162)
T ss_dssp CSSCCCTTSTTSSSS
T ss_pred cceeecCCCCcCcCc
Confidence 666666666665443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.72 E-value=8.2e-10 Score=110.99 Aligned_cols=154 Identities=18% Similarity=0.193 Sum_probs=85.6
Q ss_pred CeEEEEEcCCCCcccc----------cCccccCCCCCcEEEccCCCCccc----CcccccCCCCCCEEeccCCcccccCC
Q 037905 39 ERVTMLRFPGMGLSGQ----------LPIAIGNLTELHTVSLRFNALRGT----IPSDFAKLSNLRNLYLQGNLFSGEIP 104 (606)
Q Consensus 39 ~~l~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p 104 (606)
++|+.|+|+++.+... +...+...++|+.|+|++|.+... +...+..+++|+.|+|++|.+...-.
T Consensus 59 ~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~ 138 (344)
T d2ca6a1 59 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 138 (344)
T ss_dssp TTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHH
T ss_pred CCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhhhhcccccchheeccccccccccc
Confidence 5677777776654311 112345667777777777777632 23334556777777777777642110
Q ss_pred c-------------cccCCCCCcEEecCCCcCCcc----cchhhhcCCCcceeeccccccccc-----C-CCCCCCCCCC
Q 037905 105 G-------------LLFSLGNLIRLNLAKNNFSGT----ISADFNKLTRLGTLYLQENQLTGS-----I-PDLGAFSSLA 161 (606)
Q Consensus 105 ~-------------~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-----~-~~~~~l~~L~ 161 (606)
. .....+.|+.|++++|++... +...+..+++|++|+|++|+|+.. + ..+..+++|+
T Consensus 139 ~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~ 218 (344)
T d2ca6a1 139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 218 (344)
T ss_dssp HHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCC
T ss_pred ccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhc
Confidence 0 112455677777777766521 223345566777777777776531 1 2245566677
Q ss_pred EEEccCCcCccc----CCcc---ccCCCCCcccCCCCC
Q 037905 162 QFNVSFNKLNGS----IPKR---FARLPSSAFEGNSLC 192 (606)
Q Consensus 162 ~L~l~~N~l~~~----~p~~---~~~l~~l~~~~n~l~ 192 (606)
.|+|++|.++.. +... ..+|..|++.+|.+.
T Consensus 219 ~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 219 VLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp EEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred ccccccccccccccccccccccccccchhhhhhcCccC
Confidence 777777766532 1112 233444556666654
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.57 E-value=4.6e-09 Score=105.33 Aligned_cols=156 Identities=17% Similarity=0.177 Sum_probs=113.9
Q ss_pred CCeEEEEEcCCCCcc----cccCc---------cccCCCCCcEEEccCCCCcc----cCcccccCCCCCCEEeccCCccc
Q 037905 38 GERVTMLRFPGMGLS----GQLPI---------AIGNLTELHTVSLRFNALRG----TIPSDFAKLSNLRNLYLQGNLFS 100 (606)
Q Consensus 38 ~~~l~~L~L~~n~l~----~~~p~---------~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~ 100 (606)
.++|++|+|++|.+. ..+.. .....+.|+.|++++|+++. .+...+..++.|++|+|++|+++
T Consensus 120 ~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 199 (344)
T d2ca6a1 120 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 199 (344)
T ss_dssp CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCC
T ss_pred cccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhccccccccccc
Confidence 478999999999862 11111 22467899999999999873 23344667889999999999987
Q ss_pred cc-----CCccccCCCCCcEEecCCCcCCcc----cchhhhcCCCcceeecccccccccCC-----CC--CCCCCCCEEE
Q 037905 101 GE-----IPGLLFSLGNLIRLNLAKNNFSGT----ISADFNKLTRLGTLYLQENQLTGSIP-----DL--GAFSSLAQFN 164 (606)
Q Consensus 101 ~~-----~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~-----~~--~~l~~L~~L~ 164 (606)
.. +...+..+++|+.|+|++|.|... +...+..+++|++|+|++|.|+..-. .+ .....|+.|+
T Consensus 200 ~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ 279 (344)
T d2ca6a1 200 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLR 279 (344)
T ss_dssp HHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEE
T ss_pred ccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEE
Confidence 32 334567889999999999998632 44567889999999999999975321 12 2346799999
Q ss_pred ccCCcCcccCC----c----cccCCCCCcccCCCCCC
Q 037905 165 VSFNKLNGSIP----K----RFARLPSSAFEGNSLCG 193 (606)
Q Consensus 165 l~~N~l~~~~p----~----~~~~l~~l~~~~n~l~~ 193 (606)
+++|+|+..-. . ....+..|+++||.+..
T Consensus 280 ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 280 LQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp CCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred CCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 99999874321 1 23467778899998853
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=9.6e-09 Score=106.37 Aligned_cols=110 Identities=22% Similarity=0.214 Sum_probs=75.5
Q ss_pred eEEEEEcCCCCccccc-CccccCCCCCcEEEccCCCCcc----cCcccccCCCCCCEEeccCCccccc----CCcccc-C
Q 037905 40 RVTMLRFPGMGLSGQL-PIAIGNLTELHTVSLRFNALRG----TIPSDFAKLSNLRNLYLQGNLFSGE----IPGLLF-S 109 (606)
Q Consensus 40 ~l~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~ 109 (606)
+|+.|||++|+|++.. ...+..+++|++|+|++|.|+. .+...+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6888999999887532 2345667888888888888872 3355567888888888888888621 122222 2
Q ss_pred CCCCcEEecCCCcCCcc----cchhhhcCCCcceeecccccccc
Q 037905 110 LGNLIRLNLAKNNFSGT----ISADFNKLTRLGTLYLQENQLTG 149 (606)
Q Consensus 110 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~ 149 (606)
..+|+.|+|++|+|+.. ++..+..+++|++|+|++|+++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 34688888888887633 34456667777777777777754
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=8.1e-10 Score=98.22 Aligned_cols=123 Identities=20% Similarity=0.173 Sum_probs=88.1
Q ss_pred CCcEEEccCCCCcccCcccccCCCCCCEEeccCCcccccCCccccCCCCCcEEecCCCcCCccc--chhhhcCCCcceee
Q 037905 64 ELHTVSLRFNALRGTIPSDFAKLSNLRNLYLQGNLFSGEIPGLLFSLGNLIRLNLAKNNFSGTI--SADFNKLTRLGTLY 141 (606)
Q Consensus 64 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~L~ 141 (606)
+++.|+++++... + .+..+..+..|++.+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4566777665533 2 3555666667777777665 66666678999999999999998543 45678899999999
Q ss_pred cccccccccCC-CCCCCCCCCEEEccCCcCcccCCc-------cccCCCCCc-ccCCCC
Q 037905 142 LQENQLTGSIP-DLGAFSSLAQFNVSFNKLNGSIPK-------RFARLPSSA-FEGNSL 191 (606)
Q Consensus 142 l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~-------~~~~l~~l~-~~~n~l 191 (606)
|++|+|+...+ .+....+|+.|++++|+++..... .+..+|+|. ++|+.+
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LDg~~v 156 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDGHEL 156 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEETTEEC
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEECcCCC
Confidence 99999996554 233445799999999999866542 245677764 455554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=1.4e-08 Score=104.99 Aligned_cols=15 Identities=33% Similarity=0.324 Sum_probs=7.4
Q ss_pred CCCCCEEEccCCcCc
Q 037905 157 FSSLAQFNVSFNKLN 171 (606)
Q Consensus 157 l~~L~~L~l~~N~l~ 171 (606)
+++|++|+|++|+|+
T Consensus 396 ~~~L~~L~Ls~N~i~ 410 (460)
T d1z7xw1 396 NHSLRELDLSNNCLG 410 (460)
T ss_dssp CCCCCEEECCSSSCC
T ss_pred CCCCCEEECCCCcCC
Confidence 344555555555544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.99 E-value=1.1e-05 Score=76.57 Aligned_cols=129 Identities=13% Similarity=0.049 Sum_probs=83.5
Q ss_pred CCceEEEEEEEcCCcEEEEEEeccCc-cCHHHHHHHHHHHcCCC-CCCcccceEEEEeCCceEEEEeecCCCChhhhhhc
Q 037905 328 GTFGTAYKATLEMGIVVAVKRLKDVT-VSEKEFREKMEVVGSMD-HENLVPLRAYYYSRDEKLLVHDYMPMGSLSALLHG 405 (606)
Q Consensus 328 G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 405 (606)
++.+.||+.... +..+++|+..... .....+.+|...+..+. +--+.+++.++..++..++||++++|.++.+....
T Consensus 25 ~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~ 103 (263)
T d1j7la_ 25 MSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED 103 (263)
T ss_dssp CSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT
T ss_pred CCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc
Confidence 344789998765 5566788775432 23345667777765442 33356777888788888999999999887654421
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------------
Q 037905 406 NRGAGRTPLNWETRSGLALGASRAIAYLHSK------------------------------------------------- 436 (606)
Q Consensus 406 ~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~------------------------------------------------- 436 (606)
. -. ...++.++++.++.||+.
T Consensus 104 ~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 104 E-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp C-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred c-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 1 11 112334444444444421
Q ss_pred --------CCCCCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 437 --------GPANSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 437 --------~~~i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
..+++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1225699999999999987667799998764
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.94 E-value=3e-06 Score=74.78 Aligned_cols=85 Identities=15% Similarity=0.176 Sum_probs=36.6
Q ss_pred CeEEEEEcCCC-Ccccc----cCccccCCCCCcEEEccCCCCcc----cCcccccCCCCCCEEeccCCccccc----CCc
Q 037905 39 ERVTMLRFPGM-GLSGQ----LPIAIGNLTELHTVSLRFNALRG----TIPSDFAKLSNLRNLYLQGNLFSGE----IPG 105 (606)
Q Consensus 39 ~~l~~L~L~~n-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~ 105 (606)
++|+.|+|+++ .++.. +-..+...++|++|+|++|.|.. .+...+...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 34555555543 33321 12234445555555555555541 1112233344555555555555421 111
Q ss_pred cccCCCCCcEEecCCCcC
Q 037905 106 LLFSLGNLIRLNLAKNNF 123 (606)
Q Consensus 106 ~~~~l~~L~~L~l~~N~l 123 (606)
.+...++|+.|+|++|++
T Consensus 95 aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HTTTTCCCSEEECCCCSS
T ss_pred HHHhCCcCCEEECCCCcC
Confidence 233334455555554443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.74 E-value=4.7e-06 Score=73.49 Aligned_cols=111 Identities=13% Similarity=0.092 Sum_probs=72.6
Q ss_pred cCCCCCcEEEccCC-CCccc----CcccccCCCCCCEEeccCCcccccC----CccccCCCCCcEEecCCCcCCcc----
Q 037905 60 GNLTELHTVSLRFN-ALRGT----IPSDFAKLSNLRNLYLQGNLFSGEI----PGLLFSLGNLIRLNLAKNNFSGT---- 126 (606)
Q Consensus 60 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~---- 126 (606)
.+.++|++|+|+++ .++.. +-..+...+.|++|+|++|.+.... ...+...+.|+.|+|++|.|...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 45688999999874 56521 2334667788999999999887322 23344567888999999888732
Q ss_pred cchhhhcCCCcceeecccccccccCC--------CCCCCCCCCEEEccCCcC
Q 037905 127 ISADFNKLTRLGTLYLQENQLTGSIP--------DLGAFSSLAQFNVSFNKL 170 (606)
Q Consensus 127 ~p~~~~~l~~L~~L~l~~N~l~~~~~--------~~~~l~~L~~L~l~~N~l 170 (606)
+-..+...++|++|++++|.+...-. .+...++|+.|+++.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 22245556778888888887653211 123456777777766543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.65 E-value=3.9e-05 Score=72.14 Aligned_cols=74 Identities=11% Similarity=0.060 Sum_probs=51.4
Q ss_pred cccCCc-eEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCC--CCCcccceEEEEeCCceEEEEeecCCCChh
Q 037905 325 LGKGTF-GTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMD--HENLVPLRAYYYSRDEKLLVHDYMPMGSLS 400 (606)
Q Consensus 325 ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 400 (606)
+..|.. +.||+....++..+++|....... ..+..|...++.+. .-.+.++++++.+.+..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT--SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH--hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 455554 689999988788888998765432 23556666665543 233566777777888889999999886654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.38 E-value=3e-05 Score=67.98 Aligned_cols=62 Identities=13% Similarity=0.135 Sum_probs=28.6
Q ss_pred CeEEEEEcCC-CCcccc----cCccccCCCCCcEEEccCCCCccc----CcccccCCCCCCEEeccCCccc
Q 037905 39 ERVTMLRFPG-MGLSGQ----LPIAIGNLTELHTVSLRFNALRGT----IPSDFAKLSNLRNLYLQGNLFS 100 (606)
Q Consensus 39 ~~l~~L~L~~-n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 100 (606)
++|+.|+|++ +.|+.. +-.++...++|++|+|++|.|+.. +-..+...++|+.|++++|.+.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 4555555554 234321 122344555555555555555421 1122334455555555555554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.29 E-value=0.00036 Score=69.98 Aligned_cols=74 Identities=8% Similarity=0.074 Sum_probs=45.1
Q ss_pred cccccCCceEEEEEEEcC-CcEEEEEEeccC--------ccCHHHHHHHHHHHcCC-CC--CCcccceEEEEeCCceEEE
Q 037905 323 EVLGKGTFGTAYKATLEM-GIVVAVKRLKDV--------TVSEKEFREKMEVVGSM-DH--ENLVPLRAYYYSRDEKLLV 390 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--------~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~lv 390 (606)
+.||.|....||+.+..+ ++.++||.-... ..+......|.+.++.+ .+ ..+.+++. .+.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 468999999999998543 678888864321 11223345566666544 22 23444443 356677899
Q ss_pred EeecCCCC
Q 037905 391 HDYMPMGS 398 (606)
Q Consensus 391 ~e~~~~g~ 398 (606)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.15 E-value=2.5e-05 Score=68.53 Aligned_cols=115 Identities=18% Similarity=0.196 Sum_probs=78.0
Q ss_pred ccccCCCCCcEEEccC-CCCcc----cCcccccCCCCCCEEeccCCcccccCC----ccccCCCCCcEEecCCCcCCcc-
Q 037905 57 IAIGNLTELHTVSLRF-NALRG----TIPSDFAKLSNLRNLYLQGNLFSGEIP----GLLFSLGNLIRLNLAKNNFSGT- 126 (606)
Q Consensus 57 ~~l~~l~~L~~L~L~~-N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~l~~N~l~~~- 126 (606)
....+.++|++|+|++ |.|+. .+-..+...++|+.|+|++|.++...- ..+...++|+.|++++|.+...
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g 90 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 90 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchh
Confidence 3445678999999997 56762 233445678899999999999874322 2355678899999999988632
Q ss_pred ---cchhhhcCCCcceeec--ccccccc-----cCCCCCCCCCCCEEEccCCcCc
Q 037905 127 ---ISADFNKLTRLGTLYL--QENQLTG-----SIPDLGAFSSLAQFNVSFNKLN 171 (606)
Q Consensus 127 ---~p~~~~~l~~L~~L~l--~~N~l~~-----~~~~~~~l~~L~~L~l~~N~l~ 171 (606)
+-..+...++|+.++| ++|.+.. +...+...++|+.|+++.|...
T Consensus 91 ~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 91 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 2245567788886555 5666643 1112446788888888777543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.95 E-value=0.002 Score=62.53 Aligned_cols=67 Identities=10% Similarity=0.044 Sum_probs=47.2
Q ss_pred eEEEEEEEcCCcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCc-----ccc--eEEEEeCCceEEEEeecCCC
Q 037905 331 GTAYKATLEMGIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENL-----VPL--RAYYYSRDEKLLVHDYMPMG 397 (606)
Q Consensus 331 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~l--~~~~~~~~~~~lv~e~~~~g 397 (606)
-.||+++.++|..+++|+.+....+.+++..|...+..+....+ +.. -..+...+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 58999999999999999988777778888888887766532211 111 11223456678899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.11 E-value=0.0072 Score=60.10 Aligned_cols=72 Identities=13% Similarity=0.155 Sum_probs=47.6
Q ss_pred cccccCCceEEEEEEEcC--------CcEEEEEEeccCccCHHHHHHHHHHHcCCCCCCcc-cceEEEEeCCceEEEEee
Q 037905 323 EVLGKGTFGTAYKATLEM--------GIVVAVKRLKDVTVSEKEFREKMEVVGSMDHENLV-PLRAYYYSRDEKLLVHDY 393 (606)
Q Consensus 323 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~ 393 (606)
+.|+.|-.-.+|+++..+ ...|.+++... ........+|..+++.+.-.++. ++++++. -.+|+||
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~ef 122 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEEY 122 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEECC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEEE
Confidence 457888889999998653 35677777663 33344556788777766433444 5666652 2689999
Q ss_pred cCCCCh
Q 037905 394 MPMGSL 399 (606)
Q Consensus 394 ~~~g~L 399 (606)
++|..+
T Consensus 123 i~g~~l 128 (395)
T d1nw1a_ 123 IPSRPL 128 (395)
T ss_dssp CCEEEC
T ss_pred eccccC
Confidence 987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.50 E-value=0.082 Score=50.09 Aligned_cols=28 Identities=18% Similarity=0.234 Sum_probs=24.7
Q ss_pred CCCCCCCCCCEEecCCCcEEEeecccCc
Q 037905 440 NSHGNIKSSNILLSKSYEARISDFGLAH 467 (606)
Q Consensus 440 i~HrDlkp~Nill~~~~~~kl~DfG~a~ 467 (606)
+||+|+.++||+++.+...-|.||+.+.
T Consensus 185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 185 VIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCcchhhhhcccccceeEecccccc
Confidence 5699999999999998777899999764
|